Citrus Sinensis ID: 022617

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290----
Protein Sequence
MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKVG
Secondary Structure (PSIPRED)
ccccccccccccccccccEEEEEEEEcccEEEEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEcccccccccccccEEcccccccccccHHcccccccccccccHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccccccccccccccHHHEEEEEEEEEEccEEEEEEEEccccEEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEccccccHHHccHHHHcccccccccEEHHHHHHHHHHHHHcccccccccHHHHHHHHHcccEEccccccHcHHHHHHHHccccHcccccHHHHHccccHcccccHHccccccccHHHHcccc
Coil and Loop (DISEMBL)
mdgasnrsssgvdmflpnyklgktlgigsfGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYevietpsdIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYchrnmvvhrdlkpenllldskwnvkiadfglsnimrdghflktscgspnyaapevisgklyagpevdvwsCGVILYALLcgtlpfddenipNLFKKIkggiytlpshlspgardliprmlivdpmkritipeirqhpwfqahlprylavpppdtmqqakkvg
Flexible Loop (DISEMBL)
mdgasnrsssgvdmFLPNYKLGKTLGIGSFGKVKIAehaltghkvaikilnrrkiknmemeeKVRREIKILRLFMHPHIIRLyevietpsdIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGiytlpshlspgarDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKVG
Low Complexity Region (SEG)
MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKVG
Disordered region (IsUnstruct)
************DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAV*************
Disordered Region (DISOPRED)
******************YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAV*************
Disordered Region (DISEMBL)
**********GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP**********
Disordered Region (DISPRO)
*************MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDT*Q******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKVG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	294	2.2.26 [Sep-21-2011]
Q38997	535	SNF1-related protein kina	yes	no	0.996	0.547	0.938	1e-165
P92958	512	SNF1-related protein kina	no	no	1.0	0.574	0.908	1e-157
Q02723	502	Carbon catabolite-derepre	N/A	no	0.979	0.573	0.753	1e-127
Q54YF2	727	5'-AMP-activated serine/t	yes	no	0.901	0.364	0.729	1e-114
Q8BRK8	552	5'-AMP-activated protein	yes	no	0.891	0.474	0.679	1e-110
Q5RD00	552	5'-AMP-activated protein	yes	no	0.891	0.474	0.683	1e-110
Q09137	552	5'-AMP-activated protein	yes	no	0.891	0.474	0.679	1e-109
P54646	552	5'-AMP-activated protein	yes	no	0.891	0.474	0.679	1e-109
Q28948	552	5'-AMP-activated protein	no	no	0.891	0.474	0.679	1e-109
Q5RDH5	554	5'-AMP-activated protein	no	no	0.891	0.472	0.687	1e-109

>sp|Q38997|KIN10_ARATH SNF1-related protein kinase catalytic subunit alpha KIN10 OS=Arabidopsis thaliana GN=KIN10 PE=1 SV=2

 Score =  579 bits (1493), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 275/293 (93%), Positives = 285/293 (97%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG+   S SGV+  LPNYKLG+TLGIGSFG+VKIAEHALTGHKVAIKILNRRKIKNMEM
Sbjct: 24  MDGSGTGSRSGVESILPNYKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEM 83

Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
           EEKVRREIKILRLFMHPHIIRLYEVIETP+DIY+VMEYV SGELFDYIVEKGRLQEDEAR
Sbjct: 84  EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEAR 143

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 144 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 203

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 204 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 263

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           SPGARDLIPRML+VDPMKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKK+
Sbjct: 264 SPGARDLIPRMLVVDPMKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKI 316

Catalytic subunit of the probable trimeric SNF1-related protein kinase (SnRK) complex, which may play a role in a signal transduction cascade regulating gene expression and carbohydrate metabolism in higher plants. The SnRK complex may also be involved in the regulation of fatty acid synthesis by phosphorylation of acetyl-CoA carboxylase and in assimilation of nitrogen by phosphorylating nitrate reductase. In vitro, KIN10 exhibits kinase activity on sucrose phosphate synthase and the kinase activity is inhibited by PRL1. May be a subunit of a SCF ubiquitin ligase complex and thus be involved in proteasomal ubiquitination.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P92958|KIN11_ARATH SNF1-related protein kinase catalytic subunit alpha KIN11 OS=Arabidopsis thaliana GN=KIN11 PE=1 SV=1

 Score =  555 bits (1431), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 268/295 (90%), Positives = 280/295 (94%), Gaps = 1/295 (0%)

Query: 1   MDGASNR-SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME 59
           MD +SNR  ++GV+  LPNYKLGKTLGIGSFGKVKIAEH +TGHKVAIKILNRRKIKNME
Sbjct: 1   MDHSSNRFGNNGVESILPNYKLGKTLGIGSFGKVKIAEHVVTGHKVAIKILNRRKIKNME 60

Query: 60  MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
           MEEKVRREIKILRLFMHPHIIR YEVIET SDIYVVMEYVKSGELFDYIVEKGRLQEDEA
Sbjct: 61  MEEKVRREIKILRLFMHPHIIRQYEVIETTSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 120

Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
           RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS+ N+KIADFGLSN+MRDGHFLKTSCGS
Sbjct: 121 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSRCNIKIADFGLSNVMRDGHFLKTSCGS 180

Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239
           PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH
Sbjct: 181 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 240

Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKVG 294
           LS  ARDLIPRMLIVDP+KRITIPEIRQH WFQ HLPRYLAV PPDT++QAKK+ 
Sbjct: 241 LSSEARDLIPRMLIVDPVKRITIPEIRQHRWFQTHLPRYLAVSPPDTVEQAKKIN 295

Catalytic subunit of the probable trimeric SNF1-related protein kinase (SnRK) complex, which may play a role in a signal transduction cascade regulating gene expression and carbohydrate metabolism in higher plants. The SnRK complex may also be involved in the regulation of fatty acid synthesis by phosphorylation of acetyl-CoA carboxylase and in assimilation of nitrogen by phosphorylating nitrate reductase. In vitro, KIN11 exhibits kinase activity on sucrose phosphate synthase and the kinase activity is inhibited by PRL1. May be a subunit of a SCF ubiquitin ligase complex and thus be involved in proteasomal ubiquitination. Involved in innate antiviral defenses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q02723|RKIN1_SECCE Carbon catabolite-derepressing protein kinase OS=Secale cereale GN=RKIN1 PE=2 SV=1

 Score =  455 bits (1170), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 223/296 (75%), Positives = 247/296 (83%), Gaps = 8/296 (2%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG    S +     L NY LGK LG+G+F KV IAEH  T HKVAIK+LNRR+++  EM
Sbjct: 1   MDGGGEHSEA-----LKNYYLGKILGVGTFAKVIIAEHKHTRHKVAIKVLNRRQMRAPEM 55

Query: 61  EEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQED 117
           EEK +REIKILRLF+   HPHIIR+YEVI TP DI+VVMEY ++G+L DYI+EK RLQED
Sbjct: 56  EEKAKREIKILRLFIDLIHPHIIRVYEVIVTPKDIFVVMEYCQNGDLLDYILEKRRLQED 115

Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177
           EAR  FQQIIS VEYCHRN VVHRDLKPENLLLDSK+NVK+ADFGLSN+M DGHFLKTSC
Sbjct: 116 EARRTFQQIISAVEYCHRNKVVHRDLKPENLLLDSKYNVKLADFGLSNVMHDGHFLKTSC 175

Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP 237
           GS NYAAPEVISGKLYAGPE+DVWSCGVILYALLCG +PFDD+NIPNLFKKIKGG Y LP
Sbjct: 176 GSLNYAAPEVISGKLYAGPEIDVWSCGVILYALLCGAVPFDDDNIPNLFKKIKGGTYILP 235

Query: 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
            +LS   RDLI RMLIVDPMKRITI EIR+H WFQ  LPRYLAVPPPD MQQAK +
Sbjct: 236 IYLSDLVRDLISRMLIVDPMKRITIGEIRKHSWFQNRLPRYLAVPPPDMMQQAKMI 291

Essential for release from glucose repression.

Secale cereale (taxid: 4550)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54YF2|AMPKA_DICDI 5'-AMP-activated serine/threonine-protein kinase catalytic subunit alpha OS=Dictyostelium discoideum GN=snfA PE=2 SV=1

 Score =  411 bits (1057), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 194/266 (72%), Positives = 229/266 (86%), Gaps = 1/266 (0%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY+L KTLGIGSFGKVK+AEH  TG KVAIKILNR KIKN++M+EK+RREI+ ++LF HP
Sbjct: 30  NYRLDKTLGIGSFGKVKLAEHIRTGVKVAIKILNRTKIKNLKMDEKIRREIQNMKLFRHP 89

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LYEVIET +DI++VMEYV  GELF+YIV+ G+L EDE+R  FQQ+ISGV+YCH +M
Sbjct: 90  HIIKLYEVIETTTDIFMVMEYVTGGELFEYIVKNGKLLEDESRRLFQQMISGVDYCHHHM 149

Query: 138 VVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
           VVHRDLKPENLLLD     +KIADFGLSN+M+DG FLKTSCGSPNYAAPEVISGKLYAGP
Sbjct: 150 VVHRDLKPENLLLDPINKCIKIADFGLSNMMQDGDFLKTSCGSPNYAAPEVISGKLYAGP 209

Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
           EVDVWSCGVILYA LC  LPFDDE+IP LFKKI+ G++++P  +SP   DLI +ML+VDP
Sbjct: 210 EVDVWSCGVILYAFLCAKLPFDDESIPMLFKKIREGVFSIPDFVSPSCADLIKKMLVVDP 269

Query: 257 MKRITIPEIRQHPWFQAHLPRYLAVP 282
           +KRITI EIR HPWFQ  LP+YL+ P
Sbjct: 270 VKRITIHEIRNHPWFQVKLPKYLSSP 295

Activated enzyme phosphorylates target proteins and initiates downstream signaling pathways that shift metabolism from anabolic to catabolic pathways. Acts as a highly sensitive cellular energy sensor.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8BRK8|AAPK2_MOUSE 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Mus musculus GN=Prkaa2 PE=1 SV=3

 Score =  397 bits (1019), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 178/262 (67%), Positives = 223/262 (85%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct: 15  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct: 75  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEVEARRLFQQILSAVDYCHRHM 134

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           VVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPDYLNRSVATLLMHMLQVDPL 254

Query: 258 KRITIPEIRQHPWFQAHLPRYL 279
           KR TI +IR+H WF+  LP YL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYL 276

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5RD00|AAPK2_PONAB 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Pongo abelii GN=PRKAA2 PE=2 SV=1

 Score =  397 bits (1019), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 179/262 (68%), Positives = 222/262 (84%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct: 15  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct: 75  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           VVHRDLKPEN+LLD+  N KIADFGLSNIM DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAHMNAKIADFGLSNIMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254

Query: 258 KRITIPEIRQHPWFQAHLPRYL 279
           KR TI +IR+H WF+  LP YL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYL 276

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Pongo abelii (taxid: 9601)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09137|AAPK2_RAT 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Rattus norvegicus GN=Prkaa2 PE=1 SV=1

 Score =  396 bits (1017), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 178/262 (67%), Positives = 223/262 (85%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct: 15  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct: 75  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEVEARRLFQQILSAVDYCHRHM 134

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           VVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSIATLLMHMLQVDPL 254

Query: 258 KRITIPEIRQHPWFQAHLPRYL 279
           KR TI +IR+H WF+  LP YL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYL 276

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens GN=PRKAA2 PE=1 SV=2

 Score =  395 bits (1016), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 178/262 (67%), Positives = 222/262 (84%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct: 15  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct: 75  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           VVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254

Query: 258 KRITIPEIRQHPWFQAHLPRYL 279
           KR TI +IR+H WF+  LP YL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYL 276

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q28948|AAPK2_PIG 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Sus scrofa GN=PRKAA2 PE=2 SV=2

 Score =  395 bits (1015), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 178/262 (67%), Positives = 223/262 (85%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct: 15  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct: 75  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           VVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254

Query: 258 KRITIPEIRQHPWFQAHLPRYL 279
           KR TI +IR+H WF+  LP YL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYL 276

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Sus scrofa (taxid: 9823)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5RDH5|AAPK1_PONAB 5'-AMP-activated protein kinase catalytic subunit alpha-1 (Fragment) OS=Pongo abelii GN=PRKAA1 PE=2 SV=2

 Score =  395 bits (1014), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 180/262 (68%), Positives = 221/262 (84%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y LG TLG+G+FGKVK+ +H LTGHKVA+KILNR+KI+++++  K+RREI+ L+LF HP
Sbjct: 21  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 80

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI TPSDI++VMEYV  GELFDYI + GRL E E+R  FQQI+SGV+YCHR+M
Sbjct: 81  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 140

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           VVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 141 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 200

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WS GVILYALLCGTLPFDD+++P LFKKI  GI+  P +L+P    L+  ML VDPM
Sbjct: 201 VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPM 260

Query: 258 KRITIPEIRQHPWFQAHLPRYL 279
           KR TI +IR+H WF+  LP+YL
Sbjct: 261 KRATIKDIREHEWFKQDLPKYL 282

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Pongo abelii (taxid: 9601)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 6

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	294
224080209	515	predicted protein [Populus trichocarpa]	0.996	0.568	0.955	1e-165
356568694	514	PREDICTED: SNF1-related protein kinase c	0.996	0.570	0.945	1e-163
451353779	514	alpha subunit of SnRK1 [Solanum berthaul	0.996	0.570	0.941	1e-163
255578302	468	5-AMP-activated protein kinase, putative	0.996	0.626	0.948	1e-163
30678280	535	SNF1-related protein kinase catalytic su	0.996	0.547	0.938	1e-163
18395701	512	SNF1-related protein kinase catalytic su	0.996	0.572	0.938	1e-163
350535933	514	SNF1 protein [Solanum lycopersicum] gi|7	0.996	0.570	0.938	1e-162
356526455	510	PREDICTED: SNF1-related protein kinase c	0.996	0.574	0.938	1e-162
222422903	512	AT3G01090 [Arabidopsis thaliana]	0.996	0.572	0.935	1e-162
449454522	515	PREDICTED: SNF1-related protein kinase c	0.996	0.568	0.945	1e-162

>gi|224080209|ref|XP_002306053.1| predicted protein [Populus trichocarpa] gi|222849017|gb|EEE86564.1| predicted protein [Populus trichocarpa]

 Score =  586 bits (1510), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 280/293 (95%), Positives = 287/293 (97%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG+S R SS VDM+L NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM+M
Sbjct: 1   MDGSSYRGSSSVDMYLANYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMDM 60

Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
           EEKVRREIKILRLFMHPHIIRLYEVIETP+DIYVVMEYVKSGELFDYIVEKGRLQEDEAR
Sbjct: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           SPGARDLIPRML+VDPMKR+TIPEIRQH WFQA LPRYLAVPPPDTMQQAKK+
Sbjct: 241 SPGARDLIPRMLVVDPMKRMTIPEIRQHQWFQARLPRYLAVPPPDTMQQAKKI 293

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356568694|ref|XP_003552545.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Glycine max]

 Score =  581 bits (1497), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 277/293 (94%), Positives = 285/293 (97%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG + R  +G+DMFLPNYKLGKTLGIGSFGKVKIAEH LTGHKVAIKILNRRKIKNMEM
Sbjct: 1   MDGPAGRGGAGLDMFLPNYKLGKTLGIGSFGKVKIAEHVLTGHKVAIKILNRRKIKNMEM 60

Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
           EEKVRREIKILRLFMHPHIIRLYEVIETP+DIYVVMEYVKSGELFDYIVEKGRLQEDEAR
Sbjct: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 180

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           SPGARDLIP ML+VDPM+R+TIPEIRQHPWFQA LPRYLAVPPPDTMQQAKK+
Sbjct: 241 SPGARDLIPGMLVVDPMRRMTIPEIRQHPWFQARLPRYLAVPPPDTMQQAKKI 293

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|451353779|gb|AGF39571.1| alpha subunit of SnRK1 [Solanum berthaultii]

 Score =  580 bits (1496), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 276/293 (94%), Positives = 284/293 (96%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG + + +S VD FL NYKLGKTLGIGSFGKVKIAEH LTGHKVA+KILNRRKI+NM+M
Sbjct: 1   MDGTAVQGTSSVDSFLRNYKLGKTLGIGSFGKVKIAEHTLTGHKVAVKILNRRKIRNMDM 60

Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
           EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR
Sbjct: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           S GARDLIPRMLIVDPMKR+TIPEIR HPWFQAHLPRYLAVPPPDTMQQAKK+
Sbjct: 241 SAGARDLIPRMLIVDPMKRMTIPEIRLHPWFQAHLPRYLAVPPPDTMQQAKKI 293

Source: Solanum berthaultii

Species: Solanum berthaultii

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255578302|ref|XP_002530018.1| 5-AMP-activated protein kinase, putative [Ricinus communis] gi|223530497|gb|EEF32380.1| 5-AMP-activated protein kinase, putative [Ricinus communis]

 Score =  579 bits (1493), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 278/293 (94%), Positives = 285/293 (97%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG+S+R  S  D+FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM
Sbjct: 1   MDGSSHRGGSSADVFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60

Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
           EEKVRREIKILRLFMHPHIIRLYEVIET +DIYVVMEYVKSGELFDYIVEKGRLQEDEAR
Sbjct: 61  EEKVRREIKILRLFMHPHIIRLYEVIETSTDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 180

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           SPGARDLIPRML+VDPMKR+TIPEIR HPWFQA LPRYLAVPPPDTMQQAKK+
Sbjct: 241 SPGARDLIPRMLVVDPMKRMTIPEIRLHPWFQARLPRYLAVPPPDTMQQAKKI 293

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30678280|ref|NP_850488.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana] gi|38503401|sp|Q38997.2|KIN10_ARATH RecName: Full=SNF1-related protein kinase catalytic subunit alpha KIN10; Short=AKIN10; AltName: Full=AKIN alpha-2; Short=AKINalpha2 gi|20260542|gb|AAM13169.1| putative SNF1-related protein kinase [Arabidopsis thaliana] gi|34098893|gb|AAQ56829.1| At3g01090 [Arabidopsis thaliana] gi|332640087|gb|AEE73608.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana]

 Score =  579 bits (1493), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 275/293 (93%), Positives = 285/293 (97%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG+   S SGV+  LPNYKLG+TLGIGSFG+VKIAEHALTGHKVAIKILNRRKIKNMEM
Sbjct: 24  MDGSGTGSRSGVESILPNYKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEM 83

Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
           EEKVRREIKILRLFMHPHIIRLYEVIETP+DIY+VMEYV SGELFDYIVEKGRLQEDEAR
Sbjct: 84  EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEAR 143

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 144 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 203

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 204 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 263

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           SPGARDLIPRML+VDPMKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKK+
Sbjct: 264 SPGARDLIPRMLVVDPMKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKI 316

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18395701|ref|NP_566130.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana] gi|186509642|ref|NP_001118546.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana] gi|6714479|gb|AAF26165.1|AC008261_22 putative SNF1-related protein kinase [Arabidopsis thaliana] gi|166600|gb|AAA32736.1| SNF1-related protein kinase [Arabidopsis thaliana] gi|1742969|emb|CAA64384.1| ser/thr protein kinase [Arabidopsis thaliana] gi|111609954|gb|ABH11527.1| SNR2 [Arabidopsis thaliana] gi|332640086|gb|AEE73607.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana] gi|332640088|gb|AEE73609.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana]

 Score =  578 bits (1491), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 275/293 (93%), Positives = 285/293 (97%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG+   S SGV+  LPNYKLG+TLGIGSFG+VKIAEHALTGHKVAIKILNRRKIKNMEM
Sbjct: 1   MDGSGTGSRSGVESILPNYKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEM 60

Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
           EEKVRREIKILRLFMHPHIIRLYEVIETP+DIY+VMEYV SGELFDYIVEKGRLQEDEAR
Sbjct: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEAR 120

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 180

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           SPGARDLIPRML+VDPMKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKK+
Sbjct: 241 SPGARDLIPRMLVVDPMKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKI 293

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350535933|ref|NP_001233965.1| SNF1 protein [Solanum lycopersicum] gi|7672782|gb|AAF66639.1|AF143743_1 SNF1 [Solanum lycopersicum]

 Score =  578 bits (1490), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 275/293 (93%), Positives = 283/293 (96%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG + + +S VD FL NYKLGKTLGIGSFGKVKIAEH LTGHKVA+KILNRRKI+NM+M
Sbjct: 1   MDGTAVQGTSSVDSFLRNYKLGKTLGIGSFGKVKIAEHTLTGHKVAVKILNRRKIRNMDM 60

Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
           EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR
Sbjct: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           S GARDLIPRMLIVDPMKR+TIPEIR HPWFQAHLPRYLAVPPPDT QQAKK+
Sbjct: 241 SAGARDLIPRMLIVDPMKRMTIPEIRLHPWFQAHLPRYLAVPPPDTTQQAKKI 293

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356526455|ref|XP_003531833.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Glycine max]

 Score =  577 bits (1486), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 275/293 (93%), Positives = 283/293 (96%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG + R  +G+DMFLPNYKLGKTLGIGSFGKVKIAEH LTGHKVAIKILNRRKIKNMEM
Sbjct: 1   MDGPAGRGGAGLDMFLPNYKLGKTLGIGSFGKVKIAEHVLTGHKVAIKILNRRKIKNMEM 60

Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
           EEKVRREIKILRLFMHPHIIRLYEVIETP+DIY VMEYVKSGELFDYIVEKGRLQEDEAR
Sbjct: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYFVMEYVKSGELFDYIVEKGRLQEDEAR 120

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 180

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           SP ARDLIP ML+VDPM+R+TIPEIRQHPWFQA LPRYLAVPPPDTMQQAKK+
Sbjct: 241 SPNARDLIPGMLVVDPMRRMTIPEIRQHPWFQARLPRYLAVPPPDTMQQAKKI 293

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|222422903|dbj|BAH19438.1| AT3G01090 [Arabidopsis thaliana]

 Score =  577 bits (1486), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 274/293 (93%), Positives = 285/293 (97%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG+   S SGV+  LPNYKLG+TLGIGSFG+VKIAEHALTGHKVAIKILNRRKIKNMEM
Sbjct: 1   MDGSGTGSRSGVESILPNYKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEM 60

Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
           EEKVRREIKILRLFMHPHIIRLY+VIETP+DIY+VMEYV SGELFDYIVEKGRLQEDEAR
Sbjct: 61  EEKVRREIKILRLFMHPHIIRLYKVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEAR 120

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 180

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           SPGARDLIPRML+VDPMKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKK+
Sbjct: 241 SPGARDLIPRMLVVDPMKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKI 293

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449454522|ref|XP_004145003.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Cucumis sativus] gi|449474166|ref|XP_004154092.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Cucumis sativus] gi|449498915|ref|XP_004160670.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Cucumis sativus]

 Score =  576 bits (1485), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 277/293 (94%), Positives = 285/293 (97%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           MDG + RS  G+DM +PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN++M
Sbjct: 1   MDGPTGRSGGGMDMNVPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNLDM 60

Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
           EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR
Sbjct: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 180

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           S GAR+LIP ML+VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK+
Sbjct: 241 SSGARELIPSMLVVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKI 293

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	294
TAIR|locus:2102132	535	KIN10 "AT3G01090" [Arabidopsis	0.996	0.547	0.938	4.2e-150
TAIR|locus:2094672	512	KIN11 "SNF1 kinase homolog 11"	0.996	0.572	0.911	3.6e-144
TAIR|locus:2175663	494	SnRK1.3 "SNF1-related protein	0.993	0.591	0.781	7e-125
DICTYBASE|DDB_G0277905	727	snfA "AMP-activated protein ki	0.931	0.376	0.705	1.1e-105
FB|FBgn0023169	582	SNF1A "SNF1A/AMP-activated pro	0.962	0.486	0.655	2.3e-101
UNIPROTKB|Q5RD00	552	PRKAA2 "5'-AMP-activated prote	0.908	0.483	0.674	6.2e-101
UNIPROTKB|Q28948	552	PRKAA2 "5'-AMP-activated prote	0.908	0.483	0.670	7.9e-101
MGI|MGI:1336173	552	Prkaa2 "protein kinase, AMP-ac	0.908	0.483	0.670	7.9e-101
RGD|620893	552	Prkaa2 "protein kinase, AMP-ac	0.908	0.483	0.670	1e-100
UNIPROTKB|P54646	552	PRKAA2 "5'-AMP-activated prote	0.908	0.483	0.670	1.3e-100

TAIR|locus:2102132 KIN10 "AT3G01090" [Arabidopsis thaliana (taxid:3702)]

 Score = 1465 (520.8 bits), Expect = 4.2e-150, P = 4.2e-150
 Identities = 275/293 (93%), Positives = 285/293 (97%)

Query:     1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
             MDG+   S SGV+  LPNYKLG+TLGIGSFG+VKIAEHALTGHKVAIKILNRRKIKNMEM
Sbjct:    24 MDGSGTGSRSGVESILPNYKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEM 83

Query:    61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
             EEKVRREIKILRLFMHPHIIRLYEVIETP+DIY+VMEYV SGELFDYIVEKGRLQEDEAR
Sbjct:    84 EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEAR 143

Query:   121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
             NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct:   144 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 203

Query:   181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
             NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct:   204 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 263

Query:   241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
             SPGARDLIPRML+VDPMKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKK+
Sbjct:   264 SPGARDLIPRMLVVDPMKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKI 316

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0000152 "nuclear ubiquitin ligase complex" evidence=IPI

GO:0003006 "developmental process involved in reproduction" evidence=IMP

GO:0010050 "vegetative phase change" evidence=IMP

GO:0010260 "organ senescence" evidence=IMP

GO:0080022 "primary root development" evidence=IMP

GO:0009594 "detection of nutrient" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0010182 "sugar mediated signaling pathway" evidence=IMP

GO:0006007 "glucose catabolic process" evidence=RCA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2094672 KIN11 "SNF1 kinase homolog 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1409 (501.1 bits), Expect = 3.6e-144, P = 3.6e-144
 Identities = 268/294 (91%), Positives = 280/294 (95%)

Query:     1 MDGASNR-SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME 59
             MD +SNR  ++GV+  LPNYKLGKTLGIGSFGKVKIAEH +TGHKVAIKILNRRKIKNME
Sbjct:     1 MDHSSNRFGNNGVESILPNYKLGKTLGIGSFGKVKIAEHVVTGHKVAIKILNRRKIKNME 60

Query:    60 MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
             MEEKVRREIKILRLFMHPHIIR YEVIET SDIYVVMEYVKSGELFDYIVEKGRLQEDEA
Sbjct:    61 MEEKVRREIKILRLFMHPHIIRQYEVIETTSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 120

Query:   120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
             RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS+ N+KIADFGLSN+MRDGHFLKTSCGS
Sbjct:   121 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSRCNIKIADFGLSNVMRDGHFLKTSCGS 180

Query:   180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239
             PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH
Sbjct:   181 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 240

Query:   240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
             LS  ARDLIPRMLIVDP+KRITIPEIRQH WFQ HLPRYLAV PPDT++QAKK+
Sbjct:   241 LSSEARDLIPRMLIVDPVKRITIPEIRQHRWFQTHLPRYLAVSPPDTVEQAKKI 294

GO:0004672 "protein kinase activity" evidence=IEA;ISS;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2175663 SnRK1.3 "SNF1-related protein kinase 1.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1227 (437.0 bits), Expect = 7.0e-125, P = 7.0e-125
 Identities = 229/293 (78%), Positives = 260/293 (88%)

Query:     1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
             MDG+S ++++ +   LPNY++GKTLG GSF KVK+A H  TGHKVAIKILNR KIKNM +
Sbjct:     1 MDGSSEKTTNKLVSILPNYRIGKTLGHGSFAKVKLALHVATGHKVAIKILNRSKIKNMGI 60

Query:    61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
             E KV+REIKILR  MHPHIIR YEVIETP+DIYVVMEYVKSGELFDYIVEKG+LQEDEAR
Sbjct:    61 EIKVQREIKILRFLMHPHIIRQYEVIETPNDIYVVMEYVKSGELFDYIVEKGKLQEDEAR 120

Query:   121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
             + FQQIISGVEYCHRNM+VHRDLKPEN+LLDS+ N+KI DFGLSN+M DGHFLKTSCGSP
Sbjct:   121 HLFQQIISGVEYCHRNMIVHRDLKPENVLLDSQCNIKIVDFGLSNVMHDGHFLKTSCGSP 180

Query:   181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
             NYAAPEVISGK Y GP+VD+WSCGVILYALLCGTLPFDDENIPN+F+KIK G+YTLP+HL
Sbjct:   181 NYAAPEVISGKPY-GPDVDIWSCGVILYALLCGTLPFDDENIPNVFEKIKRGMYTLPNHL 239

Query:   241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
             S  ARDLIPRML+VDP  RI+I EIRQHPWF  HLP YL++PP DT+ QAKK+
Sbjct:   240 SHFARDLIPRMLMVDPTMRISITEIRQHPWFNNHLPLYLSIPPLDTIDQAKKI 292

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030003 "cellular cation homeostasis" evidence=RCA

DICTYBASE|DDB_G0277905 snfA "AMP-activated protein kinase alpha subunit" [Dictyostelium discoideum (taxid:44689)]

 Score = 1046 (373.3 bits), Expect = 1.1e-105, P = 1.1e-105
 Identities = 196/278 (70%), Positives = 234/278 (84%)

Query:     9 SSGVD---MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR 65
             S G++     + NY+L KTLGIGSFGKVK+AEH  TG KVAIKILNR KIKN++M+EK+R
Sbjct:    18 SGGIEKSSQIIGNYRLDKTLGIGSFGKVKLAEHIRTGVKVAIKILNRTKIKNLKMDEKIR 77

Query:    66 REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
             REI+ ++LF HPHII+LYEVIET +DI++VMEYV  GELF+YIV+ G+L EDE+R  FQQ
Sbjct:    78 REIQNMKLFRHPHIIKLYEVIETTTDIFMVMEYVTGGELFEYIVKNGKLLEDESRRLFQQ 137

Query:   126 IISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA 184
             +ISGV+YCH +MVVHRDLKPENLLLD     +KIADFGLSN+M+DG FLKTSCGSPNYAA
Sbjct:   138 MISGVDYCHHHMVVHRDLKPENLLLDPINKCIKIADFGLSNMMQDGDFLKTSCGSPNYAA 197

Query:   185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA 244
             PEVISGKLYAGPEVDVWSCGVILYA LC  LPFDDE+IP LFKKI+ G++++P  +SP  
Sbjct:   198 PEVISGKLYAGPEVDVWSCGVILYAFLCAKLPFDDESIPMLFKKIREGVFSIPDFVSPSC 257

Query:   245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 282
              DLI +ML+VDP+KRITI EIR HPWFQ  LP+YL+ P
Sbjct:   258 ADLIKKMLVVDPVKRITIHEIRNHPWFQVKLPKYLSSP 295

GO:0046956 "positive phototaxis" evidence=IMP

GO:0008283 "cell proliferation" evidence=IMP

GO:0007005 "mitochondrion organization" evidence=IMP

GO:0006754 "ATP biosynthetic process" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0007165 "signal transduction" evidence=ISS

GO:0004679 "AMP-activated protein kinase activity" evidence=ISS

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

FB|FBgn0023169 SNF1A "SNF1A/AMP-activated protein kinase" [Drosophila melanogaster (taxid:7227)]

 Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
 Identities = 188/287 (65%), Positives = 235/287 (81%)

Query:     8 SSSGVDMF-LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR 66
             S++G  +  + +Y LG TLG G+FGKVKI EH +T  KVA+KILNR+KIK++++  K+RR
Sbjct:    16 SANGQPLVKIGHYLLGATLGTGTFGKVKIGEHQITRVKVAVKILNRQKIKSLDVVGKIRR 75

Query:    67 EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQI 126
             EI+ L+LF HPHII+LY+VI TPSDI+++MEYV  GELFDYIV+ G+LQE +AR FFQQI
Sbjct:    76 EIQNLKLFRHPHIIKLYQVISTPSDIFMIMEYVSGGELFDYIVKHGKLQEHQARRFFQQI 135

Query:   127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             ISGV+YCHR+M+VHRDLKPENLLLD   +VKIADFGLSN+M DG FL+TSCGSPNYAAPE
Sbjct:   136 ISGVDYCHRHMIVHRDLKPENLLLDHNMHVKIADFGLSNMMLDGEFLRTSCGSPNYAAPE 195

Query:   187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARD 246
             VISGKLYAGPEVD+WSCGVILYALLCGTLPFDDE++P LF+KIK GI+ +P +L+    +
Sbjct:   196 VISGKLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFRKIKSGIFPIPEYLNKQVVN 255

Query:   247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
             L+ +ML VDP+KR  I EI++H WFQ  LP YL    P +++Q   V
Sbjct:   256 LVCQMLQVDPLKRANIEEIKKHEWFQKDLPAYLF---PSSIEQDSNV 299

GO:0006468 "protein phosphorylation" evidence=ISS;IMP;NAS

GO:0004703 "G-protein coupled receptor kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;NAS

GO:0004679 "AMP-activated protein kinase activity" evidence=IMP

GO:0005634 "nucleus" evidence=IDA

GO:0031588 "AMP-activated protein kinase complex" evidence=IC

GO:0005524 "ATP binding" evidence=IEA

GO:0006911 "phagocytosis, engulfment" evidence=IMP

GO:0045197 "establishment or maintenance of epithelial cell apical/basal polarity" evidence=IMP

GO:0000278 "mitotic cell cycle" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0044058 "regulation of digestive system process" evidence=IMP

GO:0001558 "regulation of cell growth" evidence=IMP

GO:0042595 "behavioral response to starvation" evidence=IMP

GO:0030730 "sequestering of triglyceride" evidence=IMP

GO:0009267 "cellular response to starvation" evidence=IMP

GO:0006629 "lipid metabolic process" evidence=IMP

GO:0007411 "axon guidance" evidence=IGI

GO:0042331 "phototaxis" evidence=IGI

UNIPROTKB|Q5RD00 PRKAA2 "5'-AMP-activated protein kinase catalytic subunit alpha-2" [Pongo abelii (taxid:9601)]

 Score = 1001 (357.4 bits), Expect = 6.2e-101, P = 6.2e-101
 Identities = 180/267 (67%), Positives = 223/267 (83%)

Query:    18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct:    15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74

Query:    78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct:    75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134

Query:   138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
             VVHRDLKPEN+LLD+  N KIADFGLSNIM DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct:   135 VVHRDLKPENVLLDAHMNAKIADFGLSNIMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194

Query:   198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
             VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct:   195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254

Query:   258 KRITIPEIRQHPWFQAHLPRYLAVPPP 284
             KR TI +IR+H WF+  LP YL    P
Sbjct:   255 KRATIKDIREHEWFKQDLPSYLFPEDP 281

GO:0003682 "chromatin binding" evidence=ISS

GO:0004679 "AMP-activated protein kinase activity" evidence=ISS

GO:0008610 "lipid biosynthetic process" evidence=ISS

GO:0010508 "positive regulation of autophagy" evidence=ISS

GO:0031669 "cellular response to nutrient levels" evidence=ISS

GO:0032007 "negative regulation of TOR signaling cascade" evidence=ISS

GO:0035174 "histone serine kinase activity" evidence=ISS

GO:0035404 "histone-serine phosphorylation" evidence=ISS

GO:0042149 "cellular response to glucose starvation" evidence=ISS

GO:0042593 "glucose homeostasis" evidence=ISS

GO:0042752 "regulation of circadian rhythm" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0045821 "positive regulation of glycolysis" evidence=ISS

GO:0055089 "fatty acid homeostasis" evidence=ISS

GO:2000505 "regulation of energy homeostasis" evidence=ISS

UNIPROTKB|Q28948 PRKAA2 "5'-AMP-activated protein kinase catalytic subunit alpha-2" [Sus scrofa (taxid:9823)]

 Score = 1000 (357.1 bits), Expect = 7.9e-101, P = 7.9e-101
 Identities = 179/267 (67%), Positives = 224/267 (83%)

Query:    18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct:    15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74

Query:    78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct:    75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134

Query:   138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
             VVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct:   135 VVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194

Query:   198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
             VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct:   195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254

Query:   258 KRITIPEIRQHPWFQAHLPRYLAVPPP 284
             KR TI +IR+H WF+  LP YL    P
Sbjct:   255 KRATIKDIREHEWFKQDLPSYLFPEDP 281

GO:0042593 "glucose homeostasis" evidence=ISS

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0050405 "[acetyl-CoA carboxylase

GO:0047322 "[hydroxymethylglutaryl-CoA reductase (NADPH)

GO:0048511 "rhythmic process" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0016568 "chromatin modification" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0006695 "cholesterol biosynthetic process" evidence=IEA

GO:0006633 "fatty acid biosynthetic process" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:1336173 Prkaa2 "protein kinase, AMP-activated, alpha 2 catalytic subunit" [Mus musculus (taxid:10090)]

 Score = 1000 (357.1 bits), Expect = 7.9e-101, P = 7.9e-101
 Identities = 179/267 (67%), Positives = 224/267 (83%)

Query:    18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct:    15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74

Query:    78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct:    75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEVEARRLFQQILSAVDYCHRHM 134

Query:   138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
             VVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct:   135 VVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194

Query:   198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
             VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct:   195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPDYLNRSVATLLMHMLQVDPL 254

Query:   258 KRITIPEIRQHPWFQAHLPRYLAVPPP 284
             KR TI +IR+H WF+  LP YL    P
Sbjct:   255 KRATIKDIREHEWFKQDLPSYLFPEDP 281

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003682 "chromatin binding" evidence=IDA

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IMP

GO:0004679 "AMP-activated protein kinase activity" evidence=ISO;IMP;IDA;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=ISO

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO;TAS

GO:0006629 "lipid metabolic process" evidence=IEA

GO:0006631 "fatty acid metabolic process" evidence=IEA

GO:0006633 "fatty acid biosynthetic process" evidence=IEA

GO:0006694 "steroid biosynthetic process" evidence=IEA

GO:0006695 "cholesterol biosynthetic process" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0006950 "response to stress" evidence=ISO;IMP;TAS

GO:0008202 "steroid metabolic process" evidence=IEA

GO:0008203 "cholesterol metabolic process" evidence=IEA

GO:0008610 "lipid biosynthetic process" evidence=IDA

GO:0010508 "positive regulation of autophagy" evidence=IMP

GO:0014823 "response to activity" evidence=ISO

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016126 "sterol biosynthetic process" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016324 "apical plasma membrane" evidence=ISO

GO:0016568 "chromatin modification" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019216 "regulation of lipid metabolic process" evidence=ISO

GO:0030674 "protein binding, bridging" evidence=ISO

GO:0031000 "response to caffeine" evidence=ISO

GO:0031588 "AMP-activated protein kinase complex" evidence=ISO

GO:0031669 "cellular response to nutrient levels" evidence=IDA

GO:0032007 "negative regulation of TOR signaling cascade" evidence=IMP

GO:0035174 "histone serine kinase activity" evidence=IDA

GO:0042149 "cellular response to glucose starvation" evidence=IDA

GO:0042593 "glucose homeostasis" evidence=IMP

GO:0042752 "regulation of circadian rhythm" evidence=IMP

GO:0043066 "negative regulation of apoptotic process" evidence=IMP

GO:0043234 "protein complex" evidence=ISO

GO:0045821 "positive regulation of glycolysis" evidence=ISO

GO:0046872 "metal ion binding" evidence=IEA

GO:0047322 "[hydroxymethylglutaryl-CoA reductase (NADPH)

GO:0048511 "rhythmic process" evidence=IEA

GO:0050405 "[acetyl-CoA carboxylase

GO:0051291 "protein heterooligomerization" evidence=ISO

GO:0055089 "fatty acid homeostasis" evidence=ISO

GO:2000505 "regulation of energy homeostasis" evidence=ISO

RGD|620893 Prkaa2 "protein kinase, AMP-activated, alpha 2 catalytic subunit" [Rattus norvegicus (taxid:10116)]

 Score = 999 (356.7 bits), Expect = 1.0e-100, P = 1.0e-100
 Identities = 179/267 (67%), Positives = 224/267 (83%)

Query:    18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct:    15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74

Query:    78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct:    75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEVEARRLFQQILSAVDYCHRHM 134

Query:   138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
             VVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct:   135 VVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194

Query:   198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
             VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct:   195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSIATLLMHMLQVDPL 254

Query:   258 KRITIPEIRQHPWFQAHLPRYLAVPPP 284
             KR TI +IR+H WF+  LP YL    P
Sbjct:   255 KRATIKDIREHEWFKQDLPSYLFPEDP 281

GO:0003682 "chromatin binding" evidence=IEA;ISO;ISS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0004679 "AMP-activated protein kinase activity" evidence=IEA;ISO;IMP;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA;IDA

GO:0005634 "nucleus" evidence=IEA;ISO;TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005737 "cytoplasm" evidence=IDA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0006633 "fatty acid biosynthetic process" evidence=IEA

GO:0006695 "cholesterol biosynthetic process" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0006950 "response to stress" evidence=ISO;IDA

GO:0008610 "lipid biosynthetic process" evidence=IEA;ISO;ISS

GO:0010508 "positive regulation of autophagy" evidence=IEA;ISO;ISS

GO:0014823 "response to activity" evidence=IDA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016324 "apical plasma membrane" evidence=IDA

GO:0019216 "regulation of lipid metabolic process" evidence=IDA

GO:0030674 "protein binding, bridging" evidence=IDA

GO:0031000 "response to caffeine" evidence=IDA

GO:0031588 "AMP-activated protein kinase complex" evidence=IDA

GO:0031669 "cellular response to nutrient levels" evidence=ISO;ISS

GO:0032007 "negative regulation of TOR signaling cascade" evidence=IEA;ISO;ISS

GO:0035174 "histone serine kinase activity" evidence=IEA;ISO;ISS

GO:0035404 "histone-serine phosphorylation" evidence=ISS

GO:0042149 "cellular response to glucose starvation" evidence=IEA;ISO;ISS

GO:0042593 "glucose homeostasis" evidence=IEA;ISO;ISS

GO:0042752 "regulation of circadian rhythm" evidence=IEA;ISO;ISS

GO:0043066 "negative regulation of apoptotic process" evidence=IEA;ISO;ISS

GO:0043234 "protein complex" evidence=IDA

GO:0045821 "positive regulation of glycolysis" evidence=IDA

GO:0046872 "metal ion binding" evidence=IEA

GO:0047322 "[hydroxymethylglutaryl-CoA reductase (NADPH)

GO:0048511 "rhythmic process" evidence=IEA

GO:0050405 "[acetyl-CoA carboxylase

GO:0051291 "protein heterooligomerization" evidence=IDA

GO:0055089 "fatty acid homeostasis" evidence=IDA

GO:0071417 "cellular response to organic nitrogen" evidence=IEP

GO:2000505 "regulation of energy homeostasis" evidence=IDA

UNIPROTKB|P54646 PRKAA2 "5'-AMP-activated protein kinase catalytic subunit alpha-2" [Homo sapiens (taxid:9606)]

 Score = 998 (356.4 bits), Expect = 1.3e-100, P = 1.3e-100
 Identities = 179/267 (67%), Positives = 223/267 (83%)

Query:    18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct:    15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74

Query:    78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct:    75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134

Query:   138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
             VVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct:   135 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194

Query:   198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
             VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct:   195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254

Query:   258 KRITIPEIRQHPWFQAHLPRYLAVPPP 284
             KR TI +IR+H WF+  LP YL    P
Sbjct:   255 KRATIKDIREHEWFKQDLPSYLFPEDP 281

GO:0005524 "ATP binding" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006633 "fatty acid biosynthetic process" evidence=IEA

GO:0006695 "cholesterol biosynthetic process" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0048511 "rhythmic process" evidence=IEA

GO:0047322 "[hydroxymethylglutaryl-CoA reductase (NADPH)

GO:0050405 "[acetyl-CoA carboxylase

GO:0005515 "protein binding" evidence=IPI

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0042593 "glucose homeostasis" evidence=ISS

GO:0003682 "chromatin binding" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0042752 "regulation of circadian rhythm" evidence=ISS

GO:0042149 "cellular response to glucose starvation" evidence=ISS

GO:0032007 "negative regulation of TOR signaling cascade" evidence=ISS

GO:0031669 "cellular response to nutrient levels" evidence=ISS

GO:0008610 "lipid biosynthetic process" evidence=ISS

GO:0006950 "response to stress" evidence=ISS

GO:2000505 "regulation of energy homeostasis" evidence=ISS

GO:0045821 "positive regulation of glycolysis" evidence=ISS

GO:0004679 "AMP-activated protein kinase activity" evidence=IDA

GO:0035174 "histone serine kinase activity" evidence=ISS

GO:0010508 "positive regulation of autophagy" evidence=ISS

GO:0055089 "fatty acid homeostasis" evidence=ISS

GO:0004672 "protein kinase activity" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0006112 "energy reserve metabolic process" evidence=TAS

GO:0006853 "carnitine shuttle" evidence=TAS

GO:0007050 "cell cycle arrest" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0042304 "regulation of fatty acid biosynthetic process" evidence=TAS

GO:0044255 "cellular lipid metabolic process" evidence=TAS

GO:0044281 "small molecule metabolic process" evidence=TAS

GO:0046320 "regulation of fatty acid oxidation" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q54YF2	AMPKA_DICDI	2, ., 7, ., 1, 1, ., 1	0.7293	0.9013	0.3645	yes	no
Q38997	KIN10_ARATH	2, ., 7, ., 1, 1, ., 1	0.9385	0.9965	0.5476	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pg.C_LG_IV1177 hypothetical protein (515 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	294
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-116
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-106
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-85
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-80
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-76
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-73
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-73
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-68
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-68
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-68
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-63
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-62
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-61
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-58
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-56
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-55
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-55
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-55
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-55
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-54
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-53
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-52
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-51
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-51
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-51
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-50
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-49
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-49
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-49
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-49
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-48
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-48
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-48
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-48
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-47
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-47
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-47
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-47
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-47
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-47
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-46
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-46
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-46
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-46
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-46
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-46
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-46
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-45
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-45
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-45
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-44
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-44
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-44
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-44
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-43
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-43
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-43
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-43
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-43
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-43
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-43
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-42
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-42
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-42
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-41
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-41
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-40
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-39
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-39
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-39
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-39
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-39
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-39
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-38
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-38
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-38
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-38
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-37
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-37
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-37
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-37
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-37
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-37
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-37
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-37
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-37
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-37
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-37
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-37
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-36
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-36
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-36
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-36
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-36
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-36
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-36
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-36
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-35
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-35
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-35
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-35
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-35
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-34
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-34
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-34
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-34
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-34
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-34
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-34
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-33
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-33
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-33
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-33
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-33
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-33
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-33
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-33
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-32
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-32
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-32
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-32
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-32
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-32
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-32
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-32
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-32
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-32
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-32
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-32
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-32
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-31
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-31
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-31
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-31
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-31
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-30
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-30
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-30
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-30
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-30
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-29
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-29
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-29
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-29
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-28
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-28
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-28
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-28
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-28
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-28
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-28
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-28
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-27
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-27
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-27
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-27
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-27
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-27
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-27
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-27
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-27
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-26
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-26
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-26
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-26
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-26
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-26
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-26
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-26
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-26
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-25
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-25
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-25
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-25
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-25
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-25
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-24
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-24
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-24
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-24
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-24
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-24
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-23
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-23
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-23
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-23
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-23
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-22
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-22
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-21
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-21
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-21
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-21
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-20
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-20
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-19
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-19
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-19
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-16
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-14
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-13
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-13
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-12
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-11
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-08
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	6e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	6e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	2e-04
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	3e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	7e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.001

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  334 bits (860), Expect = e-116
 Identities = 128/257 (49%), Positives = 172/257 (66%), Gaps = 7/257 (2%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y++ + LG GSFGKV +A    TG  VAIK++ ++KIK  +  E++ REIKIL+   HP+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+RLY+V E    +Y+VMEY + G+LFD + ++GRL EDEAR + +QI+S +EY H   +
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           VHRDLKPEN+LLD   +VK+ADFGL+  +  G  L T  G+P Y APEV+ GK Y G  V
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY-GKAV 177

Query: 199 DVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSH---LSPGARDLIPRMLIV 254
           D+WS GVILY LL G  PF  D+ +  LFKKI       P     +SP A+DLI ++L+ 
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVK 237

Query: 255 DPMKRITIPEIRQHPWF 271
           DP KR+T  E  QHP+F
Sbjct: 238 DPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  309 bits (794), Expect = e-106
 Identities = 127/261 (48%), Positives = 162/261 (62%), Gaps = 9/261 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+L + LG GSFG V  A+H  TG  VA+KIL +R  K  + ++  RREI+ILR   HP+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEK-SKKDQTARREIRILRRLSHPN 59

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+RL +  E    +Y+VMEY + G+LFDY+   G L EDEA+    QI+ G+EY H N +
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRDLKPEN+LLD    VKIADFGL+  +++    L T  G+P Y APEV+ G    GP+
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLP----SHLSPGARDLIPR 250
           VDVWS GVILY LL G  PF  ENI +   L ++I G          S  S  A+DLI +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 251 MLIVDPMKRITIPEIRQHPWF 271
            L  DP KR T  EI QHPWF
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  255 bits (654), Expect = 3e-85
 Identities = 104/251 (41%), Positives = 149/251 (59%), Gaps = 5/251 (1%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG GSFGKV +     TG   A+K+L ++KI   +  E    E  IL    HP I++L+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
             +T   +Y+V+EY   GELF ++ ++GR  E+ AR +  +I+  +EY H   +++RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 145 PENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
           PEN+LLD+  ++K+ DFGL+  +  +G    T CG+P Y APEV+ GK Y G  VD WS 
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSL 179

Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-- 261
           GV+LY +L G  PF  E+   +++KI       P  LSP ARDLI  +L  DP KR+   
Sbjct: 180 GVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239

Query: 262 -IPEIRQHPWF 271
              EI+ HP+F
Sbjct: 240 GAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  244 bits (625), Expect = 3e-80
 Identities = 108/261 (41%), Positives = 158/261 (60%), Gaps = 8/261 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +++  KTLG GSFG+V +  H  +G   A+KIL++ KI  ++  E V  E +IL+   HP
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            ++ LY   +  S++Y+VMEYV  GELF ++ + GR  E  AR +  Q++  +EY H   
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD 121

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +V+RDLKPENLLLDS   +KI DFG +  ++   +  T CG+P Y APE+I  K Y G  
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGY-GKA 178

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD W+ G+++Y +L G  PF D+N   +++KI  G    PS  SP A+DLI  +L VD  
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT 238

Query: 258 KRI-----TIPEIRQHPWFQA 273
           KR+      + +I+ HPWF  
Sbjct: 239 KRLGNLKNGVNDIKNHPWFAG 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  232 bits (593), Expect = 1e-76
 Identities = 105/248 (42%), Positives = 138/248 (55%), Gaps = 36/248 (14%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G FG V +A    TG KVAIKI+   K  +  + E++ REI+IL+   HP+I++LY 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIK--KEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
           V E  + +Y+VMEY + G L D + E  G+L EDE      QI+ G+EY H N ++HRDL
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 144 KPENLLLDSK-WNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
           KPEN+LLDS    VK+ADFGLS ++      LKT  G+P Y APEV+ GK Y   + D+W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT 261
           S GVILY L                               P  +DLI +ML  DP KR +
Sbjct: 179 SLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS 207

Query: 262 IPEIRQHP 269
             EI +H 
Sbjct: 208 AKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  225 bits (577), Expect = 2e-73
 Identities = 90/260 (34%), Positives = 138/260 (53%), Gaps = 12/260 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK--VRREIKILRLFM 75
            Y++ K +G GSFGKV +      G    +K ++   + NM  +E+     E+KIL+   
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID---LSNMSEKEREDALNEVKILKKLN 57

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----VEKGRLQEDEARNFFQQIISGVE 131
           HP+II+ YE  E    + +VMEY   G+L   I     E     E++  ++F Q+   ++
Sbjct: 58  HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISG 190
           Y H   ++HRD+KP+N+ L S   VK+ DFG+S ++       KT  G+P Y +PE+   
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIP 249
           K Y   + D+WS G +LY L     PF+ EN+  L  KI  G Y  +PS  S   R+L+ 
Sbjct: 178 KPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236

Query: 250 RMLIVDPMKRITIPEIRQHP 269
            +L  DP +R +I +I Q P
Sbjct: 237 SLLQKDPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  225 bits (576), Expect = 5e-73
 Identities = 95/280 (33%), Positives = 154/280 (55%), Gaps = 27/280 (9%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMH 76
           ++K GK +G GSF  V +A+   T  + AIKIL++R++   +  + V+ E ++L RL  H
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           P II+LY   +   ++Y V+EY  +GEL  YI + G L E   R +  +I+  +EY H  
Sbjct: 62  PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM---------------------RDGHFLKT 175
            ++HRDLKPEN+LLD   ++KI DFG + ++                     ++     +
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT 235
             G+  Y +PE+++ K  AG   D+W+ G I+Y +L G  PF   N    F+KI    Y+
Sbjct: 182 FVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Query: 236 LPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWF 271
            P +  P A+DLI ++L++DP  R+ +     E++ HP+F
Sbjct: 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  212 bits (543), Expect = 3e-68
 Identities = 93/258 (36%), Positives = 143/258 (55%), Gaps = 15/258 (5%)

Query: 28  GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE 87
           G++G+V +A+   TG   AIK++ +  +      ++V  E  IL     P++++LY   +
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 88  TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147
              ++Y+VMEY+  G+L   +   G L ED AR +  +I+  +EY H N ++HRDLKP+N
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 148 LLLDSKWNVKIADFGLS-------NIMRDGHFLKTS--CGSPNYAAPEVISGKLYAGPEV 198
           +L+DS  ++K+ DFGLS        I  +    +     G+P+Y APEVI G+ +    V
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182

Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRMLIVDP 256
           D WS G ILY  L G  PF  E    +F+ I  G    P    +S  A DLI ++L+ DP
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242

Query: 257 MKRI---TIPEIRQHPWF 271
            KR+   +I EI+ HP+F
Sbjct: 243 EKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  212 bits (542), Expect = 3e-68
 Identities = 94/257 (36%), Positives = 143/257 (55%), Gaps = 10/257 (3%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG+G FG+V++ +        A+K + +R I     +E +  E +IL    HP I++LY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
             +    IY++MEY   GEL+  + ++G   E  AR +   ++   EY H   +++RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 145 PENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 204
           PENLLLDS   VK+ DFG +  ++ G    T CG+P Y APE+I  K Y    VD WS G
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGY-DFSVDYWSLG 179

Query: 205 VILYALLCGTLPF--DDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDPMKRI 260
           ++LY LL G  PF  DDE+   ++  I  G   L  P+++   A+DLI ++L  +P +R+
Sbjct: 180 ILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239

Query: 261 -----TIPEIRQHPWFQ 272
                 I +I++H WF 
Sbjct: 240 GNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  212 bits (541), Expect = 4e-68
 Identities = 94/264 (35%), Positives = 141/264 (53%), Gaps = 14/264 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK--ILNRRKIKNMEMEEKVRREIKILRLFM 75
            +  G+ LG GSFG V +A    TG  +A+K   L+    + +E    + REI+IL    
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE---ALEREIRILSSLQ 57

Query: 76  HPHIIRLY--EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I+R Y  E  E  + + + +EYV  G L   + + G+L E   R + +QI+ G+ Y 
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISG 190
           H N +VHRD+K  N+L+DS   VK+ADFG +  + D   G    +  G+P + APEVI G
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIYT-LPSHLSPGARDL 247
           + Y G   D+WS G  +  +  G  P+ +    +  L+K    G    +P HLS  A+D 
Sbjct: 178 EEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236

Query: 248 IPRMLIVDPMKRITIPEIRQHPWF 271
           + + L  DP KR T  E+ QHP+ 
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  201 bits (512), Expect = 7e-63
 Identities = 105/279 (37%), Positives = 160/279 (57%), Gaps = 13/279 (4%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+TLG GSFG+V+IA+H  TG   AIK L +R+I  M+  + V +E  IL    
Sbjct: 17  LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP I+ +    +  + +Y ++E+V  GELF ++ + GR   D A+ +  +++   EY H 
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLLLD+K +VK+ DFG +  + D  F  T CG+P Y APEVI  K + G
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF--TLCGTPEYLAPEVIQSKGH-G 193

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV+LY  + G  PF D+    +++KI  G    P+     ARDL+  +L  D
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTD 253

Query: 256 PMKRI-TIP----EIRQHPWFQAH-----LPRYLAVPPP 284
             KR+ T+     +++ HP+F          RY   P P
Sbjct: 254 HTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIP 292

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  197 bits (502), Expect = 6e-62
 Identities = 92/260 (35%), Positives = 151/260 (58%), Gaps = 8/260 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           + +  KT+G G+FG+V +    ++ H  A+K++   ++  ++ E+ V  E ++L+   HP
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            IIRL+        +Y++MEYV  GELF Y+   GR        +  +I+  +EY H   
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE 121

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +V+RDLKPEN+LLD + ++K+ DFG +  +RD  +  T CG+P Y APEVI  K +    
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW--TLCGTPEYLAPEVIQSKGH-NKA 178

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD W+ G+++Y +L G  PF D+N   +++KI  G    P HL   A+DLI ++L+VD  
Sbjct: 179 VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRT 238

Query: 258 KRI-----TIPEIRQHPWFQ 272
           +R+        +++ H WF+
Sbjct: 239 RRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  198 bits (502), Expect = 5e-61
 Identities = 98/282 (34%), Positives = 144/282 (51%), Gaps = 30/282 (10%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMH 76
           +Y++ + LG GSFG+V +A        VA+K+L ++     +  E+  REI+IL  L   
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE---KGRLQEDEARNFFQQIISGVEYC 133
           P+I++LY+  +    +Y+VMEYV  G L D + +   KG L E EA     QI+S +EY 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 134 HRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDG-------HFLKTSCGSPNYAAP 185
           H   ++HRD+KPEN+LLD     VK+ DFGL+ ++ D            TS G+P Y AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 186 EVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----- 238
           EV+ G    YA    D+WS G+ LY LL G  PF+ E   +   +    I  LP+     
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 239 --------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                    +S  A DL+ ++L  DP  R++      H    
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279

Length = 384

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  187 bits (477), Expect = 4e-58
 Identities = 95/297 (31%), Positives = 142/297 (47%), Gaps = 62/297 (20%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
           KL K LG G++G V  A    TG  VA+K     KI+    EE +     REI +L+   
Sbjct: 3   KLEK-LGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKELK 56

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCH 134
           HP+I++L +VI T   +Y+V EY    +L  Y+    G L  +  ++   Q++ G+ YCH
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YA 183
            + ++HRDLKP+N+L++    +K+ADFGL+           + G P            Y 
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLA----------RAFGIPLRTYTHEVVTLWYR 165

Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFK--KIKG--------G 232
           APE++ G  +    VD+WS G I   ++ G   F  D  I  LFK  +I G        G
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225

Query: 233 IYTLPSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
           +  LP +                  L P   DL+ +ML  +P KRI+  E  +HP+F
Sbjct: 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  180 bits (460), Expect = 8e-56
 Identities = 86/264 (32%), Positives = 135/264 (51%), Gaps = 15/264 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y++ +T+G GSFG V+       G  +  K ++   +   E ++ V  E+ ILR   HP+
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EVNILRELKHPN 60

Query: 79  IIRLY--EVIETPSDIYVVMEYVKSGELFDYI----VEKGRLQEDEARNFFQQIISGVEY 132
           I+R Y   +  +   +Y+VMEY + G+L   I     E+  ++E+       Q++  +  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 133 CHR-----NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPE 186
           CH      N V+HRDLKP N+ LD+  NVK+ DFGL+ I+        +  G+P Y +PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180

Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGAR 245
            ++   Y   + D+WS G ++Y L   + PF   N   L  KIK G +  +P   S    
Sbjct: 181 QLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239

Query: 246 DLIPRMLIVDPMKRITIPEIRQHP 269
           ++I  ML VDP KR +  E+ Q P
Sbjct: 240 EVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  180 bits (458), Expect = 1e-55
 Identities = 75/259 (28%), Positives = 137/259 (52%), Gaps = 6/259 (2%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +++L + +G G+FGKV I +   T    A+K +N++K         V  E +IL+   HP
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            ++ L+   +   ++Y+V++ +  G+L  ++ +K +  E++ + +  +I+  +EY H   
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           ++HRD+KP+N+LLD + +V I DF ++  +       ++ G+P Y APEV+  + Y    
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVA 179

Query: 198 VDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
           VD WS GV  Y  L G  P+          +  K +      P+  S  A D I ++L  
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER 239

Query: 255 DPMKRI--TIPEIRQHPWF 271
           DP KR+   + +++ HP+F
Sbjct: 240 DPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  181 bits (462), Expect = 1e-55
 Identities = 94/257 (36%), Positives = 146/257 (56%), Gaps = 8/257 (3%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIR 81
           K LG GSFGKV +AE   T    A+K+L +  I   +  E    E ++L L   HP + +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T   ++ VMEYV  G+L  +I   GR  E  AR +  +I+ G+++ H   +++R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK +N+LLDS+ ++KIADFG+    +  G    T CG+P+Y APE++S + Y GP VD 
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179

Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W+ GV+LY +L G  PF+ ++   LF+ I       P  LS  A+ ++   L  +P KR+
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239

Query: 261 TIP-----EIRQHPWFQ 272
                   +I+ HP+F+
Sbjct: 240 GCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  178 bits (453), Expect = 6e-55
 Identities = 84/258 (32%), Positives = 134/258 (51%), Gaps = 8/258 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY+LG  +G G+FG V    +  TG  VAIK ++  KIK   ++  + +EI +L+   HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++    IET   +Y+++EY ++G L   I + G   E     +  Q++ G+ Y H   
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
           V+HRD+K  N+L      VK+ADFG++  +        +  G+P + APEVI      G 
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS---GA 176

Query: 197 EV--DVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
               D+WS G  +  LL G  P+ D N +  LF+ ++     LP  +SP  +D + +   
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236

Query: 254 VDPMKRITIPEIRQHPWF 271
            DP  R T  ++ +HPW 
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  177 bits (452), Expect = 9e-55
 Identities = 85/256 (33%), Positives = 139/256 (54%), Gaps = 8/256 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +++ + +G G FG+V  A H  TG +VAIK++    +++ E +EK+  EI+IL+   HP+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHPN 58

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           I++ Y       ++++VME+   G L D +    + L E +     ++++ G+EY H N 
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           ++HRD+K  N+LL S   VK+ DFGLS  + D     T  G+P + APEVI+GK Y   +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY-DYK 177

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTL--PSHLSPGARDLIPRMLIV 254
            D+WS G+    L  G  P+ +        KI   G   L  P   S   +D + + L  
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237

Query: 255 DPMKRITIPEIRQHPW 270
           +P KR T  ++ +HP+
Sbjct: 238 NPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  175 bits (446), Expect = 8e-54
 Identities = 90/268 (33%), Positives = 145/268 (54%), Gaps = 21/268 (7%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILN--------RRKIKNMEMEEKVRREIK 69
           N++ GK LG G+FG+V +     TG ++A+K +         ++++  +E       EI+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALE------CEIQ 56

Query: 70  ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           +L+   H  I++ Y  +     + + MEY+  G + D +   G L E   R + +QI+ G
Sbjct: 57  LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG----LSNIMRDGHFLKTSCGSPNYAAP 185
           VEY H NM+VHRD+K  N+L DS  NVK+ DFG    L  I   G  +K+  G+P + +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLSPG 243
           EVISG+ Y G + DVWS G  +  +L    P+ + E +  +FK   +     LPSH+SP 
Sbjct: 177 EVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPD 235

Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF 271
           AR+ + R  + +  KR +  E+ +H + 
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  177 bits (450), Expect = 1e-53
 Identities = 96/255 (37%), Positives = 137/255 (53%), Gaps = 7/255 (2%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV +     TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +T   +  VMEY   GELF ++  +    ED AR +  +I+S + Y H   VV+RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 143 LKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
           LK ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G  VD W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179

Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260
             GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP +R+ 
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239

Query: 261 ----TIPEIRQHPWF 271
                  EI +H +F
Sbjct: 240 GGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  170 bits (433), Expect = 9e-52
 Identities = 90/260 (34%), Positives = 135/260 (51%), Gaps = 16/260 (6%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---NMEMEEKVRREIKILRLFMHPHI 79
           K LG GS G V    H  TG   A+K     KI    + E  +++ RE+K LR    P++
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALK-----KIHVDGDEEFRKQLLRELKTLRSCESPYV 61

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-V 138
           ++ Y       +I +V+EY+  G L D + + G++ E       +QI+ G++Y H    +
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPE 197
           +HRD+KP NLL++SK  VKIADFG+S ++ +      T  G+  Y +PE I G+ Y+   
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLF---KKI-KGGIYTLPSHL-SPGARDLIPRML 252
            D+WS G+ L     G  PF     P+ F   + I  G   +LP+   SP  RD I   L
Sbjct: 182 -DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240

Query: 253 IVDPMKRITIPEIRQHPWFQ 272
             DP KR +  E+ QHP+ +
Sbjct: 241 QKDPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  169 bits (431), Expect = 1e-51
 Identities = 93/262 (35%), Positives = 137/262 (52%), Gaps = 20/262 (7%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-----P 77
           K +  G+FG V +A+   TG   AIK+L   K  +M  + +V   +K  R  M      P
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVL---KKSDMIAKNQVT-NVKAERAIMMIQGESP 57

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           ++ +LY   ++   +Y+VMEY+  G+    I   G L ED A+ +  +++ GVE  H+  
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           ++HRD+KPENLL+D   ++K+ DFGLS   R+G   K   G+P+Y APE I G       
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGV-GDDKM 173

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLIPRMLI 253
            D WS G +++  L G  PF  E    +F  I       P       SP A DLI R+L 
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233

Query: 254 VDPMKRI---TIPEIRQHPWFQ 272
           +DP KR+      EI+ HP+F+
Sbjct: 234 MDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  171 bits (435), Expect = 2e-51
 Identities = 96/254 (37%), Positives = 145/254 (57%), Gaps = 6/254 (2%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIR 81
           K LG GSFGKV +AE   T    AIK L +  +   +  E    E ++L L + HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T   ++ VMEY+  G+L  +I   GR  E  AR +  +II G+++ H+  +++R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           DLK +N+LLD   ++KIADFG+   N+  +G    T CG+P+Y APE++ G+ Y    VD
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGK-ASTFCGTPDYIAPEILKGQKYNE-SVD 178

Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
            WS GV+LY +L G  PF  E+   LF  I       P  +S  A+D + ++   DP KR
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238

Query: 260 ITIP-EIRQHPWFQ 272
           + +  +IRQHP+F+
Sbjct: 239 LGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  169 bits (431), Expect = 3e-51
 Identities = 90/289 (31%), Positives = 145/289 (50%), Gaps = 39/289 (13%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            YK+   +G G+ G V  A+   TG  VA+K +  R+++   +  +  REIK L+   HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHP 59

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRN 136
           ++++L +V    S   +VMEY+ S  L + + ++ R L E + +++ + ++ GV Y H N
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA 194
            ++HRDLKP NLL+ +   +KIADFGL+ +  +      S    +  Y APE++ G    
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDEN-------------IPNLFKKIKGGIYTLPSH-- 239
            P VD+W+ G I   LL G+  F  EN              PN   +   G+ +LP +  
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE--ETWPGLTSLPDYNK 236

Query: 240 -----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                             SP A DL+  +L+ DP KR++  E  +HP+F
Sbjct: 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  168 bits (428), Expect = 4e-50
 Identities = 90/290 (31%), Positives = 145/290 (50%), Gaps = 37/290 (12%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++++ K +G G+FG+V +     TG   A+K+L +  +        VR E  IL     P
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            I++LY   +    +Y+VMEY+  G+L + ++ K    E+ AR +  +++  ++  H+  
Sbjct: 62  WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-------------------------- 171
            +HRD+KP+N+L+D+  ++K+ADFGL   M                              
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181

Query: 172 ----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK 227
                  ++ G+P+Y APEV+ G  Y G E D WS GVILY +L G  PF  + +   + 
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240

Query: 228 KIKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRIT-IPEIRQHPWFQ 272
           KI     +L  P    +SP A DLI R L+ DP  R+    EI+ HP+F+
Sbjct: 241 KIINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  166 bits (422), Expect = 1e-49
 Identities = 100/301 (33%), Positives = 141/301 (46%), Gaps = 63/301 (20%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-------VRREIKI 70
            Y+ GK LG G++  V  A    TG  VAIK     KIK  E +E          REIK+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIK-----KIKLGERKEAKDGINFTALREIKL 55

Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISG 129
           L+   HP+II L +V    S+I +V E++   +L   I +K   L   + +++    + G
Sbjct: 56  LQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRG 114

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-------- 181
           +EY H N ++HRDLKP NLL+ S   +K+ADFGL+           S GSPN        
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA----------RSFGSPNRKMTHQVV 164

Query: 182 ---YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFD-----------------D 219
              Y APE++ G  + G  VD+WS G I   LL     LP D                 +
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE 224

Query: 220 ENIPNL--------FKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
           EN P +        FK      +  +    S  A DL+ R+L ++P KRIT  +  +HP+
Sbjct: 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Query: 271 F 271
           F
Sbjct: 285 F 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  165 bits (419), Expect = 2e-49
 Identities = 91/300 (30%), Positives = 143/300 (47%), Gaps = 72/300 (24%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILRLFMHPHI 79
           +G G++G+V  A +  TG  VA+K     KI+ ME E++       REIK+L+   HP+I
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALK-----KIR-MENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 80  IRLYEVI--ETPSDIYVVMEYVK---SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           +RL E++  +    IY+V EY+    +G L    V   +  E + + + +Q++ G++Y H
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV---KFTESQIKCYMKQLLEGLQYLH 117

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------YAAP 185
            N ++HRD+K  N+L+++   +K+ADFGL+          T   S +         Y  P
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPY-------TKRNSADYTNRVITLWYRPP 170

Query: 186 EVISG-KLYAGPEVDVWSCGVILYAL---------------------LCGTLPFDDENIP 223
           E++ G   Y GPEVD+WS G IL  L                     LCG+    DEN P
Sbjct: 171 ELLLGATRY-GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP--TDENWP 227

Query: 224 NLFKKIKGGIYTLPSH------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            + K                        + P A DL+ ++L +DP KRI+  +  QH +F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  164 bits (417), Expect = 7e-49
 Identities = 97/256 (37%), Positives = 140/256 (54%), Gaps = 8/256 (3%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV + +   TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHR 141
               +T   +  VMEY   GELF ++  +    ED AR +  +I+S ++Y H    VV+R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK ENL+LD   ++KI DFGL    ++DG  +KT CG+P Y APEV+    Y G  VD 
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179

Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP +R+
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239

Query: 261 -----TIPEIRQHPWF 271
                   EI QH +F
Sbjct: 240 GGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  164 bits (417), Expect = 8e-49
 Identities = 93/258 (36%), Positives = 144/258 (55%), Gaps = 9/258 (3%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIR 81
           + LG GSFGKV +A    +G   A+K+L +  I   +  E    E +IL L   HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           LY   +TP  ++ VME+V  G+L  +I +  R  E  AR +  +I S + + H   +++R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK +N+LLD + + K+ADFG+    + +G    T CG+P+Y APE++   LY GP VD 
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179

Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W+ GV+LY +LCG  PF+ EN  +LF+ I       P+ LS  A D++   +  +P  R+
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239

Query: 261 TI------PEIRQHPWFQ 272
                     I +HP+F+
Sbjct: 240 GSLTLGGEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  161 bits (410), Expect = 3e-48
 Identities = 96/291 (32%), Positives = 141/291 (48%), Gaps = 49/291 (16%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
           KLGK +G G++G V  A   LTG  VAIK     KIK     E +     REIK+L+   
Sbjct: 3   KLGK-IGEGTYGVVYKARDKLTGEIVAIK-----KIKLRFESEGIPKTALREIKLLKELN 56

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCH 134
           HP+II+L +V     D+Y+V E++ + +L+  I ++ R L E   +++  Q++ G+ +CH
Sbjct: 57  HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-YAAPEVISGKLY 193
            + ++HRDLKPENLL++++  +K+ADFGL+          T       Y APE++ G   
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 194 AGPEVDVWSCGVILYALL------------------CGTL---------------PFDDE 220
               VD+WS G I   LL                    TL                    
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 221 NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
           + P   KK    +  L  + SP A DL+ +ML  DP KRIT  +   HP+F
Sbjct: 236 SFP---KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  163 bits (414), Expect = 4e-48
 Identities = 94/301 (31%), Positives = 142/301 (47%), Gaps = 56/301 (18%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE----KVRREIKILRLF 74
           Y+L K +G G++G V  A    TG KVAIK     KI N+  +     ++ REIK+LR  
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIK-----KISNVFDDLIDAKRILREIKLLRHL 56

Query: 75  MHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
            H +II L +++  PS     D+Y+V E +++ +L   I     L +D  + F  QI+ G
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG 115

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAA 184
           ++Y H   V+HRDLKP N+L++S  ++KI DFGL+  + D    +    +       Y A
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV-DPDEDEKGFLTEYVVTRWYRA 174

Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPF----------------------DDENI 222
           PE++         +D+WS G I   LL     F                      D + I
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234

Query: 223 PNLFKKIKGGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            +  +K +  + +LP              SP A DL+ +ML+ DP KRIT  E   HP+ 
Sbjct: 235 TS--EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Query: 272 Q 272
            
Sbjct: 293 A 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  162 bits (412), Expect = 5e-48
 Identities = 94/258 (36%), Positives = 143/258 (55%), Gaps = 10/258 (3%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIR 81
             LG GSFGKV +AE   T    AIKIL +  I   +  E    E ++L L   P  + +
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQ 65

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T   +Y VMEYV  G+L  +I + G+ +E  A  +  +I  G+ + H   +++R
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125

Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           DLK +N++LD++ ++KIADFG+   NI   G   +T CG+P+Y APE+I+ + Y G  VD
Sbjct: 126 DLKLDNVMLDAEGHIKIADFGMCKENIF-GGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183

Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
            W+ GV+LY +L G  PFD E+   LF+ I     + P  LS  A  +   +L   P KR
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243

Query: 260 ITI-----PEIRQHPWFQ 272
           +        +IR+H +F+
Sbjct: 244 LGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  160 bits (405), Expect = 8e-48
 Identities = 88/258 (34%), Positives = 133/258 (51%), Gaps = 10/258 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK--VRREIKILRLFM 75
            Y+  + +G G+FG V +         V IK +    ++ M  +E+   + E ++L+L  
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP---VEQMTKDERLAAQNECQVLKLLS 57

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYC 133
           HP+II  YE       + +VMEY   G L +YI ++    L ED   +FF QI+  + + 
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 134 HRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
           H  +++HRDLK +N+LLD    V KI DFG+S I+       T  G+P Y +PE+  GK 
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP 177

Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRM 251
           Y   + D+W+ G +LY L      F+  N+P L  KI  G +  +    SP  R LI  M
Sbjct: 178 Y-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSM 236

Query: 252 LIVDPMKRITIPEIRQHP 269
           L +DP KR  + +I   P
Sbjct: 237 LNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  161 bits (409), Expect = 1e-47
 Identities = 91/239 (38%), Positives = 132/239 (55%), Gaps = 2/239 (0%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV +     TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +T   +  VMEY   GELF ++  +    E+ AR +  +I+S +EY H   VV+RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 143 LKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
           +K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G  VD W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179

Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
             GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP +R+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  158 bits (402), Expect = 2e-47
 Identities = 82/257 (31%), Positives = 131/257 (50%), Gaps = 8/257 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K+ K LG GS+G V   +        A+K ++   +   E E+ V  EI+IL    HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYC 133
           +II   E     + + +VMEY   G+L   I +    +  + E E    F Q++ G++  
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
           H   ++HRDLK  N+LL +   VKI D G+S +++  +  KT  G+P+Y APEV  G+ Y
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGRPY 178

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRML 252
           +    D+WS G +LY +     PF+  ++ +L  K++ G Y  +P   S   ++ I  ML
Sbjct: 179 SYKS-DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237

Query: 253 IVDPMKRITIPEIRQHP 269
            V P  R    +I   P
Sbjct: 238 QVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  161 bits (408), Expect = 2e-47
 Identities = 87/260 (33%), Positives = 135/260 (51%), Gaps = 15/260 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G +G+V +A+   TG  VA+K + +  +  +     V  E  IL       +++L  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
             +    +Y+ MEYV  G+    +   G L ED AR +  ++   V+  H    +HRDLK
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128

Query: 145 PENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
           PEN L+D+  ++K+ DFGLS  I+   +   +  GSP+Y APEV+ GK Y    VD WS 
Sbjct: 129 PENFLIDASGHIKLTDFGLSKGIVTYAN---SVVGSPDYMAPEVLRGKGY-DFTVDYWSL 184

Query: 204 GVILYALLCGTLPFDD-------ENIPNLFKKIKGGIYTLPSH-LSPGARDLIPRMLIVD 255
           G +LY  LCG  PF         EN+    + ++  +Y  P   LS  A DLI ++ I D
Sbjct: 185 GCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL-IND 243

Query: 256 PMKRI-TIPEIRQHPWFQAH 274
           P +R  ++ +I+ HP+F+  
Sbjct: 244 PSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  159 bits (404), Expect = 3e-47
 Identities = 99/289 (34%), Positives = 143/289 (49%), Gaps = 42/289 (14%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR-REIKILR-LFMH 76
           YK+ K LG G+FG V +A +  TG  VAIK + ++K  + E  E +  RE+K LR L  H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWE--ECMNLREVKSLRKLNEH 57

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCH 134
           P+I++L EV     ++Y V EY++ G L+  +   +     E   R+   QI+ G+ + H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI--SGKL 192
           ++   HRDLKPENLL+     VKIADFGL+  +R          +  Y APE++  S   
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS- 175

Query: 193 YAGPEVDVWSCGVI---LYAL---------------LCGTL-PFDDENIPNLFK------ 227
           Y+ P VD+W+ G I   LY L               +C  L     ++ P  +K      
Sbjct: 176 YSSP-VDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234

Query: 228 -----KIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                     ++ L  + SP A DLI  ML  DP KR T  +  QHP+F
Sbjct: 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  158 bits (401), Expect = 7e-47
 Identities = 88/272 (32%), Positives = 144/272 (52%), Gaps = 17/272 (6%)

Query: 18  NYKLGKTLGIGSFGKV----KIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKIL- 71
           N++L + LG G++GKV    K+  H   G   A+K+L +  I +  +  E  R E ++L 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHD-AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59

Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
            +   P ++ L+   +T + ++++++YV  GELF ++ ++    E E R +  +I+  ++
Sbjct: 60  AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVIS 189
           + H+  +++RD+K EN+LLDS+ +V + DFGLS         +    CG+  Y APEVI 
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 190 GKLYA-GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGA 244
           G        VD WS GV+ + LL G  PF  +   N   +I   I       P  +S  A
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239

Query: 245 RDLIPRMLIVDPMKRI---TIPEIRQHPWFQA 273
           RD I ++L  DP KR+      EI+ HP+FQ 
Sbjct: 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  159 bits (403), Expect = 9e-47
 Identities = 94/257 (36%), Positives = 137/257 (53%), Gaps = 7/257 (2%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV +     +G   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +T   +  VMEYV  GELF ++  +    ED  R +  +I+S ++Y H   +V+RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 143 LKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
           LK ENL+LD   ++KI DFGL    + D   +KT CG+P Y APEV+    Y G  VD W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179

Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260
             GV++Y ++CG LPF +++   LF+ I       P  LS  A+ L+  +LI DP KR+ 
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG 239

Query: 261 ----TIPEIRQHPWFQA 273
                  EI +H +F  
Sbjct: 240 GGPDDAKEIMRHSFFTG 256

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  158 bits (402), Expect = 1e-46
 Identities = 91/254 (35%), Positives = 146/254 (57%), Gaps = 6/254 (2%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIR 81
           K LG GSFGKV +AE   T    AIK L +  +   +  E    E ++L L + HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           LY   +T  +++ VMEY+  G+L  +I    +     A  +  +II G+++ H   +V+R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           DLK +N+LLD+  ++KIADFG+   N++ D     T CG+P+Y APE++ G+ Y    VD
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKY-NTSVD 178

Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
            WS GV+LY +L G  PF   +   LF+ I+      P  L+  A+D++ ++ + +P +R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238

Query: 260 ITIP-EIRQHPWFQ 272
           + +  +IRQHP+F+
Sbjct: 239 LGVKGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  158 bits (402), Expect = 1e-46
 Identities = 94/263 (35%), Positives = 144/263 (54%), Gaps = 17/263 (6%)

Query: 23  KTLGIGSFGKV----KIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLFMHP 77
           K LG G +GKV    K+     TG   A+K+L +  I +N +     + E  IL    HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGAD-TGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            I+ L    +T   +Y+++EY+  GELF ++  +G   ED A  +  +I   +E+ H+  
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVI--SGKLYA 194
           +++RDLKPEN+LLD++ +VK+ DFGL    + +G    T CG+  Y APE++  SG    
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH--- 177

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
           G  VD WS G ++Y +L G  PF  EN      KI  G   LP +L+P ARDL+ ++L  
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237

Query: 255 DPMKRI-----TIPEIRQHPWFQ 272
           +P  R+        E++ HP+F+
Sbjct: 238 NPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  158 bits (402), Expect = 2e-46
 Identities = 96/287 (33%), Positives = 157/287 (54%), Gaps = 21/287 (7%)

Query: 18  NYKLGKTLGIGSFGKV----KIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILR 72
           N++L K LG G++GKV    K+  H  TG   A+K+L +  + +  +  E  R E  +L 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHD-TGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59

Query: 73  LFMH-PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                P ++ L+   +T + ++++++YV  GE+F ++ ++    EDE R +  +II  +E
Sbjct: 60  HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN--IMRDGHFLKTSCGSPNYAAPEVIS 189
           + H+  +V+RD+K EN+LLDS+ +V + DFGLS   +  +     + CG+  Y APE+I 
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179

Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----TLPSHLSPGAR 245
           GK   G  VD WS G++++ LL G  PF  E   N   ++   I       PS + P A+
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239

Query: 246 DLIPRMLIVDPMKRI-----TIPEIRQHPWFQAHLPRYLA---VPPP 284
           DL+ ++L  DP KR+        EI++HP+F+      LA   V PP
Sbjct: 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPP 286

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  157 bits (400), Expect = 3e-46
 Identities = 97/295 (32%), Positives = 142/295 (48%), Gaps = 45/295 (15%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR---EIKILRLFM 75
           +K  K LG G  G+V +     TG   A+K+L++   K M    KV+R   E +IL    
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDK---KEMIKRNKVKRVLTEQEILATLD 59

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYC 133
           HP +  LY   +T + + +VM+Y   GELF  +       L E+ AR +  +++  +EY 
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSN--------IMRDGHFLKT---------- 175
           H   +V+RDLKPEN+LL    ++ ++DF LS         + +                 
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179

Query: 176 -----------SC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP 223
                      S  G+  Y APEVISG  + G  VD W+ G++LY +L GT PF   N  
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRD 238

Query: 224 NLFKKIKGGIYTLPSH--LSPGARDLIPRMLIVDPMKRI----TIPEIRQHPWFQ 272
             F  I     T P    +S  ARDLI ++L+ DP KR+       EI+QHP+F+
Sbjct: 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  157 bits (398), Expect = 4e-46
 Identities = 85/254 (33%), Positives = 134/254 (52%), Gaps = 5/254 (1%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GSFGKV       T    A+K + +  I +         E  +L     P I+ L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
             ++P  +Y+V+ ++  GELF ++  +GR     AR +  +++  +E  H+  V++RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 145 PENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
           PEN+LLD + ++ + DFGL  + M+D     T CG+P Y APE++ G  Y    VD W+ 
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTL 179

Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI- 262
           GV+LY +L G  PF DEN+  +++KI       P      A+DL+  +L  DP +R+   
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239

Query: 263 --PEIRQHPWFQAH 274
              EI+ HP+F   
Sbjct: 240 GAQEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  155 bits (395), Expect = 7e-46
 Identities = 92/264 (34%), Positives = 144/264 (54%), Gaps = 10/264 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           YK  + +G G+ G+V  A    TG +VAIK +  RK +N E    +  EI I++   HP+
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKE---LIINEILIMKDCKHPN 76

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           I+  Y+      +++VVMEY+  G L D I +   R+ E +     ++++ G+EY H   
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 196
           V+HRD+K +N+LL    +VK+ADFG +  +      + S  G+P + APEVI  K Y GP
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY-GP 195

Query: 197 EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 253
           +VD+WS G++   +  G  P+  E  +  LF     GI  L  P   SP  +D + + L+
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255

Query: 254 VDPMKRITIPEIRQHPWFQAHLPR 277
            DP KR +  E+ QHP+ +   P+
Sbjct: 256 KDPEKRPSAEELLQHPFLKKACPK 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  156 bits (397), Expect = 7e-46
 Identities = 87/256 (33%), Positives = 135/256 (52%), Gaps = 9/256 (3%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIR 81
           K +G GSFGKV +A+H   G   A+K+L ++ I   + ++ +  E  +L +   HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T   +Y V++YV  GELF ++  +    E  AR +  +I S + Y H   +++R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           DLKPEN+LLDS+ +V + DFGL    I        T CG+P Y APEV+  + Y    VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKT-TSTFCGTPEYLAPEVLRKQPY-DRTVD 178

Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
            W  G +LY +L G  PF   +   ++  I      L  ++S  AR L+  +L  D  KR
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKR 238

Query: 260 I----TIPEIRQHPWF 271
           +       EI+ H +F
Sbjct: 239 LGAKDDFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  155 bits (394), Expect = 2e-45
 Identities = 88/259 (33%), Positives = 140/259 (54%), Gaps = 10/259 (3%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIR 81
           K LG GSFGKV +AE   T    AIK+L +  I   +  +    E +IL L   HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T   ++ VMEYV  G+L   I    +  E  +R +  ++   + + HR+ V++R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK +N+LLD++ + K+ADFG+    + +G    T CG+P+Y APE++    Y GP VD 
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDW 179

Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W+ GV++Y ++ G  PF+ +N  +LF+ I       P  LS  A  ++   +  +P KR+
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239

Query: 261 -------TIPEIRQHPWFQ 272
                      I+QHP+F+
Sbjct: 240 GCVASQGGEDAIKQHPFFK 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  153 bits (389), Expect = 3e-45
 Identities = 84/268 (31%), Positives = 132/268 (49%), Gaps = 15/268 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRLF 74
            +  G+ LG G+F     A    TG  +A+K +   +  + E E   E +R+EI+++   
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HPHIIR+       S   + +E++  G +   + + G  +E    N+ +Q++ G+ Y H
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 135 RNMVVHRDLKPENLLLDSK-WNVKIADFGL-----SNIMRDGHFLKTSCGSPNYAAPEVI 188
            N ++HRD+K  NLL+DS    ++IADFG      +     G F     G+  + APEV+
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYT--LPSHLSPG 243
            G+ Y G   DVWS G ++  +     P++ E   N   L  KI        +P HLSPG
Sbjct: 181 RGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239

Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            RD+  R L + P  R    E+ +HP F
Sbjct: 240 LRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  152 bits (385), Expect = 9e-45
 Identities = 82/261 (31%), Positives = 132/261 (50%), Gaps = 16/261 (6%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILN--------RRKIKNMEMEEKVRREIKI 70
           ++ G+ LG GSFG V    +   G   A+K ++        +  +K +E      +EI +
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE------QEIAL 55

Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGV 130
           L    HP+I++         ++Y+ +E V  G L   + + G   E   R + +QI+ G+
Sbjct: 56  LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL 115

Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           EY H    VHRD+K  N+L+D+   VK+ADFG++  + +  F K+  GSP + APEVI+ 
Sbjct: 116 EYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIY-TLPSHLSPGARDLI 248
           +   G   D+WS G  +  +  G  P+   E +  +FK  +      +P HLS  A+D I
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235

Query: 249 PRMLIVDPMKRITIPEIRQHP 269
            + L  DP  R T  E+ +HP
Sbjct: 236 LKCLQRDPSLRPTAAELLEHP 256

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  151 bits (385), Expect = 1e-44
 Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 14/258 (5%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
            LGK LG G+FG+V   +    G K    VA+K L  ++  + +  E+  RE +I+R   
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL--KEDASEQQIEEFLREARIMRKLD 59

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           HP++++L  V      +Y+VMEY++ G+L  Y+ + + +L   +  +F  QI  G+EY  
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSP-NYAAPEVISGKL 192
               +HRDL   N L+     VKI+DFGLS ++  D ++ K     P  + APE +    
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 193 YAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIP 249
           +   + DVWS GV+L+ +   G  P+   +   + + +K G Y L  P +  P   DL+ 
Sbjct: 180 F-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLPQPPNCPPELYDLML 237

Query: 250 RMLIVDPMKRITIPEIRQ 267
           +    DP  R T  E+ +
Sbjct: 238 QCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  151 bits (384), Expect = 2e-44
 Identities = 87/269 (32%), Positives = 140/269 (52%), Gaps = 24/269 (8%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKIL----NRRKIKNMEMEEKVRREIKILRLF 74
           ++ G  +G G+FGKV  A +  TG  +A+K +    N  K       +++  E+K+L L 
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK-----TIKEIADEMKVLELL 56

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA--RNFFQQIISGVEY 132
            HP++++ Y V      +Y+ MEY   G L + ++E GR+  DE   R +  Q++ G+ Y
Sbjct: 57  KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAY 114

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-----GHFLKTSCGSPNYAAPEV 187
            H + +VHRD+KP N+ LD    +K+ DFG +  +++     G  +++  G+P Y APEV
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 188 ISGKLYAGPE--VDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLPSH--LS 241
           I+G    G     D+WS G ++  +  G  P+   D     +F    G    +P    LS
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS 234

Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPW 270
           P  +D + R L  DP KR T  E+ QHP+
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  152 bits (385), Expect = 3e-44
 Identities = 91/268 (33%), Positives = 141/268 (52%), Gaps = 23/268 (8%)

Query: 28  GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE 87
           G++G V +  H  T  + A+K +N++ +      ++V  E  IL    +P ++ ++   E
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71

Query: 88  TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147
           T   + +VMEYV+ G+    +   G L  D AR +F + +  +EY H   +VHRDLKP+N
Sbjct: 72  TKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDN 131

Query: 148 LLLDSKWNVKIADFGLSNI--------MRDGH-------FL-KTSCGSPNYAAPEVISGK 191
           LL+ S  ++K+ DFGLS I        + +GH       FL K  CG+P Y APEVI  +
Sbjct: 132 LLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ 191

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH---LSPGARDLI 248
            Y  P VD W+ G+ILY  L G +PF  +    LF ++       P     L   A+DLI
Sbjct: 192 GYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLI 250

Query: 249 PRMLIVDPMKRITIP---EIRQHPWFQA 273
            R+L  +P++R+      E++QH +F  
Sbjct: 251 SRLLRQNPLERLGTGGAFEVKQHRFFLG 278

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  151 bits (383), Expect = 7e-44
 Identities = 86/254 (33%), Positives = 143/254 (56%), Gaps = 6/254 (2%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIR 81
           K LG GSFGKV +AE    G   A+K L +  +   +  E    E ++L L + +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           LY   +T   ++ VME++  G+L  +I +KGR     A  +  +I+ G+++ H   +++R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           DLK +N++LD   ++KIADFG+   N+  D     T CG+P+Y APE++ G  Y    VD
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNR-ASTFCGTPDYIAPEILQGLKYTF-SVD 178

Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
            WS GV+LY +L G  PF  ++   LF+ I+      P  ++  ++D++ ++   DP +R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238

Query: 260 ITIP-EIRQHPWFQ 272
           + +   IR HP+F+
Sbjct: 239 LGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  149 bits (378), Expect = 1e-43
 Identities = 96/274 (35%), Positives = 143/274 (52%), Gaps = 15/274 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G FG+V   +   TG   A K L+++++K  + E+    E KIL       I+ L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
             ET  D+ +VM  +  G+L  +I   G     EAR  F   QII G+E+ H+  +V+RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPEN+LLD   NV+I+D GL+  ++ G  +K   G+P Y APEV+ G++Y    VD ++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-VDWFA 179

Query: 203 CGVILYALLCGTLPFDD--ENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
            G  LY ++ G  PF    E +    L ++        P   SP A+DL   +L  DP K
Sbjct: 180 LGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239

Query: 259 RI-----TIPEIRQHPWFQA-HLPRYLA--VPPP 284
           R+     +  E+R+HP F+  +  R  A  + PP
Sbjct: 240 RLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  148 bits (377), Expect = 2e-43
 Identities = 82/261 (31%), Positives = 126/261 (48%), Gaps = 19/261 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK------VAIKILNRRKIKNMEMEEKVRREIKILRL 73
            LGK LG G+FG+V      L G        VA+K L  ++  + +  E+  RE +I+R 
Sbjct: 2   TLGKKLGEGAFGEVYKGT--LKGKGDGKEVEVAVKTL--KEDASEQQIEEFLREARIMRK 57

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVE 131
             HP+I++L  V      + +VMEY+  G+L DY+ +     L   +  +F  QI  G+E
Sbjct: 58  LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG-SP-NYAAPEVIS 189
           Y      +HRDL   N L+     VKI+DFGLS  + D  + K   G  P  + APE + 
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177

Query: 190 GKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARD 246
              +   + DVWS GV+L+ +   G  P+   +   + + +K G Y L  P +  P    
Sbjct: 178 EGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG-YRLPKPPNCPPELYK 235

Query: 247 LIPRMLIVDPMKRITIPEIRQ 267
           L+ +    DP  R T  E+ +
Sbjct: 236 LMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  150 bits (380), Expect = 2e-43
 Identities = 96/255 (37%), Positives = 146/255 (57%), Gaps = 8/255 (3%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLY 83
           LG GSFGKV +AE   T    AIKIL +  +   +  E    E ++L L   P  + +L+
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 84  EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
              +T   +Y VMEYV  G+L  +I + G+ +E +A  +  +I  G+ + HR  +++RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 144 KPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           K +N++LDS+ ++KIADFG+    M DG   +T CG+P+Y APE+I+ + Y G  VD W+
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186

Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI 262
            GV+LY +L G  PFD E+   LF+ I     + P  LS  A  +   ++   P KR+  
Sbjct: 187 YGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246

Query: 263 -PE----IRQHPWFQ 272
            PE    IR+H +F+
Sbjct: 247 GPEGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  149 bits (378), Expect = 2e-43
 Identities = 90/275 (32%), Positives = 146/275 (53%), Gaps = 17/275 (6%)

Query: 17  PNYKLG--KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           P   L     +G GS G V IA    TG +VA+K ++ RK +  E+   +  E+ I+R +
Sbjct: 17  PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL---LFNEVVIMRDY 73

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I+ +Y       +++VVME+++ G L D IV   R+ E++       ++  + + H
Sbjct: 74  QHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLH 132

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
              V+HRD+K +++LL S   VK++DFG  + + ++    K+  G+P + APEVIS   Y
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDL 247
            G EVD+WS G+++  ++ G  P+ +E      K+I+     LP  L      SP  R  
Sbjct: 193 -GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD---NLPPKLKNLHKVSPRLRSF 248

Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 282
           + RML+ DP +R T  E+  HP+     P    VP
Sbjct: 249 LDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  147 bits (373), Expect = 4e-43
 Identities = 82/246 (33%), Positives = 128/246 (52%), Gaps = 6/246 (2%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++++   +G GSFG V            A+K ++  K+   E EE +  E ++L      
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGR-LQEDEARNFFQQIISGVEYCHR 135
           +IIR YE       + +VMEY ++G+L   + +++GR L ED+   FF QI+ G+ + H 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYA 194
             ++HRD+K  NL LD+  NVKI D G++ ++ D  +F  T  G+P Y +PE+   K Y 
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY- 178

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLI 253
             + DVW+ GV+LY    G  PFD  N   L  KI  G++  +    S     LI + L 
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238

Query: 254 VDPMKR 259
            D  +R
Sbjct: 239 KDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 5e-43
 Identities = 90/295 (30%), Positives = 145/295 (49%), Gaps = 48/295 (16%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K +G G+FG+V++ +   TGH  A+K L + ++   E    VR E  IL    +P +++L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           Y   +  + +Y++MEY+  G++   +++K    E+E R +  + I  ++  H+   +HRD
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRD 126

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGH---------------FLKTSC---------- 177
           +KP+NLLLD+K ++K++DFGL   ++  H               FL              
Sbjct: 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAE 186

Query: 178 --------------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP 223
                         G+P+Y APEV     Y   E D WS GVI+Y +L G  PF  +N  
Sbjct: 187 TWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQ 245

Query: 224 NLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIP---EIRQHPWF 271
             ++KI     TL       LSP A+DLI R+   +  +R+      EI+ HP+F
Sbjct: 246 ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  148 bits (375), Expect = 6e-43
 Identities = 95/296 (32%), Positives = 140/296 (47%), Gaps = 52/296 (17%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILR-- 72
           Y+    +G G++G V  A    TG  VA+K     K++    EE +     REI +L+  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALK-----KVRVPLSEEGIPLSTLREIALLKQL 55

Query: 73  -LFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYI---VEKGRLQEDEARNFF 123
             F HP+I+RL +V   P       + +V E+V   +L  Y+    + G L  +  ++  
Sbjct: 56  ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPPETIKDLM 113

Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNY 182
           +Q++ GV++ H + +VHRDLKP+N+L+ S   VKIADFGL+ I        TS   +  Y
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTSVVVTLWY 172

Query: 183 AAPEVISGKLYAGPEVDVWSCGVILY------ALLCGT--------------LPFDDENI 222
            APEV+    YA P VD+WS G I         L  GT              LP ++E  
Sbjct: 173 RAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231

Query: 223 PN-LFKKIKGGIYTLPS------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            N    +     YT  S       +     DL+ +ML  +P KRI+  E  QHP+F
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  147 bits (372), Expect = 8e-43
 Identities = 88/260 (33%), Positives = 128/260 (49%), Gaps = 14/260 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR----EIKILRL 73
           +Y   + LG G+FG+  +         V  K +N        + EK RR    EI IL L
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLT-----RLSEKERRDALNEIVILSL 55

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRL-QEDEARNFFQQIISGVE 131
             HP+II  Y      + + + MEY   G L+D IV  KG+L +E+    +  QI+S V 
Sbjct: 56  LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISG 190
           Y H+  ++HRD+K  N+ L     +K+ DFG+S I+   + +  +  G+P Y +PE+  G
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIP 249
             Y   + D+W+ G +LY LL     FD  N  NL  KI  G YT + S  S     L+ 
Sbjct: 176 VKYNF-KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH 234

Query: 250 RMLIVDPMKRITIPEIRQHP 269
            +L  DP KR T  E+   P
Sbjct: 235 SLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  148 bits (376), Expect = 1e-42
 Identities = 95/278 (34%), Positives = 139/278 (50%), Gaps = 26/278 (9%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIR 81
           LG G FGKV +AE+  TG   AIK L +  I   +  E +  E +I        HP ++ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T   +  VMEY   G+L  +I       E  A  +   ++ G++Y H N +V+R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAGPEV 198
           DLK +NLLLD++  VKIADFGL    M  G   +TS  CG+P + APEV++   Y    V
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGM--GFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182

Query: 199 DVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
           D W  GV++Y +L G  PF  DDE    +F  I       P  LS  A  ++ R+L  +P
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVNDEVRYPRFLSREAISIMRRLLRRNP 240

Query: 257 MKRI-----TIPEIRQHPWF-----QAHLPRYLAVPPP 284
            +R+        ++++ P+F        L R   + PP
Sbjct: 241 ERRLGSGEKDAEDVKKQPFFRDINWDDLLAR--KIKPP 276

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  146 bits (370), Expect = 3e-42
 Identities = 85/273 (31%), Positives = 154/273 (56%), Gaps = 19/273 (6%)

Query: 18  NYKLGKTLGIGSFGKV----KIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILR 72
           N++L K LG G++GKV    K++ H  +G   A+K+L +  I +  +  E  R E ++L 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHD-SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59

Query: 73  -LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
            +   P ++ L+   +T + ++++++Y+  GELF ++ ++ R +E E + +  +I+  +E
Sbjct: 60  HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN--IMRDGHFLKTSCGSPNYAAPEVIS 189
           + H+  +++RD+K EN+LLDS  +V + DFGLS      +     + CG+  Y AP+++ 
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179

Query: 190 GKLYAGPE-VDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKGGIYTLPSHLSPGA 244
           G      + VD WS GV++Y LL G  PF    +  +   + ++I       P  +S  A
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239

Query: 245 RDLIPRMLIVDPMKRI-----TIPEIRQHPWFQ 272
           +D+I R+L+ DP KR+        EI++HP+FQ
Sbjct: 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  146 bits (370), Expect = 5e-42
 Identities = 94/262 (35%), Positives = 144/262 (54%), Gaps = 8/262 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++     LG GSFGKV +AE   T    AIKIL +  +   +  E    E ++L L   P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 78  -HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
             + +L+   +T   +Y VMEYV  G+L   I + GR +E  A  +  +I  G+ + H  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
            +++RDLK +N++LDS+ ++KIADFG+    M DG   KT CG+P+Y APE+I+ + Y G
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-G 179

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV+LY +L G  PF+ E+   LF+ I       P  +S  A  +   ++   
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239

Query: 256 PMKRITI-PE----IRQHPWFQ 272
           P KR+   PE    I++H +F+
Sbjct: 240 PGKRLGCGPEGERDIKEHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  143 bits (364), Expect = 3e-41
 Identities = 95/294 (32%), Positives = 149/294 (50%), Gaps = 55/294 (18%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
           K+ K +G G++G V  A   LTG  VA+K     KI+    +E V     REI +L+   
Sbjct: 3   KVEK-IGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKELN 56

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA--RNFFQQIISGVEYC 133
           HP+I+RL +V+ + + +Y+V E++   +L  Y+        D    +++  Q++ G+ YC
Sbjct: 57  HPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI----MRD-GHFLKTSCGSPNYAAPEVI 188
           H + V+HRDLKP+NLL+D +  +K+ADFGL+      +R   H + T      Y APE++
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW----YRAPEIL 171

Query: 189 SG-KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFK--KIKG--------GIYT 235
            G + Y+ P VD+WS G I +A +    P    D  I  LF+  +  G        G+ +
Sbjct: 172 LGSRQYSTP-VDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229

Query: 236 LPSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
           LP +                  L     DL+ +ML+ DP KRI+     QHP+F
Sbjct: 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  144 bits (364), Expect = 5e-41
 Identities = 83/256 (32%), Positives = 139/256 (54%), Gaps = 9/256 (3%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR---LFMHPHIIR 81
           +G G+FG+V       T    A+K+L++++I   +       E  IL    L   P I+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L    +T SD+Y+V +Y+  GELF ++ ++GR  ED A+ +  +++  +E+ H+  +V+R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLKPEN+LLD+  ++ + DFGLS   + D     T CG+  Y APEV+  +      VD 
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH-LSPGARDLIPRMLIVDPMKR 259
           WS GV+++ + CG  PF  E+   +++ I  G    P + LS   R  +  +L  +P  R
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240

Query: 260 I----TIPEIRQHPWF 271
           +       E+++HP+F
Sbjct: 241 LGAHRDAVELKEHPFF 256

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  141 bits (356), Expect = 7e-40
 Identities = 88/256 (34%), Positives = 136/256 (53%), Gaps = 9/256 (3%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIR 81
           K +G GSFGKV +A H       A+K+L ++ I   + E+ +  E  +L +   HP ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T   +Y V++Y+  GELF ++  +    E  AR +  +I S + Y H   +V+R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           DLKPEN+LLDS+ ++ + DFGL   NI  +G    T CG+P Y APEV+  + Y    VD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGT-TSTFCGTPEYLAPEVLHKQPY-DRTVD 178

Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
            W  G +LY +L G  PF   N   ++  I      L  +++  AR L+  +L  D  KR
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 238

Query: 260 I----TIPEIRQHPWF 271
           +       EI+ H +F
Sbjct: 239 LGAKDDFMEIKNHIFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  140 bits (355), Expect = 1e-39
 Identities = 84/255 (32%), Positives = 132/255 (51%), Gaps = 7/255 (2%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLFMHPHIIR 81
           K +G GSFGKV +A+    G   A+K+L ++ I K  E    +     +L+   HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T   +Y V++YV  GELF ++  +    E  AR +  ++ S + Y H   +++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLKPEN+LLDS+ +V + DFGL    +       T CG+P Y APEV+  + Y    VD 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY-DRTVDW 179

Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W  G +LY +L G  PF   ++  ++  I      LP   +  A DL+  +L  D  +R+
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239

Query: 261 ----TIPEIRQHPWF 271
                  EI+ H +F
Sbjct: 240 GAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  138 bits (348), Expect = 3e-39
 Identities = 87/261 (33%), Positives = 144/261 (55%), Gaps = 12/261 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKIL--NRRKIKNMEMEEKVRREIKILRLFM 75
           N++LGK LG G+FG+V +   A TG ++A+K +  +    +  +    +  EI++L+  +
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 76  HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           H  I++ Y  +  P +  + + ME++  G + D +   G L E+  R + +QI+ GV Y 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFG----LSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           H NM+VHRD+K  N+L DS  NVK+ DFG    L  I   G  +K+  G+P + +PEVIS
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLSPGARDL 247
           G+ Y G + D+WS G  +  +L    P+ + E +  +FK   +     LP H+S   RD 
Sbjct: 183 GEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241

Query: 248 IPRMLIVDPMKRITIPEIRQH 268
           + R+  V+   R +  E+ +H
Sbjct: 242 LKRIF-VEAKLRPSADELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  139 bits (350), Expect = 3e-39
 Identities = 88/273 (32%), Positives = 152/273 (55%), Gaps = 14/273 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GS G V IA    +G +VA+K+++ RK +  E+   +  E+ I+R + H +++ +Y+
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHQNVVEMYK 85

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                 +++V+ME+++ G L D IV + RL E++     + ++  + Y H   V+HRD+K
Sbjct: 86  SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144

Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
            +++LL     VK++DFG  + I +D    K+  G+P + APEVIS   Y G EVD+WS 
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSL 203

Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           G+++  ++ G  P+  ++     K+++            +SP  RD + RML  +P +R 
Sbjct: 204 GIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERA 263

Query: 261 TIPEIRQHPW-FQAHLPRYLAVPPPDTMQQAKK 292
           T  E+  HP+  Q  LP  L VP    +QQ +K
Sbjct: 264 TAQELLDHPFLLQTGLPECL-VP---LIQQYRK 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  139 bits (352), Expect = 4e-39
 Identities = 87/264 (32%), Positives = 132/264 (50%), Gaps = 9/264 (3%)

Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHK-VAIKILNRRKIKNMEMEEKVRREIKILR 72
           M   ++   +TLG GSFG+V +A +       VAIK   + KI   +  + V  E KIL 
Sbjct: 27  MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN 86

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              HP  + LY   +  S +Y+V+E+V  GE F ++    R   D    +  QI+   EY
Sbjct: 87  YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEY 146

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
                +V+RDLKPENLLLD    +K+ DFG + ++    +  T CG+P Y APE++   +
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY--TLCGTPEYIAPEILL-NV 203

Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252
             G   D W+ G+ +Y +L G  PF       +++KI  GI   P  L    + L+ ++L
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLL 263

Query: 253 IVDPMKRI-----TIPEIRQHPWF 271
             D  KR          +++HPWF
Sbjct: 264 SHDLTKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 4e-39
 Identities = 100/304 (32%), Positives = 148/304 (48%), Gaps = 56/304 (18%)

Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y+    +G G++G V  A H  TG KVAIK     KI   E +   ++  REIKILR 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISPFEHQTFCQRTLREIKILRR 59

Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  PS     D+Y+V E +++ +L+  I  +  L  D  + F  QI+ 
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILR 117

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ I    H    FL     +  Y A
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 185 PEV-ISGKLYAGPEVDVWSCGVILYALLCGTLPF----------------------DDEN 221
           PE+ ++ K Y    +D+WS G IL  +L     F                      D   
Sbjct: 178 PEIMLNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236

Query: 222 IPNLFKKIKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
           I +   + +  I +LP            +  P A DL+ +ML  +P KRIT+ E   HP+
Sbjct: 237 IIS--LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Query: 271 FQAH 274
            + +
Sbjct: 295 LEQY 298

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  137 bits (346), Expect = 4e-39
 Identities = 77/251 (30%), Positives = 136/251 (54%), Gaps = 6/251 (2%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K +G GSFGK  + +    G +  IK +N  K+   E EE  R+E+ +L    HP+I++ 
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQY 64

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYI-VEKGRL-QEDEARNFFQQIISGVEYCHRNMVVH 140
            E  E   ++Y+VM+Y + G+L+  I  ++G L  ED+  ++F QI   +++ H   ++H
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYAGPEVD 199
           RD+K +N+ L     +K+ DFG++ ++     L  +C G+P Y +PE+   + Y   + D
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN-KSD 183

Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMK 258
           +W+ G +LY +      F+  N+ NL  KI  G Y  + SH S   R+L+ ++   +P  
Sbjct: 184 IWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRD 243

Query: 259 RITIPEIRQHP 269
           R ++  I +  
Sbjct: 244 RPSVNSILEKN 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  136 bits (346), Expect = 6e-39
 Identities = 76/228 (33%), Positives = 113/228 (49%), Gaps = 15/228 (6%)

Query: 20  KLGKTLGIGSFGKVKIA----EHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRLF 74
           +LGK LG G+FG+V       +   T  KVA+K L   K    E E E+   E  I++  
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREEFLEEASIMKKL 58

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYC 133
            HP+I+RL  V      +Y+V EY+  G+L D++ + G  L   +      QI  G+EY 
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG--SPNYAAPEVISG 190
                VHRDL   N L+     VKI+DFGLS +I  D ++ K   G     + APE +  
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178

Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
             +   + DVWS GV+L+ +   G  P+   +   + + ++ G Y LP
Sbjct: 179 GKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG-YRLP 224

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  136 bits (345), Expect = 9e-39
 Identities = 73/266 (27%), Positives = 129/266 (48%), Gaps = 26/266 (9%)

Query: 23  KTLGIGSFGKVKIAE---HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           K LG G+FG+V   +         +VA+K L  ++  + E  +   +E ++++   HP++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL--KEDASEEERKDFLKEARVMKKLGHPNV 58

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ---------QIISGV 130
           +RL  V      +Y+V+EY++ G+L DY+ +   +     ++            QI  G+
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG-SPN-YAAPEV 187
           EY      VHRDL   N L+     VKI+DFGLS ++  D ++ K + G  P  + APE 
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 188 ISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN--LFKKIKGGIYTL--PSHLSP 242
           +   ++   + DVWS GV+L+ +   G  P+    + N  + + ++ G Y L  P +   
Sbjct: 179 LKDGIF-TSKSDVWSFGVLLWEIFTLGATPY--PGLSNEEVLEYLRKG-YRLPKPEYCPD 234

Query: 243 GARDLIPRMLIVDPMKRITIPEIRQH 268
              +L+     +DP  R T  E+ + 
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  136 bits (343), Expect = 2e-38
 Identities = 77/263 (29%), Positives = 128/263 (48%), Gaps = 15/263 (5%)

Query: 22  GKTLGIGSFGKVKIAEHALTGHKVAIK------ILNRRKIKNMEMEEKVRREIKILRLFM 75
           G  +G GSFG V +  +A +G  +A+K      +    K +   M + + REI +L+   
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           H +I++          + + +EYV  G +   +   G  +E   RNF +QI+ G+ Y H 
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSN-------IMRDGHFLKTSCGSPNYAAPEVI 188
             ++HRD+K  N+L+D+K  +KI+DFG+S          +      +  GS  + APEV+
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDL 247
               Y   + D+WS G ++  +L G  PF D        KI       +PS++S  A D 
Sbjct: 185 KQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDF 243

Query: 248 IPRMLIVDPMKRITIPEIRQHPW 270
           + +   +D  KR T  E+ +HP+
Sbjct: 244 LEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  137 bits (346), Expect = 7e-38
 Identities = 87/301 (28%), Positives = 131/301 (43%), Gaps = 53/301 (17%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KT+GIG+FG+V +     T    A+K L +  +        V+ E  IL    +  +++L
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           Y   +   ++Y VM+Y+  G++   ++  G  +ED AR +  ++   +E  H+   +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---------------------------- 174
           +KP+N+L+D   ++K+ DFGL    R  H  K                            
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186

Query: 175 ----------TSC------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD 218
                       C      G+PNY APEV+    Y     D WS GVILY +L G  PF 
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFL 245

Query: 219 DENIPNLFKKIKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWF 271
            +       K+     TL  PS   LS  A DLI R L      R+      EI+ HP+F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304

Query: 272 Q 272
           +
Sbjct: 305 K 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  134 bits (339), Expect = 8e-38
 Identities = 83/261 (31%), Positives = 132/261 (50%), Gaps = 13/261 (4%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
             LG G+ G V    H  TG  +A+K + R +I    +++++ RE+ IL     P+I+  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINE-AIQKQILRELDILHKCNSPYIVGF 64

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM-VVH 140
           Y       DI + MEY+  G L   + E +GR+ E         ++ G+ Y H    ++H
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           RD+KP N+L++S+  +K+ DFG+S  + +    KT  G+ +Y APE I G  Y   + D+
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNS-LAKTFVGTSSYMAPERIQGNDY-SVKSDI 182

Query: 201 WSCGVILYALLCGTLPFDDENIP-----NLFKKI-KGGIYTLPSH-LSPGARDLIPRMLI 253
           WS G+ L  L  G  P+  EN P      L + I       LPS   SP  +D +   LI
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLI 242

Query: 254 VDPMKRITIPEIRQHPWFQAH 274
            DP +R +  E+ +HP+ + +
Sbjct: 243 KDPRERPSYKELLEHPFIKKY 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  133 bits (337), Expect = 8e-38
 Identities = 83/246 (33%), Positives = 126/246 (51%), Gaps = 7/246 (2%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y + + +G GSFG+  + +H  +  K A+K +  R  K+    E  R+E  +L    HP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKMKHP 58

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRL-QEDEARNFFQQIISGVEYCHR 135
           +I+   E  E    +Y+VMEY   G+L   I +++G+L  ED    +F Q+  GV++ H 
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYA 194
             V+HRD+K +N+ L     VK+ DFG + ++   G +  T  G+P Y  PE+     Y 
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLI 253
             + D+WS G ILY L     PF   +  NL  K+ +G    LPSH S   R LI +M  
Sbjct: 179 N-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237

Query: 254 VDPMKR 259
            +P  R
Sbjct: 238 RNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  134 bits (337), Expect = 1e-37
 Identities = 89/266 (33%), Positives = 146/266 (54%), Gaps = 14/266 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR---EIKILRLF 74
           N++ GK LG G+FG+V +     TG ++A K + +   ++ E  ++V     EI++L+  
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQV-QFDPESPETSKEVSALECEIQLLKNL 61

Query: 75  MHPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
            H  I++ Y  +   ++  + + MEY+  G + D +   G L E   R + +QI+ G+ Y
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFG----LSNIMRDGHFLKTSCGSPNYAAPEVI 188
            H NM+VHRD+K  N+L DS  NVK+ DFG    L  I   G  +++  G+P + +PEVI
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLSPGARD 246
           SG+ Y G + DVWS G  +  +L    P+ + E +  +FK   +     LPSH+S  ARD
Sbjct: 182 SGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240

Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272
            +   + V+   R +  E+ +HP+ Q
Sbjct: 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  135 bits (341), Expect = 1e-37
 Identities = 82/263 (31%), Positives = 145/263 (55%), Gaps = 21/263 (7%)

Query: 23  KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVR--REIKILRLFMHP 77
           K LG GSFGKV +         G   A+K+L +  +K   + ++VR   E  IL    HP
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHP 58

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            I++L+   +T   +Y+++++++ G+LF  + ++    E++ + +  ++   +++ H   
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 196
           +++RDLKPEN+LLD + ++K+ DFGLS    D      S CG+  Y APEV++ + +   
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-Q 177

Query: 197 EVDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
             D WS GV+++ +L G+LPF   D +    +  K K G   +P  LSP A+ L+  +  
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG---MPQFLSPEAQSLLRALFK 234

Query: 254 VDPMKRI-----TIPEIRQHPWF 271
            +P  R+      + EI++HP+F
Sbjct: 235 RNPANRLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  134 bits (339), Expect = 1e-37
 Identities = 87/301 (28%), Positives = 144/301 (47%), Gaps = 64/301 (21%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRL 73
           N+K  + LG G++  V    +  TG  VA+K ++      ++ EE       REI +++ 
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH------LDAEEGTPSTAIREISLMKE 54

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI---VEKGRLQEDEARNFFQQIISGV 130
             H +I+RL++VI T + + +V EY+   +L  Y+     +G L  +  ++F  Q++ G+
Sbjct: 55  LKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113

Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN--------- 181
            +CH N V+HRDLKP+NLL++ +  +K+ADFGL+           + G P          
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR----------AFGIPVNTFSNEVVT 163

Query: 182 --YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKG----- 231
             Y AP+V+ G       +D+WS G I+  ++ G   F   ++E+      +I G     
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223

Query: 232 ---GIYTLPS------------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
              GI  LP                   H  P   DL+ R+L ++P  RI+  +  QHPW
Sbjct: 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Query: 271 F 271
           F
Sbjct: 284 F 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  135 bits (341), Expect = 1e-37
 Identities = 82/282 (29%), Positives = 150/282 (53%), Gaps = 22/282 (7%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIR 81
           + +G GS+ KV + E   T    A+K++ +  + + E  + V+ E  +      HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T S ++ V+E+V  G+L  ++  + +L E+ AR +  +I   + + H   +++R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK +N+LLD++ ++K+ D+G+    +R G    T CG+PNY APE++ G+ Y G  VD 
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179

Query: 201 WSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGARDLIPRM 251
           W+ GV+++ ++ G  PFD        D+N  + LF+ I      +P  LS  A  ++   
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239

Query: 252 LIVDPMKRI------TIPEIRQHPWFQA----HLPRYLAVPP 283
           L  DP +R+         +I+ HP+F+      L +   +PP
Sbjct: 240 LNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  133 bits (338), Expect = 2e-37
 Identities = 87/300 (29%), Positives = 128/300 (42%), Gaps = 78/300 (26%)

Query: 28  GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR--------REIKILRLFMHPHI 79
           G++G V  A    TG  VA+K     K+K     EK +        REI IL    HP+I
Sbjct: 16  GTYGVVYRARDKKTGEIVALK-----KLKM----EKEKEGFPITSLREINILLKLQHPNI 66

Query: 80  IRLYEVI--ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRN 136
           + + EV+       IY+VMEYV+  +L   +   K    + E +    Q++SGV + H N
Sbjct: 67  VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAP 185
            ++HRDLK  NLLL+++  +KI DFGL+             GSP            Y AP
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAR----------EYGSPLKPYTQLVVTLWYRAP 175

Query: 186 EVISGKLYAGPEVDVWSCGVILYALL---------------------CGTLPFDDENIPN 224
           E++ G       +D+WS G I   LL                      GT P  ++  P 
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT-P-TEKIWPG 233

Query: 225 LFK--KIKGGIYTLPSHLSPGAR-----------DLIPRMLIVDPMKRITIPEIRQHPWF 271
             +    K   +T   +     +           DL+ R+L  DP KRI+  +  +HP+F
Sbjct: 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  134 bits (339), Expect = 2e-37
 Identities = 85/257 (33%), Positives = 138/257 (53%), Gaps = 7/257 (2%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIR 81
           K +G GSFGKV +A+  L G   A+K+L ++ + N + ++ +  E  +L +   HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T   +Y V+++V  GELF ++  +    E  AR +  +I S + Y H   +V+R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLKPEN+LLDS+ +V + DFGL    +       T CG+P Y APEVI  + Y    VD 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-TVDW 179

Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W  G +LY +L G  PF   ++  ++  I      L    S  A  ++  +L  D  +R+
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL 239

Query: 261 ----TIPEIRQHPWFQA 273
                  EI++HP+F++
Sbjct: 240 GAKEDFLEIQEHPFFES 256

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  132 bits (335), Expect = 3e-37
 Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 23/269 (8%)

Query: 22  GKTLGIGSFGKVKIAEHALTGHKVAIK-------ILNRRKIKNMEMEEKVRREIKILRLF 74
           G+ +G G++G+V +A +  TG  +A+K       I  R   +  +M + +R EI+ L+  
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H +I++      T   + + +EYV  G +   +   GR +E   R F +Q++ G+ Y H
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD--GHFLKTSC-GSPNYAAPEVI--S 189
              ++HRDLK +NLL+D+    KI+DFG+S    D   +    S  GS  + APEVI   
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLP-------SHLS 241
            + Y+  +VD+WS G ++  +  G  P+ D+E I  +FK   G   + P        +LS
Sbjct: 186 SQGYSA-KVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK--LGNKRSAPPIPPDVSMNLS 242

Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPW 270
           P A D +     ++P  R T  E+ QHP+
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  132 bits (335), Expect = 3e-37
 Identities = 77/267 (28%), Positives = 128/267 (47%), Gaps = 16/267 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+L + +G+G+   V  A       KVAIK ++  K     ++E +R+E++ +    HP+
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDE-LRKEVQAMSQCNHPN 60

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFD---YIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ Y       ++++VM Y+  G L D       +G L E       ++++ G+EY H 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVISG 190
           N  +HRD+K  N+LL    +VKIADFG+S  + DG        KT  G+P + APEV+  
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHLSPGA----- 244
                 + D+WS G+    L  G  P+     +  L   ++    +L +           
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240

Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWF 271
           R +I   L  DP KR T  E+ +H +F
Sbjct: 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 4e-37
 Identities = 85/261 (32%), Positives = 134/261 (51%), Gaps = 20/261 (7%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G+FGKV  A+H  TG   A KI+   +I++ E  E    EI IL    HP+I+ LYE
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECKHPNIVGLYE 69

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
                + +++++E+   G L   ++E  R L E + R   +Q++  + + H + V+HRDL
Sbjct: 70  AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129

Query: 144 KPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP-- 196
           K  N+LL    +VK+ADFG+S      + +   F+    G+P + APEV++ + +     
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI----GTPYWMAPEVVACETFKDNPY 185

Query: 197 --EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 251
             + D+WS G+ L  L     P  + N +  L K +K    TL  PS  S    D +   
Sbjct: 186 DYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSC 245

Query: 252 LIVDPMKRITIPEIRQHPWFQ 272
           L+ DP  R T  E+ +HP+  
Sbjct: 246 LVKDPDDRPTAAELLKHPFVS 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 5e-37
 Identities = 87/268 (32%), Positives = 143/268 (53%), Gaps = 24/268 (8%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKIL--------NRRKIKNMEMEEKVRREIK 69
           N++LGK LG G+FG+V +   A TG ++A+K +          +++  +E E      I+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECE------IQ 56

Query: 70  ILRLFMHPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
           +L+   H  I++ Y  +  P +  + + +EY+  G + D +   G L E+  R + +QI+
Sbjct: 57  LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL 116

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS----NIMRDGHFLKTSCGSPNYA 183
            GV Y H NM+VHRD+K  N+L DS  NVK+ DFG S     I   G  +K+  G+P + 
Sbjct: 117 QGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176

Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLS 241
           +PEVISG+ Y G + DVWS    +  +L    P+ + E +  +FK   +     LP  +S
Sbjct: 177 SPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235

Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHP 269
              RD + + + V+  +R T   + +HP
Sbjct: 236 DACRDFL-KQIFVEEKRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  133 bits (337), Expect = 5e-37
 Identities = 84/318 (26%), Positives = 140/318 (44%), Gaps = 75/318 (23%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK------VRREIK 69
           L +Y++   LG G+FG+V  A    TG  VA+K       K +   EK        REIK
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-------KILMHNEKDGFPITALREIK 59

Query: 70  ILRLFMHPHIIRLYEVI--------ETPSDIYVVMEYVK---SGELFDYIVEKGRLQEDE 118
           IL+   HP+++ L ++              +Y+V  Y+    SG L +  V   +L E +
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV---KLTESQ 116

Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG 178
            + +  Q++ G+ Y H N ++HRD+K  N+L+D++  +KIADFGL+             G
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 179 SPN------------YAAPEVISGKLYAGPEVDVWSCGVILYAL---------------- 210
                          Y  PE++ G+      VD+W  G +   +                
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236

Query: 211 -----LCGTLPFDDENIPNLFKKIKG--GIYTLPSH----------LSPGARDLIPRMLI 253
                LCGT    +E  P  ++ + G  G+++  ++          L P   DL+ ++L 
Sbjct: 237 HLIFKLCGTP--TEETWPG-WRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293

Query: 254 VDPMKRITIPEIRQHPWF 271
           +DP KR+T  +  +HP+F
Sbjct: 294 LDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  132 bits (334), Expect = 5e-37
 Identities = 92/277 (33%), Positives = 141/277 (50%), Gaps = 18/277 (6%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G FG+V   +   TG   A K LN++++K  +  E    E +IL       I+ L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 85  VIETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
             +T +D+ +VM  +  G+L  +I     E     E  A  +  QIISG+E+ H+  +++
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVD 199
           RDLKPEN+LLD+  NV+I+D GL+  ++DG    K   G+P + APE++ G+ Y    VD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEY-DFSVD 179

Query: 200 VWSCGVILYALLCGTLPF--DDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            ++ GV LY ++    PF    E + N  L ++I     T P   SP ++     +L  D
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239

Query: 256 PMKRI-----TIPEIRQHPWFQAHLPRYL---AVPPP 284
           P KR+         +R HP F+    R L    +PPP
Sbjct: 240 PEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPP 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  133 bits (335), Expect = 1e-36
 Identities = 74/260 (28%), Positives = 122/260 (46%), Gaps = 13/260 (5%)

Query: 24  TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLY 83
            +G G FG+V++     TG   A+K++ +  +   E       E  IL +   P I +L 
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 84  EVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
              +   ++Y+VMEY   G+L   +   + +  ED A+ +  +++  +   H+   VHRD
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127

Query: 143 LKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTS-CGSPNYAAPEVI-----SGKLYAG 195
           +KPEN+L+D   ++K+ADFG +  +  +         G+P+Y APEV+      GK   G
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYG 187

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSHL--SPGARDLIPRM 251
            E D WS GVI Y ++ G  PF +      +  I         P     S    DLI + 
Sbjct: 188 VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLI-QS 246

Query: 252 LIVDPMKRITIPEIRQHPWF 271
           L+    +R+    +  HP+F
Sbjct: 247 LLCGQKERLGYEGLCCHPFF 266

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  130 bits (329), Expect = 1e-36
 Identities = 79/259 (30%), Positives = 136/259 (52%), Gaps = 7/259 (2%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y++ K +G GSFGK+ +A+         IK ++  K+   E +E  ++E+ +L    HP
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE-KEASKKEVILLAKMKHP 59

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRL-QEDEARNFFQQIISGVEYCHR 135
           +I+  +   +    +++VMEY   G+L   I  ++G L  ED+  ++F QI  G+++ H 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 136 NMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLY 193
             ++HRD+K +N+ L     V K+ DFG++  + D   L  +C G+P Y +PE+   + Y
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRML 252
              + D+WS G +LY L     PF+  N+  L  KI +G    +  + S   R LI ++ 
Sbjct: 180 NN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238

Query: 253 IVDPMKRITIPEIRQHPWF 271
            V P  R +I  I + P+ 
Sbjct: 239 KVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  130 bits (330), Expect = 2e-36
 Identities = 84/284 (29%), Positives = 139/284 (48%), Gaps = 37/284 (13%)

Query: 5   SNRSSSGVDMFLPNYKLGKTLGI--GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
            ++S S +  FL N ++ K L +  G FGKV + +H  T      K+  ++ IK      
Sbjct: 2   MDKSLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQ-----KLFVQKIIKAKNFNA 56

Query: 63  KVRREIKILRLFM--HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
               E  + +L M  +P+ I+LY  + T     ++M+Y+K G+LFD + ++G+L E E +
Sbjct: 57  I---EPMVHQL-MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVK 112

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSC-- 177
              +Q++  +   H++ ++H D+K EN+L D +K  + + D+GL  I+  G     SC  
Sbjct: 113 KIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII--GT---PSCYD 167

Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD---DENI------PNLFKK 228
           G+ +Y +PE I G  Y     D W+ GV+ Y LL G  PF    DE +          KK
Sbjct: 168 GTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK 226

Query: 229 IKGGIYTLPSHLSPGARDLIPRMLIVDPMKR-ITIPEIRQHPWF 271
           +         ++S  A D +  ML  +   R     EI +HP+ 
Sbjct: 227 L-----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  131 bits (331), Expect = 2e-36
 Identities = 86/266 (32%), Positives = 140/266 (52%), Gaps = 11/266 (4%)

Query: 17  PNYKLGK--TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           P  K  +   +G G+ G V  A    TG +VAIK +N   ++    +E +  EI ++R  
Sbjct: 17  PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMREN 73

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I+   +      +++VVMEY+  G L D + E   + E +     ++ +  +E+ H
Sbjct: 74  KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH 132

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
            N V+HRD+K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPR 250
            GP+VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R
Sbjct: 193 -GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251

Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLP 276
            L +D  KR +  E+ QHP+ +   P
Sbjct: 252 CLEMDVEKRGSAKELLQHPFLKIAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  130 bits (328), Expect = 3e-36
 Identities = 88/272 (32%), Positives = 134/272 (49%), Gaps = 32/272 (11%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR-----EIKI 70
           L N+K+ K +G G F  V  A   L G  VA+K     K++  EM +   R     EI +
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALK-----KVQIFEMMDAKARQDCLKEIDL 55

Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI---VEKGRL-QEDEARNFFQQI 126
           L+   HP++I+        +++ +V+E   +G+L   I    ++ RL  E     +F Q+
Sbjct: 56  LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTS-----CGS 179
            S +E+ H   ++HRD+KP N+ + +   VK+ D GL      G F   KT+      G+
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTTAAHSLVGT 169

Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIYT-L 236
           P Y +PE I    Y   + D+WS G +LY +     PF  D  N+ +L KKI+   Y  L
Sbjct: 170 PYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL 228

Query: 237 PS-HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           P+ H S   RDL+ R +  DP KR  I  + Q
Sbjct: 229 PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  131 bits (332), Expect = 4e-36
 Identities = 91/298 (30%), Positives = 144/298 (48%), Gaps = 49/298 (16%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR-----REIKILRL 73
           Y   K +G G++G V  A+++ T  KVAIK     KI N   + ++      REIK+LR 
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIK-----KIANA-FDNRIDAKRTLREIKLLRH 60

Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
             H ++I + +++  P      D+Y+V E + + +L   I     L +D  + F  Q++ 
Sbjct: 61  LDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLR 119

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEV 187
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+    + G F+     +  Y APE+
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179

Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLF-K 227
           +         +DVWS G I   LL     F                    +E++  +  +
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239

Query: 228 KIKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
           K +  I +LP            H +P A DL+ +ML+ DP KRIT+ E   HP+  + 
Sbjct: 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  130 bits (328), Expect = 5e-36
 Identities = 85/301 (28%), Positives = 131/301 (43%), Gaps = 61/301 (20%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRL 73
            Y++   +G G++G V    +  TG  VAIK     K K  E +E V+    RE+K+LR 
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQ 56

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEY 132
             H +I+ L E       +Y+V EYV+   L + +    G L  D  R++  Q++  + Y
Sbjct: 57  LRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------YA 183
           CH + ++HRD+KPEN+L+     +K+ DFG +  +R          +           Y 
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR-------PASPLTDYVATRWYR 168

Query: 184 APEVISGKLYAGPEVDVWSCGVILYALL---------------------CGTLP------ 216
           APE++ G    G  VDVW+ G I+  LL                      G LP      
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228

Query: 217 ------FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
                 F     P    + +      P  +S  A D +   L +DP +R+T  E+ QHP+
Sbjct: 229 FSSNPRFAGVAFPEP-SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Query: 271 F 271
           F
Sbjct: 288 F 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  128 bits (324), Expect = 9e-36
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 27/260 (10%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG GS+G V  A H  TG  VAIK++        E  +++ +EI IL+    P+I++ Y 
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQCDSPYIVKYYG 65

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
                +D+++VMEY  +G + D +    + L E+E      Q + G+EY H N  +HRD+
Sbjct: 66  SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125

Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           K  N+LL+ +   K+ADFG+S  + D      T  G+P + APEVI    Y   + D+WS
Sbjct: 126 KAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-NNKADIWS 184

Query: 203 CGVILYALLCGTLPFDDEN-------IPNL----FKKIKGGIYTLPSHLSPGARDLIPRM 251
            G+    +  G  P+ D +       IPN                P   SP   D + + 
Sbjct: 185 LGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD--------PEKWSPEFNDFVKKC 236

Query: 252 LIVDPMKRITIPEIRQHPWF 271
           L+ DP +R +  ++ QHP+ 
Sbjct: 237 LVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  130 bits (329), Expect = 1e-35
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 58/306 (18%)

Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----MEMEEKVRREIKILR 72
             YK  + +G G++G V  A    +G KVAIK     KI +      + ++  RE+KILR
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILR 59

Query: 73  LFMHPHIIRLYEVIETPS----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
            F H +II + +++  P     D+YVVM+ ++S +L   I     L E+  R F  Q++ 
Sbjct: 60  HFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR 118

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL-----SNIMRDGHFLKTSCGSPNYA 183
           G++Y H   V+HRDLKP NLL++    ++I DFG+     S+     +F+     +  Y 
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 184 APEVISGKLYAGPE----VDVWSCGVILYALLCGTLPFDDENIPNLFKKI---------- 229
           APE+    L + PE    +D+WS G I   +L     F  +N  +  K I          
Sbjct: 179 APEL----LLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234

Query: 230 ----------KGGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQH 268
                     +  I  LP              SP A DL+ +ML  DP +RIT+ +  QH
Sbjct: 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294

Query: 269 PWFQAH 274
           P+   +
Sbjct: 295 PFLAQY 300

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  129 bits (325), Expect = 1e-35
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 9/262 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   + +G G+ G V  A    TG +VAIK +N +K    E+   +  EI +++   +P+
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMKELKNPN 77

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+   +      +++VVMEY+  G L D + E   + E +     ++ +  +E+ H N V
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHANQV 136

Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRD+K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y GP+
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 195

Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
           VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LSP  RD + R L +
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEM 255

Query: 255 DPMKRITIPEIRQHPWFQAHLP 276
           D  KR +  E+ QHP+ +   P
Sbjct: 256 DVEKRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  129 bits (325), Expect = 2e-35
 Identities = 82/267 (30%), Positives = 146/267 (54%), Gaps = 18/267 (6%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIR 81
           + +G GS+ KV +     T    A+K++ +  + + E  + V+ E  +  +   HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T S ++ V+EYV  G+L  ++  + +L E+ AR +  +I   + Y H   +++R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK +N+LLDS+ ++K+ D+G+    +R G    T CG+PNY APE++ G+ Y G  VD 
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179

Query: 201 WSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGARDLIPRM 251
           W+ GV+++ ++ G  PFD        D+N  + LF+ I      +P  LS  A  ++   
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239

Query: 252 LIVDPMKRI-TIPE-----IRQHPWFQ 272
           L  DP +R+   P+     I+ HP+F+
Sbjct: 240 LNKDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  128 bits (323), Expect = 2e-35
 Identities = 95/296 (32%), Positives = 146/296 (49%), Gaps = 67/296 (22%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           +G G++G V    +  TG  VA+K     KI+    EE V     REI +L+   HP+I+
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKELQHPNIV 62

Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDE-ARNFFQQIISGVEYCHRNM 137
            L +V+   S +Y++ E++ S +L  Y+  + KG+  + E  +++  QI+ G+ +CH   
Sbjct: 63  CLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 186
           V+HRDLKP+NLL+D+K  +K+ADFGL+           + G P            Y APE
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR----------AFGIPVRVYTHEVVTLWYRAPE 171

Query: 187 VISG-KLYAGPEVDVWSCGVILYAL---------------------LCGTLPFDD----- 219
           V+ G   Y+ P VD+WS G I   +                     + GT P +D     
Sbjct: 172 VLLGSPRYSTP-VDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT-PTEDVWPGV 229

Query: 220 ENIP---NLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            ++P   N F K K G   +   +L     DL+ +MLI DP KRI+  +   HP+F
Sbjct: 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  128 bits (323), Expect = 2e-35
 Identities = 88/293 (30%), Positives = 146/293 (49%), Gaps = 48/293 (16%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-NMEME---EKVRREIKILRL 73
           N++  + +G G++G V  A + LTG  VA+K     KI+ + E E       REI +L+ 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKE 55

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY--IVEKGRLQEDEARNFFQQIISGVE 131
             HP+I++L +VI T + +Y+V E++   +L  +        +     +++  Q++ G+ 
Sbjct: 56  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVI 188
           +CH + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++
Sbjct: 115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL 172

Query: 189 SGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIPNLFK----------KIKGGIYTL 236
            G  Y    VD+WS G I   ++      P D E I  LF+           +  G+ +L
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSL 231

Query: 237 PSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
           P +                  L    RDL+ +ML  DP KRI+      HP+F
Sbjct: 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  127 bits (321), Expect = 1e-34
 Identities = 86/280 (30%), Positives = 132/280 (47%), Gaps = 37/280 (13%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G+G+FG V  A   LTG  VAIK +  +      + ++  RE+K+L+   H +II L
Sbjct: 16  QPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIISL 74

Query: 83  YEVIETPS-DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
            ++  +P  DIY V E +  G     ++    L++   + F  QI+ G++Y H   VVHR
Sbjct: 75  SDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHR 132

Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
           DLKP N+L++   ++KI DFGL+ I      +     +  Y APE++        EVD+W
Sbjct: 133 DLKPSNILINENCDLKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIW 190

Query: 202 SCGVILYAL---------------------LCGTLPFD------DEN----IPNLFKKIK 230
           S G I   +                     L GT P D       EN    + +L K+  
Sbjct: 191 SAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREP 250

Query: 231 GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
                   +  P A DL+ +ML+ DP KRI+  E   HP+
Sbjct: 251 VPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  128 bits (323), Expect = 1e-34
 Identities = 88/287 (30%), Positives = 140/287 (48%), Gaps = 42/287 (14%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G+V  A    TG KVAIK L  R  ++    ++  RE+++L+   H ++I L +
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81

Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E   D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 82  VFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGI 139

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP N+ ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 140 IHRDLKPSNIAVNEDCELKILDFGLAR-HTD-DEMTGYVATRWYRAPEIMLNWMHYNQTV 197

Query: 199 DVWSCGVILYALLCG-TL-PFDDEN-----I--------PNLFKKI-----KGGIYTLPS 238
           D+WS G I+  LL G TL P  D       I          L +KI     +  I +LP 
Sbjct: 198 DIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQ 257

Query: 239 H-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
                        +P A DL+ +ML++DP KRIT  E   HP+   +
Sbjct: 258 MPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  125 bits (315), Expect = 4e-34
 Identities = 82/265 (30%), Positives = 142/265 (53%), Gaps = 15/265 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GS G V IA    +G  VA+K ++ RK +  E+   +  E+ I+R + H +++ +Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 84

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                 +++VVME+++ G L D IV   R+ E++       ++  +   H   V+HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
            +++LL     VK++DFG  + + ++    K+  G+P + APE+IS +L  GPEVD+WS 
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS-RLPYGPEVDIWSL 202

Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPRMLIVDPM 257
           G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R+L+ DP 
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259

Query: 258 KRITIPEIRQHPWFQAHLPRYLAVP 282
           +R T  E+ +HP+     P    VP
Sbjct: 260 QRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 6e-34
 Identities = 86/282 (30%), Positives = 136/282 (48%), Gaps = 35/282 (12%)

Query: 16  LPN----YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
           LP+    ++L + +G G++GKV  A H  TG  VAIKI++  +    + EE+++ E  IL
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNIL 56

Query: 72  RLFM-HPHIIRLYEVIETPSD------IYVVMEYVKSGELFDYI----VEKGRLQEDEAR 120
           R +  HP+I   Y      +       +++VME    G + D +     +  RL+E+   
Sbjct: 57  RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKT 175
              ++ + G+ Y H N V+HRD+K +N+LL     VK+ DFG+S      + R      T
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN----T 172

Query: 176 SCGSPNYAAPEVISGKLYAGP----EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIK 230
             G+P + APEVI+             DVWS G+    L  G  P  D + +  LFK  +
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232

Query: 231 GGIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
               TL  P + S    D I   LI +  +R  + E+ +HP+
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  124 bits (313), Expect = 8e-34
 Identities = 82/265 (30%), Positives = 144/265 (54%), Gaps = 15/265 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GS G V IA    TG +VA+K ++ RK +  E+   +  E+ I+R + H +++ +Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRDYHHENVVDMYN 86

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                 +++VVME+++ G L D IV   R+ E++       ++  + Y H   V+HRD+K
Sbjct: 87  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
            +++LL S   +K++DFG  + + ++    K+  G+P + APEVIS +L  G EVD+WS 
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS-RLPYGTEVDIWSL 204

Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPRMLIVDPM 257
           G+++  ++ G  P+ +E      ++I+     LP  +      S   R  +  ML+ +P 
Sbjct: 205 GIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDLMLVREPS 261

Query: 258 KRITIPEIRQHPWFQAHLPRYLAVP 282
           +R T  E+ QHP+ +   P    VP
Sbjct: 262 QRATAQELLQHPFLKLAGPPSCIVP 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  124 bits (312), Expect = 9e-34
 Identities = 82/262 (31%), Positives = 139/262 (53%), Gaps = 9/262 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   + +G G+ G V  A    TG +VAIK +N   ++    +E +  EI ++R   +P+
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPN 77

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+   +      +++VVMEY+  G L D + E   + E +     ++ +  +++ H N V
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQV 136

Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRD+K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y GP+
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 195

Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
           VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L +
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEM 255

Query: 255 DPMKRITIPEIRQHPWFQAHLP 276
           D  +R +  E+ QHP+ +   P
Sbjct: 256 DVDRRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  125 bits (316), Expect = 9e-34
 Identities = 82/294 (27%), Positives = 141/294 (47%), Gaps = 45/294 (15%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K +G G+FG+V++ +   TGH  A+KIL +  +   E    +R E  IL       ++++
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           +   +   ++Y++ME++  G++   +++K  L E+  + +  + +  ++  H+   +HRD
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGH------------------------------- 171
           +KP+NLLLD+K +VK++DFGL   ++  H                               
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186

Query: 172 -----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226
                   ++ G+P+Y APEV     Y     D WS GVI+Y +L G  PF  E     +
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245

Query: 227 KKIKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQA 273
           +K+     TL  P    +S  A+DLI R    D   RI    + EI+ HP+F+ 
Sbjct: 246 RKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  126 bits (317), Expect = 1e-33
 Identities = 85/309 (27%), Positives = 140/309 (45%), Gaps = 57/309 (18%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++   K +G G+FG+V++ +   TG   A+K L + ++   +    V+ E  +L     P
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            ++ LY   +    +Y++ME++  G+L   +++     ED  R +  + +  +E  H+  
Sbjct: 62  WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-----------------------------NIMR 168
            +HRD+KP+N+L+D   ++K++DFGLS                             ++  
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181

Query: 169 DGHFLKTS-------------------CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYA 209
           D   L  S                    G+P+Y APE+   + Y G E D WS G I++ 
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFE 240

Query: 210 LLCGTLPFDDENIPNLFKKIKGGIYTL--PS--HLSPGARDLIPRMLIVDPMKRI---TI 262
            L G  PF  EN    ++KI     TL  P   HLS  A DLI R LI +   R+     
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLI-RRLITNAENRLGRGGA 299

Query: 263 PEIRQHPWF 271
            EI+ HP+F
Sbjct: 300 HEIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  124 bits (312), Expect = 2e-33
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 16/271 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++++ K +G G+FG+V + +   T    A+KILN+ ++         R E  +L      
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRN 136
            I  L+   +  + +Y+VM+Y   G+L   + + + RL ED AR +  +++  +   H+ 
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVIS----G 190
             VHRD+KP+N+LLD   ++++ADFG    M     +++S   G+P+Y +PE++     G
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHL---SPGAR 245
               GPE D WS GV +Y +L G  PF  E++   + KI      +  PSH+   S  A+
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAK 241

Query: 246 DLIPRMLIVDPMKRI---TIPEIRQHPWFQA 273
           DLI R LI    +R+    I + ++H +F+ 
Sbjct: 242 DLIQR-LICSRERRLGQNGIEDFKKHAFFEG 271

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  124 bits (311), Expect = 3e-33
 Identities = 83/271 (30%), Positives = 145/271 (53%), Gaps = 16/271 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++++ K +G G+FG+V + +        A+KILN+ ++         R E  +L    + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRN 136
            I  L+   +  +++Y+VM+Y   G+L   + + + RL ED AR +  +++  ++  H+ 
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT-SCGSPNYAAPEVIS----G 190
             VHRD+KP+N+L+D   ++++ADFG    +M DG    + + G+P+Y +PE++     G
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSH---LSPGAR 245
           K   GPE D WS GV +Y +L G  PF  E++   + KI      +  P+    +S  A+
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAK 241

Query: 246 DLIPRMLIVDPMKRI---TIPEIRQHPWFQA 273
           DLI R LI     R+    I + +QHP+F  
Sbjct: 242 DLI-RRLICSREHRLGQNGIEDFKQHPFFTG 271

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  122 bits (309), Expect = 3e-33
 Identities = 92/305 (30%), Positives = 138/305 (45%), Gaps = 63/305 (20%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILR 72
            Y+  + +G G++GKV  A    TG  VA+K     K + +EM+E+       REI +L+
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALK-----KTR-LEMDEEGIPPTALREISLLQ 55

Query: 73  LFMH-PHIIRLYEVIETPSD-----IYVVMEYVKSGELFDYIVEKGR-----LQEDEARN 121
           +     +I+RL +V           +Y+V EY+ S +L  ++   GR     L     ++
Sbjct: 56  MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKS 114

Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSN-----IMRDGHFLKT 175
           F  Q++ GV +CH++ V+HRDLKP+NLL+D  K  +KIAD GL       +    H + T
Sbjct: 115 FMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVT 174

Query: 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIK---- 230
                 Y APEV+ G  +    VD+WS G I   +      F  D  +  L    K    
Sbjct: 175 LW----YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230

Query: 231 ------GGI------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR 266
                  G+                    +P  LSP   DL+ +ML  DP KRI+     
Sbjct: 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAAL 289

Query: 267 QHPWF 271
            HP+F
Sbjct: 290 THPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  124 bits (312), Expect = 5e-33
 Identities = 78/266 (29%), Positives = 142/266 (53%), Gaps = 12/266 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y++ K +G G+FG+V++  H  T    A+K+L++ ++           E  I+     P
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            +++L+   +    +Y+VMEY+  G+L + ++    + E  AR +  +++  ++  H   
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 162

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVIS---GKL 192
            +HRD+KP+N+LLD   ++K+ADFG    M     ++  T+ G+P+Y +PEV+    G  
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLP--SHLSPGARDLI 248
           Y G E D WS GV LY +L G  PF  +++   + KI       T P  + +S  A++LI
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 282

Query: 249 PRMLIVDPMK--RITIPEIRQHPWFQ 272
              L    ++  R  + EI++H +F+
Sbjct: 283 CAFLTDREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  122 bits (307), Expect = 5e-33
 Identities = 85/278 (30%), Positives = 143/278 (51%), Gaps = 9/278 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   + +G G+ G V  A    TG +VAI+ +N   ++    +E +  EI ++R   +P+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 78

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+   +      +++VVMEY+  G L D + E   + E +     ++ +  +E+ H N V
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 137

Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRD+K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y GP+
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 196

Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
           VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256

Query: 255 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 257 DVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  121 bits (307), Expect = 5e-33
 Identities = 84/301 (27%), Positives = 135/301 (44%), Gaps = 67/301 (22%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMHP 77
           YK+   +G G+F +V  A+   TG   AIK + +      ++     REI+ LR L  HP
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHP 58

Query: 78  HIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEY 132
           +I+RL EV+       + +V E +    L++ I  KGR   L E   +++  Q++  +++
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELMD-MNLYELI--KGRKRPLPEKRVKSYMYQLLKSLDH 115

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------- 181
            HRN + HRD+KPEN+L+     +K+ADFG             SC               
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFG-------------SCRGIYSKPPYTEYIST 161

Query: 182 --YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNL------- 225
             Y APE +    Y GP++D+W+ G + + +L     F   N       I ++       
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE 221

Query: 226 --------------FKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
                         F   KG G+  L  + S    DL+ ++L  DP +RIT  +  +HP+
Sbjct: 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Query: 271 F 271
           F
Sbjct: 282 F 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  122 bits (307), Expect = 6e-33
 Identities = 92/288 (31%), Positives = 137/288 (47%), Gaps = 41/288 (14%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVR----REIK 69
           + K  K LG G FGKV++  +      TG +VA+K LN         EE+ R    REI+
Sbjct: 5   HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH------SGEEQHRSDFEREIE 58

Query: 70  ILRLFMHPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEAR--NFFQQ 125
           ILR   H +I++   V E P    + ++MEY+ SG L DY+ ++ R Q +  R   F  Q
Sbjct: 59  ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQ 117

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-N 181
           I  G++Y      +HRDL   N+L++S+  VKI+DFGL+ ++   +D +++K    SP  
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 182 YAAPEVIS-GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH- 239
           + APE +   K  +    DVWS GV LY L   T     ++ P  F ++ G         
Sbjct: 178 WYAPECLRTSKFSS--ASDVWSFGVTLYELF--TYGDPSQSPPAEFLRMIGIAQGQMIVT 233

Query: 240 -----LSPGARDLIPR-----MLIVDPMKRITIPEIRQHPWFQAHLPR 277
                L  G R  +PR       + D MK     E +  P F   +  
Sbjct: 234 RLLELLKEGER--LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  122 bits (308), Expect = 7e-33
 Identities = 88/313 (28%), Positives = 140/313 (44%), Gaps = 76/313 (24%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILRL 73
           Y+    +G G+FG+V  A H  T   VA+K     K+  ME E++       REIKIL+L
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVL-MENEKEGFPITALREIKILQL 67

Query: 74  FMHPHIIRLYEVIETP--------SDIYVVMEYVK---SGELFDYIVEKGRLQEDEARNF 122
             H +++ L E+  T            Y+V E+ +   +G L +  V   +    E +  
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEIKKV 124

Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN- 181
            + +++G+ Y HRN ++HRD+K  N+L+     +K+ADFGL+       F  +    PN 
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA-----FSLSKNSKPNR 179

Query: 182 ---------YAAPEVISGKLYAGPEVDVWSCGVI---------------------LYALL 211
                    Y  PE++ G+   GP +D+W  G I                     L + L
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239

Query: 212 CGTL-----PFDDENIPNLFKKI---KGGIYTLPSHLSP-----GARDLIPRMLIVDPMK 258
           CG++     P   + +  LFKK+   +G    +   L P      A DLI ++L++DP K
Sbjct: 240 CGSITPEVWP-GVDKLE-LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAK 297

Query: 259 RITIPEIRQHPWF 271
           RI       H +F
Sbjct: 298 RIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 1e-32
 Identities = 80/280 (28%), Positives = 134/280 (47%), Gaps = 15/280 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           ++  + LG G FG+V   +   TG   A K L +++IK  + E     E +IL       
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRN 136
           ++ L    ET   + +V+  +  G+L  +I   G    DE R  F   +I  G+E  HR 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            +V+RDLKPEN+LLD   +++I+D GL+  + +G  ++   G+  Y APEV+  + Y   
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY-TF 180

Query: 197 EVDVWSCGVILYALLCGTLPFD--DENIP--NLFKKIKGGIYTLPSHLSPGARDLIPRML 252
             D W  G ++Y ++ G  PF    E +    + +++K          S  AR +  ++L
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240

Query: 253 IVDPMKRI-----TIPEIRQHPWFQAHLPRYLA---VPPP 284
             DP  R+        E++ HP+F+    + L    + PP
Sbjct: 241 TKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  122 bits (308), Expect = 1e-32
 Identities = 78/277 (28%), Positives = 146/277 (52%), Gaps = 12/277 (4%)

Query: 7   RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR 66
           R    + M   +Y + K +G G+FG+V++  H  +    A+K+L++ ++           
Sbjct: 33  RKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 67  EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQI 126
           E  I+     P +++L+   +    +Y+VMEY+  G+L + ++    + E  A+ +  ++
Sbjct: 93  ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEV 151

Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAA 184
           +  ++  H   ++HRD+KP+N+LLD   ++K+ADFG    M +   ++  T+ G+P+Y +
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211

Query: 185 PEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----P 237
           PEV+    G  Y G E D WS GV L+ +L G  PF  +++   + KI     +L     
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271

Query: 238 SHLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQ 272
             +S  A++LI   L    ++  R  + EI+QHP+F+
Sbjct: 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  120 bits (303), Expect = 2e-32
 Identities = 81/265 (30%), Positives = 130/265 (49%), Gaps = 20/265 (7%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + LG G FG+V   +   TG   A K L +++IK  + E     E +IL       ++ L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVH 140
               ET   + +V+  +  G+L  +I   G    +E R  F   +I  G+E  H+  +V+
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA-GPEVD 199
           RDLKPEN+LLD   +++I+D GL+  + +G  +K   G+  Y APEV+  + Y   P  D
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP--D 183

Query: 200 VWSCGVILYALLCGTLPFDD-------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252
            W+ G +LY ++ G  PF         E +  L K+++          SP AR L   +L
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---EEYSEKFSPDARSLCKMLL 240

Query: 253 IVDPMKRI-----TIPEIRQHPWFQ 272
             DP +R+        E+++HP F+
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 2e-32
 Identities = 78/260 (30%), Positives = 133/260 (51%), Gaps = 9/260 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           + L + +G GSFG+V  A    T   VAIK+++  + ++ E+E+ +++EI+ L     P+
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-EIED-IQQEIQFLSQCRSPY 60

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I + Y      S ++++MEY   G   D +++ G+L E       ++++ G+EY H    
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEGK 119

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVISGKLYAGP 196
           +HRD+K  N+LL  + +VK+ADFG+S  +      K  T  G+P + APEVI    Y   
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTS-TMSKRNTFVGTPFWMAPEVIKQSGYDE- 177

Query: 197 EVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHL-SPGARDLIPRMLIV 254
           + D+WS G+    L  G  P  D   +  LF   K    +L  +  S   +D +   L  
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237

Query: 255 DPMKRITIPEIRQHPWFQAH 274
           DP +R +  E+ +H + +  
Sbjct: 238 DPKERPSAKELLKHKFIKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  121 bits (304), Expect = 2e-32
 Identities = 90/297 (30%), Positives = 136/297 (45%), Gaps = 61/297 (20%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE---KVRREIKILRLFMHPHIIR 81
           +G G++G+V  A    TG  VA+K   + ++ N E E       REIKILR   H +I+ 
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALK---KVRLDN-EKEGFPITAIREIKILRQLNHRNIVN 70

Query: 82  LYEVIETPSD----------IYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISG 129
           L E++    D           Y+V EY+   +L   ++E G     ED  ++F +Q++ G
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMG-LLESGLVHFSEDHIKSFMKQLLEG 128

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTSCGSPNYAAPEV 187
           + YCH+   +HRD+K  N+LL++K  +K+ADFGL+ +    +         +  Y  PE+
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPEL 188

Query: 188 ISGKLYAGPEVDVWSCGVILYAL---------------------LCGTLPFDDENIPNLF 226
           + G+   GP +DVWSCG IL  L                     LCG+ P      P++ 
Sbjct: 189 LLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS-P-CPAVWPDVI 246

Query: 227 KKIKGGIYTLP-------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
           K       T+              S +   A DL+  ML +DP KR T  E    PW
Sbjct: 247 KLP--YFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  122 bits (308), Expect = 2e-32
 Identities = 83/295 (28%), Positives = 137/295 (46%), Gaps = 41/295 (13%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G+FG V        G +VA+K +     +N+   ++V RE+K+L  F H +++  
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFRELKMLCFFKHDNVLSA 64

Query: 83  YEVIETP-----SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            ++++ P      +IYVV E ++S +L   IV    L  D  + F  QI+ G++Y H   
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNI--MRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           ++HRD+KP NLL++S   +KI DFGL+ +    +   +     +  Y APE++ G  +  
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYT 183

Query: 196 PEVDVWSCGVILYALLCGTLPFD----------------DENIPNLFKKIKGG------- 232
             VD+WS G I   LL   + F                   ++  +    +G        
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243

Query: 233 ---------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278
                    +YTL S  +  A  L+ RML+ DP KRI+  +   HP+      RY
Sbjct: 244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRY 298

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 4e-32
 Identities = 82/264 (31%), Positives = 139/264 (52%), Gaps = 16/264 (6%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K +G G+FG+V + +   TG   A+KILN+ ++         R E  +L       I  L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +   +  +++Y+VM+Y   G+L   + +   RL ED AR +  +++  ++  H+   VHR
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR 126

Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVI----SGKLYAG 195
           D+KP+N+LLD   ++++ADFG    +     ++++   G+P+Y +PE++     GK   G
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYG 186

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSH---LSPGARDLIPR 250
           PE D WS GV +Y +L G  PF  E++   + KI      +  P     +S  A+DLI R
Sbjct: 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLI-R 245

Query: 251 MLIVDPMKRI---TIPEIRQHPWF 271
            LI  P  R+    + + + HP+F
Sbjct: 246 RLICSPETRLGRNGLQDFKDHPFF 269

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  121 bits (305), Expect = 4e-32
 Identities = 94/325 (28%), Positives = 146/325 (44%), Gaps = 67/325 (20%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A   +TG  VAIK L+R   +N+   ++  RE+ +++L  
Sbjct: 15  LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSR-PFQNVTHAKRAYRELVLMKLVN 73

Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDY---IVEKGRLQEDEARNFFQQI 126
           H +II L  V      +E   D+Y+VME      L D     V +  L  +       Q+
Sbjct: 74  HKNIIGLLNVFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQM 127

Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
           + G+++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APE
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 187

Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFK 227
           VI G  Y    VD+WS G I+  ++ GT+ F                    DE +  L  
Sbjct: 188 VILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246

Query: 228 KIKGGIYTLPSH-------LSPG-----------------ARDLIPRMLIVDPMKRITIP 263
            ++  +   P +       L P                  ARDL+ +ML++DP KRI++ 
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306

Query: 264 EIRQHP----WFQAHLPRYLAVPPP 284
           +  QHP    W+    P  +  PPP
Sbjct: 307 DALQHPYINVWYD---PSEVEAPPP 328

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  121 bits (304), Expect = 5e-32
 Identities = 88/290 (30%), Positives = 135/290 (46%), Gaps = 48/290 (16%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           +G G+ G V    H  TG   A+K++          E+ VR    REI+ILR   HP+++
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNH------EDTVRRQICREIEILRDVNHPNVV 135

Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
           + +++ +   +I V++E++  G L    +   +   D AR    QI+SG+ Y HR  +VH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVH 191

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKL----YAG 195
           RD+KP NLL++S  NVKIADFG+S I+ +      +S G+  Y +PE I+  L    Y G
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDG 251

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL------------PSHLSPG 243
              D+WS GV +     G  PF       + +  +G   +L            P+  S  
Sbjct: 252 YAGDIWSLGVSILEFYLGRFPF------GVGR--QGDWASLMCAICMSQPPEAPATASRE 303

Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF---------QAHLPRYLAVPPP 284
            R  I   L  +P KR +  ++ QHP+                 L  PP 
Sbjct: 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPPPR 353

Length = 353

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  120 bits (302), Expect = 5e-32
 Identities = 78/280 (27%), Positives = 146/280 (52%), Gaps = 20/280 (7%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIR 81
           + +G GS+ KV +          A+K++ +  + + E  + V+ E  +  +   +P ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T S +++V+EYV  G+L  ++  + +L E+ AR +  +I   + + H   +++R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK +N+LLD+  ++K+ D+G+    +  G    T CG+PNY APE++ G+ Y G  VD 
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179

Query: 201 WSCGVILYALLCGTLPFD------DENIPN-LFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
           W+ GV+++ ++ G  PFD      D N  + LF+ I      +P  LS  A  ++   L 
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239

Query: 254 VDPMKRI------TIPEIRQHPWFQA----HLPRYLAVPP 283
            DP +R+         +I+ H +F++     L +    PP
Sbjct: 240 KDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPP 279

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  120 bits (303), Expect = 6e-32
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 55/306 (17%)

Query: 21  LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----------VRREIK 69
            G  LG G++GKV+ A   LTG  VAIK +   +I N   +++             RE+K
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 70  ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           I+    H +I+ L +V      I +VM+ + + +L   +  K RL E + +    QI++G
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNG 131

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN------IMRDGHFLKTSCGSPN-- 181
           +   H+   +HRDL P N+ ++SK   KIADFGL+               +T        
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191

Query: 182 -------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI----- 229
                  Y APE++ G       VD+WS G I   LL G   F  EN  +   +I     
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251

Query: 230 -----------KGGIYTLPSHLSP------------GARDLIPRMLIVDPMKRITIPEIR 266
                      K  +YT  +   P             A DL+  +L ++P++RI+  E  
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311

Query: 267 QHPWFQ 272
           +H +F+
Sbjct: 312 KHEYFK 317

Length = 335

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  121 bits (305), Expect = 6e-32
 Identities = 83/276 (30%), Positives = 144/276 (52%), Gaps = 24/276 (8%)

Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR-----REI 68
           M   ++ + K +G G+FG+V++  H  +    A+K+L++      EM ++        E 
Sbjct: 40  MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-----FEMIKRSDSAFFWEER 94

Query: 69  KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
            I+       I++L+   +    +Y+VMEY+  G+L + ++    + E  AR +  +++ 
Sbjct: 95  DIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVL 153

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFL-KTSCGSPNYAAPE 186
            ++  H    +HRD+KP+N+LLD   ++K+ADFG    M  +G     T+ G+P+Y +PE
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213

Query: 187 VI---SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI---KGGIYTLPS-- 238
           V+    G  Y G E D WS GV LY +L G  PF  +++   + KI   K  + T P   
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL-TFPDDI 272

Query: 239 HLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQ 272
            +S  A+DLI   L    ++  R  + EI+ HP+F+
Sbjct: 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  119 bits (299), Expect = 9e-32
 Identities = 92/297 (30%), Positives = 149/297 (50%), Gaps = 55/297 (18%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLF 74
           Y+  + +G G++G V  A   +T   +A+K     KI+  + +E V     REI +L+  
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALK-----KIRLEQEDEGVPSTAIREISLLKEM 58

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDE--ARNFFQQIISGVEY 132
            H +I+RL +V+ +   +Y+V EY+   +L  ++       ++    + +  QI+ G+ Y
Sbjct: 59  QHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 133 CHRNMVVHRDLKPENLLLDSKWN-VKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPE 186
           CH + V+HRDLKP+NLL+D + N +K+ADFGL+      +    H + T      Y APE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW----YRAPE 173

Query: 187 VISG-KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFK--KIKG--------GI 233
           ++ G + Y+ P VD+WS G I +A +    P    D  I  LFK  +I G        G+
Sbjct: 174 ILLGSRHYSTP-VDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231

Query: 234 YTLPSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            +LP +                  L P   DL+ +ML +DP KRIT     +H +F+
Sbjct: 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288

Length = 294

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  117 bits (294), Expect = 3e-31
 Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 17/264 (6%)

Query: 18  NYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILN-------RRKIKNMEMEEKVRREIK 69
            Y + + LG G+FG V K+ +     + +A+K +N       + K +  +    +  E+ 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 70  ILRLFM-HPHIIRLYEVIETPSDIYVVMEYVKS---GELFDYIVEKG-RLQEDEARNFFQ 124
           I++  + HP+I+R Y+       +Y+VM+ ++    GE F+ + EK  R  E+   N F 
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 125 QIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYA 183
           Q++  + Y H+   +VHRDL P N++L     V I DFGL+   +    L +  G+  Y+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180

Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHL-S 241
            PE++  + Y G + DVW+ G ILY +     PF   N+ +L  KI   +Y  LP  + S
Sbjct: 181 CPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239

Query: 242 PGARDLIPRMLIVDPMKRITIPEI 265
               D+I   L  D   R  I ++
Sbjct: 240 EDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  116 bits (293), Expect = 6e-31
 Identities = 78/269 (28%), Positives = 131/269 (48%), Gaps = 30/269 (11%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE----KVRREIKILRLFMHPHII 80
           LG G++G V    H  TG  +A+K     +I+ +E++E    ++  E+ IL   + P+I+
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMK-----EIR-LELDESKFNQIIMELDILHKAVSPYIV 62

Query: 81  RLYEVIETPSDIYVVMEYVKSG---ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             Y        +Y+ MEY+ +G   +L+   V    + ED  R     ++ G+++     
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 138 -VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            ++HRD+KP N+L++    VK+ DFG+S  +      KT+ G  +Y APE I      GP
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERIKS---GGP 178

Query: 197 --------EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK----GGIYTLPSHLSPGA 244
                   + DVWS G+ +  +  G  P+  E   N+F ++     G   TLPS  S  A
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238

Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQA 273
           +D + + L   P +R T  ++ +HPW   
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  116 bits (293), Expect = 7e-31
 Identities = 83/265 (31%), Positives = 130/265 (49%), Gaps = 24/265 (9%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G+ G V       TG   A+K +      N ++++++ RE++I +    P+I++ Y 
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 85  --VIETPSDIYVVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNM 137
             + E+ S I + MEY + G L D I +K     GR+ E       + ++ G+ Y H   
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           ++HRD+KP N+LL  K  VK+ DFG+S  + +     T  G+  Y APE I GK Y+   
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-LAGTFTGTSFYMAPERIQGKPYS-IT 183

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFK-KIKGGIYTLPSHL---SPGA--------R 245
            DVWS G+ L  +     PF  E  P L   ++   I  +P+      PG         +
Sbjct: 184 SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFK 243

Query: 246 DLIPRMLIVDPMKRITIPEIRQHPW 270
           D I + L  DP +R T  ++ +HPW
Sbjct: 244 DFIKQCLEKDPTRRPTPWDMLEHPW 268

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  118 bits (297), Expect = 7e-31
 Identities = 87/305 (28%), Positives = 133/305 (43%), Gaps = 55/305 (18%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLGIG+FG+V +A    T    A+K L ++ +        V+ E  IL    +  ++RL
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           Y   +   ++Y VM+Y+  G++   ++  G   ED AR +  ++   VE  H+   +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----------------------TSC--- 177
           +KP+N+L+D   ++K+ DFGL    R  H  K                       +C   
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186

Query: 178 -----------------------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT 214
                                  G+PNY APEV+    Y     D WS GVILY +L G 
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245

Query: 215 LPFDDEN-IPNLFKKIKGGI---YTLPSHLSPGARDLIPRML--IVDPMKRITIPEIRQH 268
            PF  +  +    K I           + LSP A DLI ++     D + +    EI+ H
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAH 305

Query: 269 PWFQA 273
           P+F+ 
Sbjct: 306 PFFKT 310

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  116 bits (293), Expect = 9e-31
 Identities = 92/313 (29%), Positives = 135/313 (43%), Gaps = 63/313 (20%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE-----KVRREIKILRLF 74
           KL + +G G++G V  A    +G  VA+K     K++ M+ E         REI +L   
Sbjct: 11  KLNR-IGEGTYGIVYRARDTTSGEIVALK-----KVR-MDNERDGIPISSLREITLLLNL 63

Query: 75  MHPHIIRLYEVIETPS--DIYVVMEYVKS--GELFDYIVEKGRLQEDEARNFFQQIISGV 130
            HP+I+ L EV+       I++VMEY +     L D +       E + +    Q++ G+
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM--PTPFSESQVKCLMLQLLRGL 121

Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAP 185
           +Y H N ++HRDLK  NLLL  K  +KIADFGL+     G   K    +P      Y AP
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPM--TPKVVTLWYRAP 177

Query: 186 EVISGKLYAGPEVDVWSCGVILYALL------------------CGTLPFDDENI-PNLF 226
           E++ G       +D+W+ G IL  LL                     L   +E+I P   
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237

Query: 227 KKIKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH- 274
                G +TLP             LS     L+  +L+ DP KR T  E  +  +F+   
Sbjct: 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297

Query: 275 LPRYLAVPPPDTM 287
           LP       P+ M
Sbjct: 298 LPC-----EPEMM 305

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  116 bits (294), Expect = 1e-30
 Identities = 95/325 (29%), Positives = 148/325 (45%), Gaps = 65/325 (20%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI----KNMEMEEKVRREIKIL 71
           L  Y++ + LG G++G V  A    T   VA+K     KI    +N    ++  REI  L
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK-----KIFDAFRNATDAQRTFREIMFL 60

Query: 72  RLFM-HPHIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           +    HP+I++L  VI  E   DIY+V EY+++ +L   I     L++   R    Q++ 
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLLK 118

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------- 181
            ++Y H   V+HRDLKP N+LL+S   VK+ADFGL+  + +   L+ +  +P        
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE---LEENPENPVLTDYVAT 175

Query: 182 --YAAPEVISGKLYAGPEVDVWSCGVILYALLCG--------TL---------------- 215
             Y APE++ G       VD+WS G IL  +L G        TL                
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235

Query: 216 -------PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
                  PF    + +L  + +  +  L    S  A DL+ ++L+ +P KR+T  E  +H
Sbjct: 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Query: 269 PWFQ--------AHLPRYLAVPPPD 285
           P+            LP  + +P  D
Sbjct: 296 PYVAQFHNPSDEPVLPYPITIPLDD 320

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  117 bits (294), Expect = 1e-30
 Identities = 85/294 (28%), Positives = 144/294 (48%), Gaps = 45/294 (15%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K +G G+FG+V++ +   TGH  A+KIL +  +   E    +R E  IL       ++++
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           +   +   ++Y++ME++  G++   +++K  L E+E + +  + +  ++  H+   +HRD
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRD 126

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGH---FLK------------------------- 174
           +KP+NLLLDSK +VK++DFGL   ++  H   F +                         
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186

Query: 175 --------TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226
                   ++ G+P+Y APEV     Y     D WS GVI+Y +L G  PF  E     +
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245

Query: 227 KKIKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRITIP---EIRQHPWFQA 273
           KK+     TL  P    +S  A+DLI R    +   RI  P   EI+ +P+F+ 
Sbjct: 246 KKVMNWKETLIFPPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNPFFEG 298

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  116 bits (292), Expect = 2e-30
 Identities = 88/300 (29%), Positives = 134/300 (44%), Gaps = 53/300 (17%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           YK+ + +G GS+G V  A    TG KVAIK +N    +++    ++ REIK+LRL  HP 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND-VFEHVSDATRILREIKLLRLLRHPD 60

Query: 79  IIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           I+ +  ++  PS     DIYVV E ++S +L   I     L  +  + F  Q++  ++Y 
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--------CGSPNYAAP 185
           H   V HRDLKP+N+L ++   +KI DFGL+ +     F  T           +  Y AP
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARV----AFNDTPTAIFWTDYVATRWYRAP 175

Query: 186 EVISGKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL--- 240
           E + G  ++   P +D+WS G I   +L G   F  +N+ +    I   + T        
Sbjct: 176 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 241 ----------------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                                        P A  L+ R+L  DP  R T  E    P+F+
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  116 bits (291), Expect = 4e-30
 Identities = 82/301 (27%), Positives = 140/301 (46%), Gaps = 58/301 (19%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + LG GS G V  A  +    +VA+K +     ++++      REIKI+R   H +I+++
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDHDNIVKV 67

Query: 83  YEVI-----ETPSDI---------YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           YEV+     +   D+         Y+V EY+++      ++E+G L E+ AR F  Q++ 
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLR 125

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHF-----LKTSCGSPNY 182
           G++Y H   V+HRDLKP N+ ++++  V KI DFGL+ I+ D H+     L     +  Y
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEGLVTKWY 184

Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCG------------------TLPFDDEN--- 221
            +P ++         +D+W+ G I   +L G                  ++P   E    
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRN 244

Query: 222 -----IPNLFKKIKGGIYT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                IP+  +   G         LP  ++P A D + ++L  +PM R+T  E   HP+ 
Sbjct: 245 ELLNVIPSFVRNDGGEPRRPLRDLLPG-VNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303

Query: 272 Q 272
            
Sbjct: 304 S 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  115 bits (290), Expect = 6e-30
 Identities = 89/305 (29%), Positives = 137/305 (44%), Gaps = 55/305 (18%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLGIG+FG+V +A    T    A+K L ++ + N      V+ E  IL    +  +++L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           Y   +   ++Y VM+Y+  G++   ++      E  AR +  ++   +E  H+   +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 143 LKPENLLLDSKWNVKIADFGL----------------SNIMRD----------------G 170
           +KP+N+L+D   ++K+ DFGL                S+I +D                G
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 171 HFLKT----------SC------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT 214
             LKT           C      G+PNY APEV+  K Y     D WS GVIL+ +L G 
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245

Query: 215 LPFDDENIPNLFKKIKGGIYTL--PSH--LSPGARDLIPRMLIV--DPMKRITIPEIRQH 268
            PF          K+     TL  P    LSP A DLI ++     + + R    +I+ H
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305

Query: 269 PWFQA 273
           P+F  
Sbjct: 306 PFFSE 310

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  112 bits (282), Expect = 1e-29
 Identities = 76/257 (29%), Positives = 134/257 (52%), Gaps = 7/257 (2%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   + +G GS+G+V +  H   G +  IK LN R     E  +   +E ++L    HP+
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE-RKAAEQEAQLLSQLKHPN 60

Query: 79  IIRLYEVIETPSD-IYVVMEYVKSGELFDYIVE-KGRL-QEDEARNFFQQIISGVEYCHR 135
           I+   E  E     +Y+VM + + G+L+  + E KG+L  E++   +F QI   ++Y H 
Sbjct: 61  IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYA 194
             ++HRDLK +N+ L     +K+ D G++ ++ +      T  G+P Y +PE+ S K Y 
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY- 179

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNL-FKKIKGGIYTLPSHLSPGARDLIPRMLI 253
             + DVW+ G  +Y +      F+ +++ +L ++ I+G +  +P   SP   +LI  ML 
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239

Query: 254 VDPMKRITIPEIRQHPW 270
             P KR ++  I + P+
Sbjct: 240 KRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  113 bits (284), Expect = 1e-29
 Identities = 81/283 (28%), Positives = 127/283 (44%), Gaps = 41/283 (14%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKIL----NRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           +G GS+G V   +H  TG  VAIK      + + +K + M     REI++L+   H +++
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-----REIRMLKQLRHENLV 63

Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
            L EV      +Y+V E+V    L D       L E   R +  QI+ G+E+CH + ++H
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGPEVD 199
           RD+KPEN+L+     VK+ DFG +  +     + T    +  Y APE++ G    G  VD
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVD 183

Query: 200 VWSCGVILYALLCGTLPF-DDENIPNLFKKIK------------------GGIYTLPS-- 238
           +W+ G ++  +L G   F  D +I  L+  IK                       LP   
Sbjct: 184 IWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVK 243

Query: 239 ----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                      LS    DL  + L +DP  R +  ++  H +F
Sbjct: 244 EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 2e-29
 Identities = 83/262 (31%), Positives = 130/262 (49%), Gaps = 16/262 (6%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+L + +G G++G V  A    TG  VAIK++   K++  +  E +++EI +L+   HP+
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPN 61

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFD-YIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           I+  +        +++VMEY   G L D Y V +G L E +     ++ + G+ Y H   
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAG- 195
            +HRD+K  N+LL    +VK+ADFG+S  +       K+  G+P + APEV + +   G 
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181

Query: 196 -PEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPSHL------SPGARDL 247
             + D+W+ G+    L     P FD   +  LF   K      P  L      SP   D 
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF--PPPKLKDKEKWSPVFHDF 239

Query: 248 IPRMLIVDPMKRITIPEIRQHP 269
           I + L  DP KR T  ++ QHP
Sbjct: 240 IKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 3e-29
 Identities = 68/265 (25%), Positives = 137/265 (51%), Gaps = 15/265 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-- 76
           Y+  + +G G++G V   +H  TG  VA+KI+N     + ++ + ++RE+ +L       
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINL-DTPDDDVSD-IQREVALLSQLRQSQ 60

Query: 77  -PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P+I + Y        ++++MEY + G +   +++ G + E       ++++  ++Y H+
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHK 119

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYA 194
             V+HRD+K  N+L+ +  NVK+ DFG++ ++      + T  G+P + APEVI+   Y 
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARDLIP 249
             + D+WS G+ +Y +  G  P+ D    + F+ +     + P     +  S   R+ + 
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDV---DAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236

Query: 250 RMLIVDPMKRITIPEIRQHPWFQAH 274
             L  +P +R++  E+ +  W +AH
Sbjct: 237 ACLDEEPKERLSAEELLKSKWIKAH 261

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  110 bits (277), Expect = 1e-28
 Identities = 86/285 (30%), Positives = 135/285 (47%), Gaps = 42/285 (14%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKILR---LFMHPHII 80
           +G+G++G V  A    +GH VA+K  + R   N + +     RE+ +L+    F HP+I+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALK--SVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 81  RLYEVIET-----PSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYC 133
           RL +V  T      + + +V E+V   +L  Y+  V    L  +  ++  +Q + G+++ 
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
           H N +VHRDLKPEN+L+ S   VK+ADFGL+ I      L     +  Y APEV+    Y
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTY 184

Query: 194 AGPEVDVWSCGVILY------ALLCGT--------------LPFDDE-----NIP--NLF 226
           A P VD+WS G I         L CG               LP +D+      +P     
Sbjct: 185 ATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFS 243

Query: 227 KKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            +    + ++   +      L+  ML  +P KRI+     QHP+F
Sbjct: 244 PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  111 bits (279), Expect = 1e-28
 Identities = 94/309 (30%), Positives = 144/309 (46%), Gaps = 71/309 (22%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALT--GHKVAIK---------ILNRRKIKNMEMEEKVRR 66
            Y+L K LG G++G V  A +A T     VAIK         IL +R +          R
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----------R 50

Query: 67  EIKILRLFM-HPHIIRLYEV-IETPS---DIYVVMEYVKSGELFDYIVEKGRLQEDEARN 121
           E+K+LR F  H +I  LY++ I  P    ++Y+  E +++ +L   I     L +   ++
Sbjct: 51  ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQS 109

Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTS 176
           F  QI+ G++Y H   V+HRDLKP NLL+++   +KI DFGL+    +       F+   
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169

Query: 177 CGSPNYAAPEV-ISGKLYAGPEVDVWSCGVILYALLCGTLPF------------------ 217
             +  Y APE+ +S + Y    +DVWS G IL  LL     F                  
Sbjct: 170 VATRWYRAPEIMLSFQSYT-KAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228

Query: 218 -DDE---------------NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT 261
            D+E               ++PN+ KK    I+   + L   A DL+ ++L  DP KRI+
Sbjct: 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPL---ALDLLEKLLAFDPTKRIS 285

Query: 262 IPEIRQHPW 270
           + E  +HP+
Sbjct: 286 VEEALEHPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  110 bits (276), Expect = 1e-28
 Identities = 75/262 (28%), Positives = 128/262 (48%), Gaps = 14/262 (5%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + LG G FG+V   +   TG   A K L +++IK  + E     E +IL       ++ L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVH 140
               ET   + +V+  +  G+L  +I   G    DE R  F   ++  G+E   R  +V+
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA-GPEVD 199
           RDLKPEN+LLD + +++I+D GL+  + +G  ++   G+  Y APEVI+ + Y   P  D
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP--D 183

Query: 200 VWSCGVILYALLCGTLPFD--DENIP--NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            W  G ++Y ++ G  PF    E +    + +++K          S  A+ +   +L  +
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKN 243

Query: 256 PMKRITI-----PEIRQHPWFQ 272
           P +R+         ++QHP F+
Sbjct: 244 PKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  110 bits (275), Expect = 2e-28
 Identities = 78/276 (28%), Positives = 135/276 (48%), Gaps = 15/276 (5%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + LG G FG+V   +   TG   A K L +++IK  + E     E +IL       ++ L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVH 140
               ET   + +V+  +  G+L  +I   G    +E R  F   +I+ G+E  HR   V+
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           RDLKPEN+LLD   +++I+D GL+  + +G  ++   G+  Y APEV++ + Y     D 
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDY 184

Query: 201 WSCGVILYALLCGTLPF--DDENIP--NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
           W  G ++Y ++ G  PF    E +    + +++        +  S  A+ +   +L  DP
Sbjct: 185 WGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDP 244

Query: 257 MKRITIP-----EIRQHPWFQ-AHLPRYLA--VPPP 284
            +R+        E+++HP+F+  +  R  A  + PP
Sbjct: 245 KQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  111 bits (278), Expect = 2e-28
 Identities = 82/290 (28%), Positives = 138/290 (47%), Gaps = 43/290 (14%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83

Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 84  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 141

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 199

Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------------------ 240
           D+WS G I+  LL G   F   +  +  K I   + T  + L                  
Sbjct: 200 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 259

Query: 241 -------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 276
                        +P A DL+ +ML++D  KRIT  +   H +F Q H P
Sbjct: 260 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  111 bits (278), Expect = 3e-28
 Identities = 92/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81

Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCG 138

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198

Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++ G + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257

Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317

Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  109 bits (274), Expect = 3e-28
 Identities = 85/294 (28%), Positives = 142/294 (48%), Gaps = 55/294 (18%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
           KL K +G G++G V  A++  T   VA+K     +++  + +E V     REI +L+   
Sbjct: 4   KLEK-IGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKELK 57

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           H +I+RLY+V+ +   + +V EY      + FD     G +  +  ++F  Q++ G+ +C
Sbjct: 58  HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFC 115

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVI 188
           H + V+HRDLKP+NLL++    +K+ADFGL+        +   C S       Y  P+V+
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLAR----AFGIPVRCYSAEVVTLWYRPPDVL 171

Query: 189 SG-KLYAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKG--------GIYT 235
            G KLY+   +D+WS G I   L     P     D ++      ++ G        G+  
Sbjct: 172 FGAKLYS-TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230

Query: 236 LP------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
           LP                    L+   RDL+  +L+ +P++RI+  E  QHP+F
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  108 bits (271), Expect = 6e-28
 Identities = 77/246 (31%), Positives = 127/246 (51%), Gaps = 6/246 (2%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GSFG+V       T   VAIKI++  + ++ E+E+ +++EI +L     P+I R Y 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIED-IQQEITVLSQCDSPYITRYYG 69

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                + ++++MEY+  G   D +++ G L+E       ++I+ G++Y H    +HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 145 PENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
             N+LL  + +VK+ADFG++  + D    + T  G+P + APEVI    Y   + D+WS 
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF-KADIWSL 187

Query: 204 GVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI 262
           G+    L  G  P  D   +  LF   K    TL    S   ++ +   L  DP  R T 
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTA 247

Query: 263 PEIRQH 268
            E+ +H
Sbjct: 248 KELLKH 253

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  108 bits (270), Expect = 8e-28
 Identities = 86/282 (30%), Positives = 132/282 (46%), Gaps = 31/282 (10%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIR 81
           +G G FG+V     A TG   A+K L++++IK  + E     E  +L L      P I+ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +     TP  +  +++ +  G+L  ++ + G   E E R +  +II G+E+ H   VV+R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYAAPEVISGKLYAGPE 197
           DLKP N+LLD   +V+I+D GL+       F K     S G+  Y APEV+   +     
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 176

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGARDLIPRMLI 253
            D +S G +L+ LL G  PF      +   +I     T    LP   SP  R L+  +L 
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235

Query: 254 VDPMKRITI-----PEIRQHP------WFQAHLPRYLAVPPP 284
            D  +R+        E+++HP      W    L +Y   PPP
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKY---PPP 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 9e-28
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 14/204 (6%)

Query: 21  LGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
             K LG G FG V + +    G   VAIK++    +     E+    E K++    HP++
Sbjct: 8   FLKELGSGQFGVVHLGK--WRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNL 61

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMV 138
           ++LY V      I++V EY+ +G L +Y+ E KG+L  +   +    +   +EY   N  
Sbjct: 62  VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 195
           +HRDL   N L+     VK++DFGL+  + D  +  +S G+     +A PEV     ++ 
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 196 PEVDVWSCGVILYALL-CGTLPFD 218
            + DVWS GV+++ +   G +P++
Sbjct: 181 -KSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  107 bits (269), Expect = 1e-27
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 12/225 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           + L + LG G FG+V   E       +VAIKIL   K  ++  ++  ++E++ L+   H 
Sbjct: 8   FTLERKLGSGYFGEV--WEGLWKNRVRVAIKIL---KSDDLLKQQDFQKEVQALKRLRHK 62

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYCHR 135
           H+I L+ V      +Y++ E ++ G L  ++   E   L      +   Q+  G+ Y   
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYA 194
              +HRDL   N+L+      K+ADFGL+ ++++  +L +    P  + APE  S   ++
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182

Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 238
             + DVWS G++LY +   G +P+   N   ++ +I  G Y +P 
Sbjct: 183 T-KSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPC 225

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  108 bits (270), Expect = 1e-27
 Identities = 77/274 (28%), Positives = 135/274 (49%), Gaps = 15/274 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G FG+V   +   TG   A K L+++++K    E+    E +IL     P I+ L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
             E+ + + +VM  +  G+L  +I   G    +  R      QI  G+ + H   +V+RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           +KPEN+LLD + N +++D GL+  ++DG  +    G+  Y APE++  + Y+ P VD ++
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP-VDWFA 179

Query: 203 CGVILYALLCGTLPFDD--ENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
            G  +Y ++ G  PF D  E +       + ++  +     + +  ++D+    L   P 
Sbjct: 180 MGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239

Query: 258 KRITIPEI----RQHPWFQA-HLPRYLA--VPPP 284
            R+   E     R+H +F+  + PR  A  +PPP
Sbjct: 240 DRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  107 bits (269), Expect = 2e-27
 Identities = 83/295 (28%), Positives = 133/295 (45%), Gaps = 56/295 (18%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE-----KVR-REIKILRL 73
           KL K +G GS+G V    +  TG  VAIK       K +E E+     K+  REI++L+ 
Sbjct: 5   KLSK-IGEGSYGVVFKCRNRETGQIVAIK-------KFVESEDDPVIKKIALREIRMLKQ 56

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
             HP+++ L EV      +++V EY     L +       + E   +    Q +  V +C
Sbjct: 57  LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-YAAPEVISGKL 192
           H++  +HRD+KPEN+L+  +  +K+ DFG + I+       T   +   Y APE++ G  
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 193 YAGPEVDVWSCGVILYALLCG------------------TLPFDDENIP---NLFKK--- 228
             GP VDVW+ G +   LL G                  TL    + IP    +F     
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL---GDLIPRHQQIFSTNQF 233

Query: 229 IKGGIYTLPS------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            KG   ++P             ++S  A   +   L +DP +R++  E+ +HP+F
Sbjct: 234 FKG--LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  108 bits (270), Expect = 3e-27
 Identities = 82/292 (28%), Positives = 137/292 (46%), Gaps = 44/292 (15%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+  K +G G++G V  A    TG KVAIK L R   ++    ++  RE+++L+   H +
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHEN 75

Query: 79  IIRLYEVIETP-------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
           +I L +V  TP        D Y+VM ++  G     +++  +L ED  +    Q++ G++
Sbjct: 76  VIGLLDVF-TPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           Y H   ++HRDLKP NL ++    +KI DFGL+   +    +     +  Y APEVI   
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVVTRWYRAPEVILNW 190

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KG 231
           ++    VD+WS G I+  +L G   F   +  +   +I                    K 
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250

Query: 232 GIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            +  LP            + +P A +++ +ML++D   RIT  E   HP+F+
Sbjct: 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  106 bits (265), Expect = 3e-27
 Identities = 74/260 (28%), Positives = 130/260 (50%), Gaps = 10/260 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR--REIKILRLFMH 76
           Y L + LG GSFG V + +      +  +K+L    +  +   E V+  +E ++L    H
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEY 132
           P I++ +          ++ EY +  +L   + E       L E++   +F Q++ GV Y
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGK 191
            H+  ++HRDLK +N+ L +   +KI DFG+S ++     L T+  G+P Y +PE +  +
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPR 250
            Y   + D+WS G ILY + C    F+ +N  ++  +I +G   +LP   S     ++  
Sbjct: 181 GY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS 239

Query: 251 MLIVDPMKRITIPEIRQHPW 270
           ML  DP  R +  EI ++P+
Sbjct: 240 MLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  107 bits (269), Expect = 5e-27
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74

Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCG 131

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F   +                P   KK++  + 
Sbjct: 192 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ E  Q
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310

Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 311 HPYINVWYDPAEVEAPPP 328

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  105 bits (264), Expect = 5e-27
 Identities = 68/225 (30%), Positives = 118/225 (52%), Gaps = 12/225 (5%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G FG V + +      KVAIK +N   +     EE    E K++    HP +++L
Sbjct: 10  KELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQL 64

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V      +Y+V E++++G L +Y+ ++ G+L +D   +  Q +  G+EY  RN  +HR
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L+ S   VK++DFG++  + D  +  +S G+     ++ PEV +   Y+  + 
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSS-KS 182

Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
           DVWS GV+++ +   G +PF+ ++   + + I  G       L+ 
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS 227

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  106 bits (265), Expect = 6e-27
 Identities = 80/277 (28%), Positives = 128/277 (46%), Gaps = 41/277 (14%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPH 78
             LG G+ G V   +H  TG  +A      +K+ ++  +  VR    RE++I+     P+
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMA------KKVVHIGAKSSVRKQILRELQIMHECRSPY 64

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYC---H 134
           I+  Y      ++I + ME++  G L D I +K G +  +        ++ G+ Y    H
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS----NIMRDGHFLKTSCGSPNYAAPEVISG 190
           R  ++HRD+KP N+L++S+  +K+ DFG+S    N + D     T  G+  Y +PE I G
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQG 176

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------TLPS 238
             Y   + DVWS G+ +  L  G  PF   NI +  +    GI              LPS
Sbjct: 177 GKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235

Query: 239 -HLSPGARDLIPRMLIVDPMKRITIPEI-RQHPWFQA 273
                  RD +   L+ DP +R T  ++    P+ QA
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  108 bits (272), Expect = 7e-27
 Identities = 79/259 (30%), Positives = 130/259 (50%), Gaps = 22/259 (8%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR--EIKILRLFMH 76
           Y + + LG G+ G V  A+    G   A+K+++   ++ M   +K R   E+  L     
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD---MEGMSEADKNRAQAEVCCLLNCDF 90

Query: 77  PHIIRLYE--VIETPSD------IYVVMEYVKSGELFDYIVEKGR----LQEDEARNFFQ 124
             I++ +E    + P +      I +V++Y  +G+L   I  + +     +E EA   F 
Sbjct: 91  FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150

Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPN 181
           Q++  V + H   ++HRD+K  N+LL S   VK+ DFG S +          +T CG+P 
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHL 240
           Y APE+   K Y+  + D++S GV+LY LL    PFD EN+  +  K   G Y  LP  +
Sbjct: 211 YVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSI 269

Query: 241 SPGARDLIPRMLIVDPMKR 259
           SP  ++++  +L  DP +R
Sbjct: 270 SPEMQEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  105 bits (262), Expect = 1e-26
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 6/252 (2%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GSFG+V       T   VAIKI++  + ++ E+E+ +++EI +L     P++ + Y 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIED-IQQEITVLSQCDSPYVTKYYG 69

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                + ++++MEY+  G   D ++  G   E +     ++I+ G++Y H    +HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 145 PENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
             N+LL  + +VK+ADFG++  + D    + T  G+P + APEVI    Y   + D+WS 
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS-KADIWSL 187

Query: 204 GVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI 262
           G+    L  G  P  D + +  LF   K    TL    S   ++ I   L  DP  R T 
Sbjct: 188 GITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTA 247

Query: 263 PEIRQHPWFQAH 274
            E+ +H +   +
Sbjct: 248 KELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  106 bits (266), Expect = 1e-26
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A   + G  VA+K L+R   +N    ++  RE+ +L+   
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 78

Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I     L  +       Q++ G
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI--HMELDHERMSYLLYQMLCG 135

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195

Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDD-------------------ENIPNLFKKIK 230
           G  Y    VD+WS G I+  L+ G++ F                     E +  L   ++
Sbjct: 196 GMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254

Query: 231 GGIYTLPSH-------LSPG----------------ARDLIPRMLIVDPMKRITIPEIRQ 267
             +   P +       L P                 ARDL+ +ML++DP KRI++ E  +
Sbjct: 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314

Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 315 HPYITVWYDPAEAEAPPP 332

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  106 bits (265), Expect = 1e-26
 Identities = 82/291 (28%), Positives = 140/291 (48%), Gaps = 45/291 (15%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A       KVA+K L+R   +++    +  RE+++L+   H ++I L +
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      IE  +++Y+V   +  G   + IV+  +L ++  +    Q++ G++Y H   +
Sbjct: 82  VFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGI 139

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP N+ ++    ++I DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTV 197

Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKGG-----IYTLPS 238
           D+WS G I+  LL G   F   +                P + KKI        I +LP 
Sbjct: 198 DIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP- 256

Query: 239 HL------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 276
           H+            +P A DL+ +ML++D  KRI+  E   HP+F Q H P
Sbjct: 257 HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  104 bits (260), Expect = 2e-26
 Identities = 85/282 (30%), Positives = 132/282 (46%), Gaps = 31/282 (10%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIR 81
           +G G FG+V     A TG   A+K L++++IK  + E     E  +L L      P I+ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +     TP  +  +++ +  G+L  ++ + G   E E R +  +II G+E+ H   VV+R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 142 DLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           DLKP N+LLD   +V+I+D GL+     +  H    S G+  Y APEV+          D
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGTAYDSSAD 178

Query: 200 VWSCGVILYALLCGTLPF------DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
            +S G +L+ LL G  PF      D   I  +   +      LP   SP  + L+  +L 
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN---VELPDSFSPELKSLLEGLLQ 235

Query: 254 VDPMKRITI-----PEIRQHP------WFQAHLPRYLAVPPP 284
            D  KR+        E+++H       W Q +L +Y   PPP
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKY---PPP 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  103 bits (259), Expect = 3e-26
 Identities = 78/253 (30%), Positives = 124/253 (49%), Gaps = 10/253 (3%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L N+++ K +G G F +V  A   L G  VA+K +    + + +      +EI +L+   
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----VEKGRLQEDEARNFFQQIISGVE 131
           HP++I+ Y      +++ +V+E   +G+L   I     +K  + E     +F Q+ S +E
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISG 190
           + H   V+HRD+KP N+ + +   VK+ D GL            S  G+P Y +PE I  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIY-TLPS-HLSPGARD 246
             Y   + D+WS G +LY +     PF  D  N+ +L KKI+   Y  LPS H S   R 
Sbjct: 181 NGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239

Query: 247 LIPRMLIVDPMKR 259
           L+   +  DP KR
Sbjct: 240 LVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  104 bits (260), Expect = 3e-26
 Identities = 78/273 (28%), Positives = 132/273 (48%), Gaps = 19/273 (6%)

Query: 24  TLGIGSFGKVKIAEHALTGHKVAIK----ILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
            LG G++G V    H  TG  +A+K     +N ++ K + M+  +      +R    P+ 
Sbjct: 8   ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDIS-----MRSVDCPYT 62

Query: 80  IRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRN 136
           +  Y  +    D+++ ME + +   + +  + +KG  + ED        I+  +EY H  
Sbjct: 63  VTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122

Query: 137 M-VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL-YA 194
           + V+HRD+KP N+L++    VK+ DFG+S  + D        G   Y APE I+ +L   
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 182

Query: 195 GPEV--DVWSCGVILYALLCGTLPFDDENIP--NLFKKIKGGIYTLPSH-LSPGARDLIP 249
           G +V  DVWS G+ +  L  G  P+D    P   L + ++     LP+   SP  +D + 
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVN 242

Query: 250 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 282
           + L  +  +R   PE+ QHP+F+ HL +   V 
Sbjct: 243 KCLKKNYKERPNYPELLQHPFFELHLSKNTDVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  102 bits (256), Expect = 6e-26
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 10/261 (3%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L N+++ K +G G F +V  A   L    VA+K +   ++ + +  +   +EI +L+   
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGEL---FDYIVEKGRL-QEDEARNFFQQIISGVE 131
           HP++I+  +     +++ +V+E   +G+L     Y  ++ RL  E     +F Q+ S VE
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISG 190
           + H   V+HRD+KP N+ + +   VK+ D GL            S  G+P Y +PE I  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIY-TLPS-HLSPGARD 246
             Y   + D+WS G +LY +     PF  D  N+ +L +KI+   Y  LP+ H S   R+
Sbjct: 181 NGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239

Query: 247 LIPRMLIVDPMKRITIPEIRQ 267
           L+   +  DP +R  I  + Q
Sbjct: 240 LVSMCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  102 bits (256), Expect = 8e-26
 Identities = 73/248 (29%), Positives = 127/248 (51%), Gaps = 6/248 (2%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G GSFG+V       T   VAIKI++  + ++ E+E+ +++EI +L     P++ + 
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIED-IQQEITVLSQCDSPYVTKY 67

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           Y      + ++++MEY+  G   D ++E G L E +     ++I+ G++Y H    +HRD
Sbjct: 68  YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 126

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGPEVDVW 201
           +K  N+LL     VK+ADFG++  + D    + +  G+P + APEVI    Y   + D+W
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS-KADIW 185

Query: 202 SCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           S G+    L  G  P  +   +  LF   K    TL  + S   ++ +   L  +P  R 
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245

Query: 261 TIPEIRQH 268
           T  E+ +H
Sbjct: 246 TAKELLKH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  103 bits (257), Expect = 8e-26
 Identities = 83/281 (29%), Positives = 131/281 (46%), Gaps = 36/281 (12%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V    H  T   VAIK     + +N E++E   RE+K+LR     +I+ L E
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSE-ENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                  +Y+V EYV+   L         +  ++ R++  Q+I  + +CH+N +VHRD+K
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127

Query: 145 PENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWS 202
           PENLL+     +K+ DFG +  + +G     +    +  Y +PE++ G  Y G  VD+WS
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY-GKAVDMWS 186

Query: 203 CGVILYALLCGTLPFDDEN-IPNLF--KKIKGGI--------YTLP----------SH-- 239
            G IL  L  G   F  E+ I  LF  +K+ G +        Y+ P          +H  
Sbjct: 187 VGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQ 246

Query: 240 ---------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                    LS    DL+  +L ++P  R    +   HP F
Sbjct: 247 SLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  103 bits (259), Expect = 1e-25
 Identities = 91/313 (29%), Positives = 142/313 (45%), Gaps = 54/313 (17%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K +G G++G V  A    TG KVAIK L+R   ++    ++  RE+ +L+   H ++I L
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHENVIGL 79

Query: 83  YEVIETPS------DIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHR 135
            +V  +        D Y+VM Y+++    D     G  L ED+ +    Q++ G++Y H 
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYMQT----DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG---SPNYAAPEVISGKL 192
             ++HRDLKP NL ++    +KI DFGL+      H      G   +  Y APEVI   +
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWM 190

Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKI-----KGG 232
           +    VD+WS G I+  +L G   F  ++                P   +K+     K  
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250

Query: 233 IYTLPS-----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLA 280
           I +LP              SP A DL+ +ML +D  KR+T  E  +HP+F          
Sbjct: 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310

Query: 281 VPPP--DTMQQAK 291
              P  D+++  K
Sbjct: 311 EQQPYDDSLENEK 323

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 1e-25
 Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 28/204 (13%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +      G  KVA+K L   K   M  E  ++ E +I++   H  
Sbjct: 9   KLERKLGAGQFGEVWMG--TWNGTTKVAVKTL---KPGTMSPEAFLQ-EAQIMKKLRHDK 62

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN--------FFQQIISGV 130
           +++LY V      IY+V EY+  G L D+      L+  E +            QI  G+
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLDF------LKSGEGKKLRLPQLVDMAAQIAEGM 116

Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVI 188
            Y      +HRDL   N+L+      KIADFGL+ ++ D  +  +     P  + APE  
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176

Query: 189 SGKLYAGPEV--DVWSCGVILYAL 210
               Y    +  DVWS G++L  +
Sbjct: 177 ---NYGRFTIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  101 bits (254), Expect = 2e-25
 Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 8/251 (3%)

Query: 21  LGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           LG+ +G G FG V +    +    K+A+ +   +   +  + EK  +E  I+R F HPHI
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           ++L  VI     +++VME    GEL  Y+ V K  L       +  Q+ + + Y      
Sbjct: 70  VKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF 128

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 196
           VHRD+   N+L+ S   VK+ DFGLS  + D  + K S G  P  + APE I+ + +   
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188

Query: 197 EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 254
             DVW  GV ++ +L  G  PF      ++  +I  G    +P +  P    L+ +    
Sbjct: 189 S-DVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 247

Query: 255 DPMKRITIPEI 265
           DP KR    E+
Sbjct: 248 DPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  102 bits (255), Expect = 2e-25
 Identities = 83/262 (31%), Positives = 126/262 (48%), Gaps = 17/262 (6%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
           N   GKTLG G+FGKV  A            KVA+K+L  +   +    E +  E+KI+ 
Sbjct: 36  NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML--KPTAHSSEREALMSELKIMS 93

Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISG 129
            L  H +I+ L         I V+ EY   G+L +++  K    L  ++  +F  Q+  G
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPE 186
           + +      +HRDL   N+LL     VKI DFGL+ +IM D +++ K +   P  + APE
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213

Query: 187 VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL-PSHLSPG 243
            I   +Y   E DVWS G++L+ +   G+ P+    + + F K IK G     P H    
Sbjct: 214 SIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272

Query: 244 ARDLIPRMLIVDPMKRITIPEI 265
             D++      DP+KR T  +I
Sbjct: 273 IYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  101 bits (253), Expect = 4e-25
 Identities = 81/296 (27%), Positives = 132/296 (44%), Gaps = 62/296 (20%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPH 78
           + LG GS+  V      + G  VA+K+++      M+ EE V     RE  +L+   H +
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVIS------MKTEEGVPFTAIREASLLKGLKHAN 64

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNM 137
           I+ L+++I T   +  V EY+ + +L  Y+++  G L     R F  Q++ G+ Y H   
Sbjct: 65  IVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA---------PEVI 188
           ++HRDLKP+NLL+     +K+ADFGL+           S  S  Y++         P+V+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR--------AKSIPSQTYSSEVVTLWYRPPDVL 175

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKG-----------GIYTL 236
            G       +D+W  G I   +L G   F    ++    +KI             G+  L
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235

Query: 237 PSH-------------------LS--PGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
           P++                   LS  P A DL  +ML++ P  RI+  +   HP+F
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  100 bits (250), Expect = 6e-25
 Identities = 80/259 (30%), Positives = 129/259 (49%), Gaps = 20/259 (7%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G+FGKV  A++  TG   A K+++    K+ E  E    EI IL    HP+I++L +
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVID---TKSEEELEDYMVEIDILASCDHPNIVKLLD 69

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
                +++++++E+   G +   ++E  R L E + R   +Q +  + Y H N ++HRDL
Sbjct: 70  AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129

Query: 144 KPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVI----SGKLYA 194
           K  N+L     ++K+ADFG+S      I R   F+    G+P + APEV+    S     
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKDRPY 185

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTL--PSHLSPGARDLIPRM 251
             + DVWS G+ L  +     P  + N   +  KI K    TL  PS  S   +D + + 
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245

Query: 252 LIVDPMKRITIPEIRQHPW 270
           L  +   R T  ++ QHP+
Sbjct: 246 LEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  100 bits (249), Expect = 6e-25
 Identities = 68/223 (30%), Positives = 116/223 (52%), Gaps = 12/223 (5%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL K LG G FG+V +  +     KVA+K L   K   M ++  +  E  +++   H  +
Sbjct: 9   KLVKKLGAGQFGEVWMGYYN-NSTKVAVKTL---KPGTMSVQAFLE-EANLMKTLQHDKL 63

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +RLY V+     IY++ EY+  G L D++   E G++   +  +F  QI  G+ Y  R  
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAG 195
            +HRDL+  N+L+      KIADFGL+ ++ D  +  +     P  + APE I+   +  
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT- 182

Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + DVWS G++LY ++  G +P+   +  ++   ++ G Y +P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMP 224

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  100 bits (251), Expect = 7e-25
 Identities = 80/303 (26%), Positives = 133/303 (43%), Gaps = 52/303 (17%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
           KL K LG G++  V      LT + VA+K +       +E EE       RE+ +L+   
Sbjct: 10  KLDK-LGEGTYATVYKGRSKLTDNLVALKEIR------LEHEEGAPCTAIREVSLLKDLK 62

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRL-QEDEARNFFQQIISGVEYCH 134
           H +I+ L+++I T   + +V EY+   +L  Y+ + G        + F  Q++ G+ YCH
Sbjct: 63  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVIS 189
           R  V+HRDLKP+NLL++ +  +K+ADFGL+        + T   S       Y  P+++ 
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYSNEVVTLWYRPPDILL 177

Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIK 230
           G      ++D+W  G I Y +  G   F                    +E  P +    +
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237

Query: 231 GGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279
              Y  P +           L     +L+ ++L  +  KRI+  E  +HP+F     R  
Sbjct: 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIH 297

Query: 280 AVP 282
            +P
Sbjct: 298 KLP 300

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 99.6 bits (248), Expect = 8e-25
 Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 12/230 (5%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
            L + +G G FG V +  + L   KVAIK +    +     EE    E +++    HP +
Sbjct: 7   TLVQEIGSGQFGLVWLG-YWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKL 61

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           ++LY V    S I +V E+++ G L DY+  ++G+  ++        +  G+ Y   + V
Sbjct: 62  VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 195
           +HRDL   N L+     VK++DFG++  + D  +  +S G+     +++PEV S   Y+ 
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA 244
            + DVWS GV+++ +   G  P+++ +   + + I  G       L+  +
Sbjct: 181 -KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS 229

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 44/144 (30%), Positives = 84/144 (58%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K +  G+FGKV +          A+K++ +  + N  M  +V+ E   L L   P I+ L
Sbjct: 10  KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           Y  +++ +++Y+VMEY+  G++   +   G   E+ A  +  ++   ++Y HR+ ++HRD
Sbjct: 70  YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRD 129

Query: 143 LKPENLLLDSKWNVKIADFGLSNI 166
           LKP+N+L+ ++ ++K+ DFGLS +
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  102 bits (256), Expect = 2e-24
 Identities = 54/189 (28%), Positives = 86/189 (45%), Gaps = 21/189 (11%)

Query: 41  TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD-IYVVMEYV 99
           TGH+VAIK+L     +      + RRE  +     HP+I+ L +  E P   ++ V EYV
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNV 156
               L + +   G L   E      Q++  +   H   +VHRDLKP+N+++     + + 
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 157 KIADFGLS------------NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 204
           K+ DFG+              + R    L    G+P Y APE + G+    P  D+++ G
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVL----GTPTYCAPEQLRGEPVT-PNSDLYAWG 176

Query: 205 VILYALLCG 213
           +I    L G
Sbjct: 177 LIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 98.4 bits (245), Expect = 4e-24
 Identities = 77/258 (29%), Positives = 124/258 (48%), Gaps = 18/258 (6%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G++G V  A    T  ++AIK +     ++    + +  EI +     H +I++   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEI---PERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFF--QQIISGVEYCHRNMVVHR 141
                    + ME V  G L   +  K G L+++E    F  +QI+ G++Y H N +VHR
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132

Query: 142 DLKPENLLLDSKWNV-KIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVIS-GKLYAGPEV 198
           D+K +N+L+++   V KI+DFG S  +       +T  G+  Y APEVI  G    G   
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPA 192

Query: 199 DVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYT----LPSHLSPGARDLIPRML 252
           D+WS G  +  +  G  PF +   P   +FK    G++     +P  LS  A++ I R  
Sbjct: 193 DIWSLGCTIVEMATGKPPFIELGEPQAAMFKV---GMFKIHPEIPESLSAEAKNFILRCF 249

Query: 253 IVDPMKRITIPEIRQHPW 270
             DP KR +  ++ Q P+
Sbjct: 250 EPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 97.8 bits (243), Expect = 4e-24
 Identities = 74/249 (29%), Positives = 123/249 (49%), Gaps = 9/249 (3%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G+FG+V           VA+K  + R+    +++ K  +E +IL+ + HP+I+RL  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
           V      IY+VME V+ G+   ++  +G RL+  E     +   +G+EY      +HRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEVDV 200
              N L+  K  +KI+DFG+S    DG +  T         + APE ++   Y+  E DV
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS-ESDV 179

Query: 201 WSCGVILY-ALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA-RDLIPRMLIVDPMK 258
           WS G++L+ A   G +P+ + +     + I+ G+      L P A   L+ R    DP +
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ 239

Query: 259 RITIPEIRQ 267
           R +   + Q
Sbjct: 240 RPSFSTVHQ 248

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 98.6 bits (245), Expect = 4e-24
 Identities = 77/259 (29%), Positives = 130/259 (50%), Gaps = 20/259 (7%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G+FGKV  A++  TG   A K++   + K+ E  E    EI+IL    HP+I++L  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATCNHPYIVKLLG 76

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
                  +++++E+   G +   ++E  R L E + +   +Q++  ++Y H   ++HRDL
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 144 KPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGP- 196
           K  N+LL    ++K+ADFG+S      + R   F+    G+P + APEV+  + +   P 
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCETMKDTPY 192

Query: 197 --EVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTL--PSHLSPGARDLIPRM 251
             + D+WS G+ L  +     P  + N   +  KI K    TL  PS  S   RD +   
Sbjct: 193 DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTA 252

Query: 252 LIVDPMKRITIPEIRQHPW 270
           L   P  R +  ++ +HP+
Sbjct: 253 LDKHPETRPSAAQLLEHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 98.5 bits (245), Expect = 4e-24
 Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 22/273 (8%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMH 76
            +++ +T+G G++GKV    +   G   A+KIL+       +++E++  E  IL+ L  H
Sbjct: 23  TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNH 78

Query: 77  PHIIRLYEVIETPS-----DIYVVMEYVKSG---ELFDYIVEKG-RLQEDEARNFFQQII 127
           P++++ Y +           +++V+E    G   EL   ++  G RL E          +
Sbjct: 79  PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPE 186
            G+++ H N ++HRD+K  N+LL ++  VK+ DFG+S  +      + TS G+P + APE
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198

Query: 187 VISGK----LYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTL--PSH 239
           VI+ +           DVWS G+    L  G  P FD   +  LFK  +    TL  P  
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEK 258

Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                   I + LI D   R ++  + +HP+ +
Sbjct: 259 WCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 98.6 bits (246), Expect = 5e-24
 Identities = 76/269 (28%), Positives = 122/269 (45%), Gaps = 15/269 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLY 83
           +G G+ G+V       TGH +A+K +  R+  N E  +++  ++ + L+    P+I++ Y
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80

Query: 84  EVIETPSDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNM-VVH 140
               T SD+++ ME        D +++  +G + ED        I+  + Y      V+H
Sbjct: 81  GYFITDSDVFICME--LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIH 138

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP---E 197
           RD+KP N+LLD+  NVK+ DFG+S  + D      S G   Y APE I            
Sbjct: 139 RDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIR 198

Query: 198 VDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLPSH--LSPGARDLIPRMLI 253
            DVWS G+ L  L  G  P+         L K ++    +LP +   SP     +   L 
Sbjct: 199 ADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLT 258

Query: 254 VDPMKRITIPEIRQHPWFQAHLPRYLAVP 282
            D  KR    E+ QHP+ + +    + V 
Sbjct: 259 KDHRKRPKYRELLQHPFIRRYETAEVDVA 287

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 97.4 bits (243), Expect = 5e-24
 Identities = 72/254 (28%), Positives = 114/254 (44%), Gaps = 17/254 (6%)

Query: 23  KTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           K LG G+FG V    + +   K   VA+K L +  I   + E    RE  ++    HP I
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE--FLREASVMAQLDHPCI 58

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVV 139
           +RL  V +    + +VME    G L  Y+ ++  +   + +    Q+  G+ Y      V
Sbjct: 59  VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGS-P-NYAAPEVIS-GKLYA 194
           HRDL   N+LL ++   KI+DFG+S  +  G  ++  T+ G  P  + APE I+ GK  +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177

Query: 195 GPEVDVWSCGVILY-ALLCGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 251
             + DVWS GV L+ A   G  P+ +     +   ++ G   L  P         ++   
Sbjct: 178 --KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ERLPRPEECPQEIYSIMLSC 234

Query: 252 LIVDPMKRITIPEI 265
               P  R T  E+
Sbjct: 235 WKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 97.7 bits (243), Expect = 5e-24
 Identities = 71/255 (27%), Positives = 127/255 (49%), Gaps = 19/255 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL +T+G G FG V + ++   G+KVA+K      IKN    +    E  ++    H ++
Sbjct: 9   KLLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEASVMTQLRHSNL 61

Query: 80  IRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRN 136
           ++L  VI E    +Y+V EY+  G L DY+  +GR  L  D    F   +   +EY   N
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAG 195
             VHRDL   N+L+      K++DFGL+   ++    + +   P  + APE +  K ++ 
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS- 177

Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 252
            + DVWS G++L+ +   G +P+    + ++  +++ G Y +  P    P   D++ +  
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQCW 236

Query: 253 IVDPMKRITIPEIRQ 267
            +D   R +  ++R+
Sbjct: 237 HLDAATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 1e-23
 Identities = 77/274 (28%), Positives = 120/274 (43%), Gaps = 35/274 (12%)

Query: 18  NYKLGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKI 70
              L + LG GSFG V   +A+  + G    +VAIK +N    +N  M E++    E  +
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN----ENASMRERIEFLNEASV 62

Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ------ 124
           ++ F   H++RL  V+ T     VVME +  G+L  Y+  + R  E E            
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQK 120

Query: 125 ------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSC 177
                 +I  G+ Y      VHRDL   N ++     VKI DFG++ +I    ++ K   
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 178 GS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKG 231
           G  P  + APE +   ++   + DVWS GV+L+ +      P+    +E +      I G
Sbjct: 181 GLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV--IDG 237

Query: 232 GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
           G   LP +      +L+      +P  R T  EI
Sbjct: 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 1e-23
 Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 64/268 (23%)

Query: 66  REIKILRLFMHPHIIRLYEVIETPSD--IYVVMEYVKS--GELFDYIVEKGRLQEDEA-- 119
           REI +LR   H +++ L EV    +D  +Y++ +Y +    ++  +  +  R+    +  
Sbjct: 51  REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN----VKIADFGLSNIMRDGHFLKT 175
           ++   QI++GV Y H N V+HRDLKP N+L+  +      VKI D GL+ +      LK 
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP--LKP 168

Query: 176 SCGSPN------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF----DDENIPNL 225
                       Y APE++ G  +    +D+W+ G I   LL     F          N 
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228

Query: 226 FK--------KIKG--------GIYTLPSH--------------------------LSPG 243
           F+        ++ G         I  +P +                              
Sbjct: 229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQ 288

Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF 271
             DL+ ++L  DP KRIT  E  +HP+F
Sbjct: 289 GFDLLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 97.3 bits (242), Expect = 1e-23
 Identities = 70/203 (34%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 20  KLGKTLGIGSFGKVKI----AEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           K  + LG G FGKV +      +  TG  VA+K L R      +     ++EI IL+   
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY 64

Query: 76  HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           H +I++            + ++MEYV  G L DY+  K +L   +   F QQI  G+ Y 
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYL 123

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNY-AAPEVI- 188
           H    +HRDL   N+LLD+   VKI DFGL+  + +GH    ++    SP +  A E + 
Sbjct: 124 HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 189 SGKLYAGPEVDVWSCGVILYALL 211
             K       DVWS GV LY LL
Sbjct: 184 ENKFSYAS--DVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 96.6 bits (240), Expect = 2e-23
 Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 26/270 (9%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMHP 77
           +++ +T+G G++GKV    +   G K A+KIL+       +++E++  E  IL+ L  HP
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHP 75

Query: 78  HIIRLYEV-----IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------FFQQI 126
           ++++ Y +     ++    +++V+E    G + D +  KG L+  E            + 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEA 133

Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAP 185
           + G+++ H N  +HRD+K  N+LL ++  VK+ DFG+S  +        TS G+P + AP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193

Query: 186 EVISGKLYAGP----EVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTL--PS 238
           EVI+ +           DVWS G+    L  G  P  D   +  LFK  +    TL  P 
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE 253

Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
             S    D I + L  D  KR T+ ++ QH
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 96.2 bits (239), Expect = 3e-23
 Identities = 78/292 (26%), Positives = 128/292 (43%), Gaps = 52/292 (17%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
           KL K LG G++  V      LT + VA+K +       +E EE       RE+ +L+   
Sbjct: 9   KLDK-LGEGTYATVFKGRSKLTENLVALKEIR------LEHEEGAPCTAIREVSLLKNLK 61

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE-DEARNFFQQIISGVEYCH 134
           H +I+ L+++I T   + +V EY+ S +L  Y+   G L      + F  Q++ G+ YCH
Sbjct: 62  HANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVIS 189
           +  ++HRDLKP+NLL++ K  +K+ADFGL+        + T   S       Y  P+V+ 
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLL 176

Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIK 230
           G       +D+W  G ILY +  G   F                    +E  P +    +
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236

Query: 231 GGIYTLPSHLSPGARDLIPR-----------MLIVDPMKRITIPEIRQHPWF 271
              Y  P + +    +  PR           +L+ +   RI+     +H +F
Sbjct: 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.7 bits (238), Expect = 3e-23
 Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 31/270 (11%)

Query: 22  GKTLGIGSFGKVKIAEHALTGHKVAIK--ILNRRKIKNMEME-EKVRREIKILRLFMHPH 78
           G+ LG G++G V        G  +A+K   L+   +   E E EK++ E+ +L+   H +
Sbjct: 5   GEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I++        + I + ME+V  G +   +   G L E     + +QI+ GV Y H N V
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-------------SNIMRDGHFLKTSCGSPNYAAP 185
           VHRD+K  N++L     +K+ DFG              SN+++  H      G+P + AP
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH------GTPYWMAP 177

Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-----KGGIYTLPSHL 240
           EVI+   Y G + D+WS G  ++ +  G  P    ++  L         +G +  LP   
Sbjct: 178 EVINESGY-GRKSDIWSIGCTVFEMATGKPPL--ASMDRLAAMFYIGAHRGLMPRLPDSF 234

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
           S  A D +   L  D  +R +  ++ +H +
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 96.0 bits (239), Expect = 3e-23
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 15/197 (7%)

Query: 25  LGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           LG G+FG V++  +      TG  VA+K L     +++   E   REI+IL+   H +I+
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE---REIEILKSLQHDNIV 68

Query: 81  RLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           +   V  +    ++ +VMEY+  G L DY+ + + RL   +   +  QI  G+EY     
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLY 193
            VHRDL   N+L++S+  VKI DFGL+ ++   ++ + ++    SP +  APE ++   +
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188

Query: 194 AGPEVDVWSCGVILYAL 210
           +    DVWS GV+LY L
Sbjct: 189 S-VASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 95.3 bits (237), Expect = 3e-23
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 14/225 (6%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM-EEKVRREIKILRLFMHPHIIR 81
           K LG G FG VK  +     + VAIK+     IK   M E++   E K++    H  +++
Sbjct: 10  KELGTGQFGVVKYGKWR-GQYDVAIKM-----IKEGSMSEDEFIEEAKVMMKLSHEKLVQ 63

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVH 140
           LY V      IY+V EY+ +G L +Y+ E G R Q  +     + +  G+ Y      +H
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPE 197
           RDL   N L+D +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++  +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSS-K 181

Query: 198 VDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLS 241
            DVW+ GV+++ +   G +P++  N     +K+  G+     HL+
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA 226

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 6e-23
 Identities = 71/254 (27%), Positives = 123/254 (48%), Gaps = 17/254 (6%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KLG T+G G FG V + ++   G KVA+K L      +    +    E  ++    HP++
Sbjct: 9   KLGATIGKGEFGDVMLGDYR--GQKVAVKCLKD----DSTAAQAFLAEASVMTTLRHPNL 62

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
           ++L  V+   + +Y+V EY+  G L DY+  +GR  +   +   F   +  G+EY     
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGP 196
            VHRDL   N+L+      K++DFGL+     G     S   P  + APE +  K ++  
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---DSGKLPVKWTAPEALREKKFST- 178

Query: 197 EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 253
           + DVWS G++L+ +   G +P+    + ++   ++ G Y +  P    P    ++     
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKDCWE 237

Query: 254 VDPMKRITIPEIRQ 267
           +DP KR T  ++R+
Sbjct: 238 LDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 95.4 bits (237), Expect = 7e-23
 Identities = 79/303 (26%), Positives = 135/303 (44%), Gaps = 52/303 (17%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
           KL K LG G++  V      LT + VA+K +       +E EE       RE+ +L+   
Sbjct: 10  KLEK-LGEGTYATVFKGRSKLTENLVALKEIR------LEHEEGAPCTAIREVSLLKDLK 62

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE-DEARNFFQQIISGVEYCH 134
           H +I+ L++++ T   + +V EY+   +L  Y+ + G +      + F  QI+ G+ YCH
Sbjct: 63  HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVIS 189
           R  V+HRDLKP+NLL++ +  +K+ADFGL+        + T   S       Y  P+V+ 
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLL 177

Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIK 230
           G      ++D+W  G I + +  G   F                    +E  P +    +
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237

Query: 231 GGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279
              Y  P +           L     +L+ + L  +  KRI+  E  +H +F++   R  
Sbjct: 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIH 297

Query: 280 AVP 282
           ++P
Sbjct: 298 SLP 300

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 95.3 bits (237), Expect = 7e-23
 Identities = 62/186 (33%), Positives = 95/186 (51%), Gaps = 11/186 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GSFG V  A    T   VAIK ++    ++ E  + + +E++ L+   HP+ I    
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 85  VIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
                   ++VMEY   G   D + V K  LQE E        + G+ Y H +  +HRD+
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDI 141

Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLYAGPEVD 199
           K  N+LL     VK+ADFG ++++   +   +  G+P + APEVI     G+ Y G +VD
Sbjct: 142 KAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMDEGQ-YDG-KVD 196

Query: 200 VWSCGV 205
           VWS G+
Sbjct: 197 VWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 8e-23
 Identities = 86/299 (28%), Positives = 130/299 (43%), Gaps = 63/299 (21%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
           KL K LG GS+  V      LTG  VA+K +       +E EE       RE  +L+   
Sbjct: 9   KLDK-LGEGSYATVYKGRSKLTGQLVALKEIR------LEHEEGAPFTAIREASLLKDLK 61

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCH 134
           H +I+ L+++I T   + +V EY+ + +L  Y+ + G  L     R F  Q++ G+ YCH
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYA---------AP 185
           +  V+HRDLKP+NLL+  +  +K+ADFGL+           S  S  Y+          P
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLAR--------AKSVPSKTYSNEVVTLWYRPP 172

Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF--------------------DDENIPNL 225
           +V+ G       +D+W  G I Y +  G   F                     +E  P +
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232

Query: 226 -----FKKIKGGIYT---LPSHLS-----PGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                FK      Y    L +H       P   +L  + L  +P KRI+  E  +HP+F
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 94.4 bits (235), Expect = 1e-22
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 16/221 (7%)

Query: 20  KLGKTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           +  K LG G+FG V     I E       VAIK+L  R+  + +  +++  E  ++    
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASVD 67

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           HPH++RL  +  +   + ++ + +  G L DY+   K  +      N+  QI  G+ Y  
Sbjct: 68  HPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186

Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFDDEN---IPNLFKK 228
           +Y   + DVWS GV ++ L+  G  P++      IP+L +K
Sbjct: 187 IYTH-KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 93.9 bits (233), Expect = 2e-22
 Identities = 84/283 (29%), Positives = 128/283 (45%), Gaps = 39/283 (13%)

Query: 18  NYKLGKTLGIGSFGKV-KIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILR 72
           N  LGKTLG G FGKV K     L G      VA+K+L  ++  +      +  E  +L+
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML--KENASSSELRDLLSEFNLLK 58

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-----VEKGRLQEDEARN------ 121
              HPH+I+LY        + +++EY K G L  ++     V    L  D  RN      
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 122 -------------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIM 167
                        F  QI  G++Y     +VHRDL   N+L+     +KI+DFGLS ++ 
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 168 RDGHFLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224
            +  ++K S G     + A E +   +Y   + DVWS GV+L+ ++  G  P+       
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237

Query: 225 LFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEI 265
           LF  +K G Y +  P + S    +L+      +P KR T  +I
Sbjct: 238 LFNLLKTG-YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 93.7 bits (233), Expect = 2e-22
 Identities = 72/268 (26%), Positives = 113/268 (42%), Gaps = 29/268 (10%)

Query: 25  LGIGSFGKVKIAE--HALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           LG G+FGKV + E  H         VA+K L  ++  + +  +   RE ++L  F H +I
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAELLTNFQHENI 70

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI--------------VEKGRLQEDEARNFFQQ 125
           ++ Y V        +V EY++ G+L  ++                 G L   +      Q
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NY 182
           I SG+ Y      VHRDL   N L+     VKI DFG+S  +   D + +      P  +
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190

Query: 183 AAPE-VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHL 240
             PE ++  K     E DVWS GV+L+ +   G  P+   +   + + I  G        
Sbjct: 191 MPPESIMYRKFTT--ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRT 248

Query: 241 SP-GARDLIPRMLIVDPMKRITIPEIRQ 267
            P    D++      DP +RI I +I +
Sbjct: 249 CPSEVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 94.0 bits (233), Expect = 3e-22
 Identities = 74/296 (25%), Positives = 132/296 (44%), Gaps = 40/296 (13%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y+  + LG GS+  V   +  + G  VA+K++  ++ +         RE  +L+   H 
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLKHA 63

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRN 136
           +I+ L+++I T   + +V EYV + +L  Y+ +  G L  +  + F  Q++ G+ Y H+ 
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAG 195
            ++HRDLKP+NLL+     +K+ADFGL+       H       +  Y  P+V+ G     
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 196 PEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKI-----------KGGIYTLPSHLSP- 242
             +D+W  G I   ++ G   F   ++I +  ++I             G+++LP H  P 
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP-HFKPE 241

Query: 243 ---------------------GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
                                 A DL  ++L   P  R++      H +F    PR
Sbjct: 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPR 297

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 92.4 bits (230), Expect = 4e-22
 Identities = 70/230 (30%), Positives = 115/230 (50%), Gaps = 13/230 (5%)

Query: 17  PNY-KLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILR 72
           P+Y  + K +G G FG+V      L G     VAIK L         ++     E  I+ 
Sbjct: 3   PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMG 60

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVE 131
            F HP+IIRL  V+     + ++ EY+++G L  ++ E  G+    +     + I SG++
Sbjct: 61  QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG--SP-NYAAPEVI 188
           Y      VHRDL   N+L++S    K++DFGLS  + D     T+ G   P  + APE I
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180

Query: 189 SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           + + +     DVWS G++++ ++  G  P+ D +  ++ K ++ G Y LP
Sbjct: 181 AYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLP 228

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 91.8 bits (228), Expect = 7e-22
 Identities = 72/227 (31%), Positives = 118/227 (51%), Gaps = 17/227 (7%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEME-EKVRREIKILRLFM 75
             KL K LG G FG+V +  +   GH KVAIK L     K   M  E    E  +++   
Sbjct: 7   TLKLVKKLGAGQFGEVWMGYY--NGHTKVAIKSL-----KQGSMSPEAFLAEANLMKQLQ 59

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYC 133
           HP ++RLY V+ T   IY++ EY+++G L D++   E  +L  ++  +   QI  G+ + 
Sbjct: 60  HPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGK 191
            R   +HRDL+  N+L+      KIADFGL+ ++ D  +  +     P  + APE I+  
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178

Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            +   + DVWS G++L  ++  G +P+     P + + ++ G Y +P
Sbjct: 179 TFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMP 223

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 92.2 bits (229), Expect = 7e-22
 Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 28/272 (10%)

Query: 20  KLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           KLGK LG G FG V   ++++   +  KVA+K +        E+EE +  E   ++ F H
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFDH 60

Query: 77  PHIIRLYEVIETPSDI------YVVMEYVKSGELFDYIVEKGRLQEDEAR-------NFF 123
           P++++L  V    S +       V++ ++K G+L  +++   RL     +        F 
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFM 119

Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--- 180
             I  G+EY      +HRDL   N +L     V +ADFGLS  +  G + +    +    
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTL 236
            + A E ++ ++Y   + DVW+ GV ++ +   G  P+   ++  I +      G     
Sbjct: 180 KWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL--RHGNRLKQ 236

Query: 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           P        DL+      DP  R T  ++R+ 
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 92.0 bits (228), Expect = 1e-21
 Identities = 67/235 (28%), Positives = 121/235 (51%), Gaps = 28/235 (11%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           +D ++ R  +G+      ++L + +G G++G+V    H  TG   AIK+++  +    + 
Sbjct: 6   IDLSALRDPAGI------FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DE 55

Query: 61  EEKVRREIKILRLFMHPHIIRLYE---VIETPS----DIYVVMEYVKSGELFDYIVE-KG 112
           EE+++ EI +L+ + H   I  Y    + ++P      +++VME+  +G + D +   KG
Sbjct: 56  EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG 115

Query: 113 R-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDG 170
             L+ED      ++I+ G+ + H + V+HRD+K +N+LL     VK+ DFG+S  + R  
Sbjct: 116 NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175

Query: 171 HFLKTSCGSPNYAAPEVISGKLYAGPEV------DVWSCGVILYALLCGTLPFDD 219
               T  G+P + APEVI+      P+       D+WS G+    +  G  P  D
Sbjct: 176 GRRNTFIGTPYWMAPEVIACD--ENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 91.1 bits (226), Expect = 2e-21
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 18/202 (8%)

Query: 23  KTLGIGSFGKVKIA----EHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           + LG G FGKV++     E   TG +VA+K L      N   +  +++EI+ILR   H +
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHEN 67

Query: 79  IIRLYEVI---ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           I++ Y+ I   +  + I ++ME++ SG L +Y+   K ++   +   +  QI  G++Y  
Sbjct: 68  IVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNY-AAPE-VIS 189
               VHRDL   N+L++S+  VKI DFGL+  +      + +K    SP +  APE +I 
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 190 GKLYAGPEVDVWSCGVILYALL 211
            K Y     DVWS GV LY LL
Sbjct: 187 SKFYIAS--DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.9 bits (225), Expect = 2e-21
 Identities = 65/224 (29%), Positives = 119/224 (53%), Gaps = 15/224 (6%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL K LG G FG+V +A +    H KVA+K +   K  +M +E  +  E  +++   H  
Sbjct: 9   KLEKKLGAGQFGEVWMATY--NKHTKVAVKTM---KPGSMSVEAFLA-EANVMKTLQHDK 62

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRN 136
           +++L+ V+ T   IY++ E++  G L D++   E  +    +  +F  QI  G+ +  + 
Sbjct: 63  LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+ +    KIADFGL+ ++ D  +  +     P  + APE I+   + 
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181

Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
             + DVWS G++L  ++  G +P+   + P + + ++ G Y +P
Sbjct: 182 -IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 223

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 14/224 (6%)

Query: 65  RREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----LQEDEAR 120
           R E+  L    H  I++ ++  ++   + ++MEY   G+L   I ++ +     QE E  
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---C 177
             F QI+  ++  H   ++HRDLK  N+ L     +K+ DFG S    D   L  +   C
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-L 236
           G+P Y APE+   K Y+  + D+WS GVILY LL    PF   +   + +++  G Y   
Sbjct: 233 GTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291

Query: 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLA 280
           P  +S G + L+  +L  +P  R T  ++           +Y+A
Sbjct: 292 PCPVSSGMKALLDPLLSKNPALRPTTQQL-----LHTEFLKYVA 330

Length = 478

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 89.4 bits (222), Expect = 5e-21
 Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 29/203 (14%)

Query: 23  KTLGIGSFGKVKIAE-HALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           K LG GSFG V+  E     G    VA+K L   K+ ++  +    +E  I+    H ++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD--FLKEAAIMHSLDHENL 58

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR--------NFFQQIISGVE 131
           IRLY V+ T   + +V E    G L D      RL++D           ++  QI +G+ 
Sbjct: 59  IRLYGVVLTHP-LMMVTELAPLGSLLD------RLRKDALGHFLISTLCDYAVQIANGMR 111

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------YAAP 185
           Y      +HRDL   N+LL S   VKI DFGL   +             +      + AP
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM--EEHLKVPFAWCAP 169

Query: 186 EVISGKLYAGPEVDVWSCGVILY 208
           E +  + ++    DVW  GV L+
Sbjct: 170 ESLRTRTFSHAS-DVWMFGVTLW 191

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.8 bits (220), Expect = 9e-21
 Identities = 72/251 (28%), Positives = 121/251 (48%), Gaps = 15/251 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 69

Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ---QIISGVEYCHRNMVVHR 141
           V       Y++ E++  G L DY+ E  R QE  A        QI S +EY  +   +HR
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKNFIHR 128

Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGPEVD 199
           DL   N L+     VK+ADFGLS +M    +   +    P  + APE ++   ++  + D
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI-KSD 187

Query: 200 VWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDP 256
           VW+ GV+L+ +   G  P+   ++  +++ ++ G Y +  P    P   +L+      +P
Sbjct: 188 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCPPKVYELMRACWQWNP 246

Query: 257 MKRITIPEIRQ 267
             R +  EI Q
Sbjct: 247 SDRPSFAEIHQ 257

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 89.2 bits (221), Expect = 9e-21
 Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 34/275 (12%)

Query: 19  YKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + LG+ LG G FG V+ A+      +  KVA+K+L      + ++EE +R E   ++ F 
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFD 59

Query: 76  HPHIIRLYEV---------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR------ 120
           HP++I+L  V         +  P    V++ ++K G+L  +++   R+ E+         
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIP---MVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTL 115

Query: 121 -NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
             F   I SG+EY      +HRDL   N +L+    V +ADFGLS  +  G + +  C S
Sbjct: 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 180 P---NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGG 232
                + A E ++  +Y     DVW+ GV ++ ++  G  P+   ++  I N    IKG 
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL--IKGN 232

Query: 233 IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
               P        +L+ +    +P  R +   +R 
Sbjct: 233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 88.4 bits (219), Expect = 1e-20
 Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 30/209 (14%)

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           P+++ L++ I +   +++V+++ + G+L+ +I +   + E+  + +  +++  ++  HR 
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----YAAPEVISGKL 192
            +V RDL P N+LLD + ++++  F   + + D      SC        Y APEV  G  
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED------SCDGEAVENMYCAPEV-GGIS 157

Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----LPSHLSPGARDL 247
                 D WS G IL+ LL G           L +    GI T     +P  +S  AR L
Sbjct: 158 EETEACDWWSLGAILFELLTGK---------TLVECHPSGINTHTTLNIPEWVSEEARSL 208

Query: 248 IPRMLIVDPMKRI-----TIPEIRQHPWF 271
           + ++L  +P +R+      + +I+ HP+F
Sbjct: 209 LQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.4 bits (221), Expect = 1e-20
 Identities = 82/285 (28%), Positives = 128/285 (44%), Gaps = 34/285 (11%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G GSFG V  A    T   VAIK ++    ++ E  + + +E+K L+   HP+ I  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 83  YEVIETPSDIYVVMEYV--KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
                     ++VMEY    + +L +  V K  LQE E        + G+ Y H + ++H
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 148

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLYAGP 196
           RD+K  N+LL     VK+ADFG ++I    +   +  G+P + APEVI     G+ Y G 
Sbjct: 149 RDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMDEGQ-YDG- 203

Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFK-KIKGGIYTLPSHLSPGA---------RD 246
           +VDVWS G+    L         E  P LF       +Y +  + SP           R+
Sbjct: 204 KVDVWSLGITCIELA--------ERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255

Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 291
            +   L   P  R T  E+ +H +     P  + +   D +Q+ K
Sbjct: 256 FVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLI---DLIQRTK 297

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 88.9 bits (220), Expect = 1e-20
 Identities = 66/202 (32%), Positives = 110/202 (54%), Gaps = 18/202 (8%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHK-VAIKILNRRKIKNME--MEEKVRREIKILR--- 72
           Y+    +G G++GKV  A     G + VA+K   R +++  E  M     RE+ +LR   
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHLE 59

Query: 73  LFMHPHIIRLYEV-----IETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQ 125
            F HP+++RL++V      +  + + +V E+V   +L  Y+  V +  +  +  ++   Q
Sbjct: 60  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 118

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
           ++ G+++ H + VVHRDLKP+N+L+ S   +K+ADFGL+ I      L +   +  Y AP
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 186 EVISGKLYAGPEVDVWSCGVIL 207
           EV+    YA P VD+WS G I 
Sbjct: 179 EVLLQSSYATP-VDLWSVGCIF 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 88.0 bits (218), Expect = 2e-20
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 8/194 (4%)

Query: 24  TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLY 83
            LG G+ G V  A H LT   +A+K++       +E+++++  E++IL     P+II  Y
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 84  EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
                 + I +  E++  G L  Y     ++ E         ++ G+ Y     ++HRD+
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121

Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
           KP N+L++++  VK+ DFG+S  + +    KT  G+  Y APE ISG+ Y G   DVWS 
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQY-GIHSDVWSL 179

Query: 204 GVILYALLCGTLPF 217
           G+    L  G  P+
Sbjct: 180 GISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 87.9 bits (218), Expect = 2e-20
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 29/220 (13%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           L   +  + LG G+FGKV   E       L+   VAIK L  ++    +++++ R+E ++
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL--KENAEPKVQQEFRQEAEL 61

Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE----------------KGRL 114
           +    HP+I+ L  V        ++ EY+  G+L +++V                 K  L
Sbjct: 62  MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 115 QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174
              +  +   QI +G+EY   +  VHRDL   N L+     VKI+DFGLS  +    + +
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181

Query: 175 TSCGSP---NYAAPEVI-SGKLYAGPEVDVWSCGVILYAL 210
               S     +  PE I  GK     E D+WS GV+L+ +
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKF--TTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 87.4 bits (216), Expect = 7e-20
 Identities = 61/187 (32%), Positives = 96/187 (51%), Gaps = 13/187 (6%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GSFG V  A ++ T   VA+K ++    +  E  + + +E+K L+   HP+ I    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 85  VIETPSDIYVVMEYV--KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
                   ++VMEY    + +L +  V K  LQE E        + G+ Y H + ++HRD
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLYAGPEV 198
           +K  N+LL     VK+ADFG ++     +   +  G+P + APEVI     G+ Y G +V
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQ-YDG-KV 201

Query: 199 DVWSCGV 205
           DVWS G+
Sbjct: 202 DVWSLGI 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 86.3 bits (213), Expect = 8e-20
 Identities = 72/267 (26%), Positives = 124/267 (46%), Gaps = 23/267 (8%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +++L + +G G++G V  A +  TG   AIK++   K++  E    V++EI +++   H 
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHS 66

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+  +        +++ ME+   G L D     G L E +     ++ + G+ Y H   
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            +HRD+K  N+LL    +VK+ADFG+S  I       K+  G+P + APEV + +   G 
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186

Query: 197 E--VDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPSHLSPGARD------- 246
               D+W+ G+    L     P FD   +  LF      + T  +   P  +D       
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMTKSNFQPPKLKDKMKWSNS 240

Query: 247 ---LIPRMLIVDPMKRITIPEIRQHPW 270
               +   L  +P KR T  ++ QHP+
Sbjct: 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 86.2 bits (213), Expect = 9e-20
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 21/229 (9%)

Query: 23  KTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILRLFM 75
           K +G G FG+V      + G K   VAIK L           EK R+    E  I+  F 
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK------PGYTEKQRQDFLSEASIMGQFS 64

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCH 134
           H +IIRL  V+       ++ EY+++G L  Y+ +  G     +     + I +G++Y  
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSP-NYAAPEVISG 190
               VHRDL   N+L++S    K++DFGLS ++ D   G +  +    P  + APE I+ 
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 238
           + +     DVWS G++++ ++  G  P+ D +   + K I  G + LP+
Sbjct: 185 RKFTSAS-DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPA 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.1 bits (213), Expect = 1e-19
 Identities = 72/237 (30%), Positives = 118/237 (49%), Gaps = 18/237 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEK-VRREIKILRLFM 75
           K+ K +G G FG+V      L G +   VAIK L   K    E + +    E  I+  F 
Sbjct: 7   KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL---KAGYTEKQRRDFLSEASIMGQFD 63

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYC 133
           HP+II L  V+     + +V EY+++G L D  + K  G+    +     + I SG++Y 
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSP-NYAAPEVIS 189
                VHRDL   N+L++S    K++DFGLS ++ D     +       P  + APE I+
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLS-PGA 244
            + +     DVWS G++++ ++  G  P+ + +  ++ K I+ G Y LP+ +  P A
Sbjct: 183 YRKFTSAS-DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAA 237

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 85.5 bits (211), Expect = 2e-19
 Identities = 62/217 (28%), Positives = 112/217 (51%), Gaps = 22/217 (10%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           ++L + +G G++G+V    H  TG   AIK+++       + EE++++EI +L+ + H  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63

Query: 79  IIRLYE---VIETP----SDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISG 129
            I  Y    + + P      +++VME+  +G + D I   +   L+E+      ++I+ G
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVI 188
           + + H++ V+HRD+K +N+LL     VK+ DFG+S  + R      T  G+P + APEVI
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 189 SGKLYAGPEV------DVWSCGVILYALLCGTLPFDD 219
           +      P+       D+WS G+    +  G  P  D
Sbjct: 184 ACD--ENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 75/292 (25%), Positives = 135/292 (46%), Gaps = 53/292 (18%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y + + +G G  G+V +A   +   +VA+K +     +N  ++++  RE KI    +HP 
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 79  IIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGRLQEDEARNF------------FQQ 125
           I+ +Y  I +  D +Y  M Y++ G     +++    +E  ++              F +
Sbjct: 64  IVPVYS-ICSDGDPVYYTMPYIE-GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTS---- 176
           I + +EY H   V+HRDLKP+N+LL     V I D+G + I +         +       
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDERNI 180

Query: 177 -----------CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL 225
                       G+P+Y APE + G   A    D+++ GVILY +L  + P+  +     
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKK---- 235

Query: 226 FKKI--KGGIYTLPSHLSPGARDLIP-------RMLIVDPMKRI-TIPEIRQ 267
            +KI  +  I + P  ++P  R++ P       + L VDP +R  ++ E++Q
Sbjct: 236 GRKISYRDVILS-PIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285

Length = 932

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 84.8 bits (210), Expect = 3e-19
 Identities = 65/262 (24%), Positives = 119/262 (45%), Gaps = 22/262 (8%)

Query: 23  KTLGIGSFGKV---KIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            TLG G FG+V   K       G +  V +K L + K +N++ E   RRE+ + R   H 
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE--FRRELDMFRKLSHK 68

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARN--------FFQQIIS 128
           +++RL  +       Y+++EY   G+L  ++   K + ++ +              QI  
Sbjct: 69  NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYAAPE 186
           G+++      VHRDL   N L+ S+  VK++   LS  +   + + L+ +     + APE
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188

Query: 187 VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI--YTLPSHLSPG 243
            +    ++  + DVWS GV+++ +   G LPF   +   +  +++ G     +P      
Sbjct: 189 AVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR 247

Query: 244 ARDLIPRMLIVDPMKRITIPEI 265
              L+ R   V+P  R +  E+
Sbjct: 248 LYKLMTRCWAVNPKDRPSFSEL 269

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 84.2 bits (208), Expect = 4e-19
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 14/231 (6%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L    LG+ +G G FG V   E+  TG KVA+K      IK     +    E  ++    
Sbjct: 5   LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKN-----IKCDVTAQAFLEETAVMTKLH 57

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR--NFFQQIISGVEYC 133
           H +++RL  VI   + +Y+VME +  G L +++  +GR      +   F   +  G+EY 
Sbjct: 58  HKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
               +VHRDL   N+L+      K++DFGL+ +   G  +  S     + APE +  K +
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKF 174

Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPG 243
           +  + DVWS GV+L+ +   G  P+   ++  + + ++ G    P    P 
Sbjct: 175 SS-KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA 224

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 84.1 bits (208), Expect = 4e-19
 Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 10/189 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G+FG V          +VA+K    R     +++ K  +E +IL+ + HP+I++L  
Sbjct: 3   IGKGNFGDVYKGVLK-GNTEVAVKTC--RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 85  VIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
           V      IY+VME V  G L  ++  +K RL   +         +G+EY      +HRDL
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119

Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----YAAPEVISGKLYAGPEVD 199
              N L+     +KI+DFG+S     G +   S G       + APE ++   Y   E D
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIY-TVSDGLKQIPIKWTAPEALNYGRYTS-ESD 177

Query: 200 VWSCGVILY 208
           VWS G++L+
Sbjct: 178 VWSYGILLW 186

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 87.1 bits (215), Expect = 5e-19
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 35/250 (14%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y++ K +G G FG+V + +H  T      K ++ R +K  E  + V  E+ ++R   
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EVNVMRELK 70

Query: 76  HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISG 129
           H +I+R  +     ++  +Y++ME+  +G+L   I +     G+++E    +  +Q++  
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 130 VEYCHR-------NMVVHRDLKPENLLLDSKWN-----------------VKIADFGLSN 165
           + YCH          V+HRDLKP+N+ L +                     KI DFGLS 
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 166 IMRDGHFLKTSCGSPNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENI 222
            +       +  G+P Y +PE++    K Y   + D+W+ G I+Y L  G  PF    N 
Sbjct: 191 NIGIESMAHSCVGTPYYWSPELLLHETKSY-DDKSDMWALGCIIYELCSGKTPFHKANNF 249

Query: 223 PNLFKKIKGG 232
             L  ++K G
Sbjct: 250 SQLISELKRG 259

Length = 1021

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 84.0 bits (208), Expect = 6e-19
 Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 12/223 (5%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L + LG G FG+V       T   VA+K L   K   M+ ++ +  E +I++   HP +
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTT-PVAVKTL---KPGTMDPKDFLA-EAQIMKKLRHPKL 63

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           I+LY V      IY+V E +K G L +Y+    GR L+  +  +   Q+ SG+ Y     
Sbjct: 64  IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSP-NYAAPEVISGKLYAG 195
            +HRDL   N+L+      K+ADFGL+  I  D +  +     P  + APE      ++ 
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS- 182

Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + DVWS G++L  ++  G +P+       + +++  G Y +P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMP 224

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 84.8 bits (210), Expect = 6e-19
 Identities = 73/292 (25%), Positives = 135/292 (46%), Gaps = 53/292 (18%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V    H  +G  +A      RK+ ++E++  +R    RE+K+L     P+I+
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMA------RKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNM-V 138
             Y    +  +I + ME++  G L D +++K GR+ E+        ++ G+ Y      +
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y   + 
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYT-VQS 179

Query: 199 DVWSCGVILYALLCGTLPF---DDENIPNLF-KKIKGG---------------------I 233
           D+WS G+ L  +  G  P    D + +  +F + +  G                     I
Sbjct: 180 DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239

Query: 234 Y------------TLPS-HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           +             LPS   S   +D + + L  +P +R  + E+ +HP+ +
Sbjct: 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 84.3 bits (208), Expect = 8e-19
 Identities = 76/262 (29%), Positives = 120/262 (45%), Gaps = 15/262 (5%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G GSFG V  A        VAIK ++    ++ E  + + +E++ L+   HP+ I+ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 83  YEVIETPSDIYVVMEYV--KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
                     ++VMEY    + +L +  V K  LQE E        + G+ Y H + ++H
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLYAGP 196
           RD+K  N+LL     VK+ DFG ++IM   +      G+P + APEVI     G+ Y G 
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQ-YDG- 193

Query: 197 EVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPS-HLSPGARDLIPRMLIV 254
           +VDVWS G+    L     P F+   +  L+   +     L S H S   R+ +   L  
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253

Query: 255 DPMKRITIPEIRQHPWFQAHLP 276
            P  R T   + +H +     P
Sbjct: 254 IPQDRPTSEVLLKHRFVLRERP 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 18/231 (7%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V    H  +G  +A      RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y   ++ ++
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126

Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  + D
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 184

Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           +WS G+ L  +  G  P     IP    K    ++  P    P   +  PR
Sbjct: 185 IWSMGLSLVEMAIGRYP-----IPPPDAKELELMFGCPVEGDPAESETSPR 230

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 83.1 bits (205), Expect = 1e-18
 Identities = 76/251 (30%), Positives = 126/251 (50%), Gaps = 19/251 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L K LG G FG+V +        KVA+K L   K   M   E    E +I++   H  +
Sbjct: 9   QLIKKLGNGQFGEVWMGTWNGNT-KVAVKTL---KPGTMS-PESFLEEAQIMKKLRHDKL 63

Query: 80  IRLYEVI-ETPSDIYVVMEYVKSGELFDYIVE-KGR-LQEDEARNFFQQIISGVEYCHRN 136
           ++LY V+ E P  IY+V EY+  G L D++ + +GR L+     +   Q+ +G+ Y  R 
Sbjct: 64  VQLYAVVSEEP--IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLY 193
             +HRDL+  N+L+      KIADFGL+ ++ D  +  +     P  + APE  + G+  
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPR 250
              + DVWS G++L  L+  G +P+   N   + ++++ G Y +  P        +L+ +
Sbjct: 182 I--KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHELMLQ 238

Query: 251 MLIVDPMKRIT 261
               DP +R T
Sbjct: 239 CWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 83.6 bits (206), Expect = 2e-18
 Identities = 56/197 (28%), Positives = 104/197 (52%), Gaps = 13/197 (6%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V   +H  +G  +A      RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + E  R+ E+        ++ G+ Y   ++ ++
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126

Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  + D
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 184

Query: 200 VWSCGVILYALLCGTLP 216
           +WS G+ L  L  G  P
Sbjct: 185 IWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 83.2 bits (206), Expect = 2e-18
 Identities = 75/266 (28%), Positives = 123/266 (46%), Gaps = 24/266 (9%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-VRREIK-ILRLFMHPHIIRL 82
           +G G+FG V    H  +G  +A+K   R +    E E+K +  ++  ++R    P+I++ 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVK---RIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68

Query: 83  YEVIETPSDIYVVMEYVK-SGELFD---YIVEKGRLQEDEARNFFQQIISGVEYCHRNM- 137
           Y  +    D ++ ME +  S + F    Y V K  + E+         +  + Y    + 
Sbjct: 69  YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-SCGSPNYAAPEVISGKLYAGP 196
           ++HRD+KP N+LLD   N+K+ DFG+S  + D    KT   G   Y APE I      G 
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSARDGY 187

Query: 197 EV--DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------TLPSHLSPGARD 246
           +V  DVWS G+ LY +  G  P+   N  ++F ++   +         +     SP   +
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNSEEREFSPSFVN 245

Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272
            I   LI D  KR    E+ +HP+ +
Sbjct: 246 FINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 80.1 bits (197), Expect = 1e-17
 Identities = 69/208 (33%), Positives = 105/208 (50%), Gaps = 22/208 (10%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L   K   M   E   +E ++++   H  +
Sbjct: 9   RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTL---KPGTMS-PEAFLQEAQVMKKLRHEKL 63

Query: 80  IRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGR----LQEDEARNFFQQIISGVEYCH 134
           ++LY V+ E P  IY+V EY+  G L D++  KG     L+  +  +   QI SG+ Y  
Sbjct: 64  VQLYAVVSEEP--IYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE 119

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKL 192
           R   VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE     L
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE---AAL 176

Query: 193 YAGPEV--DVWSCGVILYALLC-GTLPF 217
           Y    +  DVWS G++L  L   G +P+
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.4 bits (196), Expect = 3e-17
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 30/216 (13%)

Query: 25  LGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           +G G FG V    + +        A+K LNR  I ++E  E+  +E  I++ F HP+++ 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 82  LYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARN--------FFQQIISGVE 131
           L   I  PS+    VV+ Y+K G+L ++I         E  N        F  Q+  G+E
Sbjct: 61  LLG-ICLPSEGSPLVVLPYMKHGDLRNFI-------RSETHNPTVKDLIGFGLQVAKGME 112

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPE 186
           Y      VHRDL   N +LD  + VK+ADFGL+  + D  +      T    P  + A E
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 187 VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN 221
            +  + +   + DVWS GV+L+ L+  G  P+ D +
Sbjct: 173 SLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVD 207

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.4 bits (196), Expect = 4e-17
 Identities = 75/248 (30%), Positives = 112/248 (45%), Gaps = 49/248 (19%)

Query: 21  LGKTLGIGSFGKVKIAEH-ALTGHK----VAIKILNRRK--------IKNMEMEEKVRRE 67
           LGK LG G+FG+V  AE   L        VA+K+L            +  MEM + + + 
Sbjct: 16  LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 74

Query: 68  IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY----------------IVEK 111
                   H +II L  V      +YVV+EY   G L D+                   +
Sbjct: 75  --------HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126

Query: 112 GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171
             L + +  +F  Q+  G+E+      +HRDL   N+L+     +KIADFGL+   RD H
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA---RDIH 183

Query: 172 ----FLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224
               + KT+ G  P  + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242

Query: 225 LFKKIKGG 232
           LFK +K G
Sbjct: 243 LFKLLKEG 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.1 bits (195), Expect = 4e-17
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILR 72
           K+ + +G G FG+V      L G +   VAIK L           EK RR    E  I+ 
Sbjct: 7   KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK------SGYTEKQRRDFLSEASIMG 60

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVE 131
            F HP+II L  V+     + ++ E++++G L  ++ +  G+    +     + I +G++
Sbjct: 61  QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-----P-NYAAP 185
           Y      VHRDL   N+L++S    K++DFGLS  + D     T   S     P  + AP
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDD 219
           E I+ + +     DVWS G++++ ++  G  P+ D
Sbjct: 181 EAIAYRKFTSAS-DVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 79.9 bits (197), Expect = 4e-17
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 14/196 (7%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y + KTL  GS G+V +A        V +KI           +     E  +L+   HP
Sbjct: 67  GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---------GQKGTTLIEAMLLQNVNHP 117

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRN 136
            +IR+ + + + +   +V+ +  S +L+ Y+      L  D+A    +QI+ G+ Y H  
Sbjct: 118 SVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ 176

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
            ++HRD+K EN+ ++    V I D G +   +    FL  + G+    APEV++   Y  
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA-GTVETNAPEVLARDKY-N 234

Query: 196 PEVDVWSCGVILYALL 211
            + D+WS G++L+ +L
Sbjct: 235 SKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.5 bits (193), Expect = 4e-17
 Identities = 54/192 (28%), Positives = 99/192 (51%), Gaps = 9/192 (4%)

Query: 23  KTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
             LG G+FG VK   + +  +   VA+KIL +    +  +++++ RE  +++   +P+I+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
           R+  + E  S   +VME  + G L  ++ +   + E        Q+  G++Y      VH
Sbjct: 60  RMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYAGP 196
           RDL   N+LL ++   KI+DFGLS  +  D ++ K          + APE ++   ++  
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS- 177

Query: 197 EVDVWSCGVILY 208
           + DVWS GV+++
Sbjct: 178 KSDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 78.5 bits (193), Expect = 5e-17
 Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 27/269 (10%)

Query: 21  LGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           LGKTLG G FG V   E  L       KVA+K +        EME+ +  E   ++ F H
Sbjct: 3   LGKTLGEGEFGSV--MEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLS-EAVCMKEFDH 59

Query: 77  PHIIRL----YEVIET---PSDIYVVMEYVKSGELFDYIV------EKGRLQEDEARNFF 123
           P+++RL     + +E+   PS + V++ ++K G+L  +++          L       F 
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPV-VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118

Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--- 180
             I SG+EY      +HRDL   N +L+   NV +ADFGLS  + +G + +    +    
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK-GGIYTLPS 238
            + A E ++ ++Y   + DVWS GV ++ +   G  P+       ++  ++ G     P 
Sbjct: 179 KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237

Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
               G   L+    +++P  R +   +R 
Sbjct: 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 78.1 bits (192), Expect = 7e-17
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 12/216 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           LG G+FG VK   + +   +  VAIK+L     K++   +++ RE +I+    +P+I+R+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR--DEMMREAEIMHQLDNPYIVRM 60

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
             V E  + + +VME    G L  ++  +K  +          Q+  G++Y      VHR
Sbjct: 61  IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 142 DLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGS-P-NYAAPEVISGKLYAGPE 197
           DL   N+LL ++   KI+DFGLS  +   D ++   S G  P  + APE I+ + ++   
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS-R 178

Query: 198 VDVWSCGVILY-ALLCGTLPFDDENIPNLFKKIKGG 232
            DVWS G+ ++ A   G  P+     P +   I+ G
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 78.2 bits (192), Expect = 7e-17
 Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 18/206 (8%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  KVAIK L    +    M E   +E +I++   H  +
Sbjct: 9   RLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKL 63

Query: 80  IRLYEVI-ETPSDIYVVMEYVKSGELFDYIVE-KGR-LQEDEARNFFQQIISGVEYCHRN 136
           + LY V+ E P  IY+V E++  G L D++ E  G+ L+  +  +   QI  G+ Y  R 
Sbjct: 64  VPLYAVVSEEP--IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+      KIADFGL+ ++ D  +  +     P  + APE     LY 
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYG 178

Query: 195 GPEV--DVWSCGVILYALLC-GTLPF 217
              +  DVWS G++L  L+  G +P+
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 77.8 bits (191), Expect = 1e-16
 Identities = 69/261 (26%), Positives = 118/261 (45%), Gaps = 15/261 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y+L + +G G++G V  A +  TG   A+KI+      +  +   +++EI +++   H 
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKHC 66

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+  +    +   +++ MEY   G L D     G L E +     ++ + G+ Y H   
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            +HRD+K  N+LL    +VK+ADFG+ + I       K+  G+P + APEV + +   G 
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186

Query: 197 E--VDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPSHL------SPGARDL 247
               D+W+ G+    L     P FD   +  LF   K      P  L      S    + 
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ--PPKLKDKTKWSSTFHNF 244

Query: 248 IPRMLIVDPMKRITIPEIRQH 268
           +   L  +P KR T   +  H
Sbjct: 245 VKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 90/334 (26%), Positives = 136/334 (40%), Gaps = 68/334 (20%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNME 59
           +D   NRS +       +YKLG  +G GSFG V  A    T  KVAIK +L   + KN  
Sbjct: 56  IDNDINRSPN------KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-- 107

Query: 60  MEEKVRREIKILRLFMHPHIIRLYEVIETPS------DIY--VVMEYVKSGELFDYIVEK 111
                 RE+ I++   H +II L +   T        +I+  VVME++    +  Y+   
Sbjct: 108 ------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHY 160

Query: 112 GR----LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-VKIADFGLSNI 166
            R    L     + +  Q+   + Y H   + HRDLKP+NLL+D   + +K+ DFG +  
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220

Query: 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL------YALLCGTLPFD-- 218
           +  G    +   S  Y APE++ G       +D+WS G I+      Y +  G    D  
Sbjct: 221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280

Query: 219 -----------------------DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
                                  D   P++  K K      P      A + I + L  +
Sbjct: 281 VRIIQVLGTPTEDQLKEMNPNYADIKFPDV--KPKDLKKVFPKGTPDDAINFISQFLKYE 338

Query: 256 PMKRITIPEIRQHPWFQA------HLPRYLAVPP 283
           P+KR+   E    P+F         LP+Y+   P
Sbjct: 339 PLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLP 372

Length = 440

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.8 bits (191), Expect = 1e-16
 Identities = 71/218 (32%), Positives = 104/218 (47%), Gaps = 16/218 (7%)

Query: 23  KTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           K LG G+FG V     + E       VAIKILN        +E     E  I+    HPH
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPH 70

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           ++RL  V  +P+ I +V + +  G L DY+ E K  +      N+  QI  G+ Y     
Sbjct: 71  LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 194
           +VHRDL   N+L+ S  +VKI DFGL+ ++        + G      + A E I  + + 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 195 GPEVDVWSCGVILYALLC-GTLPFD---DENIPNLFKK 228
             + DVWS GV ++ L+  G  P+D      IP+L +K
Sbjct: 190 H-QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 77.7 bits (191), Expect = 1e-16
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 21  LGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L + LG G+FGKV +AE + L+  K    VA+K L   K   +   +  +RE ++L    
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQ 65

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----------------VEKGRLQEDEA 119
           H HI++ Y V      + +V EY+K G+L  ++                  KG L   + 
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
            +   QI SG+ Y      VHRDL   N L+ +   VKI DFG+S  +    + +    +
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 180 P---NYAAPEVISGKLYAGPEVDVWSCGVILYALL 211
                +  PE I  + +   E DVWS GVIL+ + 
Sbjct: 186 MLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 56/189 (29%), Positives = 93/189 (49%), Gaps = 11/189 (5%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G+FG+V          K  + +   ++    E++ K   E +IL+ + HP+I++L  
Sbjct: 3   LGKGNFGEVF---KGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 85  VIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
           V      IY+VME V  G+   ++  +K  L+  +   F     +G+ Y      +HRDL
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119

Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----YAAPEVISGKLYAGPEVD 199
              N L+     +KI+DFG+S    DG +  +S G       + APE ++   Y+  E D
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIY--SSSGLKQIPIKWTAPEALNYGRYSS-ESD 176

Query: 200 VWSCGVILY 208
           VWS G++L+
Sbjct: 177 VWSYGILLW 185

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 76.6 bits (189), Expect = 3e-16
 Identities = 74/292 (25%), Positives = 114/292 (39%), Gaps = 57/292 (19%)

Query: 21  LGKTLGIGSFGKVKIAE-----------HALTGHK-----VAIKILNRRKIKNMEMEEKV 64
             + LG G FG+V + E            A   +      VA+K+L  R   +    E  
Sbjct: 9   FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL--RPDASDNAREDF 66

Query: 65  RREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ 124
            +E+KIL     P+I RL  V      + ++MEY+++G+L  +      LQ+  A     
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF------LQKHVAETSGL 120

Query: 125 -----------------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167
                            QI SG+ Y      VHRDL   N L+   + +KIADFG+S  +
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 168 RDGHFLKTSCGSP----NYAAPEVISGKLYAGPEVDVWSCGVILYAL--LCGTLPFDD-- 219
               + +   G       + A E +    +   + DVW+ GV L+ +  LC   P++   
Sbjct: 181 YSSDYYRVQ-GRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLT 238

Query: 220 -----ENIPNLFKKIKGGIYTLPSHLSP-GARDLIPRMLIVDPMKRITIPEI 265
                EN  + F+     IY       P    +L+      D   R T  EI
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 76.6 bits (188), Expect = 4e-16
 Identities = 73/249 (29%), Positives = 114/249 (45%), Gaps = 49/249 (19%)

Query: 21  LGKTLGIGSFGKVKIAE---------HALTGHKVAIKILNRRK--------IKNMEMEEK 63
           LGK LG G FG+V +AE         + +T  KVA+K+L            I  MEM + 
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVT--KVAVKMLKSDATEKDLSDLISEMEMMKM 79

Query: 64  VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI--------------- 108
           + +         H +II L         +YV++EY   G L +Y+               
Sbjct: 80  IGK---------HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130

Query: 109 -VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NI 166
            V + +L   +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190

Query: 167 MRDGHFLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP 223
               ++ KT+ G     + APE +  ++Y   + DVWS GV+L+ +   G  P+    + 
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVE 249

Query: 224 NLFKKIKGG 232
            LFK +K G
Sbjct: 250 ELFKLLKEG 258

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 76.6 bits (188), Expect = 5e-16
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 33/241 (13%)

Query: 21  LGKTLGIGSFGKVKIAEHALTGHK--------VAIKILNRRKIKNMEMEEKVRREIKILR 72
           LGK LG G FG+V +AE AL   K        VA+K+L +      ++ + V  E+++++
Sbjct: 19  LGKPLGEGCFGQVVMAE-ALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMK 75

Query: 73  LF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ----------EDEARN 121
           +   H +II L         +YV++EY   G L +Y+  +               DE   
Sbjct: 76  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135

Query: 122 FFQ------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK 174
           F        Q+  G+EY      +HRDL   N+L+     +KIADFGL+ ++    ++ K
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 175 TSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG 231
           T+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +K 
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254

Query: 232 G 232
           G
Sbjct: 255 G 255

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 75.9 bits (186), Expect = 6e-16
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 25/215 (11%)

Query: 18  NYKLGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILR 72
           N  L + LG G+FGKV +AE + L   +    VA+K L   K  +    +   RE ++L 
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLT 62

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-------------RLQEDEA 119
              H HI++ Y V      + +V EY+K G+L  ++   G              L + + 
Sbjct: 63  NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122

Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
            +  QQI +G+ Y      VHRDL   N L+     VKI DFG+S  +    + +    +
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Query: 180 P---NYAAPEVISGKLYAGPEVDVWSCGVILYALL 211
                +  PE I  + +   E DVWS GV+L+ + 
Sbjct: 183 MLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 76.6 bits (188), Expect = 6e-16
 Identities = 74/244 (30%), Positives = 119/244 (48%), Gaps = 39/244 (15%)

Query: 21  LGKTLGIGSFGKVKIAEHALTGHK--------VAIKILNRRKIKNMEMEEKVRREIKILR 72
           LGK LG G FG+V +AE A+   K        VA+K+L +    + ++ + V  E+++++
Sbjct: 16  LGKPLGEGCFGQVVMAE-AIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVS-EMEMMK 72

Query: 73  LF-MHPHIIRLYEVIETPSDIYVVMEYVKSGEL-----------FDYIVEKGRLQEDEAR 120
           +   H +II L         +YV++EY   G L            DY  +  +L E++  
Sbjct: 73  MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132

Query: 121 -----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---- 171
                +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+   RD H    
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA---RDVHNIDY 189

Query: 172 FLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKK 228
           + KT+ G     + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK 
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248

Query: 229 IKGG 232
           +K G
Sbjct: 249 LKEG 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.8 bits (186), Expect = 8e-16
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 13/209 (6%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           +K  K LG G+FG V        G K    VAIK L  R+  + +  +++  E  ++   
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASV 66

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
            +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y 
Sbjct: 67  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISG 190
               +VHRDL   N+L+ +  +VKI DFGL+ ++        + G      + A E I  
Sbjct: 126 EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185

Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFD 218
           ++Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 186 RIYTH-QSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 74.6 bits (183), Expect = 3e-15
 Identities = 68/243 (27%), Positives = 118/243 (48%), Gaps = 37/243 (15%)

Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G FG+V  AE            +T   VA+K+L +    + ++ + +  E+++
Sbjct: 16  LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVT---VAVKML-KDNATDKDLADLIS-EMEL 70

Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----------------VEKGR 113
           ++L   H +II L  V      +YV++EY   G L +++                V + +
Sbjct: 71  MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130

Query: 114 LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHF 172
           L   +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+  + D  ++
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190

Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KTS G     + APE +  ++Y   + DVWS G++++ +   G  P+    +  LFK +
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTH-QSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249

Query: 230 KGG 232
           + G
Sbjct: 250 REG 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 73.1 bits (179), Expect = 5e-15
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 27/210 (12%)

Query: 25  LGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           LG G+FGKV +AE H L   +    VA+K L   K  +    +  +RE ++L +  H HI
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTVLQHQHI 69

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI---------------VEKGRLQEDEARNFFQ 124
           +R Y V      + +V EY++ G+L  ++               V  G+L   +      
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---N 181
           QI SG+ Y      VHRDL   N L+     VKI DFG+S  +    + +    +     
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALL 211
           +  PE I  + +   E D+WS GV+L+ + 
Sbjct: 190 WMPPESILYRKFT-TESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 73.5 bits (181), Expect = 5e-15
 Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 19/232 (8%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
             +GK         V +A+H  T   VA+K +N     + E  + +++EI   R   HP+
Sbjct: 4   TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPN 60

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRN 136
           I+         S++YVV   +  G   D +       L E       + +++ ++Y H  
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSN---IMRDGHFLKTSCGSP-------NYAAPE 186
             +HR +K  ++LL     V ++  GL     +++ G   +     P        + +PE
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178

Query: 187 VISGKLYA-GPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTL 236
           V+   L     + D++S G+    L  G +PF D      L +K++G +  L
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL 230

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 73.1 bits (179), Expect = 7e-15
 Identities = 73/290 (25%), Positives = 120/290 (41%), Gaps = 47/290 (16%)

Query: 20  KLGKTLGIGSFGKVKIAE------------HALTGHKVAIKILNRRKIKNMEMEEKVRRE 67
           +L + LG G FG+V + E                G  V + +   R            +E
Sbjct: 8   RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKE 67

Query: 68  IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARN----- 121
           IKI+    +P+IIRL  V  +   + ++ EY+++G+L  ++ ++        A N     
Sbjct: 68  IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 122 ------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175
                    QI SG++Y      VHRDL   N L+ + + +KIADFG+S  +  G + + 
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 176 SCGSP---NYAAPE-VISGKLYAGPEVDVWSCGVILYAL--LCGTLPF----DDENIPN- 224
              +     + A E ++ GK       DVW+ GV L+ +  LC   P+    D++ I N 
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTAS--DVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT 245

Query: 225 --LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
              F+     IY   + L P          +   M R    +I+  P F 
Sbjct: 246 GEFFRNQGRQIYLSQTPLCPSP--------VFKLMMRCWSRDIKDRPTFN 287

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 25/229 (10%)

Query: 25  LGIGSFGKVKIAEHALTGHKV--AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           +G G+FG+V  A     G K+  AIK+L     +N   +     E+ + +L  HP+II L
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV-LCKLGHHPNIINL 68

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA----------------RNFFQQI 126
               E    +Y+ +EY   G L D++ +   L+ D A                  F   +
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAA 184
            +G++Y      +HRDL   N+L+      KIADFGLS    +  ++K + G     + A
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPVRWMA 186

Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
            E ++  +Y   + DVWS GV+L+ ++  G  P+       L++K+  G
Sbjct: 187 IESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 21/232 (9%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPH 78
           K    +G G+FG+V  A     G ++   I   ++  + +       E+++L +L  HP+
Sbjct: 10  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA----------------RNF 122
           II L    E    +Y+ +EY   G L D++ +   L+ D A                 +F
Sbjct: 70  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129

Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-N 181
              +  G++Y  +   +HRDL   N+L+   +  KIADFGLS   ++ +  KT    P  
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVR 188

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
           + A E ++  +Y     DVWS GV+L+ ++  G  P+       L++K+  G
Sbjct: 189 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 71.3 bits (174), Expect = 2e-14
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)

Query: 25  LGIGSFGKVKIAEHALTGHKV--AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           +G G+FG+V  A     G ++  AIK +     K+   +     E+ + +L  HP+II L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNIINL 61

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA----------------RNFFQQI 126
               E    +Y+ +EY   G L D++ +   L+ D A                 +F   +
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAA 184
             G++Y  +   +HRDL   N+L+   +  KIADFGLS       ++K + G     + A
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 179

Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
            E ++  +Y     DVWS GV+L+ ++  G  P+       L++K+  G
Sbjct: 180 IESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 56/222 (25%), Positives = 105/222 (47%), Gaps = 26/222 (11%)

Query: 13  DMFLPNYKLGKTLGIGSFGKVKI-AEHALTGHKVAIKILNRRKIKNMEMEEKVRR----- 66
           D FL ++++   L  G+FGK+ I A  A T    A + +N       + E  + +     
Sbjct: 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG 203

Query: 67  ---------EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-----KG 112
                    EI  L    H +I+++ E++ + ++ Y++ +     +L+ ++ +     K 
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKD 262

Query: 113 RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171
           R    + R   +Q++  VEY H   ++HRD+K EN+ L+    + + DFG +        
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322

Query: 172 -FLKTSCGSPNYAAPEVISGKLYAGPEV-DVWSCGVILYALL 211
            F     G+    +PE+++G  Y   E+ D+WSCG+IL  +L
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYC--EITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.0 bits (171), Expect = 6e-14
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 16/218 (7%)

Query: 23  KTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           K LG G+FG V        G      VAIK+L  R+  + +  +++  E  ++     P+
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL--RENTSPKANKEILDEAYVMAGVGSPY 70

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           + RL  +  T S + +V + +  G L DY+ E K R+   +  N+  QI  G+ Y     
Sbjct: 71  VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 194
           +VHRDL   N+L+ S  +VKI DFGL+ ++   +  +       P  + A E I  + + 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 195 GPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 228
             + DVWS GV ++ L+  G  P+D      IP+L +K
Sbjct: 190 H-QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 70.0 bits (171), Expect = 6e-14
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 16/221 (7%)

Query: 20  KLGKTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           +  K LG G FG V     I E       VAIK +  R  +    E  +   +  +    
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQE--ITDHMLAMGSLD 67

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           H +I+RL  +    S + +V +    G L D++ + +  L      N+  QI  G+ Y  
Sbjct: 68  HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
            + +VHR+L   N+LL S   V+IADFG+++++   D  +  +   +P  + A E I   
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 228
            Y   + DVWS GV ++ ++  G  P+       +P+L +K
Sbjct: 187 RYTH-QSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 70.0 bits (171), Expect = 7e-14
 Identities = 64/255 (25%), Positives = 113/255 (44%), Gaps = 40/255 (15%)

Query: 25  LGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           LG  +FGK+      L G      VAIK L  + I N +   + ++E  ++    HP+I+
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVE-----------------KGRLQEDEARNFF 123
            L  V+     + ++ EY+  G+L ++++                  K  L   +  +  
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS---P 180
            QI +G+EY   +  VH+DL   N+L+  + +VKI+D GLS  +    + +    S    
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLP---FDDENIPNLFKKIKGGIYTL 236
            +  PE I    ++  + D+WS GV+L+ +   G  P   F ++ +  + +K        
Sbjct: 191 RWMPPEAIMYGKFSS-DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK-------- 241

Query: 237 PSHLSPGARDLIPRM 251
              L P + D  PRM
Sbjct: 242 -RQLLPCSEDCPPRM 255

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 79/287 (27%), Positives = 117/287 (40%), Gaps = 78/287 (27%)

Query: 20  KLGKTLGIGSFGKVKIA-----EHALTGHKVAIKILNRRKIKNMEMEEK-VRREIKIL-R 72
           KLGK LG G+FGKV  A     E + +   VA+K+L   K      E K +  E+KIL  
Sbjct: 10  KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML---KEGATASEYKALMTELKILIH 66

Query: 73  LFMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDY------------------------ 107
           +  H +++ L      P   + V++EY K G L +Y                        
Sbjct: 67  IGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQK 126

Query: 108 IVEKGRL-----QEDEARNFFQ--------------------------------QIISGV 130
             +K RL      +  A + F                                 Q+  G+
Sbjct: 127 EGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGM 186

Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEV 187
           E+      +HRDL   N+LL     VKI DFGL+ +I +D  ++ K     P  + APE 
Sbjct: 187 EFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246

Query: 188 ISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGG 232
           I  K+Y   + DVWS GV+L+ +   G  P+    I   F +++K G
Sbjct: 247 IFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG 292

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 68/286 (23%), Positives = 124/286 (43%), Gaps = 69/286 (24%)

Query: 53  RKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVE 110
           ++I+   +     REI +LR   HP++I L +V  + +D  ++++ +Y +  +L+ +I++
Sbjct: 34  KQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLW-HIIK 91

Query: 111 KGR----------LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNV 156
             R          L     ++   QI+ G+ Y H N V+HRDLKP N+L+      +  V
Sbjct: 92  FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 151

Query: 157 KIADFGLSNI----MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC 212
           KIAD G + +    ++    L     +  Y APE++ G  +    +D+W+ G I   LL 
Sbjct: 152 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Query: 213 G-------------TLPFDDENIPNLFK-------KIKGGIYTLPSH------------- 239
                         + P+  + +  +F        K    I  +P H             
Sbjct: 212 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT 271

Query: 240 ------------LSPGAR--DLIPRMLIVDPMKRITIPEIRQHPWF 271
                       + P ++   L+ ++L +DP+KRIT  +  Q P+F
Sbjct: 272 NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 67/285 (23%)

Query: 53  RKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIV- 109
           ++I+   +     REI +LR   HP++I L +V  + SD  ++++ +Y +  +L+  I  
Sbjct: 34  KQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKF 92

Query: 110 --------EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVK 157
                   +  +L     ++   QI+ G+ Y H N V+HRDLKP N+L+      +  VK
Sbjct: 93  HRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152

Query: 158 IADFGLSNI----MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG 213
           IAD G + +    ++    L     +  Y APE++ G  +    +D+W+ G I   LL  
Sbjct: 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212

Query: 214 -------------TLPF------------------DDENI------PNLFKKIKGGIYTL 236
                        + PF                  D E+I      P L K  +   Y  
Sbjct: 213 EPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYAN 272

Query: 237 PS--------HLSPGARD--LIPRMLIVDPMKRITIPEIRQHPWF 271
            S         + P ++   L+ ++L +DP KRIT  +  Q P+F
Sbjct: 273 SSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.3 bits (167), Expect = 2e-13
 Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 30/270 (11%)

Query: 23  KTLGIGSFGKV------KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
             LG G+FG+V       I        +VA+K L  RK    + +++  +E  ++  F H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNH 58

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE--------DEARNFFQQIIS 128
           P+I++L  V       Y++ME ++ G+L  Y+    R++          E  +    +  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAK 117

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWN-----VKIADFGLS-NIMRDGHFLKTSCGSPN- 181
           G  Y  +   +HRDL   N L+  K       VKI DFGL+ +I +  ++ K   G    
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 182 -YAAPE-VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK-GGIYTLP 237
            + APE ++ GK     + DVWS GV+++ +L  G  P+   N   + + +  GG    P
Sbjct: 178 RWMAPESLLDGKFTT--QSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP 235

Query: 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
            +       L+      DP +R T   I++
Sbjct: 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 68.4 bits (167), Expect = 2e-13
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 11/226 (4%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           K+ + LG G FG++      L   +   VAI  L  R   + +       E   L  F H
Sbjct: 8   KIERILGTGRFGELCRGCLKLPSKRELPVAIHTL--RAGCSDKQRRGFLAEALTLGQFDH 65

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR 135
            +I+RL  VI   + + +V EY+ +G L  ++ + +G+L   +       + SG++Y   
Sbjct: 66  SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFG-LSNIMRDGHFLKTSCGSPN-YAAPEVISGKLY 193
              VH+ L    +L++S    KI+ F  L     +  +   S  SP  +AAPE I    +
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185

Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 238
           +    DVWS G++++ ++  G  P+ D +  ++ K ++ G + LP+
Sbjct: 186 S-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPA 229

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 40/151 (26%), Positives = 77/151 (50%), Gaps = 8/151 (5%)

Query: 67  EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQI 126
           E  ILR   HP II+L           +++   K+ +L+ Y+  K  +   +     + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191

Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS----NIMRDGHFLKTSCGSPNY 182
           +  ++Y H N ++HRD+K EN+ ++   +V + DFG +    +I  + ++     G+   
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY--GWAGTIAT 249

Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCG 213
            APE+++   Y GP VD+WS G++L+ +   
Sbjct: 250 NAPELLARDPY-GPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 68.1 bits (166), Expect = 3e-13
 Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 33/278 (11%)

Query: 23  KTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRLFM 75
           + LG GSFG V    A   + G    +VA+K +N    ++  + E++    E  +++ F 
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----ESASLRERIEFLNEASVMKGFT 67

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV--------EKGRLQE--DEARNFFQQ 125
             H++RL  V+       VVME +  G+L  Y+           GR      E      +
Sbjct: 68  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG--SPNY 182
           I  G+ Y +    VHRDL   N ++   + VKI DFG++ +I    ++ K   G     +
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHL 240
            APE +   ++     D+WS GV+L+ +      P+   +   + K +  GG    P + 
Sbjct: 188 MAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 246

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQ------HPWFQ 272
                DL+      +P  R T  EI        HP F 
Sbjct: 247 PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 68.0 bits (166), Expect = 4e-13
 Identities = 69/245 (28%), Positives = 103/245 (42%), Gaps = 49/245 (20%)

Query: 25  LGIGSFGKVKIAE----HAL----------TGHK--VAIKILNRRKIKNMEMEEKVRREI 68
           LG G FG+V + E      L           G    VA+KIL     KN   +    +E+
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND--FLKEV 70

Query: 69  KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------- 121
           KIL     P+IIRL  V      + ++ EY+++G+L  ++       ++E  N       
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130

Query: 122 ------------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169
                          QI SG++Y      VHRDL   N L+     +KIADFG+S  +  
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190

Query: 170 GHFLKTSCGSP---NYAAPEVI-SGKLYAGPEVDVWSCGVILYALL--CGTLPF----DD 219
           G + +    +     + A E I  GK       DVW+ GV L+ +L  C   P+    D+
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTAS--DVWAFGVTLWEILMLCKEQPYGELTDE 248

Query: 220 ENIPN 224
           + I N
Sbjct: 249 QVIEN 253

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 67.5 bits (165), Expect = 5e-13
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 43/223 (19%)

Query: 23  KTLGIGSFGKV--KIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           + +G G+FG+V    A   L       VA+K+L      +M+ +   +RE  ++  F HP
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREAALMAEFDHP 68

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYI----------------------VEKGRLQ 115
           +I++L  V      + ++ EY+  G+L +++                      +    L 
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175
             E     +Q+ +G+ Y      VHRDL   N L+     VKIADFGLS  +    + K 
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK- 187

Query: 176 SCGSPN------YAAPEVISGKLYA--GPEVDVWSCGVILYAL 210
              S N      +  PE I    Y     E DVW+ GV+L+ +
Sbjct: 188 --ASENDAIPIRWMPPESI---FYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 67.6 bits (165), Expect = 6e-13
 Identities = 71/260 (27%), Positives = 109/260 (41%), Gaps = 48/260 (18%)

Query: 25  LGIGSFGKVKIAEHALTGHK-----------------VAIKILNRRKIKNMEMEEKVRRE 67
           LG G FG+V + E A    K                 VA+K+L  R+  N        +E
Sbjct: 13  LGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKML--REDANKNARNDFLKE 69

Query: 68  IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA-------- 119
           IKI+     P+IIRL  V  T   + ++ EY+++G+L  ++  +   QE           
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL-SRHEPQEAAEKADVVTIS 128

Query: 120 ----RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175
                    QI SG++Y      VHRDL   N L+   + +KIADFG+S  +  G + + 
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 176 SCGS--P-NYAAPE-VISGKLYAGPEVDVWSCGVILYALL--CGTLPFDD-------ENI 222
              +  P  + + E ++ GK       DVW+ GV L+ +L  C   P+         EN 
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTAS--DVWAFGVTLWEILTLCKEQPYSQLSDEQVIENT 246

Query: 223 PNLFKKIKGGIYTLPSHLSP 242
              F+     +Y     L P
Sbjct: 247 GEFFRDQGRQVYLPKPALCP 266

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 67.4 bits (164), Expect = 6e-13
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 31/213 (14%)

Query: 21  LGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRL 73
           + + LG GSFG V   IA+  +      +VAIK +N    +   M E++    E  +++ 
Sbjct: 10  MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN----EAASMRERIEFLNEASVMKE 65

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ--------- 124
           F   H++RL  V+       V+ME +  G+L  Y+     L+ +   N  Q         
Sbjct: 66  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS---LRPEMENNPVQAPPSLKKMI 122

Query: 125 ----QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG- 178
               +I  G+ Y + N  VHRDL   N ++   + VKI DFG++ +I    ++ K   G 
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 182

Query: 179 -SPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 210
               + +PE +   ++     DVWS GV+L+ +
Sbjct: 183 LPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 9e-13
 Identities = 47/178 (26%), Positives = 85/178 (47%), Gaps = 7/178 (3%)

Query: 66  REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
           REI IL+   H  II L       S + +VM   K  +LF Y+   G L  ++A    ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC----GSPN 181
           ++  + Y H   ++HRD+K EN+ LD   N  + DFG +  + D H     C    G+  
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL-DAHPDTPQCYGWSGTLE 252

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239
             +PE+++   Y   + D+WS G++L+ +    +    + + +   +++  I  +  H
Sbjct: 253 TNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309

Length = 392

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 42/152 (27%), Positives = 80/152 (52%), Gaps = 18/152 (11%)

Query: 67  EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQ 125
           E ++LR   HP ++ L +V        +V+   +S +L+ Y+  + R L   +     +Q
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRPLGLAQVTAVARQ 268

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY--- 182
           ++S ++Y H   ++HRD+K EN+L++   ++ + DFG +       F + S  +P +   
Sbjct: 269 LLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC------FARGSWSTPFHYGI 322

Query: 183 ------AAPEVISGKLYAGPEVDVWSCGVILY 208
                  APEV++G  Y  P VD+WS G++++
Sbjct: 323 AGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 58/231 (25%), Positives = 108/231 (46%), Gaps = 21/231 (9%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           ++G+  G  +   V +A H  TG  V ++I +       E  + ++ E+ +   F HP+I
Sbjct: 5   EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNI 61

Query: 80  IRLYEVIETPSDIYVV---MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           +  + V  T S ++V+   M Y  +  L      +G + E    N     + G+ Y H+N
Sbjct: 62  MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYA-------APE 186
             +HR++K  ++L+     V ++  GLS++   +R+G   K     P ++       +PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178

Query: 187 VISGKLYA-GPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYT 235
           ++   LY    + D++S G+    L  G +PF D      L +K+KG  Y+
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS 229

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 82/323 (25%), Positives = 131/323 (40%), Gaps = 82/323 (25%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK-------VAIKILNRRKIKNMEMEEKVRREIKIL- 71
           +LGK LG G+FGKV   E +  G         VA+K+L  ++       + +  E+KIL 
Sbjct: 10  RLGKVLGHGAFGKV--VEASAFGIDKKSSCNTVAVKML--KEGATASEHKALMSELKILI 65

Query: 72  RLFMHPHIIRLYEVIETPSD-IYVVMEYVKSGEL------------------------FD 106
            +  H +++ L      P+  + V++E+ K G L                        F 
Sbjct: 66  HIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFR 125

Query: 107 YIVEKGRL-------QEDEARNFFQ-------------------------------QIIS 128
            +VE+ R+       Q     + FQ                               Q+  
Sbjct: 126 AMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVAR 185

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAP 185
           G+E+      +HRDL   N+LL     VKI DFGL+ +I +D  ++ K S   P  + AP
Sbjct: 186 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245

Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSP 242
           E I  K+Y   + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P
Sbjct: 246 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATP 304

Query: 243 GARDLIPRMLIVDPMKRITIPEI 265
               ++      DP +R T   +
Sbjct: 305 EIYRIMLACWQGDPKERPTFSAL 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 39/97 (40%), Positives = 56/97 (57%), Gaps = 4/97 (4%)

Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP 237
           G+P+Y APE++ GK + GP VD W+ GV L+  L G  PF+DE    +F+ I       P
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 238 ---SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                LS  A++ I  +L +DP KR  + E++QHP F
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 64.7 bits (157), Expect = 4e-12
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 25/194 (12%)

Query: 45  VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104
           VAIK L  +      + E+ + E  +     HP+I+ L  V+     + ++  Y    +L
Sbjct: 38  VAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95

Query: 105 FDYIVEK------GRLQED-------EARNFFQ---QIISGVEYCHRNMVVHRDLKPENL 148
            +++V +      G   +D       E  +F     QI +G+E+   + VVH+DL   N+
Sbjct: 96  HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNV 155

Query: 149 LLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVIS-GKLYAGPEVDVWSCG 204
           L+  K NVKI+D GL   +    + K    S  P  + +PE I  GK     + D+WS G
Sbjct: 156 LVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI--DSDIWSYG 213

Query: 205 VILYALLC-GTLPF 217
           V+L+ +   G  P+
Sbjct: 214 VVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.8 bits (150), Expect = 4e-11
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 19/214 (8%)

Query: 23  KTLGIGSFGKVKIAE-HALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
             +G G FGKV + E H      +V +K L  R     + +    +E++  R   HP+++
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKEL--RASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYI-----VEKGRLQEDEARNFFQQIISGVEYCHR 135
           +            +V+E+   G+L +Y+     +     Q+D  +    ++ SG+ + H+
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKL 192
              +H DL   N  L +  +VKI D+GL+     + +++   C + P  + APE++  + 
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 193 YAGPEVD------VWSCGVILYALL-CGTLPFDD 219
                 D      +WS GV ++ L      P+ D
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 10/171 (5%)

Query: 87  ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPE 146
           E+P D Y+     +       I E   L   +   F  Q+ +G+E+      VHRDL   
Sbjct: 210 ESPYDQYLPSAP-ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268

Query: 147 NLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGPEVDVWSC 203
           N+L+     VKI DFGL+ +IMRD +++ K S   P  + APE I   LY     DVWS 
Sbjct: 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS-DVWSF 327

Query: 204 GVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL--PSHLSPGARDLIPR 250
           G++L+ +   G  P+ +  +   F   IK G Y +  P+H S    +++ +
Sbjct: 328 GILLWEIFTLGGTPYPELPMNEQFYNAIKRG-YRMAKPAHASDEIYEIMQK 377

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 58/182 (31%), Positives = 86/182 (47%), Gaps = 14/182 (7%)

Query: 99  VKSGELFDYIVEKGRLQEDEAR-------NFFQQIISGVEYCHRNMVVHRDLKPENLLLD 151
           V+SG   D  V    L+EDE         +F  Q+  G+ +      +HRDL   N+LL 
Sbjct: 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT 248

Query: 152 SKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILY 208
                KI DFGL+ +I  D ++ +K +   P  + APE I   +Y   E DVWS G++L+
Sbjct: 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGILLW 307

Query: 209 ALLC-GTLPFDDENIPNLF-KKIKGGIYTL-PSHLSPGARDLIPRMLIVDPMKRITIPEI 265
            +   G+ P+    + + F K IK G   L P        D++      DP+KR T  +I
Sbjct: 308 EIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367

Query: 266 RQ 267
            Q
Sbjct: 368 VQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 60.9 bits (148), Expect = 8e-11
 Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 6/117 (5%)

Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-N 181
           QI  G+ Y H+  V+H+D+   N ++D +  VKI D  LS  +   D H L  +   P  
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           + A E +  K Y+    DVWS GV+L+ L+  G  P+ + +   +   +K G Y L 
Sbjct: 185 WMALESLVNKEYSSAS-DVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRLA 239

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 50/145 (34%), Positives = 73/145 (50%), Gaps = 7/145 (4%)

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCG 178
           +F  Q+  G+E+      VHRDL   N+LL     VKI DFGL+ +IM D +++ K S  
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300

Query: 179 SP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-Y 234
            P  + APE I   LY     DVWS G++L+ +   G  P+    + + F  KIK G   
Sbjct: 301 LPVKWMAPESIFDNLYTTLS-DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359

Query: 235 TLPSHLSPGARDLIPRMLIVDPMKR 259
             P H +    D++ +    +P KR
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 81/332 (24%), Positives = 128/332 (38%), Gaps = 89/332 (26%)

Query: 20  KLGKTLGIGSFGKVKIA-----EHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           KLGK LG G+FG+V  A     +   T   VA+K+L      +      +  E+KIL  +
Sbjct: 10  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHI 67

Query: 74  FMHPHIIRLYEVIETPSD-IYVVMEYVK-----------SGELFDYIVEKGRL------- 114
             H +++ L      P   + V++E+ K            GE   Y  +  R        
Sbjct: 68  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGY 127

Query: 115 ----------------------------------------QEDEARNFFQ---------Q 125
                                                   QED  +             Q
Sbjct: 128 GDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQ 187

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NY 182
           +  G+E+      +HRDL   N+LL     VKI DFGL+ +I +D  ++ K     P  +
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247

Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSH 239
            APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K G     P +
Sbjct: 248 MAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 306

Query: 240 LSPGARDLIPRMLIV---DPMKRITIPEIRQH 268
            +P   ++   ML     +P +R T  E+ +H
Sbjct: 307 TTP---EMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)

Query: 18  NYKLGKTLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           +  L + LG G+FG+V    +        ++ + +    +  + + E     E  I+  F
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-------GRLQEDEARNFFQQII 127
            H +I+RL  V       ++++E +  G+L  ++ E          L   +     + + 
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCG--SPN 181
            G +Y   N  +HRD+   N LL  K      KIADFG++ +I R  ++ K         
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF 217
           +  PE     ++   + DVWS GV+L+ +   G +P+
Sbjct: 187 WMPPEAFLDGIFTS-KTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 18/211 (8%)

Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMHPHIIR-L 82
           +G G FGKV ++E   T   VA  ++   K   + + + +  ++    R+  HP+I++ L
Sbjct: 3   IGNGWFGKVLLSE-IYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ----QIISGVEYCHRNMV 138
            + +E      +V EY + G+L  Y+ ++   + +      Q    +I +GV + H++  
Sbjct: 62  GQCVEAIP-YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---CGSPNYAAPEVIS---GKL 192
           +H DL   N  L S   VK+ D+G+        +++T    C    + APE++    G L
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL 180

Query: 193 YAGPEV---DVWSCGVILYALL-CGTLPFDD 219
               +    +VW+ GV L+ L      P+  
Sbjct: 181 ITAEQTKPSNVWALGVTLWELFENAAQPYSH 211

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 56.5 bits (136), Expect = 3e-09
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 19/212 (8%)

Query: 23  KTLGIGSFGKVKIAE--HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           K +G G FGKV + E     T  +V +K L  R   +++ + K   E +  R   H +++
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKEL--RVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQ---QIISGVEYCHR 135
           +        +   +VME+   G+L  Y+    K  L   +     +   +I  G+ + H+
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLS--NIMRDGHFLKTSCGSP-NYAAPEVIS--- 189
           N  +H DL   N LL +   VKI D+GLS      D +        P  + APE++    
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 190 GKLYA---GPEVDVWSCGVILYALL-CGTLPF 217
           G L       E +VWS GV ++ L   G+ P+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 16/194 (8%)

Query: 88  TPSDIYVVMEYVKS--GELFDYIVEKGR-----LQEDEARNFFQQIISGVEYCHRNMVVH 140
             SD YV M  V S   +  D   E+       L  D+   F  Q+  G+++      +H
Sbjct: 176 QGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIH 235

Query: 141 RDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYAGPE 197
           RD+   N+LL      KI DFGL+ +IM D ++ +K +   P  + APE I   +Y   +
Sbjct: 236 RDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYT-VQ 294

Query: 198 VDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL--PSHLSPGARDLIPRMLI 253
            DVWS G++L+ +   G  P+    + + F K +K G Y +  P    P    ++     
Sbjct: 295 SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-YQMSRPDFAPPEIYSIMKMCWN 353

Query: 254 VDPMKRITIPEIRQ 267
           ++P +R T  +I Q
Sbjct: 354 LEPTERPTFSQISQ 367

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 16/200 (8%)

Query: 33  VKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92
           V +A +  TG  V ++ +N     N EM   ++ E+ + +LF HP+I+         +++
Sbjct: 16  VNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74

Query: 93  YVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL 150
           +VV  ++  G   D I       + E       Q ++  ++Y H    VHR +K  ++L+
Sbjct: 75  WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134

Query: 151 DSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYAA-------PEVISGKLYA-GPEVD 199
                V ++  GL +    +  G  L+     P Y+        PEV+   L     + D
Sbjct: 135 SVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 192

Query: 200 VWSCGVILYALLCGTLPFDD 219
           ++S G+    L  G +PF D
Sbjct: 193 IYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 90/365 (24%), Positives = 137/365 (37%), Gaps = 110/365 (30%)

Query: 12  VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR-----RKIK-NMEMEEKVR 65
           +D+    +K+   LG G+FGKV  A         A+KI+       R  K  ++  EKVR
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVR 183

Query: 66  RE--------IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGE-LFDYIVEKGRLQE 116
           +         +KI R F +          ET   + +VM   K G  L D+I++ G    
Sbjct: 184 QADPADRFPLMKIQRYFQN----------ET-GHMCIVMP--KYGPCLLDWIMKHGPFSH 230

Query: 117 DEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDSK----------------WNVKIA 159
                   Q    ++Y H  + ++H DLKPEN+L+++                   V+I 
Sbjct: 231 RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRIC 290

Query: 160 DFGLSNIMRDGHFLKTSCGSPNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPF 217
           D G      + H       + +Y +PEV+   G +Y+    D+WS G I+Y L  G L +
Sbjct: 291 DLG--GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYS---TDMWSMGCIIYELYTGKLLY 345

Query: 218 DD-ENIP--NLFKKIKGGI-------------------------YTLPSHLSPGAR---- 245
           D  +N+   +L +K  G +                          T P HL+  AR    
Sbjct: 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPV 405

Query: 246 ----------DLIPRMLIVDPMKRIT-------------IPEIRQHPWFQAHLPRYLAVP 282
                     DLI  +L  D  KR+               PE RQHP    +      + 
Sbjct: 406 REVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHP---NYPDNRSMLR 462

Query: 283 PPDTM 287
           P   M
Sbjct: 463 PTPIM 467

Length = 467

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 6e-07
 Identities = 27/69 (39%), Positives = 38/69 (55%), Gaps = 2/69 (2%)

Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG- 178
           +   +Q+++G+   HR  +VHRD+KPENLL+     VKI DFG +  M  G       G 
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGM 371

Query: 179 -SPNYAAPE 186
             P Y+ PE
Sbjct: 372 LDPRYSPPE 380

Length = 507

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 14/97 (14%)

Query: 21  LGKTLGIGSFGKVKIA-----EHALTGHKVAIKILN---RRKIKNMEMEEKVRREIKIL- 71
           LG+TLG G+FG+V  A      H+ +  KVA+K+L    R   K   M E     +KI+ 
Sbjct: 41  LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSE-----LKIMS 95

Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI 108
            L  H +I+ L         IY++ EY + G+L DY+
Sbjct: 96  HLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 59/231 (25%), Positives = 92/231 (39%), Gaps = 61/231 (26%)

Query: 12  VDMFL---------PNYK-----LGKTLGIGSFGKVK----IAEHALTGHKVAIKILNRR 53
           VDMF+         P++K     LGK LG G+FG V     + + +    K  +K     
Sbjct: 113 VDMFVLAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY 172

Query: 54  KIKNMEMEEKVRREI-----KILRLFMHPH---------IIRLYEVIETPSDIYVVMEYV 99
               + M E+VRR         +  F+ P          ++  YE   T +D+      +
Sbjct: 173 GAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADL------M 226

Query: 100 KSGELFDYIVEKGRLQE--DEAR----------NFFQQIISGVEYCHRNMVVHRDLKPEN 147
           +S E F Y VE   L +  D  +             +QI+  ++  H   +VHRD+KP+N
Sbjct: 227 QSKE-FPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285

Query: 148 LLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           ++      + KI D G +  +R G          NY   E +    YA PE
Sbjct: 286 IIFSEGSGSFKIIDLGAAADLRVGI---------NYIPKEFLLDPRYAAPE 327

Length = 566

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 8/100 (8%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
           N + GKTLG G+FGKV  A     G      +VA+K+L      + +  E +  E+KIL 
Sbjct: 39  NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS--AHTDEREALMSELKILS 96

Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK 111
            L  H +I+ L         + V+ EY   G+L +++ +K
Sbjct: 97  HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.5 bits (103), Expect = 2e-05
 Identities = 29/108 (26%), Positives = 44/108 (40%), Gaps = 13/108 (12%)

Query: 114 LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173
           L E+E      Q +  +   HR       L   + LL    +V       S    D +F+
Sbjct: 14  LNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSRP--DPYFM 71

Query: 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221
                     APEVI G+ Y   + D++S G+ LY  L   LP+++E 
Sbjct: 72  ----------APEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEER 108

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 24/170 (14%)

Query: 34  KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR-----EIKILRLF--MHPHIIRLYEVI 86
            I      G    +K    ++ ++ E++EK+RR     E +IL         +  +Y+V 
Sbjct: 11  IIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV- 69

Query: 87  ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPE 146
             P +  +VMEY++ GEL    +E+ R       +  +++   V   H+  +VH DL   
Sbjct: 70  -DPDNGLIVMEYIE-GELLKDALEEARP------DLLREVGRLVGKLHKAGIVHGDLTTS 121

Query: 147 NLLLDSKWNVKIADFGLSNIMR-------DGHFLKTSCGSPNYAAPEVIS 189
           N++L     +   DFGL            D H L+ +  S +  A E+ +
Sbjct: 122 NIILSGG-RIYFIDFGLGEFSDEVEDKAVDLHVLERALESTHEKAEELFA 170

Length = 204

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 29/163 (17%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR------RKIKN--------------M 58
             +G  +G+G    V +A     G KVA+K  +R      RK+K                
Sbjct: 93  EAIGTKIGVGKESDVYVAIDP-KGRKVAVKF-HRLGRTSFRKVKRNRDYLADKEHGSWLY 150

Query: 59  EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDE 118
                  RE + L+   +P  +++ + I       VVMEY++  EL+     + RL  + 
Sbjct: 151 VSRLAAEREFEALQRL-YPEGVKVPKPIAWNRHA-VVMEYIEGVELY-----RLRLDVEN 203

Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161
                 +I+  V   +R  +VH DL   N+L+    ++ + D+
Sbjct: 204 PDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246

Length = 304

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.3 bits (94), Expect = 7e-04
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 49/203 (24%)

Query: 12  VDMFLPNYKLGKTLGIGSFGKV----KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR- 66
           +D+    +K+ K +G G FG V      ++H +    VA       KI+N+E E  V   
Sbjct: 7   IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVA-------KIENLENETIVMET 59

Query: 67  -------EIKILRLFMHPHII-----------------RLYEVIETPSDIYVVME--YVK 100
                  +I  + L+ + H I                 R+Y         ++++E     
Sbjct: 60  LVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYR-------FILLEKLVEN 112

Query: 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160
           + E+F  I  K +      +N  + +++ +EY H + + H D+KPEN+++D      I D
Sbjct: 113 TKEIFKRIKCKNK---KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169

Query: 161 FGL-SNIMRDGHFLKTSCGSPNY 182
           +G+ S+ +  G  ++ S    + 
Sbjct: 170 YGIASHFIIHGKHIEYSKEQKDL 192

Length = 294

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 39.3 bits (92), Expect = 0.001
 Identities = 36/202 (17%), Positives = 83/202 (41%), Gaps = 8/202 (3%)

Query: 42  GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD----IYVVME 97
             +V I+   +    +  + +    EIK LR     +I+++Y  I    D    + +++E
Sbjct: 43  NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102

Query: 98  YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDSKWNV 156
           Y   G L + + ++  L      +       G+   ++     +++L   + L+   + +
Sbjct: 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKL 162

Query: 157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV-DVWSCGVILYALLCGTL 215
           KI   GL  I+    F   +     Y + ++++          D++S GV+L+ +  G +
Sbjct: 163 KIICHGLEKILSSPPFKNVNFMV--YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220

Query: 216 PFDDENIPNLFKKIKGGIYTLP 237
           PF++     ++  I     +L 
Sbjct: 221 PFENLTTKEIYDLIINKNNSLK 242

Length = 283

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	294
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.89
PRK10345	210	hypothetical protein; Provisional	99.86
smart00090	237	RIO RIO-like kinase.	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
KOG1243	690	consensus Protein kinase [General function predict	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.67
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.56
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.55
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
KOG3087	229	consensus Serine/threonine protein kinase [General	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
COG4248	637	Uncharacterized protein with protein kinase and he	99.36
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.36
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.28
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.26
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.26
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.11
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.08
PRK09902	216	hypothetical protein; Provisional	99.02
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.94
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.92
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.85
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.84
PF01636	239	APH: Phosphotransferase enzyme family This family	98.66
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.6
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.57
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.49
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.49
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.39
PLN02876	822	acyl-CoA dehydrogenase	98.31
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.3
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.26
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.22
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.07
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.06
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.06
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.04
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.02
PRK05231	319	homoserine kinase; Provisional	97.98
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.98
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.93
KOG2270	520	consensus Serine/threonine protein kinase involved	97.84
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.77
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.75
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.73
PLN02756	418	S-methyl-5-thioribose kinase	97.43
PLN02236	344	choline kinase	97.37
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.33
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.3
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.27
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.14
PRK10593	297	hypothetical protein; Provisional	97.09
PRK12396	409	5-methylribose kinase; Reviewed	97.04
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.92
PTZ00384	383	choline kinase; Provisional	96.78
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.77
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.76
PRK11768	325	serine/threonine protein kinase; Provisional	96.61
PTZ00296	442	choline kinase; Provisional	96.18
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.96
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.81
PRK06148	1013	hypothetical protein; Provisional	95.61
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.37
PRK10271	188	thiK thiamine kinase; Provisional	95.18

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-59  Score=397.59  Aligned_cols=264  Identities=39%  Similarity=0.697  Sum_probs=250.7

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+.........+++.+|+++.++|+||||++++++|++.+++|++.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999999988888888999999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKT  175 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~  175 (294)
                      |.|..++|..+++++++++|.+++.++.||+.||.|||+.+|+|||||..|++++++-++||+|||+|+..... ....+
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999988755 67788


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      .+|||-|.|||++..... +..+||||+||+||-|+.|++||...+..+....|......+|..++.+.++||.++|+.|
T Consensus       178 lCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~  256 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPN  256 (592)
T ss_pred             ecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCC
Confidence            899999999999997766 8999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCHhHHhcCCcc-cccCCccccC
Q 022617          256 PMKRITIPEIRQHPWF-QAHLPRYLAV  281 (294)
Q Consensus       256 p~~Rps~~~il~h~~~-~~~~~~~~~~  281 (294)
                      |.+|||++++|+|+|| +...|.+.-.
T Consensus       257 P~~Rpsl~~vL~h~Ff~~g~~p~~lp~  283 (592)
T KOG0575|consen  257 PSERPSLDEVLDHPFFKSGFTPARLPS  283 (592)
T ss_pred             cccCCCHHHHhcCHhhhCCCcCCCCCc
Confidence            9999999999999999 5556655544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-59  Score=384.29  Aligned_cols=264  Identities=42%  Similarity=0.747  Sum_probs=237.7

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccch----HHHHHHHHHHHHHHhCCCCceeEEEEE
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM----EMEEKVRREIKILRLFMHPHIIRLYEV   85 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~   85 (294)
                      -....+.+.|.+.+.||+|+||.|-+|..+.+++.||||++........    .....+.+|+++|++|+||||++++++
T Consensus       165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~  244 (475)
T KOG0615|consen  165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF  244 (475)
T ss_pred             CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence            3445688999999999999999999999999999999999987755542    233457799999999999999999999


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC---CcEEEeeec
Q 022617           86 IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFG  162 (294)
Q Consensus        86 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~---~~~~l~dfg  162 (294)
                      |+.+...|+|+||++||.|.+.+-.++.+.+...+.+++|++.|+.|||+.||+||||||+|||++.+   ..+||+|||
T Consensus       245 f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  245 FEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             eecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999876   679999999


Q ss_pred             ccccccCCCccccccCCCcccCCccccCCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhCCCccC---
Q 022617          163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGIYTL---  236 (294)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~---  236 (294)
                      +|..........+.+||+.|.|||++.+..  +...+.|||||||++|-+++|.+||....... +.++|..+...+   
T Consensus       325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~  404 (475)
T KOG0615|consen  325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL  404 (475)
T ss_pred             hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence            999999889999999999999999996543  33457899999999999999999998765544 888888887644   


Q ss_pred             -CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          237 -PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       237 -~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                       +..++.+..+||.+||..||++|||+.|+|+||||+.
T Consensus       405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~  442 (475)
T KOG0615|consen  405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD  442 (475)
T ss_pred             hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence             3578999999999999999999999999999999985

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-57  Score=366.73  Aligned_cols=261  Identities=31%  Similarity=0.528  Sum_probs=236.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-eE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-DI   92 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~   92 (294)
                      ...++.+.++.||+|..|+||+++|+.+++-+|+|++...  .+....+++.+|+++++..+||||+.+|+.|..+. .+
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            3445788899999999999999999999999999999433  34466789999999999999999999999999988 49


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      .++||||++|||++++...+.+++..+..++.+++++|.|||+ .+|+||||||+|||++..|.+||+|||.+....+. 
T Consensus       154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999999999999988999999999999999999999995 99999999999999999999999999999887666 


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhCC-CccCCCC-CChhH
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-----NIPNLFKKIKGG-IYTLPSH-LSPGA  244 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~-~~~~~~~-~~~~l  244 (294)
                      .-++.+||..|||||.+.+..+ +.++||||||+.++|+.+|+.||...     +..++...|..+ .+.+|.. +++++
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef  311 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF  311 (364)
T ss_pred             hcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence            5567889999999999999988 89999999999999999999999764     677777777764 4567776 99999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                      ++||..||++||.+|||+.|+++|||+++....-
T Consensus       312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence            9999999999999999999999999999865543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-56  Score=363.31  Aligned_cols=260  Identities=38%  Similarity=0.682  Sum_probs=242.5

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-.++|+++++||+|+||.|+.++.+++++-||+|++.+..+...........|..+|.+++||+|++++..|+++..+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            44679999999999999999999999999999999999998888777889999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~  172 (294)
                      +|+||+.||.|...|++.+.+++..++.++.+|+.||.|||++||+|||+||+|||++.+|+++|+|||++...- .+..
T Consensus       102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998543 4455


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-CCCCCChhHHHHHHHh
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRM  251 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~  251 (294)
                      ....+||+.|||||++.+..+ +.++|+||||+++|+|++|.+||...+...+.+++..+... .+...+.+.+++++++
T Consensus       182 t~tfcGT~eYmAPEil~~~gy-~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L  260 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLGKGY-DKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL  260 (357)
T ss_pred             cccccCCccccChHHHhcCCC-CcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH
Confidence            666799999999999999987 89999999999999999999999999999999999999844 4455999999999999


Q ss_pred             cccCCCCCC----CHhHHhcCCccccc
Q 022617          252 LIVDPMKRI----TIPEIRQHPWFQAH  274 (294)
Q Consensus       252 l~~~p~~Rp----s~~~il~h~~~~~~  274 (294)
                      |+.||++|.    ++.+|.+||||+..
T Consensus       261 L~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  261 LKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             hccCHHHhcCCCCChHHhhcCcccccC
Confidence            999999996    68999999999764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-55  Score=368.82  Aligned_cols=260  Identities=37%  Similarity=0.665  Sum_probs=240.7

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   92 (294)
                      .-..+|..++.||.|+|++|++|+++.+++.||||++.+.-+....-.+.+..|-..|.+| .||+|++++..|.+...+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            3446899999999999999999999999999999999877666666677888999999999 799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      |+|+||+++|.|.++|.+.+.+++...+.++.+|+.||.|||+.||+||||||+|||++.+++++|.|||.+........
T Consensus       150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999876532211


Q ss_pred             c--------------ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCC
Q 022617          173 L--------------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS  238 (294)
Q Consensus       173 ~--------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  238 (294)
                      .              ...+||..|.+||.+..... ++.+|||+|||++|+|+.|.+||.+.+.--..++|+.....+++
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~  308 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE  308 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence            1              34679999999999998877 89999999999999999999999999999999999999999999


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +.++.+.+||+++|..||.+|+++++|.+||||...
T Consensus       309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence            999999999999999999999999999999999865

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-54  Score=351.71  Aligned_cols=265  Identities=41%  Similarity=0.706  Sum_probs=242.3

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .....++|.+.+.||+|+|++||+|+++.++..||||.+.+... .....+.+..|+.+|+.++||||+.+++++..++.
T Consensus         5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            34567899999999999999999999999999999999987765 44567888999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC------CcEEEeeecccc
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK------WNVKIADFGLSN  165 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~------~~~~l~dfg~~~  165 (294)
                      +|+|||||+||+|.+++.+.+.+++..++.++.||+.|+++||+++|+||||||.|||++.+      -.+||+|||+|+
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999875      358999999999


Q ss_pred             cccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCCh
Q 022617          166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSP  242 (294)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~  242 (294)
                      ...........+|++.|||||++....| +.++|+||+|+++|+|++|+.||+..+..++...+..+..   ..+...+.
T Consensus       164 ~L~~~~~a~tlcGSplYMAPEV~~~~~Y-dAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~  242 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAPEVIMSQQY-DAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN  242 (429)
T ss_pred             hCCchhHHHHhhCCccccCHHHHHhccc-cchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence            9988888888999999999999998888 7899999999999999999999999999999888877663   33456788


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                      .+.+++...++.+|.+|.++.+-+.|+++.......
T Consensus       243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~  278 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDR  278 (429)
T ss_pred             chhhhhhHHHhcCccccCchHHhhhhhhcccCcccc
Confidence            888999999999999999999999999998765443

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-53  Score=362.89  Aligned_cols=262  Identities=61%  Similarity=1.073  Sum_probs=244.0

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc--hHHHHHHHHHHHHHHhCC-CCceeEEEEEEEc
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLFM-HPHIIRLYEVIET   88 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   88 (294)
                      .....++|.+.+.||.|+||+|+.|.+..++..||+|++.......  ....+.+.+|+.++++++ ||||+++++++..
T Consensus        12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t   91 (370)
T KOG0583|consen   12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT   91 (370)
T ss_pred             cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence            4577889999999999999999999999999999999876652221  134567789999999999 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-CcEEEeeecccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIM  167 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~dfg~~~~~  167 (294)
                      ...+++||||+.||.|.+++.+.+++.+..+..+++|++.|++|+|+.||+||||||+||+++.+ +++||+|||++...
T Consensus        92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            99999999999999999999998999999999999999999999999999999999999999999 99999999999988


Q ss_pred             -cCCCccccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCC-ChhH
Q 022617          168 -RDGHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL-SPGA  244 (294)
Q Consensus       168 -~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~l  244 (294)
                       .........+|++.|+|||++.+.. +.+.++||||+|+++|.|++|..||+..+...+...+..+...+|..+ +.++
T Consensus       172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~  251 (370)
T KOG0583|consen  172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA  251 (370)
T ss_pred             CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence             4566777889999999999999887 888999999999999999999999999999999999999999999999 9999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      ..++++||..||.+|+|+.+|+.||||+.
T Consensus       252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  252 RSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-53  Score=334.83  Aligned_cols=267  Identities=39%  Similarity=0.729  Sum_probs=248.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-.++|...+.||.|+||.|.+++++.+|..||+|++.+..+......+...+|..+|+.+.||+++++++.+.+.+.++
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            44678999999999999999999999999999999999998888888899999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      +||||.+||.|.+++.+.+++++..++.++.|++.|+.|||+.+|++||+||+|||++.+|.+||+|||+|......  .
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999877554  5


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcc
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  253 (294)
                      .+.+|||.|+|||++....+ +.++|+|+||+++|||+.|.+||...+...+.++|..+...+|+.+++++++|++++|+
T Consensus       199 ~TlCGTPeYLAPEii~sk~y-nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~  277 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGY-NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQ  277 (355)
T ss_pred             EEecCCccccChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHh
Confidence            67889999999999999888 79999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCC-----CHhHHhcCCccccc-----CCccccCCC
Q 022617          254 VDPMKRI-----TIPEIRQHPWFQAH-----LPRYLAVPP  283 (294)
Q Consensus       254 ~~p~~Rp-----s~~~il~h~~~~~~-----~~~~~~~~~  283 (294)
                      .|-.+|.     -.++|.+||||+..     +.+.+..|-
T Consensus       278 vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~  317 (355)
T KOG0616|consen  278 VDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPF  317 (355)
T ss_pred             hhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCC
Confidence            9999994     46789999999753     455555443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-53  Score=367.61  Aligned_cols=261  Identities=53%  Similarity=0.924  Sum_probs=249.8

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-.+-|++++.||.|+.|.|-+|++..+|+..|||++.............+.+|+-+|+.+.|||+++++++|+...++|
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly   88 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY   88 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence            44677999999999999999999999999999999998775445556788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      ++.||+.||-|++++-+.+++++.+...+++||+.|+.|+|..+|+|+|+||+|++++..+++||+|||+|.....+...
T Consensus        89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            99999999999999999999999999999999999999999999999999999999999989999999999988888888


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcc
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  253 (294)
                      .+.+|++.|.+||++.+.+|.+.++||||-|+++|.|++|++||++.+...+..+++.+.+.+|..++.+.++|+.+||.
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~  248 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLD  248 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhc
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCHhHHhcCCccccc
Q 022617          254 VDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .||..|.|.++|++|||++..
T Consensus       249 VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  249 VDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             cCccccccHHHHhhCchhhcC
Confidence            999999999999999999775

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.7e-54  Score=340.86  Aligned_cols=271  Identities=26%  Similarity=0.498  Sum_probs=233.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ++.|..+.++|+|+||.||+|+++.+|+-||||.+..+. ++....+-..+|+.+|++|+|+|++.++.+|...+.+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            367999999999999999999999999999999985443 3445567788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCcc
Q 022617           96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~  173 (294)
                      +|||+. ++.+.+++. ..++.+.++.++.|++.|+.|+|+.+++||||||+||+|+.+|.+||+|||+|+... .+...
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            999987 666667664 458999999999999999999999999999999999999999999999999999876 45555


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC-----------------
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL-----------------  236 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  236 (294)
                      ...+.|..|+|||.+.+...++...|||++||++.||++|.+.|.+.+..+..-.|......+                 
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            667789999999999986666899999999999999999999999887766665553322111                 


Q ss_pred             --C------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcchH
Q 022617          237 --P------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ  288 (294)
Q Consensus       237 --~------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~~~  288 (294)
                        |            +..+.-+.++++.||..||.+|++.+++|.||||.++..+..+...++.++
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~~~~k~~~~~~  304 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIERELKAKKPNEAE  304 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHHHHHhcccchh
Confidence              1            344567889999999999999999999999999998888877777776653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-54  Score=337.61  Aligned_cols=248  Identities=33%  Similarity=0.570  Sum_probs=222.2

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEE-EEEcCC-
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE-VIETPS-   90 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~-   90 (294)
                      ..-..+|+++++||.|.||+||++.+..+|..+|.|.+.....+ ....+.+..|+.+|++|+||||+++++ .+.+++ 
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            34456799999999999999999999999999999999865544 456788999999999999999999988 444444 


Q ss_pred             eEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCCeEecCCCcEEEeeec
Q 022617           91 DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHR--NM--VVHRDLKPENLLLDSKWNVKIADFG  162 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~--~~--i~h~di~p~nili~~~~~~~l~dfg  162 (294)
                      -++++||+|++|+|..+++.    .+.+++..+|.++.|++.||+.+|.  ..  ++||||||.||+++.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            49999999999999999974    3469999999999999999999998  44  9999999999999999999999999


Q ss_pred             ccccccCCC-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-CC-CC
Q 022617          163 LSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LP-SH  239 (294)
Q Consensus       163 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~-~~  239 (294)
                      +++.+.... ...+.+|||.||+||.+.+.++ +.++||||+||++|||+..+.||.+.+...+.++|..+..+ +| ..
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~  252 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH  252 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence            999886654 4457789999999999999998 79999999999999999999999999999999999988754 66 67


Q ss_pred             CChhHHHHHHHhcccCCCCCCCH
Q 022617          240 LSPGARDLIPRMLIVDPMKRITI  262 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~  262 (294)
                      ++.++..+|..|+..||+.||+.
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCc
Confidence            99999999999999999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-53  Score=352.34  Aligned_cols=261  Identities=34%  Similarity=0.510  Sum_probs=227.7

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCC
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS   90 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   90 (294)
                      ...+.++|.+.++||.|.||.||+|+.+.++..||||.+....... + .-.=.+|++.|++++ ||||+++.+++.+++
T Consensus         5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-e-e~~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-E-ECMNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-H-HHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            3467899999999999999999999999999999999987655442 2 233457999999999 999999999998877


Q ss_pred             -eEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           91 -DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        91 -~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                       .+++|||||+. +|.++++.+ ..+++..++.++.||+++|+|+|++|++|||+||+|||++.+..+||+|||+|+...
T Consensus        83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence             99999999964 999999764 579999999999999999999999999999999999999988899999999999988


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------  233 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------  233 (294)
                      ........+.|..|+|||++....+++.+.|||++||+++|+.+.++.|.+.+..+.+-+|..-.               
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence            87777788899999999999887777999999999999999999999998877666555542211               


Q ss_pred             ----ccC-----------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          234 ----YTL-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       234 ----~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                          +.+           -+..+.++.++|.+||++||++|||+.|+|+||||+...
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                111           135788999999999999999999999999999998753

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-52  Score=341.75  Aligned_cols=258  Identities=34%  Similarity=0.576  Sum_probs=222.0

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC--eEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--DIY   93 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~   93 (294)
                      ..+|...+.||+|.||+||++.+..+|..+|+|.+....   ....+.+.+|+.+|++++||||+++++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            567999999999999999999999889999999986652   122677999999999999999999999754444  699


Q ss_pred             EEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeecccccccC--
Q 022617           94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRD--  169 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~~--  169 (294)
                      ++|||+.+|+|.+++.+.+ .+++..++.+++|++++|.|||++||+|+||||+|||++. ++.+||+|||++.....  
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999877 7999999999999999999999999999999999999999 79999999999876653  


Q ss_pred             --CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhC--CCccCCCCCChhH
Q 022617          170 --GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKG--GIYTLPSHLSPGA  244 (294)
Q Consensus       170 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~--~~~~~~~~~~~~l  244 (294)
                        ........+|+.|||||++........++|||||||++.||+||+.||.. .......-.+..  ..+.+|..++.+.
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence              22234567999999999998643334699999999999999999999987 333333333322  2357788899999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ++|+.+|++.+|.+|||+.++|+|||.+...+
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999998776

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-52  Score=354.90  Aligned_cols=257  Identities=33%  Similarity=0.618  Sum_probs=240.9

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      +++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+....+ ...+.+.+|+++++.++||||+.+++.|+...++|+|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            368999999999999999999999999999999998776544 4578899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-cc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~  174 (294)
                      +||+.| +|..+++.++.++++.+..++.+++.||.|||+.+|.|+|+||.||++..+|.+|++|||+++.....+. ..
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            999977 9999999999999999999999999999999999999999999999999999999999999988765543 34


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhccc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV  254 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  254 (294)
                      ...|||.|||||.+.+..+ +..+|+|||||++||++.|++||.......+.+.|..+....|...+.++.+|+..+|.+
T Consensus       159 sikGtPlYmAPElv~e~py-d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k  237 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPY-DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIK  237 (808)
T ss_pred             eccCcccccCHHHHcCCCc-cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence            5569999999999998888 899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCHhHHhcCCcccccC
Q 022617          255 DPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       255 ~p~~Rps~~~il~h~~~~~~~  275 (294)
                      ||.+|.++.+++.|||.+...
T Consensus       238 dP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  238 DPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             ChhhcccHHHHhcChHHhhhh
Confidence            999999999999999998754

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-51  Score=345.63  Aligned_cols=254  Identities=36%  Similarity=0.699  Sum_probs=230.8

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|+||.||+|.+..+++.|++|++.............+.+|++++++++||||+++++++.+.+..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999987655444445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS  176 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  176 (294)
                      ||+.+++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--~~~  158 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--WTL  158 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--ccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999987654322  234


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCC
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP  256 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  256 (294)
                      .+++.|+|||++.+..+ +.++||||||+++|+|++|..||.........+.+......++..++..+.+++++||+.||
T Consensus       159 ~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (291)
T cd05612         159 CGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDR  237 (291)
T ss_pred             cCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCH
Confidence            57899999999987766 78999999999999999999999998888888888888888888899999999999999999


Q ss_pred             CCCCC-----HhHHhcCCcccc
Q 022617          257 MKRIT-----IPEIRQHPWFQA  273 (294)
Q Consensus       257 ~~Rps-----~~~il~h~~~~~  273 (294)
                      .+||+     ++++++||||+.
T Consensus       238 ~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         238 TRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HHccCCccCCHHHHhcCccccC
Confidence            99995     999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.2e-51  Score=349.79  Aligned_cols=255  Identities=39%  Similarity=0.713  Sum_probs=232.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|.+.+.||.|++|.||+|.++.+++.|++|++.............+.+|+.++++++||||+++++++...+..+++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            58899999999999999999999999999999999765544444567789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      |||+.+++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  174 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FT  174 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ce
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987654332  23


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      ..+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.......+.+..+...++..++..+.+++.+||+.|
T Consensus       175 ~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d  253 (329)
T PTZ00263        175 LCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTD  253 (329)
T ss_pred             ecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcC
Confidence            467899999999987766 7899999999999999999999998888888888888888888889999999999999999


Q ss_pred             CCCCCC-----HhHHhcCCcccc
Q 022617          256 PMKRIT-----IPEIRQHPWFQA  273 (294)
Q Consensus       256 p~~Rps-----~~~il~h~~~~~  273 (294)
                      |.+||+     ++++++||||++
T Consensus       254 P~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        254 HTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHHcCCCCCCCHHHHhcCCccCC
Confidence            999997     799999999976

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-51  Score=335.96  Aligned_cols=272  Identities=29%  Similarity=0.449  Sum_probs=232.7

Q ss_pred             CCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617            7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI   86 (294)
Q Consensus         7 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   86 (294)
                      .+...+-.-.+.|.+.+.||.|..++||+|+..-.++.|+||++..+.+.+.  ...+++|+..++.++||||++++..|
T Consensus        16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sF   93 (516)
T KOG0582|consen   16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSF   93 (516)
T ss_pred             cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEE
Confidence            3444556677899999999999999999999999999999999998876653  78999999999999999999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                      .....+|+||.+|.+||+.++++..-  .+++..+..++++++.||.|||+.|.+|||||+.||||+.+|.|+|+|||.+
T Consensus        94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence            99999999999999999999998753  4899999999999999999999999999999999999999999999999976


Q ss_pred             ccccC-CCc----cccccCCCcccCCcc-ccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC-
Q 022617          165 NIMRD-GHF----LKTSCGSPNYAAPEV-ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-  237 (294)
Q Consensus       165 ~~~~~-~~~----~~~~~~~~~~~aPE~-~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  237 (294)
                      ..... +..    ....+++++|+|||+ ......++.++||||||++..|+.+|..||....+..+.-....+.++.+ 
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            54332 211    145589999999999 44433448999999999999999999999998877665554444443311 


Q ss_pred             ---------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcccc
Q 022617          238 ---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLA  280 (294)
Q Consensus       238 ---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~  280 (294)
                               ..++..++.++..||.+||.+|||++++|+|+||++..++-..
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~  305 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYL  305 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhc
Confidence                     3567789999999999999999999999999999887655433

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.9e-51  Score=345.19  Aligned_cols=259  Identities=37%  Similarity=0.665  Sum_probs=234.4

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .=.++|.+++.||+|+||.||+|+-+.+|+.||+|++.++..........++.|-.+|....+++|++++..|++..++|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            34678999999999999999999999999999999999998888888999999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC----
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD----  169 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~----  169 (294)
                      |||||++||++..+|.+.+.|+++.++.++.+++.|+..||+.|++|+||||+|+||+..|++||+|||++.....    
T Consensus       218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999753211    


Q ss_pred             ------------------CCcc--------------------------ccccCCCcccCCccccCCccCCCchhHHHHHH
Q 022617          170 ------------------GHFL--------------------------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV  205 (294)
Q Consensus       170 ------------------~~~~--------------------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~  205 (294)
                                        ....                          .+.+|||.|+|||++.+..+ +...|+|||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG~  376 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLGC  376 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHHH
Confidence                              0000                          12358999999999999987 79999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC--CCCChhHHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617          206 ILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH  274 (294)
Q Consensus       206 ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~  274 (294)
                      |+|||+.|.+||...++.+..++|..-.  ..+|  ..++.+..+||.+||. ||++|.-   ++||.+||||+..
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            9999999999999999999988887654  3333  4678999999999999 9999985   9999999999875

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.2e-51  Score=346.23  Aligned_cols=251  Identities=38%  Similarity=0.616  Sum_probs=225.6

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG  102 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  102 (294)
                      +.||+|+||.||+|.+..+++.|++|++.............+.+|+.++++++||||+++++++...+..+++|||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997655444445567788999999999999999999999999999999999999


Q ss_pred             ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCCc
Q 022617          103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPN  181 (294)
Q Consensus       103 sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~  181 (294)
                      +|.+++.+++.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..... ........+++.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            9999998888899999999999999999999999999999999999999999999999999865322 222334568999


Q ss_pred             ccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC-
Q 022617          182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-  260 (294)
Q Consensus       182 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-  260 (294)
                      |+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......++..++.++.+++.+||..||++|| 
T Consensus       161 y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05571         161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             ccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            999999987776 789999999999999999999999888888888888777888889999999999999999999999 


Q ss_pred             ----CHhHHhcCCccccc
Q 022617          261 ----TIPEIRQHPWFQAH  274 (294)
Q Consensus       261 ----s~~~il~h~~~~~~  274 (294)
                          ++.++++||||+..
T Consensus       240 ~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         240 GGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CCCCCHHHHHcCCCcCCC
Confidence                89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-50  Score=331.31  Aligned_cols=265  Identities=33%  Similarity=0.551  Sum_probs=237.0

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      ..+...=.+.|++++.||.|.-|+||+|..+.++..+|+|++.+.....+....++..|-++|..++||.++.+++.++.
T Consensus        69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            45566667889999999999999999999999999999999998888877888899999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      ++..|++||||.||+|..+++++  +.+++..++.++.+++.||.|||-.||++|||||+|||+.++|+++|+||.++..
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            99999999999999999999876  4599999999999999999999999999999999999999999999999998642


Q ss_pred             ccC-----------------------------------C----------------------CccccccCCCcccCCcccc
Q 022617          167 MRD-----------------------------------G----------------------HFLKTSCGSPNYAAPEVIS  189 (294)
Q Consensus       167 ~~~-----------------------------------~----------------------~~~~~~~~~~~~~aPE~~~  189 (294)
                      ...                                   .                      ...+..+||-.|.|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            100                                   0                      0011235788999999999


Q ss_pred             CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCC--CCChhHHHHHHHhcccCCCCCCC----Hh
Q 022617          190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRMLIVDPMKRIT----IP  263 (294)
Q Consensus       190 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps----~~  263 (294)
                      +... +.+.|+|+||+++|||+.|..||.+.+..+...++......+|.  ..+..+++||+++|.+||.+|..    +.
T Consensus       309 G~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~  387 (459)
T KOG0610|consen  309 GEGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA  387 (459)
T ss_pred             cCCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence            8877 89999999999999999999999999999988888777766553  67889999999999999999999    99


Q ss_pred             HHhcCCccccc
Q 022617          264 EIRQHPWFQAH  274 (294)
Q Consensus       264 ~il~h~~~~~~  274 (294)
                      ||.+||||+..
T Consensus       388 eIK~HpFF~gV  398 (459)
T KOG0610|consen  388 EIKRHPFFEGV  398 (459)
T ss_pred             HhhcCccccCC
Confidence            99999999875

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.5e-50  Score=344.31  Aligned_cols=260  Identities=33%  Similarity=0.584  Sum_probs=232.8

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCC-ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ...-.++|++.+.||.|+||.||+|.+..++ ..+++|++.............+.+|+.+++.++||||+++++++...+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            4456678999999999999999999876554 689999987655444445677889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ..+++|||+.+++|.+++.+++.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998765432


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHH
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR  250 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (294)
                        .....+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.....+.+......++..++..+.+++++
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  261 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK  261 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence              234568899999999987666 78999999999999999999999998888888888888888888999999999999


Q ss_pred             hcccCCCCCC-----CHhHHhcCCccccc
Q 022617          251 MLIVDPMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       251 ~l~~~p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      ||+.+|.+|+     +++++++||||++.
T Consensus       262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999995     89999999999864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-51  Score=347.89  Aligned_cols=261  Identities=31%  Similarity=0.554  Sum_probs=231.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ..-...|...++||+|+.|.||.|....+++.|++|.+.......   .+.+.+|+.+++..+|+||+.+++.|...+.+
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence            455678999999999999999999999999999999998776544   46789999999999999999999999888999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      |+||||++||+|.+.+... .+++.++..+++++++||+|||..||+|+|||.+|||++.+|.+||+|||++....... 
T Consensus       346 WVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             EEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            9999999999999998644 58999999999999999999999999999999999999999999999999987765544 


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-C--ccCCCCCChhHHHHH
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-I--YTLPSHLSPGARDLI  248 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~li  248 (294)
                      .....+||++|||||+.....| +.+.||||||++++||+.|++||-+.++...+..|... .  ...+..++..+++|+
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL  503 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL  503 (550)
T ss_pred             ccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence            5567789999999999998888 89999999999999999999999876666655555433 3  345678999999999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                      .+||..|+++|+++.|||+||||+..-+..
T Consensus       504 ~~cL~~dv~~RasA~eLL~HpFl~~a~p~s  533 (550)
T KOG0578|consen  504 DRCLVVDVEQRASAKELLEHPFLKMAKPES  533 (550)
T ss_pred             HHHhhcchhcCCCHHHHhcChhhhhcCCHH
Confidence            999999999999999999999996544333

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.3e-50  Score=313.13  Aligned_cols=255  Identities=33%  Similarity=0.540  Sum_probs=223.1

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      .+|...++||+|.||.||+|+|..+|+.||||.+......+ -......+|++.|+.++|+||+.++++|...+.+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            58999999999999999999999999999999998775443 23467789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc-
Q 022617           97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-  174 (294)
                      ||++. +|+..++.. ..++...++.++.+++.+++|||.+.|+||||||+|+||+.+|.+||+|||+++.+....... 
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            99976 999999754 569999999999999999999999999999999999999999999999999999887655433 


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--------------------
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------------------  234 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------  234 (294)
                      ..+.|..|+|||.+.+...++...||||.||++.||+.|.+.|.+.+..+....+.....                    
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            337788999999999887779999999999999999999988888777666655532110                    


Q ss_pred             --c------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          235 --T------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       235 --~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                        +      +.+..+.+..+++.+|+.+||.+|+++.|+|+|+||++
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence              0      11345678899999999999999999999999999986

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.3e-49  Score=333.54  Aligned_cols=256  Identities=27%  Similarity=0.467  Sum_probs=222.1

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      .|++.+.||+|+||.||+|.+..+++.|++|.+.............+.+|+.++++++|++++++++++...+..++++|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            48889999999999999999999999999999876554444445567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            99999999888643  3589999999999999999999999999999999999999999999999999987654444445


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      ..++..|+|||.+.+..+ +.++||||||+++|+|++|+.||.....    ......+.......+..++.++.+++.+|
T Consensus       161 ~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  239 (285)
T cd05631         161 RVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML  239 (285)
T ss_pred             CCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence            578999999999988777 7899999999999999999999986543    23333344444566678899999999999


Q ss_pred             cccCCCCCCC-----HhHHhcCCccccc
Q 022617          252 LIVDPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       252 l~~~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      |+.||++||+     ++++++||||+..
T Consensus       240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         240 LTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             hhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            9999999997     8999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-49  Score=337.95  Aligned_cols=249  Identities=33%  Similarity=0.604  Sum_probs=224.0

Q ss_pred             ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617           25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL  104 (294)
Q Consensus        25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL  104 (294)
                      ||+|+||.||+|.+..+++.|++|++.............+.+|+.++++++||||+++++++...+..++++||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999998765444445567788999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCCccc
Q 022617          105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYA  183 (294)
Q Consensus       105 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~  183 (294)
                      .+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ........+++.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            99998888899999999999999999999999999999999999999999999999999875322 22233456899999


Q ss_pred             CCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC---
Q 022617          184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI---  260 (294)
Q Consensus       184 aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---  260 (294)
                      |||.+.+..+ +.++||||||+++|+|++|..||...+.....+.+......++..++.++.+++.+||..||.+||   
T Consensus       161 aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~  239 (312)
T cd05585         161 APELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN  239 (312)
T ss_pred             CHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence            9999987766 789999999999999999999999888888888888888888889999999999999999999997   


Q ss_pred             CHhHHhcCCccccc
Q 022617          261 TIPEIRQHPWFQAH  274 (294)
Q Consensus       261 s~~~il~h~~~~~~  274 (294)
                      ++.++++||||++.
T Consensus       240 ~~~e~l~hp~~~~~  253 (312)
T cd05585         240 GAQEIKNHPFFSQL  253 (312)
T ss_pred             CHHHHHcCCCcCCC
Confidence            57999999999874

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-49  Score=338.59  Aligned_cols=250  Identities=37%  Similarity=0.623  Sum_probs=224.1

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG  102 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  102 (294)
                      +.||+|+||.||++.+..+++.|++|++.............+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997654444445667788999999999999999999999999999999999999


Q ss_pred             ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCCc
Q 022617          103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPN  181 (294)
Q Consensus       103 sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~  181 (294)
                      +|..++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ........+++.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            9999998888899999999999999999999999999999999999999999999999998765322 222234568899


Q ss_pred             ccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC-
Q 022617          182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-  260 (294)
Q Consensus       182 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-  260 (294)
                      |+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+......++..+++++.+++.+||+.||++|| 
T Consensus       161 y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05595         161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             cCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence            999999987766 789999999999999999999999888888888887777788889999999999999999999998 


Q ss_pred             ----CHhHHhcCCcccc
Q 022617          261 ----TIPEIRQHPWFQA  273 (294)
Q Consensus       261 ----s~~~il~h~~~~~  273 (294)
                          ++.++++||||.+
T Consensus       240 ~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         240 GGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             CCCCCHHHHHcCCCcCC
Confidence                8999999999976

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-52  Score=318.36  Aligned_cols=276  Identities=42%  Similarity=0.697  Sum_probs=247.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      -.+.+.|++.+.||+|.|+.|+++.+..+|+.+++|++....+... ..+++.+|+.+-+.|+||||+++++.+.+....
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFH   85 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence            3577899999999999999999999999999999999987766554 678999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEEEeeecccccccC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRD  169 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~l~dfg~~~~~~~  169 (294)
                      |+|+|++.|+.|..-|-.+...++..+-..++||++||.|+|..||+|+|++|+|+++-.   ..-+||+|||++.....
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            999999999999887766677889999999999999999999999999999999999943   34599999999998887


Q ss_pred             CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhHH
Q 022617          170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR  245 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~  245 (294)
                      +......+|+|.|+|||++...++ +..+|||+-|+++|-++.|.+||.+.+...+.+.|+.+...++    +.++++.+
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak  244 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK  244 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence            777778899999999999999988 7899999999999999999999999999999999998886554    57899999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcchHHH
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQA  290 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~~~~~  290 (294)
                      +++++||..||.+|.|+.|.|+|||+++.-..-.....+++.-+-
T Consensus       245 ~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~l  289 (355)
T KOG0033|consen  245 SLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCL  289 (355)
T ss_pred             HHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHH
Confidence            999999999999999999999999998865555555566654433

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.9e-49  Score=338.61  Aligned_cols=250  Identities=37%  Similarity=0.626  Sum_probs=224.2

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG  102 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  102 (294)
                      +.||+|+||.||++.+..+++.|++|++.............+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997655444455677888999999999999999999999999999999999999


Q ss_pred             ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCCc
Q 022617          103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPN  181 (294)
Q Consensus       103 sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~  181 (294)
                      +|..++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..... ........+++.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            9999998888899999999999999999999999999999999999999999999999999865322 222234468899


Q ss_pred             ccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC-
Q 022617          182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-  260 (294)
Q Consensus       182 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-  260 (294)
                      |+|||.+.+..+ +.++||||||+++|+|++|..||...+.....+.+......++..++.++.+++++||..||.+|+ 
T Consensus       161 y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (328)
T cd05593         161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG  239 (328)
T ss_pred             ccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence            999999987766 789999999999999999999999888888888877777788889999999999999999999997 


Q ss_pred             ----CHhHHhcCCcccc
Q 022617          261 ----TIPEIRQHPWFQA  273 (294)
Q Consensus       261 ----s~~~il~h~~~~~  273 (294)
                          ++.++++||||..
T Consensus       240 ~~~~~~~~il~h~~~~~  256 (328)
T cd05593         240 GGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCCCCHHHHhcCCCcCC
Confidence                8999999999976

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-49  Score=339.20  Aligned_cols=255  Identities=31%  Similarity=0.550  Sum_probs=225.0

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||+|.+..+++.|++|++.............+.+|+.+++.++|+||+++++++...+..++++
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997665444445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS  176 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  176 (294)
                      ||+++++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....  .....
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~  158 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV  158 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999876543  23445


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC------CCCChhHHHHH
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP------SHLSPGARDLI  248 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~------~~~~~~l~~li  248 (294)
                      .+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+..+....+....  ...+      ..++.++.+++
T Consensus       159 ~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li  237 (333)
T cd05600         159 VGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI  237 (333)
T ss_pred             ccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence            68899999999988766 789999999999999999999999888777666554322  1111      14588999999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCccccc
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .+||+.+|++||++.++++||||++.
T Consensus       238 ~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         238 TKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHhhChhhhcCCHHHHHhCcccCCC
Confidence            99999999999999999999999874

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-50  Score=346.12  Aligned_cols=260  Identities=35%  Similarity=0.620  Sum_probs=241.9

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCe
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSD   91 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~   91 (294)
                      ..-.++|+++++||+|.||+|+++..+.+++.||||+.++..+-..+..+....|..++.... ||+++.++..|+++++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            345678999999999999999999999999999999999998888888899999999888775 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CC
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~  170 (294)
                      +|+||||+.||++..+ +..+.+++..+..++..++.||.|||++||++||||.+|||++.+|++||+|||++...- .+
T Consensus       444 l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence            9999999999995544 345779999999999999999999999999999999999999999999999999997654 56


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHH
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR  250 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (294)
                      ....+.+||+.|+|||++.+..| +.+.|+|+||++||+|+.|..||.+.+.+++...|..+...+|..++.+..+++++
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~  601 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRR  601 (694)
T ss_pred             CccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHH
Confidence            67788899999999999999999 89999999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCCC-----HhHHhcCCccccc
Q 022617          251 MLIVDPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       251 ~l~~~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      +|..+|++|.-     +++|..||||+.+
T Consensus       602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  602 LLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             HhccCcccccCCCCCCchhhhhCCccccC
Confidence            99999999995     5789999999865

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-50  Score=309.71  Aligned_cols=263  Identities=37%  Similarity=0.690  Sum_probs=245.8

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      ..-.--.++|.+++.||.|.||.||+|+.+.++--+++|++.++.+......+.+.+|+++...|+||||++++++|-+.
T Consensus        15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            33444567899999999999999999999999999999999988888778889999999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~--~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      ..+|+++||...|++...+.  ....+++...+.++.|++.|+.|+|..+++||||||+|+|++.++.++++|||.+...
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999999999998  5567999999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHH
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL  247 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (294)
                      + .......+||..|.|||...+... +...|+|++|++.|+++.|.+||......+..+.|.+....+|+.++.+..++
T Consensus       175 p-~~kR~tlcgt~dyl~pEmv~~~~h-d~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl  252 (281)
T KOG0580|consen  175 P-SNKRKTLCGTLDYLPPEMVEGRGH-DKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL  252 (281)
T ss_pred             C-CCCceeeecccccCCHhhcCCCCc-cchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence            6 445567889999999999998887 78999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      |.+||.++|.+|.+..|+++|||+.+.
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHHhc
Confidence            999999999999999999999999764

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-49  Score=334.14  Aligned_cols=260  Identities=31%  Similarity=0.484  Sum_probs=227.0

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      -|+..-.+.|..+++||+|.||.||+|++..+|+.||+|.+..+.... .......+||.+|++|.||||+++.+...+.
T Consensus       110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~  188 (560)
T KOG0600|consen  110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSK  188 (560)
T ss_pred             cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence            345566778999999999999999999999999999999998765333 4567788999999999999999999998776


Q ss_pred             --CeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           90 --SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        90 --~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                        ..+|+|+|||+. +|.-++.+. -.+++.+++-+++||+.+|.|+|..|++|||||.+||||+.+|.+||+|||+|++
T Consensus       189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceee
Confidence              689999999987 999998763 3699999999999999999999999999999999999999999999999999996


Q ss_pred             ccCCC--ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc----------
Q 022617          167 MRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----------  234 (294)
Q Consensus       167 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  234 (294)
                      .....  .....+.|..|+|||.+.+...++.+.|+||.|||+.||++|++.|.+.+..+.+..|.+.+.          
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            65433  345567799999999999888779999999999999999999999999888777777644321          


Q ss_pred             cCC-------------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 TLP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 ~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      .+|                   ..++....+|+..||..||++|.|+.++|+|+||
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            111                   3457778899999999999999999999999999

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-52  Score=341.67  Aligned_cols=276  Identities=26%  Similarity=0.389  Sum_probs=240.5

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-...|+..+.||+|.||.||+|.+..+++.||+|++..+...  ....++.+|+.++..++++||.++++.+.....+|
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw   87 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW   87 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence            3455788899999999999999999999999999999876543  45789999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-  172 (294)
                      ++||||.||++.+.++....+.+.++.-++++++.|+.|||.++.+|+|||+.||++..+|.++|+|||.+........ 
T Consensus        88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999999999999998888789999999999999999999999999999999999999999999999999887765443 


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCChhHHHHHHHh
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM  251 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~  251 (294)
                      ..+.+||+.|||||++....| +.++||||||++.++|.+|.+|+....+....-.|-+..+ .+...+++.+++||..|
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y-~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGY-DTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC  246 (467)
T ss_pred             cccccccccccchhhhccccc-cchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence            377889999999999997777 7999999999999999999999988777544444444443 33347888999999999


Q ss_pred             cccCCCCCCCHhHHhcCCcccccCCccccCCCCcchHHHhh
Q 022617          252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK  292 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~  292 (294)
                      |++||+.||++.++|+|+|++...+.......-+.+++|+.
T Consensus       247 L~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~  287 (467)
T KOG0201|consen  247 LDKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRV  287 (467)
T ss_pred             hhcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhh
Confidence            99999999999999999999996555555555555666654

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.4e-49  Score=335.39  Aligned_cols=251  Identities=37%  Similarity=0.654  Sum_probs=223.0

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||+|+||+||+|.++.+++.|++|++.............+..|..++..+ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999999999999999998765443334456677788888766 699999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~  180 (294)
                      ++|.+++.+...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.... .........+++
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            9999999888889999999999999999999999999999999999999999999999999986532 222333456899


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      .|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.....+.+.......+..++.++.+++.+||+.||.+||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  239 (320)
T cd05590         161 DYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL  239 (320)
T ss_pred             cccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence            9999999987766 789999999999999999999999998888888888888888888999999999999999999999


Q ss_pred             CH------hHHhcCCccccc
Q 022617          261 TI------PEIRQHPWFQAH  274 (294)
Q Consensus       261 s~------~~il~h~~~~~~  274 (294)
                      ++      +++++||||+..
T Consensus       240 ~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         240 GSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CCCCCCCHHHHHcCCCcCCC
Confidence            98      899999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.7e-49  Score=333.98  Aligned_cols=256  Identities=36%  Similarity=0.585  Sum_probs=227.4

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC-ceeEEEEEEEcCCeEEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~   96 (294)
                      +|++.+.||.|+||.||+|.+..+++.|++|++.............+..|..+++.+.|+ +++++++++...+..|++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999765443444556778899999999764 6888999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCcccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKT  175 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~~~  175 (294)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.... .......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            999999999999888889999999999999999999999999999999999999999999999999886432 2222334


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      ..+++.|+|||++.+..+ +.++|+||+|+++|+|++|+.||...+.......+......++..++.++.+++.+||..|
T Consensus       161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  239 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH  239 (324)
T ss_pred             ecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            568999999999988776 7899999999999999999999999988888888888888888899999999999999999


Q ss_pred             CCCCCCH-----hHHhcCCccccc
Q 022617          256 PMKRITI-----PEIRQHPWFQAH  274 (294)
Q Consensus       256 p~~Rps~-----~~il~h~~~~~~  274 (294)
                      |.+|++.     .++++||||+..
T Consensus       240 P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         240 PAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999986     899999999763

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-50  Score=327.46  Aligned_cols=259  Identities=50%  Similarity=0.874  Sum_probs=246.7

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ..+..+|.+.+.||+|.||.|-+|.+...|+.|+||.+.++.+.++.+.-.+++|++++..|+||||+.++.+|+..+.+
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            35667999999999999999999999889999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      .+||||..+|.|.+++.+++.+++.+.+.+++||+.|+.|+|+.+++|+|+|.+|||++.++++||.|||++..+.....
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf  208 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF  208 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988888


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhc
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  252 (294)
                      ..+.+|++.|.+||+.++.+|.++..|.||||+++|-|..|..||++.+...+.++|..+.+.- +.-+.+..-||+.||
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE-P~~PSdA~gLIRwmL  287 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE-PETPSDASGLIRWML  287 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC-CCCCchHHHHHHHHH
Confidence            8999999999999999999999999999999999999999999999999999999999887643 345677889999999


Q ss_pred             ccCCCCCCCHhHHhcCCccc
Q 022617          253 IVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       253 ~~~p~~Rps~~~il~h~~~~  272 (294)
                      -.||++|.|+++|.+|=|+.
T Consensus       288 mVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  288 MVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             hcCcccchhHHHHhhhheee
Confidence            99999999999999998884

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-49  Score=342.39  Aligned_cols=256  Identities=35%  Similarity=0.658  Sum_probs=226.2

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|.+.+.||.|++|+||+|.+..+++.|++|++.............+.+|+.+++.++|+|++++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999997665444455678889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----  171 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-----  171 (294)
                      ||+.+++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999987654332     


Q ss_pred             -------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022617          172 -------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF  226 (294)
Q Consensus       172 -------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~  226 (294)
                                               ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                     2234468899999999988766 78999999999999999999999988877777


Q ss_pred             HHHhC--CCccCC--CCCChhHHHHHHHhcccCCCCCCC-HhHHhcCCccccc
Q 022617          227 KKIKG--GIYTLP--SHLSPGARDLIPRMLIVDPMKRIT-IPEIRQHPWFQAH  274 (294)
Q Consensus       227 ~~~~~--~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps-~~~il~h~~~~~~  274 (294)
                      ..+..  .....+  ..++.++.++|.+||. +|.+||+ +.++++||||++.
T Consensus       240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            66665  333333  3469999999999997 9999999 9999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-49  Score=321.34  Aligned_cols=260  Identities=33%  Similarity=0.534  Sum_probs=223.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----   88 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   88 (294)
                      -.+..+|...+.||.|++|.|+.|.++.+|+.||+|.+... +.+....++..+|+++|+.++|+||+.+.+++..    
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            45667788899999999999999999999999999998633 3455678999999999999999999999999854    


Q ss_pred             -CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           89 -PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        89 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                       -+.+|+|+|+|+ .+|...++++..++++.+..++.|++.||.|+|+.+++|||+||+|++++.++.+|++|||+|+..
T Consensus        97 ~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen   97 KFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             ccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence             467999999995 499999988888999999999999999999999999999999999999999999999999999987


Q ss_pred             cC---CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc----------
Q 022617          168 RD---GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----------  234 (294)
Q Consensus       168 ~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  234 (294)
                      ..   .......+.|..|+|||.+.....++.+.||||+||++.||++|+..|.+.+....++.+..-..          
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            53   33345567799999999987666668999999999999999999999988765544443322111          


Q ss_pred             ---------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          235 ---------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       235 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                           ...++.++...+|+++||..||.+|+|++|+|.||||...
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence                                 1115778899999999999999999999999999999765

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-48  Score=329.84  Aligned_cols=251  Identities=31%  Similarity=0.534  Sum_probs=219.9

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCce-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHK-VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-   90 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~-~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   90 (294)
                      ..-.....+.+.||.|+||+||.+.+.  |+. +++|++......... .+.+.+|+.++++++||||++++|++.++. 
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            344556677888999999999999985  455 999999877666554 789999999999999999999999999887 


Q ss_pred             eEEEEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCeEecCCC-cEEEeeeccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDSKW-NVKIADFGLSNI  166 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~-i~h~di~p~nili~~~~-~~~l~dfg~~~~  166 (294)
                      .+++||||+.+|+|.+++.+  ...++...+..++.||+.|+.|||+.+ |+|+||||+|||++.++ ++||+|||+++.
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            79999999999999999987  578999999999999999999999999 99999999999999998 999999999987


Q ss_pred             ccCC-CccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hCCCccCCCCCC
Q 022617          167 MRDG-HFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSHLS  241 (294)
Q Consensus       167 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~  241 (294)
                      .... .......||..|||||++.+  ..+ +.++||||+|+++|||+||+.||...........+  ....+.++..++
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~  272 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECP  272 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence            6654 33334689999999999994  466 89999999999999999999999998875555554  344466677899


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+..++++||..||..||++.+|+.
T Consensus       273 ~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  273 PHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            99999999999999999999999876

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.8e-48  Score=337.30  Aligned_cols=256  Identities=31%  Similarity=0.566  Sum_probs=220.6

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|+||+||+|.+..+++.|++|++.............+.+|+.+++.++|+||+++++.+.+...++++|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997655444455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----  171 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-----  171 (294)
                      ||++|++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999986432210     


Q ss_pred             -------------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022617          172 -------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE  220 (294)
Q Consensus       172 -------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~  220 (294)
                                                     ......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                           0123468999999999987776 78999999999999999999999988


Q ss_pred             CHHHHHHHHhCCC--ccCCC--CCChhHHHHHHHhcccCCC---CCCCHhHHhcCCccccc
Q 022617          221 NIPNLFKKIKGGI--YTLPS--HLSPGARDLIPRMLIVDPM---KRITIPEIRQHPWFQAH  274 (294)
Q Consensus       221 ~~~~~~~~~~~~~--~~~~~--~~~~~l~~li~~~l~~~p~---~Rps~~~il~h~~~~~~  274 (294)
                      ........+....  ..++.  .++.++.+++.+|+. +|.   .||++++|++||||+..
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            8877777776432  33333  468899999999775 344   46899999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.4e-49  Score=336.25  Aligned_cols=251  Identities=38%  Similarity=0.626  Sum_probs=224.3

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG  102 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  102 (294)
                      +.||+|+||.||++.+..+++.|++|++.............+.+|+.+++.++|+||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997665444445667788999999999999999999999999999999999999


Q ss_pred             ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617          103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP  180 (294)
Q Consensus       103 sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  180 (294)
                      +|..++.+...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++..... ........+++
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            999999888889999999999999999999997 7999999999999999999999999999865322 22233446899


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      .|+|||++.+..+ +.++||||||+++|+|++|..||...+.....+.+......++..++.++.+++.+||+.||++|+
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~  239 (325)
T cd05594         161 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL  239 (325)
T ss_pred             ccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence            9999999987766 789999999999999999999999888888888887777788889999999999999999999997


Q ss_pred             -----CHhHHhcCCccccc
Q 022617          261 -----TIPEIRQHPWFQAH  274 (294)
Q Consensus       261 -----s~~~il~h~~~~~~  274 (294)
                           ++.++++||||++.
T Consensus       240 ~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         240 GGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             CCCCCCHHHHhcCCCcCCC
Confidence                 89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.4e-48  Score=332.63  Aligned_cols=251  Identities=35%  Similarity=0.570  Sum_probs=222.8

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||.|+||.||+|.+..+++.|++|++.............+..|..++..+ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4689999999999999999999999999765444444456677888888765 799999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-CccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~  180 (294)
                      ++|...+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......+++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            999999988888999999999999999999999999999999999999999999999999998754322 2233445789


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      .|+|||++.+..+ +.++|+||||+++|+|++|+.||...+.....+.+.......+..++.++.+++.+||+.||++||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~  239 (321)
T cd05591         161 DYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL  239 (321)
T ss_pred             cccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence            9999999987776 789999999999999999999999999888888888887777888999999999999999999999


Q ss_pred             -------CHhHHhcCCccccc
Q 022617          261 -------TIPEIRQHPWFQAH  274 (294)
Q Consensus       261 -------s~~~il~h~~~~~~  274 (294)
                             ++.++++||||+..
T Consensus       240 ~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         240 GCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             CCCCCCCCHHHHhcCCccCCC
Confidence                   89999999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-49  Score=329.30  Aligned_cols=264  Identities=41%  Similarity=0.728  Sum_probs=230.1

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc-----------hHHHHHHHHHHHHHHhCCCCceeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----------MEMEEKVRREIKILRLFMHPHIIRL   82 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~   82 (294)
                      ...++|++.+.||+|.||.|-+|++..+++.||||++.+.....           ....+...+|+.++++|.|+||+++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            45679999999999999999999999999999999997554331           1234689999999999999999999


Q ss_pred             EEEEEcC--CeEEEEEeccCCCChHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEe
Q 022617           83 YEVIETP--SDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA  159 (294)
Q Consensus        83 ~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~  159 (294)
                      +.+..++  +.+|+|+|||..|.+...- ..++ +++.+++.++.+++.+|.|||.+||+||||||+|+|++.+|++||+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence            9998654  6799999999987766432 3445 9999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCC------CccccccCCCcccCCccccC---CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q 022617          160 DFGLSNIMRDG------HFLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK  230 (294)
Q Consensus       160 dfg~~~~~~~~------~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~  230 (294)
                      |||.+..+..+      ......+|||-|+|||.+.+   ..+.+.+.|||++|+++|.++.|+.||.+....+...+|.
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv  332 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV  332 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence            99998866322      23345789999999999876   4566789999999999999999999999999999999999


Q ss_pred             CCCccCCCC--CChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          231 GGIYTLPSH--LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       231 ~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                      .....+|..  +..+++++|.+||.+||++|.++.+|..|||........
T Consensus       333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            988777764  789999999999999999999999999999998764433

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.7e-48  Score=332.53  Aligned_cols=254  Identities=34%  Similarity=0.569  Sum_probs=222.7

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHH---HhCCCCceeEEEEEEEcCCeEEEE
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL---RLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      |++.+.||.|++|.||+|.+..+++.|++|++.............+.+|..++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78899999999999999999999999999999765443334455666666554   567799999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~  174 (294)
                      |||+.+++|...+. .+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus        81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            99999999998875 45799999999999999999999999999999999999999999999999998764322 22233


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhccc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV  254 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  254 (294)
                      ...+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.......+..++..+.+++.+||+.
T Consensus       160 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~  238 (324)
T cd05589         160 TFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR  238 (324)
T ss_pred             ccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhc
Confidence            4568899999999987766 789999999999999999999999988888888888877778888999999999999999


Q ss_pred             CCCCCC-----CHhHHhcCCccccc
Q 022617          255 DPMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       255 ~p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      ||.+||     ++.++++||||++.
T Consensus       239 dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         239 NPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             CHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            999999     69999999999874

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-49  Score=335.23  Aligned_cols=259  Identities=31%  Similarity=0.550  Sum_probs=241.1

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe-EE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD-IY   93 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~   93 (294)
                      ..++|.+++.+|.|+||.+++++++.+++.+++|.+......... .....+|..++++++||||+.+.+.|..++. ++
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            357899999999999999999999999999999999888766654 3488899999999999999999999988888 99


Q ss_pred             EEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           94 VVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      |+|+||+||+|.+.+.+++  .++++.+..++.|++.|+.|||+..|+|+|||+.||+++.++.++|+|||++.......
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999997654  69999999999999999999999999999999999999999999999999999988776


Q ss_pred             -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHH
Q 022617          172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP  249 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~  249 (294)
                       .....+||+.|++||.+.+.++ +.++|||||||++|||++-+++|...+...+..++.... .++|..++.+++.+|+
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~  239 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK  239 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence             6778889999999999999999 799999999999999999999999999999999998887 7889999999999999


Q ss_pred             HhcccCCCCCCCHhHHhcCCcccccC
Q 022617          250 RMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       250 ~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      .||+.+|+.||++.++|.+|.+....
T Consensus       240 ~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  240 SMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHhhcCCccCCCHHHHhhChhhhhHH
Confidence            99999999999999999999887443

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-48  Score=338.42  Aligned_cols=256  Identities=34%  Similarity=0.643  Sum_probs=222.3

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|+||+||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++..++..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997655444455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----  171 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-----  171 (294)
                      ||+.+++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......     
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999886432111     


Q ss_pred             ----------------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCC
Q 022617          172 ----------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF  217 (294)
Q Consensus       172 ----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~  217 (294)
                                                        ......+|+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence                                              0012358899999999987776 78999999999999999999999


Q ss_pred             CCCCHHHHHHHHhCCC--ccCC--CCCChhHHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617          218 DDENIPNLFKKIKGGI--YTLP--SHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH  274 (294)
Q Consensus       218 ~~~~~~~~~~~~~~~~--~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~  274 (294)
                      ...+.......+....  ...+  ..+++++.++|.+|+. +|.+|++   +.++++||||+..
T Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9888777666665432  2222  2568899999999996 8999998   9999999999764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.5e-48  Score=332.02  Aligned_cols=250  Identities=30%  Similarity=0.564  Sum_probs=217.9

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||+|+||.||+|.+..+++.|++|++.............+.+|..+++++ +||||+++++++...+.++++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999999999999999999876555555567788999999888 699999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~  180 (294)
                      ++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .........++.
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            9999999888899999999999999999999999999999999999999999999999999986432 222333456889


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---------NIPNLFKKIKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      .|+|||++.+..+ +.++|+||||+++|+|++|+.||...         ......+.+.......|..++.++.+++.+|
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~  239 (329)
T cd05588         161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF  239 (329)
T ss_pred             cccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            9999999987766 78999999999999999999999632         1223445566666777888999999999999


Q ss_pred             cccCCCCCCC------HhHHhcCCcccc
Q 022617          252 LIVDPMKRIT------IPEIRQHPWFQA  273 (294)
Q Consensus       252 l~~~p~~Rps------~~~il~h~~~~~  273 (294)
                      |+.||.+|++      ++++++||||+.
T Consensus       240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         240 LNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             hccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999997      789999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3e-48  Score=330.03  Aligned_cols=251  Identities=37%  Similarity=0.633  Sum_probs=223.2

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||.|+||+||+|.+..+++.|++|++.............+..|..+++.+ +||||+++++++...+.++++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999999999999999999765444444556677888888877 699999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  180 (294)
                      ++|...+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ........++.
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            99999998888899999999999999999999999999999999999999999999999998864322 22223345788


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      .|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.......+..++.++.++|.+||..||.+||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~  239 (318)
T cd05570         161 DYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL  239 (318)
T ss_pred             cccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcC
Confidence            9999999988776 789999999999999999999999888888888888777777888999999999999999999999


Q ss_pred             CH-----hHHhcCCccccc
Q 022617          261 TI-----PEIRQHPWFQAH  274 (294)
Q Consensus       261 s~-----~~il~h~~~~~~  274 (294)
                      ++     .++++||||+..
T Consensus       240 s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         240 GCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCCCCCHHHHhcCCCcCCC
Confidence            99     999999999774

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.3e-48  Score=329.44  Aligned_cols=251  Identities=33%  Similarity=0.604  Sum_probs=219.7

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||.|+||.||+|.++.+++.|++|++.............+..|..++.. ++|+|++++++++...+..+++|||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999976543222334556677777765 4899999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  180 (294)
                      ++|..++.+...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++..... ........++.
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            99999998888899999999999999999999999999999999999999999999999998864321 22233456899


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      .|+|||++.+..+ +.++||||||+++|+|++|..||...+.....+.+.......+..++.++.+++.+||..||++||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~  239 (316)
T cd05620         161 DYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL  239 (316)
T ss_pred             CccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence            9999999987776 789999999999999999999999888888888888777777888999999999999999999999


Q ss_pred             CH-hHHhcCCccccc
Q 022617          261 TI-PEIRQHPWFQAH  274 (294)
Q Consensus       261 s~-~~il~h~~~~~~  274 (294)
                      ++ +++++||||+..
T Consensus       240 ~~~~~~~~h~~f~~~  254 (316)
T cd05620         240 GVVGNIRGHPFFKTI  254 (316)
T ss_pred             CChHHHHcCCCcCCC
Confidence            97 589999999774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.4e-48  Score=326.19  Aligned_cols=253  Identities=30%  Similarity=0.477  Sum_probs=211.4

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||+|++|.||+|.++.+++.+++|++...... ....+.+.+|+.+++.++|+||+++++++...+..++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            4799999999999999999999999999999998654322 234567788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--ccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~  174 (294)
                      ||++++++..+......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            999987666655555679999999999999999999999999999999999999999999999999987654322  122


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--------------------
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------------------  234 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------  234 (294)
                      ...++..|+|||++.+..+ +.++|+||||+++|+|++|+.||...+..+....+.....                    
T Consensus       160 ~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         160 EYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             ccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            3457889999999987766 7899999999999999999999987654433322211100                    


Q ss_pred             -c-----------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 -T-----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 -~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                       +           ....++.++.+++.+||+.||++|||++++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             0           012367789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.1e-48  Score=331.76  Aligned_cols=250  Identities=34%  Similarity=0.597  Sum_probs=219.2

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||.|+||+||+|.+..+++.|++|++.............+..|.. +++.++||||+++++.+...+..+++|||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999999999999999997654433333445555544 56789999999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  180 (294)
                      ++|..++.+++.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ........+++
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            99999998888899999999999999999999999999999999999999999999999999865322 22233446889


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      .|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+..++..+.+++.+||+.||.+||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (323)
T cd05575         161 EYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL  239 (323)
T ss_pred             hhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence            9999999987766 789999999999999999999999988888888888777777888999999999999999999999


Q ss_pred             CH----hHHhcCCcccc
Q 022617          261 TI----PEIRQHPWFQA  273 (294)
Q Consensus       261 s~----~~il~h~~~~~  273 (294)
                      ++    .++++||||+.
T Consensus       240 ~~~~~~~~il~~~~~~~  256 (323)
T cd05575         240 GAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             CCCCCHHHHHcCCCcCC
Confidence            87    69999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-48  Score=328.93  Aligned_cols=261  Identities=44%  Similarity=0.764  Sum_probs=240.3

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCC
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS   90 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   90 (294)
                      ...+...|.+.+.||.|.||.||.|.++.+|+.+|+|++.+...........+.+|+++|+++. |||++.+.+.|++..
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            4567779999999999999999999999999999999998887766556789999999999999 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC----CcEEEeeeccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK----WNVKIADFGLSNI  166 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~----~~~~l~dfg~~~~  166 (294)
                      .+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|++|+|+||+|+++...    +.++++|||++..
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999999776 49999999999999999999999999999999999999643    4799999999999


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC----CCCCCh
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----PSHLSP  242 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~  242 (294)
                      ..........+||+.|+|||++....+ +...||||+|+++|.|++|..||.+.+.......+..+.+.+    +..++.
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            888777888899999999999998777 799999999999999999999999998888888888776543    457899


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .+.++|..||..||..|+|+.++|+|||++..
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999999999999999999999999875

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.6e-48  Score=329.68  Aligned_cols=255  Identities=35%  Similarity=0.570  Sum_probs=225.9

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      +|++.+.||+|+||.||+|.+..+++.|++|++................|..++..+. |++++++++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5889999999999999999999999999999987654433344556677778877774 789999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCcccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKT  175 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~  175 (294)
                      ||+++++|.+.+...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999875432 222334


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      ..+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+......++..++.++.+++.+||+.+
T Consensus       161 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~  239 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH  239 (323)
T ss_pred             CCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccC
Confidence            568899999999988776 7899999999999999999999999988888888888888888899999999999999999


Q ss_pred             CCCCCCH-----hHHhcCCcccc
Q 022617          256 PMKRITI-----PEIRQHPWFQA  273 (294)
Q Consensus       256 p~~Rps~-----~~il~h~~~~~  273 (294)
                      |++|++.     .++++||||+.
T Consensus       240 p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         240 PGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             HHhcCCCCCCCHHHHhcCCCcCC
Confidence            9999984     89999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.1e-48  Score=324.37  Aligned_cols=253  Identities=27%  Similarity=0.487  Sum_probs=211.3

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||.|+||.||+|.+..++..|++|++......  .....+.+|+.++++++|+||+++++++...+..+++
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            46799999999999999999999999999999998654321  2235677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      +||+++ +|.+++...+ .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            999976 9999887654 47899999999999999999999999999999999999999999999999987543322 22


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------------
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------------  233 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------  233 (294)
                      ....+++.|+|||.+.+....+.++||||+|+++|+|++|+.||.+.+..+....+....                    
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            344578899999998765444789999999999999999999998776555443332100                    


Q ss_pred             -c---------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          234 -Y---------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       234 -~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                       .         ......+.++.+++.+||+.||.+|||++|+++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence             0         0113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.9e-48  Score=329.48  Aligned_cols=252  Identities=36%  Similarity=0.614  Sum_probs=221.8

Q ss_pred             cccccccCceEEEEEEEc---cCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           22 GKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      ++.||+|+||.||++.+.   .+++.|++|++...... .......+.+|+.+++.++||||+++++.+..++..+++||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            367999999999999864   46789999998754332 22334567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccc
Q 022617           98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTS  176 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~  176 (294)
                      |+.+++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... .......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            999999999998888899999999999999999999999999999999999999999999999999864322 2223344


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCC
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP  256 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  256 (294)
                      .+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+..++.++.+++.+||+.+|
T Consensus       161 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  239 (323)
T cd05584         161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP  239 (323)
T ss_pred             CCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence            68899999999987766 78999999999999999999999998888888888888888888999999999999999999


Q ss_pred             CCCC-----CHhHHhcCCccccc
Q 022617          257 MKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       257 ~~Rp-----s~~~il~h~~~~~~  274 (294)
                      ++||     +++++++||||+..
T Consensus       240 ~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         240 SSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             hHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.9e-48  Score=327.89  Aligned_cols=251  Identities=38%  Similarity=0.659  Sum_probs=219.1

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||.|+||.||+|.+..+++.||+|++................|..++.. .+||||+++++++...+..+++|||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            468999999999999999999999999976543333334455566666654 4799999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-CccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~  180 (294)
                      ++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...... .......+++
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            999999988888999999999999999999999999999999999999999999999999998754322 2334456899


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      .|+|||.+.+..+ +.++|+||||+++|+|++|..||.+.+.......+......++..++.++.+++.+||..+|++||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~  239 (316)
T cd05592         161 DYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL  239 (316)
T ss_pred             cccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence            9999999987766 789999999999999999999999988888888888777778888999999999999999999999


Q ss_pred             CH-hHHhcCCccccc
Q 022617          261 TI-PEIRQHPWFQAH  274 (294)
Q Consensus       261 s~-~~il~h~~~~~~  274 (294)
                      ++ .++++||||+..
T Consensus       240 ~~~~~l~~h~~~~~~  254 (316)
T cd05592         240 GVDGDIRQHPFFRGI  254 (316)
T ss_pred             CChHHHHcCcccCCC
Confidence            86 589999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-48  Score=337.34  Aligned_cols=256  Identities=31%  Similarity=0.573  Sum_probs=219.2

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|+||.||+|.+..+++.|++|++.............+.+|++++++++||||+++++++...+..|++|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999987654444455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----  171 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-----  171 (294)
                      ||+.+++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999885321100     


Q ss_pred             -------------------------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHH
Q 022617          172 -------------------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY  208 (294)
Q Consensus       172 -------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~  208 (294)
                                                                 ......+++.|+|||++.+..+ +.++||||||+++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~  239 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF  239 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence                                                       0012358899999999987766 78999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHhCC--CccCC--CCCChhHHHHHHHhcccCCCCC---CCHhHHhcCCccccc
Q 022617          209 ALLCGTLPFDDENIPNLFKKIKGG--IYTLP--SHLSPGARDLIPRMLIVDPMKR---ITIPEIRQHPWFQAH  274 (294)
Q Consensus       209 ~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~l~~li~~~l~~~p~~R---ps~~~il~h~~~~~~  274 (294)
                      +|++|..||...........+...  ...++  ..++.++.++|.+||. +|.+|   +++.++++||||++.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999999887776666665432  22333  3578999999999997 66665   599999999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.6e-48  Score=335.33  Aligned_cols=257  Identities=31%  Similarity=0.524  Sum_probs=218.9

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ..|.+++.||+|+||+||+|.+..+++.|++|++.............+.+|+.++++++|+||+++++++.+.+.++++|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            36899999999999999999999999999999997765555556678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC------
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------  170 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~------  170 (294)
                      ||+++++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.+++++|+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999986432100      


Q ss_pred             ------------------------------------------CccccccCCCcccCCccccCCccCCCchhHHHHHHHHH
Q 022617          171 ------------------------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY  208 (294)
Q Consensus       171 ------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~  208 (294)
                                                                .......+++.|+|||.+.+..+ +.++||||||+++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~  239 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILF  239 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHH
Confidence                                                      00113468899999999987766 78999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHhC--CCccCC--CCCChhHHHHHHHhc--ccCCCCCCCHhHHhcCCccccc
Q 022617          209 ALLCGTLPFDDENIPNLFKKIKG--GIYTLP--SHLSPGARDLIPRML--IVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       209 ~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~--~~~~~~l~~li~~~l--~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +|++|..||...........+..  .....+  ..++.++.++|.+|+  ..+|..|+++.++++||||+..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            99999999988776655555442  222333  357899999999955  4455569999999999999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-48  Score=329.93  Aligned_cols=248  Identities=29%  Similarity=0.524  Sum_probs=221.5

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-...++.++.||+|.||.||.|.++ ....|++|.+......    .+.+.+|++++++|+|++|++++++|..++.++
T Consensus       203 i~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  203 IPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             ecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            34456788999999999999999996 4457999998765433    367779999999999999999999999988999


Q ss_pred             EEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           94 VVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      |||||+..|+|.++|..  ...+...+.+.++.||+++++||++++++||||...|||++++..+||+|||+++...+..
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            99999999999999986  4568999999999999999999999999999999999999999999999999999665554


Q ss_pred             ccccc--cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617          172 FLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL  247 (294)
Q Consensus       172 ~~~~~--~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  247 (294)
                      .....  ..+..|.|||++....+ +.+||+||||++|||++| |+.||.+++..+.++.+..+. .+.|..||.++.++
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~l  436 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYEL  436 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHH
Confidence            43332  34778999999999988 899999999999999999 999999999999999998776 78889999999999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      |..||..+|++|||++.+..
T Consensus       437 M~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  437 MKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHhhCCcccCCCHHHHHH
Confidence            99999999999999997765

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.4e-48  Score=326.09  Aligned_cols=258  Identities=27%  Similarity=0.471  Sum_probs=209.9

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||.|++|.||+|.+..+++.|++|++......  .....+.+|+.+++.++||||+++++++......+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            36899999999999999999999999999999998654322  2234567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccc
Q 022617           96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~  173 (294)
                      +||+++ +|.+++... +.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus        82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence            999965 888877654 56899999999999999999999999999999999999999999999999998654322 222


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhCC--C-----------------
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGG--I-----------------  233 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~--~-----------------  233 (294)
                      ....+++.|+|||++.+....+.++||||||+++|+|++|..||.+... ......+...  .                 
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            3455788999999987655447889999999999999999999976432 2222221100  0                 


Q ss_pred             --cc--CC---------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          234 --YT--LP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       234 --~~--~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                        ..  .+         ..++.++.+++.+||+.||.+|||+.++++||||++.-+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence              00  00         124567889999999999999999999999999988543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.3e-48  Score=329.41  Aligned_cols=251  Identities=31%  Similarity=0.567  Sum_probs=217.0

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||+|+||.||+|.+..+++.|++|++.............+.+|+.++.++ +||||+++++++...+..++++||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4689999999999999999999999999876555545567788898888776 799999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  180 (294)
                      ++|..++.+.+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ........++.
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999865322 22233456789


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD---------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      .|+|||++.+..+ +.++|+||||+++|+|++|..||..         .......+.+......+|..++..+.+++.+|
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~  239 (329)
T cd05618         161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF  239 (329)
T ss_pred             cccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            9999999987766 7899999999999999999999952         11223445556666777888999999999999


Q ss_pred             cccCCCCCCC------HhHHhcCCccccc
Q 022617          252 LIVDPMKRIT------IPEIRQHPWFQAH  274 (294)
Q Consensus       252 l~~~p~~Rps------~~~il~h~~~~~~  274 (294)
                      |+.||++||+      +.++++||||+..
T Consensus       240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         240 LNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             hcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999998      5799999999763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-48  Score=322.13  Aligned_cols=255  Identities=29%  Similarity=0.482  Sum_probs=220.6

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||++.+..+++.|++|++.............+.+|+.+++.++|+|++++++.+..++..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            58899999999999999999998999999999876554444445567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      |+.+++|.+++...  ..+++..+..++.|++.|+.|||+.|++|+||+|+||++++++.++|+|||++...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999999888653  4589999999999999999999999999999999999999999999999999876654444344


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      ..++..|+|||.+.+..+ +.++|+||+|+++|++++|..||.+.....    ....+.......+..++..+.+++.+|
T Consensus       161 ~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (285)
T cd05605         161 RVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL  239 (285)
T ss_pred             ccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence            567899999999987766 788999999999999999999998765433    233344444556667899999999999


Q ss_pred             cccCCCCCC-----CHhHHhcCCcccc
Q 022617          252 LIVDPMKRI-----TIPEIRQHPWFQA  273 (294)
Q Consensus       252 l~~~p~~Rp-----s~~~il~h~~~~~  273 (294)
                      |..||.+||     ++.++++||||..
T Consensus       240 l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         240 LTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             ccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            999999999     8999999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3e-47  Score=325.71  Aligned_cols=257  Identities=24%  Similarity=0.437  Sum_probs=219.1

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      ..++|++.+.||.|++|.||++.+..++..+++|++....  .......+.+|++++++++|+|++++++++...+..++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4579999999999999999999999999999999986542  22345778999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      +|||+++++|.+++.+...+++..++.++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  159 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  159 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-cc
Confidence            999999999999998888899999999999999999999986 5999999999999999999999999998765332 22


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC----------------------
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG----------------------  231 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~----------------------  231 (294)
                      ....++..|+|||.+.+..+ +.++||||||+++|+|++|+.||...+..++...+..                      
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            34568899999999987766 7899999999999999999999976655443322211                      


Q ss_pred             ------------------------CC-ccC-CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          232 ------------------------GI-YTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       232 ------------------------~~-~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                                              .. ... ...++.++.+||.+||+.||++|||+.+|++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                    00 011 124678999999999999999999999999999998753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-47  Score=328.83  Aligned_cols=257  Identities=34%  Similarity=0.588  Sum_probs=219.8

Q ss_pred             CCcccccccccCceEEEEEEEc---cCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI   92 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   92 (294)
                      +|++.+.||+|+||.||++.+.   .+++.+++|++...... .....+.+..|+.+++.++ |++|+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999864   46789999998654322 2234567788999999995 89999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      +++|||+.+++|.+++.++..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999987543222 


Q ss_pred             -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhCCCccCCCCCChhHHH
Q 022617          172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGARD  246 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
                       ......++..|+|||.+.+....+.++||||||+++|+|++|..||...    ........+......++..++..+.+
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD  240 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence             2223468999999999886654478999999999999999999999642    33445555666666777889999999


Q ss_pred             HHHHhcccCCCCCC-----CHhHHhcCCccccc
Q 022617          247 LIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       247 li~~~l~~~p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      ++.+||+.||++||     +++++++||||++.
T Consensus       241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999     88899999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.3e-48  Score=335.36  Aligned_cols=256  Identities=33%  Similarity=0.548  Sum_probs=219.5

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      .+|.+++.||+|+||+||+|.+..+++.+++|++.............+.+|+.++++++|+||+++++.+...+.+++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            36899999999999999999999999999999987655444455678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC------
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------  170 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~------  170 (294)
                      ||+++++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999986432100      


Q ss_pred             ------------------------------------------CccccccCCCcccCCccccCCccCCCchhHHHHHHHHH
Q 022617          171 ------------------------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY  208 (294)
Q Consensus       171 ------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~  208 (294)
                                                                .......+++.|+|||++.+..+ +.++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~  239 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILY  239 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHH
Confidence                                                      00112357899999999987777 78999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHhCCC--ccC--CCCCChhHHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617          209 ALLCGTLPFDDENIPNLFKKIKGGI--YTL--PSHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH  274 (294)
Q Consensus       209 ~l~~g~~p~~~~~~~~~~~~~~~~~--~~~--~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~  274 (294)
                      +|++|..||...+.......+....  ...  ...+++++.++|.+|+ .+|.+|++   ++++++||||+..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            9999999998877666555554322  222  2467899999999987 59999997   9999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.5e-48  Score=331.47  Aligned_cols=257  Identities=28%  Similarity=0.504  Sum_probs=221.8

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|.+.+.||.|+||+||+|.+..+++.|++|++.............+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998665544455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--c
Q 022617           97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L  173 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--~  173 (294)
                      ||+++++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........  .
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            999999999999876 6799999999999999999999999999999999999999999999999999876543322  1


Q ss_pred             ccccCCCcccCCccccC-----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--c--cCCCCCChhH
Q 022617          174 KTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--Y--TLPSHLSPGA  244 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~--~~~~~~~~~l  244 (294)
                      ....+++.|+|||.+..     ....+.++||||||+++|+|++|..||...........+....  .  +....++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            23357899999999863     2233688999999999999999999998877776666654432  2  2223578999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .+++..||+ +|.+|||++++++||||+..
T Consensus       241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            999999998 99999999999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.6e-47  Score=325.08  Aligned_cols=251  Identities=36%  Similarity=0.614  Sum_probs=218.4

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||+|+||.||+|.+..+++.||+|++................|..+++. ++||||+++++++...+.++++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            468999999999999999999999999876543222334556667777765 5899999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-CccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~  180 (294)
                      ++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......++.
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            999999988788999999999999999999999999999999999999999999999999998653221 2233456789


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      .|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.....+.+.......+..++.++.+++.+||+.+|++||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  239 (316)
T cd05619         161 DYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL  239 (316)
T ss_pred             cccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcC
Confidence            9999999987766 789999999999999999999999888888888887776667778899999999999999999999


Q ss_pred             CHh-HHhcCCccccc
Q 022617          261 TIP-EIRQHPWFQAH  274 (294)
Q Consensus       261 s~~-~il~h~~~~~~  274 (294)
                      ++. ++++||||+..
T Consensus       240 ~~~~~l~~h~~~~~~  254 (316)
T cd05619         240 GVKGDIRQHPFFREI  254 (316)
T ss_pred             CChHHHHcCcccCCC
Confidence            996 89999999774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.7e-48  Score=335.79  Aligned_cols=256  Identities=31%  Similarity=0.525  Sum_probs=219.3

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|+||.||+|.+..+++.|++|++.............+.+|+.+++.++|+||+++++.+..++.++++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999987654444445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC------
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------  170 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~------  170 (294)
                      ||+++++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......      
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999987422100      


Q ss_pred             --------------------------------------CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh
Q 022617          171 --------------------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC  212 (294)
Q Consensus       171 --------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~  212 (294)
                                                            .......+++.|+|||++.+..+ +.++||||||+++|+|++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~  239 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence                                                  00012358899999999987776 789999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhCCC--c--cCCCCCChhHHHHHHHhcccCCCCCC---CHhHHhcCCccccc
Q 022617          213 GTLPFDDENIPNLFKKIKGGI--Y--TLPSHLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAH  274 (294)
Q Consensus       213 g~~p~~~~~~~~~~~~~~~~~--~--~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~h~~~~~~  274 (294)
                      |+.||......+....+....  .  +....++.++.++|.+|+ .+|.+|+   ++.++++||||+..
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            999999887766655554322  1  222467899999999987 5999999   99999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-47  Score=332.33  Aligned_cols=259  Identities=30%  Similarity=0.528  Sum_probs=223.1

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-.++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            44578999999999999999999999999999999987554444444566788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--  171 (294)
                      +++||++|++|.+++.+ ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+.......  
T Consensus       120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            99999999999998854 468999999999999999999999999999999999999999999999999987654322  


Q ss_pred             ccccccCCCcccCCccccCCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCCC--CCChhH
Q 022617          172 FLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPGA  244 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~--~~~~~l  244 (294)
                      ......+++.|+|||.+.+..   ..+.++|+||||+++|+|++|..||...+.......+....  ...+.  .++.++
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA  278 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence            123456899999999986532   23689999999999999999999999888777777776533  33333  579999


Q ss_pred             HHHHHHhcccCCCC--CCCHhHHhcCCcccc
Q 022617          245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA  273 (294)
Q Consensus       245 ~~li~~~l~~~p~~--Rps~~~il~h~~~~~  273 (294)
                      .++|.+||+.+|++  |+|+.++++||||+.
T Consensus       279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            99999999999988  999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.4e-47  Score=319.04  Aligned_cols=255  Identities=42%  Similarity=0.748  Sum_probs=230.0

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||++.+..+++.+++|++.............+.+|+++++++.||||+++++++...+..++++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999987655444455678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS  176 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  176 (294)
                      ||+++++|.+++.+...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++......  ....
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~  158 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL  158 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence            99999999999988888999999999999999999999999999999999999999999999999998766444  2334


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCC
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP  256 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  256 (294)
                      .+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+.....+.+..+...++...+..+.+++.+||..+|
T Consensus       159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  237 (290)
T cd05580         159 CGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDL  237 (290)
T ss_pred             CCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCH
Confidence            57889999999876655 78899999999999999999999888877777777777777888889999999999999999


Q ss_pred             CCCC-----CHhHHhcCCccccc
Q 022617          257 MKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       257 ~~Rp-----s~~~il~h~~~~~~  274 (294)
                      .+|+     +++++++||||+..
T Consensus       238 ~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         238 TKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             HHccCcccCCHHHHHcCcccccC
Confidence            9999     89999999999764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.5e-47  Score=325.01  Aligned_cols=256  Identities=36%  Similarity=0.579  Sum_probs=225.6

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCCeEEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~   96 (294)
                      +|...+.||.|+||+||+|.++.+++.||+|++...........+.+..|..+++.+.| ++++++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47889999999999999999999999999999876543333445667788888888864 77888999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT  175 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~  175 (294)
                      ||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            999999999999888889999999999999999999999999999999999999999999999999987543222 2234


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      ..+++.|+|||++.+..+ +.++|+||+|+++|+|++|..||.........+.+.......+..++.++.+++.+||+.+
T Consensus       161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~  239 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH  239 (323)
T ss_pred             ccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccC
Confidence            457899999999987766 7899999999999999999999999888888888888887888889999999999999999


Q ss_pred             CCCCCC-----HhHHhcCCccccc
Q 022617          256 PMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       256 p~~Rps-----~~~il~h~~~~~~  274 (294)
                      |.+|++     ..++++||||+..
T Consensus       240 p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         240 PSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HhhCCCCCCCCHHHHhcCcccCCC
Confidence            999997     4789999999874

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5e-48  Score=328.82  Aligned_cols=251  Identities=30%  Similarity=0.577  Sum_probs=221.4

Q ss_pred             cccccccCceEEEEEEE---ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617           22 GKTLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY   98 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~---~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   98 (294)
                      ++.||+|+||.||++.+   ..+++.+++|++....... .....+.+|++++++++||||+++++++..++..|+++||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            36799999999999986   3578899999997654322 2345677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccccccc
Q 022617           99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSC  177 (294)
Q Consensus        99 ~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~  177 (294)
                      +.+++|.+++.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  159 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC  159 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence            999999999988888999999999999999999999999999999999999999999999999998765433 2233456


Q ss_pred             CCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCC
Q 022617          178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM  257 (294)
Q Consensus       178 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  257 (294)
                      +++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.......+......++..++.++.+++.+||+.||+
T Consensus       160 g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~  238 (318)
T cd05582         160 GTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA  238 (318)
T ss_pred             CChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence            7899999999987666 789999999999999999999999988888888888878888888999999999999999999


Q ss_pred             CCCC-----HhHHhcCCccccc
Q 022617          258 KRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       258 ~Rps-----~~~il~h~~~~~~  274 (294)
                      +||+     +.++++||||+..
T Consensus       239 ~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         239 NRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HcCCCCCCCHHHHhCCCCcCCC
Confidence            9999     7789999999763

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.7e-47  Score=328.69  Aligned_cols=266  Identities=31%  Similarity=0.506  Sum_probs=216.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS---   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   90 (294)
                      .+.++|++.+.||+|+||.||++.+..++..+++|++.... ........+.+|+.+++.++||||+++++++...+   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            46789999999999999999999999999999999986543 22344567789999999999999999999986443   


Q ss_pred             ---eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           91 ---DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        91 ---~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                         ..++++||+++ +|.+.+.  ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence               57999999976 6777663  35789999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-----------------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK-----------------  230 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-----------------  230 (294)
                      ..........++..|+|||.+.+..+ +.++||||||+++|+|++|+.||.+.+..+....+.                 
T Consensus       174 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         174 CTNFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             ccCccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            44444445567889999999988776 789999999999999999999998765433221111                 


Q ss_pred             -----CCCcc--------------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCC
Q 022617          231 -----GGIYT--------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP  284 (294)
Q Consensus       231 -----~~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~  284 (294)
                           .....                    .....+.++.+++.+||..||++|||+.|+|+||||+.++......++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~  331 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPP  331 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcccccCCC
Confidence                 00000                    0112457789999999999999999999999999999877655444433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-47  Score=331.94  Aligned_cols=256  Identities=31%  Similarity=0.600  Sum_probs=221.5

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|+||.||+|.+..+++.|++|++.............+.+|+.++..++|++++++++.+...+.++++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997655444455678889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----  171 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-----  171 (294)
                      ||++|++|.+++.+.+.+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999876432110     


Q ss_pred             -------------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022617          172 -------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE  220 (294)
Q Consensus       172 -------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~  220 (294)
                                                     ......+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCC
Confidence                                           0112358899999999987776 78999999999999999999999988


Q ss_pred             CHHHHHHHHhCCC--ccCCC--CCChhHHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617          221 NIPNLFKKIKGGI--YTLPS--HLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH  274 (294)
Q Consensus       221 ~~~~~~~~~~~~~--~~~~~--~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~  274 (294)
                      ........+....  ..++.  .++.++.++|.+|+. +|.+|++   ++++++||||++.
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            8777777665422  22333  478899999999874 9999984   8999999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-47  Score=327.14  Aligned_cols=251  Identities=34%  Similarity=0.577  Sum_probs=218.4

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||.|+||+||+|.+..+++.+++|++.............+..|.. +++.++||||+++++.+...+..+++|||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999999999999999987654333333445555554 56789999999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  180 (294)
                      ++|...+.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ........+++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            99999998888899999999999999999999999999999999999999999999999999865322 22233456889


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      .|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.......+...+..+.+++.+||..+|.+||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~  239 (325)
T cd05604         161 EYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL  239 (325)
T ss_pred             hhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence            9999999988776 789999999999999999999999888888888887777777778999999999999999999999


Q ss_pred             CH----hHHhcCCccccc
Q 022617          261 TI----PEIRQHPWFQAH  274 (294)
Q Consensus       261 s~----~~il~h~~~~~~  274 (294)
                      ++    .++++||||+..
T Consensus       240 ~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         240 GAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             CCCCCHHHHhcCCCcCCC
Confidence            86    589999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6e-47  Score=326.58  Aligned_cols=259  Identities=31%  Similarity=0.481  Sum_probs=214.5

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|...+.||.|+||.||+|.+..+++.|++|++....  .......+.+|++++++++|+||+++++++...+.+
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            344678999999999999999999999999999999985432  234457789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++++||+.+++|.+.    ...++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus       148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            999999999988653    345678889999999999999999999999999999999999999999999987654322 


Q ss_pred             ccccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-hCCCccCCCCCChh
Q 022617          172 FLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKKI-KGGIYTLPSHLSPG  243 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~-~~~~~~~~~~~~~~  243 (294)
                      ......++..|+|||.+..    ..+.+.++||||||+++|+|++|+.||......   .....+ .......+..++.+
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE  303 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence            2234568899999998743    233356899999999999999999999743322   222222 22334455678999


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      +.++|.+||+.||++|||+.|+++||||......
T Consensus       304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            9999999999999999999999999999887533

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.3e-47  Score=325.22  Aligned_cols=250  Identities=33%  Similarity=0.576  Sum_probs=217.7

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHH-HHHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI-KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||.|+||.||+|.+..+++.|++|++.............+..|. .+++.++|+||+++++++...+..++++||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999999999999999998765443333344555554 467889999999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  180 (294)
                      ++|...+.+...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ........+++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999865322 22233446789


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      .|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.......+...+..+.+++.+||+.+|.+||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (321)
T cd05603         161 EYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL  239 (321)
T ss_pred             ccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence            9999999987766 789999999999999999999999988888888887777778888999999999999999999999


Q ss_pred             CH----hHHhcCCcccc
Q 022617          261 TI----PEIRQHPWFQA  273 (294)
Q Consensus       261 s~----~~il~h~~~~~  273 (294)
                      ++    .++++|+||..
T Consensus       240 ~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         240 GAKADFLEIKNHVFFSP  256 (321)
T ss_pred             CCCCCHHHHhCCCCcCC
Confidence            75    59999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-47  Score=326.84  Aligned_cols=256  Identities=33%  Similarity=0.558  Sum_probs=209.0

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----CeE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----SDI   92 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   92 (294)
                      +|++.+.||.|++|.||+|.+..+++.|++|.+.... ........+.+|+.++++++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            6899999999999999999999999999999986432 2223345788999999999999999999987543     358


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++++||++ ++|.+++.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... 
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999995 5999999888889999999999999999999999999999999999999999999999999987543221 


Q ss_pred             ---ccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----------------
Q 022617          172 ---FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK----------------  230 (294)
Q Consensus       172 ---~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~----------------  230 (294)
                         ......++..|+|||++.+  ..+ +.++||||||+++|+|++|+.||.+.+.......+.                
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence               1133468899999999865  334 789999999999999999999997655332221110                


Q ss_pred             -----------CCC-c---cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          231 -----------GGI-Y---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       231 -----------~~~-~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                                 ... .   ...+.++..+.+++.+||+.||++|||++++++||||+..-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                       000 0   011346788999999999999999999999999999977533

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.3e-47  Score=316.94  Aligned_cols=249  Identities=34%  Similarity=0.535  Sum_probs=212.7

Q ss_pred             ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617           25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL  104 (294)
Q Consensus        25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL  104 (294)
                      ||.|+||+||++.+..+++.+++|.+.............+..|+.++++++|+|++++.+++......+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999998765544444456778899999999999999999999999999999999999999


Q ss_pred             HHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-cccccCC
Q 022617          105 FDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGS  179 (294)
Q Consensus       105 ~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~  179 (294)
                      ...+..    +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            988743    34689999999999999999999999999999999999999999999999999876543322 2334678


Q ss_pred             CcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       180 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      +.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||.....    ......+.......+..++..+.+++.+||+.|
T Consensus       161 ~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  239 (280)
T cd05608         161 PGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD  239 (280)
T ss_pred             cCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCC
Confidence            89999999988776 7899999999999999999999976432    233333444445556778999999999999999


Q ss_pred             CCCCC-----CHhHHhcCCccccc
Q 022617          256 PMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       256 p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      |++||     +++++++||||+..
T Consensus       240 P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         240 PEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             HHHhcCCCCCCHHHHhcChhhhcC
Confidence            99999     78999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.8e-47  Score=323.80  Aligned_cols=251  Identities=29%  Similarity=0.549  Sum_probs=217.7

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||+|+||.||+|.+..+++.+++|++.............+.+|..++.++ .|++|+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876555555567788999998888 599999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~  180 (294)
                      ++|..++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999986532 222334456899


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHhCCCccCCCCCChhHHHHHHHhcc
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-------NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  253 (294)
                      .|+|||.+.+..+ +.++|+||||+++|+|++|..||...       ......+.+.......|..++..+.+++.+||+
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  239 (327)
T cd05617         161 NYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN  239 (327)
T ss_pred             ccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999987766 78999999999999999999999532       223344555555667788899999999999999


Q ss_pred             cCCCCCCC------HhHHhcCCccccc
Q 022617          254 VDPMKRIT------IPEIRQHPWFQAH  274 (294)
Q Consensus       254 ~~p~~Rps------~~~il~h~~~~~~  274 (294)
                      .||.+|++      ++++++||||+..
T Consensus       240 ~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         240 KDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             cCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            99999998      5799999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-48  Score=304.09  Aligned_cols=266  Identities=41%  Similarity=0.692  Sum_probs=239.0

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc-----chHHHHHHHHHHHHHHhCC-CCceeEEEEE
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLFM-HPHIIRLYEV   85 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~   85 (294)
                      .+.+...|.-.+.||.|..+.|-++.++.+++.+++|++......     .....+.-.+|+.+|+++. ||+|+++.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            356778899999999999999999999999999999998643221     2334566678999999885 9999999999


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617           86 IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus        86 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                      |+++..+++|+|.++-|.|.+++.+.-.+++.+.+.+++|+++++.|||..+|+|+|+||+||+++++-+++|+|||+++
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence            99999999999999999999999988899999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCcccCCcccc-----CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC---
Q 022617          166 IMRDGHFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP---  237 (294)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---  237 (294)
                      ....+......+|||+|.|||.+.     +.+.++...|+|+.|++||-++.|.+||......-+...|+.+...+.   
T Consensus       172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe  251 (411)
T KOG0599|consen  172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE  251 (411)
T ss_pred             ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence            999998888899999999999874     333347789999999999999999999999888999999999987654   


Q ss_pred             -CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          238 -SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       238 -~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                       .+++...+++|.+||+.||.+|.|++|+|.||||.+..-.
T Consensus       252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~  292 (411)
T KOG0599|consen  252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ  292 (411)
T ss_pred             hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence             5789999999999999999999999999999999766433

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.4e-47  Score=324.62  Aligned_cols=250  Identities=34%  Similarity=0.584  Sum_probs=216.8

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHH-HHHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI-KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||.|+||+||+|.+..+++.|++|++.............+..|. .+++.++|+||+++++++...+..++++||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999998765433323333444444 456889999999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  180 (294)
                      ++|.+++.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ........+++
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999865322 22233456899


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      .|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+..++..+.+++.+||+.+|.+||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (325)
T cd05602         161 EYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL  239 (325)
T ss_pred             cccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence            9999999987766 789999999999999999999999888888888877777777788999999999999999999999


Q ss_pred             CHh----HHhcCCcccc
Q 022617          261 TIP----EIRQHPWFQA  273 (294)
Q Consensus       261 s~~----~il~h~~~~~  273 (294)
                      ++.    ++++|+||+.
T Consensus       240 ~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         240 GAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             CCCCCHHHHhcCcccCC
Confidence            866    8999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.9e-47  Score=328.99  Aligned_cols=261  Identities=29%  Similarity=0.554  Sum_probs=222.2

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|++.+.||.|+||.||++.+..+++.+++|++.............+.+|+.+++.++||||+++++++..++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            34567999999999999999999999999999999998755444444456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            999999999999999864 4689999999999999999999999999999999999999999999999999876543222


Q ss_pred             --cccccCCCcccCCccccCCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCCC--CCChh
Q 022617          173 --LKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPG  243 (294)
Q Consensus       173 --~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~--~~~~~  243 (294)
                        .....+++.|+|||++.+..   ..+.++|+||||+++|+|++|..||...+.......+....  ...+.  .++..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  277 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH  277 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence              23456899999999986543   23689999999999999999999999888777777765433  33333  56889


Q ss_pred             HHHHHHHhcccCCCC--CCCHhHHhcCCccccc
Q 022617          244 ARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH  274 (294)
Q Consensus       244 l~~li~~~l~~~p~~--Rps~~~il~h~~~~~~  274 (294)
                      +.+++..||..++.+  |+++.++++||||+..
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            999999999865543  8999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-46  Score=310.05  Aligned_cols=254  Identities=34%  Similarity=0.554  Sum_probs=218.9

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      ++|.+.+.||.|++|.||.|.+..+++.+++|++.......  ......+.+|++++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999999899999999986543222  2234678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc-
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-  173 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  173 (294)
                      ++|++++++|.+++.+.+.+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999998654332111 


Q ss_pred             ---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC--CCccCCCCCChhHHHHH
Q 022617          174 ---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSHLSPGARDLI  248 (294)
Q Consensus       174 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li  248 (294)
                         ....++..|+|||.+.+... +.++|+||||+++|++++|+.||..............  .....+..++..+.+++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence               22346778999999987765 7899999999999999999999977655544444332  23456678899999999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCcc
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      .+||..+|++|||+.++++||||
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.7e-46  Score=313.47  Aligned_cols=249  Identities=28%  Similarity=0.472  Sum_probs=209.5

Q ss_pred             ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617           25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL  104 (294)
Q Consensus        25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL  104 (294)
                      ||.|+||.||++.++.+++.+++|.+.............+..|++++++++||||+++++++......+++|||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999999999999998655443333445567799999999999999999999999999999999999999


Q ss_pred             HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcc
Q 022617          105 FDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY  182 (294)
Q Consensus       105 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  182 (294)
                      .+++....  .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.............++..|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            98886543  5889999999999999999999999999999999999999999999999998766554444445688899


Q ss_pred             cCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhCCCccC-CCCCChhHHHHHHHhcccCCC
Q 022617          183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTL-PSHLSPGARDLIPRMLIVDPM  257 (294)
Q Consensus       183 ~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~  257 (294)
                      +|||++.+..+ +.++|+||+|+++|+|++|..||.....    .............. ...++.++.+++.+||+.||+
T Consensus       161 ~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~  239 (277)
T cd05607         161 MAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE  239 (277)
T ss_pred             cCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence            99999987775 7899999999999999999999975432    22323333222222 246899999999999999999


Q ss_pred             CCCCH----hHHhcCCccccc
Q 022617          258 KRITI----PEIRQHPWFQAH  274 (294)
Q Consensus       258 ~Rps~----~~il~h~~~~~~  274 (294)
                      +||++    +++++||||+..
T Consensus       240 ~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         240 DRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             hCCCCccchhhhhcChhhcCC
Confidence            99999    678899999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-47  Score=326.34  Aligned_cols=250  Identities=32%  Similarity=0.563  Sum_probs=215.2

Q ss_pred             ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      ||.|+||+||+|.+..+++.|++|++................|..++..+   .||||+++++.+...+..+++|||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999999999999999998765443333344455566666655   699999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  180 (294)
                      ++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..... ........++.
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999865322 22233456899


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCC-CCChhHHHHHHHhcccCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS-HLSPGARDLIPRMLIVDPMKR  259 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~R  259 (294)
                      .|+|||++.+....+.++||||||+++|+|++|..||.........+.+..+...++. .++.++.+++.+||+.||.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R  240 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR  240 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence            9999999876554478999999999999999999999998888888888776665554 478999999999999999999


Q ss_pred             C----CHhHHhcCCccccc
Q 022617          260 I----TIPEIRQHPWFQAH  274 (294)
Q Consensus       260 p----s~~~il~h~~~~~~  274 (294)
                      |    ++.++++||||+..
T Consensus       241 ~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         241 LGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCCCCCHHHHhcCccccCC
Confidence            8    69999999999763

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.5e-46  Score=314.93  Aligned_cols=256  Identities=30%  Similarity=0.495  Sum_probs=217.6

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      .|++.+.||.|+||.||++.+..+++.+++|.+.............+.+|+.++++++|++++++++.+...+..++++|
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47888999999999999999999999999999876554444445667789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      |+.+++|.+++...  ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            99999999988654  3589999999999999999999999999999999999999999999999999876544433344


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-HhCCCccCCCCCChhHHHHHHHh
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKK-IKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~-~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      ..++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||......   ..... ........+..++.++.+++.+|
T Consensus       161 ~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (285)
T cd05630         161 RVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML  239 (285)
T ss_pred             CCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence            568899999999987766 78999999999999999999999764321   11111 12222345567899999999999


Q ss_pred             cccCCCCCCC-----HhHHhcCCccccc
Q 022617          252 LIVDPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       252 l~~~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      |+.||++|||     +.++++||||+..
T Consensus       240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         240 LCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             hhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9999999999     8999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-46  Score=319.34  Aligned_cols=269  Identities=26%  Similarity=0.470  Sum_probs=221.1

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|.+.+.||.|+||.||+|.++.++..+++|.+......  .....+.+|++++++++|+|++++++++..++..+++
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            36899999999999999999999999999999998654322  2234567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      +||+++ +|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            999975 888887654 458899999999999999999999999999999999999999999999999987543322 22


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------------------c
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y  234 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~  234 (294)
                      ....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+..+....+....                   .
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            334568899999998765444789999999999999999999998766544433332100                   0


Q ss_pred             -----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcch
Q 022617          235 -----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTM  287 (294)
Q Consensus       235 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~~  287 (294)
                                 .....++.++.++|.+||+.||.+|||+.++++||||+....+....|.+-++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~  305 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPESISI  305 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccccccCCcceee
Confidence                       01134678899999999999999999999999999999887776666665443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-46  Score=316.12  Aligned_cols=252  Identities=29%  Similarity=0.486  Sum_probs=206.0

Q ss_pred             cCCcccccccccCceEEEEEEEcc-CCceEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeEEEEEEE-----
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIE-----   87 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----   87 (294)
                      .+|++.+.||.|+||.||+|.+.. ++..+++|.+....... .......+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999854 46789999986543322 2233455677766655   6999999999885     


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                      .....++++|++++ +|.+++...  ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus        80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            34568999999964 999998653  358999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-----------
Q 022617          166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----------  234 (294)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------  234 (294)
                      ............+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+....+....+.....           
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  237 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence            6654444445568899999999977766 7899999999999999999999988776655554432110           


Q ss_pred             ----------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 ----------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                      ...+.++..+.+++.+||+.||++|||+.++|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                            0113467788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-46  Score=325.76  Aligned_cols=262  Identities=29%  Similarity=0.530  Sum_probs=222.5

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      ...-.++|++.+.||.|+||.||+|.++.+++.+++|++.............+.+|+.+++.++||||+++++.+...+.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            34556899999999999999999999999999999999876544444445667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      .+++|||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            9999999999999999864 468999999999999999999999999999999999999999999999999987654322


Q ss_pred             --ccccccCCCcccCCccccCCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccC--CCCCCh
Q 022617          172 --FLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTL--PSHLSP  242 (294)
Q Consensus       172 --~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~--~~~~~~  242 (294)
                        ......+++.|+|||++....   ..+.++||||||+++|+|++|..||...+.......+....  ..+  ...++.
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  276 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence              223456899999999986532   23689999999999999999999999888777777765433  223  346899


Q ss_pred             hHHHHHHHhcccCCCC--CCCHhHHhcCCccccc
Q 022617          243 GARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH  274 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~--Rps~~~il~h~~~~~~  274 (294)
                      ++.++|.+||..++.+  |++++++++||||++.
T Consensus       277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            9999999999854443  7899999999999774

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.9e-46  Score=318.91  Aligned_cols=258  Identities=24%  Similarity=0.437  Sum_probs=216.8

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      ..++|++.+.||.|+||.||++.+..++..+++|.+....  .......+.+|++++++++|+||+++++++...+..++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            4689999999999999999999999999999999886542  22345678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      ++||+.+++|.+++.+.+.+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~  159 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  159 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-cc
Confidence            999999999999998888899999999999999999999975 7999999999999999999999999998754332 22


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------------------
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI------------------------  229 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~------------------------  229 (294)
                      ....++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...........+                        
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             ccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            33457889999999987665 78999999999999999999999765443332111                        


Q ss_pred             --------------------hCC-CccCC-CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          230 --------------------KGG-IYTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       230 --------------------~~~-~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                                          ... ....+ ..++.++.+++.+||+.||++|||+.+++.||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  307 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA  307 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence                                000 01111 135778999999999999999999999999999987643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-47  Score=314.53  Aligned_cols=251  Identities=41%  Similarity=0.722  Sum_probs=213.0

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY   98 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   98 (294)
                      |++.+.||+|++|+||++.+..+++.+++|++......... .....+|+.++++++|+||+++++++...+..++++|+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            78999999999999999999999999999999776544322 33445699999999999999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc-cCCCcccccc
Q 022617           99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSC  177 (294)
Q Consensus        99 ~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~-~~~~~~~~~~  177 (294)
                      +.+++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+... ..........
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999988889999999999999999999999999999999999999999999999999998753 3334445667


Q ss_pred             CCCcccCCcccc-CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhCCCccCC----CCCChhHHHHHH
Q 022617          178 GSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLP----SHLSPGARDLIP  249 (294)
Q Consensus       178 ~~~~~~aPE~~~-~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~----~~~~~~l~~li~  249 (294)
                      ++..|+|||.+. +... +.++|+||||+++++|++|..||.......   .............    ...+..+.+++.
T Consensus       160 ~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  238 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIK  238 (260)
T ss_dssp             SSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHH
T ss_pred             ccccccccccccccccc-cccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHH
Confidence            888999999988 4444 899999999999999999999998873322   3322222221111    122489999999


Q ss_pred             HhcccCCCCCCCHhHHhcCCcc
Q 022617          250 RMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       250 ~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      +||+.||++|||+.++++||||
T Consensus       239 ~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  239 KMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.8e-47  Score=328.68  Aligned_cols=254  Identities=32%  Similarity=0.485  Sum_probs=215.0

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-C-----CceeEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-H-----PHIIRLYEVI   86 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~   86 (294)
                      +.+..+|.|++.||+|.||.|.+|.|..+++.||||+++...    ........|+.+|..|+ |     -|+++++++|
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            456679999999999999999999999999999999986443    45677788999999887 3     4899999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC--CCcEEEeeec
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KWNVKIADFG  162 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~--~~~~~l~dfg  162 (294)
                      ...+++|+|+|.++. +|.++++.++  .++...++.++.||+.+|.+||+.||+|+||||+|||+..  ...+|++|||
T Consensus       258 ~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  258 YFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence            999999999999955 9999998774  4889999999999999999999999999999999999975  3479999999


Q ss_pred             ccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--------
Q 022617          163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------  234 (294)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  234 (294)
                      .++.....-.  ....+..|+|||++.+.++ +.+.|||||||++.||++|.+.|.+.+..+.+..|..-..        
T Consensus       337 SSc~~~q~vy--tYiQSRfYRAPEVILGlpY-~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  337 SSCFESQRVY--TYIQSRFYRAPEVILGLPY-DTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             cccccCCcce--eeeeccccccchhhccCCC-CCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9998755443  6677889999999999999 7999999999999999999999977765554443321100        


Q ss_pred             --------------------------------------------cCC-----------CCCChhHHHHHHHhcccCCCCC
Q 022617          235 --------------------------------------------TLP-----------SHLSPGARDLIPRMLIVDPMKR  259 (294)
Q Consensus       235 --------------------------------------------~~~-----------~~~~~~l~~li~~~l~~~p~~R  259 (294)
                                                                  ..|           ..-...+.+|+.+||.+||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                                                        001           0123467899999999999999


Q ss_pred             CCHhHHhcCCccccc
Q 022617          260 ITIPEIRQHPWFQAH  274 (294)
Q Consensus       260 ps~~~il~h~~~~~~  274 (294)
                      +|+.++|+||||+..
T Consensus       494 ~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGT  508 (586)
T ss_pred             CCHHHHhcCcccccc
Confidence            999999999999843

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-46  Score=332.41  Aligned_cols=253  Identities=29%  Similarity=0.419  Sum_probs=207.0

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----   89 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   89 (294)
                      ..++|++.+.||.|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+++++++...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3457999999999999999999999899999999874332       2345799999999999999998876331     


Q ss_pred             ---CeEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeee
Q 022617           90 ---SDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADF  161 (294)
Q Consensus        90 ---~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~df  161 (294)
                         ..++++|||+++ +|.+++..    ...+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               247799999975 88777653    45699999999999999999999999999999999999998664 6999999


Q ss_pred             cccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------
Q 022617          162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------  233 (294)
Q Consensus       162 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------  233 (294)
                      |++.............+++.|+|||++.+....+.++||||||+++|+|++|.+||.+....+....+....        
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            999876554444455678999999998765444789999999999999999999998766544333322100        


Q ss_pred             ---------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          234 ---------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       234 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                                           ..++...+.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                                 012345678999999999999999999999999999998753

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.5e-47  Score=303.61  Aligned_cols=255  Identities=32%  Similarity=0.431  Sum_probs=217.9

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE--cCCeEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TPSDIYV   94 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l   94 (294)
                      ++|..+..|++|.||.||+|+|+.+++-||+|.+..+.-.. -.--.-.+|+.+|.+.+||||+.+-.+..  .-+.+|+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            57999999999999999999999999999999997654221 12234578999999999999999988764  3467999


Q ss_pred             EEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-c
Q 022617           95 VMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F  172 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~  172 (294)
                      |||||+. +|..++.+-+ ++...+++-++.|++.|++|||...|+|||+||+|+|++..|.+|++|||+|+....+. .
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence            9999977 9999998765 79999999999999999999999999999999999999999999999999999887653 3


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc------------------
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------------  234 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------  234 (294)
                      ....+-|..|+|||.+.+.+.++.+.||||+||++.+++++++.|.+....+.+.+|.....                  
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~  313 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK  313 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence            44556799999999999988889999999999999999999999999887776666532110                  


Q ss_pred             -cCC------------C-CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          235 -TLP------------S-HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       235 -~~~------------~-~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                       .++            . .++..-.+|+..+|.+||.+|.|+.+.|+|+||..
T Consensus       314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence             000            1 14467779999999999999999999999999977

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-46  Score=325.72  Aligned_cols=249  Identities=24%  Similarity=0.335  Sum_probs=206.2

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      ..++|++.+.||.|+||.||+|.+..+++.|++|...         ...+.+|++++++++||||+++++++......++
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            4468999999999999999999999999999999642         2346789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC--Cc
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HF  172 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~--~~  172 (294)
                      ++|++. ++|..++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......  ..
T Consensus       161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            999995 589999888788999999999999999999999999999999999999999999999999998643221  22


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHh---------------
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNLFKKIK---------------  230 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-------~~~~~~~~~---------------  230 (294)
                      .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||....       .......+.               
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             cccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            234568999999999987776 789999999999999999998764321       011111100               


Q ss_pred             -----------CCCcc----CC-----CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          231 -----------GGIYT----LP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       231 -----------~~~~~----~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                 .....    .+     ...+.++.++|.+||+.||.+|||+.|+|+||||+..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                       00000    00     1346689999999999999999999999999999874

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.6e-46  Score=323.03  Aligned_cols=259  Identities=31%  Similarity=0.495  Sum_probs=213.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   89 (294)
                      .+.++|++.+.||.|+||.||+|.+..+++.+++|.+..... .......+.+|+.+++.++|+||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            467899999999999999999999998999999999865432 233456778899999999999999999988543    


Q ss_pred             --CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        90 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                        ...++++||+++ +|.+.+..  .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence              357999999976 77777643  5889999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC---------------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---------------  232 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------  232 (294)
                      ..........++..|+|||.+.+..+ +.++||||||+++|+|++|+.||.+.+..+....+...               
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             CCccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            55544455678999999999987766 78999999999999999999999876543332211100               


Q ss_pred             -------Cc--------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          233 -------IY--------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       233 -------~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                             ..                    ..+...+.++.++|.+||+.||++|||+.|+|+||||+.+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence                   00                    0011235678999999999999999999999999999877543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-46  Score=315.68  Aligned_cols=257  Identities=36%  Similarity=0.584  Sum_probs=222.7

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|+||+|.+..+++.+++|.+.............+.+|+++++.++|+||+++++.+...+..++++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999889999999998765554456678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--
Q 022617           97 EYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--  172 (294)
Q Consensus        97 e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--  172 (294)
                      ||+.+++|.+++.+.  ..+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998754  5689999999999999999999999999999999999999999999999998764422111  


Q ss_pred             ----------------------------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022617          173 ----------------------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN  224 (294)
Q Consensus       173 ----------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~  224 (294)
                                                  .....++..|+|||.+.+... +.++||||||+++|+|++|..||...+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                        112246778999999987666 789999999999999999999998877776


Q ss_pred             HHHHHhCCCccCCC--CCChhHHHHHHHhcccCCCCCCC----HhHHhcCCccccc
Q 022617          225 LFKKIKGGIYTLPS--HLSPGARDLIPRMLIVDPMKRIT----IPEIRQHPWFQAH  274 (294)
Q Consensus       225 ~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps----~~~il~h~~~~~~  274 (294)
                      ....+.......+.  ..+..+.+++.+||..+|++||+    ++++++||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            66666554444443  36899999999999999999999    9999999999885

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.6e-46  Score=324.01  Aligned_cols=260  Identities=30%  Similarity=0.495  Sum_probs=214.4

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   89 (294)
                      .+.++|++.+.||+|+||.||+|.+..+++.+++|++.... ........+.+|+.+++.++|+||+++++++...    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            46789999999999999999999999999999999986543 2233456788899999999999999999887543    


Q ss_pred             --CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        90 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                        ...+++|||+++ +|.+.+.  ..++...++.++.|++.||.+||+.||+|+||||+||+++.++.++|+|||++...
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         100 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             ccCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence              457999999975 7887774  35789999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------  233 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  233 (294)
                      ..........++..|+|||++.+..+ +.++||||||+++|+|++|+.||...+..+....+....              
T Consensus       177 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         177 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CCCCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            55444455678899999999988776 789999999999999999999998766544443332110              


Q ss_pred             --------cc--------------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          234 --------YT--------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       234 --------~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                              ..                    .....+..+.++|.+||+.||.+|||+.++|+||||..+....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  328 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS  328 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence                    00                    0011345788999999999999999999999999998754433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.4e-46  Score=311.18  Aligned_cols=256  Identities=28%  Similarity=0.472  Sum_probs=220.0

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      .|+..+.||.|+||+||+|.+..+++.+++|.+.............+.+|+++++.++|++++++.+.+...+..++++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            47888999999999999999999999999999876554444445667889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      |+.+++|.+++...  ..+++..+..++.|++.+|.|||+.||+|+||+|+||+++.++.++|+|||.+...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG  160 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence            99999999888653  3699999999999999999999999999999999999999999999999999876544333344


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhCCCccCCCCCChhHHHHHHHh
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF----KKIKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      ..++..|+|||.+.+..+ +.++|+||+|+++|++++|..||.........    ..+.......+..++.++.+++..|
T Consensus       161 ~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (285)
T cd05632         161 RVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML  239 (285)
T ss_pred             CCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence            568899999999987766 78999999999999999999999876544332    3333334455667889999999999


Q ss_pred             cccCCCCCCC-----HhHHhcCCccccc
Q 022617          252 LIVDPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       252 l~~~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      |+.+|++||+     +.++++|+||+..
T Consensus       240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         240 LTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             ccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            9999999999     8899999999774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-46  Score=318.33  Aligned_cols=257  Identities=30%  Similarity=0.567  Sum_probs=216.3

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||+|+||.||++.+..+++.|++|++...........+.+.+|..+++.++|+||+++++++..++.+++|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999987644444445567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--c
Q 022617           97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L  173 (294)
Q Consensus        97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--~  173 (294)
                      ||+.+++|.+++.+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........  .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999976 45789999999999999999999999999999999999999999999999999865543322  1


Q ss_pred             ccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC---CCCChhH
Q 022617          174 KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGA  244 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---~~~~~~l  244 (294)
                      ....+++.|+|||++..    ....+.++||||+|+++|+|++|+.||......+....+....  ..++   ..++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            22458899999999863    2233678999999999999999999998877766666654322  2222   3478999


Q ss_pred             HHHHHHhcccCCCC--CCCHhHHhcCCcccc
Q 022617          245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA  273 (294)
Q Consensus       245 ~~li~~~l~~~p~~--Rps~~~il~h~~~~~  273 (294)
                      .+++.+||..++++  |+++.++++||||+.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            99999988654443  789999999999976

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-46  Score=303.89  Aligned_cols=257  Identities=30%  Similarity=0.494  Sum_probs=219.8

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCC----
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPS----   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~----   90 (294)
                      ...|..+++||+|.||+||+|+++.+|+.||+|.+..+.-. +-.-....+|+.+++.++|+| |+++++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            56789999999999999999999999999999999766432 123466789999999999999 999999998776    


Q ss_pred             --eEEEEEeccCCCChHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           91 --DIYVVMEYVKSGELFDYIVEKG----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        91 --~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                        .+++++||++. +|..++....    .++...++.++.||+.|++|||+.+|+||||||.||+|+++|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              89999999965 9999997654    4778899999999999999999999999999999999999999999999999


Q ss_pred             ccccCC-CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--c-------
Q 022617          165 NIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--Y-------  234 (294)
Q Consensus       165 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~-------  234 (294)
                      ....-+ ......+.|..|+|||++.+....+...||||+||++.||++++..|.+....+....|-...  +       
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            876633 335666788999999999988777999999999999999999999999888776666552211  0       


Q ss_pred             ---------cCC------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          235 ---------TLP------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       235 ---------~~~------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                               .++            +....+..+++.+||+.+|.+|.|+..+|.||||+..
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence                     000            1223478899999999999999999999999999875

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.2e-46  Score=325.35  Aligned_cols=255  Identities=31%  Similarity=0.549  Sum_probs=213.9

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----eE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----DI   92 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   92 (294)
                      +|++.+.||.|+||.||+|.+..+++.|++|.+.... ........+.+|+.+++.++|+||+++++++..+.     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            5889999999999999999999999999999985432 23334567889999999999999999999998776     78


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++++||+. ++|.+.+.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99999996 4899988877889999999999999999999999999999999999999999999999999987543222 


Q ss_pred             -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC------------------
Q 022617          172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG------------------  232 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------------  232 (294)
                       ......++..|+|||.+.+....+.++||||+|+++|+|++|+.||...+.......+...                  
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence             2223456889999999887654478999999999999999999999877655444333210                  


Q ss_pred             -----C---------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          233 -----I---------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       233 -----~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                           .         .......+.++.++|.+||+.||.+|||+.++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                 0         01223457889999999999999999999999999999873

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-46  Score=310.95  Aligned_cols=253  Identities=30%  Similarity=0.545  Sum_probs=225.3

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||+|.+..+++.+++|++...........+.+.+|++++++++|||++++++.+..+...++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999998999999999976655454567889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccccc
Q 022617           98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC  177 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  177 (294)
                      |+.+++|.+++.+..++++..+..++.|++.+|.+||+.|++|+||+|+||++++++.++|+|||.+.............
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  160 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS  160 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence            99999999999877789999999999999999999999999999999999999999999999999987765544444556


Q ss_pred             CCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhCCCccCCCCCChhHHHHHHHhccc
Q 022617          178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV  254 (294)
Q Consensus       178 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  254 (294)
                      ++..|+|||.+.+... +.++|+||||+++|++++|..||....   ...............+...+..+.++|.+||..
T Consensus       161 ~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (258)
T cd05578         161 GTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER  239 (258)
T ss_pred             CChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccC
Confidence            7889999999887665 789999999999999999999998766   344444444455667778899999999999999


Q ss_pred             CCCCCCCH--hHHhcCCcc
Q 022617          255 DPMKRITI--PEIRQHPWF  271 (294)
Q Consensus       255 ~p~~Rps~--~~il~h~~~  271 (294)
                      ||.+||++  .++++||||
T Consensus       240 ~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         240 DPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ChhHcCCccHHHHhcCCCC
Confidence            99999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-47  Score=318.91  Aligned_cols=263  Identities=44%  Similarity=0.811  Sum_probs=245.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ..+.+=|.+.+.||+|-|+.|-+|++.-+|..|+||++.+...+... -..+.+|+..++.++||||+++|.+......+
T Consensus        14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence            35677899999999999999999999999999999999988776543 46678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe-cCCCcEEEeeecccccccCC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL-DSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili-~~~~~~~l~dfg~~~~~~~~  170 (294)
                      |+|+|.-++|+|.++|-++ ..++++..++++.||+.|+.|+|+..++|+|+||+||.+ ..-|-+||.|||++..+..+
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999999999665 569999999999999999999999999999999999877 55789999999999998888


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHH
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR  250 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (294)
                      ......+|+..|.|||++.+..|..++.||||||+++|.|.+|+.||..-+..+.+..|++.++..|..++.++++||..
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~s  252 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQS  252 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHH
Confidence            88889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCHhHHhcCCcccccCC
Q 022617          251 MLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ||..||++|.+.++|.+++|++..=+
T Consensus       253 MLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  253 MLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHhcCchhhccHHHHhccccccCCCC
Confidence            99999999999999999999998533

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.1e-46  Score=333.15  Aligned_cols=262  Identities=25%  Similarity=0.385  Sum_probs=207.9

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC------CceeEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH------PHIIRLYEVI   86 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~   86 (294)
                      +...++|++.+.||.|+||+||+|.+..+++.||||++....    ........|+++++.++|      .+++++++++
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            345689999999999999999999999899999999985321    223445667777776654      4588888888


Q ss_pred             EcC-CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCC----------
Q 022617           87 ETP-SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKW----------  154 (294)
Q Consensus        87 ~~~-~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~----------  154 (294)
                      ... ..+|++++++ |++|.+++.+.+.+++..++.++.|++.||.|||+ .||+|+||||+||+++.++          
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            654 5789999998 66999999888889999999999999999999997 5999999999999998765          


Q ss_pred             ------cEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022617          155 ------NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK  228 (294)
Q Consensus       155 ------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~  228 (294)
                            .+||+|||.+.....  ......+++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+....
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  499999998754322  2234568999999999988777 7899999999999999999999987665443333


Q ss_pred             HhCCCccCC------------------------------------------CCCChhHHHHHHHhcccCCCCCCCHhHHh
Q 022617          229 IKGGIYTLP------------------------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIR  266 (294)
Q Consensus       229 ~~~~~~~~~------------------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il  266 (294)
                      +......++                                          ......+.+||.+||.+||.+|||+.|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            221110000                                          01134577999999999999999999999


Q ss_pred             cCCcccccCCccccCC
Q 022617          267 QHPWFQAHLPRYLAVP  282 (294)
Q Consensus       267 ~h~~~~~~~~~~~~~~  282 (294)
                      +||||++..+...+.|
T Consensus       437 ~Hp~~~~~~~~~~~~~  452 (467)
T PTZ00284        437 THPYVLKYYPECRQHP  452 (467)
T ss_pred             cCccccccCCccccCC
Confidence            9999999877554433

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.5e-46  Score=306.72  Aligned_cols=249  Identities=36%  Similarity=0.692  Sum_probs=219.8

Q ss_pred             ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617           25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL  104 (294)
Q Consensus        25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL  104 (294)
                      ||.|++|.||+|.+..+++.+++|++...........+.+.+|+.++++++|+|++++++.+..++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            68999999999999988999999999766555545567899999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccC
Q 022617          105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA  184 (294)
Q Consensus       105 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~a  184 (294)
                      .+++.+...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.............++..|++
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  160 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA  160 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence            99998888899999999999999999999999999999999999999999999999999887655433334467889999


Q ss_pred             CccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHh--CCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIK--GGIYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       185 PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      ||.+.+..+ +.++|+|++|+++|++++|..||....  .......+.  ......+...+.++.+++.+||..+|++||
T Consensus       161 PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  239 (262)
T cd05572         161 PEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL  239 (262)
T ss_pred             hhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence            999876665 788999999999999999999998766  555555555  344566667789999999999999999999


Q ss_pred             C-----HhHHhcCCccccc
Q 022617          261 T-----IPEIRQHPWFQAH  274 (294)
Q Consensus       261 s-----~~~il~h~~~~~~  274 (294)
                      +     +.|+++||||++.
T Consensus       240 ~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         240 GNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             CCcccCHHHHhcChhhhCC
Confidence            9     9999999999863

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-47  Score=309.09  Aligned_cols=255  Identities=31%  Similarity=0.476  Sum_probs=218.7

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--C--
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--S--   90 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~--   90 (294)
                      ..=.|...+++|+|+||.||.|....+++.+|||.+-.+..       .-.+|+++++.+.||||+++..+|...  +  
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            34468889999999999999999999999999998754432       335799999999999999999888542  2  


Q ss_pred             -eEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-CcEEEeeeccc
Q 022617           91 -DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLS  164 (294)
Q Consensus        91 -~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~dfg~~  164 (294)
                       ...+|+||++. ||.+.+..    +..++...++-+..||+.||+|||+.||+||||||.|+|++.+ |.+||+|||.|
T Consensus        95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence             46789999965 99999974    4678999999999999999999999999999999999999975 89999999999


Q ss_pred             ccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------
Q 022617          165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----------  233 (294)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  233 (294)
                      .....+....+...+..|+|||.+.+....+.+.||||.||++.||+-|++.|.+.+..+....|.+-.           
T Consensus       174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            999888888888899999999999988877999999999999999999999999887666655542211           


Q ss_pred             -c-----c------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          234 -Y-----T------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       234 -~-----~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                       .     .            +....+++..+|+.++|+++|.+|.++.|++.||||..--..
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence             0     0            224578899999999999999999999999999999775443

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.9e-46  Score=330.13  Aligned_cols=256  Identities=27%  Similarity=0.417  Sum_probs=221.6

Q ss_pred             cccCCcccccccccCceEEEEEEEccC-CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALT-GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ....|.+.+.||.|++|.||+|.+..+ +..+++|.+...   .......+.+|+.+++.++||||+++++++...+..+
T Consensus        65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            344599999999999999999998877 778889876433   3334567788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           94 VVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      ++|||+++++|.+++..    ..++++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999999988753    34689999999999999999999999999999999999999999999999999976543


Q ss_pred             CC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617          170 GH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR  245 (294)
Q Consensus       170 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  245 (294)
                      ..   ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+..+. .+.+..++.++.
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  300 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK  300 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence            32   1234458999999999987766 789999999999999999999999888777777765544 345667899999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ++|.+||..+|++||++.+++.|||++..
T Consensus       301 ~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        301 ALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            99999999999999999999999999643

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-45  Score=330.13  Aligned_cols=265  Identities=28%  Similarity=0.474  Sum_probs=226.7

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      .......++|++.+.||.|+||+||+|.+..+++.||+|++....... .....+.+|+..+..++|+|+++++..+...
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            344566789999999999999999999999999999999987654432 4456788899999999999999998776433


Q ss_pred             C--------eEEEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617           90 S--------DIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK  157 (294)
Q Consensus        90 ~--------~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~  157 (294)
                      .        .+++++||+.+++|.+++...    .++++..++.++.|++.+|.|||+.||+|+||||+||+++.++.++
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence            2        378999999999999998643    4689999999999999999999999999999999999999999999


Q ss_pred             EeeecccccccCC---CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-
Q 022617          158 IADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-  233 (294)
Q Consensus       158 l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-  233 (294)
                      |+|||++......   .......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.......+..+. 
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~  262 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY  262 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            9999998754322   12234568899999999987766 789999999999999999999999888777777665544 


Q ss_pred             ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      .+++..+++++.+++.+||..+|.+||++.++++|||++....
T Consensus       263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~  305 (496)
T PTZ00283        263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS  305 (496)
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence            4567789999999999999999999999999999999876543

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.8e-46  Score=311.48  Aligned_cols=251  Identities=31%  Similarity=0.516  Sum_probs=204.6

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeEEEEEEEc-----C
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIET-----P   89 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~   89 (294)
                      +|++.+.||.|++|+||+|.++.+++.|++|.+....... .....+.+|+.+++.+   +|+||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5899999999999999999999999999999986543221 1223445566666554   79999999998754     3


Q ss_pred             CeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      ...++++|++.+ +|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            458999999975 899988764  34899999999999999999999999999999999999999999999999998766


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------  233 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  233 (294)
                      ..........++..|+|||++.+..+ +.++||||+|+++|+|++|..||......+....+....              
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL  237 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence            54444445567889999999987766 789999999999999999999998766554443332100              


Q ss_pred             -------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          234 -------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       234 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                   ....+.++..+.+++.+||+.||++|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                         00113567788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.2e-45  Score=311.92  Aligned_cols=264  Identities=27%  Similarity=0.494  Sum_probs=218.5

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|.+.+.||.|++|.||+|.+..+++.|++|.+......  .....+.+|+.++++++|+||+++++++..++..+++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            46799999999999999999999989999999998644322  2234667899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      +||+++ +|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence            999975 898888654 568999999999999999999999999999999999999999999999999986543222 22


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------------------c
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y  234 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~  234 (294)
                      ....+++.|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+....+....                   .
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence            234567899999998765545789999999999999999999998776554433321100                   0


Q ss_pred             c-----------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617          235 T-----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP  282 (294)
Q Consensus       235 ~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~  282 (294)
                      .           ....++.++.++|.+||..||.+|||+.++++||||+....+....|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~~~  300 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP  300 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhcCC
Confidence            0           11356788999999999999999999999999999998877666555

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-46  Score=308.90  Aligned_cols=256  Identities=29%  Similarity=0.454  Sum_probs=220.9

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||+|.+..+++.+++|++....  .......+.+|+++++.++|+|++++++++......++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            47999999999999999999999999999999986543  2233567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT  175 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~  175 (294)
                      |++++++|.+++... ++++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999998755 88999999999999999999999999999999999999999999999999987765432 2234


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCC-CChhHHHHHHHhcc
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSH-LSPGARDLIPRMLI  253 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~~~l~~li~~~l~  253 (294)
                      ..++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.... ...+.. ++.++.+++.+||.
T Consensus       158 ~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  236 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN  236 (274)
T ss_pred             ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence            456788999999987775 799999999999999999999998766555555444433 233334 78899999999999


Q ss_pred             cCCCCCCCHhHHhcCCcccccCC
Q 022617          254 VDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      .+|++|||++++++||||++...
T Consensus       237 ~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         237 KDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             CChhhCcCHHHHhhChhhcCCCc
Confidence            99999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.1e-45  Score=304.17  Aligned_cols=253  Identities=30%  Similarity=0.529  Sum_probs=217.3

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccc------hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN------MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      +|.+.+.||.|++|.||+|.+..+++.+++|.+.......      ....+.+.+|+.++++++|+|++++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5889999999999999999998889999999886543322      2234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      .++++||+++++|.+++.+.+.+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999887654211


Q ss_pred             c-------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-CccCCCCCChh
Q 022617          172 F-------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPG  243 (294)
Q Consensus       172 ~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~  243 (294)
                      .       .....++..|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...........+... ....+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE  239 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence            1       112346778999999887766 68899999999999999999999876554444443333 34566778999


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      +.+++.+||+.+|.+||++.++++||||
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         240 AIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.5e-45  Score=315.26  Aligned_cols=258  Identities=29%  Similarity=0.555  Sum_probs=217.7

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||+|+||.||++.++.+++.+++|++.............+.+|+.++..++|++++++++.+...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999986544333344566888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--cc
Q 022617           97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FL  173 (294)
Q Consensus        97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~  173 (294)
                      ||+.+++|.+++.+ ...+++..+..++.|++.|+.+||+.|++|+||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999976 4678999999999999999999999999999999999999999999999999986543222  12


Q ss_pred             ccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC---CCCChhH
Q 022617          174 KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGA  244 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---~~~~~~l  244 (294)
                      ....+++.|+|||++..    ....+.++|+||||+++|+|++|+.||...+.......+....  ...+   ..++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            23468999999999852    2233789999999999999999999999888777777765443  2222   3578999


Q ss_pred             HHHHHHhcccCCCC--CCCHhHHhcCCccccc
Q 022617          245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQAH  274 (294)
Q Consensus       245 ~~li~~~l~~~p~~--Rps~~~il~h~~~~~~  274 (294)
                      .+++.+||..++++  |++++++++||||+..
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            99999999765544  7899999999999863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.2e-45  Score=300.62  Aligned_cols=252  Identities=29%  Similarity=0.555  Sum_probs=216.4

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-CCeEEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-PSDIYVVM   96 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~   96 (294)
                      +|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|++++++++|+|++++++.+.. ....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            589999999999999999999989999999998654432 2345678889999999999999999988764 44689999


Q ss_pred             eccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           97 EYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        97 e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      |++++++|.+++...  ..+++.+++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            999999999999763  458999999999999999999999999999999999999999999999999987654322 22


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCChhHHHHHHHhc
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRML  252 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l  252 (294)
                      ....+++.|+|||.+.+..+ +.++|+||+|++++++++|+.||...+.......+..+.. ..+..++..+.+++.+||
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  238 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML  238 (257)
T ss_pred             ccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence            33456889999999887766 6889999999999999999999988776666655554443 455678999999999999


Q ss_pred             ccCCCCCCCHhHHhcCCcc
Q 022617          253 IVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       253 ~~~p~~Rps~~~il~h~~~  271 (294)
                      +.+|++|||+.++++||||
T Consensus       239 ~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         239 SKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ccCcccCCCHHHHhcCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.7e-45  Score=300.61  Aligned_cols=252  Identities=31%  Similarity=0.507  Sum_probs=220.4

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|.+.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|++++++++|+|++++++++...+..++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            588899999999999999999999999999998765433 3346778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617           98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK  174 (294)
Q Consensus        98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  174 (294)
                      |+.+++|.+++...  ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999999764  568999999999999999999999999999999999999999999999999887654332 223


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~  253 (294)
                      ...+++.|+|||.+.+... +.++|+||||+++++|++|+.||...+.......+.... ...+..++.++.+++.+||+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT  238 (256)
T ss_pred             ccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence            3457788999999987766 789999999999999999999998887777666665544 34445788999999999999


Q ss_pred             cCCCCCCCHhHHhcCCcc
Q 022617          254 VDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~  271 (294)
                      .+|++||++.++++|||+
T Consensus       239 ~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         239 KDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCcccCcCHHHHhhCCCC
Confidence            999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-45  Score=315.26  Aligned_cols=257  Identities=30%  Similarity=0.532  Sum_probs=217.3

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||+|+||.||++.+..+++.|++|++.............+.+|..+++.++|++|+++++++...+..|++|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999987544333344566788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--c
Q 022617           97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L  173 (294)
Q Consensus        97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--~  173 (294)
                      ||+.|++|.+++.+ ...+++..+..++.|++.+|.+||+.||+|+||||+||+++.++.++|+|||++........  .
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999999976 46789999999999999999999999999999999999999999999999999876543322  1


Q ss_pred             ccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC---CCCChhH
Q 022617          174 KTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGA  244 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---~~~~~~l  244 (294)
                      ....+++.|+|||++.+.    ...+.++|+||+|+++|+|++|+.||...+.......+....  .+++   ..++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            234589999999988642    223678999999999999999999998887777666665433  2333   3468899


Q ss_pred             HHHHHHhcccCCCC--CCCHhHHhcCCcccc
Q 022617          245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA  273 (294)
Q Consensus       245 ~~li~~~l~~~p~~--Rps~~~il~h~~~~~  273 (294)
                      .+++.+||..++.+  |++++++++||||+.
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            99999999876554  568999999999976

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.7e-45  Score=307.92  Aligned_cols=256  Identities=34%  Similarity=0.598  Sum_probs=220.6

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||++.+..+++.|++|.+.............+.+|+.+++.++|+||+++++.+..++..++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987654444445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----  171 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-----  171 (294)
                      ||++|++|.+++.+.+.+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+.......     
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999875321100     


Q ss_pred             -----------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC---
Q 022617          172 -----------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP---  237 (294)
Q Consensus       172 -----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---  237 (294)
                                 ......++..|+|||.+..... +.++|+||||+++|++++|..||.+....+....+.......+   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD  239 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence                       0012245778999999877665 7899999999999999999999998887777777665543322   


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCC---HhHHhcCCcccc
Q 022617          238 SHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQA  273 (294)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~  273 (294)
                      ..++.++.+++.+||+.+|++||+   +.++++||||..
T Consensus       240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            257899999999999999999998   789999999954

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-45  Score=305.65  Aligned_cols=256  Identities=31%  Similarity=0.445  Sum_probs=219.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||.|++|.||++.+..++..+++|++...   .....+.+.+|++++++++|+|++++++.+..+...+++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            35799999999999999999999888999999998543   334456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      +||+++++|.+++.+. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence            9999999999998764 569999999999999999999999999999999999999999999999999876543322 22


Q ss_pred             ccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCChhHHH
Q 022617          174 KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARD  246 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~  246 (294)
                      ....++..|+|||.+..    ....+.++|+||||+++|+|++|..||...........+.....   ..+..++.++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND  240 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence            33457888999998752    22236789999999999999999999988776666666655432   234578899999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ++.+||..+|++||++.++++||||.+.
T Consensus       241 li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         241 FLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHhccChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.9e-45  Score=306.48  Aligned_cols=254  Identities=27%  Similarity=0.481  Sum_probs=212.1

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||+|.++.+++.+++|++...... ....+.+.+|+.++++++|+|++++++++...+..++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            4799999999999999999999989999999998644321 123456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT  175 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~  175 (294)
                      ||+++++|..++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            999998888887666779999999999999999999999999999999999999999999999999987654433 2223


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------------c
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------Y  234 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~  234 (294)
                      ..++..|+|||.+.+....+.++|+||+|+++|+|++|..||.+....+....+....                     .
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            4567889999998765444789999999999999999999998766544333221100                     0


Q ss_pred             c----------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 T----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 ~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      +          ....++..+.+++.+||+.+|++||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0          012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.2e-45  Score=307.44  Aligned_cols=254  Identities=25%  Similarity=0.471  Sum_probs=214.2

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||++.+..++..+++|.+....  .......+.+|++++++++||||+++++++..++..++++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999999999999999886432  2234567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      ||+++++|.+++.+.+.+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~  157 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANS  157 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-ccc
Confidence            999999999999888889999999999999999999997 589999999999999999999999999886543322 234


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC----------------------
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------------------  233 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------  233 (294)
                      ..++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+....                      
T Consensus       158 ~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (308)
T cd06615         158 FVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP  236 (308)
T ss_pred             CCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence            457889999999877665 789999999999999999999997654433332221110                      


Q ss_pred             ---------------ccCC-CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 ---------------YTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 ---------------~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                     ...+ ..++.++.+++.+||..+|++|||+.++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                           0111 1367789999999999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.3e-45  Score=304.97  Aligned_cols=249  Identities=36%  Similarity=0.569  Sum_probs=213.8

Q ss_pred             ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617           25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL  104 (294)
Q Consensus        25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL  104 (294)
                      ||.|+||+||+|.+..+++.|++|++.............+..|++++++++|||++++++.+...+..|+++||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999998765444334456667899999999999999999999999999999999999999


Q ss_pred             HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcc
Q 022617          105 FDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY  182 (294)
Q Consensus       105 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  182 (294)
                      .+++.+..  .+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.............++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99997765  6899999999999999999999999999999999999999999999999998766544444445677899


Q ss_pred             cCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCC
Q 022617          183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK  258 (294)
Q Consensus       183 ~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  258 (294)
                      +|||.+.+..+ +.++|+||||+++++|++|+.||.....    ......+.......+..++..+.+++.+||+.+|.+
T Consensus       161 ~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  239 (277)
T cd05577         161 MAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK  239 (277)
T ss_pred             CCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence            99999877665 7899999999999999999999976543    333333334445566778999999999999999999


Q ss_pred             CC-----CHhHHhcCCccccc
Q 022617          259 RI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       259 Rp-----s~~~il~h~~~~~~  274 (294)
                      ||     ++.++++||||++.
T Consensus       240 R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         240 RLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             ccCCCcccHHHHHhChhhhcC
Confidence            99     88889999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.4e-45  Score=305.94  Aligned_cols=261  Identities=31%  Similarity=0.519  Sum_probs=222.2

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      .......+|++.+.||.|++|.||++.+..+++.+++|.+.....   ...+.+.+|+.+++.++|+|++++++++...+
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            344455789999999999999999999999999999999865432   23567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ..++++||+.+++|.+++.+ ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            99999999999999998864 46899999999999999999999999999999999999999999999999987754332


Q ss_pred             C-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHH
Q 022617          171 H-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARD  246 (294)
Q Consensus       171 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~  246 (294)
                      . ......++..|+|||.+.+... +.++|+||||+++|++++|..||...+.......+....   ...+..++..+.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD  247 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence            2 1223457789999999887666 789999999999999999999998876655444443222   2345678899999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      +|.+||..+|++||++.++++||||+...+
T Consensus       248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         248 FLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-44  Score=299.88  Aligned_cols=252  Identities=27%  Similarity=0.462  Sum_probs=214.4

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeeccccc---chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      +|++.+.||.|+||.||+|.+. +++.+++|.+......   .......+.+|++++++++|+|++++++++...+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5899999999999999999874 7888999988654321   22334678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC----
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----  170 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~----  170 (294)
                      ++||+.+++|.+++.+..++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......    
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            9999999999999988788999999999999999999999999999999999999999999999999988654211    


Q ss_pred             ---CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC---CccCCCCCChhH
Q 022617          171 ---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGA  244 (294)
Q Consensus       171 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  244 (294)
                         .......++..|+|||.+.+..+ +.++|+||||+++|++++|..||...+.......+...   ....+..++.++
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence               11223457888999999987766 78999999999999999999999876554433333322   234566789999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      .+++.+||..+|++||++.++++||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-45  Score=314.64  Aligned_cols=257  Identities=27%  Similarity=0.475  Sum_probs=210.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   89 (294)
                      .+.++|++.+.||.|+||+||+|.+..+++.|++|.+..... .......+.+|+.++++++|+||+++++++...    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            467899999999999999999999999999999999865422 223345677899999999999999999887532    


Q ss_pred             --CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        90 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                        ...+++++++ +++|.+++. ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence              4578999998 669988875 457999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------  233 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  233 (294)
                      ...  .....++..|+|||++.+....+.++||||||+++|+|++|..||...+.......+....              
T Consensus       169 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             CCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            432  2344678899999998775444789999999999999999999998765544333321100              


Q ss_pred             ---------cc--------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          234 ---------YT--------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       234 ---------~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                               ..        .....++.+.+++.+||..||.+|||+.++++||||....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                     00        0123566788999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-44  Score=298.77  Aligned_cols=254  Identities=31%  Similarity=0.496  Sum_probs=219.5

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      +|+..+.||.|++|.||+|.+..++..+++|.+......  ..+....+.+|+.+++.++|+|++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            588899999999999999999888999999998654322  234567889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      +||+++++|.+++.+..++++..+..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999876654443445


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC--CCccCCCCCChhHHHHHHHhcc
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~  253 (294)
                      ..++..|++||.+......+.++|+||||+++|++++|..||...........+..  .....+..++..+.+++.+||+
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence            56788899999987655237899999999999999999999977664444444333  2344556788999999999999


Q ss_pred             cCCCCCCCHhHHhcCCcc
Q 022617          254 VDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~  271 (294)
                      .+|++||++.+++.|||+
T Consensus       241 ~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         241 RDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCcccCcCHHHHhcCCCC
Confidence            999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-44  Score=298.14  Aligned_cols=252  Identities=34%  Similarity=0.597  Sum_probs=220.0

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+....... .....+.+|++++++++|+|++++++.+...+..++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            6899999999999999999999999999999987654433 346788999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeecccccccCCCccc
Q 022617           98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLK  174 (294)
Q Consensus        98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~  174 (294)
                      ++++++|.+++...  ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++ .++|+|||.+..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            99999999999764  3589999999999999999999999999999999999998654 57999999998765544444


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~  253 (294)
                      ...++..|+|||.+.+... +.++|+||+|+++|+|++|..||...+.......+.... .+.+..++.++.+++.+||.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  238 (256)
T cd08220         160 TVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN  238 (256)
T ss_pred             ccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHcc
Confidence            5567889999999987665 789999999999999999999998877666665554433 44566789999999999999


Q ss_pred             cCCCCCCCHhHHhcCCcc
Q 022617          254 VDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~  271 (294)
                      .+|++|||+.+++.||||
T Consensus       239 ~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         239 LDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CChhhCCCHHHHhhCCCC
Confidence            999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4e-45  Score=303.06  Aligned_cols=255  Identities=31%  Similarity=0.519  Sum_probs=217.6

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||++.++.+++.+++|.+.....  ......+.+|+++++++.|+|++++++.+...+..++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            478999999999999999999998999999999865432  244577889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc
Q 022617           97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  174 (294)
                      |++++++|.+++... .++++..++.++.|++.++++||+ .|++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-  157 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-  157 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence            999989999999876 789999999999999999999999 99999999999999999999999999988765332222 


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhCC-CccCCCC-CChhHHHH
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-----NIPNLFKKIKGG-IYTLPSH-LSPGARDL  247 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~-~~~~~~~-~~~~l~~l  247 (294)
                      ...++..|+|||.+.+..+ +.++|+||||+++|++++|..||...     ......+.+... ....+.. ++.++.++
T Consensus       158 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF  236 (265)
T ss_pred             cccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence            2567789999999887765 78999999999999999999999654     223333333332 2333344 78899999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      |.+||..+|++|||+.+++.||||+...
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         237 VNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            9999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=299.73  Aligned_cols=260  Identities=37%  Similarity=0.618  Sum_probs=242.9

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      .+-.++|..+++||.|.||.|-+++.+.+++.||+|++.++-+..++....-..|-.+|+..+||.+..+-..|+..+++
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            35678999999999999999999999999999999999988777777777778899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc-cCCC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~-~~~~  171 (294)
                      |+||||.+||.|.-.+++..-++++..+.+...|+.||.|||+.+|+++|+|.+|.+++.+|++||.|||++... ..+.
T Consensus       244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence            999999999999999998888999999999999999999999999999999999999999999999999998643 4455


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      .....+|||.|.|||++....+ +.+.|+|.+|++||+|++|++||.+.+...+.+.|.-....+|..++++.+.++..+
T Consensus       324 t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGL  402 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGL  402 (516)
T ss_pred             eeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHH
Confidence            6678899999999999999888 899999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCC-----HhHHhcCCcccc
Q 022617          252 LIVDPMKRIT-----IPEIRQHPWFQA  273 (294)
Q Consensus       252 l~~~p~~Rps-----~~~il~h~~~~~  273 (294)
                      |.+||.+|.-     +.||.+|+||..
T Consensus       403 L~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  403 LKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             hhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            9999999974     889999999954

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.1e-44  Score=302.02  Aligned_cols=258  Identities=27%  Similarity=0.394  Sum_probs=216.5

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      ..+.|++.+.||.|++|.||+|.+..+++.+++|.+...   .......+.+|+.+++.++|+|++++++.+..++..++
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            346799999999999999999999999999999998543   33446778889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Cc
Q 022617           95 VMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HF  172 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~  172 (294)
                      +|||+++++|..++.+ ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            9999999999887754 456899999999999999999999999999999999999999999999999987654322 22


Q ss_pred             cccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCChhHH
Q 022617          173 LKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGAR  245 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  245 (294)
                      .....++..|+|||.+.+.    ...+.++|+||||+++|+|++|..||...........+.....   ..+..++.++.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence            2344577899999987522    2226789999999999999999999977665554444443322   23456788999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      +++.+||..+|++||+++++++||||....
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            999999999999999999999999997643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-44  Score=304.01  Aligned_cols=270  Identities=30%  Similarity=0.472  Sum_probs=225.1

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      ..+.....+|++.+.||.|++|.||++.+..+++.+++|.+......   ....+.+|+.+++.+.|+|++++++.+...
T Consensus        13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~   89 (296)
T cd06654          13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVG   89 (296)
T ss_pred             cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence            34556678999999999999999999999989999999998654432   346788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      ...++++||+++++|.+++.+ ..++..++..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            999999999999999999854 5689999999999999999999999999999999999999999999999998875432


Q ss_pred             CC-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHH
Q 022617          170 GH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGAR  245 (294)
Q Consensus       170 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~  245 (294)
                      .. ......+++.|+|||.+.+... +.++|+||+|+++|+|++|..||................   ...+..++..+.
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  247 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR  247 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHH
Confidence            22 1223457889999999887665 789999999999999999999998766544333222221   223456888999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDT  286 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~  286 (294)
                      +++.+||..+|++||++.++++||||...  +.....+|-+
T Consensus       248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~--~~~~~~~~~~  286 (296)
T cd06654         248 DFLNRCLDMDVEKRGSAKELLQHQFLKIA--KPLSSLTPLI  286 (296)
T ss_pred             HHHHHHCcCCcccCcCHHHHhhChhhhcc--CCccccHHHH
Confidence            99999999999999999999999999875  3344555544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.6e-44  Score=299.74  Aligned_cols=253  Identities=30%  Similarity=0.490  Sum_probs=215.6

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|+||+|.+..++..+++|++.......  ....+.+|++.++.++|+|++++++.+...+..++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999998889999999986543322  5678999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           97 EYVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        97 e~~~~~sL~~~l~~~---~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      |++.+++|.+++.+.   ..+++..++.++.|++.|+.+||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   35899999999999999999999999999999999999999999999999998765443222


Q ss_pred             -----ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCC-----CCCCh
Q 022617          174 -----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLP-----SHLSP  242 (294)
Q Consensus       174 -----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~-----~~~~~  242 (294)
                           ....++..|+|||.+......+.++|+||||+++|+|++|+.||...+............. ..+     ..++.
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence                 2335778999999987664447899999999999999999999987665544444333221 111     25678


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      .+.+++.+||..||++|||+.++++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.2e-45  Score=301.73  Aligned_cols=254  Identities=31%  Similarity=0.559  Sum_probs=214.3

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeeccccc---chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      +|+..+.||.|++|.||++.+..+++.+++|++......   .....+.+.+|++++++++|+|++++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            588999999999999999999999999999998644321   12345788999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeecccccccCCC--
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH--  171 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~~~~~~--  171 (294)
                      ++||+.+++|.+++.+.+++++..++.++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+.......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998775 59999999987654321  


Q ss_pred             ---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----hCCCccCCCCCChh
Q 022617          172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-----KGGIYTLPSHLSPG  243 (294)
Q Consensus       172 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~  243 (294)
                         ......++..|+|||.+.+..+ +.++|+||||++++++++|..||...........+     .......+..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence               1123356789999999876655 78999999999999999999999654432222211     12234455678899


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                      +.+++.+||..+|++||++.++++||||+
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.6e-44  Score=295.95  Aligned_cols=252  Identities=32%  Similarity=0.525  Sum_probs=220.7

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||.+.+..+++.+++|.+....... .....+.+|++++++++|+|++++++++...+..++++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            6899999999999999999999999999999987654333 345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617           98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK  174 (294)
Q Consensus        98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  174 (294)
                      |+++++|.+++.+.  ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999999765  458999999999999999999999999999999999999999999999999987654333 223


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCChhHHHHHHHhcc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~  253 (294)
                      ...+++.|.|||.+.+... +.++|+||||+++|+|++|..||......+....+..+.. ..+..++.++.+++.+||.
T Consensus       160 ~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ  238 (256)
T ss_pred             ccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence            4457889999999887665 6889999999999999999999988777777666655443 3345678999999999999


Q ss_pred             cCCCCCCCHhHHhcCCcc
Q 022617          254 VDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~  271 (294)
                      .+|++||++.++++|||+
T Consensus       239 ~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         239 QDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cCcccCCCHHHHhhCcCC
Confidence            999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.8e-45  Score=335.46  Aligned_cols=269  Identities=26%  Similarity=0.444  Sum_probs=221.8

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      .....+...++|.+++.||.|+||+||+|.+..++..+++|++....... .....+..|+.++++++||||++++++|.
T Consensus         4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~   82 (1021)
T PTZ00266          4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFL   82 (1021)
T ss_pred             cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            34456777889999999999999999999999999999999987654333 34567889999999999999999999885


Q ss_pred             c--CCeEEEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCCeEecC--
Q 022617           88 T--PSDIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRN-------MVVHRDLKPENLLLDS--  152 (294)
Q Consensus        88 ~--~~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~-------~i~h~di~p~nili~~--  152 (294)
                      .  ...+|+||||+.+++|.++|...    ..+++..++.++.||+.||.|||+.       +|+|+||||+|||++.  
T Consensus        83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            4  46799999999999999998652    5699999999999999999999985       4999999999999964  


Q ss_pred             ---------------CCcEEEeeecccccccCCCccccccCCCcccCCccccCC-ccCCCchhHHHHHHHHHHHHhCCCC
Q 022617          153 ---------------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLP  216 (294)
Q Consensus       153 ---------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p  216 (294)
                                     .+.++|+|||++.............+++.|+|||++.+. ...+.++|||||||++|+|++|..|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                           234899999999766544444455689999999998643 2237899999999999999999999


Q ss_pred             CCCCC-HHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          217 FDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       217 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      |.... ...+...+..........++.++.+||..||..+|.+||++.++|.|||++...+.
T Consensus       243 F~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        243 FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             CCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            97544 34444444443322234678999999999999999999999999999999876554

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.5e-44  Score=298.62  Aligned_cols=254  Identities=33%  Similarity=0.549  Sum_probs=212.4

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--CCeE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDI   92 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   92 (294)
                      .+|++.+.||.|++|.||+|.+..++..+++|.+......  .......+.+|+.++++++|+|++++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3799999999999999999999999999999998654322  22345678899999999999999999998865  4678


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++++||+++++|.+++.+.+.+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            8999999999999999887889999999999999999999999999999999999999999999999999986543211 


Q ss_pred             ---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCCCCCChhHHH
Q 022617          172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD  246 (294)
Q Consensus       172 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~  246 (294)
                         ......++..|+|||.+.+..+ +.++|+||+|+++|++++|+.||...............  ...++..++..+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD  240 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence               1122346778999999887665 78999999999999999999999876554444433322  23445667888999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCccc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                      ++ +||..+|++||+++++++||||+
T Consensus       241 li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhcCcccc
Confidence            98 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-44  Score=302.88  Aligned_cols=252  Identities=30%  Similarity=0.512  Sum_probs=207.7

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||+|.+..+++.|++|.+...... ......+.+|+.++++++|+|++++++++..++..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            589999999999999999999989999999998654322 2334677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           98 YVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        98 ~~~~~sL~~~l~~~---~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      |+.+ +|.+++...   ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            9974 888888643   468999999999999999999999999999999999999999999999999987543222 12


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC---------------------
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---------------------  232 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------------  232 (294)
                      ....+++.|+|||.+.+....+.++|+||||+++|+|++|+.||...........+...                     
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            23356788999999876554478899999999999999999999765543222111000                     


Q ss_pred             --------CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          233 --------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       233 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                              .......++.++.++|.+||..||.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                    001123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.9e-44  Score=299.98  Aligned_cols=256  Identities=28%  Similarity=0.423  Sum_probs=215.6

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      -|++.+.||.|++|.||++.+..++..+++|.+....   ......+.+|+++++.++|+|++++++++...+..++++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            4789999999999999999999899999999985432   2345678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccccc
Q 022617           98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKT  175 (294)
Q Consensus        98 ~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~  175 (294)
                      |+++++|..++.+ ..++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence            9999999988754 467899999999999999999999999999999999999999999999999998654322 12234


Q ss_pred             ccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHHHH
Q 022617          176 SCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLI  248 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li  248 (294)
                      ..++..|+|||.+..    ....+.++|+||+|+++|+|++|..||...+.......+....   ...+..++.++.+++
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL  242 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence            457889999998742    2222678999999999999999999998766655555544332   233556889999999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      .+||+.+|++||++.++++||||+..-.
T Consensus       243 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         243 KKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            9999999999999999999999987533

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-44  Score=299.85  Aligned_cols=251  Identities=26%  Similarity=0.386  Sum_probs=210.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++....   ......+.+|+.+++.++|||++++++.+...+..+++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            358999999999999999999999899999999986542   22345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  174 (294)
                      +||+++++|.+++...+.+++..++.++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999986543222 223


Q ss_pred             cccCCCcccCCcccc---CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-----CCCCCChhHHH
Q 022617          175 TSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----LPSHLSPGARD  246 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~  246 (294)
                      ...++..|+|||.+.   ...+ +.++|+||||+++|+|++|..||..................     ....++..+.+
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH  243 (267)
T ss_pred             cccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence            345788999999874   2333 67999999999999999999998655433322222222211     11246788999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPW  270 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~  270 (294)
                      ++.+||+.+|++|||+.++++|||
T Consensus       244 li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         244 FVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-44  Score=297.27  Aligned_cols=250  Identities=32%  Similarity=0.509  Sum_probs=215.3

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||.|++|.||+|.+..++..+++|.+....     ....+.+|++++++++|+|++++++++......+++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence            468999999999999999999998888999999985432     157889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      +|++.+++|.+++.. ...+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR  156 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence            999999999999975 4568999999999999999999999999999999999999999999999999987665433 22


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHHHHHH
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPR  250 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~  250 (294)
                      ....++..|+|||.+.+... +.++|+||+|+++|+|++|+.||...........+....   ...+..++.++.+++.+
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK  235 (256)
T ss_pred             ccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence            33446789999999887766 789999999999999999999998765544433332221   22334678899999999


Q ss_pred             hcccCCCCCCCHhHHhcCCcc
Q 022617          251 MLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~h~~~  271 (294)
                      ||+.+|++|||+.+++.||||
T Consensus       236 ~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         236 CLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-44  Score=297.95  Aligned_cols=251  Identities=30%  Similarity=0.451  Sum_probs=215.0

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++.....   ...+.+.+|++++++++|+|++++++++...+..+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            3689999999999999999999988899999999865432   2467889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      +||+++++|.+++... .++++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  158 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR  158 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence            9999999999999776 789999999999999999999999999999999999999999999999999987654322 22


Q ss_pred             ccccCCCcccCCccccCC---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-----cCCCCCChhHH
Q 022617          174 KTSCGSPNYAAPEVISGK---LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHLSPGAR  245 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~  245 (294)
                      ....++..|+|||.+...   .. +.++|+||+|+++|+|++|..||...........+.....     ..+..++.++.
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH  237 (262)
T ss_pred             ccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence            334567789999998655   45 6889999999999999999999987665554444433311     12234577899


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPW  270 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~  270 (294)
                      +++.+||..+|.+|||+.+++.|+|
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.8e-44  Score=308.15  Aligned_cols=253  Identities=22%  Similarity=0.354  Sum_probs=204.0

Q ss_pred             cccccccc--CceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617           21 LGKTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY   98 (294)
Q Consensus        21 ~~~~lg~g--~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   98 (294)
                      ++++||+|  ++++||++.++.+++.|++|.+...... ......+.+|+.+++.++||||+++++++..++..++++||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            57889999  6789999999999999999998655432 23456788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617           99 VKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----  171 (294)
Q Consensus        99 ~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-----  171 (294)
                      +.+++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++||+.........     
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999999653  458999999999999999999999999999999999999999999999997543221110     


Q ss_pred             ---ccccccCCCcccCCccccCC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-------------
Q 022617          172 ---FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------  234 (294)
Q Consensus       172 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------  234 (294)
                         ......++..|+|||++.+. ...+.++||||||+++|+|++|..||..............+..             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence               11122356679999998753 2237899999999999999999999976544332222211110             


Q ss_pred             ---------------------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          235 ---------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       235 ---------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                                       +....+++.+.+++.+||+.||++|||+.++++||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                             0112346789999999999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3e-44  Score=296.43  Aligned_cols=252  Identities=29%  Similarity=0.558  Sum_probs=219.2

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.+|.+.+..+++.+++|.+....... .....+.+|+.++++++|+|++++++++...+..++++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            6899999999999999999999999999999987554332 335678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc-c
Q 022617           98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-K  174 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~  174 (294)
                      |+.+++|.+.+....  .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+......... .
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            999999999987543  5789999999999999999999999999999999999999999999999998765433221 2


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~  253 (294)
                      ...++..|+|||.+.+... +.++|+||+|++++++++|..||......+....+..+. ...+..++.++.++|.+||+
T Consensus       160 ~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (256)
T cd08218         160 TCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK  238 (256)
T ss_pred             hccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence            3346778999999887765 689999999999999999999998877777666655444 34566789999999999999


Q ss_pred             cCCCCCCCHhHHhcCCcc
Q 022617          254 VDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~  271 (294)
                      .+|++||++.++++||||
T Consensus       239 ~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         239 RNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CChhhCcCHHHHhhCcCC
Confidence            999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.1e-44  Score=301.44  Aligned_cols=240  Identities=18%  Similarity=0.263  Sum_probs=207.9

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----CCeEEEEEec
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSDIYVVMEY   98 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~   98 (294)
                      ..|+.|+++.||+|.+  +|+.|++|.+...........+.+.+|+.++++++||||+++++++.+    ....++++||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6789999999999987  688999999976655454556778899999999999999999999866    4578999999


Q ss_pred             cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccCCCcccccc
Q 022617           99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC  177 (294)
Q Consensus        99 ~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  177 (294)
                      +++++|.+++.+.+.++......++.+++.++.+||+. +++|+||+|+||++++++.++|+|||++.......  ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~  181 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNV  181 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--cccc
Confidence            99999999998888899999999999999999999984 89999999999999999999999999987543322  2345


Q ss_pred             CCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCCCCCChhHHHHHHHhcc
Q 022617          178 GSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       178 ~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~  253 (294)
                      ++..|+|||.+.+  ..+ +.++||||||+++|+|++|..||...+..+....+...  ....+..++.++.+++.+||+
T Consensus       182 ~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~  260 (283)
T PHA02988        182 NFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS  260 (283)
T ss_pred             CcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence            7789999999875  344 78999999999999999999999988877777766432  345555789999999999999


Q ss_pred             cCCCCCCCHhHHhc
Q 022617          254 VDPMKRITIPEIRQ  267 (294)
Q Consensus       254 ~~p~~Rps~~~il~  267 (294)
                      .||++|||+.++++
T Consensus       261 ~dp~~Rps~~ell~  274 (283)
T PHA02988        261 HDSIKRPNIKEILY  274 (283)
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999999986

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-44  Score=301.75  Aligned_cols=253  Identities=32%  Similarity=0.564  Sum_probs=212.9

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||+|.+..+++.+++|++....... .....+.+|+.++++++|+|++++++++...+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            5899999999999999999999899999999987654322 345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--ccc
Q 022617           98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK  174 (294)
Q Consensus        98 ~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~  174 (294)
                      |+ +++|.+++.. ..++++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......  ...
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 8899999865 4568999999999999999999999999999999999999999999999999987664432  133


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------------
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------  233 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  233 (294)
                      ...++..|+|||.+.+....+.++||||+|+++++|++|..+|...........+....                     
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            44578899999998765555789999999999999999988887665444333322110                     


Q ss_pred             ---------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617          234 ---------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                               .......+..+.+++.+||+.+|.+|||++++++||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                     001134678899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.7e-44  Score=304.50  Aligned_cols=257  Identities=33%  Similarity=0.498  Sum_probs=213.9

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      +|++.+.||.|++|.||+|.+..+++.|++|.+......  .......+..|++++++++|+|++++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588999999999999999999989999999999765433  123456677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      +||+ +++|.+++.+.. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 789999997765 79999999999999999999999999999999999999999999999999987654432 22


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------------
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------------  233 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------  233 (294)
                      ....++..|+|||.+.+....+.++|+||||+++++|++|..+|......+....+....                    
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            233456789999998665444789999999999999999988887665544333332110                    


Q ss_pred             ---c-----cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          234 ---Y-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       234 ---~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                         .     ......+..+.++|.+||+.+|++|||+.++++||||++.-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence               0     01134567899999999999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.6e-44  Score=311.57  Aligned_cols=259  Identities=32%  Similarity=0.535  Sum_probs=213.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   89 (294)
                      .+.++|++.+.||.|++|.||+|.+..+++.+++|++..... .......+.+|+.++++++|+|++++++++...    
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence            467899999999999999999999999999999999854322 223456677899999999999999999988543    


Q ss_pred             --CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        90 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                        ...++++||+.+ +|.+.+...  ++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          92 EFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             ccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence              357999999965 888887544  899999999999999999999999999999999999999999999999999766


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------  233 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  233 (294)
                      ..........++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+....              
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            54443344557889999999987776 789999999999999999999997665433322221100              


Q ss_pred             --------c--------------cC-------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          234 --------Y--------------TL-------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       234 --------~--------------~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                              .              ..       +...+..+.++|.+||+.||++|||+.++|.||||+.|+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~  320 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP  320 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence                    0              00       11345678999999999999999999999999999987664

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4e-44  Score=296.79  Aligned_cols=252  Identities=34%  Similarity=0.603  Sum_probs=219.6

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--CCeEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYVV   95 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv   95 (294)
                      +|++.+.||.|++|.||+|.+..++..+++|++...... ....+.+.+|++++++++|+|++++++++..  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            588999999999999999999999999999998655433 3345678899999999999999999998753  4568999


Q ss_pred             EeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCH-----RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh-----~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      +||+++++|.+++.+    ..++++..++.++.|++.++.+||     +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999975    357899999999999999999999     88999999999999999999999999999887


Q ss_pred             ccCCCc-cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCChhH
Q 022617          167 MRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGA  244 (294)
Q Consensus       167 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l  244 (294)
                      ...... .....++..|+|||.+.+... +.++|+||||+++++|++|..||...+.....+.+..... ..+..++..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL  238 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence            654433 334567889999999887665 7889999999999999999999998877777777766553 4566889999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      .+++.+||+.+|++||++.+|++|||+
T Consensus       239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         239 NEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-44  Score=315.35  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=210.0

Q ss_pred             cccccCCcccccccccCceEEEEEEEc--cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ..+..+|.+++.||.|++|.||+|...  .++..+++|.+...        ....+|+.++++++|+||+++++++....
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            345668999999999999999999754  34577999987432        23467999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ..++++|++. ++|.+++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus       160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9999999996 589999977788999999999999999999999999999999999999999999999999998765433


Q ss_pred             Cc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh----CCC-------
Q 022617          171 HF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKKIK----GGI-------  233 (294)
Q Consensus       171 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~----~~~-------  233 (294)
                      ..   .....++..|+|||.+.+..+ +.++||||||+++|+|++|+.||.+....   .....+.    ...       
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            22   123468999999999987776 78999999999999999999999654321   1111110    000       


Q ss_pred             ------------------ccCC-----CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617          234 ------------------YTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP  282 (294)
Q Consensus       234 ------------------~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~  282 (294)
                                        ...+     ..++.++.++|.+||..||++|||+.++|.||||++.=+..++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~~~~  389 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLLNIT  389 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhhcCc
Confidence                              0011     234668889999999999999999999999999987544444433

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-44  Score=304.90  Aligned_cols=266  Identities=30%  Similarity=0.484  Sum_probs=222.3

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      .......+|++.+.||.|++|.||++.+..+++.|++|.+......   ..+.+.+|+.+++.++|+|++++++++...+
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3456678999999999999999999999889999999998654322   3466788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ..++++||+++++|.+++.+ ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999999999999854 56899999999999999999999999999999999999999999999999988654332


Q ss_pred             C-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-C--ccCCCCCChhHHH
Q 022617          171 H-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-I--YTLPSHLSPGARD  246 (294)
Q Consensus       171 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~  246 (294)
                      . ......+++.|+|||.+.+..+ +.++|+||||+++|++++|..||...+.......+... .  ...+..++..+.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (297)
T cd06656         169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD  247 (297)
T ss_pred             ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence            2 1223457788999999987666 78999999999999999999999765543322222211 1  1234567889999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcccccCCccccC
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAV  281 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~  281 (294)
                      ++.+||..+|++||++.++++||||+...+.+...
T Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~  282 (297)
T cd06656         248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLT  282 (297)
T ss_pred             HHHHHccCChhhCcCHHHHhcCchhcccccccccC
Confidence            99999999999999999999999998765555433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.3e-44  Score=299.79  Aligned_cols=249  Identities=37%  Similarity=0.645  Sum_probs=219.8

Q ss_pred             ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617           25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL  104 (294)
Q Consensus        25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL  104 (294)
                      ||.|++|.||++.+..+++.+++|++.............+.+|++++++++|+|++++++.+...+..++++|++.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999988999999998766554445677899999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---------cccc
Q 022617          105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---------FLKT  175 (294)
Q Consensus       105 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---------~~~~  175 (294)
                      .+++.+.+.+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.......         ....
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            9999887889999999999999999999999999999999999999999999999999887543321         1223


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCC--ChhHHHHHHHhcc
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL--SPGARDLIPRMLI  253 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~li~~~l~  253 (294)
                      ..++..|++||....... +.++|+||||++++++++|..||...........+.......+...  +..+.+++.+||+
T Consensus       161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  239 (265)
T cd05579         161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV  239 (265)
T ss_pred             cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence            456778999999877665 7899999999999999999999998888887777776665555555  8999999999999


Q ss_pred             cCCCCCCCH---hHHhcCCccccc
Q 022617          254 VDPMKRITI---PEIRQHPWFQAH  274 (294)
Q Consensus       254 ~~p~~Rps~---~~il~h~~~~~~  274 (294)
                      .+|++|||+   .++++||||++.
T Consensus       240 ~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         240 PDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             CCHhhcCCCccHHHHhcCccccCC
Confidence            999999999   999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.2e-44  Score=299.13  Aligned_cols=253  Identities=24%  Similarity=0.343  Sum_probs=211.4

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      ..++|++.+.||+|++|.||+|.+..+++.+++|++.....   .....+.+|+.++++++|+|++++++++...+..++
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence            35689999999999999999999998999999999864422   234567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      ++||+++++|.+++..+.++++..+..++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR  163 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999987653322 22


Q ss_pred             ccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-----CCCCCChhHHH
Q 022617          174 KTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----LPSHLSPGARD  246 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~  246 (294)
                      ....++..|+|||.+..  ....+.++|+||+|+++|+|++|..||...........+......     ....++..+.+
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN  243 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence            33457789999998742  222367899999999999999999999765443333222222211     12346789999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPW  270 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~  270 (294)
                      ++.+||..+|++|||+++|++|+|
T Consensus       244 li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         244 FVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.1e-45  Score=306.12  Aligned_cols=252  Identities=29%  Similarity=0.535  Sum_probs=207.0

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||+|.+..+|+.+++|.+...... ......+.+|+.++++++|+|++++++++...+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            589999999999999999999999999999998654322 2234567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617           98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT  175 (294)
Q Consensus        98 ~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~  175 (294)
                      |+++ +|.+++.+ .+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            9975 88887765 5679999999999999999999999999999999999999999999999999987543322 2223


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhCCC--------------------c
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGI--------------------Y  234 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~~~~--------------------~  234 (294)
                      ..++..|+|||.+.+....+.++|+||||+++|+|++|..|+. +.+.......+....                    .
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            4567899999998776555789999999999999999888854 333333322221100                    0


Q ss_pred             ---------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 ---------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                               ...+.++.++.+++.+||+.||.+|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                     0113467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-44  Score=302.37  Aligned_cols=257  Identities=28%  Similarity=0.455  Sum_probs=220.2

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ...|+..+.||.|++|.||.|.+..++..+++|++.....  ......+.+|+.+++++.|+|++++++++..++..+++
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            4578899999999999999999998899999999864432  23457888999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-cc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~  174 (294)
                      +||+++++|.+++.. .++++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+........ ..
T Consensus        81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence            999999999999864 5789999999999999999999999999999999999999999999999999866543321 22


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHHhcc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  253 (294)
                      ...++..|+|||.+.+... +.++|+||||+++|+|++|..||...........+... ....+..++..+.+++.+||.
T Consensus       160 ~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN  238 (277)
T ss_pred             cccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence            3356778999999877665 78999999999999999999999877666555544333 233445678899999999999


Q ss_pred             cCCCCCCCHhHHhcCCcccccCC
Q 022617          254 VDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      .+|++||++.++++||||...-.
T Consensus       239 ~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         239 KDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             cCcccCcCHHHHHhChHhhhcch
Confidence            99999999999999999977643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.9e-44  Score=296.85  Aligned_cols=255  Identities=34%  Similarity=0.562  Sum_probs=221.8

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      .+|.+.+.||.|++|.||+|.+..+++.+++|.+......  .....+.+|+..+++++|+|++++++++...+..++++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            4689999999999999999999999999999998655422  44678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc-c
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-K  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~  174 (294)
                      ||+++++|.+++.+..++++..++.++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999999999999887889999999999999999999999 99999999999999999999999999998766443332 2


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhCCC-ccCCCC-CChhHHHHHH
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGI-YTLPSH-LSPGARDLIP  249 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~-~~~~~~-~~~~l~~li~  249 (294)
                      ...++..|+|||.+.+... +.++|+||||+++|+|++|..||...   ........+.... ...+.. ++..+.+++.
T Consensus       159 ~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  237 (264)
T cd06623         159 TFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS  237 (264)
T ss_pred             ceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence            4457789999999877755 78999999999999999999999776   4445555544333 344455 8899999999


Q ss_pred             HhcccCCCCCCCHhHHhcCCccccc
Q 022617          250 RMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       250 ~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +||..+|++||++.++++||||+..
T Consensus       238 ~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         238 ACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHccCChhhCCCHHHHHhCHHHHhc
Confidence            9999999999999999999999763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.8e-45  Score=303.62  Aligned_cols=254  Identities=36%  Similarity=0.698  Sum_probs=225.6

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ++|.+.+.||.|++|.||+|.+..+++.+++|++.............+.+|.++++++. |+||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999987655444455678889999999999 99999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc---
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---  172 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~---  172 (294)
                      ||++.+++|.+++.+.+.+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999875543221   


Q ss_pred             ------------------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc
Q 022617          173 ------------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY  234 (294)
Q Consensus       173 ------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~  234 (294)
                                        .....++..|+|||....... +.++|+||||++++++++|..||.........+.+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  239 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY  239 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence                              122346788999999877655 7899999999999999999999988776666667666677


Q ss_pred             cCCCCCChhHHHHHHHhcccCCCCCCCH----hHHhcCCcc
Q 022617          235 TLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWF  271 (294)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~----~~il~h~~~  271 (294)
                      ..+..++..+.+++.+||+.+|++||++    +++++||||
T Consensus       240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            7788899999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.5e-44  Score=299.05  Aligned_cols=250  Identities=30%  Similarity=0.464  Sum_probs=205.2

Q ss_pred             cccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHH---HhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617           24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL---RLFMHPHIIRLYEVIETPSDIYVVMEYVK  100 (294)
Q Consensus        24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  100 (294)
                      .||+|+||.||++.+..+++.+++|++...............++..++   ....|++++.+++++...+..+++|||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999989999999998765443322223334444433   34479999999999999999999999999


Q ss_pred             CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCC
Q 022617          101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP  180 (294)
Q Consensus       101 ~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  180 (294)
                      +++|.+++..++.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....... .....++.
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  159 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence            99999999888889999999999999999999999999999999999999999999999999986543322 22345788


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM  257 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  257 (294)
                      .|+|||.+......+.++|+||+|+++|+|++|..||....   ..............++..++.++.+++.+||..||.
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  239 (279)
T cd05633         160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS  239 (279)
T ss_pred             CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHH
Confidence            99999998654434789999999999999999999997543   222222223334456678899999999999999999


Q ss_pred             CCC-----CHhHHhcCCccccc
Q 022617          258 KRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       258 ~Rp-----s~~~il~h~~~~~~  274 (294)
                      +||     |+.++++||||+..
T Consensus       240 ~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         240 KRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             HhcCCCCCCHHHHHhCccccCC
Confidence            999     69999999999884

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.4e-44  Score=297.81  Aligned_cols=250  Identities=28%  Similarity=0.455  Sum_probs=209.5

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||+|.+..+++.+++|++....  .......+.+|++++++++|||++++++++...+..++++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            46889999999999999999999999999999986542  2234567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS  176 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  176 (294)
                      ||+++++|..+    ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~  153 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY  153 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence            99999988654    35788999999999999999999999999999999999999999999999998765332 22345


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhCCC-ccC-CCCCChhHHHH
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-------PNLFKKIKGGI-YTL-PSHLSPGARDL  247 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~~~-~~~-~~~~~~~l~~l  247 (294)
                      .++..|+|||.+.+..+ +.++|+||||+++|+|++|..||.....       ......+.... ... ....+.++.++
T Consensus       154 ~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         154 VGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence            67889999999987766 7899999999999999999999965321       12222222221 111 23578899999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +.+||..+|++||+++++++||||+..
T Consensus       233 i~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhcCcccccc
Confidence            999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-44  Score=311.89  Aligned_cols=247  Identities=28%  Similarity=0.414  Sum_probs=199.8

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ..+|++.+.||.|++|.||+|.+..+++.|++|+....         ....|+.++++++|+||+++++++......+++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            34799999999999999999999989999999985322         234688999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc
Q 022617           96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  174 (294)
                      +|++.+ +|.+++.+ ...+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+..........
T Consensus       136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  214 (357)
T PHA03209        136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL  214 (357)
T ss_pred             EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence            999965 88888765 4679999999999999999999999999999999999999999999999999987544333334


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCC-CCCCCH----------HHHHHHHhCC---CccCC---
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDENI----------PNLFKKIKGG---IYTLP---  237 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-~~~~~~----------~~~~~~~~~~---~~~~~---  237 (294)
                      ...++..|+|||++.+..+ +.++||||||+++|+|+++..+ |.....          ..+...+...   ...++   
T Consensus       215 ~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  293 (357)
T PHA03209        215 GLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP  293 (357)
T ss_pred             cccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence            4568899999999988776 7899999999999999985444 432211          0111111100   00000   


Q ss_pred             ---------------------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          238 ---------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       238 ---------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                                                 ..++.++.++|.+||+.||.+|||+.|+|+||||++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                       134667778999999999999999999999999986

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-46  Score=307.58  Aligned_cols=260  Identities=31%  Similarity=0.513  Sum_probs=239.7

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      +-.+.|+..++||.||||.||-++.+.+|+-||+|...+..+..+........|..+|.+++.+.|+.+-..|++.+.+|
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            44578899999999999999999999999999999998888888888888999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           94 VVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +|+..|+||+|.-+|.+.+  -+++..+..++.+|+.+|.+||+.+|++||+||+|||+++.|+++|+|+|+|..+....
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999999999998765  69999999999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhCCCccCCCCCChhHHHH
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGARDL  247 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (294)
                      .....+||.+|||||++.+..| +...|+|+|||++|+|+.|+.||....    .+++-+.+......++...+++.+++
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl  420 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL  420 (591)
T ss_pred             ccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence            8888899999999999999987 899999999999999999999997644    34555566677778888999999999


Q ss_pred             HHHhcccCCCCCCC-----HhHHhcCCccccc
Q 022617          248 IPRMLIVDPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       248 i~~~l~~~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      .+.+|.+||.+|.-     +.++.+||||++.
T Consensus       421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            99999999999986     5689999999874

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-44  Score=303.40  Aligned_cols=254  Identities=29%  Similarity=0.473  Sum_probs=211.6

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+....... ...+.+.+|+++++.++|+|++++++++...+..++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47999999999999999999998889999999986543222 34567888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT  175 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~  175 (294)
                      ||+++++|..+......+++..++.++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            999998888887666679999999999999999999999999999999999999999999999999987653322 2223


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-------------------Cc--
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-------------------IY--  234 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~--  234 (294)
                      ..++..|+|||.+.+....+.++|+||||+++|+|++|+.||......+....+...                   ..  
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            456788999999876554478899999999999999999999765543322221110                   00  


Q ss_pred             ----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 ----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                ...+.++..+.+++.+||..+|++||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                      0123568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1e-43  Score=294.82  Aligned_cols=254  Identities=33%  Similarity=0.568  Sum_probs=212.7

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI--KNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI   92 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   92 (294)
                      .+|++.+.||.|++|.||.+.+..++..|++|.+.....  ........+.+|+.+++++.|+|++++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999999999999998864321  1223457888999999999999999999988663  568


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++++||+++++|.+++.+...+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            8999999999999999887888999999999999999999999999999999999999999999999999887543211 


Q ss_pred             ---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCCCCCChhHHH
Q 022617          172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD  246 (294)
Q Consensus       172 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~  246 (294)
                         ......++..|+|||.+.+... +.++|+||||+++|+|++|+.||...............  ....+...+..+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence               1122346788999999877665 78999999999999999999999876544444443322  23345567888999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCccc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                      ++.+|+. +|++||+++++++|||++
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9999995 899999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3e-44  Score=308.25  Aligned_cols=249  Identities=28%  Similarity=0.470  Sum_probs=202.9

Q ss_pred             ccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP   89 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   89 (294)
                      .++|++.+.||.|+||.||+|.+.     .++..|++|++....  .......+.+|+.+++++ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            468999999999999999999752     345679999986432  223356788999999999 899999999988764


Q ss_pred             -CeEEEEEeccCCCChHHHHHHh---------------------------------------------------------
Q 022617           90 -SDIYVVMEYVKSGELFDYIVEK---------------------------------------------------------  111 (294)
Q Consensus        90 -~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------------------  111 (294)
                       ..++++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4589999999999999998642                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---ccccccCCCccc
Q 022617          112 -----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYA  183 (294)
Q Consensus       112 -----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~  183 (294)
                           .++++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......   ......++..|+
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence                 237778889999999999999999999999999999999999999999999987543221   112233467899


Q ss_pred             CCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHhCC-CccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617          184 APEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       184 aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp  260 (294)
                      |||++.+..+ +.++||||||+++|+|++ |..||...... .....+..+ ....+..++..+.+++.+||+.||++||
T Consensus       244 aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  322 (338)
T cd05102         244 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP  322 (338)
T ss_pred             CcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence            9999987766 789999999999999997 99999875433 333333333 3445667899999999999999999999


Q ss_pred             CHhHHhc
Q 022617          261 TIPEIRQ  267 (294)
Q Consensus       261 s~~~il~  267 (294)
                      |+.++++
T Consensus       323 s~~el~~  329 (338)
T cd05102         323 TFSALVE  329 (338)
T ss_pred             CHHHHHH
Confidence            9999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-43  Score=297.89  Aligned_cols=259  Identities=26%  Similarity=0.442  Sum_probs=214.0

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET   88 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   88 (294)
                      ..+....++|.+.+.||.|++|.||++.+..+++.+++|++....    .....+.+|+.+++++ +|+|++++++++..
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344556889999999999999999999999999999999985432    2245677889999988 79999999999864


Q ss_pred             C-----CeEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEe
Q 022617           89 P-----SDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA  159 (294)
Q Consensus        89 ~-----~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~  159 (294)
                      .     +..++++||+++++|.+++..    ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence            3     358999999999999998853    3568999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCCC-ccccccCCCcccCCccccCCc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc
Q 022617          160 DFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY  234 (294)
Q Consensus       160 dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~  234 (294)
                      |||.+....... ......++..|+|||.+....    ..+.++|+||||+++|+|++|+.||...........+.....
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  250 (291)
T cd06639         171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP  250 (291)
T ss_pred             ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence            999987654322 223345778899999875432    126889999999999999999999987765544444433321


Q ss_pred             ---cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617          235 ---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       235 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                         ..+...+..+.++|.+||+.+|++||++.+|++||||+
T Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence               23445778899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.7e-44  Score=301.05  Aligned_cols=254  Identities=33%  Similarity=0.481  Sum_probs=211.0

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIY   93 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   93 (294)
                      .++|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.++++++|||++++++++...  +..+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            35899999999999999999999989999999998755433 22334567899999999999999999998777  8999


Q ss_pred             EEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-C
Q 022617           94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-H  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~  171 (294)
                      +++||+++ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            99999975 9999887643 5899999999999999999999999999999999999999999999999988766543 2


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------------------
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------  233 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  233 (294)
                      ......++..|+|||.+.+....+.++|+||+|+++|+|++|..||...........+....                  
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            22334567889999998765545789999999999999999999998766554443322110                  


Q ss_pred             -------------ccCCCC-CChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          234 -------------YTLPSH-LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       234 -------------~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                   ..++.. ++..+.++|.+||+.+|++|||+.|++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                         011122 47889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.7e-44  Score=296.56  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=210.6

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC---
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP---   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~---   89 (294)
                      ...+.|++.+.||.|++|.||+|.+..+++.+++|++....    .....+.+|+.+++++ +|+|++++++++...   
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            45678999999999999999999999999999999986442    2245778899999988 699999999998642   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           90 ---SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        90 ---~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                         ...++++||+++++|.+++...  ..+++..+..++.|++.+++|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence               4689999999999999999763  35899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC-CccccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC
Q 022617          165 NIMRDG-HFLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP  237 (294)
Q Consensus       165 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~  237 (294)
                      ...... .......++..|+|||.+...    ...+.++|+||+|+++|+|++|..||................  ...+
T Consensus       159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06637         159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  238 (272)
T ss_pred             eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence            765332 122344578899999998532    223678999999999999999999997665544444333222  1223


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      ..++..+.+++.+||..+|.+|||+.++++||||
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            4678899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.5e-43  Score=292.20  Aligned_cols=252  Identities=36%  Similarity=0.579  Sum_probs=220.4

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIYVV   95 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv   95 (294)
                      +|++.+.||.|++|.||+|.+..+++.+++|++...... ....+.+.+|++++++++|+|++++++.+...  +..+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999989999999998655432 34568889999999999999999999999888  889999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc---
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---  172 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~---  172 (294)
                      +|++++++|.+++.+...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99999999999998877899999999999999999999999999999999999999999999999999887765543   


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHh--CCCccCCCCCChhHHHHHH
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIK--GGIYTLPSHLSPGARDLIP  249 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~--~~~~~~~~~~~~~l~~li~  249 (294)
                      .....++..|+|||.+..... +.++|+||||++++++++|..||.... .......+.  ......+...+..+.+++.
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  238 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR  238 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence            345567889999999877665 789999999999999999999998765 233333333  2334566778999999999


Q ss_pred             HhcccCCCCCCCHhHHhcCCcc
Q 022617          250 RMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       250 ~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      +||..+|++||++.++++||||
T Consensus       239 ~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         239 KCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.4e-44  Score=299.65  Aligned_cols=258  Identities=28%  Similarity=0.467  Sum_probs=215.9

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||++.+..++..+++|.+....  .......+.+|++++++++|+|++++++.+..++..++++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47999999999999999999999899999999885432  2233567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           97 EYVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        97 e~~~~~sL~~~l~~~---~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ||+++++|..++...   ..+++..+..++.|++.++.|||+ .|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~  157 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-L  157 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-c
Confidence            999999999988653   378999999999999999999997 59999999999999999999999999998755332 2


Q ss_pred             cccccCCCcccCCccccCCcc-----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhC-CCccCCCCCChh
Q 022617          173 LKTSCGSPNYAAPEVISGKLY-----AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK---IKG-GIYTLPSHLSPG  243 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~---~~~-~~~~~~~~~~~~  243 (294)
                      .....++..|+|||.+.+...     .+.++|+||||+++|+|++|..||...........   +.. .....+..++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD  237 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence            233456778999998854332     26789999999999999999999976544433332   222 234556678999


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      +.+++.+||..+|++||++.++++||||...-..
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             HHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            9999999999999999999999999999876433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-43  Score=293.63  Aligned_cols=253  Identities=31%  Similarity=0.569  Sum_probs=215.0

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||++.+..+++.+++|++...... ......+.+|++++++++|+||+++++.+...+..++++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            689999999999999999999889999999998765433 3567889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc----
Q 022617           98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----  173 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~----  173 (294)
                      |+.+++|.+++.+...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.........    
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            9999999999988777899999999999999999999999999999999999999999999999998766443321    


Q ss_pred             -ccccCCCcccCCccccCCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhC-CCccCCC--CCChhHHH
Q 022617          174 -KTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKG-GIYTLPS--HLSPGARD  246 (294)
Q Consensus       174 -~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~--~~~~~l~~  246 (294)
                       ....++..|+|||.+.+..  ..+.++|+||+|++++++++|..||.... .......+.. .....+.  .++..+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence             1245678999999987654  23788999999999999999999997653 2222222222 2233343  34889999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      ++.+||+.+|++|||+.+++.|||+
T Consensus       240 li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-43  Score=292.14  Aligned_cols=252  Identities=34%  Similarity=0.611  Sum_probs=221.6

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||++.+..+++.+++|++...... ......+.+|+++++.++|+|++++.+.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            589999999999999999999988999999998765432 2446778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-c
Q 022617           98 YVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F  172 (294)
Q Consensus        98 ~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~  172 (294)
                      ++++++|.+++.+.    ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999999764    679999999999999999999999999999999999999999999999999987665443 2


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHHh
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~  251 (294)
                      .....+++.|+|||.+.+... +.++|+||+|+++++|++|..||............... ...++..++..+.+++.+|
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL  238 (258)
T ss_pred             ecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            333457888999999877765 78899999999999999999999887776666665544 3455668899999999999


Q ss_pred             cccCCCCCCCHhHHhcCCcc
Q 022617          252 LIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h~~~  271 (294)
                      |..+|++|||+.++|+||||
T Consensus       239 l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         239 LQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             cCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.6e-44  Score=295.11  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=211.8

Q ss_pred             ccCCcccccccccCceEEEEEEEc---cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ..+|++.+.||+|+||.||+|.++   ..+..+++|.+....  .......+.+|+..+++++|||++++++++...+..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            467999999999999999999865   345689999986542  223346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +++|||+++++|.+++... ..+++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999999764 578999999999999999999999999999999999999999999999999876542222


Q ss_pred             ccc--cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617          172 FLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL  247 (294)
Q Consensus       172 ~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  247 (294)
                      ...  ...++..|+|||.+.+..+ +.++||||||+++|++++ |..||......+..+.+..+. .+.+..++..+.++
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL  240 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence            111  2223568999999887766 789999999999999875 999999888887777776553 45667889999999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+||+.+|++||++.+|++
T Consensus       241 i~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         241 MLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=293.52  Aligned_cols=249  Identities=35%  Similarity=0.576  Sum_probs=209.5

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      +.||.|++|.||+|.+..+++.+++|++.............+..|..+ ....+|+|++++++++...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            578999999999999998999999999865543332333344445444 3455899999999999999999999999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCc
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN  181 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  181 (294)
                      ++|.+++.+.+++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....   .....++..
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~  158 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD  158 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence            99999998888899999999999999999999999999999999999999999999999998875433   223356788


Q ss_pred             ccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc----CCCCCChhHHHHHHHhcccCCC
Q 022617          182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGARDLIPRMLIVDPM  257 (294)
Q Consensus       182 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~  257 (294)
                      |+|||.+.+..+ +.++|+||||+++|++++|..||...+.......+......    ....++.++.+++.+||+.+|+
T Consensus       159 y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  237 (260)
T cd05611         159 YLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA  237 (260)
T ss_pred             ccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence            999999887664 78999999999999999999999888777776666544332    2336789999999999999999


Q ss_pred             CCCC---HhHHhcCCcccccC
Q 022617          258 KRIT---IPEIRQHPWFQAHL  275 (294)
Q Consensus       258 ~Rps---~~~il~h~~~~~~~  275 (294)
                      +||+   ++|+++||||++..
T Consensus       238 ~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         238 KRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HccCCCcHHHHHcChHhhcCC
Confidence            9994   57999999998743

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.7e-45  Score=311.13  Aligned_cols=266  Identities=47%  Similarity=0.839  Sum_probs=250.5

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ....-.+.|.+.+.||+|.|++|.++++..++..|++|.+.++..... ....+.+|+++++.++||||++++.+.+...
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            456677899999999999999999999999999999999988765553 4455999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .+|+||||+.++.+++++.+++...+..+..++.|++.|++|+|+++|+|+|||++||+++.+-+++|+|||++..+...
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999988


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHH
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR  250 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (294)
                      ......++++.|.|||.+.+..+.+++.|+||+|+++|-|+.|.+||++.....+......+++.++-.++.++.++|++
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk  288 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK  288 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence            88889999999999999999999999999999999999999999999999999999999999999988999999999999


Q ss_pred             hcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          251 MLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      +|-.+|.+|++.++|.+|.|....++.
T Consensus       289 ~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  289 FLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             hhccCccccCCHHHhhhhcccchhhhh
Confidence            999999999999999999999776554

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.3e-43  Score=296.18  Aligned_cols=251  Identities=30%  Similarity=0.484  Sum_probs=208.9

Q ss_pred             cccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHH---HHHHHhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617           24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRRE---IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK  100 (294)
Q Consensus        24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  100 (294)
                      .||.|++|.||+|.+..+++.|++|.+................|   ...++...|++++++++++...+..++++||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999998999999999876543322222223333   344555679999999999999999999999999


Q ss_pred             CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCC
Q 022617          101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP  180 (294)
Q Consensus       101 ~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  180 (294)
                      |++|.+++.+.+.+++..++.++.|++.++.|||+.+++|+||+|+||+++.++.++|+|||++....... .....++.
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~  159 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence            99999999888889999999999999999999999999999999999999999999999999987543322 23446788


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM  257 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  257 (294)
                      .|+|||.+.+....+.++|+||+|+++|+|++|..||...   ................+..++.++.+++.+||..+|.
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  239 (278)
T cd05606         160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN  239 (278)
T ss_pred             CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence            9999999875543478899999999999999999999765   3344444444445566777899999999999999999


Q ss_pred             CCC-----CHhHHhcCCcccccC
Q 022617          258 KRI-----TIPEIRQHPWFQAHL  275 (294)
Q Consensus       258 ~Rp-----s~~~il~h~~~~~~~  275 (294)
                      +||     ++.++++||||+...
T Consensus       240 ~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         240 RRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             hccCCCCCCHHHHHhCccccCCC
Confidence            999     999999999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-43  Score=297.42  Aligned_cols=251  Identities=26%  Similarity=0.422  Sum_probs=214.6

Q ss_pred             cccCCcccccccccCceEEEEEEEccCC-----ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      -.++|++.+.||.|++|.||+|.+...+     ..+++|.+....  .......+.+|+.++++++|+|++++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            3468999999999999999999876554     679999875432  234456788999999999999999999999988


Q ss_pred             CeEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC
Q 022617           90 SDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK  153 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~  153 (294)
                      +..++++||+.+++|.+++...                ..+++..++.++.|++.||.+||+.|++|+||+|+||+++++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            9999999999999999999764                457888999999999999999999999999999999999999


Q ss_pred             CcEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022617          154 WNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI  229 (294)
Q Consensus       154 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~  229 (294)
                      +.++|+|||++.......   ......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+....+....+
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999987543322   1223345678999999877766 789999999999999998 99999988888877777


Q ss_pred             hCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          230 KGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       230 ~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .... ...+..++.++.+++.+||+.+|.+||++.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6544 45567899999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6e-44  Score=299.57  Aligned_cols=254  Identities=31%  Similarity=0.538  Sum_probs=212.3

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||+|.+..+++.|++|++..... .....+.+.+|++++++++|+|++++++++...+..++++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            479999999999999999999998999999999865432 2234578899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--ccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~  174 (294)
                      ||++++.+..+..+...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            999987676666666679999999999999999999999999999999999999999999999999987665443  223


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------------
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------  233 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  233 (294)
                      ...++..|+|||.+.+....+.++|+||||+++|+|++|..||......+....+....                     
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            34567889999999877344789999999999999999999997655443322221100                     


Q ss_pred             -----------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          234 -----------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       234 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                 ...+..++.++.++|.+||..+|++|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                       01123358889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.6e-44  Score=314.06  Aligned_cols=249  Identities=24%  Similarity=0.413  Sum_probs=202.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ....+|.+.+.||.|++|.||+|.+..+++.|++|....         ..+.+|+.++++++|+||+++++++...+..+
T Consensus       166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            346689999999999999999999999999999996321         23567999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++++++. ++|.+++... ..+++..++.++.|++.+|.|||+.||+|+||||+||+++.++.++|+|||++....... 
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            9999996 5888888654 469999999999999999999999999999999999999999999999999987653321 


Q ss_pred             --ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHhCCCc---cCC-
Q 022617          172 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE--------NIPNLFKKIKGGIY---TLP-  237 (294)
Q Consensus       172 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~--------~~~~~~~~~~~~~~---~~~-  237 (294)
                        ......++..|+|||++.+..+ +.++||||||+++|+|++|..++...        ....+.+.+.....   .++ 
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence              1123458999999999988776 78999999999999999876554221        11222222221110   000 


Q ss_pred             ------------------------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          238 ------------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       238 ------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                                                    ...+.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                          124557899999999999999999999999999975

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-43  Score=294.58  Aligned_cols=254  Identities=30%  Similarity=0.487  Sum_probs=211.8

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccc-------hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-------MEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      +|.+.+.||.|++|.||+|.+..+++.+++|.+.......       ....+.+.+|++++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5889999999999999999998899999999886432211       113456888999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ..++++||+.+++|.+++.+.+.+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998754322


Q ss_pred             C---ccccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCC----CCC
Q 022617          171 H---FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLP----SHL  240 (294)
Q Consensus       171 ~---~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~----~~~  240 (294)
                      .   ......++..|+|||.+.... ..+.++|+||||+++|++++|..||...........+...  ....+    ..+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence            1   122334678899999987654 2378899999999999999999999765544333332211  11222    356


Q ss_pred             ChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      +.++.+++.+||..+|++|||+.++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.4e-44  Score=296.89  Aligned_cols=254  Identities=28%  Similarity=0.460  Sum_probs=218.1

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      .-|++.+.||.|++|.||+|.+..++..+++|++.....  ......+.+|+.++++++|+|++++++++......++++
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            458889999999999999999988999999998754332  234567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT  175 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~  175 (294)
                      ||+++++|.+++.+ ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence            99999999999854 568999999999999999999999999999999999999999999999999886553322 1223


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhccc
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIV  254 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~  254 (294)
                      ..++..|+|||.+.+... +.++|+||||+++|++++|..||...........+.... ...+..++.++.+++.+||..
T Consensus       161 ~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (277)
T cd06641         161 FVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK  239 (277)
T ss_pred             ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence            356778999999877655 688999999999999999999998776666555554433 335567889999999999999


Q ss_pred             CCCCCCCHhHHhcCCccccc
Q 022617          255 DPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       255 ~p~~Rps~~~il~h~~~~~~  274 (294)
                      +|++||++.++++||||...
T Consensus       240 ~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         240 EPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ChhhCcCHHHHHhCHHHhhh
Confidence            99999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-43  Score=297.45  Aligned_cols=261  Identities=28%  Similarity=0.432  Sum_probs=213.5

Q ss_pred             CCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEE
Q 022617            7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEV   85 (294)
Q Consensus         7 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~   85 (294)
                      ..-+......++|++.+.||.|++|.||+|.+..+++.+++|++....    .....+..|+.+++++ +|+|+++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~   83 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGM   83 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence            344566778899999999999999999999999999999999875432    1235677899999999 69999999998


Q ss_pred             EE-----cCCeEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcE
Q 022617           86 IE-----TPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV  156 (294)
Q Consensus        86 ~~-----~~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~  156 (294)
                      +.     ..+..++++||+++++|.+++..    ...+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence            73     34578999999999999998753    3468899999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccCCC-ccccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC
Q 022617          157 KIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG  231 (294)
Q Consensus       157 ~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~  231 (294)
                      +|+|||.+....... ......++..|+|||.+...    ...+.++|+||+|+++|+|++|..||..............
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~  243 (286)
T cd06638         164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR  243 (286)
T ss_pred             EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence            999999987654322 22344578899999987532    2236789999999999999999999987655443333322


Q ss_pred             CC---ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          232 GI---YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       232 ~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      ..   ...+..++..+.+++.+||+.+|++|||+.++++|+||
T Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            22   12344567899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.7e-43  Score=297.55  Aligned_cols=258  Identities=28%  Similarity=0.359  Sum_probs=217.1

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      .....+|++.+.||.|++|+||+|.+..+++.|++|++.............+.+|+++++.++|||++++++++...+..
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~   90 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA   90 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence            45567899999999999999999999989999999998655444445567788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++++||+.| ++.+++.. ..++++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            999999975 77777654 457899999999999999999999999999999999999999999999999988654322 


Q ss_pred             ccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccC-CCCCChhHHHH
Q 022617          172 FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTL-PSHLSPGARDL  247 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~l~~l  247 (294)
                        ....++..|+|||.+.+  ....+.++|+||+|+++|+|++|..||...+.......+.... ... +..++..+.++
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF  246 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence              23356778999998742  2223689999999999999999999998877655554444322 222 23568899999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +.+||..+|++||++.+++.||||...
T Consensus       247 i~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         247 VDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HHHHhcCChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.8e-44  Score=301.64  Aligned_cols=258  Identities=29%  Similarity=0.459  Sum_probs=211.9

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI   92 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   92 (294)
                      -.++|++.+.||.|++|.||+|.+..+++.|++|++....... .......+|+.++++++|+|++++++++...  +..
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            3578999999999999999999999999999999986543222 2233456799999999999999999998654  568


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++++||+.+ +|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999965 89888865 3678999999999999999999999999999999999999999999999999987654332


Q ss_pred             -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------------
Q 022617          172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----------------  233 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  233 (294)
                       .......+..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....+....                 
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence             22233456789999998765545789999999999999999999998877666555443210                 


Q ss_pred             --ccCC-----------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 --YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 --~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                        ...+           ...+.++.++|.+||..||++|||+.+++.||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence              0000           1257788999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=291.59  Aligned_cols=246  Identities=42%  Similarity=0.718  Sum_probs=221.1

Q ss_pred             ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617           25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL  104 (294)
Q Consensus        25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL  104 (294)
                      ||.|++|.||++.+..+++.+++|++.............+..|+.++++++|+|++++++.+..++..++++|++.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            68999999999999888999999998776555555677889999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-CccccccCCCccc
Q 022617          105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYA  183 (294)
Q Consensus       105 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~  183 (294)
                      .+++.+...+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+...... .......++..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            999988878999999999999999999999999999999999999999999999999998766443 2233445778999


Q ss_pred             CCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCH-
Q 022617          184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-  262 (294)
Q Consensus       184 aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-  262 (294)
                      |||...+... +.++|+|+||+++|++++|..||...+.......+.......+...+..+.+++.+||..||++||++ 
T Consensus       161 ~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~  239 (250)
T cd05123         161 APEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG  239 (250)
T ss_pred             ChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence            9999877665 78899999999999999999999888777777777777777888889999999999999999999999 


Q ss_pred             --hHHhcCCcc
Q 022617          263 --PEIRQHPWF  271 (294)
Q Consensus       263 --~~il~h~~~  271 (294)
                        +++++||||
T Consensus       240 ~~~~l~~~~~f  250 (250)
T cd05123         240 GAEEIKAHPFF  250 (250)
T ss_pred             cHHHHHhCCCC
Confidence              999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=295.64  Aligned_cols=255  Identities=27%  Similarity=0.501  Sum_probs=215.7

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCeEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l   94 (294)
                      .|++.+.||.|++|.||+|.+..++..+++|++....  .......+.+|+.+++++.   |+|++++++++......++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            5889999999999999999999899999999986442  2233567888999999987   9999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-c
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-L  173 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  173 (294)
                      ++||+++++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            9999999999999865 5789999999999999999999999999999999999999999999999999876544322 2


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCC-CCChhHHHHHHHh
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPS-HLSPGARDLIPRM  251 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~  251 (294)
                      ....++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+.... ...+. .++.++.+++.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC  238 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence            334577889999998765555789999999999999999999998776555444433332 22222 3788999999999


Q ss_pred             cccCCCCCCCHhHHhcCCcccccC
Q 022617          252 LIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      |+.||++||++.++++||||++.-
T Consensus       239 l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         239 LDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             cCCCcccCcCHHHHhhChHhhccc
Confidence            999999999999999999997743

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.8e-43  Score=294.41  Aligned_cols=254  Identities=31%  Similarity=0.548  Sum_probs=217.0

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      .+|...+.||.|++|.||++.+..+++.+++|++....   ....+.+.+|+.+++.++|+|++++++++...+..++++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            46677789999999999999998899999999875332   233566889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT  175 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~  175 (294)
                      ||+.+++|.+++.. .+++...+..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence            99999999999876 678999999999999999999999999999999999999999999999999876543322 1223


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC---CCCCChhHHHHHHHhc
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL---PSHLSPGARDLIPRML  252 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l  252 (294)
                      ..++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.....+.   +..++..+.+++.+||
T Consensus       175 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (285)
T cd06648         175 LVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML  253 (285)
T ss_pred             ccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence            457889999999877665 789999999999999999999998877666666555443221   2347889999999999


Q ss_pred             ccCCCCCCCHhHHhcCCcccccC
Q 022617          253 IVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       253 ~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      ..+|++|||+.++++||||++.-
T Consensus       254 ~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         254 VRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             ccChhhCcCHHHHccCcccccCC
Confidence            99999999999999999998843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.4e-43  Score=296.50  Aligned_cols=249  Identities=31%  Similarity=0.512  Sum_probs=204.8

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcC--CeEEEE
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETP--SDIYVV   95 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv   95 (294)
                      |++.+.||.|++|.||+|.+..+++.+++|.+....... . .....+|+..++++. |+|++++++++.+.  +..+++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            788999999999999999999899999999986542221 1 233456888888885 99999999999887  889999


Q ss_pred             EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc
Q 022617           96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  174 (294)
                      +||+++ +|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+..........
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            999975 888888653 56899999999999999999999999999999999999999 999999999987665444334


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------------------cc-
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------YT-  235 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~~-  235 (294)
                      ...++..|+|||.+......+.++|+||||+++|+|++|..||...+..+....+....                  .. 
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            44578899999987655445789999999999999999999998766544433332100                  00 


Q ss_pred             ----------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          236 ----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       236 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                ....++.++.++|.+||..+|++||+++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                      113567899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.8e-43  Score=302.96  Aligned_cols=270  Identities=31%  Similarity=0.424  Sum_probs=217.7

Q ss_pred             ccccCCcc-cccccccCceEEEEEEEccCCceEEEEEeecccccchH-----------HHHHHHHHHHHHHhCCCCceeE
Q 022617           14 MFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----------MEEKVRREIKILRLFMHPHIIR   81 (294)
Q Consensus        14 ~~~~~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~   81 (294)
                      .+.++|.. .+.||.|++|+||+|.+..+++.|++|++.........           ....+.+|++++++++|+|+++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            45678875 57799999999999999999999999998654322100           1125778999999999999999


Q ss_pred             EEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617           82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF  161 (294)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df  161 (294)
                      +++++...+..++++|++.+ +|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             eeEEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence            99999999999999999974 99999988788999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC---------------CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022617          162 GLSNIMRDG---------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF  226 (294)
Q Consensus       162 g~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~  226 (294)
                      |.+......               .......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  243 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL  243 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            988755411               11112335778999999876655578999999999999999999999877665544


Q ss_pred             HHHhCCCc----------------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          227 KKIKGGIY----------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       227 ~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                      ..+.....                            ......+.++.+++.+||+.+|++|||+++++.||||+.+-.+-
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~  323 (335)
T PTZ00024        244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC  323 (335)
T ss_pred             HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence            43321100                            01134578899999999999999999999999999999875543


Q ss_pred             ccCCCC
Q 022617          279 LAVPPP  284 (294)
Q Consensus       279 ~~~~~~  284 (294)
                      -..|.|
T Consensus       324 ~~~~~~  329 (335)
T PTZ00024        324 DPSQLP  329 (335)
T ss_pred             CcccCC
Confidence            333333

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.8e-44  Score=300.78  Aligned_cols=264  Identities=29%  Similarity=0.498  Sum_probs=220.7

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....+.|.....||.|++|.||++.+..++..+++|.+....   ....+.+.+|+.+++.++|+|++++++.+...+..
T Consensus        18 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          18 GDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL   94 (292)
T ss_pred             CchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence            344567777888999999999999998899999999875432   23456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++++||+++++|.+++. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        95 ~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658          95 WVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             EEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            99999999999999885 4568999999999999999999999999999999999999999999999999886543221 


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHHHH
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLI  248 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li  248 (294)
                      ......++..|+|||.+.+..+ +.++|+||+|+++|++++|..||...........+....   ......++..+.+++
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  252 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL  252 (292)
T ss_pred             cCceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence            1223457889999999877666 789999999999999999999998776655544443322   222335788999999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCcccccCCccccC
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAV  281 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~  281 (294)
                      .+||..+|.+|||++++++||||+..-+..+.+
T Consensus       253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~~  285 (292)
T cd06658         253 DLMLVREPSQRATAQELLQHPFLKLAGPPSCIV  285 (292)
T ss_pred             HHHccCChhHCcCHHHHhhChhhhccCCccccc
Confidence            999999999999999999999999866655433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2e-43  Score=295.58  Aligned_cols=257  Identities=26%  Similarity=0.422  Sum_probs=210.3

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc-
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET-   88 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-   88 (294)
                      ......+.|++.+.||.|++|.||+|.+..+++.+++|++....    .....+..|+.+++++ +|+|++++++++.. 
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636          10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34456789999999999999999999999999999999985432    2345678899999888 69999999999842 


Q ss_pred             -----CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617           89 -----PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF  161 (294)
Q Consensus        89 -----~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df  161 (294)
                           ....+++|||+++++|.+++...  ..+++..++.++.|++.++.|||+.|++|+||+|+||+++.++.++|+||
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df  165 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF  165 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence                 46789999999999999999753  35888899999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-CccccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-c
Q 022617          162 GLSNIMRDG-HFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T  235 (294)
Q Consensus       162 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~  235 (294)
                      |.+...... .......++..|+|||.+..    ....+.++|+||||+++|+|++|..||...........+..... .
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  245 (282)
T cd06636         166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK  245 (282)
T ss_pred             cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence            998755322 12234457889999998752    12236789999999999999999999976654443333322221 1


Q ss_pred             -CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          236 -LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       236 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                       ....++.++.++|.+||+.||.+|||+.+|++||||
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence             223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-43  Score=297.21  Aligned_cols=252  Identities=30%  Similarity=0.524  Sum_probs=208.0

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|++++++++|+|++++++++...+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            58899999999999999999998999999998865432 22234678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617           98 YVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK  174 (294)
Q Consensus        98 ~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  174 (294)
                      |+. ++|.+++..  ...+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 589888865  3468999999999999999999999999999999999999999999999999886553322 122


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-C--------------------
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-I--------------------  233 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~--------------------  233 (294)
                      ...++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+.......+... .                    
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            3345778999999876655578899999999999999999999776543332221110 0                    


Q ss_pred             --------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          234 --------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                              ......++.++.++|.+||+.||++|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                    01123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-45  Score=290.39  Aligned_cols=274  Identities=34%  Similarity=0.608  Sum_probs=233.7

Q ss_pred             ccccccCCcc-cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcC
Q 022617           12 VDMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETP   89 (294)
Q Consensus        12 ~~~~~~~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   89 (294)
                      ...+.+-|++ .+.||+|+++.|-.+....++..|+||++.+.   .......+.+|++++.+++ |+||+.++++|+++
T Consensus        72 ~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   72 SGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             cchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3446666777 67899999999999999999999999999765   3455789999999999996 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc---EEEeeeccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNI  166 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~---~~l~dfg~~~~  166 (294)
                      ...|+|+|.+.||+|...|.+++.+++.++.+++++|+.||.+||++||.|+|+||+|||.....+   +||+||.+...
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999976544   89999998754


Q ss_pred             ccCCC--------ccccccCCCcccCCcccc----CCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------------
Q 022617          167 MRDGH--------FLKTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-------------  221 (294)
Q Consensus       167 ~~~~~--------~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-------------  221 (294)
                      .....        ...+.+|+..|||||+..    ...+++.+-|.||||+++|-|++|.+||.++.             
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            32211        122446788999999863    22334788999999999999999999996653             


Q ss_pred             --HHHHHHHHhCCCccCCC----CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcchHH
Q 022617          222 --IPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ  289 (294)
Q Consensus       222 --~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~~~~  289 (294)
                        ...+.+.|+.+.+++|.    .++.+..++++.+|..++.+|.++.++++|||++...+. ...|+|.-++|
T Consensus       309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e-kalptp~v~~r  381 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE-KALPTPQVLQR  381 (463)
T ss_pred             HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh-ccCCCCccccc
Confidence              56688899999998875    689999999999999999999999999999999988776 45555555444

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-43  Score=295.75  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=215.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||+|++|+||++.+..+++.+++|++....  .......+.+|+++++.++|+|++++++++...+..+++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            468999999999999999999999899999999886432  233467889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  174 (294)
                      +||+++++|.+++.+.++++...+..++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~~  160 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-AD  160 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-cC
Confidence            9999999999999887889999999999999999999997 689999999999999999999999999876543222 22


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHhCC-CccCCC-CCC
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-----------NLFKKIKGG-IYTLPS-HLS  241 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-----------~~~~~~~~~-~~~~~~-~~~  241 (294)
                      ...++..|+|||.+.+... +.++|+||+|+++|++++|..||......           +....+... ....+. .++
T Consensus       161 ~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd06620         161 TFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP  239 (284)
T ss_pred             ccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence            3467889999999877655 78999999999999999999999764431           222222222 222223 378


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .++.+++.+||+.||++|||+.++++|+||.+.
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            899999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.7e-44  Score=298.68  Aligned_cols=255  Identities=29%  Similarity=0.455  Sum_probs=217.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ...|+..+.||.|++|.||+|.+..++..+++|.+.....  ....+.+.+|+.++++++|+|++++++.+..++..+++
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence            4568899999999999999999988899999999864432  23456889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-cc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~  174 (294)
                      +||+++++|.+++.. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            999999999998854 5689999999999999999999999999999999999999999999999999876543321 22


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~  253 (294)
                      ...++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+.... ...+..++.++.+++.+||+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN  238 (277)
T ss_pred             cccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence            3356788999999987765 789999999999999999999997665555444443332 23445678899999999999


Q ss_pred             cCCCCCCCHhHHhcCCccccc
Q 022617          254 VDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .+|++||++.++++||||+..
T Consensus       239 ~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         239 KDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             CCcccCcCHHHHHHhHHHHHH
Confidence            999999999999999999764

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.1e-43  Score=294.60  Aligned_cols=256  Identities=27%  Similarity=0.474  Sum_probs=207.3

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ++|++.+.||.|+||.||++.++.+++.|++|.+.......  ....+..|+.. ++.+.|+|++++++++...+..+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            47999999999999999999999999999999986543221  23445555554 6677899999999999999999999


Q ss_pred             EeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      +||++ ++|.+++..    +..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99997 488888754    24689999999999999999999997 9999999999999999999999999998765443


Q ss_pred             CccccccCCCcccCCccccCC---ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhCCCccCC-CCCChhH
Q 022617          171 HFLKTSCGSPNYAAPEVISGK---LYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIYTLP-SHLSPGA  244 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~-~~~~~~l  244 (294)
                      .......++..|+|||.+.+.   ...+.++|+||||+++|+|++|+.||....  .......+.......+ ..++.++
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF  237 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence            333334577889999988542   223678999999999999999999996532  2333333332223333 3578999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      .+++.+||..+|++||++.++++||||+...
T Consensus       238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         238 QDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            9999999999999999999999999998853

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-47  Score=300.39  Aligned_cols=259  Identities=27%  Similarity=0.425  Sum_probs=223.5

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-..-|.++++||.|+||.||+|.++.+|+.+++|.+..+     ...+++..|+.++++++.++++++++.|-....+|
T Consensus        30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW  104 (502)
T KOG0574|consen   30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW  104 (502)
T ss_pred             ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence            3445689999999999999999999999999999987544     45789999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           94 VVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~-~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      +|||||+.|++.+.+. +++++++.++..+++..+.+|.|||...-+|+|||..|||++.+|+.||.|||.+........
T Consensus       105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            9999999999999886 568899999999999999999999999999999999999999999999999999877654432


Q ss_pred             -cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHHHH
Q 022617          173 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLI  248 (294)
Q Consensus       173 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li  248 (294)
                       .+...||+.|+|||++....| ...+||||||++..+|..|++||....+-..+-.+-...   +.-|..-+.++.+|+
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY-~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGY-DTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             hhCccccCcccccHHHHHHhcc-chhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence             356679999999999988878 678999999999999999999997755443332222222   122345678899999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                      ++||-++|++|.|+.++++|||+++.-..-
T Consensus       264 ~~CLiK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence            999999999999999999999999854443

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=293.23  Aligned_cols=253  Identities=32%  Similarity=0.480  Sum_probs=210.5

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC---
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS---   90 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~---   90 (294)
                      ..++|++.+.||.|++|.||+|.++.+++.+++|++.....    ....+.+|+.+++++ .|+|++++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            45899999999999999999999988899999999865432    346788999999999 6999999999996644   


Q ss_pred             ---eEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           91 ---DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        91 ---~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                         ..++++||+++++|.+++..    +..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence               48999999999999999865    35789999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCC-ccccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---c
Q 022617          164 SNIMRDGH-FLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---T  235 (294)
Q Consensus       164 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~  235 (294)
                      +....... ......++..|+|||.+...    ...+.++|+||||++++++++|..||...........+.....   .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  239 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK  239 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence            86543322 22334578889999987532    2236789999999999999999999986655444444443322   1


Q ss_pred             CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      .+..++.++.+++.+||..||++|||+.++++|||+
T Consensus       240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            223467899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-43  Score=287.56  Aligned_cols=252  Identities=33%  Similarity=0.552  Sum_probs=219.8

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|++++++++|+|++++++++...+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            588999999999999999999989999999999766433 2456789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-cccc
Q 022617           98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTS  176 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  176 (294)
                      ++++++|.+++.+...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            999999999998888899999999999999999999999999999999999999999999999999876654332 2334


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK-IKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      .++..|+|||...+... +.++|+|++|++++++++|..||........... ........+..++..+.+++.+||..+
T Consensus       160 ~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  238 (254)
T cd06627         160 VGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD  238 (254)
T ss_pred             ccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence            57889999999877664 7899999999999999999999976554333333 334445566788999999999999999


Q ss_pred             CCCCCCHhHHhcCCcc
Q 022617          256 PMKRITIPEIRQHPWF  271 (294)
Q Consensus       256 p~~Rps~~~il~h~~~  271 (294)
                      |++|||+.++++||||
T Consensus       239 p~~R~~~~~~l~~~~~  254 (254)
T cd06627         239 PNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hhhCcCHHHHhcCCCC
Confidence            9999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.3e-43  Score=291.29  Aligned_cols=250  Identities=28%  Similarity=0.490  Sum_probs=211.6

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+.............+.+|+.+++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            68999999999999999999999999999999886554444455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           97 EYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        97 e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            99999999998853    34589999999999999999999999999999999999999999999999998876543221


Q ss_pred             -cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhCCCc-cC-CCCCChhHHHH
Q 022617          173 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIY-TL-PSHLSPGARDL  247 (294)
Q Consensus       173 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~~~~-~~-~~~~~~~l~~l  247 (294)
                       .....++..|+|||.+.+... +.++|+||+|+++|+|++|..||....  .......+..... +. ...++..+.++
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL  240 (267)
T ss_pred             HHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence             223457788999999887666 788999999999999999999996543  3344444443332 22 23577899999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+||..+|++||++.++++
T Consensus       241 i~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         241 VSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHCCCCcccCcCHHHHHH
Confidence            99999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-43  Score=299.28  Aligned_cols=250  Identities=26%  Similarity=0.441  Sum_probs=207.7

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCce--EEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~--~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   92 (294)
                      .++|++.+.||.|+||.||+|.+..++..  +++|.+.  ..........+.+|++++.++ +|+|++++++++...+..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~--~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEec--ccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            35899999999999999999998877765  4666543  222334557788999999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcE
Q 022617           93 YVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV  156 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~  156 (294)
                      ++++||+++++|.+++.+..                .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence            99999999999999996542                47889999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-c
Q 022617          157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-Y  234 (294)
Q Consensus       157 ~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~  234 (294)
                      +|+|||++..............+..|+|||.+.+..+ +.++||||||+++|+|++ |..||......+..+.+.... .
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  242 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL  242 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcC
Confidence            9999999864322111112223567999998876665 789999999999999998 999998877777666665442 3


Q ss_pred             cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ..+...+.++.+++.+||+.+|++||++.+++.+
T Consensus       243 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4455688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-45  Score=288.91  Aligned_cols=254  Identities=38%  Similarity=0.665  Sum_probs=222.9

Q ss_pred             ccccCCcc-cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc---
Q 022617           14 MFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET---   88 (294)
Q Consensus        14 ~~~~~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---   88 (294)
                      .+.++|++ -++||-|-.|.|..+.++.+++.||+|++.-        ..+.++|+++.-.. .|+||+.++++|+.   
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            46777877 5789999999999999999999999998632        36778888876555 59999999999853   


Q ss_pred             -CCeEEEEEeccCCCChHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEEEeeec
Q 022617           89 -PSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFG  162 (294)
Q Consensus        89 -~~~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~l~dfg  162 (294)
                       ...+.+|||.++||.|.+.++.++.  +++.++..+++||..|+.|||+.+|.||||||+|+|++.   +..+||+|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence             4678899999999999999988765  999999999999999999999999999999999999975   4569999999


Q ss_pred             ccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhCCCccCCC
Q 022617          163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPS  238 (294)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~  238 (294)
                      ++..........+.+.|+.|.|||++...++ +..-|+||+|+++|-|++|.+||..+.    ...+..+|..+.+.+|.
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKy-dkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE  288 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhc-CCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence            9988776666777888999999999998887 788999999999999999999998754    45677788888877764


Q ss_pred             ----CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          239 ----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       239 ----~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                          .+++..+++|+.+|+.+|.+|.|+.++++|||+.+...
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence                67899999999999999999999999999999977533

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.5e-43  Score=289.25  Aligned_cols=249  Identities=32%  Similarity=0.535  Sum_probs=215.9

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||++.+..++..+++|.+.....  ....+.+.+|+.++++++|+|++++++.+...+..++++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            58999999999999999999999999999999864432  2345678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617           98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK  174 (294)
Q Consensus        98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  174 (294)
                      |+++++|.+++...  ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            99999999988653  458999999999999999999999999999999999999999999999999987654332 222


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~  253 (294)
                      ...++..|+|||++.+... +.++|+||+|+++|+|++|..||...+.......+..+. .+.+..++..+.+++.+||+
T Consensus       159 ~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK  237 (255)
T ss_pred             cccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence            3457888999999877765 789999999999999999999999887777666665544 34567788999999999999


Q ss_pred             cCCCCCCCHhHHhcCC
Q 022617          254 VDPMKRITIPEIRQHP  269 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~  269 (294)
                      .||++|||+.++++--
T Consensus       238 ~~P~~Rp~~~~il~~~  253 (255)
T cd08219         238 RNPRSRPSATTILSRG  253 (255)
T ss_pred             CCcccCCCHHHHhhcc
Confidence            9999999999998743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.4e-43  Score=300.06  Aligned_cols=244  Identities=30%  Similarity=0.503  Sum_probs=191.0

Q ss_pred             cccccccCceEEEEEEEc--cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--CCeEEEEEe
Q 022617           22 GKTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYVVME   97 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e   97 (294)
                      .++||+|+||.||+|.++  .+++.+++|.+.....     ...+.+|+.++++++||||+++++++..  ....++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            468999999999999965  3567899998854322     2456789999999999999999998854  456899999


Q ss_pred             ccCCCChHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe----cCCCcEEEeeeccc
Q 022617           98 YVKSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGLS  164 (294)
Q Consensus        98 ~~~~~sL~~~l~~~---------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili----~~~~~~~l~dfg~~  164 (294)
                      |+.+ +|.+++...         ..+++..++.++.|++.||.|||+.|++|+||||+||++    +.++.++|+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            9965 898887532         248999999999999999999999999999999999999    45678999999999


Q ss_pred             ccccCCC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHhC
Q 022617          165 NIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------NLFKKIKG  231 (294)
Q Consensus       165 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------~~~~~~~~  231 (294)
                      .......    ......+++.|+|||++.+....+.++||||+|+++|+|++|+.||......         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            7654321    1234467889999999877554578999999999999999999999643211         11111100


Q ss_pred             ----------------------------CCcc----------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          232 ----------------------------GIYT----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       232 ----------------------------~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                                  ....          .....+.++.+++.+||+.||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                        0000          001234568899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.3e-43  Score=293.20  Aligned_cols=257  Identities=33%  Similarity=0.528  Sum_probs=221.0

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .+...+.|.+.+.||.|++|.||++.+..++..+++|++.....    ....+.+|++++++++|+|++++++.+...+.
T Consensus        14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            35677889999999999999999999998899999999865432    45678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .++++||+++++|.+++.... .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            999999999999999998776 8999999999999999999999999999999999999999999999999987654332


Q ss_pred             C-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-cc--CCCCCChhHHH
Q 022617          171 H-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YT--LPSHLSPGARD  246 (294)
Q Consensus       171 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~  246 (294)
                      . ......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+.... ..  .+..++.++.+
T Consensus       170 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  248 (286)
T cd06614         170 KSKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD  248 (286)
T ss_pred             hhhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence            2 1123346778999999887766 789999999999999999999998776655544443322 22  22347899999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      +|.+||+.+|.+|||+.+++.|+||++
T Consensus       249 li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         249 FLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHHHhccChhhCcCHHHHhhChHhhc
Confidence            999999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.1e-43  Score=293.20  Aligned_cols=251  Identities=30%  Similarity=0.543  Sum_probs=207.8

Q ss_pred             CCccccccCCcccccc--cccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeEEEEEE
Q 022617           10 SGVDMFLPNYKLGKTL--GIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVI   86 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~l--g~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~   86 (294)
                      +......++|++.+.+  |.|+||.||++.++.++..+++|++........        |...... .+|+|++++++.+
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEE
Confidence            3444566788888887  999999999999999999999999865432211        1222221 2699999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeecccc
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSN  165 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~  165 (294)
                      ..++..++++||+++++|.+++.++.++++..++.++.|++.++.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            99999999999999999999998877899999999999999999999999999999999999999988 99999999887


Q ss_pred             cccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhCCCccCCCCC
Q 022617          166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-----LFKKIKGGIYTLPSHL  240 (294)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~  240 (294)
                      ......   ...++..|+|||++.+..+ +.++|+||+|+++|+|++|..||.......     ..... ......+..+
T Consensus       159 ~~~~~~---~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  233 (267)
T PHA03390        159 IIGTPS---CYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNV  233 (267)
T ss_pred             ecCCCc---cCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCccccc
Confidence            654322   2356789999999987766 788999999999999999999997544322     22222 3334555678


Q ss_pred             ChhHHHHHHHhcccCCCCCCC-HhHHhcCCcccc
Q 022617          241 SPGARDLIPRMLIVDPMKRIT-IPEIRQHPWFQA  273 (294)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps-~~~il~h~~~~~  273 (294)
                      +..+.++|.+||+.+|.+||+ ++++|+||||++
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             CHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            999999999999999999996 699999999974

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1e-42  Score=286.11  Aligned_cols=249  Identities=34%  Similarity=0.572  Sum_probs=214.6

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      .|.+.+.||.|++|.||++.+..+++.+++|++.....   .....+.+|+.++++++|+|++++++++...+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            48889999999999999999988899999999865432   346788999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccc
Q 022617           98 YVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS  176 (294)
Q Consensus        98 ~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  176 (294)
                      |+++++|.+++... ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  157 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM  157 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence            99999999999776 57999999999999999999999999999999999999999999999999998776554433455


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC-CCccCCC--CCChhHHHHHHHhcc
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-GIYTLPS--HLSPGARDLIPRMLI  253 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~l~~li~~~l~  253 (294)
                      .++..|+|||.+.+... +.++|+||||+++++|++|..||...+.......... .....+.  .++..+.+++.+||+
T Consensus       158 ~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  236 (253)
T cd05122         158 VGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ  236 (253)
T ss_pred             ecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence            67889999999877664 7899999999999999999999987644443333332 2222332  348899999999999


Q ss_pred             cCCCCCCCHhHHhcCCc
Q 022617          254 VDPMKRITIPEIRQHPW  270 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~  270 (294)
                      .||++|||+.++++|||
T Consensus       237 ~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         237 KNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CChhhCCCHHHHhcCCC
Confidence            99999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.3e-43  Score=297.35  Aligned_cols=263  Identities=29%  Similarity=0.513  Sum_probs=220.8

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ...|.....||.|+||.||+|.+..+++.|++|++.....   .....+.+|+.+++.+.|||++++++++..++..+++
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            4566777889999999999999988999999999864432   2346688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  174 (294)
                      +||+++++|.+++.. ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  175 (297)
T cd06659          97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  175 (297)
T ss_pred             EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence            999999999987754 568999999999999999999999999999999999999999999999999886543322 123


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCChhHHHHHHHh
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRM  251 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~  251 (294)
                      ...++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+.....   ..+..++..+.+++.+|
T Consensus       176 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~  254 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM  254 (297)
T ss_pred             ceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence            3457889999999987766 7899999999999999999999987766665555543322   22346788999999999


Q ss_pred             cccCCCCCCCHhHHhcCCcccccCCccccCCC
Q 022617          252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPP  283 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~  283 (294)
                      |+.+|++||++.++++||||.+.--..+.+|.
T Consensus       255 l~~~P~~Rps~~~ll~~~~~~~~~~~~~~~~~  286 (297)
T cd06659         255 LTREPQERATAQELLDHPFLLQTGLPECLVPL  286 (297)
T ss_pred             hcCCcccCcCHHHHhhChhhccCCCcccccch
Confidence            99999999999999999999876544554443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.6e-43  Score=289.15  Aligned_cols=251  Identities=31%  Similarity=0.518  Sum_probs=220.2

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||++.+..+++.+++|.+....... .....+.+|++++++++|+|++++++++......++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999987554332 345677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           98 YVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        98 ~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      |+++++|.+++.+    ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~  158 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA  158 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence            9999999999866    356899999999999999999999999999999999999999999999999998776544 33


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhc
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l  252 (294)
                      ....++..|+|||.+.+..+ +.++|+||||++++++++|+.||...+.......+.... ...+..++.++.+++.+||
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (256)
T cd08530         159 KTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML  237 (256)
T ss_pred             ccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHc
Confidence            34557889999999987766 688999999999999999999999888777666665544 3455678899999999999


Q ss_pred             ccCCCCCCCHhHHhcCCcc
Q 022617          253 IVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       253 ~~~p~~Rps~~~il~h~~~  271 (294)
                      ..+|++|||+.++++||++
T Consensus       238 ~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         238 QVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CCCcccCCCHHHHhcCCCC
Confidence            9999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.7e-43  Score=295.22  Aligned_cols=250  Identities=26%  Similarity=0.380  Sum_probs=204.4

Q ss_pred             cccCCcccccccccCceEEEEEEEcc----------------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHAL----------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH   78 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~----------------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   78 (294)
                      ..++|++.+.||+|+||.||+|.+..                ++..|++|++....  .......+.+|+.++++++|||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence            35789999999999999999998642                23469999986542  2334567889999999999999


Q ss_pred             eeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 022617           79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-------------------RLQEDEARNFFQQIISGVEYCHRNMVV  139 (294)
Q Consensus        79 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~  139 (294)
                      |+++++++...+..++++||+.+++|.+++....                   .++...++.++.|++.||.|||+.|++
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999986532                   357788999999999999999999999


Q ss_pred             ecCCCCCCeEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh--CC
Q 022617          140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GT  214 (294)
Q Consensus       140 h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~  214 (294)
                      |+||+|+||+++.++.++|+|||++........   .....++..|+|||.+....+ +.++|+||||+++|+|++  +.
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCC
Confidence            999999999999999999999999875533221   122234678999999877666 789999999999999986  67


Q ss_pred             CCCCCCCHHHHHHHHhC--------CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          215 LPFDDENIPNLFKKIKG--------GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       215 ~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .||..............        .....+..++..+.+++.+||+.+|++|||+.+|.+
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            78877665555443321        112334678899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-42  Score=288.51  Aligned_cols=253  Identities=30%  Similarity=0.432  Sum_probs=208.1

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .+.......||+|++|.||+|.+..++..+++|.+....   ....+.+.+|+.++++++|+||+++++++..++..+++
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            344455678999999999999999899999999875432   23456888999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeecccccccCCC
Q 022617           96 MEYVKSGELFDYIVEK-GRL--QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~-~~l--~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~~~~  171 (294)
                      +||+.+++|.+++... .++  ++..+..++.|++.|+++||+.|++|+||+|+||+++. ++.++|+|||.+.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            9999999999999764 455  78889999999999999999999999999999999976 6789999999887553322


Q ss_pred             c-cccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HhCCCccCCCCCChhHHH
Q 022617          172 F-LKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNL--FKK-IKGGIYTLPSHLSPGARD  246 (294)
Q Consensus       172 ~-~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~l~~  246 (294)
                      . .....++..|+|||.+.... ..+.++|+||+|+++|+|++|..||........  ... ........+..++.++.+
T Consensus       164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (268)
T cd06624         164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN  243 (268)
T ss_pred             CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence            1 22334688999999986533 236889999999999999999999975432221  111 122234556778899999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      ++.+||..+|++|||+.+++.||||
T Consensus       244 li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         244 FILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.3e-43  Score=289.56  Aligned_cols=252  Identities=29%  Similarity=0.566  Sum_probs=215.9

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|.+.+.||.|++|.||++.++.++..+++|.+....... .....+.+|+++++.++|+|++++++.+......++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5889999999999999999999999999999987654322 234677899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc-EEEeeecccccccCCCc-c
Q 022617           98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-VKIADFGLSNIMRDGHF-L  173 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~-~~l~dfg~~~~~~~~~~-~  173 (294)
                      |+.+++|.+++.+..  .+++..+..++.|++.++.+||+.+++|+||+|+||++++++. ++|+|||.+........ .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999987643  4789999999999999999999999999999999999988764 69999998876544322 2


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhc
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l  252 (294)
                      ....++..|+|||.+.+..+ +.++|+||+|++++++++|..||...+.......+.... .+....++.++.+++.+||
T Consensus       160 ~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  238 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF  238 (257)
T ss_pred             cccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence            23357788999999877665 789999999999999999999998777666665554433 3445678899999999999


Q ss_pred             ccCCCCCCCHhHHhcCCcc
Q 022617          253 IVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       253 ~~~p~~Rps~~~il~h~~~  271 (294)
                      ..+|++|||+.++++||||
T Consensus       239 ~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         239 KVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ccChhhCcCHHHHhhCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.5e-43  Score=288.95  Aligned_cols=248  Identities=25%  Similarity=0.436  Sum_probs=213.8

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      -..+|.+.+.||.|++|.||+|.++.+++.+++|.+....    .....+.+|++++++++|+|++++++++......++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            3457899999999999999999999899999999975432    235678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ++||+++++|.+++...  ..+++..++.++.|++.+|++||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999998654  3588999999999999999999999999999999999999999999999999876544322


Q ss_pred             cc--cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHH
Q 022617          173 LK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLI  248 (294)
Q Consensus       173 ~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li  248 (294)
                      ..  ....+..|+|||.+.+... +.++||||||+++|+|++ |..||.+....+....+... ....+..++.++.+++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM  238 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence            21  1223557999999877766 788999999999999998 99999888777777766654 3556678899999999


Q ss_pred             HHhcccCCCCCCCHhHHhc
Q 022617          249 PRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~  267 (294)
                      .+||+.+|++|||+.++++
T Consensus       239 ~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         239 RACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHccCCcccCCCHHHHHH
Confidence            9999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.8e-43  Score=296.28  Aligned_cols=259  Identities=32%  Similarity=0.507  Sum_probs=216.7

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      +....++|++.+.||.|++|.||++.+..+++.+++|.+....   ......+.+|+.++++++|||++++++++...+.
T Consensus        14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   90 (293)
T cd06647          14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDE   90 (293)
T ss_pred             ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence            4455689999999999999999999998889999999985432   2234678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      .++++||+++++|.+++.+ ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999999999999864 457899999999999999999999999999999999999999999999999876543322


Q ss_pred             -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-C--ccCCCCCChhHHHH
Q 022617          172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-I--YTLPSHLSPGARDL  247 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~l  247 (294)
                       ......++..|++||.+..... +.++|+||+|+++|++++|..||...........+... .  ...+..++..+.++
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  248 (293)
T ss_pred             cccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence             2233457778999999877666 78999999999999999999999876544333222221 1  12234567889999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      +.+||..+|++||++.+++.||||+...
T Consensus       249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         249 LNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            9999999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-43  Score=303.69  Aligned_cols=258  Identities=33%  Similarity=0.526  Sum_probs=211.8

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----   89 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   89 (294)
                      +..+|++.+.||.|++|+||+|.+..+++.|++|.+..... .......+.+|+.+++.++|+|++++++++...     
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            56789999999999999999999999999999999865422 223356677899999999999999999887543     


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      ...++++||+. ++|.+++.+.+++++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            35899999996 59999998888899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC-----------------
Q 022617          170 G-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-----------------  231 (294)
Q Consensus       170 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-----------------  231 (294)
                      . .......++..|+|||.+......+.++|+||||+++|+|++|..||.+.+.......+..                 
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            3 2223345678899999886543347899999999999999999999976543222211110                 


Q ss_pred             --------CC------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          232 --------GI------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       232 --------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                              ..      ......++.++.+++.+||+.+|++|||+.++++||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                    00      01124578899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-43  Score=293.38  Aligned_cols=251  Identities=31%  Similarity=0.537  Sum_probs=208.2

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY   98 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   98 (294)
                      |++.+.||.|++|.||+|.++.+++.|++|++...... ......+.+|+++++.++|+|++++++++...+..++++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            78899999999999999999999999999998654322 22345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617           99 VKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT  175 (294)
Q Consensus        99 ~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~  175 (294)
                      ++ ++|.+++....  .+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            95 59999997765  68999999999999999999999999999999999999999999999999986543221 1223


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-----------------------
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-----------------------  232 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-----------------------  232 (294)
                      ..++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+...                       
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence            345788999998876544478899999999999999999999776543322221110                       


Q ss_pred             --C----ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          233 --I----YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       233 --~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                        .    ......++..+.+++.+||+.+|.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence              0    01124567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-44  Score=301.54  Aligned_cols=258  Identities=28%  Similarity=0.419  Sum_probs=209.3

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCC
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS   90 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   90 (294)
                      +.+-...|.+++.||+||.+.||++... +.+-|++|.+..... +......+..|+.+|.+|+ |.+|+++++|-..++
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            4566779999999999999999999975 445566666544333 3456788999999999997 799999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      .+|+|||+-+ .+|..+|++... .+.-.++.++.||+.|+.++|++||+|.||||.|+++-.+ .+||+|||.|.....
T Consensus       434 ~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  434 YLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG-RLKLIDFGIANAIQP  511 (677)
T ss_pred             eEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee-eEEeeeechhcccCc
Confidence            9999999874 599999987654 3445889999999999999999999999999999999665 899999999987765


Q ss_pred             CC---ccccccCCCcccCCccccCCcc----------CCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhCCC--
Q 022617          170 GH---FLKTSCGSPNYAAPEVISGKLY----------AGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGI--  233 (294)
Q Consensus       170 ~~---~~~~~~~~~~~~aPE~~~~~~~----------~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~--  233 (294)
                      .+   .....+||+-||+||.+.....          .+.++|||||||++|+|+.|+.||.... ...-+..|....  
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~  591 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE  591 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence            44   3467789999999999842211          2678999999999999999999996533 333333444432  


Q ss_pred             ccCCCCCCh-hHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          234 YTLPSHLSP-GARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       234 ~~~~~~~~~-~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      +++|..-+. ++.++++.||+.||++||++.++|+|||++-
T Consensus       592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            345543333 3999999999999999999999999999977

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.6e-43  Score=296.71  Aligned_cols=259  Identities=28%  Similarity=0.460  Sum_probs=206.5

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ......++|++.+.||.|++|.||+|.+..+++.|++|.+....... .....+.+|++++++++|||++++++++....
T Consensus         6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865           6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             cccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            34556778999999999999999999999999999999986443221 22345668999999999999999999886543


Q ss_pred             --------eEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617           91 --------DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF  161 (294)
Q Consensus        91 --------~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df  161 (294)
                              ..++++||+.+ +|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence                    45999999965 888887654 36899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCc-----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--
Q 022617          162 GLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--  234 (294)
Q Consensus       162 g~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--  234 (294)
                      |.+........     .....++..|+|||.+.+....+.++|+||+|+++|+|++|..||...+.......+.....  
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99875533221     12234577899999887654447889999999999999999999977654433322211100  


Q ss_pred             -----------------cCC-------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 -----------------TLP-------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 -----------------~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                       ..+             ...+..+.++|.+||..||.+|||++++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                             000             1235667899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-43  Score=302.54  Aligned_cols=257  Identities=35%  Similarity=0.552  Sum_probs=217.0

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----eE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----DI   92 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   92 (294)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+.... ......+.+.+|+.+++.++|+|++++.+++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            6899999999999999999998889999999986543 22344577899999999999999999999987765     78


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      +++++|+.+ +|.+++.+..++++..++.++.|++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+....... 
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            999999974 899999877789999999999999999999999999999999999999999999999999988765443 


Q ss_pred             ---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--------------
Q 022617          172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------------  234 (294)
Q Consensus       172 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------  234 (294)
                         ......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+.....              
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence               233345678899999998774448899999999999999999999987766554444332110              


Q ss_pred             -----------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          235 -----------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       235 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                                       .....++.++.+++.+||+.+|++||++++++.||||++.-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                             011346788999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=279.88  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=219.3

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      +..++..||+|..|+|+++..+++|.-.|||.+....  +.+..+++.+.+.+..... +|+|++.+|+|..+..+++.|
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            4566788999999999999999999999999987553  5566788888888876665 899999999999999999999


Q ss_pred             eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc
Q 022617           97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  174 (294)
                      |.|.. .++.++++ .+++++..+-.+...++.||.||.+ +||+|+|+||+|||+++.|++||+|||.+...-.+..+.
T Consensus       171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht  249 (391)
T KOG0983|consen  171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT  249 (391)
T ss_pred             HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence            99954 77777765 4679999999999999999999995 579999999999999999999999999999998998899


Q ss_pred             cccCCCcccCCccccC---CccCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhCCCc-cCC--CCCChhHHHH
Q 022617          175 TSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIY-TLP--SHLSPGARDL  247 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~~~--~~~~~~l~~l  247 (294)
                      ...|.+.|||||.+..   .+| +.++|+||||+.++||.||+.||.+. ...++...+.+..+ .++  ..+++.+.+|
T Consensus       250 rsAGC~~YMaPERidp~~~~kY-DiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~f  328 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKY-DIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSF  328 (391)
T ss_pred             cccCCccccCccccCCCCCCcc-chhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHH
Confidence            9999999999999853   344 78999999999999999999999873 34444555544443 333  2489999999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      +..||++|+.+||...++|+|||+....+-
T Consensus       329 v~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a  358 (391)
T KOG0983|consen  329 VKDCLTKDHRKRPKYNKLLEHPFIKRYETA  358 (391)
T ss_pred             HHHHhhcCcccCcchHHHhcCcceeecchh
Confidence            999999999999999999999999775443

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.7e-43  Score=294.18  Aligned_cols=256  Identities=29%  Similarity=0.487  Sum_probs=209.3

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|+||+|.++.+++.+++|.+...... ......+.+|++++++++|+|++++++++......++++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            6899999999999999999999989999999998654322 233466788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeecccccccCCC-c
Q 022617           97 EYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH-F  172 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~--l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~~~~-~  172 (294)
                      ||+++ +|.+.+.....  +++..++.++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||++....... .
T Consensus        81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence            99965 88888765443  578888999999999999999999999999999999985 5579999999987543322 1


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------------------
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------  233 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------  233 (294)
                      .....++..|+|||.+.+....+.++|+||+|+++|+|++|..||......+....+....                   
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS  239 (294)
T ss_pred             cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence            2234567899999998765545789999999999999999999998765544433321100                   


Q ss_pred             --c--------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 --Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 --~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                        .        ......+.++.+++.+||+.+|++||++.++++||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence              0        0123567889999999999999999999999999999863

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-43  Score=298.29  Aligned_cols=253  Identities=30%  Similarity=0.491  Sum_probs=204.6

Q ss_pred             CCcccccccccCceEEEEEEEcc--CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIY   93 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   93 (294)
                      +|++.+.||+|++|.||+|.+..  ++..|++|.+.............+.+|+.++++++|||++++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  7899999998764323333456778899999999999999999999888  8899


Q ss_pred             EEEeccCCCChHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC----CCcEEEeeeccc
Q 022617           94 VVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS----KWNVKIADFGLS  164 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~----~~~~~l~dfg~~  164 (294)
                      +|+|++++ +|.+++...     ..+++..++.++.|++.++.|||+.+++|+||+|+||+++.    ++.++|+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999975 787777532     26899999999999999999999999999999999999999    899999999998


Q ss_pred             ccccCCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHH--
Q 022617          165 NIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN---------LFKKI--  229 (294)
Q Consensus       165 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---------~~~~~--  229 (294)
                      ........    .....++..|+|||.+.+....+.++|+||||+++++|++|+.||.......         ....+  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            76543221    2233567889999988765544789999999999999999999997543221         00000  


Q ss_pred             ------------------------hCCCccCC-----------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          230 ------------------------KGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       230 ------------------------~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                              .......+           ...+..+.+++.+||+.||++|||+.++++||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                                    00000111           1466789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.8e-43  Score=294.20  Aligned_cols=256  Identities=25%  Similarity=0.408  Sum_probs=209.0

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ++|...+.||.|++|.||++.+..+++.+++|.+......  .....+.+|+.++.++. |+|++++++++..++..+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            4677889999999999999999999999999998654322  34567888999999996 99999999999989999999


Q ss_pred             EeccCCCChHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           96 MEYVKSGELFDYIV-----EKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        96 ~e~~~~~sL~~~l~-----~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      +|++.+ ++.++..     ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            999864 7766542     235689999999999999999999974 999999999999999999999999999876554


Q ss_pred             CCccccccCCCcccCCccccCC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhCC-CccC----CCCCC
Q 022617          170 GHFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGG-IYTL----PSHLS  241 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~-~~~~----~~~~~  241 (294)
                      ........++..|+|||.+.+.  ...+.++|+||+|+++|+|++|+.||..... ......+... ....    +..++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS  240 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence            4433444678889999998765  2347899999999999999999999976432 1222222221 1122    22478


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      .++.+++.+||+.+|++|||++++++||||+...
T Consensus       241 ~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            8999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-43  Score=293.14  Aligned_cols=253  Identities=30%  Similarity=0.535  Sum_probs=204.8

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||.|++|.||+|.++.+++.|++|.+.......  ....+.+|++++++++|+||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            478999999999999999999999899999999986543221  223466899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      +||+.+ +|.+++.+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            999975 999988654 468999999999999999999999999999999999999999999999999886543221 11


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhCC--------------------
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGG--------------------  232 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~--------------------  232 (294)
                      ....++..|+|||.+.+....+.++|+||+|+++|+|++|..||.... ..+....+...                    
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            223457789999998765444788999999999999999999996554 22222111100                    


Q ss_pred             -Cc---------cCCCCCC--hhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          233 -IY---------TLPSHLS--PGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       233 -~~---------~~~~~~~--~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                       ..         ......+  .++.+++.+||..+|++|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence             00         0001233  788899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.8e-43  Score=292.77  Aligned_cols=253  Identities=28%  Similarity=0.468  Sum_probs=203.2

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++......  .....+.+|+.+++.++|+|++++++++..++..+++
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            36899999999999999999999989999999998654322  2234567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      +||+. ++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            99996 577776654 3567888999999999999999999999999999999999999999999999886543221 22


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhC------------------CCc
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKG------------------GIY  234 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~------------------~~~  234 (294)
                      ....++..|+|||.+.+....+.++|+||||+++|+|++|..||...... +....+..                  ...
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            33346789999999876544477899999999999999999999764421 11111100                  000


Q ss_pred             c-----CC---------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 T-----LP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 ~-----~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      .     .+         ...+.++.+++.+|+..||.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            0     00         1235688999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.7e-43  Score=293.61  Aligned_cols=249  Identities=26%  Similarity=0.430  Sum_probs=208.1

Q ss_pred             cCCcccccccccCceEEEEEEEccCCc--eEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   93 (294)
                      ++|++.+.||.|++|.||+|.++.++.  .+++|.+...  ......+.+.+|+++++++ +|||++++++++...+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            589999999999999999999877665  4677776422  2223456788999999999 6999999999999989999


Q ss_pred             EEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617           94 VVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK  157 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~  157 (294)
                      +++||+++++|.+++.+..                .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999996532                478899999999999999999999999999999999999999999


Q ss_pred             EeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-cc
Q 022617          158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YT  235 (294)
Q Consensus       158 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~  235 (294)
                      |+|||++..............+..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.... ..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~  238 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME  238 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            999999864322211122223457999999877766 789999999999999997 999998888777776665543 44


Q ss_pred             CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .+..++..+.+++.+||+.+|.+|||++++++.
T Consensus       239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            566789999999999999999999999999774

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-42  Score=290.45  Aligned_cols=257  Identities=30%  Similarity=0.463  Sum_probs=211.1

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--CCeEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYV   94 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l   94 (294)
                      ++|...+.||.|++|.||++.+..+++.+++|.+.....  ......+.+|++++++++|+||+++++++..  .+..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            478899999999999999999998999999999864422  2445778999999999999999999998854  347899


Q ss_pred             EEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           95 VMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ++||+++++|.+++..    ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999988753    345889999999999999999999999999999999999999999999999998654332


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhCCC-ccCC------C
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-----NIPNLFKKIKGGI-YTLP------S  238 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~~-~~~~------~  238 (294)
                      .. ....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...     ...+....+.... ..++      .
T Consensus       159 ~~-~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd06621         159 LA-GTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI  236 (287)
T ss_pred             cc-ccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence            21 23346778999999887766 78999999999999999999999765     2233333333311 1111      1


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      ..++.+.+++.+||..+|++|||+.|+++||||++...+
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence            245689999999999999999999999999999776554

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=287.46  Aligned_cols=243  Identities=28%  Similarity=0.486  Sum_probs=212.9

Q ss_pred             ccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEecc
Q 022617           23 KTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV   99 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   99 (294)
                      +.||.|++|.||+|.+...   +..+++|.+.......  ....+.+|+++++.++|+|++++++++......++++||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4689999999999999866   8899999986554322  4678899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617          100 KSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus       100 ~~~sL~~~l~~~---------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ++++|.+++...         ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         77999999999999999999999999999999999999999999999999998766543


Q ss_pred             C---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHH
Q 022617          171 H---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGAR  245 (294)
Q Consensus       171 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~  245 (294)
                      .   ......++..|+|||.+....+ +.++|+||||+++|+|++ |..||.........+.+... ....+..++.++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY  237 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence            2   2234456788999999877655 789999999999999999 69999988888777777643 3456678899999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcC
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      +++.+||+.+|++|||+.+++++
T Consensus       238 ~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         238 ELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.7e-43  Score=291.12  Aligned_cols=249  Identities=28%  Similarity=0.441  Sum_probs=213.0

Q ss_pred             ccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      .++|.+.+.||.|++|.||+|.+..     ++..+++|.+....  .....+.+.+|++++++++|+|++++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            4679999999999999999998743     35789999986443  2234578899999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcE
Q 022617           91 DIYVVMEYVKSGELFDYIVEKG--------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV  156 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~--------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~  156 (294)
                      ..++++||+++++|.+++...+              .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            9999999999999999997542              37888999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC
Q 022617          157 KIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG  232 (294)
Q Consensus       157 ~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~  232 (294)
                      +|+|||.+........   ......+..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            9999999875432221   123334678999999987776 789999999999999998 99999888888777777765


Q ss_pred             Cc-cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          233 IY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       233 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .. ..+..++..+.+++.+||+.||++||++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            54 345678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-43  Score=303.67  Aligned_cols=259  Identities=31%  Similarity=0.500  Sum_probs=212.2

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----CC
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PS   90 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~   90 (294)
                      +.++|.+.+.||.|++|.||+|.++.+++.|++|++..... .......+.+|+.++++++|+||+++++++..    ..
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            45899999999999999999999999999999999865432 22345677889999999999999999988753    35


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .+++++||+. ++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            6899999996 599999987788999999999999999999999999999999999999999999999999998654332


Q ss_pred             Cc-----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC--------------
Q 022617          171 HF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--------------  231 (294)
Q Consensus       171 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--------------  231 (294)
                      ..     .....++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+.......+..              
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            21     12345788999999986644447899999999999999999999976654332221110              


Q ss_pred             ------------CCcc-----CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          232 ------------GIYT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       232 ------------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                                  ....     .....+.++.++|.+||+.+|++||++.+++.||||++.-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence                        0000     1145688999999999999999999999999999997653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=286.12  Aligned_cols=253  Identities=32%  Similarity=0.557  Sum_probs=213.9

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeeccc--ccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK--IKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI   92 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   92 (294)
                      .+|++.+.||.|++|.||+|.+..+++.+++|.+....  .........+.+|++++++++|+|++++++++...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999999999999999875431  12234457888999999999999999999998654  468


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++++|++++++|.+++.+.+.+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            8999999999999999887889999999999999999999999999999999999999999999999999987543211 


Q ss_pred             ---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCCCCCChhHHH
Q 022617          172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD  246 (294)
Q Consensus       172 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~  246 (294)
                         ......++..|+|||.+.+... +.++|+||||++++++++|+.||...........+...  ...++..++..+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence               1123346788999999987665 78999999999999999999999876655544444322  24457788999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      ++.+||+ +|..||++.+++.|||.
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999 57999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1e-42  Score=293.13  Aligned_cols=254  Identities=31%  Similarity=0.475  Sum_probs=205.7

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCe----
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSD----   91 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~----   91 (294)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.+. |+|++++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            479999999999999999999999999999999765432 2223467788999999996 5999999999876665    


Q ss_pred             -EEEEEeccCCCChHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeeccc
Q 022617           92 -IYVVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLS  164 (294)
Q Consensus        92 -~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~  164 (294)
                       .++++||+++ +|.+++...     ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999986 888888643     35799999999999999999999999999999999999998 889999999988


Q ss_pred             ccccCC-CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC----------
Q 022617          165 NIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------  233 (294)
Q Consensus       165 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------  233 (294)
                      ...... .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+....          
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            754322 111223457789999998765444789999999999999999999998765444332221100          


Q ss_pred             ----------c--------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617          234 ----------Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       234 ----------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                                .        .....++.++.++|.+||..+|.+||++.+++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                      0        00134788899999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-43  Score=300.89  Aligned_cols=258  Identities=35%  Similarity=0.559  Sum_probs=208.0

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----   89 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   89 (294)
                      +.++|++.+.||.|++|.||+|.+..+++.|++|++...  ........+.+|+.++++++|+|++++++++...     
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            568999999999999999999999999999999998532  2223456678899999999999999999886543     


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      ...++++|++.+ +|.+.+. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          81 NDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             ceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            358999999965 8888774 45789999999999999999999999999999999999999999999999999865432


Q ss_pred             CCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---------------
Q 022617          170 GHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK---------------  230 (294)
Q Consensus       170 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~---------------  230 (294)
                      ...    .....++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+.......+.               
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            221    1223567889999987654444789999999999999999999997654332221110               


Q ss_pred             CCC-----------c-----cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          231 GGI-----------Y-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       231 ~~~-----------~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ...           .     ...+..+.++.+++.+||+.+|++|||+.++++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            000           0     011346788999999999999999999999999999987753

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-43  Score=302.13  Aligned_cols=263  Identities=30%  Similarity=0.475  Sum_probs=216.5

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ....+.++|++.+.||.|++|.||+|.+..+++.|++|++.... ........+.+|+.++++++|+|++++.+++...+
T Consensus         9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07851           9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS   87 (343)
T ss_pred             ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence            34567889999999999999999999999899999999986542 22234566788999999999999999988776554


Q ss_pred             e------EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           91 D------IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        91 ~------~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                      .      .++++|++ +++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        88 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          88 SLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence            3      89999999 5599998864 57899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc----------
Q 022617          165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----------  234 (294)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  234 (294)
                      ......  .....++..|+|||.+.+....+.++|+||||+++|++++|+.||...........+.....          
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            765433  22345677899999986544447899999999999999999999977665444433322110          


Q ss_pred             ---------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          235 ---------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       235 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                                           .....++..+.+++.+||+.+|++|||+.+++.||||+++..+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence                                 11124688999999999999999999999999999999886654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-44  Score=316.68  Aligned_cols=251  Identities=31%  Similarity=0.486  Sum_probs=208.1

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEE-EEEc---
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYE-VIET---   88 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~-~~~~---   88 (294)
                      +=..+++|.+.|.+|||+.||+|.+...+..||+|.+..   .++...+.+.+|++++++|+ |+||+.+++ ....   
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            334578899999999999999999987779999999853   36678899999999999998 999999999 3321   


Q ss_pred             C---CeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCCCcEEEeee
Q 022617           89 P---SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADF  161 (294)
Q Consensus        89 ~---~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~~~~~l~df  161 (294)
                      .   -.+.++||||+|+.|-+++..+  ..|++.++++|+.|+++|+++||...  |+|||||-+||||+.+|++|||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence            1   2478999999999999999753  45999999999999999999999998  999999999999999999999999


Q ss_pred             cccccccCCCccc----------cccCCCcccCCcccc--CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022617          162 GLSNIMRDGHFLK----------TSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI  229 (294)
Q Consensus       162 g~~~~~~~~~~~~----------~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~  229 (294)
                      |.++.........          ...-|+.|+|||.+.  .....+.++|||+|||++|.||....||+......    |
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----I  266 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----I  266 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----E
Confidence            9987543222111          113589999999863  34444899999999999999999999998764433    4


Q ss_pred             hCCCccCC--CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          230 KGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       230 ~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      ..+.+.+|  +.++..+.+||+.||+.||++||++.|++.+-+-
T Consensus       267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence            45555555  4799999999999999999999999998875443

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2e-42  Score=290.53  Aligned_cols=248  Identities=29%  Similarity=0.454  Sum_probs=210.5

Q ss_pred             ccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ..+|.+.+.||.|++|.||++.+.     .++..+++|.+...   .....+.+.+|++++++++|+|++++++++...+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            457999999999999999999853     34556889987533   2234567899999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617           91 DIYVVMEYVKSGELFDYIVEKG-------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK  157 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~-------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~  157 (294)
                      ..++++||+++++|.+++...+             .+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            9999999999999999997543             389999999999999999999999999999999999999999999


Q ss_pred             EeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC
Q 022617          158 IADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI  233 (294)
Q Consensus       158 l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~  233 (294)
                      |+|||.+........   .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..+.
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999875532221   122234668999999887665 789999999999999998 999998887777777776655


Q ss_pred             -ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       234 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                       ...+..++.++.+++.+||+.+|.+|||+.++++
T Consensus       240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             3445678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-42  Score=291.15  Aligned_cols=251  Identities=32%  Similarity=0.557  Sum_probs=208.2

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      +|++.+.||.|++|.||+|.+..++..+++|++......  .....+.+|+.++++++|+|++++++++...+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            589999999999999999999999999999998655322  224567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617           98 YVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL  173 (294)
Q Consensus        98 ~~~~~sL~~~l~~~---~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  173 (294)
                      |+.+ +|.+++...   ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            9975 898888654   358999999999999999999999999999999999999999999999999986543321 12


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------------------c-
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------Y-  234 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~-  234 (294)
                      ....++..|++||.+.+....+.++|+|+||+++|++++|..||...+..+....+....                  . 
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            234467789999998765544789999999999999999999998765544333321100                  0 


Q ss_pred             ----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 ----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                ...+.++..+.+++.+||+.||.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                      0112457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-42  Score=285.89  Aligned_cols=245  Identities=29%  Similarity=0.526  Sum_probs=209.2

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|+||.||++.++ ++..+++|.+.....    ....+.+|+.++++++|||++++++++...+..++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            56899999999999999999876 456799998754332    2457888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc-
Q 022617           97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-  174 (294)
                      ||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence            999999999998653 468999999999999999999999999999999999999999999999999887653332221 


Q ss_pred             -cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617          175 -TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       175 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~  251 (294)
                       ...++..|+|||.+.+..+ +.++|+||+|+++|++++ |+.||...+..+....+..+. ...+...+..+.+++.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC  237 (256)
T ss_pred             CCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence             2234567999999887666 789999999999999999 999999888777777776554 344566788999999999


Q ss_pred             cccCCCCCCCHhHHhc
Q 022617          252 LIVDPMKRITIPEIRQ  267 (294)
Q Consensus       252 l~~~p~~Rps~~~il~  267 (294)
                      |+.+|++|||+.++++
T Consensus       238 ~~~~p~~Rps~~~l~~  253 (256)
T cd05114         238 WHEKPEGRPTFAELLR  253 (256)
T ss_pred             ccCCcccCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.4e-42  Score=291.88  Aligned_cols=260  Identities=30%  Similarity=0.519  Sum_probs=217.7

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      .|.....||.|++|.||++.+..+++.+++|.+....   ......+.+|+.+++.++|+|++++++++...+..++++|
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence            3444578999999999999999899999999875332   2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccccc
Q 022617           98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS  176 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~  176 (294)
                      |+++++|.+++. +..+++..+..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657          98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            999999999874 4568999999999999999999999999999999999999999999999999876543321 22234


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCChhHHHHHHHhcc
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~  253 (294)
                      .++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+.....   .....++..+.+++.+||+
T Consensus       177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (292)
T cd06657         177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV  255 (292)
T ss_pred             ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence            56788999999876665 7899999999999999999999987766555554443322   2234678899999999999


Q ss_pred             cCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617          254 VDPMKRITIPEIRQHPWFQAHLPRYLAVP  282 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~~~~~~~~~~~~  282 (294)
                      .+|.+||++.++++||||....+..+.++
T Consensus       256 ~~P~~R~~~~~ll~~~~~~~~~~~~~~~~  284 (292)
T cd06657         256 RDPAQRATAAELLKHPFLAKAGPPSCIVP  284 (292)
T ss_pred             CCcccCcCHHHHhcChHHhccCCCccccc
Confidence            99999999999999999999876655433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-43  Score=291.62  Aligned_cols=245  Identities=37%  Similarity=0.565  Sum_probs=204.4

Q ss_pred             cccccccccCceEEEEEEEc----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           20 KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        20 ~~~~~lg~g~~~~vy~~~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .+.+.||.|.||.||+|.+.    ..+..|+||.+...  ...+..+.+.+|++.+++++||||+++++++...+..+++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            35688999999999999987    44578999998442  2334478899999999999999999999999988889999


Q ss_pred             EeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--
Q 022617           96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--  171 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--  171 (294)
                      +||+.+++|.+++...  ..++...++.++.|++.||.|||+.+++|++|+++||+++.++.+||+|||++.......  
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999876  679999999999999999999999999999999999999999999999999987662221  


Q ss_pred             -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHH
Q 022617          172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI  248 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  248 (294)
                       ..........|+|||.+....+ +.++||||||+++|++++ |+.||...........+.... ...+..++..+.+++
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence             1233346678999999877766 799999999999999999 789999888888888876655 345667999999999


Q ss_pred             HHhcccCCCCCCCHhHHhc
Q 022617          249 PRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~  267 (294)
                      .+||..+|++|||+.+|++
T Consensus       239 ~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  239 QQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHT-SSGGGS--HHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHh
Confidence            9999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.4e-43  Score=303.69  Aligned_cols=250  Identities=28%  Similarity=0.459  Sum_probs=204.2

Q ss_pred             cccCCcccccccccCceEEEEEEEccC-----CceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET   88 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   88 (294)
                      -.++|++.+.||.|+||.||+|.+...     +..|++|.+......  .....+.+|+.+++.+ +|+||+++++.+..
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            345799999999999999999986443     357999998654322  3356788999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHh---------------------------------------------------------
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEK---------------------------------------------------------  111 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------------------  111 (294)
                      ....+++|||+.+++|.+++...                                                         
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            99999999999999999998542                                                         


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc---cc
Q 022617          112 -------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KT  175 (294)
Q Consensus       112 -------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~---~~  175 (294)
                                   .++++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........   ..
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                         13678889999999999999999999999999999999999999999999998755332211   12


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH-HhCC-CccCCCCCChhHHHHHHHhc
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKK-IKGG-IYTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~-~~~~-~~~~~~~~~~~l~~li~~~l  252 (294)
                      ..++..|+|||++.+..+ +.++||||||+++|+|++ |..||........... +... ....+...+.++.+++.+||
T Consensus       274 ~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  352 (374)
T cd05106         274 ARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW  352 (374)
T ss_pred             CCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence            224567999999877666 789999999999999997 9999977554333323 2222 23345567899999999999


Q ss_pred             ccCCCCCCCHhHHhc
Q 022617          253 IVDPMKRITIPEIRQ  267 (294)
Q Consensus       253 ~~~p~~Rps~~~il~  267 (294)
                      +.+|.+|||+.++++
T Consensus       353 ~~dp~~RPs~~~l~~  367 (374)
T cd05106         353 NLEPTERPTFSQISQ  367 (374)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-43  Score=292.11  Aligned_cols=251  Identities=31%  Similarity=0.532  Sum_probs=209.7

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeEEEEE
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIYVVM   96 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~   96 (294)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+.... ........+.+|+++++.++|+|++++++++...  +..++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            778999999999999999999889999999997654 2233456788899999999999999999999887  8999999


Q ss_pred             eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--cc
Q 022617           97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FL  173 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~  173 (294)
                      ||+++ +|.+++.+. ..+++..++.++.|++.|+++||+.|++|+||+|+||++++++.++|+|||.+.......  ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            99975 899888665 579999999999999999999999999999999999999999999999999987665433  12


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-------------------
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------------  234 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------  234 (294)
                      ....++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+.....                   
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            3344577899999876554447899999999999999999999987665554443322110                   


Q ss_pred             ------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 ------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                  .+...++..+.+++.+||+.+|++||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                        0001137889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.1e-42  Score=284.72  Aligned_cols=242  Identities=29%  Similarity=0.501  Sum_probs=204.5

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG  102 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  102 (294)
                      +.||.|++|.||+|.+..+++.+++|.+....  .......+.+|++++++++|+||+++++++...+..++++||+.++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            46899999999999999899999999875332  2344577899999999999999999999999999999999999999


Q ss_pred             ChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc---cccC
Q 022617          103 ELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---TSCG  178 (294)
Q Consensus       103 sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~---~~~~  178 (294)
                      +|.+++.+.. .+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+..........   ....
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            9999997644 58999999999999999999999999999999999999999999999999987543322111   1122


Q ss_pred             CCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHHhcccCC
Q 022617          179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDP  256 (294)
Q Consensus       179 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p  256 (294)
                      +..|+|||.+.+..+ +.++|+||||+++|++++ |..||...........+... ....+..++..+.+++.+||+.+|
T Consensus       159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence            456999999887766 789999999999999997 99999877766655555433 345566789999999999999999


Q ss_pred             CCCCCHhHHhc
Q 022617          257 MKRITIPEIRQ  267 (294)
Q Consensus       257 ~~Rps~~~il~  267 (294)
                      ++|||+.++++
T Consensus       238 ~~Rps~~~~~~  248 (252)
T cd05084         238 GQRPSFSTVHQ  248 (252)
T ss_pred             hhCcCHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=311.49  Aligned_cols=254  Identities=28%  Similarity=0.441  Sum_probs=221.6

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      +-|.|+..||.|+||.||+|..+.++-..+-|++.   ....+..+++.-|+++|..+.||+|+++++.|...+.+|++.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            45788899999999999999999888888889884   344566788899999999999999999999988899999999


Q ss_pred             eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCccc
Q 022617           97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLK  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~~  174 (294)
                      |+|+||-++..+-. ...+++.++..+++|++.||.|||+.+|+|+|+|..|||++-+|.++|.|||.+.... .....+
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD  188 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD  188 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence            99999999887754 5679999999999999999999999999999999999999999999999999875432 223446


Q ss_pred             cccCCCcccCCcccc-----CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc---CCCCCChhHHH
Q 022617          175 TSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---LPSHLSPGARD  246 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~  246 (294)
                      ...|||+|||||+..     ..+| ++++||||||+++.+|..+.+|....++...+-++.+..++   -|+.-+..+.+
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PY-DykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D  267 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD  267 (1187)
T ss_pred             cccCCcccccchheeeccccCCCc-hhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence            678999999999863     3445 79999999999999999999999888877777777665543   35677889999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      |+.+||.+||..||++.+||+||||++.
T Consensus       268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  268 FLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            9999999999999999999999999864

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9e-43  Score=302.51  Aligned_cols=251  Identities=29%  Similarity=0.465  Sum_probs=205.4

Q ss_pred             cccCCcccccccccCceEEEEEEE-----ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET   88 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   88 (294)
                      -.++|++.+.||.|+||.||+|.+     ..++..|++|++.....  ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            345899999999999999999974     34566899999864332  23356788999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhC--------------------------------------------------------
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKG--------------------------------------------------------  112 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~--------------------------------------------------------  112 (294)
                      ....+++|||+++++|.+++.+..                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999999986421                                                        


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-
Q 022617          113 -------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-  172 (294)
Q Consensus       113 -------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-  172 (294)
                                         .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ 
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                               367888999999999999999999999999999999999999999999999876543221 


Q ss_pred             --cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHhCCC-ccCCCCCChhHHHH
Q 022617          173 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLFKKIKGGI-YTLPSHLSPGARDL  247 (294)
Q Consensus       173 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~~l~~l  247 (294)
                        .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...... ...+.+..+. ...+...+.++.++
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  349 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI  349 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence              112234567999999987766 789999999999999998 89999765433 3334444332 33455678899999


Q ss_pred             HHHhcccCCCCCCCHhHHhcC
Q 022617          248 IPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h  268 (294)
                      +.+||+.||++|||+.++++.
T Consensus       350 i~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         350 MKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-42  Score=286.22  Aligned_cols=250  Identities=27%  Similarity=0.440  Sum_probs=212.3

Q ss_pred             ccCCcccccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      .++|++.+.||.|+||.||+|.++.+   ...+++|.+....  .......+.+|+.++++++|+|++++++++...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            35799999999999999999998644   4579999876432  233456788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++++|++.+++|.+++... +.++...++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999999764 468999999999999999999999999999999999999999999999999988764211


Q ss_pred             c---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHH
Q 022617          172 F---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARD  246 (294)
Q Consensus       172 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  246 (294)
                      .   ......+..|+|||.+.+..+ +.++|+||||+++|++++ |..||...........+... ..+.+..++..+.+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1   112233568999999887666 789999999999999998 99999887777777776654 34556678999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcC
Q 022617          247 LIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ++.+||+.+|++||++.+++++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-42  Score=287.82  Aligned_cols=250  Identities=29%  Similarity=0.500  Sum_probs=210.8

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||++.+..++..+++|.+......+......+.+|+.+++.++|+|++++++++..++..++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            68999999999999999999998899999999887654444455678889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           97 EYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        97 e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      |++++++|.+++..    ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99999999998864    3458999999999999999999999999999999999999999999999999887654322 


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhCCCc-cC-CCCCChhHHHH
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI--PNLFKKIKGGIY-TL-PSHLSPGARDL  247 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~~~~-~~-~~~~~~~l~~l  247 (294)
                      ......++..|+|||.+.+... +.++|+||+|+++|+|++|..||.....  ......+..... +. +..++..+.++
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL  240 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence            1223457889999999877666 7889999999999999999999975432  333333433222 22 23578899999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+||..+|++|||+.+|++
T Consensus       241 i~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         241 VNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHhcCCCcccCCCHHHHHH
Confidence            99999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=277.59  Aligned_cols=256  Identities=29%  Similarity=0.397  Sum_probs=208.8

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      ..+-+-.+||++.+.||.|||+.||++++..+++.||+|.+.+..   .+..+...+|++..++++|||+++++++....
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            344556789999999999999999999999999999999997665   34578999999999999999999998876433


Q ss_pred             -----CeEEEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCCCcEEE
Q 022617           90 -----SDIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKI  158 (294)
Q Consensus        90 -----~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~~~~~l  158 (294)
                           ...|++++|+..|||.+.+++.    ..+++.++..++.+++.||.+||+..  ++|+||||.||++++.+.+++
T Consensus        91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence                 3489999999999999999753    36999999999999999999999998  999999999999999999999


Q ss_pred             eeecccccccCCCc----------cccccCCCcccCCcccc--CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--
Q 022617          159 ADFGLSNIMRDGHF----------LKTSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN--  224 (294)
Q Consensus       159 ~dfg~~~~~~~~~~----------~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~--  224 (294)
                      .|||.++...-.-.          ......+..|+|||.+.  .....+.++|||||||++|.||.|..||+..-...  
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            99999876532211          11234688999999875  23334789999999999999999999995422111  


Q ss_pred             HHHHHhCCC--ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          225 LFKKIKGGI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       225 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      +.-.+..+.  ++..+.++..+.++|+.||+.||.+||++.+++.+
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            000112222  23335699999999999999999999999999864

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.2e-42  Score=285.20  Aligned_cols=250  Identities=30%  Similarity=0.497  Sum_probs=212.0

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+.............+.+|++++++++|++++++++++...+..++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999899999999987554444455678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           97 EYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        97 e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ||+++++|.+++.+    ...+++..++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999999864    24589999999999999999999999999999999999999999999999999876543321


Q ss_pred             -cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhCCC-ccCCC-CCChhHHHH
Q 022617          173 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGI-YTLPS-HLSPGARDL  247 (294)
Q Consensus       173 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~-~~~~~l~~l  247 (294)
                       .....++..|.|||.+.+..+ +.++|+||||+++|+|++|..||....  .....+.+..+. .+.+. .++..+.++
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL  240 (267)
T ss_pred             ccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHH
Confidence             223457788999999887766 789999999999999999999996543  333444443332 23333 678899999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+||..+|++|||+.+|++
T Consensus       241 i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         241 VSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2e-42  Score=285.64  Aligned_cols=246  Identities=26%  Similarity=0.475  Sum_probs=208.5

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||+|++|.||.+.+. .+..+++|.+.....    ....+.+|+.++++++||||+++++++......++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            57899999999999999999875 345699998764432    2356889999999999999999999999888999999


Q ss_pred             eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc-
Q 022617           97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-  174 (294)
                      ||+.+++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            999999999999764 468999999999999999999999999999999999999999999999999887554332211 


Q ss_pred             -cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617          175 -TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       175 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~  251 (294)
                       ...++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..+. ...+...+..+.+++.+|
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC  237 (256)
T ss_pred             CCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence             2234567999999987666 789999999999999998 999998877776666665544 334556789999999999


Q ss_pred             cccCCCCCCCHhHHhcC
Q 022617          252 LIVDPMKRITIPEIRQH  268 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h  268 (294)
                      |..+|.+||++.+|+++
T Consensus       238 l~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         238 WHEKAEERPTFQQLLSS  254 (256)
T ss_pred             cCCCcccCCCHHHHHHh
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-42  Score=285.03  Aligned_cols=246  Identities=25%  Similarity=0.480  Sum_probs=209.4

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      .+|++.+.||.|++|.||++.++ ++..+++|.+......    ...+.+|+++++.++|+|++++++++...+..++++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            46899999999999999999886 5668999997543322    346778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc-
Q 022617           97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-  174 (294)
                      |++++++|.+++..+ ..+++..++.++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999999999999754 468999999999999999999999999999999999999999999999999987654332211 


Q ss_pred             -cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617          175 -TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       175 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~  251 (294)
                       ....+..|+|||.+.+..+ +.++|+||||+++|++++ |..||......+....+.... ...+..++..+.+++.+|
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC  237 (256)
T ss_pred             CCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence             1123457999999887766 789999999999999999 899998877777777666553 455667899999999999


Q ss_pred             cccCCCCCCCHhHHhcC
Q 022617          252 LIVDPMKRITIPEIRQH  268 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h  268 (294)
                      |..+|++|||+.++++.
T Consensus       238 l~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         238 WHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             hcCChhhCcCHHHHHHH
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=305.91  Aligned_cols=244  Identities=27%  Similarity=0.447  Sum_probs=216.2

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ++-.+...-++-||+|+.|.||+++.  .++.||||.+.          +.-..+|+-|++|+|+||+.+.++|...-.+
T Consensus       120 eiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~----------elkETdIKHLRkLkH~NII~FkGVCtqsPcy  187 (904)
T KOG4721|consen  120 EIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVR----------ELKETDIKHLRKLKHPNIITFKGVCTQSPCY  187 (904)
T ss_pred             cCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHh----------hhhhhhHHHHHhccCcceeeEeeeecCCcee
Confidence            44455566678899999999999986  56789999752          2234678999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      |||||||..|.|...|+...+++......|..+|+.++.|||.+.|+|+|||.-||||+.+..+||+|||-+........
T Consensus       188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST  267 (904)
T KOG4721|consen  188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST  267 (904)
T ss_pred             EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987766666


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCCCCCChhHHHHHHH
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPR  250 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~  250 (294)
                      .....||..|||||++...+. +.+.||||||+++|||+||..||.+.+...++=-+-.+.  .+.|..++..++-|+++
T Consensus       268 kMSFaGTVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kq  346 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQ  346 (904)
T ss_pred             hhhhhhhHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHH
Confidence            677789999999999999888 899999999999999999999998877666543333322  56788999999999999


Q ss_pred             hcccCCCCCCCHhHHhcCC
Q 022617          251 MLIVDPMKRITIPEIRQHP  269 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~h~  269 (294)
                      ||+..|.+||++.+||.|-
T Consensus       347 cw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  347 CWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HHhcCCCCCccHHHHHHHH
Confidence            9999999999999999874

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.2e-42  Score=298.60  Aligned_cols=255  Identities=29%  Similarity=0.498  Sum_probs=207.0

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----   89 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   89 (294)
                      +.++|.+.+.||.|++|.||+|.+..+++.|++|.+.....   ...+.+.+|++++++++|+|++++++.+...     
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            56899999999999999999999999999999999865432   3456788899999999999999998776443     


Q ss_pred             ---------CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEe
Q 022617           90 ---------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIA  159 (294)
Q Consensus        90 ---------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~  159 (294)
                               ...++++||+++ +|.+++. ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++. ++.++|+
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                     357899999974 8988875 457899999999999999999999999999999999999974 5578999


Q ss_pred             eecccccccCCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--
Q 022617          160 DFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--  233 (294)
Q Consensus       160 dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--  233 (294)
                      |||.+........    .....++..|+|||.+......+.++||||||+++|+|++|+.||...........+....  
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999875532211    1223467789999987654444789999999999999999999997665444333322110  


Q ss_pred             -----------------------c-----cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 -----------------------Y-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 -----------------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                             .     .....++.++.+++.+||+.||.+|||+.++++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                                   0     0123567889999999999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=305.78  Aligned_cols=254  Identities=30%  Similarity=0.382  Sum_probs=224.0

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      -...|.-++.||.|+||.||.|+|..+.+.|+||.+..+.....+-.+++..|+..|++++|||++.+-++|..+...|+
T Consensus        24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL  103 (948)
T KOG0577|consen   24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL  103 (948)
T ss_pred             HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence            34568888999999999999999999999999999988877777778999999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           95 VMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      |||||-| |-.+++.- .+++.+.+|..+..+.+.+|+|||+.+.+|+|||..|||+++.|.|||+|||.+......   
T Consensus       104 VMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  104 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             HHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            9999954 99998864 578999999999999999999999999999999999999999999999999998765433   


Q ss_pred             ccccCCCcccCCcccc---CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCC-CCChhHHHHH
Q 022617          174 KTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPS-HLSPGARDLI  248 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li  248 (294)
                      ++.+|||.|||||++.   .+.| +-+.||||||+++.++...++|+.+++.-...-.|..+. +.+.. .-+..+.+|+
T Consensus       180 nsFvGTPywMAPEVILAMDEGqY-dgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv  258 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  258 (948)
T ss_pred             hcccCCccccchhHheecccccc-CCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence            4678999999999974   3334 678999999999999999999988887666666665443 44443 4577899999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCcccc
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      ..||++-|.+|||.+++|+|+|+..
T Consensus       259 d~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  259 DSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             HHHHhhCcccCCcHHHHhhcchhcc
Confidence            9999999999999999999999976

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-42  Score=296.84  Aligned_cols=262  Identities=30%  Similarity=0.465  Sum_probs=214.6

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      .+..+.++|++.+.||.|++|.||++.+..+++.|++|++.... ........+.+|+.+++.++|+||+++++++....
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            34557899999999999999999999999999999999985432 22334567889999999999999999999986543


Q ss_pred             ------eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           91 ------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        91 ------~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                            ..++++|++ +++|.+++. +..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence                  458999999 669988875 467899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc----------
Q 022617          165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----------  234 (294)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  234 (294)
                      ......  .....++..|+|||.+.+....+.++|+||||+++|++++|..||...+.......+.....          
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            755332  22335678899999987644447899999999999999999999987654433332211110          


Q ss_pred             ---------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          235 ---------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       235 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                                           .....++..+.+++.+||..||++|||+.+++.||||+.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence                                 1124567889999999999999999999999999999887443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.1e-42  Score=294.00  Aligned_cols=258  Identities=31%  Similarity=0.518  Sum_probs=211.0

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-   90 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   90 (294)
                      .....++|++.+.||.|++|.||+|.++.+++.|++|.+...... ......+.+|++++++++|||++++++++.... 
T Consensus         2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            456678999999999999999999999989999999998654322 223456778999999999999999999887654 


Q ss_pred             ---------eEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEee
Q 022617           91 ---------DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD  160 (294)
Q Consensus        91 ---------~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~d  160 (294)
                               ..++++||+++ ++...+.+. ..+++..++.++.|++.||++||+.|++|+||+|+||++++++.++|+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                     79999999976 777777654 4689999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc----
Q 022617          161 FGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----  234 (294)
Q Consensus       161 fg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~----  234 (294)
                      ||.+........  ......+..|+|||.+.+....+.++|+||||+++++|++|+.||...........+.....    
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            999876543321  12223567899999886554447899999999999999999999987665444433322110    


Q ss_pred             --------------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 --------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                                .....++..+.+++.+||+.+|.+||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                      0112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3e-42  Score=287.82  Aligned_cols=252  Identities=23%  Similarity=0.376  Sum_probs=209.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      ...++|++.+.||.|++|.||+|.+..     ++..+++|.+....  .......+.+|+.+++.++|+|++++++++..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            456789999999999999999998642     34679999875332  22234568899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEE
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI  158 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l  158 (294)
                      .+..++++||+.+++|.+++.+..          .++...+..++.|++.++.|||+.|++|+||+|+||+++.++.++|
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999999986532          2567788999999999999999999999999999999999999999


Q ss_pred             eeecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-
Q 022617          159 ADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-  233 (294)
Q Consensus       159 ~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-  233 (294)
                      +|||++.........   ....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+.... 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL  239 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            999998654332211   12234668999999887665 789999999999999999 799998887777776655443 


Q ss_pred             ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ...+..++..+.+++.+||+.+|++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            45566788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.2e-42  Score=287.62  Aligned_cols=251  Identities=23%  Similarity=0.368  Sum_probs=210.7

Q ss_pred             cccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      -.++|++.+.||.|++|.||+|.+..     ++..+++|.+....  .......+.+|+.++++++|+|++++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            34689999999999999999999976     67789999875432  223346688899999999999999999999888


Q ss_pred             CeEEEEEeccCCCChHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC---cEEEe
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKG-------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIA  159 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~---~~~l~  159 (294)
                      ...++++||+.+++|.+++.+..       .+++..+..++.|++.++.|||+.+++|+||+|+||+++.++   .++|+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            89999999999999999997653       488999999999999999999999999999999999998754   59999


Q ss_pred             eecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-Cc
Q 022617          160 DFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IY  234 (294)
Q Consensus       160 dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~  234 (294)
                      |||++.........   .....+..|+|||++.+..+ +.++||||||+++|+|++ |..||...........+... ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~  240 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL  240 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99998765322211   12223457999999987766 789999999999999997 99999887777766655443 34


Q ss_pred             cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ..+..++..+.+++.+||+.+|++|||+.++++|
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            5567789999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-42  Score=295.56  Aligned_cols=244  Identities=28%  Similarity=0.476  Sum_probs=189.9

Q ss_pred             cccccccCceEEEEEEEcc--CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE--cCCeEEEEEe
Q 022617           22 GKTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TPSDIYVVME   97 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e   97 (294)
                      ..+||.|+||.||+|.+..  ++..+++|.+....     ....+.+|++++++++|||++++++++.  .....++++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            3579999999999999654  55789999875432     1345778999999999999999999884  3567899999


Q ss_pred             ccCCCChHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe----cCCCcEEEeeeccc
Q 022617           98 YVKSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGLS  164 (294)
Q Consensus        98 ~~~~~sL~~~l~~~---------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili----~~~~~~~l~dfg~~  164 (294)
                      |+++ +|.+++...         ..+++..++.++.|++.||.|||+.|++|+||||+||++    +.++.++|+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            9965 888877521         248899999999999999999999999999999999999    45678999999999


Q ss_pred             ccccCCC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHh-
Q 022617          165 NIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------NLFKKIK-  230 (294)
Q Consensus       165 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------~~~~~~~-  230 (294)
                      .......    ......++..|+|||.+.+....+.++||||||+++|+|++|..||......         .....+. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            7654322    1223457889999999877554478999999999999999999999643211         0000000 


Q ss_pred             ---------------------------CCCc----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          231 ---------------------------GGIY----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       231 ---------------------------~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                                 ....          ......+..+.+++.+||..||.+|||+.|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                                       0000          0011234568899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-42  Score=284.40  Aligned_cols=247  Identities=25%  Similarity=0.428  Sum_probs=210.1

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      ..++|++.+.||.|++|.||+|.+. +++.+++|.+.....    ..+.+.+|+.++++++|+|++++++++...+..++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            3467999999999999999999975 456799999865432    24668889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           95 VMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ++|++.+++|.+++....  .++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999999997654  689999999999999999999999999999999999999999999999999876643222


Q ss_pred             cc--cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHH
Q 022617          173 LK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI  248 (294)
Q Consensus       173 ~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  248 (294)
                      ..  ....+..|+|||.+.+... +.++|+||||+++|+|++ |+.||...........+.... .+.+..++..+.+++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM  237 (261)
T ss_pred             cccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            11  1122357999999887666 789999999999999999 999998887777666665442 345567899999999


Q ss_pred             HHhcccCCCCCCCHhHHhc
Q 022617          249 PRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~  267 (294)
                      .+||+.+|++||++.++++
T Consensus       238 ~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         238 LDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHhhcCcccCCCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-43  Score=313.81  Aligned_cols=251  Identities=28%  Similarity=0.477  Sum_probs=221.6

Q ss_pred             ccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      .-..+-+..+.||+|.||.||+|+..     .....||||.++..  .+.....++++|++++..++||||++++|+|..
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            33456777899999999999999754     23457999987543  233467899999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKG--------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW  154 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~--------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~  154 (294)
                      .+-+++|+|||..|+|.++|..+.              +++..+...++.||+.++.||.++.++|+||-++|+||.++-
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence            999999999999999999996432              288899999999999999999999999999999999999999


Q ss_pred             cEEEeeecccccccCCCccc---cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 022617          155 NVKIADFGLSNIMRDGHFLK---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK  230 (294)
Q Consensus       155 ~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~  230 (294)
                      .|||+|||+++......+..   ...-+.+|||||.+..+++ +.+|||||+|+++||+++ |+.||.+...++.++.+.
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            99999999998776555432   3345789999999999999 899999999999999999 999999999999999998


Q ss_pred             CCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          231 GGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       231 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+. .+.|.++|.++.+||..||+.+|++||++.||-.
T Consensus       720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  720 AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            777 5778899999999999999999999999999843

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-42  Score=286.46  Aligned_cols=247  Identities=24%  Similarity=0.481  Sum_probs=212.5

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ..+|++.+.||.|++|.||+|.+.. +..+++|++.....   .....+.+|+.+++.++|+|++++++++...+..+++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            4679999999999999999999986 88899999865432   2356788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-
Q 022617           96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-  172 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-  172 (294)
                      +||+++++|.+++.+.  ..++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999999999753  4589999999999999999999999999999999999999999999999999876543322 


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHH
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPR  250 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~  250 (294)
                      .....++..|+|||.+....+ +.++|+||||+++|+|++ |..||...........+... ..+.+..++..+.+++.+
T Consensus       161 ~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  239 (261)
T cd05148         161 SSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE  239 (261)
T ss_pred             ccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHH
Confidence            112234568999999877665 788999999999999998 89999887777666666544 345567889999999999


Q ss_pred             hcccCCCCCCCHhHHhc
Q 022617          251 MLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~  267 (294)
                      ||+.+|++|||+.+|++
T Consensus       240 ~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         240 CWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HcCCCchhCcCHHHHHH
Confidence            99999999999999876

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.4e-41  Score=289.15  Aligned_cols=262  Identities=27%  Similarity=0.345  Sum_probs=219.0

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .....|...+.||.|++|.||++.+..++..+++|.+.............+.+|++++++++|+|++++++++......+
T Consensus        22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (317)
T cd06635          22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW  101 (317)
T ss_pred             CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence            44566899999999999999999999899999999987654444455677889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      +++||+.| +|.+.+.. ..++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......  
T Consensus       102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            99999976 77777754 466899999999999999999999999999999999999999999999999987654322  


Q ss_pred             cccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--cCCCCCChhHHHHH
Q 022617          173 LKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--TLPSHLSPGARDLI  248 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li  248 (294)
                       ....++..|+|||.+..  ....+.++|+||+|+++|+|++|..||...........+.....  .....++..+.+++
T Consensus       179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  257 (317)
T cd06635         179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  257 (317)
T ss_pred             -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence             23456788999998742  22237889999999999999999999987766555555544332  22346788999999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~  279 (294)
                      .+||+.+|.+||++.++++|+|+....+...
T Consensus       258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  288 (317)
T cd06635         258 DSCLQKIPQDRPTSEELLKHMFVLRERPETV  288 (317)
T ss_pred             HHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence            9999999999999999999999977655543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.4e-42  Score=288.70  Aligned_cols=257  Identities=32%  Similarity=0.590  Sum_probs=215.9

Q ss_pred             CCcccccccccCceEEEEEEEc---cCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   92 (294)
                      +|++.+.||.|++|.||.|.+.   .++..|++|++...... .......+.+|+.+++++ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999874   47889999998654322 222346678899999999 589999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++++||+.+++|.+++....++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999987653322 


Q ss_pred             -ccccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhCCCccCCCCCChhHH
Q 022617          172 -FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGAR  245 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
                       ......++..|+|||.+.... ..+.++|+||||+++|+|++|..||...    ........+.....+.+..++..+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK  240 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence             122344778999999986532 2367899999999999999999999643    2344455555555666778899999


Q ss_pred             HHHHHhcccCCCCCC-----CHhHHhcCCccccc
Q 022617          246 DLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       246 ~li~~~l~~~p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      +++.+||+.+|++||     ++.++++||||+..
T Consensus       241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            999999999999997     89999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.4e-42  Score=284.32  Aligned_cols=247  Identities=26%  Similarity=0.478  Sum_probs=210.1

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      -.++|++.+.||.|++|.||+|.+. ++..+++|.+....    ...+.+.+|+.++++++|+|++++++.+...+..++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            3568999999999999999999975 56679999875432    235678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ++|++.+++|.+++.+.  ..++...+..++.|++.++.|||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999999999753  4588899999999999999999999999999999999999999999999999976544322


Q ss_pred             c--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHH
Q 022617          173 L--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI  248 (294)
Q Consensus       173 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  248 (294)
                      .  ....++..|+|||.+.+... +.++|+||||+++|+|++ |..||...........+.... .+....++.++.+++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM  237 (261)
T ss_pred             eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1  12234567999999877665 788999999999999998 999998877777666665443 344457889999999


Q ss_pred             HHhcccCCCCCCCHhHHhc
Q 022617          249 PRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~  267 (294)
                      .+||..+|++|||++++++
T Consensus       238 ~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         238 KTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1e-41  Score=289.42  Aligned_cols=258  Identities=26%  Similarity=0.336  Sum_probs=214.4

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...+.|...+.||.|++|+||+|.+..+++.+++|++.............+.+|+++++.++|+|++++++++......+
T Consensus        18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   97 (313)
T cd06633          18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW   97 (313)
T ss_pred             CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            34445778889999999999999999899999999987655444445567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      +++||+.+ ++.+++.. ..++++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+.....   
T Consensus        98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633          98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            99999965 78777765 45689999999999999999999999999999999999999999999999998764322   


Q ss_pred             cccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-cc-CCCCCChhHHHHH
Q 022617          173 LKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YT-LPSHLSPGARDLI  248 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-~~~~~~~~l~~li  248 (294)
                      .....++..|+|||.+..  ....+.++|+||||+++|+|++|..||...+.......+.... .. ....++..+.+++
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  253 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV  253 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence            234457789999999742  2223678999999999999999999998766555444443322 22 2235678899999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      .+||+.+|.+||++.++++||||+..-
T Consensus       254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         254 DYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7e-42  Score=287.17  Aligned_cols=256  Identities=25%  Similarity=0.409  Sum_probs=212.0

Q ss_pred             cccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      -.++|++.+.||.|++|.||+|.++.     .+..+++|.+....  .......+.+|+.+++.++|+|++++++++...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            45789999999999999999997652     34579999875432  222345678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEe
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA  159 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~  159 (294)
                      +..++++||+.+++|.+++.+..          ..+...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence            99999999999999999997532          24567888999999999999999999999999999999999999999


Q ss_pred             eecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-Cc
Q 022617          160 DFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IY  234 (294)
Q Consensus       160 dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~  234 (294)
                      |||++........   .....++..|+|||.+.+... +.++|+||||+++|++++ |..||......+....+... ..
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL  240 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9999875433221   111234567999999887666 789999999999999998 89999888877776665543 34


Q ss_pred             cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc------CCcccc
Q 022617          235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ------HPWFQA  273 (294)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~------h~~~~~  273 (294)
                      ..+..++..+.+++.+||+.+|++|||+.++++      ||||++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            556678899999999999999999999999987      888865

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.2e-42  Score=284.67  Aligned_cols=247  Identities=27%  Similarity=0.475  Sum_probs=207.4

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...++|++.+.||.|++|.||+|.+..+ ..+++|.+.....    ....+.+|++++++++|+|++++++.+. ....+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY   76 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence            3457899999999999999999998755 4699999864332    2356888999999999999999999875 45689


Q ss_pred             EEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           94 VVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +++||+++++|.+++.+.  ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999999999753  357899999999999999999999999999999999999999999999999987654332


Q ss_pred             cc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617          172 FL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL  247 (294)
Q Consensus       172 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  247 (294)
                      ..  ....++..|+|||...+..+ +.++|+||||+++|++++ |..||...........+.... .+.+..++..+.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  235 (262)
T ss_pred             cccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence            21  12334567999999877766 789999999999999999 899998877766666665432 34456789999999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+||+.+|++||++.+++.
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999887

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.2e-42  Score=282.45  Aligned_cols=241  Identities=25%  Similarity=0.426  Sum_probs=204.0

Q ss_pred             cccccCceEEEEEEE--ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           24 TLGIGSFGKVKIAEH--ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        24 ~lg~g~~~~vy~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      .||+|+||.||+|.+  ..++..+++|++.... ......+.+.+|+.+++.+.|+|++++++++. .+..++++||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            689999999999965  4567889999986443 23345678899999999999999999999875 4567899999999


Q ss_pred             CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc----cccc
Q 022617          102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSC  177 (294)
Q Consensus       102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~  177 (294)
                      ++|.+++.+...+++..+..++.|++.++.+||+.|++|+||+|.||+++.++.++|+|||.+.........    ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            999999988788999999999999999999999999999999999999999999999999998765433211    1112


Q ss_pred             CCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccC
Q 022617          178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       178 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      ++..|+|||.+..... +.++|+||||+++|+|++ |..||...........+..+. .+.+..++.++.++|.+||+.|
T Consensus       160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~  238 (257)
T cd05116         160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG  238 (257)
T ss_pred             CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence            3468999999876655 789999999999999998 999998877777777776544 4566789999999999999999


Q ss_pred             CCCCCCHhHHhc
Q 022617          256 PMKRITIPEIRQ  267 (294)
Q Consensus       256 p~~Rps~~~il~  267 (294)
                      |++||++.+|..
T Consensus       239 p~~Rp~~~~i~~  250 (257)
T cd05116         239 VDERPGFAVVEL  250 (257)
T ss_pred             chhCcCHHHHHH
Confidence            999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.7e-42  Score=286.58  Aligned_cols=250  Identities=23%  Similarity=0.420  Sum_probs=209.8

Q ss_pred             ccCCcccccccccCceEEEEEEEc----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .++|++.+.||+|+||.||+|.+.    .++..+++|.+....  .......+.+|+.++++++|+|++++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            367999999999999999999853    355789999986432  23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC
Q 022617           92 IYVVMEYVKSGELFDYIVEK-----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW  154 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~-----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~  154 (294)
                      .++++||+++++|.+++...                 ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence            99999999999999998532                 2377888999999999999999999999999999999999999


Q ss_pred             cEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 022617          155 NVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK  230 (294)
Q Consensus       155 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~  230 (294)
                      .++|+|||++.......   ......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+.......+.+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~  240 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR  240 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999999987653322   1222334567999999877665 789999999999999998 999998877666666655


Q ss_pred             CCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          231 GGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       231 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ... .+.+..++..+.+++.+||+.+|.+||++.+|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            443 45567789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-42  Score=281.65  Aligned_cols=243  Identities=28%  Similarity=0.543  Sum_probs=211.6

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||.|++|.||+|..  .++.+++|.+.....    ..+.+.+|+.++++++|+|++++++++......+++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            56899999999999999999986  478899999864432    457788999999999999999999999988999999


Q ss_pred             EeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      +|++++++|.+++....  .+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999999997665  689999999999999999999999999999999999999999999999999876633222 


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHHh
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~  251 (294)
                       ....+..|+|||.+....+ +.++|+||||++++++++ |..||...........+... ....+..++..+.+++.+|
T Consensus       158 -~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (256)
T cd05039         158 -SGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC  235 (256)
T ss_pred             -cCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence             2334567999999876666 689999999999999997 99999888877777766554 3445567899999999999


Q ss_pred             cccCCCCCCCHhHHhc
Q 022617          252 LIVDPMKRITIPEIRQ  267 (294)
Q Consensus       252 l~~~p~~Rps~~~il~  267 (294)
                      |..+|++|||+.++++
T Consensus       236 l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         236 WELDPAKRPTFKQLRE  251 (256)
T ss_pred             hccChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=281.46  Aligned_cols=241  Identities=26%  Similarity=0.445  Sum_probs=204.3

Q ss_pred             ccccccCceEEEEEEEccCC---ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEecc
Q 022617           23 KTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV   99 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   99 (294)
                      +.||.|++|.||+|.+...+   ..+++|.+......  .....+.+|+++++++.|+|++++++++. .+..++++||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            47999999999999876554   78999998755433  34567889999999999999999999876 45689999999


Q ss_pred             CCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc----c
Q 022617          100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----T  175 (294)
Q Consensus       100 ~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~----~  175 (294)
                      .+++|.+++.+...+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+..........    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            999999999887889999999999999999999999999999999999999999999999999987654332211    1


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~  253 (294)
                      ..++..|+|||.+.+..+ +.++||||||+++|++++ |..||...+.......+.... .+.+..++..+.+++.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            112357999999877766 789999999999999998 999998887777766665543 35566788999999999999


Q ss_pred             cCCCCCCCHhHHhc
Q 022617          254 VDPMKRITIPEIRQ  267 (294)
Q Consensus       254 ~~p~~Rps~~~il~  267 (294)
                      .+|++|||+.++++
T Consensus       237 ~~p~~Rp~~~~l~~  250 (257)
T cd05060         237 YRPEDRPTFSELES  250 (257)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.7e-42  Score=291.91  Aligned_cols=249  Identities=26%  Similarity=0.409  Sum_probs=208.2

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCce----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      ..+|++.+.||+|+||.||+|.+..++..    |++|++...  ........+.+|+.+++.++|+||+++++++... .
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            35799999999999999999998666554    899987533  2234457788999999999999999999998764 5


Q ss_pred             EEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .+++++++.+++|.+++... ..++...++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            67999999999999999764 45889999999999999999999999999999999999999999999999999865432


Q ss_pred             Ccc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617          171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR  245 (294)
Q Consensus       171 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  245 (294)
                      ...   .....+..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+.... .+.+..++.++.
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  241 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            221   12223567999999987766 789999999999999998 999998877766655554433 455667889999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcC
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      +++.+||..+|.+||++.+++.+
T Consensus       242 ~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         242 MIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999885

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.3e-42  Score=316.06  Aligned_cols=251  Identities=25%  Similarity=0.404  Sum_probs=206.1

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||.|++|.||+|.+..+++.|++|++...........+.+.+|++++++++|||++++++++..++..+++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            37899999999999999999999999999999998755434444567789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           96 MEYVKSGELFDYIVEK-----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~-----------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                      |||++|++|.+++.+.           ...+...+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999998642           23456678899999999999999999999999999999999999999999998


Q ss_pred             ccccCC-------------------CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022617          165 NIMRDG-------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL  225 (294)
Q Consensus       165 ~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~  225 (294)
                      ......                   .......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            755211                   01112358999999999987776 7899999999999999999999977554333


Q ss_pred             HHHHh-CCCc--cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          226 FKKIK-GGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       226 ~~~~~-~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ..... ....  .....++..+.+++.+||..||++||+..+.+.
T Consensus       240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            22211 1111  112467889999999999999999987655443

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=303.45  Aligned_cols=255  Identities=29%  Similarity=0.543  Sum_probs=221.2

Q ss_pred             ccCC-cccccccccCceEEEEEEEccCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe--
Q 022617           16 LPNY-KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--   91 (294)
Q Consensus        16 ~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--   91 (294)
                      .++| +....||+|.|-+||+|.|..+|..||--.+....+. .....+.+..|+.+|+.|+|+||++++++|.+...  
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence            3444 4578999999999999999999998886655444333 33456899999999999999999999999987654  


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecC-CCcEEEeeeccccccc
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDS-KWNVKIADFGLSNIMR  168 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~-~~~~~l~dfg~~~~~~  168 (294)
                      +.+|+|.+..|+|..++++.+.++...++.|++||+.+|.|||++.  |+|||||.+||+|+. .|.|||+|+|+|+...
T Consensus       118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            8899999999999999999999999999999999999999999886  999999999999986 5899999999999887


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhCCCcc--CCCCCChhHH
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYT--LPSHLSPGAR  245 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~  245 (294)
                      .+.... ..|||.|||||.+. ..| +...||||||++|+||.|+..||.. .+...+.+++..+..+  +..--.++++
T Consensus       198 ~s~aks-vIGTPEFMAPEmYE-E~Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr  274 (632)
T KOG0584|consen  198 KSHAKS-VIGTPEFMAPEMYE-ENY-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVR  274 (632)
T ss_pred             ccccce-eccCccccChHHHh-hhc-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHH
Confidence            766554 78999999999987 445 7899999999999999999999975 6677788888777643  3344578999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +||.+||.. .++|||+.|+|+||||...
T Consensus       275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  275 EFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            999999999 9999999999999999885

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.8e-42  Score=287.32  Aligned_cols=248  Identities=29%  Similarity=0.449  Sum_probs=209.7

Q ss_pred             ccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      .++|.+.+.||.|++|.||+|.+..     ++..+++|.+....   ....+.+.+|+..+++++|+|++++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            4578999999999999999998542     44568888874332   233567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW  154 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~  154 (294)
                      ..++++||+++++|.+++....                .+++..++.++.|++.++.+||+.|++|+||+|+||+++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            9999999999999999997543                378899999999999999999999999999999999999999


Q ss_pred             cEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 022617          155 NVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK  230 (294)
Q Consensus       155 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~  230 (294)
                      .++|+|||++........   .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.........+.+.
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  239 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT  239 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            999999999875533221   122345678999999887665 789999999999999998 999998888777777666


Q ss_pred             CCCc-cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          231 GGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       231 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+.. ..+..++..+.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            6553 345567899999999999999999999999977

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.6e-42  Score=287.04  Aligned_cols=249  Identities=24%  Similarity=0.408  Sum_probs=211.2

Q ss_pred             ccCCcccccccccCceEEEEEEEccC-----CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ..+|++.+.||.|++|.||+|.+..+     ++.+++|++....  .......+.+|..+++.++|+||+++++++....
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            45789999999999999999987543     5789999986442  2234567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW  154 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~  154 (294)
                      ..++++||+.+++|.+++...                ..++...++.++.|++.||.+||+.|++|+||||+||++++++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence            999999999999999998532                3478888999999999999999999999999999999999999


Q ss_pred             cEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 022617          155 NVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK  230 (294)
Q Consensus       155 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~  230 (294)
                      .++|+|||++........   .....+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+....+..+.+.
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999998775433221   123345678999999877666 789999999999999998 889998888888777776


Q ss_pred             CCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          231 GGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       231 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ... .+.+..++.++.+++.+||+.+|.+||++.+|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            655 3456789999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-42  Score=287.10  Aligned_cols=250  Identities=33%  Similarity=0.516  Sum_probs=205.5

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeEEEEEEEcCCe----
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIETPSD----   91 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~----   91 (294)
                      |++.+.||.|++|.||+|.++.+++.+++|.+......+ .....+.+|+.+++++   .|+|++++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            788999999999999999998889999999986543222 2234556677776655   59999999999987776    


Q ss_pred             -EEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           92 -IYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        92 -~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                       .++++|++.+ +|.+++.+..  .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999975 8999887643  48999999999999999999999999999999999999999999999999987765


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--------------
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------------  234 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------  234 (294)
                      .........++..|+|||.+.+... +.++|+||+|+++|+|++|..||......+....+.....              
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP  237 (287)
T ss_pred             CCcccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence            4433344456788999999987766 7899999999999999999999987766555544432100              


Q ss_pred             -------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 -------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                   ......+..+.+++.+||+.||++||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                         0001345778899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=289.19  Aligned_cols=251  Identities=31%  Similarity=0.568  Sum_probs=210.2

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY   98 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   98 (294)
                      |++.+.||.|++|.||+|.+..+++.+++|++.... ........+..|+.++++++|+|++++++++...+..++++|+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999987654 2223356778899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccccc
Q 022617           99 VKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS  176 (294)
Q Consensus        99 ~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~  176 (294)
                      +++ +|.+++.+. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            975 999999876 579999999999999999999999999999999999999999999999999987654332 22334


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------------c--
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------------Y--  234 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------~--  234 (294)
                      ..+..|+|||.+.+....+.++|+||||++++++++|..||...........+....                    .  
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            456789999998766444789999999999999999999998766554443332100                    0  


Q ss_pred             -------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 -------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                             ...+..+..+.+++.+||..+|++||+++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                   0012347789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.2e-42  Score=294.20  Aligned_cols=258  Identities=34%  Similarity=0.521  Sum_probs=210.1

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC--C
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP--S   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~   90 (294)
                      .+.++|.+.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++++ +|+||+++++++...  .
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            467899999999999999999999988899999998854322 223345677899999999 999999999998643  4


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ..++++|++++ +|..++.+. .+++...+.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            68999999975 999988665 7889999999999999999999999999999999999999999999999988755332


Q ss_pred             C------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------
Q 022617          171 H------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----------  233 (294)
Q Consensus       171 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  233 (294)
                      .      ......++..|+|||.+.+....+.++|+||||+++|+|++|+.||...........+....           
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence            2      12233567889999988665555789999999999999999999997654433322211100           


Q ss_pred             --------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 --------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                          ......++.++.+++.+||+.+|++|||+.++++||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                                01113468899999999999999999999999999999775

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=307.98  Aligned_cols=248  Identities=30%  Similarity=0.467  Sum_probs=215.5

Q ss_pred             cccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCC
Q 022617           24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGE  103 (294)
Q Consensus        24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~s  103 (294)
                      +||+|.||+||-|+|.++...++||.+....   ....+.+.+|+.+.++|+|.||++++|.+.+++.+-+.||..+|||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            6899999999999999999999999985432   2346889999999999999999999999999999999999999999


Q ss_pred             hHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeeccccccc-CCCccccccC
Q 022617          104 LFDYIVEK-GRL--QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMR-DGHFLKTSCG  178 (294)
Q Consensus       104 L~~~l~~~-~~l--~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~-~~~~~~~~~~  178 (294)
                      |.+++.+. +|+  ++..+..+.+||+++|.|||+..|+|+|||-.||+|+. .|.+||+|||-+.... -.....+..|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            99999765 677  78899999999999999999999999999999999975 6889999999887653 3344566779


Q ss_pred             CCcccCCcccc-CCccCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHh-CCCccCCCCCChhHHHHHHHhccc
Q 022617          179 SPNYAAPEVIS-GKLYAGPEVDVWSCGVILYALLCGTLPFDDE--NIPNLFKKIK-GGIYTLPSHLSPGARDLIPRMLIV  254 (294)
Q Consensus       179 ~~~~~aPE~~~-~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~  254 (294)
                      |..|||||++. +...++.++|||||||++.||.||++||...  ....+.+.=+ +.-+++|..++.+.+.||.+|+.+
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep  818 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP  818 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence            99999999985 4444588999999999999999999999753  3444444322 333678889999999999999999


Q ss_pred             CCCCCCCHhHHhcCCccccc
Q 022617          255 DPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       255 ~p~~Rps~~~il~h~~~~~~  274 (294)
                      +|.+||++.++|..||++..
T Consensus       819 d~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  819 DPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CcccCccHHHhccCcccccC
Confidence            99999999999999999887

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-42  Score=284.80  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=212.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCC-----ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      ...++|++.+.||.|++|.||++.+...+     ..+++|.+....  .......+.+|+.+++.++|+|++++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            34578999999999999999999986443     789999975432  22334677889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEE
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI  158 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l  158 (294)
                      ....++++||+++++|.+++....          .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            999999999999999999996432          3677889999999999999999999999999999999999999999


Q ss_pred             eeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-
Q 022617          159 ADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-  233 (294)
Q Consensus       159 ~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-  233 (294)
                      +|||.+........   .....++..|+|||.+.+... +.++||||||+++|++++ |..||...+.....+.+.... 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH  239 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence            99999875543321   122335678999999876665 789999999999999998 999998888777777666443 


Q ss_pred             ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ...+..++..+.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            4567778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-42  Score=288.64  Aligned_cols=251  Identities=34%  Similarity=0.559  Sum_probs=210.7

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY   98 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   98 (294)
                      |++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|++++++++|+|++++++++..++..++++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            67889999999999999999989999999998655432 23456788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccccc
Q 022617           99 VKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS  176 (294)
Q Consensus        99 ~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~  176 (294)
                      +++ +|.+++.. ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            976 88888865 3578999999999999999999999999999999999999999999999999987665443 22334


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------------------
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----------------------  233 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------  233 (294)
                      .++..|+|||.+.+....+.++|+||||+++|++++|+.||...+..+....+....                       
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            567789999998776444889999999999999999999998766554433321110                       


Q ss_pred             -------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          234 -------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       234 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                             ....+.++.++.++|.+||+.||.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                   00113467889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8e-42  Score=289.44  Aligned_cols=256  Identities=27%  Similarity=0.345  Sum_probs=213.8

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      ....|+..+.||.|++|.||+|.+..+++.+++|.+.............+.+|+++++.++|+|++++.+++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            45568899999999999999999998999999999865443344445678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           95 VMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      ++||+.+ ++.+.+.. ..++++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++......   
T Consensus        93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            9999975 88777654 456899999999999999999999999999999999999999999999999988754332   


Q ss_pred             ccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-c-CCCCCChhHHHHHH
Q 022617          174 KTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIP  249 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~~~~l~~li~  249 (294)
                      ....++..|+|||.+.+  ....+.++||||||+++|+|++|..||...........+..... . ....++..+.++|.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  248 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  248 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence            23356789999998742  22236789999999999999999999977665554444433332 2 23468889999999


Q ss_pred             HhcccCCCCCCCHhHHhcCCccccc
Q 022617          250 RMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       250 ~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +||+.+|++||++.++++|||+...
T Consensus       249 ~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         249 SCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHhhCCcccCCCHHHHhhCcccccc
Confidence            9999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.5e-42  Score=292.51  Aligned_cols=255  Identities=21%  Similarity=0.348  Sum_probs=203.6

Q ss_pred             ccccccc--CceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEecc
Q 022617           22 GKTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV   99 (294)
Q Consensus        22 ~~~lg~g--~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   99 (294)
                      .+.||.|  ++++||+|.+..+++.|++|++....... ...+.+.+|+.+++.++|+||+++++++...+..++++||+
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            4567776  88999999999999999999987554333 34578899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-----
Q 022617          100 KSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-----  172 (294)
Q Consensus       100 ~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-----  172 (294)
                      .+++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++||+.+........     
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            999999998764  3489999999999999999999999999999999999999999999999975432211110     


Q ss_pred             ---cccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------
Q 022617          173 ---LKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------  233 (294)
Q Consensus       173 ---~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------  233 (294)
                         .....++..|+|||++.+.. ..+.++||||+|+++|+|++|..||................               
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence               01112345699999987642 23688999999999999999999997765433332221111               


Q ss_pred             --------------------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          234 --------------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       234 --------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                                                      .+.+..++..+.+++.+||+.||++|||+.++++||||++....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                                            01112356789999999999999999999999999999886543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.4e-41  Score=287.92  Aligned_cols=253  Identities=27%  Similarity=0.459  Sum_probs=212.0

Q ss_pred             ccccccCCcccccccccCceEEEEEEEcc-------CCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEE
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLY   83 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~   83 (294)
                      .....++|.+.+.||+|+||.||+|.+..       +...+++|.+....  .......+.+|+++++++ +|+|+++++
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL   90 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            34556899999999999999999998643       22469999986442  223356788899999999 799999999


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 022617           84 EVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN  147 (294)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~n  147 (294)
                      +++...+..++++||+++++|.+++....                .++...+..++.|++.||.+||+.|++|+||+|+|
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  170 (307)
T cd05098          91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN  170 (307)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence            99999999999999999999999997542                37888999999999999999999999999999999


Q ss_pred             eEecCCCcEEEeeecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022617          148 LLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP  223 (294)
Q Consensus       148 ili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~  223 (294)
                      |+++.++.++|+|||.+.........   .....+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||......
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            99999999999999998755432211   11223467999999887666 789999999999999998 89999888877


Q ss_pred             HHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          224 NLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       224 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +....+.... ...+..++.++.+++.+||..+|++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            7777666554 3556778999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.9e-42  Score=288.74  Aligned_cols=263  Identities=29%  Similarity=0.424  Sum_probs=212.4

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI   92 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   92 (294)
                      .-.++|++.+.||.|++|.||+|.+..+++.+++|.+......  .....+..|+.++.+.. |+|++++++++......
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            3457899999999999999999999988999999998654322  23455666776666664 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ++++|++.+ ++.+++.. ..++++..+..++.|++.++.|||+ .|++|+||+|+||+++.++.++|+|||.+......
T Consensus        90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            999999954 78887765 4578999999999999999999997 59999999999999999999999999998765544


Q ss_pred             CccccccCCCcccCCccccCCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhCCC-ccCC--CCCChh
Q 022617          171 HFLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGI-YTLP--SHLSPG  243 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~-~~~~--~~~~~~  243 (294)
                      .......++..|+|||.+.+..   ..+.++|+||||+++|+|++|+.||..... .+....+.... ...+  ..++.+
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (296)
T cd06618         169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD  248 (296)
T ss_pred             CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence            4334445678899999986543   236789999999999999999999976322 23333333322 2222  347889


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~  279 (294)
                      +.+++.+||..+|++||++++++.||||+...+...
T Consensus       249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  284 (296)
T cd06618         249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV  284 (296)
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence            999999999999999999999999999987655443

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-42  Score=286.87  Aligned_cols=250  Identities=36%  Similarity=0.523  Sum_probs=206.9

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEEe
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      |++.+.||.|++|+||+|.+..+++.+++|.+......  .......+|+..+++++ |+|++++++++...+..++++|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            78899999999999999999888999999997644321  12234456889999999 9999999999999999999999


Q ss_pred             ccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      |+ +++|.+.+....  .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            99 669999887654  789999999999999999999999999999999999999999999999999876655444445


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC----------------------
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------------------  233 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------  233 (294)
                      ..++..|+|||.+......+.++|+||||+++++|++|+.||......+....+....                      
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            5678889999988655445789999999999999999999997665443332221100                      


Q ss_pred             --------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          234 --------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                              .......+..+.+++.+||+.+|++|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                    00112336789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=301.34  Aligned_cols=253  Identities=25%  Similarity=0.419  Sum_probs=212.4

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      .+-++..++..+.+.||+|.||+||+|.+-   -.||||++....... +..+.++.|+.++++-+|.||+-+.|++..+
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            445677888999999999999999999974   359999998776555 4789999999999999999999999999888


Q ss_pred             CeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      .. .||+.+|+|.+|..++.-. ..+.....+.|++|+++++.|||.++|+|+|+|..||++.++++|+|+|||++....
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            77 8999999999999998533 458889999999999999999999999999999999999999999999999987543


Q ss_pred             ---CCCccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----ccCCC
Q 022617          169 ---DGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPS  238 (294)
Q Consensus       169 ---~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~  238 (294)
                         .........+...|+|||++..  ....+..+|+|++|+++|||++|.+||.....+.++-.+-.+.     .....
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s  619 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS  619 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence               2222233447789999999752  2333789999999999999999999999655555444443332     22335


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .++.++++|+..||++++++||.+.+||.
T Consensus       620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  620 NCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             cCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            78899999999999999999999999987

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-42  Score=294.20  Aligned_cols=262  Identities=29%  Similarity=0.456  Sum_probs=211.7

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--   89 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   89 (294)
                      +..+.++|.+.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.++++++|+||+++++++...  
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            35677999999999999999999999988999999999865322 223356678899999999999999999987532  


Q ss_pred             ----CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617           90 ----SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus        90 ----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                          +..+++++++ +++|.+++.. ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence                3478888887 6699888754 468999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------------
Q 022617          166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------  233 (294)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------  233 (294)
                      .....  .....++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+.......+....            
T Consensus       169 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         169 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             ccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            64332  2234567889999998664444788999999999999999999997655443332221100            


Q ss_pred             -----------cc--------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          234 -----------YT--------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       234 -----------~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                                 ..        .....+.++.++|.+||..||.+||++.++++||||++...+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence                       00        0123577899999999999999999999999999999866544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=282.33  Aligned_cols=248  Identities=26%  Similarity=0.452  Sum_probs=207.0

Q ss_pred             CcccccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe----
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD----   91 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----   91 (294)
                      |++.+.||.|+||.||.|.+..+   +..+++|.+...... ......+.+|+..++.++|+|++++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            67899999999999999987654   378999998654332 2345678999999999999999999998765443    


Q ss_pred             --EEEEEeccCCCChHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           92 --IYVVMEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        92 --~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                        .++++||+.+++|..++...      ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||.
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999999988542      3589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCC
Q 022617          164 SNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPS  238 (294)
Q Consensus       164 ~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~  238 (294)
                      +.........   .....+..|+|||.+.+... +.++|+||||+++|+|++ |..||...........+..+ ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE  238 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            8765433221   11224568999999876655 789999999999999999 99999887777776666544 355667


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .++..+.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         239 DCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            889999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.5e-41  Score=286.23  Aligned_cols=249  Identities=25%  Similarity=0.366  Sum_probs=208.3

Q ss_pred             ccCCcccccccccCceEEEEEEEccCC----------------ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTG----------------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI   79 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~----------------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i   79 (294)
                      .++|++.+.||.|+||.||+|.+...+                ..+++|.+.....  ......+.+|++++++++|+|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence            468999999999999999999876543                4578998764432  2446788899999999999999


Q ss_pred             eEEEEEEEcCCeEEEEEeccCCCChHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617           80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL  148 (294)
Q Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni  148 (294)
                      +++++++......++++|++.+++|.+++.+..           .+++..++.++.|++.||.+||+.|++|+||+|+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999997765           689999999999999999999999999999999999


Q ss_pred             EecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh--CCCCCCCCCHH
Q 022617          149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIP  223 (294)
Q Consensus       149 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~  223 (294)
                      +++.++.++|+|||.+........   .....++..|+|||.+.+..+ +.++||||||+++|+|++  +..||......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            999999999999999875533321   122335678999999877665 789999999999999998  78888776666


Q ss_pred             HHHHHHhCC--------CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          224 NLFKKIKGG--------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       224 ~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .........        ....+..++.++.+++.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            655554322        12334567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.7e-41  Score=280.65  Aligned_cols=247  Identities=27%  Similarity=0.484  Sum_probs=208.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...++|++.+.||.|++|.||+|.+. .+..+++|.+......    ...+.+|+.++++++|+|++++++++. ....+
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            45678999999999999999999876 5667999998654332    356889999999999999999999875 45688


Q ss_pred             EEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           94 VVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +++||+.+++|.+++...  ..+++..++.++.|++.|+.+||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999998753  358999999999999999999999999999999999999999999999999987654322


Q ss_pred             cc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHH
Q 022617          172 FL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDL  247 (294)
Q Consensus       172 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  247 (294)
                      ..  ....++..|+|||.+.+... +.++|+||||+++|++++ |..||...+..+....+... ..+.+...+..+.++
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL  235 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            11  11223457999999876665 789999999999999999 99999887777777766543 345566789999999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+||..+|++|||+.++++
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.1e-41  Score=279.52  Aligned_cols=246  Identities=31%  Similarity=0.512  Sum_probs=211.8

Q ss_pred             CcccccccccCceEEEEEEEccCC----ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTG----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      +++.+.||.|++|.||++.+...+    ..+++|.+.....  ......+.+|+.+++.++|+|++++++++...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            467889999999999999998766    8899999854432  2256788999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           95 VMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~--l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ++|++.+++|.+++.....  +++..++.++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999976544  89999999999999999999999999999999999999999999999999876654422


Q ss_pred             ccc--ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHH
Q 022617          173 LKT--SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI  248 (294)
Q Consensus       173 ~~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  248 (294)
                      ...  ..++..|+|||.+.+..+ +.++|+||||+++++|++ |..||.........+.+.... ...+..++.++.+++
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM  237 (258)
T ss_pred             cccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence            221  235678999999866555 789999999999999998 899998877777777665544 445567899999999


Q ss_pred             HHhcccCCCCCCCHhHHhc
Q 022617          249 PRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~  267 (294)
                      .+||+.+|++|||+.++++
T Consensus       238 ~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      238 LQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHCcCChhhCcCHHHHHh
Confidence            9999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=281.91  Aligned_cols=242  Identities=26%  Similarity=0.442  Sum_probs=200.7

Q ss_pred             ccccccCceEEEEEEEccCCc--eEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEecc
Q 022617           23 KTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYV   99 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~   99 (294)
                      +.||.|++|.||+|.+..++.  .+++|.+...  ........+.+|+++++++ .|||++++++++...+..++++||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            468999999999999987775  4577876422  2234456788999999999 7999999999999999999999999


Q ss_pred             CCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617          100 KSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus       100 ~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      .+++|.+++..+.                .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999996543                378899999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCC
Q 022617          164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLS  241 (294)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~  241 (294)
                      +..............+..|+|||.+....+ +.++|+||||+++|+|++ |..||...+.......+... ....+..++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD  237 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCC
Confidence            753321111111223557999999876665 789999999999999997 99999887777766666543 344556788


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .++.+++.+||..+|.+|||+.+++.
T Consensus       238 ~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         238 DEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-41  Score=280.96  Aligned_cols=247  Identities=28%  Similarity=0.508  Sum_probs=209.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...++|++.++||.|++|.||+|.+. +++.+++|.+......    ...+.+|+.++++++|+|++++++++. .+..+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            46788999999999999999999875 5778999998644322    357888999999999999999999874 46789


Q ss_pred             EEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           94 VVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +++|++.+++|.+++...  ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999999998653  358899999999999999999999999999999999999999999999999987654222


Q ss_pred             c--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617          172 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL  247 (294)
Q Consensus       172 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  247 (294)
                      .  .....++..|+|||.+..... +.++|+||||+++|++++ |+.||...+.......+.... .+.+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             cccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            1  112234568999999877665 789999999999999998 999998887777766665443 45566788999999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+||..+|++||+++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHccCChhhCCCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.1e-41  Score=289.14  Aligned_cols=257  Identities=32%  Similarity=0.502  Sum_probs=209.2

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-CCe
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-PSD   91 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   91 (294)
                      -.+.++|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++.++|||++++.+++.. .+.
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3467899999999999999999999999999999998764422 22345678889999999999999999999865 567


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      .++++|+++ ++|.+++. ..++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        85 ~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          85 IYFVTELLG-TDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             EEEEeehhc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence            899999994 58988875 456888999999999999999999999999999999999999999999999998754322 


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC--------------------
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--------------------  231 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--------------------  231 (294)
                       .....++..|+|||.+.+....+.++|+||||+++|++++|..||...........+..                    
T Consensus       162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence             22345677899999986644447899999999999999999999976554221111100                    


Q ss_pred             ----C--Ccc-----CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          232 ----G--IYT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       232 ----~--~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                          .  ...     ....++..+.++|.+||+.+|++||++.+++.||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence                0  000     113567899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=280.57  Aligned_cols=248  Identities=27%  Similarity=0.478  Sum_probs=212.1

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...++|.+.+.||.|++|.||+|.+. +++.+++|.+.....    ..+.+.+|+.++++++|+|++++++++......+
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            45679999999999999999999976 557799999865432    2467889999999999999999999999889999


Q ss_pred             EEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           94 VVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +++|++++++|.+++.+..  .++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999997643  68999999999999999999999999999999999999999999999999987654321


Q ss_pred             cc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617          172 FL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL  247 (294)
Q Consensus       172 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  247 (294)
                      ..  .....+..|+|||.+.+... +.++|+||+|++++++++ |+.||.+.........+.... .+.+...+.++.++
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            11  12223567999999887665 789999999999999998 999998888777777766543 45566789999999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+||+.+|++||++.++++
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHcccCcccCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-41  Score=282.60  Aligned_cols=248  Identities=27%  Similarity=0.471  Sum_probs=205.4

Q ss_pred             CcccccccccCceEEEEEEEccCCc--eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC------C
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------S   90 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   90 (294)
                      |.+.+.||.|++|.||+|.+..++.  .+++|.+.... ........+.+|+.+++.++|+||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            4678999999999999999877665  58999886542 2334467788999999999999999999986432      3


Q ss_pred             eEEEEEeccCCCChHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                      ..++++||+.+++|.+++...      ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            468999999999999987431      34789999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCC
Q 022617          165 NIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSH  239 (294)
Q Consensus       165 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~  239 (294)
                      ........   ......++.|++||...+..+ +.++|+||||+++|++++ |..||...........+..+. ...+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD  238 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            76543321   112234668999999887766 789999999999999999 899998877777666666543 355677


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ++..+.+++.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            88999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-41  Score=283.39  Aligned_cols=248  Identities=28%  Similarity=0.449  Sum_probs=208.1

Q ss_pred             ccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ..+|++.+.||.|+||.||++...     .++..+++|.+....   ......+.+|+++++.++|+||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            467899999999999999999743     345678889875332   234568899999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKG---------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN  155 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~---------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~  155 (294)
                      ..++++||+.+++|.+++.+.+               .+++..+..++.|++.|+.|||+.|++|+||+|+||++++++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence            9999999999999999997643               3788999999999999999999999999999999999999999


Q ss_pred             EEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhC
Q 022617          156 VKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG  231 (294)
Q Consensus       156 ~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~  231 (294)
                      ++|+|||++........   .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ  239 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence            99999999865432221   112234578999999887766 789999999999999998 9999987776666665554


Q ss_pred             CC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       232 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .. ...+..++..+.+++.+||+.||.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            43 4456678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-41  Score=286.04  Aligned_cols=259  Identities=32%  Similarity=0.555  Sum_probs=215.6

Q ss_pred             CCcccccccccCceEEEEEEEc---cCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   92 (294)
                      +|++.+.||.|++|.||++.+.   .+++.+++|++...... .......+.+|++++.++ +|+|++++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   46688999998654322 223456778899999999 589999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ++++||+.+++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            99999999999999998777899999999999999999999999999999999999999999999999998876533221


Q ss_pred             --cccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhCCCccCCCCCChhHH
Q 022617          173 --LKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGAR  245 (294)
Q Consensus       173 --~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
                        .....++..|++||.+.+.. ..+.++|+||||+++|+|++|..||...    ......+.+.....+.+..++.++.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  240 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR  240 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence              22234688999999986554 2368899999999999999999999643    2334444555555666778899999


Q ss_pred             HHHHHhcccCCCCCCC---HhHHhcCCcccccCC
Q 022617          246 DLIPRMLIVDPMKRIT---IPEIRQHPWFQAHLP  276 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps---~~~il~h~~~~~~~~  276 (294)
                      +++.+||+.+|++|||   +.++++||||+....
T Consensus       241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             HHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            9999999999999998   567899999988643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.7e-42  Score=292.95  Aligned_cols=258  Identities=32%  Similarity=0.498  Sum_probs=209.0

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC---
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---   89 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   89 (294)
                      ..+.++|.+.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++.++|+||+++++++...   
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~   89 (342)
T cd07879          11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG   89 (342)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence            3557899999999999999999999988999999999865422 223345678999999999999999999988654   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           90 ---SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        90 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                         ...++++|++.. +|.+++  ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          90 DEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             CCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence               346899999964 777665  34689999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------------
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------  233 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  233 (294)
                      ....  .....++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+.......+....             
T Consensus       167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            4322  2233567789999998764444789999999999999999999998766443333221100             


Q ss_pred             ----------c--------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          234 ----------Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       234 ----------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                                .        ...+..+..+.++|.+||+.||++||++.+++.||||+...+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                      0        001246778999999999999999999999999999988644

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.9e-41  Score=281.81  Aligned_cols=249  Identities=26%  Similarity=0.430  Sum_probs=210.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCc---eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      .++|++.+.||.|++|.||+|.+..+++   .|++|.+....  .......+..|+.++++++|||++++++++......
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            3568999999999999999999876664   59999986432  234457889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++++||+++++|.+++... +.++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999998753 568999999999999999999999999999999999999999999999999886543322


Q ss_pred             cccc---cc---CCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChh
Q 022617          172 FLKT---SC---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPG  243 (294)
Q Consensus       172 ~~~~---~~---~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~  243 (294)
                      ....   ..   .+..|+|||.+.+..+ +.++|+||+|+++|++++ |..||.........+.+... ..+.+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA  239 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence            1111   11   1347999999887766 789999999999999886 99999888777777766544 24555678999


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+++.+||+.+|++||++.+++.
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-41  Score=286.56  Aligned_cols=255  Identities=27%  Similarity=0.472  Sum_probs=213.6

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCC-----ceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEE
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYE   84 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~   84 (294)
                      ..+.-.++|++.+.||+|++|.||++.+....     ..+++|.+....  .......+.+|+++++++ +|+|++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            34555678999999999999999999876433     679999886432  223346788999999999 7999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617           85 VIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL  148 (294)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni  148 (294)
                      ++...+..++++||+.+++|.+++...                ..+++..+..++.|++.|+.|||+.|++|+||+|+||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni  163 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV  163 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence            999999999999999999999999642                3588999999999999999999999999999999999


Q ss_pred             EecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022617          149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN  224 (294)
Q Consensus       149 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~  224 (294)
                      +++.++.++|+|||.+........   .....++..|+|||.+.+..+ +.++||||||+++|++++ |..||.......
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            999999999999999876543321   112224567999999877666 789999999999999997 999998887777


Q ss_pred             HHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          225 LFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       225 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ....+.... ...+..++..+.+++.+||..+|++|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            777665544 34566788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.2e-41  Score=283.43  Aligned_cols=247  Identities=30%  Similarity=0.465  Sum_probs=206.7

Q ss_pred             CCcccccccccCceEEEEEEEccC-----CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +|++.+.||.|+||.||+|.+...     ...+++|.+....  .......+.+|+.+++.+.||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            588999999999999999987532     2468888875432  123356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617           93 YVVMEYVKSGELFDYIVEK------------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL  148 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni  148 (294)
                      ++++||+.+++|.+++...                        .+++...++.++.|++.++.+||+.|++|+||+|+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999998642                        2478889999999999999999999999999999999


Q ss_pred             EecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022617          149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN  224 (294)
Q Consensus       149 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~  224 (294)
                      ++++++.++|+|||++........   ......+..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999875432221   122234568999999876665 789999999999999998 999998888777


Q ss_pred             HHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          225 LFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       225 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ..+.+.... ...+..++.++.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            776665432 4456678999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.3e-41  Score=281.79  Aligned_cols=248  Identities=26%  Similarity=0.388  Sum_probs=208.2

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      ..+|++.+.||.|++|+||+|.+..+++    .|++|++....  .......+.+|+.+++.+.|+|++++++++.. ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence            4689999999999999999999876666    47899875432  23345678899999999999999999999875 45


Q ss_pred             EEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .+++++++++++|.+++..+ +.+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            77899999999999999764 56899999999999999999999999999999999999999999999999998765432


Q ss_pred             Ccc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617          171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR  245 (294)
Q Consensus       171 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  245 (294)
                      ...   .....+..|+|||...+..+ +.++||||||+++|++++ |..||...........+.... .+.+..++.++.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY  241 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence            221   12234568999999877766 789999999999999998 999998877766666555543 455667899999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +++.+||..||++||++.++++
T Consensus       242 ~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         242 MIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.3e-41  Score=278.97  Aligned_cols=246  Identities=28%  Similarity=0.476  Sum_probs=206.1

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      ..++|.+.+.||.|++|.||+|.+..+ ..+++|.+.....    ..+.+.+|+.++++++|+|++++++++. .+..++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            457899999999999999999998654 4689998754332    2356788999999999999999998875 456889


Q ss_pred             EEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      +|||+.+++|.+++.+.  ..++...+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            99999999999999754  3478999999999999999999999999999999999999999999999999876543221


Q ss_pred             c--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHH
Q 022617          173 L--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLI  248 (294)
Q Consensus       173 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li  248 (294)
                      .  ....++..|+|||...+... +.++|+||||+++|+|++ |..||...........+... ..+.+...+..+.+++
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM  236 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence            1  12234567999998877665 789999999999999999 99999887777766666544 2345567899999999


Q ss_pred             HHhcccCCCCCCCHhHHhc
Q 022617          249 PRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~  267 (294)
                      .+||..+|++||+++++++
T Consensus       237 ~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         237 KLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999886

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-42  Score=309.44  Aligned_cols=260  Identities=24%  Similarity=0.424  Sum_probs=195.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCc-eEEEE--------------EeecccccchHHHHHHHHHHHHHHhCCCC
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGH-KVAIK--------------ILNRRKIKNMEMEEKVRREIKILRLFMHP   77 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~-~~~~K--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~~~   77 (294)
                      +.+.++|++.+.||+|+||+||+|..+.... ..+.|              .+.............+.+|+.++++++|+
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            4566899999999999999999987643221 11122              11111111223456688999999999999


Q ss_pred             ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC
Q 022617           78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS  152 (294)
Q Consensus        78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~  152 (294)
                      ||+++++++...+..+++++++.+ +|.+++...     .......++.++.|++.||.|||+.||+|+||||+||+++.
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence            999999999999999999999955 777776432     12346678889999999999999999999999999999999


Q ss_pred             CCcEEEeeecccccccCCC--ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCC-CCCCC--H-HHHH
Q 022617          153 KWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDEN--I-PNLF  226 (294)
Q Consensus       153 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-~~~~~--~-~~~~  226 (294)
                      ++.++|+|||++.......  ......++..|+|||++.+..+ +.++||||||+++|+|++|..+ +....  . ..+.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            9999999999997664332  2223568999999999988776 7899999999999999997754 43221  1 1121


Q ss_pred             HHHhCCC---ccC----------------------------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          227 KKIKGGI---YTL----------------------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       227 ~~~~~~~---~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +.+....   ..+                            ....+.++.+++.+||+.||.+|||+.|+|.||||...
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            1111000   000                            01345677888999999999999999999999999764

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-41  Score=294.85  Aligned_cols=251  Identities=28%  Similarity=0.453  Sum_probs=205.0

Q ss_pred             ccccCCcccccccccCceEEEEEEEccC-----CceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE   87 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   87 (294)
                      .-.++|++.+.||.|+||.||+|.+...     +..|++|++....  .....+.+.+|+++++++. ||||+++++++.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            3356888999999999999999987433     3469999986432  2233567889999999996 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHh--------------------------------------------------------
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEK--------------------------------------------------------  111 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~--------------------------------------------------------  111 (294)
                      .....+++|||+.+++|.+++..+                                                        
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999999999988642                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec
Q 022617          112 ----------------------------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD  151 (294)
Q Consensus       112 ----------------------------------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~  151 (294)
                                                              ..+++..+..++.|++.||.|||+.+++|+||+|+||+++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                    1367788899999999999999999999999999999999


Q ss_pred             CCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHH
Q 022617          152 SKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLF  226 (294)
Q Consensus       152 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~-~~~  226 (294)
                      .++.++|+|||++........   .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...... ...
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            999999999999875533221   122335678999999887766 789999999999999997 99999765433 333


Q ss_pred             HHHhCC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          227 KKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       227 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ..+..+ ....+..++.++.+++.+||+.+|++|||+.++.+
T Consensus       351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333333 34455678999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-41  Score=291.42  Aligned_cols=250  Identities=29%  Similarity=0.453  Sum_probs=202.9

Q ss_pred             ccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc-
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET-   88 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-   88 (294)
                      .++|++.+.||.|+||.||+|.+..     +++.|++|.+....  .....+.+.+|+.+++++ .|+||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            4589999999999999999997533     34789999986432  123356778899999999 79999999998754 


Q ss_pred             CCeEEEEEeccCCCChHHHHHHh---------------------------------------------------------
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEK---------------------------------------------------------  111 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------------------  111 (294)
                      ...+++++||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            45688999999999999998542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---ccccccCCCcccC
Q 022617          112 ----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAA  184 (294)
Q Consensus       112 ----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~a  184 (294)
                          .+++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......   ......++..|+|
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence                257889999999999999999999999999999999999999999999999987653221   1122334668999


Q ss_pred             CccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCC
Q 022617          185 PEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENI-PNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRIT  261 (294)
Q Consensus       185 PE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~-~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps  261 (294)
                      ||++.+..+ +.++||||||+++|+|++ |..||..... ......+.... ...+...+.++.+++.+||+.+|++||+
T Consensus       244 PE~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs  322 (337)
T cd05054         244 PESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT  322 (337)
T ss_pred             cHHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            999987776 789999999999999998 9999976443 23333333332 3345567889999999999999999999


Q ss_pred             HhHHhcC
Q 022617          262 IPEIRQH  268 (294)
Q Consensus       262 ~~~il~h  268 (294)
                      +.++++|
T Consensus       323 ~~ell~~  329 (337)
T cd05054         323 FSELVEI  329 (337)
T ss_pred             HHHHHHH
Confidence            9999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.1e-42  Score=290.46  Aligned_cols=254  Identities=28%  Similarity=0.481  Sum_probs=203.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC------
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------   89 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   89 (294)
                      .++|++.+.||.|++|.||+|.++.+++.+++|.+......+ .....+.+|+++++.++|+||+++++++...      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            589999999999999999999999999999999986543222 1234567899999999999999999887443      


Q ss_pred             --CeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           90 --SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        90 --~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                        ..++++++|+.+ +|...+.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence              346999999965 77777654 35799999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCCcc------------ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc
Q 022617          167 MRDGHFL------------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY  234 (294)
Q Consensus       167 ~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~  234 (294)
                      .......            ....+++.|+|||.+.+....+.++|+||||+++|+|++|..||.+.+.....+.+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            4332211            1123467799999887654447899999999999999999999987665443333221000


Q ss_pred             -----------------------cC-------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          235 -----------------------TL-------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       235 -----------------------~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                                             ..       .......+.+++.+||..+|++|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                                   00       02344678899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4e-41  Score=284.73  Aligned_cols=256  Identities=25%  Similarity=0.449  Sum_probs=214.3

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEc-------cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeE
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHA-------LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIR   81 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~   81 (294)
                      ...+.-.++|.+.+.||.|+||.||+|.+.       .++..+++|.+....  .......+.+|+.+++.+ +|+||++
T Consensus         8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~   85 (304)
T cd05101           8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN   85 (304)
T ss_pred             CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchh
Confidence            345677899999999999999999999753       233478999875332  223457788999999999 7999999


Q ss_pred             EEEEEEcCCeEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 022617           82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKP  145 (294)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p  145 (294)
                      +++++......++++||+++++|.+++.+..                .++...+..++.|++.||.|||+.|++|+||+|
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp  165 (304)
T cd05101          86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA  165 (304)
T ss_pred             eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence            9999999999999999999999999997642                367788899999999999999999999999999


Q ss_pred             CCeEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 022617          146 ENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN  221 (294)
Q Consensus       146 ~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~  221 (294)
                      +||+++.++.++|+|||.+........   .....++..|+|||++.+..+ +.++||||||+++|++++ |..||....
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999999876543221   112234567999999987766 788999999999999998 889998888


Q ss_pred             HHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          222 IPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       222 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ..+..+.+.... ...+..++..+.+++.+||..+|++|||+.++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            888877776544 34456789999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.2e-41  Score=289.71  Aligned_cols=255  Identities=31%  Similarity=0.489  Sum_probs=205.6

Q ss_pred             CCcccccccccCceEEEEEEEccC--CceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc----CC
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALT--GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET----PS   90 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~   90 (294)
                      +|++.+.||.|++|.||++.+..+  ++.+++|.+.... ......+.+.+|+.+++++ .|+||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            588999999999999999999877  8899999975432 2223456778899999999 59999999987532    24


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ..++++++++ ++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            5788999986 599999988888999999999999999999999999999999999999999999999999998754322


Q ss_pred             Cc-----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-------------
Q 022617          171 HF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-------------  232 (294)
Q Consensus       171 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-------------  232 (294)
                      ..     .....++..|+|||.+.+....+.++|+||+|+++|++++|..||...+.......+...             
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            11     223357889999998766444478999999999999999999999765533322221110             


Q ss_pred             ---------------C---ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          233 ---------------I---YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       233 ---------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                     .   ......++..+.+++.+||+.+|++|||+.+++.||||+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                           0   01123467899999999999999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.5e-41  Score=279.26  Aligned_cols=249  Identities=27%  Similarity=0.451  Sum_probs=209.3

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCc---eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      .++|++.+.||.|+||.||+|.+..++.   .+++|.+....  .......+.+|+.++++++|||++++++++...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            3689999999999999999998864443   68999875432  123356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++++||+++++|.+++.+. +.++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999999764 468999999999999999999999999999999999999999999999999987654322


Q ss_pred             cc----ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617          172 FL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR  245 (294)
Q Consensus       172 ~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  245 (294)
                      ..    .....+..|+|||.+.+..+ +.++|+||||+++|++++ |..||......+....+.... .+.+..++..+.
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH  239 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence            11    11122457999999987666 789999999999999887 999998877766666665543 344567889999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +++.+||+.+|.+||++.++++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHH
Confidence            9999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-41  Score=283.67  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=203.8

Q ss_pred             ccCCcccccccccCceEEEEEEEccC--------------CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALT--------------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR   81 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~--------------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   81 (294)
                      .++|++.+.||+|+||.||+|.+...              ...|++|.+....  .......+.+|++++++++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            36899999999999999999987543              2358999986432  2234567889999999999999999


Q ss_pred             EEEEEEcCCeEEEEEeccCCCChHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeE
Q 022617           82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLL  149 (294)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nil  149 (294)
                      +++++...+..++++||+.+++|.+++....            .+++..+..++.|++.|+.|||+.|++|+||+|+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999986432            3678889999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 022617          150 LDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIPN  224 (294)
Q Consensus       150 i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~~  224 (294)
                      ++.++.++|+|||++........   .....++..|+|||.+.+..+ +.++|+||||+++++|++  +..||.......
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99999999999999875433221   112234568999999887766 789999999999999988  678887766555


Q ss_pred             HHHHHhC--------CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          225 LFKKIKG--------GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       225 ~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ....+..        .....+..++..+.+++.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            5444321        112334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.2e-41  Score=277.79  Aligned_cols=241  Identities=28%  Similarity=0.458  Sum_probs=204.5

Q ss_pred             ccccccCceEEEEEEEcc-CCc--eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEecc
Q 022617           23 KTLGIGSFGKVKIAEHAL-TGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV   99 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~-~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   99 (294)
                      +.||.|++|.||+|.+.. .+.  .+++|.+......  ...+.+.+|+.++++++|+|++++++++.. ...++++|++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999999865 332  5899998765543  556788999999999999999999999987 8899999999


Q ss_pred             CCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC----cc
Q 022617          100 KSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FL  173 (294)
Q Consensus       100 ~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~----~~  173 (294)
                      .+++|.+++.++.  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......    ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999997754  68999999999999999999999999999999999999999999999999987654321    11


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC--CccCCCCCChhHHHHHHH
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPR  250 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~  250 (294)
                      ....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||......+..+.+...  ....+..++..+.+++.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ  236 (257)
T ss_pred             cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence            12345678999999887766 788999999999999998 99999887777766665532  233455678999999999


Q ss_pred             hcccCCCCCCCHhHHhc
Q 022617          251 MLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~  267 (294)
                      ||+.+|++|||+.++++
T Consensus       237 ~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         237 CWAHNPADRPTFAALRE  253 (257)
T ss_pred             HCCCCcccCCCHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.9e-41  Score=285.43  Aligned_cols=252  Identities=27%  Similarity=0.455  Sum_probs=210.3

Q ss_pred             cccccCCcccccccccCceEEEEEEEcc-------CCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYE   84 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~   84 (294)
                      +.-.++|.+.+.||.|++|.||+|.+..       ....+++|.+....  .......+.+|+.+++++ +|+||+++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            4456789999999999999999998632       34568999875432  223456788899999999 5999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617           85 VIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL  148 (294)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni  148 (294)
                      ++...+..++++||+.+++|.+++...                ..++...+..++.|++.||.|||+.|++|+||+|+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            999889999999999999999999653                2478889999999999999999999999999999999


Q ss_pred             EecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022617          149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN  224 (294)
Q Consensus       149 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~  224 (294)
                      +++.++.++|+|||.+........   .....++..|+|||.+.+..+ +.++||||||+++|++++ |..||......+
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999875543221   111223457999999887665 789999999999999999 899998888777


Q ss_pred             HHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          225 LFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       225 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ..+.+.... ...+..++.++.+++.+||+.+|++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         245 LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            777766554 3456678899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=9.7e-42  Score=282.10  Aligned_cols=252  Identities=29%  Similarity=0.511  Sum_probs=209.6

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      +|.+.+.||.|++|.||++.+...+..+++|+.......  .......+..|+.++++++|||++++++++......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            689999999999999999999877776777766432221  112344567789999999999999999999888999999


Q ss_pred             EeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +||+.+++|.+++..    ...+++..++.++.|++.++.+||+.|++|+||+|+||+++. +.++|+|||.+.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999998853    356899999999999999999999999999999999999975 579999999887653322


Q ss_pred             -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHH
Q 022617          172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP  249 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~  249 (294)
                       ......++..|+|||.+.+... +.++|+||+|+++|++++|..||...........+..+. ...+..++.++.++|.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ  238 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence             2234456788999999876655 678999999999999999999998766665555554433 4455678899999999


Q ss_pred             HhcccCCCCCCCHhHHhcCCcc
Q 022617          250 RMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       250 ~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      +||..+|++||++.++++||||
T Consensus       239 ~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         239 SMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-41  Score=279.73  Aligned_cols=248  Identities=25%  Similarity=0.410  Sum_probs=210.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .++|++.+.||+|+||.||+|.++.++.    .+++|.......  ......+.+|+.++++++|+|++++++++.. ..
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            4789999999999999999999876654    588898754432  3455778899999999999999999999887 78


Q ss_pred             EEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .++++||+.+++|.+++.++ ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            89999999999999999764 46899999999999999999999999999999999999999999999999998765432


Q ss_pred             Ccc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617          171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR  245 (294)
Q Consensus       171 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  245 (294)
                      ...   .....+..|+|||.+....+ +.++|+||||+++|++++ |..||......+....+.... .+.+..++..+.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY  241 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            211   11123457999999876666 789999999999999998 999999888777777666543 455667889999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +++.+||..+|.+||++.++++
T Consensus       242 ~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         242 MVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999887

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.9e-41  Score=279.54  Aligned_cols=247  Identities=24%  Similarity=0.361  Sum_probs=204.9

Q ss_pred             cCCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ++|++.+.||.|++|+||+|.+..+++    .+++|.+...  ........+..|+..++++.|+||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            588999999999999999999877766    4677776422  122334677888889999999999999998754 557


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++++|++.+++|.+++... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            7899999999999999754 568999999999999999999999999999999999999999999999999987553222


Q ss_pred             c---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617          172 F---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD  246 (294)
Q Consensus       172 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  246 (294)
                      .   .....++..|+|||.+.+..+ +.++|+||||+++|++++ |..||.+.........+..+. ...+..++.++.+
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYM  242 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHH
Confidence            1   122335668999999987766 789999999999999998 999998887766666555443 3445667889999


Q ss_pred             HHHHhcccCCCCCCCHhHHhc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~  267 (294)
                      ++.+||..+|.+|||+.++++
T Consensus       243 li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         243 VMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999977

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-41  Score=275.10  Aligned_cols=241  Identities=27%  Similarity=0.447  Sum_probs=205.1

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG  102 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  102 (294)
                      +.||.|++|.||+|.+.. ++.|++|.+......  .....+.+|+++++++.|+|++++++++...+..++++|++.++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            478999999999999876 899999988654332  34578899999999999999999999999999999999999999


Q ss_pred             ChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc---ccccC
Q 022617          103 ELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCG  178 (294)
Q Consensus       103 sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~  178 (294)
                      +|.+++.+. ..++...+..++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.........   .....
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999998653 46889999999999999999999999999999999999999999999999998755422211   11223


Q ss_pred             CCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHHhcccCC
Q 022617          179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDP  256 (294)
Q Consensus       179 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p  256 (294)
                      +..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+... ....+..++.++.+++.+||..+|
T Consensus       158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  236 (251)
T cd05041         158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP  236 (251)
T ss_pred             eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence            457999999877665 789999999999999998 89999887766666666543 244566788999999999999999


Q ss_pred             CCCCCHhHHhc
Q 022617          257 MKRITIPEIRQ  267 (294)
Q Consensus       257 ~~Rps~~~il~  267 (294)
                      ++|||+.++++
T Consensus       237 ~~Rp~~~ell~  247 (251)
T cd05041         237 ENRPSFSEIYN  247 (251)
T ss_pred             hhCcCHHHHHH
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6e-41  Score=276.78  Aligned_cols=242  Identities=27%  Similarity=0.524  Sum_probs=205.3

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE-EcCCeEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI-ETPSDIYV   94 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~l   94 (294)
                      ..+|++.+.||.|++|.||++..  .+..+++|.+...     ...+.+.+|+.++++++|+|++++++++ ...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence            46899999999999999999976  4778999987432     2246788999999999999999999875 45567899


Q ss_pred             EEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           95 VMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ++||+++++|.+++.+..  .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            999999999999997643  37899999999999999999999999999999999999999999999999887543322 


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHH
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR  250 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~  250 (294)
                       .....+..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||...........+..+. ...+..++..+.+++.+
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ  234 (256)
T ss_pred             -CCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence             22234567999999877665 789999999999999997 999998877777776665543 34556789999999999


Q ss_pred             hcccCCCCCCCHhHHhc
Q 022617          251 MLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~  267 (294)
                      ||+.+|++|||+.++++
T Consensus       235 ~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         235 CWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-43  Score=317.71  Aligned_cols=260  Identities=33%  Similarity=0.573  Sum_probs=229.0

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      +-.++|.++++||+|+||.|.+++++.+++-||+|++.+-..-.+....-+..|-.++..-+.+=|+.++..|.+++++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            44578999999999999999999999999999999987654444455677888889988888889999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~  172 (294)
                      +||||+.||+|-.++.+..++|+.-++.++..|+.||..||+.|++||||||+|||++..|+++|+|||.+-... ++..
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            999999999999999988899999999999999999999999999999999999999999999999999887665 3333


Q ss_pred             -cccccCCCcccCCcccc----CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCC--CCCChh
Q 022617          173 -LKTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLP--SHLSPG  243 (294)
Q Consensus       173 -~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~  243 (294)
                       .+..+|||.|.+||++.    +...++...|+||+|+++|+|+.|..||......+...+|+..  ...+|  ..++.+
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee  311 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE  311 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence             34557999999999985    2133478999999999999999999999999888888888766  45666  578999


Q ss_pred             HHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617          244 ARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH  274 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~  274 (294)
                      .++||.+.+ -+|+.|..   +++|.+||||.+.
T Consensus       312 akdLI~~ll-~~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  312 AKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             HHHHHHHHh-cChhhhcccccHHHHHhCccccCC
Confidence            999999988 56889998   9999999999763

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9.4e-41  Score=275.79  Aligned_cols=240  Identities=26%  Similarity=0.444  Sum_probs=200.3

Q ss_pred             cccccCceEEEEEEEc--cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617           24 TLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS  101 (294)
Q Consensus        24 ~lg~g~~~~vy~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  101 (294)
                      .||.|+||.||+|.+.  ..+..+++|++....  .....+.+.+|+.++++++|+|++++++++. ....++++||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            3899999999999775  344569999886442  2344567899999999999999999999886 4578999999999


Q ss_pred             CChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc----ccc
Q 022617          102 GELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTS  176 (294)
Q Consensus       102 ~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~----~~~  176 (294)
                      ++|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.........    ...
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999999875 456899999999999999999999999999999999999999999999999998754332211    111


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhccc
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIV  254 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~  254 (294)
                      ..+..|+|||.+....+ +.++|+||||+++|++++ |..||......+....+..+. ...+..++.++.+++.+||..
T Consensus       159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            22468999999877665 789999999999999996 999998887777766665543 455677899999999999999


Q ss_pred             CCCCCCCHhHHhc
Q 022617          255 DPMKRITIPEIRQ  267 (294)
Q Consensus       255 ~p~~Rps~~~il~  267 (294)
                      +|++||++.++++
T Consensus       238 ~~~~Rp~~~~i~~  250 (257)
T cd05115         238 KWEDRPNFAKVEE  250 (257)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.8e-41  Score=286.91  Aligned_cols=256  Identities=26%  Similarity=0.450  Sum_probs=213.0

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccC-------CceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeE
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALT-------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIR   81 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~   81 (294)
                      ........+|++.+.||.|+||.||+|.+...       ...+++|.+....  .......+.+|+++++++ +|+||++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~   82 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN   82 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence            44556667899999999999999999986432       2368999875432  223457888999999999 7999999


Q ss_pred             EEEEEEcCCeEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 022617           82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKP  145 (294)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p  145 (294)
                      +++++...+..++++||+++++|.+++.+..                .++...+..++.|++.||.|||+.|++|+||+|
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp  162 (334)
T cd05100          83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA  162 (334)
T ss_pred             eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence            9999999999999999999999999997532                367788899999999999999999999999999


Q ss_pred             CCeEecCCCcEEEeeecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 022617          146 ENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN  221 (294)
Q Consensus       146 ~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~  221 (294)
                      +||+++.++.++|+|||.+.........   ....++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999998765432211   11223457999999987766 788999999999999998 899999888


Q ss_pred             HHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          222 IPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       222 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ..+....+.... ...+..++.++.+++.+||..+|.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            888777766543 45566788999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.7e-41  Score=280.50  Aligned_cols=248  Identities=29%  Similarity=0.414  Sum_probs=198.4

Q ss_pred             ccCC-cccccccccCceEEEEEE----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--
Q 022617           16 LPNY-KLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--   88 (294)
Q Consensus        16 ~~~y-~~~~~lg~g~~~~vy~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   88 (294)
                      .++| ++.+.||.|+||+||++.    ...++..+++|++....  .......+.+|++++++++|||++++++++..  
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG   79 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3566 999999999999998765    33467789999986442  12345678889999999999999999998765  


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      ....++++||+.+++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            3468999999999999999865 468999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--H-------------HHHHH
Q 022617          169 DGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP--N-------------LFKKI  229 (294)
Q Consensus       169 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~--~-------------~~~~~  229 (294)
                      ....    .....++..|+|||.+..... +.++||||||+++|+|++|..||......  +             ....+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            3221    112234567999999877665 78999999999999999999998543211  0             11111


Q ss_pred             h-CCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          230 K-GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       230 ~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      . ....+.+..++.++.+++.+||+.+|++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1 1112335678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.5e-41  Score=281.30  Aligned_cols=250  Identities=26%  Similarity=0.425  Sum_probs=209.9

Q ss_pred             cccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      -.++|++.+.||.|++|.||+|.+..     ++..+++|.+....  .......+.+|+.+++++.|+|++++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            35689999999999999999998743     56789999986432  223456788999999999999999999999998


Q ss_pred             CeEEEEEeccCCCChHHHHHHhC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKG----------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN  147 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~----------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~n  147 (294)
                      ...++++||+++++|.+++....                      .+++..++.++.|++.+|.+||+.|++|+||+|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999996432                      36788899999999999999999999999999999


Q ss_pred             eEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022617          148 LLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP  223 (294)
Q Consensus       148 ili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~  223 (294)
                      |+++.++.++|+|||.+........   ......+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+....
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999998865432211   112234567999999877766 789999999999999997 88899887777


Q ss_pred             HHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          224 NLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       224 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +....+..+. .+.+..++.++.+++.+||+.+|++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            7777666554 3445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=296.63  Aligned_cols=255  Identities=37%  Similarity=0.661  Sum_probs=223.7

Q ss_pred             ccccCCcc--cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           14 MFLPNYKL--GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        14 ~~~~~y~~--~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .+..=|++  .+.||+|.||+||-|+++.+|+.||||++.+..+... ....++.|+.+|+++.||+|+.+--.|+.++.
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~er  637 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPER  637 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence            33444555  6899999999999999999999999999988776653 35889999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHH-H-HhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC---CcEEEeeeccccc
Q 022617           92 IYVVMEYVKSGELFDYI-V-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNI  166 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l-~-~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~---~~~~l~dfg~~~~  166 (294)
                      +++|||.+.| +..++| . +.+.+++...+.++.||+.||.|||.++|+|+|+||+|||+...   -.+||+|||+++.
T Consensus       638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi  716 (888)
T KOG4236|consen  638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI  716 (888)
T ss_pred             EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence            9999999977 555555 3 34679999999999999999999999999999999999999764   3699999999999


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc----CCCCCCh
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSP  242 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~  242 (294)
                      ++........+||+.|.|||++....+ ...-||||.|+++|--++|.-||..  .+++..+|+...+-    .+..++.
T Consensus       717 IgEksFRrsVVGTPAYLaPEVLrnkGy-NrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~  793 (888)
T KOG4236|consen  717 IGEKSFRRSVVGTPAYLAPEVLRNKGY-NRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISP  793 (888)
T ss_pred             cchhhhhhhhcCCccccCHHHHhhccc-cccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCH
Confidence            998888889999999999999999888 6889999999999999999999854  34555666655543    3457899


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      +..++|..+|+..-.+|-|..+.|+|||+++
T Consensus       794 ~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  794 EAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             HHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence            9999999999999999999999999999976

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.3e-41  Score=275.86  Aligned_cols=246  Identities=26%  Similarity=0.487  Sum_probs=209.7

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      .+|++.+.||.|++|.||++.+. .+..+++|.+......    ...+.+|++++++++|+|++++++++......++++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            57899999999999999999885 4678999987544322    356888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--c
Q 022617           97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L  173 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--~  173 (294)
                      ||+.+++|.+++... .+++++.++.++.|++.++++||+.+++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            999999999998764 4689999999999999999999999999999999999999999999999998875533221  1


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~  251 (294)
                      .....+..|+|||.+.+..+ +.++|+||||+++|++++ |..||.........+.+..+. ...+...+..+.+++.+|
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  237 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC  237 (256)
T ss_pred             CCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            12234568999999877665 789999999999999998 999998888777777776543 334556789999999999


Q ss_pred             cccCCCCCCCHhHHhcC
Q 022617          252 LIVDPMKRITIPEIRQH  268 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h  268 (294)
                      |+.+|++|||+.+++++
T Consensus       238 l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         238 WKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             cccChhhCCCHHHHHHh
Confidence            99999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=294.11  Aligned_cols=250  Identities=29%  Similarity=0.448  Sum_probs=217.7

Q ss_pred             cCCcccccccccCceEEEEEEEccCCc---e-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGH---K-VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~---~-~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ++-.+.++||+|+||.||+|..+..+.   . ||+|....+.........++.+|..++++++||||++++|+.....-+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            345566999999999999998765432   3 899988765555667889999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +++||+|.||+|.++|++++ .++..+...++.+.+.+|+|||+++++||||-.+|+|++.++.+||+|||+++....-.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~  316 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV  316 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence            99999999999999999876 49999999999999999999999999999999999999999999999999987654111


Q ss_pred             ccc-cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhC-CC-ccCCCCCChhHHHH
Q 022617          172 FLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG-GI-YTLPSHLSPGARDL  247 (294)
Q Consensus       172 ~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~-~~-~~~~~~~~~~l~~l  247 (294)
                      ... ....+..|+|||.+....+ +.++||||+|+++||+++ |..||.+....+....+.. +. .+.+...+.++..+
T Consensus       317 ~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~  395 (474)
T KOG0194|consen  317 MKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV  395 (474)
T ss_pred             eccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence            111 2235679999999998866 899999999999999999 8999999999999998843 33 45667889999999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+|+..+|++||++.++.+
T Consensus       396 ~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  396 MKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHhccCChhhccCHHHHHH
Confidence            99999999999999998876

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-40  Score=276.59  Aligned_cols=250  Identities=26%  Similarity=0.435  Sum_probs=209.9

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCc---eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      ..++|+..+.||.|++|.||+|.+..++.   .+++|.+....  .......+..|++++++++|+|++++.+++...+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            34688999999999999999999876554   68999875432  22335678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .++++|++++++|.+++... +.+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999999754 56899999999999999999999999999999999999999999999999998755332


Q ss_pred             Ccc----ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhH
Q 022617          171 HFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA  244 (294)
Q Consensus       171 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  244 (294)
                      ...    .....+..|+|||.+....+ +.++|+||||+++|++++ |..||...........+.... .+.+..++..+
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  239 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV  239 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence            111    11122457999999877666 789999999999999997 999998877777777765543 34445688999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+++.+||+.+|++||++.++++
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=9.9e-41  Score=279.05  Aligned_cols=251  Identities=22%  Similarity=0.321  Sum_probs=210.1

Q ss_pred             ccccCCcccccccccCceEEEEEEEcc----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-   88 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   88 (294)
                      .-.++|++.+.||+|+||.||+|.+..    .+..+++|.+...  ........+.+|+.++++++|+|++++++++.. 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            446789999999999999999999875    2577889987532  233456778899999999999999999998765 


Q ss_pred             CCeEEEEEeccCCCChHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEee
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEK--------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD  160 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~d  160 (294)
                      +...+++++++.+++|.+++...        ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            56788999999999999998653        3588999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-cc
Q 022617          161 FGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YT  235 (294)
Q Consensus       161 fg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~  235 (294)
                      ||++.........   ....++..|+|||.+.+..+ +.++||||||+++|++++ |+.||...........+..+. ..
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA  239 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence            9998755332211   12234567999999877665 789999999999999998 999998877777666665543 34


Q ss_pred             CCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+..++.++.+++.+||..+|++|||+.++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            45677899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.1e-40  Score=272.47  Aligned_cols=242  Identities=26%  Similarity=0.465  Sum_probs=203.6

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG  102 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  102 (294)
                      +.||.|++|.||++... ++..+++|.+....  .......+.+|+.++++++|+|++++++++...+..++++||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            46899999999999865 67889999876442  2233456889999999999999999999999999999999999999


Q ss_pred             ChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc--cccCC
Q 022617          103 ELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGS  179 (294)
Q Consensus       103 sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~  179 (294)
                      +|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++..........  ....+
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            999998654 457899999999999999999999999999999999999999999999999986543322111  12235


Q ss_pred             CcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCC
Q 022617          180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPM  257 (294)
Q Consensus       180 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~  257 (294)
                      ..|+|||.+.+..+ +.++|+||||+++|++++ |..||...........+.... ...+..++..+.+++.+||+.+|+
T Consensus       158 ~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  236 (250)
T cd05085         158 IKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE  236 (250)
T ss_pred             ccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence            67999999877665 789999999999999998 999998877766666665443 345667899999999999999999


Q ss_pred             CCCCHhHHhcC
Q 022617          258 KRITIPEIRQH  268 (294)
Q Consensus       258 ~Rps~~~il~h  268 (294)
                      +||++.++++.
T Consensus       237 ~Rp~~~~l~~~  247 (250)
T cd05085         237 NRPKFSELQKE  247 (250)
T ss_pred             cCCCHHHHHHH
Confidence            99999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-44  Score=326.67  Aligned_cols=259  Identities=29%  Similarity=0.501  Sum_probs=230.0

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      -+.-++.-..+||.|.||.||.|.+.++|...|+|.+...... ....+.+.+|..++..++|||+++++++-...+..+
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            3445788889999999999999999999999999998766544 566788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--  171 (294)
                      |.||||++|+|.++++...-.++.....+..|++.+++|||+.||+|+||||.||+++.+|.+|++|||.|....+..  
T Consensus      1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            999999999999999887778888889999999999999999999999999999999999999999999998765442  


Q ss_pred             ---ccccccCCCcccCCccccCCc--cCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHhCCCccCCCCCChhH
Q 022617          172 ---FLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLPSHLSPGA  244 (294)
Q Consensus       172 ---~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
                         ......||+.|||||++.+.+  ...-++|||||||++.||+||+.||..  +.+.-+...-...++++|..++++-
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence               234567999999999997543  346789999999999999999999975  4456666677778889999999999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      ++|+++||..||+.|.++.||++|-|-+.
T Consensus      1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            99999999999999999999999998754

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.5e-41  Score=282.05  Aligned_cols=252  Identities=31%  Similarity=0.464  Sum_probs=207.1

Q ss_pred             cccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVI   86 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   86 (294)
                      ....++|.+.+.||.|++|.||++.+.     .++..+++|.+....  .....+.+.+|+.+++++ +|+||+++++++
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            455678999999999999999999752     345579999875432  223456788999999999 799999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                      ...+..++++||+.+++|.+++....  .+++..+..++.|++.++.|||+.+++|+||+|+||+++.++.++++|||.+
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999999997543  3899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHhCC-CccCCC
Q 022617          165 NIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGG-IYTLPS  238 (294)
Q Consensus       165 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~-~~~~~~-~~~~~~  238 (294)
                      ........   .....++..|+|||.+.+... +.++||||+|+++|++++ |..||......... ..+..+ ....+.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            75533221   112234678999999887766 789999999999999998 99999876544433 333322 223445


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ..+.++.+++.+||..+|++|||+.++++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            67899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.4e-40  Score=275.14  Aligned_cols=247  Identities=26%  Similarity=0.477  Sum_probs=207.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...++|++.+.||.|++|.||++.+. .+..+++|.+....    .....+.+|+.++++++|+|++++++++.. ...+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            46789999999999999999999865 55679999875432    234678889999999999999999999877 7789


Q ss_pred             EEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           94 VVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +++||+++++|.+++.+.  ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999763  357888999999999999999999999999999999999999999999999887654322


Q ss_pred             cc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617          172 FL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL  247 (294)
Q Consensus       172 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  247 (294)
                      ..  ....++..|+|||.+..... +.++|+||||+++|++++ |..||...+.......+.... .+.+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence            11  12234567999999877665 788999999999999998 999998887777776665543 34456788999999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+||..+|++||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999998865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.7e-41  Score=278.66  Aligned_cols=249  Identities=25%  Similarity=0.447  Sum_probs=210.5

Q ss_pred             cCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .+|++.+.||.|+||.||+|+++.     +.+.+++|.+....  .......+.+|+.++++++|+|++++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            689999999999999999999753     34678999875432  22356788999999999999999999999998899


Q ss_pred             EEEEEeccCCCChHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeec
Q 022617           92 IYVVMEYVKSGELFDYIVEKG---------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG  162 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg  162 (294)
                      .++++||+++++|.+++....         .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++++|||
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence            999999999999999997655         68999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC--ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCCc--cCC
Q 022617          163 LSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY--TLP  237 (294)
Q Consensus       163 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~--~~~  237 (294)
                      ++.......  ......++..|+|||.+.+... +.++|+||||+++|++++ |..||...........+.....  ..+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            876443222  1223345667999999877665 688999999999999998 8899987776676666664443  345


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ..++..+.+++.+||+.+|++|||+.++++.
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            6788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-40  Score=281.20  Aligned_cols=249  Identities=25%  Similarity=0.385  Sum_probs=202.6

Q ss_pred             ccCCcccccccccCceEEEEEEEcc----------------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHAL----------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI   79 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~----------------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i   79 (294)
                      .++|++.+.||.|+||.||++.+..                ++..+++|++....  .......+.+|++++++++|+|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence            4689999999999999999986532                23468999876432  23345788899999999999999


Q ss_pred             eEEEEEEEcCCeEEEEEeccCCCChHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617           80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL  148 (294)
Q Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni  148 (294)
                      +++++++...+..++++||+.+++|.+++.+..           .+++..++.++.|++.|+.+||+.|++|+||+|+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999997542           366778999999999999999999999999999999


Q ss_pred             EecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh--CCCCCCCCCHH
Q 022617          149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIP  223 (294)
Q Consensus       149 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~  223 (294)
                      +++.++.++|+|||.+........   ......+..|++||......+ +.++|+||||+++|+|++  |..||......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999875433221   112223567999998776666 789999999999999998  78898776555


Q ss_pred             HHHHHHh--------CCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          224 NLFKKIK--------GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       224 ~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .......        ....+.+..++..+.+++.+||+.||++||++.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            5443321        1123445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.2e-40  Score=283.14  Aligned_cols=246  Identities=23%  Similarity=0.352  Sum_probs=195.7

Q ss_pred             CceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCChHHHH
Q 022617           29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI  108 (294)
Q Consensus        29 ~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l  108 (294)
                      +++.||.+++..+++.+++|++..... .......+.+|+++++.++|+||+++++++...+..++++||+.+++|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            445667777777899999999876532 2345678999999999999999999999999999999999999999999999


Q ss_pred             HHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--------ccccccC
Q 022617          109 VEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--------FLKTSCG  178 (294)
Q Consensus       109 ~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~  178 (294)
                      .+.  ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++++||+.+.......        ......+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence            764  458899999999999999999999999999999999999999999999999876442211        1122345


Q ss_pred             CCcccCCccccCC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhCCCc----------------------
Q 022617          179 SPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-KKIKGGIY----------------------  234 (294)
Q Consensus       179 ~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-~~~~~~~~----------------------  234 (294)
                      +..|+|||.+... ...+.++|+||+|+++|+|++|..||......... +.+.....                      
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN  250 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence            6789999998653 22367899999999999999999999865543322 22211100                      


Q ss_pred             -----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          235 -----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       235 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                                 .....++.++.+++.+||..||++|||+.++|+||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                       00112345788999999999999999999999999998643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.8e-40  Score=276.11  Aligned_cols=249  Identities=29%  Similarity=0.472  Sum_probs=207.9

Q ss_pred             cccCCcccccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      -..+|.+.+.||.|++|.||+|.+...   ...+++|.+....  .....+.+.+|+.++++++|+|++++++++.. ..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            346799999999999999999987544   3468899875432  23445688899999999999999999999875 55


Q ss_pred             EEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .++++||+.+++|.+++.+.. .++...++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            789999999999999997644 5899999999999999999999999999999999999999999999999998765433


Q ss_pred             Cccc--cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHH
Q 022617          171 HFLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARD  246 (294)
Q Consensus       171 ~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  246 (294)
                      ....  ....+..|+|||.+....+ +.++|+||||+++|++++ |..||......+....+... ..+.+..++..+.+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  239 (270)
T ss_pred             cceecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence            2211  2223457999999876665 789999999999999986 99999887776666665544 34566788999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~  267 (294)
                      ++.+|+..+|++|||+.++++
T Consensus       240 li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         240 LMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999886

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=311.24  Aligned_cols=249  Identities=27%  Similarity=0.458  Sum_probs=218.1

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCc-----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ..+-+....||+|.||.||.|.......     .|++|.+.  ...+.....++.+|..++++++||||++++|++.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~--~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK--RLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecc--ccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            4566778899999999999998654332     37777764  4455677899999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           91 DIYVVMEYVKSGELFDYIVEK-------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~-------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      ..++++|||.||+|..+|++.       ..++...+..++.|++.++.||++++++|+||..+|+|++....+||+|||+
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999999865       2488999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccc---cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH-HHhCCCccCCC
Q 022617          164 SNIMRDGHFLKTS---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFK-KIKGGIYTLPS  238 (294)
Q Consensus       164 ~~~~~~~~~~~~~---~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~-~~~~~~~~~~~  238 (294)
                      |+......+....   ..+..|||||.+....+ +.++||||||+++||+++ |..||...+..+... -...++.+.|.
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~  927 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS  927 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence            9965544332222   34579999999998878 899999999999999999 999999988888777 56677788899


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .|+..+.++|..||+.+|++||++..|++
T Consensus       928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            99999999999999999999999999988

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.4e-40  Score=306.83  Aligned_cols=150  Identities=29%  Similarity=0.591  Sum_probs=139.7

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|.+.+.||.|+||+||+|.+..+++.|++|++.............+..|+.+++.++|+||+++++.+......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            47899999999999999999999999999999999766555555667889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                      |||+.|++|.+++...+.+++..++.++.||+.||.|||..||+|+||||+|||++.++.++|+|||++.
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-40  Score=277.63  Aligned_cols=248  Identities=27%  Similarity=0.434  Sum_probs=200.5

Q ss_pred             cCCcccccccccCceEEEEEEE----ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--C
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEH----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--S   90 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~   90 (294)
                      .-|++.+.||+|++|.||+|..    ..++..+++|.+....  .......+.+|+++++++.|+|++++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            3478999999999999999974    4567889999986442  233456789999999999999999999998765  5


Q ss_pred             eEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           91 DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      ..++++||++|++|.+++.+. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            689999999999999999765 3589999999999999999999999999999999999999999999999999876543


Q ss_pred             CCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHh
Q 022617          170 GHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---------------NIPNLFKKIK  230 (294)
Q Consensus       170 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------------~~~~~~~~~~  230 (294)
                      ...    .....++..|+|||.+.+..+ +.++||||||+++|+++++..|....               ........+.
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence            221    123345667999999877665 78999999999999999977654221               1111122222


Q ss_pred             CC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          231 GG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       231 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+ ..+.+..++..+.+++.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            22 23445678999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=250.15  Aligned_cols=257  Identities=29%  Similarity=0.532  Sum_probs=221.3

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      .+|+-.++||+|.+|+|++|++..+++-|++|.+..+.-++ -.-....+|+-+++.++|.||+++++...+++.+.+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            46888899999999999999999999999999997765333 23467789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617           97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  174 (294)
                      |+|.. +|..+..+ ++.++.+.++.++.|++.++.+.|++++.|+|+||.|.+|+.+|.+|+.|||+++.+.-+- ..+
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            99965 88887754 6789999999999999999999999999999999999999999999999999998776543 445


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-------cc----CC-----
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-------YT----LP-----  237 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-------~~----~~-----  237 (294)
                      ..+.|..|++|.++.+.+..+...|+||-||++.|+.. |++.|.+.+..+...+|....       ++    +|     
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            56678899999999999888999999999999999998 888899988888777763211       10    00     


Q ss_pred             -------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          238 -------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       238 -------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                                   +.++..-++++.++|.-+|.+|.++++.++||||.+.-
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence                         23344556899999999999999999999999998754

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.7e-41  Score=277.77  Aligned_cols=239  Identities=20%  Similarity=0.300  Sum_probs=195.9

Q ss_pred             ccccccCceEEEEEEEccCCc-------eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           23 KTLGIGSFGKVKIAEHALTGH-------KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~-------~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      +.||.|+||.||+|.+...+.       .+++|.+...   .....+.+.+|..+++.+.|||++++++++..+...+++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            469999999999998865443       3788876433   223456788899999999999999999999998999999


Q ss_pred             EeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc--------EEEeeeccccc
Q 022617           96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--------VKIADFGLSNI  166 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~--------~~l~dfg~~~~  166 (294)
                      |||+++++|.+++..++ .+++..+..++.|++.+++|||+.|++|+||+|+||+++.++.        ++++|||.+..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997654 5899999999999999999999999999999999999987664        69999998765


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhCCCccCCCCCChhHH
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR  245 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
                      ....   ....++..|+|||.+.+....+.++|+||||+++|++++| ..|+.......... ........+...+.++.
T Consensus       158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  233 (258)
T cd05078         158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWTELA  233 (258)
T ss_pred             cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcHHHH
Confidence            4322   2234677899999997655447899999999999999998 56666655544333 33344556667788999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcC
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      +++.+||+.+|++|||+++|++.
T Consensus       234 ~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         234 NLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHhccChhhCCCHHHHHHh
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.8e-40  Score=273.95  Aligned_cols=250  Identities=29%  Similarity=0.508  Sum_probs=209.5

Q ss_pred             CCcccccccccCceEEEEEEEcc-CCceEEEEEeecccc-------cchHHHHHHHHHHHHHHh-CCCCceeEEEEEEEc
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKI-------KNMEMEEKVRREIKILRL-FMHPHIIRLYEVIET   88 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~   88 (294)
                      +|++.+.||.|++|.||++.+.. .++.+++|.+.....       ........+.+|+.++.+ ++|+|++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            58999999999999999999987 678899998854321       122345567778887765 789999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      .+..++++||+.+++|.+++..    ...+++..++.++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999998743    3468999999999999999999996 7899999999999999999999999999


Q ss_pred             cccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-CC-CCCC
Q 022617          164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LP-SHLS  241 (294)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~-~~~~  241 (294)
                      +.............++..|++||.+.+..+ +.++|+||||+++|++++|..||...........+...... .+ ..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS  239 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence            876654433345567889999999987666 78999999999999999999999887776666665544422 22 2578


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .++.+++.+||+.||++||++.++..+
T Consensus       240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         240 EDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            899999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=294.24  Aligned_cols=261  Identities=33%  Similarity=0.613  Sum_probs=243.4

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +.-..+.+++..||.|+||.|=++..+.....+|+|++.+..+.+....+.+..|-.++..++.++|++++..|.+.+++
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            34556788899999999999999988766667999999888888878888999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      |++||-|-||.|+..+..++.+.+...+.++..+++|+.|||.+||+++|+||+|.+++.+|-+||.|||++.....+..
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCCCCCChhHHHHHHH
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPR  250 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~  250 (294)
                      ..+.+||+.|.|||++.+... +.+.|+|+||+++|||++|.+||.+.++....+.|.++.  +.+|..++....++|++
T Consensus       576 TwTFcGTpEYVAPEIILnKGH-D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGH-DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             eeeecCCcccccchhhhccCc-chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence            999999999999999987766 799999999999999999999999999999999888776  67889999999999999


Q ss_pred             hcccCCCCCCC-----HhHHhcCCccccc
Q 022617          251 MLIVDPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       251 ~l~~~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      +++.+|.+|.-     +.+|.+|-||..+
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence            99999999997     8899999999764

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.1e-40  Score=275.89  Aligned_cols=248  Identities=29%  Similarity=0.444  Sum_probs=198.9

Q ss_pred             ccCCcccccccccCceEEEEEE----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--C
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--P   89 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   89 (294)
                      ..+|++.+.||+|+||.||.+.    +..++..|++|.+....   ......+.+|++++++++|+|++++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            3589999999999999999997    44578899999975432   3345778899999999999999999998743  3


Q ss_pred             CeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      ..+++++||+++++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            4689999999999999999764 468999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcc----ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHH
Q 022617          169 DGHFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN----------------LFKK  228 (294)
Q Consensus       169 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~----------------~~~~  228 (294)
                      .....    .....+..|+|||.+.+..+ +.++|+||||+++++|++|..++.......                +.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            32211    11123446999999877666 789999999999999999877654322110                1111


Q ss_pred             HhC-CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          229 IKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       229 ~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +.. ...+.+..++.++.+++.+||+.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            111 123445678899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.3e-41  Score=272.52  Aligned_cols=229  Identities=24%  Similarity=0.396  Sum_probs=190.9

Q ss_pred             cCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCChHHH
Q 022617           28 GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY  107 (294)
Q Consensus        28 g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~  107 (294)
                      |.++.||++.++.+++.+++|.+....        ...+|...+....|||++++++++...+..++++||+++++|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            889999999999999999999986542        122334444556799999999999999999999999999999999


Q ss_pred             HHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccCCcc
Q 022617          108 IVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV  187 (294)
Q Consensus       108 l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~  187 (294)
                      +.+...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.......  .....+..|+|||.
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~  153 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEV  153 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccCCcc
Confidence            9888889999999999999999999999999999999999999999999999999875543321  23345667999999


Q ss_pred             ccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCH-----
Q 022617          188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-----  262 (294)
Q Consensus       188 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----  262 (294)
                      ..+... +.++|+||+|+++|++++|..|+.......    ........+..++..+.+++.+||+.||++||++     
T Consensus       154 ~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~  228 (237)
T cd05576         154 GGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV  228 (237)
T ss_pred             cCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence            876666 788999999999999999998875432211    0111234566788999999999999999999985     


Q ss_pred             hHHhcCCcc
Q 022617          263 PEIRQHPWF  271 (294)
Q Consensus       263 ~~il~h~~~  271 (294)
                      +++++||||
T Consensus       229 ~~~~~h~~~  237 (237)
T cd05576         229 EDIKSHPFF  237 (237)
T ss_pred             HHHHcCCCC
Confidence            999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.8e-40  Score=287.07  Aligned_cols=255  Identities=28%  Similarity=0.436  Sum_probs=207.8

Q ss_pred             CccccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEE
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYE   84 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~   84 (294)
                      ....-.++|.+.+.||.|+||.||+|.+.     ..++.|++|++.....  ....+.+.+|+.++.++. |+||+++++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~  108 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLG  108 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            34555678999999999999999999864     3456899999965432  223457889999999997 999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHHHhC----------------------------------------------------
Q 022617           85 VIETPSDIYVVMEYVKSGELFDYIVEKG----------------------------------------------------  112 (294)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------  112 (294)
                      ++...+..++++||+.+++|.+++.+++                                                    
T Consensus       109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence            9999999999999999999999986432                                                    


Q ss_pred             ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 022617          113 ----------------------------------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPE  146 (294)
Q Consensus       113 ----------------------------------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~  146 (294)
                                                                    .++...++.++.|++.||.|||+.+++|+||+|+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~  268 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR  268 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence                                                          2566678889999999999999999999999999


Q ss_pred             CeEecCCCcEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022617          147 NLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENI  222 (294)
Q Consensus       147 nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~  222 (294)
                      ||+++.++.++|+|||++.......   ......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.....
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            9999999999999999987543211   1122345678999999987665 789999999999999998 8999976554


Q ss_pred             HHHH-HHHhCC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          223 PNLF-KKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       223 ~~~~-~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .+.. ..+..+ ....+..++.++.+++.+||..+|.+||++.+|++.
T Consensus       348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4433 333333 244566789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.9e-40  Score=271.62  Aligned_cols=241  Identities=27%  Similarity=0.499  Sum_probs=204.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||.|++|.||.+..  +++.+++|.+....     ....+.+|+.++++++|+|++++++++..+ ..+++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence            36799999999999999999874  67789999875432     245788899999999999999999998654 57899


Q ss_pred             EeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      +||+.+++|.+++....  .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......  .
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~  154 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--V  154 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--C
Confidence            99999999999997643  4789999999999999999999999999999999999999999999999988654322  1


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~  251 (294)
                      .....+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..+. ...+..++..+.+++.+|
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  233 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSC  233 (254)
T ss_pred             CCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHH
Confidence            22334568999999877666 789999999999999997 999998888777777665543 334567889999999999


Q ss_pred             cccCCCCCCCHhHHhc
Q 022617          252 LIVDPMKRITIPEIRQ  267 (294)
Q Consensus       252 l~~~p~~Rps~~~il~  267 (294)
                      |+.+|++||++.+++.
T Consensus       234 l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         234 WETEPKKRPSFHKLRE  249 (254)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-40  Score=284.16  Aligned_cols=250  Identities=28%  Similarity=0.452  Sum_probs=200.7

Q ss_pred             ccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc-
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET-   88 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-   88 (294)
                      .++|++.+.||.|+||.||+|.+.     .+++.|++|.+.....  ......+.+|+.++.++ +|+|++++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            468999999999999999999853     4567899999864432  23356788999999999 58999999998754 


Q ss_pred             CCeEEEEEeccCCCChHHHHHHh---------------------------------------------------------
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEK---------------------------------------------------------  111 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------------------  111 (294)
                      ....++++||+++++|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            45688999999999999998642                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc---cccccC
Q 022617          112 ----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCG  178 (294)
Q Consensus       112 ----------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~  178 (294)
                                ..++...+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||++........   .....+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                      1357778889999999999999999999999999999999999999999999875432211   112234


Q ss_pred             CCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHhCC-CccCCCCCChhHHHHHHHhcccC
Q 022617          179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENI-PNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       179 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~-~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      +..|+|||.+.+..+ +.++|+||||+++|++++ |..||..... ......+..+ ....+...++++.+++..||+.+
T Consensus       244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~  322 (343)
T cd05103         244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  322 (343)
T ss_pred             CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence            567999999877766 789999999999999997 9999976543 2333333332 33445567889999999999999


Q ss_pred             CCCCCCHhHHhcC
Q 022617          256 PMKRITIPEIRQH  268 (294)
Q Consensus       256 p~~Rps~~~il~h  268 (294)
                      |++|||+.+|++|
T Consensus       323 p~~Rps~~eil~~  335 (343)
T cd05103         323 PSQRPTFSELVEH  335 (343)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.4e-40  Score=274.28  Aligned_cols=238  Identities=21%  Similarity=0.278  Sum_probs=192.0

Q ss_pred             cccccCceEEEEEEEccC------------------------CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce
Q 022617           24 TLGIGSFGKVKIAEHALT------------------------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI   79 (294)
Q Consensus        24 ~lg~g~~~~vy~~~~~~~------------------------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i   79 (294)
                      +||+|+||.||+|....+                        ...+++|++....   ......+.+|+.+++.++|+||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            699999999999975321                        2358888875432   2334677888999999999999


Q ss_pred             eEEEEEEEcCCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC----
Q 022617           80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----  154 (294)
Q Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~----  154 (294)
                      +++++++......++||||+++++|..++.+ .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999999865 45689999999999999999999999999999999999997643    


Q ss_pred             ---cEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHh
Q 022617          155 ---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIK  230 (294)
Q Consensus       155 ---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~p~~~~~~~~~~~~~~  230 (294)
                         .++++|||.+......   ....++..|+|||.+.+....+.++|+||||+++|+++ +|..||.............
T Consensus       159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  235 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE  235 (274)
T ss_pred             ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence               3799999987543221   22345678999998876544478999999999999985 6999998766554433322


Q ss_pred             CCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          231 GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                       .....+...+..+.+++.+||+.+|++|||+.+++++
T Consensus       236 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         236 -KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             2334445567789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.3e-40  Score=270.87  Aligned_cols=239  Identities=21%  Similarity=0.308  Sum_probs=192.6

Q ss_pred             ccccccCceEEEEEEEcc------------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           23 KTLGIGSFGKVKIAEHAL------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~------------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      +.||.|++|.||+|....            ....+++|++....   ......+.+|+.+++.++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            468999999999998532            22358888875432   234567888999999999999999999999988


Q ss_pred             eEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc-------EEEeeec
Q 022617           91 DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-------VKIADFG  162 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~-------~~l~dfg  162 (294)
                      ..++++||+++++|..++.+. ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999999988653 56899999999999999999999999999999999999987654       8999999


Q ss_pred             ccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhCCCccCCCCCC
Q 022617          163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLPSHLS  241 (294)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
                      .+......   ....++..|+|||.+......+.++||||||+++|+|+ +|..||......+... ............+
T Consensus       158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~  233 (262)
T cd05077         158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPSC  233 (262)
T ss_pred             CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCCCh
Confidence            88654221   23346778999998875444478999999999999998 5888887665444332 2223333334456


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .++.+++.+||+.||.+||++.+|+++
T Consensus       234 ~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         234 KELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=278.78  Aligned_cols=253  Identities=31%  Similarity=0.493  Sum_probs=208.4

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC--Cc----eeEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PH----IIRLYEVI   86 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~----i~~~~~~~   86 (294)
                      +.+.++|.++..+|+|.||.|..+.|..++..+|||++..-.    ...+...-|++++.++.+  |+    ++.+.++|
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            567899999999999999999999999999999999985322    345666779999999842  32    67777889


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC------------
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS------------  152 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~------------  152 (294)
                      ...++.|+|+|.+ |.|+.+++.+++  +++...++.++.|++.++++||+.+++|.|+||+||++.+            
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            9999999999999 669999998764  5889999999999999999999999999999999999832            


Q ss_pred             --------CCcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022617          153 --------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN  224 (294)
Q Consensus       153 --------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~  224 (294)
                              +..++++|||.|+.....  ....+.|.-|+|||++.+-.+ +...|+||+||+++|+++|...|..++..+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    234899999999865433  366778999999999999988 788999999999999999999998776544


Q ss_pred             ---HHHHHhCCCc------------------cCC-------------------------CCCChhHHHHHHHhcccCCCC
Q 022617          225 ---LFKKIKGGIY------------------TLP-------------------------SHLSPGARDLIPRMLIVDPMK  258 (294)
Q Consensus       225 ---~~~~~~~~~~------------------~~~-------------------------~~~~~~l~~li~~~l~~~p~~  258 (294)
                         +.+.+....+                  ..+                         ...-.+|.+|+++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence               4443322110                  000                         011235789999999999999


Q ss_pred             CCCHhHHhcCCcccc
Q 022617          259 RITIPEIRQHPWFQA  273 (294)
Q Consensus       259 Rps~~~il~h~~~~~  273 (294)
                      |+|+.|+|.||||+.
T Consensus       397 RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  397 RITLREALSHPFFAR  411 (415)
T ss_pred             cccHHHHhcCHHhhc
Confidence            999999999999975

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-39  Score=269.50  Aligned_cols=242  Identities=27%  Similarity=0.414  Sum_probs=196.1

Q ss_pred             ccccccCceEEEEEEEcc---CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE-cCCeEEEEEec
Q 022617           23 KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE-TPSDIYVVMEY   98 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~   98 (294)
                      +.||+|+||.||+|.+..   .+..+++|.+...  ........+.+|+.+++.++|||++++++++. .++..++++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998653   3457999987432  22334567888999999999999999999765 45568899999


Q ss_pred             cCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-----
Q 022617           99 VKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-----  172 (294)
Q Consensus        99 ~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-----  172 (294)
                      +.+++|.+++.+. ...+...+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+........     
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999999764 3467778889999999999999999999999999999999999999999999875432211     


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHH
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR  250 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~  250 (294)
                      .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+.... ...+..++..+.+++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            112234668999999877666 789999999999999999 567777777666666555443 33455678999999999


Q ss_pred             hcccCCCCCCCHhHHhc
Q 022617          251 MLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~  267 (294)
                      ||..+|++||++.++++
T Consensus       238 cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         238 CWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HcCCChhhCCCHHHHHH
Confidence            99999999999999987

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=283.26  Aligned_cols=253  Identities=27%  Similarity=0.419  Sum_probs=203.5

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      ..+....++|.-...||.|+||+||+|... ++..||||.+.......   ..++.+|++++.+++|||+++++|||.+.
T Consensus        68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~  143 (361)
T KOG1187|consen   68 DELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEG  143 (361)
T ss_pred             HHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence            344556678999999999999999999986 44889999775443221   45699999999999999999999999988


Q ss_pred             C-eEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCeEecCCCcEEEeeecc
Q 022617           90 S-DIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNM---VVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        90 ~-~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~---i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      + ..++|+||+..|+|.+++....  ++++....+|+.+++.||+|||...   |+|+|||++|||++++...||+|||+
T Consensus       144 ~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGL  223 (361)
T KOG1187|consen  144 GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGL  223 (361)
T ss_pred             CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccC
Confidence            8 5999999999999999997654  8999999999999999999999854   99999999999999999999999999


Q ss_pred             cccccC-CCccccc-cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHHH-HHhCCC-
Q 022617          164 SNIMRD-GHFLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN------IPNLFK-KIKGGI-  233 (294)
Q Consensus       164 ~~~~~~-~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~------~~~~~~-~~~~~~-  233 (294)
                      +...+. ....... .+|.+|++||....+.. +.++||||+|++++|+++|+.+.+...      ..+... .+.... 
T Consensus       224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~  302 (361)
T KOG1187|consen  224 AKLGPEGDTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL  302 (361)
T ss_pred             cccCCccccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence            976655 4433333 79999999999987666 789999999999999999998887532      112111 122211 


Q ss_pred             -----ccCC-CCCC--h---hHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          234 -----YTLP-SHLS--P---GARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       234 -----~~~~-~~~~--~---~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                           ..+. ..++  .   .+..+..+|++.+|.+||+..++++
T Consensus       303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                 1111 2233  2   3557788899999999999998755

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.7e-40  Score=276.09  Aligned_cols=249  Identities=28%  Similarity=0.421  Sum_probs=205.3

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      ..+|++.+.||+|++|.||+|.+..++.    .+++|.+....  .......+.+|+.+++.++|+|++++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            3578899999999999999999877775    46888775432  223345688899999999999999999998654 4


Q ss_pred             EEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .+++++++++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            678999999999999987643 5899999999999999999999999999999999999999999999999998765432


Q ss_pred             Cc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617          171 HF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR  245 (294)
Q Consensus       171 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  245 (294)
                      ..   .....++..|+|||.+.+... +.++||||||+++|++++ |..||.+.........+.... .+.+..++..+.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY  241 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence            21   112234568999999877666 789999999999999997 999998876666555554433 445567889999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcC
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      +++.+||..+|++||++.++++.
T Consensus       242 ~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         242 MVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999998873

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.9e-40  Score=270.05  Aligned_cols=236  Identities=21%  Similarity=0.282  Sum_probs=192.3

Q ss_pred             ccccccCceEEEEEEEccCC----------ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           23 KTLGIGSFGKVKIAEHALTG----------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~----------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +.||.|+||.||+|.+..++          ..+++|++.....    ....+.+|+.++++++|+|++++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46899999999999998766          3477787643321    15778899999999999999999999887 778


Q ss_pred             EEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-------cEEEeeeccc
Q 022617           93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-------NVKIADFGLS  164 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-------~~~l~dfg~~  164 (294)
                      ++++||+++++|.+++.... .++...+..++.|++.+|.|||+.|++|+||+|+||+++.++       .++|+|||.+
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998765 789999999999999999999999999999999999999887       7999999998


Q ss_pred             ccccCCCccccccCCCcccCCccccCC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCCccCCCCCCh
Q 022617          165 NIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP  242 (294)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
                      .....   .....++..|+|||.+.+. ...+.++|+||||+++|++++ |..||.............. ....+.....
T Consensus       156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~  231 (259)
T cd05037         156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPMPDCA  231 (259)
T ss_pred             ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCCCCch
Confidence            76543   2233456689999998766 334789999999999999999 6888876654333333322 2222223347


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+.+++.+||..+|++|||+.++++
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         232 ELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            8999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.7e-40  Score=272.05  Aligned_cols=242  Identities=26%  Similarity=0.440  Sum_probs=201.2

Q ss_pred             ccccccCceEEEEEEEccCC------ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           23 KTLGIGSFGKVKIAEHALTG------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      +.||.|++|.||+|.+....      ..+++|.+....  .......+.+|+.+++.++|+||+++++++......++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36899999999999986443      678999875432  1233567888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-----cEEEeeeccc
Q 022617           97 EYVKSGELFDYIVEK-------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-----NVKIADFGLS  164 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-----~~~l~dfg~~  164 (294)
                      ||+++++|.+++.+.       ..+++..+..++.|++.++.|||+.+++|+||+|+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999999642       2378889999999999999999999999999999999999877     8999999998


Q ss_pred             ccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCC
Q 022617          165 NIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSH  239 (294)
Q Consensus       165 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~  239 (294)
                      ........   ......+..|+|||.+.+... +.++|+||||+++|+|++ |..||...........+... ....+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN  237 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence            75533221   112234678999999987766 789999999999999998 99999877766666555433 3455667


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ++..+.+++.+||..+|++||++.++++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8999999999999999999999999876

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.8e-40  Score=273.69  Aligned_cols=249  Identities=30%  Similarity=0.456  Sum_probs=203.8

Q ss_pred             ccCCcccccccccCceEEEEEEEc----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--C
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--P   89 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   89 (294)
                      .+.|++.+.||.|++|.||+|...    .+++.+++|++......  .....+.+|+++++.+.|+|++++++++..  .
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            357889999999999999999864    34788999998655432  346789999999999999999999999877  5


Q ss_pred             CeEEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      ...++++||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            67999999999999999997654 58999999999999999999999999999999999999999999999999987664


Q ss_pred             CCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHH
Q 022617          169 DGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------------NLFKKI  229 (294)
Q Consensus       169 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------------~~~~~~  229 (294)
                      ....    ......+..|++||...+... +.++|+||||+++++|++|..|+......               ...+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            2221    112234557999999877665 78999999999999999999998653221               122222


Q ss_pred             hCC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          230 KGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       230 ~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ... ..+.+..++.++.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            222 23445567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=278.52  Aligned_cols=260  Identities=37%  Similarity=0.578  Sum_probs=235.0

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI   92 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   92 (294)
                      +-..+|..+.+||.|+||.|.+|..+.+.+.||||++.++-+......+--..|..+|.... -|.+++++..|+.-+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            34568999999999999999999999999999999998876665555666667777777665 47889999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc-cCCC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~-~~~~  171 (294)
                      |+||||++||+|-..++.-+.+.+..+..++.+|+-+|-+||++||+++|+|..|||++.+|++||.|||++... ....
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence            999999999999999999899999999999999999999999999999999999999999999999999998643 2334


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      ...+..||+.|+|||++..+++ +.+.|+|++|+++|||+.|+.||++.+..++.+.|+.....+|..++.+..++....
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~  584 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGL  584 (683)
T ss_pred             ceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHH
Confidence            4567789999999999999998 899999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCC-----HhHHhcCCccccc
Q 022617          252 LIVDPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       252 l~~~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      |.+.|.+|.-     -++|..||||+.+
T Consensus       585 ltK~P~kRLGcg~~ge~di~~H~FFR~i  612 (683)
T KOG0696|consen  585 LTKHPGKRLGCGPEGERDIREHPFFRRI  612 (683)
T ss_pred             hhcCCccccCCCCccccchhhCcchhhc
Confidence            9999999986     3579999999754

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.4e-39  Score=269.61  Aligned_cols=247  Identities=26%  Similarity=0.452  Sum_probs=202.1

Q ss_pred             CcccccccccCceEEEEEEEcc---CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----
Q 022617           19 YKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----   90 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   90 (294)
                      |++.+.||.|++|.||+|.+..   ++..+++|++...... ....+.+.+|++++++++|||++++++++...+     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            6788999999999999998643   4678999998654333 334677889999999999999999999885432     


Q ss_pred             -eEEEEEeccCCCChHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           91 -DIYVVMEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        91 -~~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                       ..+++++|+.+++|.+++...      ..++...++.++.|++.+++|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             247889999999999887532      1478899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCC
Q 022617          164 SNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPS  238 (294)
Q Consensus       164 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~  238 (294)
                      +........   ......+..|++||.+..... +.++|+||||+++|+|++ |..||...+..+....+.... ...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP  238 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            876533221   112234567999999877666 688999999999999999 899998877766666554433 34456


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ..+..+.+++.+||+.+|++|||+.+++.
T Consensus       239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         239 DCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            78899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-40  Score=303.52  Aligned_cols=254  Identities=31%  Similarity=0.554  Sum_probs=208.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   89 (294)
                      ....+|..++.||+||||.||+++++-+|..||||.+....  ......++.+|+.++.+|+||||++++..|.+.    
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            36678899999999999999999999999999999997765  446678999999999999999999988643110    


Q ss_pred             --------------------------------------------------------------------------------
Q 022617           90 --------------------------------------------------------------------------------   89 (294)
Q Consensus        90 --------------------------------------------------------------------------------   89 (294)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------CeEEEEEeccCCCChHHHHHHhCCC-CHHHHHHHHHHHHHHHHHH
Q 022617           90 -----------------------------------SDIYVVMEYVKSGELFDYIVEKGRL-QEDEARNFFQQIISGVEYC  133 (294)
Q Consensus        90 -----------------------------------~~~~lv~e~~~~~sL~~~l~~~~~l-~~~~~~~~~~ql~~~l~~L  133 (294)
                                                         ..+||.||||+..+|.+++.++... .....|+++++|++||+|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                               0268999999886666666555443 4889999999999999999


Q ss_pred             HhCCceecCCCCCCeEecCCCcEEEeeeccccccc-------------------CCCccccccCCCcccCCccccCCc--
Q 022617          134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-------------------DGHFLKTSCGSPNYAAPEVISGKL--  192 (294)
Q Consensus       134 h~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~--  192 (294)
                      |+.|++||||||.||+++.++.|||+|||+++...                   +.......+||..|+|||.+.+..  
T Consensus       714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            99999999999999999999999999999998721                   001123446899999999998766  


Q ss_pred             cCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhCCCccCCCCC----ChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          193 YAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHL----SPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       193 ~~~~~~Di~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .++.++||||||++++||+.   ||. .+.....+..+.++..+.+..+    -+.-..+|++||+.||.+|||+.|+|+
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            34899999999999999985   454 4666777777777776665222    234468999999999999999999999


Q ss_pred             CCccc
Q 022617          268 HPWFQ  272 (294)
Q Consensus       268 h~~~~  272 (294)
                      +.||-
T Consensus       871 s~llp  875 (1351)
T KOG1035|consen  871 SELLP  875 (1351)
T ss_pred             ccCCC
Confidence            99995

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.6e-39  Score=272.31  Aligned_cols=253  Identities=18%  Similarity=0.202  Sum_probs=193.6

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccC---CceEEEEEeecccccchHH--------HHHHHHHHHHHHhCCCCcee
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEM--------EEKVRREIKILRLFMHPHII   80 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~   80 (294)
                      .+...++|++.+.||+|+||+||+|.+..+   +..+++|+...........        ......+...+..+.|++++
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            456678999999999999999999998777   6677777653322110000        01122333445667899999


Q ss_pred             EEEEEEEcCC----eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcE
Q 022617           81 RLYEVIETPS----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV  156 (294)
Q Consensus        81 ~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~  156 (294)
                      ++++.+....    ..+++++++. .++.+.+......++..++.++.|++.++.|||+.+++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            9998765433    3467888874 4788877766667889999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccCCC--------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHH---
Q 022617          157 KIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPN---  224 (294)
Q Consensus       157 ~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~---  224 (294)
                      +|+|||++.......        ......+++.|+|||+..+..+ +.++||||||+++|+|++|..||.... ...   
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            999999987653211        1122358899999999887776 799999999999999999999998763 222   


Q ss_pred             -----HHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          225 -----LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       225 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                           ....+...... ...++.++.+++..|++.+|++||++.+|++
T Consensus       245 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        245 AAKCDFIKRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HhHHHHHHHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                 22333333322 3456899999999999999999999999875

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.9e-41  Score=267.35  Aligned_cols=259  Identities=31%  Similarity=0.488  Sum_probs=206.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-   88 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   88 (294)
                      .-...|.+...||+|.+|.||+|..+.++.    .+|+|.+.-+.-. .-.....-+|+.+++.++|+|++.+..++.+ 
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            345689999999999999999996554443    6899988655221 1234677899999999999999999998876 


Q ss_pred             CCeEEEEEeccCCCChHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC----CcEEEe
Q 022617           89 PSDIYVVMEYVKSGELFDYIVE-----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK----WNVKIA  159 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~----~~~~l~  159 (294)
                      +..+++++||.+. +|++.|.-     ...++...++.++.||+.++.|||+..++|||+||.||++..+    |.+||+
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence            8899999999976 99999963     2469999999999999999999999999999999999999877    899999


Q ss_pred             eecccccccCCC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC---------HHHHH
Q 022617          160 DFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---------IPNLF  226 (294)
Q Consensus       160 dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---------~~~~~  226 (294)
                      |+|+++.+.++-    ..+..+-|..|+|||.+.+....+.+.|+|++||++.||++.++.|.+..         ..+..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999998876543    23445678899999999999888999999999999999999988884421         11111


Q ss_pred             HHHhCC--C-----cc----CC--------------------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCC
Q 022617          227 KKIKGG--I-----YT----LP--------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  269 (294)
Q Consensus       227 ~~~~~~--~-----~~----~~--------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~  269 (294)
                      .+|..-  .     ++    +|                          ..-++...+++.+||..||.+|.|++++++|+
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            111100  0     00    00                          11234467999999999999999999999999


Q ss_pred             ccccc
Q 022617          270 WFQAH  274 (294)
Q Consensus       270 ~~~~~  274 (294)
                      ||+..
T Consensus       339 yF~~d  343 (438)
T KOG0666|consen  339 YFTED  343 (438)
T ss_pred             ccccC
Confidence            99875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=285.38  Aligned_cols=244  Identities=36%  Similarity=0.603  Sum_probs=209.8

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   93 (294)
                      +.+.|.+...+|.|+|+.|-.+.+..+++.+++|++..+.       ....+|+.++... .|+|++++.+.+.+....|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence            5678999999999999999999999999999999987652       2234556444444 6999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe-cCCCcEEEeeecccccccCCCc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL-DSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili-~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      +|||.+.|+-+.+.+...+... .++..|+.+|+.|+.+||.+|++|||++|+|||+ .+.++++|+|||.+......  
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999999988888776554444 7788899999999999999999999999999999 58899999999999876555  


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      ..+.+-|..|.|||++....+ +.+.||||||+++|+|++|..||...... ++...+..+...  ..++.+.++|+++|
T Consensus       470 ~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~L  546 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQL  546 (612)
T ss_pred             hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHHh
Confidence            334456889999999997777 89999999999999999999999876555 555666555443  78899999999999


Q ss_pred             cccCCCCCCCHhHHhcCCcc
Q 022617          252 LIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h~~~  271 (294)
                      |+.||.+||++.+++.||||
T Consensus       547 L~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  547 LQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ccCChhhCcChhhhccCcch
Confidence            99999999999999999999

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.4e-39  Score=263.45  Aligned_cols=240  Identities=51%  Similarity=0.873  Sum_probs=210.2

Q ss_pred             CceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCChHHHH
Q 022617           29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI  108 (294)
Q Consensus        29 ~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l  108 (294)
                      ++|.||+|.+..+++.+++|++........  ...+.+|++.+++++|+|++++++++......++++|++++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            578999999988899999999865543221  578899999999999999999999999889999999999999999999


Q ss_pred             HHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccCCccc
Q 022617          109 VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI  188 (294)
Q Consensus       109 ~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~  188 (294)
                      .....++...++.++.+++.++.+||+.+++|+||+|.||+++.++.++++|||.+.............++..|++||..
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            87766899999999999999999999999999999999999999999999999999877665444556678899999998


Q ss_pred             cCCccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhCCCccCCCC---CChhHHHHHHHhcccCCCCCCCHhH
Q 022617          189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSH---LSPGARDLIPRMLIVDPMKRITIPE  264 (294)
Q Consensus       189 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~  264 (294)
                      ..... +.++|+|++|++++++++|..||.. .......+.+..........   ++.++.+++.+||..+|++||++.+
T Consensus       159 ~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  237 (244)
T smart00220      159 LGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEE  237 (244)
T ss_pred             ccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHH
Confidence            86666 6799999999999999999999987 66666666666555443333   8899999999999999999999999


Q ss_pred             HhcCCcc
Q 022617          265 IRQHPWF  271 (294)
Q Consensus       265 il~h~~~  271 (294)
                      +++||||
T Consensus       238 ~~~~~~~  244 (244)
T smart00220      238 ALQHPFF  244 (244)
T ss_pred             HhhCCCC
Confidence            9999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=266.68  Aligned_cols=259  Identities=29%  Similarity=0.546  Sum_probs=232.3

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   93 (294)
                      =..+|+++++||+|+++.|.+++++++.+-|++|+++++.+.+.+.+...+.|..+..+- +||.++-++.+|..+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            356899999999999999999999999999999999999888888888888898888765 5899999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc-cCCCc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~-~~~~~  172 (294)
                      +|.||.+||+|--.++++..++++.++.+...|+.||.|||+.||+++|+|..||+++..|++||.|+|+.... ..+..
T Consensus       328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~  407 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT  407 (593)
T ss_pred             EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998653 45566


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHhCCCccCCCCCChhH
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD--------ENIPNLFKKIKGGIYTLPSHLSPGA  244 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
                      .++.+||+-|.|||++.+..+ +...|+|+||++|++|+.|+.||+-        +...-+.+.|.......|..++-..
T Consensus       408 tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvka  486 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKA  486 (593)
T ss_pred             cccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhh
Confidence            778899999999999999998 8999999999999999999999953        2233345556666677888888889


Q ss_pred             HHHHHHhcccCCCCCCC------HhHHhcCCccccc
Q 022617          245 RDLIPRMLIVDPMKRIT------IPEIRQHPWFQAH  274 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps------~~~il~h~~~~~~  274 (294)
                      ..+++..|++||.+|..      +.++..|+||+..
T Consensus       487 s~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i  522 (593)
T KOG0695|consen  487 SHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI  522 (593)
T ss_pred             HHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence            99999999999999975      7789999999753

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.2e-38  Score=263.41  Aligned_cols=242  Identities=24%  Similarity=0.335  Sum_probs=190.3

Q ss_pred             ccccccCceEEEEEEEcc--CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617           23 KTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK  100 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  100 (294)
                      +.||+|+||.||+|.+..  ++..+++|.+.....  ......+.+|+.++++++|||++++++++.+....++++||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            468999999999998643  446789998754432  2234578889999999999999999999998899999999999


Q ss_pred             CCChHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc---
Q 022617          101 SGELFDYIVEKG-----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---  172 (294)
Q Consensus       101 ~~sL~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~---  172 (294)
                      +++|.+++....     ..+...+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999996532     356677889999999999999999999999999999999999999999998865432221   


Q ss_pred             cccccCCCcccCCccccCCc------cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH-HhCCCc-----cCCCC
Q 022617          173 LKTSCGSPNYAAPEVISGKL------YAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKK-IKGGIY-----TLPSH  239 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~-~~~~~~-----~~~~~  239 (294)
                      .....++..|+|||.+.+..      ..+.++|+||||+++|+|++ |..||......+.... +.....     .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            12234567899999885421      12678999999999999996 9999977655444332 222222     12235


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+..+.++++.|+ .+|++|||+++|+.
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            6788999999998 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=279.83  Aligned_cols=248  Identities=30%  Similarity=0.474  Sum_probs=214.7

Q ss_pred             ccCCcccccccccCceEEEEEEEccC--C--ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALT--G--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~--~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .......+.||.|.||.||.|....-  |  -.||||..+.+.  ..+..+.+..|..++++++||||++++|+|.+ +-
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            34455677899999999999986432  2  358889876543  23347889999999999999999999999974 68


Q ss_pred             EEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .|+|||.++-|.|..+++.++ .++......++.||+.||+|||+..++||||-.+||++....-+||+|||+++.....
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999999999998764 5888999999999999999999999999999999999999888999999999988776


Q ss_pred             Ccccccc--CCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617          171 HFLKTSC--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD  246 (294)
Q Consensus       171 ~~~~~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  246 (294)
                      .+.....  .+.-|||||.++-..+ +.++|+|.||++|||++. |..||.+....+.+..+.++. .+.|++||+.+..
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYs  623 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYS  623 (974)
T ss_pred             chhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHH
Confidence            6544333  3668999999987777 789999999999999988 999999999888888887655 7889999999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~  267 (294)
                      ++.+||+++|.+||.+.+|..
T Consensus       624 lmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  624 LMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHhccCcccCCcHHHHHH
Confidence            999999999999999888644

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.3e-38  Score=263.22  Aligned_cols=242  Identities=22%  Similarity=0.345  Sum_probs=190.3

Q ss_pred             ccccccCceEEEEEEEcc--CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617           23 KTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK  100 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  100 (294)
                      +.||+|+||.||+|....  ....+++|.+....  .......+.+|+..++.++|+||+++++.+......++++||+.
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            368999999999997532  33467888764332  23345667889999999999999999999999999999999999


Q ss_pred             CCChHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc---
Q 022617          101 SGELFDYIVEKG-----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---  172 (294)
Q Consensus       101 ~~sL~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~---  172 (294)
                      +++|.+++....     ..++..+..++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||.+........   
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999997643     245778889999999999999999999999999999999999999999998864322211   


Q ss_pred             cccccCCCcccCCccccC------CccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH-hCCCc-----cCCCC
Q 022617          173 LKTSCGSPNYAAPEVISG------KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIY-----TLPSH  239 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~-~~~~~-----~~~~~  239 (294)
                      .....++..|+|||++..      ....+.++||||||+++|+|++ |..||......+..... .....     ..+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            122334667999998742      2233678999999999999999 88899877655544443 22222     22346


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ++..+.+++..|+ .||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            7888999999998 59999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.8e-38  Score=261.19  Aligned_cols=242  Identities=22%  Similarity=0.335  Sum_probs=189.6

Q ss_pred             ccccccCceEEEEEEEccCC--ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617           23 KTLGIGSFGKVKIAEHALTG--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK  100 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  100 (294)
                      +.||.|+||.||++....++  ..+++|.+....  .......+.+|+.+++.++|||++++++.+......++++||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            36899999999999754332  345666654332  22345788899999999999999999999999999999999999


Q ss_pred             CCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---cc
Q 022617          101 SGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FL  173 (294)
Q Consensus       101 ~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---~~  173 (294)
                      +++|.+++.+.    ...+...++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......   ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999999754    235677888999999999999999999999999999999999999999999875432211   12


Q ss_pred             ccccCCCcccCCccccCC------ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC------ccCCCCC
Q 022617          174 KTSCGSPNYAAPEVISGK------LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI------YTLPSHL  240 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~------~~~~~~~  240 (294)
                      ....++..|+|||++...      ...+.++||||||+++|+|++ +..||......+....+....      ...+..+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            234567889999987432      112578999999999999997 677887766655555433221      2233457


Q ss_pred             ChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          241 SPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +..+.+++..|| .+|++||++.++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            888999999999 67999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=288.14  Aligned_cols=248  Identities=28%  Similarity=0.459  Sum_probs=220.5

Q ss_pred             cCCcccccccccCceEEEEEEEccCC---ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...+|.++||.|.||.||.+..+..+   ..||||.++...  .+....++..|..++-++.||||+++.|+....+-++
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence            35678999999999999999987655   469999985432  3345788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      |++|||+.|+|+.+|..+ +.++..++.-|++.|+.++.||.+.|++||||..+|||++.+-.+|++|||+++...+...
T Consensus       707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            999999999999999754 6799999999999999999999999999999999999999999999999999997755441


Q ss_pred             c--ccc--cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617          173 L--KTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD  246 (294)
Q Consensus       173 ~--~~~--~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  246 (294)
                      .  ...  ..+.+|.|||.+...++ +.++|+||+|++|||.|+ |..||-.+...+.++.+..+. .+.|-+||..|.+
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~q  865 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQ  865 (996)
T ss_pred             ccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence            1  111  23579999999999998 899999999999999998 999999999999999998776 5677799999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~  267 (294)
                      |+..||++|-.+||.+.||++
T Consensus       866 LMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  866 LMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             HHHHHHHHHhhcCCCHHHHHH
Confidence            999999999999999999876

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=269.83  Aligned_cols=273  Identities=29%  Similarity=0.470  Sum_probs=223.2

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc----chHHHHHHHHHHHHHHhCCCCceeEEEEEEE-
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK----NMEMEEKVRREIKILRLFMHPHIIRLYEVIE-   87 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-   87 (294)
                      ..+.++|-++.+||.|||+.||+|.|....+.|++|+-......    .....+...+|+.+.+.|.||.|+++++++. 
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            35778999999999999999999999988899999997543211    2234566789999999999999999999995 


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEec---CCCcEEEeeec
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLD---SKWNVKIADFG  162 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~---~~~~~~l~dfg  162 (294)
                      +...+|-|+|||+|.+|+-+++.++.+++.+++.++.||+.||.||.+..  |+|-|+||.|||+-   ..|.+||.|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            45678999999999999999999999999999999999999999999765  99999999999994   45789999999


Q ss_pred             ccccccCCCcc--------ccccCCCcccCCccccC---CccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH--
Q 022617          163 LSNIMRDGHFL--------KTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKK--  228 (294)
Q Consensus       163 ~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~--  228 (294)
                      ++.........        +...||..|+|||.+.-   .+-.+.+.|+||+|+++|.++.|+.||..+.. .++++.  
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            99887654332        23357889999999753   23336789999999999999999999976532 333322  


Q ss_pred             HhC-CC--ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCc
Q 022617          229 IKG-GI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD  285 (294)
Q Consensus       229 ~~~-~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~  285 (294)
                      |.+ ..  ++..+.++++..+||++||++.-++|.+..++..||||..+..+....-.|.
T Consensus       699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s~gs~~  758 (775)
T KOG1151|consen  699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVSTGSPA  758 (775)
T ss_pred             hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccccCCCc
Confidence            222 22  4455689999999999999999999999999999999987665554444433

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=256.50  Aligned_cols=254  Identities=24%  Similarity=0.410  Sum_probs=210.7

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      +.+-+..||.|+||+|++..++.+|+..|||.+.....  ....+++..|.+...+- +.|||++++|..-.++..|+.|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            45567789999999999999999999999999976543  23456777777765544 5899999999998899999999


Q ss_pred             eccCCCChHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           97 EYVKSGELFDYIV-----EKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        97 e~~~~~sL~~~l~-----~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      |.|+. ||+.+-+     .+..++++.+-.+....+.||.||.. ..|+|||+||+|||++..|.+||+|||.+....++
T Consensus       143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            99964 8877654     24569999999999999999999985 57999999999999999999999999999888777


Q ss_pred             CccccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhCCCccC---C---CCCCh
Q 022617          171 HFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTL---P---SHLSP  242 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~---~---~~~~~  242 (294)
                      -......|...|+|||.+.... .++.++|+||||+++||+.||+.||.. ++..+.+..+..+.++.   +   -.++.
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~  301 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF  301 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence            7777788999999999986433 247899999999999999999999875 33344444444444322   1   24788


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .+..+|..||.+|-+.||.+.+++++||++.-
T Consensus       302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             HHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            99999999999999999999999999999653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.8e-39  Score=246.00  Aligned_cols=253  Identities=26%  Similarity=0.496  Sum_probs=209.9

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcC--CeE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETP--SDI   92 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~   92 (294)
                      .++|++++++|+|.++.|+.|.+..+++.+++|++.+-.      -+.+.+|+++|+.|. +|||++++++..++  +..
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            468999999999999999999998899999999986543      478999999999998 99999999998664  456


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~~~~  171 (294)
                      .+++|+.+..+...+   -..++...+...+.+++.||.|+|+.||+|+|+||.|++|+. ...++|+|+|+|.+...+.
T Consensus       111 aLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            799999987554444   356788899999999999999999999999999999999986 4579999999999988877


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhCC-------------CccC-
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGG-------------IYTL-  236 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~~~-------------~~~~-  236 (294)
                      ..+..+.+..|.-||.+..-...+.+-|+|||||++..|+..+.||. +.+..+..-+|.+-             ...+ 
T Consensus       188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld  267 (338)
T KOG0668|consen  188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD  267 (338)
T ss_pred             eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence            77788888899999999877666899999999999999999988884 33333322222110             0000 


Q ss_pred             -----------------------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          237 -----------------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       237 -----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                                             ....+++..+++.++|..|-++|+|+.|++.||||......
T Consensus       268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence                                   12356899999999999999999999999999999875443

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-40  Score=256.75  Aligned_cols=258  Identities=28%  Similarity=0.473  Sum_probs=210.6

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-----   88 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----   88 (294)
                      ...+.|.-..+||+|.||.||+|+.+.+++.|++|.+..+.-.. -.-....+|+++|..|+|+|++.++.+|..     
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            45678889999999999999999999999999998764432111 123456789999999999999998877632     


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           89 ---PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        89 ---~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                         ...+|+|+++|.. +|.-++.+. ..++..++..++++++.+|.|+|...|+|+|+|+.|++|+.+|.++|+|||++
T Consensus        93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence               3458999999976 999999765 56999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc-----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------
Q 022617          165 NIMRDGHF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------  233 (294)
Q Consensus       165 ~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------  233 (294)
                      +.+..+..     ....+.|..|++||.+.+...+++..|||+-||++.+|+++.+.+.++.....+..|..-+      
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            76543322     1233458899999999988888999999999999999999999998887666554443211      


Q ss_pred             -cc---------------CCC-------------CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          234 -YT---------------LPS-------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       234 -~~---------------~~~-------------~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                       ++               ++.             .-+++..++++.+|..||.+|+++.++++|.||..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence             10               110             11346679999999999999999999999999966

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=271.08  Aligned_cols=249  Identities=25%  Similarity=0.431  Sum_probs=220.3

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ++-..+.....+||.|.||.||.+.|+...-.|+||.+..+.    ...+++..|..+++.++|||+++++++|..+--.
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            344455666789999999999999999888899999875443    3478999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           93 YVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      |||+|||..|+|.++|.+..  .++.-.+..|+.||..|+.||..++++|+||-..|+|+.++..+|+.|||+++.....
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            99999999999999997643  4777788899999999999999999999999999999999999999999999987665


Q ss_pred             Ccc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617          171 HFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD  246 (294)
Q Consensus       171 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  246 (294)
                      .+.  ..--.+.-|.|||.+....+ +.++|+|+||+++||+.| |-.||.+.+.......+.++. ..-|.+|++.+.+
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYe  497 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYE  497 (1157)
T ss_pred             ceecccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHH
Confidence            543  23335678999999988888 899999999999999999 999999999999888887665 6778899999999


Q ss_pred             HHHHhcccCCCCCCCHhHHh
Q 022617          247 LIPRMLIVDPMKRITIPEIR  266 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il  266 (294)
                      |+++||+++|.+||++.+|-
T Consensus       498 LMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHhcCCcccCccHHHHH
Confidence            99999999999999999873

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=275.45  Aligned_cols=259  Identities=28%  Similarity=0.415  Sum_probs=222.7

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCC---ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      +-.++.+..++||+|.||.|++|.|+..+   ..||||++.......  ...++.+|..++.+|+|+|++++||+..+ .
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q  183 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q  183 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence            34567788999999999999999987543   368999986554332  67899999999999999999999999886 7


Q ss_pred             eEEEEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      ...+|+|.+..|||.+.|.+  ...+....+-.++.||+.|+.||..++++|+|+-..|+++-....+||+|||+.+...
T Consensus       184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence            78899999999999999976  3457788888999999999999999999999999999999988899999999998776


Q ss_pred             CCCccc----cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCCh
Q 022617          169 DGHFLK----TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSP  242 (294)
Q Consensus       169 ~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~  242 (294)
                      .+...-    ......-|+|||.+...++ +.++|+|++|+++|||++ |+.||.+.....+++.+.++. .+.|..|+.
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cse  342 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSE  342 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChH
Confidence            544321    1123568999999999998 899999999999999999 999999999999999887543 677889999


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ++.+++..||..+|.+|||+..|....+.....+
T Consensus       343 dIY~imk~cWah~paDRptFsair~~~~l~eaqp  376 (1039)
T KOG0199|consen  343 DIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQP  376 (1039)
T ss_pred             HHHHHHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence            9999999999999999999999987666655443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=269.81  Aligned_cols=248  Identities=25%  Similarity=0.426  Sum_probs=215.1

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .+...+.++||+|.||.|.+|.-. .+..||+|..+.....  .....+.+|+++|.+|+||||+.++++|..++.++++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            456788999999999999999874 4688999998766433  4468999999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      +||++.|+|.+++..+.  .+......+++.||+.+++||.+.+++||||.++|+|++.++++||+|||+++....+...
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999999999998873  3456677889999999999999999999999999999999999999999999866544433


Q ss_pred             ---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhCC--------CccCCCCC
Q 022617          174 ---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIPNLFKKIKGG--------IYTLPSHL  240 (294)
Q Consensus       174 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  240 (294)
                         ...+.+.+|+|+|.+..+++ +.++|+|++|+++||+++  ...||.....++..++....        ....|..+
T Consensus       694 ~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c  772 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC  772 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence               23356789999999988888 799999999999999876  89999998888877765332        23567889


Q ss_pred             ChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          241 SPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +.++.+++.+||..+-++||+++++-.
T Consensus       773 p~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  773 PQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             cHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            999999999999999999999999855

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=252.60  Aligned_cols=267  Identities=31%  Similarity=0.540  Sum_probs=220.4

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC---
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---   89 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   89 (294)
                      -.+..+|.-++.+|.|.- .|..|.|.-.++++++|....+ +.+....+...+|+.++..++|+|+++.+.++.-.   
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence            345678999999999998 8999999999999999998766 44455678899999999999999999999998432   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           90 ---SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        90 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                         ...|++||++.. +|...+.  ..++-+.+..++.|++.++.+||+.||+|||+||+||++..++..|+.|||++..
T Consensus        91 ~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   91 EEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence               458999999965 9998886  4578889999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------------
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------  233 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  233 (294)
                      ........+.+.+..|+|||++.+..+ ....||||+||++.+|++|+..|.+.+..+...++....             
T Consensus       168 e~~~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  168 EDTDFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             cCcccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            776667778889999999999988875 789999999999999999999997765444333321110             


Q ss_pred             --------------cc----CC-----------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc-CCccccCCC
Q 022617          234 --------------YT----LP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH-LPRYLAVPP  283 (294)
Q Consensus       234 --------------~~----~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~-~~~~~~~~~  283 (294)
                                    ..    +|           ..-...+++++.+||..||++|.|++++|+||||+-| -+.....|+
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~  326 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPP  326 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCC
Confidence                          00    00           1123457899999999999999999999999999955 244455555


Q ss_pred             Cc
Q 022617          284 PD  285 (294)
Q Consensus       284 ~~  285 (294)
                      |.
T Consensus       327 pe  328 (369)
T KOG0665|consen  327 PE  328 (369)
T ss_pred             Cc
Confidence            55

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.3e-39  Score=270.58  Aligned_cols=254  Identities=28%  Similarity=0.480  Sum_probs=215.2

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC------CceeEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH------PHIIRLYEVI   86 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~   86 (294)
                      +.+..+|.+....|.|=|++|..|.|...|..||||++....    ...+.=..|+++|++|..      -++++++..|
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            467789999999999999999999999999999999985433    334566789999999963      4789999899


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-CcEEEeeec
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFG  162 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~dfg  162 (294)
                      ...+++|+|+|.+. .+|.+.+++.+   .|....+..++.|++-||..|.+.|++|.||||.|||+++. ..+||||||
T Consensus       504 ~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  504 KHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             hhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence            99999999999995 59999998754   38888999999999999999999999999999999999875 568999999


Q ss_pred             ccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC-----
Q 022617          163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----  237 (294)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  237 (294)
                      .|.....+... ++..+..|+|||++.+.+| +...|+||.||++||+.||+..|.+.....++.-.+....++|     
T Consensus       583 SA~~~~eneit-PYLVSRFYRaPEIiLG~~y-d~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  583 SASFASENEIT-PYLVSRFYRAPEIILGLPY-DYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccccccccccc-HHHHHHhccCcceeecCcc-cCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            99877655433 4445668999999999998 7999999999999999999999998887777776654443333     


Q ss_pred             ------------------------------------------------CCCC-------hhHHHHHHHhcccCCCCCCCH
Q 022617          238 ------------------------------------------------SHLS-------PGARDLIPRMLIVDPMKRITI  262 (294)
Q Consensus       238 ------------------------------------------------~~~~-------~~l~~li~~~l~~~p~~Rps~  262 (294)
                                                                      ..++       ..+.+|+..||..||++|.|+
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence                                                            0111       257789999999999999999


Q ss_pred             hHHhcCCcccc
Q 022617          263 PEIRQHPWFQA  273 (294)
Q Consensus       263 ~~il~h~~~~~  273 (294)
                      .++|.||||+.
T Consensus       741 nqAL~HpFi~~  751 (752)
T KOG0670|consen  741 NQALKHPFITE  751 (752)
T ss_pred             HHHhcCCcccC
Confidence            99999999974

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.9e-37  Score=277.73  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=174.0

Q ss_pred             cccCCcccccccccCceEEEEEEEccC----CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEE-----
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALT----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV-----   85 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-----   85 (294)
                      -.++|.+.+.||+|+||.||+|.+..+    +..|++|.+.......     ....+  .++...+.++..+...     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            456899999999999999999999888    8999999874322111     11111  1111111222111111     


Q ss_pred             -EEcCCeEEEEEeccCCCChHHHHHHhCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 022617           86 -IETPSDIYVVMEYVKSGELFDYIVEKGR--------------------LQEDEARNFFQQIISGVEYCHRNMVVHRDLK  144 (294)
Q Consensus        86 -~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~  144 (294)
                       .......++++||+++++|.+++.....                    .....+..++.|++.+|.|||+.||+|+|||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             2456679999999999999999865321                    1133466899999999999999999999999


Q ss_pred             CCCeEecC-CCcEEEeeecccccccCC--CccccccCCCcccCCccccCCcc---------------------CCCchhH
Q 022617          145 PENLLLDS-KWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLY---------------------AGPEVDV  200 (294)
Q Consensus       145 p~nili~~-~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~---------------------~~~~~Di  200 (294)
                      |+|||++. ++.+||+|||++......  .......+++.|+|||.+.....                     .+.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 578999999999754322  22234567889999997532211                     1235699


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---------------------cCCCCCChhHHHHHHHhcccCCCCC
Q 022617          201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---------------------TLPSHLSPGARDLIPRMLIVDPMKR  259 (294)
Q Consensus       201 ~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~l~~li~~~l~~~p~~R  259 (294)
                      ||+||++|+|+++..+++.. .......+.....                     ...........+||.+||+.||.+|
T Consensus       363 wSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            99999999999977665332 1111111111100                     0001112334589999999999999


Q ss_pred             CCHhHHhcCCcccccCC
Q 022617          260 ITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       260 ps~~~il~h~~~~~~~~  276 (294)
                      ||+.++|+||||+..-.
T Consensus       442 ~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        442 ISAKAALAHPYFDREGL  458 (566)
T ss_pred             CCHHHHhCCcCcCCCCc
Confidence            99999999999987533

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=257.15  Aligned_cols=134  Identities=28%  Similarity=0.474  Sum_probs=116.6

Q ss_pred             cccc-cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-----C---CceeEEE
Q 022617           13 DMFL-PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-----H---PHIIRLY   83 (294)
Q Consensus        13 ~~~~-~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~---~~i~~~~   83 (294)
                      +.+. ++|.+.++||.|-|+|||+|.|....+.||+|+.+...    ...+....||++|++++     +   .+|++++
T Consensus        73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll  148 (590)
T KOG1290|consen   73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL  148 (590)
T ss_pred             ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence            4666 89999999999999999999999999999999976443    45677889999998874     2   4699999


Q ss_pred             EEEEc----CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEec
Q 022617           84 EVIET----PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLD  151 (294)
Q Consensus        84 ~~~~~----~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~  151 (294)
                      +.|..    ..++|+|+|++ |.+|..+|+..  +.++...+++|++|++.+|.|||. .||+|.||||+|||+.
T Consensus       149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            99854    56899999999 66999999865  459999999999999999999995 6899999999999983

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-37  Score=267.51  Aligned_cols=257  Identities=30%  Similarity=0.538  Sum_probs=218.6

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ..-|..++.||-|+||.|.++...+++..||+|.+.+..+-.+.....++.|-.+|..-..+-|++++..|.+.+.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            44578889999999999999998889999999999888887778888889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-------
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-------  168 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-------  168 (294)
                      |+|+.||++-.+|-+-+-++++.++.++.++..|+.+.|+.|++|+||||+||||+.+|++||.|||+++-+.       
T Consensus       708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999976431       


Q ss_pred             --CCC----------------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh
Q 022617          169 --DGH----------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC  212 (294)
Q Consensus       169 --~~~----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~  212 (294)
                        ++.                                  .....+||+-|+|||++....+ +...|+||.|+++|+|+.
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhHHHHHHhh
Confidence              000                                  0012258999999999988877 678899999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhCC----CccCCCCCChhHHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617          213 GTLPFDDENIPNLFKKIKGG----IYTLPSHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH  274 (294)
Q Consensus       213 g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~  274 (294)
                      |+.||-.....+...++..=    -++.-..++.+..++|.+++ -+++.|.-   ++++..||||+.+
T Consensus       867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence            99999776655544333211    13334578999999998865 45777874   6789999999875

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=272.95  Aligned_cols=255  Identities=28%  Similarity=0.457  Sum_probs=214.7

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEc----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET----   88 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----   88 (294)
                      .-.+.|.+.+.||.|.+|.||+++++.+++..|+|+.....    +..+++..|+++++.+. |||++.++++|..    
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            44568999999999999999999999999999999976543    23467888999998875 8999999999843    


Q ss_pred             -CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617           89 -PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus        89 -~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                       ++.+|+|||+|.|||.-+++++-  ..+.++.+..++..++.++.+||+..++|+|||=.||+++.++.+||+|||.+.
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa  171 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA  171 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence             56899999999999999999763  468899999999999999999999999999999999999999999999999987


Q ss_pred             cccCC-CccccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-c--CC
Q 022617          166 IMRDG-HFLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T--LP  237 (294)
Q Consensus       166 ~~~~~-~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--~~  237 (294)
                      ..... ...+...||++|||||++...    ...+.++|+||||++..||.-|.+|+..+.+...+-.|-...+ .  -|
T Consensus       172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp  251 (953)
T KOG0587|consen  172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRP  251 (953)
T ss_pred             eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccch
Confidence            66433 344677899999999998522    2225789999999999999999999988766554444433322 1  12


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617          238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                      ..-+.++.++|..||-+|..+||+..++|+|||++
T Consensus       252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             hhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            34567899999999999999999999999999998

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=271.20  Aligned_cols=242  Identities=32%  Similarity=0.506  Sum_probs=197.2

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC------C
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------S   90 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   90 (294)
                      .-|...+.||.|+||.||+++++.+|..||||.+....  .....+...+|++++++++|+||++++++-+..      .
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            66778899999999999999999999999999987654  223467888999999999999999999875432      3


Q ss_pred             eEEEEEeccCCCChHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC--CC--cEEEeeecc
Q 022617           91 DIYVVMEYVKSGELFDYIVE---KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KW--NVKIADFGL  163 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~---~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~--~~--~~~l~dfg~  163 (294)
                      .-.++||||.||+|...+.+   ...+++.+++.++.++..||.|||+.||+||||||.||++..  +|  ..||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            46799999999999999964   345999999999999999999999999999999999999943  23  479999999


Q ss_pred             cccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhCC------
Q 022617          164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-----NLFKKIKGG------  232 (294)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-----~~~~~~~~~------  232 (294)
                      |+...++....+.+||..|.+||.+....+.+...|.||+|+++|++.||..||......     .+...+.+.      
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i  250 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI  250 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence            999999888889999999999999986555588999999999999999999999654322     222222111      


Q ss_pred             --------------CccCCCCCChh----HHHHHHHhcccCCCCCC
Q 022617          233 --------------IYTLPSHLSPG----ARDLIPRMLIVDPMKRI  260 (294)
Q Consensus       233 --------------~~~~~~~~~~~----l~~li~~~l~~~p~~Rp  260 (294)
                                    ..+.+..++..    +-..+..+|..+|.+|-
T Consensus       251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                          11223333433    33567778888999887

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-35  Score=262.54  Aligned_cols=260  Identities=22%  Similarity=0.299  Sum_probs=185.9

Q ss_pred             cccCCcccccccccCceEEEEEEEc----------------cCCceEEEEEeecccccchH-----------HHHHHHHH
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHA----------------LTGHKVAIKILNRRKIKNME-----------MEEKVRRE   67 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~----------------~~~~~~~~K~~~~~~~~~~~-----------~~~~~~~e   67 (294)
                      -.++|++.++||+|+||+||+|.+.                ..++.|+||.+.........           ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3679999999999999999999752                24467999998643211100           11223346


Q ss_pred             HHHHHhCCCCc-----eeEEEEEEEc--------CCeEEEEEeccCCCChHHHHHHhC----------------------
Q 022617           68 IKILRLFMHPH-----IIRLYEVIET--------PSDIYVVMEYVKSGELFDYIVEKG----------------------  112 (294)
Q Consensus        68 ~~~l~~l~~~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~----------------------  112 (294)
                      +.++.+++|.+     ++++++++..        ....++|+||+++++|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            66667776654     3566676643        356899999999999999886321                      


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc--ccCCCcccCCccc
Q 022617          113 --RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT--SCGSPNYAAPEVI  188 (294)
Q Consensus       113 --~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~aPE~~  188 (294)
                        .++...++.++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||++...........  ...++.|+|||.+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence              235567888999999999999999999999999999999999999999999865433222222  2347899999987


Q ss_pred             cCCcc---------------------CCCchhHHHHHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHhCCC--
Q 022617          189 SGKLY---------------------AGPEVDVWSCGVILYALLCGTL-PFDDENIP-----------NLFKKIKGGI--  233 (294)
Q Consensus       189 ~~~~~---------------------~~~~~Di~slG~ll~~l~~g~~-p~~~~~~~-----------~~~~~~~~~~--  233 (294)
                      .....                     .....|+||+|+++++|+++.. |+......           ...+......  
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~  462 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD  462 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence            53221                     0124699999999999999875 66432110           1111111122  


Q ss_pred             ccCCCCCChhHHHHHHHhcccCC---CCCCCHhHHhcCCccccc
Q 022617          234 YTLPSHLSPGARDLIPRMLIVDP---MKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~~il~h~~~~~~  274 (294)
                      +......+....+++.+||..+|   .+|+|+.|+|+||||...
T Consensus       463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            23334678899999999999866   689999999999999653

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=287.10  Aligned_cols=240  Identities=21%  Similarity=0.297  Sum_probs=187.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .+...|+..+.||+|+||.||+|.+..++..|++|.+.....       ....|++.+++++||||+++++++...+..+
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            344567888899999999999999988999999998753321       1124578899999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH---RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh---~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      +||||+++++|.+++.   .+++..+..++.|++.|++|||   +.+++|+||||+||+++.++..++. ++........
T Consensus       760 lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        760 LIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             EEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence            9999999999999995   3788999999999999999999   6699999999999999988877765 5544322111


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhC---------CCc--
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-----IPNLFKKIKG---------GIY--  234 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~---------~~~--  234 (294)
                         ....++..|+|||++.+..+ +.++||||+|+++|||++|+.||+...     ..........         ...  
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ---CCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence               12356789999999987776 789999999999999999999985421     1111111100         000  


Q ss_pred             --cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          235 --TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       235 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                        ..+.....++.+++.+||+.+|++|||+.++++.
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence              0011122356789999999999999999999874

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=268.38  Aligned_cols=244  Identities=33%  Similarity=0.490  Sum_probs=193.7

Q ss_pred             CcccccccccCce-EEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEE
Q 022617           19 YKLGKTLGIGSFG-KVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        19 y~~~~~lg~g~~~-~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      |.-.+.+|.|+.| .||+|..  .++.||||.+-.+.      ..-+.+|+..|+..+ ||||+++++.-.+.+..|++.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            4446778899987 4689986  67899999874332      457789999999885 999999999988899999999


Q ss_pred             eccCCCChHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---C--CcEEEeeecccccc
Q 022617           97 EYVKSGELFDYIVEKGR----LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---K--WNVKIADFGLSNIM  167 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~----l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~--~~~~l~dfg~~~~~  167 (294)
                      |.|. .+|.++++....    ......+.++.|++.||++||+.+|+|||+||.||||+.   +  .+++|+|||++...
T Consensus       583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            9996 599999986411    122445789999999999999999999999999999975   3  46899999999876


Q ss_pred             cCCC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCCcc---CCCC
Q 022617          168 RDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT---LPSH  239 (294)
Q Consensus       168 ~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~---~~~~  239 (294)
                      ..+.    ......|+.+|.|||++..... ..+.|||||||++|+.++ |.+||...-..+  .+|..+...   +.+.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~  738 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPL  738 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccC
Confidence            5432    2345578999999999987766 678999999999999999 599996543322  234444332   2222


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ...+..+||.+|+.++|..||++.++|.||||=..
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            22388999999999999999999999999999443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=242.73  Aligned_cols=254  Identities=24%  Similarity=0.419  Sum_probs=198.2

Q ss_pred             CCCCCCCcc-----ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh--CCCC
Q 022617            5 SNRSSSGVD-----MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL--FMHP   77 (294)
Q Consensus         5 ~~~~~~~~~-----~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~   77 (294)
                      +++|.++..     .+..+..+.+.||+|.||.||+|.+  .|+.||||+|....      +....+|.++.+.  |+|+
T Consensus       194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHE  265 (513)
T KOG2052|consen  194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHE  265 (513)
T ss_pred             cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccc
Confidence            556666664     5667899999999999999999998  57889999985432      4567777777764  5899


Q ss_pred             ceeEEEEEEEcC----CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-----C---CceecCCCC
Q 022617           78 HIIRLYEVIETP----SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-----N---MVVHRDLKP  145 (294)
Q Consensus        78 ~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-----~---~i~h~di~p  145 (294)
                      ||+.+++.-...    ..+|+|++|.+.|||.|+|.+ ..++.+...+++..++.+|++||.     +   .|.|||||.
T Consensus       266 NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS  344 (513)
T KOG2052|consen  266 NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS  344 (513)
T ss_pred             hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence            999999875433    358999999999999999976 689999999999999999999994     2   399999999


Q ss_pred             CCeEecCCCcEEEeeecccccccCCC-----ccccccCCCcccCCccccCCc----cC-CCchhHHHHHHHHHHHHhC--
Q 022617          146 ENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKL----YA-GPEVDVWSCGVILYALLCG--  213 (294)
Q Consensus       146 ~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~----~~-~~~~Di~slG~ll~~l~~g--  213 (294)
                      .|||++.++.+.|+|+|+|.......     ..+..+||.+|||||++....    +. -..+||||||.++||+.-.  
T Consensus       345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~  424 (513)
T KOG2052|consen  345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE  424 (513)
T ss_pred             ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence            99999999999999999987654432     346778999999999985321    11 2468999999999998842  


Q ss_pred             --------CCCCCC-----CCHHHHHHHHhC--CCccCCCC-----CChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          214 --------TLPFDD-----ENIPNLFKKIKG--GIYTLPSH-----LSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       214 --------~~p~~~-----~~~~~~~~~~~~--~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                              ++||.+     .+.+++.+.+-.  ..+..|..     .-..+..+|+.||-.+|.-|.|+--|.+
T Consensus       425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             cCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence                    667754     234555544322  22333322     1235678999999999999999887654

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-37  Score=239.48  Aligned_cols=254  Identities=30%  Similarity=0.528  Sum_probs=207.9

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----CeE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----SDI   92 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   92 (294)
                      +.+-.+-||.|.||.||.+.|..+|+.|++|.+..- ..+....+.+.+|+++|..++|.|++..+++..-+     ..+
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            445578899999999999999999999999988543 34455678899999999999999999988776433     347


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      |+++|.+.. +|..+|-+...++.+.++-++.||+.+|.|||+.+|.|+||||.|.+++.+..+||+|||+++..+....
T Consensus       133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            788999965 9999998888999999999999999999999999999999999999999999999999999987654332


Q ss_pred             --cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------------
Q 022617          173 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----------------  233 (294)
Q Consensus       173 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  233 (294)
                        ....+-|.+|+|||.+.+....+.+.||||.||++.|++..+..|...++....+.|.+-.                 
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence              2233567899999999998888999999999999999999999986655444333332110                 


Q ss_pred             ------ccCC-----------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          234 ------YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       234 ------~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                            ...|           ..-..+...++..++..||+.|.+..+.+.|++...
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence                  0001           123446678889999999999999999999999843

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=260.66  Aligned_cols=255  Identities=31%  Similarity=0.516  Sum_probs=214.8

Q ss_pred             ccCCcccccccccCceEEEEEEEcc-------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE   87 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   87 (294)
                      ..+..+.+.||+|.||.|++|....       ....||||........  ...+.+..|+++++.+. |+|++.+++.+.
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            3444677799999999999997431       1456889987544322  56788999999999886 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD  151 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~  151 (294)
                      ..+.++++.||+..|+|.+++.+++                .++...+..++.||+.++.||++.+++|||+-.+||+++
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT  452 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence            9999999999999999999997655                388899999999999999999999999999999999999


Q ss_pred             CCCcEEEeeecccccccCCCccc--ccc--CCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCC-HHHH
Q 022617          152 SKWNVKIADFGLSNIMRDGHFLK--TSC--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN-IPNL  225 (294)
Q Consensus       152 ~~~~~~l~dfg~~~~~~~~~~~~--~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~-~~~~  225 (294)
                      .+..+|++|||+++.........  ...  -+..|||||.+....+ +.++|+||+|+++||+++ |..||.+.. ..++
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l  531 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL  531 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence            99999999999998654443322  122  3567999999998777 899999999999999999 999998855 6666


Q ss_pred             HHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          226 FKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      .+.+..+. ...|..++.++.++++.||+.+|++||++.++.+  +|...+
T Consensus       532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~~l  580 (609)
T KOG0200|consen  532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEKHL  580 (609)
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHHHH
Confidence            76666665 5778899999999999999999999999999987  666543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=6.8e-33  Score=221.13  Aligned_cols=212  Identities=49%  Similarity=0.817  Sum_probs=186.8

Q ss_pred             ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617           25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL  104 (294)
Q Consensus        25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL  104 (294)
                      ||.|.+|.||++.+..+++.+++|++.......  ....+.+|+..++.+.|++++++++++......++++|++++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999986554321  357889999999999999999999999998999999999998999


Q ss_pred             HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeecccccccCCC-ccccccCCCc
Q 022617          105 FDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH-FLKTSCGSPN  181 (294)
Q Consensus       105 ~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~  181 (294)
                      .+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+||+.+....... ..........
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            9999765 47899999999999999999999999999999999999999 8999999999987665443 1233456789


Q ss_pred             ccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCC
Q 022617          182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT  261 (294)
Q Consensus       182 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  261 (294)
                      |.+||........+.+.|+|++|++++++                               ..+.+++..|++.+|++||+
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~  207 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS  207 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcC
Confidence            99999987763447899999999999998                               78899999999999999999


Q ss_pred             HhHHhcCC
Q 022617          262 IPEIRQHP  269 (294)
Q Consensus       262 ~~~il~h~  269 (294)
                      +.++++++
T Consensus       208 ~~~l~~~~  215 (215)
T cd00180         208 AKEILEHL  215 (215)
T ss_pred             HHHHhhCC
Confidence            99999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-35  Score=248.83  Aligned_cols=202  Identities=33%  Similarity=0.575  Sum_probs=181.4

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHH-----HHHHHHHHHHHHhCC---CCceeEEEEEEEc
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM-----EEKVRREIKILRLFM---HPHIIRLYEVIET   88 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~-----~~~~~~e~~~l~~l~---~~~i~~~~~~~~~   88 (294)
                      ..|...+.+|.|+||.|++|.++.++..|++|.+.++++-....     ...+-.|+++|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35999999999999999999999999999999987765443222     234667999999998   9999999999999


Q ss_pred             CCeEEEEEeccC-CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           89 PSDIYVVMEYVK-SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        89 ~~~~~lv~e~~~-~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      ++.+|+++|..+ |.+|.++|+....+++.+.+.+++|++.++++||+.||+|||||-+||.++.+|-+||+|||.+...
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~  720 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT  720 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence            999999999764 5689999999999999999999999999999999999999999999999999999999999998766


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD  219 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~  219 (294)
                      .. ...+..+||..|.|||++.+.+|.+..-|||+||+++|-+.....||.+
T Consensus       721 ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  721 KS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            44 3456778999999999999999999999999999999999999999864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-36  Score=257.63  Aligned_cols=262  Identities=26%  Similarity=0.391  Sum_probs=221.7

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-.++|..+..+|+|.+|.||+|+|+.+++..++|+++...   .....-+.+|+-+++.++|+||+.+++.+.....+|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            45678999999999999999999999999999999996553   344678889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-c
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~  172 (294)
                      +.||||+|++|.+.-.-.+++++.++..+.+..+++++|||+.|-+|||||-.||++++.|.+++.|||.+......- .
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            999999999999987777899999999999999999999999999999999999999999999999999876553322 2


Q ss_pred             cccccCCCcccCCcccc---CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC-----CCCCChhH
Q 022617          173 LKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL-----PSHLSPGA  244 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l  244 (294)
                      .....|++.|+|||+..   ...+ ....|||++|+...++-..+.|.....+........+..+..     +..-++.+
T Consensus       169 rksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence            34557999999999852   3334 578999999999999998888865554444444443333322     23457789


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~  279 (294)
                      .+|++.+|.++|++||+++.+|.|||....++...
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl  282 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRL  282 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccchhhHH
Confidence            99999999999999999999999999988876543

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=252.22  Aligned_cols=246  Identities=27%  Similarity=0.409  Sum_probs=210.6

Q ss_pred             CCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ..+-+++||+|+||+||+|.+--.++    +|++|++....  ..+...++.+|.-.+.+++|+|++++++++.... +.
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            45667899999999999998864454    58888876443  3345688999999999999999999999997654 88


Q ss_pred             EEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ||++|+++|+|.++++.+ .++-....+.|..||++++.|||++.++||||-.+|||+++-..+|+.|||++........
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999754 5688899999999999999999999999999999999999999999999999987643322


Q ss_pred             c---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617          173 L---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL  247 (294)
Q Consensus       173 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  247 (294)
                      .   ....-.+-|+|-|.+....+ +.++|+||+|+++||++| |..|+.+....++-..+..+. .+-|+.++.++..+
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~  932 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMV  932 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHH
Confidence            1   11223567888888888877 899999999999999999 999999999999888887655 67788999999999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+||-.|+..||+++++..
T Consensus       933 mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  933 MVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHhccCcccCccHHHHHH
Confidence            99999999999999998765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.2e-34  Score=238.98  Aligned_cols=254  Identities=26%  Similarity=0.432  Sum_probs=203.0

Q ss_pred             ccccccCCcccccccccCceEEEEEEEcc---CCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEE
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE   87 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   87 (294)
                      +..+...|+++++||.|.|++||++.+..   .+..|++|.+......     ..+..|+++|..+. +.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhc
Confidence            44677889999999999999999999877   6788999998765433     56899999999996 789999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeeccccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNI  166 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~  166 (294)
                      .++...+|+||++...-.++..   .++..++..+++.++.||.++|..||+|+||||+|++.+. .++..|+|||++..
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence            9999999999999988777764   3678899999999999999999999999999999999975 57899999999862


Q ss_pred             cc-----------------C----------------C------------CccccccCCCcccCCccccCCccCCCchhHH
Q 022617          167 MR-----------------D----------------G------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVW  201 (294)
Q Consensus       167 ~~-----------------~----------------~------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~  201 (294)
                      ..                 .                +            .......||++|+|||++......+.++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            10                 0                0            0011224899999999998877778999999


Q ss_pred             HHHHHHHHHHhCCCCCCCC--CHHH------------HH--------------------------------HHHhCCCc-
Q 022617          202 SCGVILYALLCGTLPFDDE--NIPN------------LF--------------------------------KKIKGGIY-  234 (294)
Q Consensus       202 slG~ll~~l~~g~~p~~~~--~~~~------------~~--------------------------------~~~~~~~~-  234 (294)
                      |-|+++..+++++.||...  +...            +.                                +.+..... 
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            9999999999999998321  1000            00                                00000000 


Q ss_pred             ----cC-CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          235 ----TL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       235 ----~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                          .. ....+..+.+++.+||..||.+|.|++++|+||||.+
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence                00 0123557889999999999999999999999999974

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=236.12  Aligned_cols=239  Identities=23%  Similarity=0.364  Sum_probs=187.0

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHH--hCCCCceeEEEEEEEcCC---
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR--LFMHPHIIRLYEVIETPS---   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~~---   90 (294)
                      .......++||+|.||.||+|+.  +++.||||++....      .+.+..|.++.+  .++|+||+++++.-....   
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            56778899999999999999987  56899999986543      355666666665  457999999998865443   


Q ss_pred             -eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---------CCceecCCCCCCeEecCCCcEEEee
Q 022617           91 -DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR---------NMVVHRDLKPENLLLDSKWNVKIAD  160 (294)
Q Consensus        91 -~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~---------~~i~h~di~p~nili~~~~~~~l~d  160 (294)
                       .+++|++|.+.|+|-++|+. ..++.....+++..++.+|+|||+         -.|+|||||..|||+.+|+++.|+|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence             79999999999999999965 468999999999999999999995         3599999999999999999999999


Q ss_pred             ecccccccCCC---ccccccCCCcccCCccccCCccCC-----CchhHHHHHHHHHHHHhCCCCCC--------------
Q 022617          161 FGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAG-----PEVDVWSCGVILYALLCGTLPFD--------------  218 (294)
Q Consensus       161 fg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~ll~~l~~g~~p~~--------------  218 (294)
                      ||+|..+....   .....+||.+|||||++.+...-.     .+.||||+|.++||+++....++              
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            99998775433   223478999999999986532211     46899999999999998644332              


Q ss_pred             ---CCCHHHHHHHHh--CCCccCCC-----CCChhHHHHHHHhcccCCCCCCCHh
Q 022617          219 ---DENIPNLFKKIK--GGIYTLPS-----HLSPGARDLIPRMLIVDPMKRITIP  263 (294)
Q Consensus       219 ---~~~~~~~~~~~~--~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~  263 (294)
                         ....+++...+.  +.++.++.     .....+.+.++.||+.||+.|.|+.
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence               112334444332  33333332     3455788999999999999999975

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-33  Score=209.35  Aligned_cols=217  Identities=23%  Similarity=0.413  Sum_probs=179.9

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS   90 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   90 (294)
                      +++-.+...-...||+|++|.|-+.++..+|+-.|+|.+...- . ....+++.+|+.+..+. .+|+++.+++.+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            5555666777888999999999999999999999999986543 2 23456677777776655 5899999999998899


Q ss_pred             eEEEEEeccCCCChHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccc
Q 022617           91 DIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                      .+|+.||.++. ||..+-.    ..+.+++..+-+++..++.||.|||++ .++|||+||+||||+.+|++|++|||.+.
T Consensus       119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999999965 8877653    457799999999999999999999965 79999999999999999999999999998


Q ss_pred             cccCCCccccccCCCcccCCccccC---CccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhC
Q 022617          166 IMRDGHFLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKG  231 (294)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~  231 (294)
                      ...++-......|...|+|||.+..   .+.++.++||||||+++.||.+++.||+. ..+.+.++++..
T Consensus       198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            8877776666789999999998753   22347899999999999999999999974 344444444433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=6.1e-32  Score=218.29  Aligned_cols=214  Identities=49%  Similarity=0.809  Sum_probs=185.3

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY   98 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   98 (294)
                      |++.+.||.|+++.||++.+..+++.+++|.+......  ...+.+.+|++.+++++|+|++++++++......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999888999999998755432  2467889999999999999999999999988999999999


Q ss_pred             cCCCChHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--cccc
Q 022617           99 VKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKT  175 (294)
Q Consensus        99 ~~~~sL~~~l~~~~~-l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~  175 (294)
                      +.+++|.+++..... +++..++.++.+++.++.+||+.+++|+|++|.||+++.++.++|+|||.+.......  ....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999999987766 8999999999999999999999999999999999999999999999999988765543  3344


Q ss_pred             ccCCCcccCCccc-cCCccCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHhCCCcc
Q 022617          176 SCGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYT  235 (294)
Q Consensus       176 ~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~--~~~~~~~~~~~~~~~~  235 (294)
                      ..++..|++||.+ ..... +.++|+|+||++++++++|+.||..  .+...+.+.+..+...
T Consensus       159 ~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             eeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence            5677889999998 44444 6799999999999999999999977  4555777777776643

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-33  Score=226.75  Aligned_cols=255  Identities=18%  Similarity=0.281  Sum_probs=213.0

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCC-----ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEE
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE   84 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   84 (294)
                      +++.....|++..-++.+|.||.||.|.+.+..     +.+.+|.+...  -+.-....+..|.-++..+.|||++.+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            344556678888999999999999999776433     34556654211  12234577888888999999999999999


Q ss_pred             EEEc-CCeEEEEEeccCCCChHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc
Q 022617           85 VIET-PSDIYVVMEYVKSGELFDYIVEK--------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN  155 (294)
Q Consensus        85 ~~~~-~~~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~  155 (294)
                      +..+ ...-+.++.+.+-++|..++.-.        ..++..++..++.|++.|++|||+.|++|.||-.+|.+|++.-+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence            8754 45678889999999999999721        24778889999999999999999999999999999999999999


Q ss_pred             EEEeeecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhC
Q 022617          156 VKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG  231 (294)
Q Consensus       156 ~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~  231 (294)
                      +||+|=.+++......++   +..-.+..||+||.+....+ +.++|+||||+++|||+| |+.||...++.++..-+++
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd  513 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD  513 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence            999999999877655443   23334678999999998888 799999999999999999 9999999999999998888


Q ss_pred             CC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       232 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +. ..-|-+||.++..++.-||...|++||+++|+..
T Consensus       514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            76 5667899999999999999999999999999865

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=209.53  Aligned_cols=252  Identities=29%  Similarity=0.467  Sum_probs=190.7

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEE-EEcCCe
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEV-IETPSD   91 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~~~~~   91 (294)
                      .+.+.|.|.+.||.|.||.+-+|.|+.+++.+++|.++.+..    ...++.+|+.---.|. |.||+.-++. |++.+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            577899999999999999999999999999999999876653    3567777766444443 7888876654 677788


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec--CCCcEEEeeecccccccC
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD--SKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~--~~~~~~l~dfg~~~~~~~  169 (294)
                      +++++||++.|+|.+-+.. ..+-+...+.++.|++.|+.|+|+++++|||||.+||||-  +.-++||+|||.+...+.
T Consensus        97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            9999999999999988754 3467888999999999999999999999999999999993  334799999999875432


Q ss_pred             CCccccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhCCC---ccCC
Q 022617          170 GHFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDEN-----IPNLFKKIKGGI---YTLP  237 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~~~---~~~~  237 (294)
                        .....--...|.+||.+..    .-...+.+|+|.||++++.+++|+.||....     .....+-.....   +...
T Consensus       176 --tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F  253 (378)
T KOG1345|consen  176 --TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF  253 (378)
T ss_pred             --eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence              1222223557889997642    2223578999999999999999999995321     111222222222   2333


Q ss_pred             CCCChhHHHHHHHhcccCCCCCC---CHhHHhcCCccc
Q 022617          238 SHLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQ  272 (294)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~h~~~~  272 (294)
                      ..+++.+..++++-|..+|++|-   ++....+..|..
T Consensus       254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            56788999999999999999994   344444455553

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=7.6e-31  Score=247.62  Aligned_cols=193  Identities=17%  Similarity=0.198  Sum_probs=140.3

Q ss_pred             CceeEEEEEE-------EcCCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617           77 PHIIRLYEVI-------ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL  148 (294)
Q Consensus        77 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni  148 (294)
                      +||.++++++       .....++.++|++ +++|.+++.. ...+++.+++.++.||+.||.|||++||+|+||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            4566666655       2234577788888 5599999965 34589999999999999999999999999999999999


Q ss_pred             EecCCCc-------------------EEEeeecccccccCCC-----------------ccccccCCCcccCCccccCCc
Q 022617          149 LLDSKWN-------------------VKIADFGLSNIMRDGH-----------------FLKTSCGSPNYAAPEVISGKL  192 (294)
Q Consensus       149 li~~~~~-------------------~~l~dfg~~~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~~~  192 (294)
                      |++..+.                   ++++|||++.......                 ......+++.|+|||++.+..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            9965444                   5555555554211000                 001124677899999998887


Q ss_pred             cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       193 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      + +.++|||||||++|||++|..|+.....  ....+.... .+...........++.+||..+|.+||++.|+++||||
T Consensus       192 ~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~  268 (793)
T PLN00181        192 S-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI  268 (793)
T ss_pred             C-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence            7 7899999999999999999888653221  111221111 11111234566789999999999999999999999999


Q ss_pred             cc
Q 022617          272 QA  273 (294)
Q Consensus       272 ~~  273 (294)
                      ..
T Consensus       269 ~~  270 (793)
T PLN00181        269 NE  270 (793)
T ss_pred             hh
Confidence            76

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-28  Score=195.55  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=208.6

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVI   86 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~   86 (294)
                      ++++..++...|+++++||.|+||.++.+.+--++++||||.-...     +....++.|+...+.|. .++|+.++.+.
T Consensus        19 s~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFG   93 (449)
T KOG1165|consen   19 SSSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFG   93 (449)
T ss_pred             CCCCceEecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeec
Confidence            5567789999999999999999999999999999999999975322     23578888999988886 59999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-----CcEEEee
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-----WNVKIAD  160 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-----~~~~l~d  160 (294)
                      .+..+-.+|+|.+ |.||+++..= ...++...+..++.|++.-+.++|++.++++||||+|+||...     ..+.++|
T Consensus        94 qeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD  172 (449)
T KOG1165|consen   94 QEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIID  172 (449)
T ss_pred             cccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEe
Confidence            9999999999999 6799999864 4569999999999999999999999999999999999999643     3589999


Q ss_pred             ecccccccCCCc--------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH
Q 022617          161 FGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKI  229 (294)
Q Consensus       161 fg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~  229 (294)
                      ||++....++..        ..+..||.+||+-....+.+. +.+.|+-+||.++++.+-|.+||.+..   ...-.++|
T Consensus       173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI  251 (449)
T KOG1165|consen  173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI  251 (449)
T ss_pred             ccchhhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence            999987654432        234568999999999888877 899999999999999999999997743   44444555


Q ss_pred             hCCCccC-----CCCCChhHHHHHHHhcccCCCCCCCHhHH
Q 022617          230 KGGIYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPEI  265 (294)
Q Consensus       230 ~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~i  265 (294)
                      -..+...     -.++|.++..-++-.-..+-.+-|+.+-+
T Consensus       252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl  292 (449)
T KOG1165|consen  252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL  292 (449)
T ss_pred             ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence            4433322     25678888888888888888888886644

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=3.2e-29  Score=195.08  Aligned_cols=159  Identities=24%  Similarity=0.293  Sum_probs=128.0

Q ss_pred             CChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCC
Q 022617          102 GELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP  180 (294)
Q Consensus       102 ~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  180 (294)
                      |||.+++.++ .++++..++.++.|++.||.|||+.+      ||+||+++.++.+++  ||.+.......    ..+++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            5899999764 56999999999999999999999998      999999999999999  99887654322    25789


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhCCCccC-------CCCCCh--hHHHHHHH
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGIYTL-------PSHLSP--GARDLIPR  250 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~-------~~~~~~--~l~~li~~  250 (294)
                      .|+|||++.+..+ +.++||||||+++|+|++|..||..... ......+.......       +...+.  ++.+++.+
T Consensus        69 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       69 YFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             cccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            9999999988777 7899999999999999999999975432 22223322221111       112333  69999999


Q ss_pred             hcccCCCCCCCHhHHhcCCcccc
Q 022617          251 MLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      ||..+|.+||++.++++|+|+..
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-27  Score=184.65  Aligned_cols=249  Identities=22%  Similarity=0.255  Sum_probs=202.1

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeEEEEEEE
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIE   87 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~   87 (294)
                      +..--...+.|+++++||+|+||.+|+|....+|..||||+-...-.     ...+..|..+.+.|++ .+|+.+..++.
T Consensus         7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~   81 (341)
T KOG1163|consen    7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGT   81 (341)
T ss_pred             chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence            33445678899999999999999999999999999999998643321     3467788889998885 78999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEEEeeecc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGL  163 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~l~dfg~  163 (294)
                      +..+-.+||+.+ |.||+++..- ...++...+.-++-|++.-++|+|.++++|+||||+|+++.-   ..++.|+|||+
T Consensus        82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence            999999999999 6799999863 456899999999999999999999999999999999999953   45699999999


Q ss_pred             cccccCCC--------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhCC
Q 022617          164 SNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKKIKGG  232 (294)
Q Consensus       164 ~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~~~  232 (294)
                      +....+..        ......||.+|.+-....+... +.+.|+-|+|.++.+.--|.+||.+....   .-.++|...
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek  239 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK  239 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh
Confidence            97654322        1234468889998888776665 78999999999999999999999875433   333444444


Q ss_pred             CccC-----CCCCChhHHHHHHHhcccCCCCCCCHhH
Q 022617          233 IYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPE  264 (294)
Q Consensus       233 ~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~  264 (294)
                      +...     -.++|.++.-.+.-|-..--++-|+..-
T Consensus       240 K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y  276 (341)
T KOG1163|consen  240 KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY  276 (341)
T ss_pred             hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence            4333     3578999999999999998899998553

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-27  Score=200.33  Aligned_cols=246  Identities=23%  Similarity=0.309  Sum_probs=194.0

Q ss_pred             CCcccccccccCceEEEEEEEccCC-ceEEEEEeecccccchHHHHHHHHHHHHHHhCC----CCceeEEEEEE-EcCCe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFM----HPHIIRLYEVI-ETPSD   91 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~   91 (294)
                      +|++.+.||+|+||.||.+.+..++ ..+|+|+........   ...+..|..++..+.    .+++..+++.+ ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999987664 578899875442221   126778888888886    36899999999 57788


Q ss_pred             EEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-----CcEEEeeeccc
Q 022617           92 IYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-----WNVKIADFGLS  164 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-----~~~~l~dfg~~  164 (294)
                      -++||+.+ |.+|.++....  +.++...+..++.|++.+|.+||+.|++||||||.|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999999 67999988654  469999999999999999999999999999999999999754     46999999999


Q ss_pred             cccc---CCC-------c-cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC--
Q 022617          165 NIMR---DGH-------F-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--  231 (294)
Q Consensus       165 ~~~~---~~~-------~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--  231 (294)
                      +...   ...       . .....||..|.++.+..+... +.+.|+||++.++.+++.|.+||..............  
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            8321   110       1 123458999999999888877 8999999999999999999999976553222222211  


Q ss_pred             --CCcc-CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          232 --GIYT-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       232 --~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                        .... .....+.++..+...+-..+...+|+...+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence              1111 234566788888888888999999998887663

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=6.4e-29  Score=224.03  Aligned_cols=262  Identities=34%  Similarity=0.525  Sum_probs=207.4

Q ss_pred             cCC-cccccccccCceEEEEEEEccCCceEEEEEeec---ccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           17 PNY-KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR---RKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        17 ~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~---~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +.| .....+|.|.+|.|+.+......+.+..|.+..   ...........+..|+-+-..+.|+|++..+..+.+....
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            445 568889999999888888776666666666542   1222223333377788888899999987766655554444


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      .-.||||++ +|..++.+.+.++..++--+++|++.++.|+|+.|+.|+|+|++|++++.+|.+|++|||.+.....+..
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            445999999 9999998887899999999999999999999999999999999999999999999999999876654332


Q ss_pred             -----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH--------HhCCCccCCC
Q 022617          173 -----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-KK--------IKGGIYTLPS  238 (294)
Q Consensus       173 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-~~--------~~~~~~~~~~  238 (294)
                           .....++..|.|||++.+..+.....||||.|+++..|.+|+.||......+.. ..        +..+...+..
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence                 345568899999999999999888999999999999999999999754433221 11        1111223335


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~  279 (294)
                      .++.+.+.+|.+||+.+|.+|.|+++|++.+||+.+--+.+
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v  596 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHV  596 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEe
Confidence            67888999999999999999999999999999998765544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=224.21  Aligned_cols=247  Identities=26%  Similarity=0.359  Sum_probs=191.6

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccc-ccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK-IKNMEMEEKVRREIKILRLFMHPHIIRLYEVI   86 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   86 (294)
                      ...-+..+..+|...+.||++.|=.|.+|++. .|. |++|++-+.. .-+.....+-..+++ ....++||++++.-.-
T Consensus        14 ~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~   90 (1431)
T KOG1240|consen   14 VEVYFSDLSVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL   90 (1431)
T ss_pred             HHHHhhcCccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH
Confidence            33444556668999999999999999999985 444 9999996553 112222333334444 5667899999998887


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      ...+..|++-+|... +|.|.+..+..+..-+.+.++.|++.|+..+|+.||+|||||.+||||+.-+.+.|+||..-..
T Consensus        91 ~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   91 VTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCC
Confidence            888889999999976 9999999888899999999999999999999999999999999999999999999999986532


Q ss_pred             c--cCC------CccccccCCCcccCCccccCC----------ccCCCchhHHHHHHHHHHHHh-CCCCCCCC-------
Q 022617          167 M--RDG------HFLKTSCGSPNYAAPEVISGK----------LYAGPEVDVWSCGVILYALLC-GTLPFDDE-------  220 (294)
Q Consensus       167 ~--~~~------~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~-g~~p~~~~-------  220 (294)
                      .  +..      ..+++.....+|.|||.+...          ..-+++.||||+||++.|+++ |++||.-.       
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~  249 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRS  249 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhc
Confidence            2  111      123444556799999987531          113678999999999999998 89888322       


Q ss_pred             ----CHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          221 ----NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       221 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                          +.+...+.|          -+..++.++..|++.||++|.++++.|+-
T Consensus       250 ~~~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  250 GNADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cCccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                222222222          23478999999999999999999999885

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=9.3e-25  Score=186.03  Aligned_cols=252  Identities=39%  Similarity=0.653  Sum_probs=209.2

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC-ceeEEEEEEEcCCeEEEEEe
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e   97 (294)
                      |.+.+.||.|+|+.||.+.+.   ..+++|.+.............+.+|..+++.+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999986   77899998776555444678899999999999988 79999999987777899999


Q ss_pred             ccCCCChHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeecccccccCCC--
Q 022617           98 YVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH--  171 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~---~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~~~~~~--  171 (294)
                      ++.++++.+++....   .++......++.|++.++.++|..+++|+|++|+||+++..+ .++++|||.+.......  
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999998776664   799999999999999999999999999999999999999988 79999999987554332  


Q ss_pred             -----ccccccCCCcccCCccccCC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhCCCcc-CCCC
Q 022617          172 -----FLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYT-LPSH  239 (294)
Q Consensus       172 -----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~-~~~~  239 (294)
                           ......++..|++||.+.+.  .......|+|++|++++++++|..||....    .......+.....+ ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 23566789999999999874  344789999999999999999999987665    34555544444433 2221


Q ss_pred             CC--------hhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          240 LS--------PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       240 ~~--------~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      ..        ..+.+++..++..+|..|.+..+...+++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            11        47899999999999999999999888866644

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.94  E-value=1.2e-26  Score=189.17  Aligned_cols=241  Identities=23%  Similarity=0.294  Sum_probs=157.9

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC----------CceeE
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH----------PHIIR   81 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~----------~~i~~   81 (294)
                      ...........+.||.|+++.||.+.|..+++.+++|++...........+.+++|.-....+.+          -.++.
T Consensus         7 ~~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~   86 (288)
T PF14531_consen    7 LGQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV   86 (288)
T ss_dssp             SS--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred             CCCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence            34444566778999999999999999999999999999987764455566777776655444322          23333


Q ss_pred             EEEEEEcC------------C-----eEEEEEeccCCCChHHHHHH---hCC----CCHHHHHHHHHHHHHHHHHHHhCC
Q 022617           82 LYEVIETP------------S-----DIYVVMEYVKSGELFDYIVE---KGR----LQEDEARNFFQQIISGVEYCHRNM  137 (294)
Q Consensus        82 ~~~~~~~~------------~-----~~~lv~e~~~~~sL~~~l~~---~~~----l~~~~~~~~~~ql~~~l~~Lh~~~  137 (294)
                      .++.....            +     ..+++++-+.+ +|.++++-   ...    +.......+..|++..+++||..|
T Consensus        87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G  165 (288)
T PF14531_consen   87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG  165 (288)
T ss_dssp             -SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence            33332211            1     24678888854 88888642   222    223334566799999999999999


Q ss_pred             ceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccCCccccCC-------ccCCCchhHHHHHHHHHHH
Q 022617          138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-------LYAGPEVDVWSCGVILYAL  210 (294)
Q Consensus       138 i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~ll~~l  210 (294)
                      ++|+||+|+|++++.+|.+.|+||+.....+....  ....+..|.|||.....       -..+.+.|.|+||+++|.|
T Consensus       166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             eEecccceeeEEEcCCCCEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            99999999999999999999999987765443222  13445778999875321       1226788999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCC
Q 022617          211 LCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR  259 (294)
Q Consensus       211 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  259 (294)
                      +++..||............    +..-.++|+.++.||..+|+.+|.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~~----f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEWD----FSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGGG----GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCcccccccc----chhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999999866443332221    11122789999999999999999987

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.7e-25  Score=190.02  Aligned_cols=169  Identities=18%  Similarity=0.200  Sum_probs=131.2

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEcc-CCceEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCceeE-EEEE
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKI--KNMEMEEKVRREIKILRLFMHPHIIR-LYEV   85 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~   85 (294)
                      +....+.++|++.+.||+|+||+||+|.+.. +++.++||+......  ........+.+|++++++++|+|+++ +++.
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~   90 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT   90 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence            3456788999999999999999999999876 677789998653211  12234567999999999999999885 4432


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCeEecCCCcEEEeeeccc
Q 022617           86 IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL-KPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        86 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di-~p~nili~~~~~~~l~dfg~~  164 (294)
                          +..+++|||+.|++|... .   +..   ...++.+++.+|.+||+.||+|+|| ||+||+++.++.++|+|||++
T Consensus        91 ----~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence                457999999999899632 1   111   2467889999999999999999999 999999999999999999999


Q ss_pred             ccccCCCcc---------ccccCCCcccCCcccc
Q 022617          165 NIMRDGHFL---------KTSCGSPNYAAPEVIS  189 (294)
Q Consensus       165 ~~~~~~~~~---------~~~~~~~~~~aPE~~~  189 (294)
                      .........         ....+++.|++||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            865433211         1234567789999874

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-27  Score=206.37  Aligned_cols=242  Identities=31%  Similarity=0.544  Sum_probs=207.0

Q ss_pred             cccccCceEEEEEEE---ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEEecc
Q 022617           24 TLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVMEYV   99 (294)
Q Consensus        24 ~lg~g~~~~vy~~~~---~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~   99 (294)
                      .+|.|.+|.|+++.-   ...++.+++|+..+......... .-..|-.++...+ ||.+++++..++.+...+++.++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            368899999987642   34567788888766544433322 4445667777776 999999999999999999999999


Q ss_pred             CCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCC
Q 022617          100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS  179 (294)
Q Consensus       100 ~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  179 (294)
                      .|+.|...+.....+.+.....+...++-++.++|+.+++|+|+|++||+++.+|++++.|||++...-.....   +|+
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt  156 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGT  156 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccc
Confidence            99999999888888889999999999999999999999999999999999999999999999998766443332   789


Q ss_pred             CcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCC
Q 022617          180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR  259 (294)
Q Consensus       180 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  259 (294)
                      ..|||||+..   .+..+.|.||+|+++++|++|..||..    +....|.+....+|...+...++++..++..+|.+|
T Consensus       157 ~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nr  229 (612)
T KOG0603|consen  157 YEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENR  229 (612)
T ss_pred             hhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence            9999999998   236789999999999999999999987    777888888899999999999999999999999999


Q ss_pred             CC-----HhHHhcCCcccccCC
Q 022617          260 IT-----IPEIRQHPWFQAHLP  276 (294)
Q Consensus       260 ps-----~~~il~h~~~~~~~~  276 (294)
                      .-     +.++++|+||+.+.-
T Consensus       230 Lg~~~~~~~eik~h~f~~~i~~  251 (612)
T KOG0603|consen  230 LGAGPDGVDEIKQHEFFQSIDW  251 (612)
T ss_pred             hccCcchhHHHhccchheeeeH
Confidence            86     479999999988743

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.93  E-value=2e-25  Score=176.84  Aligned_cols=176  Identities=16%  Similarity=0.152  Sum_probs=136.3

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHH------HHHHHHHHHhCCCCceeEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK------VRREIKILRLFMHPHIIRLYEVI   86 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~------~~~e~~~l~~l~~~~i~~~~~~~   86 (294)
                      +.+.++|++.+.+|.|+||.||++.+  ++..+++|++.............      +.+|+..+.++.|+++..+.+++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            46789999999999999999999765  46689999997665444333333      57899999999999999998886


Q ss_pred             EcC--------CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEE
Q 022617           87 ETP--------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI  158 (294)
Q Consensus        87 ~~~--------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l  158 (294)
                      ...        +..+++|||++|.+|.++..    +++    ....+++.++..+|+.|++|+|++|+||+++.+| ++|
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence            533        35789999999999988742    233    2456999999999999999999999999999988 999


Q ss_pred             eeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHH
Q 022617          159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL  211 (294)
Q Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~  211 (294)
                      +|||.............           ......+ ..++|+|+||+++....
T Consensus       176 iDfg~~~~~~e~~a~d~-----------~vler~y-~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRKAKDR-----------IDLERHY-GIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchhhHHH-----------HHHHhHh-cccccccceeEeehHHH
Confidence            99998765432221111           2222334 37899999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=1.9e-24  Score=169.30  Aligned_cols=144  Identities=22%  Similarity=0.247  Sum_probs=113.1

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeecccccchH-----------------------HHHHHHHHHHHHHhCCCC
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----------------------MEEKVRREIKILRLFMHP   77 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~   77 (294)
                      +...||+|++|.||+|.+. +|+.|++|++.........                       .......|++.+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            3568999999999999997 8999999999765321111                       012334599999999887


Q ss_pred             ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCeEecCCCcE
Q 022617           78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVVHRDLKPENLLLDSKWNV  156 (294)
Q Consensus        78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~L-h~~~i~h~di~p~nili~~~~~~  156 (294)
                      ++..+..+...  ..+++|||++|+++........+++...+..++.|++.+|.++ |+.|++|+||||+||++++ +.+
T Consensus        80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~v  156 (190)
T cd05147          80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GKL  156 (190)
T ss_pred             CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-CcE
Confidence            76444333222  2379999999877766544567899999999999999999999 7999999999999999984 689


Q ss_pred             EEeeeccccccc
Q 022617          157 KIADFGLSNIMR  168 (294)
Q Consensus       157 ~l~dfg~~~~~~  168 (294)
                      +|+|||++....
T Consensus       157 ~LiDFG~a~~~~  168 (190)
T cd05147         157 YIIDVSQSVEHD  168 (190)
T ss_pred             EEEEccccccCC
Confidence            999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-24  Score=170.92  Aligned_cols=241  Identities=23%  Similarity=0.374  Sum_probs=192.0

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      +...+..+|.....|..|++++.  |..++.|++....... ....++..|+-.|+-+.||||+++++.|.++-.+.++.
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            45566788899999999999985  4557788876665544 23567888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCCCcEEEe--eecccccccCC
Q 022617           97 EYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIA--DFGLSNIMRDG  170 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~--l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~~~~~l~--dfg~~~~~~~~  170 (294)
                      .|++.+||...+.....  .+..++.+++.+++.+++|||+..  |.--.+....++|+++-+.+|+  |--++...   
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe---  343 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---  343 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec---
Confidence            99999999999975433  677789999999999999999875  4445788999999998766554  32222111   


Q ss_pred             CccccccCCCcccCCccccCCcc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hCCCccCCCCCChhHHH
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSHLSPGARD  246 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~  246 (294)
                         ....-.+.|++||.++..+.  +-.++|+|||++++||+.|...||....+-+.--++  ..-....|++.+..+..
T Consensus       344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~k  420 (448)
T KOG0195|consen  344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNK  420 (448)
T ss_pred             ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHH
Confidence               12234678999999875433  246789999999999999999999887665544433  34457889999999999


Q ss_pred             HHHHhcccCCCCCCCHhHHh
Q 022617          247 LIPRMLIVDPMKRITIPEIR  266 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il  266 (294)
                      ++.-|++.||.+||.+..|+
T Consensus       421 lm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  421 LMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHhcCCCCcCCCcceeh
Confidence            99999999999999988764

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=5.9e-23  Score=161.44  Aligned_cols=145  Identities=17%  Similarity=0.214  Sum_probs=114.7

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeecccccch-----------------------HHHHHHHHHHHHHHhCCCC
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----------------------EMEEKVRREIKILRLFMHP   77 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~~~   77 (294)
                      +...||+|++|.||+|.+. +|+.|++|++........                       .....+..|+..+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 899999999876521100                       0122346789999999999


Q ss_pred             ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcE
Q 022617           78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNV  156 (294)
Q Consensus        78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~  156 (294)
                      ++..+..+....  .+++|||++|+++.........++......++.|++.++.++|. .|++|+||||+||+++ ++.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            875554443332  47999999987665443345678889999999999999999999 9999999999999999 7899


Q ss_pred             EEeeecccccccC
Q 022617          157 KIADFGLSNIMRD  169 (294)
Q Consensus       157 ~l~dfg~~~~~~~  169 (294)
                      +|+|||++.....
T Consensus       157 ~liDFG~a~~~~~  169 (190)
T cd05145         157 YIIDVSQAVELDH  169 (190)
T ss_pred             EEEEcccceecCC
Confidence            9999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=2.4e-23  Score=189.45  Aligned_cols=222  Identities=36%  Similarity=0.607  Sum_probs=172.1

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      .-.-...+|..++.|..|++|.||+++|+.+.++|++|+ .+..        .+.+-  ++..-..|.++          
T Consensus        77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~--------lilRn--ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN--------LILRN--ILTFAGNPFVV----------  135 (1205)
T ss_pred             ccCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccc--------hhhhc--cccccCCccee----------
Confidence            344566789999999999999999999999999999954 2221        11111  12222222222          


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                                 ++-...++.-++++.+.        +.++.|||+.||+|+|++|+|.+|+.-|++|+.|||++......
T Consensus       136 -----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                       24444455555555443        78899999999999999999999999999999999987543211


Q ss_pred             C---------------ccccc-cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc
Q 022617          171 H---------------FLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY  234 (294)
Q Consensus       171 ~---------------~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~  234 (294)
                      .               ...+. ++++.|.|||++....| +...|+|+||+++|+.+-|..||.+...++++..+..+..
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            1               11222 68999999999988878 7889999999999999999999999999999998877765


Q ss_pred             cCCC---CCChhHHHHHHHhcccCCCCCC---CHhHHhcCCcccc
Q 022617          235 TLPS---HLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQA  273 (294)
Q Consensus       235 ~~~~---~~~~~l~~li~~~l~~~p~~Rp---s~~~il~h~~~~~  273 (294)
                      ..+.   .++++.++++.++|+.+|..|.   .+.++..|+||+.
T Consensus       276 ~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  276 EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence            5553   5788999999999999999997   4668889999975

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=5.1e-22  Score=154.26  Aligned_cols=189  Identities=16%  Similarity=0.118  Sum_probs=138.9

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccch-HHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCCeEEEEE
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRLFMH-PHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ..+...|++|+||+||.+..  .+.+++.+.+.....-.. -....+.+|++++++|.| +++++++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34678899999999997765  667788776644332111 122357899999999964 789999886    4568999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCeEecCCCcEEEeeecccccccCCCcc--
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL-KPENLLLDSKWNVKIADFGLSNIMRDGHFL--  173 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di-~p~nili~~~~~~~l~dfg~~~~~~~~~~~--  173 (294)
                      +|+.|.+|...+..       ....++.|++.++.++|+.|++|+|| +|+||+++.++.++|+|||++.........  
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999888754321       12357789999999999999999999 799999999999999999999754432210  


Q ss_pred             ------------ccccCCCcccCCccccCC-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022617          174 ------------KTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDE  220 (294)
Q Consensus       174 ------------~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~  220 (294)
                                  .....++.+++|+...-- ...-.+.++++.|.-+|.++|+..+...+
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                        011246677777654322 12126789999999999999998886443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=2.1e-22  Score=186.01  Aligned_cols=243  Identities=22%  Similarity=0.298  Sum_probs=187.0

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      ..+..-+..|.|.+.||.|++|.||.|.+.+ ++.||||+-.....-+-.....+...++ .+  --+.|+.+...+.-.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQ  766 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccC
Confidence            3456667899999999999999999999876 9999999987766554444444444444 11  124566666666667


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-------CCcEEEeeec
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-------KWNVKIADFG  162 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-------~~~~~l~dfg  162 (294)
                      +..++++||.+.|||.+++...+.+++..+..++.|++..+..||..+|+||||||+|+++..       ...++|+|||
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            888899999999999999998888999999999999999999999999999999999999942       2359999999


Q ss_pred             cccc---ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCC
Q 022617          163 LSNI---MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH  239 (294)
Q Consensus       163 ~~~~---~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
                      .+..   +.+.......+.+-.+-.+|.+.+.++ ++.+|.|+|+.+++-|+.|+..          +...........+
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y~----------q~~~g~~~~~~~~  915 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKYM----------EVKNGSSWMVKTN  915 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHHH----------HhcCCcceecccc
Confidence            8754   345666777888999999999999999 8999999999999999998532          1122222222222


Q ss_pred             CC-----hhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          240 LS-----PGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       240 ~~-----~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ++     .....++..+|+.|-..-|.+.+|..
T Consensus       916 ~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~  948 (974)
T KOG1166|consen  916 FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRT  948 (974)
T ss_pred             chhhhhHHHHHHHHHHHhCcCcccchhHHHHHH
Confidence            22     23457888899866666666666543

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=1.4e-20  Score=148.80  Aligned_cols=138  Identities=27%  Similarity=0.399  Sum_probs=107.7

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-----CCCceeEEEEEEEcCC---
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-----MHPHIIRLYEVIETPS---   90 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---   90 (294)
                      ..-.+.||+|+++.||.  +..++.. +||++.....   ...+.+.+|+..++.+     .||||++++++++++.   
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            34567899999999995  7767665 6998865432   2346789999999999     5799999999998874   


Q ss_pred             eEE-EEEec--cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCCeEecC----CCcEEEee-e
Q 022617           91 DIY-VVMEY--VKSGELFDYIVEKGRLQEDEARNFFQQIISGV-EYCHRNMVVHRDLKPENLLLDS----KWNVKIAD-F  161 (294)
Q Consensus        91 ~~~-lv~e~--~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l-~~Lh~~~i~h~di~p~nili~~----~~~~~l~d-f  161 (294)
                      .++ +|+||  +.++||.+++++. .+++.  ..++.+++.++ .|||+.+|+|+||||+||+++.    ++.++|+| |
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            333 78999  4478999999653 45555  35577777777 9999999999999999999974    33799999 5


Q ss_pred             cccc
Q 022617          162 GLSN  165 (294)
Q Consensus       162 g~~~  165 (294)
                      |...
T Consensus       155 G~~~  158 (210)
T PRK10345        155 GEST  158 (210)
T ss_pred             CCcc
Confidence            5443

>smart00090 RIO RIO-like kinase

Probab=99.86  E-value=5.7e-21  Score=154.58  Aligned_cols=145  Identities=19%  Similarity=0.206  Sum_probs=115.5

Q ss_pred             CCcccccccccCceEEEEEE-EccCCceEEEEEeecccccch---------------------HHHHHHHHHHHHHHhCC
Q 022617           18 NYKLGKTLGIGSFGKVKIAE-HALTGHKVAIKILNRRKIKNM---------------------EMEEKVRREIKILRLFM   75 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~-~~~~~~~~~~K~~~~~~~~~~---------------------~~~~~~~~e~~~l~~l~   75 (294)
                      -|++.+.||.|++|.||+|. +..+|+.|++|++........                     .....+.+|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 667899999999875432100                     01234578999999997


Q ss_pred             CC--ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCeEecC
Q 022617           76 HP--HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDS  152 (294)
Q Consensus        76 ~~--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~-i~h~di~p~nili~~  152 (294)
                      +.  .++++++.    ...++||||++|.+|.........+.......++.|++.++.+||+.| ++|+||+|+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            53  34555543    234799999999888776544555667778899999999999999999 99999999999999 


Q ss_pred             CCcEEEeeecccccc
Q 022617          153 KWNVKIADFGLSNIM  167 (294)
Q Consensus       153 ~~~~~l~dfg~~~~~  167 (294)
                      ++.++|+|||.+...
T Consensus       184 ~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CCCEEEEEChhhhcc
Confidence            789999999988654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.1e-20  Score=156.03  Aligned_cols=187  Identities=26%  Similarity=0.424  Sum_probs=142.9

Q ss_pred             CCCceeEEEEEEEc---------------------------CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHH
Q 022617           75 MHPHIIRLYEVIET---------------------------PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII  127 (294)
Q Consensus        75 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~  127 (294)
                      +||||+++.+.|.+                           +..+|++|..+.. ||..++-.+ ..+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence            49999999877632                           3468999999865 999999654 457778888999999


Q ss_pred             HHHHHHHhCCceecCCCCCCeEec--CCC--cEEEeeecccccccC-------CCccccccCCCcccCCccccCCc----
Q 022617          128 SGVEYCHRNMVVHRDLKPENLLLD--SKW--NVKIADFGLSNIMRD-------GHFLKTSCGSPNYAAPEVISGKL----  192 (294)
Q Consensus       128 ~~l~~Lh~~~i~h~di~p~nili~--~~~--~~~l~dfg~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~----  192 (294)
                      +++.|||++|+.|+|+|.+||++.  +|+  .+.++|||.+-.-..       ........|...-+|||+....+    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999994  333  478899997643221       11222334677889999875322    


Q ss_pred             -cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHh
Q 022617          193 -YAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP  263 (294)
Q Consensus       193 -~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  263 (294)
                       .+-.++|.|+.|.+.||+++...||.......  ...-.....+.+|+.+++.+++++...|+.||++|++..
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence             22357999999999999999999997733211  111123445678889999999999999999999999944

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=1.8e-19  Score=144.31  Aligned_cols=138  Identities=24%  Similarity=0.333  Sum_probs=114.9

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++.||+|++|.||+|.+  .+..+++|+.........     .....+.+|+.++..+.++++..+..++...+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36789999999999987  667899998654332221     12346778999999999999887777776777889999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      ||++|++|.+++.....    ....++.+++.++.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999999865432    7889999999999999999999999999999999 77899999998864

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=9.6e-20  Score=157.99  Aligned_cols=197  Identities=27%  Similarity=0.466  Sum_probs=157.2

Q ss_pred             HHhCCCCceeEEEEEEEcCCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCCe
Q 022617           71 LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMV-VHRDLKPENL  148 (294)
Q Consensus        71 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i-~h~di~p~ni  148 (294)
                      |+.+.|.|+.++++.+......+.+++||.-|+|.+.+.. .-.++......++++++.++.|||+..| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            3567899999999999999999999999999999999976 3468888899999999999999998875 9999999999


Q ss_pred             EecCCCcEEEeeecccccccC---CCccccccCCCcccCCccccCCcc------CCCchhHHHHHHHHHHHHhCCCCCCC
Q 022617          149 LLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISGKLY------AGPEVDVWSCGVILYALLCGTLPFDD  219 (294)
Q Consensus       149 li~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~------~~~~~Di~slG~ll~~l~~g~~p~~~  219 (294)
                      +++....+|++|||+......   ............|.|||.+.....      .+.+.|+||+|++++++++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999876642   111122234557999999865311      25679999999999999999999965


Q ss_pred             C----CHHHHHHHHhC-CCccCCC------CCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          220 E----NIPNLFKKIKG-GIYTLPS------HLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       220 ~----~~~~~~~~~~~-~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .    ...+....+.+ +...+.+      ..++++..++..||..+|.+||++.++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            2    22345555555 2221111      34557999999999999999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=4.7e-19  Score=140.57  Aligned_cols=133  Identities=23%  Similarity=0.301  Sum_probs=107.5

Q ss_pred             cccccCceEEEEEEEccCCceEEEEEeecccccc-----hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617           24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY   98 (294)
Q Consensus        24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   98 (294)
                      .||+|++|.||++.+  ++..+++|+........     ......+.+|+++++.+.++++..+..++......+++||+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999985  56789999865432221     11236678899999999988765555555566677899999


Q ss_pred             cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        99 ~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      ++|++|.+++.....       .++.+++.++.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998754321       8889999999999999999999999999999 78999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2.4e-20  Score=159.23  Aligned_cols=174  Identities=27%  Similarity=0.457  Sum_probs=138.7

Q ss_pred             CeEEEEEeccCCCChHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      .++++.|++|...+|.+|+.++.   ..+......++.|+..++.|   +|.+|+|++|.||+...+..++|+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            35889999999999999997543   36677888999999999999   9999999999999999999999999999876


Q ss_pred             ccCCC-------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCCcc--C
Q 022617          167 MRDGH-------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT--L  236 (294)
Q Consensus       167 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~--~  236 (294)
                      .....       .+....++..|++||.+.+..+ +.++|||+||+++++++. -...+   ........+..+.++  +
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~~~  481 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIPPEF  481 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCChHH
Confidence            65444       4556779999999999999988 899999999999999996 22222   222333344555544  3


Q ss_pred             CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      ..+++.+ ..|+.+||...|.+||++.+.--|+|.
T Consensus       482 ~~d~p~e-~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  482 LQDYPEE-YTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhcCcHH-HHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            3445544 589999999999999977776667664

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=7.7e-19  Score=139.12  Aligned_cols=141  Identities=21%  Similarity=0.297  Sum_probs=109.9

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccch-------------------HHHHHHHHHHHHHHhCCCC-
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-------------------EMEEKVRREIKILRLFMHP-   77 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~~~-   77 (294)
                      .|.+.+.||.|++|.||++.+. +++.+++|++........                   ........|+.++..+.++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3888999999999999999875 799999999764321100                   0112356788888888776 


Q ss_pred             -ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcE
Q 022617           78 -HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV  156 (294)
Q Consensus        78 -~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~  156 (294)
                       .++.+++.    ...+++|||++|++|..+...      .....++.+++.++.++|+.|++|+||+|+||++++++.+
T Consensus        95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence             44444432    345899999999988776421      3456788999999999999999999999999999999999


Q ss_pred             EEeeecccccccC
Q 022617          157 KIADFGLSNIMRD  169 (294)
Q Consensus       157 ~l~dfg~~~~~~~  169 (294)
                      +|+|||.+.....
T Consensus       165 ~liDfg~~~~~~~  177 (198)
T cd05144         165 YIIDWPQMVSTDH  177 (198)
T ss_pred             EEEECCccccCCC
Confidence            9999999865433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1.2e-17  Score=151.38  Aligned_cols=139  Identities=20%  Similarity=0.237  Sum_probs=112.4

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      ..|...+.||+|++|+||++.+..  ..+++|+.......     .......+.+|+++++.++|++++.+..++.....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345678999999999999998743  34455543222111     11234568899999999999999888777777778


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      .+++|||++|++|.+++.        ....++.+++.++.+||+.|++|+||+|+||++ .++.++|+|||++..
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            899999999999999885        356789999999999999999999999999999 577999999999865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=3.6e-20  Score=167.50  Aligned_cols=258  Identities=34%  Similarity=0.570  Sum_probs=209.0

Q ss_pred             cccCCcccccccccCceEEEEEEEccCC-ceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI   92 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   92 (294)
                      -...|.+.+.||.|.++.|-.+....+. ..++.|.+.... ........+..|..+-..+. |+|++..++....++..
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            4678999999999999999888764333 345666654443 23344566667888878887 99999999999999999


Q ss_pred             EEEEeccCCCChHHHH-HHhC-CCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCeEecCCC-cEEEeeeccccccc
Q 022617           93 YVVMEYVKSGELFDYI-VEKG-RLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMR  168 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l-~~~~-~l~~~~~~~~~~ql~~~l~~Lh-~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~~~  168 (294)
                      ++..++..|+++.+-+ .... ..+.......+.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.|||++....
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999999988 5444 5677788899999999999999 99999999999999999999 99999999998765


Q ss_pred             C-C---CccccccC-CCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhCC----CccCCC
Q 022617          169 D-G---HFLKTSCG-SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-KKIKGG----IYTLPS  238 (294)
Q Consensus       169 ~-~---~~~~~~~~-~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-~~~~~~----~~~~~~  238 (294)
                      . .   .......+ ++.|.|||...+..+..+..|+||.|+++.-+++|..||......... ......    ....+.
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            5 2   22334456 899999999988767688999999999999999999999764433311 111111    244556


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      ..+....+++.+++..+|..|.+.+++-.+||+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            78888999999999999999999999999999988

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=9.2e-18  Score=131.79  Aligned_cols=139  Identities=21%  Similarity=0.312  Sum_probs=99.9

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHH---------------------HHHHHHHHHhCCCCc-
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK---------------------VRREIKILRLFMHPH-   78 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~~~~-   78 (294)
                      +.+.||+|++|+||+|.+. +++.|++|++.............                     ...|...+..+.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999987 78999999986543221111111                     135566666665433 


Q ss_pred             -eeEEEEEEEcCCeEEEEEeccCCCChHH-HHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCc
Q 022617           79 -IIRLYEVIETPSDIYVVMEYVKSGELFD-YIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWN  155 (294)
Q Consensus        79 -i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~  155 (294)
                       ++++++.    ...++++||++++++.. .+.... . ......++.+++.++.++|. .|++|+||+|+||+++ ++.
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence             4555543    23589999999843321 121111 1 16688999999999999999 9999999999999999 889


Q ss_pred             EEEeeecccccc
Q 022617          156 VKIADFGLSNIM  167 (294)
Q Consensus       156 ~~l~dfg~~~~~  167 (294)
                      ++++|||.+...
T Consensus       153 ~~liDfg~a~~~  164 (187)
T cd05119         153 VYIIDVPQAVEI  164 (187)
T ss_pred             EEEEECcccccc
Confidence            999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=7e-17  Score=131.04  Aligned_cols=138  Identities=19%  Similarity=0.273  Sum_probs=105.6

Q ss_pred             ccccc-ccCceEEEEEEEccCCceEEEEEeecccc-----c-----chHHHHHHHHHHHHHHhCCCCce--eEEEEEEEc
Q 022617           22 GKTLG-IGSFGKVKIAEHALTGHKVAIKILNRRKI-----K-----NMEMEEKVRREIKILRLFMHPHI--IRLYEVIET   88 (294)
Q Consensus        22 ~~~lg-~g~~~~vy~~~~~~~~~~~~~K~~~~~~~-----~-----~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~   88 (294)
                      ...|| .||.|+||.+...  +..++||.+.....     .     .......+.+|+.++.++.|+++  +.++++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            34576 7888899988763  67899998854321     0     11234567889999999998775  677766433


Q ss_pred             CC----eEEEEEeccCC-CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           89 PS----DIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        89 ~~----~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      ..    ..++++|+++| .+|.+++.. .++++..    +.+++.++.+||+.||+|+||+|.||+++.++.++|+|||.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            22    23599999987 689888754 4555543    56899999999999999999999999999988999999998


Q ss_pred             ccc
Q 022617          164 SNI  166 (294)
Q Consensus       164 ~~~  166 (294)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            865

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.72  E-value=3.3e-16  Score=137.80  Aligned_cols=231  Identities=19%  Similarity=0.274  Sum_probs=160.8

Q ss_pred             CcccccccccCceEEE-EEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           19 YKLGKTLGIGSFGKVK-IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy-~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      |++ +...-++.+ +| .|..+.++.++.+.++....-   .....+.+.++.++.++||||+++++.++..+.+|+|+|
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE   89 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE   89 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence            444 444444444 44 566777889999998865432   445678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-ccc
Q 022617           98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKT  175 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh-~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~  175 (294)
                      .+.  .|...+++.+   ...+...+.||+.||.+|| +.+++|++|+-..|+++..|.++|++|..+........ ...
T Consensus        90 rV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~  164 (690)
T KOG1243|consen   90 RVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS  164 (690)
T ss_pred             ccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc
Confidence            984  7888887643   7778888999999999998 66799999999999999999999999998765543321 112


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      ...-..|..|+......   ...|.|.||+++++++.|..+  ....           .......+.....+..+-+--.
T Consensus       165 ~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~~--~~~~-----------~~~~~~ipk~~~~~~~k~~~~~  228 (690)
T KOG1243|consen  165 LYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSLL--TKTD-----------LSNTGKIPKALIELYCKKLGAT  228 (690)
T ss_pred             chhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcccC--cchh-----------hhccCccchhHHHHHHHHhccc
Confidence            22233456666543332   357999999999999998222  1110           1111233444444444444445


Q ss_pred             CCCCCCHhH-----HhcCCcccccC
Q 022617          256 PMKRITIPE-----IRQHPWFQAHL  275 (294)
Q Consensus       256 p~~Rps~~~-----il~h~~~~~~~  275 (294)
                      +..||....     .+-|+||++.+
T Consensus       229 ~~~r~n~~~~~~~~~~~~gff~n~f  253 (690)
T KOG1243|consen  229 ELKRPNKLRFILECRLLGGFFRNDF  253 (690)
T ss_pred             cccccchhhHHHHHHhccccccchH
Confidence            556665222     23388887754

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=2e-16  Score=119.59  Aligned_cols=132  Identities=23%  Similarity=0.293  Sum_probs=111.2

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CceeEEEEEEEcCCeEEEEEec
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PHIIRLYEVIETPSDIYVVMEY   98 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~   98 (294)
                      +++.|+.|.++.||++.+..  ..+++|.......     ...+.+|+..++.+.+  .++++++.+....+..++++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            56789999999999999743  6799999754432     4578889999999976  5899999888877889999999


Q ss_pred             cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN---MVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        99 ~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~---~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      ++|.++..+       +......++.+++.+++.||..   +++|+|++|.||++++++.++++||+.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            988777654       5566778889999999999985   699999999999999988999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=1.2e-17  Score=135.12  Aligned_cols=236  Identities=19%  Similarity=0.259  Sum_probs=160.5

Q ss_pred             EEEEEEEccCCceEEEEEeecccccch-HHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----eEEEEEeccCCCChH
Q 022617           32 KVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELF  105 (294)
Q Consensus        32 ~vy~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~  105 (294)
                      .||++-++..|..++-..+......+. ........-+..+-.+-|.|+++++.||.+.+     ...+++||+..+++.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            346666666665554433332222211 12233344455566677999999999986543     478899999999999


Q ss_pred             HHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCCCcEEEeeecccccccC-----CCccc
Q 022617          106 DYIVEK----GRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-----GHFLK  174 (294)
Q Consensus       106 ~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-----~~~~~  174 (294)
                      .+|++.    ..+......+|+-||+.||.|||+..  |+|+++..+.|+++.+|-+|++--........     .....
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~  240 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS  240 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence            999753    45788888899999999999999875  99999999999999998888764332221110     11122


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhCCCccCCCCCChhHHHHHHHhcc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  253 (294)
                      ...+.++|.+||.=..... .-++|||++|+...+|.-+..--.... .....+.+....+.+..+.   -+.++..|++
T Consensus       241 ~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len~l---qr~~i~kcl~  316 (458)
T KOG1266|consen  241 VNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLENGL---QRGSITKCLE  316 (458)
T ss_pred             ccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccCcc---ccCcCccccc
Confidence            3345778999997554444 467999999999999987765533222 2222223333333322222   2467889999


Q ss_pred             cCCCCCCCHhHHhcCCcc
Q 022617          254 VDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~  271 (294)
                      ..|..||++++++.||.+
T Consensus       317 ~eP~~rp~ar~llfHpll  334 (458)
T KOG1266|consen  317 GEPNGRPDARLLLFHPLL  334 (458)
T ss_pred             CCCCCCcchhhhhcCcee
Confidence            999999999999999986

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=8e-17  Score=140.12  Aligned_cols=259  Identities=23%  Similarity=0.264  Sum_probs=195.6

Q ss_pred             cccccCCcccccccc--cCceEEEEEEE--ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEE
Q 022617           13 DMFLPNYKLGKTLGI--GSFGKVKIAEH--ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE   87 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~--g~~~~vy~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   87 (294)
                      .-+...+.+.+.+|.  |.+|.+|.+..  ..++..+++|.-........ ....-.+|+.-.++++ |++.++.+..++
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~-~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL-DSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc-ccccccchhhcccccCccccccccCcccc
Confidence            345567888899999  99999999988  88889999998433322111 1222334555555554 889999888999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCCeEecCC-CcEEEeee
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIIS----GVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADF  161 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~----~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~df  161 (294)
                      ..+..++-+|.++ .+|..+...-. .+++..++..+.+..+    |+.++|..+++|.|++|.||+...+ ..++++||
T Consensus       189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence            9999999999995 58887776543 4889999999999999    9999999999999999999999999 88999999


Q ss_pred             cccccccCCCccc-----c-ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC-CCc
Q 022617          162 GLSNIMRDGHFLK-----T-SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-GIY  234 (294)
Q Consensus       162 g~~~~~~~~~~~~-----~-~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~  234 (294)
                      ++...+.......     . ..+...|++||...+..  +..+|+|+||.++.+..++..+........+.+.-.. ...
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~  345 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL  345 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence            9987776554221     1 15678999999987664  6889999999999998887666543311111111000 111


Q ss_pred             cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      ++-...+.++...+..|++.+|..|++++.+++++++..-+
T Consensus       346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~  386 (524)
T KOG0601|consen  346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL  386 (524)
T ss_pred             hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence            22345567788899999999999999999999999998543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.60  E-value=3.7e-14  Score=110.32  Aligned_cols=143  Identities=17%  Similarity=0.203  Sum_probs=103.3

Q ss_pred             cccccccCceEEEEEEEcc------CCceEEEEEeeccccc--c-----------------hHHHHH----HHHHHHHHH
Q 022617           22 GKTLGIGSFGKVKIAEHAL------TGHKVAIKILNRRKIK--N-----------------MEMEEK----VRREIKILR   72 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~------~~~~~~~K~~~~~~~~--~-----------------~~~~~~----~~~e~~~l~   72 (294)
                      ...||.|..+.||.|....      .+..+|+|++......  .                 ......    ..+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998653      3478999998633211  0                 011223    337999999


Q ss_pred             hCCC--CceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCeE
Q 022617           73 LFMH--PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVVHRDLKPENLL  149 (294)
Q Consensus        73 ~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~L-h~~~i~h~di~p~nil  149 (294)
                      ++..  -+++.++++    ..-+++||++++..+....-++..++.+....+..+++.++..| |+.|++|||+++.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8875  456677764    45678999997643322222233456667778889999999988 8999999999999999


Q ss_pred             ecCCCcEEEeeecccccccC
Q 022617          150 LDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus       150 i~~~~~~~l~dfg~~~~~~~  169 (294)
                      +++ +.+.|+|||.+.....
T Consensus       158 ~~~-~~v~iIDF~qav~~~h  176 (197)
T cd05146         158 WHD-GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EEC-CcEEEEECCCceeCCC
Confidence            974 5899999998876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=3.1e-14  Score=125.23  Aligned_cols=148  Identities=21%  Similarity=0.295  Sum_probs=98.9

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchH-------------------------------HH---
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-------------------------------ME---   61 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~-------------------------------~~---   61 (294)
                      ...|. .+.||+|++|.||+|..+ +|+.|+||+..+.-.....                               ..   
T Consensus       117 F~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l  194 (437)
T TIGR01982       117 FAEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL  194 (437)
T ss_pred             HhhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence            33444 367999999999999975 7899999998543111000                               00   


Q ss_pred             ---HHHHHHHHHHHhC----C-CCceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHH-HHH
Q 022617           62 ---EKVRREIKILRLF----M-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIIS-GVE  131 (294)
Q Consensus        62 ---~~~~~e~~~l~~l----~-~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~-~l~  131 (294)
                         -++.+|...+.++    + ++++.-..-+.......+++|||++|.+|.++.... ...+   ...++.+++. .+.
T Consensus       195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~  271 (437)
T TIGR01982       195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLN  271 (437)
T ss_pred             HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHH
Confidence               0133344444443    2 233322222223344568999999999998876432 1222   3345556555 467


Q ss_pred             HHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617          132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus       132 ~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      .+|..|++|+|++|.||+++.+++++++|||++....
T Consensus       272 ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       272 QVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8999999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.56  E-value=1.9e-15  Score=138.71  Aligned_cols=259  Identities=28%  Similarity=0.432  Sum_probs=200.1

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      -.+.+.+.+-+.++.++.+..+.-..++..+..|+......-.....+.+..+-.++-...+|.++.....+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            34567777788999999999998777776666666533322111122333333333333334555554444555677899


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc------
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR------  168 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~------  168 (294)
                      ++++.++++|...+.+.+..+.+-....+..+.+++.+||...+.|+|++|.|.++..+++..+.+|+......      
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence            99999999999999887878888888899999999999999999999999999999999999999997321110      


Q ss_pred             --------------------------CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 022617          169 --------------------------DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI  222 (294)
Q Consensus       169 --------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~  222 (294)
                                                +........+++.|.+||...+... ...+|+|+.|.++++.++|..||.....
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence                                      0011122347889999999988877 7889999999999999999999999999


Q ss_pred             HHHHHHHhCCCccCC---CCCChhHHHHHHHhcccCCCCCCCHh---HHhcCCccccc
Q 022617          223 PNLFKKIKGGIYTLP---SHLSPGARDLIPRMLIVDPMKRITIP---EIRQHPWFQAH  274 (294)
Q Consensus       223 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~---~il~h~~~~~~  274 (294)
                      +...+++.....+.+   ...+.+.++++...+..+|.+|..+.   +.-.|+||+..
T Consensus      1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            999998888776554   35788999999999999999999988   88999999764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.55  E-value=8.4e-15  Score=130.43  Aligned_cols=149  Identities=23%  Similarity=0.340  Sum_probs=96.7

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc---------------------------h----HH
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN---------------------------M----EM   60 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~---------------------------~----~~   60 (294)
                      ++.+...|.. +.||+|++|+||+|..+.+|+.||||+..+.-...                           .    +.
T Consensus       115 ~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~  193 (537)
T PRK04750        115 VEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF  193 (537)
T ss_pred             HHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence            4456677887 89999999999999998779999999986441100                           0    11


Q ss_pred             HHHHH------HHHHHHHhCC----CCceeEEEEE-EEcCCeEEEEEeccCCCChHHHH--HHhCC----CCHHHHHHHH
Q 022617           61 EEKVR------REIKILRLFM----HPHIIRLYEV-IETPSDIYVVMEYVKSGELFDYI--VEKGR----LQEDEARNFF  123 (294)
Q Consensus        61 ~~~~~------~e~~~l~~l~----~~~i~~~~~~-~~~~~~~~lv~e~~~~~sL~~~l--~~~~~----l~~~~~~~~~  123 (294)
                      .+.+.      +|...+.++.    +...+.+=.+ .......+++|||+.|+++.+.-  ...+.    +.+..+..++
T Consensus       194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~  273 (537)
T PRK04750        194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF  273 (537)
T ss_pred             HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence            12222      3333333332    3322222222 22345678999999999998742  22221    2222222333


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCCeEecCCC----cEEEeeeccccccc
Q 022617          124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMR  168 (294)
Q Consensus       124 ~ql~~~l~~Lh~~~i~h~di~p~nili~~~~----~~~l~dfg~~~~~~  168 (294)
                      .       .+...|++|+|++|.||+++.++    +++++|||++....
T Consensus       274 ~-------Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        274 T-------QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             H-------HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            3       34569999999999999999888    99999999987653

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=2.2e-13  Score=102.62  Aligned_cols=135  Identities=22%  Similarity=0.326  Sum_probs=106.9

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHH-----HHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-----EKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~-----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      ..+.+|+-+.+|.+..  -+.++++|.-.+..+...+..     ..-.+|..+++++..-++..+.-+..++....++||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4578999999999966  344588888665555544433     445578999999887777777777777888889999


Q ss_pred             ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      |.+|..|.+.+...       ...++..+-..+.-||..||+|||+.++||++..++ +.++|||++...
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            99998999888655       255666777778889999999999999999998874 999999998743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=1.8e-14  Score=125.61  Aligned_cols=255  Identities=18%  Similarity=0.156  Sum_probs=184.6

Q ss_pred             ccccccCCcccccccccCceEEEEEEEc-cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHA-LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP   89 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   89 (294)
                      .-....+|..+..||.+.++.|+.+.-+ .++..|++|............+. -..|..+...+ .|.+++.....|...
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccc
Confidence            4456778999999999999999987644 56667888876544333322222 23344444444 478888877777777


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-CcEEEeeeccccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMR  168 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~dfg~~~~~~  168 (294)
                      ...++--|||.++++...+.....+.+..++++..|++.++.++|+..++|.|++|+||++..+ +..+++||+......
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA  418 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence            8888999999998888777555668899999999999999999999999999999999999886 778899998876421


Q ss_pred             CCCccccccCCCccc-CCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHH
Q 022617          169 DGHFLKTSCGSPNYA-APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL  247 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~-aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (294)
                      -  .........++. ..|++........+.|+++||..+.+..++...-..   ......+..+..+...+....+..+
T Consensus       419 ~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~p~~~~~~~~~q~~  493 (524)
T KOG0601|consen  419 F--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDTPNLPGLKLQLQVL  493 (524)
T ss_pred             e--ecccccccccccccchhhccccccccccccccccccccccccCcccCcc---cccceeeecccccCCCchHHhhhhh
Confidence            1  111111222344 255555444447899999999999999987543222   1222334555555556666888999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCccc
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                      .+.+...++..||.+.++..|.=|.
T Consensus       494 ~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  494 LKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhcCCccccchhhhhhcccchhh
Confidence            9999999999999999988876543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.48  E-value=1.7e-12  Score=97.57  Aligned_cols=145  Identities=19%  Similarity=0.248  Sum_probs=112.3

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ....+-+|+.+.|+++.+  .|+.++||.-....+...     -..+...+|+..+.++.--+|.-+--++.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            678889999999999986  678888887654443332     2456677899999998876776666666677777899


Q ss_pred             EeccCC-CChHHHHHHh-CC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC---cEEEeeecccccc
Q 022617           96 MEYVKS-GELFDYIVEK-GR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIM  167 (294)
Q Consensus        96 ~e~~~~-~sL~~~l~~~-~~-l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~---~~~l~dfg~~~~~  167 (294)
                      |||++| .++.+++... .. ...+....++.++-+.+.-||..+++|||+.++||++..++   .+.++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999987 4788887653 22 23333478999999999999999999999999999997654   3589999998654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=2.4e-13  Score=104.90  Aligned_cols=127  Identities=20%  Similarity=0.210  Sum_probs=94.2

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEEEeccC
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYVK  100 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~  100 (294)
                      .+.|+.|..+.||++...  +..+++|+......    .......|+..++.+.+.++ ++++.+..  ...+++||+++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            456889999999999864  77899998754321    12345678888888765443 45555433  34579999999


Q ss_pred             CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCCeEecCCCcEEEeeecccc
Q 022617          101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV-----VHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus       101 ~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i-----~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                      |.++...     .   ......+.+++.+++.||..++     +|+|++|.||+++ ++.++++||+.+.
T Consensus        75 G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9887653     0   1123456789999999999885     9999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.36  E-value=4e-11  Score=101.04  Aligned_cols=238  Identities=16%  Similarity=0.170  Sum_probs=159.2

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEE------EE-cCCe
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV------IE-TPSD   91 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------~~-~~~~   91 (294)
                      .....-||+|+.+.+|..-.-   ...+-|+++....-.     ......++...-.||-+-.-+.+      .. ....
T Consensus        13 i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             cCCCccccCCccceeeecchh---hchhheeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            345677899999999976432   224678886554221     11111122233345433321111      11 2233


Q ss_pred             EEEEEeccCCCC-hHHHHH------HhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           92 IYVVMEYVKSGE-LFDYIV------EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        92 ~~lv~e~~~~~s-L~~~l~------~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                      +.++|..+.|.. ...+..      +.....+....+.++.++.+.+.||+.|.+-||+.++|+|+++++.+.|+|-..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            778888877642 222221      1233678899999999999999999999999999999999999999999987766


Q ss_pred             ccccCCCccccccCCCcccCCcccc-----CCccCCCchhHHHHHHHHHHHHh-CCCCCCCCC--------HHHHHH---
Q 022617          165 NIMRDGHFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN--------IPNLFK---  227 (294)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~--------~~~~~~---  227 (294)
                      ....++....+.++...|.+||...     +... +...|-|.||+++++++. |++||.+..        .+..+.   
T Consensus       165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eeccCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            6656777788889999999999764     2223 567899999999999998 499996642        111110   


Q ss_pred             -----HHhCCCccCC-----CCCChhHHHHHHHhccc--CCCCCCCHhHH
Q 022617          228 -----KIKGGIYTLP-----SHLSPGARDLIPRMLIV--DPMKRITIPEI  265 (294)
Q Consensus       228 -----~~~~~~~~~~-----~~~~~~l~~li~~~l~~--~p~~Rps~~~i  265 (294)
                           +...+..+.|     .-+++++..++.+|+..  ++.-|||++..
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW  293 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW  293 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence                 0111111111     35788999999999875  46789997753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.36  E-value=4.3e-11  Score=103.13  Aligned_cols=212  Identities=16%  Similarity=0.263  Sum_probs=156.1

Q ss_pred             CceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----CCeEEEEEeccCC-CC
Q 022617           29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSDIYVVMEYVKS-GE  103 (294)
Q Consensus        29 ~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~-~s  103 (294)
                      ...+.|++..+.+|..|++|.++-.....   ......-++.++++.|+|++++.+++..    ...+++|++|+++ .+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            34688999999999999999984333222   2344566888999999999999888763    4568999999875 36


Q ss_pred             hHHHHHH---------------hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617          104 LFDYIVE---------------KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus       104 L~~~l~~---------------~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      |.+.--.               +...+++.+|.++.|+..||.++|+.|+..+-+.|.+|+++.+-+++|+.+|......
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            6664421               2247889999999999999999999999999999999999998899999999877654


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHH-HHHHhCCCccCCCCCChhHHH
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNL-FKKIKGGIYTLPSHLSPGARD  246 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~  246 (294)
                      ...           .  +-+..    -.+.|.=.||.+++.|.+|..- +........ .+       .+...++.++++
T Consensus       445 ~d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~-------~I~~~yS~D~rn  500 (655)
T KOG3741|consen  445 EDP-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT-------RITTTYSTDLRN  500 (655)
T ss_pred             CCC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH-------HhhhhhhHHHHH
Confidence            322           0  11111    2356888999999999998533 111111111 11       123467889999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcC
Q 022617          247 LIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ++.-....++++ -++.+++.+
T Consensus       501 ~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  501 VVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHhcCccc-ccHHHHHHH
Confidence            999998888887 778877653

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.31  E-value=9.7e-11  Score=96.25  Aligned_cols=138  Identities=14%  Similarity=0.100  Sum_probs=98.4

Q ss_pred             cccCceEEEEEEEccCCceEEEEEeecccccch--------HHHHHHHHHHHHHHhCCCCce--eEEEEEEEc-----CC
Q 022617           26 GIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM--------EMEEKVRREIKILRLFMHPHI--IRLYEVIET-----PS   90 (294)
Q Consensus        26 g~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~-----~~   90 (294)
                      .......|+.+..  .|+.|.||..........        .....+.+|...+.+|...+|  +.++++++.     ..
T Consensus        31 ~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         31 RELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             ecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            3333334556554  567899997643321100        001137789998888865444  444666543     23


Q ss_pred             eEEEEEeccCCC-ChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-------CCcEEEee
Q 022617           91 DIYVVMEYVKSG-ELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-------KWNVKIAD  160 (294)
Q Consensus        91 ~~~lv~e~~~~~-sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-------~~~~~l~d  160 (294)
                      ..++|+|++++. +|.+++..  ..+.+......++.+++..+.-||+.|++|+|++++||+++.       +..+.++|
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            578999999875 79998854  344567778899999999999999999999999999999975       46799999


Q ss_pred             ecccc
Q 022617          161 FGLSN  165 (294)
Q Consensus       161 fg~~~  165 (294)
                      |+.+.
T Consensus       189 l~r~~  193 (268)
T PRK15123        189 LHRAQ  193 (268)
T ss_pred             CCccc
Confidence            99875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=2.1e-11  Score=98.23  Aligned_cols=140  Identities=20%  Similarity=0.313  Sum_probs=102.0

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--ceeEEEEEEEcC---CeEEEEEe
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEVIETP---SDIYVVME   97 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~---~~~~lv~e   97 (294)
                      +.|+.|..+.+|++... +|..+++|........  .....+..|.++++.+.+.  .+++++.+....   +..++++|
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            56899999999999874 3678999997544321  1345778899999998764  457777776543   25689999


Q ss_pred             ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 022617           98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR------------------------------------------  135 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~------------------------------------------  135 (294)
                      +++|.++.+.+.. ..++.+....++.+++.++..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888765421 345555566666666666666652                                          


Q ss_pred             --------------CCceecCCCCCCeEecC--CCcEEEeeeccccc
Q 022617          136 --------------NMVVHRDLKPENLLLDS--KWNVKIADFGLSNI  166 (294)
Q Consensus       136 --------------~~i~h~di~p~nili~~--~~~~~l~dfg~~~~  166 (294)
                                    ..++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          34799999999999998  56689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.28  E-value=4e-11  Score=95.88  Aligned_cols=140  Identities=22%  Similarity=0.335  Sum_probs=106.7

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeeccccc-----------------c--hHHHHHHHHHHHHHHhCCCC--
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----------------N--MEMEEKVRREIKILRLFMHP--   77 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-----------------~--~~~~~~~~~e~~~l~~l~~~--   77 (294)
                      +.+...||-|.-|.||.|.+. .+.++++|.-..-...                 +  ........+|++.|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            356788999999999999987 7889999985321100                 0  11235577899999999866  


Q ss_pred             ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617           78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK  157 (294)
Q Consensus        78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~  157 (294)
                      .+++++++    +.-.++||+++|..|...-     ++.+....++..|+..+..+...|++|||+++-||+++++|.+.
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            67887765    5667999999997666542     23445566667777777777799999999999999999999999


Q ss_pred             Eeeeccccccc
Q 022617          158 IADFGLSNIMR  168 (294)
Q Consensus       158 l~dfg~~~~~~  168 (294)
                      ++||-.+....
T Consensus       243 vIDwPQ~v~~~  253 (304)
T COG0478         243 VIDWPQAVPIS  253 (304)
T ss_pred             EEeCcccccCC
Confidence            99998776543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.26  E-value=1e-10  Score=90.82  Aligned_cols=129  Identities=25%  Similarity=0.357  Sum_probs=85.2

Q ss_pred             EEEEEEEccCCceEEEEEeeccccc-----------------------chHHHHHHHHHHHHHHhCCCC--ceeEEEEEE
Q 022617           32 KVKIAEHALTGHKVAIKILNRRKIK-----------------------NMEMEEKVRREIKILRLFMHP--HIIRLYEVI   86 (294)
Q Consensus        32 ~vy~~~~~~~~~~~~~K~~~~~~~~-----------------------~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~   86 (294)
                      .||.|... ++..+|+|+.......                       .........+|+..|.++...  ++++++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38888875 6779999997532111                       111335677899999999876  467776552


Q ss_pred             EcCCeEEEEEeccC--CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           87 ETPSDIYVVMEYVK--SGELFDYIVEKGRLQEDEARNFFQQIISGVEY-CHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        87 ~~~~~~~lv~e~~~--~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~-Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                          .-+++|||++  |..+..+....  ++.+....++.+++..+.. +|..|++|||+++.||+++++ .+.++|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                3369999998  76666544322  2244566777788775444 689999999999999999988 999999998


Q ss_pred             ccccc
Q 022617          164 SNIMR  168 (294)
Q Consensus       164 ~~~~~  168 (294)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            87553

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=2.1e-12  Score=114.55  Aligned_cols=149  Identities=22%  Similarity=0.386  Sum_probs=113.5

Q ss_pred             HHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc----------cccCCCcccCCccccCCcc
Q 022617          125 QIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----------TSCGSPNYAAPEVISGKLY  193 (294)
Q Consensus       125 ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~  193 (294)
                      ++..|+.++|. .+++|++|.|++|.++.++.+||+.|+++.....+....          .......|.+||.+.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            44499999995 579999999999999999999999999876554322111          1124568999999988544


Q ss_pred             CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH----HHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF----KKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       194 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                       +.++|+||+|+++|.+.. |+..+.........    .............+++++++-+.+++..++.-||++.+++..
T Consensus       187 -~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  187 -TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             -cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence             899999999999999994 66665543221111    111222234457899999999999999999999999999999


Q ss_pred             Cccccc
Q 022617          269 PWFQAH  274 (294)
Q Consensus       269 ~~~~~~  274 (294)
                      |||++.
T Consensus       266 ~ff~D~  271 (700)
T KOG2137|consen  266 PFFSDP  271 (700)
T ss_pred             cccCCc
Confidence            999875

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=2.2e-09  Score=85.40  Aligned_cols=106  Identities=18%  Similarity=0.265  Sum_probs=86.4

Q ss_pred             HHHHHHHHHHHHhCCCCc--eeEEEEEEEcC----CeEEEEEeccCCC-ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHH
Q 022617           61 EEKVRREIKILRLFMHPH--IIRLYEVIETP----SDIYVVMEYVKSG-ELFDYIVEKGRLQEDEARNFFQQIISGVEYC  133 (294)
Q Consensus        61 ~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~----~~~~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~L  133 (294)
                      .....+|...+..|...+  +++++++.+..    ...++|+|++++. +|.+++......+......++.++...++-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            356778888887776443  56667776553    2458999999874 7999997755577788899999999999999


Q ss_pred             HhCCceecCCCCCCeEecCCC---cEEEeeeccccc
Q 022617          134 HRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNI  166 (294)
Q Consensus       134 h~~~i~h~di~p~nili~~~~---~~~l~dfg~~~~  166 (294)
                      |+.|++|+|+++.|||++.++   .+.++||+.+..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.08  E-value=1.3e-09  Score=85.49  Aligned_cols=142  Identities=20%  Similarity=0.245  Sum_probs=93.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHH------HHHHHHHHHHHhCCC---CceeEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME------EKVRREIKILRLFMH---PHIIRLY   83 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~------~~~~~e~~~l~~l~~---~~i~~~~   83 (294)
                      +.+.++|.+.+.+-.....-|.+..-  ++..+++|.............      ....+++....++..   .....++
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y  104 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY  104 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence            34667888888888888776766654  678999999765432221111      112334444444432   3333333


Q ss_pred             EEE-----EcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEE
Q 022617           84 EVI-----ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI  158 (294)
Q Consensus        84 ~~~-----~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l  158 (294)
                      ...     ......++++||++|..|.+...    +++    .+...+.+++..||+.|++|||.+|.|++++++ .+++
T Consensus       105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~i  175 (229)
T PF06176_consen  105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRI  175 (229)
T ss_pred             eeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEE
Confidence            222     22345678999999988876532    222    244567788899999999999999999999866 5999


Q ss_pred             eeecccc
Q 022617          159 ADFGLSN  165 (294)
Q Consensus       159 ~dfg~~~  165 (294)
                      +||+...
T Consensus       176 ID~~~k~  182 (229)
T PF06176_consen  176 IDTQGKR  182 (229)
T ss_pred             EECcccc
Confidence            9998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=99.02  E-value=8.1e-09  Score=80.77  Aligned_cols=139  Identities=10%  Similarity=0.117  Sum_probs=101.0

Q ss_pred             cccCceEEEEEEEccCCceEEEEEeecccccc---hHHHHHHHHHHHHHHhCCCCc--eeEEEEEEEc----CCeEEEEE
Q 022617           26 GIGSFGKVKIAEHALTGHKVAIKILNRRKIKN---MEMEEKVRREIKILRLFMHPH--IIRLYEVIET----PSDIYVVM   96 (294)
Q Consensus        26 g~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~----~~~~~lv~   96 (294)
                      |.||-|.|+....  .|+.+-+|.-.......   ......+.+|+..+.+|...+  ++++......    ...-+||+
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            6688889998775  34468888754111111   224578899999998886433  5555522211    12467899


Q ss_pred             eccCC-CChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc--EEEeeeccccc
Q 022617           97 EYVKS-GELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--VKIADFGLSNI  166 (294)
Q Consensus        97 e~~~~-~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~--~~l~dfg~~~~  166 (294)
                      |-++| .+|.+++.+.  .+.+......++.+++.++.-||+.|+.|+|+-+.||+++.++.  +.++||.-+..
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97753 5899988653  34577788899999999999999999999999999999987677  99999986653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.94  E-value=2.2e-08  Score=94.33  Aligned_cols=244  Identities=17%  Similarity=0.149  Sum_probs=165.8

Q ss_pred             cccccccCceEEEEEEEccC----CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE----
Q 022617           22 GKTLGIGSFGKVKIAEHALT----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY----   93 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~----   93 (294)
                      ...+..-.+|+++...+...    ..++-++.-................|++.+.+..|+|+..++.|........    
T Consensus       183 y~~ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~  262 (1351)
T KOG1035|consen  183 YPILSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLD  262 (1351)
T ss_pred             eeeeccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHH
Confidence            33366667777776665321    1122222111111112233455667788888999999999998876544332    


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC---CeEecCCCcEEEe--eeccccccc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPE---NLLLDSKWNVKIA--DFGLSNIMR  168 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~---nili~~~~~~~l~--dfg~~~~~~  168 (294)
                      +..+++...++.+.+++-+..+.+..+.+..+...++.++|+....|.-+..+   +.-++..+.+..+  ||+.+....
T Consensus       263 v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~  342 (1351)
T KOG1035|consen  263 VLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP  342 (1351)
T ss_pred             HHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCC
Confidence            44678989999999998899999999999999999999999986666555444   3444555666666  888887776


Q ss_pred             CCCccccccCCCcccCCccccCCccC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHH
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYA-GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL  247 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (294)
                      ..........+..+.++|........ +...|+|++|.+...+..+..+-..   ......+.      +.....+..++
T Consensus       343 d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~---~~~~~~~l------~~~~~~~~~d~  413 (1351)
T KOG1035|consen  343 DNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEK---SAVPVSLL------DVLSTSELLDA  413 (1351)
T ss_pred             CcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccc---ccchhhhh------ccccchhhhhh
Confidence            66665566667778888877654431 2346999999999999887544211   11111111      11222267889


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ..+|+.-++++|+++.+++.|+|.+..
T Consensus       414 ~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  414 LPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             hhhhcchhhhhccchhhhhhchhcccc
Confidence            999999999999999999999998653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.92  E-value=7.1e-08  Score=85.99  Aligned_cols=141  Identities=21%  Similarity=0.295  Sum_probs=94.2

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccc-------------------------------hHHHHH------HH
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-------------------------------MEMEEK------VR   65 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-------------------------------~~~~~~------~~   65 (294)
                      +-|+.++-|+||+|..+ +|+.||||+.++.-...                               .+..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67889999999999987 59999999975321110                               001112      22


Q ss_pred             HHHHHHHhCC-----CCceeEEEEEEEcCCeEEEEEeccCCCChHHHH--HHhCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022617           66 REIKILRLFM-----HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYCHRNMV  138 (294)
Q Consensus        66 ~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l--~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i  138 (294)
                      +|...+.+++     .+++.-+.-+++..+.-.++|||++|..+.+..  +. ...+...+...+.++.  +..+-..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            3333333332     355444444455556778999999999988874  33 3455444443333332  334446899


Q ss_pred             eecCCCCCCeEecCCCcEEEeeecccccc
Q 022617          139 VHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus       139 ~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      +|+|.+|.||++..+|++.+.|||+....
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecC
Confidence            99999999999999999999999988654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.85  E-value=6.2e-08  Score=78.06  Aligned_cols=133  Identities=16%  Similarity=0.175  Sum_probs=84.8

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeEEEEEEEcCCeEEEEEeccC
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYEVIETPSDIYVVMEYVK  100 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~  100 (294)
                      ..|+.|..+.||+.    .+..+++|......     ....+.+|.++++.+..-+  +++++++....+...++||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            56899999999984    24468899875422     2345788999999887544  5778888888888899999999


Q ss_pred             CCC-hHHHH--------------HH------h---CCCCHHHHH-HHHHH----------HHHH-HHHHH----hCCcee
Q 022617          101 SGE-LFDYI--------------VE------K---GRLQEDEAR-NFFQQ----------IISG-VEYCH----RNMVVH  140 (294)
Q Consensus       101 ~~s-L~~~l--------------~~------~---~~l~~~~~~-~~~~q----------l~~~-l~~Lh----~~~i~h  140 (294)
                      |.+ +...+              .+      .   ...+..... .+..+          +... ..+|.    ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            863 21111              00      0   001111111 11000          1111 11222    124789


Q ss_pred             cCCCCCCeEecCCCcEEEeeecccc
Q 022617          141 RDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus       141 ~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                      +|++|.||++++++ +.++||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999887 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.84  E-value=3.4e-08  Score=78.45  Aligned_cols=140  Identities=19%  Similarity=0.235  Sum_probs=96.3

Q ss_pred             cccccCceEEEEEEEccCCceEEEEEeecccccchH---------------------HHHHHHHHHHHHHhCCCC--cee
Q 022617           24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---------------------MEEKVRREIKILRLFMHP--HII   80 (294)
Q Consensus        24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~---------------------~~~~~~~e~~~l~~l~~~--~i~   80 (294)
                      .|++|..+.||.|.. .++..+++|++......-..                     .......|+.-|+++...  .++
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            566788889999986 36788999998644322111                     112234677777777543  456


Q ss_pred             EEEEEEEcCCeEEEEEeccCCCChHH-HHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEE
Q 022617           81 RLYEVIETPSDIYVVMEYVKSGELFD-YIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKI  158 (294)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l  158 (294)
                      +++++.    .-.++||+++....-. .| +.-++..++...+..++++.+.-|.. .+++|+|++.=|||+. ++.+.+
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i  207 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI  207 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence            666654    3368999996531111 11 12233444677788888888888877 8999999999999999 779999


Q ss_pred             eeecccccccCC
Q 022617          159 ADFGLSNIMRDG  170 (294)
Q Consensus       159 ~dfg~~~~~~~~  170 (294)
                      +|++.+....++
T Consensus       208 ID~~QaV~~~hp  219 (268)
T COG1718         208 IDVSQAVTIDHP  219 (268)
T ss_pred             EECccccccCCC
Confidence            999998766543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.66  E-value=3.7e-07  Score=74.00  Aligned_cols=138  Identities=21%  Similarity=0.282  Sum_probs=81.5

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--ceeEEEEEEE---cCCeEEEEE
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEVIE---TPSDIYVVM   96 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~---~~~~~~lv~   96 (294)
                      ++.|+.|..+.||.+....  ..+++|.....     .....+.+|..+++.+...  .+++++....   .....++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            4678999999999999754  58999986433     3456777888888877643  3566776442   234578999


Q ss_pred             eccCCCChHH----------------HHHH--hC--C---CCHH------HHHHH---------------HHHHHH-HHH
Q 022617           97 EYVKSGELFD----------------YIVE--KG--R---LQED------EARNF---------------FQQIIS-GVE  131 (294)
Q Consensus        97 e~~~~~sL~~----------------~l~~--~~--~---l~~~------~~~~~---------------~~ql~~-~l~  131 (294)
                      ++++|.++..                .+..  +.  +   ....      .....               ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987777                1110  00  0   0000      00000               111111 223


Q ss_pred             HHH-------hCCceecCCCCCCeEec-CCCcEEEeeeccccc
Q 022617          132 YCH-------RNMVVHRDLKPENLLLD-SKWNVKIADFGLSNI  166 (294)
Q Consensus       132 ~Lh-------~~~i~h~di~p~nili~-~~~~~~l~dfg~~~~  166 (294)
                      .++       ...++|+|++|.||+++ +++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            333       24599999999999999 666678999997753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.60  E-value=7.6e-07  Score=67.15  Aligned_cols=132  Identities=22%  Similarity=0.313  Sum_probs=94.4

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVM   96 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~   96 (294)
                      .-++.+.|+.|..|.||++.+  .|..+++|+-..+     +....+..|.++|..+...++ ++++.|...    ++.|
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~m   91 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRM   91 (201)
T ss_pred             hhhhhhhhhcccccEEEEeec--cCceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhh
Confidence            345678999999999999998  4568999985433     335788899999999987665 445555432    3559


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC-CCeEecCCCcEEEeeecccccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKP-ENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p-~nili~~~~~~~l~dfg~~~~~  167 (294)
                      ||..|.+|.++-...   +    .+-+..+++...-|...||-|+.|+- ...++..++.+.|+||..|+..
T Consensus        92 e~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          92 EYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            999998887764311   2    23344555666668899999999874 4444445558999999998744

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.57  E-value=1.3e-06  Score=71.46  Aligned_cols=133  Identities=12%  Similarity=0.033  Sum_probs=81.9

Q ss_pred             ccccCc-eEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617           25 LGIGSF-GKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVMEYVKSG  102 (294)
Q Consensus        25 lg~g~~-~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~  102 (294)
                      |..|.. +.||++...  +..+++|......      ...+.+|+.+++.+. +--+++++++....+..+++|++++|.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            444444 789999753  3678899864332      235667888887774 344677888877666788999999998


Q ss_pred             ChHHHHH----------------H--hC-----CCCHH--HHHHHHH--------------------HHHHHHHHHH---
Q 022617          103 ELFDYIV----------------E--KG-----RLQED--EARNFFQ--------------------QIISGVEYCH---  134 (294)
Q Consensus       103 sL~~~l~----------------~--~~-----~l~~~--~~~~~~~--------------------ql~~~l~~Lh---  134 (294)
                      ++.....                +  .-     +....  .......                    .+...+..|-   
T Consensus        78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  157 (244)
T cd05150          78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR  157 (244)
T ss_pred             cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence            7764320                0  00     01000  0000000                    0111122221   


Q ss_pred             ----hCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617          135 ----RNMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus       135 ----~~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                          ...++|+|+.|.||++++++.+.|+||+.+.
T Consensus       158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                2348999999999999998778899999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.49  E-value=1.3e-06  Score=77.80  Aligned_cols=142  Identities=18%  Similarity=0.288  Sum_probs=90.3

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeecccccc----------------------------hHHHHHHHHHHHH---
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----------------------------MEMEEKVRREIKI---   70 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~----------------------------~~~~~~~~~e~~~---   70 (294)
                      .+.|+..+.|.|++|+.+. |+.|+||+-++.-...                            .+..+.+..|+..   
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            4678999999999999874 9999999964331110                            0111222222222   


Q ss_pred             -------HHhCCCCc------eeEEEEEEEcCCeEEEEEeccCCCChHHHHH-HhCCCCHHHHHHHHHHHHHHHH-HHHh
Q 022617           71 -------LRLFMHPH------IIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVE-YCHR  135 (294)
Q Consensus        71 -------l~~l~~~~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~-~~~~l~~~~~~~~~~ql~~~l~-~Lh~  135 (294)
                             .+.+.|-+      |++++..+  .....++|||++|..+.+.-. +...++...+   +..+.++.. .+=.
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAYLEQIFK  319 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHHHHHHHh
Confidence                   22333444      55555433  356689999999987766532 1233555543   334444322 2446


Q ss_pred             CCceecCCCCCCeEecC----CCcEEEeeecccccccC
Q 022617          136 NMVVHRDLKPENLLLDS----KWNVKIADFGLSNIMRD  169 (294)
Q Consensus       136 ~~i~h~di~p~nili~~----~~~~~l~dfg~~~~~~~  169 (294)
                      .|++|+|-+|.||+++.    ++.+.+.|||+......
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            78999999999999984    66899999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.49  E-value=7.4e-06  Score=64.25  Aligned_cols=134  Identities=24%  Similarity=0.367  Sum_probs=91.8

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeeccccc-------------chHHHHHHHHHHHHHHhCC------CCceeEE
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-------------NMEMEEKVRREIKILRLFM------HPHIIRL   82 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-------------~~~~~~~~~~e~~~l~~l~------~~~i~~~   82 (294)
                      ...||.|+.-.||.-  . .....+||+.......             .........+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            457899999999954  3 2344689998766500             0112345555655555444      7889999


Q ss_pred             EEEEEcCCeEEEEEeccCC------CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC--
Q 022617           83 YEVIETPSDIYVVMEYVKS------GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW--  154 (294)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~------~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~--  154 (294)
                      +|+.+++....+|+|.+..      .||.+++.+ +.+++ ...+.   +-+...+|-+.+|+.+|++|.||++..+.  
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999986532      378888844 44555 44443   44445678899999999999999996432  


Q ss_pred             --cEEEee-ecc
Q 022617          155 --NVKIAD-FGL  163 (294)
Q Consensus       155 --~~~l~d-fg~  163 (294)
                        .+.|+| ||.
T Consensus       158 ~~~lvlIDG~G~  169 (199)
T PF10707_consen  158 EFRLVLIDGLGE  169 (199)
T ss_pred             ceEEEEEeCCCC
Confidence              467776 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.39  E-value=7.5e-08  Score=85.59  Aligned_cols=250  Identities=18%  Similarity=0.103  Sum_probs=168.5

Q ss_pred             CCCCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeEEE
Q 022617            5 SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLY   83 (294)
Q Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~   83 (294)
                      |+......+.-..-|......++++++.+++.+...+.... .+++...        ....-++++|.+++||| .+..+
T Consensus       230 S~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~  300 (829)
T KOG0576|consen  230 SGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYL  300 (829)
T ss_pred             cCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCccccc
Confidence            44445555666677788888899999999999876554333 5554322        45567899999999999 55656


Q ss_pred             EEEEcCCeEEEEEeccCCC-ChHHHH-HHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617           84 EVIETPSDIYVVMEYVKSG-ELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF  161 (294)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~-sL~~~l-~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df  161 (294)
                      +-++.+...++.++++.++ +....+ ...-.+-..+.....+.-+..++++|+..-+|+|    ||+-++ +..+..+|
T Consensus       301 ~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~  375 (829)
T KOG0576|consen  301 EDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDF  375 (829)
T ss_pred             ccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccc
Confidence            6666678899999999876 221111 1111233344556667778889999988777887    777665 57899999


Q ss_pred             cccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-CCCCC
Q 022617          162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHL  240 (294)
Q Consensus       162 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~  240 (294)
                      +...............+++.++|||+.....+ ...-|.|++|.-..++--|.+|-....  ..  ....+..+ .+...
T Consensus       376 ~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~-~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~--~~~~g~~p~s~~L~  450 (829)
T KOG0576|consen  376 AVPPQLTRTMKPRTAIGTPEPLAPEVIQENTI-DGCPDSGSLAVSAIQMAPGLPPRSSPP--AV--LPMIGNGPNSPMLT  450 (829)
T ss_pred             cCCcccCcccccccCCCCCCCCCchhhccccc-ccCCCccCCCcchhhcCCCCCCCCCCc--cc--cCCCCCCCCccccc
Confidence            98877766555667778999999998877766 578899999987777777766653310  00  00000000 00000


Q ss_pred             C------hhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          241 S------PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       241 ~------~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      +      ..-.++...|+...|..|+....++.|.+|..
T Consensus       451 ~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  451 DKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             hhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            1      01114667788899999999999998888865

>PLN02876 acyl-CoA dehydrogenase

Probab=98.31  E-value=1.3e-05  Score=76.79  Aligned_cols=81  Identities=19%  Similarity=0.323  Sum_probs=57.4

Q ss_pred             cccccccCceEEEEEEEccCC--ceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCce--eEEEEEEEcC---CeEE
Q 022617           22 GKTLGIGSFGKVKIAEHALTG--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHI--IRLYEVIETP---SDIY   93 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~   93 (294)
                      ++.++.|.++.+|+......+  ..+++|........  .....+.+|+.+++.+. |.++  ++++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            567788999999998765332  46788876433211  12357889999999986 5654  7788877654   4678


Q ss_pred             EEEeccCCCCh
Q 022617           94 VVMEYVKSGEL  104 (294)
Q Consensus        94 lv~e~~~~~sL  104 (294)
                      +|||+++|..+
T Consensus       121 lVME~v~G~~~  131 (822)
T PLN02876        121 YIMEYLEGRIF  131 (822)
T ss_pred             EEEEecCCccc
Confidence            99999988653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.30  E-value=6.4e-06  Score=66.96  Aligned_cols=73  Identities=10%  Similarity=0.074  Sum_probs=46.6

Q ss_pred             ccccccCce-EEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---ceeEEEEEEEcCC---eEEEE
Q 022617           23 KTLGIGSFG-KVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP---HIIRLYEVIETPS---DIYVV   95 (294)
Q Consensus        23 ~~lg~g~~~-~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~---~~~lv   95 (294)
                      +.|+.|+.. .||...     ..+++|.....     .....+.+|.++++.+...   .++++++.....+   ..+++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            456666665 588762     34788875432     1245788899999887642   3555555443322   34789


Q ss_pred             EeccCCCChH
Q 022617           96 MEYVKSGELF  105 (294)
Q Consensus        96 ~e~~~~~sL~  105 (294)
                      |++++|.++.
T Consensus        73 ~~~i~G~~l~   82 (235)
T cd05155          73 YRWLEGETAT   82 (235)
T ss_pred             EEeecCCCCC
Confidence            9999997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.26  E-value=8.9e-07  Score=73.19  Aligned_cols=136  Identities=13%  Similarity=0.213  Sum_probs=97.4

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccc------h---------H----HHHHHHHHHHHHHhCCCC--
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN------M---------E----MEEKVRREIKILRLFMHP--   77 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~------~---------~----~~~~~~~e~~~l~~l~~~--   77 (294)
                      +.+++.||-|.-+.||.+-+. .|.++++|.-......-      +         .    ..-...+|+..++.|...  
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            567889999999999999885 68888998753221110      0         0    112345688888888643  


Q ss_pred             ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617           78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK  157 (294)
Q Consensus        78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~  157 (294)
                      -+++.+++    +.-++|||.+.|-+|...-.-   .+   +..+...+...+.-|.+.|++|||+.-=||+++++++++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            35666654    566899999999888765321   12   233444556666778899999999999999999999999


Q ss_pred             Eeeecccc
Q 022617          158 IADFGLSN  165 (294)
Q Consensus       158 l~dfg~~~  165 (294)
                      ++||-...
T Consensus       243 vIDFPQmv  250 (465)
T KOG2268|consen  243 VIDFPQMV  250 (465)
T ss_pred             EeechHhh
Confidence            99997643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.22  E-value=5.6e-05  Score=58.98  Aligned_cols=130  Identities=21%  Similarity=0.264  Sum_probs=88.6

Q ss_pred             cccCCcccccccccCc-eEEEEEEEccCCceEEEEEeec---ccc-------c--ch------HHHHHHHHHHHHHHhCC
Q 022617           15 FLPNYKLGKTLGIGSF-GKVKIAEHALTGHKVAIKILNR---RKI-------K--NM------EMEEKVRREIKILRLFM   75 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~-~~vy~~~~~~~~~~~~~K~~~~---~~~-------~--~~------~~~~~~~~e~~~l~~l~   75 (294)
                      ....++.++.||.|.- |.||++..  .|+.||+|++..   ...       .  ..      .....+..|.....+|+
T Consensus        35 h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk  112 (207)
T PF13095_consen   35 HGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK  112 (207)
T ss_pred             CCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence            4478999999999999 99999986  677999999321   110       0  00      12335666766666665


Q ss_pred             ---CCce--eEEEEEEEcC------------------CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHH
Q 022617           76 ---HPHI--IRLYEVIETP------------------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY  132 (294)
Q Consensus        76 ---~~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~  132 (294)
                         +.++  ++.+|+..-.                  -...||.|+.....         .++...    +.+|..-+..
T Consensus       113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~  179 (207)
T PF13095_consen  113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKI  179 (207)
T ss_pred             hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHH
Confidence               4566  8888887211                  11356677665432         223333    4566666778


Q ss_pred             HHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617          133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus       133 Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                      +|..||+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999999988     5688999864

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.07  E-value=5.7e-05  Score=63.62  Aligned_cols=136  Identities=13%  Similarity=0.091  Sum_probs=81.1

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeEEEEE------EEcCCeEE
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYEV------IETPSDIY   93 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~   93 (294)
                      .+.+..|....+|++..  ++..+++|++...   .   ...+..|+.++..+...+  +++++..      ....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            55667787789998864  3457899987531   1   345667777777765332  4454432      23345678


Q ss_pred             EEEeccCCCChHH----HHH----------H-hCCCC--------HHHHH------------HHHHHHHHHHHHHHh---
Q 022617           94 VVMEYVKSGELFD----YIV----------E-KGRLQ--------EDEAR------------NFFQQIISGVEYCHR---  135 (294)
Q Consensus        94 lv~e~~~~~sL~~----~l~----------~-~~~l~--------~~~~~------------~~~~ql~~~l~~Lh~---  135 (294)
                      +++++++|.++..    ...          . ...+.        ..-..            .....+..++..+.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999876522    110          0 00000        00000            011112233344442   


Q ss_pred             ----CCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617          136 ----NMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus       136 ----~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                          .+++|+|++|.||++++++.+.|+||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                469999999999999998777899999774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.06  E-value=4.4e-05  Score=64.73  Aligned_cols=158  Identities=15%  Similarity=0.158  Sum_probs=90.8

Q ss_pred             CCCCCCCCCCCccccccCCcc-----cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC
Q 022617            1 MDGASNRSSSGVDMFLPNYKL-----GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM   75 (294)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~y~~-----~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~   75 (294)
                      |+-.|+-+...+..+..+|.+     .+.++.|....+|++..  ++..+++|+.....     ....+..+.+++..|.
T Consensus         1 ~~~~~~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~   73 (307)
T TIGR00938         1 MAVYTSVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV-----KAEELPFFLALTTHLA   73 (307)
T ss_pred             CCccccCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEe--CCCcEEEEEecCCC-----CHHHHHHHHHHHHHHH
Confidence            444455555666666667765     34566777789998864  23468899864421     1234556667666664


Q ss_pred             CCc--eeEEEEE------EEcCCeEEEEEeccCCCChH----HHHH----------H-hCCC--C-----HHHHHH----
Q 022617           76 HPH--IIRLYEV------IETPSDIYVVMEYVKSGELF----DYIV----------E-KGRL--Q-----EDEARN----  121 (294)
Q Consensus        76 ~~~--i~~~~~~------~~~~~~~~lv~e~~~~~sL~----~~l~----------~-~~~l--~-----~~~~~~----  121 (294)
                      ..+  +++++..      ....+..++++++++|.++.    ....          . ...+  +     ....|.    
T Consensus        74 ~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~  153 (307)
T TIGR00938        74 ARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAE  153 (307)
T ss_pred             HCCCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHH
Confidence            322  4444432      12245678999999885432    1110          0 0000  0     001100    


Q ss_pred             ------------HHHHHHHHHHHHH-------hCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617          122 ------------FFQQIISGVEYCH-------RNMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus       122 ------------~~~ql~~~l~~Lh-------~~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                                  ....+...+.++.       ..+++|+|+++.||++++++...++||+.+.
T Consensus       154 ~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       154 KCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                        0111223444443       2679999999999999988777899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.06  E-value=2.3e-05  Score=61.18  Aligned_cols=99  Identities=17%  Similarity=0.242  Sum_probs=77.6

Q ss_pred             HHHHHHHHhCCC-CceeEEEEEEEcCCeEEEEEeccCCCChHHH---HHHhCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 022617           65 RREIKILRLFMH-PHIIRLYEVIETPSDIYVVMEYVKSGELFDY---IVEKGRLQEDEARNFFQQIISGVEYCHR---NM  137 (294)
Q Consensus        65 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~---l~~~~~l~~~~~~~~~~ql~~~l~~Lh~---~~  137 (294)
                      ..|.-+++.+++ +++++++|+|-   . +++.|+.+.+++...   +..-...++..+.+++.++++.+.+|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357788888876 69999999982   2 568899876655421   1111235889999999999999999997   34


Q ss_pred             ceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617          138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus       138 i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      +...|++++|+-++++++++++|.+.+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            777999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.04  E-value=0.00026  Score=61.62  Aligned_cols=80  Identities=16%  Similarity=0.135  Sum_probs=54.0

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeeccccc--c--hHHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCeEEE
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--N--MEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~--~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l   94 (294)
                      .+.||.|....||++.+...++.++||.-......  .  .-.......|.+.|+.+.   ..++++++.+.  +...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            45789999999999998644358999985322110  1  123456677777777653   24677888774  455779


Q ss_pred             EEeccCCCC
Q 022617           95 VMEYVKSGE  103 (294)
Q Consensus        95 v~e~~~~~s  103 (294)
                      +||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999987643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.02  E-value=3.4e-05  Score=63.58  Aligned_cols=133  Identities=16%  Similarity=0.145  Sum_probs=76.8

Q ss_pred             cccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEEEeccCCC
Q 022617           24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYVKSG  102 (294)
Q Consensus        24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~  102 (294)
                      .+..|-.+.+|+..  .++..+++|.......   ...-...+|..+++.+...++ ++++....    -++++||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            45667778999887  3567888997543211   100134678888887765433 44454432    36899999987


Q ss_pred             ChHHH-------H-------HH--h-----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceecCC
Q 022617          103 ELFDY-------I-------VE--K-----GRLQE-DEARNFFQQI---------ISGVEYCHR--------NMVVHRDL  143 (294)
Q Consensus       103 sL~~~-------l-------~~--~-----~~l~~-~~~~~~~~ql---------~~~l~~Lh~--------~~i~h~di  143 (294)
                      ++...       +       .+  +     .+++. ..+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            65321       1       10  0     11121 1112221111         111222211        24899999


Q ss_pred             CCCCeEecCCCcEEEeeeccccc
Q 022617          144 KPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus       144 ~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      .|.||++++++ +.++||+.+..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999999876 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.98  E-value=0.00025  Score=60.39  Aligned_cols=153  Identities=12%  Similarity=0.172  Sum_probs=82.0

Q ss_pred             CCCCCCCccccccCCcc-----cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-
Q 022617            5 SNRSSSGVDMFLPNYKL-----GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-   78 (294)
Q Consensus         5 ~~~~~~~~~~~~~~y~~-----~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-   78 (294)
                      |+=+...+..+...|.+     .+.|+.|....+|.+... + ..+++|++.  .. .   ...+..++.+++.|...+ 
T Consensus         5 t~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~-~-g~~vLK~~~--~~-~---~~~l~~~~~~l~~L~~~gl   76 (319)
T PRK05231          5 TDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT-Q-GEYVLTLFE--RL-T---AEDLPFFLGLMQHLAARGV   76 (319)
T ss_pred             ccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeC-C-CcEEEEEec--cC-C---hHHhHHHHHHHHHHHHCCC
Confidence            33334444445556655     345667777889998753 3 368999875  11 1   233344555555543222 


Q ss_pred             -eeEEEE------EEEcCCeEEEEEeccCCCChH-----HH------HHH----hCCC--------CH---HHHH-----
Q 022617           79 -IIRLYE------VIETPSDIYVVMEYVKSGELF-----DY------IVE----KGRL--------QE---DEAR-----  120 (294)
Q Consensus        79 -i~~~~~------~~~~~~~~~lv~e~~~~~sL~-----~~------l~~----~~~l--------~~---~~~~-----  120 (294)
                       +++++.      +....+..++++++++|..+.     ..      +.+    ...+        ..   ....     
T Consensus        77 pvP~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~  156 (319)
T PRK05231         77 PVPAPVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLP  156 (319)
T ss_pred             CCCcceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhh
Confidence             344442      122345678999999886431     11      110    0000        00   0000     


Q ss_pred             -------HHHHH-HHHHHHHHH-------hCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617          121 -------NFFQQ-IISGVEYCH-------RNMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus       121 -------~~~~q-l~~~l~~Lh-------~~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                             ..+.+ +...+..+.       ..+++|+|++|.||+++.+....++||+.+.
T Consensus       157 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        157 FLADEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccChhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                   01111 111122222       2479999999999999977556899999775

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.98  E-value=8.7e-05  Score=60.27  Aligned_cols=76  Identities=16%  Similarity=0.228  Sum_probs=47.9

Q ss_pred             cccccccCceEEEEEEEcc-CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCCeEEEEEecc
Q 022617           22 GKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSDIYVVMEYV   99 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~   99 (294)
                      ++.|..|-...+|++.... .+..|++|+......    ..-...+|..+++.+...+ .+++++...  +  .+++||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence            4567788888999997543 356889997653211    1123346888888775444 344544332  2  3799999


Q ss_pred             CCCChH
Q 022617          100 KSGELF  105 (294)
Q Consensus       100 ~~~sL~  105 (294)
                      +|.++.
T Consensus        75 ~G~~l~   80 (235)
T cd05157          75 PGRTLE   80 (235)
T ss_pred             CCCcCC
Confidence            987763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.93  E-value=9.9e-05  Score=62.01  Aligned_cols=141  Identities=16%  Similarity=0.264  Sum_probs=86.5

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--ceeEEEEEEEcCC--eEEE
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEVIETPS--DIYV   94 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~--~~~l   94 (294)
                      -.+++.+..|....+|...+.  ++.+++. . +.............+|+.+++.+..-  -+...++++....  ..|.
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~-P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-K-PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEe-c-CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            344555555555667777654  7788888 3 22233345567888999999888653  3444555555444  5699


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHH-HHHHHHHHHHHh--------------------------------------
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFF-QQIISGVEYCHR--------------------------------------  135 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~-~ql~~~l~~Lh~--------------------------------------  135 (294)
                      +|++++|..+.+.+..   .+.  ..+.+ ..+...|+.||+                                      
T Consensus       103 v~~~veGe~~~~~~~~---~~~--~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~  177 (321)
T COG3173         103 VMEWVEGEVVWSALPP---ESL--GRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI  177 (321)
T ss_pred             EEEEecceeccCcCCc---ccc--hHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence            9999998433221100   000  00111 123333333332                                      


Q ss_pred             --------------------CCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617          136 --------------------NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus       136 --------------------~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                                          -.++|||+++.|+++++++-+-+.||+.+....
T Consensus       178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence                                248999999999999998889999999987654

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.84  E-value=0.001  Score=56.46  Aligned_cols=142  Identities=20%  Similarity=0.237  Sum_probs=96.0

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeeccccc--c--------------------hH-HHHHHHHHHHHHHhCCCCce
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--N--------------------ME-MEEKVRREIKILRLFMHPHI   79 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~--------------------~~-~~~~~~~e~~~l~~l~~~~i   79 (294)
                      ..|+.|.-+.||-|... +|..+|||++..+-..  +                    +. ..-....|+.-|.++...+|
T Consensus       150 GCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             cccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            34678888999999864 7888999998533211  0                    00 11223456677777776665


Q ss_pred             eEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCeEecCCCcEEE
Q 022617           80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKWNVKI  158 (294)
Q Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh-~~~i~h~di~p~nili~~~~~~~l  158 (294)
                      +-+--+..  ..-.|||++++...--.-.-++-.++...+..+-.+++.-+.-|. ..+++|.||+--|+|+..+ .+.+
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG-~lyi  305 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG-KLYI  305 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC-EEEE
Confidence            54433332  334689999964222111123456788888888888888887766 5689999999999999765 8999


Q ss_pred             eeeccccccc
Q 022617          159 ADFGLSNIMR  168 (294)
Q Consensus       159 ~dfg~~~~~~  168 (294)
                      +|.+.+....
T Consensus       306 IDVSQSVE~D  315 (520)
T KOG2270|consen  306 IDVSQSVEHD  315 (520)
T ss_pred             EEccccccCC
Confidence            9998876543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.77  E-value=0.00013  Score=64.20  Aligned_cols=162  Identities=18%  Similarity=0.224  Sum_probs=106.8

Q ss_pred             HHHHHHHHHHHHhCCCCceeEEEEEEEc-CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 022617           61 EEKVRREIKILRLFMHPHIIRLYEVIET-PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVV  139 (294)
Q Consensus        61 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~  139 (294)
                      ...+.-.+++++.+.|++....+++-.. .....+|+|++ +.||++.+..+. +-.....                  .
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~   85 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------A   85 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------c
Confidence            3567778899999999999999887642 34578899999 559999987654 2222111                  2


Q ss_pred             ecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022617          140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD  219 (294)
Q Consensus       140 h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~  219 (294)
                      |+ +-+-|++...       | .+++..                 |-      ...+++|||++|.++.++.-|...+..
T Consensus        86 ~~-~~~~~~~~~t-------d-~~~t~~-----------------~~------~~~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   86 HG-VLHLNIIYIT-------D-HFLTKY-----------------PS------PIGPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             cc-cceehhhhcc-------c-cccccC-----------------CC------CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence            22 2222222222       2 111100                 11      113589999999999999999877766


Q ss_pred             CCHHHHHHHHhCCCccC------------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          220 ENIPNLFKKIKGGIYTL------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       220 ~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ....+..+.+.+-....            .-.++..+..+...|+-..|..||...++.+++-|...
T Consensus       134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            65555555443322111            12356667788999999999999999999999999775

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.75  E-value=0.00022  Score=60.31  Aligned_cols=75  Identities=16%  Similarity=0.209  Sum_probs=47.4

Q ss_pred             ccccccCceEEEEEEEcc------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEE
Q 022617           23 KTLGIGSFGKVKIAEHAL------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVV   95 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv   95 (294)
                      +.+..|-...+|++....      .++.+++|+.....    .......+|..+++.+...++ +++++++. +   ..+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence            456667777999887543      25789999965432    112355677777777764333 45555543 2   357


Q ss_pred             EeccCCCChH
Q 022617           96 MEYVKSGELF  105 (294)
Q Consensus        96 ~e~~~~~sL~  105 (294)
                      +++++|.++.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            8998887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.73  E-value=4e-06  Score=81.77  Aligned_cols=205  Identities=19%  Similarity=0.106  Sum_probs=138.6

Q ss_pred             HHHHHHHhCCCCceeEEEEEEE--cCCeEEEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---
Q 022617           66 REIKILRLFMHPHIIRLYEVIE--TPSDIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRN---  136 (294)
Q Consensus        66 ~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~---  136 (294)
                      .|..-++...|+++.....-..  +....+..++++.+|.+.+.|-+.    .++....+.....+.+.+....|..   
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            3444455567877766554432  234467788999999999988543    2344444444444446666665533   


Q ss_pred             C--ceecCCCCCCeEecCCCcEEEeeecccccc-cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC
Q 022617          137 M--VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG  213 (294)
Q Consensus       137 ~--i~h~di~p~nili~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g  213 (294)
                      |  .+|.++++.|.+|..+-+++++++|+.+.. +.........+++.|+.|+..+.-++ +.++|+|..|+.+|....|
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHHHHHhcc
Confidence            2  678999999999999999999999999833 33334455567888999999887777 5669999999999999888


Q ss_pred             CCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          214 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       214 ~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      ..+|..-....+...+.... ...+...|.+.......+|.+...+||.-...+.-+.|
T Consensus      1437 n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1437 NAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred             cHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence            77763322222222222222 23344455666667777777888899998888887766

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.43  E-value=0.0027  Score=55.35  Aligned_cols=77  Identities=19%  Similarity=0.132  Sum_probs=51.4

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeeccccc-c---hHHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCeEE
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-N---MEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-~---~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~   93 (294)
                      ..+.||.|....||++.+.  +..++||.-...... .   .........|...|+.+.   ...+++++.++.  ...+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            4667899999999999873  456999986522211 1   013444455566666554   247888998876  4456


Q ss_pred             EEEeccCC
Q 022617           94 VVMEYVKS  101 (294)
Q Consensus        94 lv~e~~~~  101 (294)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            78999976

>PLN02236 choline kinase

Probab=97.37  E-value=0.0021  Score=55.35  Aligned_cols=142  Identities=18%  Similarity=0.166  Sum_probs=81.7

Q ss_pred             cCCcccccccccCceEEEEEEEcc----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCe
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSD   91 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~   91 (294)
                      ....-.+.+..|-...+|++....    .++.+++|+.....   ..... -.+|..+++.+...++ +++++.+.. . 
T Consensus        36 ~~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g-  109 (344)
T PLN02236         36 DEALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G-  109 (344)
T ss_pred             cCcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c-
Confidence            334445566678888999987532    24679999875432   11122 2567888877765444 355565532 2 


Q ss_pred             EEEEEeccCCCChHHH-------H----H---H--hC-------CCCHHHHHHHHHHH-----------------HHHHH
Q 022617           92 IYVVMEYVKSGELFDY-------I----V---E--KG-------RLQEDEARNFFQQI-----------------ISGVE  131 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~-------l----~---~--~~-------~l~~~~~~~~~~ql-----------------~~~l~  131 (294)
                        .+.+|+++.++...       +    +   +  +.       +...+.+..++.++                 ...+.
T Consensus       110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~  187 (344)
T PLN02236        110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN  187 (344)
T ss_pred             --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence              57888887776421       1    0   0  00       01122222322111                 11121


Q ss_pred             HHH--------hCCceecCCCCCCeEecC-CCcEEEeeeccccc
Q 022617          132 YCH--------RNMVVHRDLKPENLLLDS-KWNVKIADFGLSNI  166 (294)
Q Consensus       132 ~Lh--------~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~  166 (294)
                      .|.        ...++|+|+++.||++++ ++.+.++||..+..
T Consensus       188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            221        235899999999999986 46799999998753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.33  E-value=0.0023  Score=53.26  Aligned_cols=30  Identities=27%  Similarity=0.568  Sum_probs=25.2

Q ss_pred             CceecCCCCCCeEecCCCc-EEEeeeccccc
Q 022617          137 MVVHRDLKPENLLLDSKWN-VKIADFGLSNI  166 (294)
Q Consensus       137 ~i~h~di~p~nili~~~~~-~~l~dfg~~~~  166 (294)
                      .++|+|++|.||+++++++ .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3899999999999997555 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.30  E-value=0.0018  Score=55.51  Aligned_cols=137  Identities=12%  Similarity=0.177  Sum_probs=77.0

Q ss_pred             cccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEEEe
Q 022617           22 GKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVME   97 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e   97 (294)
                      .+.|..|-...+|++.....   +..|++|+..... .  . .-.-.+|..+++.+...++ +++++++.  +.  ++.+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~--~-~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~   90 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-D--Y-VIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQS   90 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-C--e-EechHHHHHHHHHHHhcCCCCceeEEeC--Cc--Eeeh
Confidence            44555577778998875432   2378999874321 1  1 1122567777777765555 45565552  22  4889


Q ss_pred             ccCCCChHH-------HHH-------H--hCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 022617           98 YVKSGELFD-------YIV-------E--KGR------L-QEDEARNFFQQI----------------------ISGVEY  132 (294)
Q Consensus        98 ~~~~~sL~~-------~l~-------~--~~~------l-~~~~~~~~~~ql----------------------~~~l~~  132 (294)
                      |++|.+|..       .+.       +  ..+      . ....+..+..++                      ...+..
T Consensus        91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  170 (330)
T PLN02421         91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE  170 (330)
T ss_pred             hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence            988776532       111       0  101      1 112222222221                      111222


Q ss_pred             HH----hC----CceecCCCCCCeEecC-CCcEEEeeeccccc
Q 022617          133 CH----RN----MVVHRDLKPENLLLDS-KWNVKIADFGLSNI  166 (294)
Q Consensus       133 Lh----~~----~i~h~di~p~nili~~-~~~~~l~dfg~~~~  166 (294)
                      +.    ..    -++|+|+.+.||++++ ++.++++||+.+..
T Consensus       171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            21    11    2899999999999975 56899999998753

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.27  E-value=0.0063  Score=52.16  Aligned_cols=76  Identities=16%  Similarity=0.029  Sum_probs=49.0

Q ss_pred             cccccCceEEEEEEEccCCceEEEEEeecccc----cchHHHHHHHHHHHHHHhCC--CC-ceeEEEEEEEcCCeEEEEE
Q 022617           24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKI----KNMEMEEKVRREIKILRLFM--HP-HIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~----~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv~   96 (294)
                      .||.|....||++.+...++.++||.-...-.    ...-...+..-|...|+...  .| .+++++.+-  +....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cccceehH
Confidence            57999999999999864346899998542211    11234456667777777654  24 456666543  44556889


Q ss_pred             eccCC
Q 022617           97 EYVKS  101 (294)
Q Consensus        97 e~~~~  101 (294)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            88854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.14  E-value=0.024  Score=48.06  Aligned_cols=30  Identities=20%  Similarity=0.328  Sum_probs=27.5

Q ss_pred             CceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617          137 MVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus       137 ~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      +++|+|+.++||++++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999998999999998753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK10593 hypothetical protein; Provisional

Probab=97.09  E-value=0.0076  Score=50.79  Aligned_cols=107  Identities=11%  Similarity=0.117  Sum_probs=74.9

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC---CceeEEEEEEEc---CCe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIRLYEVIET---PSD   91 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~   91 (294)
                      .-.-.+.||.|..+.||..... ++ .+++|.... .    .....+..|...++.+..   -.++++++++..   .+.
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDS-QG-NPMPLMARS-F----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             hhheeeecCCccceeEEEEEcC-CC-CEEEEEecc-c----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            3344667999999999998753 23 477787432 1    113578889999988864   368888887754   366


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN  136 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~  136 (294)
                      .+++||+++|.++.+.     ..+......+..+++++++-||+.
T Consensus        88 ~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         88 DVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             eEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            8999999999877651     123444556667788888888874

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.04  E-value=0.0065  Score=52.74  Aligned_cols=78  Identities=19%  Similarity=0.132  Sum_probs=51.5

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeeccccc---chHHHHHHHHHHHHHHhCC--CC-ceeEEEEEEEcCCeEEEE
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---NMEMEEKVRREIKILRLFM--HP-HIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv   95 (294)
                      .+.||.|....||++.+...++.++||.-...-..   ..-...+..-|.+.|+...  .| .+++++.+-  +....++
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHHhhHH
Confidence            56789999999999998544567999975422111   1234567777888887664  34 566666553  3455577


Q ss_pred             EeccCC
Q 022617           96 MEYVKS  101 (294)
Q Consensus        96 ~e~~~~  101 (294)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            887743

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.92  E-value=0.015  Score=46.44  Aligned_cols=77  Identities=17%  Similarity=0.161  Sum_probs=56.0

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCeEEEEEe
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      ..+.+..|.--..|...+  ...++.+|+=      .......+..|+.-|+.+.   .-.+++++....+..+.|+|+|
T Consensus        20 er~~v~gG~inea~~v~d--g~~~~FvK~n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle   91 (286)
T COG3001          20 EREEVSGGDINEAWRLRD--GTDPFFVKCN------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE   91 (286)
T ss_pred             cccccCCccccceeEeec--CCcceEEEec------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence            345566677777787765  4567889973      2233566777777666554   4568889999999999999999


Q ss_pred             ccCCCChH
Q 022617           98 YVKSGELF  105 (294)
Q Consensus        98 ~~~~~sL~  105 (294)
                      |++.+.+.
T Consensus        92 ~L~~~~~d   99 (286)
T COG3001          92 YLPTGPLD   99 (286)
T ss_pred             eccCCCCC
Confidence            99887665

>PTZ00384 choline kinase; Provisional

Probab=96.78  E-value=0.031  Score=48.77  Aligned_cols=78  Identities=15%  Similarity=0.106  Sum_probs=45.4

Q ss_pred             cccccccccCceEEEEEEEccC-Cce-----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeE
Q 022617           20 KLGKTLGIGSFGKVKIAEHALT-GHK-----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDI   92 (294)
Q Consensus        20 ~~~~~lg~g~~~~vy~~~~~~~-~~~-----~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~   92 (294)
                      ...+.|..|-...+|++..... +..     |++++...   .. ...-.-.+|+.+++.+...++ +++++.+.    -
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~  124 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----D  124 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----C
Confidence            3455666688889999975432 122     44443211   11 111122568888888876554 55666653    2


Q ss_pred             EEEEeccCCCChH
Q 022617           93 YVVMEYVKSGELF  105 (294)
Q Consensus        93 ~lv~e~~~~~sL~  105 (294)
                      +++.||++|.+|.
T Consensus       125 g~l~efIeGr~l~  137 (383)
T PTZ00384        125 FTIQEWVEGNTMG  137 (383)
T ss_pred             EEEEEEeccccCC
Confidence            5889999987664

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.77  E-value=0.014  Score=49.83  Aligned_cols=119  Identities=19%  Similarity=0.261  Sum_probs=75.3

Q ss_pred             CCceeEEEEEE-EcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCC
Q 022617           76 HPHIIRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSK  153 (294)
Q Consensus        76 ~~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~  153 (294)
                      .++..+.+-+- .+..+.|+++++. |+++.. +   +.-..+++..++.+.+..++-+... .+-|+++...||+|+ +
T Consensus       284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~  357 (488)
T COG5072         284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E  357 (488)
T ss_pred             chhhhcceEEecCCceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence            34444433332 3345677888887 445542 2   2235678888888888888877754 589999999999999 8


Q ss_pred             CcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHH
Q 022617          154 WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI  206 (294)
Q Consensus       154 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~l  206 (294)
                      |++.|+||-+++...........    ..--|-.+.|..  +..-+||-+-..
T Consensus       358 GnvtLIDfklsRl~~~q~~isy~----rldhp~lF~G~d--d~QFeIYrlMr~  404 (488)
T COG5072         358 GNVTLIDFKLSRLSYSQGIISYN----RLDHPDLFNGVD--DYQFEIYRLMRR  404 (488)
T ss_pred             CceEEEEeeeeecccCCceeecc----ccCchhhhcCcc--ceeeeHHHHHHH
Confidence            89999999999843332222111    222333344333  567788775443

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.76  E-value=0.0083  Score=50.13  Aligned_cols=75  Identities=12%  Similarity=0.178  Sum_probs=47.7

Q ss_pred             cccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCeEEEEE
Q 022617           20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        20 ~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      +-.+.++.|..+.+|...  .+++.+.+|+-..      .....+..|.+-|+.|.   .-.+++++++....+.-++++
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            335667888889999887  5778899998642      22346677777777774   456889999998887889999


Q ss_pred             eccCCC
Q 022617           97 EYVKSG  102 (294)
Q Consensus        97 e~~~~~  102 (294)
                      |+++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            998765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.61  E-value=0.07  Score=45.64  Aligned_cols=71  Identities=10%  Similarity=0.079  Sum_probs=41.3

Q ss_pred             cCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce--eEEE---E--EEEcCCeEEEEEeccC
Q 022617           28 GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI--IRLY---E--VIETPSDIYVVMEYVK  100 (294)
Q Consensus        28 g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~---~--~~~~~~~~~lv~e~~~  100 (294)
                      +....||.+... ++..+++|+......    ....+..|.+.+..|....+  +...   +  ....++..+.++++.+
T Consensus        36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         36 SYENRVYQFGDE-DGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             cccceEEEEecC-CCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            344578988753 566799998753322    23556667777665542221  2211   1  1223466788999988


Q ss_pred             CCC
Q 022617          101 SGE  103 (294)
Q Consensus       101 ~~s  103 (294)
                      |..
T Consensus       111 G~~  113 (325)
T PRK11768        111 GRA  113 (325)
T ss_pred             CCC
Confidence            764

>PTZ00296 choline kinase; Provisional

Probab=96.18  E-value=0.2  Score=44.73  Aligned_cols=76  Identities=12%  Similarity=0.077  Sum_probs=44.5

Q ss_pred             ccccccccCceEEEEEEEccC--------CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCe
Q 022617           21 LGKTLGIGSFGKVKIAEHALT--------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSD   91 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~--------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~   91 (294)
                      -++.|..|-...+|++.....        ++.|++++.-...   .... .-.+|..+++.+...++ +++++.+.    
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----  180 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS----  180 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence            456666777778888875421        4678999874321   1111 23456666666654444 34555442    


Q ss_pred             EEEEEeccCCCCh
Q 022617           92 IYVVMEYVKSGEL  104 (294)
Q Consensus        92 ~~lv~e~~~~~sL  104 (294)
                      -+.+.+|++|.+|
T Consensus       181 gg~I~efi~g~~l  193 (442)
T PTZ00296        181 GGRIEEWLYGDPL  193 (442)
T ss_pred             CCEEEEeeCCccC
Confidence            2357888887644

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.96  E-value=0.029  Score=46.49  Aligned_cols=45  Identities=24%  Similarity=0.443  Sum_probs=34.1

Q ss_pred             HHHHHHHHHHHHHhC--CceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617          122 FFQQIISGVEYCHRN--MVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus       122 ~~~ql~~~l~~Lh~~--~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      .+..+-.++.-++..  -++|+|+.|.|++.++.+.++|+||..|..
T Consensus       137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            344444444444444  599999999999999988999999997753

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.81  E-value=0.045  Score=47.53  Aligned_cols=60  Identities=20%  Similarity=0.287  Sum_probs=44.9

Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCeEec
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY-CHRNMVVHRDLKPENLLLD  151 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~-Lh~~~i~h~di~p~nili~  151 (294)
                      ...++-+|..|.++..+++.. ..+++....++.-...|+-. |--.+++|.|++|.||++.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            345677788899999998643 34566677777777777655 4456799999999999994

>PRK06148 hypothetical protein; Provisional

Probab=95.61  E-value=0.59  Score=46.43  Aligned_cols=31  Identities=29%  Similarity=0.457  Sum_probs=25.9

Q ss_pred             CCceecCCCCCCeEecCCC--cEE-Eeeeccccc
Q 022617          136 NMVVHRDLKPENLLLDSKW--NVK-IADFGLSNI  166 (294)
Q Consensus       136 ~~i~h~di~p~nili~~~~--~~~-l~dfg~~~~  166 (294)
                      .+++|+|+.+.||+++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4699999999999999875  454 999998754

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.37  E-value=0.043  Score=46.48  Aligned_cols=29  Identities=28%  Similarity=0.402  Sum_probs=25.4

Q ss_pred             CCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617          136 NMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus       136 ~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                      .+++|||+++.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999988 578999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.18  E-value=0.018  Score=44.72  Aligned_cols=29  Identities=17%  Similarity=0.315  Sum_probs=25.5

Q ss_pred             CceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617          137 MVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus       137 ~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      ..+|+|+.|.|+++++++ ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            479999999999998876 99999998754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	294
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-109
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-109
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-109
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-103
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-103
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-103
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-102
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-102
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-75
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-75
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-75
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-74
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-74
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-74
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-74
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-74
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-72
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-71
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-66
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-59
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-58
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-58
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-58
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-57
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-54
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-54
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-54
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-54
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-53
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-53
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-53
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-52
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-52
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-52
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-52
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-52
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-52
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-52
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-51
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-51
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-51
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-50
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-50
3soa_A	444	Full-Length Human Camkii Length = 444		2e-50
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-49
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-49
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-49
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-49
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-49
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-49
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-48
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-48
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-48
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-48
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-48
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-48
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-47
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-47
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-47
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-47
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-47
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-47
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-47
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-47
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-47
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-47
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-47
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-47
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-47
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-47
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-47
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-47
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-47
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-47
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-47
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-46
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-46
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-46
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-46
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-46
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-46
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-46
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-46
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-46
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-46
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-46
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-46
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-46
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-45
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-45
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-45
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-45
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-45
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-45
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-45
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-45
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-45
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-45
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-45
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-45
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-45
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-45
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-45
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-45
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-45
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-45
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-45
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-45
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-45
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-45
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-45
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-45
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-45
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-45
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-45
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-45
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-44
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-44
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-44
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-44
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-44
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-44
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-44
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-44
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-44
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-44
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-44
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-44
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-44
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-44
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-44
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-44
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-44
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-44
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-44
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-44
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-43
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-43
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-43
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-43
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-43
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-43
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-43
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-43
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-43
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-43
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-43
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-43
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-43
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-43
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-43
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-43
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-43
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-43
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-43
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-43
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-43
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-43
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-43
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-43
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-43
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-43
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-43
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-43
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-43
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-43
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-43
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-43
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-43
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-43
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-43
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-43
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-43
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-43
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-43
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-43
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-43
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-43
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-43
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-42
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-42
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-42
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-42
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-42
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-42
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-42
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-42
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-42
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-42
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-42
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-42
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-42
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-42
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-42
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-42
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-42
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-42
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-42
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-42
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-42
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-42
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-42
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-42
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-42
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-42
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-42
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-41
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-41
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-41
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-41
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-41
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-41
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-41
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-41
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-41
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-41
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-41
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-40
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-40
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-40
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-40
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-40
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-40
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-40
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-40
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-40
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-40
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-40
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-40
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-40
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-40
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-40
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-40
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-40
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-40
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-40
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-40
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-40
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-40
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-40
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-40
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-39
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-39
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-39
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-39
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-39
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-39
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-39
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-39
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-39
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-39
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-39
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-39
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-38
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-38
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-38
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-38
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-38
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-38
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-37
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-37
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-36
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-36
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-34
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-34
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-34
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-34
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-33
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-33
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-33
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-33
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-33
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-33
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-33
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-33
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-33
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-33
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-33
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-33
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-33
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-33
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-33
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-33
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-33
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-33
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-32
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-32
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-32
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-32
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-32
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-32
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-32
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-32
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-32
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-32
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-32
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-32
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-32
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-32
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-32
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-32
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-32
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-32
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-32
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-32
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-32
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-32
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-32
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-32
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-32
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-32
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-32
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-32
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-32
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-32
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-31
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-31
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-31
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-31
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-31
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-31
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-31
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-31
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-30
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-30
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-30
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-30
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-30
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-30
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-30
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-29
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-29
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-29
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-29
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-29
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-29
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-29
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-29
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-29
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-29
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-29
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-29
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-29
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-29
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-28
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-28
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-28
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-28
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-28
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-28
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-28
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-28
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-27
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-27
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-27
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-27
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-27
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-27
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-27
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-27
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-27
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-27
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-27
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-27
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-27
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-27
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-27
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-27
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-27
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-27
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-27
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-27
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-27
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-27
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-27
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-27
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-27
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-27
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-27
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-27
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-27
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-27
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-27
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-27
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-27
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-27
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-27
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-26
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-26
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-26
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-26
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-26
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-26
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-26
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-26
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-26
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-26
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-26
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-25
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-25
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-25
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-25
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-25
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-25
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-25
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-25
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-25
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-25
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-25
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-25
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-25
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-25
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-25
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-25
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-25
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-25
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-25
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-25
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-25
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-25
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-25
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-25
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-25
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-25
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-25
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-25
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-25
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-25
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-25
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-25
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-25
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		8e-25
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-25
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-24
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-24
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-24
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-24
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-24
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-24
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-24
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-24
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-24
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-24
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-24
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-24
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-24
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-24
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-24
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-24
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-24
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-24
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-24
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-24
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-24
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-24
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-24
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-24
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-24
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-24
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-24
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-24
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-24
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-24
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-24
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-24
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-24
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-24
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-24
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-24
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-24
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-24
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-24
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-24
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-24
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-24
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-24
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-24
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-24
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-24
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-24
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-24
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-24
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-24
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-24
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-24
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-23
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-23
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-23
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-23
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-23
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-23
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-23
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-23
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-23
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-23
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-23
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-23
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-23
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-23
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-23
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-23
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-23
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-23
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-23
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-23
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-23
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-23
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-23
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-23
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-23
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-23
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-23
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-23
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-23
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-23
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-23
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-23
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-23
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-23
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-23
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-23
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-23
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-23
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-23
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-23
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-23
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-23
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-23
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-22
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-22
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-22
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-22
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-22
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-22
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-22
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-22
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-22
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-22
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-22
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-22
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-22
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-22
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-22
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-22
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-22
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-22
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-22
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-22
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-22
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-22
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-22
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-22
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-22
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-21
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-21
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-21
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-21
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-21
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-21
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-21
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-21
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-21
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-21
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-21
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-21
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-21
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-21
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-21
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-21
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-21
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-21
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-21
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-21
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-21
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-21
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-21
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-21
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-20
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-20
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-20
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-20
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-20
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-20
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-20
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-20
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-20
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-20
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-20
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-20
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-20
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-20
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-20
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-20
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-20
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-20
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-20
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-20
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-20
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-20
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-20
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-20
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-20
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-20
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-20
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-20
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-20
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-20
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-20
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-20
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-20
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-20
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-20
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-20
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-20
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-20
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-19
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-19
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-19
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-19
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-19
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-19
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-19
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-19
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-19
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-19
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		9e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-18
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-18
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-18
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-18
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-18
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-18
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-18
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-18
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-18
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-17
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-17
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-17
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-17
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-17
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-17
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-17
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-17
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-17
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-17
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-17
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-16
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-16
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-16
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-16
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-16
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-16
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-16
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-16
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-16
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-16
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-16
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-16
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-15
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-15
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-15
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-15
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-15
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-15
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-15
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-15
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-15
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-15
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-15
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-15
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-15
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-14
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-13
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-13
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-13
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-13
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-13
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-13
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-13
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-12
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-12
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-12
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-11
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-11
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-11

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  392 bits (1007), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 178/262 (67%), Positives = 222/262 (84%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           VVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 191
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct: 192 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 251
Query: 258 KRITIPEIRQHPWFQAHLPRYL 279
           KR TI +IR+H WF+  LP YL
Sbjct: 252 KRATIKDIREHEWFKQDLPSYL 273

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  390 bits (1001), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 179/262 (68%), Positives = 220/262 (83%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y LG TLG+G+FGKVK+ +H LTGHKVA+KILNR+KI+++++  K+RREI+ L+LF HP
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI TPSDI++VMEYV  GELFDYI + GRL E E+R  FQQI+SGV+YCHR+M
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           VVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+ SCGSPNYAAPEVISG+LYAGPE
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPE 196
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WS GVILYALLCGTLPFDD+++P LFKKI  GI+  P +L+P    L+  ML VDPM
Sbjct: 197 VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPM 256
Query: 258 KRITIPEIRQHPWFQAHLPRYL 279
           KR TI +IR+H WF+  LP+YL
Sbjct: 257 KRATIKDIREHEWFKQDLPKYL 278

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  389 bits (1000), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 177/262 (67%), Positives = 221/262 (84%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           VVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+ SCGSPNYAAPEVISG+LYAGPE
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPE 191
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct: 192 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 251
Query: 258 KRITIPEIRQHPWFQAHLPRYL 279
           KR TI +IR+H WF+  LP YL
Sbjct: 252 KRATIKDIREHEWFKQDLPSYL 273

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  370 bits (949), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 174/261 (66%), Positives = 208/261 (79%), Gaps = 1/261 (0%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y + +TLG GSFGKVK+A H  T  KVA+K ++R+ +K  +M  +V REI  L+L  HPH
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           II+LY+VI TP+DI +V+EY   GELFDYIVEK R+ EDE R FFQQII  +EYCHR+ +
Sbjct: 71  IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVI+GKLYAGPEV
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEV 189
Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           DVWSCG++LY +L G LPFDDE IPNLFKK+   +Y +P  LSPGA+ LI RM++ DPM+
Sbjct: 190 DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQ 249
Query: 259 RITIPEIRQHPWFQAHLPRYL 279
           RITI EIR+ PWF  +LP YL
Sbjct: 250 RITIQEIRRDPWFNVNLPDYL 270

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  370 bits (949), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 179/268 (66%), Positives = 212/268 (79%), Gaps = 3/268 (1%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY++ KTLG GSFGKVK+A H  TG KVA+KI+N++ +   +M+ ++ REI  LRL  HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI++  +I +V+EY    ELFDYIV++ ++ E EAR FFQQIIS VEYCHR+ 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVISGKLYAGPE
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 187
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VDVWSCGVILY +LC  LPFDDE+IP LFK I  G+YTLP  LSPGA  LI RMLIV+P+
Sbjct: 188 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 247
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPD 285
            RI+I EI Q  WF+  LP YL   PPD
Sbjct: 248 NRISIHEIMQDDWFKVDLPEYLL--PPD 273

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  370 bits (949), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 179/268 (66%), Positives = 212/268 (79%), Gaps = 3/268 (1%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY++ KTLG GSFGKVK+A H  TG KVA+KI+N++ +   +M+ ++ REI  LRL  HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI++  +I +V+EY    ELFDYIV++ ++ E EAR FFQQIIS VEYCHR+ 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVISGKLYAGPE
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 183
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VDVWSCGVILY +LC  LPFDDE+IP LFK I  G+YTLP  LSPGA  LI RMLIV+P+
Sbjct: 184 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 243
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPD 285
            RI+I EI Q  WF+  LP YL   PPD
Sbjct: 244 NRISIHEIMQDDWFKVDLPEYLL--PPD 269

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  369 bits (947), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 178/273 (65%), Positives = 213/273 (78%), Gaps = 1/273 (0%)
Query: 7   RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR 66
           +SS      + NY++ KTLG GSFGKVK+A H  TG KVA+KI+N++ +   +M+ ++ R
Sbjct: 3   KSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER 62
Query: 67  EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQI 126
           EI  LRL  HPHII+LY+VI++  +I +V+EY    ELFDYIV++ ++ E EAR FFQQI
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQI 121
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
           IS VEYCHR+ +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPE
Sbjct: 122 ISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 181
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARD 246
           VISGKLYAGPEVDVWSCGVILY +LC  LPFDDE+IP LFK I  G+YTLP  LSPGA  
Sbjct: 182 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG 241
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279
           LI RMLIV+P+ RI+I EI Q  WF+  LP YL
Sbjct: 242 LIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYL 274

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  369 bits (947), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 178/273 (65%), Positives = 213/273 (78%), Gaps = 1/273 (0%)
Query: 7   RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR 66
           +SS      + NY++ KTLG GSFGKVK+A H  TG KVA+KI+N++ +   +M+ ++ R
Sbjct: 4   KSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER 63
Query: 67  EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQI 126
           EI  LRL  HPHII+LY+VI++  +I +V+EY    ELFDYIV++ ++ E EAR FFQQI
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQI 122
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
           IS VEYCHR+ +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPE
Sbjct: 123 ISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 182
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARD 246
           VISGKLYAGPEVDVWSCGVILY +LC  LPFDDE+IP LFK I  G+YTLP  LSPGA  
Sbjct: 183 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG 242
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279
           LI RMLIV+P+ RI+I EI Q  WF+  LP YL
Sbjct: 243 LIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYL 275

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  279 bits (713), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 129/256 (50%), Positives = 186/256 (72%), Gaps = 1/256 (0%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY+L KT+G G+F KVK+A H LTG +VAIKI+++ ++    ++ K+ RE++I+++  HP
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ-KLFREVRIMKILNHP 71
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++L+EVIET   +Y++MEY   GE+FDY+V  GR++E EAR+ F+QI+S V+YCH+  
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +VHRDLK ENLLLD+  N+KIADFG SN    G  L T CGSP YAAPE+  GK Y GPE
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ R L+++P+
Sbjct: 192 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPI 251
Query: 258 KRITIPEIRQHPWFQA 273
           KR T+ +I +  W  A
Sbjct: 252 KRGTLEQIMKDRWINA 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 134/273 (49%), Positives = 192/273 (70%), Gaps = 7/273 (2%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY+L KT+G G+F KVK+A H LTG +VA+KI+++ ++ +  ++ K+ RE++I+++  HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIMKVLNHP 73
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++L+EVIET   +Y+VMEY   GE+FDY+V  GR++E EAR  F+QI+S V+YCH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +VHRDLK ENLLLD+  N+KIADFG SN    G+ L T CGSP YAAPE+  GK Y GPE
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + LI++P 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPS 253
Query: 258 KRITIPEIRQHPWFQA-----HLPRYLAVPPPD 285
           KR T+ +I +  W         L  Y+A P PD
Sbjct: 254 KRGTLEQIMKDRWMNVGHEDDELKPYVA-PLPD 285

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  277 bits (709), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 128/253 (50%), Positives = 185/253 (73%), Gaps = 1/253 (0%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY+L KT+G G+F KVK+A H LTG +VA+KI+++ ++ +  ++ K+ RE++I+++  HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIMKVLNHP 73
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++L+EVIET   +Y+VMEY   GE+FDY+V  GR++E EAR  F+QI+S V+YCH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +VHRDLK ENLLLD+  N+KIADFG SN    G+ L T CGSP YAAPE+  GK Y GPE
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + LI++P 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPS 253
Query: 258 KRITIPEIRQHPW 270
           KR T+ +I +  W
Sbjct: 254 KRGTLEQIMKDRW 266

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  276 bits (706), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 127/253 (50%), Positives = 185/253 (73%), Gaps = 1/253 (0%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY+L KT+G G+F KVK+A H LTG +VA++I+++ ++ +  ++ K+ RE++I+++  HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ-KLFREVRIMKVLNHP 73
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++L+EVIET   +Y+VMEY   GE+FDY+V  GR++E EAR  F+QI+S V+YCH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +VHRDLK ENLLLD+  N+KIADFG SN    G+ L T CGSP YAAPE+  GK Y GPE
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + LI++P 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPS 253
Query: 258 KRITIPEIRQHPW 270
           KR T+ +I +  W
Sbjct: 254 KRGTLEQIMKDRW 266

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/271 (47%), Positives = 190/271 (70%), Gaps = 1/271 (0%)
Query: 3   GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
           G S  S +     + NY+L KT+G G+F KVK+A H LTG +VAIKI+++ ++    ++ 
Sbjct: 1   GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ- 59
Query: 63  KVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNF 122
           K+ RE++I+++  HP+I++L+EVIET   +Y++MEY   GE+FDY+V  GR++E EAR+ 
Sbjct: 60  KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY 182
           F+QI+S V+YCH+  +VHRDLK ENLLLD+  N+KIADFG SN    G  L   CG+P Y
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPY 179
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
           AAPE+  GK Y GPEVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S 
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273
              +L+ R L+++P+KR T+ +I +  W  A
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 128/259 (49%), Positives = 187/259 (72%), Gaps = 1/259 (0%)
Query: 12  VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
            D+ + NY+L KT+G G+F KVK+A H LTG +VA+KI+++ ++ +  ++ K+ RE++I+
Sbjct: 2   ADLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIM 60
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
           ++  HP+I++L+EVIET   +Y+VMEY   GE+FDY+V  G ++E EAR  F+QI+S V+
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           YCH+  +VHRDLK ENLLLD+  N+KIADFG SN    G+ L T CGSP YAAPE+  GK
Sbjct: 121 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 180
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
            Y GPEVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + 
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 240
Query: 252 LIVDPMKRITIPEIRQHPW 270
           LI++P KR T+ +I +  W
Sbjct: 241 LILNPSKRGTLEQIMKDRW 259

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  274 bits (701), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 126/253 (49%), Positives = 184/253 (72%), Gaps = 1/253 (0%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY+L KT+G G+F KVK+A H LTG +VA+KI+++ ++ +  ++ K+ RE++I+++  HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIMKVLNHP 73
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++L+EVIET   +Y+VMEY   GE+FDY+V  GR++E EAR  F+QI+S V+YCH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +VHRDLK ENLLLD+  N+KIADFG SN    G+ L   CG+P YAAPE+  GK Y GPE
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + LI++P 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPS 253
Query: 258 KRITIPEIRQHPW 270
           KR T+ +I +  W
Sbjct: 254 KRGTLEQIMKDRW 266

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  274 bits (700), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 126/253 (49%), Positives = 184/253 (72%), Gaps = 1/253 (0%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY+L KT+G G+F KVK+A H LTG +VA++I+++ ++ +  ++ K+ RE++I+++  HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ-KLFREVRIMKVLNHP 73
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++L+EVIET   +Y+VMEY   GE+FDY+V  GR++E EAR  F+QI+S V+YCH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +VHRDLK ENLLLD+  N+KIADFG SN    G+ L   CGSP YAAPE+  GK Y GPE
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + LI++P 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPS 253
Query: 258 KRITIPEIRQHPW 270
           KR T+ +I +  W
Sbjct: 254 KRGTLEQIMKDRW 266

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  268 bits (684), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 125/253 (49%), Positives = 180/253 (71%), Gaps = 1/253 (0%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY+L KT+G G+F KVK+A H LTG +VA+KI+++ ++ +  ++ K+ RE++I ++  HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIXKVLNHP 73
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++L+EVIET   +Y+V EY   GE+FDY+V  GR +E EAR  F+QI+S V+YCH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +VHRDLK ENLLLD+  N+KIADFG SN    G+ L   CG+P YAAPE+  GK Y GPE
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P + S    +L+ + LI++P 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKFLILNPS 253
Query: 258 KRITIPEIRQHPW 270
           KR T+ +I +  W
Sbjct: 254 KRGTLEQIXKDRW 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  265 bits (678), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 129/268 (48%), Positives = 191/268 (71%), Gaps = 1/268 (0%)
Query: 3   GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
           G S  S++     + NY+L KT+G G+F KVK+A H LTG +VA+KI+++ ++    ++ 
Sbjct: 1   GNSITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQ- 59
Query: 63  KVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNF 122
           K+ RE++I+++  HP+I++L+EVIET   +Y+VMEY   GE+FDY+V  GR++E EAR  
Sbjct: 60  KLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK 119
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY 182
           F+QI+S V+YCH+  +VHRDLK ENLLLD   N+KIADFG SN    G+ L T CGSP Y
Sbjct: 120 FRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPY 179
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
           AAPE+  GK Y GPEVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S 
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPW 270
              +L+ ++L+++P+KR ++ +I +  W
Sbjct: 240 DCENLLKKLLVLNPIKRGSLEQIMKDRW 267

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  224 bits (570), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 123/266 (46%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+L K +G G+FG  ++     +   VA+K + R +    +++E V+REI   R   HP+
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 75
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+R  EVI TP+ + +VMEY   GELF+ I   GR  EDEAR FFQQ+ISGV YCH   V
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 139 VHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV+  K Y G 
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIPR 250
             DVWSCGV LY +L G  PF+D   P  F+K    I    Y +P   H+SP  R LI R
Sbjct: 196 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 255
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLP 276
           + + DP KRI+IPEIR H WF  +LP
Sbjct: 256 IFVADPAKRISIPEIRNHEWFLKNLP 281

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  222 bits (566), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 123/266 (46%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+L K +G G+FG  ++         VA+K + R +    +++E V+REI   R   HP+
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+R  EVI TP+ + +VMEY   GELF+ I   GR  EDEAR FFQQ+ISGV Y H   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQV 136
Query: 139 VHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            HRDLK EN LLD      +KIADFG S         K++ G+P Y APEV+  K Y G 
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGK 196
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIPR 250
             DVWSCGV LY +L G  PF+D   P  F+K    I    Y +P   H+SP  R LI R
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLP 276
           + + DP KRI+IPEIR H WF  +LP
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  221 bits (562), Expect = 5e-58,   Method: Compositional matrix adjust.
 Identities = 123/269 (45%), Positives = 157/269 (58%), Gaps = 12/269 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+L K +G G+FG  ++     +   VA+K + R +    +++E V+REI   R   HP+
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+R  EVI TP+ + +VMEY   GELF+ I   GR  EDEAR FFQQ+ISGV YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 139 VHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            HRDLK EN LLD      +KI  FG S         K++ G+P Y APEV+  K Y G 
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIPR 250
             DVWSCGV LY +L G  PF+D   P  F+K    I    Y +P   H+SP  R LI R
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYL 279
           + + DP KRI+IPEIR H WF  +LP  L
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKNLPADL 285

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  221 bits (562), Expect = 5e-58,   Method: Compositional matrix adjust.
 Identities = 123/269 (45%), Positives = 156/269 (57%), Gaps = 12/269 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+L K +G G+FG  ++     +   VA+K + R +    ++   V+REI   R   HP+
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIAANVKREIINHRSLRHPN 76
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+R  EVI TP+ + +VMEY   GELF+ I   GR  EDEAR FFQQ+ISGV YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 139 VHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV+  K Y G 
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIPR 250
             DVWSCGV LY +L G  PF+D   P  F+K    I    Y +P   H+SP  R LI R
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYL 279
           + + DP KRI+IPEIR H WF  +LP  L
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKNLPADL 285

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  219 bits (559), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 123/269 (45%), Positives = 156/269 (57%), Gaps = 12/269 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+L K +G G+FG  ++     +   VA+K + R +    +++E V+REI   R   HP+
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+R  EVI TP+ + +VMEY   GELF+ I   GR  EDEAR FFQQ+ISGV YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 139 VHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            HRDLK EN LLD      +KI  FG S         K + G+P Y APEV+  K Y G 
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIPR 250
             DVWSCGV LY +L G  PF+D   P  F+K    I    Y +P   H+SP  R LI R
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYL 279
           + + DP KRI+IPEIR H WF  +LP  L
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKNLPADL 285

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/266 (42%), Positives = 152/266 (57%), Gaps = 12/266 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   K +G G+FG  ++    LT   VA+K + R       ++E V+REI   R   HP+
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER----GAAIDENVQREIINHRSLRHPN 77
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+R  EVI TP+ + ++MEY   GEL++ I   GR  EDEAR FFQQ++SGV YCH   +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 139 VHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV+  + Y G 
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIPR 250
             DVWSCGV LY +L G  PF+D   P  ++K    I    Y++P    +SP    LI R
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLP 276
           + + DP  RI+IPEI+ H WF  +LP
Sbjct: 258 IFVADPATRISIPEIKTHSWFLKNLP 283

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  208 bits (530), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 111/278 (39%), Positives = 164/278 (58%), Gaps = 9/278 (3%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           +F   YK  + LG GSFG+V + +  +TG + A+K++++R++K    +E + RE+++L+ 
Sbjct: 47  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 106
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
             HP+I++LYE  E     Y+V E    GELFD I+ + R  E +A    +Q++SG+ Y 
Sbjct: 107 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 166
Query: 134 HRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           H+N +VHRDLKPENLLL+SK    N++I DFGLS        +K   G+  Y APEV+ G
Sbjct: 167 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 226
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPS--HLSPGARD 246
                 + DVWS GVILY LL G  PF+  N  ++ KK++ G YT  LP    +S  A+D
Sbjct: 227 TY--DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 284
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
           LI +ML   P  RI+  +   H W Q +    ++V  P
Sbjct: 285 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 322

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  208 bits (529), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 111/278 (39%), Positives = 164/278 (58%), Gaps = 9/278 (3%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           +F   YK  + LG GSFG+V + +  +TG + A+K++++R++K    +E + RE+++L+ 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
             HP+I++LYE  E     Y+V E    GELFD I+ + R  E +A    +Q++SG+ Y 
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 134 HRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           H+N +VHRDLKPENLLL+SK    N++I DFGLS        +K   G+  Y APEV+ G
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 202
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPS--HLSPGARD 246
                 + DVWS GVILY LL G  PF+  N  ++ KK++ G YT  LP    +S  A+D
Sbjct: 203 TY--DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
           LI +ML   P  RI+  +   H W Q +    ++V  P
Sbjct: 261 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  208 bits (529), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 111/278 (39%), Positives = 164/278 (58%), Gaps = 9/278 (3%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           +F   YK  + LG GSFG+V + +  +TG + A+K++++R++K    +E + RE+++L+ 
Sbjct: 46  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 105
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
             HP+I++LYE  E     Y+V E    GELFD I+ + R  E +A    +Q++SG+ Y 
Sbjct: 106 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 165
Query: 134 HRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           H+N +VHRDLKPENLLL+SK    N++I DFGLS        +K   G+  Y APEV+ G
Sbjct: 166 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 225
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPS--HLSPGARD 246
                 + DVWS GVILY LL G  PF+  N  ++ KK++ G YT  LP    +S  A+D
Sbjct: 226 TY--DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 283
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
           LI +ML   P  RI+  +   H W Q +    ++V  P
Sbjct: 284 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 321

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  204 bits (519), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 110/278 (39%), Positives = 161/278 (57%), Gaps = 9/278 (3%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           +F   YK  + LG GSFG+V + +  +TG + A+K++++R++K    +E + RE+++L+ 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
             HP+I +LYE  E     Y+V E    GELFD I+ + R  E +A    +Q++SG+ Y 
Sbjct: 83  LDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYX 142
Query: 134 HRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           H+N +VHRDLKPENLLL+SK    N++I DFGLS         K   G+  Y APEV+ G
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHG 202
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPS--HLSPGARD 246
                 + DVWS GVILY LL G  PF+  N  ++ KK++ G YT  LP    +S  A+D
Sbjct: 203 TY--DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
           LI + L   P  RI+  +   H W Q +    ++V  P
Sbjct: 261 LIRKXLTYVPSXRISARDALDHEWIQTYTKEQISVDVP 298

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  204 bits (518), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 108/259 (41%), Positives = 153/259 (59%), Gaps = 10/259 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           ++  +TLG G+F +V +AE   TG   A+K + ++ +K  E    +  EI +LR   H +
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKE--SSIENEIAVLRKIKHEN 81
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+ L ++ E+P+ +Y+VM+ V  GELFD IVEKG   E +A    +Q++  V Y HR  +
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 139 VHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           VHRDLKPENLL    D +  + I+DFGLS +   G  + T+CG+P Y APEV++ K Y+ 
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSK 201
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
             VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I  +
Sbjct: 202 A-VDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNL 260
Query: 252 LIVDPMKRITIPEIRQHPW 270
           +  DP KR T  +  +HPW
Sbjct: 261 MEKDPNKRYTCEQAARHPW 279

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  203 bits (517), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 117/285 (41%), Positives = 164/285 (57%), Gaps = 9/285 (3%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F  NY + + LG G+F  V+   H  TG + A KI+N +K+   + + K+ RE +I R  
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKL 85
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I+RL++ I+  S  Y+V + V  GELF+ IV +    E +A +  QQI+  + YCH
Sbjct: 86  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 135 RNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
            N +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+   
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
            Y+ P VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ L
Sbjct: 206 PYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           I  ML V+P KRIT  +  + PW         A+   DT+   KK
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKK 309

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  203 bits (516), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 160/268 (59%), Gaps = 9/268 (3%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           +F   YK  + LG GSFG+V + +  +TG + A+K++++R++K    +E + RE+++L+ 
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 88
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
             HP+I++LYE  E     Y+V E    GELFD I+ + R  E +A    +Q++SG+ Y 
Sbjct: 89  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 148
Query: 134 HRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           H+N +VHRDLKPENLLL+SK    N++I DFGLS        +K   G+  Y APEV+ G
Sbjct: 149 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 208
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPS--HLSPGARD 246
                 + DVWS GVILY LL G  PF+  N  ++ KK++ G YT  LP    +S  A+D
Sbjct: 209 TY--DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 266
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274
           LI +ML   P  RI+  +   H W Q +
Sbjct: 267 LIRKMLTYVPSMRISARDALDHEWIQTY 294

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  202 bits (515), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 117/276 (42%), Positives = 164/276 (59%), Gaps = 16/276 (5%)
Query: 9   SSGVDM------FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
           SSGVD+      F   Y+L + LG G+F  V+     L G + A KI+N +K+   +  +
Sbjct: 8   SSGVDLGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARD-HQ 66
Query: 63  KVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNF 122
           K+ RE +I RL  HP+I+RL++ I      Y++ + V  GELF+ IV +    E +A + 
Sbjct: 67  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC 126
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCG 178
            QQI+  V +CH+  VVHRDLKPENLLL SK     VK+ADFGL+  +  +        G
Sbjct: 127 IQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 186
Query: 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS 238
           +P Y +PEV+    Y  P VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS
Sbjct: 187 TPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 245
Query: 239 ----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
                ++P A+DLI +ML ++P KRIT  E  +HPW
Sbjct: 246 PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 281

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 112/263 (42%), Positives = 157/263 (59%), Gaps = 9/263 (3%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F  NY + + LG G+F  V+   H  TG + A KI+N +K+   + + K+ RE +I R  
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKL 62
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I+RL++ I+  S  Y+V + V  GELF+ IV +    E +A +  QQI+  + YCH
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 135 RNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
            N +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+   
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
            Y+ P VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ L
Sbjct: 183 PYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 248 IPRMLIVDPMKRITIPEIRQHPW 270
           I  ML V+P KRIT  +  + PW
Sbjct: 242 IDSMLTVNPKKRITADQALKVPW 264

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 112/263 (42%), Positives = 157/263 (59%), Gaps = 9/263 (3%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F  NY + + LG G+F  V+   H  TG + A KI+N +K+   + + K+ RE +I R  
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKL 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I+RL++ I+  S  Y+V + V  GELF+ IV +    E +A +  QQI+  + YCH
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 121
Query: 135 RNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
            N +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+   
Sbjct: 122 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
            Y+ P VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ L
Sbjct: 182 PYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 240
Query: 248 IPRMLIVDPMKRITIPEIRQHPW 270
           I  ML V+P KRIT  +  + PW
Sbjct: 241 IDSMLTVNPKKRITADQALKVPW 263

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  201 bits (512), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 112/263 (42%), Positives = 157/263 (59%), Gaps = 9/263 (3%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F  NY + + LG G+F  V+   H  TG + A KI+N +K+   + + K+ RE +I R  
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKL 62
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I+RL++ I+  S  Y+V + V  GELF+ IV +    E +A +  QQI+  + YCH
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 135 RNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
            N +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+   
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
            Y+ P VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ L
Sbjct: 183 PYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 248 IPRMLIVDPMKRITIPEIRQHPW 270
           I  ML V+P KRIT  +  + PW
Sbjct: 242 IDSMLTVNPKKRITADQALKVPW 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  201 bits (511), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 113/260 (43%), Positives = 157/260 (60%), Gaps = 10/260 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+L + LG G+F  V+      TG + A KI+N +K+   +  +K+ RE +I RL  HP+
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD-HQKLEREARICRLLKHPN 64
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+RL++ I      Y+V + V  GELF+ IV +    E +A +  QQI+  V +CH N +
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGI 124
Query: 139 VHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
           VHRDLKPENLLL SK     VK+ADFGL+  +  D        G+P Y +PEV+    Y 
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
            P VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A+DLI +
Sbjct: 185 KP-VDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 243
Query: 251 MLIVDPMKRITIPEIRQHPW 270
           ML ++P KRIT  E  +HPW
Sbjct: 244 MLTINPAKRITASEALKHPW 263

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  200 bits (509), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 113/261 (43%), Positives = 157/261 (60%), Gaps = 10/261 (3%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y+L + LG G+F  V+      TG + A KI+N +K+   +  +K+ RE +I RL  HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD-HQKLEREARICRLLKHP 63
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+RL++ I      Y+V + V  GELF+ IV +    E +A +  QQI+  V +CH N 
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 138 VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
           +VHRDLKPENLLL SK     VK+ADFGL+  +  D        G+P Y +PEV+    Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 249
             P VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A+DLI 
Sbjct: 184 GKP-VDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 250 RMLIVDPMKRITIPEIRQHPW 270
           +ML ++P KRIT  E  +HPW
Sbjct: 243 KMLTINPAKRITASEALKHPW 263

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  198 bits (504), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 111/261 (42%), Positives = 158/261 (60%), Gaps = 10/261 (3%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y+L + +G G+F  V+      TGH+ A KI+N +K+   +  +K+ RE +I RL  H 
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARD-HQKLEREARICRLLKHS 63
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+RL++ I      Y+V + V  GELF+ IV +    E +A +  QQI+  V +CH+  
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 138 VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
           VVHRDLKPENLLL SK     VK+ADFGL+  +  D        G+P Y +PEV+  + Y
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 249
             P VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A++LI 
Sbjct: 184 GKP-VDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 242
Query: 250 RMLIVDPMKRITIPEIRQHPW 270
           +ML ++P KRIT  E  +HPW
Sbjct: 243 QMLTINPAKRITAHEALKHPW 263

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  197 bits (501), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 106/267 (39%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F   Y +   LG GSFG+V   +  +T  + A+K++N+   KN +    + RE+++L+  
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKL 78
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I++L+E++E  S  Y+V E    GELFD I+++ R  E +A    +Q+ SG+ Y H
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 135 RNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           ++ +VHRDLKPEN+LL+SK    ++KI DFGLS   +    +K   G+  Y APEV+ G 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPS--HLSPGARDL 247
                + DVWS GVILY LL GT PF  +N  ++ K+++ G Y   LP    +S  A+DL
Sbjct: 199 Y--DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274
           I +ML   P  RIT  +  +HPW Q +
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  197 bits (500), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 120/297 (40%), Positives = 169/297 (56%), Gaps = 23/297 (7%)
Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           +DG SNR     D     +++   LG G+   V   +   T    A+K+L +   K +  
Sbjct: 43  IDG-SNR-----DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-- 94
Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
              VR EI +L    HP+II+L E+ ETP++I +V+E V  GELFD IVEKG   E +A 
Sbjct: 95  ---VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA 151
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGHFLKTSC 177
           +  +QI+  V Y H N +VHRDLKPENLL  +      +KIADFGLS I+     +KT C
Sbjct: 152 DAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC 211
Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGIYTL 236
           G+P Y APE++ G  Y GPEVD+WS G+I Y LLCG  PF DE     +F++I    Y  
Sbjct: 212 GTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF 270
Query: 237 PS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
            S     +S  A+DL+ +++++DP KR+T  +  QHPW       ++ +   DT Q+
Sbjct: 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHM---DTAQK 324

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  196 bits (498), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 106/267 (39%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F   Y +   LG GSFG+V   +  +T  + A+K++N+   KN +    + RE+++L+  
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKL 78
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I++L+E++E  S  Y+V E    GELFD I+++ R  E +A    +Q+ SG+ Y H
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 135 RNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           ++ +VHRDLKPEN+LL+SK    ++KI DFGLS   +    +K   G+  Y APEV+ G 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPS--HLSPGARDL 247
                + DVWS GVILY LL GT PF  +N  ++ K+++ G Y   LP    +S  A+DL
Sbjct: 199 Y--DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274
           I +ML   P  RIT  +  +HPW Q +
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 106/267 (39%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F   Y +   LG GSFG+V   +  +T  + A+K++N+   KN +    + RE+++L+  
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKL 78
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I++L+E++E  S  Y+V E    GELFD I+++ R  E +A    +Q+ SG+ Y H
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 135 RNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           ++ +VHRDLKPEN+LL+SK    ++KI DFGLS   +    +K   G+  Y APEV+ G 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPS--HLSPGARDL 247
                + DVWS GVILY LL GT PF  +N  ++ K+++ G Y   LP    +S  A+DL
Sbjct: 199 Y--DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274
           I +ML   P  RIT  +  +HPW Q +
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  195 bits (496), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/264 (41%), Positives = 157/264 (59%), Gaps = 10/264 (3%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F   Y+L + LG G+F  V+     L G + A  I+N +K+   +  +K+ RE +I RL 
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLL 67
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I+RL++ I      Y++ + V  GELF+ IV +    E +A +  QQI+  V +CH
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 135 RNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISG 190
           +  VVHR+LKPENLLL SK     VK+ADFGL+  +  +        G+P Y +PEV+  
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARD 246
             Y  P VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A+D
Sbjct: 188 DPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 247 LIPRMLIVDPMKRITIPEIRQHPW 270
           LI +ML ++P KRIT  E  +HPW
Sbjct: 247 LINKMLTINPSKRITAAEALKHPW 270

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  192 bits (488), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 108/259 (41%), Positives = 147/259 (56%), Gaps = 10/259 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y     LG G+F +V +AE   T   VAIK + ++ ++  E    +  EI +L    HP+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVLHKIKHPN 77
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+ L ++ E+   +Y++M+ V  GELFD IVEKG   E +A     Q++  V+Y H   +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 139 VHRDLKPENLL---LDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           VHRDLKPENLL   LD    + I+DFGLS +   G  L T+CG+P Y APEV++ K Y+ 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS- 196
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
             VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I  +
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 252 LIVDPMKRITIPEIRQHPW 270
           +  DP KR T  +  QHPW
Sbjct: 257 MEKDPEKRFTCEQALQHPW 275

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  192 bits (488), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 110/271 (40%), Positives = 161/271 (59%), Gaps = 15/271 (5%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y L  T+G GS+G+VKIA    T  + A K + +  +++++   + ++EI+I++   HP+
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---RFKQEIEIMKSLDHPN 84
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           IIRLYE  E  +DIY+VME    GELF+ +V K   +E +A    + ++S V YCH+  V
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 144
Query: 139 VHRDLKPENLLL--DSKWN-VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
            HRDLKPEN L   DS  + +K+ DFGL+   + G  ++T  G+P Y +P+V+ G LY G
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LY-G 202
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
           PE D WS GV++Y LLCG  PF       +  KI+ G +T P     ++SP A  LI R+
Sbjct: 203 PECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRL 262
Query: 252 LIVDPMKRITIPEIRQHPWFQAHL---PRYL 279
           L   P +RIT  +  +H WF+  L   PR L
Sbjct: 263 LTKSPKQRITSLQALEHEWFEKQLSSSPRNL 293

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  192 bits (488), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 110/271 (40%), Positives = 161/271 (59%), Gaps = 15/271 (5%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y L  T+G GS+G+VKIA    T  + A K + +  +++++   + ++EI+I++   HP+
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---RFKQEIEIMKSLDHPN 67
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           IIRLYE  E  +DIY+VME    GELF+ +V K   +E +A    + ++S V YCH+  V
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 139 VHRDLKPENLLL--DSKWN-VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
            HRDLKPEN L   DS  + +K+ DFGL+   + G  ++T  G+P Y +P+V+ G LY G
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LY-G 185
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
           PE D WS GV++Y LLCG  PF       +  KI+ G +T P     ++SP A  LI R+
Sbjct: 186 PECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRL 245
Query: 252 LIVDPMKRITIPEIRQHPWFQAHL---PRYL 279
           L   P +RIT  +  +H WF+  L   PR L
Sbjct: 246 LTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  192 bits (487), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 108/259 (41%), Positives = 146/259 (56%), Gaps = 10/259 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y     LG G+F +V +AE   T   VAIK + +  ++  E    +  EI +L    HP+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVLHKIKHPN 77
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+ L ++ E+   +Y++M+ V  GELFD IVEKG   E +A     Q++  V+Y H   +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 139 VHRDLKPENLL---LDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           VHRDLKPENLL   LD    + I+DFGLS +   G  L T+CG+P Y APEV++ K Y+ 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
             VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I  +
Sbjct: 198 A-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 252 LIVDPMKRITIPEIRQHPW 270
           +  DP KR T  +  QHPW
Sbjct: 257 MEKDPEKRFTCEQALQHPW 275

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  191 bits (486), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 108/259 (41%), Positives = 146/259 (56%), Gaps = 10/259 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y     LG G+F +V +AE   T   VAIK + +  ++  E    +  EI +L    HP+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVLHKIKHPN 77
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+ L ++ E+   +Y++M+ V  GELFD IVEKG   E +A     Q++  V+Y H   +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 139 VHRDLKPENLL---LDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           VHRDLKPENLL   LD    + I+DFGLS +   G  L T+CG+P Y APEV++ K Y+ 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
             VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I  +
Sbjct: 198 A-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 252 LIVDPMKRITIPEIRQHPW 270
           +  DP KR T  +  QHPW
Sbjct: 257 MEKDPEKRFTCEQALQHPW 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  191 bits (486), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 108/259 (41%), Positives = 146/259 (56%), Gaps = 10/259 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y     LG G+F +V +AE   T   VAIK + +  ++  E    +  EI +L    HP+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVLHKIKHPN 77
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+ L ++ E+   +Y++M+ V  GELFD IVEKG   E +A     Q++  V+Y H   +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 139 VHRDLKPENLL---LDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           VHRDLKPENLL   LD    + I+DFGLS +   G  L T+CG+P Y APEV++ K Y+ 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
             VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I  +
Sbjct: 198 A-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 252 LIVDPMKRITIPEIRQHPW 270
           +  DP KR T  +  QHPW
Sbjct: 257 MEKDPEKRFTCEQALQHPW 275

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 101/259 (38%), Positives = 150/259 (57%), Gaps = 9/259 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+  K LG G++G+V + +  LTG + AIKI+ +  +        +  E+ +L+   HP+
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I++LYE  E   + Y+VME  + GELFD I+ + +  E +A    +Q++SG  Y H++ +
Sbjct: 66  IMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNI 125
Query: 139 VHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           VHRDLKPENLLL+SK     +KI DFGLS     G  +K   G+  Y APEV+  K    
Sbjct: 126 VHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKY--D 183
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRM 251
            + DVWSCGVILY LLCG  PF  +    + K+++ G ++      + +S  A+ L+  M
Sbjct: 184 EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLM 243
Query: 252 LIVDPMKRITIPEIRQHPW 270
           L  +P KRI+  E   HPW
Sbjct: 244 LTYEPSKRISAEEALNHPW 262

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 102/261 (39%), Positives = 156/261 (59%), Gaps = 10/261 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+  K LG G++G+V +    +T  + AIKI+ +  + +     K+  E+ +L+L  HP+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLDHPN 97
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I++LY+  E   + Y+VME  K GELFD I+ + +  E +A    +Q++SGV Y H++ +
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 139 VHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           VHRDLKPENLLL+SK     +KI DFGLS +  +   +K   G+  Y APEV+  K    
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY--D 215
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
            + DVWS GVIL+ LL G  PF  +    + +K++ G YT  S    ++S GA+DLI +M
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275
Query: 252 LIVDPMKRITIPEIRQHPWFQ 272
           L  D  +RI+  +  +HPW +
Sbjct: 276 LQFDSQRRISAQQALEHPWIK 296

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 101/259 (38%), Positives = 150/259 (57%), Gaps = 9/259 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+  K LG G++G+V + +  LTG + AIKI+ +  +        +  E+ +L+   HP+
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 82
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I++LYE  E   + Y+VME  + GELFD I+ + +  E +A    +Q++SG  Y H++ +
Sbjct: 83  IMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNI 142
Query: 139 VHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           VHRDLKPENLLL+SK     +KI DFGLS     G  +K   G+  Y APEV+  K    
Sbjct: 143 VHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKY--D 200
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRM 251
            + DVWSCGVILY LLCG  PF  +    + K+++ G ++      + +S  A+ L+  M
Sbjct: 201 EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLM 260
Query: 252 LIVDPMKRITIPEIRQHPW 270
           L  +P KRI+  E   HPW
Sbjct: 261 LTYEPSKRISAEEALNHPW 279

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  188 bits (477), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 111/285 (38%), Positives = 162/285 (56%), Gaps = 25/285 (8%)
Query: 9   SSGVDM---------------FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRR 53
           SSGVD+               F  +Y+L + LG G+F  V+         + A KI+N +
Sbjct: 8   SSGVDLGTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTK 67
Query: 54  KIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR 113
           K+   +  +K+ RE +I RL  HP+I+RL++ I      Y+V + V  GELF+ IV +  
Sbjct: 68  KLSARD-HQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 126
Query: 114 LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRD 169
             E +A +   QI+  V + H++ +VHRDLKPENLLL SK     VK+ADFGL+  +  +
Sbjct: 127 YSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 186
Query: 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI 229
                   G+P Y +PEV+    Y  P VD+W+CGVILY LL G  PF DE+   L+++I
Sbjct: 187 QQAWFGFAGTPGYLSPEVLRKDPYGKP-VDIWACGVILYILLVGYPPFWDEDQHKLYQQI 245
Query: 230 KGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
           K G Y  PS     ++P A++LI +ML ++P KRIT  +  +HPW
Sbjct: 246 KAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  187 bits (475), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 99/261 (37%), Positives = 156/261 (59%), Gaps = 7/261 (2%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + ++K+G  LG GSF  V  AE   TG +VAIK+++++ +    M ++V+ E+KI     
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCH 134
           HP I+ LY   E  + +Y+V+E   +GE+  Y+  + +   E+EAR+F  QII+G+ Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR---DGHFLKTSCGSPNYAAPEVISGK 191
            + ++HRDL   NLLL    N+KIADFGL+  ++   + H+  T CG+PNY +PE+ +  
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLCGTPNYISPEIATRS 187
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
            + G E DVWS G + Y LL G  PFD + + N   K+    Y +PS LS  A+DLI ++
Sbjct: 188 AH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246
Query: 252 LIVDPMKRITIPEIRQHPWFQ 272
           L  +P  R+++  +  HP+  
Sbjct: 247 LRRNPADRLSLSSVLDHPFMS 267

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  187 bits (474), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 106/280 (37%), Positives = 157/280 (56%), Gaps = 14/280 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRR-KIKNMEMEEKVRREIKILRLFMHPHIIR 81
           + LG G+F +V + +  LTG   A+K + +    ++  +E     EI +L+   H +I+ 
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE----NEIAVLKKIKHENIVT 70
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L ++ E+ +  Y+VM+ V  GELFD I+E+G   E +A    QQ++S V+Y H N +VHR
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHR 130
Query: 142 DLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           DLKPENLL    +    + I DFGLS + ++G  + T+CG+P Y APEV++ K Y+   V
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKA-V 188
Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIV 254
           D WS GVI Y LLCG  PF +E    LF+KIK G Y   S     +S  A+D I  +L  
Sbjct: 189 DCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEK 248
Query: 255 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKVG 294
           DP +R T  +   HPW   +   +  + P  ++Q  K   
Sbjct: 249 DPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQKNFA 288

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  185 bits (470), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 104/273 (38%), Positives = 150/273 (54%), Gaps = 15/273 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILN----RRKIKNME-MEEKVRREIK 69
           F   Y     +G G    V+   H  TGH+ A+KI+     R   + +E + E  RRE  
Sbjct: 92  FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 70  ILRLFM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           ILR    HPHII L +  E+ S +++V + ++ GELFDY+ EK  L E E R+  + ++ 
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
            V + H N +VHRDLKPEN+LLD    ++++DFG S  +  G  L+  CG+P Y APE++
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 189 SGKLYA-----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----H 239
              +       G EVD+W+CGVIL+ LL G+ PF       + + I  G Y   S     
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            S   +DLI R+L VDP  R+T  +  QHP+F+
Sbjct: 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  184 bits (468), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 155/270 (57%), Gaps = 16/270 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE-----KVRREIKILR 72
            Y + KTLG G+ G+VK+A    T  KVAIKI+++RK       E      V  EI+IL+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              HP II++    +   D Y+V+E ++ GELFD +V   RL+E   + +F Q++  V+Y
Sbjct: 71  KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 133 CHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
            H N ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+ 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 190 GKLYAG--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYT-LP---SHLSP 242
               AG    VD WS GVIL+  L G  PF +     +L  +I  G Y  +P   + +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            A DL+ ++L+VDP  R T  E  +HPW Q
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  184 bits (468), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 155/270 (57%), Gaps = 16/270 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE-----KVRREIKILR 72
            Y + KTLG G+ G+VK+A    T  KVAIKI+++RK       E      V  EI+IL+
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              HP II++    +   D Y+V+E ++ GELFD +V   RL+E   + +F Q++  V+Y
Sbjct: 70  KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 133 CHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
            H N ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+ 
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 188
Query: 190 GKLYAG--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYT-LP---SHLSP 242
               AG    VD WS GVIL+  L G  PF +     +L  +I  G Y  +P   + +S 
Sbjct: 189 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 248
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            A DL+ ++L+VDP  R T  E  +HPW Q
Sbjct: 249 KALDLVKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  184 bits (468), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 155/270 (57%), Gaps = 16/270 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE-----KVRREIKILR 72
            Y + KTLG G+ G+VK+A    T  KVAIKI+++RK       E      V  EI+IL+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              HP II++    +   D Y+V+E ++ GELFD +V   RL+E   + +F Q++  V+Y
Sbjct: 71  KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 133 CHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
            H N ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+ 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 190 GKLYAG--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYT-LP---SHLSP 242
               AG    VD WS GVIL+  L G  PF +     +L  +I  G Y  +P   + +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            A DL+ ++L+VDP  R T  E  +HPW Q
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  184 bits (468), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 155/270 (57%), Gaps = 16/270 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE-----KVRREIKILR 72
            Y + KTLG G+ G+VK+A    T  KVAIKI+++RK       E      V  EI+IL+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              HP II++    +   D Y+V+E ++ GELFD +V   RL+E   + +F Q++  V+Y
Sbjct: 71  KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 133 CHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
            H N ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+ 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 190 GKLYAG--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYT-LP---SHLSP 242
               AG    VD WS GVIL+  L G  PF +     +L  +I  G Y  +P   + +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            A DL+ ++L+VDP  R T  E  +HPW Q
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  184 bits (468), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  184 bits (468), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  184 bits (467), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 153/270 (56%), Gaps = 16/270 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE-----KVRREIKILR 72
            Y + KTLG G+ G+VK+A    T  KVAIKI+++RK       E      V  EI+IL+
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              HP II++    +   D Y+V+E ++ GELFD +V   RL+E   + +F Q++  V+Y
Sbjct: 77  KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 133 CHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
            H N ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+ 
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 195
Query: 190 GKLYAG--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP----SHLSP 242
               AG    VD WS GVIL+  L G  PF +     +L  +I  G Y       + +S 
Sbjct: 196 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 255
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            A DL+ ++L+VDP  R T  E  +HPW Q
Sbjct: 256 KALDLVKKLLVVDPKARFTTEEALRHPWLQ 285

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  184 bits (467), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 99/271 (36%), Positives = 152/271 (56%), Gaps = 12/271 (4%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM---EEKVRREIKI 70
           M   +Y++G+ LG G F  V+      TG + A K + +R++ +       E++ RE+ I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGV 130
           LR   HP+II L+++ E  +D+ +++E V  GELFD++ EK  L EDEA  F +QI+ GV
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 131 EYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
            Y H   + H DLKPEN++L  K      +K+ DFG+++ +  G+  K   G+P + APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSP 242
           +++ +   G E D+WS GVI Y LL G  PF  E        I    Y       S+ S 
Sbjct: 182 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273
            A+D I R+L+ DP +R+TI +  +H W +A
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  184 bits (467), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 103/286 (36%), Positives = 156/286 (54%), Gaps = 22/286 (7%)
Query: 9   SSGVDMFLPN----------YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM 58
           SSGVD+   N          Y++G+ LG G F  V+      TG + A K + +R++ + 
Sbjct: 8   SSGVDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSS 67
Query: 59  E---MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ 115
                 E++ RE+ ILR   HP+II L+++ E  +D+ +++E V  GELFD++ EK  L 
Sbjct: 68  RRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT 127
Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGH 171
           EDEA  F +QI+ GV Y H   + H DLKPEN++L  K      +K+ DFG+++ +  G+
Sbjct: 128 EDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 187
Query: 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG 231
             K   G+P + APE+++ +   G E D+WS GVI Y LL G  PF  E        I  
Sbjct: 188 EFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 246
Query: 232 GIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273
             Y       S+ S  A+D I R+L+ DP +R+ I +  +H W +A
Sbjct: 247 VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKA 292

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  184 bits (466), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  184 bits (466), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  184 bits (466), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  184 bits (466), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  184 bits (466), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 192 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 281

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  184 bits (466), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 192 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 281

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  183 bits (465), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  183 bits (465), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  183 bits (465), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 89/259 (34%), Positives = 151/259 (58%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   GE++  + +  +  E     +  ++ + + YCH 
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++  
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-D 189
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 250 PSQRPMLREVLEHPWITAN 268

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 107/269 (39%), Positives = 153/269 (56%), Gaps = 16/269 (5%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE-----KVRREIKILRL 73
           Y + KTLG G+ G+VK+A    T  KVAI+I+++RK       E      V  EI+IL+ 
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 210
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
             HP II++    +   D Y+V+E ++ GELFD +V   RL+E   + +F Q++  V+Y 
Sbjct: 211 LNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 269
Query: 134 HRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           H N ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+  
Sbjct: 270 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 329
Query: 191 KLYAG--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP----SHLSPG 243
              AG    VD WS GVIL+  L G  PF +     +L  +I  G Y       + +S  
Sbjct: 330 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 389
Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           A DL+ ++L+VDP  R T  E  +HPW Q
Sbjct: 390 ALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 151/259 (58%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++ +G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  R  E     +  ++ + + YCH 
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++  
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-D 188
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +++I    +T P  ++ GARDLI R+L  +
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 256 PMKRITIPEIRQHPWFQAH 274
             +R+T+ E+ +HPW +A+
Sbjct: 249 ASQRLTLAEVLEHPWIKAN 267

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  182 bits (461), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 103/265 (38%), Positives = 149/265 (56%), Gaps = 12/265 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQ 272
           I R+L+ DP KR+TI +  QHPW +
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  182 bits (461), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 151/259 (58%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++ +G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  R  E     +  ++ + + YCH 
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++  
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMH-D 188
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +++I    +T P  ++ GARDLI R+L  +
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 256 PMKRITIPEIRQHPWFQAH 274
             +R+T+ E+ +HPW +A+
Sbjct: 249 ASQRLTLAEVLEHPWIKAN 267

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 103/265 (38%), Positives = 149/265 (56%), Gaps = 12/265 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQ 272
           I R+L+ DP KR+TI +  QHPW +
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 107/269 (39%), Positives = 153/269 (56%), Gaps = 16/269 (5%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE-----KVRREIKILRL 73
           Y + KTLG G+ G+VK+A    T  KVAI+I+++RK       E      V  EI+IL+ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
             HP II++    +   D Y+V+E ++ GELFD +V   RL+E   + +F Q++  V+Y 
Sbjct: 197 LNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 134 HRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           H N ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+  
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315
Query: 191 KLYAG--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP----SHLSPG 243
              AG    VD WS GVIL+  L G  PF +     +L  +I  G Y       + +S  
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 375
Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           A DL+ ++L+VDP  R T  E  +HPW Q
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  181 bits (460), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 152/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ ++ E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  181 bits (460), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 150/267 (56%), Gaps = 12/267 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLF 74
           +Y++G+ LG G F  V+      TG + A K + +R++ +       E++ RE+ ILR  
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 72
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+II L+++ E  +D+ +++E V  GELFD++ EK  L EDEA  F +QI+ GV Y H
Sbjct: 73  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 132
Query: 135 RNMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
              + H DLKPEN++L  K      +K+ DFG+++ +  G+  K   G+P + APE+++ 
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 192
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARD 246
           +   G E D+WS GVI Y LL G  PF  E        I    Y       S+ S  A+D
Sbjct: 193 EPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 251
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQA 273
            I R+L+ DP +R+ I +  +H W +A
Sbjct: 252 FIRRLLVKDPKRRMXIAQSLEHSWIKA 278

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 152/269 (56%), Gaps = 2/269 (0%)
Query: 6   NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR 65
           N  S      L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++R
Sbjct: 14  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 73
Query: 66  REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
           RE++I     HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  +
Sbjct: 74  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 133
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
           + + + YCH   V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  P
Sbjct: 134 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPP 192
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           E+I G+++   +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GAR
Sbjct: 193 EMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 251
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
           DLI R+L  +P +R  + E+ +HPW  A+
Sbjct: 252 DLISRLLKHNPSQRPMLREVLEHPWITAN 280

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 152/269 (56%), Gaps = 2/269 (0%)
Query: 6   NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR 65
           N  S      L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++R
Sbjct: 23  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 66  REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
           RE++I     HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  +
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 142
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
           + + + YCH   V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  P
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPP 201
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           E+I G+++   +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GAR
Sbjct: 202 EMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 260
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
           DLI R+L  +P +R  + E+ +HPW  A+
Sbjct: 261 DLISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  180 bits (456), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 150/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++  
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-D 189
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 250 PSQRPMLREVLEHPWITAN 268

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  180 bits (456), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 150/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-D 187
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 248 PSQRPMLREVLEHPWITAN 266

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 153/281 (54%), Gaps = 22/281 (7%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y +G+ LG G F  VK      TG + A K + +R+ +        E++ RE+ ILR  +
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+II L++V E  +D+ +++E V  GELFD++ +K  L E+EA +F +QI+ GV Y H 
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 136 NMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        I    Y       S  S  A+D 
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDF 252
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I ++L+ +  KR+TI E  +HPW          + P DT Q
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPW----------ITPVDTQQ 283

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 150/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-D 184
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 245 PSQRPMLREVLEHPWITAN 263

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  179 bits (455), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 150/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++  
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMH-D 185
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 246 PSQRPMLREVLEHPWITAN 264

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  179 bits (455), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 150/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 11  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 70
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 130
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++  
Sbjct: 131 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-D 188
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 249 PSQRPMLREVLEHPWITAN 267

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  179 bits (455), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 150/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-D 187
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 248 PSQRPMLREVLEHPWITAN 266

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  179 bits (455), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 150/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 6   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 65
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 66  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 125
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++  
Sbjct: 126 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-D 183
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 243
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 244 PSQRPMLREVLEHPWITAN 262

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 151/269 (56%), Gaps = 2/269 (0%)
Query: 6   NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR 65
           N  S      L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++R
Sbjct: 23  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 66  REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
           RE++I     HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  +
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 142
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
           + + + YCH   V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  P
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPP 201
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           E+I G+++   +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GAR
Sbjct: 202 EMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 260
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
           DLI R+L  +P +R  + E+ +HPW  A+
Sbjct: 261 DLISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A        +A+K+L + +++   +E ++RRE++I     
Sbjct: 4   LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 63
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 64  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 123
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++  
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-D 181
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 241
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 242 PSQRPMLREVLEHPWITAN 260

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMH-D 187
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 248 PSQRPMLREVLEHPWITAN 266

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 148/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE I G+ +  
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRXH-D 189
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 250 PSQRPXLREVLEHPWITAN 268

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  178 bits (451), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 150/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIA+FG S +        T CG+ +Y  PE+I G+++  
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-D 186
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 246
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 247 PSQRPMLREVLEHPWITAN 265

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMH-D 184
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 245 PSQRPMLREVLEHPWITAN 263

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 150/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 67  HPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 127 KKVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMH-D 184
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+     + +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 245 PSQRPMLREVLEHPWITAN 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  177 bits (450), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 150/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIA+FG S +        T CG+ +Y  PE+I G+++  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-D 187
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 248 PSQRPMLREVLEHPWITAN 266

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMH-D 186
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 246
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 247 PSQRPMLREVLEHPWITAN 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMH-D 184
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 245 PSQRPMLREVLEHPWITAN 263

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMH-D 185
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 246 PSQRPMLREVLEHPWITAN 264

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGRMH-D 184
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 245 PSQRPMLREVLEHPWITAN 263

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 98/269 (36%), Positives = 155/269 (57%), Gaps = 19/269 (7%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI---------KNME-MEEKVRREIKILR 72
           + LG G++G+V + +      + AIK++ + +          KN+E   E++  EI +L+
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              HP+II+L++V E     Y+V E+ + GELF+ I+ + +  E +A N  +QI+SG+ Y
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICY 161
Query: 133 CHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
            H++ +VHRD+KPEN+LL++K    N+KI DFGLS+     + L+   G+  Y APEV+ 
Sbjct: 162 LHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK 221
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245
            K     + DVWSCGVI+Y LLCG  PF  +N  ++ KK++ G Y        ++S  A+
Sbjct: 222 KKY--NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAK 279
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
           +LI  ML  D  KR T  E     W + +
Sbjct: 280 ELIKLMLTYDYNKRCTAEEALNSRWIKKY 308

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  177 bits (449), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMH-D 189
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 250 PSQRPMLREVLEHPWITAN 268

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  177 bits (449), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 105/293 (35%), Positives = 163/293 (55%), Gaps = 16/293 (5%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKIL 71
           +F   Y+L + +G G+F  V+   +  TG + A+KI++  K  +      E ++RE  I 
Sbjct: 21  LFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----LQEDEARNFFQQII 127
            +  HPHI+ L E   +   +Y+V E++   +L   IV++        E  A ++ +QI+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYA 183
             + YCH N ++HRD+KPEN+LL SK N   VK+ DFG++  +   G       G+P++ 
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SH 239
           APEV+  + Y  P VDVW CGVIL+ LL G LPF       LF+ I  G Y +     SH
Sbjct: 201 APEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           +S  A+DL+ RML++DP +RIT+ E   HPW +        +  P+T++Q +K
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRK 311

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  177 bits (449), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGRMH-D 184
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 245 PSQRPMLREVLEHPWITAN 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  177 bits (449), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMH-D 184
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 245 PSQRPMLREVLEHPWITAN 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  177 bits (449), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRMH-D 187
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 248 PSQRPMLREVLEHPWITAN 266

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  177 bits (449), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMH-D 184
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 245 PSQRPMLREVLEHPWITAN 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  177 bits (448), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMH-D 187
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 248 PSQRPMLREVLEHPWITAN 266

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  177 bits (448), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   GE++  + +  +  E     +  ++ + + YCH 
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +           G+ +Y  PE+I G+++  
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRMH-D 189
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 250 PSQRPMLREVLEHPWITAN 268

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  177 bits (448), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 97/263 (36%), Positives = 148/263 (56%), Gaps = 12/263 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y +G+ LG G F  VK      TG + A K + +R+ +        E++ RE+ ILR  +
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           H ++I L++V E  +D+ +++E V  GELFD++ +K  L E+EA +F +QI+ GV Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 136 NMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        I    Y       SH S  A+D 
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDF 252
Query: 248 IPRMLIVDPMKRITIPEIRQHPW 270
           I ++L+ +  KR+TI E  +HPW
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPW 275

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/263 (36%), Positives = 148/263 (56%), Gaps = 12/263 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y +G+ LG G F  VK      TG + A K + +R+ +        E++ RE+ ILR  +
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           H ++I L++V E  +D+ +++E V  GELFD++ +K  L E+EA +F +QI+ GV Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 136 NMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        I    Y       SH S  A+D 
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDF 252
Query: 248 IPRMLIVDPMKRITIPEIRQHPW 270
           I ++L+ +  KR+TI E  +HPW
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  176 bits (446), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/263 (36%), Positives = 148/263 (56%), Gaps = 12/263 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y +G+ LG G F  VK      TG + A K + +R+ +        E++ RE+ ILR  +
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           H ++I L++V E  +D+ +++E V  GELFD++ +K  L E+EA +F +QI+ GV Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 136 NMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        I    Y       SH S  A+D 
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDF 252
Query: 248 IPRMLIVDPMKRITIPEIRQHPW 270
           I ++L+ +  KR+TI E  +HPW
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPW 275

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  176 bits (446), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 93/254 (36%), Positives = 147/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 187
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +  T CG+P Y APE+I  K Y    VD W+
Sbjct: 188 LKPENLLIDQQGYIQVTDFGFAKRVKGATW--TLCGTPEYLAPEIILSKGY-NKAVDWWA 244
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 245 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 304
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 305 LKNGVNDIKNHKWF 318

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 150/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +  T CG+P Y APE+I  K Y  
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEYLAPEIILSKGY-N 217
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 277
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  175 bits (444), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 150/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +  T CG+P Y APE+I  K Y  
Sbjct: 146 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEYLAPEIILSKGY-N 202
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 203 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 262
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 263 LTKRFGNLKDGVNDIKNHKWF 283

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 150/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KT+G GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +K+ADFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  175 bits (443), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 152/274 (55%), Gaps = 4/274 (1%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++ +G+ LG G FG V +A        +A+K+L + +++   +E ++RREI+I     HP
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+R+Y        IY+++E+   GEL+  + + GR  E  +  F +++   + YCH   
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           V+HRD+KPENLL+  K  +KIADFG S +       +  CG+ +Y  PE+I GK +   +
Sbjct: 136 VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTH-DEK 193
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+W  GV+ Y  L G  PFD  +     ++I       P  LS G++DLI ++L   P 
Sbjct: 194 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPP 253
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 291
           +R+ +  + +HPW +A+  R L  PP     Q+K
Sbjct: 254 QRLPLKGVMEHPWVKANSRRVL--PPVYQSTQSK 285

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  175 bits (443), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 148/259 (57%), Gaps = 2/259 (0%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S          T  G+ +Y  PE+I G+++  
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMH-D 185
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 246 PSQRPMLREVLEHPWITAN 264

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  174 bits (442), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/295 (35%), Positives = 161/295 (54%), Gaps = 31/295 (10%)
Query: 6   NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK----------- 54
           +  SSG  + L  Y L   +G GS+G VK+A +       A+K+L+++K           
Sbjct: 2   SSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 55  ------------IKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--IYVVMEYVK 100
                       I+     E+V +EI IL+   HP++++L EV++ P++  +Y+V E V 
Sbjct: 62  PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVN 121
Query: 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160
            G + +    K  L ED+AR +FQ +I G+EY H   ++HRD+KP NLL+    ++KIAD
Sbjct: 122 QGPVMEVPTLK-PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 161 FGLSNIMRDGH-FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPF 217
           FG+SN  +     L  + G+P + APE +S   K+++G  +DVW+ GV LY  + G  PF
Sbjct: 181 FGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 218 DDENIPNLFKKIKGGIYTLPSH--LSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
            DE I  L  KIK      P    ++   +DLI RML  +P  RI +PEI+ HPW
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 96/263 (36%), Positives = 147/263 (55%), Gaps = 12/263 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y +G+ LG G F  VK      TG + A K + +R+ +        E++ RE+ ILR  +
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           H ++I L++V E  +D+ +++E V  GELFD++ +K  L E+EA +F +QI+ GV Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 136 NMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        I    Y       S  S  A+D 
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDF 252
Query: 248 IPRMLIVDPMKRITIPEIRQHPW 270
           I ++L+ +  KR+TI E  +HPW
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPW 275

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  174 bits (441), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  174 bits (441), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  174 bits (441), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  174 bits (441), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  174 bits (440), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 96/263 (36%), Positives = 147/263 (55%), Gaps = 12/263 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y +G+ LG G F  VK      TG + A K + +R+ +        E++ RE+ ILR  +
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           H ++I L++V E  +D+ +++E V  GELFD++ +K  L E+EA +F +QI+ GV Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 136 NMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        I    Y       S  S  A+D 
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDF 252
Query: 248 IPRMLIVDPMKRITIPEIRQHPW 270
           I ++L+ +  KR+TI E  +HPW
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPW 275

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  173 bits (439), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 209
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 210 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 269
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 270 LTKRFGNLKNGVNDIKNHKWF 290

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  173 bits (439), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 217
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 277
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  173 bits (439), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 217
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 277
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 217
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 277
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 209
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 210 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 269
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 270 LTKRFGNLKNGVNDIKNHKWF 290

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 237
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 297
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWF 318

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 217
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 277
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEY   GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENL++D +  +K+ DFGL+  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 187
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 188 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 244
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 245 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 304
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 305 LKNGVNDIKNHKWF 318

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 108 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 224
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 284
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 285 LKNGVNDIKNHKWF 298

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LPNGVNDIKNHKWF 297

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 150/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KT+G GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEY+  G++F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +K+ADFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 102/277 (36%), Positives = 150/277 (54%), Gaps = 16/277 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM------EMEEKVRREI 68
           F  NY+  + LG G    V+   H  T  + A+KI++     +       E+ E   +E+
Sbjct: 15  FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 69  KILR-LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
            ILR +  HP+II+L +  ET +  ++V + +K GELFDY+ EK  L E E R   + ++
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
             +   H+  +VHRDLKPEN+LLD   N+K+ DFG S  +  G  L++ CG+P+Y APE+
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 188 ISGKLYA-----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---- 238
           I   +       G EVD+WS GVI+Y LL G+ PF       + + I  G Y   S    
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275
             S   +DL+ R L+V P KR T  E   HP+FQ ++
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 148/261 (56%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEY   GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 217
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 277
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 150/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KT+G GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEY+  G++F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +K+ADFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 148/261 (56%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 217
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 277
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I  H WF
Sbjct: 278 LTKRFGNLKNGVNDIXNHKWF 298

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 94  EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 153
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 154 LKPENLLIDEQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 210
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 211 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 270
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 271 LKNGVNDIKNHKWF 284

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 102 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 161
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 162 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 218
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 219 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 278
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 279 LKNGVNDIKNHKWF 292

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 148/261 (56%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEY   GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 148/261 (56%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEY   GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEY   GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENL++D +  +++ DFGL+  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 91/254 (35%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENL++D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLIIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIIISKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 151/274 (55%), Gaps = 4/274 (1%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++ + + LG G FG V +A        +A+K+L + +++   +E ++RREI+I     HP
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+R+Y        IY+++E+   GEL+  + + GR  E  +  F +++   + YCH   
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           V+HRD+KPENLL+  K  +KIADFG S +       +  CG+ +Y  PE+I GK +   +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTH-DEK 192
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+W  GV+ Y  L G  PFD  +     ++I       P  LS G++DLI ++L   P 
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPP 252
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 291
           +R+ +  + +HPW +A+  R L  PP     Q+K
Sbjct: 253 QRLPLKGVMEHPWVKANSRRVL--PPVYQSTQSK 284

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 102/277 (36%), Positives = 149/277 (53%), Gaps = 16/277 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM------EMEEKVRREI 68
           F  NY+  + LG G    V+   H  T  + A+KI++     +       E+ E   +E+
Sbjct: 15  FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 69  KILR-LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
            ILR +  HP+II+L +  ET +  ++V + +K GELFDY+ EK  L E E R   + ++
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
             +   H+  +VHRDLKPEN+LLD   N+K+ DFG S  +  G  L+  CG+P+Y APE+
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 188 ISGKLYA-----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---- 238
           I   +       G EVD+WS GVI+Y LL G+ PF       + + I  G Y   S    
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275
             S   +DL+ R L+V P KR T  E   HP+FQ ++
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  171 bits (433), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 147/261 (56%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P + +L    +  S++Y+VMEY   GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 217
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 277
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  171 bits (433), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 142/266 (53%), Gaps = 8/266 (3%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G F K      A T    A KI+ +  +      EK+  EI I R   H H++  + 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
             E    ++VV+E  +   L +    +  L E EAR + +QI+ G +Y HRN V+HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 145 PENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
             NL L+    VKI DFGL+  +  DG   KT CG+PNY APEV+S K ++  EVDVWS 
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF-EVDVWSI 207
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP 263
           G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP  R TI 
Sbjct: 208 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 267
Query: 264 EIRQHPWFQ-----AHLP-RYLAVPP 283
           E+    +F      A LP   L +PP
Sbjct: 268 ELLNDEFFTSGYIPARLPITCLTIPP 293

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  171 bits (433), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 148/276 (53%), Gaps = 16/276 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM------EMEEKVRREI 68
           F  NY+  + LG G    V+   H  T  + A+KI++     +       E+ E   +E+
Sbjct: 2   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 61
Query: 69  KILR-LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
            ILR +  HP+II+L +  ET +  ++V + +K GELFDY+ EK  L E E R   + ++
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 121
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
             +   H+  +VHRDLKPEN+LLD   N+K+ DFG S  +  G  L+  CG+P+Y APE+
Sbjct: 122 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 188 ISGKLYA-----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---- 238
           I   +       G EVD+WS GVI+Y LL G+ PF       + + I  G Y   S    
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 241
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
             S   +DL+ R L+V P KR T  E   HP+FQ +
Sbjct: 242 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 277

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  171 bits (433), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 148/261 (56%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEY   GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENL++D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  171 bits (433), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 142/266 (53%), Gaps = 8/266 (3%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G F K      A T    A KI+ +  +      EK+  EI I R   H H++  + 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
             E    ++VV+E  +   L +    +  L E EAR + +QI+ G +Y HRN V+HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 145 PENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
             NL L+    VKI DFGL+  +  DG   KT CG+PNY APEV+S K ++  EVDVWS 
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF-EVDVWSI 203
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP 263
           G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP  R TI 
Sbjct: 204 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 263
Query: 264 EIRQHPWFQ-----AHLP-RYLAVPP 283
           E+    +F      A LP   L +PP
Sbjct: 264 ELLNDEFFTSGYIPARLPITCLTIPP 289

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 147/261 (56%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P + +L    +  S++Y+VMEY   GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 217
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 277
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 147/261 (56%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  KTLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P + +L    +  S++Y+VMEY   GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 217
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 277
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 142/266 (53%), Gaps = 8/266 (3%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G F K      A T    A KI+ +  +      EK+  EI I R   H H++  + 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
             E    ++VV+E  +   L +    +  L E EAR + +QI+ G +Y HRN V+HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 145 PENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
             NL L+    VKI DFGL+  +  DG   KT CG+PNY APEV+S K ++  EVDVWS 
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF-EVDVWSI 203
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP 263
           G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP  R TI 
Sbjct: 204 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 263
Query: 264 EIRQHPWFQ-----AHLP-RYLAVPP 283
           E+    +F      A LP   L +PP
Sbjct: 264 ELLNDEFFTSGYIPARLPITCLTIPP 289

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  171 bits (432), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 91/254 (35%), Positives = 145/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y AP +I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPAIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  170 bits (431), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 148/261 (56%), Gaps = 8/261 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  ++  +TLG GSFG+V + +H  TG+  A+KIL+++K+  ++  E    E +I +   
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+V+EY   GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +K+ADFG +  ++   +    CG+P Y APE+I  K Y  
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-N 217
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 277
Query: 256 PMKRI-----TIPEIRQHPWF 271
             KR       + +I+ H WF
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 91/254 (35%), Positives = 146/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK---- 258
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  K    
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKAFGN 283
Query: 259 -RITIPEIRQHPWF 271
            +  + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 91/254 (35%), Positives = 145/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +     G+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLAGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 91/254 (35%), Positives = 145/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +    CG+P   APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEALAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 141/266 (53%), Gaps = 8/266 (3%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G F K      A T    A KI+ +  +      EK+  EI I R   H H++  + 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
             E    ++VV+E  +   L +    +  L E EAR + +QI+ G +Y HRN V+HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 145 PENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
             NL L+    VKI DFGL+  +  DG   K  CG+PNY APEV+S K ++  EVDVWS 
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF-EVDVWSI 225
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP 263
           G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP  R TI 
Sbjct: 226 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 285
Query: 264 EIRQHPWFQ-----AHLP-RYLAVPP 283
           E+    +F      A LP   L +PP
Sbjct: 286 ELLNDEFFTSGYIPARLPITCLTIPP 311

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 161/272 (59%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEIXINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 141/266 (53%), Gaps = 8/266 (3%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G F K      A T    A KI+ +  +      EK+  EI I R   H H++  + 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
             E    ++VV+E  +   L +    +  L E EAR + +QI+ G +Y HRN V+HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 145 PENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
             NL L+    VKI DFGL+  +  DG   K  CG+PNY APEV+S K ++  EVDVWS 
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF-EVDVWSI 201
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP 263
           G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP  R TI 
Sbjct: 202 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 261
Query: 264 EIRQHPWFQ-----AHLP-RYLAVPP 283
           E+    +F      A LP   L +PP
Sbjct: 262 ELLNDEFFTSGYIPARLPITCLTIPP 287

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 141/266 (53%), Gaps = 8/266 (3%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G F K      A T    A KI+ +  +      EK+  EI I R   H H++  + 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
             E    ++VV+E  +   L +    +  L E EAR + +QI+ G +Y HRN V+HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 145 PENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
             NL L+    VKI DFGL+  +  DG   K  CG+PNY APEV+S K ++  EVDVWS 
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF-EVDVWSI 227
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP 263
           G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP  R TI 
Sbjct: 228 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 287
Query: 264 EIRQHPWFQ-----AHLP-RYLAVPP 283
           E+    +F      A LP   L +PP
Sbjct: 288 ELLNDEFFTSGYIPARLPITCLTIPP 313

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 161/272 (59%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 161/272 (59%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 103/272 (37%), Positives = 145/272 (53%), Gaps = 8/272 (2%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y  G+ LG G F K        T    A K++ +  +     +EK+  EI I +   +PH
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           ++  +   E    +YVV+E  +   L +    +  + E EAR F +Q I GV+Y H N V
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRV 163
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRDLK  NL L+   +VKI DFGL+  I  DG   KT CG+PNY APEV+  K ++  E
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSF-E 222
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WS G ILY LL G  PF+   +   + +IK   Y++P H++P A  LI RML  DP 
Sbjct: 223 VDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPT 282
Query: 258 KRITIPEIRQHPWFQA-----HLP-RYLAVPP 283
            R ++ E+    +F +      LP   L VPP
Sbjct: 283 LRPSVAELLTDEFFTSGYAPMRLPTSCLTVPP 314

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/254 (35%), Positives = 145/254 (57%), Gaps = 8/254 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+    P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H   +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
           LKPENLL+D +  +++ DFG +  ++   +     G+P Y APE+I  K Y    VD W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLXGTPEYLAPEIILSKGY-NKAVDWWA 223
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-- 260
            GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  KR   
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283
Query: 261 ---TIPEIRQHPWF 271
               + +I+ H WF
Sbjct: 284 LKNGVNDIKNHKWF 297

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 161/272 (59%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 161/272 (59%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 60
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 269

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 159/293 (54%), Gaps = 16/293 (5%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKIL 71
           +F   Y+L + +G G F  V+   +  TG + A+KI++  K  +      E ++RE  I 
Sbjct: 23  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 82
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----LQEDEARNFFQQII 127
            +  HPHI+ L E   +   +Y+V E++   +L   IV++        E  A ++ +QI+
Sbjct: 83  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYA 183
             + YCH N ++HRD+KP  +LL SK N   VK+  FG++  +   G       G+P++ 
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 202
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SH 239
           APEV+  + Y  P VDVW CGVIL+ LL G LPF       LF+ I  G Y +     SH
Sbjct: 203 APEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 260
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           +S  A+DL+ RML++DP +RIT+ E   HPW +        +  P+T++Q +K
Sbjct: 261 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRK 313

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  168 bits (425), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 161/272 (59%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  168 bits (425), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 161/272 (59%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  168 bits (425), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 161/272 (59%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  168 bits (425), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 161/272 (59%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  168 bits (425), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 161/272 (59%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 161/272 (59%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 159/293 (54%), Gaps = 16/293 (5%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKIL 71
           +F   Y+L + +G G F  V+   +  TG + A+KI++  K  +      E ++RE  I 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----LQEDEARNFFQQII 127
            +  HPHI+ L E   +   +Y+V E++   +L   IV++        E  A ++ +QI+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYA 183
             + YCH N ++HRD+KP  +LL SK N   VK+  FG++  +   G       G+P++ 
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SH 239
           APEV+  + Y  P VDVW CGVIL+ LL G LPF       LF+ I  G Y +     SH
Sbjct: 201 APEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           +S  A+DL+ RML++DP +RIT+ E   HPW +        +  P+T++Q +K
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRK 311

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 92/270 (34%), Positives = 160/270 (59%), Gaps = 14/270 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275
            L+ ++L+ +P  RITIP+I++  W+   L
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 92/270 (34%), Positives = 160/270 (59%), Gaps = 14/270 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275
            L+ ++L+ +P  RITIP+I++  W+   L
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 92/270 (34%), Positives = 160/270 (59%), Gaps = 14/270 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275
            L+ ++L+ +P  RITIP+I++  W+   L
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 152/286 (53%), Gaps = 13/286 (4%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++ +TLG GSFG+V +      G   A+K+L +  +  ++  E    E  +L +  
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP IIR++   +    I+++M+Y++ GELF  + +  R     A+ +  ++   +EY H 
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPEN+LLD   ++KI DFG +  + D  +    CG+P+Y APEV+S K Y  
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--XLCGTPDYIAPEVVSTKPY-N 181
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             +D WS G+++Y +L G  PF D N    ++KI       P   +   +DL+ R++  D
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 256 PMKRI-----TIPEIRQHPWF-----QAHLPRYLAVPPPDTMQQAK 291
             +R+        +++ HPWF     +  L R +  P    +QQ +
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQ 287

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  167 bits (422), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 160/272 (58%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I  + 
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINAML 62
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  167 bits (422), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 154/271 (56%), Gaps = 5/271 (1%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++++G+ LG G FG V +A    +   VA+K+L + +I+   +E ++RREI+I     HP
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+RLY        IY+++EY   GEL+  + +     E       +++   + YCH   
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK 143
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           V+HRD+KPENLLL  K  +KIADFG S +       KT CG+ +Y  PE+I G+++   +
Sbjct: 144 VIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRMH-NEK 201
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+W  GV+ Y LL G  PF+  +    +++I       P+ +  GA+DLI ++L  +P 
Sbjct: 202 VDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRHNPS 261
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           +R+ + ++  HPW +A+  R L   PP  +Q
Sbjct: 262 ERLPLAQVSAHPWVRANSRRVL---PPSALQ 289

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 160/272 (58%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G+ G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 108/281 (38%), Positives = 163/281 (58%), Gaps = 14/281 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRLFMHP 77
           Y +G  LG GS+GKVK    + T  + A+KIL ++K++ +   E  V++EI++LR   H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 78  HIIRLYEVI--ETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           ++I+L +V+  E    +Y+VMEY   G  E+ D + EK R    +A  +F Q+I G+EY 
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEYL 125
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR---DGHFLKTSCGSPNYAAPEVISG 190
           H   +VH+D+KP NLLL +   +KI+  G++  +         +TS GSP +  PE+ +G
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 191 -KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
              ++G +VD+WS GV LY +  G  PF+ +NI  LF+ I  G Y +P    P   DL+ 
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLK 245
Query: 250 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLA---VPP-PDT 286
            ML  +P KR +I +IRQH WF+   P   A   +PP PDT
Sbjct: 246 GMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDT 286

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/272 (37%), Positives = 144/272 (52%), Gaps = 8/272 (2%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y  G+ LG G F K        T    A K++ +  +     +EK+  EI I +   +PH
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           ++  +   E    +YVV+E  +   L +    +  + E EAR F +Q I GV+Y H N V
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRV 163
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRDLK  NL L+   +VKI DFGL+  I  DG   K  CG+PNY APEV+  K ++  E
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSF-E 222
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WS G ILY LL G  PF+   +   + +IK   Y++P H++P A  LI RML  DP 
Sbjct: 223 VDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPT 282
Query: 258 KRITIPEIRQHPWFQA-----HLP-RYLAVPP 283
            R ++ E+    +F +      LP   L VPP
Sbjct: 283 LRPSVAELLTDEFFTSGYAPMRLPTSCLTVPP 314

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  166 bits (420), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/272 (37%), Positives = 144/272 (52%), Gaps = 8/272 (2%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y  G+ LG G F K        T    A K++ +  +     +EK+  EI I +   +PH
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           ++  +   E    +YVV+E  +   L +    +  + E EAR F +Q I GV+Y H N V
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRV 163
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRDLK  NL L+   +VKI DFGL+  I  DG   K  CG+PNY APEV+  K ++  E
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSF-E 222
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WS G ILY LL G  PF+   +   + +IK   Y++P H++P A  LI RML  DP 
Sbjct: 223 VDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPT 282
Query: 258 KRITIPEIRQHPWFQA-----HLP-RYLAVPP 283
            R ++ E+    +F +      LP   L VPP
Sbjct: 283 LRPSVAELLTDEFFTSGYAPMRLPTSCLTVPP 314

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  166 bits (420), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/275 (37%), Positives = 145/275 (52%), Gaps = 8/275 (2%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           +  Y  G+ LG G F K        T    A K++ +  +     +EK+  EI I +   
Sbjct: 25  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           +PH++  +   E    +YVV+E  +   L +    +  + E EAR F +Q I GV+Y H 
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 144
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
           N V+HRDLK  NL L+   +VKI DFGL+  I  DG   K  CG+PNY APEV+  K ++
Sbjct: 145 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHS 204
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
             EVD+WS G ILY LL G  PF+   +   + +IK   Y++P H++P A  LI RML  
Sbjct: 205 F-EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHA 263
Query: 255 DPMKRITIPEIRQHPWFQA-----HLP-RYLAVPP 283
           DP  R ++ E+    +F +      LP   L VPP
Sbjct: 264 DPTLRPSVAELLTDEFFTSGYAPMRLPTSCLTVPP 298

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 91/272 (33%), Positives = 160/272 (58%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L    G+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSXQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 91/272 (33%), Positives = 160/272 (58%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEIXINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L    G+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 91/272 (33%), Positives = 160/272 (58%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEIXINKML 62
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L    G+  Y APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 91/272 (33%), Positives = 160/272 (58%), Gaps = 14/272 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L    G+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            L+ ++L+ +P  RITIP+I++  W+   L +
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 149/266 (56%), Gaps = 15/266 (5%)
Query: 19  YKLGKT--LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           Y + KT  LG G FG+V   E   TG K+A KI+  R +K+   +E+V+ EI ++    H
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDH 145
Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHR 135
            ++I+LY+  E+ +DI +VMEYV  GELFD I+++   L E +   F +QI  G+ + H+
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 136 NMVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
             ++H DLKPEN+L    D+K  +KI DFGL+   +    LK + G+P + APEV++   
Sbjct: 206 MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF 264
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLI 248
            + P  D+WS GVI Y LL G  PF  +N       I    + L       +S  A++ I
Sbjct: 265 VSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAH 274
            ++LI +   RI+  E  +HPW   H
Sbjct: 324 SKLLIKEKSWRISASEALKHPWLSDH 349

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  163 bits (413), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 91/270 (33%), Positives = 159/270 (58%), Gaps = 14/270 (5%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 61
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L    G+  Y APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------ 245
            +    VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +      
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275
            L+ ++L+ +P  RITIP+I++  W+   L
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 143/269 (53%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 211
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P+   P ARDL+ +
Sbjct: 212 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEK 270
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 271 LLVLDATKRLGCEEMEGYGPLKAHPFFES 299

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----GTAQYVSPELLTE 205
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 206 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 264
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 265 LLVLDATKRLGCEEMEGYGPLKAHPFFES 293

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 208
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 209 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----GTAQYVSPELLTE 209
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 210 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 268
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 269 LLVLDATKRLGCEEMEGYGPLKAHPFFES 297

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 208
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 209 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 209
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 210 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 268
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 269 LLVLDATKRLGCEEMEGYGPLKAHPFFES 297

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 205
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 206 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 264
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 265 LLVLDATKRLGCEEMEGYGPLKAHPFFES 293

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 206
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 207 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  162 bits (409), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 206
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 207 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  162 bits (409), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 208
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 209 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 190
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 191 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 249
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 250 LLVLDATKRLGCEEMEGYGPLKAHPFFES 278

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV----GTAQYVSPELLTE 206
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 207 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 127
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 183
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 184 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 242
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 243 LLVLDATKRLGCEEMEGYGPLKAHPFFES 271

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 184
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 185 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKAHPFFES 272

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 213
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 214 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 272
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 273 LLVLDATKRLGCEEMEGYGPLKAHPFFES 301

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 130
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 186
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 187 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 245
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 246 LLVLDATKRLGCEEMEGYGPLKAHPFFES 274

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 129
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 185
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 186 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 244
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 245 LLVLDATKRLGCEEMEGYGPLKAHPFFES 273

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 141/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 208
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F KI    Y  P    P ARDL+ +
Sbjct: 209 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 141/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 208
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F KI    Y  P    P ARDL+ +
Sbjct: 209 K-SAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 141/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF    +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 206
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 207 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 94/255 (36%), Positives = 138/255 (54%), Gaps = 7/255 (2%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV +     TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +T   +  VMEY   GELF ++  +    E+ AR +  +I+S +EY H   VV+RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 143 LKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
           +K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G  VD W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260
             GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP +R+ 
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249
Query: 261 ----TIPEIRQHPWF 271
                  E+ +H +F
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 94/255 (36%), Positives = 138/255 (54%), Gaps = 7/255 (2%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV +     TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +T   +  VMEY   GELF ++  +    E+ AR +  +I+S +EY H   VV+RD
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 133
Query: 143 LKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
           +K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G  VD W
Sbjct: 134 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 192
Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260
             GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP +R+ 
Sbjct: 193 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 252
Query: 261 ----TIPEIRQHPWF 271
                  E+ +H +F
Sbjct: 253 GGPSDAKEVMEHRFF 267

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 96/278 (34%), Positives = 156/278 (56%), Gaps = 13/278 (4%)
Query: 3   GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
           G ++ +  G+D    N++  + LG GSFGKV +A    TG   A+K+L +  I   +  E
Sbjct: 13  GVNSSNRLGID----NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVE 68
Query: 63  KVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN 121
               E +IL L   HP + +L+   +TP  ++ VME+V  G+L  +I +  R  E  AR 
Sbjct: 69  CTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF 128
Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSP 180
           +  +IIS + + H   +++RDLK +N+LLD + + K+ADFG+    + +G    T CG+P
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
           +Y APE++   LY GP VD W+ GV+LY +LCG  PF+ EN  +LF+ I       P+ L
Sbjct: 189 DYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 247
Query: 241 SPGARDLIPRMLIVDPMKRI-TIPE-----IRQHPWFQ 272
              A  ++   +  +P  R+ ++ +     I +HP+F+
Sbjct: 248 HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 94/255 (36%), Positives = 138/255 (54%), Gaps = 7/255 (2%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV +     TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +T   +  VMEY   GELF ++  +    E+ AR +  +I+S +EY H   VV+RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 143 LKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
           +K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G  VD W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260
             GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP +R+ 
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249
Query: 261 ----TIPEIRQHPWF 271
                  E+ +H +F
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 141/269 (52%), Gaps = 18/269 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+G L  YI + G   E   R +  +I+S +EY H   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 190
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----GTAQYVSPELLTE 208
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 209 K-SASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 251 MLIVDPMKRITIPE------IRQHPWFQA 273
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 139/256 (54%), Gaps = 8/256 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV + +   TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHR 141
               +T   +  VMEY   GELF ++  +    ED AR +  +I+S ++Y H    VV+R
Sbjct: 217 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 276
Query: 142 DLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK ENL+LD   ++KI DFGL    ++DG  +KT CG+P Y APEV+    Y G  VD 
Sbjct: 277 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 335
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+  +L  DP +R+
Sbjct: 336 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 395
Query: 261 -----TIPEIRQHPWF 271
                   EI QH +F
Sbjct: 396 GGGSEDAKEIMQHRFF 411

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 139/256 (54%), Gaps = 8/256 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV + +   TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHR 141
               +T   +  VMEY   GELF ++  +    ED AR +  +I+S ++Y H    VV+R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 142 DLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK ENL+LD   ++KI DFGL    ++DG  +KT CG+P Y APEV+    Y G  VD 
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 332
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+  +L  DP +R+
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 392
Query: 261 -----TIPEIRQHPWF 271
                   EI QH +F
Sbjct: 393 GGGSEDAKEIMQHRFF 408

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 137/255 (53%), Gaps = 7/255 (2%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV +     TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +T   +  VMEY   GELF ++  +    E+ AR +  +I+S +EY H   VV+RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 143 LKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
           +K ENL+LD   ++KI DFGL    + DG  +K  CG+P Y APEV+    Y G  VD W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260
             GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP +R+ 
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249
Query: 261 ----TIPEIRQHPWF 271
                  E+ +H +F
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 137/255 (53%), Gaps = 7/255 (2%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV +     TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
               +T   +  VMEY   GELF ++  +    E+ AR +  +I+S +EY H   VV+RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 143 LKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
           +K ENL+LD   ++KI DFGL    + DG  +K  CG+P Y APEV+    Y G  VD W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260
             GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP +R+ 
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249
Query: 261 ----TIPEIRQHPWF 271
                  E+ +H +F
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 140/262 (53%), Gaps = 7/262 (2%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + ++   K LG G+FGKV +     TG   A+KIL +  I   +       E ++L+   
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP +  L    +T   +  VMEY   GELF ++  +    E+ AR +  +I+S +EY H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYA 194
             VV+RD+K ENL+LD   ++KI DFGL    + DG  +K  CG+P Y APEV+    Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY- 182
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
           G  VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 255 DPMKRI-----TIPEIRQHPWF 271
           DP +R+        E+ +H +F
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 140/262 (53%), Gaps = 7/262 (2%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + ++   K LG G+FGKV +     TG   A+KIL +  I   +       E ++L+   
Sbjct: 9   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 68
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP +  L    +T   +  VMEY   GELF ++  +    E+ AR +  +I+S +EY H 
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 128
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYA 194
             VV+RD+K ENL+LD   ++KI DFGL    + DG  +K  CG+P Y APEV+    Y 
Sbjct: 129 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY- 187
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
           G  VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 247
Query: 255 DPMKRI-----TIPEIRQHPWF 271
           DP +R+        E+ +H +F
Sbjct: 248 DPKQRLGGGPSDAKEVMEHRFF 269

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 96/268 (35%), Positives = 143/268 (53%), Gaps = 8/268 (2%)
Query: 11  GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           G  + +  ++  K LG G+FGKV + +   TG   A+KIL +  I   +       E ++
Sbjct: 2   GSRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 61
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGV 130
           L+   HP +  L    +T   +  VMEY   GELF ++  +    ED AR +  +I+S +
Sbjct: 62  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 121
Query: 131 EYCHRNM-VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVI 188
           +Y H    VV+RDLK ENL+LD   ++KI DFGL    ++DG  +K  CG+P Y APEV+
Sbjct: 122 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 181
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLI 248
               Y G  VD W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+
Sbjct: 182 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 240
Query: 249 PRMLIVDPMKRI-----TIPEIRQHPWF 271
             +L  DP +R+        EI QH +F
Sbjct: 241 SGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 138/256 (53%), Gaps = 8/256 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV + +   TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 74
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHR 141
               +T   +  VMEY   GELF ++  +    ED AR +  +I+S ++Y H    VV+R
Sbjct: 75  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 134
Query: 142 DLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK ENL+LD   ++KI DFGL    ++DG  +K  CG+P Y APEV+    Y G  VD 
Sbjct: 135 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDW 193
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+  +L  DP +R+
Sbjct: 194 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 253
Query: 261 -----TIPEIRQHPWF 271
                   EI QH +F
Sbjct: 254 GGGSEDAKEIMQHRFF 269

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 145/266 (54%), Gaps = 11/266 (4%)
Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
           D  L +Y + + LG G+FG V       TG+  A K +      +   +E VR+EI+ + 
Sbjct: 47  DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMS 103
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVE 131
           +  HP ++ L++  E  +++ ++ E++  GELF+ +  E  ++ EDEA  + +Q+  G+ 
Sbjct: 104 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 163
Query: 132 YCHRNMVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           + H N  VH DLKPEN++  +K +  +K+ DFGL+  +     +K + G+  +AAPEV  
Sbjct: 164 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 223
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245
           GK   G   D+WS GV+ Y LL G  PF  EN     + +K   + +     S +S   +
Sbjct: 224 GKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 282
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWF 271
           D I ++L+ DP  R+TI +  +HPW 
Sbjct: 283 DFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 138/256 (53%), Gaps = 8/256 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV + +   TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHR 141
               +T   +  VMEY   GELF ++  +    ED AR +  +I+S ++Y H    VV+R
Sbjct: 76  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 135
Query: 142 DLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK ENL+LD   ++KI DFGL    ++DG  +K  CG+P Y APEV+    Y G  VD 
Sbjct: 136 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDW 194
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+  +L  DP +R+
Sbjct: 195 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 254
Query: 261 -----TIPEIRQHPWF 271
                   EI QH +F
Sbjct: 255 GGGSEDAKEIMQHRFF 270

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 145/266 (54%), Gaps = 11/266 (4%)
Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
           D  L +Y + + LG G+FG V       TG+  A K +      +   +E VR+EI+ + 
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMS 209
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVE 131
           +  HP ++ L++  E  +++ ++ E++  GELF+ +  E  ++ EDEA  + +Q+  G+ 
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 132 YCHRNMVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           + H N  VH DLKPEN++  +K +  +K+ DFGL+  +     +K + G+  +AAPEV  
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245
           GK   G   D+WS GV+ Y LL G  PF  EN     + +K   + +     S +S   +
Sbjct: 330 GKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWF 271
           D I ++L+ DP  R+TI +  +HPW 
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 100/286 (34%), Positives = 152/286 (53%), Gaps = 32/286 (11%)
Query: 9   SSGVDM-----------FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN 57
           SSGVD+           F   Y + +T+G+GS+ + K   H  T  + A+K++++ K   
Sbjct: 8   SSGVDLGTENLYFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDP 67
Query: 58  MEMEEKVRREIKIL-RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE 116
            E       EI+IL R   HP+II L +V +    +Y+V E ++ GEL D I+ +    E
Sbjct: 68  SE-------EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSE 120
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLL-LDSKWN---VKIADFGLSNIMR-DGH 171
            EA      I   VEY H   VVHRDLKP N+L +D   N   ++I DFG +  +R +  
Sbjct: 121 REASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENG 180
Query: 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD---ENIPNLFKK 228
            L T C + N+ APEV+  + Y     D+WS G++LY +L G  PF +   +    +  +
Sbjct: 181 LLMTPCYTANFVAPEVLKRQGY-DEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTR 239
Query: 229 IKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
           I  G +TL     + +S  A+DL+ +ML VDP +R+T  ++ QHPW
Sbjct: 240 IGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 100/277 (36%), Positives = 148/277 (53%), Gaps = 26/277 (9%)
Query: 15  FLPNYKLG---KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
           F  +Y L    K LG GSF   +   H  +    A+KI+++R      ME   ++EI  L
Sbjct: 6   FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITAL 59
Query: 72  RLFM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGV 130
           +L   HP+I++L+EV       ++VME +  GELF+ I +K    E EA    ++++S V
Sbjct: 60  KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119
Query: 131 EYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPE 186
            + H   VVHRDLKPENLL    +    +KI DFG + +   D   LKT C + +YAAPE
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNLFKKIKGGIYTLP-- 237
           +++   Y     D+WS GVILY +L G +PF   +          + KKIK G ++    
Sbjct: 180 LLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238
Query: 238 --SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
              ++S  A+DLI  +L VDP KR+ +  +R + W Q
Sbjct: 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 148/279 (53%), Gaps = 23/279 (8%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           F   Y++ + +G+GS+   K   H  T  + A+KI+++ K    E       EI+IL R 
Sbjct: 20  FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-------EIEILLRY 72
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
             HP+II L +V +    +YVV E +K GEL D I+ +    E EA      I   VEY 
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132
Query: 134 HRNMVVHRDLKPENLL-LDSKWN---VKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVI 188
           H   VVHRDLKP N+L +D   N   ++I DFG +  +R +   L T C + N+ APEV+
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFD---DENIPNLFKKIKGGIYTLP----SHLS 241
             + Y     D+WS GV+LY +L G  PF    D+    +  +I  G ++L     + +S
Sbjct: 193 ERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWF--QAHLPRY 278
             A+DL+ +ML VDP +R+T   + +HPW      LP+Y
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQY 290

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 154/272 (56%), Gaps = 10/272 (3%)
Query: 7   RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR 66
           R S  + + + +++L K LG GSFGKV +AE   T    AIK L +  +   +  E    
Sbjct: 8   RPSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV 67
Query: 67  EIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
           E ++L L + HP +  ++   +T  +++ VMEY+  G+L  +I    +     A  +  +
Sbjct: 68  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE 127
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTS--CGSPN 181
           II G+++ H   +V+RDLK +N+LLD   ++KIADFG+   N++ D    KT+  CG+P+
Sbjct: 128 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNEFCGTPD 184
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS 241
           Y APE++ G+ Y    VD WS GV+LY +L G  PF  ++   LF  I+      P  L 
Sbjct: 185 YIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 243
Query: 242 PGARDLIPRMLIVDPMKRITIP-EIRQHPWFQ 272
             A+DL+ ++ + +P KR+ +  +IRQHP F+
Sbjct: 244 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 275

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 95/270 (35%), Positives = 147/270 (54%), Gaps = 21/270 (7%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-R 72
           +F   Y + +T+G+GS+ + K   H  T  + A+K++++ K    E       EI+IL R
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE-------EIEILLR 76
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              HP+II L +V +    +Y+V E ++ GEL D I+ +    E EA      I   VEY
Sbjct: 77  YGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEY 136
Query: 133 CHRNMVVHRDLKPENLL-LDSKWN---VKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEV 187
            H   VVHRDLKP N+L +D   N   ++I DFG +  +R +   L T C + N+ APEV
Sbjct: 137 LHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEV 196
Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDD---ENIPNLFKKIKGGIYTLP----SHL 240
           +  + Y     D+WS G++LY +L G  PF +   +    +  +I  G +TL     + +
Sbjct: 197 LKRQGY-DEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTV 255
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
           S  A+DL+ +ML VDP +R+T  ++ QHPW
Sbjct: 256 SETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  153 bits (387), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 153/272 (56%), Gaps = 10/272 (3%)
Query: 7   RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR 66
           R S  + + + ++ L K LG GSFGKV +AE   T    AIK L +  +   +  E    
Sbjct: 7   RPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV 66
Query: 67  EIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
           E ++L L + HP +  ++   +T  +++ VMEY+  G+L  +I    +     A  +  +
Sbjct: 67  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE 126
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTS--CGSPN 181
           II G+++ H   +V+RDLK +N+LLD   ++KIADFG+   N++ D    KT+  CG+P+
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNXFCGTPD 183
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS 241
           Y APE++ G+ Y    VD WS GV+LY +L G  PF  ++   LF  I+      P  L 
Sbjct: 184 YIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 242
Query: 242 PGARDLIPRMLIVDPMKRITIP-EIRQHPWFQ 272
             A+DL+ ++ + +P KR+ +  +IRQHP F+
Sbjct: 243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 145/280 (51%), Gaps = 23/280 (8%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-R 72
            F   Y++ + +G+GS+   K   H  T  + A+KI+++ K    E       EI+IL R
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE-------EIEILLR 71
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              HP+II L +V +    +YVV E  K GEL D I+ +    E EA      I   VEY
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 133 CHRNMVVHRDLKPENLL-LDSKWN---VKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEV 187
            H   VVHRDLKP N+L +D   N   ++I DFG +  +R +   L T C + N+ APEV
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEV 191
Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFD---DENIPNLFKKIKGGIYTLP----SHL 240
           +  + Y     D+WS GV+LY  L G  PF    D+    +  +I  G ++L     + +
Sbjct: 192 LERQGYDAA-CDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWF--QAHLPRY 278
           S  A+DL+ + L VDP +R+T   + +HPW      LP+Y
Sbjct: 251 SDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQY 290

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 148/264 (56%), Gaps = 8/264 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++     LG GSFGKV +A+   T    AIKIL +  +   +  E    E ++L L  
Sbjct: 18  LTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLD 77
Query: 76  HP-HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            P  + +L+   +T   +Y VMEYV  G+L  +I + G+ +E +A  +  +I  G+ + H
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLY 193
           +  +++RDLK +N++LDS+ ++KIADFG+    M DG   +  CG+P+Y APE+I+ + Y
Sbjct: 138 KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPY 197
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
            G  VD W+ GV+LY +L G  PFD E+   LF+ I     + P  LS  A  +   ++ 
Sbjct: 198 -GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 256
Query: 254 VDPMKRITI-PE----IRQHPWFQ 272
             P KR+   PE    +R+H +F+
Sbjct: 257 KHPAKRLGCGPEGERDVREHAFFR 280

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 92/273 (33%), Positives = 149/273 (54%), Gaps = 24/273 (8%)
Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
           D+F+   KLG     G+FG V + E   +G +  IK +N+ +   + ME+ +  EI++L+
Sbjct: 22  DLFIFKRKLGS----GAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQ-IEAEIEVLK 75
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE---KGR-LQEDEARNFFQQIIS 128
              HP+II+++EV E   ++Y+VME  + GEL + IV    +G+ L E       +Q+++
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
            + Y H   VVH+DLKPEN+L         +KI DFGL+ + +       + G+  Y AP
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH------ 239
           EV   K     + D+WS GV++Y LL G LPF   ++  + +K     Y  P++      
Sbjct: 196 EVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK---ATYKEPNYAVECRP 250
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           L+P A DL+ +ML  DP +R +  ++  H WF+
Sbjct: 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 144/271 (53%), Gaps = 18/271 (6%)
Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNME-MEEKVRREIKI 70
           + F   Y+LG  LG G FG V  A H LT   +VAIK++ R ++     + + V   +++
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTV-FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 71  LRLFM------HPHIIRLYEVIETPSDIYVVMEY-VKSGELFDYIVEKGRLQEDEARNFF 123
             L+       HP +IRL +  ET     +V+E  + + +LFDYI EKG L E  +R FF
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNY 182
            Q+++ +++CH   VVHRD+K EN+L+D  +   K+ DFG   ++ D  +     G+  Y
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVY 204
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
           + PE IS   Y      VWS G++LY ++CG +PF+ +      ++I       P+H+SP
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSP 258
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273
               LI R L   P  R ++ EI   PW Q 
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/287 (31%), Positives = 156/287 (54%), Gaps = 19/287 (6%)
Query: 4   ASNRSSSGVDMFLPNYKLGKTLGIGSFGKV----KIAEHALTGHKVAIKILNRRKI-KNM 58
            +N +     + + N++L K LG G++GKV    KI+ H  TG   A+K+L +  I +  
Sbjct: 41  TANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHD-TGKLYAMKVLKKATIVQKA 99
Query: 59  EMEEKVRREIKILR-LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQED 117
           +  E  R E ++L  +   P ++ L+   +T + ++++++Y+  GELF ++ ++ R  E 
Sbjct: 100 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH 159
Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN--IMRDGHFLKT 175
           E + +  +I+  +E+ H+  +++RD+K EN+LLDS  +V + DFGLS   +  +      
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
Query: 176 SCGSPNYAAPEVISGKLYAGPE-VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY 234
            CG+  Y AP+++ G      + VD WS GV++Y LL G  PF  +   N   +I   I 
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279
Query: 235 T----LPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQ 272
                 P  +S  A+DLI R+L+ DP KR+        EI++H +FQ
Sbjct: 280 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 96/280 (34%), Positives = 149/280 (53%), Gaps = 14/280 (5%)
Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
            D   NR      M L ++     LG GSFGKV ++E   T    A+KIL +  +   + 
Sbjct: 8   FDNNGNRDR----MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD 63
Query: 61  EEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
            E    E ++L L    P + +L+   +T   +Y VMEYV  G+L  +I + GR +E  A
Sbjct: 64  VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA 123
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSC 177
             +  +I  G+ +     +++RDLK +N++LDS+ ++KIADFG+   NI  DG   K  C
Sbjct: 124 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-DGVTTKXFC 182
Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP 237
           G+P+Y APE+I+ + Y G  VD W+ GV+LY +L G  PF+ E+   LF+ I       P
Sbjct: 183 GTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 241
Query: 238 SHLSPGARDLIPRMLIVDPMKRITI-PE----IRQHPWFQ 272
             +S  A  +   ++   P KR+   PE    I++H +F+
Sbjct: 242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/280 (34%), Positives = 149/280 (53%), Gaps = 14/280 (5%)
Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
            D   NR      M L ++     LG GSFGKV ++E   T    A+KIL +  +   + 
Sbjct: 329 FDNNGNRDR----MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD 384
Query: 61  EEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
            E    E ++L L    P + +L+   +T   +Y VMEYV  G+L  +I + GR +E  A
Sbjct: 385 VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA 444
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSC 177
             +  +I  G+ +     +++RDLK +N++LDS+ ++KIADFG+   NI  DG   K  C
Sbjct: 445 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-DGVTTKXFC 503
Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP 237
           G+P+Y APE+I+ + Y G  VD W+ GV+LY +L G  PF+ E+   LF+ I       P
Sbjct: 504 GTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 562
Query: 238 SHLSPGARDLIPRMLIVDPMKRITI-PE----IRQHPWFQ 272
             +S  A  +   ++   P KR+   PE    I++H +F+
Sbjct: 563 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 141/266 (53%), Gaps = 15/266 (5%)
Query: 19  YKLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLF 74
           ++L + LG G +GKV   +    A TG   A+K+L +  I +N +     + E  IL   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP I+ L    +T   +Y+++EY+  GELF  +  +G   ED A  +  +I   + + H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVI--SGK 191
           +  +++RDLKPEN++L+ + +VK+ DFGL    + DG    T CG+  Y APE++  SG 
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
             A   VD WS G ++Y +L G  PF  EN      KI      LP +L+  ARDL+ ++
Sbjct: 199 NRA---VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKL 255
Query: 252 LIVDPMKRI-----TIPEIRQHPWFQ 272
           L  +   R+        E++ HP+F+
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/262 (33%), Positives = 137/262 (52%), Gaps = 9/262 (3%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMH 76
           ++   K +G GSFGKV +A H       A+K+L ++ I   + E+ +  E  +L +   H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           P ++ L+   +T   +Y V++Y+  GELF ++  +    E  AR +  +I S + Y H  
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
            +V+RDLKPEN+LLDS+ ++ + DFGL   NI  +     T CG+P Y APEV+  + Y 
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST-TSTFCGTPEYLAPEVLHKQPYD 217
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
              VD W  G +LY +L G  PF   N   ++  I      L  +++  AR L+  +L  
Sbjct: 218 R-TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 276
Query: 255 DPMKRI----TIPEIRQHPWFQ 272
           D  KR+       EI+ H +F 
Sbjct: 277 DRTKRLGAKDDFMEIKSHVFFS 298

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 140/266 (52%), Gaps = 15/266 (5%)
Query: 19  YKLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLF 74
           ++L + LG G +GKV   +    A TG   A+K+L +  I +N +     + E  IL   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP I+ L    +T   +Y+++EY+  GELF  +  +G   ED A  +  +I   + + H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVI--SGK 191
           +  +++RDLKPEN++L+ + +VK+ DFGL    + DG      CG+  Y APE++  SG 
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
             A   VD WS G ++Y +L G  PF  EN      KI      LP +L+  ARDL+ ++
Sbjct: 199 NRA---VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKL 255
Query: 252 LIVDPMKRI-----TIPEIRQHPWFQ 272
           L  +   R+        E++ HP+F+
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 11/262 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y + + LG G+FG V       TG     K +N     +   +  V+ EI I+    HP 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPK 109
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I L++  E   ++ +++E++  GELFD I  E  ++ E E  N+ +Q   G+++ H + 
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 138 VVHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           +VH D+KPEN++ ++K   +VKI DFGL+  +     +K +  +  +AAPE++  +   G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP-VG 228
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRM 251
              D+W+ GV+ Y LL G  PF  E+     + +K   +       S +SP A+D I  +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288
Query: 252 LIVDPMKRITIPEIRQHPWFQA 273
           L  +P KR+T+ +  +HPW + 
Sbjct: 289 LQKEPRKRLTVHDALEHPWLKG 310

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 87/265 (32%), Positives = 149/265 (56%), Gaps = 18/265 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GS G V +A    +G +VA+K+++ RK +  E+   +  E+ I+R + H +++ +Y+
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHFNVVEMYK 109
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                 +++V+ME+++ G L D IV + RL E++     + ++  + Y H   V+HRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
            +++LL     VK++DFG  + I +D    K   G+P + APEVIS  LYA  EVD+WS 
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYA-TEVDIWSL 227
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP------SH-LSPGARDLIPRMLIVDP 256
           G+++  ++ G  P+  ++     K+++      P      SH +SP  RD + RML+ DP
Sbjct: 228 GIMVIEMVDGEPPYFSDSPVQAMKRLRDS----PPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 257 MKRITIPEIRQHPW-FQAHLPRYLA 280
            +R T  E+  HP+  Q  LP  L 
Sbjct: 284 QERATAQELLDHPFLLQTGLPECLV 308

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 149/284 (52%), Gaps = 14/284 (4%)
Query: 9   SSGVDMFLPN--------YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           SSGVD+   N        Y   + +G GSFGK  + +    G +  IK +N  ++ + E 
Sbjct: 8   SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRL-QEDE 118
           EE  RRE+ +L    HP+I++  E  E    +Y+VM+Y + G+LF  I  +KG L QED+
Sbjct: 68  EES-RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ 126
Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC- 177
             ++F QI   +++ H   ++HRD+K +N+ L     V++ DFG++ ++     L  +C 
Sbjct: 127 ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI 186
Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP 237
           G+P Y +PE+   K Y   + D+W+ G +LY L      F+  ++ NL  KI  G +   
Sbjct: 187 GTPYYLSPEICENKPYNN-KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV 245
Query: 238 S-HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLA 280
           S H S   R L+ ++   +P  R ++  I +  +    + ++L+
Sbjct: 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLS 289

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 138/262 (52%), Gaps = 14/262 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 216
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
             Y G    VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI  
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSSECQHLIRW 270
Query: 251 MLIVDPMKRITIPEIRQHPWFQ 272
            L + P  R T  EI+ HPW Q
Sbjct: 271 CLALRPSDRPTFEEIQNHPWMQ 292

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 141/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E ++   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 187
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 240
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 241 WCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 138/262 (52%), Gaps = 14/262 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 216
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
             Y G    VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI  
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSSECQHLIRW 270
Query: 251 MLIVDPMKRITIPEIRQHPWFQ 272
            L + P  R T  EI+ HPW Q
Sbjct: 271 CLALRPSDRPTFEEIQNHPWMQ 292

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 138/262 (52%), Gaps = 14/262 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 215
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
             Y G    VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI  
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSSECQHLIRW 269
Query: 251 MLIVDPMKRITIPEIRQHPWFQ 272
            L + P  R T  EI+ HPW Q
Sbjct: 270 CLALRPSDRPTFEEIQNHPWMQ 291

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 138/262 (52%), Gaps = 14/262 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 215
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
             Y G    VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI  
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSSECQHLIRW 269
Query: 251 MLIVDPMKRITIPEIRQHPWFQ 272
            L + P  R T  EI+ HPW Q
Sbjct: 270 CLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  137 bits (345), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 138/262 (52%), Gaps = 14/262 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 216
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
             Y G    VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI  
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSXECQHLIRW 270
Query: 251 MLIVDPMKRITIPEIRQHPWFQ 272
            L + P  R T  EI+ HPW Q
Sbjct: 271 CLALRPSDRPTFEEIQNHPWMQ 292

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  137 bits (345), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 138/262 (52%), Gaps = 14/262 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 216
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
             Y G    VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI  
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSXECQHLIRW 270
Query: 251 MLIVDPMKRITIPEIRQHPWFQ 272
            L + P  R T  EI+ HPW Q
Sbjct: 271 CLALRPSDRPTFEEIQNHPWMQ 292

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  137 bits (345), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 138/262 (52%), Gaps = 14/262 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 183
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
             Y G    VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI  
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSSECQHLIRW 237
Query: 251 MLIVDPMKRITIPEIRQHPWFQ 272
            L + P  R T  EI+ HPW Q
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQ 259

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  137 bits (345), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 138/262 (52%), Gaps = 14/262 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 215
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
             Y G    VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI  
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSXECQHLIRW 269
Query: 251 MLIVDPMKRITIPEIRQHPWFQ 272
            L + P  R T  EI+ HPW Q
Sbjct: 270 CLALRPSDRPTFEEIQNHPWMQ 291

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  137 bits (344), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 203
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 256
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 257 WCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  137 bits (344), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 202
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 255
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 256 WCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  137 bits (344), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 215
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 268
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 269 WCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  137 bits (344), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 230
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 283
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 284 WCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 222
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 275
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 276 WCLALRPSDRPTFEEIQNHPWMQ 298

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 188
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 241
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 242 WCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 187
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 240
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 241 WCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 203
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIR 256
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 257 WCLALRPXDRPTFEEIQNHPWMQ 279

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 188
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 241
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 242 WCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 230
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIR 283
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 284 WCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 188
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 241
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 242 WCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 203
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIR 256
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 257 WCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 183
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 236
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 127
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 186
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 187 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIR 239
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 240 WCLALRPSDRPTFEEIQNHPWMQ 262

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 183
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIR 236
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 202
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIR 255
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 256 WCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 176
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 177 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 235
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 236 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIR 288
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 289 WCLALRPSDRPTFEEIQNHPWMQ 311

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRL--- 73
            Y++G  LG G FG V           VAIK + + +I +  E+    R  ++++ L   
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 74  -FMHPHIIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVE 131
                 +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 151
Query: 132 YCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
           +CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I  
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRY 210
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
             Y G    VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI 
Sbjct: 211 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIR 263
Query: 250 RMLIVDPMKRITIPEIRQHPWFQ 272
             L + P  R T  EI+ HPW Q
Sbjct: 264 WCLALRPSDRPTFEEIQNHPWMQ 286

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 140/272 (51%), Gaps = 29/272 (10%)
Query: 18  NYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFM 75
           +Y+L K  LG+G  GKV    H  TG K A+K+L            K R+E+    +   
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 76  HPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISG 129
            PHI+ + +V E        + ++ME ++ GELF  I E+G     E EA    + I + 
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
           +++ H + + HRD+KPENLL  SK     +K+ DFG +      + L+T C +P Y APE
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPE 199
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----S 238
           V+  + Y     D+WS GVI+Y LLCG  PF         P + ++I+ G Y  P    S
Sbjct: 200 VLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
            +S  A+ LI  +L  DP +R+TI +   HPW
Sbjct: 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 140/272 (51%), Gaps = 29/272 (10%)
Query: 18  NYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFM 75
           +Y+L K  LG+G  GKV    H  TG K A+K+L            K R+E+    +   
Sbjct: 10  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 61
Query: 76  HPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISG 129
            PHI+ + +V E        + ++ME ++ GELF  I E+G     E EA    + I + 
Sbjct: 62  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 121
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
           +++ H + + HRD+KPENLL  SK     +K+ DFG +      + L+T C +P Y APE
Sbjct: 122 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPE 180
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----S 238
           V+  + Y     D+WS GVI+Y LLCG  PF         P + ++I+ G Y  P    S
Sbjct: 181 VLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 239
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
            +S  A+ LI  +L  DP +R+TI +   HPW
Sbjct: 240 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 271

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 155/285 (54%), Gaps = 20/285 (7%)
Query: 5   SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV 64
           S ++SS +   L ++ L + +G GS+ KV +     T    A++++ +  + + E  + V
Sbjct: 42  SGKASSSLG--LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV 99
Query: 65  RREIKIL-RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF 123
           + E  +  +   HP ++ L+   +T S ++ V+EYV  G+L  ++  + +L E+ AR + 
Sbjct: 100 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 159
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNY 182
            +I   + Y H   +++RDLK +N+LLDS+ ++K+ D+G+    +R G    T CG+PNY
Sbjct: 160 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 219
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGI 233
            APE++ G+ Y G  VD W+ GV+++ ++ G  PFD        D+N  + LF+ I    
Sbjct: 220 IAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278
Query: 234 YTLPSHLSPGARDLIPRMLIVDPMKRI------TIPEIRQHPWFQ 272
             +P  LS  A  ++   L  DP +R+         +I+ HP+F+
Sbjct: 279 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 139/277 (50%), Gaps = 28/277 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 27  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 78
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 79  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 138
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 139 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 198
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 199 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 257
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
               S +S   + LI  +L  +P +R+TI E   HPW
Sbjct: 258 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 294

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/278 (34%), Positives = 139/278 (50%), Gaps = 28/278 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 11  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 62
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 63  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 122
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 123 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 182
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 183 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 241
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
               S +S   + LI  +L  +P +R+TI E   HPW 
Sbjct: 242 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/278 (34%), Positives = 139/278 (50%), Gaps = 28/278 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 63  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 114
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 115 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 174
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 175 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 234
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 235 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 293
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
               S +S   + LI  +L  +P +R+TI E   HPW 
Sbjct: 294 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/278 (34%), Positives = 139/278 (50%), Gaps = 28/278 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 57  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 108
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 168
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 229 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
               S +S   + LI  +L  +P +R+TI E   HPW 
Sbjct: 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 139/277 (50%), Gaps = 28/277 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 12  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 63
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 64  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 123
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 124 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 183
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 184 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 242
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
               S +S   + LI  +L  +P +R+TI E   HPW
Sbjct: 243 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 279

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  135 bits (339), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 139/277 (50%), Gaps = 28/277 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 17  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 68
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 69  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 128
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 129 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 188
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 189 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 247
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
               S +S   + LI  +L  +P +R+TI E   HPW
Sbjct: 248 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 284

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  135 bits (339), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 139/277 (50%), Gaps = 28/277 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 18  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 69
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 70  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 129
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 130 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 189
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 190 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 248
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
               S +S   + LI  +L  +P +R+TI E   HPW
Sbjct: 249 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 285

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  135 bits (339), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 139/277 (50%), Gaps = 28/277 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 19  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 70
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 71  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 130
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 131 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 190
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 191 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 249
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
               S +S   + LI  +L  +P +R+TI E   HPW
Sbjct: 250 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 286

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  135 bits (339), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 139/277 (50%), Gaps = 28/277 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 64
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 185 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 243
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
               S +S   + LI  +L  +P +R+TI E   HPW
Sbjct: 244 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 280

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 95/278 (34%), Positives = 139/278 (50%), Gaps = 28/278 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 64
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 185 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 243
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
               S +S   + LI  +L  +P +R+TI E   HPW 
Sbjct: 244 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  134 bits (336), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 154/285 (54%), Gaps = 20/285 (7%)
Query: 5   SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV 64
           S ++SS +   L ++ L + +G GS+ KV +     T    A+K++ +  + + E  + V
Sbjct: 10  SGKASSSLG--LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV 67
Query: 65  RREIKIL-RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF 123
           + E  +  +   HP ++ L+   +T S ++ V+EYV  G+L  ++  + +L E+ AR + 
Sbjct: 68  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 127
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNY 182
            +I   + Y H   +++RDLK +N+LLDS+ ++K+ D+G+    +R G      CG+PNY
Sbjct: 128 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNY 187
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGI 233
            APE++ G+ Y G  VD W+ GV+++ ++ G  PFD        D+N  + LF+ I    
Sbjct: 188 IAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 246
Query: 234 YTLPSHLSPGARDLIPRMLIVDPMKRI------TIPEIRQHPWFQ 272
             +P  +S  A  ++   L  DP +R+         +I+ HP+F+
Sbjct: 247 IRIPRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFR 291

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  134 bits (336), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 148/274 (54%), Gaps = 18/274 (6%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLF 74
           L ++ L + +G GS+ KV +     T    A+K++ +  + + E  + V+ E  +  +  
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP ++ L+   +T S ++ V+EYV  G+L  ++  + +L E+ AR +  +I   + Y H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLY 193
              +++RDLK +N+LLDS+ ++K+ D+G+    +R G      CG+PNY APE++ G+ Y
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 183
Query: 194 AGPEVDVWSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGA 244
            G  VD W+ GV+++ ++ G  PFD        D+N  + LF+ I      +P  LS  A
Sbjct: 184 -GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 242
Query: 245 RDLIPRMLIVDPMKRI------TIPEIRQHPWFQ 272
             ++   L  DP +R+         +I+ HP+F+
Sbjct: 243 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 276

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  134 bits (336), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 148/274 (54%), Gaps = 18/274 (6%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLF 74
           L ++ L + +G GS+ KV +     T    A+K++ +  + + E  + V+ E  +  +  
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP ++ L+   +T S ++ V+EYV  G+L  ++  + +L E+ AR +  +I   + Y H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLY 193
              +++RDLK +N+LLDS+ ++K+ D+G+    +R G      CG+PNY APE++ G+ Y
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 187
Query: 194 AGPEVDVWSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGA 244
            G  VD W+ GV+++ ++ G  PFD        D+N  + LF+ I      +P  LS  A
Sbjct: 188 -GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 246
Query: 245 RDLIPRMLIVDPMKRI------TIPEIRQHPWFQ 272
             ++   L  DP +R+         +I+ HP+F+
Sbjct: 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 149/268 (55%), Gaps = 17/268 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKV----AIKILNRRKIKNMEMEEKVRREIK--IL 71
            ++L K LG GSFGKV + +  ++G       A+K+L +  +K   + ++VR +++  IL
Sbjct: 26  QFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLK---VRDRVRTKMERDIL 81
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
               HP I++L+   +T   +Y+++++++ G+LF  + ++    E++ + +  ++   ++
Sbjct: 82  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISG 190
           + H   +++RDLKPEN+LLD + ++K+ DFGLS    D      S CG+  Y APEV++ 
Sbjct: 142 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           + +     D WS GV+++ +L GTLPF  ++       I      +P  LSP A+ L+  
Sbjct: 202 RGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 260
Query: 251 MLIVDPMKRI-----TIPEIRQHPWFQA 273
           +   +P  R+      + EI++H +F  
Sbjct: 261 LFKRNPANRLGAGPDGVEEIKRHSFFST 288

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 149/268 (55%), Gaps = 17/268 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKV----AIKILNRRKIKNMEMEEKVRREIK--IL 71
            ++L K LG GSFGKV + +  ++G       A+K+L +  +K   + ++VR +++  IL
Sbjct: 25  QFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLK---VRDRVRTKMERDIL 80
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
               HP I++L+   +T   +Y+++++++ G+LF  + ++    E++ + +  ++   ++
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISG 190
           + H   +++RDLKPEN+LLD + ++K+ DFGLS    D      S CG+  Y APEV++ 
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           + +     D WS GV+++ +L GTLPF  ++       I      +P  LSP A+ L+  
Sbjct: 201 RGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259
Query: 251 MLIVDPMKRI-----TIPEIRQHPWFQA 273
           +   +P  R+      + EI++H +F  
Sbjct: 260 LFKRNPANRLGAGPDGVEEIKRHSFFST 287

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 148/306 (48%), Gaps = 54/306 (17%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME--EKVRREIKILRLFMH 76
           Y L   +G GS+G V++A    T    AIKI+N+ KI+ +  +  E+++ E+++++   H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYI--------------VEKGRL-------- 114
           P+I RLYEV E    I +VME    G L D +              V K ++        
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 115 ------------------QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK--W 154
                             +E    N  +QI S + Y H   + HRD+KPEN L  +   +
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 155 NVKIADFGLSN---IMRDGHF--LKTSCGSPNYAAPEVISGKLYA-GPEVDVWSCGVILY 208
            +K+ DFGLS     + +G +  + T  G+P + APEV++    + GP+ D WS GV+L+
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 209 ALLCGTLPFDDENIPNLFKKI--KGGIYTLPSH--LSPGARDLIPRMLIVDPMKRITIPE 264
            LL G +PF   N  +   ++  K   +  P++  LSP ARDL+  +L  +  +R     
Sbjct: 268 LLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327
Query: 265 IRQHPW 270
             QHPW
Sbjct: 328 ALQHPW 333

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 91/299 (30%), Positives = 147/299 (49%), Gaps = 39/299 (13%)
Query: 15  FLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-R 72
           F   YKL  + LG G++ KV+ A     G + A+KI+ ++   +     +V RE++ L +
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHS---RSRVFREVETLYQ 66
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              + +I+ L E  E  +  Y+V E ++ G +  +I ++    E EA    + + + +++
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDF 126
Query: 133 CHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHF--------LKTSCGSPN 181
            H   + HRDLKPEN+L +S      VKI DF L + M+  +         L T CGS  
Sbjct: 127 LHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 182 YAAPEVI----SGKLYAGPEVDVWSCGVILYALLCGTLPF----------DDENIP---- 223
           Y APEV+        +     D+WS GV+LY +L G  PF          D   +     
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 246
Query: 224 -NLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
             LF+ I+ G Y  P    +H+S  A+DLI ++L+ D  +R++  ++ QHPW Q   P 
Sbjct: 247 NKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPE 305

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 149/268 (55%), Gaps = 17/268 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKV----AIKILNRRKIKNMEMEEKVRREIK--IL 71
            ++L K LG GSFGKV + +  ++G       A+K+L +  +K   + ++VR +++  IL
Sbjct: 25  QFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLK---VRDRVRTKMERDIL 80
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
               HP I++L+   +T   +Y+++++++ G+LF  + ++    E++ + +  ++   ++
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISG 190
           + H   +++RDLKPEN+LLD + ++K+ DFGLS    D      S CG+  Y APEV++ 
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
           + +     D WS GV+++ +L GTLPF  ++       I      +P  LSP A+ L+  
Sbjct: 201 RGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259
Query: 251 MLIVDPMKRI-----TIPEIRQHPWFQA 273
           +   +P  R+      + EI++H +F  
Sbjct: 260 LFKRNPANRLGAGPDGVEEIKRHSFFST 287

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 138/278 (49%), Gaps = 28/278 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 11  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 62
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 63  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 122
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L   C +P 
Sbjct: 123 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPY 182
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 183 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 241
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
               S +S   + LI  +L  +P +R+TI E   HPW 
Sbjct: 242 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 149/267 (55%), Gaps = 15/267 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIK--ILR 72
           +++L K LG GSFGKV +        +GH  A+K+L +  +K   + ++VR +++  IL 
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLK---VRDRVRTKMERDILA 85
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              HP +++L+   +T   +Y+++++++ G+LF  + ++    E++ + +  ++  G+++
Sbjct: 86  DVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDH 145
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGK 191
            H   +++RDLKPEN+LLD + ++K+ DFGLS    D      S CG+  Y APEV++ +
Sbjct: 146 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQ 205
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
            ++    D WS GV+++ +L G+LPF  ++       I      +P  LS  A+ L+  +
Sbjct: 206 GHS-HSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRAL 264
Query: 252 LIVDPMKRI-----TIPEIRQHPWFQA 273
              +P  R+        EI++H ++  
Sbjct: 265 FKRNPANRLGSGPDGAEEIKRHVFYST 291

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 87/265 (32%), Positives = 139/265 (52%), Gaps = 15/265 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y++  T+G GS+G+ +       G  +  K L+   +   E +  V  E+ +LR   HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHP 65
Query: 78  HIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVE 131
           +I+R Y+ I   T + +Y+VMEY + G+L   I     E+  L E+       Q+   ++
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 132 YCHR-----NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAP 185
            CHR     + V+HRDLKP N+ LD K NVK+ DFGL+ I+  D  F KT  G+P Y +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGA 244
           E ++ ++    + D+WS G +LY L     PF   +   L  KI+ G +  +P   S   
Sbjct: 186 EQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 245 RDLIPRMLIVDPMKRITIPEIRQHP 269
            ++I RML +    R ++ EI ++P
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENP 269

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 138/265 (52%), Gaps = 15/265 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y++  T+G GS+G+ +       G  +  K L+   +   E +  V  E+ +LR   HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHP 65
Query: 78  HIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVE 131
           +I+R Y+ I   T + +Y+VMEY + G+L   I     E+  L E+       Q+   ++
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 132 YCHR-----NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAP 185
            CHR     + V+HRDLKP N+ LD K NVK+ DFGL+ I+  D  F K   G+P Y +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 185
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGA 244
           E ++ ++    + D+WS G +LY L     PF   +   L  KI+ G +  +P   S   
Sbjct: 186 EQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 245 RDLIPRMLIVDPMKRITIPEIRQHP 269
            ++I RML +    R ++ EI ++P
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENP 269

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 134/278 (48%), Gaps = 28/278 (10%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K L        +   K RRE+++ 
Sbjct: 57  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL--------QDCPKARREVELH 108
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +V E +  GELF  I ++G     E EA    +
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXK 168
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D WS GVI Y LLCG  PF   +     P    +I+ G Y  P
Sbjct: 229 YVAPEVLGPEKY-DKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFP 287
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
               S +S   + LI  +L  +P +R TI E   HPW 
Sbjct: 288 NPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  129 bits (323), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 91/287 (31%), Positives = 138/287 (48%), Gaps = 25/287 (8%)
Query: 9   SSGVDMFLPNYKL-------------GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI 55
           SSGVD+   N                 K LG G F  V+      TG + A K L +R+ 
Sbjct: 8   SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR- 66
Query: 56  KNMEMEEKVRREIKILRLFMH-PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK--G 112
           +  +   ++  EI +L L    P +I L+EV E  S+I +++EY   GE+F   + +   
Sbjct: 67  RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE 126
Query: 113 RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIMRD 169
            + E++     +QI+ GV Y H+N +VH DLKP+N+LL S +   ++KI DFG+S  +  
Sbjct: 127 MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186
Query: 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI 229
              L+   G+P Y APE+++         D+W+ G+I Y LL  T PF  E+    +  I
Sbjct: 187 ACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245
Query: 230 KGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                       S +S  A D I  +L+ +P KR T      H W Q
Sbjct: 246 SQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  129 bits (323), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 133/258 (51%), Gaps = 12/258 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI-KNMEMEE----KVRREIKILRL 73
           Y     LG G+FG V  A       +V +K + + K+ ++  +E+    KV  EI IL  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSG-ELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
             H +II++ ++ E      +VME   SG +LF +I    RL E  A   F+Q++S V Y
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
                ++HRD+K EN+++   + +K+ DFG +  +  G    T CG+  Y APEV+ G  
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNP 205
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252
           Y GPE+++WS GV LY     TL F++     L + ++  I+  P  +S     L+  +L
Sbjct: 206 YRGPELEMWSLGVTLY-----TLVFEENPFCELEETVEAAIHP-PYLVSKELMSLVSGLL 259
Query: 253 IVDPMKRITIPEIRQHPW 270
              P +R T+ ++   PW
Sbjct: 260 QPVPERRTTLEKLVTDPW 277

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 138/265 (52%), Gaps = 15/265 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y++  T+G GS+G+ +       G  +  K L+   +   E +  V  E+ +LR   HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHP 65
Query: 78  HIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVE 131
           +I+R Y+ I   T + +Y+VMEY + G+L   I     E+  L E+       Q+   ++
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 132 YCHR-----NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAP 185
            CHR     + V+HRDLKP N+ LD K NVK+ DFGL+ I+  D  F K   G+P Y +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSP 185
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGA 244
           E ++ ++    + D+WS G +LY L     PF   +   L  KI+ G +  +P   S   
Sbjct: 186 EQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 245 RDLIPRMLIVDPMKRITIPEIRQHP 269
            ++I RML +    R ++ EI ++P
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENP 269

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 103/323 (31%), Positives = 158/323 (48%), Gaps = 44/323 (13%)
Query: 4   ASNRSSSGVDMFLPNYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
            S  S SG   F   Y+L +  LG G+  +V+   + +T  + A+KI+ ++      +  
Sbjct: 1   GSTDSFSG--RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRS 55
Query: 63  KVRREIKIL-RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN 121
           +V RE+++L +   H +++ L E  E     Y+V E ++ G +  +I ++    E EA  
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV 115
Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGL-SNIMRDGHF----- 172
             Q + S +++ H   + HRDLKPEN+L +       VKI DFGL S I  +G       
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIST 175
Query: 173 --LKTSCGSPNYAAPEVI-----SGKLYAGPEVDVWSCGVILYALLCGTLPF-------- 217
             L T CGS  Y APEV+        +Y     D+WS GVILY LL G  PF        
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234
Query: 218 ---DDENIPN----LFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIR 266
                E  P     LF+ I+ G Y  P    +H+S  A+DLI ++L+ D  +R++  ++ 
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294
Query: 267 QHPWFQAHLPRYLAVPPPDTMQQ 289
           QHPW Q   P    +P P  +Q+
Sbjct: 295 QHPWVQGCAPEN-TLPTPMVLQR 316

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 143/278 (51%), Gaps = 9/278 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   + +G G+ G V  A    TG +VAI+ +N   ++    +E +  EI ++R   +P+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 78
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+   +      +++VVMEY+  G L D + E   + E +     ++ +  +E+ H N V
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 137
Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRD+K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y GP+
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 196
Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
           VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 255 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 257 DVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 72/197 (36%), Positives = 113/197 (57%), Gaps = 11/197 (5%)
Query: 79  IIRLYEVIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V +CH   
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 177
Query: 138 VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 236
Query: 197 EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 237 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 289
Query: 256 PMKRITIPEIRQHPWFQ 272
           P  R T  EI+ HPW Q
Sbjct: 290 PSDRPTFEEIQNHPWMQ 306

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 146/273 (53%), Gaps = 12/273 (4%)
Query: 11  GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           G+ M   +Y + K +G G+FG+V++  H  +    A+K+L++ ++           E  I
Sbjct: 69  GLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDI 128
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGV 130
           +     P +++L+   +    +Y+VMEY+  G+L + ++    + E  A+ +  +++  +
Sbjct: 129 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLAL 187
Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVI 188
           +  H   ++HRD+KP+N+LLD   ++K+ADFG    M +   +   T+ G+P+Y +PEV+
Sbjct: 188 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVL 247
Query: 189 ---SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----PSHLS 241
               G  Y G E D WS GV L+ +L G  PF  +++   + KI     +L     + +S
Sbjct: 248 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEIS 307
Query: 242 PGARDLIPRMLIVDPMK--RITIPEIRQHPWFQ 272
             A++LI   L    ++  R  + EI+QHP+F+
Sbjct: 308 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 340

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 141/265 (53%), Gaps = 15/265 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GS G V IA    +G  VA+K ++ RK +  E+   +  E+ I+R + H +++ +Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 138
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                 +++VVME+++ G L D IV   R+ E++       ++  +   H   V+HRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
            +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GPEVD+WS 
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGPEVDIWSL 256
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPRMLIVDPM 257
           G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R+L+ DP 
Sbjct: 257 GIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPA 313
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVP 282
           +R T  E+ +HP+     P    VP
Sbjct: 314 QRATAAELLKHPFLAKAGPPASIVP 338

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 141/265 (53%), Gaps = 15/265 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GS G V IA    +G  VA+K ++ RK +  E+   +  E+ I+R + H +++ +Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 95
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                 +++VVME+++ G L D IV   R+ E++       ++  +   H   V+HRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
            +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GPEVD+WS 
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGPEVDIWSL 213
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPRMLIVDPM 257
           G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R+L+ DP 
Sbjct: 214 GIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPA 270
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVP 282
           +R T  E+ +HP+     P    VP
Sbjct: 271 QRATAAELLKHPFLAKAGPPASIVP 295

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 141/265 (53%), Gaps = 15/265 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GS G V IA    +G  VA+K ++ RK +  E+   +  E+ I+R + H +++ +Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 88
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                 +++VVME+++ G L D IV   R+ E++       ++  +   H   V+HRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
            +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GPEVD+WS 
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGPEVDIWSL 206
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPRMLIVDPM 257
           G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R+L+ DP 
Sbjct: 207 GIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPA 263
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVP 282
           +R T  E+ +HP+     P    VP
Sbjct: 264 QRATAAELLKHPFLAKAGPPASIVP 288

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 141/265 (53%), Gaps = 15/265 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GS G V IA    +G  VA+K ++ RK +  E+   +  E+ I+R + H +++ +Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 93
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                 +++VVME+++ G L D IV   R+ E++       ++  +   H   V+HRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
            +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GPEVD+WS 
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGPEVDIWSL 211
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPRMLIVDPM 257
           G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R+L+ DP 
Sbjct: 212 GIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPA 268
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVP 282
           +R T  E+ +HP+     P    VP
Sbjct: 269 QRATAAELLKHPFLAKAGPPASIVP 293

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 141/265 (53%), Gaps = 15/265 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GS G V IA    +G  VA+K ++ RK +  E+   +  E+ I+R + H +++ +Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 84
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                 +++VVME+++ G L D IV   R+ E++       ++  +   H   V+HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
            +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GPEVD+WS 
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGPEVDIWSL 202
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPRMLIVDPM 257
           G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R+L+ DP 
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPA 259
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVP 282
           +R T  E+ +HP+     P    VP
Sbjct: 260 QRATAAELLKHPFLAKAGPPASIVP 284

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 141/265 (53%), Gaps = 15/265 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GS G V IA    +G  VA+K ++ RK +  E+   +  E+ I+R + H +++ +Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 215
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                 +++VVME+++ G L D IV   R+ E++       ++  +   H   V+HRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
            +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GPEVD+WS 
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGPEVDIWSL 333
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPRMLIVDPM 257
           G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R+L+ DP 
Sbjct: 334 GIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPA 390
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVP 282
           +R T  E+ +HP+     P    VP
Sbjct: 391 QRATAAELLKHPFLAKAGPPASIVP 415

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 143/278 (51%), Gaps = 9/278 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   + +G G+ G V  A    TG +VAI+ +N   ++    +E +  EI ++R   +P+
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 79
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+   +      +++VVMEY+  G L D + E   + E +     ++ +  +E+ H N V
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 138
Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HR++K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y GP+
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 197
Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
           VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L +
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 257
Query: 255 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 258 DVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATK 295

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 142/278 (51%), Gaps = 9/278 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   + +G G+ G V  A    TG +VAI+ +N   ++    +E +  EI ++R   +P+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 78
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+   +      +++VVMEY+  G L D + E   + E +     ++ +  +E+ H N V
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 137
Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRD+K +N+LL    +VK+ DFG  + I  +        G+P + APEV++ K Y GP+
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAY-GPK 196
Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
           VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 255 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 257 DVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 142/278 (51%), Gaps = 9/278 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   + +G G+ G V  A    TG +VAI+ +N   ++    +E +  EI ++R   +P+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 78
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+   +      +++VVMEY+  G L D + E   + E +     ++ +  +E+ H N V
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 137
Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRD+K +N+LL    +VK+ DFG  + I  +        G+P + APEV++ K Y GP+
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY-GPK 196
Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
           VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 256
Query: 255 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 257 DVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 143/265 (53%), Gaps = 15/265 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GS G V IA    TG +VA+K ++ RK +  E+   +  E+ I+R + H +++ +Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRDYHHDNVVDMYS 109
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                 +++VVME+++ G L D IV   R+ E++       ++  + Y H   V+HRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
            +++LL S   +K++DFG  + + ++    K   G+P + APEVIS +L  G EVD+WS 
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVIS-RLPYGTEVDIWSL 227
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH------LSPGARDLIPRMLIVDPM 257
           G+++  ++ G  P+ +E      ++I+    +LP        +S   R  +  ML+ +P 
Sbjct: 228 GIMVIEMIDGEPPYFNEPPLQAMRRIRD---SLPPRVKDLHKVSSVLRGFLDLMLVREPS 284
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVP 282
           +R T  E+  HP+ +   P    VP
Sbjct: 285 QRATAQELLGHPFLKLAGPPSCIVP 309

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 142/278 (51%), Gaps = 9/278 (3%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   + +G G+ G V  A    TG +VAI+ +N   ++    +E +  EI ++R   +P+
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 79
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+   +      +++VVMEY+  G L D + E   + E +     ++ +  +E+ H N V
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 138
Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRD+K +N+LL    +VK+ DFG  + I  +        G+P + APEV++ K Y GP+
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY-GPK 197
Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
           VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L +
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 257
Query: 255 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 258 DVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATK 295

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 102/323 (31%), Positives = 157/323 (48%), Gaps = 44/323 (13%)
Query: 4   ASNRSSSGVDMFLPNYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
            S  S SG   F   Y+L +  LG G+  +V+   + +T  + A+KI+ ++      +  
Sbjct: 1   GSTDSFSG--RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRS 55
Query: 63  KVRREIKIL-RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN 121
           +V RE+++L +   H +++ L E  E     Y+V E ++ G +  +I ++    E EA  
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV 115
Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGL-SNIMRDGHF----- 172
             Q + S +++ H   + HRDLKPEN+L +       VKI DF L S I  +G       
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 173 --LKTSCGSPNYAAPEVI-----SGKLYAGPEVDVWSCGVILYALLCGTLPF-------- 217
             L T CGS  Y APEV+        +Y     D+WS GVILY LL G  PF        
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234
Query: 218 ---DDENIPN----LFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIR 266
                E  P     LF+ I+ G Y  P    +H+S  A+DLI ++L+ D  +R++  ++ 
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294
Query: 267 QHPWFQAHLPRYLAVPPPDTMQQ 289
           QHPW Q   P    +P P  +Q+
Sbjct: 295 QHPWVQGCAPEN-TLPTPMVLQR 316

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 145/271 (53%), Gaps = 16/271 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++++ K +G G+FG+V + +   T    A+KILN+ ++         R E  +L      
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRN 136
            I  L+   +  + +Y+VM+Y   G+L   + + + +L ED AR +  +++  ++  H+ 
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 210
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVI----SG 190
             VHRD+KP+N+LLD   ++++ADFG    M D   +++S   G+P+Y +PE++     G
Sbjct: 211 HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDG 270
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSH---LSPGAR 245
               GPE D WS GV +Y +L G  PF  E++   + KI      +  PSH   +S  A+
Sbjct: 271 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAK 330
Query: 246 DLIPRMLIVDPMKRI---TIPEIRQHPWFQA 273
           DLI R LI    +R+    I + ++H +F+ 
Sbjct: 331 DLIQR-LICSRERRLGQNGIEDFKKHAFFEG 360

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 144/271 (53%), Gaps = 16/271 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++++ K +G G+FG+V + +        A+KILN+ ++         R E  +L      
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRN 136
            I  L+   +  +++Y+VM+Y   G+L   + + + RL E+ AR +  +++  ++  H+ 
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT-SCGSPNYAAPEVIS----G 190
             VHRD+KP+N+L+D   ++++ADFG    +M DG    + + G+P+Y +PE++     G
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-----KGGIYTLPSHLSPGAR 245
           K   GPE D WS GV +Y +L G  PF  E++   + KI     +    T  + +S  A+
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 246 DLIPRMLIVDPMKRI---TIPEIRQHPWFQA 273
           DLI R LI     R+    I + ++HP+F  
Sbjct: 315 DLI-RRLICSREHRLGQNGIEDFKKHPFFSG 344

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 145/271 (53%), Gaps = 16/271 (5%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++++ K +G G+FG+V + +   T    A+KILN+ ++         R E  +L      
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRN 136
            I  L+   +  + +Y+VM+Y   G+L   + + + +L ED AR +  +++  ++  H+ 
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 194
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVI----SG 190
             VHRD+KP+N+LLD   ++++ADFG    M D   +++S   G+P+Y +PE++     G
Sbjct: 195 HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDG 254
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSH---LSPGAR 245
               GPE D WS GV +Y +L G  PF  E++   + KI      +  PSH   +S  A+
Sbjct: 255 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAK 314
Query: 246 DLIPRMLIVDPMKRI---TIPEIRQHPWFQA 273
           DLI R LI    +R+    I + ++H +F+ 
Sbjct: 315 DLIQR-LICSRERRLGQNGIEDFKKHAFFEG 344

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 142/266 (53%), Gaps = 12/266 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y++ K +G G+FG+V++  H  T    A+K+L++ ++           E  I+     P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            +++L+   +    +Y+VMEY+  G+L + ++    + E  AR +  +++  ++  H   
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVI---SGKL 192
            +HRD+KP+N+LLD   ++K+ADFG    M     ++  T+ G+P+Y +PEV+    G  
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLP--SHLSPGARDLI 248
           Y G E D WS GV LY +L G  PF  +++   + KI       T P  + +S  A++LI
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 308
Query: 249 PRMLIVDPMK--RITIPEIRQHPWFQ 272
              L    ++  R  + EI++H +F+
Sbjct: 309 CAFLTDREVRLGRNGVEEIKRHLFFK 334

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 142/266 (53%), Gaps = 12/266 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y++ K +G G+FG+V++  H  T    A+K+L++ ++           E  I+     P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            +++L+   +    +Y+VMEY+  G+L + ++    + E  AR +  +++  ++  H   
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVI---SGKL 192
            +HRD+KP+N+LLD   ++K+ADFG    M     ++  T+ G+P+Y +PEV+    G  
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 253
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLP--SHLSPGARDLI 248
           Y G E D WS GV LY +L G  PF  +++   + KI       T P  + +S  A++LI
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 313
Query: 249 PRMLIVDPMK--RITIPEIRQHPWFQ 272
              L    ++  R  + EI++H +F+
Sbjct: 314 CAFLTDREVRLGRNGVEEIKRHLFFK 339

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 142/266 (53%), Gaps = 12/266 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y++ K +G G+FG+V++  H  T    A+K+L++ ++           E  I+     P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            +++L+   +    +Y+VMEY+  G+L + ++    + E  AR +  +++  ++  H   
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVI---SGKL 192
            +HRD+KP+N+LLD   ++K+ADFG    M     ++  T+ G+P+Y +PEV+    G  
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 253
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLP--SHLSPGARDLI 248
           Y G E D WS GV LY +L G  PF  +++   + KI       T P  + +S  A++LI
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 313
Query: 249 PRMLIVDPMK--RITIPEIRQHPWFQ 272
              L    ++  R  + EI++H +F+
Sbjct: 314 CAFLTDREVRLGRNGVEEIKRHLFFK 339

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  121 bits (303), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 146/296 (49%), Gaps = 38/296 (12%)
Query: 11  GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           G   F+ N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +
Sbjct: 4   GSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISL 62
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIIS 128
           L+   HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ 
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQ 121
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAP 185
           G+ +CH + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y AP
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 179
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIY 234
           E++ G  Y    VD+WS G I   ++     F  D  I  LF+  +           G+ 
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 239
Query: 235 TLPSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           ++P +                  L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 240 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 146/296 (49%), Gaps = 38/296 (12%)
Query: 11  GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           G   F+ N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +
Sbjct: 4   GSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISL 62
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIIS 128
           L+   HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ 
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQ 121
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAP 185
           G+ +CH + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y AP
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 179
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIY 234
           E++ G  Y    VD+WS G I   ++     F  D  I  LF+  +           G+ 
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 239
Query: 235 TLPSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           ++P +                  L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 240 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 146/291 (50%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++   +L D++       +     +++  Q++ G+ +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKPENLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 120 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 147/291 (50%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 62
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++ S +L D++       +     +++  Q++ G+ +C
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 146/289 (50%), Gaps = 38/289 (13%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 65
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHR 135
           +I++L +VI T + +Y+V E++ S +L D++       +     +++  Q++ G+ +CH 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKL 192
           + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 193 YAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH-- 239
           Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 240 ----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                           L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 60/309 (19%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLF 74
           +++L   LG G++G V  A H  TG  VAIK     KI+  +      +  REIKIL+ F
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKILKHF 66
Query: 75  MHPHIIRLYEV-----IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
            H +II ++ +      E  +++Y++ E +++      ++    L +D  + F  Q +  
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           V+  H + V+HRDLKP NLL++S  ++K+ DFGL+ I+ +     +          E ++
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 190 GKLYAGPEV-----------DVWSCGVILYAL---------------------LCGTLPF 217
            + Y  PEV           DVWSCG IL  L                     + GT P 
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT-PH 243
Query: 218 DDENIPNLFK-KIKGGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEI 265
            D ++  +   + +  I +LP +           ++P   DL+ RML+ DP KRIT  E 
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 266 RQHPWFQAH 274
            +HP+ Q +
Sbjct: 304 LEHPYLQTY 312

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 60/309 (19%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLF 74
           +++L   LG G++G V  A H  TG  VAIK     KI+  +      +  REIKIL+ F
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKILKHF 66
Query: 75  MHPHIIRLYEV-----IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
            H +II ++ +      E  +++Y++ E +++      ++    L +D  + F  Q +  
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           V+  H + V+HRDLKP NLL++S  ++K+ DFGL+ I+ +     +          E ++
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 190 GKLYAGPEV-----------DVWSCGVILYAL---------------------LCGTLPF 217
            + Y  PEV           DVWSCG IL  L                     + GT P 
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT-PH 243
Query: 218 DDENIPNLFK-KIKGGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEI 265
            D ++  +   + +  I +LP +           ++P   DL+ RML+ DP KRIT  E 
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 266 RQHPWFQAH 274
            +HP+ Q +
Sbjct: 304 LEHPYLQTY 312

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 138/264 (52%), Gaps = 6/264 (2%)
Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
           D+   ++++ + +G GSFGKV I +   T    A+K +N++K         V +E++I++
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
              HP ++ L+   +   D+++V++ +  G+L  ++ +    +E+  + F  +++  ++Y
Sbjct: 71  GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDY 130
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
                ++HRD+KP+N+LLD   +V I DF ++ ++     + T  G+  Y APE+ S + 
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 193 YAGPE--VDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDL 247
            AG    VD WS GV  Y LL G  P+      +   +    +  + T PS  S     L
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250
Query: 248 IPRMLIVDPMKRIT-IPEIRQHPW 270
           + ++L  +P +R + + +++  P+
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPY 274

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 77/238 (32%), Positives = 126/238 (52%), Gaps = 10/238 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           YK+   LG G    V +AE  +   KVAIK +     +  E  ++  RE+       H +
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+ + +V E     Y+VMEY++   L +YI   G L  D A NF  QI+ G+++ H   +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAGP 196
           VHRD+KP+N+L+DS   +KI DFG++  + +    +T+   G+  Y +PE   G+  A  
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE--ATD 190
Query: 197 E-VDVWSCGVILYALLCGTLPFDDENIPNL-FKKIKGGIYTLPSHLSPGARDLIPRML 252
           E  D++S G++LY +L G  PF+ E   ++  K I+  +     +++   R  IP+ L
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV----PNVTTDVRKDIPQSL 244

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 60/309 (19%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLF 74
           +++L   LG G++G V  A H  TG  VAIK     KI+  +      +  REIKIL+ F
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKILKHF 66
Query: 75  MHPHIIRLYEV-----IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
            H +II ++ +      E  +++Y++ E +++      ++    L +D  + F  Q +  
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           V+  H + V+HRDLKP NLL++S  ++K+ DFGL+ I+ +     +          E ++
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 190 GKLYAGPEV-----------DVWSCGVILYAL---------------------LCGTLPF 217
            + Y  PEV           DVWSCG IL  L                     + GT P 
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT-PH 243
Query: 218 DDENIPNLFK-KIKGGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEI 265
            D ++  +   + +  I +LP +           ++P   DL+ RML+ DP KRIT  E 
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 266 RQHPWFQAH 274
            +HP+ Q +
Sbjct: 304 LEHPYLQTY 312

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 120
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKPENLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 120
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKPENLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 62
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 121
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKPENLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 122 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 143/289 (49%), Gaps = 38/289 (13%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 65
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           +I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +CH 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHS 124
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKL 192
           + V+HRDLKPENLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 193 YAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH-- 239
           Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 240 ----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                           L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 63
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E+V     +  D     G +     +++  Q++ G+ +C
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 122
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLSFC 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 146/295 (49%), Gaps = 40/295 (13%)
Query: 12  VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
           VDM   N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L
Sbjct: 4   VDM--ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLL 60
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISG 129
           +   HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G
Sbjct: 61  KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQG 119
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPE 186
           + +CH + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPE 177
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYT 235
           ++ G  Y    VD+WS G I   ++     F  D  I  LF+  +           G+ +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 237
Query: 236 LPSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           +P +                  L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 238 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 118
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 143/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E+V        D     G +     +++  Q++ G+ +C
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTG-IPLPLIKSYLFQLLQGLAFC 118
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 120
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 178
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 63
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 122
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 118
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 38/289 (13%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 61
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           +I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +CH 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHS 120
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKL 192
           + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 193 YAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH-- 239
           Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 240 ----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                           L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 62
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 121
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 38/289 (13%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   HP
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 66
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           +I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +CH 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHS 125
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKL 192
           + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 193 YAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH-- 239
           Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +  
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 243
Query: 240 ----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                           L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 120
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 120
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 38/289 (13%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 65
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           +I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +CH 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHS 124
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKL 192
           + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 193 YAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH-- 239
           Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 240 ----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                           L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 38/289 (13%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 64
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           +I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +CH 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHS 123
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKL 192
           + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 193 YAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH-- 239
           Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 240 ----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                           L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 118
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 142/289 (49%), Gaps = 38/289 (13%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 65
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           +I++L +VI T + +Y+V E++        D     G +     +++  Q++ G+ +CH 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTG-IPLPLIKSYLFQLLQGLAFCHS 124
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKL 192
           + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 193 YAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH-- 239
           Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 240 ----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                           L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 147/288 (51%), Gaps = 24/288 (8%)
Query: 11  GVDMFLP--NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI 68
           G DM +P  +  + + +G GSFG V  AE    G  VA+KIL  +      + E +R E+
Sbjct: 29  GDDMDIPWCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLR-EV 85
Query: 69  KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEAR--NFFQQ 125
            I++   HP+I+     +  P ++ +V EY+  G L+  + + G R Q DE R  +    
Sbjct: 86  AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 126 IISGVEYCH-RNM-VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPN 181
           +  G+ Y H RN  +VHRDLK  NLL+D K+ VK+ DFGLS  ++   FL  K + G+P 
Sbjct: 146 VAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPE 204
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSH 239
           + APEV+  +  +  + DV+S GVIL+ L     P+ + N   +   +  K     +P +
Sbjct: 205 WMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQ--HPWFQAHLPRYLAVPPPD 285
           L+P    +I      +P KR +   I     P  ++      AVPPP+
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS------AVPPPN 305

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 129/262 (49%), Gaps = 27/262 (10%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG GS+G V  A H  TG  VAIK     ++      +++ +EI I++    PH+++ Y 
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
                +D+++VMEY  +G + D I  + + L EDE     Q  + G+EY H    +HRD+
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDI 151
Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWS 202
           K  N+LL+++ + K+ADFG++  + D    +    G+P + APEVI    Y     D+WS
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGY-NCVADIWS 210
Query: 203 CGVILYALLCGTLPFDD-----------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
            G+    +  G  P+ D            N P  F+K        P   S    D + + 
Sbjct: 211 LGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK--------PELWSDNFTDFVKQC 262
Query: 252 LIVDPMKRITIPEIRQHPWFQA 273
           L+  P +R T  ++ QHP+ ++
Sbjct: 263 LVKSPEQRATATQLLQHPFVRS 284

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 143/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+  + R   +   +     REI +L+   
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 143/291 (49%), Gaps = 38/291 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + +G G++G V  A + LTG  VA+  + R   +   +     REI +L+   
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           HP+I++L +VI T + +Y+V E++     +  D     G +     +++  Q++ G+ +C
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 118
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISG 190
           H + V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH 239
             Y    VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 93/288 (32%), Positives = 148/288 (51%), Gaps = 24/288 (8%)
Query: 11  GVDMFLP--NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI 68
           G DM +P  +  + + +G GSFG V  AE    G  VA+KIL  +      + E +R E+
Sbjct: 29  GDDMDIPWCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLR-EV 85
Query: 69  KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEAR--NFFQQ 125
            I++   HP+I+     +  P ++ +V EY+  G L+  + + G R Q DE R  +    
Sbjct: 86  AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 126 IISGVEYCH-RNM-VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPN 181
           +  G+ Y H RN  +VHR+LK  NLL+D K+ VK+ DFGLS  ++   FL  K++ G+P 
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPE 204
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSH 239
           + APEV+  +  +  + DV+S GVIL+ L     P+ + N   +   +  K     +P +
Sbjct: 205 WMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQ--HPWFQAHLPRYLAVPPPD 285
           L+P    +I      +P KR +   I     P  ++      AVPPP+
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS------AVPPPN 305

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 141/276 (51%), Gaps = 19/276 (6%)
Query: 11  GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           G D FL      + LG G FG+V   +   TG   A K LN++++K  +  +    E KI
Sbjct: 183 GEDWFLDF----RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQI 126
           L       I+ L    ET +D+ +VM  +  G++  +I     +    QE  A  +  QI
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAP 185
           +SG+E+ H+  +++RDLKPEN+LLD   NV+I+D GL+  ++ G    K   G+P + AP
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPN--LFKKIKGGIYTLPSHLS 241
           E++ G+ Y    VD ++ GV LY ++    PF    E + N  L +++     T P   S
Sbjct: 359 ELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 242 PGARDLIPRMLIVDPMKRITIPE-----IRQHPWFQ 272
           P ++D    +L  DP KR+   +     +R HP F+
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 141/276 (51%), Gaps = 19/276 (6%)
Query: 11  GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           G D FL      + LG G FG+V   +   TG   A K LN++++K  +  +    E KI
Sbjct: 183 GEDWFLDF----RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQI 126
           L       I+ L    ET +D+ +VM  +  G++  +I     +    QE  A  +  QI
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAP 185
           +SG+E+ H+  +++RDLKPEN+LLD   NV+I+D GL+  ++ G    K   G+P + AP
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPN--LFKKIKGGIYTLPSHLS 241
           E++ G+ Y    VD ++ GV LY ++    PF    E + N  L +++     T P   S
Sbjct: 359 ELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 242 PGARDLIPRMLIVDPMKRITIPE-----IRQHPWFQ 272
           P ++D    +L  DP KR+   +     +R HP F+
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 141/276 (51%), Gaps = 19/276 (6%)
Query: 11  GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           G D FL      + LG G FG+V   +   TG   A K LN++++K  +  +    E KI
Sbjct: 183 GEDWFLDF----RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQI 126
           L       I+ L    ET +D+ +VM  +  G++  +I     +    QE  A  +  QI
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAP 185
           +SG+E+ H+  +++RDLKPEN+LLD   NV+I+D GL+  ++ G    K   G+P + AP
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPN--LFKKIKGGIYTLPSHLS 241
           E++ G+ Y    VD ++ GV LY ++    PF    E + N  L +++     T P   S
Sbjct: 359 ELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 242 PGARDLIPRMLIVDPMKRITIPE-----IRQHPWFQ 272
           P ++D    +L  DP KR+   +     +R HP F+
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 141/276 (51%), Gaps = 19/276 (6%)
Query: 11  GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           G D FL      + LG G FG+V   +   TG   A K LN++++K  +  +    E KI
Sbjct: 183 GEDWFLDF----RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQI 126
           L       I+ L    ET +D+ +VM  +  G++  +I     +    QE  A  +  QI
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAP 185
           +SG+E+ H+  +++RDLKPEN+LLD   NV+I+D GL+  ++ G    K   G+P + AP
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPN--LFKKIKGGIYTLPSHLS 241
           E++ G+ Y    VD ++ GV LY ++    PF    E + N  L +++     T P   S
Sbjct: 359 ELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 242 PGARDLIPRMLIVDPMKRITIPE-----IRQHPWFQ 272
           P ++D    +L  DP KR+   +     +R HP F+
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 134/266 (50%), Gaps = 12/266 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            ++  + LG G FG+V   +   TG   A K L +++IK  + E     E +IL      
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHR 135
            ++ L    ET   + +V+  +  G+L  +I   G+    EAR  F   +I  G+E  HR
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +V+RDLKPEN+LLD   +++I+D GL+  + +G  +K   G+  Y APEV+  + Y  
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLIPRM 251
              D W+ G +LY ++ G  PF         ++++  +  +P       SP AR L  ++
Sbjct: 365 -SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
Query: 252 LIVDPMKRI-----TIPEIRQHPWFQ 272
           L  DP +R+     +  E+++HP F+
Sbjct: 424 LCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 143/296 (48%), Gaps = 43/296 (14%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+    +G G++G V  +    +G K+A+K L+R   +++   ++  RE+++L+   H +
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 111
Query: 79  IIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
           +I L +V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y
Sbjct: 112 VIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKY 169
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
            H   ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   +
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWM 227
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------KGGIYTLPSH----- 239
           +    VD+WS G I+  LL G   F   +  N  ++I           I  +PSH     
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNY 287
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 276
                              +P A DL+ +ML++D  KRIT  E   HP+F Q H P
Sbjct: 288 INSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDP 343

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 134/266 (50%), Gaps = 12/266 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            ++  + LG G FG+V   +   TG   A K L +++IK  + E     E +IL      
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHR 135
            ++ L    ET   + +V+  +  G+L  +I   G+    EAR  F   +I  G+E  HR
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +V+RDLKPEN+LLD   +++I+D GL+  + +G  +K   G+  Y APEV+  + Y  
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLIPRM 251
              D W+ G +LY ++ G  PF         ++++  +  +P       SP AR L  ++
Sbjct: 365 -SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
Query: 252 LIVDPMKRI-----TIPEIRQHPWFQ 272
           L  DP +R+     +  E+++HP F+
Sbjct: 424 LCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 131/266 (49%), Gaps = 12/266 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y + + LG G FG V       +      K +   K+K  + +  V++EI IL +  H +
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTD-QVLVKKEISILNIARHRN 62
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNM 137
           I+ L+E  E+  ++ ++ E++   ++F+ I      L E E  ++  Q+   +++ H + 
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 138 VVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           + H D++PEN++  ++ +  +KI +FG +  ++ G   +    +P Y APEV    + + 
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
              D+WS G ++Y LL G  PF  E    + + I    YT        +S  A D + R+
Sbjct: 183 A-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPR 277
           L+ +   R+T  E  QHPW +  + R
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIER 267

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 92/318 (28%), Positives = 143/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        ++    +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++C  + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 138/285 (48%), Gaps = 38/285 (13%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y+L + +G G+   V+ A  A    KVAIK +N  K +   M+E + +EI+ +    HP
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-SMDE-LLKEIQAMSQCHHP 68
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFD---YIVEKGR-----LQEDEARNFFQQIISG 129
           +I+  Y       ++++VM+ +  G + D   +IV KG      L E       ++++ G
Sbjct: 69  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL------KTSCGSPNYA 183
           +EY H+N  +HRD+K  N+LL    +V+IADFG+S  +  G  +      KT  G+P + 
Sbjct: 129 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL---PSHL 240
           APEV+        + D+WS G+    L  G  P+      + +  +K  + TL   P  L
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIELATGAAPY------HKYPPMKVLMLTLQNDPPSL 242
Query: 241 SPGARD-------------LIPRMLIVDPMKRITIPEIRQHPWFQ 272
             G +D             +I   L  DP KR T  E+ +H +FQ
Sbjct: 243 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 287

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 137/285 (48%), Gaps = 38/285 (13%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y+L + +G G+   V+ A  A    KVAIK +N  K +   M+E + +EI+ +    HP
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-SMDE-LLKEIQAMSQCHHP 73
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFD---YIVEKGR-----LQEDEARNFFQQIISG 129
           +I+  Y       ++++VM+ +  G + D   +IV KG      L E       ++++ G
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------HFLKTSCGSPNYA 183
           +EY H+N  +HRD+K  N+LL    +V+IADFG+S  +  G         KT  G+P + 
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL---PSHL 240
           APEV+        + D+WS G+    L  G  P+      + +  +K  + TL   P  L
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPY------HKYPPMKVLMLTLQNDPPSL 247
Query: 241 SPGARD-------------LIPRMLIVDPMKRITIPEIRQHPWFQ 272
             G +D             +I   L  DP KR T  E+ +H +FQ
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 91/318 (28%), Positives = 144/318 (45%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ ++++  
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +      +++   L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHERMSYLLYQMLVG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS GVI+  ++ G + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 145/300 (48%), Gaps = 48/300 (16%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           P Y     +G G++G V  A   L   +VAIK ++    ++    ++  REIKIL  F H
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYXQRTLREIKILLRFRH 84
Query: 77  PHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
            +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ G++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILRGLK 142
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEV 187
           Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 188 ISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-IPNL 225
           +         +D+WS G IL  +L                      G+   +D N I NL
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 226 FKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
             K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 263 --KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   L   +VAI     RKI   E +   ++  REIKIL  
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAI-----RKISPFEHQTYCQRTLREIKILLR 81
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 139
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 260 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 272 QAH 274
           + +
Sbjct: 318 EQY 320

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 91/318 (28%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 86
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 143
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 144 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 203
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++C  + F      D  N          P   KK++  + 
Sbjct: 204 GMGYK-ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 262
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 263 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 322
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 323 HPYINVWYDPSEAEAPPP 340

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   L   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 81
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 139
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 260 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 272 QAH 274
           + +
Sbjct: 318 EQY 320

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 139/290 (47%), Gaps = 43/290 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 85  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 260
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 276
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   L   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 28  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 82
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 140
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 261 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318
Query: 272 QAH 274
           + +
Sbjct: 319 EQY 321

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 91/318 (28%), Positives = 144/318 (45%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ ++++  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +      +++   L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHERMSYLLYQMLVG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS GVI+  ++ G + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 91/318 (28%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 76  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 132
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++C  + F      D  N          P   KK++  + 
Sbjct: 193 GMGYK-ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 251
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 252 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 311
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 312 HPYINVWYDPSEAEAPPP 329

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 140/301 (46%), Gaps = 50/301 (16%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   L   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 21  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 75
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 133
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC------------------GTLPFDDENIPNLF 226
           PE++         +D+WS G IL  +L                   G L   ++   N  
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCI 253
Query: 227 KKIKGGIYTLP---------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQA 273
             +K   Y L          + L P A     DL+ +ML  +P KRI + +   HP+ + 
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313
Query: 274 H 274
           +
Sbjct: 314 Y 314

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/303 (29%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y   + +G G++G V  A   +   +VAIK     KI   E +   ++  REI+IL  
Sbjct: 43  PRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIK-----KISPFEHQTYCQRTLREIQILLR 97
Query: 74  FMHPHIIRLYEVI-----ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H ++I + +++     E   D+Y+V + +++ +L+  +++  +L  D    F  QI+ 
Sbjct: 98  FRHENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYK-LLKSQQLSNDHICYFLYQILR 155
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLL+++  ++KI DFGL+ I    H    FL     +  Y A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRA 215
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 223 PNLFKKIKGGIYTLPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            N+  K +  + +LPS                A DL+ RML  +P KRIT+ E   HP+ 
Sbjct: 276 INM--KARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYL 333
Query: 272 QAH 274
           + +
Sbjct: 334 EQY 336

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   L   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 21  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 75
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 133
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 253
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 254 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311
Query: 272 QAH 274
           + +
Sbjct: 312 EQY 314

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   L   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 28  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 82
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 140
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 261 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318
Query: 272 QAH 274
           + +
Sbjct: 319 EQY 321

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   L   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 29  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 83
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 84  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 141
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 261
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 262 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 319
Query: 272 QAH 274
           + +
Sbjct: 320 EQY 322

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   L   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 20  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 74
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 75  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 132
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 252
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 253 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 310
Query: 272 QAH 274
           + +
Sbjct: 311 EQY 313

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   L   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 81
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 139
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 260 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 272 QAH 274
           + +
Sbjct: 318 EQY 320

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   L   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 81
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 139
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 260 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 272 QAH 274
           + +
Sbjct: 318 EQY 320

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 141/298 (47%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 109 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXGXVATRWYRAPEIMLNWMHYNQTV 224
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 284
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 285 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 342

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 91/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        ++    +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++C  + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 NYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 142/300 (47%), Gaps = 47/300 (15%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRD--GHFLKTSCGSPNYAAPEVISGKLYAGP 196
           +HRDLKP NL ++    +KI DFGL+    D    F+ T      Y APE++   ++   
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRW----YRAPEIMLNWMHYNQ 202
Query: 197 EVDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GI 233
            VD+WS G I+  LL G   F   +                  L KKI           +
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 234 YTLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
             +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 141/298 (47%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 98
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 99  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 156
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 157 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 214
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 215 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 274
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 275 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 332

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 141/298 (47%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 95  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 270
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 271 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 328

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 141/298 (47%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 139/290 (47%), Gaps = 43/290 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 85  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 260
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 276
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 142/300 (47%), Gaps = 47/300 (15%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRD--GHFLKTSCGSPNYAAPEVISGKLYAGP 196
           +HRDLKP NL ++    +KI DFGL+    D    F+ T      Y APE++   ++   
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRW----YRAPEIMLNWMHYNQ 202
Query: 197 EVDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GI 233
            VD+WS G I+  LL G   F   +                  L KKI           +
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 234 YTLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
             +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 263 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 141/298 (47%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 109 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 224
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 284
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 285 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 342

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   L   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 81
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKCQHLSNDHICYFLYQILR 139
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 260 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 272 QAH 274
           + +
Sbjct: 318 EQY 320

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 141/298 (47%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 108 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 165
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 223
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 224 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 283
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 284 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 341

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 86/292 (29%), Positives = 140/292 (47%), Gaps = 47/292 (16%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 85  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRD--GHFLKTSCGSPNYAAPEVISGKLYAGP 196
           +HRDLKP NL ++    +KI DFGL+    D    F+ T      Y APE++   ++   
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRW----YRAPEIMLNWMHYNQ 198
Query: 197 EVDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GI 233
            VD+WS G I+  LL G   F   +                  L KKI           +
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 234 YTLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 276
             +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P
Sbjct: 259 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 128/278 (46%), Gaps = 49/278 (17%)
Query: 13  DMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI- 70
           +  + +YK+  + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 64
Query: 71  LRLFMHPHIIRLYEVIET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +     G     SC    
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTGEKYDKSC---- 179
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
                            D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 180 -----------------DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
               S +S   + LI  +L  +P +R+TI E   HPW 
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 92/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++ G + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 92/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++ G + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 91/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   +   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 23  PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 77
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 135
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 256 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 272 QAH 274
           + +
Sbjct: 314 EQY 316

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 142/303 (46%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   +   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 23  PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 77
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 135
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPF----------------------DDENI 222
           PE++         +D+WS G IL  +L     F                      D   I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 256 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 272 QAH 274
           + +
Sbjct: 314 EQY 316

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 143/286 (50%), Gaps = 44/286 (15%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A++   G   A+K +   K ++  +     REI IL+   H +I++LY+
Sbjct: 10  IGEGTYGVVYKAQNNY-GETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 85  VIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           VI T   + +V E++     +L D  V +G L+   A++F  Q+++G+ YCH   V+HRD
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 143 LKPENLLLDSKWNVKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           LKP+NLL++ +  +KIADFGL+      + +  H + T      Y AP+V+ G       
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW----YRAPDVLMGSKKYSTT 181
Query: 198 VDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIK----GGIY 234
           +D+WS G I   ++ GT  F                   + +N PN+ +  K      +Y
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 235 ------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
                 +    L     DL+ +ML +DP +RIT  +  +H +F+ +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 92/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCG 139
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++ G + F      D  N          P   KK++  + 
Sbjct: 200 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 319 HPYINVWYDPSEAEAPPP 336

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 91/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   +   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 25  PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 79
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 137
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 258 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 272 QAH 274
           + +
Sbjct: 316 EQY 318

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 90/318 (28%), Positives = 143/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ ++++  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +      +++   L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++ G + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 143/286 (50%), Gaps = 44/286 (15%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A++   G   A+K +   K ++  +     REI IL+   H +I++LY+
Sbjct: 10  IGEGTYGVVYKAQNNY-GETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 85  VIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           VI T   + +V E++     +L D  V +G L+   A++F  Q+++G+ YCH   V+HRD
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 143 LKPENLLLDSKWNVKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           LKP+NLL++ +  +KIADFGL+      + +  H + T      Y AP+V+ G       
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW----YRAPDVLMGSKKYSTT 181
Query: 198 VDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIK----GGIY 234
           +D+WS G I   ++ GT  F                   + +N PN+ +  K      +Y
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 235 ------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
                 +    L     DL+ +ML +DP +RIT  +  +H +F+ +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 91/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   +   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 43  PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 97
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 155
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 276 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333
Query: 272 QAH 274
           + +
Sbjct: 334 EQY 336

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 91/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   +   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 23  PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 77
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 135
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 256 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 272 QAH 274
           + +
Sbjct: 314 EQY 316

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 149/311 (47%), Gaps = 41/311 (13%)
Query: 4   ASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK 63
           +S R +      +  Y+  + +G G++G V  A+ +  G  VA+K + R   ++  +   
Sbjct: 8   SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAEDEGIPST 65
Query: 64  VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF 123
             REI +L+   HP+I+ L +VI +   + +V E+++          K  LQ+ + + + 
Sbjct: 66  AIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN-----IMRDGHFLKTSCG 178
            Q++ GV +CH++ ++HRDLKP+NLL++S   +K+ADFGL+      +    H + T   
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW- 184
Query: 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKG--- 231
              Y AP+V+ G       VD+WS G I   ++ G   F    DD+ +P +F  +     
Sbjct: 185 ---YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241
Query: 232 ----GIYTLP---------------SHLSPG----ARDLIPRMLIVDPMKRITIPEIRQH 268
                +  LP               S + PG      DL+  ML  DP KRI+  +   H
Sbjct: 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301
Query: 269 PWFQAHLPRYL 279
           P+F+   P+ +
Sbjct: 302 PYFKDLDPQIM 312

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 142/303 (46%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   +   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 23  PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 77
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 135
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPF----------------------DDENI 222
           PE++         +D+WS G IL  +L     F                      D   I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 256 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 272 QAH 274
           + +
Sbjct: 314 EQY 316

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 91/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   +   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 31  PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 85
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 86  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 143
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 263
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 264 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 321
Query: 272 QAH 274
           + +
Sbjct: 322 EQY 324

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 91/303 (30%), Positives = 145/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   +   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 23  PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 77
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 135
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 256 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 272 QAH 274
           + +
Sbjct: 314 EQY 316

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 148/309 (47%), Gaps = 41/309 (13%)
Query: 4   ASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK 63
           +S R +      +  Y+  + +G G++G V  A+ +  G  VA+K + R   ++  +   
Sbjct: 8   SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAEDEGIPST 65
Query: 64  VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF 123
             REI +L+   HP+I+ L +VI +   + +V E+++          K  LQ+ + + + 
Sbjct: 66  AIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN-----IMRDGHFLKTSCG 178
            Q++ GV +CH++ ++HRDLKP+NLL++S   +K+ADFGL+      +    H + T   
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW- 184
Query: 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKG--- 231
              Y AP+V+ G       VD+WS G I   ++ G   F    DD+ +P +F  +     
Sbjct: 185 ---YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241
Query: 232 ----GIYTLP---------------SHLSPG----ARDLIPRMLIVDPMKRITIPEIRQH 268
                +  LP               S + PG      DL+  ML  DP KRI+  +   H
Sbjct: 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301
Query: 269 PWFQAHLPR 277
           P+F+   P+
Sbjct: 302 PYFKDLDPQ 310

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 90/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +      +++   L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++ G + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 90/318 (28%), Positives = 143/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ ++++  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +      +++   L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHERMSYLLYQMLVG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++ G + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 92/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++ G + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 133/274 (48%), Gaps = 24/274 (8%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++++ K +G G+F +V + +   TG   A+KI+N+  +         R E  +L      
Sbjct: 62  DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRN 136
            I +L+   +  + +Y+VMEY   G+L   + + G R+  + AR +  +I+  ++  HR 
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT--SCGSPNYAAPEVISG---- 190
             VHRD+KP+N+LLD   ++++ADFG    +R    +++  + G+P+Y +PE++      
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 191 --KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS------- 241
                 GPE D W+ GV  Y +  G  PF  ++    + K    I     HLS       
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK----IVHYKEHLSLPLVDEG 297
Query: 242 --PGARDLIPRMLIVDPMK--RITIPEIRQHPWF 271
               ARD I R+L     +  R    + R HP+F
Sbjct: 298 VPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFF 331

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 91/303 (30%), Positives = 144/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   +   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 25  PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-----KISPFEHQTYCQRTLREIKILLA 79
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 137
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 258 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 272 QAH 274
             +
Sbjct: 316 AQY 318

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 90/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +      +++   L  +       Q++ G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++ G + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 318 HPYINVWYDPSEAEAPPP 335

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 92/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 83
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCG 140
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 141 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVIL 200
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++ G + F      D  N          P   KK++  + 
Sbjct: 201 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 259
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
           T                 P  L P            ARDL+ +ML++D  KRI++ E  Q
Sbjct: 260 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 319
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P     PPP
Sbjct: 320 HPYINVWYDPSEAEAPPP 337

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 176
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 237 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 356 HPYINVWYDPAEVEAPPP 373

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 176
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 237 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 356 HPYINVWYDPAEVEAPPP 373

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 141/294 (47%), Gaps = 29/294 (9%)
Query: 12  VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
           + + + ++ + + +G G FG+V     A TG   A+K L++++IK  + E     E  +L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 72  RLFMH---PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
            L      P I+ +     TP  +  +++ +  G+L  ++ + G   E + R +  +II 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 303
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYAA 184
           G+E+ H   VV+RDLKP N+LLD   +V+I+D GL+       F K     S G+  Y A
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMA 358
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLS 241
           PEV+   +      D +S G +L+ LL G  PF      +  +  +  +     LP   S
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 418
Query: 242 PGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQA------HLPRYLAVPPP 284
           P  R L+  +L  D  +R+        E+++ P+F++       L +Y   PPP
Sbjct: 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY---PPP 469

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 141/294 (47%), Gaps = 29/294 (9%)
Query: 12  VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
           + + + ++ + + +G G FG+V     A TG   A+K L++++IK  + E     E  +L
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 72  RLFMH---PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
            L      P I+ +     TP  +  +++ +  G+L  ++ + G   E + R +  +II 
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 302
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYAA 184
           G+E+ H   VV+RDLKP N+LLD   +V+I+D GL+       F K     S G+  Y A
Sbjct: 303 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMA 357
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLS 241
           PEV+   +      D +S G +L+ LL G  PF      +  +  +  +     LP   S
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 417
Query: 242 PGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQA------HLPRYLAVPPP 284
           P  R L+  +L  D  +R+        E+++ P+F++       L +Y   PPP
Sbjct: 418 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY---PPP 468

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 258 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 318 HPYINVWYDPAEVEAPPP 335

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 80
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 137
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 138 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 197
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 198 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 256
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 257 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 316
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 317 HPYINVWYDPAEVEAPPP 334

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 141/295 (47%), Gaps = 29/295 (9%)
Query: 11  GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
            + + + ++ + + +G G FG+V     A TG   A+K L++++IK  + E     E  +
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 71  LRLFMH---PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
           L L      P I+ +     TP  +  +++ +  G+L  ++ + G   E + R +  +II
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYA 183
            G+E+ H   VV+RDLKP N+LLD   +V+I+D GL+       F K     S G+  Y 
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYM 357
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHL 240
           APEV+   +      D +S G +L+ LL G  PF      +  +  +  +     LP   
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417
Query: 241 SPGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQA------HLPRYLAVPPP 284
           SP  R L+  +L  D  +R+        E+++ P+F++       L +Y   PPP
Sbjct: 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY---PPP 469

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 141/295 (47%), Gaps = 29/295 (9%)
Query: 11  GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
            + + + ++ + + +G G FG+V     A TG   A+K L++++IK  + E     E  +
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 71  LRLFMH---PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
           L L      P I+ +     TP  +  +++ +  G+L  ++ + G   E + R +  +II
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYA 183
            G+E+ H   VV+RDLKP N+LLD   +V+I+D GL+       F K     S G+  Y 
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYM 357
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHL 240
           APEV+   +      D +S G +L+ LL G  PF      +  +  +  +     LP   
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417
Query: 241 SPGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQA------HLPRYLAVPPP 284
           SP  R L+  +L  D  +R+        E+++ P+F++       L +Y   PPP
Sbjct: 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY---PPP 469

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 258 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 318 HPYINVWYDPAEVEAPPP 335

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 139
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 200 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 258
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 259 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 318
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 319 HPYINVWYDPAEVEAPPP 336

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 139
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 200 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 258
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 259 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 318
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 319 HPYINVWYDPAEVEAPPP 336

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 132
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 193 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 251
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 252 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 311
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 312 HPYINVWYDPAEVEAPPP 329

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 132
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 193 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 251
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 252 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 311
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 312 HPYINVWYDPAEVEAPPP 329

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 131
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 192 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 311 HPYINVWYDPAEVEAPPP 328

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 143/320 (44%), Gaps = 58/320 (18%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A   + G  VA+K L+R   +N    ++  RE+ +L+   
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR--NFFQQII 127
           H +II L  V      +E   D+Y+VME + +      + +   ++ D  R      Q++
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQML 136
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
            G+++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 196
Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------ 235
           I G  YA   VD+WS G I+  L+ G + F   +  + + K+   + T            
Sbjct: 197 ILGMGYAA-NVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPT 255
Query: 236 -------------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEI 265
                               P  + P            ARDL+ +ML++DP KRI++ E 
Sbjct: 256 VRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 315
Query: 266 RQHPWFQA-HLPRYLAVPPP 284
            +HP+    + P     PPP
Sbjct: 316 LRHPYITVWYDPAEAEAPPP 335

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVI--QMELDHERMSYLLYQMLXG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 258 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 318 HPYINVWYDPAEVEAPPP 335

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVI--QMELDHERMSYLLYQMLXG 131
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 192 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 311 HPYINVWYDPAEVEAPPP 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVI--QMELDHERMSYLLYQMLXG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 258 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 317
Query: 268 HPWFQA-HLPRYLAVPPP 284
           HP+    + P  +  PPP
Sbjct: 318 HPYINVWYDPAEVEAPPP 335

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 141/301 (46%), Gaps = 50/301 (16%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   +   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 25  PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-----KISPFEHQTYCQRTLREIKILLA 79
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V + +++ +L+  +++   L  D    F  QI+ 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSNDHICYFLYQILR 137
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG------------G 232
           PE++         +D+WS G IL  +L     F  ++  +    I G            G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCG 257
Query: 233 I--------YTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQA 273
           I         +LP       + L P A     DL+ +ML  +P KRI + +   HP+   
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317
Query: 274 H 274
           +
Sbjct: 318 Y 318

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 135/308 (43%), Gaps = 49/308 (15%)
Query: 9   SSGVDMFLPN--------YKLGKTLGIGSFGKVKIAEHALTGHKVAIKIL----NRRKIK 56
           SSGVD+   N        Y+    +G GS+G V    +  TG  VAIK      + + +K
Sbjct: 9   SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK 68
Query: 57  NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE 116
            + M     REIK+L+   H +++ L EV +     Y+V E+V    L D  +    L  
Sbjct: 69  KIAM-----REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDY 123
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKT 175
              + +  QII+G+ +CH + ++HRD+KPEN+L+     VK+ DFG +  +   G     
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIY 234
              +  Y APE++ G +  G  VDVW+ G ++  +  G   F  D +I  L+  +     
Sbjct: 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243
Query: 235 TLPSH------------------------------LSPGARDLIPRMLIVDPMKRITIPE 264
            +P H                              LS    DL  + L +DP KR    E
Sbjct: 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303
Query: 265 IRQHPWFQ 272
           +  H +FQ
Sbjct: 304 LLHHDFFQ 311

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 142/286 (49%), Gaps = 44/286 (15%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A++   G   A+K +   K ++  +     REI IL+   H +I++LY+
Sbjct: 10  IGEGTYGVVYKAQNNY-GETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 85  VIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           VI T   + +V E++     +L D  V +G L+   A++F  Q+++G+ YCH   V+HRD
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 143 LKPENLLLDSKWNVKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           LKP+NLL++ +  +KIADFGL+      + +  H + T      Y AP+V+ G       
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW----YRAPDVLMGSKKYSTT 181
Query: 198 VDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIKGG----IY 234
           +D+WS G I   ++ G   F                   + +N PN+ +  K      +Y
Sbjct: 182 IDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 235 ------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
                 +    L     DL+ +ML +DP +RIT  +  +H +F+ +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/303 (30%), Positives = 143/303 (47%), Gaps = 54/303 (17%)
Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
           P Y     +G G++G V  A   +   +VAIK     KI   E +   ++  REIKIL  
Sbjct: 43  PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 97
Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           F H +II + ++I  P+     D+Y+V  ++   +L+  +++   L  D    F  QI+ 
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYLVT-HLMGADLYK-LLKTQHLSNDHICYFLYQILR 155
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
           G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN-I 222
           PE++         +D+WS G IL  +L                      G+   +D N I
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 223 PNLFKKIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF 271
            NL  K +  + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ 
Sbjct: 276 INL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333
Query: 272 QAH 274
           + +
Sbjct: 334 EQY 336

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TGH+VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DF L+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFYLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNAMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 143/320 (44%), Gaps = 58/320 (18%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A   + G  VA+K L+R   +N    ++  RE+ +L+   
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 79
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR--NFFQQII 127
           H +II L  V      +E   D+Y+VME + +      + +   ++ D  R      Q++
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQML 134
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
            G+++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEV
Sbjct: 135 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEV 194
Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------ 235
           I G  Y    VD+WS G I+  L+ G++ F   +  + + K+   + T            
Sbjct: 195 ILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPT 253
Query: 236 -------------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEI 265
                               P  + P            ARDL+ +ML++DP KRI++ E 
Sbjct: 254 VRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 266 RQHPWFQA-HLPRYLAVPPP 284
            +HP+    + P     PPP
Sbjct: 314 LRHPYITVWYDPAEAEAPPP 333

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGXVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 94  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 270 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 327

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 112 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 169
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXGYVATRWYRAPEIMLNWMHYNQTV 227
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 228 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 287
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 288 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 345

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 91  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 267 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 324

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 96  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 272 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 329

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 139/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL     D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDSELKILDFGLCRHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 100 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 157
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 158 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 215
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 216 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 275
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 276 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 333

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 95  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 270
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 271 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 328

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 109 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 224
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 284
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 285 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 342

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 96  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 272 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 329

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 86
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 87  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 144
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 145 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 202
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 203 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 262
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 263 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 320

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 100 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 157
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 158 IHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 215
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 216 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 275
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 276 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 333

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 91  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 267 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 324

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 101 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 158
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 276
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 277 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 334

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 101 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 158
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 276
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 277 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 334

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 94  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 270 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 327

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 87
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 88  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 145
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 146 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 203
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 204 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 263
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 264 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 321

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 96  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 272 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 329

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 112 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 169
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 227
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 228 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 287
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 288 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 345

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 96  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 272 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 329

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 95  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 270
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 271 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 328

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 94  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 270 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 327

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 91  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 267 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 324

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 124/253 (49%), Gaps = 10/253 (3%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L N+++ K +G G F +V  A   L G  VA+K +    + + +      +EI +L+   
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----VEKGRLQEDEARNFFQQIISGVE 131
           HP++I+ Y      +++ +V+E   +G+L   I     +K  + E     +F Q+ S +E
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISG 190
           + H   V+HRD+KP N+ + +   VK+ D GL            S  G+P Y +PE I  
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIY-TLPS-HLSPGARD 246
             Y   + D+WS G +LY +     PF  D  N+ +L KKI+   Y  LPS H S   R 
Sbjct: 211 NGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
Query: 247 LIPRMLIVDPMKR 259
           L+   +  DP KR
Sbjct: 270 LVNMCINPDPEKR 282

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 108 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 165
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 223
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 224 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 283
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 284 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 341

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 138/290 (47%), Gaps = 43/290 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 85  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 276
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 95  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 153 IHRDLKPSNLAVNEDSELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 270
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 271 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 328

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 86  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 143
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 201
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 202 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 261
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 262 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 319

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 94  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 270 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 327

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 86  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 143
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 201
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 202 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 261
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 262 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 319

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 91  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 149 IHRDLKPSNLAVNEDSELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 267 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 324

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 130/271 (47%), Gaps = 45/271 (16%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRLFMHPHIIRLY 83
           LG G+FG+V  A +AL     AIK     KI++ E +   +  E+ +L    H +++R Y
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIK-----KIRHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 84  -------------EVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISG 129
                          ++  S +++ MEY ++G L+D I  E    Q DE    F+QI+  
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK-------------- 174
           + Y H   ++HRDLKP N+ +D   NVKI DFGL+ N+ R    LK              
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGG 232
           ++ G+  Y A EV+ G  +   ++D++S G+I + ++    PF    E + N+ KK++  
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV-NILKKLRSV 244
Query: 233 IYTLPSHLSPGARDL---IPRMLIV-DPMKR 259
               P         +   I R+LI  DP KR
Sbjct: 245 SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI D+GL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDYGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L++   +++   ++  RE+++L+   H ++I L +
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSK-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 101 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 158
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    V
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 276
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 277 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 334

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 139/293 (47%), Gaps = 44/293 (15%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+  + +G G++G V  A    TG KVAIK L R   ++    ++  RE+++L+   H +
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRHEN 85
Query: 79  IIRLYEVIETP-------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
           +I L +V  TP       +D Y+VM ++  G     +++  +L ED  +    Q++ G+ 
Sbjct: 86  VIGLLDVF-TPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 142
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           Y H   ++HRDLKP NL ++    +KI DFGL+   +    +     +  Y APEVI   
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMXGXVVTRWYRAPEVILNW 200
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI---------------------- 229
           +     VD+WS G I+  ++ G   F   +  +  K+I                      
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260
Query: 230 ---------KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273
                    K    ++ ++ SP A +L+ +ML++D  +R+T  E   HP+F++
Sbjct: 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 136/303 (44%), Gaps = 53/303 (17%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +  L   I  +  L  +       Q++ G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVI--QMELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 258 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 317
Query: 268 HPW 270
           HP+
Sbjct: 318 HPY 320

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 135/303 (44%), Gaps = 53/303 (17%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L+R   +N    ++  RE+ +++   
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 76  HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V      +E   D+Y+VME + +       V +  L  +       Q++ G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
           G  Y    VD+WS G I+  ++   + F      D  N          P   KK++  + 
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
                             P  L P            ARDL+ +ML++DP KRI++ +  Q
Sbjct: 258 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 317
Query: 268 HPW 270
           HP+
Sbjct: 318 HPY 320

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 9/207 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+LG+ LG G   +V +A        VA+K+L     ++     + RRE +      HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 79  IIRLYEV--IETPSDI--YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           I+ +Y+    ETP+    Y+VMEYV    L D +  +G +    A          + + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISG 190
           +N ++HRD+KP N+L+ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G
Sbjct: 134 QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF 217
                   DV+S G +LY +L G  PF
Sbjct: 194 D-SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 136/295 (46%), Gaps = 44/295 (14%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+  + +G G++G V  A++  T   VA+K + R    +  +     REI +L+   H +
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKN 62
Query: 79  IIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           I+RL++V+ +   + +V E+      + FD     G L  +  ++F  Q++ G+ +CH  
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGK 191
            V+HRDLKP+NLL++    +K+ADFGL+        +   C S       Y  P+V+ G 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLADFGLARAFG----IPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 192 LYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYT-----------LPSH 239
                 +D+WS G I   L     P F   ++ +  K+I   + T           LP +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
                             L+   RDL+  +L  +P++RI+  E  QHP+F    P
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 139/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI  FGL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILGFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 139/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI D GL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDAGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 142/298 (47%), Gaps = 46/298 (15%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKILRLFMHP 77
           +K  + LG G++  V    +  TG  VA+K +   K+ + E       REI +++   H 
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELKHE 63
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG------RLQEDEARNFFQQIISGVE 131
           +I+RLY+VI T + + +V E++ + +L  Y+  +        L+ +  + F  Q++ G+ 
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISG 190
           +CH N ++HRDLKP+NLL++ +  +K+ DFGL+       +   +   +  Y AP+V+ G
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLF-------KKIKGGIYTLPSH 239
                  +D+WSCG IL  ++ G   F    D+E +  +F       + +   +  LP +
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242
Query: 240 ---------------LSPGAR--------DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
                          L P  +        D +  +L ++P  R++  +   HPWF  +
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 9/207 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+LG+ LG G   +V +A        VA+K+L     ++     + RRE +      HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 79  IIRLYEV--IETPSDI--YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           I+ +Y+    ETP+    Y+VMEYV    L D +  +G +    A          + + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISG 190
           +N ++HRD+KP N+++ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF 217
                   DV+S G +LY +L G  PF
Sbjct: 194 D-SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 9/207 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+LG+ LG G   +V +A        VA+K+L     ++     + RRE +      HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 79  IIRLYEV--IETPSDI--YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           I+ +Y+    ETP+    Y+VMEYV    L D +  +G +    A          + + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISG 190
           +N ++HRD+KP N+++ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF 217
                   DV+S G +LY +L G  PF
Sbjct: 194 D-SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 138/306 (45%), Gaps = 64/306 (20%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----MEMEEKVRREIKILRL 73
            Y++ +T+G G++G V  A   LTG +VAIK     KI N    +   ++  RE+KIL+ 
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIK-----KIPNAFDVVTNAKRTLRELKILKH 109
Query: 74  FMHPHIIRLYEVIETP------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
           F H +II + +++           +YVV++ ++S +L   I     L  +  R F  Q++
Sbjct: 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLL 168
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
            G++Y H   V+HRDLKP NLL++    +KI DFG++        L TS     Y   E 
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR------GLCTSPAEHQYFMTEY 222
Query: 188 ISGKLYAGPE-----------VDVWSCGVILYALLCGTLPFDDENIPNLFK--------- 227
           ++ + Y  PE           +D+WS G I   +L     F  +N  +  +         
Sbjct: 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282
Query: 228 -----------KIKGGIYTLPSH-------LSPGAR----DLIPRMLIVDPMKRITIPEI 265
                      +++  I +LP         + PGA      L+ RML  +P  RI+    
Sbjct: 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 342
Query: 266 RQHPWF 271
            +HP+ 
Sbjct: 343 LRHPFL 348

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 139/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI D GL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDRGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 146/310 (47%), Gaps = 73/310 (23%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILRLF 74
           KL K +G G+FG+V  A H  TG KVA+K +       ME E++       REIKIL+L 
Sbjct: 22  KLAK-IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLL 74
Query: 75  MHPHIIRLYEVIETPSD--------IYVVMEYVK---SGELFDYIVEKGRLQEDEARNFF 123
            H +++ L E+  T +         IY+V ++ +   +G L + +V   +    E +   
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 131
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-- 181
           Q +++G+ Y HRN ++HRD+K  N+L+     +K+ADFGL+       F       PN  
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-----FSLAKNSQPNRY 186
Query: 182 --------YAAPEVISGKLYAGPEVDVWSCGVI---------------------LYALLC 212
                   Y  PE++ G+   GP +D+W  G I                     L + LC
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 246
Query: 213 GTL-PFDDENIPN--LFKK---IKGGIYTLPSHL-----SPGARDLIPRMLIVDPMKRIT 261
           G++ P    N+ N  L++K   +KG    +   L      P A DLI ++L++DP +RI 
Sbjct: 247 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 306
Query: 262 IPEIRQHPWF 271
             +   H +F
Sbjct: 307 SDDALNHDFF 316

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 139/298 (46%), Gaps = 43/298 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    TG +VA+K L+R   +++   ++  RE+++L+   H ++I L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 85  V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           V      +E  +D+Y+V   +  G   + IV+  +L +D  +    QI+ G++Y H   +
Sbjct: 89  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +HRDLKP NL ++    +KI D GL+    D   +     +  Y APE++   ++    V
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDGGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIYT 235
           D+WS G I+  LL G   F   +                  L KKI           +  
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 236 LPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP 284
           +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P
Sbjct: 265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 322

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 9/207 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+LG+ LG G   +V +A        VA+K+L     ++     + RRE +      HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 79  IIRLYEV--IETPSDI--YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           I+ +Y+    ETP+    Y+VMEYV    L D +  +G +    A          + + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISG 190
           +N ++HRD+KP N+++ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF 217
                   DV+S G +LY +L G  PF
Sbjct: 194 D-SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 138/306 (45%), Gaps = 64/306 (20%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----MEMEEKVRREIKILRL 73
            Y++ +T+G G++G V  A   LTG +VAIK     KI N    +   ++  RE+KIL+ 
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIK-----KIPNAFDVVTNAKRTLRELKILKH 110
Query: 74  FMHPHIIRLYEVIETP------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
           F H +II + +++           +YVV++ ++S +L   I     L  +  R F  Q++
Sbjct: 111 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLL 169
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
            G++Y H   V+HRDLKP NLL++    +KI DFG++        L TS     Y   E 
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR------GLCTSPAEHQYFMTEY 223
Query: 188 ISGKLYAGPE-----------VDVWSCGVILYALLCGTLPFDDENIPNLFK--------- 227
           ++ + Y  PE           +D+WS G I   +L     F  +N  +  +         
Sbjct: 224 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 283
Query: 228 -----------KIKGGIYTLPSH-------LSPGAR----DLIPRMLIVDPMKRITIPEI 265
                      +++  I +LP         + PGA      L+ RML  +P  RI+    
Sbjct: 284 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 343
Query: 266 RQHPWF 271
            +HP+ 
Sbjct: 344 LRHPFL 349

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 94/310 (30%), Positives = 148/310 (47%), Gaps = 73/310 (23%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILRLF 74
           KL K +G G+FG+V  A H  TG KVA+K +       ME E++       REIKIL+L 
Sbjct: 22  KLAK-IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLL 74
Query: 75  MHPHIIRLYEVIETPSD--------IYVVMEYVK---SGELFDYIVEKGRLQEDEARNFF 123
            H +++ L E+  T +         IY+V ++ +   +G L + +V   +    E +   
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 131
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-- 181
           Q +++G+ Y HRN ++HRD+K  N+L+     +K+ADFGL+   R     K S   PN  
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA---RAFSLAKNS--QPNRY 186
Query: 182 --------YAAPEVISGKLYAGPEVDVWSCGVI---------------------LYALLC 212
                   Y  PE++ G+   GP +D+W  G I                     L + LC
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 246
Query: 213 GTL-PFDDENIPN--LFKK---IKGGIYTLPSHL-----SPGARDLIPRMLIVDPMKRIT 261
           G++ P    N+ N  L++K   +KG    +   L      P A DLI ++L++DP +RI 
Sbjct: 247 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 306
Query: 262 IPEIRQHPWF 271
             +   H +F
Sbjct: 307 SDDALNHDFF 316

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 129/271 (47%), Gaps = 45/271 (16%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRLFMHPHIIRLY 83
           LG G+FG+V  A +AL     AIK     KI++ E +   +  E+ +L    H +++R Y
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIK-----KIRHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 84  -------------EVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISG 129
                          ++  S +++ MEY ++  L+D I  E    Q DE    F+QI+  
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK-------------- 174
           + Y H   ++HRDLKP N+ +D   NVKI DFGL+ N+ R    LK              
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGG 232
           ++ G+  Y A EV+ G  +   ++D++S G+I + ++    PF    E + N+ KK++  
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV-NILKKLRSV 244
Query: 233 IYTLPSHLSPGARDL---IPRMLIV-DPMKR 259
               P         +   I R+LI  DP KR
Sbjct: 245 SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 146/310 (47%), Gaps = 73/310 (23%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILRLF 74
           KL K +G G+FG+V  A H  TG KVA+K +       ME E++       REIKIL+L 
Sbjct: 21  KLAK-IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLL 73
Query: 75  MHPHIIRLYEVIETPSD--------IYVVMEYVK---SGELFDYIVEKGRLQEDEARNFF 123
            H +++ L E+  T +         IY+V ++ +   +G L + +V   +    E +   
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 130
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-- 181
           Q +++G+ Y HRN ++HRD+K  N+L+     +K+ADFGL+       F       PN  
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-----FSLAKNSQPNRY 185
Query: 182 --------YAAPEVISGKLYAGPEVDVWSCGVI---------------------LYALLC 212
                   Y  PE++ G+   GP +D+W  G I                     L + LC
Sbjct: 186 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 213 GTL-PFDDENIPN--LFKK---IKGGIYTLPSHL-----SPGARDLIPRMLIVDPMKRIT 261
           G++ P    N+ N  L++K   +KG    +   L      P A DLI ++L++DP +RI 
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305
Query: 262 IPEIRQHPWF 271
             +   H +F
Sbjct: 306 SDDALNHDFF 315

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 94/310 (30%), Positives = 148/310 (47%), Gaps = 73/310 (23%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILRLF 74
           KL K +G G+FG+V  A H  TG KVA+K +       ME E++       REIKIL+L 
Sbjct: 22  KLAK-IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLL 74
Query: 75  MHPHIIRLYEVIETPSD--------IYVVMEYVK---SGELFDYIVEKGRLQEDEARNFF 123
            H +++ L E+  T +         IY+V ++ +   +G L + +V   +    E +   
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 131
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-- 181
           Q +++G+ Y HRN ++HRD+K  N+L+     +K+ADFGL+   R     K S   PN  
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA---RAFSLAKNS--QPNRY 186
Query: 182 --------YAAPEVISGKLYAGPEVDVWSCGVI---------------------LYALLC 212
                   Y  PE++ G+   GP +D+W  G I                     L + LC
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 246
Query: 213 GTL-PFDDENIPN--LFKK---IKGGIYTLPSHL-----SPGARDLIPRMLIVDPMKRIT 261
           G++ P    N+ N  L++K   +KG    +   L      P A DLI ++L++DP +RI 
Sbjct: 247 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 306
Query: 262 IPEIRQHPWF 271
             +   H +F
Sbjct: 307 SDDALNHDFF 316

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 9/207 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+LG+ LG G   +V +A        VA+K+L     ++     + RRE +      HP 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 79  IIRLYEV--IETPSDI--YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           I+ +Y+    ETP+    Y+VMEYV    L D +  +G +    A          + + H
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 150
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISG 190
           +N ++HRD+KP N+++ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G
Sbjct: 151 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF 217
                   DV+S G +LY +L G  PF
Sbjct: 211 D-SVDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 133/274 (48%), Gaps = 19/274 (6%)
Query: 9   SSGVDMFLPNY------------KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK 56
           SSGVD+   N             KL K +G GSFG+V       T   VAIKI++  + +
Sbjct: 8   SSGVDLGTENLYFQSMDPEELFTKLEK-IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE 66
Query: 57  NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE 116
           +      +++EI +L     P++ + Y      + ++++MEY+  G   D ++E G L E
Sbjct: 67  DEIE--DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDE 123
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-T 175
            +     ++I+ G++Y H    +HRD+K  N+LL     VK+ADFG++  + D    + T
Sbjct: 124 TQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 183
Query: 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIY 234
             G+P + APEVI    Y   + D+WS G+    L  G  P  + + +  LF   K    
Sbjct: 184 FVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP 242
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           TL  + S   ++ +   L  +P  R T  E+ +H
Sbjct: 243 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 276

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 131/270 (48%), Gaps = 10/270 (3%)
Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           + G  N  +   ++F    K+GK    GSFG+V       T   VAIKI++  + ++   
Sbjct: 10  LPGMQNLKADPEELFTKLEKIGK----GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE 65
Query: 61  EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
              +++EI +L     P++ + Y      + ++++MEY+  G   D ++E G L E +  
Sbjct: 66  --DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIA 122
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGS 179
              ++I+ G++Y H    +HRD+K  N+LL     VK+ADFG++  + D    +    G+
Sbjct: 123 TILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGT 182
Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPS 238
           P + APEVI    Y   + D+WS G+    L  G  P  + + +  LF   K    TL  
Sbjct: 183 PFWMAPEVIKQSAYDS-KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG 241
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           + S   ++ +   L  +P  R T  E+ +H
Sbjct: 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+LG+ LG G   +V +A        VA+K+L     ++     + RRE +      HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 79  IIRLYEV--IETPSDI--YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           I+ +Y     ETP+    Y+VMEYV    L D +  +G +    A          + + H
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISG 190
           +N ++HRD+KP N+++ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF 217
                   DV+S G +LY +L G  PF
Sbjct: 194 D-SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 136/295 (46%), Gaps = 44/295 (14%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+  + +G G++G V  A++  T   VA+K + R    +  +     REI +L+   H +
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKN 62
Query: 79  IIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           I+RL++V+ +   + +V E+      + FD     G L  +  ++F  Q++ G+ +CH  
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGK 191
            V+HRDLKP+NLL++    +K+A+FGL+        +   C S       Y  P+V+ G 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFG----IPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 192 LYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYT-----------LPSH 239
                 +D+WS G I   L     P F   ++ +  K+I   + T           LP +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 240 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
                             L+   RDL+  +L  +P++RI+  E  QHP+F    P
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 123/246 (50%), Gaps = 6/246 (2%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GSFG+V       T   VAIKI++  + ++      +++EI +L     P++ + Y 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE--DIQQEITVLSQCDSPYVTKYYG 72
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                + ++++MEY+  G   D ++E G L E +     ++I+ G++Y H    +HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 145 PENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
             N+LL     VK+ADFG++  + D    + T  G+P + APEVI    Y   + D+WS 
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSL 190
Query: 204 GVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI 262
           G+    L  G  P  + + +  LF   K    TL  + S   ++ +   L  +P  R T 
Sbjct: 191 GITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTA 250
Query: 263 PEIRQH 268
            E+ +H
Sbjct: 251 KELLKH 256

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 133/294 (45%), Gaps = 52/294 (17%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK------VRREIKILRL 73
           K+GK +G GS+G V    +  TG  VAIK       K +E E+         REI++L+ 
Sbjct: 7   KIGK-IGEGSYGVVFKCRNRDTGQIVAIK-------KFLESEDDPVIKKIALREIRMLKQ 58
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
             HP+++ L EV      +++V EY     L +    +  + E   ++   Q +  V +C
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKL 192
           H++  +HRD+KPEN+L+     +K+ DFG + ++     +      +  Y +PE++ G  
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 193 YAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKGGIYTLPSH--------- 239
             GP VDVW+ G +   LL G +P      D +   L +K  G +  +P H         
Sbjct: 179 QYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDL--IPRHQQVFSTNQY 235
Query: 240 ---------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                                +S  A  L+   L +DP +R+T  ++  HP+F+
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 134/289 (46%), Gaps = 51/289 (17%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    +G KVAIK L+R   ++    ++  RE+ +L+   H ++I L +
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 85  VIETPS------DIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNM 137
           V    S      D Y+VM ++++    D     G +  E++ +    Q++ G++Y H   
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG 146
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG---SPNYAAPEVISGKLYA 194
           VVHRDLKP NL ++    +KI DFGL+      H      G   +  Y APEVI   ++ 
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHY 201
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIY 234
              VD+WS G I+  +L G   F  ++  +   +I                    K  I 
Sbjct: 202 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 261
Query: 235 TLPS-----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           +LP              SP A DL+ +ML +D  KR+T  +   HP+F+
Sbjct: 262 SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 123/246 (50%), Gaps = 6/246 (2%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GSFG+V       T   VAIKI++  + ++      +++EI +L     P+I R + 
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIE--DIQQEITVLSQCDSPYITRYFG 84
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                + ++++MEY+  G   D +++ G L+E       ++I+ G++Y H    +HRD+K
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 145 PENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSC 203
             N+LL  + +VK+ADFG++  + D    +    G+P + APEVI    Y   + D+WS 
Sbjct: 144 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDF-KADIWSL 202
Query: 204 GVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI 262
           G+    L  G  P  D + +  LF   K    TL    S   ++ +   L  DP  R T 
Sbjct: 203 GITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTA 262
Query: 263 PEIRQH 268
            E+ +H
Sbjct: 263 KELLKH 268

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 129/268 (48%), Gaps = 10/268 (3%)
Query: 3   GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
           G  N  +   ++F    ++GK    GSFG+V       T   VAIKI++  +    +  E
Sbjct: 13  GMQNNIADPEELFTKLERIGK----GSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIE 66
Query: 63  KVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNF 122
            +++EI +L      ++ + Y      S ++++MEY+  G   D ++  G   E +    
Sbjct: 67  DIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATM 125
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPN 181
            ++I+ G++Y H    +HRD+K  N+LL  + +VK+ADFG++  + D    + T  G+P 
Sbjct: 126 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 185
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHL 240
           + APEVI    Y   + D+WS G+    L  G  P  D + +  LF   K    TL    
Sbjct: 186 WMAPEVIQQSAYDS-KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDF 244
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQH 268
           +   ++ I   L  DP  R T  E+ +H
Sbjct: 245 TKSFKEFIDACLNKDPSFRPTAKELLKH 272

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 133/289 (46%), Gaps = 51/289 (17%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V  A    +G KVAIK L+R   ++    ++  RE+ +L+   H ++I L +
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQHENVIGLLD 108
Query: 85  VIETPS------DIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNM 137
           V    S      D Y+VM ++++    D     G    E++ +    Q++ G++Y H   
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQT----DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG 164
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG---SPNYAAPEVISGKLYA 194
           VVHRDLKP NL ++    +KI DFGL+      H      G   +  Y APEVI   ++ 
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHY 219
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIY 234
              VD+WS G I+  +L G   F  ++  +   +I                    K  I 
Sbjct: 220 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 279
Query: 235 TLPS-----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           +LP              SP A DL+ +ML +D  KR+T  +   HP+F+
Sbjct: 280 SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 138/292 (47%), Gaps = 43/292 (14%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G++G V  A  A    KVA+K L+R   +++    +  RE+++L+   H ++I L
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 83  YEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
            +V      IE  S++Y+V   +  G   + IV+   L ++  +    Q++ G++Y H  
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            ++HRDLKP N+ ++    ++I DFGL+   +    +     +  Y APE++   ++   
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIYTL 236
            VD+WS G I+  LL G   F   +  +  K+I                    +  I +L
Sbjct: 209 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSL 268
Query: 237 P-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 276
           P              +P A DL+ RML++D  +R++  E   H +F Q H P
Sbjct: 269 PPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 320

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 135/299 (45%), Gaps = 46/299 (15%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKIL 71
           M    Y+    +G+G++G V  A    +GH VA+K +   ++ N E  +     RE+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALL 57
Query: 72  R---LFMHPHIIRLYEVIETPSD-----IYVVMEYVKSGELFDYI--VEKGRLQEDEARN 121
           R    F HP+++RL +V  T        + +V E+V   +L  Y+       L  +  ++
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 116
Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN 181
             +Q + G+++ H N +VHRDLKPEN+L+ S   VK+ADFGL+ I      L     +  
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLW 176
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYA------LLCGTLPFD-------------DENI 222
           Y APEV+    YA P VD+WS G I         L CG    D             +++ 
Sbjct: 177 YRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 235
Query: 223 PNLFKKIKGGI---------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           P      +G             +P     GA+ L+  ML  +P KRI+     QH +  
Sbjct: 236 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLL-EMLTFNPHKRISAFRALQHSYLH 293

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 135/299 (45%), Gaps = 46/299 (15%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKIL 71
           M    Y+    +G+G++G V  A    +GH VA+K +   ++ N E  +     RE+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALL 57
Query: 72  R---LFMHPHIIRLYEVIETPSD-----IYVVMEYVKSGELFDYI--VEKGRLQEDEARN 121
           R    F HP+++RL +V  T        + +V E+V   +L  Y+       L  +  ++
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 116
Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN 181
             +Q + G+++ H N +VHRDLKPEN+L+ S   VK+ADFGL+ I      L     +  
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLW 176
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYA------LLCGTLPFD-------------DENI 222
           Y APEV+    YA P VD+WS G I         L CG    D             +++ 
Sbjct: 177 YRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 235
Query: 223 PNLFKKIKGGI---------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           P      +G             +P     GA+ L+  ML  +P KRI+     QH +  
Sbjct: 236 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLL-EMLTFNPHKRISAFRALQHSYLH 293

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 8/272 (2%)
Query: 3   GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEME 61
           GA   S+   ++     +LG+ +G G FG V    + +     +A+ I   +   +  + 
Sbjct: 1   GAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR 60
Query: 62  EKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEAR 120
           EK  +E   +R F HPHI++L  VI T + ++++ME    GEL  ++ V K  L      
Sbjct: 61  EKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI 119
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
            +  Q+ + + Y      VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G  
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 181 --NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTL 236
              + APE I+ + +     DVW  GV ++ +L  G  PF      ++  +I+ G    +
Sbjct: 180 PIKWMAPESINFRRFTSAS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 238
Query: 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           P +  P    L+ +    DP +R    E++  
Sbjct: 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 122/246 (49%), Gaps = 6/246 (2%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GSFG+V       T   VAIKI++  + ++      +++EI +L     P++ + Y 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE--DIQQEITVLSQCDSPYVTKYYG 72
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
                + ++++MEY+  G   D ++E G L E +     ++I+ G++Y H    +HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 145 PENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSC 203
             N+LL     VK+ADFG++  + D    +    G+P + APEVI    Y   + D+WS 
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS-KADIWSL 190
Query: 204 GVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI 262
           G+    L  G  P  + + +  LF   K    TL  + S   ++ +   L  +P  R T 
Sbjct: 191 GITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTA 250
Query: 263 PEIRQH 268
            E+ +H
Sbjct: 251 KELLKH 256

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 127/274 (46%), Gaps = 8/274 (2%)
Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNME 59
             GA   S+   ++     +LG+ +G G FG V    + +     +A+ I   +   +  
Sbjct: 22  FQGAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS 81
Query: 60  MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDE 118
           + EK  +E   +R F HPHI++L  VI T + ++++ME    GEL  ++ V K  L    
Sbjct: 82  VREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLAS 140
Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG 178
              +  Q+ + + Y      VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G
Sbjct: 141 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 200
Query: 179 SP--NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IY 234
                + APE I+ + +     DVW  GV ++ +L  G  PF      ++  +I+ G   
Sbjct: 201 KLPIKWMAPESINFRRFTSAS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 259
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
            +P +  P    L+ +    DP +R    E++  
Sbjct: 260 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 293

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 114/223 (51%), Gaps = 12/223 (5%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL K LG G FG+V +  +     KVA+K L   K   M ++  +  E  +++   H  +
Sbjct: 16  KLVKRLGAGQFGEVWMGYYN-NSTKVAVKTL---KPGTMSVQAFLE-EANLMKTLQHDKL 70
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +RLY V+     IY++ EY+  G L D++   E G++   +  +F  QI  G+ Y  R  
Sbjct: 71  VRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 130
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAG 195
            +HRDL+  N+L+      KIADFGL+ ++ D  +  +     P  + APE I+   +  
Sbjct: 131 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT- 189
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + DVWS G++LY ++  G +P+      ++   +  G Y +P
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQG-YRMP 231

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 135/305 (44%), Gaps = 43/305 (14%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE----KVRREIKILRLFMHPHII 80
           LG G++  V   +  LT + VA+K +       +E EE       RE+ +L+   H +I+
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIR------LEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRL-QEDEARNFFQQIISGVEYCHRNMVV 139
            L+++I T   + +V EY+   +L  Y+ + G +      + F  Q++ G+ YCHR  V+
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVL 122
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           HRDLKP+NLL++ +  +K+ADFGL+               +  Y  P+++ G      ++
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI 182
Query: 199 DVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIKGGIYTLPSH 239
           D+W  G I Y +  G   F                    +E  P +    +   Y  P +
Sbjct: 183 DMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKY 242
Query: 240 -----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
                      L     DL+ ++L  +   RI+  +  +HP+F +   R   +P   ++ 
Sbjct: 243 RAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIF 302
Query: 289 QAKKV 293
             K++
Sbjct: 303 ALKEI 307

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 138/292 (47%), Gaps = 43/292 (14%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G++G V  A  A    KVA+K L+R   +++    +  RE+++L+   H ++I L
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 83  YEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
            +V      IE  S++Y+V   +  G   + IV+   L ++  +    Q++ G++Y H  
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            ++HRDLKP N+ ++    ++I DFGL+   +    +     +  Y APE++   ++   
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHYNQ 200
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIYTL 236
            VD+WS G I+  LL G   F   +  +  K+I                    +  I +L
Sbjct: 201 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSL 260
Query: 237 P-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 276
           P              +P A DL+ RML++D  +R++  E   H +F Q H P
Sbjct: 261 PPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 312

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 130/264 (49%), Gaps = 19/264 (7%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLY 83
           LG G++G V+   H  +G  +A+K +  R   N + ++++  ++ I +R    P  +  Y
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 116
Query: 84  EVIETPSDIYVVMEYVKSG--ELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNM-VV 139
             +    D+++ ME + +   + +  +++KG+ + ED        I+  +E+ H  + V+
Sbjct: 117 GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 176
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA---GP 196
           HRD+KP N+L+++   VK+ DFG+S  + D        G   Y APE I+ +L       
Sbjct: 177 HRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSV 236
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------DLIPR 250
           + D+WS G+ +  L     P+D    P  F+++K  +   PS   P  +      D   +
Sbjct: 237 KSDIWSLGITMIELAILRFPYDSWGTP--FQQLK-QVVEEPSPQLPADKFSAEFVDFTSQ 293
Query: 251 MLIVDPMKRITIPEIRQHPWFQAH 274
            L  +  +R T PE+ QHP+F  H
Sbjct: 294 CLKKNSKERPTYPELMQHPFFTLH 317

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 138/292 (47%), Gaps = 43/292 (14%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G++G V  A  A    KVA+K L+R   +++    +  RE+++L+   H ++I L
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 83  YEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
            +V      IE  S++Y+V   +  G   + IV+   L ++  +    Q++ G++Y H  
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            ++HRDLKP N+ ++    ++I DFGL+   +    +     +  Y APE++   ++   
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIYTL 236
            VD+WS G I+  LL G   F   +  +  K+I                    +  I +L
Sbjct: 209 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSL 268
Query: 237 P-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 276
           P              +P A DL+ RML++D  +R++  E   H +F Q H P
Sbjct: 269 PPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 320

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 135/299 (45%), Gaps = 46/299 (15%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKIL 71
           M    Y+    +G+G++G V  A    +GH VA+K +   ++ N E  +     RE+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALL 57
Query: 72  R---LFMHPHIIRLYEVIETPSD-----IYVVMEYVKSGELFDYI--VEKGRLQEDEARN 121
           R    F HP+++RL +V  T        + +V E+V   +L  Y+       L  +  ++
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 116
Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN 181
             +Q + G+++ H N +VHRDLKPEN+L+ S   VK+ADFGL+ I      L     +  
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLW 176
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYA------LLCGTLPFD-------------DENI 222
           Y APEV+    YA P VD+WS G I         L CG    D             +++ 
Sbjct: 177 YRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 235
Query: 223 PNLFKKIKGGI---------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           P      +G             +P     GA+ L+  ML  +P KRI+     QH +  
Sbjct: 236 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLL-EMLTFNPHKRISAFRALQHSYLH 293

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 126/271 (46%), Gaps = 45/271 (16%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRLFMHPHIIRLY 83
           LG G+FG+V  A +AL     AIK     KI++ E +   +  E+ +L    H +++R Y
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIK-----KIRHTEEKLSTILSEVXLLASLNHQYVVRYY 68
Query: 84  -------------EVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISG 129
                          ++  S +++  EY ++  L+D I  E    Q DE    F+QI+  
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK-------------- 174
           + Y H   ++HR+LKP N+ +D   NVKI DFGL+ N+ R    LK              
Sbjct: 129 LSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGG 232
           ++ G+  Y A EV+ G  +   ++D +S G+I +  +    PF    E + N+ KK++  
Sbjct: 189 SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERV-NILKKLRSV 244
Query: 233 IYTLPSHLSPGARDL---IPRMLIV-DPMKR 259
               P         +   I R+LI  DP KR
Sbjct: 245 SIEFPPDFDDNKXKVEKKIIRLLIDHDPNKR 275

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 20/259 (7%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G+FGKV  A++  T    A K+++    K+ E  E    EI IL    HP+I++L +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVID---TKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
                +++++++E+   G +   ++E  R L E + +   +Q +  + Y H N ++HRDL
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 144 KPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP-- 196
           K  N+L     ++K+ADFG+S      I R   F+    G+P + APEV+  +       
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKDRPY 217
Query: 197 --EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRM 251
             + DVWS G+ L  +     P  + N   +  KI          PS  S   +D + + 
Sbjct: 218 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 277
Query: 252 LIVDPMKRITIPEIRQHPW 270
           L  +   R T  ++ QHP+
Sbjct: 278 LEKNVDARWTTSQLLQHPF 296

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 133/298 (44%), Gaps = 41/298 (13%)
Query: 14  MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILN--RRKIKNMEMEEKVRREIKIL 71
           M    Y+    +G+G++G V  A    +GH VA+K +           +     RE+ +L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 72  R---LFMHPHIIRLYEVIETPSD-----IYVVMEYVKSGELFDYI--VEKGRLQEDEARN 121
           R    F HP+++RL +V  T        + +V E+V   +L  Y+       L  +  ++
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN 181
             +Q + G+++ H N +VHRDLKPEN+L+ S   VK+ADFGL+ I      L     +  
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILY------ALLCGT--------------LPFDDE- 220
           Y APEV+    YA P VD+WS G I         L CG               LP +D+ 
Sbjct: 185 YRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243
Query: 221 ----NIPNLFKKIKG--GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
               ++P      +G   + ++   +      L+  ML  +P KRI+     QH +  
Sbjct: 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 121/255 (47%), Gaps = 8/255 (3%)
Query: 20  KLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +LG+ +G G FG V    + +     +A+ I   +   +  + EK  +E   +R F HPH
Sbjct: 16  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 75
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           I++L  VI T + ++++ME    GEL  ++ V K  L       +  Q+ + + Y     
Sbjct: 76  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--NYAAPEVISGKLYAG 195
            VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +  
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI 253
              DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +   
Sbjct: 195 AS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 253
Query: 254 VDPMKRITIPEIRQH 268
            DP +R    E++  
Sbjct: 254 YDPSRRPRFTELKAQ 268

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 121/255 (47%), Gaps = 8/255 (3%)
Query: 20  KLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +LG+ +G G FG V    + +     +A+ I   +   +  + EK  +E   +R F HPH
Sbjct: 10  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           I++L  VI T + ++++ME    GEL  ++ V K  L       +  Q+ + + Y     
Sbjct: 70  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 128
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--NYAAPEVISGKLYAG 195
            VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +  
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI 253
              DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +   
Sbjct: 189 AS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 247
Query: 254 VDPMKRITIPEIRQH 268
            DP +R    E++  
Sbjct: 248 YDPSRRPRFTELKAQ 262

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 130/264 (49%), Gaps = 19/264 (7%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLY 83
           LG G++G V+   H  +G  +A+K +  R   N + ++++  ++ I +R    P  +  Y
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 84  EVIETPSDIYVVMEYVKSG--ELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNM-VV 139
             +    D+++ ME + +   + +  +++KG+ + ED        I+  +E+ H  + V+
Sbjct: 73  GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA---GP 196
           HRD+KP N+L+++   VK+ DFG+S  + D        G   Y APE I+ +L       
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSV 192
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------DLIPR 250
           + D+WS G+ +  L     P+D    P  F+++K  +   PS   P  +      D   +
Sbjct: 193 KSDIWSLGITMIELAILRFPYDSWGTP--FQQLK-QVVEEPSPQLPADKFSAEFVDFTSQ 249
Query: 251 MLIVDPMKRITIPEIRQHPWFQAH 274
            L  +  +R T PE+ QHP+F  H
Sbjct: 250 CLKKNSKERPTYPELMQHPFFTLH 273

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 134/294 (45%), Gaps = 43/294 (14%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKILR--- 72
            Y+    +G G++GKV  A     G +     L R +++  E  M     RE+ +LR   
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 73  LFMHPHIIRLYEV-----IETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQ 125
            F HP+++RL++V      +  + + +V E+V        D + E G +  +  ++   Q
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQ 128
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
           ++ G+++ H + VVHRDLKP+N+L+ S   +K+ADFGL+ I      L +   +  Y AP
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 186 EVISGKLYAGPEVDVWSCGVILYA------LLCGTLPFD-------------DENIPN-- 224
           EV+    YA P VD+WS G I         L  G+   D             +E+ P   
Sbjct: 189 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 225 ------LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                    K    I    + +    +DL+ + L  +P KRI+      HP+FQ
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 121/255 (47%), Gaps = 8/255 (3%)
Query: 20  KLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +LG+ +G G FG V    + +     +A+ I   +   +  + EK  +E   +R F HPH
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           I++L  VI T + ++++ME    GEL  ++ V K  L       +  Q+ + + Y     
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--NYAAPEVISGKLYAG 195
            VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +  
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI 253
              DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +   
Sbjct: 192 AS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 250
Query: 254 VDPMKRITIPEIRQH 268
            DP +R    E++  
Sbjct: 251 YDPSRRPRFTELKAQ 265

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 121/255 (47%), Gaps = 8/255 (3%)
Query: 20  KLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +LG+ +G G FG V    + +     +A+ I   +   +  + EK  +E   +R F HPH
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           I++L  VI T + ++++ME    GEL  ++ V K  L       +  Q+ + + Y     
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--NYAAPEVISGKLYAG 195
            VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +  
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI 253
              DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +   
Sbjct: 192 AS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 250
Query: 254 VDPMKRITIPEIRQH 268
            DP +R    E++  
Sbjct: 251 YDPSRRPRFTELKAQ 265

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 121/255 (47%), Gaps = 8/255 (3%)
Query: 20  KLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +LG+ +G G FG V    + +     +A+ I   +   +  + EK  +E   +R F HPH
Sbjct: 15  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 74
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           I++L  VI T + ++++ME    GEL  ++ V K  L       +  Q+ + + Y     
Sbjct: 75  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 133
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--NYAAPEVISGKLYAG 195
            VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +  
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 193
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI 253
              DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +   
Sbjct: 194 AS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 252
Query: 254 VDPMKRITIPEIRQH 268
            DP +R    E++  
Sbjct: 253 YDPSRRPRFTELKAQ 267

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 134/294 (45%), Gaps = 43/294 (14%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKILR--- 72
            Y+    +G G++GKV  A     G +     L R +++  E  M     RE+ +LR   
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 73  LFMHPHIIRLYEV-----IETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQ 125
            F HP+++RL++V      +  + + +V E+V        D + E G +  +  ++   Q
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQ 128
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
           ++ G+++ H + VVHRDLKP+N+L+ S   +K+ADFGL+ I      L +   +  Y AP
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 186 EVISGKLYAGPEVDVWSCGVILYA------LLCGTLPFD-------------DENIPN-- 224
           EV+    YA P VD+WS G I         L  G+   D             +E+ P   
Sbjct: 189 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 225 ------LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                    K    I    + +    +DL+ + L  +P KRI+      HP+FQ
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 128/265 (48%), Gaps = 17/265 (6%)
Query: 10  SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK 69
           SG  + +   KL +T+G G FG V + ++   G+KVA+K      IKN    +    E  
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEAS 238
Query: 70  ILRLFMHPHIIRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQI 126
           ++    H ++++L  VI E    +Y+V EY+  G L DY+  +GR  L  D    F   +
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAP 185
              +EY   N  VHRDL   N+L+      K++DFGL+   ++    + +   P  + AP
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAP 355
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPG 243
           E +  K ++  + DVWS G++L+ +   G +P+    + ++  ++ KG     P    P 
Sbjct: 356 EALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 414
Query: 244 ARDLIPRMLIVDPMKRITIPEIRQH 268
             D++     +D   R T  ++R+ 
Sbjct: 415 VYDVMKNCWHLDAATRPTFLQLREQ 439

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 20/259 (7%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G+FGKV  A++  T    A K+++    K+ E  E    EI IL    HP+I++L +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVID---TKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
                +++++++E+   G +   ++E  R L E + +   +Q +  + Y H N ++HRDL
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 144 KPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP-- 196
           K  N+L     ++K+ADFG+S      I R   F+    G+P + APEV+  +       
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI----GTPYWMAPEVVMCETSKDRPY 217
Query: 197 --EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRM 251
             + DVWS G+ L  +     P  + N   +  KI          PS  S   +D + + 
Sbjct: 218 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 277
Query: 252 LIVDPMKRITIPEIRQHPW 270
           L  +   R T  ++ QHP+
Sbjct: 278 LEKNVDARWTTSQLLQHPF 296

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 134/294 (45%), Gaps = 43/294 (14%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKILR--- 72
            Y+    +G G++GKV  A     G +     L R +++  E  M     RE+ +LR   
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 73  LFMHPHIIRLYEV-----IETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQ 125
            F HP+++RL++V      +  + + +V E+V        D + E G +  +  ++   Q
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQ 128
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
           ++ G+++ H + VVHRDLKP+N+L+ S   +K+ADFGL+ I      L +   +  Y AP
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 186 EVISGKLYAGPEVDVWSCGVILYA------LLCGTLPFD-------------DENIPN-- 224
           EV+    YA P VD+WS G I         L  G+   D             +E+ P   
Sbjct: 189 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 225 ------LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                    K    I    + +    +DL+ + L  +P KRI+      HP+FQ
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 20/259 (7%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G+FGKV  A++  T    A K+++    K+ E  E    EI IL    HP+I++L +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVID---TKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
                +++++++E+   G +   ++E  R L E + +   +Q +  + Y H N ++HRDL
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 144 KPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP-- 196
           K  N+L     ++K+ADFG+S      I R   F+    G+P + APEV+  +       
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI----GTPYWMAPEVVMCETSKDRPY 217
Query: 197 --EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRM 251
             + DVWS G+ L  +     P  + N   +  KI          PS  S   +D + + 
Sbjct: 218 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 277
Query: 252 LIVDPMKRITIPEIRQHPW 270
           L  +   R T  ++ QHP+
Sbjct: 278 LEKNVDARWTTSQLLQHPF 296

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 114/223 (51%), Gaps = 12/223 (5%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL K LG G FG+V +  +     KVA+K L   K   M ++  +  E  +++   H  +
Sbjct: 15  KLVKKLGAGQFGEVWMGYYN-NSTKVAVKTL---KPGTMSVQAFLE-EANLMKTLQHDKL 69
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +RLY V+     IY++ E++  G L D++   E G++   +  +F  QI  G+ Y  R  
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 129
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAG 195
            +HRDL+  N+L+      KIADFGL+ ++ D  +  +     P  + APE I+   +  
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT- 188
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + +VWS G++LY ++  G +P+      ++   +  G Y +P
Sbjct: 189 IKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQG-YRMP 230

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 108/218 (49%), Gaps = 19/218 (8%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +++ + LG G FG V    H  TG +VAIK    R+  + +  E+   EI+I++   HP+
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLNHPN 74
Query: 79  IIRLYEVIE-----TPSDI-YVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISG 129
           ++   EV +      P+D+  + MEY + G+L  Y+ +      L+E   R     I S 
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 130 VEYCHRNMVVHRDLKPENLLLD---SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
           + Y H N ++HRDLKPEN++L     +   KI D G +  +  G       G+  Y APE
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 194
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN 224
           ++  K Y    VD WS G + +  + G  PF    +PN
Sbjct: 195 LLEQKKYT-VTVDYWSFGTLAFECITGFRPF----LPN 227

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 108/218 (49%), Gaps = 19/218 (8%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +++ + LG G FG V    H  TG +VAIK    R+  + +  E+   EI+I++   HP+
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 79  IIRLYEVIE-----TPSDI-YVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISG 129
           ++   EV +      P+D+  + MEY + G+L  Y+ +      L+E   R     I S 
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 130 VEYCHRNMVVHRDLKPENLLLD---SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
           + Y H N ++HRDLKPEN++L     +   KI D G +  +  G       G+  Y APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN 224
           ++  K Y    VD WS G + +  + G  PF    +PN
Sbjct: 194 LLEQKKYT-VTVDYWSFGTLAFECITGFRPF----LPN 226

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 121/253 (47%), Gaps = 8/253 (3%)
Query: 20  KLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +LG+ +G G FG V    + +     +A+ I   +   +  + EK  +E   +R F HPH
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           I++L  VI T + ++++ME    GEL  ++ V K  L       +  Q+ + + Y     
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--NYAAPEVISGKLYAG 195
            VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +  
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI 253
              DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +   
Sbjct: 572 AS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 630
Query: 254 VDPMKRITIPEIR 266
            DP +R    E++
Sbjct: 631 YDPSRRPRFTELK 643

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRLFMHPHI 79
           L + +GIG FGKV  A     G +VA+K       +++    E VR+E K+  +  HP+I
Sbjct: 11  LEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVV 139
           I L  V     ++ +VME+ + G L + ++   R+  D   N+  QI  G+ Y H   +V
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 140 ---HRDLKPENLLLDSKWN--------VKIADFGLSNIMRDGHFLK--TSCGSPNYAAPE 186
              HRDLK  N+L+  K          +KI DFGL+   R+ H     ++ G+  + APE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA---REWHRTTKMSAAGAYAWMAPE 184
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF 217
           VI   +++    DVWS GV+L+ LL G +PF
Sbjct: 185 VIRASMFSKGS-DVWSYGVLLWELLTGEVPF 214

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 121/255 (47%), Gaps = 8/255 (3%)
Query: 20  KLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +LG+ +G G FG V    + +     +A+ I   +   +  + EK  +E   +R F HPH
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           I++L  VI T + ++++ME    GEL  ++ V K  L       +  Q+ + + Y     
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--NYAAPEVISGKLYAG 195
            VHRD+   N+L+ +   VK+ DFGLS  M D  + K S G     + APE I+ + +  
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI 253
              DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +   
Sbjct: 192 AS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 250
Query: 254 VDPMKRITIPEIRQH 268
            DP +R    E++  
Sbjct: 251 YDPSRRPRFTELKAQ 265

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 120/255 (47%), Gaps = 8/255 (3%)
Query: 20  KLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +LG+ +G G FG V    + +     +A+ I   +   +  + EK  +E   +R F HPH
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           I++L  VI T + ++++ME    GEL  ++ V K  L       +  Q+ + + Y     
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--NYAAPEVISGKLYAG 195
            VHRD+   N+L+ S   VK+ DFGLS  M D    K S G     + APE I+ + +  
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI 253
              DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +   
Sbjct: 192 AS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 250
Query: 254 VDPMKRITIPEIRQH 268
            DP +R    E++  
Sbjct: 251 YDPSRRPRFTELKAQ 265

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 131/291 (45%), Gaps = 57/291 (19%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKI--LNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           LG G F  V  A    T   VAIK   L  R      +     REIK+L+   HP+II L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRL--QEDEARNFFQQIISGVEYCHRNMVVH 140
            +     S+I +V +++++    + I++   L       + +    + G+EY H++ ++H
Sbjct: 78  LDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 135
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPEVIS 189
           RDLKP NLLLD    +K+ADFGL+           S GSPN           Y APE++ 
Sbjct: 136 RDLKPNNLLLDENGVLKLADFGLAK----------SFGSPNRAYXHQVVTRWYRAPELLF 185
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF-----DDENIPNLFKKIKG-------GIYTLP 237
           G    G  VD+W+ G IL  LL   +PF     D + +  +F+ +          + +LP
Sbjct: 186 GARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244
Query: 238 SHLS----PG-------------ARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            +++    PG               DLI  + + +P  RIT  +  +  +F
Sbjct: 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 91
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 152 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 211
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 267
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 268 EMNPN------YTEFKFPQIKAHPWTKVFRPR 293

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 84
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 145 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 204
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 260
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 261 EMNPN------YTEFKFPQIKAHPWTKVFRPR 286

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 8/253 (3%)
Query: 20  KLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +LG+ +G G FG V    + +     +A+ I   +   +  + EK  +E   +R F HPH
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           I++L  VI T + ++++ME    GEL  ++ V K  L       +  Q+ + + Y     
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--NYAAPEVISGKLYAG 195
            VHRD+   N+L+ +   VK+ DFGLS  M D  + K S G     + APE I+ + +  
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI 253
              DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +   
Sbjct: 572 AS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 630
Query: 254 VDPMKRITIPEIR 266
            DP +R    E++
Sbjct: 631 YDPSRRPRFTELK 643

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 106
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 226
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 282
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 283 EMNPN------YTEFKFPQIKAHPWTKVFRPR 308

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 80
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 141 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 200
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 256
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 257 EMNPN------YTEFKFPQIKAHPWTKVFRPR 282

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 72
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 248
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 249 EMNPN------YTEFKFPQIKAHPWTKVFRPR 274

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 84
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 145 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 204
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 260
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 261 EMNPN------YTEFKFPQIKAHPWTKVFRPR 286

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 73
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 134 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 193
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 249
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 250 EMNPN------YTEFKFPQIKAHPWTKVFRPR 275

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 72
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 248
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 249 EMNPN------YTEFKFPQIKAHPWTKVFRPR 274

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 76
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 137 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 196
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 252
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 253 EMNPN------YTEFKFPQIKAHPWTKVFRPR 278

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 119/258 (46%), Gaps = 19/258 (7%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           LG+ +G G+FG+V           VA+K  + R+    +++ K  +E +IL+ + HP+I+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVV 139
           RL  V      IY+VME V+ G+   ++  E  RL+            +G+EY      +
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGP 196
           HRDL   N L+  K  +KI+DFG+S    DG +  +         + APE ++   Y+  
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS- 294
Query: 197 EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI------KGGIYTLPSHLSPGARDLIP 249
           E DVWS G++L+     G  P+     PNL  +       KGG    P         L+ 
Sbjct: 295 ESDVWSFGILLWETFSLGASPY-----PNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349
Query: 250 RMLIVDPMKRITIPEIRQ 267
           +    +P +R +   I Q
Sbjct: 350 QCWAYEPGQRPSFSTIYQ 367

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 77
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 138 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 197
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 253
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 254 EMNPN------YTEFKFPQIKAHPWTKVFRPR 279

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 129/288 (44%), Gaps = 34/288 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  +  KN        RE++I+R   H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDH 72
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV +        Y   K  L     + +  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 248
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           ++ P             P+I+ HPW +   PR     PP+ +    ++
Sbjct: 249 EMNPN------YTEFAFPQIKAHPWTKVFRPRT----PPEAIALCSRL 286

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 126/271 (46%), Gaps = 34/271 (12%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F  ++K  + +G G FG+V  A+H + G    IK   R K  N    EK  RE+K L   
Sbjct: 9   FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNN----EKAEREVKALAKL 61
Query: 75  MHPHIIRLYEVI-------ETPSD---------IYVVMEYVKSGELFDYIVEK--GRLQE 116
            H +I+             ET S          +++ ME+   G L  +I ++   +L +
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176
             A   F+QI  GV+Y H   +++RDLKP N+ L     VKI DFGL   +++      S
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS 181
Query: 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL--CGTLPFDDENIPNLFKKIKGGIY 234
            G+  Y +PE IS + Y G EVD+++ G+IL  LL  C T  F+       F  ++ GI 
Sbjct: 182 KGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDT-AFE---TSKFFTDLRDGI- 235
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
            +        + L+ ++L   P  R    EI
Sbjct: 236 -ISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 100
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 161 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 220
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 276
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 277 EMNPN------YTEFKFPQIKAHPWTKVFRPR 302

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 85
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 146 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 205
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 261
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 262 EMNPN------YTEFKFPQIKAHPWTKVFRPR 287

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 151
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 212 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 271
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 327
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 328 EMNPN------YTEFKFPQIKAHPWTKVFRPR 353

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 134/285 (47%), Gaps = 30/285 (10%)
Query: 22  GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           G+ LG G FG+     H  TG  + +K L R    + E +    +E+K++R   HP++++
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
              V+     +  + EY+K G L   I     +    +  +F + I SG+ Y H   ++H
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIH 131
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDG-------HFLK--------TSCGSPNYAAP 185
           RDL   N L+    NV +ADFGL+ +M D          LK        T  G+P + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK---KIKGGI-YTLPSHLS 241
           E+I+G+ Y   +VDV+S G++L  ++ G +  D + +P        ++G +    P +  
Sbjct: 192 EMINGRSY-DEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP 249
Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA---HLPRYLAVPP 283
           P    +  R   +DP KR +   ++   W +    HL  +L + P
Sbjct: 250 PSFFPITVRCCDLDPEKRPSF--VKLEHWLETLRMHLAGHLPLGP 292

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 108
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 169 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 228
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 284
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 285 EMNPN------YTEFKFPQIKAHPWTKVFRPR 310

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 106
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 226
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 282
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 283 EMNPN------YTEFKFPQIKAHPWTKVFRPR 308

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 110
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 171 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 230
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 286
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 287 EMNPN------YTEFKFPQIKAHPWTKVFRPR 312

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 72
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 248
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 249 EMNPN------YTEFKFPQIKAHPWTKVFRPR 274

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 91/316 (28%), Positives = 143/316 (45%), Gaps = 58/316 (18%)
Query: 3   GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
           G+ + S++     +  Y+    LG G++G+V  A   +T   VAIK     +I+    EE
Sbjct: 20  GSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK-----RIRLEHEEE 74
Query: 63  KVR----REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDE 118
            V     RE+ +L+   H +II L  VI     ++++ EY ++ +L  Y+ +   +    
Sbjct: 75  GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRV 133
Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWN--VKIADFGLSN-----IMR 168
            ++F  Q+I+GV +CH    +HRDLKP+NLLL   D+     +KI DFGL+      I +
Sbjct: 134 IKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193
Query: 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFK 227
             H + T      Y  PE++ G  +    VD+WS   I   +L  T  F  D  I  LFK
Sbjct: 194 FTHEIITLW----YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249
Query: 228 KIKGGIYTLPSHLS-PGARDL------IPR------------------------MLIVDP 256
             +  +  LP   + PG   L       P+                        ML +DP
Sbjct: 250 IFE--VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307
Query: 257 MKRITIPEIRQHPWFQ 272
           +KRI+     +HP+F 
Sbjct: 308 VKRISAKNALEHPYFS 323

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 120/260 (46%), Gaps = 23/260 (8%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           LG+ +G G+FG+V           VA+K  + R+    +++ K  +E +IL+ + HP+I+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVV 139
           RL  V      IY+VME V+ G+   ++  E  RL+            +G+EY      +
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-----PNYAAPEVISGKLYA 194
           HRDL   N L+  K  +KI+DFG+S    DG  +  + G        + APE ++   Y+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADG--VXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI------KGGIYTLPSHLSPGARDL 247
             E DVWS G++L+     G  P+     PNL  +       KGG    P         L
Sbjct: 294 S-ESDVWSFGILLWETFSLGASPY-----PNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347
Query: 248 IPRMLIVDPMKRITIPEIRQ 267
           + +    +P +R +   I Q
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQ 367

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 25  LGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           LG G+FG V++  +      TG  VA+K L        + +   +REI+IL+      I+
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIV 71
Query: 81  RLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           +   V   P   ++ +VMEY+ SG L D++   + RL       +  QI  G+EY     
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAPEVISGKLY 193
            VHRDL   N+L++S+ +VKIADFGL+ ++   +D   ++    SP  + APE +S  ++
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF 191
Query: 194 AGPEVDVWSCGVILYALL 211
           +  + DVWS GV+LY L 
Sbjct: 192 SR-QSDVWSFGVVLYELF 208

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 25  LGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           LG G+FG V++  +      TG  VA+K L        + +   +REI+IL+      I+
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIV 74
Query: 81  RLYEVIETP--SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           +   V   P    + +VMEY+ SG L D++   + RL       +  QI  G+EY     
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAPEVISGKLY 193
            VHRDL   N+L++S+ +VKIADFGL+ ++   +D + ++    SP  + APE +S  ++
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 194
Query: 194 AGPEVDVWSCGVILYALL 211
           +  + DVWS GV+LY L 
Sbjct: 195 SR-QSDVWSFGVVLYELF 211

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 128/265 (48%), Gaps = 17/265 (6%)
Query: 10  SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK 69
           SG  + +   KL +T+G G FG V + ++   G+KVA+K      IKN    +    E  
Sbjct: 14  SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEAS 66
Query: 70  ILRLFMHPHIIRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQI 126
           ++    H ++++L  VI E    +Y+V EY+  G L DY+  +GR  L  D    F   +
Sbjct: 67  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAP 185
              +EY   N  VHRDL   N+L+      K++DFGL+   ++    + +   P  + AP
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAP 183
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPG 243
           E +  K ++  + DVWS G++L+ +   G +P+    + ++  ++ KG     P    P 
Sbjct: 184 EALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 242
Query: 244 ARDLIPRMLIVDPMKRITIPEIRQH 268
             +++     +D   R +  ++R+ 
Sbjct: 243 VYEVMKNCWHLDAAMRPSFLQLREQ 267

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 128/288 (44%), Gaps = 34/288 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  +  KN        RE++I+R   H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDH 72
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 248
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
           ++ P             P+I+ HPW +   PR     PP+ +    ++
Sbjct: 249 EMNPN------YTEFAFPQIKAHPWTKVFRPR----TPPEAIALCSRL 286

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 25  LGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           LG G+FG V++  +      TG  VA+K L        + +   +REI+IL+      I+
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIV 87
Query: 81  RLYEVIETP--SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           +   V   P    + +VMEY+ SG L D++   + RL       +  QI  G+EY     
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAPEVISGKLY 193
            VHRDL   N+L++S+ +VKIADFGL+ ++   +D + ++    SP  + APE +S  ++
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 194 AGPEVDVWSCGVILYALL 211
           +  + DVWS GV+LY L 
Sbjct: 208 SR-QSDVWSFGVVLYELF 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 25  LGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           LG G+FG V++  +      TG  VA+K L        + +   +REI+IL+      I+
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIV 75
Query: 81  RLYEVIETP--SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           +   V   P    + +VMEY+ SG L D++   + RL       +  QI  G+EY     
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 135
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAPEVISGKLY 193
            VHRDL   N+L++S+ +VKIADFGL+ ++   +D + ++    SP  + APE +S  ++
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 195
Query: 194 AGPEVDVWSCGVILYALL 211
           +  + DVWS GV+LY L 
Sbjct: 196 SR-QSDVWSFGVVLYELF 212

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 140/303 (46%), Gaps = 58/303 (19%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G  G V  A       +VAIK   +  + + +  +   REIKI+R   H +I+++
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 83  YEVIETPS---------------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
           +E++  PS                +Y+V EY+++      ++E+G L E+ AR F  Q++
Sbjct: 74  FEIL-GPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHARLFMYQLL 130
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHF-----LKTSCGSPN 181
            G++Y H   V+HRDLKP NL ++++   +KI DFGL+ IM D H+     L     +  
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM-DPHYSHKGHLSEGLVTKW 189
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-----------ENIPNLFKKIK 230
           Y +P ++         +D+W+ G I   +L G   F             E+IP + ++ +
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249
Query: 231 GGIYTL---------------PSHLSPG----ARDLIPRMLIVDPMKRITIPEIRQHPWF 271
             + ++                + L PG    A D + ++L   PM R+T  E   HP+ 
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309
Query: 272 QAH 274
             +
Sbjct: 310 SIY 312

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 128/267 (47%), Gaps = 35/267 (13%)
Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLF 74
           L  Y+L K LG G++G V  +    TG  VA+K +     +N    ++  REI IL  L 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELS 66
Query: 75  MHPHIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
            H +I+ L  V+  +   D+Y+V +Y+++      ++    L+    +    Q+I  ++Y
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLS----NIMR------------------DG 170
            H   ++HRD+KP N+LL+++ +VK+ADFGLS    NI R                  D 
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK 230
             L     +  Y APE++ G       +D+WS G IL  +LCG   F   +  N  ++I 
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 231 GGIYTLPSH------LSPGARDLIPRM 251
           G I   PS+       SP A+ +I  +
Sbjct: 245 GVI-DFPSNEDVESIQSPFAKTMIESL 270

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 122/272 (44%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 72
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E    +Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 248
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 249 EMNPN------YTEFKFPQIKAHPWTKVFRPR 274

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 122/272 (44%), Gaps = 30/272 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  +  KN        RE++I+R   H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDH 72
Query: 77  PHIIRL----YEVIETPSDIYV--VMEYVKSGELF---DYIVEKGRLQEDEARNFFQQII 127
            +I+RL    Y   E   ++Y+  V++YV          Y   K  L     + +  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGAR 245
           +I G       +DVWS G +L  LL G   F  D  +  L + IK     L +      R
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 248
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
           ++ P             P+I+ HPW +   PR
Sbjct: 249 EMNPN------YTEFKFPQIKAHPWTKVFRPR 274

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 126/284 (44%), Gaps = 47/284 (16%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F  ++K  + +G G FG+V  A+H + G    I+   R K  N    EK  RE+K L   
Sbjct: 10  FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIR---RVKYNN----EKAEREVKALAKL 62
Query: 75  MHPHIIRLYEVI-------ETPSD----------------------IYVVMEYVKSGELF 105
            H +I+             ET  D                      +++ ME+   G L 
Sbjct: 63  DHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE 122
Query: 106 DYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163
            +I ++   +L +  A   F+QI  GV+Y H   ++HRDLKP N+ L     VKI DFGL
Sbjct: 123 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGL 182
Query: 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL--CGTLPFDDEN 221
              +++      S G+  Y +PE IS + Y G EVD+++ G+IL  LL  C T  F+   
Sbjct: 183 VTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDT-AFE--- 237
Query: 222 IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
               F  ++ GI  +        + L+ ++L   P  R    EI
Sbjct: 238 TSKFFTDLRDGI--ISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 279

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 127/265 (47%), Gaps = 17/265 (6%)
Query: 10  SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK 69
           SG  + +   KL +T+G G FG V + ++   G+KVA+K      IKN    +    E  
Sbjct: 5   SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEAS 57
Query: 70  ILRLFMHPHIIRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQI 126
           ++    H ++++L  VI E    +Y+V EY+  G L DY+  +GR  L  D    F   +
Sbjct: 58  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 117
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAP 185
              +EY   N  VHRDL   N+L+      K++DFGL+   ++    + +   P  + AP
Sbjct: 118 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAP 174
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPG 243
           E +    ++  + DVWS G++L+ +   G +P+    + ++  ++ KG     P    P 
Sbjct: 175 EALREAAFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 233
Query: 244 ARDLIPRMLIVDPMKRITIPEIRQH 268
             +++     +D   R +  ++R+ 
Sbjct: 234 VYEVMKNCWHLDAAMRPSFLQLREQ 258

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 23  KTLGIGSFGKVKI----AEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           + LG G FGKV +      +  TG  VA+K L  +     +     ++EI ILR   H H
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 79  IIRLYEVIETP--SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           II+     E    + + +VMEYV  G L DY+  +  +   +   F QQI  G+ Y H  
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNY-AAPEVISG-K 191
             +HRDL   N+LLD+   VKI DFGL+  + +GH    ++    SP +  APE +   K
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYK 213
Query: 192 LYAGPEVDVWSCGVILYALL 211
            Y     DVWS GV LY LL
Sbjct: 214 FYYAS--DVWSFGVTLYELL 231

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 19/264 (7%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLY 83
           LG G++G V+   H  +G   A+K +  R   N + ++++  ++ I  R    P  +  Y
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI--RATVNSQEQKRLLXDLDISXRTVDCPFTVTFY 99
Query: 84  EVIETPSDIYVVMEYVKSG--ELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNM-VV 139
             +    D+++  E   +   + +  +++KG+ + ED        I+  +E+ H  + V+
Sbjct: 100 GALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 159
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA---GP 196
           HRD+KP N+L+++   VK  DFG+S  + D        G   Y APE I+ +L       
Sbjct: 160 HRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSV 219
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------DLIPR 250
           + D+WS G+    L     P+D    P  F+++K  +   PS   P  +      D   +
Sbjct: 220 KSDIWSLGITXIELAILRFPYDSWGTP--FQQLK-QVVEEPSPQLPADKFSAEFVDFTSQ 276
Query: 251 MLIVDPMKRITIPEIRQHPWFQAH 274
            L  +  +R T PE+ QHP+F  H
Sbjct: 277 CLKKNSKERPTYPELXQHPFFTLH 300

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 124/255 (48%), Gaps = 17/255 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL +T+G G FG V + ++   G+KVA+K      IKN    +    E  ++    H ++
Sbjct: 9   KLLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEASVMTQLRHSNL 61
Query: 80  IRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRN 136
           ++L  VI E    +Y+V EY+  G L DY+  +GR  L  D    F   +   +EY   N
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAG 195
             VHRDL   N+L+      K++DFGL+   ++    + +   P  + APE +  K ++ 
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS- 177
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLI 253
            + DVWS G++L+ +   G +P+    + ++  ++ KG     P    P   +++     
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 237
Query: 254 VDPMKRITIPEIRQH 268
           +D   R +  ++R+ 
Sbjct: 238 LDAAMRPSFLQLREQ 252

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 94/298 (31%), Positives = 139/298 (46%), Gaps = 42/298 (14%)
Query: 9   SSGVDMFLPN------------YKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRK 54
           SSGVD+   N            Y + K +G G   KV      L   K   AIK +N  +
Sbjct: 8   SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVF---QVLNEKKQIYAIKYVNLEE 64
Query: 55  IKNMEMEEKVRREIKIL-RLFMHP-HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG 112
             N  ++   R EI  L +L  H   IIRLY+   T   IY+VME   + +L  ++ +K 
Sbjct: 65  ADNQTLDS-YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK 122
Query: 113 RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DG 170
            +   E +++++ ++  V   H++ +VH DLKP N L+     +K+ DFG++N M+    
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTT 181
Query: 171 HFLKTS-CGSPNYAAPEVI---SGKLYAG-------PEVDVWSCGVILYALLCGTLPFDD 219
             +K S  G+ NY  PE I   S     G       P+ DVWS G ILY +  G  PF  
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-- 239
Query: 220 ENIPNLFKKIKGGI-----YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           + I N   K+   I        P       +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 240 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 130/265 (49%), Gaps = 25/265 (9%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V    H  +G  +A      RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y   ++ ++
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  + D
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 185
Query: 200 VWSCGVILYALLCGTLPF------DDENIP-NLFKKIKGGIYTLPSHLSPGA-----RDL 247
           +WS G+ L  +  G  P       +D   P  +F+ +   +   P  L  G      +D 
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 245
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQ 272
           + + LI +P +R  + ++  H + +
Sbjct: 246 VNKCLIKNPAERADLKQLMVHAFIK 270

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 123/254 (48%), Gaps = 19/254 (7%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           L K LG G FG VK+ +     + VA+K++    +     E++  +E + +    HP ++
Sbjct: 12  LLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLV 66
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVV 139
           + Y V      IY+V EY+ +G L +Y+   G+ L+  +       +  G+ +   +  +
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGP 196
           HRDL   N L+D    VK++DFG++  + D  ++ +S G+     ++APEV     Y+  
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 197 EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             DVW+ G++++ +   G +P+D      +  K+  G      HL   A D I +++   
Sbjct: 186 S-DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL---ASDTIYQIMYSC 241
Query: 256 ----PMKRITIPEI 265
               P KR T  ++
Sbjct: 242 WHELPEKRPTFQQL 255

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 92/298 (30%), Positives = 137/298 (45%), Gaps = 42/298 (14%)
Query: 9   SSGVDMFLPN------------YKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRK 54
           SSGVD+   N            Y + K +G G   KV      L   K   AIK +N  +
Sbjct: 8   SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVF---QVLNEKKQIYAIKYVNLEE 64
Query: 55  IKNMEMEEKVRREIKIL-RLFMHP-HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG 112
             N  ++   R EI  L +L  H   IIRLY+   T   IY+VME   + +L  ++ +K 
Sbjct: 65  ADNQTLDS-YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK 122
Query: 113 RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172
            +   E +++++ ++  V   H++ +VH DLKP N L+     +K+ DFG++N M+    
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXX 181
Query: 173 L---KTSCGSPNYAAPEVI---SGKLYAG-------PEVDVWSCGVILYALLCGTLPFDD 219
                +  G+ NY  PE I   S     G       P+ DVWS G ILY +  G  PF  
Sbjct: 182 XVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-- 239
Query: 220 ENIPNLFKKIKGGI-----YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           + I N   K+   I        P       +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 240 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 140/293 (47%), Gaps = 30/293 (10%)
Query: 2   DGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNME 59
           D AS+ ++  + +    Y + K +G G   KV      L   K   AIK +N  +  N  
Sbjct: 41  DKASSSANECISVKGRIYSILKQIGSGGSSKVF---QVLNEKKQIYAIKYVNLEEADNQT 97
Query: 60  MEEKVRREIKIL-RLFMHPH-IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQED 117
           ++   R EI  L +L  H   IIRLY+   T   IY+VME   + +L  ++ +K  +   
Sbjct: 98  LDS-YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKT 175
           E +++++ ++  V   H++ +VH DLKP N L+     +K+ DFG++N M+      +K 
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 214
Query: 176 S-CGSPNYAAPEVI---SGKLYAG-------PEVDVWSCGVILYALLCGTLPFDDENIPN 224
           S  G+ NY  PE I   S     G       P+ DVWS G ILY +  G  PF  + I N
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIIN 272
Query: 225 LFKKIKGGI-----YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
              K+   I        P       +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 273 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 138/311 (44%), Gaps = 55/311 (17%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   K +G GSFG V  A+   +      K+L  ++ KN        RE++I+R+  HP+
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN--------RELQIMRIVKHPN 93
Query: 79  IIRLYEVIETPSD------IYVVMEYVKSGELFDYIVEKGRLQEDEA----RNFFQQIIS 128
           ++ L     +  D      + +V+EYV    ++       +L++       + +  Q++ 
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
            + Y H   + HRD+KP+NLLLD    V K+ DFG + I+  G    +   S  Y APE+
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPEL 212
Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIK-------GGIYTL-PS 238
           I G       +D+WS G ++  L+ G   F  E+ I  L + IK         I T+ P+
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272
Query: 239 HLS--------------------PGARDLIPRMLIVDPMKRITIPEIRQHPWF------Q 272
           ++                     P A DLI R+L   P  R+T  E   HP+F      +
Sbjct: 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332
Query: 273 AHLPRYLAVPP 283
           A +P    +PP
Sbjct: 333 ARMPNGRELPP 343

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 23  KTLGIGSFGKVKI----AEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           + LG G FGKV +      +  TG  VA+K L  ++    ++    +REI+ILR   H H
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KEGCGPQLRSGWQREIEILRTLYHEH 71
Query: 79  IIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           I++     E   +  + +VMEYV  G L DY+  +  +   +   F QQI  G+ Y H  
Sbjct: 72  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNY-AAPEVI-SGK 191
             +HR L   N+LLD+   VKI DFGL+  + +GH    ++    SP +  APE +   K
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 192 LYAGPEVDVWSCGVILYALL 211
            Y     DVWS GV LY LL
Sbjct: 191 FYYAS--DVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 23  KTLGIGSFGKVKI----AEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           + LG G FGKV +      +  TG  VA+K L  ++    ++    +REI+ILR   H H
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KEGCGPQLRSGWQREIEILRTLYHEH 72
Query: 79  IIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           I++     E   +  + +VMEYV  G L DY+  +  +   +   F QQI  G+ Y H  
Sbjct: 73  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQ 131
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNY-AAPEVI-SGK 191
             +HR L   N+LLD+   VKI DFGL+  + +GH    ++    SP +  APE +   K
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 191
Query: 192 LYAGPEVDVWSCGVILYALL 211
            Y     DVWS GV LY LL
Sbjct: 192 FYYAS--DVWSFGVTLYELL 209

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 127/259 (49%), Gaps = 19/259 (7%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V    H  +G  +A      RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y   ++ ++
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 146
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  + D
Sbjct: 147 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 204
Query: 200 VWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGA-----RDLIPRMLI 253
           +WS G+ L  +  G  P         +F+ +   +   P  L  G      +D + + LI
Sbjct: 205 IWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 264
Query: 254 VDPMKRITIPEIRQHPWFQ 272
            +P +R  + ++  H + +
Sbjct: 265 KNPAERADLKQLMVHAFIK 283

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 140/293 (47%), Gaps = 30/293 (10%)
Query: 2   DGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNME 59
           D AS+ ++  + +    Y + K +G G   KV      L   K   AIK +N  +  N  
Sbjct: 41  DKASSSANECISVKGRIYSILKQIGSGGSSKVF---QVLNEKKQIYAIKYVNLEEADNQT 97
Query: 60  MEEKVRREIKIL-RLFMHP-HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQED 117
           ++   R EI  L +L  H   IIRLY+   T   IY+VME   + +L  ++ +K  +   
Sbjct: 98  LDS-YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKT 175
           E +++++ ++  V   H++ +VH DLKP N L+     +K+ DFG++N M+      +K 
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 214
Query: 176 S-CGSPNYAAPEVI---SGKLYAG-------PEVDVWSCGVILYALLCGTLPFDDENIPN 224
           S  G+ NY  PE I   S     G       P+ DVWS G ILY +  G  PF  + I N
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIIN 272
Query: 225 LFKKIKGGI-----YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
              K+   I        P       +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 273 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G FG V +  + L   KVAIK +    +     EE    E +++    HP +++L
Sbjct: 13  QEIGSGQFGLVHLG-YWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQL 67
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V    + I +V E+++ G L DY+  ++G    +        +  G+ Y     V+HR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 127
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+    
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKS- 185
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 233
           DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 221

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G FG V +  + L   KVAIK +    +     EE    E +++    HP +++L
Sbjct: 11  QEIGSGQFGLVHLG-YWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQL 65
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V    + I +V E+++ G L DY+  ++G    +        +  G+ Y     V+HR
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+    
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKS- 183
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 233
           DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 219

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 140/293 (47%), Gaps = 30/293 (10%)
Query: 2   DGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNME 59
           D AS+ ++  + +    Y + K +G G   KV      L   K   AIK +N  +  N  
Sbjct: 41  DKASSSANECISVKGRIYSILKQIGSGGSSKVF---QVLNEKKQIYAIKYVNLEEADNQT 97
Query: 60  MEEKVRREIKIL-RLFMHP-HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQED 117
           ++   R EI  L +L  H   IIRLY+   T   IY+VME   + +L  ++ +K  +   
Sbjct: 98  LDS-YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKT 175
           E +++++ ++  V   H++ +VH DLKP N L+     +K+ DFG++N M+      +K 
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 214
Query: 176 S-CGSPNYAAPEVI---SGKLYAG-------PEVDVWSCGVILYALLCGTLPFDDENIPN 224
           S  G+ NY  PE I   S     G       P+ DVWS G ILY +  G  PF  + I N
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIIN 272
Query: 225 LFKKIKGGI-----YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
              K+   I        P       +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 273 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G FG V +  + L   KVAIK +    +     EE    E +++    HP +++L
Sbjct: 16  QEIGSGQFGLVHLG-YWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQL 70
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V    + I +V E+++ G L DY+  ++G    +        +  G+ Y     V+HR
Sbjct: 71  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 130
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+    
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKS- 188
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 233
           DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 189 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 224

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 113/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 26  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 79
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 80  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 138
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D  +  +     P  + APE I+   + 
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 199 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 236

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G FG V +  + L   KVAIK +    +     EE    E +++    HP +++L
Sbjct: 13  QEIGSGQFGLVHLG-YWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQL 67
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V    + I +V E+++ G L DY+  ++G    +        +  G+ Y     V+HR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHR 127
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+    
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKS- 185
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 233
           DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 221

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G FG V +  + L   KVAIK +    +     EE    E +++    HP +++L
Sbjct: 14  QEIGSGQFGLVHLG-YWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQL 68
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V    + I +V E+++ G L DY+  ++G    +        +  G+ Y     V+HR
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+    
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKS- 186
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 233
           DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 222

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 113/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 22  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 75
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 76  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D  +  +     P  + APE I+   + 
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 195 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 232

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 113/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 21  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 74
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 75  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 133
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D  +  +     P  + APE I+   + 
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 194 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 231

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 131/267 (49%), Gaps = 26/267 (9%)
Query: 27  IGSFGKVKIAEHALTGHKV-AIKILNRRKIKNMEMEEKVRREIKIL-RLFMHP-HIIRLY 83
           IGS G  K+ +      ++ AIK +N  +  N  ++   R EI  L +L  H   IIRLY
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS-YRNEIAYLNKLQQHSDKIIRLY 75
Query: 84  EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
           +   T   IY+VME   + +L  ++ +K  +   E +++++ ++  V   H++ +VH DL
Sbjct: 76  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 134
Query: 144 KPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTS-CGSPNYAAPEVI---SGKLYAG-- 195
           KP N L+     +K+ DFG++N M+      +K S  G+ NY  PE I   S     G  
Sbjct: 135 KPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193
Query: 196 -----PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPSHLSPGAR 245
                P+ DVWS G ILY +  G  PF  + I N   K+   I        P       +
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 251
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 252 DVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 113/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 11  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 64
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 65  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 123
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D  +  +     P  + APE I+   + 
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 184 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 135/272 (49%), Gaps = 22/272 (8%)
Query: 17  PN--YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           PN  +++   LG G+FGKV  A++  TG   A K++   + K+ E  E    EI+IL   
Sbjct: 9   PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATC 65
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYC 133
            HP+I++L         +++++E+   G +   ++E  R L E + +   +Q++  + + 
Sbjct: 66  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 125
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVI 188
           H   ++HRDLK  N+L+  + ++++ADFG+S      + +   F+    G+P + APEV+
Sbjct: 126 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----GTPYWMAPEVV 181
Query: 189 SGKLYAGP----EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLS 241
             +         + D+WS G+ L  +     P  + N +  L K  K    TL  PS  S
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 241
Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273
              RD +   L  +P  R +  ++ +HP+  +
Sbjct: 242 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 273

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 131/267 (49%), Gaps = 26/267 (9%)
Query: 27  IGSFGKVKIAEHALTGHKV-AIKILNRRKIKNMEMEEKVRREIKIL-RLFMHP-HIIRLY 83
           IGS G  K+ +      ++ AIK +N  +  N  ++   R EI  L +L  H   IIRLY
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS-YRNEIAYLNKLQQHSDKIIRLY 78
Query: 84  EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
           +   T   IY+VME   + +L  ++ +K  +   E +++++ ++  V   H++ +VH DL
Sbjct: 79  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 137
Query: 144 KPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTS-CGSPNYAAPEVI---SGKLYAG-- 195
           KP N L+     +K+ DFG++N M+      +K S  G+ NY  PE I   S     G  
Sbjct: 138 KPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 196
Query: 196 -----PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPSHLSPGAR 245
                P+ DVWS G ILY +  G  PF  + I N   K+   I        P       +
Sbjct: 197 KSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 254
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 255 DVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 128/280 (45%), Gaps = 26/280 (9%)
Query: 9   SSGVDMFLPN--------YKLGKT-------LGIGSFGKVKIAEHALTGHKVAIKILNRR 53
           SSGVD+   N        +++ +T       LG G +G+V +         VA+K L   
Sbjct: 9   SSGVDLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL--- 65
Query: 54  KIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR 113
           K   ME+EE ++ E  +++   HP++++L  V       Y+V EY+  G L DY+ E  R
Sbjct: 66  KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNR 124
Query: 114 LQEDEARNFF--QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DG 170
            +       +   QI S +EY  +   +HRDL   N L+     VK+ADFGLS +M  D 
Sbjct: 125 EEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT 184
Query: 171 HFLKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKK 228
           +        P  + APE ++   ++  + DVW+ GV+L+ +   G  P+   ++  ++  
Sbjct: 185 YTAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDL 243
Query: 229 I-KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           + KG     P    P   +L+       P  R +  E  Q
Sbjct: 244 LEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQ 283

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 135/272 (49%), Gaps = 22/272 (8%)
Query: 17  PN--YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           PN  +++   LG G+FGKV  A++  TG   A K++   + K+ E  E    EI+IL   
Sbjct: 17  PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATC 73
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYC 133
            HP+I++L         +++++E+   G +   ++E  R L E + +   +Q++  + + 
Sbjct: 74  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVI 188
           H   ++HRDLK  N+L+  + ++++ADFG+S      + +   F+    G+P + APEV+
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----GTPYWMAPEVV 189
Query: 189 SGKLYAGP----EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLS 241
             +         + D+WS G+ L  +     P  + N +  L K  K    TL  PS  S
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249
Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273
              RD +   L  +P  R +  ++ +HP+  +
Sbjct: 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 131/267 (49%), Gaps = 26/267 (9%)
Query: 27  IGSFGKVKIAEHALTGHKV-AIKILNRRKIKNMEMEEKVRREIKIL-RLFMHP-HIIRLY 83
           IGS G  K+ +      ++ AIK +N  +  N  ++   R EI  L +L  H   IIRLY
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS-YRNEIAYLNKLQQHSDKIIRLY 74
Query: 84  EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
           +   T   IY+VME   + +L  ++ +K  +   E +++++ ++  V   H++ +VH DL
Sbjct: 75  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 133
Query: 144 KPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTS-CGSPNYAAPEVI---SGKLYAG-- 195
           KP N L+     +K+ DFG++N M+      +K S  G+ NY  PE I   S     G  
Sbjct: 134 KPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 192
Query: 196 -----PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPSHLSPGAR 245
                P+ DVWS G ILY +  G  PF  + I N   K+   I        P       +
Sbjct: 193 KSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 250
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 251 DVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 113/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 16  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 69
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 70  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D  +  +     P  + APE I+   + 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 189 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 118/229 (51%), Gaps = 25/229 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL K LG G FG+V +A +     KVA+K +   K  +M +E  +  E  +++   H  +
Sbjct: 18  KLEKKLGAGQFGEVWMATYN-KHTKVAVKTM---KPGSMSVEAFLA-EANVMKTLQHDKL 72
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR--------NFFQQIISGVE 131
           ++L+ V+ T   IY++ E++  G L D+      L+ DE          +F  QI  G+ 
Sbjct: 73  VKLHAVV-TKEPIYIITEFMAKGSLLDF------LKSDEGSKQPLPKLIDFSAQIAEGMA 125
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVIS 189
           +  +   +HRDL+  N+L+ +    KIADFGL+ ++ D  +  +     P  + APE I+
Sbjct: 126 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 185
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
              +   + DVWS G++L  ++  G +P+   + P + + ++ G Y +P
Sbjct: 186 FGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 232

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 118/229 (51%), Gaps = 25/229 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL K LG G FG+V +A +     KVA+K +   K  +M +E  +  E  +++   H  +
Sbjct: 191 KLEKKLGAGQFGEVWMATYN-KHTKVAVKTM---KPGSMSVEAFLA-EANVMKTLQHDKL 245
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR--------NFFQQIISGVE 131
           ++L+ V+ T   IY++ E++  G L D+      L+ DE          +F  QI  G+ 
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDF------LKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVIS 189
           +  +   +HRDL+  N+L+ +    KIADFGL+ ++ D  +  +     P  + APE I+
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
              +   + DVWS G++L  ++  G +P+   + P + + ++ G Y +P
Sbjct: 359 FGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G FG V +  + L   KVAIK +    +     E+    E +++    HP +++L
Sbjct: 33  QEIGSGQFGLVHLG-YWLNKDKVAIKTIKEGSMS----EDDFIEEAEVMMKLSHPKLVQL 87
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V    + I +V E+++ G L DY+  ++G    +        +  G+ Y     V+HR
Sbjct: 88  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 147
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+    
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKS- 205
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 233
           DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 206 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 241

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 126/261 (48%), Gaps = 27/261 (10%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V    H  +G  +A      RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y   ++ ++
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 130
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D        G+ +Y +PE + G  Y+  + D
Sbjct: 131 HRDVKPSNILVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPERLQGTHYS-VQSD 188
Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFK--------KIKGGIYTLPSHLSPGARDLIPRM 251
           +WS G+ L  +  G  P     I  L          K+   +++L        +D + + 
Sbjct: 189 IWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLE------FQDFVNKC 242
Query: 252 LIVDPMKRITIPEIRQHPWFQ 272
           LI +P +R  + ++  H + +
Sbjct: 243 LIKNPAERADLKQLMVHAFIK 263

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 23  KTLGIGSFGKVKI----AEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           + LG G FGKV +      +  TG  VA+K L  +     +     ++EI ILR   H H
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 79  IIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           II+     E   +  + +VMEYV  G L DY+  +  +   +   F QQI  G+ Y H  
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNY-AAPEVISG-K 191
             +HR+L   N+LLD+   VKI DFGL+  + +GH    ++    SP +  APE +   K
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 192 LYAGPEVDVWSCGVILYALL 211
            Y     DVWS GV LY LL
Sbjct: 197 FYYAS--DVWSFGVTLYELL 214

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V   +H  +G      ++  RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 24  LGAGNGGVVTKVQHRPSG------LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + E  R+ E+        ++ G+ Y   ++ ++
Sbjct: 78  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 137
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y APE + G  Y+  + D
Sbjct: 138 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAPERLQGTHYS-VQSD 195
Query: 200 VWSCGVILYALLCGTLPF 217
           +WS G+ L  L  G  P 
Sbjct: 196 IWSMGLSLVELAVGRYPI 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 116/231 (50%), Gaps = 21/231 (9%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILR 72
           K+ K +G+G FG+V      + G +   VAIK L           +K RR    E  I+ 
Sbjct: 32  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLK------AGYTDKQRRDFLSEASIMG 85
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVE 131
            F HP+II L  V+     + ++ EY+++G L  ++ +  GR    +     + I SG++
Sbjct: 86  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 145
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEV 187
           Y      VHRDL   N+L++S    K++DFG+S ++ D      T+ G      + APE 
Sbjct: 146 YLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 188 ISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           I+ + +     DVWS G++++ ++  G  P+ D +  ++ K I+ G Y LP
Sbjct: 206 IAYRKFTSAS-DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 254

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 23  KTLGIGSFGKVKI----AEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           + LG G FGKV +      +  TG  VA+K L  +     +     ++EI ILR   H H
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 79  IIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           II+     E   +  + +VMEYV  G L DY+  +  +   +   F QQI  G+ Y H  
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNY-AAPEVISG-K 191
             +HR+L   N+LLD+   VKI DFGL+  + +GH    ++    SP +  APE +   K
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 192 LYAGPEVDVWSCGVILYALL 211
            Y     DVWS GV LY LL
Sbjct: 197 FYYAS--DVWSFGVTLYELL 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 25  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 78
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 79  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 137
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   + 
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 198 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 235

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 24  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 77
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 78  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 136
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   + 
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 197 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 234

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 22  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 75
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 76  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   + 
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 195 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 232

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 16  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 69
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 70  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   + 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 189 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 112/217 (51%), Gaps = 22/217 (10%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           ++L + +G G++G+V    H  TG   AIK+++       + EE++++EI +L+ + H  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 81
Query: 79  IIRLYE---VIETP----SDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISG 129
            I  Y    + + P      +++VME+  +G + D I   +   L+E+      ++I+ G
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVI 188
           + + H++ V+HRD+K +N+LL     VK+ DFG+S  + R      T  G+P + APEVI
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 189 SGKLYAGPEV------DVWSCGVILYALLCGTLPFDD 219
           +      P+       D+WS G+    +  G  P  D
Sbjct: 202 ACD--ENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 113/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 12  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 65
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 66  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 124
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HR+L+  N+L+    + KIADFGL+ ++ D  +  +     P  + APE I+   + 
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 184
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 185 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 222

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 18  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 71
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 72  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 130
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   + 
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 190
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 191 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 228

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 116/231 (50%), Gaps = 21/231 (9%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILR 72
           K+ K +G+G FG+V      + G +   VAIK L           +K RR    E  I+ 
Sbjct: 11  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLK------AGYTDKQRRDFLSEASIMG 64
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVE 131
            F HP+II L  V+     + ++ EY+++G L  ++ +  GR    +     + I SG++
Sbjct: 65  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 124
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEV 187
           Y      VHRDL   N+L++S    K++DFG+S ++ D      T+ G      + APE 
Sbjct: 125 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 188 ISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           I+ + +     DVWS G++++ ++  G  P+ D +  ++ K I+ G Y LP
Sbjct: 185 IAYRKFTSAS-DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 233

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 16  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 69
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 70  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   + 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 189 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 116/231 (50%), Gaps = 21/231 (9%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILR 72
           K+ K +G+G FG+V      + G +   VAIK L           +K RR    E  I+ 
Sbjct: 17  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLK------AGYTDKQRRDFLSEASIMG 70
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVE 131
            F HP+II L  V+     + ++ EY+++G L  ++ +  GR    +     + I SG++
Sbjct: 71  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 130
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEV 187
           Y      VHRDL   N+L++S    K++DFG+S ++ D      T+ G      + APE 
Sbjct: 131 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 188 ISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           I+ + +     DVWS G++++ ++  G  P+ D +  ++ K I+ G Y LP
Sbjct: 191 IAYRKFTSAS-DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 239

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G FG+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 17  KLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 70
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 71  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 129
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   + 
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 189
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 190 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 227

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 66
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPN---YAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++ +D  F K      +   + AP
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 187 ESLTESKFSVAS-DVWSFGVVLYELF 211

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 90/332 (27%), Positives = 132/332 (39%), Gaps = 82/332 (24%)
Query: 13  DMFLPNYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKI 70
           D+    Y++  TLG G+FGKV +  +H   G  VA+KI     +KN++   E  R EI++
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKI-----VKNVDRYCEAARSEIQV 64
Query: 71  LRLFMHP------HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRL--QEDEARNF 122
           L              +++ E  E    I +V E +     +D+I E G L  + D  R  
Sbjct: 65  LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKM 123
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLL---------------DSKW----NVKIADFGL 163
             QI   V + H N + H DLKPEN+L                D +     ++K+ DFG 
Sbjct: 124 AYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP 223
           +    + H   T   + +Y APEVI    ++ P  DVWS G IL     G   F   +  
Sbjct: 184 ATYDDEHH--STLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 224 NLFKKIKGGIYTLPSHLSPGAR-------------------------------------- 245
                ++  +  LP H+    R                                      
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 246 ------DLIPRMLIVDPMKRITIPEIRQHPWF 271
                 DLI +ML  DP KRIT+ E  +HP+F
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 110/224 (49%), Gaps = 12/224 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G FG VK  +     + VAIK++    +     E++   E K++    H  +++L
Sbjct: 30  KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQL 84
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V      I+++ EY+ +G L +Y+ E + R Q  +     + +   +EY      +HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++    
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKS- 202
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLS 241
           D+W+ GV+++ +   G +P++        + I  G+     HL+
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 246

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 113/251 (45%), Gaps = 19/251 (7%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG GSFG+V   E   TG + A+K         + +E     E+        P I+ LY 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVK--------KVRLEVFRAEELMACAGLTSPRIVPLYG 152
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
            +     + + ME ++ G L   + E+G L ED A  +  Q + G+EY H   ++H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 145 PENLLLDSKWN-VKIADFGLSNIMRDGHFLKTSC------GSPNYAAPEVISGKLYAGPE 197
            +N+LL S  +   + DFG +  ++     K+        G+  + APEV+ G+     +
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR-SCDAK 271
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRMLIV 254
           VDVWS   ++  +L G  P+       L  KI      +  +P   +P     I   L  
Sbjct: 272 VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRK 331
Query: 255 DPMKRITIPEI 265
           +P+ R++  E+
Sbjct: 332 EPIHRVSAAEL 342

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 99
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V EY+++G L  ++ +   +    +     + I SG
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +P
Sbjct: 160 MKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 220 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 12/225 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G FG VK  +     + VAIK++    +     E++   E K++    H  +++L
Sbjct: 15  KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQL 69
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V      I+++ EY+ +G L +Y+ E + R Q  +     + +   +EY      +HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++    
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKS- 187
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
           D+W+ GV+++ +   G +P++        + I  G+     HL+ 
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 232

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V    H  +G  +A      RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y   ++ ++
Sbjct: 130 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 189
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  + D
Sbjct: 190 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 247
Query: 200 VWSCGVILYALLCGTLPF 217
           +WS G+ L  +  G  P 
Sbjct: 248 IWSMGLSLVEMAVGRYPI 265

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 87
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V EY+++G L  ++ +   +    +     + I SG
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +P
Sbjct: 148 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 208 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 258

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 12/225 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G FG VK  +     + VAIK++    +     E++   E K++    H  +++L
Sbjct: 14  KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQL 68
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V      I+++ EY+ +G L +Y+ E + R Q  +     + +   +EY      +HR
Sbjct: 69  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 128
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++    
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKS- 186
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
           D+W+ GV+++ +   G +P++        + I  G+     HL+ 
Sbjct: 187 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 231

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/307 (23%), Positives = 134/307 (43%), Gaps = 43/307 (14%)
Query: 6   NRSSSGVDMFLPNYKLGKTLGIGSFGKV------------KIAEHALTGHKVAIKILNRR 53
           N+     D ++ +Y++ +TL  G F K+            K  E +L   K      N  
Sbjct: 20  NKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 54  KIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL--FD---YI 108
           KI      +  + E++I+    + + +    +I    ++Y++ EY+++  +  FD   ++
Sbjct: 80  KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 109 VEKGR---LQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDSKWNVKIADFGLS 164
           ++K     +     +   + +++   Y H    + HRD+KP N+L+D    VK++DFG S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 165 NIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDE-NI 222
             M D   +K S G+  +  PE  S +  Y G +VD+WS G+ LY +    +PF  + ++
Sbjct: 200 EYMVDKK-IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 223 PNLFKKIKGGIYTLP-------------------SHLSPGARDLIPRMLIVDPMKRITIP 263
             LF  I+      P                   + LS    D +   L  +P +RIT  
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318
Query: 264 EIRQHPW 270
           +  +H W
Sbjct: 319 DALKHEW 325

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 99
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V EY+++G L  ++ +   +    +     + I SG
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 220 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 12/225 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G FG VK  +     + VAIK++    +     E++   E K++    H  +++L
Sbjct: 10  KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQL 64
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V      I+++ EY+ +G L +Y+ E + R Q  +     + +   +EY      +HR
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++    
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKS- 182
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
           D+W+ GV+++ +   G +P++        + I  G+     HL+ 
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 135/301 (44%), Gaps = 39/301 (12%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y   + LG G F  V + E    GH  A+K   R      +  E+ +RE  + RLF HP
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALK---RILCHEQQDREEAQREADMHRLFNHP 86
Query: 78  HIIRL--YEVIETPS--DIYVVMEYVKSGELFDYIV---EKGR-LQEDEARNFFQQIISG 129
           +I+RL  Y + E  +  + ++++ + K G L++ I    +KG  L ED+       I  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN---IMRDGH--------FLKTSCG 178
           +E  H     HRDLKP N+LL  +    + D G  N   I  +G         +    C 
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC- 205
Query: 179 SPNYAAPEVISGKLYA--GPEVDVWSCGVILYALLCGTLPFD----DENIPNLFKKIKGG 232
           + +Y APE+ S + +       DVWS G +LYA++ G  P+D      +   L  + +  
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 233 IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           I   P H S     L+  M+ VDP +R  IP +         L +  A+ PP   Q   +
Sbjct: 266 IPQSPRH-SSALWQLLNSMMTVDPHQRPHIPLL---------LSQLEALQPPAPGQHTTQ 315
Query: 293 V 293
           +
Sbjct: 316 I 316

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 70
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V EY+++G L  ++ +   +    +     + I SG
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 191 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 241

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 99
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V EY+++G L  ++ +   +    +     + I SG
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 220 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 99
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V EY+++G L  ++ +   +    +     + I SG
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 220 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 12/225 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G FG VK  +     + VAIK++    +     E++   E K++    H  +++L
Sbjct: 21  KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQL 75
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V      I+++ EY+ +G L +Y+ E + R Q  +     + +   +EY      +HR
Sbjct: 76  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 135
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++    
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKS- 193
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
           D+W+ GV+++ +   G +P++        + I  G+     HL+ 
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 238

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 97
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V EY+++G L  ++ +   +    +     + I SG
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 157
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +P
Sbjct: 158 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 218 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 268

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 99
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V EY+++G L  ++ +   +    +     + I SG
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 220 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 129/273 (47%), Gaps = 23/273 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L   K  NM   E   +E ++++   H  +
Sbjct: 188 RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTL---KPGNMS-PEAFLQEAQVMKKLRHEKL 242
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 243 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 301
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL  ++ D  +  +     P  + APE  + G+   
Sbjct: 302 YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 362 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 418
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
              DP +R T        + QA L  Y     P
Sbjct: 419 WRKDPEERPTF------EYLQAFLEDYFTSTEP 445

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 142/304 (46%), Gaps = 50/304 (16%)
Query: 1   MDGASNRSSSG-----VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRK 54
           + GAS R  S      V++     ++ + L  G F  V  A+   +G + A+K +L+  +
Sbjct: 7   LGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE 66
Query: 55  IKNMEMEEKVRREIKILRLFMHPHIIRLY-------EVIETPSDIYVVMEYVKSGELFDY 107
            KN  + ++V     + +L  HP+I++         E  +T    ++++  +  G+L ++
Sbjct: 67  EKNRAIIQEV---CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEF 123
Query: 108 IVE---KGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADFG 162
           + +   +G L  D     F Q    V++ HR    ++HRDLK ENLLL ++  +K+ DFG
Sbjct: 124 LKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183
Query: 163 LSNIMRDGHFLK---------------TSCGSPNYAAPEVISGKLYA----GPEVDVWSC 203
            +  +   H+                 T   +P Y  PE+I   LY+    G + D+W+ 
Sbjct: 184 SATTI--SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID--LYSNFPIGEKQDIWAL 239
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA--RDLIPRMLIVDPMKRIT 261
           G ILY L     PF+D        +I  G Y++P H +       LI  ML V+P +R++
Sbjct: 240 GCILYLLCFRQHPFED----GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLS 295
Query: 262 IPEI 265
           I E+
Sbjct: 296 IAEV 299

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 19/273 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G G++G V    H  +G  +A+K + R  +   E ++ +     ++R    P+I++ Y 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 85  VIETPSDIYVVMEYVKSGELFD------YIVEKGRLQEDEARNFFQQIISGVEYCHRNM- 137
            +    D ++ ME + +   FD      Y V    + E+         +  + +   N+ 
Sbjct: 89  ALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS-GKLYAGP 196
           ++HRD+KP N+LLD   N+K+ DFG+S  + D        G   Y APE I       G 
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY 206
Query: 197 EV--DVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIYTLPS----HLSPGARDLI 248
           +V  DVWS G+ LY L  G  P+   N     L + +KG    L +      SP   + +
Sbjct: 207 DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFV 266
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAV 281
              L  D  KR    E+ +HP+   +  R + V
Sbjct: 267 NLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V    H  +G  +A      RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y   ++ ++
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  + D
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 185
Query: 200 VWSCGVILYALLCGTLP 216
           +WS G+ L  +  G  P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 113/254 (44%), Gaps = 25/254 (9%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG GSFG+V   E   TG + A+K         + +E     E+        P I+ LY 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVK--------KVRLEVFRAEELMACAGLTSPRIVPLYG 133
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
            +     + + ME ++ G L   + E+G L ED A  +  Q + G+EY H   ++H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 145 PENLLLDSKWN-VKIADF---------GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
            +N+LL S  +   + DF         GL   +  G ++    G+  + APEV+ G+   
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP---GTETHMAPEVVLGR-SC 249
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRM 251
             +VDVWS   ++  +L G  P+       L  KI      +  +P   +P     I   
Sbjct: 250 DAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEG 309
Query: 252 LIVDPMKRITIPEI 265
           L  +P+ R++  E+
Sbjct: 310 LRKEPIHRVSAAEL 323

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 127/273 (46%), Gaps = 21/273 (7%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 75
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+VMEY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 76  VQLYAVV-SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRML 252
             + DVWS G++L  L   G +P+       +  +++ G     P        DL+ +  
Sbjct: 195 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 252
Query: 253 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
             DP +R T        + QA L  Y     P 
Sbjct: 253 RKDPEERPTF------EYLQAFLEDYFTSTEPQ 279

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V    H  +G  +A      RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y   ++ ++
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  + D
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 185
Query: 200 VWSCGVILYALLCGTLP 216
           +WS G+ L  +  G  P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V    H  +G  +A      RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y   ++ ++
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  + D
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 212
Query: 200 VWSCGVILYALLCGTLP 216
           +WS G+ L  +  G  P
Sbjct: 213 IWSMGLSLVEMAVGRYP 229

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V    H  +G  +A      RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y   ++ ++
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  + D
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 185
Query: 200 VWSCGVILYALLCGTLP 216
           +WS G+ L  +  G  P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
           LG G+ G V    H  +G  +A      RK+ ++E++  +R    RE+++L     P+I+
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
             Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y   ++ ++
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  + D
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 185
Query: 200 VWSCGVILYALLCGTLP 216
           +WS G+ L  +  G  P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 121/258 (46%), Gaps = 14/258 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GSF  V       T  +VA   L  RK+   E + + + E + L+   HP+I+R Y+
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEXLKGLQHPNIVRFYD 92
Query: 85  VIETPSD----IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM--V 138
             E+       I +V E   SG L  Y+      +    R++ +QI+ G+++ H     +
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 139 VHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRDLK +N+ +     +VKI D GL+ + R   F K   G+P + APE    K      
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFXAPEXYEEKY--DES 209
Query: 198 VDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLIV 254
           VDV++ G           P+ + +N   +++++  G+   +      P  +++I   +  
Sbjct: 210 VDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 269
Query: 255 DPMKRITIPEIRQHPWFQ 272
           +  +R +I ++  H +FQ
Sbjct: 270 NKDERYSIKDLLNHAFFQ 287

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 134/296 (45%), Gaps = 51/296 (17%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMH 76
           +Y+L + LG G + +V  A +     KV +KIL   K      + K++REIKIL  L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KNKIKREIKILENLRGG 91
Query: 77  PHIIRLYEVIETPSDIY--VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           P+II L ++++ P      +V E+V +    D+      L + + R +  +I+  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNT---DFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 135 RNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
              ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++     
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 194 AGPEVDVWSCGVILYALLCGTLPF--------------------------DDENIP---- 223
               +D+WS G +L +++    PF                          D  NI     
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 224 -------NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                  +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 90/332 (27%), Positives = 131/332 (39%), Gaps = 82/332 (24%)
Query: 13  DMFLPNYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKI 70
           D+    Y++  TLG G+FGKV +  +H   G  VA+KI     +KN++   E  R EI++
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKI-----VKNVDRYCEAARSEIQV 64
Query: 71  LRLFMHP------HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRL--QEDEARNF 122
           L              +++ E  E    I +V E +     +D+I E G L  + D  R  
Sbjct: 65  LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKM 123
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLL---------------DSKW----NVKIADFGL 163
             QI   V + H N + H DLKPEN+L                D +     ++K+ DFG 
Sbjct: 124 AYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP 223
           +    + H   T     +Y APEVI    ++ P  DVWS G IL     G   F   +  
Sbjct: 184 ATYDDEHH--STLVXXRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 224 NLFKKIKGGIYTLPSHLSPGAR-------------------------------------- 245
                ++  +  LP H+    R                                      
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 246 ------DLIPRMLIVDPMKRITIPEIRQHPWF 271
                 DLI +ML  DP KRIT+ E  +HP+F
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 117/232 (50%), Gaps = 21/232 (9%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILR 72
           K+ + +G G FG+V      L G +   VAIK L       +   EK RR    E  I+ 
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLK------VGYTEKQRRDFLCEASIMG 99
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVE 131
            F HP+++ L  V+     + +V+E++++G L  ++ +  G+    +     + I +G+ 
Sbjct: 100 QFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMR 159
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEV 187
           Y      VHRDL   N+L++S    K++DFGLS ++ D    + T+ G      + APE 
Sbjct: 160 YLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 188 ISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 238
           I  + +     DVWS G++++ ++  G  P+ D +  ++ K I+ G Y LP+
Sbjct: 220 IQYRKFTSAS-DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLPA 269

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 12/225 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G FG VK  +     + VAIK++    +     E++   E K++    H  +++L
Sbjct: 15  KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQL 69
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V      I+++ EY+ +G L +Y+ E + R Q  +     + +   +EY      +HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++    
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSRGSKFPVRWSPPEVLMYSKFSSKS- 187
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
           D+W+ GV+++ +   G +P++        + I  G+     HL+ 
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 232

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 129/274 (47%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKL 75
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V+EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 76  VQLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 195 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 251
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              DP +R T        + QA L  Y     P 
Sbjct: 252 WRKDPEERPTF------EYLQAFLEDYFTSTEPQ 279

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 29/274 (10%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
           N + GKTLG G+FGKV  A     G      KVA+K+L  +   + + +E +  E+KI+ 
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMS 104
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR----------- 120
            L  H +I+ L         + V+ EY   G+L +++  K R+ E +             
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTR 164
Query: 121 ---NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KT 175
              +F  Q+  G+ +      +HRD+   N+LL +    KI DFGL+ +IM D +++ K 
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 176 SCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 233
           +   P  + APE I   +Y   + DVWS G++L+ +   G  P+    + + F K+    
Sbjct: 225 NARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283
Query: 234 YTL--PSHLSPGARDLIPRMLIVDPMKRITIPEI 265
           Y +  P+        ++     ++P  R T  +I
Sbjct: 284 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 129/270 (47%), Gaps = 25/270 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
           N + GKTLG G+FGKV  A     G      KVA+K+L  +   + + +E +  E+KI+ 
Sbjct: 39  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMS 96
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEAR--------N 121
            L  H +I+ L         + V+ EY   G+L +++  K    L +++ R        +
Sbjct: 97  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 156
Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGS 179
           F  Q+  G+ +      +HRD+   N+LL +    KI DFGL+ +IM D +++ K +   
Sbjct: 157 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 180 P-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL- 236
           P  + APE I   +Y   + DVWS G++L+ +   G  P+    + + F K+    Y + 
Sbjct: 217 PVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA 275
Query: 237 -PSHLSPGARDLIPRMLIVDPMKRITIPEI 265
            P+        ++     ++P  R T  +I
Sbjct: 276 QPAFAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 99
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V EY+++G L  ++ +   +    +     + I SG
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGL+ ++ D      T+ G      + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 220 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 97
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 217
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 218 ESLTESKFSVAS-DVWSFGVVLYELF 242

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 29/274 (10%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
           N + GKTLG G+FGKV  A     G      KVA+K+L  +   + + +E +  E+KI+ 
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMS 104
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR----------- 120
            L  H +I+ L         + V+ EY   G+L +++  K R+ E +             
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 121 ---NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KT 175
              +F  Q+  G+ +      +HRD+   N+LL +    KI DFGL+ +IM D +++ K 
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 176 SCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 233
           +   P  + APE I   +Y   + DVWS G++L+ +   G  P+    + + F K+    
Sbjct: 225 NARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283
Query: 234 YTL--PSHLSPGARDLIPRMLIVDPMKRITIPEI 265
           Y +  P+        ++     ++P  R T  +I
Sbjct: 284 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 121/230 (52%), Gaps = 25/230 (10%)
Query: 23  KTLGIGSFGKVKIA----EHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           + LG G FGKV++     E   TG +VA+K L      N   +  +++EI+ILR   H +
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHEN 84
Query: 79  IIRLYEVIETP---SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           I++ Y+ I T    + I ++ME++ SG L +Y+ + K ++   +   +  QI  G++Y  
Sbjct: 85  IVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPE-VIS 189
               VHRDL   N+L++S+  VKI DFGL+  +   ++   +K    SP +  APE ++ 
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239
            K Y     DVWS GV L+ LL  T    D +   LF K+ G     P+H
Sbjct: 204 SKFYIAS--DVWSFGVTLHELL--TYCDSDSSPMALFLKMIG-----PTH 244

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 11  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 64
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 184
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 185 ESLTESKFSVAS-DVWSFGVVLYELF 209

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 12  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 65
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 126 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 185
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 186 ESLTESKFSVAS-DVWSFGVVLYELF 210

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 121/230 (52%), Gaps = 25/230 (10%)
Query: 23  KTLGIGSFGKVKIA----EHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           + LG G FGKV++     E   TG +VA+K L      N   +  +++EI+ILR   H +
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHEN 72
Query: 79  IIRLYEVIETP---SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           I++ Y+ I T    + I ++ME++ SG L +Y+ + K ++   +   +  QI  G++Y  
Sbjct: 73  IVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 131
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPE-VIS 189
               VHRDL   N+L++S+  VKI DFGL+  +   ++   +K    SP +  APE ++ 
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239
            K Y     DVWS GV L+ LL  T    D +   LF K+ G     P+H
Sbjct: 192 SKFYIAS--DVWSFGVTLHELL--TYCDSDSSPMALFLKMIG-----PTH 232

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 20  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 73
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 134 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 193
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 194 ESLTESKFSVAS-DVWSFGVVLYELF 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 66
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 187 ESLTESKFSVAS-DVWSFGVVLYELF 211

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 66
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 187 ESLTESKFSVAS-DVWSFGVVLYELF 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 114/224 (50%), Gaps = 22/224 (9%)
Query: 3   GASNRSSSGVDMFLPNY-KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKN 57
           G   R S  +  F   + K  + LG G+FG V++  +      TG  VA+K L       
Sbjct: 13  GLVPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----- 67
Query: 58  MEMEEKVR---REIKILRLFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-K 111
              EE +R   REI+IL+   H +I++   V  +    ++ ++MEY+  G L DY+ + K
Sbjct: 68  -STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK 126
Query: 112 GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---R 168
            R+   +   +  QI  G+EY      +HRDL   N+L++++  VKI DFGL+ ++   +
Sbjct: 127 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 186
Query: 169 DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALL 211
           +   +K    SP  + APE ++   ++    DVWS GV+LY L 
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKFSVAS-DVWSFGVVLYELF 229

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           KL + LG G  G+V +  +   GH KVA+K L +  +      +    E  +++   H  
Sbjct: 16  KLVERLGAGQAGEVWMGYY--NGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQR 69
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRN 136
           ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +    
Sbjct: 70  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
             +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   + 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
             + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 189 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 17  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 70
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 131 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 190
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 191 ESLTESKFSVAS-DVWSFGVVLYELF 215

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 129/270 (47%), Gaps = 25/270 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
           N + GKTLG G+FGKV  A     G      KVA+K+L  +   + + +E +  E+KI+ 
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMS 104
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEAR--------N 121
            L  H +I+ L         + V+ EY   G+L +++  K    L +++ R        +
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 164
Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGS 179
           F  Q+  G+ +      +HRD+   N+LL +    KI DFGL+ +IM D +++ K +   
Sbjct: 165 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 180 P-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL- 236
           P  + APE I   +Y   + DVWS G++L+ +   G  P+    + + F K+    Y + 
Sbjct: 225 PVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA 283
Query: 237 -PSHLSPGARDLIPRMLIVDPMKRITIPEI 265
            P+        ++     ++P  R T  +I
Sbjct: 284 QPAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 19  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 72
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 133 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 192
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 193 ESLTESKFSVAS-DVWSFGVVLYELF 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 113/220 (51%), Gaps = 22/220 (10%)
Query: 7   RSSSGVDMFLPNY-KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEME 61
           R S  +  F   + K  + LG G+FG V++  +      TG  VA+K L          E
Sbjct: 17  RGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STE 70
Query: 62  EKVR---REIKILRLFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQ 115
           E +R   REI+IL+   H +I++   V  +    ++ ++MEY+  G L DY+ + K R+ 
Sbjct: 71  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 130
Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHF 172
             +   +  QI  G+EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   
Sbjct: 131 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 190
Query: 173 LKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALL 211
           +K    SP  + APE ++   ++    DVWS GV+LY L 
Sbjct: 191 VKEPGESPIFWYAPESLTESKFSVAS-DVWSFGVVLYELF 229

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 69
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 190 ESLTESKFSVAS-DVWSFGVVLYELF 214

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 114/229 (49%), Gaps = 21/229 (9%)
Query: 23  KTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILRLFM 75
           + +G G FG+V      L G +   VAIK L       +   EK RR    E  I+  F 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLK------VGYTEKQRRDFLGEASIMGQFD 81
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCH 134
           HP+II L  V+     + +V EY+++G L  ++ +  G+    +     + I +G++Y  
Sbjct: 82  HPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLS 141
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISG 190
               VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + APE I+ 
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 238
           + +     DVWS G++++ ++  G  P+ +    ++ K ++ G Y LPS
Sbjct: 202 RKFTSAS-DVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEG-YRLPS 248

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 18  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 71
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 132 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 191
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 192 ESLTESKFSVAS-DVWSFGVVLYELF 216

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 75
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 76  VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 195 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 251
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              DP +R T        + QA L  Y     P 
Sbjct: 252 WRKDPEERPTF------EYLQAFLEDYFTSTEPQ 279

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 32/280 (11%)
Query: 13  DMFLP--NYKLGKTLGIGSFGKVKIAE---HALTGHKVAIKILNRRKIKNMEMEEKVRRE 67
           D+ +P   + LG+ LG G FG V+ A+      +  KVA+K+L    I + ++EE +R E
Sbjct: 17  DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-E 75
Query: 68  IKILRLFMHPHIIRLYEV---------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDE 118
              ++ F HPH+ +L  V         +  P    V++ ++K G+L  +++   R+ E+ 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIP---MVILPFMKHGDLHAFLL-ASRIGENP 131
Query: 119 AR-------NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171
                     F   I  G+EY      +HRDL   N +L     V +ADFGLS  +  G 
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 172 FLKTSCGSP---NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFK 227
           + +  C S     + A E ++  LY     DVW+ GV ++ ++  G  P+       ++ 
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250
Query: 228 KIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR 266
            + GG     P        DL+ +    DP +R +   +R
Sbjct: 251 YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLR 290

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKL 75
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 76  VQLYAVV-SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 195 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 251
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              DP +R T        + QA L  Y     P 
Sbjct: 252 WRKDPEERPTF------EYLQAFLEDYFTSTEPQ 279

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 113/224 (50%), Gaps = 15/224 (6%)
Query: 7   RSSSGVDMFLPNYKL--GKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEK 63
           R  S  D  +P+ ++  G+ +G GSFG V K   H      VA+K+LN       +++  
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQA- 78
Query: 64  VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNF 122
            + E+ +LR   H +I+ L+    T   + +V ++ +   L+ ++ + + + +  +  + 
Sbjct: 79  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 137
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGS 179
            +Q   G++Y H   ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS
Sbjct: 138 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 180 PNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221
             + APEVI    K     + DV++ G++LY L+ G LP+ + N
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 10  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 64
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 65  VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 123
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 124 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 183
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 184 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 240
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              DP +R T        + QA L  Y     P 
Sbjct: 241 WRKDPEERPTF------EYLQAFLEDYFTSTEPQ 268

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 12  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 66
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 67  VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 125
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 126 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 186 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 242
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              DP +R T        + QA L  Y     P 
Sbjct: 243 WRKDPEERPTF------EYLQAFLEDYFTSTEPQ 270

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKIRHEKL 75
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 76  VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 195 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 251
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              DP +R T        + QA L  Y     P 
Sbjct: 252 WRKDPEERPTF------EYLQAFLEDYFTSTEPQ 279

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 113/224 (50%), Gaps = 15/224 (6%)
Query: 7   RSSSGVDMFLPNYKL--GKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEK 63
           R  S  D  +P+ ++  G+ +G GSFG V K   H      VA+K+LN       +++  
Sbjct: 23  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQA- 77
Query: 64  VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNF 122
            + E+ +LR   H +I+ L+    T   + +V ++ +   L+ ++ + + + +  +  + 
Sbjct: 78  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 136
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGS 179
            +Q   G++Y H   ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS
Sbjct: 137 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 180 PNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221
             + APEVI    K     + DV++ G++LY L+ G LP+ + N
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 113/223 (50%), Gaps = 15/223 (6%)
Query: 8   SSSGVDMFLPNYKL--GKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKV 64
           S S  D  +P+ ++  G+ +G GSFG V K   H      VA+K+LN       +++   
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQA-F 56
Query: 65  RREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFF 123
           + E+ +LR   H +I+ L+    T   + +V ++ +   L+ ++ + + + +  +  +  
Sbjct: 57  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 115
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSP 180
           +Q   G++Y H   ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS 
Sbjct: 116 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 181 NYAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221
            + APEVI    K     + DV++ G++LY L+ G LP+ + N
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 99
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V EY+++G L  ++ +   +    +     + I SG
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGL  ++ D      T+ G      + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 220 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 113/223 (50%), Gaps = 15/223 (6%)
Query: 8   SSSGVDMFLPNYKL--GKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKV 64
           S S  D  +P+ ++  G+ +G GSFG V K   H      VA+K+LN       +++   
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQA-F 56
Query: 65  RREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFF 123
           + E+ +LR   H +I+ L+    T   + +V ++ +   L+ ++ + + + +  +  +  
Sbjct: 57  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 115
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSP 180
           +Q   G++Y H   ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS 
Sbjct: 116 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 181 NYAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221
            + APEVI    K     + DV++ G++LY L+ G LP+ + N
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 121/258 (46%), Gaps = 29/258 (11%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKIL----NRRKIKNMEMEEKVRREIKILRLFMHPH 78
           K +G G FG V           VAIK L    +  + + +E  ++ +RE+ I+    HP+
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           I++LY ++  P  +  VME+V  G+L+  +++K   ++          I  G+EY     
Sbjct: 85  IVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 138 --VVHRDLKPENLLLDS-----KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
             +VHRDL+  N+ L S         K+ADFGLS   +  H +    G+  + APE I  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETIGA 200
Query: 191 KLYAGPE-VDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--------GGIYTLPSHLS 241
           +  +  E  D +S  +ILY +L G  PFD+ +    + KIK        G   T+P    
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDEYS----YGKIKFINMIREEGLRPTIPEDCP 256
Query: 242 PGARDLIPRMLIVDPMKR 259
           P  R++I      DP KR
Sbjct: 257 PRLRNVIELCWSGDPKKR 274

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +L K LG G FG+V +      G+ KVAIK L    +      E    E +I++   H  
Sbjct: 12  QLIKRLGNGQFGEVWMG--TWNGNTKVAIKTLKPGTMS----PESFLEEAQIMKKLKHDK 65
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGR-LQEDEARNFFQQIISGVEYCHRN 136
           +++LY V+ +   IY+V EY+  G L D++ + +GR L+     +   Q+ +G+ Y  R 
Sbjct: 66  LVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLY 193
             +HRDL+  N+L+ +    KIADFGL+ ++ D     +     P  + APE  + G+  
Sbjct: 125 NYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFT 184
Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRM 251
              + DVWS G++L  L+  G +P+   N   + ++++ G     P        +L+   
Sbjct: 185 I--KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHC 242
Query: 252 LIVDPMKRITIPEIRQ--HPWFQAHLPRY 278
              DP +R T   ++     +F A  P+Y
Sbjct: 243 WKKDPEERPTFEYLQSFLEDYFTATEPQY 271

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 110/224 (49%), Gaps = 12/224 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G FG VK  +     + VAIK++    +     E++   E K++    H  +++L
Sbjct: 30  KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQL 84
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           Y V      I+++ EY+ +G L +Y+ E + R Q  +     + +   +EY      +HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L++ +  VK++DFGLS  + D     +S GS     ++ PEV+    ++  + 
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE-ETSSVGSKFPVRWSPPEVLMYSKFSS-KS 202
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLS 241
           D+W+ GV+++ +   G +P++        + I  G+     HL+
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 246

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 109/226 (48%), Gaps = 33/226 (14%)
Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM-EEKVRREIKILRL 73
           +L +++  + LG G FG V  A++ +     AIK   R ++ N E+  EKV RE+K L  
Sbjct: 3   YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIK---RIRLPNRELAREKVMREVKALAK 59
Query: 74  FMHPHIIRLYEV-IE-------TPSD----IYVVMEYVKSGELFDYIVEKGRLQEDE--- 118
             HP I+R +   +E        PS     +Y+ M+  +   L D++  +  ++E E   
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT--- 175
             + F QI   VE+ H   ++HRDLKP N+       VK+ DFGL   M      +T   
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 176 ----------SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL 211
                       G+  Y +PE I G  Y+  +VD++S G+IL+ LL
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSH-KVDIFSLGLILFELL 224

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 116/253 (45%), Gaps = 13/253 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G GSFG V  A        VAIK ++    ++ E  + + +E++ L+   HP+ I+ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 83  YEVIETPSDIYVVMEYV--KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
                     ++VMEY    + +L +  V K  LQE E        + G+ Y H + ++H
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG---KLYAGPE 197
           RD+K  N+LL     VK+ DFG ++IM   +      G+P + APEVI       Y G +
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG-K 233
Query: 198 VDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPS-HLSPGARDLIPRMLIVD 255
           VDVWS G+    L     P F+   +  L+   +     L S H S   R+ +   L   
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 293
Query: 256 PMKRITIPEIRQH 268
           P  R T   + +H
Sbjct: 294 PQDRPTSEVLLKH 306

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 75
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 76  VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL   N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 135 YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 195 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 251
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              DP +R T        + QA L  Y     P 
Sbjct: 252 WRKDPEERPTF------EYLQAFLEDYFTSTEPQ 279

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 99
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V E +++G L  ++ +   +    +     + I SG
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +P
Sbjct: 160 MKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 220 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 116/253 (45%), Gaps = 13/253 (5%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G GSFG V  A        VAIK ++    ++ E  + + +E++ L+   HP+ I+ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 83  YEVIETPSDIYVVMEYV--KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
                     ++VMEY    + +L +  V K  LQE E        + G+ Y H + ++H
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG---KLYAGPE 197
           RD+K  N+LL     VK+ DFG ++IM   +      G+P + APEVI       Y G +
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG-K 194
Query: 198 VDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPS-HLSPGARDLIPRMLIVD 255
           VDVWS G+    L     P F+   +  L+   +     L S H S   R+ +   L   
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 254
Query: 256 PMKRITIPEIRQH 268
           P  R T   + +H
Sbjct: 255 PQDRPTSEVLLKH 267

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 125/268 (46%), Gaps = 23/268 (8%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +++LY 
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 85  VI-ETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNMVVHR 141
           V+ E P  IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R   VHR
Sbjct: 330 VVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 387
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAGPEV 198
           DL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+     + 
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI--KS 445
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVDP 256
           DVWS G++L  L   G +P+       +  +++ G     P        DL+ +    +P
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 505
Query: 257 MKRITIPEIRQHPWFQAHLPRYLAVPPP 284
            +R T        + QA L  Y     P
Sbjct: 506 EERPTF------EYLQAFLEDYFTSTEP 527

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 14  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 67
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+ + K R+   +   +  QI  G
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 127
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HR+L   N+L++++  VKI DFGL+ ++   ++ + +K    SP  + AP
Sbjct: 128 MEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 187
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 188 ESLTESKFSVAS-DVWSFGVVLYELF 212

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKL 75
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 76  VQLYAVV-SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 195 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 251
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              DP +R T        + QA L  Y     P 
Sbjct: 252 WRKDPEERPTF------EYLQAFLEDYFTSTEPQ 279

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 23/273 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKL 241
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 361 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 417
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
              +P +R T        + QA L  Y     P
Sbjct: 418 WRKEPEERPTF------EYLQAFLEDYFTSTEP 444

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 21  LGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +G+ +G GSFG V K   H      VA+K+LN       +++   + E+ +LR   H +I
Sbjct: 12  VGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNI 66
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           + L+    T   + +V ++ +   L+ ++ + + + +  +  +  +Q   G++Y H   +
Sbjct: 67  L-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYAAPEVI--SGKLY 193
           +HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI    K  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDEN 221
              + DV++ G++LY L+ G LP+ + N
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 23/273 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKL 241
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 361 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 417
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
              +P +R T        + QA L  Y     P
Sbjct: 418 WRKEPEERPTF------EYLQAFLEDYFTSTEP 444

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 32/223 (14%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY +   +G GS+G V +A    T   VAIK +NR   +++   +++ REI IL      
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSD 85
Query: 78  HIIRLYEVIETPSDI------YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
           +IIRLY++I  P D+      Y+V+E +   +L         L E+  +     ++ G  
Sbjct: 86  YIIRLYDLI-IPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGL---------SNIMRD------------- 169
           + H + ++HRDLKP N LL+   +VK+ DFGL         +NI+ D             
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 170 -GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL 211
               L +   +  Y APE+I  +      +D+WS G I   LL
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 75
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V+EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 76  VQLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D     +     P  + APE  + G+   
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 195 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 251
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              DP +R T        + QA L  Y     P 
Sbjct: 252 WRKDPEERPTF------EYLQAFLEDYFTSTEPQ 279

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 69
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++MEY+  G L DY+     R+   +   +  QI  G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 190 ESLTESKFSVAS-DVWSFGVVLYELF 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKL 72
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 73  VQLYAVV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 192 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 248
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              +P +R T        + QA L  Y     P 
Sbjct: 249 WRKEPEERPTF------EYLQAFLEDYFTSTEPQ 276

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 21  LGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +G+ +G GSFG V K   H      VA+K+LN       +++   + E+ +LR   H +I
Sbjct: 12  VGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNI 66
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           + L+    T   + +V ++ +   L+ ++ + + + +  +  +  +Q   G++Y H   +
Sbjct: 67  L-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYAAPEVI--SGKLY 193
           +HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI    K  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDEN 221
              + DV++ G++LY L+ G LP+ + N
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 21  LGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +G+ +G GSFG V K   H      VA+K+LN       +++   + E+ +LR   H +I
Sbjct: 14  VGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNI 68
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           + L+    T   + +V ++ +   L+ ++ + + + +  +  +  +Q   G++Y H   +
Sbjct: 69  L-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 127
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYAAPEVI--SGKLY 193
           +HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI    K  
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDEN 221
              + DV++ G++LY L+ G LP+ + N
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 70
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V E +++G L  ++ +   +    +     + I SG
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 191 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 241

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 115/245 (46%), Gaps = 14/245 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G++G V          ++AIK +  R   +    + +  EI + +   H +I++   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFF--QQIISGVEYCHRNMVVHR 141
                  I + ME V  G L   +  K G L+++E    F  +QI+ G++Y H N +VHR
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 142 DLKPENLLLDSKWNV-KIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVIS-GKLYAGPEV 198
           D+K +N+L+++   V KI+DFG S  +       +T  G+  Y APE+I  G    G   
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----TLPSHLSPGARDLIPRMLIV 254
           D+WS G  +  +  G  PF +   P      K G++     +P  +S  A+  I +    
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 265
Query: 255 DPMKR 259
           DP KR
Sbjct: 266 DPDKR 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 14  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 68
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 69  VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 127
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 128 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 187
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 188 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 244
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              +P +R T        + QA L  Y     P 
Sbjct: 245 WRKEPEERPTF------EYLQAFLEDYFTSTEPQ 272

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 115/245 (46%), Gaps = 14/245 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G++G V          ++AIK +  R   +    + +  EI + +   H +I++   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFF--QQIISGVEYCHRNMVVHR 141
                  I + ME V  G L   +  K G L+++E    F  +QI+ G++Y H N +VHR
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 132
Query: 142 DLKPENLLLDSKWNV-KIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVIS-GKLYAGPEV 198
           D+K +N+L+++   V KI+DFG S  +       +T  G+  Y APE+I  G    G   
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 192
Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----TLPSHLSPGARDLIPRMLIV 254
           D+WS G  +  +  G  PF +   P      K G++     +P  +S  A+  I +    
Sbjct: 193 DIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 251
Query: 255 DPMKR 259
           DP KR
Sbjct: 252 DPDKR 256

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 21/233 (9%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKI 70
           N  + K +G G FG+V      L   K   VAIK L       +   EK RR    E  I
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEASI 99
Query: 71  LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
           +  F HP+IIRL  V+     + +V E +++G L  ++ +   +    +     + I SG
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAP 185
           ++Y      VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I+ + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 220 EAIAYRKFTSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 21  LGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +G+ +G GSFG V K   H      VA+K+LN       +++   + E+ +LR   H +I
Sbjct: 16  VGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVNI 70
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           + L+    T   + +V ++ +   L+ ++   + + +  +  +  +Q   G++Y H   +
Sbjct: 71  L-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 129
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           +HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI  +  + 
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ-DSN 188
Query: 196 P---EVDVWSCGVILYALLCGTLPFDDEN 221
           P   + DV++ G++LY L+ G LP+ + N
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKL 72
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 73  VQLYAVV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 192 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 248
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              +P +R T        + QA L  Y     P 
Sbjct: 249 WRKEPEERPTF------EYLQAFLEDYFTSTEPQ 276

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 25/267 (9%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G+FG V  A+       VAIK     +I++    +    E++ L    HP+I++L
Sbjct: 15  EVVGRGAFGVVCKAK--WRAKDVAIK-----QIESESERKAFIVELRQLSRVNHPNIVKL 67
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRL---QEDEARNFFQQIISGVEYCHR---N 136
           Y     P  + +VMEY + G L++ +     L       A ++  Q   GV Y H     
Sbjct: 68  YGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 125
Query: 137 MVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
            ++HRDLKP NLLL +   V KI DFG +  ++    +  + GS  + APEV  G  Y+ 
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSNYS- 182
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRML 252
            + DV+S G+IL+ ++    PFD+   P    ++    G    L  +L      L+ R  
Sbjct: 183 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCW 242
Query: 253 IVDPMKRITIPEIRQHPWFQAHLPRYL 279
             DP +R ++ EI +      HL RY 
Sbjct: 243 SKDPSQRPSMEEIVK---IMTHLMRYF 266

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 25/267 (9%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G G+FG V  A+       VAIK     +I++    +    E++ L    HP+I++L
Sbjct: 14  EVVGRGAFGVVCKAK--WRAKDVAIK-----QIESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRL---QEDEARNFFQQIISGVEYCHR---N 136
           Y     P  + +VMEY + G L++ +     L       A ++  Q   GV Y H     
Sbjct: 67  YGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 137 MVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
            ++HRDLKP NLLL +   V KI DFG +  ++    +  + GS  + APEV  G  Y+ 
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSNYS- 181
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRML 252
            + DV+S G+IL+ ++    PFD+   P    ++    G    L  +L      L+ R  
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCW 241
Query: 253 IVDPMKRITIPEIRQHPWFQAHLPRYL 279
             DP +R ++ EI +      HL RY 
Sbjct: 242 SKDPSQRPSMEEIVK---IMTHLMRYF 265

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 121/260 (46%), Gaps = 12/260 (4%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLY 83
           +G G+ G+V       TGH +A+K +  R+  N E  +++  ++ + L+    P+I++ +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 84  EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVVHRD 142
               T +D+++ ME + +         +G + E         I+  + Y   ++ V+HRD
Sbjct: 91  GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 150
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE----V 198
           +KP N+LLD +  +K+ DFG+S  + D      S G   Y APE I       P+     
Sbjct: 151 VKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210
Query: 199 DVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLPSHL--SPGARDLIPRMLIV 254
           DVWS G+ L  L  G  P+ +   +   L K ++     LP H+  S   +  +   L  
Sbjct: 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTK 270
Query: 255 DPMKRITIPEIRQHPWFQAH 274
           D  KR    ++ +H + + +
Sbjct: 271 DHRKRPKYNKLLEHSFIKRY 290

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 23/273 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKL 241
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 242 VQLYAVV-SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+   
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 361 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 417
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
              +P +R T        + QA L  Y     P
Sbjct: 418 WRKEPEERPTF------EYLQAFLEDYFTSTEP 444

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 120/258 (46%), Gaps = 29/258 (11%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKIL----NRRKIKNMEMEEKVRREIKILRLFMHPH 78
           K +G G FG V           VAIK L    +  + + +E  ++ +RE+ I+    HP+
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           I++LY ++  P  +  VME+V  G+L+  +++K   ++          I  G+EY     
Sbjct: 85  IVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 138 --VVHRDLKPENLLLDS-----KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
             +VHRDL+  N+ L S         K+ADFG S   +  H +    G+  + APE I  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNFQWMAPETIGA 200
Query: 191 KLYAGPE-VDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--------GGIYTLPSHLS 241
           +  +  E  D +S  +ILY +L G  PFD+ +    + KIK        G   T+P    
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDEYS----YGKIKFINMIREEGLRPTIPEDCP 256
Query: 242 PGARDLIPRMLIVDPMKR 259
           P  R++I      DP KR
Sbjct: 257 PRLRNVIELCWSGDPKKR 274

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 113/224 (50%), Gaps = 15/224 (6%)
Query: 7   RSSSGVDMFLPNYKL--GKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEK 63
           R  S  D  +P+ ++  G+ +G GSFG V K   H      VA+K+LN       +++  
Sbjct: 16  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQA- 70
Query: 64  VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNF 122
            + E+ +LR   H +I+ L+    T   + +V ++ +   L+ ++ + + + +  +  + 
Sbjct: 71  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 129
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHFLKTSCGS 179
            +Q   G++Y H   ++HRDLK  N+ L     VKI DFGL+   +     H  +   GS
Sbjct: 130 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 180 PNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221
             + APEVI    K     + DV++ G++LY L+ G LP+ + N
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 14/274 (5%)
Query: 3   GASNRSSSGVD---MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME 59
           GA + SS   D   M   +  +   LG G +G+V           VA+K L   K   ME
Sbjct: 1   GAMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTME 57
Query: 60  MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
           +EE ++ E  +++   HP++++L  V       Y++ E++  G L DY+ E  R + +  
Sbjct: 58  VEEFLK-EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV 116
Query: 120 RNFF--QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTS 176
              +   QI S +EY  +   +HRDL   N L+     VK+ADFGLS +M  D +     
Sbjct: 117 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 176
Query: 177 CGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGI 233
              P  + APE ++   ++  + DVW+ GV+L+ +   G  P+   ++  +++ + K   
Sbjct: 177 AKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 235
Query: 234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
              P        +L+      +P  R +  EI Q
Sbjct: 236 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 113/224 (50%), Gaps = 15/224 (6%)
Query: 7   RSSSGVDMFLPNYKL--GKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEK 63
           R  S  D  +P+ ++  G+ +G GSFG V K   H      VA+K+LN       +++  
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQA- 78
Query: 64  VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNF 122
            + E+ +LR   H +I+ L+    T   + +V ++ +   L+ ++ + + + +  +  + 
Sbjct: 79  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 137
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHFLKTSCGS 179
            +Q   G++Y H   ++HRDLK  N+ L     VKI DFGL+   +     H  +   GS
Sbjct: 138 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 180 PNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221
             + APEVI    K     + DV++ G++LY L+ G LP+ + N
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 18  NYKLGKTLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           N + GK LG G+FGKV  A     + TG  + + +   ++  +    E +  E+K++ +L
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK--------------GRLQEDEA 119
             H +I+ L         IY++ EY   G+L +Y+  K               RL+E+E 
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 120 RN---------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRD 169
            N         F  Q+  G+E+      VHRDL   N+L+     VKI DFGL+ +IM D
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 170 GHF-LKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP--- 223
            ++ ++ +   P  + APE +   +Y   + DVWS G++L+ +   G  P+    IP   
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYP--GIPVDA 282
Query: 224 NLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
           N +K I+ G     P + +     ++      D  KR + P +
Sbjct: 283 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 118/249 (47%), Gaps = 11/249 (4%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
           V       Y+++E++  G L DY+ E  R + +     +   QI S +EY  +   +HRD
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVDV 200
           L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDV 200
Query: 201 WSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           W+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 259 RITIPEIRQ 267
           R +  EI Q
Sbjct: 261 RPSFAEIHQ 269

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 114/248 (45%), Gaps = 36/248 (14%)
Query: 18  NYKLGKTLGIGSFGKV-KIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILR 72
           N  LGKTLG G FGKV K     L G      VA+K+L +      E+ + +  E  +L+
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRD-LLSEFNVLK 81
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR------------------- 113
              HPH+I+LY        + +++EY K G L  ++ E  +                   
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 114 -----LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIM 167
                L   +  +F  QI  G++Y     +VHRDL   N+L+     +KI+DFGLS ++ 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 168 RDGHFLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224
            +  ++K S G     + A E +   +Y   + DVWS GV+L+ ++  G  P+       
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 225 LFKKIKGG 232
           LF  +K G
Sbjct: 261 LFNLLKTG 268

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 16/275 (5%)
Query: 3   GASNRSSSGVD---MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME 59
           GA + SS   D   M   +  +   LG G +G+V           VA+K L   K   ME
Sbjct: 1   GAMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTME 57
Query: 60  MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
           +EE ++ E  +++   HP++++L  V       Y++ E++  G L DY+ E  R + +  
Sbjct: 58  VEEFLK-EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV 116
Query: 120 RNFF--QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177
              +   QI S +EY  +   +HRDL   N L+     VK+ADFGLS +M  G       
Sbjct: 117 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHA 175
Query: 178 GSP---NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGG 232
           G+     + APE ++   ++  + DVW+ GV+L+ +   G  P+   ++  +++ + K  
Sbjct: 176 GAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 234
Query: 233 IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
               P        +L+      +P  R +  EI Q
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 16/218 (7%)
Query: 25  LGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           LG G+FG V+   + +   +  VAIK+L ++  +  + EE + RE +I+    +P+I+RL
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEE-MMREAQIMHQLDNPYIVRL 75
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN---FFQQIISGVEYCHRNMVV 139
             V +  + + +VME    G L  ++V  G+ +E    N      Q+  G++Y      V
Sbjct: 76  IGVCQAEA-LMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP--NYAAPEVISGKLYAG 195
           HRDL   N+LL ++   KI+DFGLS  +   D ++   S G     + APE I+ + ++ 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 196 PEVDVWSCGVILY-ALLCGTLPFDDENIPNLFKKIKGG 232
              DVWS GV ++ AL  G  P+     P +   I+ G
Sbjct: 193 -RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 126/275 (45%), Gaps = 16/275 (5%)
Query: 3   GASNRSSSGVD---MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME 59
           GA + SS   D   M   +  +   LG G +G+V           VA+K L   K   ME
Sbjct: 1   GAMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTME 57
Query: 60  MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
           +EE ++ E  +++   HP++++L  V       Y++ E++  G L DY+ E  R QE  A
Sbjct: 58  VEEFLK-EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSA 115
Query: 120 RNFF---QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKT 175
                   QI S +EY  +   +HRDL   N L+     VK+ADFGLS +M  D +    
Sbjct: 116 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 175
Query: 176 SCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGG 232
               P  + APE ++   ++  + DVW+ GV+L+ +   G  P+   ++  +++ + K  
Sbjct: 176 GAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 234
Query: 233 IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
               P        +L+      +P  R +  EI Q
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 112/226 (49%), Gaps = 14/226 (6%)
Query: 23  KTLGIGSFGKV-KIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           K +G G FG+V K      +G K   VAIK L     +   ++     E  I+  F H +
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMGQFSHHN 107
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNM 137
           IIRL  VI     + ++ EY+++G L  ++ EK G     +     + I +G++Y     
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLY 193
            VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + APE IS + +
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 238
                DVWS G++++ ++  G  P+ + +   + K I  G + LP+
Sbjct: 228 TSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPT 271

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 120/258 (46%), Gaps = 29/258 (11%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKIL----NRRKIKNMEMEEKVRREIKILRLFMHPH 78
           K +G G FG V           VAIK L    +  + + +E  ++ +RE+ I+    HP+
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           I++LY ++  P  +  VME+V  G+L+  +++K   ++          I  G+EY     
Sbjct: 85  IVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 138 --VVHRDLKPENLLLDS-----KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
             +VHRDL+  N+ L S         K+ADF LS   +  H +    G+  + APE I  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWMAPETIGA 200
Query: 191 KLYAGPE-VDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--------GGIYTLPSHLS 241
           +  +  E  D +S  +ILY +L G  PFD+ +    + KIK        G   T+P    
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDEYS----YGKIKFINMIREEGLRPTIPEDCP 256
Query: 242 PGARDLIPRMLIVDPMKR 259
           P  R++I      DP KR
Sbjct: 257 PRLRNVIELCWSGDPKKR 274

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 20  KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  + LG G+FG V++  +      TG  VA+K L          EE +R   REI+IL+
Sbjct: 16  KFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------STEEHLRDFEREIEILK 69
Query: 73  LFMHPHIIRLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISG 129
              H +I++   V  +    ++ ++ME++  G L +Y+ + K R+   +   +  QI  G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKG 129
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAP 185
           +EY      +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP  + AP
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL 211
           E ++   ++    DVWS GV+LY L 
Sbjct: 190 ESLTESKFSVAS-DVWSFGVVLYELF 214

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 11/271 (4%)
Query: 3   GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
           GA + +    +M   +  +   LG G +G+V           VA+K L   K   ME+EE
Sbjct: 1   GAMDPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEE 57
Query: 63  KVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNF 122
            ++ E  +++   HP++++L  V       Y++ E++  G L DY+ E  R + +     
Sbjct: 58  FLK-EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 116
Query: 123 F--QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGS 179
           +   QI S +EY  +   +HRDL   N L+     VK+ADFGLS +M  D +        
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 180 P-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTL 236
           P  + APE ++   ++  + DVW+ GV+L+ +   G  P+   ++  +++ + K      
Sbjct: 177 PIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           P        +L+      +P  R +  EI Q
Sbjct: 236 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 23  KTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILRLFM 75
           K +G G  G+V      + G +   VAIK L           E+ RR    E  I+  F 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK------AGYTERQRRDFLSEASIMGQFD 108
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCH 134
           HP+IIRL  V+       +V EY+++G L  ++    G+    +     + + +G+ Y  
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR---DGHFLKTSCGSP-NYAAPEVISG 190
               VHRDL   N+L+DS    K++DFGLS ++    D  +  T    P  + APE I+ 
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 238
           + ++    DVWS GV+++ +L  G  P+ +    ++   ++ G Y LP+
Sbjct: 229 RTFSSAS-DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPA 275

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 11/249 (4%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
           V       Y++ E++  G L DY+ E  R + +     +   QI S +EY  +   +HRD
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVDV 200
           L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDV 200
Query: 201 WSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           W+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 259 RITIPEIRQ 267
           R +  EI Q
Sbjct: 261 RPSFAEIHQ 269

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 11/249 (4%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 80
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
           V       Y++ E++  G L DY+ E  R + +     +   QI S +EY  +   +HRD
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 140
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVDV 200
           L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + DV
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDV 199
Query: 201 WSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           W+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P  
Sbjct: 200 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 259
Query: 259 RITIPEIRQ 267
           R +  EI Q
Sbjct: 260 RPSFAEIHQ 268

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 118/250 (47%), Gaps = 13/250 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF---QQIISGVEYCHRNMVVHR 141
           V       Y+++E++  G L DY+ E  R QE  A        QI S +EY  +   +HR
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVD 199
           DL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSD 194
Query: 200 VWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P 
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 254
Query: 258 KRITIPEIRQ 267
            R +  EI Q
Sbjct: 255 DRPSFAEIHQ 264

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 11/249 (4%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
           V       Y++ E++  G L DY+ E  R + +     +   QI S +EY  +   +HRD
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVDV 200
           L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDV 195
Query: 201 WSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           W+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 259 RITIPEIRQ 267
           R +  EI Q
Sbjct: 256 RPSFAEIHQ 264

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 13/250 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 77
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
           V       Y+++E++  G L DY+ E  R + +     +   QI S +EY  +   +HRD
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 137
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEVD 199
           L   N L+     VK+ADFGLS +M  G       G+     + APE ++   ++  + D
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS-IKSD 195
Query: 200 VWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P 
Sbjct: 196 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 255
Query: 258 KRITIPEIRQ 267
            R +  EI Q
Sbjct: 256 DRPSFAEIHQ 265

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 114/228 (50%), Gaps = 33/228 (14%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL K LG G FG+V +A +     KVA+K +   K  +M +E  +  E  +++   H  +
Sbjct: 185 KLEKKLGAGQFGEVWMATYN-KHTKVAVKTM---KPGSMSVEAFLA-EANVMKTLQHDKL 239
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR--------NFFQQIISGVE 131
           ++L+ V+ T   IY++ E++  G L D+      L+ DE          +F  QI  G+ 
Sbjct: 240 VKLHAVV-TKEPIYIITEFMAKGSLLDF------LKSDEGSKQPLPKLIDFSAQIAEGMA 292
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISG 190
           +  +   +HRDL+  N+L+ +    KIADFGL+ +             P  + APE I+ 
Sbjct: 293 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARV---------GAKFPIKWTAPEAINF 343
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
             +   + DVWS G++L  ++  G +P+   + P + + ++ G Y +P
Sbjct: 344 GSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 389

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 52/288 (18%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIK--ILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           K LG GS G V + + +  G  VA+K  +++   I  ME++     +        HP++I
Sbjct: 39  KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD-------HPNVI 90
Query: 81  RLYEVIETPSDIYVVMEY--------VKSGELFDYIVEKGRLQED-EARNFFQQIISGVE 131
           R Y    T   +Y+ +E         V+S  + D   E  +LQ++    +  +QI SGV 
Sbjct: 91  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVA 147
Query: 132 YCHRNMVVHRDLKPENLLLDS-------------KWNVKIADFGLSNIMRDGHF-----L 173
           + H   ++HRDLKP+N+L+ +                + I+DFGL   +  G       L
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 174 KTSCGSPNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230
               G+  + APE++  S K      +D++S G + Y +L  G  PF D+        I 
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNII 265
Query: 231 GGIYTLPS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            GI++L          L   A DLI +M+  DP+KR T  ++ +HP F
Sbjct: 266 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 52/288 (18%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIK--ILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           K LG GS G V + + +  G  VA+K  +++   I  ME++     +        HP++I
Sbjct: 39  KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD-------HPNVI 90
Query: 81  RLYEVIETPSDIYVVMEY--------VKSGELFDYIVEKGRLQED-EARNFFQQIISGVE 131
           R Y    T   +Y+ +E         V+S  + D   E  +LQ++    +  +QI SGV 
Sbjct: 91  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVA 147
Query: 132 YCHRNMVVHRDLKPENLLLDS-------------KWNVKIADFGLSNIMRDGHF-----L 173
           + H   ++HRDLKP+N+L+ +                + I+DFGL   +  G       L
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 174 KTSCGSPNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230
               G+  + APE++  S K      +D++S G + Y +L  G  PF D+        I 
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNII 265
Query: 231 GGIYTLPS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            GI++L          L   A DLI +M+  DP+KR T  ++ +HP F
Sbjct: 266 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 23  KTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILRLFM 75
           K +G G  G+V      + G +   VAIK L           E+ RR    E  I+  F 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK------AGYTERQRRDFLSEASIMGQFD 108
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCH 134
           HP+IIRL  V+       +V EY+++G L  ++    G+    +     + + +G+ Y  
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISG 190
               VHRDL   N+L+DS    K++DFGLS ++ D      T+ G      + APE I+ 
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAF 228
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 238
           + ++    DVWS GV+++ +L  G  P+ +    ++   ++ G Y LP+
Sbjct: 229 RTFSSAS-DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPA 275

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 11/249 (4%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
           V       Y++ E++  G L DY+ E  R + +     +   QI S +EY  +   +HRD
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVDV 200
           L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDV 195
Query: 201 WSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           W+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 259 RITIPEIRQ 267
           R +  EI Q
Sbjct: 256 RPSFAEIHQ 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 11/249 (4%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 89
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
           V       Y++ E++  G L DY+ E  R + +     +   QI S +EY  +   +HRD
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 149
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVDV 200
           L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + DV
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDV 208
Query: 201 WSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           W+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P  
Sbjct: 209 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 268
Query: 259 RITIPEIRQ 267
           R +  EI Q
Sbjct: 269 RPSFAEIHQ 277

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 118/250 (47%), Gaps = 13/250 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF---QQIISGVEYCHRNMVVHR 141
           V       Y+++E++  G L DY+ E  R QE  A        QI S +EY  +   +HR
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVD 199
           DL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSD 194
Query: 200 VWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P 
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 254
Query: 258 KRITIPEIRQ 267
            R +  EI Q
Sbjct: 255 DRPSFAEIHQ 264

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 112/218 (51%), Gaps = 16/218 (7%)
Query: 25  LGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           LG G+FG V+   + +   +  VAIK+L ++  +  + EE +R E +I+    +P+I+RL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMR-EAQIMHQLDNPYIVRL 401
Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN---FFQQIISGVEYCHRNMVV 139
             V +  + + +VME    G L  ++V  G+ +E    N      Q+  G++Y      V
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGS--PNYAAPEVISGKLYAG 195
           HR+L   N+LL ++   KI+DFGLS  +   D ++   S G     + APE I+ + ++ 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 196 PEVDVWSCGVILY-ALLCGTLPFDDENIPNLFKKIKGG 232
              DVWS GV ++ AL  G  P+     P +   I+ G
Sbjct: 519 -RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 35/226 (15%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY++   +G GS+G V +A        VAIK +NR   +++   +++ REI IL      
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSD 87
Query: 78  HIIRLYEVIETPSDI------YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
           +IIRL+++I  P D+      Y+V+E +   +L         L E   +     ++ G +
Sbjct: 88  YIIRLHDLI-IPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEK 145
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHF---------------- 172
           + H + ++HRDLKP N LL+   +VKI DFGL+   N  +D H                 
Sbjct: 146 FIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPH 205
Query: 173 -------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL 211
                  L +   +  Y APE+I  +      +D+WS G I   LL
Sbjct: 206 NKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 21  LGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LF 74
            GKTLG G+FGKV  A       +     VA+K+L  +   ++   E +  E+K+L  L 
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLG 84
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK------------------GRLQE 116
            H +I+ L           V+ EY   G+L +++  K                    L  
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LK 174
           ++  +F  Q+  G+ +      +HRDL   N+LL      KI DFGL+ +I  D ++ +K
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 175 TSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKG 231
            +   P  + APE I   +Y   E DVWS G+ L+ L   G+ P+    + +  +K IK 
Sbjct: 205 GNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263
Query: 232 GIYTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           G   L P H      D++      DP+KR T  +I Q
Sbjct: 264 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 11/249 (4%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 78
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
           V       Y++ E++  G L DY+ E  R + +     +   QI S +EY  +   +HRD
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 138
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVDV 200
           L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + DV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDV 197
Query: 201 WSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           W+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P  
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 257
Query: 259 RITIPEIRQ 267
           R +  EI Q
Sbjct: 258 RPSFAEIHQ 266

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
           N + GKTLG G+FGKV  A     G      KVA+K+L  +   + + +E +  E+KI+ 
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMS 104
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQ 115
            L  H +I+ L         + V+ EY   G+L +++  K                 +L 
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLS 164
Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL- 173
             +  +F  Q+  G+ +      +HRD+   N+LL +    KI DFGL+ +IM D +++ 
Sbjct: 165 SRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 224
Query: 174 KTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG 231
           K +   P  + APE I   +Y   + DVWS G++L+ +   G  P+    + + F K+  
Sbjct: 225 KGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 283
Query: 232 GIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEI 265
             Y +  P+        ++     ++P  R T  +I
Sbjct: 284 DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 11/249 (4%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 77
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
           V       Y++ E++  G L DY+ E  R + +     +   QI S +EY  +   +HRD
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 137
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVDV 200
           L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + DV
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS-IKSDV 196
Query: 201 WSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           W+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P  
Sbjct: 197 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 256
Query: 259 RITIPEIRQ 267
           R +  EI Q
Sbjct: 257 RPSFAEIHQ 265

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 96/192 (50%), Gaps = 13/192 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G FG+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF---QQIISGVEYCHRNMVVHR 141
           V       Y++ E++  G L DY+ E  R QE  A        QI S +EY  +   +HR
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L+     VK+ADFGLS +M  G       G+     + APE ++   ++  + 
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS-IKS 191
Query: 199 DVWSCGVILYAL 210
           DVW+ GV+L+ +
Sbjct: 192 DVWAFGVLLWEI 203

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 11/249 (4%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 78
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
           V       Y++ E++  G L DY+ E  R + +     +   QI S +EY  +   +HRD
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 138
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVDV 200
           L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + DV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS-IKSDV 197
Query: 201 WSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           W+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P  
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 257
Query: 259 RITIPEIRQ 267
           R +  EI Q
Sbjct: 258 RPSFAEIHQ 266

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 21  LGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +G+ +G GSFG V K   H      VA+K+LN       +++   + E+ +LR   H +I
Sbjct: 12  VGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNI 66
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           + L+    T   + +V ++ +   L+ ++ + + + +  +  +  +Q   G++Y H   +
Sbjct: 67  L-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHFLKTSCGSPNYAAPEVI--SGKLY 193
           +HRDLK  N+ L     VKI DFGL+   +     H  +   GS  + APEVI    K  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDEN 221
              + DV++ G++LY L+ G LP+ + N
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 21  LGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LF 74
            GKTLG G+FGKV  A       +     VA+K+L  +   ++   E +  E+K+L  L 
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLG 107
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK------------------GRLQE 116
            H +I+ L           V+ EY   G+L +++  K                    L  
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LK 174
           ++  +F  Q+  G+ +      +HRDL   N+LL      KI DFGL+ +I  D ++ +K
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 175 TSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKG 231
            +   P  + APE I   +Y   E DVWS G+ L+ L   G+ P+    + +  +K IK 
Sbjct: 228 GNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 286
Query: 232 GIYTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           G   L P H      D++      DP+KR T  +I Q
Sbjct: 287 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 21  LGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +G+ +G GSFG V K   H      VA+K+LN       +++   + E+ +LR   H +I
Sbjct: 28  VGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVNI 82
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           + L+    T   + +V ++ +   L+ ++   + + +  +  +  +Q   G++Y H   +
Sbjct: 83  L-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           +HRDLK  N+ L     VKI DFGL+   +     H  +   GS  + APEVI  +  + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ-DSN 200
Query: 196 P---EVDVWSCGVILYALLCGTLPFDDEN 221
           P   + DV++ G++LY L+ G LP+ + N
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 117/250 (46%), Gaps = 13/250 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF---QQIISGVEYCHRNMVVHR 141
           V       Y++ E++  G L DY+ E  R QE  A        QI S +EY  +   +HR
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVD 199
           DL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSD 194
Query: 200 VWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P 
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 254
Query: 258 KRITIPEIRQ 267
            R +  EI Q
Sbjct: 255 DRPSFAEIHQ 264

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 21  LGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LF 74
            GKTLG G+FGKV  A       +     VA+K+L  +   ++   E +  E+K+L  L 
Sbjct: 43  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLG 100
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK------------------GRLQE 116
            H +I+ L           V+ EY   G+L +++  K                    L  
Sbjct: 101 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LK 174
           ++  +F  Q+  G+ +      +HRDL   N+LL      KI DFGL+ +I  D ++ +K
Sbjct: 161 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 175 TSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKG 231
            +   P  + APE I   +Y   E DVWS G+ L+ L   G+ P+    + +  +K IK 
Sbjct: 221 GNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 279
Query: 232 GIYTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           G   L P H      D++      DP+KR T  +I Q
Sbjct: 280 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 23  KTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           K LG G+FG V     + E       VAIKILN        +E     E  I+    HPH
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPH 101
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           ++RL  V  +P+ I +V + +  G L +Y+ E K  +      N+  QI  G+ Y     
Sbjct: 102 LVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 160
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 194
           +VHRDL   N+L+ S  +VKI DFGL+ ++        + G      + A E I  + + 
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 220
Query: 195 GPEVDVWSCGVILYALLC-GTLPFD---DENIPNLFKK 228
             + DVWS GV ++ L+  G  P+D      IP+L +K
Sbjct: 221 H-QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 257

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 21  LGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LF 74
            GKTLG G+FGKV  A       +     VA+K+L  +   ++   E +  E+K+L  L 
Sbjct: 45  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLG 102
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK------------------GRLQE 116
            H +I+ L           V+ EY   G+L +++  K                    L  
Sbjct: 103 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LK 174
           ++  +F  Q+  G+ +      +HRDL   N+LL      KI DFGL+ +I  D ++ +K
Sbjct: 163 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 175 TSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKG 231
            +   P  + APE I   +Y   E DVWS G+ L+ L   G+ P+    + +  +K IK 
Sbjct: 223 GNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 281
Query: 232 GIYTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           G   L P H      D++      DP+KR T  +I Q
Sbjct: 282 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 117/250 (46%), Gaps = 13/250 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF---QQIISGVEYCHRNMVVHR 141
           V       Y++ E++  G L DY+ E  R QE  A        QI S +EY  +   +HR
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVD 199
           DL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSD 194
Query: 200 VWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P 
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 254
Query: 258 KRITIPEIRQ 267
            R +  EI Q
Sbjct: 255 DRPSFAEIHQ 264

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 21  LGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +G+ +G GSFG V K   H      VA+K+LN       +++   + E+ +LR   H +I
Sbjct: 28  VGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVNI 82
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           + L+    T   + +V ++ +   L+ ++   + + +  +  +  +Q   G++Y H   +
Sbjct: 83  L-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           +HRDLK  N+ L     VKI DFGL+   +     H  +   GS  + APEVI  +  + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ-DSN 200
Query: 196 P---EVDVWSCGVILYALLCGTLPFDDEN 221
           P   + DV++ G++LY L+ G LP+ + N
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 21  LGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           L   +G GSFG V K   H      VA+KIL +      E  +  R E+ +LR   H +I
Sbjct: 40  LSTRIGSGSFGTVYKGKWHG----DVAVKIL-KVVDPTPEQFQAFRNEVAVLRKTRHVNI 94
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           + L+    T  ++ +V ++ +   L+ ++ V++ + Q  +  +  +Q   G++Y H   +
Sbjct: 95  L-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNI 153
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYAAPEVISGKLYA- 194
           +HRD+K  N+ L     VKI DFGL+ +         ++   GS  + APEVI  +    
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP 213
Query: 195 -GPEVDVWSCGVILYALLCGTLPFDDEN 221
              + DV+S G++LY L+ G LP+   N
Sbjct: 214 FSFQSDVYSYGIVLYELMTGELPYSHIN 241

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 21  LGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LF 74
            GKTLG G+FGKV  A       +     VA+K+L  +   ++   E +  E+K+L  L 
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLG 107
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK------------------GRLQE 116
            H +I+ L           V+ EY   G+L +++  K                    L  
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LK 174
           ++  +F  Q+  G+ +      +HRDL   N+LL      KI DFGL+ +I  D ++ +K
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 175 TSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKG 231
            +   P  + APE I   +Y   E DVWS G+ L+ L   G+ P+    + +  +K IK 
Sbjct: 228 GNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 286
Query: 232 GIYTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           G   L P H      D++      DP+KR T  +I Q
Sbjct: 287 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 15/229 (6%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           K+ + +G G FG+V        G K   VAIK L     +    E     E  I+  F H
Sbjct: 19  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRRE--FLSEASIMGQFEH 76
Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHR 135
           P+IIRL  V+     + ++ E++++G L  ++ +  G+    +     + I SG+ Y   
Sbjct: 77  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE 136
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------YAAPEVIS 189
              VHRDL   N+L++S    K++DFGLS  + +     T   S        + APE I+
Sbjct: 137 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + +     D WS G++++ ++  G  P+ D +  ++   I+   Y LP
Sbjct: 197 FRKFTSAS-DAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQD-YRLP 243

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 13/192 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF---QQIISGVEYCHRNMVVHR 141
           V       Y++ E++  G L DY+ E  R QE  A        QI S +EY  +   +HR
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L+     VK+ADFGLS +M  G       G+     + APE ++   ++  + 
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPESLAYNKFS-IKS 191
Query: 199 DVWSCGVILYAL 210
           DVW+ GV+L+ +
Sbjct: 192 DVWAFGVLLWEI 203

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 113/248 (45%), Gaps = 36/248 (14%)
Query: 18  NYKLGKTLGIGSFGKV-KIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILR 72
           N  LGKTLG G FGKV K     L G      VA+K+L +      E+ + +  E  +L+
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRD-LLSEFNVLK 81
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR------------------- 113
              HPH+I+LY        + +++EY K G L  ++ E  +                   
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 114 -----LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIM 167
                L   +  +F  QI  G++Y     +VHRDL   N+L+     +KI+DFGLS ++ 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 168 RDGHFLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224
            +   +K S G     + A E +   +Y   + DVWS GV+L+ ++  G  P+       
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 225 LFKKIKGG 232
           LF  +K G
Sbjct: 261 LFNLLKTG 268

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 113/248 (45%), Gaps = 36/248 (14%)
Query: 18  NYKLGKTLGIGSFGKV-KIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILR 72
           N  LGKTLG G FGKV K     L G      VA+K+L +      E+ + +  E  +L+
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRD-LLSEFNVLK 81
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR------------------- 113
              HPH+I+LY        + +++EY K G L  ++ E  +                   
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 114 -----LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIM 167
                L   +  +F  QI  G++Y     +VHRDL   N+L+     +KI+DFGLS ++ 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 168 RDGHFLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224
            +   +K S G     + A E +   +Y   + DVWS GV+L+ ++  G  P+       
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 225 LFKKIKGG 232
           LF  +K G
Sbjct: 261 LFNLLKTG 268

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
           N + GKTLG G+FGKV  A     G      KVA+K+L  +   + + +E +  E+KI+ 
Sbjct: 32  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMS 89
Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR---------------LQE 116
            L  H +I+ L         + V+ EY   G+L +++  K                 L +
Sbjct: 90  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK 149
Query: 117 DEAR--------NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIM 167
           ++ R        +F  Q+  G+ +      +HRD+   N+LL +    KI DFGL+ +IM
Sbjct: 150 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 168 RDGHFL-KTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224
            D +++ K +   P  + APE I   +Y   + DVWS G++L+ +   G  P+    + +
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNS 268
Query: 225 LFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEI 265
            F K+    Y +  P+        ++     ++P  R T  +I
Sbjct: 269 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 311

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGH-------KVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           LGK LG G+FG+V +AE             KVA+K+L +      ++ + +  E++++++
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 89
Query: 74  F-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQE 116
              H +II L         +YV++EY   G L +Y+  +                 +L  
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 149
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
            +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++ KT
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
           + G     + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 268

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 23  KTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           K LG G+FG V     + E       VAIKILN        +E     E  I+    HPH
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPH 78
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           ++RL  V  +P+ I +V + +  G L +Y+ E K  +      N+  QI  G+ Y     
Sbjct: 79  LVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 137
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 194
           +VHRDL   N+L+ S  +VKI DFGL+ ++        + G      + A E I  + + 
Sbjct: 138 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 197
Query: 195 GPEVDVWSCGVILYALLC-GTLPFD---DENIPNLFKK 228
             + DVWS GV ++ L+  G  P+D      IP+L +K
Sbjct: 198 H-QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 234

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 27/235 (11%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           K+ + +G G FG+V        G K   VAIK L     +    E     E  I+  F H
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRRE--FLSEASIMGQFEH 74
Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHR 135
           P+IIRL  V+     + ++ E++++G L  ++ +  G+    +     + I SG+ Y   
Sbjct: 75  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE 134
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY------------A 183
              VHRDL   N+L++S    K++DFGLS       FL+ +   P Y             
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGLS------RFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           APE I+ + +     D WS G++++ ++  G  P+ D +  ++   I+   Y LP
Sbjct: 189 APEAIAFRKFTSAS-DAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQD-YRLP 241

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 117/249 (46%), Gaps = 11/249 (4%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 322
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
           V       Y++ E++  G L DY+ E  R + +     +   QI S +EY  +   +HR+
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRN 382
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVDV 200
           L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + DV
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDV 441
Query: 201 WSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           W+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P  
Sbjct: 442 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 501
Query: 259 RITIPEIRQ 267
           R +  EI Q
Sbjct: 502 RPSFAEIHQ 510

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGH-------KVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           LGK LG G+FG+V +AE             KVA+K+L +      ++ + +  E++++++
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 89
Query: 74  F-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQE 116
              H +II L         +YV++EY   G L +Y+  +                 +L  
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSS 149
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
            +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++ KT
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
           + G     + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 268

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  LGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L + LG G+FGKV +AE + L+  K    VA+K L   K   +   +  +RE ++L    
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQ 75
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----------------VEKGRLQEDEA 119
           H HI++ Y V      + +V EY+K G+L  ++                  KG L   + 
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
            +   QI SG+ Y      VHRDL   N L+ +   VKI DFG+S  +    + +    +
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 180 P---NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLP-FDDENIPNLFKKIKGGIY 234
                +  PE I  + +   E DVWS GVIL+ +   G  P F   N   +    +G + 
Sbjct: 196 MLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 254
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
             P        D++      +P +R+ I EI
Sbjct: 255 ERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 97/192 (50%), Gaps = 13/192 (6%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF---QQIISGVEYCHRNMVVHR 141
           V       Y+++E++  G L DY+ E  R QE  A        QI S +EY  +   +HR
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
           DL   N L+     VK+ADFGLS +M  G       G+     + APE ++   ++  + 
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS-IKS 191
Query: 199 DVWSCGVILYAL 210
           DVW+ GV+L+ +
Sbjct: 192 DVWAFGVLLWEI 203

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGH-------KVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           LGK LG G+FG+V +AE             KVA+K+L +      ++ + +  E++++++
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 82
Query: 74  F-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQE 116
              H +II L         +YV++EY   G L +Y+  +                 +L  
Sbjct: 83  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 142
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
            +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++ KT
Sbjct: 143 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
           + G     + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 261

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGH-------KVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           LGK LG G+FG+V +AE             KVA+K+L +      ++ + +  E++++++
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 130
Query: 74  F-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQE 116
              H +II L         +YV++EY   G L +Y+  +                 +L  
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
            +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++ KT
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
           + G     + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 309

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGH-------KVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           LGK LG G+FG+V +AE             KVA+K+L +      ++ + +  E++++++
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 89
Query: 74  F-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQE 116
              H +II L         +YV++EY   G L +Y+  +                 +L  
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 149
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
            +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++ KT
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
           + G     + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 268

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 15/217 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           N+     LG G FGKV     A  G  VA+K L   + +  E++   + E++++ + +H 
Sbjct: 39  NFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERXQGGELQ--FQTEVEMISMAVHR 95
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII----SGVEYC 133
           +++RL     TP++  +V  Y+ +G +   + E+   Q        Q+I      G+ Y 
Sbjct: 96  NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 155
Query: 134 HRNM---VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYAAPEVI 188
           H +    ++HRD+K  N+LLD ++   + DFGL+ +M  +D H      G+  + APE +
Sbjct: 156 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYL 215
Query: 189 S-GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN 224
           S GK  +  + DV+  GV+L  L+ G   FD   + N
Sbjct: 216 STGK--SSEKTDVFGYGVMLLELITGQRAFDLARLAN 250

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGH-------KVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           LGK LG G+FG+V +AE             KVA+K+L +      ++ + +  E++++++
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 81
Query: 74  F-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQE 116
              H +II L         +YV++EY   G L +Y+  +                 +L  
Sbjct: 82  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 141
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
            +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++ KT
Sbjct: 142 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
           + G     + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 260

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 23/233 (9%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILR 72
           K+ + +G G FG+V      L G +   VAIK L           EK RR    E  I+ 
Sbjct: 36  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG------YTEKQRRDFLSEASIMG 89
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVE 131
            F HP++I L  V+   + + ++ E++++G L  ++ +  G+    +     + I +G++
Sbjct: 90  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 149
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------YAAP 185
           Y      VHRDL   N+L++S    K++DFGLS  + D     T   +        + AP
Sbjct: 150 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I  + +     DVWS G++++ ++  G  P+ D    ++   I+   Y LP
Sbjct: 210 EAIQYRKFTSAS-DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-YRLP 260

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGH-------KVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           LGK LG G+FG+V +AE             KVA+K+L +      ++ + +  E++++++
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 74
Query: 74  F-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQE 116
              H +II L         +YV++EY   G L +Y+  +                 +L  
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
            +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++ KT
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
           + G     + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGH-------KVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           LGK LG G+FG+V +AE             KVA+K+L +      ++ + +  E++++++
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 78
Query: 74  F-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQE 116
              H +II L         +YV++EY   G L +Y+  +                 +L  
Sbjct: 79  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 138
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
            +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++ KT
Sbjct: 139 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
           + G     + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 257

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 114/243 (46%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGH-------KVAIKILNRRKIKNMEMEEKVRREIKILRL 73
           LGK LG G+FG+V +AE             KVA+K+L +      ++ + +  E++++++
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 89
Query: 74  F-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQE 116
              H +II L         +YV++EY   G L +Y+  +                 +L  
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSS 149
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176
            +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+   RD H +   
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA---RDIHHIDXX 206
Query: 177 CGSPN------YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
             + N      + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265
Query: 230 KGG 232
           K G
Sbjct: 266 KEG 268

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 117/250 (46%), Gaps = 13/250 (5%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG G +G+V           VA+K L   K   ME+EE ++ E  +++   HP++++L  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 283
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF---QQIISGVEYCHRNMVVHR 141
           V       Y++ E++  G L DY+ E  R QE  A        QI S +EY  +   +HR
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHR 342
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGPEVD 199
           +L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  + D
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSD 401
Query: 200 VWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      +P 
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 461
Query: 258 KRITIPEIRQ 267
            R +  EI Q
Sbjct: 462 DRPSFAEIHQ 471

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 32/278 (11%)
Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           KLGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  +
Sbjct: 32  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 89
Query: 74  FMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEK-------GRLQEDEARNFFQ- 124
             H +++ L      P   + V++E+ K G L  Y+  K           ED  ++F   
Sbjct: 90  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTL 149
Query: 125 --------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
                   Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D  +++ 
Sbjct: 150 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 209
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKG 231
                   + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K 
Sbjct: 210 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 268
Query: 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           G     P + +P     +      +P +R T  E+ +H
Sbjct: 269 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 15/217 (6%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           N+     LG G FGKV     A  G  VA+K L   + +  E++   + E++++ + +H 
Sbjct: 31  NFXNKNILGRGGFGKVYKGRLA-DGXLVAVKRLKEERTQGGELQ--FQTEVEMISMAVHR 87
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII----SGVEYC 133
           +++RL     TP++  +V  Y+ +G +   + E+   Q        Q+I      G+ Y 
Sbjct: 88  NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 134 HRNM---VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYAAPEVI 188
           H +    ++HRD+K  N+LLD ++   + DFGL+ +M  +D H      G   + APE +
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYL 207
Query: 189 S-GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN 224
           S GK  +  + DV+  GV+L  L+ G   FD   + N
Sbjct: 208 STGK--SSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 32/278 (11%)
Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           KLGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  +
Sbjct: 67  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 124
Query: 74  FMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGR-------LQEDEARNFFQ- 124
             H +++ L      P   + V++E+ K G L  Y+  K           ED  ++F   
Sbjct: 125 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 184
Query: 125 --------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
                   Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D  +++ 
Sbjct: 185 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKG 231
                   + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K 
Sbjct: 245 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 303
Query: 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           G     P + +P     +      +P +R T  E+ +H
Sbjct: 304 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 32/278 (11%)
Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           KLGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  +
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 87
Query: 74  FMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGR-------LQEDEARNFFQ- 124
             H +++ L      P   + V++E+ K G L  Y+  K           ED  ++F   
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 125 --------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
                   Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D  +++ 
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKG 231
                   + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K 
Sbjct: 208 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           G     P + +P     +      +P +R T  E+ +H
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           L   LG G+   V    H  TG   AIK+ N   I  +   +   RE ++L+   H +I+
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFN--NISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 81  RLYEVIE--TPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEYCHR 135
           +L+ + E  T     ++ME+   G L+  + E      L E E     + ++ G+ +   
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 136 NMVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           N +VHR++KP N++     D +   K+ DFG +  + D     +  G+  Y  P++    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 192 LYA-------GPEVDVWSCGVILYALLCGTLPF 217
           +         G  VD+WS GV  Y    G+LPF
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           KLGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  +
Sbjct: 21  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 78
Query: 74  FMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGR-------LQEDEARNFFQ- 124
             H +++ L      P   + V+ E+ K G L  Y+  K           ED  ++F   
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 125 --------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
                   Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D  +++ 
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKG 231
                   + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K 
Sbjct: 199 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 257
Query: 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           G     P + +P     +      +P +R T  E+ +H
Sbjct: 258 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 120/246 (48%), Gaps = 43/246 (17%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVR---RE 67
           LGK LG G+FG+V +AE           A+T   VA+K+L     K+   EE +     E
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVT---VAVKML-----KDDATEEDLSDLVSE 90
Query: 68  IKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQ 115
           ++++++   H +II L         +YV++EY   G L +Y+  +            R+ 
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 116 EDEAR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRD 169
           E++       +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I   
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 170 GHFLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF 226
            ++ KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LF
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 227 KKIKGG 232
           K +K G
Sbjct: 270 KLLKEG 275

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           KLGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  +
Sbjct: 21  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 78
Query: 74  FMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGR-------LQEDEARNFFQ- 124
             H +++ L      P   + V+ E+ K G L  Y+  K           ED  ++F   
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 125 --------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
                   Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D  +++ 
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKG 231
                   + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K 
Sbjct: 199 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 257
Query: 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           G     P + +P     +      +P +R T  E+ +H
Sbjct: 258 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 131/292 (44%), Gaps = 56/292 (19%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIK--ILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           K LG GS G V + + +  G  VA+K  +++   I  ME++     +        HP++I
Sbjct: 21  KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD-------HPNVI 72
Query: 81  RLYEVIETPSDIYVVMEY--------VKSGELFDYIVEKGRLQED-EARNFFQQIISGVE 131
           R Y    T   +Y+ +E         V+S  + D   E  +LQ++    +  +QI SGV 
Sbjct: 73  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVA 129
Query: 132 YCHRNMVVHRDLKPENLLLDS-------------KWNVKIADFGLSNIMRDGHF-----L 173
           + H   ++HRDLKP+N+L+ +                + I+DFGL   +  G       L
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 174 KTSCGSPNYAAPEV------ISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF 226
               G+  + APE+      +  K      +D++S G + Y +L  G  PF D+      
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247
Query: 227 KKIKGGIYTLPS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
             I  GI++L          L   A DLI +M+  DP+KR T  ++ +HP F
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 23/274 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +     T  +VAIK L    +      E   +E ++++   H  +
Sbjct: 11  RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 65
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGR-LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   I +V EY+  G L D++  E G+ L+  +  +   QI SG+ Y  R  
Sbjct: 66  VQLYAVV-SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 124
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYA 194
            VHRDL+  N+L+      K+ADFGL+ ++ D     +     P  + APE  + G+   
Sbjct: 125 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 184
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRM 251
             + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ + 
Sbjct: 185 --KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 241
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              +P +R T        + QA L  Y     P 
Sbjct: 242 WRKEPEERPTF------EYLQAFLEDYFTSTEPQ 269

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 15/214 (7%)
Query: 22  GKTLGIGSFGKVKIAEHALTGHKVAIKILNRR-KIKNMEMEEKVRREIKILRLFMHPHII 80
           G  +G G FG V   +  +    VA+K L     I   E++++  +EIK++    H +++
Sbjct: 36  GNKMGEGGFGVV--YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
            L        D+ +V  Y+ +G L D +    G   L         Q   +G+ + H N 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-----CGSPNYAAPEVISGKL 192
            +HRD+K  N+LLD  +  KI+DFGL+       F +T       G+  Y APE + G++
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASE--KFAQTVMXXRIVGTTAYMAPEALRGEI 211
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226
              P+ D++S GV+L  ++ G    D+   P L 
Sbjct: 212 --TPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 15/214 (7%)
Query: 22  GKTLGIGSFGKVKIAEHALTGHKVAIKILNRR-KIKNMEMEEKVRREIKILRLFMHPHII 80
           G  +G G FG V   +  +    VA+K L     I   E++++  +EIK++    H +++
Sbjct: 36  GNKMGEGGFGVV--YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
            L        D+ +V  Y+ +G L D +    G   L         Q   +G+ + H N 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-----CGSPNYAAPEVISGKL 192
            +HRD+K  N+LLD  +  KI+DFGL+       F +T       G+  Y APE + G++
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASE--KFAQTVMXSRIVGTTAYMAPEALRGEI 211
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226
              P+ D++S GV+L  ++ G    D+   P L 
Sbjct: 212 --TPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 117/269 (43%), Gaps = 31/269 (11%)
Query: 31  GKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK---------VRREIKILRLF-MHPHII 80
           GK+      + GH     I+ R    N ++  K           RE+++LR    HP++I
Sbjct: 22  GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVI 81
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQED-EARNFFQQIISGVEYCHRNMVV 139
           R +   +     Y+ +E   +  L +Y+ +K       E     QQ  SG+ + H   +V
Sbjct: 82  RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 140 HRDLKPENLLLD-----SKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISG 190
           HRDLKP N+L+       K    I+DFGL   +  G H      G P    + APE++S 
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 191 KLYAGP--EVDVWSCGVILYALLC-GTLPFD-----DENIPNLFKKIKGGIYTLPSHLSP 242
                P   VD++S G + Y ++  G+ PF        NI  L             H   
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLGACSLDCLHPEKHEDV 258
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWF 271
            AR+LI +M+ +DP KR +   + +HP+F
Sbjct: 259 IARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           + L   LG G+   V    H  TG   AIK+ N   I  +   +   RE ++L+   H +
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFN--NISFLRPVDVQMREFEVLKKLNHKN 68
Query: 79  IIRLYEVIE--TPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEYC 133
           I++L+ + E  T     ++ME+   G L+  + E      L E E     + ++ G+ + 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 134 HRNMVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
             N +VHR++KP N++     D +   K+ DFG +  + D        G+  Y  P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYE 188
Query: 190 GKLYA-------GPEVDVWSCGVILYALLCGTLPF 217
             +         G  VD+WS GV  Y    G+LPF
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 131/292 (44%), Gaps = 56/292 (19%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIK--ILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
           K LG GS G V + + +  G  VA+K  +++   I  ME++     +        HP++I
Sbjct: 21  KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD-------HPNVI 72
Query: 81  RLYEVIETPSDIYVVMEY--------VKSGELFDYIVEKGRLQED-EARNFFQQIISGVE 131
           R Y    T   +Y+ +E         V+S  + D   E  +LQ++    +  +QI SGV 
Sbjct: 73  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVA 129
Query: 132 YCHRNMVVHRDLKPENLLLDS-------------KWNVKIADFGLSNIMRDGHF-----L 173
           + H   ++HRDLKP+N+L+ +                + I+DFGL   +  G       L
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 174 KTSCGSPNYAAPEV------ISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF 226
               G+  + APE+      +  K      +D++S G + Y +L  G  PF D+      
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247
Query: 227 KKIKGGIYTLPS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
             I  GI++L          L   A DLI +M+  DP+KR T  ++ +HP F
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           LG GSFG+V   +   TG + A+K   + +++   +EE V            P I+ LY 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVEELV-----ACAGLSSPRIVPLYG 131
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
            +     + + ME ++ G L   I + G L ED A  +  Q + G+EY H   ++H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 145 PENLLLDSKWN-VKIADF---------GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
            +N+LL S  +   + DF         GL   +  G ++    G+  + APEV+ GK   
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP---GTETHMAPEVVMGK-PC 247
Query: 195 GPEVDVWSCGVILYALLCGTLPF 217
             +VD+WS   ++  +L G  P+
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 19  YKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           Y++ K +G GSFG+V K  +H +  H VA+K++   K        +   EI+IL      
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQH-VALKMVRNEK----RFHRQAAEEIRILEHLRKQ 153
Query: 78  ------HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDE---ARNFFQQIIS 128
                 ++I + E     + I +  E + S  L++ +++K + Q       R F   I+ 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 129 GVEYCHRNMVVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
            ++  H+N ++H DLKPEN+LL    +  +K+ DFG S    +   + T   S  Y APE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPE 269
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCG--TLPFDDE 220
           VI G  Y  P +D+WS G IL  LL G   LP +DE
Sbjct: 270 VILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++M+ +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 77  NPHVCRLLGICLT-STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 196 IYTH-QSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 120/243 (49%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G+FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 93
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++EY   G L +Y+  +            R+ E++
Sbjct: 94  MKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF 172
                  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 230 KGG 232
           K G
Sbjct: 273 KEG 275

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 120/243 (49%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G+FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 93
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++EY   G L +Y+  +            R+ E++
Sbjct: 94  MKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF 172
                  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 230 KGG 232
           K G
Sbjct: 273 KEG 275

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 119/243 (48%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 139
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++EY   G L +Y+  +            R+ E++
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF 172
                  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
Query: 230 KGG 232
           K G
Sbjct: 319 KEG 321

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 19  YKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           Y++ K +G GSFG+V K  +H +  H VA+K++   K        +   EI+IL      
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQH-VALKMVRNEK----RFHRQAAEEIRILEHLRKQ 153
Query: 78  ------HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDE---ARNFFQQIIS 128
                 ++I + E     + I +  E + S  L++ +++K + Q       R F   I+ 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 129 GVEYCHRNMVVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
            ++  H+N ++H DLKPEN+LL    +  +K+ DFG S    +   + T   S  Y APE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPE 269
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCG--TLPFDDE 220
           VI G  Y  P +D+WS G IL  LL G   LP +DE
Sbjct: 270 VILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           KLGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  +
Sbjct: 21  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 78
Query: 74  FMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGR-------LQEDEARNFFQ- 124
             H +++ L      P   + V++E+ K G L  Y+  K           ED  ++F   
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 125 --------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
                   Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D   ++ 
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKG 231
                   + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K 
Sbjct: 199 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 257
Query: 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           G     P + +P     +      +P +R T  E+ +H
Sbjct: 258 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           KLGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  +
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 87
Query: 74  FMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGR-------LQEDEARNFFQ- 124
             H +++ L      P   + V++E+ K G L  Y+  K           ED  ++F   
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 125 --------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
                   Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D   ++ 
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKG 231
                   + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K 
Sbjct: 208 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           G     P + +P     +      +P +R T  E+ +H
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 126/276 (45%), Gaps = 30/276 (10%)
Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           KLGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  +
Sbjct: 32  KLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHI 89
Query: 74  FMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGR-----LQEDEARNFFQ--- 124
             H +++ L      P   + V++E+ K G L  Y+  K         ED  ++F     
Sbjct: 90  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEH 149
Query: 125 ------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSC 177
                 Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D   ++   
Sbjct: 150 LIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 178 GS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI 233
                 + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K G 
Sbjct: 210 ARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
               P + +P     +      +P +R T  E+ +H
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 119/243 (48%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 26  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 80
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++EY   G L +Y+  +            R+ E++
Sbjct: 81  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 140
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF 172
                  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYY 200
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 201 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 259
Query: 230 KGG 232
           K G
Sbjct: 260 KEG 262

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           KLGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  +
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 87
Query: 74  FMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGR-------LQEDEARNFFQ- 124
             H +++ L      P   + V++E+ K G L  Y+  K           ED  ++F   
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 125 --------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
                   Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D   ++ 
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKG 231
                   + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K 
Sbjct: 208 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           G     P + +P     +      +P +R T  E+ +H
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 119/243 (48%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 31  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 85
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++EY   G L +Y+  +            R+ E++
Sbjct: 86  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 145
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF 172
                  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 205
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 206 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 264
Query: 230 KGG 232
           K G
Sbjct: 265 KEG 267

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 31/276 (11%)
Query: 21  LGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLF 74
           LGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  + 
Sbjct: 32  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIG 89
Query: 75  MHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKG------RLQEDEARNFFQ--- 124
            H +++ L      P   + V++E+ K G L  Y+  K       +  ED  ++F     
Sbjct: 90  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEH 149
Query: 125 ------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSC 177
                 Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D   ++   
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 178 GS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI 233
                 + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K G 
Sbjct: 210 ARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
               P + +P     +      +P +R T  E+ +H
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 125/278 (44%), Gaps = 32/278 (11%)
Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           KLGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  +
Sbjct: 21  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 78
Query: 74  FMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGR-------LQEDEARNFFQ- 124
             H +++ L      P   + V+ E+ K G L  Y+  K           ED  ++F   
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 125 --------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT 175
                   Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D   ++ 
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 176 SCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKG 231
                   + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K 
Sbjct: 199 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 257
Query: 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           G     P + +P     +      +P +R T  E+ +H
Sbjct: 258 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++M+ +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 80  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 199 IYTH-QSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 119/243 (48%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 28  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 82
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++EY   G L +Y+  +            R+ E++
Sbjct: 83  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 142
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF 172
                  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 202
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 203 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 261
Query: 230 KGG 232
           K G
Sbjct: 262 KEG 264

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 120/243 (49%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G+FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 93
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++EY   G L +Y+  +            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF 172
                  +   Q+  G+EY      +HRDL   N+L+     ++IADFGL+ +I    ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYY 213
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 230 KGG 232
           K G
Sbjct: 273 KEG 275

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 116/255 (45%), Gaps = 16/255 (6%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           L + LG G FG+V   E   T HK   + + +   +K   ++ +EK   E  I++   HP
Sbjct: 28  LNRILGEGFFGEV--YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 85
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRN 136
           HI++L  +IE     +++ME    GEL  Y+   K  L+      +  QI   + Y    
Sbjct: 86  HIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 144
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 194
             VHRD+   N+L+ S   VK+ DFGLS  + D  + K S       + +PE I+ + + 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 195 GPEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
               DVW   V ++ +L  G  PF   +++++  + +  KG     P    P    L+ R
Sbjct: 205 TAS-DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE--KGDRLPKPDLCPPVLYTLMTR 261
Query: 251 MLIVDPMKRITIPEI 265
               DP  R    E+
Sbjct: 262 CWDYDPSDRPRFTEL 276

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++M+ +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 77  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 196 IYTH-QSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 23/233 (9%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILR 72
           K+ + +G G FG+V      L G +   VAIK L           EK RR    E  I+ 
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS------GYTEKQRRDFLSEASIMG 63
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVE 131
            F HP++I L  V+   + + ++ E++++G L  ++ +  G+    +     + I +G++
Sbjct: 64  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------YAAP 185
           Y      VHR L   N+L++S    K++DFGLS  + D     T   +        + AP
Sbjct: 124 YLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
           E I  + +     DVWS G++++ ++  G  P+ D    ++   I+   Y LP
Sbjct: 184 EAIQYRKFTSAS-DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-YRLP 234

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++M+ +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 79  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 198 IYTH-QSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 117/243 (48%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G+FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 93
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++EY   G L +Y+  +            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173
                  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+  + +  + 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 174 KTSCGSP---NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
           K +        + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 214 KNTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 230 KGG 232
           K G
Sbjct: 273 KEG 275

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 116/255 (45%), Gaps = 16/255 (6%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           L + LG G FG+V   E   T HK   + + +   +K   ++ +EK   E  I++   HP
Sbjct: 16  LNRILGEGFFGEV--YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRN 136
           HI++L  +IE     +++ME    GEL  Y+   K  L+      +  QI   + Y    
Sbjct: 74  HIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 194
             VHRD+   N+L+ S   VK+ DFGLS  + D  + K S       + +PE I+ + + 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 195 GPEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
               DVW   V ++ +L  G  PF   +++++  + +  KG     P    P    L+ R
Sbjct: 193 TAS-DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE--KGDRLPKPDLCPPVLYTLMTR 249
Query: 251 MLIVDPMKRITIPEI 265
               DP  R    E+
Sbjct: 250 CWDYDPSDRPRFTEL 264

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++M+ +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 197 IYTH-QSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++M+ +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 76  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 195 IYTH-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GSFG+V   +   TG + A+K   + +++   +EE V            P I+ LY 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVEELV-----ACAGLSSPRIVPLYG 117
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
            +     + + ME ++ G L   I + G L ED A  +  Q + G+EY H   ++H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 145 PENLLLDSKWN-VKIADF---------GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
            +N+LL S  +   + DF         GL   +  G ++    G+  + APEV+ GK   
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP---GTETHMAPEVVMGK-PC 233
Query: 195 GPEVDVWSCGVILYALLCGTLPF 217
             +VD+WS   ++  +L G  P+
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 116/255 (45%), Gaps = 16/255 (6%)
Query: 21  LGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           L + LG G FG+V   E   T HK   + + +   +K   ++ +EK   E  I++   HP
Sbjct: 12  LNRILGEGFFGEV--YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 69
Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRN 136
           HI++L  +IE     +++ME    GEL  Y+   K  L+      +  QI   + Y    
Sbjct: 70  HIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 128
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 194
             VHRD+   N+L+ S   VK+ DFGLS  + D  + K S       + +PE I+ + + 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 195 GPEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
               DVW   V ++ +L  G  PF   +++++  + +  KG     P    P    L+ R
Sbjct: 189 TAS-DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE--KGDRLPKPDLCPPVLYTLMTR 245
Query: 251 MLIVDPMKRITIPEI 265
               DP  R    E+
Sbjct: 246 CWDYDPSDRPRFTEL 260

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 22  GKTLGIGSFGKVKIAEHALTGHKVAIKILNRR-KIKNMEMEEKVRREIKILRLFMHPHII 80
           G  +G G FG V   +  +    VA+K L     I   E++++  +EIK++    H +++
Sbjct: 30  GNKMGEGGFGVV--YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 87
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
            L        D+ +V  Y+ +G L D +    G   L         Q   +G+ + H N 
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 147
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGL---SNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
            +HRD+K  N+LLD  +  KI+DFGL   S             G+  Y APE + G++  
Sbjct: 148 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEI-- 205
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226
            P+ D++S GV+L  ++ G    D+   P L 
Sbjct: 206 TPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 237

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 107/253 (42%), Gaps = 51/253 (20%)
Query: 11  GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIK 69
           G++     Y LGKTLG GSFG V       +G + A+K +L   + KN        RE+ 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN--------RELD 52
Query: 70  ILRLFMHPHIIRLYEVIETPSD-------------------------------------- 91
           I+++  H +II+L +   T  D                                      
Sbjct: 53  IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 92  IYVVMEYVKSG--ELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148
           + V+MEYV     ++    +  GR +  +    +  Q+   V + H   + HRD+KP+NL
Sbjct: 113 LNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 149 LLDSKWN-VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 207
           L++SK N +K+ DFG +  +           S  Y APE++ G     P +D+WS G + 
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 208 YALLCGTLPFDDE 220
             L+ G   F  E
Sbjct: 233 GELILGKPLFSGE 245

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 17/218 (7%)
Query: 13  DMFLPNYKL----GKTLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIKNMEMEEKVR 65
           D+ +P+ ++     + +G G FG V   E+   A    + AIK L+R  I  M+  E   
Sbjct: 13  DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVEAFL 70
Query: 66  REIKILRLFMHPHIIRLYEVIETPSDI-YVVMEYVKSGELFDYIVEKGRLQE-DEARNFF 123
           RE  ++R   HP+++ L  ++  P  + +V++ Y+  G+L  +I    R     +  +F 
Sbjct: 71  REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG 130
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--- 180
            Q+  G+EY      VHRDL   N +LD  + VK+ADFGL+  + D  +           
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 181 --NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP 216
              + A E +    +   + DVWS GV+L+ LL    P
Sbjct: 191 PVKWTALESLQTYRFTT-KSDVWSFGVLLWELLTRGAP 227

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 25  LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
           +G GSFG+V   +   TG + A+K   + +++   +EE V            P I+ LY 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVEELV-----ACAGLSSPRIVPLYG 133
Query: 85  VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
            +     + + ME ++ G L   I + G L ED A  +  Q + G+EY H   ++H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 145 PENLLLDSKWN-VKIADF---------GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
            +N+LL S  +   + DF         GL   +  G ++    G+  + APEV+ GK   
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP---GTETHMAPEVVMGK-PC 249
Query: 195 GPEVDVWSCGVILYALLCGTLPF 217
             +VD+WS   ++  +L G  P+
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAI--KILNRRKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I   I+  R+  + +  +++  E  ++    
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 110 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 168
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 169 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 228
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 229 IYTH-QSDVWSYGVTVWELMTFGSKPYD 255

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 18  NYKLGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILR 72
           N  L + LG G+FGKV +AE + L   +    VA+K L   K  +    +   RE ++L 
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLT 70
Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-------------RLQEDEA 119
              H HI++ Y V      + +V EY+K G+L  ++   G              L + + 
Sbjct: 71  NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQM 130
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
            +  QQI +G+ Y      VHRDL   N L+     VKI DFG+S  +    + +    +
Sbjct: 131 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 180 P---NYAAPEVISGKLYAGPEVDVWSCGVILYALL 211
                +  PE I  + +   E DVWS GV+L+ + 
Sbjct: 191 MLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIF 224

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 89/353 (25%), Positives = 145/353 (41%), Gaps = 87/353 (24%)
Query: 13  DMFLPNYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKI 70
           D     Y++  TLG G+FG+V +  +H   G +VA+KI     IKN+E  +E  R EI +
Sbjct: 29  DWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKI-----IKNVEKYKEAARLEINV 83
Query: 71  LRLFMHPH------IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE--DEARNF 122
           L              +++++  +    + +  E +     FD++ +   L     + R+ 
Sbjct: 84  LEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLS-TFDFLKDNNYLPYPIHQVRHM 142
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLL-----------LDSKWN--------VKIADFGL 163
             Q+   V++ H N + H DLKPEN+L           L+ K +        V++ DFG 
Sbjct: 143 AFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGS 202
Query: 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF---DDE 220
           +    + H   T   + +Y APEVI    ++ P  DVWS G I++    G   F   D+ 
Sbjct: 203 ATFDHEHH--STIVSTRHYRAPEVILELGWSQP-CDVWSIGCIIFEYYVGFTLFQTHDNR 259
Query: 221 NIPNLFKKIKG-----------------------------GIYT------LPSHLSPGAR 245
               + ++I G                             G Y       L  +L+  A 
Sbjct: 260 EHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAE 319
Query: 246 ------DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
                 DLI  ML  +P KR+T+ E  QHP+F       L   PP+ +  + +
Sbjct: 320 EHHQLFDLIESMLEYEPAKRLTLGEALQHPFFAR-----LRAEPPNKLWDSSR 367

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 21  LGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLF 74
           LGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  + 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIG 88
Query: 75  MHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGRL---QEDEARNFFQ------ 124
            H +++ L      P   + V++E+ K G L  Y+  K       +D  ++F        
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 125 ---QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS- 179
              Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D  +++      
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 180 -PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YT 235
              + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K G    
Sbjct: 209 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 267
Query: 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
            P + +P     +      +P +R T  E+ +H
Sbjct: 268 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 21  LGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLF 74
           LGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL  + 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIG 88
Query: 75  MHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGRL---QEDEARNFFQ------ 124
            H +++ L      P   + V++E+ K G L  Y+  K       +D  ++F        
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 125 ---QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS- 179
              Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D  +++      
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 180 -PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YT 235
              + APE I  ++Y   + DVWS GV+L+ +   G  P+    I   F +++K G    
Sbjct: 209 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMR 267
Query: 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
            P + +P     +      +P +R T  E+ +H
Sbjct: 268 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 121/267 (45%), Gaps = 24/267 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPH 78
           K    +G G+FG+V  A     G ++   I   ++  + +       E+++L +L  HP+
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA----------------RNF 122
           II L    E    +Y+ +EY   G L D++ +   L+ D A                 +F
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-N 181
              +  G++Y  +   +HRDL   N+L+   +  KIADFGLS   ++ +  KT    P  
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVR 206
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PS 238
           + A E ++  +Y     DVWS GV+L+ ++  G  P+       L++K+  G Y L  P 
Sbjct: 207 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPL 264
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEI 265
           +      DL+ +     P +R +  +I
Sbjct: 265 NCDDEVYDLMRQCWREKPYERPSFAQI 291

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             + +G G FG V    + ++       A+K LNR  I ++    +   E  I++ F HP
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 109
Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G++Y   
Sbjct: 110 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 169
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISG 190
              VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
           + +   + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P
Sbjct: 230 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQP 277
Query: 250 RMLIVDPMKRITI----PEIRQHPWFQAHLPRYLAV 281
                DP+  + +    P+    P F   + R  A+
Sbjct: 278 EY-CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 108/235 (45%), Gaps = 40/235 (17%)
Query: 13  DMFLPN-YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
           D  +P+ Y++   +G GS+G V  A   L    VAIK +  R  +++   +++ REI IL
Sbjct: 48  DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKRILREIAIL 106
Query: 72  RLFMHPHIIRLYEVI-----ETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQ 124
               H H++++ +++     E   ++YVV+E   S   +LF   V    L E   +    
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV---YLTELHIKTLLY 163
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---------------RD 169
            ++ GV+Y H   ++HRDLKP N L++   +VK+ DFGL+  +                D
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 170 GHFLKTSCGSPN-------------YAAPEVISGKLYAGPEVDVWSCGVILYALL 211
              L T   + N             Y APE+I  +      +DVWS G I   LL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 121/267 (45%), Gaps = 24/267 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPH 78
           K    +G G+FG+V  A     G ++   I   ++  + +       E+++L +L  HP+
Sbjct: 18  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 77
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA----------------RNF 122
           II L    E    +Y+ +EY   G L D++ +   L+ D A                 +F
Sbjct: 78  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-N 181
              +  G++Y  +   +HRDL   N+L+   +  KIADFGLS   ++ +  KT    P  
Sbjct: 138 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVR 196
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PS 238
           + A E ++  +Y     DVWS GV+L+ ++  G  P+       L++K+  G Y L  P 
Sbjct: 197 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPL 254
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEI 265
           +      DL+ +     P +R +  +I
Sbjct: 255 NCDDEVYDLMRQCWREKPYERPSFAQI 281

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             + +G G FG V    + ++       A+K LNR  I ++    +   E  I++ F HP
Sbjct: 53  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 110
Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G++Y   
Sbjct: 111 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 170
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISG 190
              VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
           + +   + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P
Sbjct: 231 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQP 278
Query: 250 RMLIVDPMKRITI----PEIRQHPWFQAHLPRYLAV 281
                DP+  + +    P+    P F   + R  A+
Sbjct: 279 EY-CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             + +G G FG V    + ++       A+K LNR  I ++    +   E  I++ F HP
Sbjct: 26  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 83
Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G++Y   
Sbjct: 84  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 143
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISG 190
              VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
           + +   + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P
Sbjct: 204 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQP 251
Query: 250 RMLIVDPMKRITI----PEIRQHPWFQAHLPRYLAV 281
                DP+  + +    P+    P F   + R  A+
Sbjct: 252 EY-CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 119/243 (48%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G+FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 93
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++ Y   G L +Y+  +            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF 172
                  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 230 KGG 232
           K G
Sbjct: 273 KEG 275

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             + +G G FG V    + ++       A+K LNR  I ++    +   E  I++ F HP
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 88
Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G++Y   
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 148
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISG 190
              VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
           + +   + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P
Sbjct: 209 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQP 256
Query: 250 RMLIVDPMKRITI----PEIRQHPWFQAHLPRYLAV 281
                DP+  + +    P+    P F   + R  A+
Sbjct: 257 EY-CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             + +G G FG V    + ++       A+K LNR  I ++    +   E  I++ F HP
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 89
Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G++Y   
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 149
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISG 190
              VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
           + +   + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P
Sbjct: 210 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQP 257
Query: 250 RMLIVDPMKRITI----PEIRQHPWFQAHLPRYLAV 281
                DP+  + +    P+    P F   + R  A+
Sbjct: 258 EY-CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             + +G G FG V    + ++       A+K LNR  I ++    +   E  I++ F HP
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 91
Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G++Y   
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISG 190
              VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
           + +   + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P
Sbjct: 212 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQP 259
Query: 250 RMLIVDPMKRITI----PEIRQHPWFQAHLPRYLAV 281
                DP+  + +    P+    P F   + R  A+
Sbjct: 260 EY-CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 195 IYTH-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             + +G G FG V    + ++       A+K LNR  I ++    +   E  I++ F HP
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 86
Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G++Y   
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISG 190
              VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
           + +   + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P
Sbjct: 207 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQP 254
Query: 250 RMLIVDPMKRITI----PEIRQHPWFQAHLPRYLAV 281
                DP+  + +    P+    P F   + R  A+
Sbjct: 255 EY-CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             + +G G FG V    + ++       A+K LNR  I ++    +   E  I++ F HP
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 91
Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G++Y   
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISG 190
              VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
           + +   + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P
Sbjct: 212 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQP 259
Query: 250 RMLIVDPMKRITI----PEIRQHPWFQAHLPRYLAV 281
                DP+  + +    P+    P F   + R  A+
Sbjct: 260 EY-CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 11/229 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           + +L + LG GSFG V+  E      K   VA+K L    +   E  +   RE+  +   
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
            H ++IRLY V+ TP  + +V E    G L D + + +G         +  Q+  G+ Y 
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYA--APEVIS 189
                +HRDL   NLLL ++  VKI DFGL   +   D H++        +A  APE + 
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + ++    D W  GV L+ +   G  P+   N   +  KI      LP
Sbjct: 198 TRTFSHAS-DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             + +G G FG V    + ++       A+K LNR  I ++    +   E  I++ F HP
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 90
Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G++Y   
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISG 190
              VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
           + +   + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P
Sbjct: 211 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQP 258
Query: 250 RMLIVDPMKRITI----PEIRQHPWFQAHLPRYLAV 281
                DP+  + +    P+    P F   + R  A+
Sbjct: 259 EY-CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 11/229 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           + +L + LG GSFG V+  E      K   VA+K L    +   E  +   RE+  +   
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
            H ++IRLY V+ TP  + +V E    G L D + + +G         +  Q+  G+ Y 
Sbjct: 73  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYA--APEVIS 189
                +HRDL   NLLL ++  VKI DFGL   +   D H++        +A  APE + 
Sbjct: 132 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + ++    D W  GV L+ +   G  P+   N   +  KI      LP
Sbjct: 192 TRTFSHAS-DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 11/229 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           + +L + LG GSFG V+  E      K   VA+K L    +   E  +   RE+  +   
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
            H ++IRLY V+ TP  + +V E    G L D + + +G         +  Q+  G+ Y 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYA--APEVIS 189
                +HRDL   NLLL ++  VKI DFGL   +   D H++        +A  APE + 
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + ++    D W  GV L+ +   G  P+   N   +  KI      LP
Sbjct: 188 TRTFSHAS-DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 118/243 (48%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G+FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 93
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++EY   G L +Y+  +            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ 153
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF 172
                  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I      
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 230 KGG 232
           K G
Sbjct: 273 KEG 275

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 115/248 (46%), Gaps = 27/248 (10%)
Query: 46  AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV-IETPSDIYVVMEYVKSGEL 104
           A+K LNR  I ++    +   E  I++ F HP+++ L  + + +     VV+ Y+K G+L
Sbjct: 121 AVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178
Query: 105 FDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163
            ++I  E       +   F  Q+  G+++      VHRDL   N +LD K+ VK+ADFGL
Sbjct: 179 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 238
Query: 164 SNIMRDGHF----LKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF 217
           +  M D  F     KT    P  + A E +  + +   + DVWS GV+L+ L+  G  P+
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 297
Query: 218 DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWFQA 273
            D N            + +  +L  G R L P     DP+  + +    P+    P F  
Sbjct: 298 PDVN-----------TFDITVYLLQGRRLLQPEY-CPDPLYEVMLKCWHPKAEMRPSFSE 345
Query: 274 HLPRYLAV 281
            + R  A+
Sbjct: 346 LVSRISAI 353

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 118/243 (48%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G+FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 93
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++EY   G L +Y+  +            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF 172
                  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I      
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 230 KGG 232
           K G
Sbjct: 273 KEG 275

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 119/243 (48%), Gaps = 37/243 (15%)
Query: 21  LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
           LGK LG G+FG+V +AE           A+T   VA+K+L +      ++ + V  E+++
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVT---VAVKML-KDDATEKDLSDLVS-EMEM 93
Query: 71  LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----------GRLQEDE 118
           +++   H +II L         +YV++ Y   G L +Y+  +            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 119 AR-----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF 172
                  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
            KT+ G     + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 230 KGG 232
           K G
Sbjct: 273 KEG 275

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 11/229 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           + +L + LG GSFG V+  E      K   VA+K L    +   E  +   RE+  +   
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
            H ++IRLY V+ TP  + +V E    G L D + + +G         +  Q+  G+ Y 
Sbjct: 73  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYA--APEVIS 189
                +HRDL   NLLL ++  VKI DFGL   +   D H++        +A  APE + 
Sbjct: 132 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + ++    D W  GV L+ +   G  P+   N   +  KI      LP
Sbjct: 192 TRTFSHAS-DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 11/212 (5%)
Query: 22  GKTLGIGSFGKVKIAEHALTGHKVAIKILNRR-KIKNMEMEEKVRREIKILRLFMHPHII 80
           G   G G FG V   +  +    VA+K L     I   E++++  +EIK+     H +++
Sbjct: 27  GNKXGEGGFGVV--YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLV 84
Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
            L        D+ +V  Y  +G L D +    G   L         Q   +G+ + H N 
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENH 144
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTS--CGSPNYAAPEVISGKLYA 194
            +HRD+K  N+LLD  +  KI+DFGL+         +  S   G+  Y APE + G++  
Sbjct: 145 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEIT- 203
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226
            P+ D++S GV+L  ++ G    D+   P L 
Sbjct: 204 -PKSDIYSFGVVLLEIITGLPAVDEHREPQLL 234

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 11/229 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           + +L + LG GSFG V+  E      K   VA+K L    +   E  +   RE+  +   
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
            H ++IRLY V+ TP  + +V E    G L D + + +G         +  Q+  G+ Y 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYA--APEVIS 189
                +HRDL   NLLL ++  VKI DFGL   +   D H++        +A  APE + 
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + ++    D W  GV L+ +   G  P+   N   +  KI      LP
Sbjct: 188 TRTFSHAS-DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 115/248 (46%), Gaps = 27/248 (10%)
Query: 46  AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV-IETPSDIYVVMEYVKSGEL 104
           A+K LNR  I ++    +   E  I++ F HP+++ L  + + +     VV+ Y+K G+L
Sbjct: 63  AVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 120
Query: 105 FDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163
            ++I  E       +   F  Q+  G+++      VHRDL   N +LD K+ VK+ADFGL
Sbjct: 121 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 180
Query: 164 SNIMRDGHF----LKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF 217
           +  M D  F     KT    P  + A E +  + +   + DVWS GV+L+ L+  G  P+
Sbjct: 181 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 239
Query: 218 DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWFQA 273
            D N            + +  +L  G R L P     DP+  + +    P+    P F  
Sbjct: 240 PDVN-----------TFDITVYLLQGRRLLQPEY-CPDPLYEVMLKCWHPKAEMRPSFSE 287
Query: 274 HLPRYLAV 281
            + R  A+
Sbjct: 288 LVSRISAI 295

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 115/248 (46%), Gaps = 27/248 (10%)
Query: 46  AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV-IETPSDIYVVMEYVKSGEL 104
           A+K LNR  I ++    +   E  I++ F HP+++ L  + + +     VV+ Y+K G+L
Sbjct: 62  AVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 119
Query: 105 FDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163
            ++I  E       +   F  Q+  G+++      VHRDL   N +LD K+ VK+ADFGL
Sbjct: 120 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 164 SNIMRDGHF----LKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF 217
           +  M D  F     KT    P  + A E +  + +   + DVWS GV+L+ L+  G  P+
Sbjct: 180 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 238
Query: 218 DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWFQA 273
            D N            + +  +L  G R L P     DP+  + +    P+    P F  
Sbjct: 239 PDVN-----------TFDITVYLLQGRRLLQPEY-CPDPLYEVMLKCWHPKAEMRPSFSE 286
Query: 274 HLPRYLAV 281
            + R  A+
Sbjct: 287 LVSRISAI 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 115/248 (46%), Gaps = 27/248 (10%)
Query: 46  AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV-IETPSDIYVVMEYVKSGEL 104
           A+K LNR  I ++    +   E  I++ F HP+++ L  + + +     VV+ Y+K G+L
Sbjct: 67  AVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 124
Query: 105 FDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163
            ++I  E       +   F  Q+  G+++      VHRDL   N +LD K+ VK+ADFGL
Sbjct: 125 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 184
Query: 164 SNIMRDGHF----LKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF 217
           +  M D  F     KT    P  + A E +  + +   + DVWS GV+L+ L+  G  P+
Sbjct: 185 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 243
Query: 218 DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWFQA 273
            D N            + +  +L  G R L P     DP+  + +    P+    P F  
Sbjct: 244 PDVN-----------TFDITVYLLQGRRLLQPEY-CPDPLYEVMLKCWHPKAEMRPSFSE 291
Query: 274 HLPRYLAV 281
            + R  A+
Sbjct: 292 LVSRISAI 299

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 115/248 (46%), Gaps = 27/248 (10%)
Query: 46  AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV-IETPSDIYVVMEYVKSGEL 104
           A+K LNR  I ++    +   E  I++ F HP+++ L  + + +     VV+ Y+K G+L
Sbjct: 63  AVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 120
Query: 105 FDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163
            ++I  E       +   F  Q+  G+++      VHRDL   N +LD K+ VK+ADFGL
Sbjct: 121 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 180
Query: 164 SNIMRDGHF----LKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF 217
           +  M D  F     KT    P  + A E +  + +   + DVWS GV+L+ L+  G  P+
Sbjct: 181 ARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 239
Query: 218 DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWFQA 273
            D N            + +  +L  G R L P     DP+  + +    P+    P F  
Sbjct: 240 PDVN-----------TFDITVYLLQGRRLLQPEY-CPDPLYEVMLKCWHPKAEMRPSFSE 287
Query: 274 HLPRYLAV 281
            + R  A+
Sbjct: 288 LVSRISAI 295

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 82  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 141 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 200
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 201 IYTH-QSDVWSYGVTVWELMTFGSKPYD 227

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 79  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 198 IYTH-QSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 83  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 202 IYTH-QSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 195 IYTH-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 78  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 197 IYTH-QSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 101 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 160 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 219
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 220 IYTH-QSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K L  G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++M+ +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 83  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 202 IYTH-QSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             + +G G FG V    + ++       A+K LNR  I ++    +   E  I++ F HP
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 89
Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G+++   
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 149
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSP-NYAAPEVISG 190
              VHRDL   N +LD K+ VK+ADFGL+  M D  F     KT    P  + A E +  
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
           + +   + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P
Sbjct: 210 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQP 257
Query: 250 RMLIVDPMKRITI----PEIRQHPWFQAHLPRYLAV 281
                DP+  + +    P+    P F   + R  A+
Sbjct: 258 EY-CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++M+ +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 80  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFG + ++   +  +       P  + A E I  +
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 199 IYTH-QSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 115/248 (46%), Gaps = 27/248 (10%)
Query: 46  AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV-IETPSDIYVVMEYVKSGEL 104
           A+K LNR  I ++    +   E  I++ F HP+++ L  + + +     VV+ Y+K G+L
Sbjct: 62  AVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 119
Query: 105 FDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163
            ++I  E       +   F  Q+  G+++      VHRDL   N +LD K+ VK+ADFGL
Sbjct: 120 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 164 SNIMRDGHF----LKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF 217
           +  M D  F     KT    P  + A E +  + +   + DVWS GV+L+ L+  G  P+
Sbjct: 180 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 238
Query: 218 DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWFQA 273
            D N            + +  +L  G R L P     DP+  + +    P+    P F  
Sbjct: 239 PDVN-----------TFDITVYLLQGRRLLQPEY-CPDPLYEVMLKCWHPKAEMRPSFSE 286
Query: 274 HLPRYLAV 281
            + R  A+
Sbjct: 287 LVSRISAI 294

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 79  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 198 IYTH-QSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 86  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 145 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 204
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 205 IYTH-QSDVWSYGVTVWELMTFGSKPYD 231

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++M+ +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFG + ++   +  +       P  + A E I  +
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 197 IYTH-QSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++M+ +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFG + ++   +  +       P  + A E I  +
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 197 IYTH-QSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 73  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 132 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 191
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 192 IYTH-QSDVWSYGVTVWELMTFGSKPYD 218

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 79  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 198 IYTH-QSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKI-LNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           K LG G+FG VK   + +      + + + + +  +  +++++  E  +++   +P+I+R
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +  + E  S + +VME  + G L  Y+ +   +++        Q+  G++Y   +  VHR
Sbjct: 435 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 493
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYAGPE 197
           DL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++  +
Sbjct: 494 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS-K 552
Query: 198 VDVWSCGVILY-ALLCGTLPF 217
            DVWS GV+++ A   G  P+
Sbjct: 553 SDVWSFGVLMWEAFSYGQKPY 573

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKI-LNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           K LG G+FG VK   + +      + + + + +  +  +++++  E  +++   +P+I+R
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +  + E  S + +VME  + G L  Y+ +   +++        Q+  G++Y   +  VHR
Sbjct: 436 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 494
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYAGPE 197
           DL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++  +
Sbjct: 495 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS-K 553
Query: 198 VDVWSCGVILY-ALLCGTLPF 217
            DVWS GV+++ A   G  P+
Sbjct: 554 SDVWSFGVLMWEAFSYGQKPY 574

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAI--KILNRRKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I   I   R+  + +  +++  E  ++    
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 70  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 189 IYTH-QSDVWSYGVTVWELMTFGSKPYD 215

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAI--KILNRRKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I   I   R+  + +  +++  E  ++    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 195 IYTH-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 121/267 (45%), Gaps = 24/267 (8%)
Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPH 78
           K    +G G+FG+V  A     G ++   I   ++  + +       E+++L +L  HP+
Sbjct: 25  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 84
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA----------------RNF 122
           II L    E    +Y+ +EY   G L D++ +   L+ D A                 +F
Sbjct: 85  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-N 181
              +  G++Y  +   +HR+L   N+L+   +  KIADFGLS   ++ +  KT    P  
Sbjct: 145 AADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVR 203
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PS 238
           + A E ++  +Y     DVWS GV+L+ ++  G  P+       L++K+  G Y L  P 
Sbjct: 204 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPL 261
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEI 265
           +      DL+ +     P +R +  +I
Sbjct: 262 NCDDEVYDLMRQCWREKPYERPSFAQI 288

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 30/276 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             + +G G FG V    + ++       A+K LNR  I ++    +   E  I++ F HP
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 90
Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHR 135
           +++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G++Y   
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISG 190
              VHRDL   N +LD K+ VK+ADFGL+  M D        KT    P  + A E +  
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 249
           + +   + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P
Sbjct: 211 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQP 258
Query: 250 RMLIVDPMKRITI----PEIRQHPWFQAHLPRYLAV 281
                DP+  + +    P+    P F   + R  A+
Sbjct: 259 EY-CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 19  YKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           Y++ K +G G FG+V K  +H +  H VA+K++   K        +   EI+IL      
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQH-VALKMVRNEK----RFHRQAAEEIRILEHLRKQ 153
Query: 78  ------HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDE---ARNFFQQIIS 128
                 ++I + E     + I +  E + S  L++ +++K + Q       R F   I+ 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 129 GVEYCHRNMVVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
            ++  H+N ++H DLKPEN+LL    +  +K+ DFG S       +      S  Y APE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQ--SRFYRAPE 269
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCG--TLPFDDE 220
           VI G  Y  P +D+WS G IL  LL G   LP +DE
Sbjct: 270 VILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 11/229 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           + +L + LG GSFG V+  E      K   VA+K L    +   E  +   RE+  +   
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
            H ++IRLY V+ TP  + +V E    G L D + + +G         +  Q+  G+ Y 
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYA--APEVIS 189
                +HRDL   NLLL ++  VKI DFGL   +   D H +        +A  APE + 
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + ++    D W  GV L+ +   G  P+   N   +  KI      LP
Sbjct: 198 TRTFSHAS-DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 11/229 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           + +L + LG GSFG V+  E      K   VA+K L    +   E  +   RE+  +   
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
            H ++IRLY V+ TP  + +V E    G L D + + +G         +  Q+  G+ Y 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYA--APEVIS 189
                +HRDL   NLLL ++  VKI DFGL   +   D H +        +A  APE + 
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
            + ++    D W  GV L+ +   G  P+   N   +  KI      LP
Sbjct: 188 TRTFSHAS-DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 16/218 (7%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKV----AIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           K LG G+FG V        G  V    AIK+L  R+  + +  +++  E  ++     P+
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL--RENTSPKANKEILDEAYVMAGVGSPY 80
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           + RL  +  T S + +V + +  G L D++ E +GRL   +  N+  QI  G+ Y     
Sbjct: 81  VSRLLGICLT-STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR 139
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 194
           +VHRDL   N+L+ S  +VKI DFGL+ ++        + G      + A E I  + + 
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT 199
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 228
             + DVWS GV ++ L+  G  P+D      IP+L +K
Sbjct: 200 H-QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 236

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKI-LNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           K LG G+FG VK   + +      + + + + +  +  +++++  E  +++   +P+I+R
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +  + E  S + +VME  + G L  Y+ +   +++        Q+  G++Y   +  VHR
Sbjct: 91  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 149
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYAGPE 197
           DL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++  +
Sbjct: 150 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS-K 208
Query: 198 VDVWSCGVILY-ALLCGTLPF 217
            DVWS GV+++ A   G  P+
Sbjct: 209 SDVWSFGVLMWEAFSYGQKPY 229

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKI-LNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           K LG G+FG VK   + +      + + + + +  +  +++++  E  +++   +P+I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +  + E  S + +VME  + G L  Y+ +   +++        Q+  G++Y   +  VHR
Sbjct: 93  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYAGPE 197
           DL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++  +
Sbjct: 152 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS-K 210
Query: 198 VDVWSCGVILY-ALLCGTLPF 217
            DVWS GV+++ A   G  P+
Sbjct: 211 SDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKI-LNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           K LG G+FG VK   + +      + + + + +  +  +++++  E  +++   +P+I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +  + E  S + +VME  + G L  Y+ +   +++        Q+  G++Y   +  VHR
Sbjct: 93  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYAGPE 197
           DL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++  +
Sbjct: 152 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS-K 210
Query: 198 VDVWSCGVILY-ALLCGTLPF 217
            DVWS GV+++ A   G  P+
Sbjct: 211 SDVWSFGVLMWEAFSYGQKPY 231

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKI-LNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           K LG G+FG VK   + +      + + + + +  +  +++++  E  +++   +P+I+R
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +  + E  S + +VME  + G L  Y+ +   +++        Q+  G++Y   +  VHR
Sbjct: 77  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYAGPE 197
           DL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++  +
Sbjct: 136 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS-K 194
Query: 198 VDVWSCGVILY-ALLCGTLPF 217
            DVWS GV+++ A   G  P+
Sbjct: 195 SDVWSFGVLMWEAFSYGQKPY 215

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKI-LNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           K LG G+FG VK   + +      + + + + +  +  +++++  E  +++   +P+I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +  + E  S + +VME  + G L  Y+ +   +++        Q+  G++Y   +  VHR
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYAGPE 197
           DL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++  +
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS-K 200
Query: 198 VDVWSCGVILY-ALLCGTLPF 217
            DVWS GV+++ A   G  P+
Sbjct: 201 SDVWSFGVLMWEAFSYGQKPY 221

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 103/201 (51%), Gaps = 8/201 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKI-LNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           K LG G+FG VK   + +      + + + + +  +  +++++  E  +++   +P+I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +  + E  S + +VME  + G L  Y+ +   +++        Q+  G++Y   +  VHR
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYAGPE 197
           DL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++   
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 191
Query: 198 VDVWSCGVILY-ALLCGTLPF 217
            DVWS GV+++ A   G  P+
Sbjct: 192 -DVWSFGVLMWEAFSYGQKPY 211

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKI-LNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           K LG G+FG VK   + +      + + + + +  +  +++++  E  +++   +P+I+R
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +  + E  S + +VME  + G L  Y+ +   +++        Q+  G++Y   +  VHR
Sbjct: 71  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 129
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYAGPE 197
           DL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++  +
Sbjct: 130 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SK 188
Query: 198 VDVWSCGVILY-ALLCGTLPF 217
            DVWS GV+++ A   G  P+
Sbjct: 189 SDVWSFGVLMWEAFSYGQKPY 209

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 21  LGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           LGK LG G FG V    + +   T  KVA+K +        E+EE +  E   ++ F HP
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKDFSHP 96
Query: 78  HIIRLYEV-IETPSD----IYVVMEYVKSGELFDYIVEKGRLQE-------DEARNFFQQ 125
           ++IRL  V IE  S       V++ ++K G+L  Y++   RL+             F   
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL-YSRLETGPKHIPLQTLLKFMVD 155
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NY 182
           I  G+EY      +HRDL   N +L     V +ADFGLS  +  G + +    +     +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF 217
            A E ++ ++Y   + DVW+ GV ++ +   G  P+
Sbjct: 216 IAIESLADRVYTS-KSDVWAFGVTMWEIATRGMTPY 250

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K L  G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 195 IYTH-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAI--KILNRRKIKNMEMEEKVRREIKILRLFM 75
            +K  K L  G+FG V        G KV I   I   R+  + +  +++  E  ++    
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 83  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  +
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 202 IYTH-QSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFG + ++   +  +       P  + A E I  +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 195 IYTH-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 83  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFG + ++   +  +       P  + A E I  +
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 202 IYTH-QSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFM 75
            +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T S + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 78  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFG + ++   +  +       P  + A E I  +
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFD 218
           +Y   + DVWS GV ++ L+  G+ P+D
Sbjct: 197 IYTH-QSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKI-LNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           K LG G+FG VK   + +      + + + + +  +  +++++  E  +++   +P+I+R
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +  + E  S + +VME  + G L  Y+ +   +++        Q+  G++Y   +  VHR
Sbjct: 77  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMR---DGHFLKTSCGSP-NYAAPEVISGKLYAGPE 197
           DL   N+LL ++   KI+DFGLS  +R   + +  +T    P  + APE I+   ++  +
Sbjct: 136 DLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSS-K 194
Query: 198 VDVWSCGVILY-ALLCGTLPF 217
            DVWS GV+++ A   G  P+
Sbjct: 195 SDVWSFGVLMWEAFSYGQKPY 215

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 108/234 (46%), Gaps = 25/234 (10%)
Query: 3   GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEME 61
            A  RS   +D F    ++ +  G G+FG V++ +   TG  VAIK ++   + +N E++
Sbjct: 13  AADERSRKEMDRF----QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ 68
Query: 62  EKVRREIKILRLFMHPHIIRLYEVIET-----PSDIY--VVMEYVKSGELFDYIVEKGRL 114
             + +++ +L    HP+I++L     T       DIY  VVMEYV    L        R 
Sbjct: 69  --IMQDLAVLH---HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRR 122
Query: 115 QEDEA----RNFFQQIISGVEYCH--RNMVVHRDLKPENLLL-DSKWNVKIADFGLSNIM 167
           Q        + F  Q+I  +   H     V HRD+KP N+L+ ++   +K+ DFG +  +
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221
                      S  Y APE+I G  +    VD+WS G I   ++ G   F  +N
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 121/285 (42%), Gaps = 36/285 (12%)
Query: 25  LGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           LG G+FGKV +AE H L   +    VA+K L   K  +    +  +RE ++L +  H HI
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTMLQHQHI 105
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI---------------VEKGRLQEDEARNFFQ 124
           +R + V      + +V EY++ G+L  ++               V  G L   +      
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---N 181
           Q+ +G+ Y      VHRDL   N L+     VKI DFG+S  +    + +    +     
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLP-FDDENIPNLFKKIKGGIYTLPSH 239
           +  PE I  + +   E DVWS GV+L+ +   G  P +   N   +    +G     P  
Sbjct: 226 WMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 284
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
             P    ++      +P +R +I ++  H   QA     LA  PP
Sbjct: 285 CPPEVYAIMRGCWQREPQQRHSIKDV--HARLQA-----LAQAPP 322

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 89/346 (25%), Positives = 137/346 (39%), Gaps = 100/346 (28%)
Query: 13  DMFLPNYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILN---------RRKIKNMEMEE 62
           D     Y++   LG G+FGKV +  +HA    +VA+KI+          R +I  ++  +
Sbjct: 47  DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIK 106
Query: 63  KVRREIKILRLFM------HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE 116
           +  +E K L + M      H H+   +E++   +      E++K      Y +       
Sbjct: 107 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNT-----FEFLKENNFQPYPL------- 154
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLL-----LDSKWN--------------VK 157
              R+   Q+   + + H N + H DLKPEN+L      ++ +N              ++
Sbjct: 155 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 214
Query: 158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLP 216
           +ADFG +    + H   T   + +Y  PEVI    +A P  DVWS G IL+    G TL 
Sbjct: 215 VADFGSATFDHEHH--TTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLF 271
Query: 217 FDDENIPNL--FKKIKGGIYTLPSHLSPGAR----------------------------- 245
              EN  +L   +KI G I   PSH+    R                             
Sbjct: 272 QTHENREHLVMMEKILGPI---PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL 328
Query: 246 ---------------DLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
                          DL+ RML  DP +RIT+ E   HP+F    P
Sbjct: 329 KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 374

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 89/346 (25%), Positives = 137/346 (39%), Gaps = 100/346 (28%)
Query: 13  DMFLPNYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILN---------RRKIKNMEMEE 62
           D     Y++   LG G+FGKV +  +HA    +VA+KI+          R +I  ++  +
Sbjct: 15  DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIK 74
Query: 63  KVRREIKILRLFM------HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE 116
           +  +E K L + M      H H+   +E++   +      E++K      Y +       
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNT-----FEFLKENNFQPYPL------- 122
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLL-----LDSKWN--------------VK 157
              R+   Q+   + + H N + H DLKPEN+L      ++ +N              ++
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLP 216
           +ADFG +    + H   T   + +Y  PEVI    +A P  DVWS G IL+    G TL 
Sbjct: 183 VADFGSATFDHEHH--TTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLF 239
Query: 217 FDDENIPNL--FKKIKGGIYTLPSHLSPGAR----------------------------- 245
              EN  +L   +KI G I   PSH+    R                             
Sbjct: 240 QTHENREHLVMMEKILGPI---PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL 296
Query: 246 ---------------DLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
                          DL+ RML  DP +RIT+ E   HP+F    P
Sbjct: 297 KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 342

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 121/285 (42%), Gaps = 36/285 (12%)
Query: 25  LGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           LG G+FGKV +AE H L   +    VA+K L   K  +    +  +RE ++L +  H HI
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTMLQHQHI 76
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI---------------VEKGRLQEDEARNFFQ 124
           +R + V      + +V EY++ G+L  ++               V  G L   +      
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---N 181
           Q+ +G+ Y      VHRDL   N L+     VKI DFG+S  +    + +    +     
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLP-FDDENIPNLFKKIKGGIYTLPSH 239
           +  PE I  + +   E DVWS GV+L+ +   G  P +   N   +    +G     P  
Sbjct: 197 WMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 255
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
             P    ++      +P +R +I ++  H   QA     LA  PP
Sbjct: 256 CPPEVYAIMRGCWQREPQQRHSIKDV--HARLQA-----LAQAPP 293

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 89/346 (25%), Positives = 137/346 (39%), Gaps = 100/346 (28%)
Query: 13  DMFLPNYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILN---------RRKIKNMEMEE 62
           D     Y++   LG G+FGKV +  +HA    +VA+KI+          R +I  ++  +
Sbjct: 24  DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIK 83
Query: 63  KVRREIKILRLFM------HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE 116
           +  +E K L + M      H H+   +E++   +      E++K      Y +       
Sbjct: 84  EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNT-----FEFLKENNFQPYPL------- 131
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLL-----LDSKWN--------------VK 157
              R+   Q+   + + H N + H DLKPEN+L      ++ +N              ++
Sbjct: 132 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 191
Query: 158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLP 216
           +ADFG +    + H   T   + +Y  PEVI    +A P  DVWS G IL+    G TL 
Sbjct: 192 VADFGSATFDHEHH--TTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLF 248
Query: 217 FDDENIPNL--FKKIKGGIYTLPSHLSPGAR----------------------------- 245
              EN  +L   +KI G I   PSH+    R                             
Sbjct: 249 QTHENREHLVMMEKILGPI---PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL 305
Query: 246 ---------------DLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
                          DL+ RML  DP +RIT+ E   HP+F    P
Sbjct: 306 KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 351

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 121/285 (42%), Gaps = 36/285 (12%)
Query: 25  LGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           LG G+FGKV +AE H L   +    VA+K L   K  +    +  +RE ++L +  H HI
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTMLQHQHI 82
Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI---------------VEKGRLQEDEARNFFQ 124
           +R + V      + +V EY++ G+L  ++               V  G L   +      
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---N 181
           Q+ +G+ Y      VHRDL   N L+     VKI DFG+S  +    + +    +     
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLP-FDDENIPNLFKKIKGGIYTLPSH 239
           +  PE I  + +   E DVWS GV+L+ +   G  P +   N   +    +G     P  
Sbjct: 203 WMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 261
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
             P    ++      +P +R +I ++  H   QA     LA  PP
Sbjct: 262 CPPEVYAIMRGCWQREPQQRHSIKDV--HARLQA-----LAQAPP 299

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 130/302 (43%), Gaps = 50/302 (16%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIK-----ILNRRKIKNME---MEEKVRREIKI 70
           Y + + +  GS+G V     +  G  VAIK     + + R +  +    + ++V REI++
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 71  LRLFMHPHIIRLYEVI---ETPS--DIYVVMEYVKSGELFDYIVEKGRL--QEDEARNFF 123
           L  F HP+I+ L ++    E P+   +Y+V E +++      ++   R+       + F 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQYFM 140
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYA 183
             I+ G+   H   VVHRDL P N+LL    ++ I DF L+                 Y 
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR 200
Query: 184 APEVISGKLYAGPEVDVWSCGVILY------ALLCGTLPFDDEN---------------- 221
           APE++         VD+WS G ++       AL  G+  ++  N                
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 222 --IPNLFKKIKGGIYTLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
              P+    ++  +  +P+           P A DLI +ML  +P +RI+  +  +HP+F
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
Query: 272 QA 273
           ++
Sbjct: 321 ES 322

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 130/302 (43%), Gaps = 50/302 (16%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIK-----ILNRRKIKNME---MEEKVRREIKI 70
           Y + + +  GS+G V     +  G  VAIK     + + R +  +    + ++V REI++
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 71  LRLFMHPHIIRLYEVI---ETPS--DIYVVMEYVKSGELFDYIVEKGRL--QEDEARNFF 123
           L  F HP+I+ L ++    E P+   +Y+V E +++      ++   R+       + F 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQYFM 140
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYA 183
             I+ G+   H   VVHRDL P N+LL    ++ I DF L+                 Y 
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR 200
Query: 184 APEVISGKLYAGPEVDVWSCGVILY------ALLCGTLPFDDEN---------------- 221
           APE++         VD+WS G ++       AL  G+  ++  N                
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 222 --IPNLFKKIKGGIYTLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
              P+    ++  +  +P+           P A DLI +ML  +P +RI+  +  +HP+F
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
Query: 272 QA 273
           ++
Sbjct: 321 ES 322

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 23  KTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           K LG G FG V     I E       V IK++  +     +  + V   +  +    H H
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAH 76
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           I+RL  +    S + +V +Y+  G L D++ + +G L      N+  QI  G+ Y   + 
Sbjct: 77  IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 194
           +VHR+L   N+LL S   V++ADFG+++++   D   L +   +P  + A E I    Y 
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 228
             + DVWS GV ++ L+  G  P+       +P+L +K
Sbjct: 196 H-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 35/271 (12%)
Query: 21  LGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRL 73
           L + LG GSFG V    A   + G    +VA+K +N    ++  + E++    E  +++ 
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----ESASLRERIEFLNEASVMKG 76
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------ 121
           F   H++RL  V+       VVME +  G+L  Y+    R    EA N            
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEM 132
Query: 122 --FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG 178
                +I  G+ Y +    VHRDL   N ++   + VKI DFG++ +I    ++ K   G
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKG 192
Query: 179 --SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIY 234
                + APE +   ++     D+WS GV+L+ +      P+   +   + K +  GG  
Sbjct: 193 LLPVRWMAPESLKDGVFTTSS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
             P +      DL+      +P  R T  EI
Sbjct: 252 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/315 (23%), Positives = 129/315 (40%), Gaps = 68/315 (21%)
Query: 22  GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           G  +G G++G V  A+           +   ++I+   +     REI +LR   HP++I 
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYAL---KQIEGTGISMSACREIALLRELKHPNVIS 82
Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----------LQEDEARNFFQQIISGVE 131
           L +V  + +D  V + +  +     +I++  R          L     ++   QI+ G+ 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 132 YCHRNMVVHRDLKPENLLL----DSKWNVKIADFGLSNI----MRDGHFLKTSCGSPNYA 183
           Y H N V+HRDLKP N+L+      +  VKIAD G + +    ++    L     +  Y 
Sbjct: 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCG-------------TLPFDDENIPNLFK--- 227
           APE++ G  +    +D+W+ G I   LL               + P+  + +  +F    
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262
Query: 228 ----KIKGGIYTLPSH-------------------------LSPGAR--DLIPRMLIVDP 256
               K    I  +P H                         + P ++   L+ ++L +DP
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322
Query: 257 MKRITIPEIRQHPWF 271
           +KRIT  +  Q P+F
Sbjct: 323 IKRITSEQAMQDPYF 337

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 23  KTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           K LG G FG V     I E       V IK++  +     +  + V   +  +    H H
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAH 94
Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           I+RL  +    S + +V +Y+  G L D++ + +G L      N+  QI  G+ Y   + 
Sbjct: 95  IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 194
           +VHR+L   N+LL S   V++ADFG+++++   D   L +   +P  + A E I    Y 
Sbjct: 154 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 213
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 228
             + DVWS GV ++ L+  G  P+       +P+L +K
Sbjct: 214 H-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 250

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 4/210 (1%)
Query: 36  AEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95
           AE  +    VA+K+ +     +     + +RE +       PH++ +++  E    +YV 
Sbjct: 53  AEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112
Query: 96  MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN 155
              +   +L   +  +G L    A    +QI S ++  H     HRD+KPEN+L+ +   
Sbjct: 113 XRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF 172
Query: 156 VKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG 213
             + DFG+++   D     L  + G+  Y APE  S + +A    D+++   +LY  L G
Sbjct: 173 AYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFS-ESHATYRADIYALTCVLYECLTG 231
Query: 214 TLPFDDENIPNLFKKIKGGIYTLPSHLSPG 243
           + P+  + +      I   I   PS + PG
Sbjct: 232 SPPYQGDQLSVXGAHINQAI-PRPSTVRPG 260

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 108/236 (45%), Gaps = 27/236 (11%)
Query: 7   RSSSGVDMFLPNY-------KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME 59
           R +S   +FL  +       ++G+ +G G FG+V    H     +VAI++++  +  N +
Sbjct: 16  RKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVY---HGRWHGEVAIRLIDIER-DNED 71
Query: 60  MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDE 118
             +  +RE+   R   H +++       +P  + ++    K   L+  + + K  L  ++
Sbjct: 72  QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNK 131
Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL---SNIMRDGHF--- 172
            R   Q+I+ G+ Y H   ++H+DLK +N+  D+   V I DFGL   S +++ G     
Sbjct: 132 TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDK 190
Query: 173 LKTSCGSPNYAAPEVI--------SGKLYAGPEVDVWSCGVILYALLCGTLPFDDE 220
           L+   G   + APE+I          KL      DV++ G I Y L     PF  +
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 35/271 (12%)
Query: 21  LGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRL 73
           L + LG GSFG V    A   + G    +VA+K +N    ++  + E++    E  +++ 
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----ESASLRERIEFLNEASVMKG 75
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------ 121
           F   H++RL  V+       VVME +  G+L  Y+    R    EA N            
Sbjct: 76  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEM 131
Query: 122 --FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG 178
                +I  G+ Y +    VHRDL   N ++   + VKI DFG++ +I    ++ K   G
Sbjct: 132 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 191
Query: 179 --SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIY 234
                + APE +   ++     D+WS GV+L+ +      P+   +   + K +  GG  
Sbjct: 192 LLPVRWMAPESLKDGVFTTSS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 250
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
             P +      DL+      +P  R T  EI
Sbjct: 251 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 281

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 35/271 (12%)
Query: 21  LGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRL 73
           L + LG GSFG V    A   + G    +VA+K +N    ++  + E++    E  +++ 
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----ESASLRERIEFLNEASVMKG 76
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------ 121
           F   H++RL  V+       VVME +  G+L  Y+    R    EA N            
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEM 132
Query: 122 --FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG 178
                +I  G+ Y +    VHRDL   N ++   + VKI DFG++ +I    ++ K   G
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 192
Query: 179 --SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIY 234
                + APE +   ++     D+WS GV+L+ +      P+   +   + K +  GG  
Sbjct: 193 LLPVRWMAPESLKDGVFTTSS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
             P +      DL+      +P  R T  EI
Sbjct: 252 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/328 (25%), Positives = 136/328 (41%), Gaps = 78/328 (23%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP- 77
           Y L + LG G F  V +A+  +    VA+KI+   K+      E    EIK+L+      
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDAD 76
Query: 78  ----------HIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNF 122
                     HI++L +    + P+ ++VVM +   GE    +++K     +     +  
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 123 FQQIISGVEYCHRNM-VVHRDLKPENLLL---DSKWN---VKIADFGLSNIMRDGHFLKT 175
            +Q++ G++Y HR   ++H D+KPEN+L+   DS  N   +KIAD G +    D H+   
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWYDEHY-TN 194
Query: 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF----------DDENIPNL 225
           S  +  Y +PEV+ G  + G   D+WS   +++ L+ G   F          DD++I  +
Sbjct: 195 SIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 226 FK--------KIKGGIYTLPSHLSPG------------------------------ARDL 247
            +         ++ G YT     S G                                D 
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHL 275
           +  ML +DP KR     +  HPW +  L
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDTL 341

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/328 (25%), Positives = 136/328 (41%), Gaps = 78/328 (23%)
Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP- 77
           Y L + LG G F  V +A+  +    VA+KI+   K+      E    EIK+L+      
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDAD 76
Query: 78  ----------HIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNF 122
                     HI++L +    + P+ ++VVM +   GE    +++K     +     +  
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 123 FQQIISGVEYCHRNM-VVHRDLKPENLLL---DSKWN---VKIADFGLSNIMRDGHFLKT 175
            +Q++ G++Y HR   ++H D+KPEN+L+   DS  N   +KIAD G +    D H+   
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWYDEHY-TN 194
Query: 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF----------DDENIPNL 225
           S  +  Y +PEV+ G  + G   D+WS   +++ L+ G   F          DD++I  +
Sbjct: 195 SIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 226 FK--------KIKGGIYTLPSHLSPG------------------------------ARDL 247
            +         ++ G YT     S G                                D 
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHL 275
           +  ML +DP KR     +  HPW +  L
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDTL 341

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 10  SGVDMFLPN--------YKLGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIK 56
           S  D+F+P+          + + LG GSFG V   +A+  +      +VAIK +N    +
Sbjct: 1   SAADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN----E 56
Query: 57  NMEMEEKVR--REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRL 114
              M E++    E  +++ F   H++RL  V+       V+ME +  G+L  Y+    R 
Sbjct: 57  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RS 112
Query: 115 QEDEARN--------------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160
              E  N                 +I  G+ Y + N  VHRDL   N ++   + VKI D
Sbjct: 113 LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 172
Query: 161 FGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 210
           FG++ +I    ++ K   G     + +PE +   ++     DVWS GV+L+ +
Sbjct: 173 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEI 224

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 132/295 (44%), Gaps = 49/295 (16%)
Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y+L + LG G + +V  A +     KVA+KIL   K K ++ E K+   ++       P
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLR-----GGP 92
Query: 78  HIIRLYEVIETPSDIY--VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           +II L ++++ P      +V E+V +    D+      L + + R +  +I+  ++YCH 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNT---DFKQLYQTLTDYDIRFYMYEILKALDYCHS 149
Query: 136 NMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
             ++HRD+KP N+L+D +   +++ D+GL+     G        S  +  PE++      
Sbjct: 150 MGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 209
Query: 195 GPEVDVWSCGVILYALLCGTLPF--------------------------DDENIP----- 223
              +D+WS G +L +++    PF                          D  NI      
Sbjct: 210 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 269
Query: 224 ------NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                 +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 270 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 41/235 (17%)
Query: 8   SSSGVDMFLPN--------YKLGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRK 54
           S S  D+++P+          + + LG GSFG V   +A+  +      +VAIK +N   
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--- 58
Query: 55  IKNMEMEEKVR--REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG 112
            +   M E++    E  +++ F   H++RL  V+       V+ME +  G+L  Y+    
Sbjct: 59  -EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL---- 113
Query: 113 RLQEDEARN--------------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158
           R    E  N                 +I  G+ Y + N  VHRDL   N ++   + VKI
Sbjct: 114 RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 173
Query: 159 ADFGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 210
            DFG++ +I    ++ K   G     + +PE +   ++     DVWS GV+L+ +
Sbjct: 174 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEI 227

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 104/236 (44%), Gaps = 44/236 (18%)
Query: 77  PHIIRLYEVIETPSDIY--VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           P+II L ++++ P      +V E+V +    D+   +  L + + R +  +I+  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNT---DFKQLRQTLTDYDIRFYMYEILKALDYCH 148
Query: 135 RNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
              ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++     
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 194 AGPEVDVWSCGVILYALLCGTLPF--------------------------DDENIP---- 223
               +D+WS G +L +++    PF                          D  NI     
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 224 -------NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                  +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 35/271 (12%)
Query: 21  LGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRL 73
           L + LG GSFG V    A   + G    +VA+K +N    ++  + E++    E  +++ 
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----ESASLRERIEFLNEASVMKG 76
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------ 121
           F   H++RL  V+       VVME +  G+L  Y+    R    EA N            
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEM 132
Query: 122 --FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG 178
                +I  G+ Y +    VHR+L   N ++   + VKI DFG++ +I    ++ K   G
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 192
Query: 179 --SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIY 234
                + APE +   ++     D+WS GV+L+ +      P+   +   + K +  GG  
Sbjct: 193 LLPVRWMAPESLKDGVFTTSS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
             P +      DL+      +P  R T  EI
Sbjct: 252 DQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 35/271 (12%)
Query: 21  LGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRL 73
           L + LG GSFG V    A   + G    +VA+K +N    ++  + E++    E  +++ 
Sbjct: 22  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----ESASLRERIEFLNEASVMKG 77
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------ 121
           F   H++RL  V+       VVME +  G+L  Y+    R    EA N            
Sbjct: 78  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEM 133
Query: 122 --FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG 178
                +I  G+ Y +    VHR+L   N ++   + VKI DFG++ +I    ++ K   G
Sbjct: 134 IQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 193
Query: 179 --SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIY 234
                + APE +   ++     D+WS GV+L+ +      P+   +   + K +  GG  
Sbjct: 194 LLPVRWMAPESLKDGVFTTSS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 252
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
             P +      DL+      +P  R T  EI
Sbjct: 253 DQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 283

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 10  SGVDMFLPN--------YKLGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIK 56
           S  D+++P+          + + LG GSFG V   +A+  +      +VAIK +N    +
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN----E 58
Query: 57  NMEMEEKVR--REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRL 114
              M E++    E  +++ F   H++RL  V+       V+ME +  G+L  Y+    R 
Sbjct: 59  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RS 114
Query: 115 QEDEARN--------------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160
              E  N                 +I  G+ Y + N  VHRDL   N ++   + VKI D
Sbjct: 115 LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 174
Query: 161 FGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 210
           FG++ +I    ++ K   G     + +PE +   ++     DVWS GV+L+ +
Sbjct: 175 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEI 226

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 114/271 (42%), Gaps = 35/271 (12%)
Query: 21  LGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRL 73
           L + LG GSFG V    A   + G    +VA+K +N    ++  + E++    E  +++ 
Sbjct: 18  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----ESASLRERIEFLNEASVMKG 73
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------ 121
           F   H++RL  V+       VVME +  G+L  Y+    R    EA N            
Sbjct: 74  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEM 129
Query: 122 --FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG 178
                +I  G+ Y +    VHRDL   N ++   + VKI DFG++ +I       K   G
Sbjct: 130 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKG 189
Query: 179 --SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIY 234
                + APE +   ++     D+WS GV+L+ +      P+   +   + K +  GG  
Sbjct: 190 LLPVRWMAPESLKDGVFTTSS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 248
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
             P +      DL+      +P  R T  EI
Sbjct: 249 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 279

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 10  SGVDMFLPN--------YKLGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIK 56
           S  D+++P+          + + LG GSFG V   +A+  +      +VAIK +N    +
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN----E 58
Query: 57  NMEMEEKVR--REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRL 114
              M E++    E  +++ F   H++RL  V+       V+ME +  G+L  Y+    R 
Sbjct: 59  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RS 114
Query: 115 QEDEARN--------------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160
              E  N                 +I  G+ Y + N  VHRDL   N ++   + VKI D
Sbjct: 115 LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 174
Query: 161 FGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 210
           FG++ +I    ++ K   G     + +PE +   ++     DVWS GV+L+ +
Sbjct: 175 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEI 226

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 39/232 (16%)
Query: 10  SGVDMFLPN--------YKLGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIK 56
           S  D+++P+          + + LG GSFG V   +A+  +      +VAIK +N    +
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN----E 65
Query: 57  NMEMEEKVR--REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRL 114
              M E++    E  +++ F   H++RL  V+       V+ME +  G+L  Y+     L
Sbjct: 66  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL---RSL 122
Query: 115 QEDEARN-------------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161
           +   A N                +I  G+ Y + N  VHRDL   N ++   + VKI DF
Sbjct: 123 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 182
Query: 162 GLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 210
           G++ +I    ++ K   G     + +PE +   ++     DVWS GV+L+ +
Sbjct: 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEI 233

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 10  SGVDMFLPN--------YKLGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIK 56
           S  D+++P+          + + LG GSFG V   +A+  +      +VAIK +N    +
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN----E 65
Query: 57  NMEMEEKVR--REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRL 114
              M E++    E  +++ F   H++RL  V+       V+ME +  G+L  Y+    R 
Sbjct: 66  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RS 121
Query: 115 QEDEARN--------------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160
              E  N                 +I  G+ Y + N  VHRDL   N ++   + VKI D
Sbjct: 122 LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 181
Query: 161 FGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 210
           FG++ +I    ++ K   G     + +PE +   ++     DVWS GV+L+ +
Sbjct: 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEI 233

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 114/271 (42%), Gaps = 35/271 (12%)
Query: 21  LGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRL 73
           L + LG GSFG V    A   + G    +VA+K +N    ++  + E++    E  +++ 
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----ESASLRERIEFLNEASVMKG 76
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------ 121
           F   H++RL  V+       VVME +  G+L  Y+    R    EA N            
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEM 132
Query: 122 --FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG 178
                +I  G+ Y +    VHRDL   N ++   + VKI DFG++ +I       K   G
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKG 192
Query: 179 --SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIY 234
                + APE +   ++     D+WS GV+L+ +      P+   +   + K +  GG  
Sbjct: 193 LLPVRWMAPESLKDGVFTTSS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
             P +      DL+      +P  R T  EI
Sbjct: 252 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 114/271 (42%), Gaps = 35/271 (12%)
Query: 21  LGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRL 73
           L + LG GSFG V    A   + G    +VA+K +N    ++  + E++    E  +++ 
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----ESASLRERIEFLNEASVMKG 76
Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------ 121
           F   H++RL  V+       VVME +  G+L  Y+    R    EA N            
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEM 132
Query: 122 --FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG 178
                +I  G+ Y +    VHRDL   N ++   + VKI DFG++ +I       K   G
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKG 192
Query: 179 --SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIY 234
                + APE +   ++     D+WS GV+L+ +      P+   +   + K +  GG  
Sbjct: 193 LLPVRWMAPESLKDGVFTTSS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
             P +      DL+      +P  R T  EI
Sbjct: 252 DQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 10  SGVDMFLPN--------YKLGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIK 56
           S  D+++P+          + + LG GSFG V   +A+  +      +VAIK +N    +
Sbjct: 32  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN----E 87
Query: 57  NMEMEEKVR--REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRL 114
              M E++    E  +++ F   H++RL  V+       V+ME +  G+L  Y+    R 
Sbjct: 88  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RS 143
Query: 115 QEDEARN--------------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160
              E  N                 +I  G+ Y + N  VHRDL   N ++   + VKI D
Sbjct: 144 LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 203
Query: 161 FGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 210
           FG++ +I    ++ K   G     + +PE +   ++     DVWS GV+L+ +
Sbjct: 204 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEI 255

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 44/236 (18%)
Query: 77  PHIIRLYEVIETPSDIY--VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           P+II L ++++ P      +V E+V +    D+      L + + R +  +I+  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNT---DFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 135 RNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
              ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++     
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 194 AGPEVDVWSCGVILYALLCGTLPF--------------------------DDENIP---- 223
               +D+WS G +L +++    PF                          D  NI     
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 224 -------NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                  +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 44/236 (18%)
Query: 77  PHIIRLYEVIETPSDIY--VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           P+II L ++++ P      +V E+V +    D+      L + + R +  +I+  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNT---DFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 135 RNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
              ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++     
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 194 AGPEVDVWSCGVILYALLCGTLPF--------------------------DDENIP---- 223
               +D+WS G +L +++    PF                          D  NI     
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 224 -------NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                  +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 44/236 (18%)
Query: 77  PHIIRLYEVIETPSDIY--VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           P+II L ++++ P      +V E+V +    D+      L + + R +  +I+  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNT---DFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 135 RNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
              ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++     
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 194 AGPEVDVWSCGVILYALLCGTLPF--------------------------DDENIP---- 223
               +D+WS G +L +++    PF                          D  NI     
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 224 -------NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                  +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	294
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	0.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	0.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	0.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	0.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	0.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	0.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	0.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	0.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	0.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-176
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-169
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-168
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-166
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-165
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-165
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-163
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-157
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-153
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-152
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-151
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-145
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-144
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-143
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-143
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-142
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-138
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-136
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-129
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-129
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-128
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-127
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-126
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-124
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-124
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-122
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-122
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-120
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-120
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-119
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-118
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-118
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-118
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-117
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-117
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-117
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-116
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-116
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-114
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-114
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-114
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-114
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-113
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-113
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-111
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-111
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-109
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-107
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-107
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-106
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-104
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-102
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-100
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-94
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-92
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-88
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-87
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-86
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-85
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-82
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-81
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-81
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-81
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-80
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-78
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-76
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-75
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-75
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-74
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-74
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-73
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-73
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-73
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-72
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-72
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-72
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-71
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-71
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-71
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-70
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-70
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-70
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-69
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-69
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-68
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-66
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-63
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-63
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-62
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-62
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-61
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-60
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-59
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-59
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-59
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-58
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-58
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-58
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-57
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-57
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-56
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-55
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-54
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-53
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-52
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-52
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-52
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-52
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-52
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-51
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-51
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-49
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-49
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-49
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-49
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-49
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-48
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-48
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-48
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-47
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-47
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-47
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-47
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-47
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-47
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-46
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-46
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-46
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-46
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-46
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-46
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-45
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-45
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-45
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-44
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-44
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-43
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-43
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-43
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-42
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-41
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-41
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-06
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-41
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-41
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-40
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-35
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-34
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-33
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-33
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-32
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-31
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-31
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-30
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-30
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-30
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-29
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-29
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-29
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-27
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-26
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-04
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-26
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-26
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-24
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-22
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-22
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-19
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-18
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-15
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-10
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	5e-04

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  555 bits (1433), Expect = 0.0
 Identities = 181/281 (64%), Positives = 226/281 (80%)

Query: 5   SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV 64
           + +      + + +Y LG TLG+G+FGKVK+ +H LTGHKVA+KILNR+KI+++++  K+
Sbjct: 4   AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI 63

Query: 65  RREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ 124
           RREI+ L+LF HPHII+LY+VI TPSDI++VMEYV  GELFDYI + GRL E E+R  FQ
Sbjct: 64  RREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ 123

Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA 184
           QI+SGV+YCHR+MVVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAA
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA 183

Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA 244
           PEVISG+LYAGPEVD+WS GVILYALLCGTLPFDD+++P LFKKI  GI+  P +L+P  
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243

Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
             L+  ML VDPMKR TI +IR+H WF+  LP+YL    P 
Sbjct: 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPS 284

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  543 bits (1402), Expect = 0.0
 Identities = 178/262 (67%), Positives = 222/262 (84%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++  K++REI+ L+LF HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI TP+D ++VMEYV  GELFDYI + GR++E EAR  FQQI+S V+YCHR+M
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           VVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 191

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP+
Sbjct: 192 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 251

Query: 258 KRITIPEIRQHPWFQAHLPRYL 279
           KR TI +IR+H WF+  LP YL
Sbjct: 252 KRATIKDIREHEWFKQDLPSYL 273

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  541 bits (1396), Expect = 0.0
 Identities = 174/272 (63%), Positives = 208/272 (76%), Gaps = 1/272 (0%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y + +TLG GSFGKVK+A H  T  KVA+K ++R+ +K  +M  +V REI  L+L  HP
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           HII+LY+VI TP+DI +V+EY   GELFDYIVEK R+ EDE R FFQQII  +EYCHR+ 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVI+GKLYAGPE
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE 188

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VDVWSCG++LY +L G LPFDDE IPNLFKK+   +Y +P  LSPGA+ LI RM++ DPM
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPM 248

Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
           +RITI EIR+ PWF  +LP YL          
Sbjct: 249 QRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 280

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  530 bits (1368), Expect = 0.0
 Identities = 131/283 (46%), Positives = 192/283 (67%), Gaps = 1/283 (0%)

Query: 3   GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
           G S  S +     + NY+L KT+G G+F KVK+A H LTG +VAIKI+++ ++    ++ 
Sbjct: 1   GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ- 59

Query: 63  KVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNF 122
           K+ RE++I+++  HP+I++L+EVIET   +Y++MEY   GE+FDY+V  GR++E EAR+ 
Sbjct: 60  KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119

Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY 182
           F+QI+S V+YCH+  +VHRDLK ENLLLD+  N+KIADFG SN    G  L   CG+P Y
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPY 179

Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
           AAPE+  GK Y GPEVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S 
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239

Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
              +L+ R L+++P+KR T+ +I +  W  A        P  +
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVE 282

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  517 bits (1334), Expect = 0.0
 Identities = 116/281 (41%), Positives = 154/281 (54%), Gaps = 12/281 (4%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
              Y   K +G G+FG  ++    LT   VA+K + R       ++E V+REI   R   
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLR 74

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+R  EVI TP+ + ++MEY   GEL++ I   GR  EDEAR FFQQ++SGV YCH 
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134

Query: 136 NMVVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
             + HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV+  + Y
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEY 194

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK----IKGGIYTLPS--HLSPGARDL 247
            G   DVWSCGV LY +L G  PF+D   P  ++K    I    Y++P    +SP    L
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254

Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288
           I R+ + DP  RI+IPEI+ H WF  +LP  L        Q
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQ 295

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  513 bits (1324), Expect = 0.0
 Identities = 92/278 (33%), Positives = 159/278 (57%), Gaps = 8/278 (2%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R       L   CG+  Y APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLP-SHLSPGARDLI 248
            +    VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDT 286
            ++L+ +P  RITIP+I++  W+   L +    P   +
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS 280

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  511 bits (1318), Expect = 0.0
 Identities = 92/274 (33%), Positives = 158/274 (57%), Gaps = 8/274 (2%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++   ++  E +++EI I ++ 
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R       L   CG+  Y APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLP-SHLSPGARDLI 248
            +    VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 282
            ++L+ +P  RITIP+I++  W+   L +    P
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  503 bits (1298), Expect = 0.0
 Identities = 105/289 (36%), Positives = 163/289 (56%), Gaps = 14/289 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKILRLFMH 76
            Y +G  LG GS+GKVK    + T  + A+KIL ++K++ +   E  V++EI++LR   H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 77  PHIIRLYEVI--ETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
            ++I+L +V+  E    +Y+VMEY   G  E+ D +  + R    +A  +F Q+I G+EY
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEY 124

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNYAAPEVIS 189
            H   +VH+D+KP NLLL +   +KI+  G++  +         +TS GSP +  PE+ +
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 190 G-KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLI 248
           G   ++G +VD+WS GV LY +  G  PF+ +NI  LF+ I  G Y +P    P   DL+
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLL 244

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPP----PDTMQQAKKV 293
             ML  +P KR +I +IRQH WF+   P   A  P    PDT  + + +
Sbjct: 245 KGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSM 293

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  487 bits (1255), Expect = e-176
 Identities = 102/280 (36%), Positives = 144/280 (51%), Gaps = 8/280 (2%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y  G+ LG G F K      A T    A KI+ +  +      EK+  EI I R   H 
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           H++  +   E    ++VV+E  +   L +    +  L E EAR + +QI+ G +Y HRN 
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
           V+HRDLK  NL L+    VKI DFGL+  +  DG   K  CG+PNY APEV+S K +   
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SF 194

Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
           EVDVWS G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 254

Query: 257 MKRITIPEIRQHPWFQAHL------PRYLAVPPPDTMQQA 290
             R TI E+    +F +           L +PP  ++  +
Sbjct: 255 TARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPS 294

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  471 bits (1213), Expect = e-169
 Identities = 103/282 (36%), Positives = 142/282 (50%), Gaps = 7/282 (2%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y  G+ LG G F K      A T    A KI+ +  +      EK+  EI I R   H 
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           H++  +   E    ++VV+E  +   L +    +  L E EAR + +QI+ G +Y HRN 
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
           V+HRDLK  NL L+    VKI DFGL+  +  DG   K  CG+PNY APEV+S K +   
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SF 220

Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
           EVDVWS G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 280

Query: 257 MKRITIPEIRQHPWFQAH-----LPRYLAVPPPDTMQQAKKV 293
             R TI E+    +F +      LP      PP        +
Sbjct: 281 TARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSL 322

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  466 bits (1202), Expect = e-168
 Identities = 104/297 (35%), Positives = 161/297 (54%), Gaps = 31/297 (10%)

Query: 6   NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI---------- 55
           +  SSG  + L  Y L   +G GS+G VK+A +       A+K+L+++K+          
Sbjct: 2   SSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61

Query: 56  -------------KNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--IYVVMEYVK 100
                        +     E+V +EI IL+   HP++++L EV++ P++  +Y+V E V 
Sbjct: 62  PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVN 121

Query: 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160
            G + + +     L ED+AR +FQ +I G+EY H   ++HRD+KP NLL+    ++KIAD
Sbjct: 122 QGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIAD 180

Query: 161 FGLSNIMRDGH-FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPF 217
           FG+SN  +     L  + G+P + APE +S   K+++G  +DVW+ GV LY  + G  PF
Sbjct: 181 FGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 218 DDENIPNLFKKIKGGIYTLPSH--LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            DE I  L  KIK      P    ++   +DLI RML  +P  RI +PEI+ HPW  
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  462 bits (1191), Expect = e-166
 Identities = 88/296 (29%), Positives = 143/296 (48%), Gaps = 15/296 (5%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--- 57
           +           +     Y++G  LG G FG V           VAIK + + +I +   
Sbjct: 27  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 86

Query: 58  MEMEEKVRREIKILRLFMH--PHIIRLYEVIETPSDIYVVMEYVK-SGELFDYIVEKGRL 114
           +    +V  E+ +L+        +IRL +  E P    +++E  +   +LFD+I E+G L
Sbjct: 87  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 146

Query: 115 QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFL 173
           QE+ AR+FF Q++  V +CH   V+HRD+K EN+L+D  +  +K+ DFG   +++D    
Sbjct: 147 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-Y 205

Query: 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI 233
               G+  Y+ PE I    Y G    VWS G++LY ++CG +PF+ +      ++I  G 
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQ 259

Query: 234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ-AHLPRYLAVPPPDTMQ 288
                 +S   + LI   L + P  R T  EI+ HPW Q   LP+  A     ++ 
Sbjct: 260 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLS 315

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  461 bits (1189), Expect = e-165
 Identities = 80/274 (29%), Positives = 125/274 (45%), Gaps = 12/274 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILR 72
            Y     LG G+FG V  A       +V +K + + K+            KV  EI IL 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSG-ELFDYIVEKGRLQEDEARNFFQQIISGVE 131
              H +II++ ++ E      +VME   SG +LF +I    RL E  A   F+Q++S V 
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           Y     ++HRD+K EN+++   + +K+ DFG +  +  G    T CG+  Y APEV+ G 
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGN 204

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
            Y GPE+++WS GV LY L+    PF +       ++        P  +S     L+  +
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLVSGL 258

Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
           L   P +R T+ ++   PW    +          
Sbjct: 259 LQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEV 292

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  459 bits (1184), Expect = e-165
 Identities = 98/270 (36%), Positives = 155/270 (57%), Gaps = 3/270 (1%)

Query: 9   SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI 68
           ++ +   + ++K+G  LG GSF  V  AE   TG +VAIK+++++ +    M ++V+ E+
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62

Query: 69  KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQII 127
           KI     HP I+ LY   E  + +Y+V+E   +GE+  Y+  +     E+EAR+F  QII
Sbjct: 63  KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPE 186
           +G+ Y H + ++HRDL   NLLL    N+KIADFGL+  +        T CG+PNY +PE
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182

Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARD 246
           + +   + G E DVWS G + Y LL G  PFD + + N   K+    Y +PS LS  A+D
Sbjct: 183 IATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD 241

Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
           LI ++L  +P  R+++  +  HP+   +  
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  454 bits (1171), Expect = e-163
 Identities = 91/286 (31%), Positives = 136/286 (47%), Gaps = 16/286 (5%)

Query: 8   SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN---MEMEEKV 64
                + F   Y+LG  LG G FG V          +VAIK++ R ++     +      
Sbjct: 22  GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81

Query: 65  RREIKILRL----FMHPHIIRLYEVIETPSDIYVVMEYVKSG-ELFDYIVEKGRLQEDEA 119
             E+ +L        HP +IRL +  ET     +V+E      +LFDYI EKG L E  +
Sbjct: 82  PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS 141

Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCG 178
           R FF Q+++ +++CH   VVHRD+K EN+L+D +    K+ DFG   ++ D  +     G
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-TDFDG 200

Query: 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS 238
           +  Y+ PE IS   Y      VWS G++LY ++CG +PF+ +      ++I       P+
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPA 254

Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
           H+SP    LI R L   P  R ++ EI   PW Q         P  
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSK 300

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  437 bits (1127), Expect = e-157
 Identities = 94/276 (34%), Positives = 154/276 (55%), Gaps = 4/276 (1%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + ++ +G+ LG G FG V +A        +A+K+L + +++   +E ++RREI+I     
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+R+Y        IY+++E+   GEL+  + + GR  E  +  F +++   + YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLL+  K  +KIADFG S +       +T CG+ +Y  PE+I GK +  
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTH-D 190

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+W  GV+ Y  L G  PFD  +     ++I       P  LS G++DLI ++L   
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYH 250

Query: 256 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 291
           P +R+ +  + +HPW +A+  R L  PP     Q+K
Sbjct: 251 PPQRLPLKGVMEHPWVKANSRRVL--PPVYQSTQSK 284

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  431 bits (1111), Expect = e-153
 Identities = 70/332 (21%), Positives = 135/332 (40%), Gaps = 47/332 (14%)

Query: 6   NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME------ 59
           N+     D ++ +Y++ +TL  G F K+ + E        A+K   +  ++         
Sbjct: 20  NKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSN 77

Query: 60  --------MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK 111
                     +  + E++I+    + + +    +I    ++Y++ EY+++  +  +    
Sbjct: 78  NDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF 137

Query: 112 GRLQ--------EDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDSKWNVKIADFG 162
             L             +   + +++   Y H    + HRD+KP N+L+D    VK++DFG
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG 197

Query: 163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDE- 220
            S  M D   +K S G+  +  PE  S +  Y G +VD+WS G+ LY +    +PF  + 
Sbjct: 198 ESEYMVDKK-IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256

Query: 221 NIPNLFKKIKGGIYTLP-------------------SHLSPGARDLIPRMLIVDPMKRIT 261
           ++  LF  I+      P                   + LS    D +   L  +P +RIT
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316

Query: 262 IPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV 293
             +  +H W        L     +  ++ KK+
Sbjct: 317 SEDALKHEWLADTNIEDLREFSKELYKKRKKL 348

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  428 bits (1102), Expect = e-152
 Identities = 106/273 (38%), Positives = 152/273 (55%), Gaps = 16/273 (5%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI-----KNMEMEEKVRREIK 69
               Y + KTLG G+ G+VK+A    T  KVAIKI+++RK      +  +    V  EI+
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67

Query: 70  ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           IL+   HP II++    +   D Y+V+E ++ GELFD +V   RL+E   + +F Q++  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126

Query: 130 VEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
           V+Y H N ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186

Query: 187 VISGKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLPS----H 239
           V+     A     VD WS GVIL+  L G  PF +     +L  +I  G Y         
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246

Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           +S  A DL+ ++L+VDP  R T  E  +HPW Q
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  422 bits (1088), Expect = e-151
 Identities = 87/274 (31%), Positives = 153/274 (55%), Gaps = 2/274 (0%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++  
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMH-D 185

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245

Query: 256 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
           P +R  + E+ +HPW  A+  +       ++  +
Sbjct: 246 PSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  407 bits (1049), Expect = e-145
 Identities = 113/279 (40%), Positives = 159/279 (56%), Gaps = 9/279 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           NY + + LG G+F  V+   H  TG + A KI+N +K+   + + K+ RE +I R   HP
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHP 65

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+RL++ I+  S  Y+V + V  GELF+ IV +    E +A +  QQI+  + YCH N 
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125

Query: 138 VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
           +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+    Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 184

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
              VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ LI  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244

Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
           ML V+P KRIT  +  + PW         A+   DT+  
Sbjct: 245 MLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC 283

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  407 bits (1049), Expect = e-144
 Identities = 103/273 (37%), Positives = 149/273 (54%), Gaps = 15/273 (5%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----MEMEEKVRREIK 69
           F   Y     +G G    V+   H  TGH+ A+KI+     +       E+ E  RRE  
Sbjct: 92  FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151

Query: 70  ILR-LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
           ILR +  HPHII L +  E+ S +++V + ++ GELFDY+ EK  L E E R+  + ++ 
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
            V + H N +VHRDLKPEN+LLD    ++++DFG S  +  G  L+  CG+P Y APE++
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271

Query: 189 SGKLYA-----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----H 239
              +       G EVD+W+CGVIL+ LL G+ PF       + + I  G Y   S     
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331

Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            S   +DLI R+L VDP  R+T  +  QHP+F+
Sbjct: 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  409 bits (1052), Expect = e-143
 Identities = 107/287 (37%), Positives = 155/287 (54%), Gaps = 16/287 (5%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI----- 55
            D   +  S         Y + KTLG G+ G+VK+A    T  KVAI+I+++RK      
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178

Query: 56  KNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ 115
           +  +    V  EI+IL+   HP II++    +   D Y+V+E ++ GELFD +V   RL+
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLK 237

Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHF 172
           E   + +F Q++  V+Y H N ++HRDLKPEN+LL S+     +KI DFG S I+ +   
Sbjct: 238 EATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297

Query: 173 LKTSCGSPNYAAPEVISGKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKI 229
           ++T CG+P Y APEV+     A     VD WS GVIL+  L G  PF +     +L  +I
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357

Query: 230 KGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
             G Y         +S  A DL+ ++L+VDP  R T  E  +HPW Q
Sbjct: 358 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  402 bits (1036), Expect = e-143
 Identities = 104/269 (38%), Positives = 154/269 (57%), Gaps = 12/269 (4%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
               Y L  T+G GS+G+VKIA    T  + A K + +  +++    ++ ++EI+I++  
Sbjct: 7   INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSL 63

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+IIRLYE  E  +DIY+VME    GELF+ +V K   +E +A    + ++S V YCH
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123

Query: 135 RNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           +  V HRDLKPEN L  +      +K+ DFGL+   + G  ++T  G+P Y +P+V+ G 
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 183

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
            Y GPE D WS GV++Y LLCG  PF       +  KI+ G +T P     ++SP A  L
Sbjct: 184 -Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241

Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
           I R+L   P +RIT  +  +H WF+  L 
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLS 270

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  401 bits (1033), Expect = e-142
 Identities = 102/281 (36%), Positives = 150/281 (53%), Gaps = 16/281 (5%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN------MEMEEKVRREI 68
           F  NY+  + LG G    V+   H  T  + A+KI++     +       E+ E   +E+
Sbjct: 15  FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74

Query: 69  KILR-LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
            ILR +  HP+II+L +  ET +  ++V + +K GELFDY+ EK  L E E R   + ++
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
             +   H+  +VHRDLKPEN+LLD   N+K+ DFG S  +  G  L+  CG+P+Y APE+
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

Query: 188 ISGKLYA-----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---- 238
           I   +       G EVD+WS GVI+Y LL G+ PF       + + I  G Y   S    
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254

Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279
             S   +DL+ R L+V P KR T  E   HP+FQ ++   +
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  394 bits (1014), Expect = e-138
 Identities = 116/285 (40%), Positives = 162/285 (56%), Gaps = 9/285 (3%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F  NY + + LG G+F  V+   H  TG + A KI+N +K+   + + K+ RE +I R  
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKL 85

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I+RL++ I+  S  Y+V + V  GELF+ IV +    E +A +  QQI+  + YCH
Sbjct: 86  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145

Query: 135 RNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
            N +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+   
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
            Y    VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264

Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           I  ML V+P KRIT  +  + PW         A+   DT+   KK
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKK 309

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  385 bits (990), Expect = e-136
 Identities = 84/264 (31%), Positives = 138/264 (52%), Gaps = 14/264 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +   + LG G+FG V + E   +G +  IK +N+ + +     E++  EI++L+   HP+
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPN 81

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCH 134
           II+++EV E   ++Y+VME  + GEL + IV        L E       +Q+++ + Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 135 RNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
              VVH+DLKPEN+L         +KI DFGL+ + +       + G+  Y APEV    
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD 201

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---HLSPGARDLI 248
           +    + D+WS GV++Y LL G LPF   ++  + +K              L+P A DL+
Sbjct: 202 V--TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL 259

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQ 272
            +ML  DP +R +  ++  H WF+
Sbjct: 260 KQMLTKDPERRPSAAQVLHHEWFK 283

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  381 bits (979), Expect = e-129
 Identities = 82/303 (27%), Positives = 125/303 (41%), Gaps = 39/303 (12%)

Query: 7   RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR 66
           RS S        +++ + LG G FG V    H  TG +VAIK   +      +  E+   
Sbjct: 4   RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCL 61

Query: 67  EIKILRLFMHPHIIRLYEVIETPSDI------YVVMEYVKSGELFDYIVEKGR---LQED 117
           EI+I++   HP+++   EV +    +       + MEY + G+L  Y+ +      L+E 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121

Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLK 174
             R     I S + Y H N ++HRDLKPEN++L         KI D G +  +  G    
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181

Query: 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-KKIKGGI 233
              G+  Y APE++  K Y    VD WS G + +  + G  PF     P  +  K++   
Sbjct: 182 EFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240

Query: 234 Y-------------------TLPSHLSPGARDLIPR----MLIVDPMKRITIPEIRQHPW 270
                                 P+HLS      + R    ML+    +R T P+      
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300

Query: 271 FQA 273
           FQA
Sbjct: 301 FQA 303

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  368 bits (947), Expect = e-129
 Identities = 68/306 (22%), Positives = 114/306 (37%), Gaps = 47/306 (15%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            + L   LG G+   V    H  TG   AIK+ N          +   RE ++L+   H 
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHK 67

Query: 78  HIIRLYEVIE--TPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEY 132
           +I++L+ + E  T     ++ME+   G L+  + E      L E E     + ++ G+ +
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 133 CHRNMVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
              N +VHR++KP N++     D +   K+ DFG +  + D     +  G+  Y  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 189 SGKLYA-------GPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGGIYT-- 235
              +         G  VD+WS GV  Y    G+LPF     P     +  KI  G  +  
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 236 -------------------LPSHLSPGARD----LIPRMLIVDPMKRITIPEIRQHPWFQ 272
                              +   LS G +     ++  +L  D  K     +        
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

Query: 273 AHLPRY 278
            H    
Sbjct: 308 LHRGNS 313

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  366 bits (942), Expect = e-128
 Identities = 105/267 (39%), Positives = 158/267 (59%), Gaps = 10/267 (3%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F   Y +   LG GSFG+V   +  +T  + A+K++N+   KN +    + RE+++L+  
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKL 78

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+I++L+E++E  S  Y+V E    GELFD I+++ R  E +A    +Q+ SG+ Y H
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138

Query: 135 RNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           ++ +VHRDLKPEN+LL+SK    ++KI DFGLS   +    +K   G+  Y APEV+ G 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
            Y   + DVWS GVILY LL GT PF  +N  ++ K+++ G Y         +S  A+DL
Sbjct: 199 -Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274
           I +ML   P  RIT  +  +HPW Q +
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  366 bits (940), Expect = e-127
 Identities = 85/311 (27%), Positives = 134/311 (43%), Gaps = 22/311 (7%)

Query: 2   DGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME 61
           D AS+ ++  + +    Y + K +G G   KV    +       AIK +N  +  N  ++
Sbjct: 41  DKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD 99

Query: 62  EKVRREIKILRLFMHP--HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
              R EI  L         IIRLY+   T   IY+VME     +L  ++ +K  +   E 
Sbjct: 100 -SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWER 157

Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTS 176
           +++++ ++  V   H++ +VH DLKP N L+     +K+ DFG++N M+         + 
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 216

Query: 177 CGSPNYAAPEVISG----------KLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPN 224
            G+ NY  PE I            K    P+ DVWS G ILY +  G  PF      I  
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276

Query: 225 LFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPP 283
           L   I        P       +D++   L  DP +RI+IPE+  HP+ Q        +  
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336

Query: 284 PDTMQQAKKVG 294
             T +    +G
Sbjct: 337 GTTEEMKYVLG 347

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  362 bits (931), Expect = e-126
 Identities = 80/273 (29%), Positives = 122/273 (44%), Gaps = 22/273 (8%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y + K +G G   KV    +       AIK +N  +  N  ++   R EI  L      
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQH 86

Query: 78  --HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
              IIRLY+   T   IY+VME   + +L  ++ +K  +   E +++++ ++  V   H+
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISG-- 190
           + +VH DLKP N L+     +K+ DFG++N M+         +  G+ NY  PE I    
Sbjct: 146 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 191 --------KLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGI-YTLPSH 239
                   K    P+ DVWS G ILY +  G  PF      I  L   I        P  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264

Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  358 bits (921), Expect = e-124
 Identities = 81/295 (27%), Positives = 127/295 (43%), Gaps = 22/295 (7%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y + K +G G   KV    +       AIK +N  +  N  ++   R EI  L      
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQH 67

Query: 78  --HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
              IIRLY+   T   IY+VME   + +L  ++ +K  +   E +++++ ++  V   H+
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKL 192
           + +VH DLKP N L+     +K+ DFG++N M+         +  G+ NY  PE I    
Sbjct: 127 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 193 YA----------GPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGI-YTLPSH 239
            +           P+ DVWS G ILY +  G  PF      I  L   I        P  
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245

Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKVG 294
                +D++   L  DP +RI+IPE+  HP+ Q        +    T +    +G
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 300

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  359 bits (923), Expect = e-124
 Identities = 68/305 (22%), Positives = 115/305 (37%), Gaps = 47/305 (15%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            + L   LG G+   V    H  TG   AIK+ N      +   +   RE ++L+   H 
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHK 67

Query: 78  HIIRLYEVIE--TPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEY 132
           +I++L+ + E  T     ++ME+   G L+  + E      L E E     + ++ G+ +
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 133 CHRNMVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
              N +VHR++KP N++     D +   K+ DFG +  + D     +  G+  Y  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 189 SGKLYA-------GPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGGIYT-- 235
              +         G  VD+WS GV  Y    G+LPF     P     +  KI  G  +  
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 236 -------------------LPSHLSPGARD----LIPRMLIVDPMKRITIPEIRQHPWFQ 272
                              +   LS G +     ++  +L  D  K     +        
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

Query: 273 AHLPR 277
            H   
Sbjct: 308 LHRMV 312

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  350 bits (900), Expect = e-122
 Identities = 102/262 (38%), Positives = 147/262 (56%), Gaps = 12/262 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            +   + LG G+F +V + +  LTG   A+K + +        +  +  EI +L+   H 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+ L ++ E+ +  Y+VM+ V  GELFD I+E+G   E +A    QQ++S V+Y H N 
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126

Query: 138 VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
           +VHRDLKPENLL  +      + I DFGLS + ++G  + T+CG+P Y APEV++ K Y 
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPY- 184

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
              VD WS GVI Y LLCG  PF +E    LF+KIK G Y   S     +S  A+D I  
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244

Query: 251 MLIVDPMKRITIPEIRQHPWFQ 272
           +L  DP +R T  +   HPW  
Sbjct: 245 LLEKDPNERYTCEKALSHPWID 266

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  355 bits (912), Expect = e-122
 Identities = 109/265 (41%), Positives = 156/265 (58%), Gaps = 10/265 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y+L + LG G+F  V+     L G + A  I+N +K+   +  +K+ RE +I RL  HP
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHP 70

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+RL++ I      Y++ + V  GELF+ IV +    E +A +  QQI+  V +CH+  
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 138 VVHRDLKPENLLLDSKWN---VKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLY 193
           VVHR+LKPENLLL SK     VK+ADFGL+  +  +        G+P Y +PEV+    Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 249
            G  VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A+DLI 
Sbjct: 191 -GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249

Query: 250 RMLIVDPMKRITIPEIRQHPWFQAH 274
           +ML ++P KRIT  E  +HPW    
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHR 274

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  344 bits (884), Expect = e-120
 Identities = 97/268 (36%), Positives = 150/268 (55%), Gaps = 12/268 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRLF 74
           +Y++G+ LG G F  V+      TG + A K + +R++ +       E++ RE+ ILR  
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP+II L+++ E  +D+ +++E V  GELFD++ EK  L EDEA  F +QI+ GV Y H
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125

Query: 135 RNMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
              + H DLKPEN++L  K      +K+ DFG+++ +  G+  K   G+P + APE+++ 
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 185

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARD 246
           +   G E D+WS GVI Y LL G  PF  E        I    Y        + S  A+D
Sbjct: 186 EPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 244

Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274
            I R+L+ DP +R+TI +  +H W +A 
Sbjct: 245 FIRRLLVKDPKRRMTIAQSLEHSWIKAI 272

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  351 bits (902), Expect = e-120
 Identities = 109/274 (39%), Positives = 161/274 (58%), Gaps = 9/274 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            YK  + LG GSFG+V + +  +TG + A+K++++R++K    +E + RE+++L+   HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++LYE  E     Y+V E    GELFD I+ + R  E +A    +Q++SG+ Y H+N 
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 138 VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
           +VHRDLKPENLLL+SK    N++I DFGLS        +K   G+  Y APEV+ G  Y 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-Y- 204

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
             + DVWS GVILY LL G  PF+  N  ++ KK++ G YT        +S  A+DLI +
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264

Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
           ML   P  RI+  +   H W Q +    ++V  P
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  344 bits (884), Expect = e-119
 Identities = 100/288 (34%), Positives = 156/288 (54%), Gaps = 16/288 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKILRLFMH 76
           Y+L + +G G F  V+   +  TG + A+KI++  K  +      E ++RE  I  +  H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ----EDEARNFFQQIISGVEY 132
           PHI+ L E   +   +Y+V E++   +L   IV++        E  A ++ +QI+  + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 133 CHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVI 188
           CH N ++HRD+KP  +LL SK N   VK+  FG++  +   G       G+P++ APEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGA 244
             + Y G  VDVW CGVIL+ LL G LPF       LF+ I  G Y +      H+S  A
Sbjct: 206 KREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESA 263

Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           +DL+ RML++DP +RIT+ E   HPW +        +  P+T++Q +K
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRK 311

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  341 bits (876), Expect = e-118
 Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 39/291 (13%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           +  +++    LG G+FG+V  A +AL     AIK +   +    E    +  E+ +L   
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASL 59

Query: 75  MHPHIIRLYEV-------------IETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEAR 120
            H +++R Y               ++  S +++ MEY ++G L+D I  +    Q DE  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS---------------N 165
             F+QI+  + Y H   ++HRDLKP N+ +D   NVKI DFGL+               N
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL 225
           +      L ++ G+  Y A EV+ G  +   ++D++S G+I + ++            N+
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNI 237

Query: 226 FKKIKGGIYTLPSHL----SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            KK++      P           + +I  ++  DP KR     +    W  
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  342 bits (880), Expect = e-118
 Identities = 98/284 (34%), Positives = 150/284 (52%), Gaps = 12/284 (4%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRLFM 75
           Y +G+ LG G F  VK      TG + A K + +R+ +        E++ RE+ ILR  +
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+II L++V E  +D+ +++E V  GELFD++ +K  L E+EA +F +QI+ GV Y H 
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133

Query: 136 NMVVHRDLKPENLLLDSK----WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        I    Y          S  A+D 
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDF 252

Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 291
           I ++L+ +  KR+TI E  +HPW      +   V     +    
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLEN 296

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  340 bits (875), Expect = e-118
 Identities = 97/284 (34%), Positives = 150/284 (52%), Gaps = 12/284 (4%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRLFM 75
           Y +G+ LG G F  VK      TG + A K + +R+ +        E++ RE+ ILR  +
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           H ++I L++V E  +D+ +++E V  GELFD++ +K  L E+EA +F +QI+ GV Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133

Query: 136 NMVVHRDLKPENLLLDSK----WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        I    Y        H S  A+D 
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDF 252

Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 291
           I ++L+ +  KR+TI E  +HPW      +   V     +    
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  340 bits (874), Expect = e-117
 Identities = 99/267 (37%), Positives = 147/267 (55%), Gaps = 12/267 (4%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132

Query: 136 NMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN++L  +      +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y        + S  A+D 
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251

Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274
           I R+L+ DP KR+TI +  QHPW +  
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWIKPK 278

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  340 bits (874), Expect = e-117
 Identities = 94/271 (34%), Positives = 141/271 (52%), Gaps = 21/271 (7%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
           F   Y++ + +G+GS+   K   H  T  + A+KI+++ K            EI+IL R 
Sbjct: 20  FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRY 72

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
             HP+II L +V +    +YVV E +K GEL D I+ +    E EA      I   VEY 
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 134 HRNMVVHRDLKPENLLLDSK----WNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVI 188
           H   VVHRDLKP N+L   +     +++I DFG +  +R +   L T C + N+ APEV+
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFD---DENIPNLFKKIKGGIYTLPS----HLS 241
             + Y     D+WS GV+LY +L G  PF    D+    +  +I  G ++L       +S
Sbjct: 193 ERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251

Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
             A+DL+ +ML VDP +R+T   + +HPW  
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  345 bits (886), Expect = e-117
 Identities = 104/279 (37%), Positives = 161/279 (57%), Gaps = 10/279 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y +   LG GSFG+V   +  +T  + A+K++N+   KN +    + RE+++L+   HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++L+E++E  S  Y+V E    GELFD I+++ R  E +A    +Q+ SG+ Y H++ 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 138 VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
           +VHRDLKPEN+LL+SK    ++KI DFGLS   +    +K   G+  Y APEV+ G  Y 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y- 199

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
             + DVWS GVILY LL GT PF  +N  ++ K+++ G Y         +S  A+DLI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
           ML   P  RIT  +  +HPW Q +      +    +++ 
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLES 298

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  338 bits (869), Expect = e-116
 Identities = 110/266 (41%), Positives = 155/266 (58%), Gaps = 14/266 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +++   LG G+   V   +   T    A+K+L +        ++ VR EI +L    HP+
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPN 109

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           II+L E+ ETP++I +V+E V  GELFD IVEKG   E +A +  +QI+  V Y H N +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169

Query: 139 VHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           VHRDLKPENLL  +      +KIADFGLS I+     +KT CG+P Y APE++ G  Y G
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-G 228

Query: 196 PEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
           PEVD+WS G+I Y LLCG  PF DE     +F++I    Y   S     +S  A+DL+ +
Sbjct: 229 PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288

Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLP 276
           ++++DP KR+T  +  QHPW      
Sbjct: 289 LIVLDPKKRLTTFQALQHPWVTGKAA 314

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  337 bits (867), Expect = e-116
 Identities = 90/311 (28%), Positives = 137/311 (44%), Gaps = 54/311 (17%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFM 75
            Y L   +G GS+G V++A    T    AIKI+N+ KI+  N +  E+++ E+++++   
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ-------------------- 115
           HP+I RLYEV E    I +VME    G L D +                           
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146

Query: 116 --------------------EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-- 153
                               E    N  +QI S + Y H   + HRD+KPEN L  +   
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206

Query: 154 WNVKIADFGLSNIMR-----DGHFLKTSCGSPNYAAPEVISGKLYA-GPEVDVWSCGVIL 207
           + +K+ DFGLS         + + + T  G+P + APEV++    + GP+ D WS GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 208 YALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIP 263
           + LL G +PF   N  +   ++        +     LSP ARDL+  +L  +  +R    
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326

Query: 264 EIRQHPWFQAH 274
              QHPW    
Sbjct: 327 RALQHPWISQF 337

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  331 bits (852), Expect = e-114
 Identities = 87/285 (30%), Positives = 133/285 (46%), Gaps = 13/285 (4%)

Query: 19  YKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMH 76
           Y L  K LG G F  V+      TG + A K L +R+    +   ++  EI +L      
Sbjct: 30  YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSC 88

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCH 134
           P +I L+EV E  S+I +++EY   GE+F   + +    + E++     +QI+ GV Y H
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 135 RNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           +N +VH DLKP+N+LL S     ++KI DFG+S  +     L+   G+P Y APE+++  
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
                  D+W+ G+I Y LL  T PF  E+    +  I              +S  A D 
Sbjct: 209 PI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDF 267

Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           I  +L+ +P KR T      H W Q      L  P   +     +
Sbjct: 268 IQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQ 312

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  331 bits (851), Expect = e-114
 Identities = 95/272 (34%), Positives = 141/272 (51%), Gaps = 23/272 (8%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHP 77
               K LG GSF   +   H  +    A+KI+++R       E   ++EI  L     HP
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHP 66

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++L+EV       ++VME +  GELF+ I +K    E EA    ++++S V + H   
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126

Query: 138 VVHRDLKPENLLLDSKW---NVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLY 193
           VVHRDLKPENLL   +     +KI DFG + +   D   LKT C + +YAAPE+++   Y
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNLFKKIKGGIYTLPS----HLSP 242
                D+WS GVILY +L G +PF   +          + KKIK G ++       ++S 
Sbjct: 187 -DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245

Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
            A+DLI  +L VDP KR+ +  +R + W Q  
Sbjct: 246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  337 bits (866), Expect = e-114
 Identities = 104/279 (37%), Positives = 161/279 (57%), Gaps = 10/279 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+  K LG G++G+V +    +T  + AIKI+ +  +       K+  E+ +L+L  HP+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPN 97

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I++LY+  E   + Y+VME  K GELFD I+ + +  E +A    +Q++SGV Y H++ +
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157

Query: 139 VHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           VHRDLKPENLLL+SK     +KI DFGLS +  +   +K   G+  Y APEV+  K Y  
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-Y-D 215

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
            + DVWS GVIL+ LL G  PF  +    + +K++ G YT  S    ++S GA+DLI +M
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275

Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQA 290
           L  D  +RI+  +  +HPW +    +  +     ++  A
Sbjct: 276 LQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  337 bits (866), Expect = e-114
 Identities = 97/284 (34%), Positives = 155/284 (54%), Gaps = 19/284 (6%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM----------EMEEKVRRE 67
           +Y   + LG G++G+V + +      + AIK++ + +              +  E++  E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 68  IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
           I +L+   HP+II+L++V E     Y+V E+ + GELF+ I+ + +  E +A N  +QI+
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAA 184
           SG+ Y H++ +VHRD+KPEN+LL++K    N+KI DFGLS+     + L+   G+  Y A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216

Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HL 240
           PEV+  K Y   + DVWSCGVI+Y LLCG  PF  +N  ++ KK++ G Y        ++
Sbjct: 217 PEVLKKK-Y-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
           S  A++LI  ML  D  KR T  E     W + +          
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  328 bits (844), Expect = e-113
 Identities = 69/267 (25%), Positives = 127/267 (47%), Gaps = 12/267 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y + + LG G FG V       +      K +  +       +  V++EI IL +  H 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHR 61

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRN 136
           +I+ L+E  E+  ++ ++ E++   ++F+ I      L E E  ++  Q+   +++ H +
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 137 MVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
            + H D++PEN++  ++ +  +KI +FG +  ++ G   +    +P Y APEV    +  
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV- 180

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
               D+WS G ++Y LL G  PF  E    + + I    YT        +S  A D + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPR 277
           +L+ +   R+T  E  QHPW +  + R
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIER 267

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  330 bits (848), Expect = e-113
 Identities = 80/282 (28%), Positives = 141/282 (50%), Gaps = 11/282 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y + + LG G+FG V       TG     K +N     +      V+ EI I+    HP
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHP 108

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRN 136
            +I L++  E   ++ +++E++  GELFD I  +  ++ E E  N+ +Q   G+++ H +
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 137 MVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
            +VH D+KPEN++ ++K    VKI DFGL+  +     +K +  +  +AAPE++  +   
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV- 227

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
           G   D+W+ GV+ Y LL G  PF  E+     + +K   +         +SP A+D I  
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287

Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           +L  +P KR+T+ +  +HPW +       +  P     + ++
Sbjct: 288 LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 329

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  323 bits (830), Expect = e-111
 Identities = 91/310 (29%), Positives = 147/310 (47%), Gaps = 42/310 (13%)

Query: 3   GASNRSSSGVDMFLPNYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME 61
           G+++  S     F   Y+L +  LG G+  +V+   + +T  + A+KI+ ++      + 
Sbjct: 1   GSTDSFSGR---FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIR 54

Query: 62  EKVRREIKIL-RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
            +V RE+++L +   H +++ L E  E     Y+V E ++ G +  +I ++    E EA 
Sbjct: 55  SRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS 114

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHF----- 172
              Q + S +++ H   + HRDLKPEN+L +       VKI DF L + ++         
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174

Query: 173 ---LKTSCGSPNYAAPEVISGKLYA----GPEVDVWSCGVILYALLCGTLPFDDENIPN- 224
              L T CGS  Y APEV+              D+WS GVILY LL G  PF      + 
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234

Query: 225 --------------LFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIR 266
                         LF+ I+ G Y  P     H+S  A+DLI ++L+ D  +R++  ++ 
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294

Query: 267 QHPWFQAHLP 276
           QHPW Q   P
Sbjct: 295 QHPWVQGCAP 304

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  324 bits (832), Expect = e-111
 Identities = 96/265 (36%), Positives = 147/265 (55%), Gaps = 13/265 (4%)

Query: 19  YKLGKT--LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           Y + KT  LG G FG+V   E   TG K+A KI+  R +K+   +E+V+ EI ++    H
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDH 145

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHR 135
            ++I+LY+  E+ +DI +VMEYV  GELFD I+++   L E +   F +QI  G+ + H+
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 136 NMVVHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
             ++H DLKPEN+L  ++    +KI DFGL+   +    LK + G+P + APEV++   +
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD-F 264

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 249
                D+WS GVI Y LL G  PF  +N       I    + L       +S  A++ I 
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324

Query: 250 RMLIVDPMKRITIPEIRQHPWFQAH 274
           ++LI +   RI+  E  +HPW   H
Sbjct: 325 KLLIKEKSWRISASEALKHPWLSDH 349

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  327 bits (840), Expect = e-109
 Identities = 84/263 (31%), Positives = 140/263 (53%), Gaps = 11/263 (4%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y + + LG G+FG V       TG+  A K +      +   +E VR+EI+ + +  HP 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPT 215

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNM 137
           ++ L++  E  +++ ++ E++  GELF+ +  E  ++ EDEA  + +Q+  G+ + H N 
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 138 VVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
            VH DLKPEN++  +K    +K+ DFGL+  +     +K + G+  +AAPEV  GK   G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
              D+WS GV+ Y LL G  PF  EN     + +K   + +       +S   +D I ++
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 394

Query: 252 LIVDPMKRITIPEIRQHPWFQAH 274
           L+ DP  R+TI +  +HPW    
Sbjct: 395 LLADPNTRMTIHQALEHPWLTPG 417

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  318 bits (817), Expect = e-107
 Identities = 80/294 (27%), Positives = 125/294 (42%), Gaps = 50/294 (17%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMHP 77
               K LG GS G V   + +  G  VA+K +        +  +    EIK+L     HP
Sbjct: 17  VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLI------DFCDIALMEIKLLTESDDHP 69

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-------RLQEDEARNFFQQIISGV 130
           ++IR Y    T   +Y+ +E   +  L D +  K          +E    +  +QI SGV
Sbjct: 70  NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 131 EYCHRNMVVHRDLKPENLLLDSK-------------WNVKIADFGLSNIMRDGHF----- 172
            + H   ++HRDLKP+N+L+ +                + I+DFGL   +  G       
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 173 LKTSCGSPNYAAPEVISG------KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNL 225
           L    G+  + APE++        K      +D++S G + Y +L  G  PF D+     
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247

Query: 226 FKKIKGGIYTLPS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
              I  GI++L          L   A DLI +M+  DP+KR T  ++ +HP F 
Sbjct: 248 -SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  316 bits (812), Expect = e-107
 Identities = 92/272 (33%), Positives = 133/272 (48%), Gaps = 27/272 (9%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHP 77
               + LG+G  GKV    +  T  K A+K+L            K RRE+++  R    P
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCP 115

Query: 78  HIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQ--EDEARNFFQQIISGVE 131
           HI+R+ +V E        + +VME +  GELF  I ++G     E EA    + I   ++
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 132 YCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
           Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPS----HL 240
             + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P+     +
Sbjct: 236 GPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           S   + LI  +L  +P +R+TI E   HPW  
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  311 bits (799), Expect = e-106
 Identities = 94/277 (33%), Positives = 139/277 (50%), Gaps = 29/277 (10%)

Query: 15  FLPNYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-R 72
              +Y+L K  LG+G  GKV    H  TG K A+K+L            K R+E+    +
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQ 77

Query: 73  LFMHPHIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQ--EDEARNFFQQI 126
               PHI+ + +V E        + ++ME ++ GELF  I E+G     E EA    + I
Sbjct: 78  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137

Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYA 183
            + +++ H + + HRD+KPENLL  SK     +K+ DFG +        L+T C +P Y 
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYV 196

Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPS- 238
           APEV+  + Y     D+WS GVI+Y LLCG  PF         P + ++I+ G Y  P+ 
Sbjct: 197 APEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255

Query: 239 ---HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
               +S  A+ LI  +L  DP +R+TI +   HPW  
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  305 bits (782), Expect = e-104
 Identities = 82/328 (25%), Positives = 138/328 (42%), Gaps = 43/328 (13%)

Query: 3   GASNRSSSG-----VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN 57
           GAS R  S      V++     ++ + L  G F  V  A+   +G + A+K L       
Sbjct: 9   GASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL---SNE 65

Query: 58  MEMEEKVRREIKILR-LFMHPHIIRLY-------EVIETPSDIYVVMEYVKSGELFDYIV 109
            E    + +E+  ++ L  HP+I++         E  +T    ++++  +  G+L +++ 
Sbjct: 66  EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK 125

Query: 110 E---KGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADFGLS 164
           +   +G L  D     F Q    V++ HR    ++HRDLK ENLLL ++  +K+ DFG +
Sbjct: 126 KMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

Query: 165 NIMRDGHFLK-------------TSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYA 209
             +                    T   +P Y  PE+I        G + D+W+ G ILY 
Sbjct: 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245

Query: 210 LLCGTLPFDDENIPNLFKKIKGGIYTLPSHL--SPGARDLIPRMLIVDPMKRITIPEIRQ 267
           L     PF+D        +I  G Y++P H         LI  ML V+P +R++I E+  
Sbjct: 246 LCFRQHPFEDGAK----LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVH 301

Query: 268 HPWFQAHLPRY-LAVPPPDTMQQAKKVG 294
                A         P  + ++Q    G
Sbjct: 302 QLQEIAAARNVNPKSPITELLEQNGGYG 329

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  299 bits (768), Expect = e-102
 Identities = 71/280 (25%), Positives = 111/280 (39%), Gaps = 26/280 (9%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y   + LG G F  V + E    GH  A+K +        +  E+ +RE  + RLF HP
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRLFNHP 86

Query: 78  HIIRLYEVIETPSD----IYVVMEYVKSGELFDYI----VEKGRLQEDEARNFFQQIISG 129
           +I+RL              ++++ + K G L++ I     +   L ED+       I  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----------LKTSCGS 179
           +E  H     HRDLKP N+LL  +    + D G  N                       +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 180 PNYAAPEVISGKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTL 236
            +Y APE+ S + +       DVWS G +LYA++ G  P+D      +          ++
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 237 P--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
           P     S     L+  M+ VDP +R  IP +         
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  299 bits (768), Expect = e-100
 Identities = 67/272 (24%), Positives = 113/272 (41%), Gaps = 25/272 (9%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMH 76
           ++     LG G+ G + +         VA+K +               RE+++LR    H
Sbjct: 25  SFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEH 77

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHR 135
           P++IR +   +     Y+ +E   +  L +Y+ +K       E     QQ  SG+ + H 
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 136 NMVVHRDLKPENLLLDSKWN-----VKIADFGLSNIMRDGH----FLKTSCGSPNYAAPE 186
             +VHRDLKP N+L+            I+DFGL   +  G           G+  + APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 187 VISGKLYA--GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS---HL 240
           ++S          VD++S G + Y ++  G+ PF           +            H 
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
              AR+LI +M+ +DP KR +   + +HP+F 
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  290 bits (744), Expect = 2e-97
 Identities = 48/309 (15%), Positives = 93/309 (30%), Gaps = 50/309 (16%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-- 75
               G  LG         A    TG    + +    +       ++++ E+  LRL    
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 76  -----------------------HPHIIRLYEVIETPS--DIYVVMEYVKS------GEL 104
                                     +IR+            + +   ++S        L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164
             +      L          Q+I  +   H   +VH  L+P +++LD +  V +  F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 165 NIMRDGHFLKTSCGSPNYAAPEVIS----------GKLYAGPEVDVWSCGVILYALLCGT 214
             +RDG     S  S  +  PE+ +           +       D W+ G+++Y + C  
Sbjct: 254 --VRDGAR-VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 215 LPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
           LP   +      +     I+    ++    R L+   L      R+   +  + P ++  
Sbjct: 311 LPITKDAALGGSEW----IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366

Query: 275 LPRYLAVPP 283
                A  P
Sbjct: 367 RTELSAALP 375

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  286 bits (733), Expect = 4e-97
 Identities = 87/274 (31%), Positives = 141/274 (51%), Gaps = 15/274 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y++  T+G GS+G+ +       G  +  K L+   +   E ++ +  E+ +LR   HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHP 65

Query: 78  HIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVE 131
           +I+R Y+ I   T + +Y+VMEY + G+L   I +    +  L E+       Q+   ++
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 132 YCHR-----NMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAP 185
            CHR     + V+HRDLKP N+ LD K NVK+ DFGL+ I+  D  F KT  G+P Y +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185

Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGA 244
           E ++   Y   + D+WS G +LY L     PF   +   L  KI+ G +  +P   S   
Sbjct: 186 EQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244

Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278
            ++I RML +    R ++ EI ++P    H   +
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  280 bits (718), Expect = 2e-94
 Identities = 86/272 (31%), Positives = 122/272 (44%), Gaps = 48/272 (17%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHP 77
               + LG+G  GKV    +  T  K A+K+L            K RRE+++  R    P
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCP 71

Query: 78  HIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQ--EDEARNFFQQIISGVE 131
           HI+R+ +V E        + +VME +  GELF  I ++G     E EA    + I   ++
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131

Query: 132 YCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
           Y H   + HRD+KPENLL  SK     +K+ DFG                     A E  
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETT 171

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPS----HL 240
             K Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P+     +
Sbjct: 172 GEK-Y-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           S   + LI  +L  +P +R+TI E   HPW  
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  276 bits (707), Expect = 4e-92
 Identities = 75/269 (27%), Positives = 137/269 (50%), Gaps = 6/269 (2%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           +  Y   + +G GSFGK  + +    G +  IK +N  ++ + E EE  RRE+ +L    
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE-SRREVAVLANMK 81

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYC 133
           HP+I++  E  E    +Y+VM+Y + G+LF  I        QED+  ++F QI   +++ 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKL 192
           H   ++HRD+K +N+ L     V++ DFG++ ++       +   G+P Y +PE+   K 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201

Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRM 251
           Y   + D+W+ G +LY L      F+  ++ NL  KI  G +  +  H S   R L+ ++
Sbjct: 202 Y-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260

Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLA 280
              +P  R ++  I +  +    + ++L+
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAKRIEKFLS 289

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  262 bits (673), Expect = 7e-88
 Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 30/280 (10%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F  ++K  + +G G FG+V  A+H + G    IK +           EK  RE+K L   
Sbjct: 9   FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKL 61

Query: 75  MHPHIIRLYEVIETPSD----------------IYVVMEYVKSGELFDYIVEK--GRLQE 116
            H +I+      +                    +++ ME+   G L  +I ++   +L +
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121

Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176
             A   F+QI  GV+Y H   +++RDLKP N+ L     VKI DFGL   +++      S
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181

Query: 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL 236
            G+  Y +PE IS + Y G EVD+++ G+IL  LL       + +    F  ++ GI  +
Sbjct: 182 KGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGI--I 236

Query: 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
                   + L+ ++L   P  R    EI +        P
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  263 bits (674), Expect = 1e-87
 Identities = 87/264 (32%), Positives = 137/264 (51%), Gaps = 10/264 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYA 194
           ++HRDLKPEN+LL+   +++I DFG + ++          +  G+  Y +PE+++ K   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA- 209

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
               D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ ++L++
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269

Query: 255 DPMKRITIP------EIRQHPWFQ 272
           D  KR+          ++ HP+F+
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFE 293

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  259 bits (664), Expect = 4e-86
 Identities = 64/270 (23%), Positives = 104/270 (38%), Gaps = 7/270 (2%)

Query: 5   SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV 64
               S     F  +++    LG GS+G+V        G   A+K          +   K+
Sbjct: 45  GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL 104

Query: 65  RREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFF 123
                  ++  HP  +RL +  E    +Y+  E      L  +    G  L E +   + 
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYL 163

Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYA 183
           +  +  + + H   +VH D+KP N+ L  +   K+ DFGL   +      +   G P Y 
Sbjct: 164 RDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYM 223

Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
           APE++ G  Y G   DV+S G+ +  + C   LP   E    L +          + LS 
Sbjct: 224 APELLQGS-Y-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP--EFTAGLSS 279

Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
             R ++  ML  DP  R T   +   P  +
Sbjct: 280 ELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  259 bits (664), Expect = 2e-85
 Identities = 45/297 (15%), Positives = 79/297 (26%), Gaps = 44/297 (14%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             KL + L +G    V +          A+K+       +    E++          +  
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 78  HIIRLYEV--IETPSDI------------------------YVVMEYVKS------GELF 105
                 +   +  PSD                          ++M             L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 106 DYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165
              V +G            Q+I          +VH    P+NL +     + + D     
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

Query: 166 IMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDEN--- 221
             + G     S     YA  E ++         ++ W  G+ +Y + C  LPF       
Sbjct: 243 --KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300

Query: 222 ------IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                             +   + L    + LI R L  D  +R+   E  + P F 
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  251 bits (644), Expect = 1e-82
 Identities = 94/262 (35%), Positives = 146/262 (55%), Gaps = 8/262 (3%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  +   KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +   R      T CG+P   APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGY-N 216

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276

Query: 256 PMKRI-----TIPEIRQHPWFQ 272
             KR       + +I+ H WF 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  247 bits (634), Expect = 1e-81
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 10/264 (3%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L N+++ K +G G F +V  A   L G  VA+K +    + + +      +EI +L+   
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----LQEDEARNFFQQIISGVE 131
           HP++I+ Y      +++ +V+E   +G+L   I    +    + E     +F Q+ S +E
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISG 190
           + H   V+HRD+KP N+ + +   VK+ D GL            +  G+P Y +PE I  
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIYT-LPS-HLSPGARD 246
             Y   + D+WS G +LY +     PF  D  N+ +L KKI+   Y  LPS H S   R 
Sbjct: 211 NGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269

Query: 247 LIPRMLIVDPMKRITIPEIRQHPW 270
           L+   +  DP KR  +  +     
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAK 293

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  249 bits (638), Expect = 2e-81
 Identities = 68/256 (26%), Positives = 131/256 (51%), Gaps = 6/256 (2%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + +G GSFGKV I +   T    A+K +N++K         V +E++I++   HP ++ L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           +   +   D+++V++ +  G+L  ++ +    +E+  + F  +++  ++Y     ++HRD
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG--PEVDV 200
           +KP+N+LLD   +V I DF ++ ++     + T  G+  Y APE+ S +  AG    VD 
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200

Query: 201 WSCGVILYALLCGTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           WS GV  Y LL G  P+      +   +    +  + T PS  S     L+ ++L  +P 
Sbjct: 201 WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPD 260

Query: 258 KRI-TIPEIRQHPWFQ 272
           +R   + +++  P+  
Sbjct: 261 QRFSQLSDVQNFPYMN 276

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  246 bits (630), Expect = 6e-81
 Identities = 84/262 (32%), Positives = 144/262 (54%), Gaps = 8/262 (3%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++ +TLG GSFG+V +      G   A+K+L +  +  ++  E    E  +L +  
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP IIR++   +    I+++M+Y++ GELF  + +  R     A+ +  ++   +EY H 
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPEN+LLD   ++KI DFG +  + D     T CG+P+Y APEV+S K Y  
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPY-N 181

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             +D WS G+++Y +L G  PF D N    ++KI       P   +   +DL+ R++  D
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241

Query: 256 PMKRI-----TIPEIRQHPWFQ 272
             +R+        +++ HPWF+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  243 bits (621), Expect = 8e-80
 Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 38/289 (13%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRL 73
           +L +++  + LG G FG V  A++ +     AIK +   ++ N E+  EKV RE+K L  
Sbjct: 3   YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI---RLPNRELAREKVMREVKALAK 59

Query: 74  FMHPHIIRLYEVIET------------PSDIYVVMEYVKSGELFDYIVEKGRLQ---EDE 118
             HP I+R +                    +Y+ M+  +   L D++  +  ++      
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---- 174
             + F QI   VE+ H   ++HRDLKP N+       VK+ DFGL   M      +    
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 175 ---------TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN- 224
                       G+  Y +PE I G  Y   +VD++S G+IL+ LL    PF  +     
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVR 235

Query: 225 LFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
               ++   +  L +   P    ++  ML   PM+R     I ++  F+
Sbjct: 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  242 bits (619), Expect = 4e-78
 Identities = 49/313 (15%), Positives = 93/313 (29%), Gaps = 48/313 (15%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM--- 75
              G  LG         A    TG    + +    +       ++++ E+  LRL     
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 76  -------------------HPHIIRLYEVIETPSDIYVVMEYV-----------KSGELF 105
                               P   ++  V     D++V+  +                L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 106 DYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165
            +      L          Q+I  +   H   +VH  L+P +++LD +  V +  F    
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL- 258

Query: 166 IMRDGHFLKTSC----GSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPF 217
            +RDG    +        P   A  ++              D W+ G+ +Y + C  LP 
Sbjct: 259 -VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

Query: 218 DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            D+      +     I+    ++    R L+   L      R+   +  + P ++  L  
Sbjct: 318 TDDAALGGSEW----IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE-QLRT 372

Query: 278 YLAVPPPDTMQQA 290
            L+   P      
Sbjct: 373 ELSAALPLYQTDG 385

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  234 bits (599), Expect = 7e-76
 Identities = 93/271 (34%), Positives = 146/271 (53%), Gaps = 4/271 (1%)

Query: 5   SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV 64
             R S  + + + ++ L K LG GSFGKV +AE   T    AIK L +  +   +  E  
Sbjct: 5   KERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64

Query: 65  RREIKILRLFM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF 123
             E ++L L   HP +  ++   +T  +++ VMEY+  G+L  +I    +     A  + 
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124

Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNY 182
            +II G+++ H   +V+RDLK +N+LLD   ++KIADFG+    M       T CG+P+Y
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184

Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
            APE++ G+ Y    VD WS GV+LY +L G  PF  ++   LF  I+      P  L  
Sbjct: 185 IAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 243

Query: 243 GARDLIPRMLIVDPMKRI-TIPEIRQHPWFQ 272
            A+DL+ ++ + +P KR+    +IRQHP F+
Sbjct: 244 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  232 bits (595), Expect = 2e-75
 Identities = 94/263 (35%), Positives = 141/263 (53%), Gaps = 7/263 (2%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + ++   K LG G+FGKV +     TG   A+KIL +  I   +       E ++L+   
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP +  L    +T   +  VMEY   GELF ++  +    E+ AR +  +I+S +EY H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYA 194
             VV+RD+K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY- 182

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
           G  VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242

Query: 255 DPMKRI-----TIPEIRQHPWFQ 272
           DP +R+        E+ +H +F 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFFL 265

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  232 bits (595), Expect = 6e-75
 Identities = 85/256 (33%), Positives = 133/256 (51%), Gaps = 7/256 (2%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIR 81
           K +G GSFGKV +A H       A+K+L ++ I   + E+ +  E  +L   + HP ++ 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           L+   +T   +Y V++Y+  GELF ++  +    E  AR +  +I S + Y H   +V+R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163

Query: 142 DLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLKPEN+LLDS+ ++ + DFGL    +       T CG+P Y APEV+  + Y    VD 
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDW 222

Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W  G +LY +L G  PF   N   ++  I      L  +++  AR L+  +L  D  KR+
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 282

Query: 261 TIP----EIRQHPWFQ 272
                  EI+ H +F 
Sbjct: 283 GAKDDFMEIKSHVFFS 298

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  228 bits (585), Expect = 6e-74
 Identities = 84/260 (32%), Positives = 134/260 (51%), Gaps = 11/260 (4%)

Query: 23  KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLFMHPH 78
           + LG G +GKV          TG   A+K+L +  I +N +     + E  IL    HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+ L    +T   +Y+++EY+  GELF  +  +G   ED A  +  +I   + + H+  +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           ++RDLKPEN++L+ + +VK+ DFGL    + DG    T CG+  Y APE++    +    
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRA 201

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
           VD WS G ++Y +L G  PF  EN      KI      LP +L+  ARDL+ ++L  +  
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAA 261

Query: 258 KRI-----TIPEIRQHPWFQ 272
            R+        E++ HP+F+
Sbjct: 262 SRLGAGPGDAGEVQAHPFFR 281

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  229 bits (585), Expect = 9e-74
 Identities = 93/265 (35%), Positives = 147/265 (55%), Gaps = 9/265 (3%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           + N++  + LG GSFGKV +A    TG   A+K+L +  I   +  E    E +IL L  
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81

Query: 76  -HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP + +L+   +TP  ++ VME+V  G+L  +I +  R  E  AR +  +IIS + + H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLY 193
              +++RDLK +N+LLD + + K+ADFG+    + +G    T CG+P+Y APE++   LY
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY 201

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
            GP VD W+ GV+LY +LCG  PF+ EN  +LF+ I       P+ L   A  ++   + 
Sbjct: 202 -GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMT 260

Query: 254 VDPMKRI------TIPEIRQHPWFQ 272
            +P  R+          I +HP+F+
Sbjct: 261 KNPTMRLGSLTQGGEHAILRHPFFK 285

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  227 bits (580), Expect = 3e-73
 Identities = 74/259 (28%), Positives = 139/259 (53%), Gaps = 11/259 (4%)

Query: 23  KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           K LG GSFGKV + +           A+K+L +  +K  +   + + E  IL    HP I
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFI 88

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVV 139
           ++L+   +T   +Y+++++++ G+LF  + ++    E++ + +  ++   +++ H   ++
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148

Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
           +RDLKPEN+LLD + ++K+ DFGLS   +       + CG+  Y APEV++ + +     
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSA 207

Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
           D WS GV+++ +L GTLPF  ++       I      +P  LSP A+ L+  +   +P  
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPAN 267

Query: 259 RI-----TIPEIRQHPWFQ 272
           R+      + EI++H +F 
Sbjct: 268 RLGAGPDGVEEIKRHSFFS 286

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  229 bits (586), Expect = 9e-73
 Identities = 96/257 (37%), Positives = 139/257 (54%), Gaps = 8/257 (3%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K LG G+FGKV + +   TG   A+KIL +  I   +       E ++L+   HP +  L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHR 141
               +T   +  VMEY   GELF ++  +    ED AR +  +I+S ++Y H    VV+R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273

Query: 142 DLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           DLK ENL+LD   ++KI DFGL    ++DG  +KT CG+P Y APEV+    Y G  VD 
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 332

Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
           W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+  +L  DP +R+
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 392

Query: 261 -----TIPEIRQHPWFQ 272
                   EI QH +F 
Sbjct: 393 GGGSEDAKEIMQHRFFA 409

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  226 bits (579), Expect = 9e-73
 Identities = 89/264 (33%), Positives = 144/264 (54%), Gaps = 8/264 (3%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++     LG GSFGKV ++E   T    A+KIL +  +   +  E    E ++L L  
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78

Query: 76  -HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
             P + +L+   +T   +Y VMEYV  G+L  +I + GR +E  A  +  +I  G+ +  
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
              +++RDLK +N++LDS+ ++KIADFG+    + DG   KT CG+P+Y APE+I+ + Y
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 198

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
            G  VD W+ GV+LY +L G  PF+ E+   LF+ I       P  +S  A  +   ++ 
Sbjct: 199 -GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 257

Query: 254 VDPMKRI-----TIPEIRQHPWFQ 272
             P KR+        +I++H +F+
Sbjct: 258 KHPGKRLGCGPEGERDIKEHAFFR 281

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  228 bits (583), Expect = 1e-72
 Identities = 73/262 (27%), Positives = 133/262 (50%), Gaps = 14/262 (5%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K +G G+FG+V++  H  T    A+K+L++ ++           E  I+     P +++L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           +   +    +Y+VMEY+  G+L   ++    + E  AR +  +++  ++  H    +HRD
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA---GPE 197
           +KP+N+LLD   ++K+ADFG    M     ++     G+P+Y +PEV+  +      G E
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLIPRMLI 253
            D WS GV LY +L G  PF  +++   + KI     +L       +S  A++LI    +
Sbjct: 254 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI-CAFL 312

Query: 254 VDPMKRIT---IPEIRQHPWFQ 272
            D   R+    + EI++H +F+
Sbjct: 313 TDREVRLGRNGVEEIKRHLFFK 334

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  226 bits (578), Expect = 1e-72
 Identities = 47/290 (16%), Positives = 98/290 (33%), Gaps = 37/290 (12%)

Query: 18  NYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
              +   LG G+F +V  A       A    K  +K+          +     + ++ L+
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG---TQLMERLK 122

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-----LQEDEARNFFQQII 127
             M    ++ Y      +   +V E    G L + I          + +    +F  +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 128 SGVEYCHRNMVVHRDLKPENLLL-----------DSKWNVKIADFGLS---NIMRDGHFL 173
             +E  H   ++H D+KP+N +L           D    + + D G S    +   G   
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGG 232
              C +  +   E++S K +   ++D +     +Y +L GT     +E      + +   
Sbjct: 243 TAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301

Query: 233 IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP---WFQAHLPRYL 279
           +  L         +    ML +     +   ++ +      FQ H    +
Sbjct: 302 LPHLDM-----WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI 346

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  229 bits (586), Expect = 8e-72
 Identities = 82/264 (31%), Positives = 132/264 (50%), Gaps = 15/264 (5%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + LG G FG+V   +   TG   A K LN++++K  +  +    E KIL       I+ L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVEYCHRNMV 138
               ET +D+ +VM  +  G++  +I     +    QE  A  +  QI+SG+E+ H+  +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           ++RDLKPEN+LLD   NV+I+D GL+  +       K   G+P + APE++ G+ Y    
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFS 369

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
           VD ++ GV LY ++    PF           L +++     T P   SP ++D    +L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429

Query: 254 VDPMKRI-----TIPEIRQHPWFQ 272
            DP KR+     +   +R HP F+
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  223 bits (571), Expect = 1e-71
 Identities = 81/274 (29%), Positives = 144/274 (52%), Gaps = 18/274 (6%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++ L + +G GS+ KV +     T    A+K++ +  + + E  + V+ E  +     
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67

Query: 76  -HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP ++ L+   +T S ++ V+EYV  G+L  ++  + +L E+ AR +  +I   + Y H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLY 193
              +++RDLK +N+LLDS+ ++K+ D+G+    +R G    T CG+PNY APE++ G+ Y
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 187

Query: 194 AGPEVDVWSCGVILYALLCGTLPF---------DDENIPNLFKKIKGGIYTLPSHLSPGA 244
            G  VD W+ GV+++ ++ G  PF         D      LF+ I      +P  LS  A
Sbjct: 188 -GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 246

Query: 245 RDLIPRMLIVDPMKRI------TIPEIRQHPWFQ 272
             ++   L  DP +R+         +I+ HP+F+
Sbjct: 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  229 bits (586), Expect = 2e-71
 Identities = 77/261 (29%), Positives = 128/261 (49%), Gaps = 12/261 (4%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           + LG G FG+V   +   TG   A K L +++IK  + E     E +IL       ++ L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
               ET   + +V+  +  G+L  +I  + +    E  A  +  +I  G+E  HR  +V+
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
           RDLKPEN+LLD   +++I+D GL+  + +G  +K   G+  Y APEV+  + Y     D 
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY-TFSPDW 368

Query: 201 WSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
           W+ G +LY ++ G  PF           + + +K          SP AR L  ++L  DP
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDP 428

Query: 257 MKRI-----TIPEIRQHPWFQ 272
            +R+     +  E+++HP F+
Sbjct: 429 AERLGCRGGSAREVKEHPLFK 449

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  222 bits (569), Expect = 8e-71
 Identities = 80/274 (29%), Positives = 144/274 (52%), Gaps = 18/274 (6%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++ L + +G GS+ KV +     T    A++++ +  + + E  + V+ E  +     
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110

Query: 76  -HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            HP ++ L+   +T S ++ V+EYV  G+L  ++  + +L E+ AR +  +I   + Y H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
              +++RDLK +N+LLDS+ ++K+ D+G+    +R G    T CG+PNY APE++ G+ Y
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230

Query: 194 AGPEVDVWSCGVILYALLCGTLPF---------DDENIPNLFKKIKGGIYTLPSHLSPGA 244
            G  VD W+ GV+++ ++ G  PF         D      LF+ I      +P  LS  A
Sbjct: 231 -GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289

Query: 245 RDLIPRMLIVDPMKRI------TIPEIRQHPWFQ 272
             ++   L  DP +R+         +I+ HP+F+
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  221 bits (565), Expect = 1e-70
 Identities = 82/267 (30%), Positives = 143/267 (53%), Gaps = 17/267 (6%)

Query: 23  KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLFMH-P 77
           K LG G++GKV +        TG   A+K+L +  I +  +  E  R E ++L      P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            ++ L+   +T + ++++++Y+  GELF ++ ++ R  E E + +  +I+  +E+ H+  
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS--NIMRDGHFLKTSCGSPNYAAPEVISGKLYA- 194
           +++RD+K EN+LLDS  +V + DFGLS   +  +       CG+  Y AP+++ G     
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239

Query: 195 GPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
              VD WS GV++Y LL G  PF    +  +   + ++I       P  +S  A+DLI R
Sbjct: 240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 299

Query: 251 MLIVDPMKRI-----TIPEIRQHPWFQ 272
           +L+ DP KR+        EI++H +FQ
Sbjct: 300 LLMKDPKKRLGCGPRDADEIKEHLFFQ 326

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  227 bits (580), Expect = 7e-70
 Identities = 89/264 (33%), Positives = 144/264 (54%), Gaps = 8/264 (3%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++     LG GSFGKV ++E   T    A+KIL +  +   +  E    E ++L L  
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 76  -HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
             P + +L+   +T   +Y VMEYV  G+L  +I + GR +E  A  +  +I  G+ +  
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
              +++RDLK +N++LDS+ ++KIADFG+    + DG   KT CG+P+Y APE+I+ + Y
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
            G  VD W+ GV+LY +L G  PF+ E+   LF+ I       P  +S  A  +   ++ 
Sbjct: 520 -GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 578

Query: 254 VDPMKRI-----TIPEIRQHPWFQ 272
             P KR+        +I++H +F+
Sbjct: 579 KHPGKRLGCGPEGERDIKEHAFFR 602

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  221 bits (565), Expect = 9e-70
 Identities = 76/265 (28%), Positives = 135/265 (50%), Gaps = 16/265 (6%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K +G G+FG+V + +        A+KILN+ ++         R E  +L       I  L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +   +  +++Y+VM+Y   G+L   +   + RL E+ AR +  +++  ++  H+   VHR
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR 199

Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA----G 195
           D+KP+N+L+D   ++++ADFG    + +   +++S   G+P+Y +PE++          G
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYG 259

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARDLIPR 250
           PE D WS GV +Y +L G  PF  E++   + KI             + +S  A+DLI R
Sbjct: 260 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLI-R 318

Query: 251 MLIVDPMKRIT---IPEIRQHPWFQ 272
            LI     R+    I + ++HP+F 
Sbjct: 319 RLICSREHRLGQNGIEDFKKHPFFS 343

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  220 bits (562), Expect = 1e-69
 Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 18/267 (6%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
           K +G G+F +V + +   TG   A+KI+N+  +         R E  +L       I +L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHR 141
           +   +  + +Y+VMEY   G+L   + + G R+  + AR +  +I+  ++  HR   VHR
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186

Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA----- 194
           D+KP+N+LLD   ++++ADFG    +R    +++    G+P+Y +PE++           
Sbjct: 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246

Query: 195 -GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARDLI 248
            GPE D W+ GV  Y +  G  PF  ++    + KI      L        +   ARD I
Sbjct: 247 YGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFI 306

Query: 249 PRMLIVDPMKRIT---IPEIRQHPWFQ 272
            + L+  P  R+      + R HP+F 
Sbjct: 307 -QRLLCPPETRLGRGGAGDFRTHPFFF 332

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  215 bits (550), Expect = 3e-69
 Identities = 62/295 (21%), Positives = 110/295 (37%), Gaps = 36/295 (12%)

Query: 3   GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
           GA    S     +   +   + +G G FG V      L G   AIK   +    +++ E+
Sbjct: 1   GAMGMKSR----YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQ 55

Query: 63  KVRREIKIL-RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----LQED 117
              RE+     L  H H++R +        + +  EY   G L D I E  R     +E 
Sbjct: 56  NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115

Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-------------------SKWNVKI 158
           E ++   Q+  G+ Y H   +VH D+KP N+ +                    +K   KI
Sbjct: 116 ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175

Query: 159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD 218
            D G    +      +   G   + A EV+       P+ D+++  + +           
Sbjct: 176 GDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232

Query: 219 DENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           +    + + +I+ G    +P  LS    +L+  M+  DP +R +   + +H    
Sbjct: 233 NG---DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  224 bits (573), Expect = 1e-68
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 12/261 (4%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL---FMHPHI 79
           + +G G FG+V     A TG   A+K L++++IK  + E     E  +L L      P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVV 139
           + +     TP  +  +++ +  G+L  ++ + G   E + R +  +II G+E+ H   VV
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314

Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
           +RDLKP N+LLD   +V+I+D GL+           S G+  Y APEV+   +      D
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSAD 373

Query: 200 VWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
            +S G +L+ LL G  PF      +   + +        LP   SP  R L+  +L  D 
Sbjct: 374 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 433

Query: 257 MKRI-----TIPEIRQHPWFQ 272
            +R+        E+++ P+F+
Sbjct: 434 NRRLGCLGRGAQEVKESPFFR 454

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  209 bits (535), Expect = 2e-66
 Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 19/274 (6%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
                 +G GSFG+V   +   TG + A+K         + +E     E+        P 
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK--------VRLEVFRVEELVACAGLSSPR 111

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+ LY  +     + + ME ++ G L   I + G L ED A  +  Q + G+EY H   +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171

Query: 139 VHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSC------GSPNYAAPEVISGK 191
           +H D+K +N+LL S      + DFG +  ++     K+        G+  + APEV+ GK
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGG--IYTLPSHLSPGARDLI 248
                +VD+WS   ++  +L G  P+      P   K       I  +P   +P     I
Sbjct: 232 PC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 282
              L  +P+ R +  E+R+           L  P
Sbjct: 291 QEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  200 bits (511), Expect = 2e-63
 Identities = 66/264 (25%), Positives = 127/264 (48%), Gaps = 14/264 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
            K    +G GSF  V       T  +VA   L  RK+      ++ + E ++L+   HP+
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 86

Query: 79  IIRLY----EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           I+R Y      ++    I +V E + SG L  Y+     ++    R++ +QI+ G+++ H
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 135 RN--MVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
                ++HRDLK +N+ +     +VKI D GL+ + R   F K   G+P + APE+   K
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK 205

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGI--YTLPSHLSPGARDLI 248
                 VDV++ G+ +  +     P+ + +N   +++++  G+   +      P  +++I
Sbjct: 206 --YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQ 272
              +  +  +R +I ++  H +FQ
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFFQ 287

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  199 bits (508), Expect = 7e-63
 Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 12/280 (4%)

Query: 2   DGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME 61
           +G         D           LG G++G V          ++AIK +     ++    
Sbjct: 7   EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYS 63

Query: 62  EKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEA- 119
           + +  EI + +   H +I++          I + ME V  G L   +  K G L+++E  
Sbjct: 64  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123

Query: 120 -RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSC 177
              + +QI+ G++Y H N +VHRD+K +N+L+++    +KI+DFG S  +   +    + 
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 183

Query: 178 -GSPNYAAPEVISGKLY-AGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGI 233
            G+  Y APE+I       G   D+WS G  +  +  G  PF +  E    +FK     +
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV 243

Query: 234 Y-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           +  +P  +S  A+  I +    DP KR    ++    + +
Sbjct: 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  199 bits (507), Expect = 2e-62
 Identities = 65/331 (19%), Positives = 120/331 (36%), Gaps = 77/331 (23%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAI-------KILNRRKI------------ 55
           +L +++  + +G G FG V  A++ +     AI       + L R K+            
Sbjct: 4   YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 63

Query: 56  ------------------------------------KNMEMEEKVRREIKILRLFMHPHI 79
                                                +    +    +I+ +  F   + 
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDE---ARNFFQQIISGVEYCHRN 136
           +   +       +Y+ M+  +   L D++  +  L++ E     + F QI   VE+ H  
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-------------SCGSPNYA 183
            ++HRDLKP N+       VK+ DFGL   M      +T               G+  Y 
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYT-LPSHLS 241
           +PE I G  Y   +VD++S G+IL+ LL     F  +     +   ++   +  L +   
Sbjct: 244 SPEQIHGNNY-SHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKY 299

Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           P    ++  ML   P +R    +I ++  F+
Sbjct: 300 PQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  197 bits (502), Expect = 9e-62
 Identities = 76/316 (24%), Positives = 129/316 (40%), Gaps = 66/316 (20%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRL 73
            Y+    +G GS+G V    +  TG  VAIK     K    E +  ++    REI++L+ 
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQ 58

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEY 132
             HP+++ L EV      +++V EY     +   +    R + E   ++   Q +  V +
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------- 181
           CH++  +HRD+KPEN+L+     +K+ DFG +   R           P+           
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFA---R-------LLTGPSDYYDDEVATRW 167

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK----------KI 229
           Y +PE++ G    GP VDVW+ G +   LL G    P   + +  L+           + 
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-VDQLYLIRKTLGDLIPRH 226

Query: 230 KGGIYTLP--------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHP 269
           +    T                       ++S  A  L+   L +DP +R+T  ++  HP
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286

Query: 270 WFQA-HLPRYLAVPPP 284
           +F+       LA    
Sbjct: 287 YFENIREIEDLAKEHD 302

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  197 bits (502), Expect = 2e-61
 Identities = 87/328 (26%), Positives = 136/328 (41%), Gaps = 73/328 (22%)

Query: 1   MDGASNRSSSGVDMFLP--------NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR 52
           M    +  SSGVD+            Y+    +G GS+G V    +  TG  VAIK    
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---- 56

Query: 53  RKIKNMEMEEKVR----REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI 108
            K    + ++ V+    REIK+L+   H +++ L EV +     Y+V E+V    + D +
Sbjct: 57  -KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL 114

Query: 109 -VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167
            +    L     + +  QII+G+ +CH + ++HRD+KPEN+L+     VK+ DFG +   
Sbjct: 115 ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA--- 171

Query: 168 RDGHFLKTSCGSPN-----------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT-- 214
           R       +  +P            Y APE++ G +  G  VDVW+ G ++  +  G   
Sbjct: 172 R-------TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224

Query: 215 LPFDDENIPNLFK--KIKG--------GIYTLP--------------------SHLSPGA 244
            P D + I  L+      G             P                      LS   
Sbjct: 225 FPGDSD-IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVV 283

Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            DL  + L +DP KR    E+  H +FQ
Sbjct: 284 IDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  194 bits (496), Expect = 1e-60
 Identities = 81/328 (24%), Positives = 138/328 (42%), Gaps = 71/328 (21%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV----RREIKILRL 73
            Y     LG G++  V   +  LT + VA+K     +I+ +E EE       RE+ +L+ 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALK-----EIR-LEHEEGAPCTAIREVSLLKD 56

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEY 132
             H +I+ L+++I T   + +V EY+   +L  Y+ + G  +     + F  Q++ G+ Y
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------- 181
           CHR  V+HRDLKP+NLL++ +  +K+ADFGL+   R       +   P            
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLA---R-------AKSIPTKTYDNEVVTLW 165

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG------ 231
           Y  P+++ G      ++D+W  G I Y +  G    P        L    +I G      
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQLHFIFRILGTPTEET 224

Query: 232 --GIYTLP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
             GI +                       L     DL+ ++L  +   RI+  +  +HP+
Sbjct: 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

Query: 271 F------QAHLPRYLAVPPPDTMQQAKK 292
           F         LP   ++     +Q  K+
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQKE 312

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  191 bits (487), Expect = 4e-59
 Identities = 88/305 (28%), Positives = 133/305 (43%), Gaps = 69/305 (22%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR--------REIK 69
            Y+    LG G F  V  A    T   VAIK     KIK +    + +        REIK
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIK-----KIK-LGHRSEAKDGINRTALREIK 64

Query: 70  ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIIS 128
           +L+   HP+II L +     S+I +V +++++ +L   I      L     + +    + 
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------- 181
           G+EY H++ ++HRDLKP NLLLD    +K+ADFGL+           S GSPN       
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA----------KSFGSPNRAYTHQV 173

Query: 182 ----YAAPEVISG-KLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG- 231
               Y APE++ G ++Y G  VD+W+ G IL  LL     LP D + +  L +  +  G 
Sbjct: 174 VTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGT 231

Query: 232 -------GIYTLP-----------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
                   + +LP                 S       DLI  + + +P  RIT  +  +
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291

Query: 268 HPWFQ 272
             +F 
Sbjct: 292 MKYFS 296

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  189 bits (483), Expect = 4e-59
 Identities = 79/315 (25%), Positives = 140/315 (44%), Gaps = 73/315 (23%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILR 72
            Y+  + +G G++G V  A++  T   VA+K     +++ ++ +++       REI +L+
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALK-----RVR-LDDDDEGVPSSALREICLLK 56

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVE 131
              H +I+RL++V+ +   + +V E+    +L  Y     G L  +  ++F  Q++ G+ 
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------- 181
           +CH   V+HRDLKP+NLL++    +K+A+FGL+   R       + G P           
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLA---R-------AFGIPVRCYSAEVVTL 165

Query: 182 -YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF---DDENIPNLFK--KIKG---- 231
            Y  P+V+ G       +D+WS G I   L     P    +D     L +  ++ G    
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTE 224

Query: 232 ----GIYTLP------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHP 269
                +  LP                    L+   RDL+  +L  +P++RI+  E  QHP
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284

Query: 270 WFQAHLPRYLAVPPP 284
           +F           PP
Sbjct: 285 YFS-------DFCPP 292

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  188 bits (479), Expect = 3e-58
 Identities = 86/322 (26%), Positives = 147/322 (45%), Gaps = 67/322 (20%)

Query: 4   ASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK 63
           +S R +      +  Y+  + +G G++G V  A+ +  G  VA+K     +I+ ++ E++
Sbjct: 8   SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALK-----RIR-LDAEDE 60

Query: 64  -----VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQED 117
                  REI +L+   HP+I+ L +VI +   + +V E+++  +L   +   K  LQ+ 
Sbjct: 61  GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS 119

Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177
           + + +  Q++ GV +CH++ ++HRDLKP+NLL++S   +K+ADFGL+   R       + 
Sbjct: 120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA---R-------AF 169

Query: 178 GSPN-----------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPN 224
           G P            Y AP+V+ G       VD+WS G I   ++ G    P   +    
Sbjct: 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD-DDQ 228

Query: 225 LFK--KIKG--------GIYTLP-------------------SHLSPGARDLIPRMLIVD 255
           L K   I G         +  LP                           DL+  ML  D
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD 288

Query: 256 PMKRITIPEIRQHPWFQAHLPR 277
           P KRI+  +   HP+F+   P+
Sbjct: 289 PNKRISARDAMNHPYFKDLDPQ 310

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  187 bits (477), Expect = 3e-58
 Identities = 91/303 (30%), Positives = 146/303 (48%), Gaps = 68/303 (22%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILR 72
            Y   + +G G++G V  A++   G   A+K     KI+ +E E++       REI IL+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALK-----KIR-LEKEDEGIPSTTIREISILK 55

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVE 131
              H +I++LY+VI T   + +V E++   +L   + V +G L+   A++F  Q+++G+ 
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------- 181
           YCH   V+HRDLKP+NLL++ +  +KIADFGL+   R       + G P           
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLA---R-------AFGIPVRKYTHEIVTL 164

Query: 182 -YAAPEVISG-KLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG---- 231
            Y AP+V+ G K Y    +D+WS G I   ++ GT   P   E    L +  +I G    
Sbjct: 165 WYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNS 222

Query: 232 ----GIYTLP------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHP 269
                +  LP                    L     DL+ +ML +DP +RIT  +  +H 
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282

Query: 270 WFQ 272
           +F+
Sbjct: 283 YFK 285

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  187 bits (478), Expect = 7e-58
 Identities = 95/336 (28%), Positives = 150/336 (44%), Gaps = 80/336 (23%)

Query: 1   MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
           M  ++  S++ +D +    ++ K LG G++G+V  A   +T   VAIK     +I+ +E 
Sbjct: 22  MSVSAAPSATSIDRYR---RITK-LGEGTYGEVYKAIDTVTNETVAIK-----RIR-LEH 71

Query: 61  EEK-----VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ 115
           EE+       RE+ +L+   H +II L  VI     ++++ EY ++ +L  Y+ +   + 
Sbjct: 72  EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS 130

Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-----NVKIADFGLSNIMRDG 170
               ++F  Q+I+GV +CH    +HRDLKP+NLLL          +KI DFGL+   R  
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---R-- 185

Query: 171 HFLKTSCGSPN-----------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPF 217
                + G P            Y  PE++ G  +    VD+WS   I   +L  T   P 
Sbjct: 186 -----AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240

Query: 218 DDENIPNLFK--KIKG--------GIYTLP-------------------SHLSPGARDLI 248
           D E I  LFK  ++ G        G+  LP                   + L     DL+
Sbjct: 241 DSE-IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLL 299

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
             ML +DP+KRI+     +HP+F  H         P
Sbjct: 300 TAMLEMDPVKRISAKNALEHPYFS-HND-----FDP 329

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  186 bits (474), Expect = 2e-57
 Identities = 80/328 (24%), Positives = 141/328 (42%), Gaps = 75/328 (22%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV----RREIKILRL 73
            +K  + LG G++  V    +  TG  VA+K     ++K ++ EE       REI +++ 
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALK-----EVK-LDSEEGTPSTAIREISLMKE 59

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI------VEKGRLQEDEARNFFQQII 127
             H +I+RLY+VI T + + +V E++ + +L  Y+           L+ +  + F  Q++
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------ 181
            G+ +CH N ++HRDLKP+NLL++ +  +K+ DFGL+   R       + G P       
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA---R-------AFGIPVNTFSSE 168

Query: 182 -----YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG- 231
                Y AP+V+ G       +D+WSCG IL  ++ G    P  ++    L     I G 
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIMGT 227

Query: 232 -------GIYTLP-----------------------SHLSPGARDLIPRMLIVDPMKRIT 261
                   +  LP                         L     D +  +L ++P  R++
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287

Query: 262 IPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
             +   HPWF      + ++    +   
Sbjct: 288 AKQALHHPWFA-EYYHHASMGGSRSHHH 314

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  184 bits (469), Expect = 7e-57
 Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 75/311 (24%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR--------REIK 69
            Y+    +G+G++G V  A    +GH VA+K      ++ +               RE+ 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALK-----SVR-VPNGGGGGGGLPISTVREVA 63

Query: 70  ILR---LFMHPHIIRLYEVI-----ETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEA 119
           +LR    F HP+++RL +V      +    + +V E+V   +L  Y+       L  +  
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122

Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
           ++  +Q + G+++ H N +VHRDLKPEN+L+ S   VK+ADFGL+   R           
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA---R-------IYSY 172

Query: 180 PN----------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK 227
                       Y APEV+    Y    VD+WS G I   +         + E    L K
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGK 230

Query: 228 --KIKG--------GIYTLP----------------SHLSPGARDLIPRMLIVDPMKRIT 261
              + G           +LP                  +      L+  ML  +P KRI+
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290

Query: 262 IPEIRQHPWFQ 272
                QH +  
Sbjct: 291 AFRALQHSYLH 301

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  182 bits (465), Expect = 3e-56
 Identities = 74/258 (28%), Positives = 121/258 (46%), Gaps = 20/258 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
            + + +G GSFG V  AE    G  VA+KIL  +      + E   RE+ I++   HP+I
Sbjct: 40  NIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNI 96

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI---VEKGRLQEDEARNFFQQIISGVEYCHRN 136
           +     +  P ++ +V EY+  G L+  +     + +L E    +    +  G+ Y H  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 137 --MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLY 193
              +VHR+LK  NLL+D K+ VK+ DFGLS +         S  G+P + APEV+  +  
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS 216

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------TLPSHLSPGARDL 247
              + DV+S GVIL+ L     P+   N+     ++   +        +P +L+P    +
Sbjct: 217 -NEKSDVYSFGVILWELATLQQPW--GNLNPA--QVVAAVGFKCKRLEIPRNLNPQVAAI 271

Query: 248 IPRMLIVDPMKRITIPEI 265
           I      +P KR +   I
Sbjct: 272 IEGCWTNEPWKRPSFATI 289

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  182 bits (464), Expect = 3e-56
 Identities = 77/259 (29%), Positives = 121/259 (46%), Gaps = 28/259 (10%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           ++ + +G G+FG V  A+       VAIK     +I++    +    E++ L    HP+I
Sbjct: 11  EVEEVVGRGAFGVVCKAKW--RAKDVAIK-----QIESESERKAFIVELRQLSRVNHPNI 63

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEYCHR- 135
           ++LY     P  + +VMEY + G L++ +             A ++  Q   GV Y H  
Sbjct: 64  VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 136 --NMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGK 191
               ++HRDLKP NLLL +   V KI DFG +    D     T+  GS  + APEV  G 
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNKGSAAWMAPEVFEGS 178

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHLSPGARD 246
            Y   + DV+S G+IL+ ++    PFD+  I     +I   ++      L  +L      
Sbjct: 179 NY-SEKCDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235

Query: 247 LIPRMLIVDPMKRITIPEI 265
           L+ R    DP +R ++ EI
Sbjct: 236 LMTRCWSKDPSQRPSMEEI 254

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  182 bits (464), Expect = 6e-55
 Identities = 85/312 (27%), Positives = 123/312 (39%), Gaps = 54/312 (17%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +Y   K +G GSFG V  A+   +G  VAIK +L  ++ KN        RE++I+R   H
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 106

Query: 77  PHIIRLYEVIETPSD------IYVVMEYVKS---GELFDYIVEKGRLQEDEARNFFQQII 127
            +I+RL     +  +      + +V++YV          Y   K  L     + +  Q+ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
             + Y H   + HRD+KP+NLLLD     +K+ DFG +  +  G    +   S  Y APE
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 226

Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNL-- 225
           +I G       +DVWS G +L  LL G   F                     E I  +  
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286

Query: 226 ------FKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ----- 272
                 F +IK             P A  L  R+L   P  R+T  E   H +F      
Sbjct: 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346

Query: 273 -AHLPRYLAVPP 283
              LP     P 
Sbjct: 347 NVKLPNGRDTPA 358

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  179 bits (457), Expect = 8e-55
 Identities = 79/324 (24%), Positives = 134/324 (41%), Gaps = 76/324 (23%)

Query: 18  NY-KLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKI 70
            Y  + + +G G++GKV K  +    G  VA+K     +++ ++  E+       RE+ +
Sbjct: 12  QYECVAE-IGEGAYGKVFKARDLKNGGRFVALK-----RVR-VQTGEEGMPLSTIREVAV 64

Query: 71  LR---LFMHPHIIRLYEVIETPSD-----IYVVMEYVKSGELFDYI--VEKGRLQEDEAR 120
           LR    F HP+++RL++V           + +V E+V   +L  Y+  V +  +  +  +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           +   Q++ G+++ H + VVHRDLKP+N+L+ S   +K+ADFGL+   R            
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA---R-------IYSFQ 173

Query: 181 N----------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK- 227
                      Y APEV+    Y    VD+WS G I   +           + +  L K 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKI 231

Query: 228 -KIKG--------GIYTLPSH----------------LSPGARDLIPRMLIVDPMKRITI 262
             + G            LP                  +    +DL+ + L  +P KRI+ 
Sbjct: 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291

Query: 263 PEIRQHPWFQAHLPRYLAVPPPDT 286
                HP+FQ  L R         
Sbjct: 292 YSALSHPYFQD-LERCKENLDSHL 314

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  177 bits (450), Expect = 3e-54
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 21/263 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
            +G+ +G GSFG V           VA+K+LN       +  +  + E+ +LR   H +I
Sbjct: 27  TVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNI 82

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           +       T   + +V ++ +   L+ ++   + + +  +  +  +Q   G++Y H   +
Sbjct: 83  LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISGKLYA- 194
           +HRDLK  N+ L     VKI DFGL+         H  +   GS  + APEVI  +    
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 195 -GPEVDVWSCGVILYALLCGTLPFDDENIPNL--------FKKIKGGIYTLPSHLSPGAR 245
              + DV++ G++LY L+ G LP+   NI N            +   +  + S+     +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259

Query: 246 DLIPRMLIVDPMKRITIPEIRQH 268
            L+   L     +R + P I   
Sbjct: 260 RLMAECLKKKRDERPSFPRILAE 282

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  173 bits (441), Expect = 4e-53
 Identities = 50/256 (19%), Positives = 102/256 (39%), Gaps = 17/256 (6%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
                L     G++        G+ + +K+L  R     +  +    E   LR+F HP++
Sbjct: 13  NFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRD-FNEECPRLRIFSHPNV 69

Query: 80  IRLYEVIETP--SDIYVVMEYVKSGELFDYIVEKGRLQEDEAR--NFFQQIISGVEYCH- 134
           + +    ++P      ++  ++  G L++ + E      D+++   F   +  G+ + H 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 135 -RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
              ++    L   ++++D     +I+   +    +          +P + APE +  K  
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPE 185

Query: 194 AGPE--VDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIY-TLPSHLSPGARDLIP 249
                  D+WS  V+L+ L+   +PF D  N+    K    G+  T+P  +SP    L+ 
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMK 245

Query: 250 RMLIVDPMKRITIPEI 265
             +  DP KR     I
Sbjct: 246 ICMNEDPAKRPKFDMI 261

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  173 bits (440), Expect = 8e-53
 Identities = 75/268 (27%), Positives = 117/268 (43%), Gaps = 25/268 (9%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----MEMEEKVRREIKILRLFM 75
           +  K +G G FG V           VAIK L     +     +E  ++ +RE+ I+    
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCH 134
           HP+I++LY ++  P    +VME+V  G+L+  +++K   ++          I  G+EY  
Sbjct: 82  HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 135 RN--MVVHRDLKPENLLLDSKW-----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
                +VHRDL+  N+ L S         K+ADFGLS        +    G+  + APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPET 197

Query: 188 ISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHL 240
           I    + Y   + D +S  +ILY +L G  PFD+ +     K I          T+P   
Sbjct: 198 IGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIREEGLRPTIPEDC 255

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQH 268
            P  R++I      DP KR     I + 
Sbjct: 256 PPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  172 bits (437), Expect = 1e-52
 Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 19/263 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRLFMHPH 78
            L + +GIG FGKV  A     G +VA+K       +++ +  E VR+E K+  +  HP+
Sbjct: 10  TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-- 136
           II L  V     ++ +VME+ + G L   +  K R+  D   N+  QI  G+ Y H    
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 137 -MVVHRDLKPENLLLDSK--------WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
             ++HRDLK  N+L+  K          +KI DFGL+          ++ G+  + APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEV 185

Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIY-TLPSHLSPGAR 245
           I   ++     DVWS GV+L+ LL G +PF   + +   +      +   +PS       
Sbjct: 186 IRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFA 244

Query: 246 DLIPRMLIVDPMKRITIPEIRQH 268
            L+      DP  R +   I   
Sbjct: 245 KLMEDCWNPDPHSRPSFTNILDQ 267

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  174 bits (443), Expect = 2e-52
 Identities = 87/331 (26%), Positives = 144/331 (43%), Gaps = 68/331 (20%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-EKVR----REIKILRLF 74
           KL K +G G+FG+V  A H  TG KVA+K     K+  ME E E       REIKIL+L 
Sbjct: 21  KLAK-IGQGTFGEVFKARHRKTGQKVALK-----KVL-MENEKEGFPITALREIKILQLL 73

Query: 75  MHPHIIRLYEVI--------ETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQ 125
            H +++ L E+              IY+V ++ +  +L   +     +    E +   Q 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---- 181
           +++G+ Y HRN ++HRD+K  N+L+     +K+ADFGL+         + +  +      
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192

Query: 182 -YAAPEVISGKLYAGPEVDVWSCGVILYAL---------------------LCGTLPFDD 219
            Y  PE++ G+   GP +D+W  G I+  +                     LCG+     
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-I-TP 250

Query: 220 ENIPN-----LFKKIKGGIY-------TLPSH-LSPGARDLIPRMLIVDPMKRITIPEIR 266
           E  PN     L++K++            L ++   P A DLI ++L++DP +RI   +  
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310

Query: 267 QHPWFQ-----AHLPRYLAVPPPDTMQQAKK 292
            H +F      + L   L+       +    
Sbjct: 311 NHDFFWSDPMPSDLKGMLSTHLTSMFEYLAP 341

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  173 bits (440), Expect = 2e-52
 Identities = 58/263 (22%), Positives = 111/263 (42%), Gaps = 22/263 (8%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           ++G+ +G G FG+V    H     +VAI++++  +    +++   +RE+   R   H ++
Sbjct: 36  EIGELIGKGRFGQVY---HGRWHGEVAIRLIDIERDNEDQLKA-FKREVMAYRQTRHENV 91

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           +       +P  + ++    K   L+  +   K  L  ++ R   Q+I+ G+ Y H   +
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIM------RDGHFLKTSCGSPNYAAPEVISGKL 192
           +H+DLK +N+  D    V I DFGL +I       R    L+   G   + APE+I    
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 193 YAGPE--------VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL--PSHLSP 242
               E         DV++ G I Y L     PF  +    +  ++  G+        +  
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270

Query: 243 GARDLIPRMLIVDPMKRITIPEI 265
              D++      +  +R T  ++
Sbjct: 271 EISDILLFCWAFEQEERPTFTKL 293

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  173 bits (440), Expect = 2e-52
 Identities = 83/279 (29%), Positives = 148/279 (53%), Gaps = 14/279 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
                 +G GS G V +A    +G +VA+K+++   ++  +  E +  E+ I+R + H +
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFN 103

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           ++ +Y+      +++V+ME+++ G L D IV + RL E++     + ++  + Y H   V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRD+K +++LL     VK++DFG    I +D    K+  G+P + APEVIS  LY   E
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY-ATE 221

Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
           VD+WS G+++  ++ G  P+  ++ +  + +        L     +SP  RD + RML+ 
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281

Query: 255 DPMKRITIPEIRQHPWF-QAHLPRYLAVPPPDTMQQAKK 292
           DP +R T  E+  HP+  Q  LP  L       +Q  +K
Sbjct: 282 DPQERATAQELLDHPFLLQTGLPECLV----PLIQLYRK 316

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  172 bits (438), Expect = 3e-52
 Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 23/265 (8%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
             G+ LG G FG+     H  TG  + +K L R    + E +    +E+K++R   HP++
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           ++   V+     +  + EY+K G L   I     +    +  +F + I SG+ Y H   +
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---------------KTSCGSPNYA 183
           +HRDL   N L+    NV +ADFGL+ +M D                    T  G+P + 
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF--KKIKGGI-YTLPSHL 240
           APE+I+G+ Y   +VDV+S G++L  ++       D     +     ++G +    P + 
Sbjct: 190 APEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC 248

Query: 241 SPGARDLIPRMLIVDPMKRITIPEI 265
            P    +  R   +DP KR +  ++
Sbjct: 249 PPSFFPITVRCCDLDPEKRPSFVKL 273

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  172 bits (437), Expect = 3e-52
 Identities = 75/248 (30%), Positives = 124/248 (50%), Gaps = 8/248 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           YK+   LG G    V +AE  +   KVAIK +     +  E  ++  RE+       H +
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+ + +V E     Y+VMEY++   L +YI   G L  D A NF  QI+ G+++ H   +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC--GSPNYAAPEVISGKLYAGP 196
           VHRD+KP+N+L+DS   +KI DFG++  + +    +T+   G+  Y +PE   G+     
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDE 191

Query: 197 EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPG----ARDLIPRM 251
             D++S G++LY +L G  PF+ E  +    K I+  +  + + +         ++I R 
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRA 251

Query: 252 LIVDPMKR 259
              D   R
Sbjct: 252 TEKDKANR 259

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  171 bits (435), Expect = 6e-52
 Identities = 85/279 (30%), Positives = 143/279 (51%), Gaps = 14/279 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y   + +G G+ G V  A    TG +VAI+ +N   ++    +E +  EI ++R   +P+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 78

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+   +      +++VVMEY+  G L D +V +  + E +     ++ +  +E+ H N V
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           +HRD+K +N+LL    +VK+ DFG    I  +     T  G+P + APEV++ K Y GP+
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 196

Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
           VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 256

Query: 255 DPMKRITIPEIRQHPWFQ-AHLPRYLAVPPPDTMQQAKK 292
           D  KR +  E+ QH + + A     L       +  AK+
Sbjct: 257 DVEKRGSAKELLQHQFLKIAKPLSSLT----PLIAAAKE 291

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  172 bits (439), Expect = 2e-51
 Identities = 86/314 (27%), Positives = 134/314 (42%), Gaps = 59/314 (18%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           Y   K +G GSFG V  A+   +  +VAIK +L  ++ KN        RE++I+R+  HP
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN--------RELQIMRIVKHP 92

Query: 78  HIIRLYEVIETPS------DIYVVMEYVKS---GELFDYIVEKGRLQEDEARNFFQQIIS 128
           +++ L     +         + +V+EYV          Y   K  +     + +  Q++ 
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 129 GVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAP 185
            + Y H   + HRD+KP+NLLLD     +K+ DFG + I+  G     S  C S  Y AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYIC-SRYYRAP 210

Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNL- 225
           E+I G       +D+WS G ++  L+ G   F                     E I  + 
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270

Query: 226 -------FKKIKGGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF----- 271
                  F +I+   ++        P A DLI R+L   P  R+T  E   HP+F     
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330

Query: 272 -QAHLPRYLAVPPP 284
            +A +P    +PP 
Sbjct: 331 GEARMPNGRELPPL 344

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  170 bits (434), Expect = 2e-51
 Identities = 69/298 (23%), Positives = 127/298 (42%), Gaps = 53/298 (17%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-H 76
           +Y+L + LG G + +V  A +     KV +KIL          ++K++REIKIL      
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRGG 90

Query: 77  PHIIRLYEVIETPS---DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           P+II L ++++ P       V  E+V + +          L + + R +  +I+  ++YC
Sbjct: 91  PNIITLADIVKDPVSRTPALVF-EHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 146

Query: 134 HRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
           H   ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++    
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 193 YAGPEVDVWSCGVILYALLCGTLPF--------------------DDENIPNLF--KKIK 230
                +D+WS G +L +++    PF                    D  +  + +  +   
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266

Query: 231 GGIYTLPSH----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                L  H                +SP A D + ++L  D   R+T  E  +HP+F 
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  167 bits (424), Expect = 1e-49
 Identities = 90/311 (28%), Positives = 140/311 (45%), Gaps = 64/311 (20%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
             +++L   LG G++G V  A H  TG  VAIK     KI+  +         REIKIL+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKILK 64

Query: 73  LFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQQ 125
            F H +II ++ +    S     ++Y++ E +++    D   ++    L +D  + F  Q
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYFIYQ 120

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---- 181
            +  V+  H + V+HRDLKP NLL++S  ++K+ DFGL+ I+ +     +          
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 182 -------YAAPEVISGKLYAGPEVDVWSCGVILYALL---------------------CG 213
                  Y APEV+         +DVWSCG IL  L                       G
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240

Query: 214 TLPFDDENIPNLF-KKIKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRIT 261
           T P  D ++  +   + +  I +LP             ++P   DL+ RML+ DP KRIT
Sbjct: 241 T-PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299

Query: 262 IPEIRQHPWFQ 272
             E  +HP+ Q
Sbjct: 300 AKEALEHPYLQ 310

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  169 bits (430), Expect = 1e-49
 Identities = 83/325 (25%), Positives = 134/325 (41%), Gaps = 62/325 (19%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEK-VRREIKIL 71
           L  Y+  K +G G+ G V  A  A+    VAIK     K+      +   K   RE+ ++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLM 115

Query: 72  RLFMHPHIIRLYEVIETPS------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
           +   H +II L  V           D+Y+VME + +  L   I  +  L  +       Q
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQ 172

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
           ++ G+++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y AP
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232

Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLF 226
           EVI G  Y    VD+WS G I+  ++   + F                     E +  L 
Sbjct: 233 EVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291

Query: 227 KKIKGGIYTLP-----------------------SHLSPGARDLIPRMLIVDPMKRITIP 263
             ++  +   P                          +  ARDL+ +ML++DP KRI++ 
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351

Query: 264 EIRQHPWFQA-HLPRYLAVPPPDTM 287
           +  QHP+    + P  +  PPP   
Sbjct: 352 DALQHPYINVWYDPAEVEAPPPQIY 376

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  165 bits (420), Expect = 1e-49
 Identities = 67/274 (24%), Positives = 119/274 (43%), Gaps = 15/274 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+L + +G G  G V  AE  +    VA+K+++     +     +++RE +       PH
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           ++ +++  E    +YV M  +   +L   +  +G L    A    +QI S ++  H    
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC--GSPNYAAPEVISGKLYAGP 196
            HRD+KPEN+L+ +     + DFG+++   D    +     G+  Y APE  S   +A  
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES-HATY 214

Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPG----ARDLIPRML 252
             D+++   +LY  L G+ P+  + +  +   I   I   PS + PG       +I R +
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI-PRPSTVRPGIPVAFDAVIARGM 273

Query: 253 IVDPMKR-ITIPEIRQHPWFQAHLPRYLAVPPPD 285
             +P  R +T  +        A     LA    D
Sbjct: 274 AKNPEDRYVTCGD------LSAAAHAALATADQD 301

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  165 bits (419), Expect = 2e-49
 Identities = 76/258 (29%), Positives = 128/258 (49%), Gaps = 10/258 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRLFMHP 77
           +   + +G GSFG+V       T   VAIKI++   ++  E E E +++EI +L     P
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQEITVLSQCDSP 80

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           ++ + Y      + ++++MEY+  G   D ++E G L E +     ++I+ G++Y H   
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 139

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGP 196
            +HRD+K  N+LL     VK+ADFG++  + D    + T  G+P + APEVI    Y   
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DS 198

Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
           + D+WS G+    L  G  P  + + P   LF   K    TL  + S   ++ +   L  
Sbjct: 199 KADIWSLGITAIELARGEPPHSELH-PMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 257

Query: 255 DPMKRITIPEIRQHPWFQ 272
           +P  R T  E+ +H +  
Sbjct: 258 EPSFRPTAKELLKHKFIL 275

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  166 bits (422), Expect = 3e-49
 Identities = 85/322 (26%), Positives = 134/322 (41%), Gaps = 62/322 (19%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEK-VRREIKIL 71
           L  Y+  K +G G+ G V  A  A+    VAIK     K+      +   K   RE+ ++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVLM 78

Query: 72  RLFMHPHIIRLYEVI------ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
           +   H +II L  V       E   D+Y+VME + +  L   I  +  L  +       Q
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMELDHERMSYLLYQ 135

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
           ++ G+++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y AP
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195

Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLF 226
           EVI G  Y    VD+WS G I+  ++ G + F                     E +  L 
Sbjct: 196 EVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254

Query: 227 KKIKGGIYTLP-----------------------SHLSPGARDLIPRMLIVDPMKRITIP 263
             ++  +   P                          +  ARDL+ +ML++D  KRI++ 
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314

Query: 264 EIRQHPWFQA-HLPRYLAVPPP 284
           E  QHP+    + P     PPP
Sbjct: 315 EALQHPYINVWYDPSEAEAPPP 336

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  162 bits (412), Expect = 3e-48
 Identities = 83/311 (26%), Positives = 132/311 (42%), Gaps = 64/311 (20%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI--KNMEMEEKVRREIKILRL 73
              Y   K LG G  G V  A       +VAIK     KI   + +  +   REIKI+R 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRR 64

Query: 74  FMHPHIIRLYEVIETPS--------------DIYVVMEYVKSGELFD--YIVEKGRLQED 117
             H +I++++E++                   +Y+V EY+++    D   ++E+G L E+
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEE 120

Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTS 176
            AR F  Q++ G++Y H   V+HRDLKP NL ++++   +KI DFGL+ IM D H+    
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM-DPHYSHKG 179

Query: 177 CGSPN-----YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------- 217
             S       Y +P ++         +D+W+ G I   +L G   F              
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239

Query: 218 -----DDENIPNLFKKIKGGIYTLPS-----------HLSPGARDLIPRMLIVDPMKRIT 261
                 +E+   L   I   I    +            +S  A D + ++L   PM R+T
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299

Query: 262 IPEIRQHPWFQ 272
             E   HP+  
Sbjct: 300 AEEALSHPYMS 310

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  161 bits (409), Expect = 3e-48
 Identities = 70/263 (26%), Positives = 123/263 (46%), Gaps = 13/263 (4%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIR 81
             LG G++G V+   H  +G  +A+K +  R   N + ++++  ++ I +R    P  + 
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVT 70

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDY---IVEKGRLQEDEARNFFQQIISGVEYCHRNM- 137
            Y  +    D+++ ME + +     Y   I +   + ED        I+  +E+ H  + 
Sbjct: 71  FYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP- 196
           V+HRD+KP N+L+++   VK+ DFG+S  + D        G   Y APE I+ +L     
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY 190

Query: 197 --EVDVWSCGVILYALLCGTLPFDDENIP--NLFKKIKGGIYTLPS-HLSPGARDLIPRM 251
             + D+WS G+ +  L     P+D    P   L + ++     LP+   S    D   + 
Sbjct: 191 SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQC 250

Query: 252 LIVDPMKRITIPEIRQHPWFQAH 274
           L  +  +R T PE+ QHP+F  H
Sbjct: 251 LKKNSKERPTYPELMQHPFFTLH 273

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  162 bits (412), Expect = 8e-48
 Identities = 71/320 (22%), Positives = 120/320 (37%), Gaps = 59/320 (18%)

Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----------- 65
             Y + + +  GS+G V     +  G  VAIK     ++ N   + +             
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIK-----RVFNTVSDGRTVNILSDSFLCKR 75

Query: 66  --REIKILRLFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIV-EKGRLQED 117
             REI++L  F HP+I+ L ++           +Y+V E +++ +L   I  ++  +   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQ 134

Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177
             + F   I+ G+   H   VVHRDL P N+LL    ++ I DF L+             
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194

Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL---------------------CGTLP 216
               Y APE++         VD+WS G ++  +                       GT  
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254

Query: 217 FDD-ENIPN----------LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
            +D     +          L          +     P A DLI +ML  +P +RI+  + 
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314

Query: 266 RQHPWFQA-HLPRYLAVPPP 284
            +HP+F++   P  L     
Sbjct: 315 LRHPYFESLFDPLDLTEGLS 334

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  161 bits (410), Expect = 2e-47
 Identities = 88/301 (29%), Positives = 136/301 (45%), Gaps = 54/301 (17%)

Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR---REIKILRL 73
           P Y     +G G++G V  A   L   +VAIK     KI   E +   +   REIKIL  
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 81

Query: 74  FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQQI 126
           F H +II + ++I  P+     D+Y+V + +++    D   +++   L  D    F  QI
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQI 137

Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNY 182
           + G++Y H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN 221
            APE++         +D+WS G IL  +L                      G+   +D N
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 222 ----------IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                     + +L  K K     L  +    A DL+ +ML  +P KRI + +   HP+ 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

Query: 272 Q 272
           +
Sbjct: 318 E 318

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  160 bits (406), Expect = 2e-47
 Identities = 66/266 (24%), Positives = 119/266 (44%), Gaps = 12/266 (4%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHP 77
            +    +G G+ G+V       TGH +A+K +  R+  N E  +++  ++ ++ +    P
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I++ +    T +D+++ ME + +         +G + E         I+  + Y     
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 138 -VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            V+HRD+KP N+LLD +  +K+ DFG+S  + D      S G   Y APE I       P
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204

Query: 197 E----VDVWSCGVILYALLCGTLPFDDENIP--NLFKKIKGGIYTLPSHL--SPGARDLI 248
           +     DVWS G+ L  L  G  P+ +       L K ++     LP H+  S   +  +
Sbjct: 205 DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFV 264

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAH 274
              L  D  KR    ++ +H + + +
Sbjct: 265 KDCLTKDHRKRPKYNKLLEHSFIKRY 290

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  159 bits (404), Expect = 3e-47
 Identities = 65/253 (25%), Positives = 114/253 (45%), Gaps = 13/253 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+LG+ LG G   +V +A        VA+K+L     ++     + RRE +      HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 79  IIRLYEVIETPSDI----YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           I+ +Y+  E  +      Y+VMEYV    L D +  +G +    A          + + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC----GSPNYAAPEVISG 190
           +N ++HRD+KP N+++ +   VK+ DFG++  + D     T      G+  Y +PE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSH---LSPGARD 246
                   DV+S G +LY +L G  PF  ++ +   ++ ++       +    LS     
Sbjct: 194 D-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 252

Query: 247 LIPRMLIVDPMKR 259
           ++ + L  +P  R
Sbjct: 253 VVLKALAKNPENR 265

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  158 bits (402), Expect = 5e-47
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 28/285 (9%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y+L + +G G+   V+ A  A    KVAIK +N  K +   M+E + +EI+ +    HP
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-SMDE-LLKEIQAMSQCHHP 73

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYI--------VEKGRLQEDEARNFFQQIISG 129
           +I+  Y       ++++VM+ +  G + D I         + G L E       ++++ G
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL------KTSCGSPNYA 183
           +EY H+N  +HRD+K  N+LL    +V+IADFG+S  +  G  +      KT  G+P + 
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL----- 236
           APEV+        + D+WS G+    L  G  P+     P   L   ++    +L     
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-PMKVLMLTLQNDPPSLETGVQ 252

Query: 237 ----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
                       R +I   L  DP KR T  E+ +H +FQ    +
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  158 bits (401), Expect = 8e-47
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 15/273 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +++   LG G+FGKV  A++  TG   A K++     K+ E  E    EI+IL    HP+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHPY 77

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           I++L         +++++E+   G +   ++E    L E + +   +Q++  + + H   
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYA-- 194
           ++HRDLK  N+L+  + ++++ADFG+S         + +  G+P + APEV+  +     
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197

Query: 195 --GPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL--PSHLSPGARDLI 248
               + D+WS G+ L  +     P  + N P   L K  K    TL  PS  S   RD +
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256

Query: 249 PRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLA 280
              L  +P  R +  ++ +HP+       + L 
Sbjct: 257 KIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  158 bits (401), Expect = 9e-47
 Identities = 77/270 (28%), Positives = 131/270 (48%), Gaps = 11/270 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            + + + LG GS+G V  A H  TG  VAIK      +      +++ +EI I++    P
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ-----VPVESDLQEIIKEISIMQQCDSP 84

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFD-YIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           H+++ Y      +D+++VMEY  +G + D   +    L EDE     Q  + G+EY H  
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAG 195
             +HRD+K  N+LL+++ + K+ADFG++  + D    + T  G+P + APEVI    Y  
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-N 203

Query: 196 PEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 252
              D+WS G+    +  G  P+ D + +  +F        T   P   S    D + + L
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCL 263

Query: 253 IVDPMKRITIPEIRQHPWFQAHLPRYLAVP 282
           +  P +R T  ++ QHP+ ++     +   
Sbjct: 264 VKSPEQRATATQLLQHPFVRSAKGVSILRD 293

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  158 bits (403), Expect = 1e-46
 Identities = 85/295 (28%), Positives = 135/295 (45%), Gaps = 47/295 (15%)

Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
             Y     +G G++G V  A    +G KVAIK L+R   ++    ++  RE+ +L+   H
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQH 82

Query: 77  PHIIRLYEVIETPS------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGV 130
            ++I L +V    S      D Y+VM ++++ +L   +    +  E++ +    Q++ G+
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--GLKFSEEKIQYLVYQMLKGL 139

Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVI 188
           +Y H   VVHRDLKP NL ++    +KI DFGL+         ++ T      Y APEVI
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----YRAPEVI 195

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLF-KK 228
              ++    VD+WS G I+  +L G   F                     E +  L  K 
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255

Query: 229 IKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
            K  I +LP              SP A DL+ +ML +D  KR+T  +   HP+F+
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  159 bits (404), Expect = 1e-46
 Identities = 82/308 (26%), Positives = 137/308 (44%), Gaps = 47/308 (15%)

Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
             Y+    +G G++G V  A    TG +VA+K L  R  +++   ++  RE+++L+   H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 77  PHIIRLYEVIETPS------DIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQQIIS 128
            ++I L +V           D+Y+V   + +    D   IV+  +L +D  +    QI+ 
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILR 143

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
           G++Y H   ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIM 201

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLF-KK 228
              ++    VD+WS G I+  LL G   F                     E +  +  + 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261

Query: 229 IKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLP 276
            +  I +L               +P A DL+ +ML++D  KRIT  +   H +F   H P
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321

Query: 277 RYLAVPPP 284
               V  P
Sbjct: 322 DDEPVADP 329

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  158 bits (403), Expect = 2e-46
 Identities = 78/322 (24%), Positives = 127/322 (39%), Gaps = 61/322 (18%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLF 74
           +  +++ +  G G+FG V++ +   TG  VAIK ++   + +N E+     + ++ L + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-----QIMQDLAVL 76

Query: 75  MHPHIIRLYEVIETPS-----DIY--VVMEYVKS---GELFDYIVEKGRLQEDEARNFFQ 124
            HP+I++L     T       DIY  VVMEYV         +Y   +        + F  
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136

Query: 125 QIISGVEYCHRNM--VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTS--CGS 179
           Q+I  +   H     V HRD+KP N+L++ +   +K+ DFG +  +        +  C S
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYIC-S 194

Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDE 220
             Y APE+I G  +    VD+WS G I   ++ G   F                     E
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254

Query: 221 NIPNL--------FKKIKG-----GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
            +  L            KG              +  A DL+  +L   P +R+   E   
Sbjct: 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314

Query: 268 HPWFQ------AHLPRYLAVPP 283
           HP+F         LP    +P 
Sbjct: 315 HPYFDELHDPATKLPNNKDLPE 336

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  159 bits (404), Expect = 3e-46
 Identities = 78/324 (24%), Positives = 124/324 (38%), Gaps = 80/324 (24%)

Query: 20  KLGKTLGIGSFGKVKIA--EHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             G  +G G++G V  A  +        A+K     +I+   +     REI +LR   HP
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALK-----QIEGTGISMSACREIALLRELKHP 78

Query: 78  HIIRLYEVIETPSD--IYVVMEYV--------KSGELFDYIVEKGRLQEDEARNFFQQII 127
           ++I L +V  + +D  ++++ +Y         K         +  +L     ++   QI+
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWN----VKIADFGLSNIMRDGHFLKTSCGSPN-- 181
            G+ Y H N V+HRDLKP N+L+  +      VKIAD G + +      LK         
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVV 196

Query: 182 ----YAAPEVISG-KLYAGPEVDVWSCGVILYALL------------------------- 211
               Y APE++ G + Y    +D+W+ G I   LL                         
Sbjct: 197 VTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255

Query: 212 -----CGTLPFDDE--------NIPNLFKKIKGGIYTLPS----------HLSPGARDLI 248
                 G  P D +            L K  +   YT  S               A  L+
Sbjct: 256 RIFNVMGF-PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 314

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQ 272
            ++L +DP+KRIT  +  Q P+F 
Sbjct: 315 QKLLTMDPIKRITSEQAMQDPYFL 338

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  157 bits (399), Expect = 7e-46
 Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 59/314 (18%)

Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEK-VRREIKILR 72
             Y+  + +G G++G V  A    TG KVAIK     K+      E+  K   RE+++L+
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLK 79

Query: 73  LFMHPHIIRLYEVIETPS------DIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQ 124
              H ++I L +V           D Y+VM ++ +    D   +++  +L ED  +    
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVY 135

Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNY 182
           Q++ G+ Y H   ++HRDLKP NL ++    +KI DFGL+         ++ T      Y
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----Y 191

Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI------------- 229
            APEVI   +     VD+WS G I+  ++ G   F   +  +  K+I             
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251

Query: 230 -------KGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                  K  +  LP           ++ SP A +L+ +ML++D  +R+T  E   HP+F
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

Query: 272 QA-HLPRYLAVPPP 284
           ++ H          
Sbjct: 312 ESLHDTEDEPQVQK 325

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  156 bits (395), Expect = 2e-45
 Identities = 71/268 (26%), Positives = 113/268 (42%), Gaps = 10/268 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +   + +G GSFG V  A        VAIK ++    ++ E  + + +E++ L+   HP+
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
            I+           ++VMEY          V K  LQE E        + G+ Y H + +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG--P 196
           +HRD+K  N+LL     VK+ DFG ++IM       +  G+P + APEVI          
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDG 232

Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL-PSHLSPGARDLIPRMLI 253
           +VDVWS G+    L     P  + N     L+   +     L   H S   R+ +   L 
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 291

Query: 254 VDPMKRITIPEIRQHPWF-QAHLPRYLA 280
             P  R T   + +H +  +   P  + 
Sbjct: 292 KIPQDRPTSEVLLKHRFVLRERPPTVIM 319

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  156 bits (395), Expect = 2e-45
 Identities = 63/301 (20%), Positives = 123/301 (40%), Gaps = 49/301 (16%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           ++    LG G+ G V    H  +G  +A K+++        +  ++ RE+++L     P+
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPY 92

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM- 137
           I+  Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y      
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y   +
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY-SVQ 210

Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-------------------------- 231
            D+WS G+ L  +  G  P    +   L                                
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270

Query: 232 -----GIYTLPSHL-------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273
                 I+ L  ++             S   +D + + LI +P +R  + ++  H + + 
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330

Query: 274 H 274
            
Sbjct: 331 S 331

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  156 bits (395), Expect = 3e-45
 Identities = 81/328 (24%), Positives = 126/328 (38%), Gaps = 84/328 (25%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
            Y LGKTLG GSFG V       +G + A+K +L   + KN        RE+ I+++  H
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN--------RELDIMKVLDH 59

Query: 77  PHIIRLYEVIETPS--------------------------------------DIYVVMEY 98
            +II+L +   T                                         + V+MEY
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 99  VKS---GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-W 154
           V       L  +I     +  +    +  Q+   V + H   + HRD+KP+NLL++SK  
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 155 NVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC 212
            +K+ DFG +  +        +  C S  Y APE++ G     P +D+WS G +   L+ 
Sbjct: 180 TLKLCDFGSAKKLIPSEPS-VAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237

Query: 213 GTLPF-------------------DDENIPNL--------FKKIKGGIYT--LPSHLSPG 243
           G   F                     E +  +        F  +K   +   LP      
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSL 297

Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF 271
           A DL+ ++L  +P  RI   E   HP+F
Sbjct: 298 AIDLLEQILRYEPDLRINPYEAMAHPFF 325

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  151 bits (384), Expect = 2e-44
 Identities = 59/292 (20%), Positives = 110/292 (37%), Gaps = 51/292 (17%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
            L + +G G +G+V        G  VA+KI + R  K+   E     E+    +  H +I
Sbjct: 11  TLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENI 64

Query: 80  IRLY----EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH- 134
           +           + + ++++  Y + G L+DY+ +   L           I SG+ + H 
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 135 -------RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-----KTSCGSPNY 182
                  +  + HRDLK +N+L+       IAD GL+ +                G+  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 183 AAPEVISGKLYAGPE-----VDVWSCGVILYALLCGT----------LPFDDENIPNL-F 226
            APEV+   +          VD+W+ G++L+ +               PF D    +  F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 227 KKIKGGIY------TLPSHLS-----PGARDLIPRMLIVDPMKRITIPEIRQ 267
           + ++  +        +P+             L+      +P  R+T   I++
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  152 bits (385), Expect = 3e-44
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 17/267 (6%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIR 81
             +G G++G V    H  +G  +A+K +  R   + + ++++  ++ + +R    P+I++
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85

Query: 82  LYEVIETPSDIYVVMEYVKSGELFDY----IVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            Y  +    D ++ ME + +     Y     V    + E+         +  + +   N+
Sbjct: 86  FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145

Query: 138 -VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            ++HRD+KP N+LLD   N+K+ DFG+S  + D        G   Y APE I        
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205

Query: 197 ---EVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTLPSHL----SPGARDL 247
                DVWS G+ LY L  G  P+   N     L + +KG    L +      SP   + 
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINF 265

Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274
           +   L  D  KR    E+ +HP+   +
Sbjct: 266 VNLCLTKDESKRPKYKELLKHPFILMY 292

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  151 bits (383), Expect = 3e-43
 Identities = 79/337 (23%), Positives = 133/337 (39%), Gaps = 91/337 (27%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVR--REIKI 70
           L  Y+L K LG G++G V  +    TG  VA+K     KI +      + + R  REI I
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQ-RTFREIMI 61

Query: 71  LRLF-MHPHIIRLYEVIETPS--DIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQQ 125
           L     H +I+ L  V+   +  D+Y+V +Y+++    D   ++    L+    +    Q
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDVYLVFDYMET----DLHAVIRANILEPVHKQYVVYQ 117

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---- 181
           +I  ++Y H   ++HRD+KP N+LL+++ +VK+ADFGLS    +   +  +         
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 182 ------------------YAAPEVI-SGKLYAGPEVDVWSCGVILYALLC---------- 212
                             Y APE++     Y    +D+WS G IL  +LC          
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKY-TKGIDMWSLGCILGEILCGKPIFPGSST 236

Query: 213 -----------GTLPFDD-------------ENIP--------NLFKKIKGGIYTLPSHL 240
                           +D             E++         N           L    
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296

Query: 241 -----SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                +  A DL+ ++L  +P KRI+  +  +HP+  
Sbjct: 297 PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  149 bits (379), Expect = 3e-43
 Identities = 72/292 (24%), Positives = 136/292 (46%), Gaps = 23/292 (7%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMHP 77
           ++L + +G G++G+V    H  TG   AIK+++       + EE++++EI +L+    H 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHR 81

Query: 78  HIIRLYE------VIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISG 129
           +I   Y              +++VME+  +G + D I   +   L+E+      ++I+ G
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVI 188
           + + H++ V+HRD+K +N+LL     VK+ DFG+S  +      + +  G+P + APEVI
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 189 SGKLYA----GPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL-PSHLS 241
           +           + D+WS G+    +  G  P  D + P   LF   +     L     S
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKWS 260

Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPDTMQQAKK 292
              +  I   L+ +  +R    ++ +HP+       R + +   D + + KK
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKK 312

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  150 bits (381), Expect = 4e-43
 Identities = 66/330 (20%), Positives = 117/330 (35%), Gaps = 63/330 (19%)

Query: 5   SNRSSSGVDMFLPN---YKLGKTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNME 59
            N    G+  FLP    Y+L   +G G      V +A +  TG  V ++ +N     N E
Sbjct: 10  ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-E 68

Query: 60  MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE--KGRLQED 117
           M   ++ E+ + +LF HP+I+         ++++VV  ++  G   D I       + E 
Sbjct: 69  MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL 128

Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-------- 169
                 Q ++  ++Y H    VHR +K  ++L+     V ++    +  M          
Sbjct: 129 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188

Query: 170 GHFLKTSCGSPNYAAPEVISGKLYA-GPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFK 227
             F K S     + +PEV+   L     + D++S G+    L  G +PF D      L +
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248

Query: 228 KIKGGIYTL---------------------------------------------PSHLSP 242
           K+ G +  L                                                 SP
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308

Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                + + L  +P  R +   +  H +F+
Sbjct: 309 HFHHFVEQCLQRNPDARPSASTLLNHSFFK 338

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  153 bits (389), Expect = 2e-42
 Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 24/248 (9%)

Query: 19  YKLGKTLGIGSFGKVKIAE-HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           Y++   +  G  G + +A    + G  V +K L      + E +     E + L   +HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL--VHSGDAEAQAMAMAERQFLAEVVHP 139

Query: 78  HIIRLYEVIETPSDI-----YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
            I++++  +E          Y+VMEYV    L        +L   EA  +  +I+  + Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSY 197

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGK 191
            H   +V+ DLKPEN++L  +  +K+ D G  + +   G+      G+P + APE++   
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY----GTPGFQAPEIVRTG 252

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
                  D+++ G  L AL       +   +  L +                   L+ R 
Sbjct: 253 --PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED------DPVLKTYDSYGRLLRRA 304

Query: 252 LIVDPMKR 259
           +  DP +R
Sbjct: 305 IDPDPRQR 312

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  146 bits (371), Expect = 5e-42
 Identities = 63/315 (20%), Positives = 120/315 (38%), Gaps = 56/315 (17%)

Query: 2   DGASNRSSSGVDMFLPNY-----KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK 56
              S+ S SG+ + +        ++ K +G G +G+V + +    G KVA+K+    +  
Sbjct: 17  QSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEA 74

Query: 57  NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKG 112
           +   E     EI    L  H +I+         +     +Y++ +Y ++G L+DY+    
Sbjct: 75  SWFRE----TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST- 129

Query: 113 RLQEDEARNFFQQIISGVEYCH--------RNMVVHRDLKPENLLLDSKWNVKIADFGLS 164
            L            +SG+ + H        +  + HRDLK +N+L+       IAD GL+
Sbjct: 130 TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189

Query: 165 NIMRDGHFL-----KTSCGSPNYAAPEVISGKLYAGPE-----VDVWSCGVILYALLCGT 214
                          T  G+  Y  PEV+   L           D++S G+IL+ +    
Sbjct: 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249

Query: 215 ----------LPFDDENIPNL-FKKIKGGIY------TLPSHLS-----PGARDLIPRML 252
                     LP+ D    +  ++ ++  +       + P+  S          L+    
Sbjct: 250 VSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309

Query: 253 IVDPMKRITIPEIRQ 267
             +P  R+T   +++
Sbjct: 310 AHNPASRLTALRVKK 324

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  146 bits (371), Expect = 4e-41
 Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 43/228 (18%)

Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEK-VRREIKILR 72
             Y++   +G GS+G V  A   L    VAIK     KI  +    ++ K + REI IL 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAILN 107

Query: 73  LFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
              H H++++ +++         ++YVV+E   S +          L E   +     ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLL 166

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------ 181
            GV+Y H   ++HRDLKP N L++   +VK+ DFGL+  +       +            
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226

Query: 182 ----------------------YAAPEVISGKLYAGPEVDVWSCGVIL 207
                                 Y APE+I  +      +DVWS G I 
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 46.0 bits (109), Expect = 8e-06
 Identities = 18/56 (32%), Positives = 26/56 (46%), Gaps = 1/56 (1%)

Query: 222 IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLP 276
           I    K+    +       S  A  L+ RML+ +P KRITI E   HP+F+   + 
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  144 bits (364), Expect = 5e-41
 Identities = 58/316 (18%), Positives = 120/316 (37%), Gaps = 56/316 (17%)

Query: 1   MDGASNRSSSGVDMFLPNY-----KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI 55
            D  ++ S SG+ + +         L +++G G FG+V   +    G +VA+KI + R+ 
Sbjct: 21  YDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREE 78

Query: 56  KNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEK 111
           ++   E     EI    +  H +I+         +     +++V +Y + G LFDY+  +
Sbjct: 79  RSWFRE----AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NR 133

Query: 112 GRLQEDEARNFFQQIISGVEYCHRNM--------VVHRDLKPENLLLDSKWNVKIADFGL 163
             +  +          SG+ + H  +        + HRDLK +N+L+       IAD GL
Sbjct: 134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193

Query: 164 SNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPE-----VDVWSCGVILYALLCG 213
           +                  G+  Y APEV+   +           D+++ G++ + +   
Sbjct: 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

Query: 214 T----------LPFDDENIPNL-FKKIKGGIY------TLPSHLS-----PGARDLIPRM 251
                      LP+ D    +   ++++  +        +P+             ++   
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 313

Query: 252 LIVDPMKRITIPEIRQ 267
              +   R+T   I++
Sbjct: 314 WYANGAARLTALRIKK 329

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  146 bits (369), Expect = 6e-41
 Identities = 77/348 (22%), Positives = 117/348 (33%), Gaps = 97/348 (27%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEK-VRREIKIL 71
             NY +   +G GS+G V +A    T   VAIK     K+  M    ++ K + REI IL
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILREITIL 79

Query: 72  RLFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQI 126
                 +IIRLY++I         ++Y+V+E   S +L         L E+  +     +
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNL 138

Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----- 181
           + G  + H + ++HRDLKP N LL+   +VK+ DFGL+  +                   
Sbjct: 139 LLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 182 ------------------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP 223
                             Y APE+I  +      +D+WS G I   LL       ++   
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258

Query: 224 N--LFK---------KIKGGIYTLPSHL----------------------SPGARDLIPR 250
              LF                    S+                        P     I  
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318

Query: 251 M--------------------------LIVDPMKRITIPEIRQHPWFQ 272
                                      L  +P KRITI +   HP+ +
Sbjct: 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  141 bits (358), Expect = 1e-40
 Identities = 39/248 (15%), Positives = 77/248 (31%), Gaps = 36/248 (14%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+L    G     +   A       +VA+  ++ + +   ++ ++       L     P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           + R+ +V+ T +   VV E+++ G L +            A    Q + +  +  HR  V
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
                 P  + +    +V +A                                  A P+ 
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPD--------ANPQD 183

Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFK---KIKGGIYTLPSHLSPGA----RDLIPRM 251
           D+   G  LYALL    P  +  + +      +   G    P+ +          +  R 
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARS 243

Query: 252 LIVDPMKR 259
           +  D   R
Sbjct: 244 VQGDGGIR 251

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  142 bits (360), Expect = 2e-40
 Identities = 63/294 (21%), Positives = 116/294 (39%), Gaps = 47/294 (15%)

Query: 1   MDGASNRSSSGVDMFLP-------NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRR 53
           M    +  SSGVD+            +L +    G FG V  A+       VA+KI   +
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQ 58

Query: 54  KIKNMEMEEKVRREIKILRLFMHPHIIRLY----EVIETPSDIYVVMEYVKSGELFDYIV 109
             ++ + E     E+  L    H +I++             D++++  + + G L D++ 
Sbjct: 59  DKQSWQNE----YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL- 113

Query: 110 EKGRLQEDEARNFFQQIISGVEYCHRNM----------VVHRDLKPENLLLDSKWNVKIA 159
           +   +  +E  +  + +  G+ Y H ++          + HRD+K +N+LL +     IA
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173

Query: 160 DFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPE----VDVWSCGVILYALLC 212
           DFGL+     G          G+  Y APEV+ G +    +    +D+++ G++L+ L  
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

Query: 213 GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM--LIVDPMKRITIPE 264
                D               Y LP     G    +  M  ++V   KR  + +
Sbjct: 234 RCTAADGPVDE----------YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD 277

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  138 bits (349), Expect = 1e-37
 Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 11/223 (4%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
            +   LG G +G+V           VA+K L   K   ME  E+  +E  +++   HP++
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTME-VEEFLKEAAVMKEIKHPNL 278

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           ++L  V       Y++ E++  G L DY+    +  +          QI S +EY  +  
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY--AAPEVISGKLYAG 195
            +HR+L   N L+     VK+ADFGLS +M    +   +         APE ++   ++ 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS- 397

Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
            + DVW+ GV+L+ +   G  P+   ++  +++ ++   Y + 
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME 439

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  136 bits (344), Expect = 1e-37
 Identities = 71/256 (27%), Positives = 118/256 (46%), Gaps = 13/256 (5%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
            LG+ +G G+FG+V           VA+K    R+    +++ K  +E +IL+ + HP+I
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNI 174

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMV 138
           +RL  V      IY+VME V+ G+   ++  +G  L+            +G+EY      
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY----AAPEVISGKLYA 194
           +HRDL   N L+  K  +KI+DFG+S    DG +   S G         APE ++   Y+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVY-AASGGLRQVPVKWTAPEALNYGRYS 293

Query: 195 GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 251
             E DVWS G++L+     G  P+ + +     + ++ G   L  P         L+ + 
Sbjct: 294 -SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAVFRLMEQC 351

Query: 252 LIVDPMKRITIPEIRQ 267
              +P +R +   I Q
Sbjct: 352 WAYEPGQRPSFSTIYQ 367

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  131 bits (333), Expect = 6e-37
 Identities = 64/224 (28%), Positives = 112/224 (50%), Gaps = 19/224 (8%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL +T+G G FG V + +    G+KVA+K +     KN    +    E  ++    H ++
Sbjct: 24  KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNL 76

Query: 80  IRLYEVI--ETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHR 135
           ++L  VI  E    +Y+V EY+  G L DY+  +GR  L  D    F   +   +EY   
Sbjct: 77  VQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYA 194
           N  VHRDL   N+L+      K++DFGL+   ++    + +   P  + APE +  K ++
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS 192

Query: 195 GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
             + DVWS G++L+ +   G +P+    + ++  +++ G Y + 
Sbjct: 193 -TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMD 234

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (339), Expect = 2e-36
 Identities = 64/223 (28%), Positives = 112/223 (50%), Gaps = 17/223 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL +T+G G FG V + +    G+KVA+K +     KN    +    E  ++    H ++
Sbjct: 196 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNL 248

Query: 80  IRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRN 136
           ++L  VI E    +Y+V EY+  G L DY+  +GR  L  D    F   +   +EY   N
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAG 195
             VHRDL   N+L+      K++DFGL+   ++    + +   P  + APE +  K ++ 
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFST 365

Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
            + DVWS G++L+ +   G +P+    + ++  +++ G Y + 
Sbjct: 366 -KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMD 406

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  130 bits (328), Expect = 3e-36
 Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 11/223 (4%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
            +   LG G +G+V           VA+K L   K   ME  E+  +E  +++   HP++
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTME-VEEFLKEAAVMKEIKHPNL 71

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           ++L  V       Y++ E++  G L DY+    +  +          QI S +EY  +  
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 195
            +HRDL   N L+     VK+ADFGLS +M    +   +    P  + APE ++   ++ 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS- 190

Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
            + DVW+ GV+L+ +   G  P+   ++  +++ ++   Y + 
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME 232

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  130 bits (328), Expect = 4e-36
 Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 17/225 (7%)

Query: 20  KLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           K  + LG G+FG V++         TG  VA+K L   +    E      REI+IL+   
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 69

Query: 76  HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEY 132
           H +I++   V  +     + ++MEY+  G L DY+ + K R+   +   +  QI  G+EY
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSP-NYAAPEVI 188
                 +HRDL   N+L++++  VKI DFGL+ ++         K    SP  + APE +
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI 233
           +   ++    DVWS GV+LY L   T     ++ P  F ++ G  
Sbjct: 190 TESKFS-VASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGND 231

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  130 bits (328), Expect = 7e-36
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 17/225 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           K  + LG G+FG V++  +      TG  VA+K L   +    E      REI+IL+   
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 100

Query: 76  HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEY 132
           H +I++   V  +     + ++MEY+  G L DY+ + K R+   +   +  QI  G+EY
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCG-SP-NYAAPEVI 188
                 +HRDL   N+L++++  VKI DFGL+ ++      +     G SP  + APE +
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI 233
           +   ++    DVWS GV+LY L   T     ++ P  F ++ G  
Sbjct: 221 TESKFS-VASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGND 262

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  129 bits (327), Expect = 1e-35
 Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 20/230 (8%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVR---REIKILR 72
           K  K LG G+FG V        G K    VAIK L     +     +  +    E  ++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-----REATSPKANKEILDEAYVMA 72

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVE 131
              +PH+ RL  +  T + + ++ + +  G L DY+ E K  +      N+  QI  G+ 
Sbjct: 73  SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVI 188
           Y     +VHRDL   N+L+ +  +VKI DFGL+ ++        + G   P  + A E I
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 189 SGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
             ++Y   + DVWS GV ++ L+  G+ P+D      +   ++ G   LP
Sbjct: 192 LHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP 239

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  131 bits (332), Expect = 2e-35
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 13/223 (5%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +        +VAIK L           E   +E ++++   H  +
Sbjct: 187 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKL 241

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  +    L+  +  +   QI SG+ Y  R  
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 195
            VHRDL+  N+L+      K+ADFGL+ ++ D  +        P  + APE      +  
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT- 359

Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
            + DVWS G++L  L   G +P+       +  +++ G Y +P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 401

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  132 bits (334), Expect = 2e-35
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 13/223 (5%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           +L   LG G FG+V +        +VAIK L   K   M   E   +E ++++   H  +
Sbjct: 270 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL---KPGTMS-PEAFLQEAQVMKKLRHEKL 324

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
           ++LY V+ +   IY+V EY+  G L D++  +    L+  +  +   QI SG+ Y  R  
Sbjct: 325 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 195
            VHRDL+  N+L+      K+ADFGL+ ++ D  +        P  + APE      +  
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT- 442

Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
            + DVWS G++L  L   G +P+       +  +++ G Y +P
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 484

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  127 bits (320), Expect = 7e-35
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           K  + LG G FGKV++  +      TG +VA+K L  +          +++EI+ILR   
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNLY 81

Query: 76  HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEY 132
           H +I++   +        I ++ME++ SG L +Y+   K ++   +   +  QI  G++Y
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSP-NYAAPEVI 188
                 VHRDL   N+L++S+  VKI DFGL+  +        +K    SP  + APE +
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201

Query: 189 SGKLYAGPEVDVWSCGVILY 208
               +     DVWS GV L+
Sbjct: 202 MQSKFY-IASDVWSFGVTLH 220

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  127 bits (321), Expect = 7e-35
 Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 15/200 (7%)

Query: 20  KLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           K    LG G+FG V++         TG  VA+K L   +    + +   +REI+IL+   
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALH 82

Query: 76  HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEY 132
              I++   V   P    + +VMEY+ SG L D++   + RL       +  QI  G+EY
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTSCG-SP-NYAAPEVI 188
                 VHRDL   N+L++S+ +VKIADFGL+ ++     +++    G SP  + APE +
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 189 SGKLYAGPEVDVWSCGVILY 208
           S  +++  + DVWS GV+LY
Sbjct: 203 SDNIFS-RQSDVWSFGVVLY 221

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  125 bits (317), Expect = 1e-34
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 11/222 (4%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
              + +G G FG V +    L   KVAIK +   +   M  EE    E +++    HP +
Sbjct: 11  TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI---REGAMS-EEDFIEEAEVMMKLSHPKL 65

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMV 138
           ++LY V    + I +V E+++ G L DY+   +G    +        +  G+ Y     V
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 196
           +HRDL   N L+     +K++DFG++  + D  +  ++    P  +A+PEV S   Y+  
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-S 184

Query: 197 EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
           + DVWS GV+++ +   G +P+++ +   + + I  G + L 
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLY 225

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  124 bits (315), Expect = 2e-34
 Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 11/222 (4%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
            L K LG G FG VK+ +     + VA+K++     +    E++  +E + +    HP +
Sbjct: 11  TLLKELGSGQFGVVKLGK-WKGQYDVAVKMIK----EGSMSEDEFFQEAQTMMKLSHPKL 65

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMV 138
           ++ Y V      IY+V EY+ +G L +Y+   G+ L+  +       +  G+ +   +  
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 196
           +HRDL   N L+D    VK++DFG++  + D  ++ +     P  ++APEV     Y+  
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS-S 184

Query: 197 EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
           + DVW+ G++++ +   G +P+D      +  K+  G + L 
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLY 225

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  126 bits (317), Expect = 3e-34
 Identities = 65/281 (23%), Positives = 106/281 (37%), Gaps = 48/281 (17%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L N KL + +G G +G V      L    VA+K+ +    +N   E    + I  + L  
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINE----KNIYRVPLME 65

Query: 76  HPHIIRLYEVIETPSDI-----YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGV 130
           H +I R     E  +        +VMEY  +G L  Y+          +      +  G+
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGL 124

Query: 131 EYCH---------RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS----- 176
            Y H         +  + HRDL   N+L+ +     I+DFGLS  +     ++       
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 177 ----CGSPNYAAPEVISGKL------YAGPEVDVWSCGVILYALLCG-TLPFDDENIPNL 225
                G+  Y APEV+ G +       A  +VD+++ G+I + +    T  F  E++P  
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE- 243

Query: 226 FKKIKGGIYTLPSHLSPGARDLIPRM--LIVDPMKRITIPE 264
                   Y +      G       M  L+    +R   PE
Sbjct: 244 --------YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE 276

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  124 bits (314), Expect = 3e-34
 Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL + LG G FG+V +        KVA+K L   K  +M   +    E  +++   H  +
Sbjct: 16  KLVERLGAGQFGEVWMGY-YNGHTKVAVKSL---KQGSMS-PDAFLAEANLMKQLQHQRL 70

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
           +RLY V+ T   IY++ EY+++G L D++       L  ++  +   QI  G+ +     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 195
            +HRDL+  N+L+    + KIADFGL+ ++ D  +        P  + APE I+   +  
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT- 188

Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
            + DVWS G++L  ++  G +P+     P + + ++ G Y + 
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMV 230

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  125 bits (316), Expect = 4e-34
 Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 14/227 (6%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           K  K LG G+FG V        G K    VAIK L  R+  + +  +++  E  ++    
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           +PH+ RL  +  T + + ++ + +  G L DY+ E K  +      N+  QI  G+ Y  
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVISGK 191
              +VHRDL   N+L+ +  +VKI DFGL+ ++        + G   P  + A E I  +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 192 LYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
           +Y   + DVWS GV ++ L+  G+ P+D      +   ++ G   LP
Sbjct: 195 IYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP 239

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  124 bits (314), Expect = 6e-34
 Identities = 72/200 (36%), Positives = 97/200 (48%), Gaps = 16/200 (8%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           K  + LG G FGKV +  +  T       VA+K L  +     +     ++EI ILR   
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTLY 91

Query: 76  HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           H HII+     E      + +VMEYV  G L DY+  +  +   +   F QQI  G+ Y 
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYL 150

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCG-SP-NYAAPEVIS 189
           H    +HRDL   N+LLD+   VKI DFGL+  + +GH  +     G SP  + APE + 
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210

Query: 190 -GKLYAGPEVDVWSCGVILY 208
             K Y     DVWS GV LY
Sbjct: 211 EYKFYY--ASDVWSFGVTLY 228

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  124 bits (314), Expect = 7e-34
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 16/228 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEME-EKVRREIKILRLF 74
           +  K LG G FG V        G      V IK++   + K+     + V   +  +   
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI---EDKSGRQSFQAVTDHMLAIGSL 72

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
            H HI+RL  +    S + +V +Y+  G L D++ + +G L      N+  QI  G+ Y 
Sbjct: 73  DHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVISG 190
             + +VHR+L   N+LL S   V++ADFG+++++           +  P  + A E I  
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191

Query: 191 KLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
             Y   + DVWS GV ++ L+  G  P+    +  +   ++ G   L 
Sbjct: 192 GKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLA 237

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  123 bits (311), Expect = 1e-33
 Identities = 70/225 (31%), Positives = 109/225 (48%), Gaps = 12/225 (5%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +LG+ +G G FG V    +    +    VAIK    +   +  + EK  +E   +R F H
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQFDH 75

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR 135
           PHI++L  VI T + ++++ME    GEL  ++   K  L       +  Q+ + + Y   
Sbjct: 76  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG-SP-NYAAPEVISGKLY 193
              VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G  P  + APE I+ + +
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 194 AGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
                DVW  GV ++ +L  G  PF      ++  +I+ G   LP
Sbjct: 195 T-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLP 237

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  126 bits (318), Expect = 1e-33
 Identities = 86/351 (24%), Positives = 132/351 (37%), Gaps = 86/351 (24%)

Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKIL 71
           D     Y++ K +G GSFG+V  A        VA+K+     ++N +    +   EI+IL
Sbjct: 93  DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKM-----VRNEKRFHRQAAEEIRIL 147

Query: 72  RLFMH------PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ---EDEARNF 122
                       ++I + E     + I +  E + S  L++ I +K + Q       R F
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELI-KKNKFQGFSLPLVRKF 205

Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
              I+  ++  H+N ++H DLKPEN+LL    +  +K+ DFG S       +  T   S 
Sbjct: 206 AHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TYIQSR 263

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYAL---------------------LCGTLP--- 216
            Y APEVI G  Y G  +D+WS G IL  L                     L G      
Sbjct: 264 FYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322

Query: 217 ----------FDDENIPN--LFKKIKGGIYTLPSHLS--------PGAR----------- 245
                        +  P       +  G   L    S        P +R           
Sbjct: 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD 382

Query: 246 ----DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
               D + + L  DP  R+T  +  +HPW +  LP+     PP   + + K
Sbjct: 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK-----PPTGEKTSVK 428

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  123 bits (310), Expect = 2e-33
 Identities = 56/222 (25%), Positives = 105/222 (47%), Gaps = 11/222 (4%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
              K LG G FG VK  +     + VAIK++     +    E++   E K++    H  +
Sbjct: 27  TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKL 81

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           ++LY V      I+++ EY+ +G L +Y+   + R Q  +     + +   +EY      
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 196
           +HRDL   N L++ +  VK++DFGLS  + D  +  +     P  ++ PEV+    ++  
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-S 200

Query: 197 EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
           + D+W+ GV+++ +   G +P++        + I  G   L 
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLY 241

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  124 bits (314), Expect = 2e-33
 Identities = 78/339 (23%), Positives = 128/339 (37%), Gaps = 82/339 (24%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKILRL---- 73
           Y L + LG G F  V +A+  +    VA+KI     ++  +   E    EIK+L+     
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKI-----VRGDKVYTEAAEDEIKLLQRVNDA 75

Query: 74  -------FMHPHIIRLYE--VIETPSDIYV--VMEYVKSGELFDYIV--EKGRLQEDEAR 120
                      HI++L +    + P+ ++V  V E V    L   I   E   +     +
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134

Query: 121 NFFQQIISGVEYCHRNM-VVHRDLKPENLLLD------SKWNVKIADFGLSNIMRDGHFL 173
              +Q++ G++Y HR   ++H D+KPEN+L++      +   +KIAD G +         
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHY 192

Query: 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL----------------------- 210
             S  +  Y +PEV+ G  + G   D+WS   +++ L                       
Sbjct: 193 TNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251

Query: 211 ----LCGTLP-------------FDDE----NIPNL-FKKIKGGIYTLPSHLSPGAR--- 245
               L G LP             F+      NI  L F  ++  +          A+   
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311

Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
           D +  ML +DP KR     +  HPW +  L       P 
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  125 bits (317), Expect = 2e-33
 Identities = 63/223 (28%), Positives = 114/223 (51%), Gaps = 13/223 (5%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
           KL K LG G FG+V +A       KVA+K +   K  +M +E  +  E  +++   H  +
Sbjct: 191 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTM---KPGSMSVEAFLA-EANVMKTLQHDKL 245

Query: 80  IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
           ++L+ V+ T   IY++ E++  G L D++           +  +F  QI  G+ +  +  
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 195
            +HRDL+  N+L+ +    KIADFGL+ ++ D  +        P  + APE I+   +  
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT- 363

Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
            + DVWS G++L  ++  G +P+   + P + + ++ G Y +P
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  122 bits (308), Expect = 3e-33
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 11/209 (5%)

Query: 20  KLGKTLGIGSFGKVKIAE---HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +L + LG GSFG V+  E    +     VA+K L    +   E  +   RE+  +    H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR 135
            ++IRLY V+ TP  + +V E    G L D + + +G         +  Q+  G+ Y   
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSP---NYAAPEVISGK 191
              +HRDL   NLLL ++  VKI DFGL   + ++               + APE +  +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199

Query: 192 LYAGPEVDVWSCGVILYALL-CGTLPFDD 219
            ++    D W  GV L+ +   G  P+  
Sbjct: 200 TFS-HASDTWMFGVTLWEMFTYGQEPWIG 227

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  121 bits (305), Expect = 7e-33
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 19/228 (8%)

Query: 21  LGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVR----REIKILRLF 74
             K LG G+FG VK   + +      VA+KIL     KN   +  ++     E  +++  
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-----KNEANDPALKDELLAEANVMQQL 75

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            +P+I+R+  + E  S   +VME  + G L  Y+ +   +++        Q+  G++Y  
Sbjct: 76  DNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--P-NYAAPEVISG 190
            +  VHRDL   N+LL ++   KI+DFGLS  +  D ++ K       P  + APE I+ 
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194

Query: 191 KLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
             ++  + DVWS GV+++     G  P+       +   ++ G   + 
Sbjct: 195 YKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMG 240

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  126 bits (318), Expect = 8e-33
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 12/225 (5%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           +LG+ +G G FG V    +         VAIK    +   +  + EK  +E   +R F H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQFDH 450

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR 135
           PHI++L  VI T + ++++ME    GEL  ++   K  L       +  Q+ + + Y   
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG-SP-NYAAPEVISGKLY 193
              VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G  P  + APE I+ + +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 194 AGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
                DVW  GV ++ +L  G  PF      ++  +I+ G   LP
Sbjct: 570 T-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLP 612

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  121 bits (305), Expect = 8e-33
 Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 12/225 (5%)

Query: 20  KLGKTLGIGSFGKVKIAE---HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
            L + LG G FG+V       H      VA+K    +K   ++ +EK   E  I++   H
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNLDH 72

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHR 135
           PHI++L  +IE     +++ME    GEL  Y+   K  L+      +  QI   + Y   
Sbjct: 73  PHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLY 193
              VHRD+   N+L+ S   VK+ DFGLS  + D  + K S    P  + +PE I+ + +
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191

Query: 194 AGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
                DVW   V ++ +L  G  PF      ++   ++ G   LP
Sbjct: 192 T-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLP 234

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  120 bits (304), Expect = 2e-32
 Identities = 68/230 (29%), Positives = 110/230 (47%), Gaps = 19/230 (8%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR---REIKILRL 73
            + K +G G  G+V      + G     VAIK L     K    E + R    E  I+  
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-----KAGYTERQRRDFLSEASIMGQ 106

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEY 132
           F HP+IIRL  V+       +V EY+++G L  ++    G+    +     + + +G+ Y
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGS--P-NYAAPEVI 188
                 VHRDL   N+L+DS    K++DFGLS ++ D      T+ G   P  + APE I
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226

Query: 189 SGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
           + + ++    DVWS GV+++ +L  G  P+ +    ++   ++ G Y LP
Sbjct: 227 AFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLP 274

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  120 bits (302), Expect = 9e-32
 Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 15/228 (6%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEME-EKVRREIKILRLFM 75
            + K +G G FG+V      L   K   VAIK L   K+   E +      E  I+  F 
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMGQFD 104

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
           HP+IIRL  V+     + +V EY+++G L  ++ +   +    +     + I SG++Y  
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGS--P-NYAAPEVISG 190
               VHRDL   N+L++S    K++DFGL  ++ D      T+ G   P  + +PE I+ 
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 191 KLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
           + +     DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 225 RKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  117 bits (296), Expect = 3e-31
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 16/229 (6%)

Query: 20  KLGKTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRLF 74
              K +G G FG+V               VAIK L   K    E +      E  I+  F
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQF 103

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
            H +IIRL  VI     + ++ EY+++G L  ++ E  G     +     + I +G++Y 
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGS--P-NYAAPEVIS 189
                VHRDL   N+L++S    K++DFGLS ++ D      T+ G   P  + APE IS
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 190 GKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
            + +     DVWS G++++ ++  G  P+ + +   + K I  G + LP
Sbjct: 224 YRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLP 270

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  117 bits (296), Expect = 6e-31
 Identities = 59/339 (17%), Positives = 119/339 (35%), Gaps = 88/339 (25%)

Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKIL 71
            +    + + + +G G+FG+V + +H       A+K+     ++N++      + E  IL
Sbjct: 31  MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKV-----VRNIKKYTRSAKIEADIL 85

Query: 72  R-LFMHP----HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQ 124
           + +        +I++ +        + ++ E      L++ I          ++ + +  
Sbjct: 86  KKIQNDDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCI 144

Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDS-------------------------KWNVKIA 159
           +I+  + Y  +  + H DLKPEN+LLD                             +K+ 
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 160 DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL--------- 210
           DFG +    D H    +  +  Y APEVI    +     D+WS G +L  L         
Sbjct: 205 DFGCATFKSDYHGSIIN--TRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRT 261

Query: 211 ------------LCGTLP--------------FDDENIPNLF--------KKIKGGIYTL 236
                       +   +P              + +++   L           IK     L
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321

Query: 237 PSHLS---PGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           P +         D +  +L +DP  R +  E+ +H + +
Sbjct: 322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  115 bits (290), Expect = 1e-30
 Identities = 46/237 (19%), Positives = 89/237 (37%), Gaps = 28/237 (11%)

Query: 20  KLGKTLGIGSFGKV-------KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
              ++LG G+F K+             L   +V +K+L      +    E       ++ 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAASMMS 67

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVE 131
              H H++  Y V     +  +V E+VK G L  Y+   K  +         +Q+ + + 
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127

Query: 132 YCHRNMVVHRDLKPENLLLDSKWN--------VKIADFGLSNIMRDGHFLKTSCGSP-NY 182
           +   N ++H ++  +N+LL  + +        +K++D G+S  +     L+        +
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ----ERIPW 183

Query: 183 AAPEVIS-GKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
             PE I   K       D WS G  L+ +   G  P    +     +  +   + LP
Sbjct: 184 VPPECIENPKNLN-LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-HQLP 238

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  115 bits (291), Expect = 1e-30
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 36/294 (12%)

Query: 20  KLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
            LG+ LG G FG V   ++ +   +  KVA+K+L    I + ++EE +R E   ++ F H
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKEFDH 84

Query: 77  PHIIRLYEV------IETPSDIYVVMEYVKSGELFDYI------VEKGRLQEDEARNFFQ 124
           PH+ +L  V              V++ ++K G+L  ++           L       F  
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-N 181
            I  G+EY      +HRDL   N +L     V +ADFGLS  I    ++ +      P  
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PS 238
           + A E ++  LY     DVW+ GV ++ ++  G  P+       ++  + GG   L  P 
Sbjct: 205 WLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG-NRLKQPP 262

Query: 239 HLSPGARDLIPRML---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
                  DL   M      DP +R +   +R        L   L      +  Q
Sbjct: 263 ECMEEVYDL---MYQCWSADPKQRPSFTCLRM------ELENILGHLSVLSTSQ 307

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  116 bits (292), Expect = 2e-30
 Identities = 77/351 (21%), Positives = 124/351 (35%), Gaps = 84/351 (23%)

Query: 13  DMFLPNYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKI 70
           D     Y++   LG G+FGKV +  +HA    +VA+KI     I+N+    E  R EI +
Sbjct: 15  DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKI-----IRNVGKYREAARLEINV 69

Query: 71  LRLFMHP------HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNF 122
           L+             + + +       + +  E +     F+++ E           R+ 
Sbjct: 70  LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHM 128

Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDS-------------------KWNVKIADFGL 163
             Q+   + + H N + H DLKPEN+L  +                     ++++ADFG 
Sbjct: 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188

Query: 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL------------- 210
           +    D     T   + +Y  PEVI    +A P  DVWS G IL+               
Sbjct: 189 A--TFDHEHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENR 245

Query: 211 --------LCGTLP------------FDDENIPNLFKKIKGGIYTLPSHLSPGAR----- 245
                   + G +P            F    +         G Y   +     +      
Sbjct: 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSD-GRYVKENCKPLKSYMLQDS 304

Query: 246 -------DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
                  DL+ RML  DP +RIT+ E   HP+F    P   +        +
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  114 bits (288), Expect = 4e-30
 Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 29/272 (10%)

Query: 20  KLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
            LGK LG G FG V    + +   T  KVA+K +        E+EE +  E   ++ F H
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKDFSH 95

Query: 77  PHIIRLYEVI-----ETPSDIYVVMEYVKSGELFDYI------VEKGRLQEDEARNFFQQ 125
           P++IRL  V      +      V++ ++K G+L  Y+           +       F   
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NY 182
           I  G+EY      +HRDL   N +L     V +ADFGLS  I    ++ +      P  +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSH 239
            A E ++ ++Y   + DVW+ GV ++ +   G  P+       ++  +  G + L  P  
Sbjct: 216 IAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-HRLKQPED 273

Query: 240 LSPGARDLIPRML---IVDPMKRITIPEIRQH 268
                 ++   M      DP+ R T   +R  
Sbjct: 274 CLDELYEI---MYSCWRTDPLDRPTFSVLRLQ 302

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  113 bits (285), Expect = 6e-30
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 14/227 (6%)

Query: 20  KLGKT-LGIGSFGKVKIAEHALTG--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
            +    LG G+FG V+   + +      VAIK+L  ++       E++ RE +I+    +
Sbjct: 12  LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDN 69

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHR 135
           P+I+RL  V +  + + +VME    G L  ++  ++  +          Q+  G++Y   
Sbjct: 70  PYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--P-NYAAPEVISGK 191
              VHRDL   N+LL ++   KI+DFGLS  +  D  +         P  + APE I+ +
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188

Query: 192 LYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
            ++    DVWS GV ++  L  G  P+     P +   I+ G   + 
Sbjct: 189 KFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRME 233

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  112 bits (283), Expect = 2e-29
 Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 31/273 (11%)

Query: 20  KLGKTLGIGSFGKV-----KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
            + + LG GSFG V     K         +VAIK +N  +  +M    +   E  +++ F
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEF 85

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR----------NFFQ 124
              H++RL  V+       V+ME +  G+L  Y+        +                 
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-N 181
           +I  G+ Y + N  VHRDL   N ++   + VKI DFG++ +I    ++ K   G  P  
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PS 238
           + +PE +   ++     DVWS GV+L+ +      P+   +   + + +  G   L  P 
Sbjct: 206 WMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-GLLDKPD 263

Query: 239 HLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
           +      +L   M +    +P  R +  EI   
Sbjct: 264 NCPDMLFEL---MRMCWQYNPKMRPSFLEIISS 293

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  115 bits (290), Expect = 3e-29
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 13/225 (5%)

Query: 21  LGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
               LG G+FG V+   + +      VAIK+L  ++       E++ RE +I+    +P+
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPY 397

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
           I+RL  V +  + + +VME    G L  ++V  +  +          Q+  G++Y     
Sbjct: 398 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--P-NYAAPEVISGKLY 193
            VHR+L   N+LL ++   KI+DFGLS  +  D  +         P  + APE I+ + +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 194 AGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
           +    DVWS GV ++  L  G  P+     P +   I+ G   + 
Sbjct: 517 S-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRME 559

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  111 bits (279), Expect = 5e-29
 Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 17/230 (7%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
              + +G G FG V   E+        + AIK L+  +I  M+  E   RE  ++R   H
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS--RITEMQQVEAFLREGLLMRGLNH 81

Query: 77  PHIIRLYEVIETPSD--IYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYC 133
           P+++ L  ++  P +   +V++ Y+  G+L  +I   +      +  +F  Q+  G+EY 
Sbjct: 82  PNVLALIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVI 188
                VHRDL   N +LD  + VK+ADFGL+  + D  +              + A E +
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200

Query: 189 SGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
               +   + DVWS GV+L+ LL  G  P+   +  +L   +  G   LP
Sbjct: 201 QTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-RRLP 248

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  111 bits (281), Expect = 5e-29
 Identities = 88/332 (26%), Positives = 128/332 (38%), Gaps = 82/332 (24%)

Query: 13  DMFLPNYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKI 70
           D+    Y++  TLG G+FGKV +  +H   G  VA+KI     +KN++   E  R EI++
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKI-----VKNVDRYCEAARSEIQV 64

Query: 71  LRLFMHP------HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNF 122
           L              +++ E  E    I +V E +     +D+I E G    + D  R  
Sbjct: 65  LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKM 123

Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDS-------------------KWNVKIADFGL 163
             QI   V + H N + H DLKPEN+L                        ++K+ DFG 
Sbjct: 124 AYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183

Query: 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL------------- 210
           +    + H    S  + +Y APEVI    ++ P  DVWS G IL                
Sbjct: 184 ATYDDEHHSTLVS--TRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSK 240

Query: 211 --------LCGTLP------------FDDENIPNLFKKIKGGIY-----TLPSHLSP--- 242
                   + G LP            F  + +        G         L   +     
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300

Query: 243 ---GARDLIPRMLIVDPMKRITIPEIRQHPWF 271
                 DLI +ML  DP KRIT+ E  +HP+F
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  111 bits (280), Expect = 6e-29
 Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 39/280 (13%)

Query: 20  KLGKTLGIGSFGKVKIAE-HALTGH----KVAIKILNRRKIKNMEMEEK-VRREIKILRL 73
           + GKTLG G+FGKV  A    L       KVA+K+L   K      E++ +  E+KI+  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSH 105

Query: 74  FM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN----------- 121
              H +I+ L         + V+ EY   G+L +++  K R+ E +              
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 122 ---FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSC 177
              F  Q+  G+ +      +HRD+   N+LL +    KI DFGL+ +IM D +++    
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 178 GS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPF-DDENIPNLFKKIKGGI 233
              P  + APE I   +Y   + DVWS G++L+ +   G  P+         +K +K G 
Sbjct: 226 ARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG- 283

Query: 234 YTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
           Y +  P+        +   M     ++P  R T  +I   
Sbjct: 284 YQMAQPAFAPKNIYSI---MQACWALEPTHRPTFQQICSF 320

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  109 bits (275), Expect = 2e-28
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 17/230 (7%)

Query: 20  KLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
              + +G G FG V    + ++       A+K LN  +I ++    +   E  I++ F H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSH 85

Query: 77  PHIIRLYEVIETPSD--IYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYC 133
           P+++ L  +    S+    VV+ Y+K G+L ++I  E       +   F  Q+  G++Y 
Sbjct: 86  PNVLSLLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVI 188
                VHRDL   N +LD K+ VK+ADFGL+  M D  +      +       + A E +
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 189 SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
             + +   + DVWS GV+L+ L+  G  P+ D N  ++   +  G   L 
Sbjct: 205 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLL 252

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  109 bits (273), Expect = 1e-27
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 17/230 (7%)

Query: 20  KLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
              + +G G FG V    + ++       A+K LN  +I ++    +   E  I++ F H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSH 149

Query: 77  PHIIRLYEVIETPSD--IYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYC 133
           P+++ L  +    S+    VV+ Y+K G+L ++I  E       +   F  Q+  G+++ 
Sbjct: 150 PNVLSLLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVI 188
                VHRDL   N +LD K+ VK+ADFGL+  M D  F      +       + A E +
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 189 SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
             + +   + DVWS GV+L+ L+  G  P+ D N  ++   +  G   L 
Sbjct: 269 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLL 316

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  108 bits (271), Expect = 1e-27
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 32/217 (14%)

Query: 20  KLGKTLGIGSFGKVKIAE-HALTGH----KVAIKILNRRKIKNMEMEEK-VRREIKILRL 73
             GKTLG G+FGKV  A  + L        VA+K+L   K      E + +  E+K+L  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKVLSY 82

Query: 74  FM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDY------------------IVEKGRL 114
              H +I+ L           V+ EY   G+L ++                    ++  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 115 QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL 173
             ++  +F  Q+  G+ +      +HRDL   N+LL      KI DFGL+ +I  D +++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 174 KTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILY 208
                  P  + APE I   +Y   E DVWS G+ L+
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  108 bits (271), Expect = 1e-27
 Identities = 62/289 (21%), Positives = 114/289 (39%), Gaps = 31/289 (10%)

Query: 20  KLGKTLGIGSFGKV-----KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
            L + LG G+FG+V         +  +  +VA+K L   ++ + + E     E  I+  F
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKF 90

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR-------NFFQQII 127
            H +I+R   V       +++ME +  G+L  ++ E        +        +  + I 
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGS-P-N 181
            G +Y   N  +HRD+   N LL         KI DFG++ +I R  ++ K  C   P  
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PS 238
           +  PE     ++   + D WS GV+L+ +   G +P+  ++   + + +  G   +  P 
Sbjct: 211 WMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPK 268

Query: 239 HLSPGARDLIPRML---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
           +       +   M       P  R     I +   +    P  +    P
Sbjct: 269 NCPGPVYRI---MTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 314

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  107 bits (269), Expect = 2e-27
 Identities = 73/278 (26%), Positives = 115/278 (41%), Gaps = 37/278 (13%)

Query: 20  KLGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
            L   LG G+FGKV +AE H L   +    VA+K L   K  +    +  +RE ++L + 
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTML 100

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------- 121
            H HI+R + V      + +V EY++ G+L  ++   G   +  A               
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 122 --FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG 178
                Q+ +G+ Y      VHRDL   N L+     VKI DFG+S +I    ++      
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 179 S-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYT 235
             P  +  PE I  + +   E DVWS GV+L+ +   G  P+   +       I  G   
Sbjct: 221 MLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RE 278

Query: 236 L--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
           L  P    P    +   M      +P +R +I ++   
Sbjct: 279 LERPRACPPEVYAI---MRGCWQREPQQRHSIKDVHAR 313

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  106 bits (268), Expect = 2e-27
 Identities = 82/294 (27%), Positives = 123/294 (41%), Gaps = 44/294 (14%)

Query: 20  KLGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
            L + LG G+FGKV +AE + L+  K    VA+K L   K   +   +  +RE ++L   
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNL 74

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY----------------IVEKGRLQEDE 118
            H HI++ Y V      + +V EY+K G+L  +                   KG L   +
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSC 177
             +   QI SG+ Y      VHRDL   N L+ +   VKI DFG+S ++    ++     
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 178 GS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY 234
              P  +  PE I  + +   E DVWS GVIL+ +   G  P+   +   + + I  G  
Sbjct: 195 TMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG-R 252

Query: 235 TL--PSHLSPGARDLIPRML---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPP 283
            L  P        D+   ML     +P +R+ I EI         L       P
Sbjct: 253 VLERPRVCPKEVYDV---MLGCWQREPQQRLNIKEI------YKILHALGKATP 297

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  107 bits (270), Expect = 3e-27
 Identities = 62/289 (21%), Positives = 115/289 (39%), Gaps = 31/289 (10%)

Query: 20  KLGKTLGIGSFGKV-----KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
            L + LG G+FG+V         +  +  +VA+K L   ++ + + E     E  I+  F
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEALIISKF 131

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY-------IVEKGRLQEDEARNFFQQII 127
            H +I+R   V       ++++E +  G+L  +         +   L   +  +  + I 
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCG-SP-N 181
            G +Y   N  +HRD+   N LL         KI DFG++ +I R G++ K  C   P  
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PS 238
           +  PE     ++   + D WS GV+L+ +   G +P+  ++   + + +  G   +  P 
Sbjct: 252 WMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPK 309

Query: 239 HLSPGARDLIPRML---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
           +       +   M       P  R     I +   +    P  +    P
Sbjct: 310 NCPGPVYRI---MTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 355

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (267), Expect = 4e-27
 Identities = 82/288 (28%), Positives = 127/288 (44%), Gaps = 47/288 (16%)

Query: 20  KLGKTLGIGSFGKVKIAE-HALTGH----KVAIKILNRRKIKNMEMEEK-VRREIKILRL 73
            LGKTLG G FGKV  A    L G      VA+K+L   K      E + +  E  +L+ 
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENASPSELRDLLSEFNVLKQ 82

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY------------------------IV 109
             HPH+I+LY        + +++EY K G L  +                          
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 110 EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMR 168
           ++  L   +  +F  QI  G++Y     +VHRDL   N+L+     +KI+DFGLS ++  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 169 DGHFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNL 225
           +  ++K S G  P  + A E +   +Y   + DVWS GV+L+ ++  G  P+       L
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261

Query: 226 FKKIKGGIYTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
           F  +K G + +  P + S     L   ML     +P KR    +I + 
Sbjct: 262 FNLLKTG-HRMERPDNCSEEMYRL---MLQCWKQEPDKRPVFADISKD 305

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  107 bits (268), Expect = 6e-27
 Identities = 72/282 (25%), Positives = 128/282 (45%), Gaps = 40/282 (14%)

Query: 20  KLGKTLGIGSFGKVKIAE-------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
            LGK LG G FG+V +AE              VA+K+L  +     +    +  E+++++
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMK 141

Query: 73  LFM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDY----------------IVEKGRLQ 115
           +   H +II L         +YV++EY   G L +Y                 V + ++ 
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK 174
             +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++ K
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 175 TSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG 231
           T+ G  P  + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +K 
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 320

Query: 232 GIYTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
           G + +  P++ +     +   M       P +R T  ++ + 
Sbjct: 321 G-HRMDKPANCTNELYMM---MRDCWHAVPSQRPTFKQLVED 358

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  106 bits (266), Expect = 1e-26
 Identities = 65/241 (26%), Positives = 109/241 (45%), Gaps = 22/241 (9%)

Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKIL 71
           + ++  Y++   +G GSFG+V  A   +    VAIKI     IKN +    + + E+++L
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKI-----IKNKKAFLNQAQIEVRLL 104

Query: 72  RLFMHP------HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFF 123
            L          +I+ L       + + +V E + S  L+D +       +  +  R F 
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFA 163

Query: 124 QQIISGVEYCHRNM--VVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
           QQ+ + + +       ++H DLKPEN+LL    +  +KI DFG S  +    +      S
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQS 221

Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239
             Y +PEV+ G  Y    +D+WS G IL  +  G   F   N  +   KI   +   P+H
Sbjct: 222 RFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280

Query: 240 L 240
           +
Sbjct: 281 I 281

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 13/27 (48%), Positives = 15/27 (55%)

Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQ 272
           DLI RML  DP  RI      QH +F+
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFK 377

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  104 bits (261), Expect = 3e-26
 Identities = 72/282 (25%), Positives = 129/282 (45%), Gaps = 40/282 (14%)

Query: 20  KLGKTLGIGSFGKVKIAE-------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
            LGK LG G+FG+V +AE              VA+K+L  +     +    +  E+++++
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMK 95

Query: 73  LFM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDY----------------IVEKGRLQ 115
           +   H +II L         +YV++EY   G L +Y                 V + ++ 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK 174
             +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++ K
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215

Query: 175 TSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKG 231
           T+ G  P  + APE +  ++Y   + DVWS GV+++ +   G  P+    +  LFK +K 
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274

Query: 232 GIYTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
           G + +  P++ +     +   M       P +R T  ++ + 
Sbjct: 275 G-HRMDKPANCTNELYMM---MRDCWHAVPSQRPTFKQLVED 312

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  105 bits (263), Expect = 3e-26
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 40/282 (14%)

Query: 20  KLGKTLGIGSFGKVKIAE-------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
            LGK LG G+FG+V +AE             KVA+K+L        +    +  E+++++
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDLISEMEMMK 129

Query: 73  LFM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN---------- 121
           +   H +II L         +YV++EY   G L +Y+  +     + + N          
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 122 ------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK 174
                    Q+  G+EY      +HRDL   N+L+     +KIADFGL+ +I    ++ K
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249

Query: 175 TSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKG 231
           T+ G  P  + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK +K 
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308

Query: 232 GIYTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
           G + +  PS+ +     +   M       P +R T  ++ + 
Sbjct: 309 G-HRMDKPSNCTNELYMM---MRDCWHAVPSQRPTFKQLVED 346

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  103 bits (260), Expect = 3e-26
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 33/217 (15%)

Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           KLGK LG G+FG+V  A+        T   VA+K+L   +         +  E+KIL   
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKILIHI 87

Query: 75  M-HPHIIRLYEV---IETPSDIYVVMEYVKSGELFDYI----------------VEKGRL 114
             H +++ L         P  + V++E+ K G L  Y+                + K  L
Sbjct: 88  GHHLNVVNLLGACTKPGGP--LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 115 QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL 173
             +    +  Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+ +I +D  ++
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205

Query: 174 KTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILY 208
           +      P  + APE I  ++Y   + DVWS GV+L+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  104 bits (261), Expect = 4e-26
 Identities = 73/280 (26%), Positives = 115/280 (41%), Gaps = 44/280 (15%)

Query: 20  KLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVR---REIKILRLF 74
           K    +G G+FG+V  A     G +   AIK +     K    ++  R    E+++L   
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAGELEVLCKL 82

Query: 75  M-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------ 121
             HP+II L    E    +Y+ +EY   G L D++ +   L+ D A              
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 122 ----FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177
               F   +  G++Y  +   +HRDL   N+L+   +  KIADFGLS   R         
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKT 199

Query: 178 GS--P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGI 233
               P  + A E ++  +Y     DVWS GV+L+ ++  G  P+       L++K+  G 
Sbjct: 200 MGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 257

Query: 234 YTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
           Y L  P +      DL   M       P +R +  +I   
Sbjct: 258 YRLEKPLNCDDEVYDL---MRQCWREKPYERPSFAQILVS 294

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  103 bits (259), Expect = 7e-26
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 37/222 (16%)

Query: 20  KLGKTLGIGSFGKVKIAE-HALTGH----KVAIKILNRRKIKNMEMEEK-VRREIKILRL 73
           + GK LG G+FGKV  A  + ++      +VA+K+L   K K    E + +  E+K++  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQ 104

Query: 74  FM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ-------- 124
              H +I+ L         IY++ EY   G+L +Y+  K     ++   +          
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 125 ---------------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMR 168
                          Q+  G+E+      VHRDL   N+L+     VKI DFGL+ +IM 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 169 DGHFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILY 208
           D +++       P  + APE +   +Y   + DVWS G++L+
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLW 265

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  100 bits (252), Expect = 3e-25
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 29/243 (11%)

Query: 20  KLGKTLGIGSFGKV-----KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           +  + LG   FGKV                VAIK L  +      + E+ R E  +    
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARL 69

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------- 121
            HP+++ L  V+     + ++  Y   G+L +++V +    +  + +             
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 122 ---FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSC 177
                 QI +G+EY   + VVH+DL   N+L+  K NVKI+D GL   +    ++     
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 178 GS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY 234
              P  + APE I    ++  + D+WS GV+L+ +   G  P+   +  ++ + I+    
Sbjct: 190 SLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-Q 247

Query: 235 TLP 237
            LP
Sbjct: 248 VLP 250

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  100 bits (251), Expect = 1e-24
 Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 45/287 (15%)

Query: 20  KLGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           +  + +G G+FG+V  A    L  ++    VA+K+L  ++  + +M+   +RE  ++  F
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEF 107

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------- 121
            +P+I++L  V      + ++ EY+  G+L +++            +             
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 122 -----------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRD 169
                        +Q+ +G+ Y      VHRDL   N L+     VKIADFGLS NI   
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 170 GHFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLF 226
            ++      + P  +  PE I    Y   E DVW+ GV+L+ +   G  P+       + 
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286

Query: 227 KKIKGGIYTL--PSHLSPGARDLIPRML---IVDPMKRITIPEIRQH 268
             ++ G   L  P +      +L   M       P  R +   I + 
Sbjct: 287 YYVRDG-NILACPENCPLELYNL---MRLCWSKLPADRPSFCSIHRI 329

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 93.4 bits (233), Expect = 3e-22
 Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 56/230 (24%)

Query: 25  LGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
           +G G FGKV    + +    G KVA+K       ++ +  E+   EI+ L    HPH++ 
Sbjct: 47  IGHGVFGKVYKGVLRD----GAKVALKRRTP---ESSQGIEEFETEIETLSFCRHPHLVS 99

Query: 82  LY-------EVIETPSDIYVVMEYVKSGELFDYIVEKG----------RLQ--EDEARNF 122
           L        E+I       ++ +Y+++G L  ++              RL+     AR  
Sbjct: 100 LIGFCDERNEMI-------LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR-- 150

Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGS 179
                 G+ Y H   ++HRD+K  N+LLD  +  KI DFG+S    +    H      G+
Sbjct: 151 ------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204

Query: 180 PNYAAPE-VISGKLYAGPEVDVWSCGVILYALLCG------TLPFDDENI 222
             Y  PE  I G+L    + DV+S GV+L+ +LC       +LP +  N+
Sbjct: 205 LGYIDPEYFIKGRLTE--KSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 92.2 bits (230), Expect = 7e-22
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 35/213 (16%)

Query: 25  LGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKN-MEMEEKVRREIKILRLFMHPHIIRL 82
           +G G FG V K     +    VA+K L         E++++  +EIK++    H +++ L
Sbjct: 39  MGEGGFGVVYK---GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ-----------EDEARNFFQQIISGVE 131
                   D+ +V  Y+ +G L D +                  +  A         G+ 
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------GIN 147

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS------CGSPNYAAP 185
           + H N  +HRD+K  N+LLD  +  KI+DFGL+   R       +       G+  Y AP
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLA---RASEKFAQTVMTSRIVGTTAYMAP 204

Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFD 218
           E + G++    + D++S GV+L  ++ G    D
Sbjct: 205 EALRGEITP--KSDIYSFGVVLLEIITGLPAVD 235

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 31/228 (13%)

Query: 13  DMFLPNYKLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK 69
           D F     LG+    G FGKV   ++A     G  VA+K L   + +  E++ +   E++
Sbjct: 30  DNFSNKNILGR----GGFGKVYKGRLA----DGTLVAVKRLKEERTQGGELQFQT--EVE 79

Query: 70  ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQED---EARNFFQQI 126
           ++ + +H +++RL     TP++  +V  Y+ +G +   + E+   Q       R   Q+I
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR---QRI 136

Query: 127 ISGV----EYCHRNM---VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSC 177
             G      Y H +    ++HRD+K  N+LLD ++   + DFGL+ +M     H      
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 178 GSPNYAAPE-VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN 224
           G+  + APE + +GK     + DV+  GV+L  L+ G   FD   + N
Sbjct: 197 GTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAFDLARLAN 242

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 86.5 bits (214), Expect = 2e-19
 Identities = 55/270 (20%), Positives = 94/270 (34%), Gaps = 72/270 (26%)

Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
           D+F   Y + + LG G F  V ++        VA+K++   +       E    EI++L+
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLK 88

Query: 73  LFM-----HP---HIIRLYE--VIETPSDIYVVMEYVKSGE-LFDYIV--EKGRLQEDEA 119
                    P    +++L +   I   +  ++ M +   G  L  +I+      L     
Sbjct: 89  SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCV 148

Query: 120 RNFFQQIISGVEYCHRNM-VVHRDLKPENLLL---------------------------- 150
           +   QQ++ G++Y H    ++H D+KPEN+LL                            
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208

Query: 151 ---------------------DSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-YAAPEVI 188
                                  K  VKIAD G +  +       T       Y + EV+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVL 265

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFD 218
            G  Y     D+WS   + + L  G   F+
Sbjct: 266 IGSGY-NTPADIWSTACMAFELATGDYLFE 294

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 85.1 bits (211), Expect = 3e-19
 Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 32/228 (14%)

Query: 9   SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI 68
           S GV M  PN+++GK +G G+FG++++ ++  T   VAIK+   +          +  E 
Sbjct: 1   SMGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-----LHLEY 55

Query: 69  KILRLFMH-PHIIRLYEVIETPSDIYVVMEYV-KSGE-LFDYIVEKGRLQEDEARNFFQQ 125
           +  +       I ++Y          +V+E +  S E LFD                  Q
Sbjct: 56  RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDL--CDRTFSLKTVLMIAIQ 113

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWN-----VKIADFGLSNIMRDG----HFL--- 173
           +IS +EY H   +++RD+KPEN L+    N     + I DF L+    D     H     
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173

Query: 174 -KTSCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYALLCGTLP 216
            K+  G+  Y +   I+  L  G E     D+ + G +    L G+LP
Sbjct: 174 HKSLTGTARYMS---INTHL--GKEQSRRDDLEALGHMFMYFLRGSLP 216

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 81.2 bits (201), Expect = 5e-18
 Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 32/228 (14%)

Query: 9   SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI 68
           S   ++   +YK+G+ +G GSFG +    + L   +VAIK    R+    ++    R E 
Sbjct: 2   SGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQL----RDEY 56

Query: 69  KILRLFMH-PHIIRLYEVIETPSDIYVVMEYV-KS-GELFDYIVEKGRLQEDEARNFFQQ 125
           +  +L      I  +Y   +      +V++ +  S  +L D      +          +Q
Sbjct: 57  RTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQ 114

Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWN-----VKIADFGLSNIMRDG----HFL--- 173
           +++ V+  H   +V+RD+KP+N L+    +     + + DFG+    RD     H     
Sbjct: 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174

Query: 174 -KTSCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYALLCGTLP 216
            K   G+  Y +   I+  L  G E     D+ + G +    L G+LP
Sbjct: 175 KKNLSGTARYMS---INTHL--GREQSRRDDLEALGHVFMYFLRGSLP 217

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 81.3 bits (201), Expect = 9e-18
 Identities = 51/238 (21%), Positives = 85/238 (35%), Gaps = 45/238 (18%)

Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
           DM    + LGK +G G FG + +A       K A  ++     +N  +      E+K  +
Sbjct: 33  DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF----SELKFYQ 88

Query: 73  LFMHPHIIRLYEVIETPSDI-------------------YVVMEYV-KSGELFDYIVEKG 112
                  I+ +   +    +                   ++VME +     L     + G
Sbjct: 89  RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID--LQKISGQNG 146

Query: 113 RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI--ADFGLSNIMRDG 170
             ++        +++  +EY H N  VH D+K  NLLL  K   ++  AD+GLS      
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206

Query: 171 ----HFL----KTSCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYALLCGTLP 216
                +     K   G+  +      S   + G  +    DV   G  +   LCG LP
Sbjct: 207 GNHKQYQENPRKGHNGTIEFT-----SLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)

Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM- 75
             ++LG+ +G GSFG++ +  +  T  +VAIK+ N +          +  E KI R+   
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LLYESKIYRILQG 61

Query: 76  HPHIIRLYEVIETPSDIYVVMEYV-KS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
              I  +           +VM+ +  S  +LF++     +L          Q+I+ VE+ 
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFV 119

Query: 134 HRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFL--------KTSCGSPNY 182
           H    +HRD+KP+N L+        V I DFGL+   RD            K   G+  Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 183 AAPEVISGKLYAGPEV----DVWSCGVILYALLCGTLP 216
           A+   ++  L  G E     D+ S G +L   L G+LP
Sbjct: 180 AS---VNTHL--GIEQSRRDDLESLGYVLMYFLRGSLP 212

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 75.9 bits (187), Expect = 4e-16
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 13/159 (8%)

Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
             Y+LG+ +G GSFG + +      G +VAIK+    K K+ ++      E KI ++   
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQL----HIESKIYKMMQG 63

Query: 77  -PHIIRLYEVIETPSDIYVVMEYV-KS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
              I  +           +VME +  S  +LF++     +           Q+IS +EY 
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYI 121

Query: 134 HRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRD 169
           H    +HRD+KP+N L+        V I DFGL+   RD
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 75.7 bits (185), Expect = 8e-16
 Identities = 35/228 (15%), Positives = 65/228 (28%), Gaps = 49/228 (21%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-----EKVRREIKILR 72
             +  + +G G FG+V           VAIKI+       +        E++  EI I +
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 73  LF---------MHPHIIRLYEV------------------------------IETPSDIY 93
                           I L  V                                    ++
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 94  VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDS 152
           +V+E+   G   + +  K       A++   Q+ + +     ++   HRDL   N+LL  
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197

Query: 153 KWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVD 199
               K+               L+ S      +  E     ++    +D
Sbjct: 198 TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.5 bits (178), Expect = 9e-15
 Identities = 45/245 (18%), Positives = 82/245 (33%), Gaps = 56/245 (22%)

Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
           DM    +K+G  +G G FG + +A+   +   V        K++  +    +  E+K  +
Sbjct: 31  DMAAAAWKVGLPIGQGGFGCIYLADM-NSSESVGSDAPCVVKVEPSD-NGPLFTELKFYQ 88

Query: 73  LFMHPHIIRLYEVIETPSDI-------------------YVVMEYV-KSGELFDYIVEKG 112
               P  I+ +        +                   +++M+       L        
Sbjct: 89  RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANA 146

Query: 113 R-------LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--VKIADFGL 163
           +       LQ         +I+  +EY H +  VH D+K  NLLL+ K    V + D+GL
Sbjct: 147 KRFSRKTVLQ------LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGL 200

Query: 164 SNIMRDG----HFL----KTSCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYALL 211
           +           +     +   G+  +      S   + G       D+   G  +   L
Sbjct: 201 AYRYCPEGVHKAYAADPKRCHDGTIEFT-----SIDAHNGVAPSRRGDLEILGYCMIQWL 255

Query: 212 CGTLP 216
            G LP
Sbjct: 256 TGHLP 260

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 32/237 (13%), Positives = 76/237 (32%), Gaps = 40/237 (16%)

Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
           D     +KL       + G +  A    T    +     +  +K    + ++  E    +
Sbjct: 38  DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97

Query: 73  LFMHPHIIRLYEVIETPSDIYV--VMEYVKSGELFDYIV--------EKGRLQEDEARNF 122
               P  +  ++ + +   + +   M +    + + ++V        +     +   ++ 
Sbjct: 98  RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQS--ALDVSPKHV 155

Query: 123 F---------QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI--ADFGLSNIMRDGH 171
                      +++  +E+ H N  VH ++  EN+ +D +   ++  A +G +       
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

Query: 172 --------FLKTSCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYALLCGTLP 216
                         G   +      S  L+ G       D+ S G  +   L G LP
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI-----SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.0 bits (158), Expect = 3e-12
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 15/174 (8%)

Query: 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164
               + K  L  +    +  Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240

Query: 165 -NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDD- 219
            +I +D  +++      P  + APE I  ++Y   + DVWS GV+L+ +   G  P+   
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGV 299

Query: 220 ENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
           +      +++K G   +  P + +P        ML     +P +R T  E+ +H
Sbjct: 300 KIDEEFCRRLKEG-TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEH 349

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.8 bits (142), Expect = 4e-10
 Identities = 37/159 (23%), Positives = 62/159 (38%), Gaps = 21/159 (13%)

Query: 20  KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           KLGK LG G+FG+V  A+        T   VA+K+L  ++         +  E+KIL   
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 82

Query: 75  M-HPHIIRLY-EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
             H +++ L     +    + V++E+ K G L  Y+  K        RN F    +    
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--------RNEFVPYKTKGAR 134

Query: 133 CHRNMV----VHRDLKPENLLLDSKWNVKIADFGLSNIM 167
             +       +  DLK     + S  +   + F     +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 40.4 bits (95), Expect = 5e-04
 Identities = 31/173 (17%), Positives = 63/173 (36%), Gaps = 28/173 (16%)

Query: 31  GKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRRE--------IKILRLFMHPHIIRL 82
            +  I   +     V IK   ++  ++  ++E +R+         + +++ F  P    +
Sbjct: 348 AEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPY-I 406

Query: 83  YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
           ++V     +  ++M Y+      D I +   +         +         H+N V+H D
Sbjct: 407 FDV--DLDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEIVGK--------LHKNDVIHND 456

Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-------DGHFLKTSCGSPNYAAPEVI 188
           L   N + D    + I DFGL  I         D    K +  S ++   + I
Sbjct: 457 LTTSNFIFDKD--LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEI 507

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	294
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.51
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.26
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.0
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.96
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.82
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.64
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.49
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.38
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.32
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.22
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.12
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.07
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.0
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.82
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.68
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.61
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.55
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.52
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.4
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.34
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.21
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.21
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.78
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.75
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.62
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.21
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.17
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.97

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1e-67  Score=434.97  Aligned_cols=263  Identities=67%  Similarity=1.158  Sum_probs=227.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||+|+||+||+|.++.+++.||+|++.............+.+|++++++++||||+++++++.+++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            37899999999999999999999999999999999877665555677899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      |||+ +++|.+++.+++++++..++.++.|++.||.|||++||+||||||+||+++.++++||+|||+|...........
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  170 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT  170 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence            9999 569999999889999999999999999999999999999999999999999999999999999987766666667


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      ..||+.|+|||++.+..+.+.++||||||+++|+|++|+.||.+.+...+.+.+..+...+|..+++++.++|.+||+.|
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  250 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN  250 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            78999999999999888767899999999999999999999999999999999999888899999999999999999999


Q ss_pred             CCCCCCHhHHhcCCcccccCCccc
Q 022617          256 PMKRITIPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       256 p~~Rps~~~il~h~~~~~~~~~~~  279 (294)
                      |++|||++|+++||||+..+|.++
T Consensus       251 P~~R~s~~eil~hpw~k~~~p~~L  274 (275)
T 3hyh_A          251 PLNRISIHEIMQDDWFKVDLPEYL  274 (275)
T ss_dssp             GGGSCCHHHHHHCHHHHTTCCGGG
T ss_pred             hhHCcCHHHHHcCcccccCCChhh
Confidence            999999999999999999888765

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.9e-66  Score=433.20  Aligned_cols=259  Identities=34%  Similarity=0.626  Sum_probs=240.0

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      -.++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|++++++++||||+++++++++++.+|+
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34679999999999999999999999999999999987665555567889999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC---C
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---H  171 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~---~  171 (294)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......   .
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999876432   2


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+......+|..+++++.+||.+|
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l  268 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL  268 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH
Confidence            3456689999999999988877 789999999999999999999999999999999999888899999999999999999


Q ss_pred             cccCCCCCCCHhH------HhcCCccccc
Q 022617          252 LIVDPMKRITIPE------IRQHPWFQAH  274 (294)
Q Consensus       252 l~~~p~~Rps~~~------il~h~~~~~~  274 (294)
                      |..||++|||++|      |++||||++.
T Consensus       269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          269 LVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             SCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             ccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            9999999999988      5899999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-64  Score=429.14  Aligned_cols=261  Identities=28%  Similarity=0.559  Sum_probs=229.0

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++++.||+|+||+||+|+++.+|+.||||++....... ...+.+.+|++++++++||||+++++++.+++.+|+|
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            469999999999999999999999999999999998765443 3467899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-c
Q 022617           96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F  172 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~  172 (294)
                      ||||+|++|.+++..++  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... .
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence            99999999999997643  57899999999999999999999999999999999999999999999999998764332 2


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCChhHHHHHHHh
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM  251 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~  251 (294)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+..+.. +.+..++.++.+||.+|
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~  260 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL  260 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHH
Confidence            345579999999999998877 7899999999999999999999999998888888776654 56778999999999999


Q ss_pred             cccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          252 LIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                      |+.||++|||+.|+|+||||++.+.++
T Consensus       261 L~~dP~~R~s~~e~l~hp~~~~~~~~~  287 (350)
T 4b9d_A          261 FKRNPRDRPSVNSILEKGFIAKRIEKF  287 (350)
T ss_dssp             TCSSGGGSCCHHHHHTSHHHHTTGGGT
T ss_pred             ccCChhHCcCHHHHhcCHHhhcCCCcC
Confidence            999999999999999999998766544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.6e-64  Score=425.38  Aligned_cols=262  Identities=29%  Similarity=0.514  Sum_probs=233.7

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ...|++.+.||+|+||+||+|.++.+|+.||||++.......   .+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467999999999999999999999999999999997654333   35678999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Cccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~  174 (294)
                      ||||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ....
T Consensus       150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            999999999999864 67999999999999999999999999999999999999999999999999999876543 3445


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCChhHHHHHHHh
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRM  251 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~  251 (294)
                      ..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.....   ..+..+++++.+||.+|
T Consensus       229 ~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~  307 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL  307 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence            6789999999999988887 8999999999999999999999999988888888766543   33457899999999999


Q ss_pred             cccCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617          252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVP  282 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~  282 (294)
                      |..||++|||+.|+|+||||++..+....+|
T Consensus       308 L~~dP~~R~ta~e~l~Hp~~~~~~~p~~l~p  338 (346)
T 4fih_A          308 LVRDPAQRATAAELLKHPFLAKAGPPASIVP  338 (346)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGCCCGGGTGG
T ss_pred             cCCChhHCcCHHHHhcCHhhcCCCCCcccCc
Confidence            9999999999999999999998665444443

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.6e-64  Score=417.76  Aligned_cols=256  Identities=30%  Similarity=0.565  Sum_probs=226.4

Q ss_pred             cCCcccccccccCceEEEEEEEc---cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ++|++++.||+|+||+||+|++.   .+++.||+|++......... ...+.+|++++++++||||+++++++.+++.+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            68999999999999999999874   46788999999765443322 346788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~  172 (294)
                      +||||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|..... ...
T Consensus       103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  182 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  182 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999976533 333


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhc
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  252 (294)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+......+|..+++++.+||.+||
T Consensus       183 ~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  261 (304)
T 3ubd_A          183 AYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF  261 (304)
T ss_dssp             CCSCCCCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccccCcccCCHHHhccCCC-CCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence            456689999999999988877 7899999999999999999999999999999999998888899999999999999999


Q ss_pred             ccCCCCCCC-----HhHHhcCCccccc
Q 022617          253 IVDPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       253 ~~~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      +.||++|||     ++|+++||||+..
T Consensus       262 ~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          262 KRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             CSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             ccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            999999998     5799999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-62  Score=425.09  Aligned_cols=263  Identities=29%  Similarity=0.511  Sum_probs=234.1

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      ..+.|++.+.||+|+||.||+|.++.+|+.||||++.......   .+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            3467999999999999999999999999999999997654333   3568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccc
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL  173 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~  173 (294)
                      |||||+||+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ...
T Consensus       226 VmEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  304 (423)
T 4fie_A          226 VMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  304 (423)
T ss_dssp             EEECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred             EEeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence            999999999999985 467999999999999999999999999999999999999999999999999999876443 344


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHHHHHH
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPR  250 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~  250 (294)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+....   ...+..++.++.+||.+
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred             cccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence            56689999999999988887 899999999999999999999999998888888876654   33446789999999999


Q ss_pred             hcccCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617          251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP  282 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~  282 (294)
                      ||..||++|||+.|+|+||||++.-+....+|
T Consensus       384 ~L~~dP~~R~ta~ell~Hp~~~~~~~p~~l~p  415 (423)
T 4fie_A          384 LLVRDPAQRATAAELLKHPFLAKAGPPASIVP  415 (423)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCCGGGTGG
T ss_pred             HcCCChhHCcCHHHHhcCHHhcCCCCCccccc
Confidence            99999999999999999999998655444333

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.5e-62  Score=403.83  Aligned_cols=254  Identities=26%  Similarity=0.508  Sum_probs=221.1

Q ss_pred             ccCC-cccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----CC
Q 022617           16 LPNY-KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PS   90 (294)
Q Consensus        16 ~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~   90 (294)
                      .++| ++.+.||+|+||+||+|.++.++..||+|++....... ...+.+.+|++++++++||||+++++++.+    ++
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence            3455 78889999999999999999999999999997665433 446789999999999999999999999865    35


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecC-CCcEEEeeecccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDS-KWNVKIADFGLSNIM  167 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~-~~~~~l~dfg~~~~~  167 (294)
                      .+|+||||++||+|.+++.+.+.+++..++.++.|++.||.|||++|  |+||||||+|||++. ++.+||+|||+|...
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            68999999999999999999999999999999999999999999998  999999999999984 789999999999764


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhCCCc--cCCCCCChhH
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIY--TLPSHLSPGA  244 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~l  244 (294)
                      .. ......+||+.|+|||++.+ .+ +.++||||||+++|+|++|+.||.+. ....+...+..+..  ..+..+++++
T Consensus       183 ~~-~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  259 (290)
T 3fpq_A          183 RA-SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  259 (290)
T ss_dssp             CT-TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             CC-CccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence            33 34456689999999999875 45 89999999999999999999999764 45556666665543  3456788999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      .+||.+||+.||++|||+.|+|+||||++
T Consensus       260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.4e-61  Score=405.37  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=220.5

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .+.|++.++||+|+||+||+|+++.+|+.||||++..+...        .+|+.++++++||||+++++++.+++.+|+|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            35688899999999999999999999999999999755322        4699999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeecccccccCCCc--
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHF--  172 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~~~~~~~--  172 (294)
                      |||++|++|.+++++.+++++..++.++.|++.||.|||++||+||||||+|||++.+| ++||+|||++........  
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            99999999999999999999999999999999999999999999999999999999887 699999999986643221  


Q ss_pred             ----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCChhHH
Q 022617          173 ----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGAR  245 (294)
Q Consensus       173 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  245 (294)
                          ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+...+.....   ..++.+++++.
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             ceecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence                223469999999999998877 7899999999999999999999988776666666655543   45778999999


Q ss_pred             HHHHHhcccCCCCCCCHhHH-------------hcCCccccc
Q 022617          246 DLIPRMLIVDPMKRITIPEI-------------RQHPWFQAH  274 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~i-------------l~h~~~~~~  274 (294)
                      ++|.+||+.||.+|||+.|+             |+|||++..
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            99999999999999999997             679999764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-59  Score=404.44  Aligned_cols=259  Identities=29%  Similarity=0.473  Sum_probs=223.8

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-----   88 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----   88 (294)
                      .+.++|++++.||+|+||+||+|.++.+|+.||||++..... .....+.+.+|+++|+.++||||+++++++..     
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence            356789999999999999999999999999999999965432 33446778899999999999999999998754     


Q ss_pred             -CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           89 -PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        89 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                       .+.+|+||||++ ++|.+++.+++++++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++...
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence             367999999996 589999988889999999999999999999999999999999999999999999999999999765


Q ss_pred             cCC-----CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-------
Q 022617          168 RDG-----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-------  235 (294)
Q Consensus       168 ~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  235 (294)
                      ...     ......+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+..+....+......       
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            332     23345689999999999988766689999999999999999999999998887777666432110       


Q ss_pred             ------------------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          236 ------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       236 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                              ..+.+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                                    113568899999999999999999999999999999874

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.3e-58  Score=386.48  Aligned_cols=252  Identities=28%  Similarity=0.427  Sum_probs=219.8

Q ss_pred             ccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      .++|.+.+.||+|+||+||+|.+.     .++..||||++...   .....+.+.+|++++++++||||+++++++.+++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            468999999999999999999874     35778999998643   3345678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617           91 DIYVVMEYVKSGELFDYIVEK-------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK  157 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~-------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~  157 (294)
                      .+++||||+++|+|.+++.+.             ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+|
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence            999999999999999999764             3599999999999999999999999999999999999999999999


Q ss_pred             EeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC
Q 022617          158 IADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI  233 (294)
Q Consensus       158 l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~  233 (294)
                      |+|||++........   .....+|+.|+|||++.+..+ +.++||||||+++|||+| |+.||.+.+..++...+..+.
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~  247 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  247 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999976544332   223457999999999988877 799999999999999998 999999999888888887655


Q ss_pred             -ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       234 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                       .+.|..++.++.+++.+||+.||++|||+.+|+  +++++
T Consensus       248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence             567889999999999999999999999999994  47765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-58  Score=386.55  Aligned_cols=253  Identities=28%  Similarity=0.449  Sum_probs=202.6

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   90 (294)
                      .++|++++.||+|+||+||+|.++.+++.||||++....  .....+.+.+|++++++++||||+++++++...+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            457999999999999999999999999999999987543  2344578899999999999999999999986544     


Q ss_pred             -------eEEEEEeccCCCChHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEee
Q 022617           91 -------DIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD  160 (294)
Q Consensus        91 -------~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~d  160 (294)
                             .+|++|||+.|++|.+++.....   .+...++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   37999999999999999986554   44567889999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCc-------------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHH
Q 022617          161 FGLSNIMRDGHF-------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLF  226 (294)
Q Consensus       161 fg~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~  226 (294)
                      ||++........             ....+||+.|+|||++.+..+ +.++|||||||++|+|++   ||.... .....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~~  237 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTL  237 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence            999986643321             123469999999999998877 799999999999999996   775432 22233


Q ss_pred             HHHhCCCc-cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          227 KKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       227 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ..+..... +.+...++.+.+||.+||+.||.+|||+.|+++||||++.
T Consensus       238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            33333332 2233456778899999999999999999999999999873

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.5e-58  Score=412.59  Aligned_cols=261  Identities=28%  Similarity=0.471  Sum_probs=228.7

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHH---HHHHHHhCCCCceeEEEEEEEcC
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR---EIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      ..-.++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+   ++.+++.++||||++++++|.++
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            344678999999999999999999999999999999997665443333333333   46667778999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      +.+|+||||+.||+|.++|.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|.....
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999987644


Q ss_pred             CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhCCCccCCCCCChhHHH
Q 022617          170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGIYTLPSHLSPGARD  246 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
                      .. ....+||+.|+|||++.....++.++|||||||++|+|++|..||.+.   +...+...+......+|..+++++.+
T Consensus       345 ~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~d  423 (689)
T 3v5w_A          345 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS  423 (689)
T ss_dssp             CC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             CC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHH
Confidence            33 345689999999999975544489999999999999999999999753   34456666777778888999999999


Q ss_pred             HHHHhcccCCCCCCC-----HhHHhcCCccccc
Q 022617          247 LIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       247 li~~~l~~~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      ||.+||..||.+|++     +++|++||||++.
T Consensus       424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             HHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            999999999999998     7999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4e-57  Score=382.49  Aligned_cols=249  Identities=27%  Similarity=0.422  Sum_probs=213.0

Q ss_pred             ccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ..+|.+.+.||+|+||+||+|.+.     .+++.||||++...   .....+.+.+|++++++++||||+++++++.+.+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            357888999999999999999864     35788999998643   3345678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHh---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc
Q 022617           91 DIYVVMEYVKSGELFDYIVEK---------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN  155 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~---------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~  155 (294)
                      .+++||||+++|+|.+++.+.               .++++.++..++.|++.||.|||+.+|+||||||+|||++.++.
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence            999999999999999999653               35899999999999999999999999999999999999999999


Q ss_pred             EEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhC
Q 022617          156 VKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG  231 (294)
Q Consensus       156 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~  231 (294)
                      +||+|||++.......   ......+|+.|+|||++.+..+ +.++||||||+++|||+| |+.||...+..+....+..
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  275 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ  275 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999998654332   2234568999999999998887 899999999999999999 9999999888888887766


Q ss_pred             C-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          232 G-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       232 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      + ..+.|..+++++.+++.+||+.||++|||+.||+++
T Consensus       276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            5 467788999999999999999999999999999873

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-56  Score=379.05  Aligned_cols=267  Identities=48%  Similarity=0.880  Sum_probs=243.8

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      +.+......++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus         6 s~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   84 (328)
T 3fe3_A            6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIE   84 (328)
T ss_dssp             -----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4455566788999999999999999999999999999999999765443 345678889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      ..+..++||||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           85 TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             ECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            99999999999999999999998899999999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHH
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL  247 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (294)
                      ..........+++.|+|||++.+..+.+.++||||||+++|+|++|..||.+.+.......+..+....|..++.++.++
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  244 (328)
T 3fe3_A          165 TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL  244 (328)
T ss_dssp             SSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             CCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            66666667789999999999988877668999999999999999999999999999999999988888889999999999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      +.+||..||.+|||++|+++||||+...
T Consensus       245 i~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          245 LKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.1e-57  Score=379.03  Aligned_cols=253  Identities=25%  Similarity=0.416  Sum_probs=220.7

Q ss_pred             cccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      +.-.+++++.+.||+|+||+||+|.+.     .+++.||||++....  .....+.+.+|+.++++++||||+++++++.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            344578899999999999999999853     466789999986442  2234578999999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD  151 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~  151 (294)
                      .++.+++||||+++|+|.++|..+                ..+++..+..++.|++.||.|||+.+|+||||||+|||++
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999643                3589999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022617          152 SKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFK  227 (294)
Q Consensus       152 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~  227 (294)
                      +++.+||+|||+++......   ......+|+.|+|||++.+..+ +.++||||||+++|||+| |..||.+.+..++..
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999997654332   2334568999999999988877 899999999999999998 899999999988888


Q ss_pred             HHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          228 KIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       228 ~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .+..+. .+.|..++.++.+++.+||+.||++|||+.+|+++
T Consensus       259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            887655 56788999999999999999999999999999873

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-56  Score=384.44  Aligned_cols=253  Identities=25%  Similarity=0.433  Sum_probs=209.7

Q ss_pred             cccccCCcccccccccCceEEEEEEEc---cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET   88 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   88 (294)
                      ..+.++|++.+.||+|+||+||+|.++   .+++.||+|.+....     ....+.+|+++++.+ +||||+++++++.+
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            457789999999999999999999875   356789999885442     235678899999988 59999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-CcEEEeeecccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIM  167 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~dfg~~~~~  167 (294)
                      .+.+|+||||++|++|.+++   +.+++.+++.++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+|...
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999999998   358999999999999999999999999999999999999876 79999999999754


Q ss_pred             cCCC-----------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCC
Q 022617          168 RDGH-----------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD  218 (294)
Q Consensus       168 ~~~~-----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~  218 (294)
                      ....                             .....+||+.|+|||++.+....+.++||||+||++|+|++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            3221                             12334699999999999877655899999999999999999999995


Q ss_pred             C-CCHHHHHHHHhC--------------------------------------C----------------CccCCCCCChh
Q 022617          219 D-ENIPNLFKKIKG--------------------------------------G----------------IYTLPSHLSPG  243 (294)
Q Consensus       219 ~-~~~~~~~~~~~~--------------------------------------~----------------~~~~~~~~~~~  243 (294)
                      . .+..+....+..                                      .                .......++++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            4 333333222210                                      0                01122457889


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      +.+||.+||..||.+|||++|+|+||||++
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999999999986

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.7e-57  Score=406.85  Aligned_cols=258  Identities=33%  Similarity=0.632  Sum_probs=234.7

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +.+.++|++.+.||+|+||.||+|.++.+|+.||+|++....   ....+.+.+|+++|+.++||||+++++++.+++.+
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            356689999999999999999999999999999999986543   23457788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC--CcEEEeeecccccccC
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK--WNVKIADFGLSNIMRD  169 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~--~~~~l~dfg~~~~~~~  169 (294)
                      |++|||+.||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+  +.+||+|||++.....
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999999999999864 4679999999999999999999999999999999999999854  8999999999998877


Q ss_pred             CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhHH
Q 022617          170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR  245 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~  245 (294)
                      .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......++    ..++.++.
T Consensus       310 ~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          310 KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             TSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             CCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            666667789999999999998887 7899999999999999999999999999999888887665443    57899999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +||.+||..||.+|||+.|+|+||||+..
T Consensus       389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          389 DFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence            99999999999999999999999999865

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-56  Score=372.70  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=206.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +.-.+++++.+.||+|+||+||+|.++   ..||||++..... .....+.+.+|+.++++++||||+++++++.. +.+
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence            344678999999999999999999864   3599999865433 33456889999999999999999999998754 568


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-  170 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-  170 (294)
                      ++||||++||+|.+++... .++++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+|...... 
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999999999754 57999999999999999999999999999999999999999999999999999765432 


Q ss_pred             --CccccccCCCcccCCccccCCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhCCC-----ccCCCCC
Q 022617          171 --HFLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGI-----YTLPSHL  240 (294)
Q Consensus       171 --~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~-----~~~~~~~  240 (294)
                        .......||+.|+|||++.+..  ..+.++||||||+++|||+||+.||.+.+... ....+..+.     ...+..+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  266 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC  266 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence              2234557999999999986432  23789999999999999999999998765444 333343332     1345678


Q ss_pred             ChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          241 SPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      +.++.+++.+||+.||++|||+.|++++
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999988664

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.3e-56  Score=377.59  Aligned_cols=267  Identities=65%  Similarity=1.137  Sum_probs=240.4

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|++.+.||+|+||.||+|.+..+++.|++|++.............+.+|+.+++.++||||+++++++..++..
T Consensus         5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            34578999999999999999999999999999999998765444434456789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ++++||+ +++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            9999999 569999998889999999999999999999999999999999999999999999999999999987766666


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhc
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  252 (294)
                      .....+++.|+|||++.+..+.+.++||||||+++|+|++|..||...........+.......+..+++++.++|.+||
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  243 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI  243 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTS
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHc
Confidence            66778999999999998877767899999999999999999999988776666666666667778889999999999999


Q ss_pred             ccCCCCCCCHhHHhcCCcccccCCcccc
Q 022617          253 IVDPMKRITIPEIRQHPWFQAHLPRYLA  280 (294)
Q Consensus       253 ~~~p~~Rps~~~il~h~~~~~~~~~~~~  280 (294)
                      +.||.+|||+.|+++||||+..++.+..
T Consensus       244 ~~dP~~Rpt~~eil~hp~~~~~~~~~~~  271 (336)
T 3h4j_B          244 VADPMQRITIQEIRRDPWFNVNLPDYLR  271 (336)
T ss_dssp             CSSGGGSCCHHHHTTCHHHHTTCCGGGS
T ss_pred             CCChhHCcCHHHHHhChhhccCCccccC
Confidence            9999999999999999999988776543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2e-54  Score=369.08  Aligned_cols=259  Identities=36%  Similarity=0.608  Sum_probs=236.3

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      -.++|++.+.||+|+||.||+|.++.+++.||+|++.............+.+|+.+++.++||||+++++++...+.+++
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            35789999999999999999999999999999999976644444456788899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCcc
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFL  173 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~  173 (294)
                      +|||++|++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.+|.++|+|||++.... .....
T Consensus        83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            99999999999999988899999999999999999999999999999999999999999999999999987532 23334


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcc
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  253 (294)
                      ....+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+......++..++.++.++|.+||+
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~  241 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  241 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             cccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            55678999999999988777 78999999999999999999999999988888888888888888999999999999999


Q ss_pred             cCCCCCC-----CHhHHhcCCccccc
Q 022617          254 VDPMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       254 ~~p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      .||.+||     ++.++++||||+..
T Consensus       242 ~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          242 KDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             SSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            9999999     89999999999753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-54  Score=384.87  Aligned_cols=274  Identities=66%  Similarity=1.155  Sum_probs=249.6

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      ........++|.+.+.||.|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~   87 (476)
T 2y94_A            8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST   87 (476)
T ss_dssp             -CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            34456678999999999999999999999999999999999976654444456789999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      .+..++++||+.|++|.+++.+++.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999999999999888889999999999999999999999999999999999999999999999999998776


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHH
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLI  248 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  248 (294)
                      .........+++.|+|||++.+..+.+.++||||||+++|+|++|..||...........+..+....+..++.++.++|
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li  247 (476)
T 2y94_A          168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLL  247 (476)
T ss_dssp             TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred             ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHH
Confidence            66556667899999999999887776789999999999999999999999988888888998888888889999999999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP  282 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~  282 (294)
                      .+||..||.+|||+.++++||||++.++.+...+
T Consensus       248 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~  281 (476)
T 2y94_A          248 KHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPE  281 (476)
T ss_dssp             HHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTS
T ss_pred             HHHcCCCchhCcCHHHHHhCHHhhhcCccccCCC
Confidence            9999999999999999999999999887765433

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-54  Score=372.05  Aligned_cols=261  Identities=36%  Similarity=0.630  Sum_probs=232.0

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCe
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSD   91 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   91 (294)
                      ..-.++|++.+.||+|+||.||+|.++.+++.||+|++.............+.+|..+++.+ +||||+++++++...+.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            34567999999999999999999999999999999999776554555567788999999988 69999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CC
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~  170 (294)
                      +|+||||+.|++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.... ..
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999987533 22


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHH
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR  250 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (294)
                      .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+......++..++.++.++|.+
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  257 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKS  257 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            33445678999999999987766 78999999999999999999999999999999999988888889999999999999


Q ss_pred             hcccCCCCCCCH------hHHhcCCccccc
Q 022617          251 MLIVDPMKRITI------PEIRQHPWFQAH  274 (294)
Q Consensus       251 ~l~~~p~~Rps~------~~il~h~~~~~~  274 (294)
                      ||+.||.+||++      .++++||||++.
T Consensus       258 lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          258 FMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            999999999998      899999999863

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.5e-54  Score=359.22  Aligned_cols=272  Identities=66%  Similarity=1.174  Sum_probs=235.2

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      |........++|++.+.||+|++|.||+|.+..+++.|++|++.............+.+|+.+++.++||||+++++++.
T Consensus         2 s~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   81 (276)
T 2h6d_A            2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS   81 (276)
T ss_dssp             -----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CcccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            44566778899999999999999999999999899999999997655444445678899999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      ..+..++++|++.+++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           82 TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHH
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL  247 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (294)
                      ..........+++.|+|||.+.+....+.++|+||||+++|+|++|..||...........+.......+..++..+.++
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  241 (276)
T 2h6d_A          162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL  241 (276)
T ss_dssp             CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence            65554555678899999999987766568999999999999999999999998888888888888777888899999999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~  279 (294)
                      +.+||+.||.+|||+.++++||||++.++.+.
T Consensus       242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~  273 (276)
T 2h6d_A          242 LMHMLQVDPLKRATIKDIREHEWFKQDLPSYL  273 (276)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHTTCCGGG
T ss_pred             HHHHccCChhhCCCHHHHHhChhhccCchhcc
Confidence            99999999999999999999999999887654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.7e-54  Score=369.40  Aligned_cols=261  Identities=38%  Similarity=0.667  Sum_probs=236.1

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      -..+.++|++.+.||.|+||.||+|.++.+++.|++|++........   ...+.+.+|+.++++++||||+++++++..
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            35678899999999999999999999999999999999976543321   135678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC----cEEEeeeccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLS  164 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~----~~~l~dfg~~  164 (294)
                      .+..++||||+.|++|.+++...+.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++    .++|+|||++
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999999999998888899999999999999999999999999999999999998776    7999999999


Q ss_pred             ccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCC
Q 022617          165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHL  240 (294)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~  240 (294)
                      .............+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+......++    ..+
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             eEcCCCCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence            87766555566779999999999987776 7899999999999999999999999998888888887766554    578


Q ss_pred             ChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      +.++.++|.+||..||.+|||+.|+++||||+.
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            999999999999999999999999999999985

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-54  Score=362.24  Aligned_cols=257  Identities=33%  Similarity=0.677  Sum_probs=235.5

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      -.++|++.+.||+|+||.||+|.++.+++.||+|++...........+.+.+|..+++.++||||+++++++.+.+.+++
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            35789999999999999999999999999999999976654444456778899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK  174 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  174 (294)
                      +|||+.|++|.+++.+...+++..++.++.|++.||.|||+.||+|+||||+||+++.+|.++|+|||++......  ..
T Consensus        84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~  161 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TY  161 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BC
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--cc
Confidence            9999999999999998889999999999999999999999999999999999999999999999999999865432  33


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhccc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV  254 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  254 (294)
                      ...+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+......++..++.++.+++.+||..
T Consensus       162 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~  240 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR  240 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             cccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence            5578999999999988777 789999999999999999999999988888888888888888899999999999999999


Q ss_pred             CCCCCC-----CHhHHhcCCccccc
Q 022617          255 DPMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       255 ~p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      ||.+||     +++++++||||++.
T Consensus       241 dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          241 DLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CHHHcCCCcCCCHHHHhcCccccCC
Confidence            999999     89999999999764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.5e-54  Score=366.84  Aligned_cols=265  Identities=34%  Similarity=0.578  Sum_probs=235.0

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEE
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIE   87 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   87 (294)
                      ......-.++|++.+.||+|+||.||+|.++.+++.||+|++.............+..|..+++.+ +||||+++++++.
T Consensus         9 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~   88 (345)
T 1xjd_A            9 SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   88 (345)
T ss_dssp             -------CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CccCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence            344556778999999999999999999999999999999999765443334456778889988876 8999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      ..+.+++||||+.|++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.+|.++|+|||++...
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999998754


Q ss_pred             cC-CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHH
Q 022617          168 RD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARD  246 (294)
Q Consensus       168 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
                      .. ........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||.+.+.......+......++..++.++.+
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  247 (345)
T 1xjd_A          169 MLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD  247 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ccCCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence            32 233455678999999999988777 7999999999999999999999999999999998888888888899999999


Q ss_pred             HHHHhcccCCCCCCCHh-HHhcCCccccc
Q 022617          247 LIPRMLIVDPMKRITIP-EIRQHPWFQAH  274 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~-~il~h~~~~~~  274 (294)
                      +|.+||..||.+||++. ++++||||+..
T Consensus       248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            99999999999999998 99999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-54  Score=370.38  Aligned_cols=250  Identities=28%  Similarity=0.445  Sum_probs=213.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCC-----ceEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeEEEEEEEcC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIETP   89 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~   89 (294)
                      .++|++.+.||+|+||+||+|.+...+     +.||+|.+....  .....+.+.+|+++++++.| |||++++++|..+
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            468999999999999999999976543     579999886443  22345779999999999976 8999999998654


Q ss_pred             -CeEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC
Q 022617           90 -SDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS  152 (294)
Q Consensus        90 -~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~  152 (294)
                       +.+++|||||++|+|.++|.+.                ..+++..+..++.|++.||.|||+.+|+||||||+|||++.
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence             5689999999999999999753                34899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHH
Q 022617          153 KWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN-IPNLFK  227 (294)
Q Consensus       153 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~-~~~~~~  227 (294)
                      ++.+||+|||+|+......   ......+|+.|+|||++.+..+ +.++||||||+++|||+| |..||.+.. ...+..
T Consensus       221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~  299 (353)
T 4ase_A          221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  299 (353)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred             CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999998654332   2234467899999999988877 799999999999999998 999998765 344555


Q ss_pred             HHhCC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          228 KIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       228 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .+..+ ..+.|..+++++.+++.+||+.||++|||+.+|++|
T Consensus       300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            55444 467788899999999999999999999999999987

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-53  Score=357.86  Aligned_cols=267  Identities=30%  Similarity=0.486  Sum_probs=231.8

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      .+....++|++.+.||+|+||+||+|.+..+++.|++|++.......   .+.+.+|+.++++++||||+++++++...+
T Consensus        14 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGD   90 (297)
T ss_dssp             BSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             CcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence            34567789999999999999999999999999999999987554333   467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ..+++|||+.+++|.+++.+ ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            99999999999999999965 46899999999999999999999999999999999999999999999999998765433


Q ss_pred             C-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC---CccCCCCCChhHHH
Q 022617          171 H-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARD  246 (294)
Q Consensus       171 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~  246 (294)
                      . ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+...   ....+..++..+.+
T Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (297)
T 3fxz_A          170 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD  248 (297)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred             ccccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHH
Confidence            2 3345578999999999988877 78999999999999999999999887766655544322   23445678999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP  282 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~  282 (294)
                      ++.+||+.||.+|||+.++++||||+...+.....|
T Consensus       249 li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~~p  284 (297)
T 3fxz_A          249 FLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTP  284 (297)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGGHH
T ss_pred             HHHHHccCChhHCcCHHHHhhChhhcccCcccccch
Confidence            999999999999999999999999998665544333

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.3e-53  Score=362.19  Aligned_cols=259  Identities=31%  Similarity=0.555  Sum_probs=232.3

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   93 (294)
                      -.++|++.+.||+|+||.||+|.++.+++.||+|++.............+.+|..+++++ +||||+++++++...+.++
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   86 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF   86 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence            457899999999999999999999999999999999877666666678889999999988 8999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~  172 (294)
                      +||||+.|++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.... ....
T Consensus        87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence            999999999999999988899999999999999999999999999999999999999999999999999997532 2334


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHhCCCccCCCCCChh
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD---------ENIPNLFKKIKGGIYTLPSHLSPG  243 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~~~~~  243 (294)
                      .....+++.|+|||++.+..+ +.++|+||||+++|+|++|..||..         .......+.+......++..++.+
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~  245 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK  245 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             ccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHH
Confidence            455678999999999988777 7999999999999999999999965         234455666777777888899999


Q ss_pred             HHHHHHHhcccCCCCCCCH------hHHhcCCccccc
Q 022617          244 ARDLIPRMLIVDPMKRITI------PEIRQHPWFQAH  274 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~------~~il~h~~~~~~  274 (294)
                      +.++|.+||+.||.+||++      .++++||||++.
T Consensus       246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            9999999999999999995      799999999753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.5e-53  Score=364.27  Aligned_cols=258  Identities=36%  Similarity=0.644  Sum_probs=237.5

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|++.+.||+|+||.||+|.++.+++.|++|++.............+.+|+.+++.++||||+++++++...+.+
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            35568999999999999999999999999999999999766544445567888999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ++||||+.|++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......  
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999865433  


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhc
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  252 (294)
                      .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..+...++..++.++.++|.+||
T Consensus       195 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL  273 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHS
T ss_pred             cccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            234568999999999988776 7899999999999999999999999999999999988888888999999999999999


Q ss_pred             ccCCCCCCC-----HhHHhcCCcccc
Q 022617          253 IVDPMKRIT-----IPEIRQHPWFQA  273 (294)
Q Consensus       253 ~~~p~~Rps-----~~~il~h~~~~~  273 (294)
                      +.||.+||+     +++|++||||+.
T Consensus       274 ~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          274 QVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             hcCHHhccCCccCCHHHHHhCcCcCC
Confidence            999999998     999999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-53  Score=369.80  Aligned_cols=260  Identities=31%  Similarity=0.561  Sum_probs=230.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   92 (294)
                      .-.++|++.+.||+|+||.||+|+++.+++.||+|++.............+.+|..+++++ +||||+++++++...+.+
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            3457899999999999999999999999999999999877655555566788899999877 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc-cCCC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~-~~~~  171 (294)
                      ++||||++|++|..++.+.+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++... ....
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence            999999999999999998899999999999999999999999999999999999999999999999999999753 3334


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhCCCccCCCCCCh
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---------NIPNLFKKIKGGIYTLPSHLSP  242 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~  242 (294)
                      ......+|+.|+|||++.+..+ +.++||||||+++|+|++|..||...         ....+.+.+......+|..++.
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~  287 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV  287 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             ccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCH
Confidence            4556678999999999988877 79999999999999999999999632         3344666777778888899999


Q ss_pred             hHHHHHHHhcccCCCCCCCH------hHHhcCCccccc
Q 022617          243 GARDLIPRMLIVDPMKRITI------PEIRQHPWFQAH  274 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~------~~il~h~~~~~~  274 (294)
                      ++.++|.+||+.||.+||++      ++|++||||++.
T Consensus       288 ~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            99999999999999999985      799999999764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3e-53  Score=367.05  Aligned_cols=265  Identities=25%  Similarity=0.497  Sum_probs=238.1

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      .+.+...++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...
T Consensus         8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A            8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            45566789999999999999999999999999999999999776555555567889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      +..++|+||+.|++|.+++.+...+++..++.++.|++.||.|||+.||+|+||||+||+++.+|.++|+|||++.....
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999987766


Q ss_pred             CCccccccCCCcccCCccccCC--ccCCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhCCCccCCCCCChhH
Q 022617          170 GHFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDD---ENIPNLFKKIKGGIYTLPSHLSPGA  244 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
                      ........+|+.|+|||++...  ...+.++||||||+++|+|++|..||..   .........+.......+..++.++
T Consensus       168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~  247 (384)
T 4fr4_A          168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM  247 (384)
T ss_dssp             TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHH
Confidence            6666677899999999998642  2237899999999999999999999974   3455666667777778888999999


Q ss_pred             HHHHHHhcccCCCCCCC-HhHHhcCCccccc
Q 022617          245 RDLIPRMLIVDPMKRIT-IPEIRQHPWFQAH  274 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps-~~~il~h~~~~~~  274 (294)
                      .++|.+||..||.+||+ ++++++||||++.
T Consensus       248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            99999999999999998 8999999999753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.8e-53  Score=364.06  Aligned_cols=260  Identities=35%  Similarity=0.566  Sum_probs=234.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCe
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSD   91 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   91 (294)
                      ..-.++|++.+.||+|+||.||+|.++.+++.||+|++.............+..|..++..+ +||+|+++++++...+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            45568999999999999999999999999999999999766544444567788899999887 79999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CC
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~  170 (294)
                      +|+||||++|++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.+|.++|+|||++.... ..
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999997543 23


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHH
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR  250 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (294)
                      .......+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.....+.+......++..++.++.++|.+
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  254 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG  254 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            33455678999999999988777 79999999999999999999999999999999999888888889999999999999


Q ss_pred             hcccCCCCCCC-----HhHHhcCCcccc
Q 022617          251 MLIVDPMKRIT-----IPEIRQHPWFQA  273 (294)
Q Consensus       251 ~l~~~p~~Rps-----~~~il~h~~~~~  273 (294)
                      ||..||.+||+     +++|++||||+.
T Consensus       255 lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          255 LMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            99999999995     699999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-53  Score=361.56  Aligned_cols=258  Identities=26%  Similarity=0.509  Sum_probs=233.0

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .+.++|++.+.||+|+||+||+|.+..+++.+++|++....    .....+.+|+.+++.++||||+++++++...+..+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   77 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence            46789999999999999999999999999999999986432    33567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC--CCcEEEeeecccccccCC
Q 022617           94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~--~~~~~l~dfg~~~~~~~~  170 (294)
                      ++|||+.|++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.  ++.++|+|||++......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999999999765 36999999999999999999999999999999999999987  789999999999887666


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhHHH
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARD  246 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~  246 (294)
                      .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.......+    ..++.++.+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence            55566678999999999987766 7899999999999999999999999988888888877665544    478999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ++.+||..||.+|||+.|+|+||||++...
T Consensus       237 li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          237 FVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             HHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence            999999999999999999999999987644

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-53  Score=360.10  Aligned_cols=262  Identities=38%  Similarity=0.660  Sum_probs=233.7

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      ...+.++|++.+.||+|+||.||+|.+..+++.|++|++........   ...+.+.+|+.++++++||||+++++++..
T Consensus         6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   85 (326)
T 2y0a_A            6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN   85 (326)
T ss_dssp             CSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            35677899999999999999999999999999999999976543221   135778999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC----cEEEeeeccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLS  164 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~----~~~l~dfg~~  164 (294)
                      .+..++++||+.+++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++    .++|+|||++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999999998888899999999999999999999999999999999999998877    7999999999


Q ss_pred             ccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCC
Q 022617          165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHL  240 (294)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~  240 (294)
                      .............+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+.......+    ..+
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             eECCCCCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence            87765555556678999999999987766 7899999999999999999999998888887777765554443    578


Q ss_pred             ChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +..+.++|.+||..||.+|||+.++|+||||+..
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            9999999999999999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.6e-53  Score=352.83  Aligned_cols=266  Identities=33%  Similarity=0.678  Sum_probs=237.4

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|++.+.||.|++|+||+|.+..++..|++|++.............+.+|+.++++++||||+++++++...+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            34568999999999999999999999999999999999766555445567889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ++++||+++++|.+++.+...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-  163 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  163 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence            9999999999999999988899999999999999999999999999999999999999999999999999886543332 


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhc
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  252 (294)
                      .....+++.|+|||.+.+... +.++||||||+++|+|++|..||...........+.......+..++.++.+++.+||
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  242 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL  242 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHC
T ss_pred             ccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHh
Confidence            234568899999999987766 7899999999999999999999999999888888888888888899999999999999


Q ss_pred             ccCCCCCCCHhHHhcCCcccccCCcccc
Q 022617          253 IVDPMKRITIPEIRQHPWFQAHLPRYLA  280 (294)
Q Consensus       253 ~~~p~~Rps~~~il~h~~~~~~~~~~~~  280 (294)
                      +.||.+|||+.++++||||++.......
T Consensus       243 ~~~p~~Rps~~e~l~h~~~~~~~~~~~~  270 (279)
T 3fdn_A          243 KHNPSQRPMLREVLEHPWITANSSKPSN  270 (279)
T ss_dssp             CSSGGGSCCHHHHHHCHHHHHHCSSCCC
T ss_pred             ccChhhCCCHHHHhhCccccCCccCccc
Confidence            9999999999999999999987655433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.5e-53  Score=363.08  Aligned_cols=267  Identities=42%  Similarity=0.737  Sum_probs=219.5

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      ...+....++|++.+.||+|+||+||+|.+..+++.||+|++......    ...+.+|+.+++.++||||+++++++..
T Consensus        12 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~   87 (361)
T 3uc3_A           12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILT   87 (361)
T ss_dssp             CCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence            334455678999999999999999999999999999999998654322    3567899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc--EEEeeeccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--VKIADFGLSNI  166 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~--~~l~dfg~~~~  166 (294)
                      .+..++++||+.+++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.  ++|+|||++..
T Consensus        88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999999999999999999988889999999999999999999999999999999999999987665  99999999875


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhCCCccCCC--CC
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPS--HL  240 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~--~~  240 (294)
                      ...........+++.|+|||++.+..+.+.++||||||+++|+|++|+.||....    .......+.......+.  .+
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI  247 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence            5444445566789999999999887775556999999999999999999997643    34445555555444443  68


Q ss_pred             ChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617          241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~  279 (294)
                      +.++.++|.+||..||.+|||+.++++||||++.++...
T Consensus       248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~  286 (361)
T 3uc3_A          248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADL  286 (361)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCCC-
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCchhh
Confidence            999999999999999999999999999999988765543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.8e-53  Score=364.95  Aligned_cols=260  Identities=42%  Similarity=0.718  Sum_probs=233.3

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ..+.++|++.+.||.|+||.||+|.++.+++.|++|++....... ...+.+.+|+.++++++||||+++++++...+..
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  103 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFH  103 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            356678999999999999999999999999999999997654432 4467789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC---CcEEEeeecccccccC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRD  169 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~---~~~~l~dfg~~~~~~~  169 (294)
                      ++++||+.|++|.+.+.....+++..++.++.|++.||.|||+.||+|+||||+||+++.+   +.++|+|||++.....
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            9999999999999999888889999999999999999999999999999999999999765   4599999999987765


Q ss_pred             CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhHH
Q 022617          170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR  245 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~  245 (294)
                      ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..+....+    ..++.++.
T Consensus       184 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          184 SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             CCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             CcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            555556678999999999988776 7899999999999999999999999888888888877665444    35799999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ++|.+||..||.+|||+.++|+||||+..
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.6e-52  Score=347.58  Aligned_cols=265  Identities=42%  Similarity=0.696  Sum_probs=237.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .+.++|++.+.||.|++|.||+|.+..+++.|++|++...... ......+.+|+.++++++||||+++++++...+..+
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   81 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence            5678999999999999999999999999999999999766543 344577889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc---EEEeeecccccccCC
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDG  170 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~---~~l~dfg~~~~~~~~  170 (294)
                      +++||+.+++|.+.+.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            99999999999999988899999999999999999999999999999999999999986655   999999999877666


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhHHH
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARD  246 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~  246 (294)
                      .......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+.......+    ..+++++.+
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             ccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence            65566778999999999988777 7899999999999999999999999888888888776654443    478999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcccccCCcccc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLA  280 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~  280 (294)
                      ++.+||+.||++|||+.++++||||++.......
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  274 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALKVPWICNRERVASA  274 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred             HHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence            9999999999999999999999999886444433

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.6e-53  Score=370.67  Aligned_cols=261  Identities=41%  Similarity=0.718  Sum_probs=232.2

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      ...+.++|++.+.||+|+||+||+|.+..+++.+++|++....... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            4567889999999999999999999999999999999997665433 346778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec---CCCcEEEeeeccccccc
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD---SKWNVKIADFGLSNIMR  168 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~---~~~~~~l~dfg~~~~~~  168 (294)
                      .+++|||+.|++|.+.+...+.+++..++.++.|++.||.|||+.||+|+||||+||+++   .++.++|+|||++....
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999999999999889999999999999999999999999999999999999998   46789999999997665


Q ss_pred             CCC-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChh
Q 022617          169 DGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPG  243 (294)
Q Consensus       169 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~  243 (294)
                      ... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..+....+    ..++++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  243 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE  243 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             CCCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence            433 2345678999999999988777 7899999999999999999999999998888888877765444    478999


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +.++|.+||+.||.+|||+.|+|+||||+..
T Consensus       244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          244 AKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            9999999999999999999999999999764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.6e-52  Score=348.47  Aligned_cols=261  Identities=40%  Similarity=0.750  Sum_probs=235.6

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      ...+.++|++.+.||+|+||+||+|.+..++..+++|++.......   .+.+.+|++++++++||||+++++++...+.
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            3467889999999999999999999999999999999987654332   5678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe---cCCCcEEEeeeccccccc
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili---~~~~~~~l~dfg~~~~~~  168 (294)
                      .++++||+.+++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999999999988899999999999999999999999999999999999999   778899999999998776


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCC----CCChhH
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGA  244 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l  244 (294)
                      .........+++.|+|||.+.+. + +.++||||||+++|+|++|..||...........+.......+.    .++..+
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA  238 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred             CccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence            66666677899999999998765 4 78999999999999999999999998888888888777666553    789999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      .+++.+||+.||.+|||+.++++||||++.+..
T Consensus       239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence            999999999999999999999999999886543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-52  Score=356.86  Aligned_cols=266  Identities=32%  Similarity=0.533  Sum_probs=224.2

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEc---cCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhCCCCceeEEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMHPHIIRLY   83 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~   83 (294)
                      +........++|++.+.||+|+||.||+|.+.   .+++.|++|++...... .......+.+|+.++++++||||++++
T Consensus         8 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~   87 (327)
T 3a62_A            8 NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI   87 (327)
T ss_dssp             -----CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEE
T ss_pred             CCCCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCcccee
Confidence            33444567789999999999999999999985   68899999998765322 223456678899999999999999999


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           84 EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      +++...+..+++|||+.+++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           88 YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             EEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            99999999999999999999999999888999999999999999999999999999999999999999999999999999


Q ss_pred             cccccC-CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCCh
Q 022617          164 SNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSP  242 (294)
Q Consensus       164 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
                      +..... ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......++..++.
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~  246 (327)
T 3a62_A          168 CKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ  246 (327)
T ss_dssp             C----------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCH
T ss_pred             ccccccCCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Confidence            875432 223345568999999999987766 789999999999999999999999998888888888888888889999


Q ss_pred             hHHHHHHHhcccCCCCCC-----CHhHHhcCCccccc
Q 022617          243 GARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      ++.++|.+||..||.+||     ++.++++||||+..
T Consensus       247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            999999999999999999     88999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.5e-53  Score=356.24  Aligned_cols=271  Identities=28%  Similarity=0.477  Sum_probs=220.1

Q ss_pred             CCCCCCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEE
Q 022617            3 GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL   82 (294)
Q Consensus         3 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   82 (294)
                      .+++.+....+.+.++|++.+.||+|+||+||+|.+. +++.||+|++..... .......+.+|++++++++||||+++
T Consensus         7 ~~~~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~   84 (311)
T 3niz_A            7 HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSL   84 (311)
T ss_dssp             --------CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeee
Confidence            3455777788999999999999999999999999986 588999999865432 22345778899999999999999999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617           83 YEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF  161 (294)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df  161 (294)
                      ++++...+..+++|||+++ +|.+.+... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Df  163 (311)
T 3niz_A           85 IDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADF  163 (311)
T ss_dssp             EEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccC
Confidence            9999999999999999976 888887654 45999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc------
Q 022617          162 GLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------  234 (294)
Q Consensus       162 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------  234 (294)
                      |++...... .......+++.|+|||++.+....+.++||||||+++|+|++|+.||.+....+....+.....      
T Consensus       164 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  243 (311)
T 3niz_A          164 GLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE  243 (311)
T ss_dssp             TTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred             cCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence            999876433 2334456799999999987755458899999999999999999999987665554444322100      


Q ss_pred             ------------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          235 ------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       235 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                                              .....++.++.++|.+||+.||.+|||+.|+|+||||++.-+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                                    012357789999999999999999999999999999998543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.2e-52  Score=362.50  Aligned_cols=262  Identities=32%  Similarity=0.547  Sum_probs=227.4

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCceeEEEEEEEcCC
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ...-.++|++.+.||+|+||.||+|+++.+++.||+|++.............+.+|..+ ++.++||||+++++++...+
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            34567899999999999999999999999999999999987765554555666777766 56789999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-C
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-D  169 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~  169 (294)
                      .+|+||||+.|++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.+|+++|+|||++.... .
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999999999988899999999999999999999999999999999999999999999999999997643 3


Q ss_pred             CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHH
Q 022617          170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP  249 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  249 (294)
                      ........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+......++..++.++.++|.
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  271 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE  271 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHH
T ss_pred             CCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Confidence            334456678999999999988776 7899999999999999999999999999998888888888888899999999999


Q ss_pred             HhcccCCCCCCCH----hHHhcCCccccc
Q 022617          250 RMLIVDPMKRITI----PEIRQHPWFQAH  274 (294)
Q Consensus       250 ~~l~~~p~~Rps~----~~il~h~~~~~~  274 (294)
                      +||+.||.+||++    .++++||||+..
T Consensus       272 ~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          272 GLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            9999999999986    699999999753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3e-52  Score=349.52  Aligned_cols=258  Identities=28%  Similarity=0.522  Sum_probs=217.7

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||+|+||+||+|.+..+++.|++|++..... .......+.+|+.++++++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            689999999999999999999999999999999976543 3344577889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Cccc
Q 022617           97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~  174 (294)
                      ||+++ ++.+.+.. ++.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+...... ....
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            99986 66655544 678999999999999999999999999999999999999999999999999999766433 2334


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhCCC--------------------
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGI--------------------  233 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-~~~~~~~~~~~~~~~~~--------------------  233 (294)
                      ...+++.|+|||++.+....+.++||||||+++|+|++|..| |...+..+....+....                    
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence            556799999999998776558999999999999999987777 55555555555442210                    


Q ss_pred             ---------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          234 ---------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                               ......++.++.+++.+||+.||++|||++|+++||||++..|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence                     1122357889999999999999999999999999999998654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.2e-52  Score=347.96  Aligned_cols=262  Identities=34%  Similarity=0.681  Sum_probs=237.1

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|++.+.||+|++|.||+|.+..++..|++|++.............+.+|+.++++++|+||+++++++...+..
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            34568999999999999999999999999999999998765544444467889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ++++|++.+++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~  168 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-R  168 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-C
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-c
Confidence            999999999999999998889999999999999999999999999999999999999999999999999998665432 2


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhc
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  252 (294)
                      .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+.......+..++.++.++|.+||
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  247 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL  247 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHS
T ss_pred             cccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHh
Confidence            344568999999999988776 7899999999999999999999999888888888888878888899999999999999


Q ss_pred             ccCCCCCCCHhHHhcCCcccccCC
Q 022617          253 IVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       253 ~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ..||.+|||+.++++||||+....
T Consensus       248 ~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          248 RYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             CSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             hcCHhhCCCHHHHhhCHHHHhhcc
Confidence            999999999999999999987543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.7e-53  Score=372.61  Aligned_cols=260  Identities=37%  Similarity=0.607  Sum_probs=226.6

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+.++
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            45678999999999999999999999999999999997665444455677888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccC-CC
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GH  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~  171 (294)
                      +||||+++++|.+++.+...+++..++.++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||++..... ..
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            999999999999999988999999999999999999999998 9999999999999999999999999999875432 23


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......++..+++++.++|.+|
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  383 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL  383 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            3445678999999999988777 799999999999999999999999999999999888888888899999999999999


Q ss_pred             cccCCCCCC-----CHhHHhcCCccccc
Q 022617          252 LIVDPMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       252 l~~~p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      |+.||.+||     +++++++||||++.
T Consensus       384 L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          384 LKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             TCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999999     99999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-52  Score=359.27  Aligned_cols=260  Identities=30%  Similarity=0.559  Sum_probs=230.2

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ..+.++|++.+.||.|+||.||+|.+..+++.+++|++....   ......+.+|+.++++++||||+++++++...+..
T Consensus        47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            456789999999999999999999999999999999986543   22346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC--CCcEEEeeecccccccC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRD  169 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~--~~~~~l~dfg~~~~~~~  169 (294)
                      +++|||+.+++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.  ++.++|+|||++.....
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            9999999999999998754 36999999999999999999999999999999999999974  46799999999987766


Q ss_pred             CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC----CCCCChhHH
Q 022617          170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----PSHLSPGAR  245 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~  245 (294)
                      ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......    ...++.++.
T Consensus       204 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          204 DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            555556678999999999988776 789999999999999999999999988877777776554333    346899999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ++|.+||..||.+|||+.++++||||+....
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            9999999999999999999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-51  Score=346.24  Aligned_cols=260  Identities=37%  Similarity=0.584  Sum_probs=237.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...++|++.+.||+|+||.||+|.+..+++.+++|++...........+.+.+|+.++++++|+||+++++++...+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            45679999999999999999999999999999999998766555566788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Cc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~  172 (294)
                      +++||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999998765432 23


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhc
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  252 (294)
                      .....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||......+....+.......+..++..+.+++.+||
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  250 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML  250 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHc
Confidence            344568899999999987766 7899999999999999999999999888888888888888888899999999999999


Q ss_pred             ccCCCCCCCHhHHhcCCccccc
Q 022617          253 IVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       253 ~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +.||++|||+.++++||||++.
T Consensus       251 ~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          251 QTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             CSSGGGSCCGGGGGGSHHHHTS
T ss_pred             ccChhhCcCHHHHhhChheecC
Confidence            9999999999999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.8e-52  Score=352.89  Aligned_cols=261  Identities=37%  Similarity=0.660  Sum_probs=234.5

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      ..+.++|++.+.||+|+||.||+|.+..+++.|++|++........   ...+.+.+|+.++++++||||+++++++...
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4578899999999999999999999999999999999976543321   1357789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC----cEEEeeecccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSN  165 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~----~~~l~dfg~~~  165 (294)
                      +..++++||+.+++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++    .++|+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999999999998888899999999999999999999999999999999999999887    79999999998


Q ss_pred             cccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCC
Q 022617          166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLS  241 (294)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~  241 (294)
                      ............+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+.......+    ..++
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             ecCccccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence            7766555556678999999999987766 7899999999999999999999999888888888777665443    5789


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ..+.++|.+||..||++|||+.++++||||+..
T Consensus       247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999999999999764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.5e-52  Score=346.35  Aligned_cols=264  Identities=32%  Similarity=0.585  Sum_probs=223.3

Q ss_pred             CCCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEE
Q 022617            6 NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV   85 (294)
Q Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   85 (294)
                      ..+...-..+.++|++.+.||+|+||.||+|.+..++..+++|++......  ...+.+.+|++++++++||||++++++
T Consensus        11 ~~~~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~   88 (285)
T 3is5_A           11 RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEV   88 (285)
T ss_dssp             --CCEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cccCCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHh
Confidence            344444567889999999999999999999999999999999998765422  235788999999999999999999999


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe---cCCCcEEE
Q 022617           86 IETPSDIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKI  158 (294)
Q Consensus        86 ~~~~~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili---~~~~~~~l  158 (294)
                      +...+..++++||+.+++|.+.+...    ..+++..++.++.|++.||.+||+.|++|+||+|+||++   +.++.++|
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl  168 (285)
T 3is5_A           89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI  168 (285)
T ss_dssp             EECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred             eecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEE
Confidence            99999999999999999999988543    679999999999999999999999999999999999999   45678999


Q ss_pred             eeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC-
Q 022617          159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-  237 (294)
Q Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  237 (294)
                      +|||++.............+++.|+|||.+.+. + +.++||||||+++|+|++|..||.+.................. 
T Consensus       169 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (285)
T 3is5_A          169 IDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-V-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV  246 (285)
T ss_dssp             CCCCCCCC----------CTTGGGCCHHHHTTC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC
T ss_pred             EeeecceecCCcccCcCcccccCcCChHHhccC-C-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc
Confidence            999999876655555666789999999998643 4 7899999999999999999999999888877776655443332 


Q ss_pred             --CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          238 --SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       238 --~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                        ..+++++.+++.+||+.||.+|||+.|+++||||++
T Consensus       247 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence              347899999999999999999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.7e-52  Score=357.61  Aligned_cols=259  Identities=37%  Similarity=0.698  Sum_probs=223.1

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .+.++|++.+.||+|+||+||+|.++.+++.|++|++.......  ....+.+.+|+.+++.++||||+++++++...+.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            46689999999999999999999999999999999986543221  1135778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc---EEEeeeccc
Q 022617           92 IYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS  164 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~---~~l~dfg~~  164 (294)
                      .++||||++|++|.+.+.+.    ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.   ++|+|||++
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999999998888643    25899999999999999999999999999999999999987654   999999999


Q ss_pred             ccccCCCc-cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CC
Q 022617          165 NIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SH  239 (294)
Q Consensus       165 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~  239 (294)
                      ........ .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.. ......+.......+    ..
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence            87654432 345578999999999988777 789999999999999999999998754 445555554444333    57


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ++.++.++|.+||..||.+|||+.++++||||+..
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            89999999999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.6e-52  Score=354.65  Aligned_cols=267  Identities=34%  Similarity=0.664  Sum_probs=224.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .+.++|++.+.||+|+||+||+|.+..+++.|++|++......  ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            4678999999999999999999999999999999998654322  23467889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--  171 (294)
                      ++|||+.+++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999999999877789999999999999999999999999999999999999999999999999997653222  


Q ss_pred             -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhCCC--ccCCCCCChhHHHH
Q 022617          172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGI--YTLPSHLSPGARDL  247 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~--~~~~~~~~~~l~~l  247 (294)
                       ......+++.|+|||++.+..+.+.++||||||+++|+|++|..||...... ..........  ......++..+.++
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence             2335578999999999987776577899999999999999999999765443 2222222222  22235689999999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP  282 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~  282 (294)
                      +.+||..||.+|||+.|+++||||++.+.+....+
T Consensus       242 i~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~~~~  276 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP  276 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCCCCCCCCC
T ss_pred             HHHHccCChhhCcCHHHHhhChhhccccccccccc
Confidence            99999999999999999999999998766554433

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.5e-52  Score=374.83  Aligned_cols=273  Identities=40%  Similarity=0.712  Sum_probs=240.9

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ....+.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++...+
T Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   99 (484)
T 3nyv_A           20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG   99 (484)
T ss_dssp             CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            34567889999999999999999999999999999999997765554555788999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe---cCCCcEEEeeecccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIM  167 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili---~~~~~~~l~dfg~~~~~  167 (294)
                      ..++++|++.+++|.+.+...+.+++..++.++.|++.||.|||+.||+|+||||+||++   +.++.++|+|||++...
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            999999999999999999888899999999999999999999999999999999999999   46789999999999877


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChh
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPG  243 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~  243 (294)
                      ..........+++.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+....+    ..++.+
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  257 (484)
T 3nyv_A          180 EASKKMKDKIGTAYYIAPEVLHGT-Y-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES  257 (484)
T ss_dssp             CCCCSHHHHTTGGGTCCHHHHHTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred             ccccccccCCCCccccCceeecCC-C-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence            666666667799999999998763 4 7899999999999999999999999998888888877654332    468999


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD  285 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~  285 (294)
                      +.++|.+||+.||.+|||+.++|+||||+...........|.
T Consensus       258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~  299 (484)
T 3nyv_A          258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPS  299 (484)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCB
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccc
Confidence            999999999999999999999999999998776555544443

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.7e-51  Score=351.40  Aligned_cols=260  Identities=37%  Similarity=0.584  Sum_probs=237.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...++|.+.+.||+|+||.||+|.+..+++.+++|++...........+.+.+|+.++++++|+||+++++++...+..+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            45678999999999999999999999999999999998766555566788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Cc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~  172 (294)
                      +++||+.+++|.+++.....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999999766432 23


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhc
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  252 (294)
                      .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||......+....+.......+..++..+.++|.+||
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  276 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML  276 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHc
Confidence            344568899999999987766 7899999999999999999999999888888888877777888899999999999999


Q ss_pred             ccCCCCCCCHhHHhcCCccccc
Q 022617          253 IVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       253 ~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +.||++|||+.++++||||++.
T Consensus       277 ~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          277 QTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             CSSGGGSCCGGGGGGSHHHHTS
T ss_pred             cCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-52  Score=349.60  Aligned_cols=262  Identities=38%  Similarity=0.688  Sum_probs=219.6

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc-----------------------hHHHHHHHHH
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----------------------MEMEEKVRRE   67 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-----------------------~~~~~~~~~e   67 (294)
                      +-....++|++.+.||+|+||.||+|.+..+++.|++|++.......                       ....+.+.+|
T Consensus         7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   86 (298)
T 2zv2_A            7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE   86 (298)
T ss_dssp             ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred             CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence            34456789999999999999999999999999999999987554221                       1124568899


Q ss_pred             HHHHHhCCCCceeEEEEEEEc--CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 022617           68 IKILRLFMHPHIIRLYEVIET--PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKP  145 (294)
Q Consensus        68 ~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p  145 (294)
                      ++++++++||||+++++++..  .+..+++|||+++++|.+++ ...++++..++.++.|++.||.|||+.|++|+||+|
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  165 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP  165 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            999999999999999999986  56899999999999998865 346799999999999999999999999999999999


Q ss_pred             CCeEecCCCcEEEeeecccccccCCC-ccccccCCCcccCCccccCCcc--CCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 022617          146 ENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYALLCGTLPFDDENI  222 (294)
Q Consensus       146 ~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~p~~~~~~  222 (294)
                      +||+++.++.++|+|||++....... ......+++.|+|||.+.+...  .+.++||||||+++|+|++|..||.....
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999999998665432 2345578999999999876542  36789999999999999999999998887


Q ss_pred             HHHHHHHhCCCccCC--CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          223 PNLFKKIKGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       223 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      ......+.......+  ..++.++.++|.+||+.||++|||+.++++||||+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            777777765554433  578999999999999999999999999999999963

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.9e-52  Score=346.35  Aligned_cols=262  Identities=38%  Similarity=0.675  Sum_probs=207.1

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|++.+.||+|++|.||+|.+..+++.|++|++...........+.+.+|+.++++++||||+++++++...+..
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            34567899999999999999999999989999999998765444434457889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++++||+++++|.+++... .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999999765 679999999999999999999999999999999999999999999999999987654322


Q ss_pred             -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHH
Q 022617          172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR  250 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (294)
                       ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+.......+..++.++.+++.+
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  245 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ  245 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred             CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence             2234567899999999987766 78999999999999999999999887766666666555566777899999999999


Q ss_pred             hcccCCCCCCCHhHHhcCCcccccC
Q 022617          251 MLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      ||+.||++|||+.++++||||++.-
T Consensus       246 ~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          246 LLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HcccCHhhCCCHHHHhcCccccCCC
Confidence            9999999999999999999998743

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.8e-51  Score=369.42  Aligned_cols=263  Identities=37%  Similarity=0.665  Sum_probs=233.1

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccch----------HHHHHHHHHHHHHHhCCCCceeEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM----------EMEEKVRREIKILRLFMHPHIIRL   82 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~   82 (294)
                      ..+.++|++++.||+|+||+||+|.++.+++.+|+|++........          ...+.+.+|+.++++++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            4678899999999999999999999999999999999976543321          235678999999999999999999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC---cEEEe
Q 022617           83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIA  159 (294)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~---~~~l~  159 (294)
                      ++++...+..++|+||+.|++|.+.+.+...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++   .++|+
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            999999999999999999999999999889999999999999999999999999999999999999998776   69999


Q ss_pred             eecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC--
Q 022617          160 DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP--  237 (294)
Q Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--  237 (294)
                      |||++.............+++.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.........+..+....+  
T Consensus       192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN  269 (504)
T ss_dssp             CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             ECCCCEEcCCCCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence            9999987766666667789999999999874 34 7899999999999999999999999999999888887765544  


Q ss_pred             --CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          238 --SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       238 --~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                        ..++.++.++|.+||..||.+|||+.|+|+||||+...+.
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence              6789999999999999999999999999999999886554

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.4e-52  Score=350.74  Aligned_cols=264  Identities=27%  Similarity=0.477  Sum_probs=207.8

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||+|+||+||+|.+..+++.|++|++.....  ......+.+|+.++++++||||+++++++..++..+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            4689999999999999999999999999999999865432  22346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           96 MEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      +||+++ +|.+++...      ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+.....
T Consensus        82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            999975 999998764      3589999999999999999999999999999999999999999999999999986643


Q ss_pred             C-CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------
Q 022617          170 G-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------  233 (294)
Q Consensus       170 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------  233 (294)
                      . .......+++.|+|||++.+....+.++||||||+++|+|++|..||.+....+....+....               
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            3 233455689999999999765444889999999999999999999999887776665543210               


Q ss_pred             -------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617          234 -------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP  282 (294)
Q Consensus       234 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~  282 (294)
                                         ...+..++.++.++|.+||+.||.+|||+.|+|+||||++....-...+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~  308 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGG  308 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC------
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhccc
Confidence                               0112357889999999999999999999999999999999776544433

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.7e-52  Score=361.55  Aligned_cols=261  Identities=29%  Similarity=0.516  Sum_probs=228.1

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ..-.++|++.+.||+|+||+||+|.++.+++.||+|++.............+.+|..+++.++||||+++++++.+.+.+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            34567999999999999999999999999999999998764433333345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      |+||||++|++|.+++.+ ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus       145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            999999999999999864 5789999999999999999999999999999999999999999999999999976654432


Q ss_pred             --cccccCCCcccCCccccCCcc---CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC----ccCCCCCChh
Q 022617          173 --LKTSCGSPNYAAPEVISGKLY---AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPSHLSPG  243 (294)
Q Consensus       173 --~~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~  243 (294)
                        .....+|+.|+|||++.+...   .+.++||||||+++|+|++|..||...+.......+....    .+....++.+
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  303 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence              235679999999999876541   2689999999999999999999999998888888876543    3333578999


Q ss_pred             HHHHHHHhcccCCCC--CCCHhHHhcCCccccc
Q 022617          244 ARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH  274 (294)
Q Consensus       244 l~~li~~~l~~~p~~--Rps~~~il~h~~~~~~  274 (294)
                      +.++|.+||..+|.+  ||++++|++||||++.
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            999999999999988  9999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-51  Score=348.31  Aligned_cols=260  Identities=26%  Similarity=0.476  Sum_probs=217.8

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      +.++|++.+.||+|++|+||+|.+..+++.|++|++.... ......+.+.+|+.++++++||||+++++++...+..++
T Consensus         1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence            4679999999999999999999999999999999986553 333456778899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccc
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL  173 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~  173 (294)
                      ++||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence            9999999999999887888999999999999999999999999999999999999999999999999999765432 233


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------------
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------------  233 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------  233 (294)
                      ....+++.|+|||.+.+....+.++||||||+++|+|++|..||.+....+....+....                    
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (311)
T 4agu_A          160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV  239 (311)
T ss_dssp             ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred             CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence            455688999999999765545899999999999999999999998877666554432210                    


Q ss_pred             -ccC----------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          234 -YTL----------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       234 -~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                       .+.          .+.++.++.+++.+||+.||.+|||++++++||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence             000          146788899999999999999999999999999998853

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.8e-51  Score=356.99  Aligned_cols=266  Identities=22%  Similarity=0.341  Sum_probs=221.2

Q ss_pred             CCCCccccccCCccccccccc--CceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV   85 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g--~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   85 (294)
                      ..+.+-.-.++|++.+.||+|  +||+||+|.+..+++.|++|++...... ......+.+|+.++++++||||++++++
T Consensus        16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~   94 (389)
T 3gni_B           16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRAT   94 (389)
T ss_dssp             --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence            344555677899999999999  9999999999999999999999766433 3556788899999999999999999999


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           86 IETPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        86 ~~~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      +...+..++|+||+.+++|.+++...  ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B           95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence            99999999999999999999999875  6799999999999999999999999999999999999999999999999998


Q ss_pred             cccccCC--------CccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC
Q 022617          164 SNIMRDG--------HFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI  233 (294)
Q Consensus       164 ~~~~~~~--------~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~  233 (294)
                      +......        .......+++.|+|||++.+  ..+ +.++||||||+++|+|++|+.||.+.........+..+.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  253 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT  253 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            7543211        11223367889999999976  344 789999999999999999999998755444333322111


Q ss_pred             c----------------------------------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          234 Y----------------------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       234 ~----------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .                                              +.+..++.++.+||.+||+.||.+|||+.|+|+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1                                              134567889999999999999999999999999


Q ss_pred             CCcccccC
Q 022617          268 HPWFQAHL  275 (294)
Q Consensus       268 h~~~~~~~  275 (294)
                      ||||++..
T Consensus       334 hp~f~~~~  341 (389)
T 3gni_B          334 HSFFKQIK  341 (389)
T ss_dssp             SGGGGGC-
T ss_pred             CHHHHHHh
Confidence            99998764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-51  Score=353.84  Aligned_cols=263  Identities=42%  Similarity=0.709  Sum_probs=213.3

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ..+.+.++|++.+.||+|+||.||+|.+..+++.|++|++....     ..+.+.+|+.++++++||||+++++++...+
T Consensus        47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            34667889999999999999999999999999999999986442     2456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEEEeeecccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGLSNIM  167 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~l~dfg~~~~~  167 (294)
                      ..++++||+.+++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.   ++.++|+|||++...
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999999999988888999999999999999999999999999999999999975   789999999999876


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhCCCcc----CCCCCCh
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYT----LPSHLSP  242 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~----~~~~~~~  242 (294)
                      ..........+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...... .....+......    ....++.
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             CcccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence            55544556678999999999988766 78999999999999999999999765543 355555554432    2357899


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~  279 (294)
                      ++.++|.+||+.||++|||+.++++||||+.......
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  317 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFV  317 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCS
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchh
Confidence            9999999999999999999999999999988655443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-52  Score=355.21  Aligned_cols=274  Identities=25%  Similarity=0.461  Sum_probs=226.7

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||+|+||+||+|.+..+++.|++|++......  .....+.+|+.++++++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            6899999999999999999999999999999998644311  11223457999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617           97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  174 (294)
                      ||+++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence            99975 999988765 459999999999999999999999999999999999999999999999999987654322 233


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--------------------
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------------------  234 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------  234 (294)
                      ...+++.|+|||++.+....+.++||||||+++|+|++|+.||.+.+..+....+.....                    
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN  238 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence            456799999999988755558899999999999999999999998887766655432110                    


Q ss_pred             ----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcchHHHhhh
Q 022617          235 ----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKV  293 (294)
Q Consensus       235 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~  293 (294)
                                .....++.++.+|+.+||+.||.+|||++|+|+||||++...+....+.+..+.+-|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  307 (324)
T 3mtl_A          239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEI  307 (324)
T ss_dssp             CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTC
T ss_pred             cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHH
Confidence                      11235788999999999999999999999999999999999998888888887776654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1e-51  Score=369.57  Aligned_cols=268  Identities=38%  Similarity=0.698  Sum_probs=234.1

Q ss_pred             CCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617            7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI   86 (294)
Q Consensus         7 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   86 (294)
                      +.......+.++|++.+.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.++++++||||+++++++
T Consensus        12 ~~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~   90 (486)
T 3mwu_A           12 ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEIL   90 (486)
T ss_dssp             --CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence            334444578899999999999999999999999999999999987554332 2357789999999999999999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec---CCCcEEEeeecc
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD---SKWNVKIADFGL  163 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~---~~~~~~l~dfg~  163 (294)
                      ...+..++++||+.+++|.+.+...+.+++..++.++.|++.||.|||+.||+|+||||+||+++   .++.++|+|||+
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           91 EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            99999999999999999999998889999999999999999999999999999999999999995   456799999999


Q ss_pred             cccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CC
Q 022617          164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SH  239 (294)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~  239 (294)
                      +.............+++.|+|||++.+. + +.++||||||+++|+|++|..||.+....+....+..+....+    ..
T Consensus       171 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  248 (486)
T 3mwu_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT  248 (486)
T ss_dssp             TTTBCCC----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGG
T ss_pred             CeECCCCCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCC
Confidence            9877666555667799999999998764 4 7899999999999999999999999998888888876654332    46


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      ++.++.++|.+||..||.+|||+.++|+||||+.....
T Consensus       249 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~  286 (486)
T 3mwu_A          249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (486)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence            89999999999999999999999999999999886543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.8e-51  Score=343.14  Aligned_cols=262  Identities=38%  Similarity=0.682  Sum_probs=229.0

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ++.++|++.+.||+|+||.||+|.+..+++.+++|++........   ...+.+.+|+.++++++||||+++++++...+
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT   81 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence            466889999999999999999999999999999999876543321   13578899999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC----cEEEeeeccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSNI  166 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~----~~~l~dfg~~~~  166 (294)
                      ..++++|++.+++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++    .++|+|||.+..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            9999999999999999998888999999999999999999999999999999999999998876    799999999987


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCCh
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSP  242 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~  242 (294)
                      ...........+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+.......+    ..++.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE  240 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence            655555555678999999999987766 7899999999999999999999999888888777766554433    57889


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      .+.+++.+||..||.+|||+.++++||||++...
T Consensus       241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            9999999999999999999999999999988543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.9e-51  Score=342.98  Aligned_cols=270  Identities=38%  Similarity=0.616  Sum_probs=230.5

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc------chHHHHHHHHHHHHHHhCC-CCceeE
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK------NMEMEEKVRREIKILRLFM-HPHIIR   81 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~------~~~~~~~~~~e~~~l~~l~-~~~i~~   81 (294)
                      ......+.++|++.+.||.|++|.||+|.+..+++.|++|++......      .....+.+.+|+.+++++. ||||++
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (298)
T 1phk_A            9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ   88 (298)
T ss_dssp             ------CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             ccCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence            344567889999999999999999999999999999999998754311      1234567889999999996 999999


Q ss_pred             EEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617           82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF  161 (294)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df  161 (294)
                      +++++...+..++++|++++++|.+++.+...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999999999998889999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCccccccCCCcccCCccccC-----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC
Q 022617          162 GLSNIMRDGHFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL  236 (294)
Q Consensus       162 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  236 (294)
                      |.+.............+++.|+|||.+.+     ....+.++||||||+++|+|++|..||...........+.......
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  248 (298)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence            99987765555556678999999998751     2223789999999999999999999999888877777776655433


Q ss_pred             C----CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          237 P----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       237 ~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                      +    ..++..+.+++.+||+.||.+|||+.++++||||++.....
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE  294 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence            3    36889999999999999999999999999999999865443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.6e-51  Score=370.34  Aligned_cols=260  Identities=30%  Similarity=0.495  Sum_probs=233.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|++.............+.+|+.++++++||||+++++++...+.++
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            55678999999999999999999999999999999997765544455677889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           94 VVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +||||+.|++|.+++...+  .+++..++.++.||+.||.|||+.||+|+||||+||+++.+|.++|+|||++.......
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999999997654  39999999999999999999999999999999999999999999999999998776655


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhCCCccCCCCCChhHHHH
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGARDL  247 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (294)
                      ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||....    ...+...+......++..++.++.++
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dL  419 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSL  419 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             cccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence            5556689999999999988777 799999999999999999999998753    45566666666667778899999999


Q ss_pred             HHHhcccCCCCCC-----CHhHHhcCCccccc
Q 022617          248 IPRMLIVDPMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       248 i~~~l~~~p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      |.+||..||.+||     ++.++++||||++.
T Consensus       420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            9999999999999     79999999999863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-51  Score=362.46  Aligned_cols=261  Identities=28%  Similarity=0.554  Sum_probs=226.7

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|++.+.||+|+||+||+|.++.+++.||+|++.............+.+|..++..++||||+++++++.+.+.+
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            34567999999999999999999999999999999999765433333344588999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++||||+.|++|.+++.+ .+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++.......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999999987 4679999999999999999999999999999999999999999999999999997654433


Q ss_pred             c--cccccCCCcccCCcccc-----CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC---CC
Q 022617          172 F--LKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SH  239 (294)
Q Consensus       172 ~--~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---~~  239 (294)
                      .  .....+|+.|+|||++.     ...+ +.++||||||+++|+|++|+.||.+.+..+....+....  ..+|   ..
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  308 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD  308 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence            2  23357899999999986     3344 789999999999999999999999988888887775432  3333   45


Q ss_pred             CChhHHHHHHHhcccCCCC--CCCHhHHhcCCccccc
Q 022617          240 LSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH  274 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~--Rps~~~il~h~~~~~~  274 (294)
                      ++.++.+||.+||..+|++  ||+++++++||||++.
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            8999999999999988888  9999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.7e-51  Score=344.01  Aligned_cols=261  Identities=34%  Similarity=0.619  Sum_probs=216.8

Q ss_pred             ccccccCCccc-ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC
Q 022617           12 VDMFLPNYKLG-KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP   89 (294)
Q Consensus        12 ~~~~~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   89 (294)
                      -..+.++|++. +.||+|+||+||+|.+..+++.|++|++.....   .....+.+|+++++++ +||||+++++++...
T Consensus         7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A            7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            34678899995 789999999999999999999999999865432   2356788999999885 799999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc---EEEeeeccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNI  166 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~---~~l~dfg~~~~  166 (294)
                      +..+++|||+.+++|.+++.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.   ++|+|||++..
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999999999998889999999999999999999999999999999999999988765   99999999875


Q ss_pred             ccCCC--------ccccccCCCcccCCccccC-----CccCCCchhHHHHHHHHHHHHhCCCCCCCCC------------
Q 022617          167 MRDGH--------FLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDEN------------  221 (294)
Q Consensus       167 ~~~~~--------~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~------------  221 (294)
                      .....        ......+++.|+|||++.+     ..+ +.++||||||+++|+|++|..||....            
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            43211        1223458999999999864     334 789999999999999999999997654            


Q ss_pred             ---HHHHHHHHhCCCccCC----CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          222 ---IPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       222 ---~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                         .......+......++    ..++.++.+++.+||..||.+|||+.++++||||++..+
T Consensus       243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence               2335555665555544    468999999999999999999999999999999987543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.6e-52  Score=353.14  Aligned_cols=266  Identities=29%  Similarity=0.446  Sum_probs=212.9

Q ss_pred             CCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617            7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI   86 (294)
Q Consensus         7 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   86 (294)
                      .+........++|++.+.||+|+||+||+|.+..+++.|++|++..... .......+.+|+.++++++||||+++++++
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (329)
T 3gbz_A           24 VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVI  102 (329)
T ss_dssp             --------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             eccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEE
Confidence            4444556778899999999999999999999999999999999965532 223456678999999999999999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec-----CCCcEEEeee
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-----SKWNVKIADF  161 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~-----~~~~~~l~df  161 (294)
                      ...+..++|+||+++ +|.+++.....+++..++.++.|++.||.|||+.||+|+||||+||+++     .++.++|+||
T Consensus       103 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          103 HHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             ecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            999999999999975 9999999888899999999999999999999999999999999999994     4456999999


Q ss_pred             cccccccCC-CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-----
Q 022617          162 GLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----  235 (294)
Q Consensus       162 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  235 (294)
                      |++...... .......+++.|+|||++.+....+.++||||||+++|+|++|..||......+....+......     
T Consensus       182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            999766433 22344567899999999987654589999999999999999999999988776665554321100     


Q ss_pred             -------------------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          236 -------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       236 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                               .+..++.++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                                     001267899999999999999999999999999999874

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-51  Score=346.59  Aligned_cols=261  Identities=30%  Similarity=0.467  Sum_probs=214.7

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc--hHHHHHHHHHHHHHHhC---CCCceeEEEEEE
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLF---MHPHIIRLYEVI   86 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~   86 (294)
                      .+.+.++|++.+.||+|+||+||+|.+..+++.||+|++.......  ......+.+|+.+++++   +||||+++++++
T Consensus         4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            3567889999999999999999999999999999999987543221  11123555666666655   499999999999


Q ss_pred             EcCC-----eEEEEEeccCCCChHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEe
Q 022617           87 ETPS-----DIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA  159 (294)
Q Consensus        87 ~~~~-----~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~  159 (294)
                      ....     ..++++|++.+ +|.+++.....  +++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence            7755     58999999975 99999987644  9999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-----
Q 022617          160 DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----  234 (294)
Q Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-----  234 (294)
                      |||.+.............+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+.....     
T Consensus       163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eCccccccCCCcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9999987766655666778999999999987776 7899999999999999999999998887776666532110     


Q ss_pred             ----------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          235 ----------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       235 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                            ...+.++.++.++|.+||+.||++|||+.|+|+||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence                                  0113578899999999999999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.3e-52  Score=355.66  Aligned_cols=258  Identities=31%  Similarity=0.541  Sum_probs=226.3

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----EMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      ..+.++|++.+.||+|+||.||+|.+..+++.|++|++........     .....+.+|+.++++++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3567899999999999999999999999999999999976543221     12345678999999999999999999999


Q ss_pred             cCCeEEEEEeccCCC-ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           88 TPSDIYVVMEYVKSG-ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      ..+..++++|++.++ +|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            999999999998666 9999998888899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHH
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARD  246 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
                      ...........+++.|+|||++.+..+.+.++||||||+++|+|++|..||....      .........+..++.++.+
T Consensus       180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~~  253 (335)
T 3dls_A          180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMS  253 (335)
T ss_dssp             CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHHH
T ss_pred             CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHHH
Confidence            7666656667789999999999887776788999999999999999999997632      2233344556678999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      +|.+||+.||.+|||+.++++||||++...
T Consensus       254 li~~~L~~dP~~Rps~~ell~hp~~~~~~~  283 (335)
T 3dls_A          254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVN  283 (335)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred             HHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence            999999999999999999999999987543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.5e-51  Score=350.85  Aligned_cols=260  Identities=39%  Similarity=0.701  Sum_probs=228.6

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc-----chHHHHHHHHHHHHHHhC-CCCceeEEEEEEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLF-MHPHIIRLYEVIE   87 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   87 (294)
                      .+.++|++.+.||.|++|.||+|.+..+|+.|+||++......     .......+.+|+.+++++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            4557899999999999999999999989999999998654311     122356788999999999 7999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      ..+..+++|||+.|++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            99999999999999999999988889999999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCccccccCCCcccCCccccCC-----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----C
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGK-----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----S  238 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~  238 (294)
                      ..........+++.|+|||++.+.     ...+.++||||||+++|+|++|..||...........+.......+    .
T Consensus       251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  330 (365)
T 2y7j_A          251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD  330 (365)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred             CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            665555667789999999988532     1237899999999999999999999998888777777766554433    4


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      .++..+.+++.+||+.||.+|||+.++++||||+.
T Consensus       331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            78899999999999999999999999999999973

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-51  Score=357.40  Aligned_cols=260  Identities=30%  Similarity=0.515  Sum_probs=225.3

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|++.+.||+|+||.||+|.++.+++.||+|++.............+.+|..++..++|+||+++++++.+.+.+
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            34568999999999999999999999999999999999765443334455688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      |+||||+.|++|.+++.+.+ .+++..++.++.|++.||.|||+.||+|+||||+||+++.++++||+|||++.......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999999999999998764 79999999999999999999999999999999999999999999999999997664433


Q ss_pred             c--cccccCCCcccCCccccC-------CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccC---C
Q 022617          172 F--LKTSCGSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTL---P  237 (294)
Q Consensus       172 ~--~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~---~  237 (294)
                      .  .....+|+.|+|||++..       ..+ +.++||||||+++|+|++|+.||...+..+....+....  ..+   +
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  295 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD  295 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence            2  234578999999999862       334 789999999999999999999999988888777776432  222   3


Q ss_pred             CCCChhHHHHHHHhcccCCCCC---CCHhHHhcCCccccc
Q 022617          238 SHLSPGARDLIPRMLIVDPMKR---ITIPEIRQHPWFQAH  274 (294)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~R---ps~~~il~h~~~~~~  274 (294)
                      ..++.++.++|.+||. +|.+|   |+++++++||||+..
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            5799999999999999 99998   599999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.9e-51  Score=365.76  Aligned_cols=261  Identities=39%  Similarity=0.695  Sum_probs=228.4

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      ...+.++|++++.||+|+||+||+|.++.++..+++|++....... .....+.+|+.+++.++||||+++++++...+.
T Consensus        32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  110 (494)
T 3lij_A           32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN  110 (494)
T ss_dssp             BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            3456778999999999999999999999999999999997654332 225678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC---CcEEEeeeccccccc
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMR  168 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~---~~~~l~dfg~~~~~~  168 (294)
                      .++|+||+.+++|.+.+.....+++..++.++.|++.||.|||+.||+|+||||+||+++..   +.++|+|||++....
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            99999999999999999888899999999999999999999999999999999999999764   459999999998776


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhH
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGA  244 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l  244 (294)
                      .........+++.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.........+..+...++    ..++.++
T Consensus       191 ~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  268 (494)
T 3lij_A          191 NQKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA  268 (494)
T ss_dssp             TTBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred             CCccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence            6666666789999999999864 34 7899999999999999999999999999888888877665443    4689999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      .++|.+||+.||.+|||+.++|+||||+...
T Consensus       269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             HHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence            9999999999999999999999999998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-51  Score=346.17  Aligned_cols=247  Identities=21%  Similarity=0.324  Sum_probs=192.9

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS----   90 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   90 (294)
                      +..+|.+.+.||+|+||+||+|.+  +|+.||||++....    ........|+..+.+++||||+++++++..++    
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence            356799999999999999999987  58899999986432    11223345666667899999999999997654    


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCeEecCCCcEEEeeec
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN--------MVVHRDLKPENLLLDSKWNVKIADFG  162 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~--------~i~h~di~p~nili~~~~~~~l~dfg  162 (294)
                      .+++||||+++++|.+++.+ .+++++.+.+++.|++.||+|||+.        +|+||||||+|||++.++.+||+|||
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            58999999999999999964 5789999999999999999999987        99999999999999999999999999


Q ss_pred             ccccccCCCc-----cccccCCCcccCCccccCCc-----cCCCchhHHHHHHHHHHHHhCCCCCCCC------------
Q 022617          163 LSNIMRDGHF-----LKTSCGSPNYAAPEVISGKL-----YAGPEVDVWSCGVILYALLCGTLPFDDE------------  220 (294)
Q Consensus       163 ~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~l~~g~~p~~~~------------  220 (294)
                      ++........     .....||+.|+|||++.+..     ..+.++||||||+++|||+||..||...            
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            9976654332     22346999999999986542     1256899999999999999997765321            


Q ss_pred             ---CHHHHHHHHhCCC--ccCCCC-----CChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          221 ---NIPNLFKKIKGGI--YTLPSH-----LSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       221 ---~~~~~~~~~~~~~--~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                         ....+...+....  +.+|..     ++..+.+++.+||+.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               1233333333322  222221     23468899999999999999999999863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.8e-51  Score=342.97  Aligned_cols=254  Identities=30%  Similarity=0.502  Sum_probs=213.8

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||+|+||+||+|.+ .+++.|++|++...... ......+.+|+.++++++||||+++++++...+..++++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            6899999999999999999998 57899999998655322 223467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617           97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK  174 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  174 (294)
                      |++++ +|.+++... +.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... ...
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence            99976 999998754 679999999999999999999999999999999999999999999999999987654322 233


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------------
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------  233 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  233 (294)
                      ...+++.|+|||++.+....+.++||||||+++|+|++|..||......+....+....                     
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T 1ob3_A          159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (288)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence            44679999999999765545899999999999999999999998877666555442110                     


Q ss_pred             --------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          234 --------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                              ......++.++.+++.+||+.||++|||+.|+++||||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                    0112457889999999999999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6e-51  Score=376.21  Aligned_cols=260  Identities=35%  Similarity=0.566  Sum_probs=236.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   92 (294)
                      .-.++|++.+.||+|+||.||+|.++.+++.||||++.............+..|..++..+ +|++|+++++++...+.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            3457899999999999999999999999999999999766444444567788899999887 689999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~  171 (294)
                      |+||||+.|++|.+++.+.+.+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.... ...
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred             EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence            9999999999999999988999999999999999999999999999999999999999999999999999997532 333


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  251 (294)
                      ......+|+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..++.+.+......+|..++.++.+||.+|
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  576 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  576 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            4456678999999999988877 899999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCH-----hHHhcCCccccc
Q 022617          252 LIVDPMKRITI-----PEIRQHPWFQAH  274 (294)
Q Consensus       252 l~~~p~~Rps~-----~~il~h~~~~~~  274 (294)
                      |+.||.+||++     ++|++||||+..
T Consensus       577 L~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          577 MTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             SCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             ccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            99999999997     999999999763

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7e-51  Score=346.11  Aligned_cols=254  Identities=39%  Similarity=0.687  Sum_probs=203.9

Q ss_pred             cccCCccc---ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCC
Q 022617           15 FLPNYKLG---KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS   90 (294)
Q Consensus        15 ~~~~y~~~---~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   90 (294)
                      +.++|.+.   +.||+|+||+||+|.+..+++.|++|++...      ....+.+|+.+++.+. ||||+++++++....
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            34567775   7899999999999999999999999998543      2456788999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC---cEEEeeecccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIM  167 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~---~~~l~dfg~~~~~  167 (294)
                      ..+++|||+.+++|.+++.+.+.+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++   .++|+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            9999999999999999999888999999999999999999999999999999999999998765   7999999999765


Q ss_pred             cCCC-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhCCCccCC--
Q 022617          168 RDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNLFKKIKGGIYTLP--  237 (294)
Q Consensus       168 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~--  237 (294)
                      .... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||....       .......+..+....+  
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          160 PPDNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             CC----------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             CCCCCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            4332 2345567999999999987776 789999999999999999999997643       3556667776665544  


Q ss_pred             --CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          238 --SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       238 --~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                        ..++.++.++|.+||..||.+|||+.++++||||++..
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence              36899999999999999999999999999999998753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-50  Score=341.97  Aligned_cols=260  Identities=39%  Similarity=0.695  Sum_probs=227.9

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ..+.++|++.+.||+|++|+||+|.+..+++.|++|++.....   .....+.+|+.++++++||||+++++++...+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            4577899999999999999999999999999999999875432   2245788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe---cCCCcEEEeeecccccccC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili---~~~~~~~l~dfg~~~~~~~  169 (294)
                      ++++|++++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999999999999888899999999999999999999999999999999999999   6788999999999875433


Q ss_pred             CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC----CCCCChhHH
Q 022617          170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----PSHLSPGAR  245 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~  245 (294)
                      . ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+..+....    +..++.++.
T Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          162 G-IMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             B-TTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             C-ccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence            2 2334468999999999987766 789999999999999999999999988888888777665433    357899999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      ++|.+||..||.+|||+.++++||||+...+.
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALSHPWIDGNTAL  271 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence            99999999999999999999999999886543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.6e-51  Score=364.60  Aligned_cols=260  Identities=32%  Similarity=0.482  Sum_probs=231.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-.++|.+.+.||+|+||.||+|.++.+++.||+|++.............+.+|+.++++++||||+++++++...+.+|
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            45688999999999999999999999999999999997665554455678899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           94 VVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      +||||++|++|.+++.+.    ..+++..++.++.|++.||.|||+.||+|+||||+||+++.+|.++|+|||++.....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999999763    3699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc-cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhCCCccCCCCCChhH
Q 022617          170 GHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGA  244 (294)
Q Consensus       170 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
                      ... .....+|+.|+|||++.+..+ +.++||||||+++|+|++|..||...    ....+.+.+......++..++.++
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~  420 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS  420 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             CCcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHH
Confidence            432 334579999999999988777 79999999999999999999999765    346677777777778888999999


Q ss_pred             HHHHHHhcccCCCCCCC-----HhHHhcCCccccc
Q 022617          245 RDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      .++|.+||+.||.+||+     +++|++||||++.
T Consensus       421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            99999999999999996     4899999999863

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.3e-51  Score=348.85  Aligned_cols=254  Identities=36%  Similarity=0.648  Sum_probs=220.8

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCe
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSD   91 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   91 (294)
                      ..+.++|++.+.||.|+||.||+|.++.+++.||+|++......       ..+|++++.++ +||||+++++++.+.+.
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            46788999999999999999999999999999999998655422       34677777777 79999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC----CcEEEeeecccccc
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK----WNVKIADFGLSNIM  167 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~----~~~~l~dfg~~~~~  167 (294)
                      .++||||+.|++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||++..+    +.++|+|||++...
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999999999999888889999999999999999999999999999999999998543    35999999999865


Q ss_pred             cCC-CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhCCCccCC----CC
Q 022617          168 RDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD---ENIPNLFKKIKGGIYTLP----SH  239 (294)
Q Consensus       168 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~---~~~~~~~~~~~~~~~~~~----~~  239 (294)
                      ... .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||..   ....++...+..+....+    ..
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             cCCCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            433 23345578999999999987666 6899999999999999999999975   455667777766665443    56


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ++.++.++|.+||..||++|||+.++++||||.++
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            89999999999999999999999999999999876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.5e-51  Score=351.87  Aligned_cols=256  Identities=36%  Similarity=0.626  Sum_probs=221.0

Q ss_pred             cccCCcc--cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           15 FLPNYKL--GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        15 ~~~~y~~--~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +.+.|.+  .+.||.|+||.||+|.+..+++.|++|++.....   ...+.+.+|+.++++++||||+++++++...+..
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  161 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI  161 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            4455665  6789999999999999999999999999865432   3457889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe--cCCCcEEEeeecccccccC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL--DSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili--~~~~~~~l~dfg~~~~~~~  169 (294)
                      ++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||++  +.++.++|+|||++.....
T Consensus       162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence            9999999999999988654 469999999999999999999999999999999999999  5667899999999987766


Q ss_pred             CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhHH
Q 022617          170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR  245 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~  245 (294)
                      ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+    ..++.++.
T Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  320 (373)
T 2x4f_A          242 REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK  320 (373)
T ss_dssp             TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHH
T ss_pred             ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHH
Confidence            555556678999999999987766 7899999999999999999999999888888777766554433    56899999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ++|.+||+.||.+|||+.++++||||++.
T Consensus       321 ~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          321 EFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            99999999999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.3e-51  Score=353.62  Aligned_cols=258  Identities=31%  Similarity=0.510  Sum_probs=210.0

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCC--
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS--   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--   90 (294)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+. |+||+++++++...+  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            46789999999999999999999999999999999986442 33455677889999999997 999999999997544  


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-  169 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-  169 (294)
                      .+|+||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..... 
T Consensus        85 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           85 DVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             CEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             EEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            78999999975 99998865 5789999999999999999999999999999999999999999999999999975432 


Q ss_pred             ---------------------CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022617          170 ---------------------GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK  228 (294)
Q Consensus       170 ---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~  228 (294)
                                           ........+|+.|+|||++.+....+.++||||||+++|+|++|+.||.+.+..+....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  242 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER  242 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                                 11123346899999999998755458999999999999999999999998877666655


Q ss_pred             HhCCCc-----------------------------------------------cCCCCCChhHHHHHHHhcccCCCCCCC
Q 022617          229 IKGGIY-----------------------------------------------TLPSHLSPGARDLIPRMLIVDPMKRIT  261 (294)
Q Consensus       229 ~~~~~~-----------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps  261 (294)
                      +.....                                               ..+..+++++.+|+.+||+.||.+|||
T Consensus       243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence            532110                                               012267889999999999999999999


Q ss_pred             HhHHhcCCccccc
Q 022617          262 IPEIRQHPWFQAH  274 (294)
Q Consensus       262 ~~~il~h~~~~~~  274 (294)
                      +.|+|+||||+..
T Consensus       323 ~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          323 ANDALKHPFVSIF  335 (388)
T ss_dssp             HHHHTTSTTTTTT
T ss_pred             HHHHhCCHHHHHh
Confidence            9999999999765

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.3e-51  Score=337.88  Aligned_cols=265  Identities=34%  Similarity=0.662  Sum_probs=224.0

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      +.++|++.+.||+|++|.||+|.+..+++.|++|++......  ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            567899999999999999999999999999999998755422  345788999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---  171 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---  171 (294)
                      ++|++++++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            99999999999999777789999999999999999999999999999999999999999999999999987653222   


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhCCC--ccCCCCCChhHHHHH
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGI--YTLPSHLSPGARDLI  248 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~--~~~~~~~~~~l~~li  248 (294)
                      ......+++.|+|||.+.+..+.+.++||||||+++|+|++|..||...... .....+....  ......++..+.+++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence            2344568899999999987766567899999999999999999999865432 2223333222  222346899999999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCcccccCCccccC
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAV  281 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~  281 (294)
                      .+||+.||.+|||+.++++||||++.+.+....
T Consensus       243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~  275 (276)
T 2yex_A          243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKR  275 (276)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCCC-----
T ss_pred             HHHCCCCchhCCCHHHHhcCccccChhhccCCC
Confidence            999999999999999999999999877665443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-50  Score=342.47  Aligned_cols=256  Identities=29%  Similarity=0.522  Sum_probs=223.7

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      .|+..+.||+|+||.||+|.+..+|+.||||++.....   ...+.+.+|+.++++++|+||+++++++...+..+++||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            47888899999999999999998999999999865432   235678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccccc
Q 022617           98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS  176 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~  176 (294)
                      |+.+++|.+++. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus       123 ~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            999999999885 4579999999999999999999999999999999999999999999999999987654432 23455


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc---CCCCCChhHHHHHHHhcc
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---LPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~  253 (294)
                      .+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+.....+   .+..++..+.+++.+||+
T Consensus       202 ~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  280 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV  280 (321)
T ss_dssp             CSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred             cCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHcc
Confidence            78999999999987776 78999999999999999999999988877777766554332   234578999999999999


Q ss_pred             cCCCCCCCHhHHhcCCcccccCCcc
Q 022617          254 VDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       254 ~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                      .||.+|||+.++++||||++.-...
T Consensus       281 ~dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          281 RDPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             SSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             CChhhCcCHHHHhcChhhccCCCcc
Confidence            9999999999999999998754433

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-50  Score=348.21  Aligned_cols=261  Identities=28%  Similarity=0.460  Sum_probs=218.1

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--   88 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   88 (294)
                      ......++|++.+.||+|+||.||+|.+..+++.|++|++....... .....+.+|+.++++++||||+++++++..  
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   89 (351)
T 3mi9_A           11 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKA   89 (351)
T ss_dssp             TTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             cccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence            33445689999999999999999999999999999999986554322 234567789999999999999999999876  


Q ss_pred             ------CCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617           89 ------PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF  161 (294)
Q Consensus        89 ------~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df  161 (294)
                            .+..++|+||+++ +|.+.+... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+||
T Consensus        90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence                  4568999999976 787777653 57999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-----CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC
Q 022617          162 GLSNIMRDG-----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL  236 (294)
Q Consensus       162 g~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  236 (294)
                      |++......     .......+++.|+|||++.+....+.++||||||+++|+|++|..||.+.........+.......
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            998765421     222345678999999998775555899999999999999999999999988777666654322111


Q ss_pred             CCC--------------------------------CChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          237 PSH--------------------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       237 ~~~--------------------------------~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      +..                                .++.+.++|.+||+.||.+|||+.|+|+||||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  317 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence            111                                2667999999999999999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-51  Score=350.89  Aligned_cols=271  Identities=33%  Similarity=0.545  Sum_probs=226.6

Q ss_pred             CCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeEEEE
Q 022617            7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYE   84 (294)
Q Consensus         7 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~   84 (294)
                      .....+..+.++|++.+.||.|+||+||+|.+..++..|++|++......  .....+.+.+|+.++++++||||+++++
T Consensus        16 ~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   95 (345)
T 3hko_A           16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE   95 (345)
T ss_dssp             CCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence            44455667889999999999999999999999999999999998765332  2345678999999999999999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHHH----------------------------------------hCCCCHHHHHHHHH
Q 022617           85 VIETPSDIYVVMEYVKSGELFDYIVE----------------------------------------KGRLQEDEARNFFQ  124 (294)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~sL~~~l~~----------------------------------------~~~l~~~~~~~~~~  124 (294)
                      ++...+..++||||+++++|.+++..                                        ...+++..++.++.
T Consensus        96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence            99999999999999999999998841                                        11236778899999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCCeEecCCC--cEEEeeecccccccCCC-----ccccccCCCcccCCccccCC-ccCCC
Q 022617          125 QIISGVEYCHRNMVVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGK-LYAGP  196 (294)
Q Consensus       125 ql~~~l~~Lh~~~i~h~di~p~nili~~~~--~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~~  196 (294)
                      |++.||.|||+.|++|+||+|+||+++.++  .++|+|||.+.......     ......+++.|+|||.+.+. ...+.
T Consensus       176 qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            999999999999999999999999998776  89999999997653221     23455689999999998652 33378


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617          197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       197 ~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                      ++||||||+++|+|++|..||......+....+.......+    ..++.++.++|.+||+.||.+|||+.++++||||+
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~  335 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS  335 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhc
Confidence            99999999999999999999999888887777765554332    24789999999999999999999999999999998


Q ss_pred             ccCCc
Q 022617          273 AHLPR  277 (294)
Q Consensus       273 ~~~~~  277 (294)
                      +...+
T Consensus       336 ~~~~~  340 (345)
T 3hko_A          336 QFSDK  340 (345)
T ss_dssp             TTSSC
T ss_pred             cChHh
Confidence            86543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=341.27  Aligned_cols=255  Identities=23%  Similarity=0.331  Sum_probs=208.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +.+.++|++.+.||+|+||+||+|.+..+++.||||++.............+.++..+.+..+|+||+++++++...+..
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            34557899999999999999999999999999999998655433333333444444444455899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++++|++ +++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            9999999 55999988765 469999999999999999999999999999999999999999999999999988776555


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCCCCCChhHHHHHH
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIP  249 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~  249 (294)
                      ......+++.|+|||++.+ .+ +.++||||||+++|+|++|..|+....   ....+....  ...+..++.++.+++.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~  286 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLV  286 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred             CCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHH
Confidence            5556678999999999876 44 789999999999999999976665432   222333322  2334678999999999


Q ss_pred             HhcccCCCCCCCHhHHhcCCcccc
Q 022617          250 RMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       250 ~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      +||+.||++|||+.++++||||++
T Consensus       287 ~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          287 MMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHcCCChhhCcCHHHHHhCccccC
Confidence            999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.2e-51  Score=362.72  Aligned_cols=259  Identities=31%  Similarity=0.521  Sum_probs=213.8

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   89 (294)
                      .+.++|++++.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...    
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence            45689999999999999999999999999999999997553 3345567889999999999999999999999654    


Q ss_pred             --CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        90 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                        ...++||||+++ +|.+.+.  ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++...
T Consensus       138 ~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          138 EFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             cCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence              457999999976 6777663  45899999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc------------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------  235 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------  235 (294)
                      ..........+++.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+..+....+......            
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          215 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             --CCCC----CCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             CCCcccCCCcccccccCHHHHcCCCC-CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence            66655666788999999999988876 78999999999999999999999988766655554321100            


Q ss_pred             ----------C---------CCC-----------CChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          236 ----------L---------PSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       236 ----------~---------~~~-----------~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                                .         +..           .+.++.+||.+||..||++|||++|+|+||||+.+...
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence                      0         000           04568999999999999999999999999999976543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.5e-50  Score=339.79  Aligned_cols=263  Identities=37%  Similarity=0.685  Sum_probs=225.8

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCceeEEEEEE--EcCC
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-MEMEEKVRREIKILRLFMHPHIIRLYEVI--ETPS   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~   90 (294)
                      .+.++|++.+.||+|+||.||+|.+..+++.+++|++....... ......+.+|++++++++|+||+++++++  ...+
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            46789999999999999999999999999999999987654322 23467899999999999999999999998  4456


Q ss_pred             eEEEEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      ..++++||+.+ +|.+++..  ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           82 KMYMVMEYCVC-GMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             CEEEEEECCSE-EHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEehhccC-CHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            89999999987 48787765  3569999999999999999999999999999999999999999999999999987654


Q ss_pred             C---CCccccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhH
Q 022617          169 D---GHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA  244 (294)
Q Consensus       169 ~---~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
                      .   ........+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||...........+.......+..++..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l  240 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL  240 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence            2   22233456899999999987532 2357899999999999999999999999888888888888888888999999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      .+++.+||..||.+|||+.++++||||++..+.
T Consensus       241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            999999999999999999999999999887554

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.3e-50  Score=334.99  Aligned_cols=260  Identities=28%  Similarity=0.428  Sum_probs=221.8

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      .-.+.+.++|++.+.||+|+||.||+|.+..++..|++|++...........+.+.+|+.++++++||||+++++++...
T Consensus         4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~   83 (294)
T 4eqm_A            4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED   83 (294)
T ss_dssp             CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred             chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence            34567889999999999999999999999999999999999776666666778899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      +..+++|||++|++|.+++.+.+++++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999999976543


Q ss_pred             CC--ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-----cCCCCCCh
Q 022617          170 GH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHLSP  242 (294)
Q Consensus       170 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~  242 (294)
                      ..  ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.+...............     ..+..++.
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred             ccccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence            32  2234468999999999988776 7899999999999999999999998876665544433332     23467899


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPW  270 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~  270 (294)
                      .+.+++.+||..||.+||+..+.+.++|
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence            9999999999999999995555544444

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-50  Score=345.29  Aligned_cols=261  Identities=28%  Similarity=0.449  Sum_probs=219.5

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|++.+.||.|++|.||+|.+..+++.|++|++.... ........+.+|+.++++++||||+++++++...+..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   99 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW   99 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence            356789999999999999999999999999999999986553 3334566788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-C
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-H  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~  171 (294)
                      ++++||+++++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus       100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            999999999889988877788999999999999999999999999999999999999999999999999999765432 2


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------------------
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------  233 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  233 (294)
                      ......+++.|+|||.+.+....+.++||||||+++|+|++|..||......+....+....                  
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence            33455689999999999876444889999999999999999999998877655544432110                  


Q ss_pred             -cc------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 -YT------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 -~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                       ..            ..+.++..+.+++.+||+.||.+|||+.|+|+||||+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence             00            113578999999999999999999999999999999863

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.8e-50  Score=347.20  Aligned_cols=257  Identities=22%  Similarity=0.387  Sum_probs=219.3

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-----CCceeEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-----HPHIIRL   82 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~   82 (294)
                      +-.....+.++|++.+.||+|+||+||+|.+..+++.||+|++...    .........|+.+++.+.     |+||+++
T Consensus        26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3345567889999999999999999999999999999999998532    234566788999999987     9999999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC--------
Q 022617           83 YEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--------  152 (294)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~--------  152 (294)
                      ++++...+..++++|++ +++|.+++....  .+++..++.++.|++.||.|||+.||+|+||||+||+++.        
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence            99999999999999999 789999998754  4999999999999999999999999999999999999975        


Q ss_pred             -----------------CCcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCC
Q 022617          153 -----------------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL  215 (294)
Q Consensus       153 -----------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~  215 (294)
                                       ++.++|+|||++.....  ......+++.|+|||++.+..+ +.++||||||+++|+|++|+.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~  257 (360)
T 3llt_A          181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSL  257 (360)
T ss_dssp             EEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSC
T ss_pred             chhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCC
Confidence                             78899999999976433  2345568999999999988777 799999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhCCCccCC----------------------------------------------CCCChhHHHHHH
Q 022617          216 PFDDENIPNLFKKIKGGIYTLP----------------------------------------------SHLSPGARDLIP  249 (294)
Q Consensus       216 p~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~l~~li~  249 (294)
                      ||......+....+.....+.+                                              ...++.+.+||.
T Consensus       258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  337 (360)
T 3llt_A          258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY  337 (360)
T ss_dssp             SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred             CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence            9988776665555433222111                                              112367889999


Q ss_pred             HhcccCCCCCCCHhHHhcCCccc
Q 022617          250 RMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       250 ~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                      +||+.||.+|||+.|+|+||||+
T Consensus       338 ~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          338 SILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHhcCChhhCCCHHHHhcCcccC
Confidence            99999999999999999999996

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-50  Score=344.79  Aligned_cols=267  Identities=33%  Similarity=0.514  Sum_probs=227.2

Q ss_pred             CCCCccccccCCccc-ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEE
Q 022617            8 SSSGVDMFLPNYKLG-KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEV   85 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~   85 (294)
                      .-...+.+.++|.+. +.||.|+||+||+|.+..+++.|++|++....... .....+.+|+.+++.+. ||||++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            334456788899998 89999999999999999999999999987654332 33567889999999995 6999999999


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEEEee
Q 022617           86 IETPSDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIAD  160 (294)
Q Consensus        86 ~~~~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~l~d  160 (294)
                      +...+..++++||+.+++|.+++..  ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.   ++.++|+|
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence            9999999999999999999999854  367999999999999999999999999999999999999987   78999999


Q ss_pred             ecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc----C
Q 022617          161 FGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----L  236 (294)
Q Consensus       161 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~  236 (294)
                      ||++.............+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+......    .
T Consensus       178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  256 (327)
T 3lm5_A          178 FGMSRKIGHACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET  256 (327)
T ss_dssp             GGGCEEC---------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             CccccccCCccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh
Confidence            999987766555556678999999999987776 78999999999999999999999988887777666554432    2


Q ss_pred             CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ...++..+.++|.+||+.||.+|||++++|+||||++.--
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            3568999999999999999999999999999999988633

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.9e-51  Score=345.14  Aligned_cols=265  Identities=25%  Similarity=0.413  Sum_probs=224.5

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ....+.++|++.+.||.|+||.||+|.+..+++.|++|++.............+.+|+.++++++||||+++++++....
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            34578899999999999999999999999999999999998765556566778999999999999999999999987654


Q ss_pred             e----EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           91 D----IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        91 ~----~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      .    .+++|||++|++|.+++...+++++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            3    499999999999999999888999999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc----CCC
Q 022617          167 MRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPS  238 (294)
Q Consensus       167 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~  238 (294)
                      .....    ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..................    ...
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  244 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence            54332    2223457999999999987766 78999999999999999999999988877766555443322    235


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      .++.++.+++.+||+.||.+||+..+++.|+|++....
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            68999999999999999999999999999999986543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.4e-50  Score=337.20  Aligned_cols=261  Identities=40%  Similarity=0.732  Sum_probs=230.5

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .+.+.++|++.+.||+|++|.||+|.+..+++.|++|++....... .....+.+|++++++++||||+++++++...+.
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            3567789999999999999999999999899999999987654332 345778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC---CcEEEeeeccccccc
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMR  168 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~---~~~~l~dfg~~~~~~  168 (294)
                      .++++|++.+++|.+.+.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.+   +.++|+|||.+....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999999999888899999999999999999999999999999999999999754   469999999998765


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhH
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGA  244 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l  244 (294)
                      .........+++.|+|||.+.+. + +.++||||||+++|+|++|..||...........+..+....+    ..++.++
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred             CCCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence            55444455678899999998764 4 7899999999999999999999999888888887776654332    5789999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      .+++.+||..||++|||+.++++||||++..
T Consensus       254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            9999999999999999999999999998764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-49  Score=332.92  Aligned_cols=257  Identities=21%  Similarity=0.340  Sum_probs=215.8

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCe
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSD   91 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   91 (294)
                      ..+.++|++.+.||+|++|+||+|.+..+++.|++|++....... .....+.+|+..+.++ +||||+++++++...+.
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            346789999999999999999999999999999999987653332 3457788899999998 89999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC--------------
Q 022617           92 IYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK--------------  153 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~--------------  153 (294)
                      .++++||+++++|.+++.+.    ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+              
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999999765    679999999999999999999999999999999999999844              


Q ss_pred             -----CcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022617          154 -----WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK  228 (294)
Q Consensus       154 -----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~  228 (294)
                           ..++|+|||.+.......   ...+++.|+|||.+.+....+.++||||||+++|+|++|..++.....  ....
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~  240 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--WHEI  240 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--HHHH
T ss_pred             ccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--HHHH
Confidence                 479999999988765432   345889999999998764446799999999999999999877654432  2222


Q ss_pred             HhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          229 IKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      ........+..++.++.+++.+||+.||.+|||+.++++||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            23333456778999999999999999999999999999999998753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.6e-49  Score=331.30  Aligned_cols=258  Identities=26%  Similarity=0.487  Sum_probs=220.4

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----   88 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   88 (294)
                      ..-...|++.+.||+|+||+||+|.+..++..|++|++...... ....+.+.+|+.++++++||||+++++++..    
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence            34455699999999999999999999999999999998765443 3456788999999999999999999999865    


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEec-CCCcEEEeeecccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLD-SKWNVKIADFGLSN  165 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~-~~~~~~l~dfg~~~  165 (294)
                      ....++++||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|  ++|+||+|+||+++ .++.++|+|||++.
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            3568999999999999999998889999999999999999999999999  99999999999997 78899999999997


Q ss_pred             cccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhCCC--ccCCCCCCh
Q 022617          166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGI--YTLPSHLSP  242 (294)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~--~~~~~~~~~  242 (294)
                      ..... ......+++.|+|||.+.+. + +.++||||||+++|+|++|..||... ........+....  ...+...++
T Consensus       181 ~~~~~-~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (290)
T 1t4h_A          181 LKRAS-FAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             GCCTT-SBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ccccc-ccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence            55433 33455689999999988754 4 78999999999999999999999874 4444555554443  234456788


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ++.+++.+||+.||.+|||+.++++||||++.
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            99999999999999999999999999999863

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.2e-50  Score=342.71  Aligned_cols=258  Identities=28%  Similarity=0.364  Sum_probs=223.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...++|++.+.||+|+||+||+|.+..+++.|++|++.............+.+|++++++++||||+++++++...+..+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence            34467999999999999999999999999999999997665555556678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      +|+||+.| +|.+++.. ..++++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......  
T Consensus       131 lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          131 LVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             EEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            99999975 88888754 567999999999999999999999999999999999999999999999999998765432  


Q ss_pred             cccccCCCcccCCcccc---CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--cCCCCCChhHHHH
Q 022617          173 LKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--TLPSHLSPGARDL  247 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l  247 (294)
                       ....+++.|+|||++.   ...+ +.++||||||+++|+|++|..||...+.......+.....  ..+..++..+.++
T Consensus       208 -~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  285 (348)
T 1u5q_A          208 -NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF  285 (348)
T ss_dssp             -CCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred             -CcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence             3456899999999984   3344 7899999999999999999999988776666555544332  2245789999999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      |.+||+.||.+|||+.++++||||....+
T Consensus       286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          286 VDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             HHHHcccChhhCcCHHHHhhChhhhccCC
Confidence            99999999999999999999999987544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-49  Score=349.81  Aligned_cols=260  Identities=30%  Similarity=0.439  Sum_probs=211.7

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC---
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---   89 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   89 (294)
                      -.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.++++++|+||+++++++...   
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  100 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL  100 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence            357889999999999999999999999999999999986542 3445567899999999999999999999998766   


Q ss_pred             --CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        90 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                        +..|+|+|++++ +|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++...
T Consensus       101 ~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          101 KFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             TCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence              579999999965 99999988888999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC-----------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCC--------
Q 022617          168 RDGH-----------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP--------  216 (294)
Q Consensus       168 ~~~~-----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p--------  216 (294)
                      ....                       ......+|+.|+|||++......+.++|||||||++|+|++|..|        
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  259 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR  259 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence            4322                       124557899999999875554448999999999999999985443        


Q ss_pred             ---CCCCCH-----------------HHHHH------------------------HHhCCCcc-------CCCCCChhHH
Q 022617          217 ---FDDENI-----------------PNLFK------------------------KIKGGIYT-------LPSHLSPGAR  245 (294)
Q Consensus       217 ---~~~~~~-----------------~~~~~------------------------~~~~~~~~-------~~~~~~~~l~  245 (294)
                         |.+.+.                 .+...                        .+......       ..+.+++++.
T Consensus       260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  339 (432)
T 3n9x_A          260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI  339 (432)
T ss_dssp             CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred             cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence               333220                 11111                        11111100       1146899999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +||.+||..||.+|||++|+|+||||++.
T Consensus       340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          340 NLLESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             HHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence            99999999999999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-50  Score=345.95  Aligned_cols=258  Identities=30%  Similarity=0.479  Sum_probs=215.0

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC--
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--   90 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   90 (294)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+  
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence            356789999999999999999999999999999999986543 33445678899999999999999999999997653  


Q ss_pred             ----eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           91 ----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        91 ----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                          .+++++|++ +++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence                469999999 6799999865 6799999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------------
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------  233 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  233 (294)
                      ....  .....+++.|+|||++.+....+.++||||||+++|+|++|+.||.+.+..+....+....             
T Consensus       178 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            5432  3345679999999998874444899999999999999999999999887666555442210             


Q ss_pred             ------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          234 ------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       234 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                                        .......++.+.+++.+||..||.+|||+.++|+||||++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                              122356789999999999999999999999999999998753

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.7e-50  Score=348.58  Aligned_cols=258  Identities=31%  Similarity=0.516  Sum_probs=209.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS---   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   90 (294)
                      .+.++|++.+.||+|+||.||+|.+..+++.|++|++.... ........+.+|+.+++.++||||+++++++...+   
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence            45789999999999999999999999999999999987543 23345677889999999999999999999997654   


Q ss_pred             ---eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           91 ---DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        91 ---~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                         ..++||||+++ +|.+.+.  ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus       101 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          101 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             cccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence               78999999975 8888884  56899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC-----------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL-----------  236 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  236 (294)
                      ..........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+.......           
T Consensus       178 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          178 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             ------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             ccccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            55544556678999999999988766 789999999999999999999999887766666554322100           


Q ss_pred             -------------------------CC------CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          237 -------------------------PS------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       237 -------------------------~~------~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                                               +.      ..+.++.+||.+||..||.+|||++|+|+||||+.+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence                                     00      01457899999999999999999999999999987644

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.1e-50  Score=355.66  Aligned_cols=259  Identities=29%  Similarity=0.443  Sum_probs=201.0

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-----   88 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----   88 (294)
                      .+.++|++.+.||.|+||+||+|.+..+++.||||++... .......+.+.+|+.++++++|+||+++++++..     
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  128 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK  128 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence            5678999999999999999999999999999999998643 2344556789999999999999999999999843     


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      ...+|+|+|+++ ++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....
T Consensus       129 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          129 FDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             CceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            357999999985 5999999888889999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC----------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh--------
Q 022617          169 DGH----------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--------  212 (294)
Q Consensus       169 ~~~----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--------  212 (294)
                      ...                            .....++|+.|+|||++......+.++|||||||++|+|++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            221                            12334679999999987554444899999999999999998        


Q ss_pred             ---CCCCCCCCCH--------------------HHHHHHHhC-----------------------C--------CccCCC
Q 022617          213 ---GTLPFDDENI--------------------PNLFKKIKG-----------------------G--------IYTLPS  238 (294)
Q Consensus       213 ---g~~p~~~~~~--------------------~~~~~~~~~-----------------------~--------~~~~~~  238 (294)
                         |..+|.+...                    .+....+..                       .        .....+
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence               6666655331                    111111100                       0        011224


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ..+.++.+||.+||..||.+|||++|+|+||||++.
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            568999999999999999999999999999999886

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.2e-50  Score=349.71  Aligned_cols=254  Identities=36%  Similarity=0.629  Sum_probs=208.1

Q ss_pred             cccccCCccc-ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCceeEEEEEEEc--
Q 022617           13 DMFLPNYKLG-KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIRLYEVIET--   88 (294)
Q Consensus        13 ~~~~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~--   88 (294)
                      ..+.++|.+. +.||.|+||+||+|.+..+++.|+||++...        ..+.+|+.++ +..+|+||+++++++..  
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            4566778886 7899999999999999999999999998522        3566788876 45589999999999875  


Q ss_pred             --CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEEEeee
Q 022617           89 --PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADF  161 (294)
Q Consensus        89 --~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~l~df  161 (294)
                        .+.+++||||+.|++|.+++...  ..+++..++.++.|++.||.|||+.||+|+||||+||+++.   ++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              56799999999999999999764  35999999999999999999999999999999999999987   788999999


Q ss_pred             cccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhCCCccCC
Q 022617          162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGIYTLP  237 (294)
Q Consensus       162 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~  237 (294)
                      |++.............+++.|+|||++.+..+ +.++||||||+++|+|++|..||.......    ....+..+...++
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  287 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence            99987655544556678999999999987777 789999999999999999999997654321    3344444443333


Q ss_pred             ----CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       238 ----~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                          ..++.++.+||.+||..||.+|||+.++++||||++..
T Consensus       288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence                56899999999999999999999999999999998643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.8e-50  Score=347.96  Aligned_cols=255  Identities=29%  Similarity=0.427  Sum_probs=214.3

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc---
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET---   88 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---   88 (294)
                      ++...++|++.+.||+|+||+||+|.+..+++.||+|++.....       ...+|+++++.++|+||+++++++..   
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCc
Confidence            45667899999999999999999999999999999999864421       22479999999999999999999843   


Q ss_pred             -----------------------------------CCeEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHH
Q 022617           89 -----------------------------------PSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISG  129 (294)
Q Consensus        89 -----------------------------------~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~  129 (294)
                                                         ...+++||||+++ +|.+.+..    ...+++..++.++.|++.|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence                                               3458999999975 88777653    4679999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCeEec-CCCcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHH
Q 022617          130 VEYCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY  208 (294)
Q Consensus       130 l~~Lh~~~i~h~di~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~  208 (294)
                      |.|||+.||+|+||||+||+++ .++.++|+|||.+.............+++.|+|||.+.+....+.++||||+|+++|
T Consensus       154 L~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          154 VGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            9999999999999999999997 688999999999987766655566778999999999887664589999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHhCCC-----------------------------ccCCCCCChhHHHHHHHhcccCCCCC
Q 022617          209 ALLCGTLPFDDENIPNLFKKIKGGI-----------------------------YTLPSHLSPGARDLIPRMLIVDPMKR  259 (294)
Q Consensus       209 ~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~R  259 (294)
                      +|++|+.||.+....+....+....                             ..++..++.++.+++.+||+.||.+|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            9999999999887766655543210                             01345688999999999999999999


Q ss_pred             CCHhHHhcCCccccc
Q 022617          260 ITIPEIRQHPWFQAH  274 (294)
Q Consensus       260 ps~~~il~h~~~~~~  274 (294)
                      ||+.|+++||||+..
T Consensus       314 ~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          314 INPYEAMAHPFFDHL  328 (383)
T ss_dssp             CCHHHHHTSGGGHHH
T ss_pred             CCHHHHhcCHHHHHH
Confidence            999999999999865

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-50  Score=343.81  Aligned_cols=263  Identities=28%  Similarity=0.421  Sum_probs=212.8

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccch--HHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM--EMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      ++....++|++.+.||.|+||.||+|.+..+++.|++|++........  .....+.+|++++++++||||+++++++..
T Consensus         4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (346)
T 1ua2_A            4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH   83 (346)
T ss_dssp             ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence            455667899999999999999999999999999999999865432221  123467899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      .+..++++||+++ +|.+++..+ ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999999976 898888654 46899999999999999999999999999999999999999999999999999766


Q ss_pred             cCCC-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc------------
Q 022617          168 RDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------  234 (294)
Q Consensus       168 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  234 (294)
                      .... ......+++.|+|||.+.+....+.++||||||+++|+|++|..||.+....+....+.....            
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            4332 334556899999999987655447899999999999999999999998877666655432110            


Q ss_pred             ----------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          235 ----------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       235 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                      .....++.++.++|.+||..||.+|||+.|+++||||++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                            0014567899999999999999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.1e-50  Score=334.60  Aligned_cols=262  Identities=25%  Similarity=0.397  Sum_probs=206.6

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      ++...++|++.+.||.|+||+||+|.+..+++.|++|++..... .......+.++...++.++||||+++++++...+.
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD   80 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence            35677899999999999999999999999999999999865432 22334455566666888999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           92 IYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      .++++||+++ +|.+++..    ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            9999999975 88887754    46799999999999999999999998 999999999999999999999999999987


Q ss_pred             ccCCCccccccCCCcccCCcccc---CCccCCCchhHHHHHHHHHHHHhCCCCCCC-CCH-HHHHHHHhCCCccCC-CCC
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENI-PNLFKKIKGGIYTLP-SHL  240 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~-~~~~~~~~~~~~~~~-~~~  240 (294)
                      ...........+++.|+|||.+.   .....+.++||||||+++|+|++|..||.. ... ......+.......+ ..+
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF  239 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence            76655555567899999999962   233337899999999999999999999985 233 333333444443333 468


Q ss_pred             ChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      +.++.+++.+||+.||++|||+.++++||||+...
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            99999999999999999999999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.6e-50  Score=344.19  Aligned_cols=259  Identities=24%  Similarity=0.432  Sum_probs=222.0

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +...++|++.+.||.|+||.||+|.+..+++.|++|++....  .......+.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  106 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI  106 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence            456789999999999999999999999999999999987542  334567889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +++|||+++++|.+++.+.+.+++..++.++.|++.+|.|||+. |++|+||+|+||+++.++.++|+|||++...... 
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999999999999888999999999999999999999996 9999999999999999999999999998655322 


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------------------
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI----------------------  229 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~----------------------  229 (294)
                      ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+                      
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence            2234568999999999988766 78999999999999999999999876654433221                      


Q ss_pred             --------------------hCCC-ccC-CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          230 --------------------KGGI-YTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       230 --------------------~~~~-~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                                          .... ... ...++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                                1111 111 234788999999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-49  Score=335.92  Aligned_cols=262  Identities=30%  Similarity=0.542  Sum_probs=216.8

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      .....+...++|++.+.||+|+||+||+|.+  +++.|++|++...... ....+.+.+|+.++++++||||+++++++.
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4455677789999999999999999999986  5788999998765433 344678899999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCCCcEEEeeec
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADFG  162 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~~~~~l~dfg  162 (294)
                      ..+..++++||+.+++|.+++.+...   +++..++.++.|++.||.|||+.|  ++|+||||+||+++.++.++|+|||
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            99999999999999999999976543   999999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCC-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hCCCccCCCC
Q 022617          163 LSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSH  239 (294)
Q Consensus       163 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~  239 (294)
                      ++....... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+  .......+..
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 3p86_A          185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN  263 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred             CCccccccccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence            987544332 2334568999999999988776 78999999999999999999999998887777666  3444667788


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhc--CCcccc
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQ--HPWFQA  273 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~--h~~~~~  273 (294)
                      ++.++.++|.+||+.||.+|||+.++++  .+++++
T Consensus       264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999999998  444444

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.9e-49  Score=332.26  Aligned_cols=261  Identities=27%  Similarity=0.442  Sum_probs=229.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|++.+.||+|++|.||+|.+..+++.|++|++......  .....+.+|+.++++++||||+++++++......
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            45667899999999999999999999999999999998765432  3467889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++++||+++++|.+++. .+++++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        96 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             EEEEECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             EEEEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            99999999999999985 4679999999999999999999999999999999999999999999999999997654432 


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHH
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR  250 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~  250 (294)
                      ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+.... ...+..++..+.+++.+
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred             ccCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence            2344568899999999987776 789999999999999999999999887777666654433 45567889999999999


Q ss_pred             hcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          251 MLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      ||..||.+|||+.++++||||......
T Consensus       254 ~l~~dp~~Rps~~~ll~~~~~~~~~~~  280 (303)
T 3a7i_A          254 CLNKEPSFRPTAKELLKHKFILRNAKK  280 (303)
T ss_dssp             HCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred             HcCCChhhCcCHHHHhhChhhhcCCCc
Confidence            999999999999999999999876543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.6e-49  Score=341.68  Aligned_cols=259  Identities=31%  Similarity=0.521  Sum_probs=219.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   89 (294)
                      .+.++|++.+.||+|+||.||+|.+..+++.|++|++....  .......+.+|++++++++||||+++++++...    
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  101 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ  101 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence            45589999999999999999999999999999999986432  334567889999999999999999999998654    


Q ss_pred             -CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           90 -SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        90 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                       ...++++|++++ +|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus       102 ~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          102 MKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             CCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence             468999999975 99998864 579999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------
Q 022617          169 DGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----------  233 (294)
Q Consensus       169 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  233 (294)
                      ....    .....+++.|+|||++.+....+.++||||||+++|+|++|+.||.+....+....+....           
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            3321    2344789999999987665545889999999999999999999998877666555543210           


Q ss_pred             --------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          234 --------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       234 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                                          ......++.++.++|.+||+.||.+|||+.++|+||||++...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                                0112467899999999999999999999999999999998744

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.6e-50  Score=352.85  Aligned_cols=261  Identities=40%  Similarity=0.696  Sum_probs=211.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      ..+.++|.+.+.||+|+||+||+|.+..+++.||+|++......     .......+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            45678999999999999999999999999999999999765432     1122345789999999999999999999986


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC---cEEEeeeccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLS  164 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~---~~~l~dfg~~  164 (294)
                      . +..+++|||+.+++|.+++..++.+++..++.++.|++.||.|||+.||+|+||||+||+++.++   .++|+|||++
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence            4 56899999999999999998888899999999999999999999999999999999999997544   5999999999


Q ss_pred             ccccCCCccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhCCCccCC----
Q 022617          165 NIMRDGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGIYTLP----  237 (294)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~----  237 (294)
                      .............+++.|+|||++.+  ....+.++||||||+++|+|++|..||..... ......+........    
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            87766555566778999999999853  22236789999999999999999999976433 334445555443332    


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ..++..+.++|.+||+.||.+|||+.++|+||||++.
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            5689999999999999999999999999999999763

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.4e-49  Score=348.52  Aligned_cols=259  Identities=30%  Similarity=0.447  Sum_probs=214.9

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC------CCCceeEEEEE
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF------MHPHIIRLYEV   85 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~   85 (294)
                      .+.+..+|++.+.||+|+||+||+|.+..+++.||+|++....    .....+.+|+.+++.+      .|+||++++++
T Consensus        92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            3567789999999999999999999999999999999986432    3346677788888776      56799999999


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc--EEEeee
Q 022617           86 IETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--VKIADF  161 (294)
Q Consensus        86 ~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~--~~l~df  161 (294)
                      +...+..++++|++. ++|.+++....  .+++..++.++.|++.||.|||+.||+|+||||+||+++.++.  ++|+||
T Consensus       168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence            999999999999996 59999997654  4899999999999999999999999999999999999999887  999999


Q ss_pred             cccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-------
Q 022617          162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------  234 (294)
Q Consensus       162 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  234 (294)
                      |++......  .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+.....       
T Consensus       247 G~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          247 GSSCYEHQR--VYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             TTCEETTCC--CCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccceecCCc--ccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            999764332  334578999999999988777 8999999999999999999999988876665544321100       


Q ss_pred             ----------------------------------------------------cCCCCCChhHHHHHHHhcccCCCCCCCH
Q 022617          235 ----------------------------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITI  262 (294)
Q Consensus       235 ----------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~  262 (294)
                                                                          .++...++.+.+||.+||+.||++|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                                                                0112347789999999999999999999


Q ss_pred             hHHhcCCcccccCCcc
Q 022617          263 PEIRQHPWFQAHLPRY  278 (294)
Q Consensus       263 ~~il~h~~~~~~~~~~  278 (294)
                      .|+|+||||++.+++.
T Consensus       404 ~e~L~Hpw~~~~~~~~  419 (429)
T 3kvw_A          404 GQALRHPWLRRRLPKP  419 (429)
T ss_dssp             HHHHTSTTTC------
T ss_pred             HHHhCChhhccCCCCC
Confidence            9999999999876654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.2e-50  Score=346.27  Aligned_cols=261  Identities=25%  Similarity=0.501  Sum_probs=227.3

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchH--------------HHHHHHHHHHHHHhCCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--------------MEEKVRREIKILRLFMH   76 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~--------------~~~~~~~e~~~l~~l~~   76 (294)
                      ..+...++|++.+.||.|++|.||+|.+  +++.|++|++.........              ....+.+|+.++++++|
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  102 (348)
T 2pml_X           25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN  102 (348)
T ss_dssp             SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred             hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence            3456678999999999999999999998  8899999998765433211              12788999999999999


Q ss_pred             CceeEEEEEEEcCCeEEEEEeccCCCChHHH------HHH--hCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCC
Q 022617           77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDY------IVE--KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPEN  147 (294)
Q Consensus        77 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~n  147 (294)
                      |||+++++++...+..+++|||+++++|.++      +.+  ...+++..++.++.|++.||.+||+ .|++|+||+|+|
T Consensus       103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999999999999999999999999999998      655  5679999999999999999999999 999999999999


Q ss_pred             eEecCCCcEEEeeecccccccCCCccccccCCCcccCCccccCC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHH
Q 022617          148 LLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNL  225 (294)
Q Consensus       148 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~  225 (294)
                      |+++.++.++|+|||.+...... ......++..|+|||.+.+. .+.+.++||||||+++|+|++|..||..... ...
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             EEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999999875443 34456689999999999876 4423389999999999999999999988766 777


Q ss_pred             HHHHhCCCccCC-------------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          226 FKKIKGGIYTLP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       226 ~~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ...+.......+                   ..++.++.+++.+||+.||.+|||+.++++||||++.
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            777777766655                   6789999999999999999999999999999999874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1e-49  Score=331.83  Aligned_cols=260  Identities=33%  Similarity=0.570  Sum_probs=225.7

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE--cCCeE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TPSDI   92 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~   92 (294)
                      ..++|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++++.  ..+..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            467999999999999999999999999999999999765433 345678999999999999999999999874  46789


Q ss_pred             EEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCeEecCCCcEEEeeecc
Q 022617           93 YVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNM-----VVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~-----i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      ++++||+++++|.+++...    ..+++..++.++.|++.||.+||+.|     ++|+||+|+||+++.++.++|+|||.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999999999754    34999999999999999999999999     99999999999999999999999999


Q ss_pred             cccccCCC-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCC
Q 022617          164 SNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLS  241 (294)
Q Consensus       164 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  241 (294)
                      +....... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+..+.. ..+..++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS  241 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred             heeeccccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccC
Confidence            87654332 2234467899999999987766 7899999999999999999999999888887777766554 5667899


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      .++.+++.+||+.||.+|||+.++++|+|+.+..+
T Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          242 DELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence            99999999999999999999999999999988654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.3e-50  Score=339.23  Aligned_cols=260  Identities=40%  Similarity=0.705  Sum_probs=215.4

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      ..+.++|++.+.||+|+||.||+|.+..+++.|++|++......     .......+.+|+.++++++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            45678999999999999999999999999999999998654321     1223456889999999999999999999987


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc---EEEeeeccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS  164 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~---~~l~dfg~~  164 (294)
                      ..+ .++++||+.+++|.+++..+..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.   ++|+|||++
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            655 8999999999999999988888999999999999999999999999999999999999987654   999999999


Q ss_pred             ccccCCCccccccCCCcccCCcccc--CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhCCCccC----C
Q 022617          165 NIMRDGHFLKTSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTL----P  237 (294)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~----~  237 (294)
                      .............+++.|+|||++.  +....+.++||||||+++|+|++|..||...... .....+..+....    +
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            8765554444556899999999974  2233378999999999999999999999764332 3333444333322    3


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      ..++..+.+++.+||..||.+|||+.++++||||+.
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            568999999999999999999999999999999965

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.3e-50  Score=342.71  Aligned_cols=255  Identities=27%  Similarity=0.432  Sum_probs=209.7

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS---   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   90 (294)
                      .+.++|++.+.||+|+||.||+|.++.+++.||+|++....  .....+.+.+|+.++++++||||+++++++.+..   
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence            35678999999999999999999999999999999987543  2335678999999999999999999999985543   


Q ss_pred             ------------------------------------------------------eEEEEEeccCCCChHHHHHHhCC---
Q 022617           91 ------------------------------------------------------DIYVVMEYVKSGELFDYIVEKGR---  113 (294)
Q Consensus        91 ------------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~---  113 (294)
                                                                            ..+++|||+++++|.+++.+...   
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999999999999976543   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-------------ccccccCCC
Q 022617          114 LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-------------FLKTSCGSP  180 (294)
Q Consensus       114 l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~  180 (294)
                      .++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......             ......+++
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            5666789999999999999999999999999999999999999999999998765432             223346899


Q ss_pred             cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCChhHHHHHHHhcccCCCCC
Q 022617          181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKR  259 (294)
Q Consensus       181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~R  259 (294)
                      .|+|||.+.+..+ +.++||||||+++|+|++|..|+..  .......+..... ......++++.+++.+||+.||.+|
T Consensus       241 ~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          241 LYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             GGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             CccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence            9999999988776 7999999999999999998665421  2222233333222 2223567788999999999999999


Q ss_pred             CCHhHHhcCCcccc
Q 022617          260 ITIPEIRQHPWFQA  273 (294)
Q Consensus       260 ps~~~il~h~~~~~  273 (294)
                      ||+.++++||||++
T Consensus       318 ps~~~~l~~~~f~~  331 (332)
T 3qd2_B          318 PEATDIIENAIFEN  331 (332)
T ss_dssp             CCHHHHHHSTTCCC
T ss_pred             CCHHHHhhchhhhc
Confidence            99999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.3e-49  Score=337.59  Aligned_cols=253  Identities=26%  Similarity=0.470  Sum_probs=213.2

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEc--CCe
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET--PSD   91 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~   91 (294)
                      ..++|++.+.||+|+||+||+|.+..+++.|++|++....      .+.+.+|+.++++++ |+||+++++++..  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            3578999999999999999999999999999999986432      467889999999997 9999999999987  677


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~~~~~  170 (294)
                      .++++|++.+++|.+++.   .+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            899999999999999874   489999999999999999999999999999999999999776 8999999999877666


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHH-------------hCCCcc-
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKI-------------KGGIYT-  235 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~-------------~~~~~~-  235 (294)
                      .......++..|+|||.+.+....+.++||||||+++|+|++|..||... ...+....+             ...... 
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence            55666778999999999987554589999999999999999999999543 222211111             111111 


Q ss_pred             -----------------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          236 -----------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       236 -----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                                             .+..++.++.+||.+||+.||.+|||++|+|+||||++...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                                   11237899999999999999999999999999999998653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-49  Score=340.66  Aligned_cols=259  Identities=32%  Similarity=0.572  Sum_probs=221.7

Q ss_pred             ccCCcccccccccCceEEEEEEEc---cCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   90 (294)
                      .++|++.+.||+|+||.||+|.+.   .+++.|++|++...... .......+.+|+++++.+ .|+||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            479999999999999999999984   47899999998654321 112345567899999999 6999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ..++||||+.+++|.+++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  212 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  212 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998754322


Q ss_pred             C--ccccccCCCcccCCccccCC-ccCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhCCCccCCCCCChh
Q 022617          171 H--FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPG  243 (294)
Q Consensus       171 ~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~  243 (294)
                      .  ......+++.|+|||++.+. ...+.++||||||+++|+|++|..||...    ....+...+.......+..++..
T Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (355)
T 1vzo_A          213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL  292 (355)
T ss_dssp             GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHH
Confidence            2  22345689999999998753 23378999999999999999999999643    34555556666667778889999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHhHHhcCCccccc
Q 022617          244 ARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      +.++|.+||..||.+||     ++.++++||||++.
T Consensus       293 ~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            99999999999999999     99999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=331.00  Aligned_cols=257  Identities=30%  Similarity=0.467  Sum_probs=217.3

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +...++|++.+.||.|++|.||+|.+..+++.|++|++....     ....+.+|+.++++++||||+++++++...+..
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   99 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL   99 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            456789999999999999999999999999999999986542     236788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++++||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            999999999999999974 5679999999999999999999999999999999999999999999999999997654432


Q ss_pred             -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHHH
Q 022617          172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDL  247 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l  247 (294)
                       ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+....   ...+..++..+.++
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  258 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF  258 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             cccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence             2344568899999999987776 789999999999999999999998877666555443332   22345678999999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      +.+||..||.+|||+.++++||||+...
T Consensus       259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          259 VKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            9999999999999999999999998753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.8e-50  Score=336.29  Aligned_cols=267  Identities=28%  Similarity=0.443  Sum_probs=198.7

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      ........++|++.+.||+|++|.||+|.+..+++.|++|++.....  ......+.+|+.++++++||||+++++++..
T Consensus         7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   84 (303)
T 2vwi_A            7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV   84 (303)
T ss_dssp             ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEES
T ss_pred             ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence            34456778999999999999999999999988999999999865432  2335678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHH--------hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEee
Q 022617           89 PSDIYVVMEYVKSGELFDYIVE--------KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD  160 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~--------~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~d  160 (294)
                      .+..++++||+.+++|.+++..        ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEe
Confidence            9999999999999999999974        35589999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCC------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc
Q 022617          161 FGLSNIMRDGH------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY  234 (294)
Q Consensus       161 fg~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~  234 (294)
                      ||.+.......      ......+++.|+|||.+.+....+.++||||||+++|+|++|..||.................
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  244 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP  244 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence            99987553321      123446889999999987533347899999999999999999999988766554443332221


Q ss_pred             ----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          235 ----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       235 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                                .....++.++.+++.+||+.||.+|||+.++++||||++...+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence                      1235678899999999999999999999999999999886543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-49  Score=336.90  Aligned_cols=261  Identities=30%  Similarity=0.448  Sum_probs=215.4

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CceeEEEEEEEc
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PHIIRLYEVIET   88 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~   88 (294)
                      .+....++|++.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.++++++|  +||+++++++..
T Consensus         3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            3 CISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             CEESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             eeeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            34567789999999999999999999985 688999999876543 33456788999999999987  999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      .+..+++||+. +++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++ ++.++|+|||++....
T Consensus        81 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           81 DQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             CCEEEEEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            99999999955 679999999888999999999999999999999999999999999999997 5689999999997654


Q ss_pred             CCC---ccccccCCCcccCCccccC----------CccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhC--C
Q 022617          169 DGH---FLKTSCGSPNYAAPEVISG----------KLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKG--G  232 (294)
Q Consensus       169 ~~~---~~~~~~~~~~~~aPE~~~~----------~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~--~  232 (294)
                      ...   ......+++.|+|||++.+          ....+.++||||||+++|+|++|..||..... ......+..  .
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  238 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  238 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence            332   2235568999999999854          12337899999999999999999999986432 233333332  2


Q ss_pred             CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          233 IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      ....+...+.++.+++.+||+.||.+|||+.++++||||+...
T Consensus       239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            2455667788999999999999999999999999999998643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6e-49  Score=341.99  Aligned_cols=259  Identities=29%  Similarity=0.448  Sum_probs=215.6

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCceeEEEEEEEcC
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM--HPHIIRLYEVIETP   89 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~   89 (294)
                      +.....+|++.+.||.|+||.||+|.+.. ++.||||++..... .......+.+|+.+++++.  |+||+++++++...
T Consensus        51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~  128 (390)
T 2zmd_A           51 ISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  128 (390)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             ccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence            34455679999999999999999999874 88999999976543 3345678999999999997  49999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      +.++++||+ .+++|.+++.+...+++..++.++.|++.||.|||+.||+|+||||+||+++ ++.+||+|||++.....
T Consensus       129 ~~~~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          129 QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             SEEEEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             CEEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            999999995 5779999999888999999999999999999999999999999999999995 57999999999986543


Q ss_pred             CC---ccccccCCCcccCCccccCC----------ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhCCC--
Q 022617          170 GH---FLKTSCGSPNYAAPEVISGK----------LYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGI--  233 (294)
Q Consensus       170 ~~---~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~--  233 (294)
                      ..   ......+++.|+|||++.+.          ...+.++||||||+++|+|++|..||.... .......+....  
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence            32   23355789999999998642          233789999999999999999999998643 333444444332  


Q ss_pred             ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ...+...+.++.++|.+||+.||.+|||+.++|+||||+..
T Consensus       287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            34566778899999999999999999999999999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.4e-51  Score=353.76  Aligned_cols=254  Identities=15%  Similarity=0.204  Sum_probs=208.3

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHH---HHHHhCCCCceeEEE-----
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI---KILRLFMHPHIIRLY-----   83 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~---~~l~~l~~~~i~~~~-----   83 (294)
                      .....++|++.+.||+|+||+||+|.+..+++.||||++...........+.+.+|+   +.+++++||||++++     
T Consensus        68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~  147 (377)
T 3byv_A           68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  147 (377)
T ss_dssp             SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred             cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence            344568999999999999999999999889999999999866555555678899999   555666899999987     


Q ss_pred             --EEEEcCCe-----------------EEEEEeccCCCChHHHHHHhCCCCH-------HHHHHHHHHHHHHHHHHHhCC
Q 022617           84 --EVIETPSD-----------------IYVVMEYVKSGELFDYIVEKGRLQE-------DEARNFFQQIISGVEYCHRNM  137 (294)
Q Consensus        84 --~~~~~~~~-----------------~~lv~e~~~~~sL~~~l~~~~~l~~-------~~~~~~~~ql~~~l~~Lh~~~  137 (294)
                        +++..++.                 .+++|||+ +++|.+++.+.+.+++       ..++.++.|++.||.|||+.|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence              77766543                 88999999 4699999987655555       788889999999999999999


Q ss_pred             ceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccCCccccCC-----------ccCCCchhHHHHHHH
Q 022617          138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-----------LYAGPEVDVWSCGVI  206 (294)
Q Consensus       138 i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~~Di~slG~l  206 (294)
                      |+|+||||+||+++.++.+||+|||++.....  ......+ +.|+|||++.+.           .+ +.++||||||++
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~i  302 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLV  302 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHH
Confidence            99999999999999999999999999986433  3334456 999999999876           55 789999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          207 LYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       207 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      +|+|++|+.||...........+.    ..+..++.++.++|.+||+.||.+|||+.++++||||++.
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            999999999997655443333332    2336789999999999999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.3e-49  Score=331.24  Aligned_cols=261  Identities=26%  Similarity=0.386  Sum_probs=219.5

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .....++|++.+.||.|++|.||+|.+..+++.+++|++....   ......+.+|+.++++++||||+++++++...+.
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            3467789999999999999999999999999999999986543   2335778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .++++||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999999998875 467999999999999999999999999999999999999999999999999987543211


Q ss_pred             -CccccccCCCcccCCcccc-----CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCC
Q 022617          171 -HFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLS  241 (294)
Q Consensus       171 -~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~  241 (294)
                       .......+++.|+|||.+.     +..+ +.++||||||+++|+|++|..||...+.......+.....   ..+..++
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS  249 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence             1223446789999999983     3334 7899999999999999999999998887766665544432   2345688


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ..+.+++.+||..||.+|||+.++++||||++...
T Consensus       250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            99999999999999999999999999999987543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.8e-49  Score=333.39  Aligned_cols=263  Identities=25%  Similarity=0.407  Sum_probs=217.4

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVI   86 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   86 (294)
                      ..+.+....++|++.+.||.|++|.||+|.+..+++.|++|++.....    ....+.+|+.+++++ +||||+++++++
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            344556778999999999999999999999999999999999865432    246788999999998 799999999999


Q ss_pred             Ec------CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEE
Q 022617           87 ET------PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI  158 (294)
Q Consensus        87 ~~------~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l  158 (294)
                      ..      .+..++++||+++++|.+++...  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEE
Confidence            76      46899999999999999999764  57999999999999999999999999999999999999999999999


Q ss_pred             eeecccccccCCC-ccccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC
Q 022617          159 ADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI  233 (294)
Q Consensus       159 ~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~  233 (294)
                      +|||++....... ......+++.|+|||.+..    ....+.++||||||+++|+|++|..||...........+....
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  250 (326)
T 2x7f_A          171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP  250 (326)
T ss_dssp             CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence            9999987654322 2334568899999999862    2223789999999999999999999998877766655554333


Q ss_pred             c--cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 Y--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 ~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .  ..+..++..+.++|.+||..||.+|||+.++++||||++.
T Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            2  2245689999999999999999999999999999999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.4e-49  Score=343.10  Aligned_cols=257  Identities=29%  Similarity=0.478  Sum_probs=202.1

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   89 (294)
                      .+.++|++.+.||+|+||.||+|.+..+++.|++|++.... ........+.+|+.+++.++||||+++++++...    
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence            56689999999999999999999999999999999986543 3334567888999999999999999999998654    


Q ss_pred             --CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        90 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                        ...++++|++ +++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence              5689999999 5699999865 67999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------  233 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  233 (294)
                      ...  .....+++.|+|||++.+....+.++||||||+++|+|++|+.||.+.+..+....+....              
T Consensus       183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          183 ADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             ccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            432  2345689999999998874444889999999999999999999999887666555443210              


Q ss_pred             ---------c--------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          234 ---------Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       234 ---------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                               .        ......++++.+||.+||..||.+|||+.++|+||||+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence                     0        01235688999999999999999999999999999998753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-49  Score=335.93  Aligned_cols=255  Identities=26%  Similarity=0.416  Sum_probs=212.5

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC--
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--   90 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   90 (294)
                      ..+.++|++.+.||+|+||+||+|.+..+++.|++|++......  ...+.+.+|++++++++||||+++++++....  
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            35678999999999999999999999999999999998754332  23567789999999999999999999998655  


Q ss_pred             eEEEEEeccCCCChHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe----cCCCcEEEeeecc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGL  163 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili----~~~~~~~l~dfg~  163 (294)
                      ..+++|||+.+++|.+++.....   +++..++.++.|++.||.|||+.|++|+||||+||++    +.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            78999999999999999976433   9999999999999999999999999999999999999    7777899999999


Q ss_pred             cccccCCCccccccCCCcccCCcccc--------CCccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhC
Q 022617          164 SNIMRDGHFLKTSCGSPNYAAPEVIS--------GKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKG  231 (294)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~  231 (294)
                      +.............+++.|+|||++.        +..+ +.++||||||+++|+|++|..||....    .......+..
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            98776666556677899999999875        3344 789999999999999999999996432    2233333322


Q ss_pred             CCc-------------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCc
Q 022617          232 GIY-------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  270 (294)
Q Consensus       232 ~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~  270 (294)
                      +.+                         .+...++..+.+++.+||+.||++|||++|+|+||-
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            211                         111234557889999999999999999999999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=328.40  Aligned_cols=270  Identities=25%  Similarity=0.418  Sum_probs=213.8

Q ss_pred             CCCCCCCccccccCCcccc-----cccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce
Q 022617            5 SNRSSSGVDMFLPNYKLGK-----TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI   79 (294)
Q Consensus         5 ~~~~~~~~~~~~~~y~~~~-----~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i   79 (294)
                      +..+....+.+..+|...+     .||.|+||.||+|.+..+++.|++|++....   ....+.+.+|+.+++.++||||
T Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i   81 (295)
T 2clq_A            5 TEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNI   81 (295)
T ss_dssp             ---------CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTB
T ss_pred             hhcccchhccccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCE
Confidence            3334444455555555555     9999999999999999999999999986543   2345778999999999999999


Q ss_pred             eEEEEEEEcCCeEEEEEeccCCCChHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCc
Q 022617           80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWN  155 (294)
Q Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~  155 (294)
                      +++++++...+..++++|++.+++|.+++....   .+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++.
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~  161 (295)
T 2clq_A           82 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV  161 (295)
T ss_dssp             CCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC
T ss_pred             eeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC
Confidence            999999999999999999999999999997652   4678999999999999999999999999999999999987 889


Q ss_pred             EEEeeecccccccCCC-ccccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHh
Q 022617          156 VKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFK-KIK  230 (294)
Q Consensus       156 ~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~--~~~-~~~  230 (294)
                      ++|+|||.+....... ......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||.......  ... ...
T Consensus       162 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  241 (295)
T 2clq_A          162 LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF  241 (295)
T ss_dssp             EEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH
T ss_pred             EEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc
Confidence            9999999987654322 233456889999999986543 23789999999999999999999997543222  111 223


Q ss_pred             CCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          231 GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      ......+..++.++.+++.+||..||++|||+.++++||||+....+
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence            44456677899999999999999999999999999999999875433

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.5e-49  Score=340.29  Aligned_cols=266  Identities=25%  Similarity=0.354  Sum_probs=209.5

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      ........++|++.+.||.|+||+||+|.+..+++.|++|++......    .....+++..++.++||||+++++++..
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYT   90 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence            333456678999999999999999999999999999999998544322    2355677888888999999999999865


Q ss_pred             CCe-------EEEEEeccCCCChHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCeEecC-CC
Q 022617           89 PSD-------IYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVEYCH--RNMVVHRDLKPENLLLDS-KW  154 (294)
Q Consensus        89 ~~~-------~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~~~~ql~~~l~~Lh--~~~i~h~di~p~nili~~-~~  154 (294)
                      ...       .+++|||+++ +|.+.+.    ....+++..++.++.|++.|+.+||  +.||+|+||||+||+++. ++
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC
Confidence            433       8899999976 6655544    3467899999999999999999999  999999999999999996 89


Q ss_pred             cEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-
Q 022617          155 NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-  233 (294)
Q Consensus       155 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-  233 (294)
                      .++|+|||++.............+++.|+|||++.+....+.++||||||+++|+|++|..||...+.......+.... 
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            9999999999877666555566789999999998766645899999999999999999999999887766665543210 


Q ss_pred             -------------------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617          234 -------------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       234 -------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~  279 (294)
                                                     ......++.++.+++.+||+.||.+|||+.|+|+||||++......
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence                                           0111235678999999999999999999999999999998754443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.1e-49  Score=340.97  Aligned_cols=265  Identities=26%  Similarity=0.410  Sum_probs=212.6

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc--------chHHHHHHHHHHHHHHhCCCCceeEE
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--------NMEMEEKVRREIKILRLFMHPHIIRL   82 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~   82 (294)
                      .+..+.++|++.+.||+|+||.||+|.+.. +..|++|++......        .....+.+.+|+.++++++||||+++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             HHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             HHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            346788999999999999999999999864 899999998654322        22345789999999999999999999


Q ss_pred             EEEEEc-----CCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcE
Q 022617           83 YEVIET-----PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV  156 (294)
Q Consensus        83 ~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~  156 (294)
                      ++++..     ....++++||+.+ +|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~  173 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI  173 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             eeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCE
Confidence            999843     3468999999975 888888654 469999999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC----
Q 022617          157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG----  232 (294)
Q Consensus       157 ~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----  232 (294)
                      +|+|||.+.............+++.|+|||.+.+....+.++||||||+++|+|++|+.||.+.........+...    
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999999986655555556678899999999887444589999999999999999999999987766655544221    


Q ss_pred             --------------------C--------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          233 --------------------I--------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       233 --------------------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                                          .        ......+++.+.++|.+||+.||.+|||+.++++||||++....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                                0        01124568889999999999999999999999999999987443

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-48  Score=328.53  Aligned_cols=268  Identities=23%  Similarity=0.355  Sum_probs=215.6

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ......++|++.+.||+|+||.||+|.+..+++.|++|++...........+.+.+|+.++++++||||+++++++...+
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            44566789999999999999999999999999999999997665555556788999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ..++++|++++++|.+++.+.+++++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998765433


Q ss_pred             C--ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCChhHH
Q 022617          171 H--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGAR  245 (294)
Q Consensus       171 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  245 (294)
                      .  ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+.....   ..+..++.++.
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  266 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD  266 (309)
T ss_dssp             ---------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred             ccccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence            2  2234568899999999987766 7899999999999999999999988776655555544332   34567899999


Q ss_pred             HHHHHhcccCCCCCC-CHhHHhcCCcccccCCccccC
Q 022617          246 DLIPRMLIVDPMKRI-TIPEIRQHPWFQAHLPRYLAV  281 (294)
Q Consensus       246 ~li~~~l~~~p~~Rp-s~~~il~h~~~~~~~~~~~~~  281 (294)
                      +++.+||+.||++|| +++++++  -+++.+......
T Consensus       267 ~li~~~l~~dP~~Rp~s~~~l~~--~l~~~l~~~~~~  301 (309)
T 2h34_A          267 AVIARGMAKNPEDRYVTCGDLSA--AAHAALATADQD  301 (309)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHH--HHHHTCC-----
T ss_pred             HHHHHhccCCHHHHHHhHHHHHH--HHHHHHHhhccc
Confidence            999999999999999 8888876  344444443333

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2e-48  Score=334.73  Aligned_cols=261  Identities=33%  Similarity=0.529  Sum_probs=217.3

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--   89 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   89 (294)
                      ...+.++|++.+.||+|+||.||+|.+..+++.|++|++...  ........+.+|+.++++++||||+++++++...  
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            456789999999999999999999999999999999998543  2334566788999999999999999999987654  


Q ss_pred             ---CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           90 ---SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        90 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                         ...++++|++.+ +|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        84 ~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           84 ENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             TTCCCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CccceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence               678999999975 99998865 6799999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCc-----------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC---
Q 022617          167 MRDGHF-----------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---  232 (294)
Q Consensus       167 ~~~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---  232 (294)
                      ......           .....+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+.......+...   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            543221           122357899999998865444478999999999999999999999887765544332210   


Q ss_pred             ---------------------C--------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          233 ---------------------I--------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       233 ---------------------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                                           .        ......++.++.+++.+||+.||++|||+.++++||||+..-.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence                                 0        0112468899999999999999999999999999999987643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.3e-48  Score=337.98  Aligned_cols=256  Identities=30%  Similarity=0.489  Sum_probs=215.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE-
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI-   92 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-   92 (294)
                      .+.++|.+.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+.. 
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence            46789999999999999999999999999999999986543 3334567888999999999999999999999876654 


Q ss_pred             -----EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           93 -----YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        93 -----~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                           ++++|++.+ +|.+.+  ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus       118 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          118 NFYDFYLVMPFMQT-DLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             TCCCCEEEEECCCE-EHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             cceeEEEEEccccc-cHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence                 999999974 888877  455999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------  233 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  233 (294)
                      ...  .....+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+....+....              
T Consensus       195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          195 DAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             ccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            432  2345679999999998874444899999999999999999999999887666555542210              


Q ss_pred             -----------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          234 -----------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       234 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                                       ...+..++..+.+||.+||+.||++|||+.|+|+||||+...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                             011246789999999999999999999999999999998653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9e-49  Score=332.95  Aligned_cols=271  Identities=27%  Similarity=0.430  Sum_probs=205.4

Q ss_pred             CCCCCccccccCCcccccccccCceEEEEEEEccCCc---eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEE
Q 022617            7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLY   83 (294)
Q Consensus         7 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   83 (294)
                      ..........++|++.+.||+|+||.||+|.+..++.   .|++|++....... ...+.+.+|+.++++++||||++++
T Consensus        13 ~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~   91 (323)
T 3qup_A           13 EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLV   91 (323)
T ss_dssp             ---CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred             HHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhh
Confidence            3445566778899999999999999999999877665   79999986553332 4467899999999999999999999


Q ss_pred             EEEEcCCeE------EEEEeccCCCChHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec
Q 022617           84 EVIETPSDI------YVVMEYVKSGELFDYIVEKG------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD  151 (294)
Q Consensus        84 ~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~  151 (294)
                      +++......      ++++||+.+++|.+++....      .+++..++.++.|++.||.|||+.|++|+||||+||+++
T Consensus        92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~  171 (323)
T 3qup_A           92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA  171 (323)
T ss_dssp             EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc
Confidence            999876655      99999999999999996543      599999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022617          152 SKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFK  227 (294)
Q Consensus       152 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~  227 (294)
                      .++.++|+|||.+........   .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+........
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~  250 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN  250 (323)
T ss_dssp             TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence            999999999999976543322   223345678999999987766 789999999999999999 999999888877777


Q ss_pred             HHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCC-------HhHHhcCCcccccCCccc
Q 022617          228 KIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRIT-------IPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       228 ~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps-------~~~il~h~~~~~~~~~~~  279 (294)
                      .+.... ...+..++.++.+++.+||+.||.+|||       ++++++|||+......++
T Consensus       251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl  310 (323)
T 3qup_A          251 YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL  310 (323)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred             HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence            766554 5667789999999999999999999999       788899999987644433

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.2e-48  Score=340.64  Aligned_cols=256  Identities=30%  Similarity=0.425  Sum_probs=211.8

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .+....+|++.+.||+|+||+||+|.+..++. +++|.+.....       ...+|+++++.++||||+++++++...+.
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence            34567789999999999999999999986665 88887754321       12369999999999999999999865433


Q ss_pred             ------EEEEEeccCCCChHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec-CCCcEEEee
Q 022617           92 ------IYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIAD  160 (294)
Q Consensus        92 ------~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~-~~~~~~l~d  160 (294)
                            ++++|||+++ ++.+.+.    ....+++..++.++.|++.||.|||+.||+|+||||+||+++ .++.++|+|
T Consensus       107 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~D  185 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID  185 (394)
T ss_dssp             SSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             CCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEee
Confidence                  8899999977 5554443    256799999999999999999999999999999999999998 789999999


Q ss_pred             ecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------
Q 022617          161 FGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------  233 (294)
Q Consensus       161 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------  233 (294)
                      ||++.............+++.|+|||.+.+....+.++||||||+++|+|++|+.||.+.+..+....+....       
T Consensus       186 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             CTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9999877655555667789999999998776545899999999999999999999999887665554443210       


Q ss_pred             ----------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          234 ----------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       234 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                                            ..++..+++++.++|.+||..||.+|||+.++++||||++.-.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                                  0123458899999999999999999999999999999987533

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.3e-48  Score=329.82  Aligned_cols=263  Identities=29%  Similarity=0.459  Sum_probs=218.9

Q ss_pred             CccccccCCcccccccccCceEEEEEEEc-cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeEEEEEE
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHA-LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVI   86 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~   86 (294)
                      ++....++|++.+.||+|+||.||+|.+. .+++.|++|++....... .....+.+|+.+++.+   +||||+++++++
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            44566789999999999999999999995 678899999987554221 1123455666666655   899999999998


Q ss_pred             E-----cCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEe
Q 022617           87 E-----TPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA  159 (294)
Q Consensus        87 ~-----~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~  159 (294)
                      .     .....++++|++++ +|.+++....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             EEEECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             eecccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEe
Confidence            7     56779999999975 9999997643  48999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------
Q 022617          160 DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------  233 (294)
Q Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------  233 (294)
                      |||.+.............+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+.........+....      
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            9999977654444455678999999999987776 789999999999999999999999887766655543210      


Q ss_pred             ---------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          234 ---------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       234 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                                           ......++..+.+++.+||..||.+|||+.++++||||++.-.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                                 1123568899999999999999999999999999999987643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.2e-49  Score=336.29  Aligned_cols=260  Identities=33%  Similarity=0.607  Sum_probs=221.9

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccch---HHHHHHHHHHHHHHhCC--CCceeEEEE
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLFM--HPHIIRLYE   84 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~--~~~i~~~~~   84 (294)
                      ...+.+.++|++.+.||+|+||.||+|.+..+++.|++|++........   .....+.+|+.+++++.  |+|++++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            3456788999999999999999999999999999999999976543321   12245677899999996  599999999


Q ss_pred             EEEcCCeEEEEEeccCC-CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec-CCCcEEEeeec
Q 022617           85 VIETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIADFG  162 (294)
Q Consensus        85 ~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~-~~~~~~l~dfg  162 (294)
                      ++..++..++++|++.+ ++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            99999999999999975 79999999888999999999999999999999999999999999999998 77899999999


Q ss_pred             ccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCCh
Q 022617          163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSP  242 (294)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
                      ++....... .....+++.|+|||.+.+....+.++||||||+++|+|++|..||....      .+.......+..++.
T Consensus       196 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~  268 (320)
T 3a99_A          196 SGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSS  268 (320)
T ss_dssp             TCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCH
T ss_pred             ccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCH
Confidence            998765432 3345689999999998776665678999999999999999999996532      223334456678999


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ++.++|.+||+.||.+|||+.++++||||++.+.
T Consensus       269 ~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            9999999999999999999999999999988653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-48  Score=333.25  Aligned_cols=257  Identities=31%  Similarity=0.470  Sum_probs=215.9

Q ss_pred             CCccccccCCcccccccccCceEEEEEEE-ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC------ceeEE
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP------HIIRL   82 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~-~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~   82 (294)
                      ...+.+.++|++.+.||+|+||+||+|.+ ..+++.|++|++....    ...+.+.+|+.+++.++|+      +++++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            34567889999999999999999999998 5678899999985432    3456788899999888765      49999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC--------
Q 022617           83 YEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--------  152 (294)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~--------  152 (294)
                      ++++...+..++++|++ +++|.+++...+  ++++..++.++.|++.||.|||+.|++|+||||+||+++.        
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence            99999999999999999 779999998765  6899999999999999999999999999999999999987        


Q ss_pred             -----------CCcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022617          153 -----------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN  221 (294)
Q Consensus       153 -----------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~  221 (294)
                                 ++.++|+|||.+......  .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             CccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                       668999999999764332  234568999999999988776 789999999999999999999998877


Q ss_pred             HHHHHHHHhCCCccC--------------------------------------------CCCCChhHHHHHHHhcccCCC
Q 022617          222 IPNLFKKIKGGIYTL--------------------------------------------PSHLSPGARDLIPRMLIVDPM  257 (294)
Q Consensus       222 ~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~l~~li~~~l~~~p~  257 (294)
                      ..+....+.....+.                                            ....+.++.+++.+||+.||.
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            665444332211111                                            112346788999999999999


Q ss_pred             CCCCHhHHhcCCccccc
Q 022617          258 KRITIPEIRQHPWFQAH  274 (294)
Q Consensus       258 ~Rps~~~il~h~~~~~~  274 (294)
                      +|||+.|+++||||+..
T Consensus       319 ~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          319 KRITLREALKHPFFDLL  335 (339)
T ss_dssp             TSCCHHHHTTSGGGGGG
T ss_pred             cccCHHHHhcCHHHHHH
Confidence            99999999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-48  Score=343.09  Aligned_cols=255  Identities=29%  Similarity=0.400  Sum_probs=211.0

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----   89 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   89 (294)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++....       ....+|++++++++|+||+++++++...     
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            3447999999999999999999999999999999985432       1234799999999999999999987432     


Q ss_pred             -CeEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-CcEEEeeecc
Q 022617           90 -SDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGL  163 (294)
Q Consensus        90 -~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~dfg~  163 (294)
                       ..+++++||+++ +|.+.+..    ...+++..++.++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||+
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence             247799999976 77776643    4679999999999999999999999999999999999999965 5689999999


Q ss_pred             cccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-----------
Q 022617          164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-----------  232 (294)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-----------  232 (294)
                      +.............+++.|+|||++.+....+.++||||||+++|+|++|+.||.+.+..+....+...           
T Consensus       204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            987655555556678999999999876644488999999999999999999999987765544443220           


Q ss_pred             ------Ccc------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          233 ------IYT------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       233 ------~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                            ...            ++...+.++.+||.+||..||.+|||+.|+++||||+.....
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence                  011            234578899999999999999999999999999999876433

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-49  Score=334.50  Aligned_cols=263  Identities=34%  Similarity=0.617  Sum_probs=210.2

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccch---HHHHHHHHHHHHHHhC----CCCcee
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLF----MHPHII   80 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l----~~~~i~   80 (294)
                      .....+.+.++|++.+.||+|+||.||+|.+..+++.|++|++........   .....+.+|+.+++++    +|+||+
T Consensus        22 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~  101 (312)
T 2iwi_A           22 GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI  101 (312)
T ss_dssp             -----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred             CccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence            344567889999999999999999999999999999999999865543221   1234456788988888    899999


Q ss_pred             EEEEEEEcCCeEEEEEec-cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec-CCCcEEE
Q 022617           81 RLYEVIETPSDIYVVMEY-VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKI  158 (294)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~-~~~~~~l  158 (294)
                      ++++++...+..++++|+ +.+++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++.++|
T Consensus       102 ~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             CEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             eEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEE
Confidence            999999989999999999 78889999999888999999999999999999999999999999999999999 7889999


Q ss_pred             eeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCC
Q 022617          159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS  238 (294)
Q Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  238 (294)
                      +|||.+....... .....++..|+|||.+.+....+.++||||||+++|+|++|+.||....      .+......++.
T Consensus       182 ~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~  254 (312)
T 2iwi_A          182 IDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPA  254 (312)
T ss_dssp             CCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCT
T ss_pred             EEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcc
Confidence            9999988765433 3345688999999998776664568999999999999999999996532      23334456677


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      .++..+.++|.+||+.||++|||+.++++||||+.....
T Consensus       255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~  293 (312)
T 2iwi_A          255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED  293 (312)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence            899999999999999999999999999999999886443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=330.69  Aligned_cols=257  Identities=30%  Similarity=0.476  Sum_probs=210.9

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE-----
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE-----   87 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   87 (294)
                      ..+.++|++.+.||+|++|.||+|.+..+++.|++|++...   +....+.+.+|+.++++++||||+++++++.     
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            46789999999999999999999999999999999998643   3345678899999999999999999999873     


Q ss_pred             ---------cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec-CCCcEE
Q 022617           88 ---------TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVK  157 (294)
Q Consensus        88 ---------~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~-~~~~~~  157 (294)
                               ..+..++++||+++ +|.+++. ++++++..++.++.|++.||.+||+.|++|+||+|+||+++ .++.++
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYMET-DLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCSE-EHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccccccccCceeEEeeccCC-CHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                     34678999999975 9999985 46799999999999999999999999999999999999997 567999


Q ss_pred             EeeecccccccCC----CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC
Q 022617          158 IADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI  233 (294)
Q Consensus       158 l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~  233 (294)
                      |+|||.+......    .......++..|+|||.+.+....+.++||||||+++|+|++|+.||...........+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999998765322    122334568899999998764444789999999999999999999999877666555443221


Q ss_pred             c------------------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 Y------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 ~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .                              .....++.++.++|.+||+.||.+|||+.++++||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            1                              1224689999999999999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.1e-48  Score=333.48  Aligned_cols=253  Identities=26%  Similarity=0.462  Sum_probs=219.1

Q ss_pred             cccccCCcccccccccCceEEEEEEEc-------cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHA-------LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYE   84 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~   84 (294)
                      ....++|++.+.||+|+||.||+|.+.       .++..|++|++....  .......+.+|+.+++++ +||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            344578999999999999999999874       244579999986542  334567899999999999 8999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617           85 VIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL  148 (294)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni  148 (294)
                      ++...+.+++|+||+.+++|.+++....                .++...++.++.|++.||.|||+.||+|+||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998653                378999999999999999999999999999999999


Q ss_pred             EecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022617          149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN  224 (294)
Q Consensus       149 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~  224 (294)
                      +++.++.+||+|||++........   .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999986543322   223345778999999987766 789999999999999999 999999988888


Q ss_pred             HHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          225 LFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       225 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ....+..+. ...+..++.++.+++.+||..||.+|||+.+++++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            877776554 55677899999999999999999999999999873

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=329.55  Aligned_cols=258  Identities=25%  Similarity=0.392  Sum_probs=221.2

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCc---eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      .+...++|++.+.||+|+||+||+|.+..+++   .|++|++....  .....+.+.+|+.++++++||||+++++++..
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            35667899999999999999999999986555   49999986432  33446788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      .+..++||||+.+++|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999999999654 57999999999999999999999999999999999999999999999999999866


Q ss_pred             cCCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCC
Q 022617          168 RDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLS  241 (294)
Q Consensus       168 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~  241 (294)
                      .....    .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ..+.+..++
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence            43321    122234668999999987766 789999999999999999 99999998888888877665 356677899


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ..+.+++.+||..||.+|||+.++++  .+++.
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~--~L~~l  311 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVS--VLDAL  311 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            99999999999999999999999987  44443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-48  Score=333.75  Aligned_cols=263  Identities=34%  Similarity=0.568  Sum_probs=190.6

Q ss_pred             CCCCCccccccCCcccc-cccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEE
Q 022617            7 RSSSGVDMFLPNYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV   85 (294)
Q Consensus         7 ~~~~~~~~~~~~y~~~~-~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   85 (294)
                      ........+.++|.+.+ .||.|+||+||+|.++.+++.||+|++....       ....+....++.+.|+|+++++++
T Consensus        18 ~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~   90 (336)
T 3fhr_A           18 GPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDV   90 (336)
T ss_dssp             --CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             CCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHH
Confidence            44445567889999965 6999999999999999999999999985431       122233344677899999999999


Q ss_pred             EEc----CCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcE
Q 022617           86 IET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNV  156 (294)
Q Consensus        86 ~~~----~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~  156 (294)
                      +..    ....+++|||+.+++|.+++.+..  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.   ++.+
T Consensus        91 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A           91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             EEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred             HhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceE
Confidence            876    456899999999999999997653  6999999999999999999999999999999999999976   4459


Q ss_pred             EEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhCC
Q 022617          157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF----KKIKGG  232 (294)
Q Consensus       157 ~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~----~~~~~~  232 (294)
                      +|+|||++...... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.........    ..+...
T Consensus       171 kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (336)
T 3fhr_A          171 KLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG  248 (336)
T ss_dssp             EECCCTTCEEC-----------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             EEeccccceecccc-ccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc
Confidence            99999999765432 2334567899999999977776 78999999999999999999999766544332    222222


Q ss_pred             Ccc----CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          233 IYT----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       233 ~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                      ...    ....++.++.+++.+||+.||.+|||+.++++||||++.....
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  298 (336)
T 3fhr_A          249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP  298 (336)
T ss_dssp             --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred             ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence            222    2257899999999999999999999999999999999865443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.9e-48  Score=332.35  Aligned_cols=256  Identities=30%  Similarity=0.488  Sum_probs=214.5

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe--
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--   91 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--   91 (294)
                      .+.++|.+.+.||.|+||.||+|.+..+|+.|++|++.... ........+.+|+.++++++||||+++++++...+.  
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence            46789999999999999999999999999999999986543 333456788999999999999999999999977654  


Q ss_pred             ----EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           92 ----IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        92 ----~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                          .++++|++.+ +|.+++.  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          100 NFYDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             GCCCCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             cceeEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence                4999999975 8888773  45899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC---------------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---------------  232 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---------------  232 (294)
                      ...  .....+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+....+...               
T Consensus       177 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          177 DAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             CCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence            432  234567899999999887444488999999999999999999999887766554443210               


Q ss_pred             ----------------CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          233 ----------------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       233 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                                      .......++.++.++|.+||..||++|||+.++++||||+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                            0122346789999999999999999999999999999998753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=336.64  Aligned_cols=271  Identities=21%  Similarity=0.327  Sum_probs=228.6

Q ss_pred             cccccCCcccccccccCceEEEEEE-----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      +...++|++.+.||+|+||.||+|.     +..++..|++|++...  ........+.+|+.++++++||||+++++++.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4556899999999999999999999     4456778999998533  23344567889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC---cEE
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKG-------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVK  157 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~---~~~  157 (294)
                      ..+..++||||+.+++|.+++....       .+++..++.++.|++.||.|||+.||+|+||||+||+++.++   .++
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999999998753       489999999999999999999999999999999999999554   599


Q ss_pred             EeeecccccccCC---CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC
Q 022617          158 IADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI  233 (294)
Q Consensus       158 l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~  233 (294)
                      |+|||++......   .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...........+..+.
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  303 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999998754221   22334456889999999877766 789999999999999998 999999998888888777654


Q ss_pred             -ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcc
Q 022617          234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDT  286 (294)
Q Consensus       234 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~  286 (294)
                       ...+..++..+.+++.+||+.||.+|||+.+++++.++-...+.....+.|..
T Consensus       304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~~~p~~  357 (367)
T 3l9p_A          304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIE  357 (367)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCCCC
T ss_pred             CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccCCCccc
Confidence             55667899999999999999999999999999999888666555555555543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.3e-49  Score=340.55  Aligned_cols=256  Identities=16%  Similarity=0.146  Sum_probs=197.4

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC--CCCceeEEE-------EE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF--MHPHIIRLY-------EV   85 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~   85 (294)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+  +|||+++++       ++
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            345699999999999999999999999999999999876655556677788885544444  699988755       45


Q ss_pred             EEcC-----------------CeEEEEEeccCCCChHHHHHHh-CCCCHHHH------HHHHHHHHHHHHHHHhCCceec
Q 022617           86 IETP-----------------SDIYVVMEYVKSGELFDYIVEK-GRLQEDEA------RNFFQQIISGVEYCHRNMVVHR  141 (294)
Q Consensus        86 ~~~~-----------------~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~------~~~~~ql~~~l~~Lh~~~i~h~  141 (294)
                      +..+                 ...++||||++ ++|.+++... ..++....      +.++.|++.||+|||+.||+|+
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence            4433                 33899999998 6999999764 34455555      6777999999999999999999


Q ss_pred             CCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022617          142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDD  219 (294)
Q Consensus       142 di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~  219 (294)
                      ||||+||+++.++.+||+|||++......  .....+++.|+|||++.+  ..+ +.++||||||+++|+|++|+.||..
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999865432  224456799999999976  445 7999999999999999999999977


Q ss_pred             CCHHHHH--HH-----HhCCC--ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          220 ENIPNLF--KK-----IKGGI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       220 ~~~~~~~--~~-----~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .......  ..     .....  .+.+..++..+.++|.+||+.||++|||+.++++||||++.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            6432110  00     00111  22235789999999999999999999999999999999874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-48  Score=327.66  Aligned_cols=250  Identities=28%  Similarity=0.465  Sum_probs=213.1

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||+|+||+||+|.+..+++.|++|++...   .....+.+.+|++++++++||||+++++++...+..++|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            57999999999999999999999999999999987432   345567899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc-
Q 022617           96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  173 (294)
                      +||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            999999999999987 467999999999999999999999999999999999999999999999999999765433221 


Q ss_pred             --------------ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhCCC
Q 022617          174 --------------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN------LFKKIKGGI  233 (294)
Q Consensus       174 --------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~------~~~~~~~~~  233 (294)
                                    ....+++.|+|||++.+..+ +.++||||||+++|+|++|..|+.......      ......   
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~---  241 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD---  241 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH---
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc---
Confidence                          14468999999999988776 789999999999999999999986532111      111111   


Q ss_pred             ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ...+..++..+.+++.+||+.||++|||+.++++  ++++.
T Consensus       242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            1235778999999999999999999999999988  66544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.2e-47  Score=317.54  Aligned_cols=251  Identities=25%  Similarity=0.468  Sum_probs=219.0

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .+.-.++|++.+.||+|+||.||+|.+. ++..|++|++......    .+.+.+|++++++++||||+++++++...+.
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP   77 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence            3556789999999999999999999876 5678999998655432    3568899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .++++||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            999999999999999997754 5999999999999999999999999999999999999999999999999999766444


Q ss_pred             Ccc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617          171 HFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD  246 (294)
Q Consensus       171 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  246 (294)
                      ...  ....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.... ...+..++..+.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  236 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ  236 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             hhhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence            322  22335667999999987766 789999999999999999 999999888888777776554 4456678999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcC
Q 022617          247 LIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ++.+||+.||.+|||+.+++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999984

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.1e-48  Score=322.05  Aligned_cols=258  Identities=27%  Similarity=0.462  Sum_probs=209.4

Q ss_pred             CCCCCCccccccCCcccccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEE
Q 022617            6 NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL   82 (294)
Q Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   82 (294)
                      +.+....+...++|++.+.||+|+||.||+|.+..+   +..+++|++....  .....+.+.+|+.++++++||||+++
T Consensus         4 ~~s~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~   81 (281)
T 1mp8_A            4 GSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKL   81 (281)
T ss_dssp             -----CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             cccccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceE
Confidence            345566788899999999999999999999998654   3469999875432  33456788999999999999999999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617           83 YEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF  161 (294)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df  161 (294)
                      ++++. .+..+++|||+.+++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+||
T Consensus        82 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           82 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             EEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             EEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcc
Confidence            99984 567899999999999999997654 6999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCC
Q 022617          162 GLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLP  237 (294)
Q Consensus       162 g~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~  237 (294)
                      |++........  .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+.... .+.+
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP  239 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred             ccccccCcccccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC
Confidence            99976644332  223345678999999977666 789999999999999997 999999888777777776543 5677


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ..++..+.+++.+||..||++|||+.++++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            889999999999999999999999999987

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.2e-47  Score=320.10  Aligned_cols=252  Identities=24%  Similarity=0.432  Sum_probs=217.5

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ....-.++|++.+.||+|+||.||++.+. ++..|++|++......    .+.+.+|++++++++|+||+++++++...+
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            33566789999999999999999999886 6778999998755433    367889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           91 DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      ..++++||+.+++|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999999999976 56799999999999999999999999999999999999999999999999999976543


Q ss_pred             CCc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617          170 GHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR  245 (294)
Q Consensus       170 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  245 (294)
                      ...  .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.... ...+..++..+.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  251 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY  251 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHH
Confidence            321  223345678999999987766 789999999999999998 999999988888888777664 445667899999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcC
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      +++.+||+.+|.+|||+.++++|
T Consensus       252 ~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999874

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2e-48  Score=339.73  Aligned_cols=254  Identities=26%  Similarity=0.458  Sum_probs=208.0

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC--------CCceeEEE
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM--------HPHIIRLY   83 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~   83 (294)
                      .+.+.++|++.+.||+|+||+||+|.+..+++.||+|++...    ......+.+|+.+++.++        |+||++++
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            356778999999999999999999999999999999998643    234577889999999885        78899999


Q ss_pred             EEEE----cCCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCC--
Q 022617           84 EVIE----TPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKW--  154 (294)
Q Consensus        84 ~~~~----~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~--  154 (294)
                      +++.    .....+++||+++ ++|.+.+...  ..+++..++.++.|++.||.|||+. ||+|+||||+||+++.++  
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred             cceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence            9987    5668999999995 5777766554  4699999999999999999999998 999999999999998775  


Q ss_pred             -----------------------------------------------cEEEeeecccccccCCCccccccCCCcccCCcc
Q 022617          155 -----------------------------------------------NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV  187 (294)
Q Consensus       155 -----------------------------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~  187 (294)
                                                                     .++|+|||.+......  .....+++.|+|||+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChh
Confidence                                                           7999999999765433  334568999999999


Q ss_pred             ccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhC---CC-------------------------
Q 022617          188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI------PNLFKKIKG---GI-------------------------  233 (294)
Q Consensus       188 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~---~~-------------------------  233 (294)
                      +.+..+ +.++||||||+++|+|++|..||...+.      ......+..   ..                         
T Consensus       265 ~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          265 LIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            988776 7899999999999999999999976442      111111111   00                         


Q ss_pred             --------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          234 --------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       234 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                                    ...+...+..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                          0111223457889999999999999999999999999974

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.2e-48  Score=324.11  Aligned_cols=253  Identities=29%  Similarity=0.513  Sum_probs=207.8

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc------
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------   88 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------   88 (294)
                      +.++|++.+.||.|+||.||+|.+..+++.|++|++...    ......+.+|+.++++++||||+++++++..      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            567899999999999999999999999999999998543    2446788999999999999999999998754      


Q ss_pred             -------CCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEee
Q 022617           89 -------PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD  160 (294)
Q Consensus        89 -------~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~d  160 (294)
                             .+..++++||+++++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence                   45789999999999999999754 3578899999999999999999999999999999999999999999999


Q ss_pred             ecccccccCC---------------CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHH
Q 022617          161 FGLSNIMRDG---------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPN  224 (294)
Q Consensus       161 fg~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~  224 (294)
                      ||.+......               .......+++.|+|||.+.+....+.++||||||+++|+|++   ||.. .....
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765322               122344578899999999865444889999999999999998   5543 33344


Q ss_pred             HHHHHhCCCccCC----CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          225 LFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       225 ~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ....+.......+    ...+..+.+++.+||+.||.+|||+.++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            5555555444333    4566779999999999999999999999999999763

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.8e-48  Score=318.62  Aligned_cols=249  Identities=24%  Similarity=0.455  Sum_probs=218.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-.++|++.+.||+|+||.||+|.+. +++.|++|++......    .+.+.+|++++++++||||+++++++...+..+
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            44578999999999999999999987 5778999998755432    357889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++|||+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            999999999999999654 458999999999999999999999999999999999999999999999999997654332 


Q ss_pred             -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHH
Q 022617          172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI  248 (294)
Q Consensus       172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  248 (294)
                       ......+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+.... ...+..++..+.+++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  240 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             ccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHH
Confidence             1223345678999999987766 789999999999999999 999999998888888877663 455667899999999


Q ss_pred             HHhcccCCCCCCCHhHHhcC
Q 022617          249 PRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h  268 (294)
                      .+||+.||.+|||+.+++++
T Consensus       241 ~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          241 NHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCcccCcCHHHHHHH
Confidence            99999999999999999884

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-47  Score=330.63  Aligned_cols=256  Identities=27%  Similarity=0.448  Sum_probs=222.7

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccC-------CceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeE
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALT-------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIR   81 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~   81 (294)
                      .......++|.+.+.||+|+||+||+|.+...       +..|++|++....  .......+.+|+++++++ +||||++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            34466778999999999999999999997533       3579999986542  334567889999999999 8999999


Q ss_pred             EEEEEEcCCeEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 022617           82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKP  145 (294)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p  145 (294)
                      +++++...+..++|+||+.+++|.+++....                .+++..++.++.|++.||.+||+.|++|+||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999998754                489999999999999999999999999999999


Q ss_pred             CCeEecCCCcEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 022617          146 ENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN  221 (294)
Q Consensus       146 ~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~  221 (294)
                      +||+++.++.++|+|||++.......   ......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||....
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999998654332   2233446778999999987766 789999999999999999 999999998


Q ss_pred             HHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          222 IPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       222 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .......+.... ...+..++.++.+++.+||+.||++|||+.+++++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          299 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            888888776654 55667899999999999999999999999999884

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-47  Score=324.75  Aligned_cols=257  Identities=29%  Similarity=0.441  Sum_probs=222.3

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEE
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLY   83 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   83 (294)
                      ....+...++|++.+.||.|+||.||+|.+.     .++..|++|++....  .....+.+.+|+.++++++||||++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~   92 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLY   92 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence            3445667789999999999999999999873     345789999986442  334567889999999999999999999


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHHHhCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCce
Q 022617           84 EVIETPSDIYVVMEYVKSGELFDYIVEKGR------------------------LQEDEARNFFQQIISGVEYCHRNMVV  139 (294)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------l~~~~~~~~~~ql~~~l~~Lh~~~i~  139 (294)
                      +++...+..++++||+.+++|.+++.....                        +++..++.++.|++.||.|||+.|++
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  172 (314)
T 2ivs_A           93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV  172 (314)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            999999999999999999999999986543                        89999999999999999999999999


Q ss_pred             ecCCCCCCeEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCC
Q 022617          140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL  215 (294)
Q Consensus       140 h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~  215 (294)
                      |+||+|+||+++.++.++|+|||++........   .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999876543322   223345778999999987766 789999999999999999 999


Q ss_pred             CCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          216 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       216 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ||...........+.... ...+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999888887777776554 55667899999999999999999999999999874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-47  Score=328.95  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=222.9

Q ss_pred             ccccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI   86 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   86 (294)
                      .+...++|++.+.||+|+||.||+|.+.     .+++.|++|++....  .......+.+|+.++++++||||+++++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3566789999999999999999999987     345789999986543  234567899999999999999999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEK------------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRD  142 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~d  142 (294)
                      ...+..++++||+.+++|.+++...                        ..+++..++.++.|++.||.|||+.|++|+|
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9999999999999999999999763                        5689999999999999999999999999999


Q ss_pred             CCCCCeEecCCCcEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCC
Q 022617          143 LKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFD  218 (294)
Q Consensus       143 i~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~  218 (294)
                      |+|+||+++.++.++|+|||++.......   ......+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCC
Confidence            99999999999999999999987653322   2234456889999999887766 789999999999999999 999999


Q ss_pred             CCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          219 DENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       219 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ..........+..+. ...+..++.++.+++.+||+.||.+|||+.++++  .|++.
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~--~L~~~  333 (343)
T 1luf_A          279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRM  333 (343)
T ss_dssp             TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             CCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH--HHHHH
Confidence            988888887776655 4567789999999999999999999999999987  45443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-47  Score=320.38  Aligned_cols=255  Identities=24%  Similarity=0.407  Sum_probs=225.1

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      +-...++..++|++.+.||.|++|+||+|.+..++..|++|++....    ...+.+.+|+.++++++||||+++++++.
T Consensus         4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   79 (288)
T 3kfa_A            4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCT   79 (288)
T ss_dssp             TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            44566788999999999999999999999999999999999986433    34577889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                      ..+..++++|++.+++|.+++...  ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccce
Confidence            999999999999999999999864  458999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCC
Q 022617          166 IMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLS  241 (294)
Q Consensus       166 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~  241 (294)
                      .......  .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+... ....+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  238 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             eccCCccccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCC
Confidence            6654332  223345778999999987766 789999999999999999 99999988887777777655 356677899


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ..+.+++.+||..||.+|||+.++++
T Consensus       239 ~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          239 EKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            99999999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=323.50  Aligned_cols=260  Identities=25%  Similarity=0.356  Sum_probs=199.8

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      ....++|++.+.||.|+||.||+|.+..+++.|++|++...... ......+.++..+++.++||||+++++++...+..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~   99 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV   99 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence            44567899999999999999999999999999999998755422 23334455566678888999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ++++||+ ++.+..+... ...+++..++.++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999999 5466666554 46799999999999999999999995 9999999999999999999999999999776555


Q ss_pred             CccccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhCCCc-cC--CCCCCh
Q 022617          171 HFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIY-TL--PSHLSP  242 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~-~~--~~~~~~  242 (294)
                      .......+++.|+|||.+..    ....+.++||||||+++|+|++|..||.. .........+..... ..  ...++.
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 2dyl_A          179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG  258 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred             ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence            54555678999999999852    22337899999999999999999999986 344444444443332 22  246899


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ++.+++.+||+.||.+|||+.++++||||+..
T Consensus       259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            99999999999999999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.1e-47  Score=317.47  Aligned_cols=262  Identities=29%  Similarity=0.450  Sum_probs=212.4

Q ss_pred             CCCCCCCCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHH----HHHHHHHHHHHhCCC
Q 022617            1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME----EKVRREIKILRLFMH   76 (294)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~----~~~~~e~~~l~~l~~   76 (294)
                      |++++.+.........++|++.+.||+|+||+||+|.+..+++.|++|++...........    +.+.+|+.++++++|
T Consensus         3 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   82 (287)
T 4f0f_A            3 MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH   82 (287)
T ss_dssp             ---------CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCC
T ss_pred             CCcCcCcchhhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCC
Confidence            3444555555566778999999999999999999999999999999999865543322221    678999999999999


Q ss_pred             CceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCC
Q 022617           77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSK  153 (294)
Q Consensus        77 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~  153 (294)
                      |||+++++++....  ++++||+.+++|.+.+.+. ..+++..++.++.|++.+|.+||+.|  ++|+||+|+||+++.+
T Consensus        83 ~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~  160 (287)
T 4f0f_A           83 PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL  160 (287)
T ss_dssp             TTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC
T ss_pred             CCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc
Confidence            99999999986655  6899999999998888654 57999999999999999999999999  9999999999999887


Q ss_pred             Cc-----EEEeeecccccccCCCccccccCCCcccCCcccc--CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Q 022617          154 WN-----VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL-  225 (294)
Q Consensus       154 ~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~-  225 (294)
                      +.     ++|+|||.+.....  ......+++.|+|||++.  ...+ +.++||||||+++|+|++|..||........ 
T Consensus       161 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  237 (287)
T 4f0f_A          161 DENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIK  237 (287)
T ss_dssp             CTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH
T ss_pred             CCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHHH
Confidence            76     99999999875433  334566899999999984  3333 6899999999999999999999976543332 


Q ss_pred             -HHHHh--CCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          226 -FKKIK--GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       226 -~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                       ...+.  ......+..+++++.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          238 FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             33332  2234567789999999999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-47  Score=329.72  Aligned_cols=260  Identities=27%  Similarity=0.434  Sum_probs=214.9

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCC-ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc------eeE
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH------IIR   81 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~   81 (294)
                      ....+.+.++|++.+.||+|+||+||+|.+..++ ..|++|++....    .....+.+|+.++++++|++      ++.
T Consensus        11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~   86 (355)
T 2eu9_A           11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVL   86 (355)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred             cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence            3445678899999999999999999999998776 689999985432    34567888999999887655      899


Q ss_pred             EEEEEEcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe---------
Q 022617           82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---------  150 (294)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili---------  150 (294)
                      +++++...+..+++||++ +++|.+.+....  .+++..++.++.|++.||.|||+.||+|+||||+||++         
T Consensus        87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence            999999999999999999 557777776553  69999999999999999999999999999999999999         


Q ss_pred             ----------cCCCcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022617          151 ----------DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE  220 (294)
Q Consensus       151 ----------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~  220 (294)
                                +.++.++|+|||.+......  .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus       166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          166 NEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             CCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCCC
Confidence                      56789999999999764332  234568999999999987776 78999999999999999999999887


Q ss_pred             CHHHHHHHHhCCCccCC--------------------------------------------CCCChhHHHHHHHhcccCC
Q 022617          221 NIPNLFKKIKGGIYTLP--------------------------------------------SHLSPGARDLIPRMLIVDP  256 (294)
Q Consensus       221 ~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~l~~li~~~l~~~p  256 (294)
                      ........+.....+.|                                            ...+.++.++|.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            76654443322111111                                            1123478899999999999


Q ss_pred             CCCCCHhHHhcCCcccccCC
Q 022617          257 MKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       257 ~~Rps~~~il~h~~~~~~~~  276 (294)
                      .+|||+.++++||||++.-+
T Consensus       323 ~~Rpt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          323 AQRITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             TTSCCHHHHTTSGGGGGCCH
T ss_pred             hhCcCHHHHhcChhhcCCCh
Confidence            99999999999999998644

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.2e-48  Score=334.88  Aligned_cols=251  Identities=27%  Similarity=0.464  Sum_probs=218.6

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-.++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|++++++++||||+++++++...+..+
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            44578999999999999999999999899999999986432  2334567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      +||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            9999999999999997654 599999999999999999999999999999999999999999999999999876543322


Q ss_pred             cc---cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHH
Q 022617          173 LK---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDL  247 (294)
Q Consensus       173 ~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  247 (294)
                      ..   ...++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+ ..+.+..++.++.++
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  347 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL  347 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             eecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            11   1224667999999987766 789999999999999998 99999998888777776654 356677899999999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+||+.||++|||+.++++
T Consensus       348 i~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          348 MEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-47  Score=333.26  Aligned_cols=257  Identities=29%  Similarity=0.429  Sum_probs=212.6

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CC-----ceeEEEE
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HP-----HIIRLYE   84 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~   84 (294)
                      ..+.+.++|++.+.||+|+||+||+|.+..+++.||+|++....    .....+..|+.+++.+. |+     +++++++
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            34567889999999999999999999999999999999986432    34566777888888775 44     4999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCeEec--CCCcEEE
Q 022617           85 VIETPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCH--RNMVVHRDLKPENLLLD--SKWNVKI  158 (294)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh--~~~i~h~di~p~nili~--~~~~~~l  158 (294)
                      ++...+..++|||++++ +|.+++...  ..+++..++.++.|++.||.|||  +.||+|+||||+||+++  .++.++|
T Consensus       124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            99999999999999965 999999765  45999999999999999999999  57999999999999995  4678999


Q ss_pred             eeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC--
Q 022617          159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL--  236 (294)
Q Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  236 (294)
                      +|||++......  .....+++.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+..+....+.......  
T Consensus       203 ~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          203 VDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EeccCceecccc--cccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999999876432  335568999999999988776 799999999999999999999999887766655543211000  


Q ss_pred             ----------------CC------------------C----------------------------CChhHHHHHHHhccc
Q 022617          237 ----------------PS------------------H----------------------------LSPGARDLIPRMLIV  254 (294)
Q Consensus       237 ----------------~~------------------~----------------------------~~~~l~~li~~~l~~  254 (294)
                                      +.                  .                            ...++.+||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                            00                  0                            003689999999999


Q ss_pred             CCCCCCCHhHHhcCCcccccC
Q 022617          255 DPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       255 ~p~~Rps~~~il~h~~~~~~~  275 (294)
                      ||.+|||+.|+|+||||++..
T Consensus       360 dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC--
T ss_pred             ChhhCCCHHHHhcCcccccCC
Confidence            999999999999999998753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.5e-47  Score=322.73  Aligned_cols=267  Identities=29%  Similarity=0.432  Sum_probs=216.0

Q ss_pred             CCCCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCceeEE
Q 022617            5 SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM--HPHIIRL   82 (294)
Q Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~   82 (294)
                      .+.+.+.+....++|++.+.||+|+||.||+|.+. +++.|++|++..... .......+.+|+.++++++  |+||+++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~   93 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRL   93 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEE
Confidence            44555667778889999999999999999999986 588999999876543 3345678899999999997  5999999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeec
Q 022617           83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG  162 (294)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg  162 (294)
                      ++++...+..++++|+ .+++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||
T Consensus        94 ~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           94 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             EEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             EEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecc
Confidence            9999999999999995 46799999998889999999999999999999999999999999999999965 799999999


Q ss_pred             ccccccCCC---ccccccCCCcccCCccccCC----------ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Q 022617          163 LSNIMRDGH---FLKTSCGSPNYAAPEVISGK----------LYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKK  228 (294)
Q Consensus       163 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~  228 (294)
                      .+.......   ......+++.|+|||.+.+.          ...+.++||||||+++|+|++|..||.... .......
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  251 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence            987654332   12344689999999998652          233679999999999999999999997653 2233333


Q ss_pred             HhCC--CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          229 IKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       229 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      +...  ....+...+.++.+++.+||+.||.+|||+.++++||||+...
T Consensus       252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            3322  2345667789999999999999999999999999999998753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.2e-48  Score=337.17  Aligned_cols=256  Identities=27%  Similarity=0.473  Sum_probs=195.0

Q ss_pred             cccccCCcc-cccccccCceEEEEEEEc--cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-
Q 022617           13 DMFLPNYKL-GKTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-   88 (294)
Q Consensus        13 ~~~~~~y~~-~~~lg~g~~~~vy~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   88 (294)
                      ..+.+.|.+ .++||+|+||+||+|.++  .+++.||+|++.....     ...+.+|+.++++++||||+++++++.. 
T Consensus        16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (405)
T 3rgf_A           16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSH   90 (405)
T ss_dssp             CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred             hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence            456677887 558999999999999965  5678999999865432     2467889999999999999999999954 


Q ss_pred             -CCeEEEEEeccCCCChHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe----cCCC
Q 022617           89 -PSDIYVVMEYVKSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKW  154 (294)
Q Consensus        89 -~~~~~lv~e~~~~~sL~~~l~~~---------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili----~~~~  154 (294)
                       ....++++||+.+ +|.+++...         ..+++..++.++.||+.||.|||+.||+|+||||+||++    +.++
T Consensus        91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred             CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence             6789999999975 888888632         249999999999999999999999999999999999999    6778


Q ss_pred             cEEEeeecccccccCC----CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------
Q 022617          155 NVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-------  223 (294)
Q Consensus       155 ~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-------  223 (294)
                      .++|+|||++......    .......+++.|+|||++.+....+.++||||||+++|+|++|..||......       
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  249 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  249 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence            9999999999765432    22344568999999999987654588999999999999999999999754431       


Q ss_pred             --HHHHHHhCCC-c-------------------------------------cCCCCCChhHHHHHHHhcccCCCCCCCHh
Q 022617          224 --NLFKKIKGGI-Y-------------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIP  263 (294)
Q Consensus       224 --~~~~~~~~~~-~-------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~  263 (294)
                        +....+.... .                                     ......+..+.+||.+||..||.+|||+.
T Consensus       250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~  329 (405)
T 3rgf_A          250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  329 (405)
T ss_dssp             CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence              2222111000 0                                     00112367889999999999999999999


Q ss_pred             HHhcCCccccc
Q 022617          264 EIRQHPWFQAH  274 (294)
Q Consensus       264 ~il~h~~~~~~  274 (294)
                      |+|+||||+..
T Consensus       330 e~L~hp~f~~~  340 (405)
T 3rgf_A          330 QAMQDPYFLED  340 (405)
T ss_dssp             HHHTSGGGTSS
T ss_pred             HHhcChhhccC
Confidence            99999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-47  Score=315.87  Aligned_cols=251  Identities=30%  Similarity=0.475  Sum_probs=205.1

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      +.-.++|++.+.||+|+||.||+|.+.  ++.+++|++....... ....+.+.+|+++++.++||||+++++++...+.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            445689999999999999999999974  7889999986543322 2335778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCeEecC--------CCcEEEee
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM---VVHRDLKPENLLLDS--------KWNVKIAD  160 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~---i~h~di~p~nili~~--------~~~~~l~d  160 (294)
                      .++++||+++++|.+++. ...+++..++.++.|++.||.+||+.|   ++|+||+|+||+++.        ++.++|+|
T Consensus        81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999999999884 567999999999999999999999999   899999999999986        67899999


Q ss_pred             ecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCCC
Q 022617          161 FGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS  238 (294)
Q Consensus       161 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~  238 (294)
                      ||.+........ ....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+....  .+.+.
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (271)
T 3dtc_A          160 FGLAREWHRTTK-MSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS  237 (271)
T ss_dssp             CCC--------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred             CCcccccccccc-cCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence            999976544332 34568999999999887766 789999999999999999999999888777666655443  45567


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .++..+.+++.+||+.||.+|||+.+++++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            899999999999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.5e-47  Score=320.34  Aligned_cols=255  Identities=19%  Similarity=0.290  Sum_probs=213.5

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCC-------ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTG-------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV   85 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   85 (294)
                      ....++|++.+.||+|+||+||+|.+..++       ..|++|++....   ....+.+.+|+.++++++||||++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            345789999999999999999999998777       469999985443   2345788999999999999999999999


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc--------E
Q 022617           86 IETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--------V  156 (294)
Q Consensus        86 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~--------~  156 (294)
                      +...+..++++||+.+++|.+++.+... +++..++.++.|++.||.|||+.|++|+||||+||+++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987654 999999999999999999999999999999999999998877        9


Q ss_pred             EEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhCCCcc
Q 022617          157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYT  235 (294)
Q Consensus       157 ~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~  235 (294)
                      +|+|||.+......   ....+++.|+|||.+.+....+.++||||||+++|+|++| ..||.......... .......
T Consensus       161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~~  236 (289)
T 4fvq_A          161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQ  236 (289)
T ss_dssp             EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCC
T ss_pred             eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccCC
Confidence            99999998654332   2334678899999998744448899999999999999995 55555555444443 3344556


Q ss_pred             CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      .+...+.++.+++.+||+.||.+|||+.++++  .+++.++
T Consensus       237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~l~~l~~  275 (289)
T 4fvq_A          237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIR--DLNSLFT  275 (289)
T ss_dssp             CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH--HHHTCC-
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhcC
Confidence            66778999999999999999999999999998  3444433

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-47  Score=326.30  Aligned_cols=249  Identities=23%  Similarity=0.343  Sum_probs=210.2

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP   89 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   89 (294)
                      ..-++.++|++.+.||.|+||+||+|.+..+++.||+|++.....     ...+.+|+.+++++ +|+||+++++++...
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   77 (330)
T 2izr_A            3 GVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCG   77 (330)
T ss_dssp             -CCEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred             ceEEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence            445678999999999999999999999999999999999865432     23578899999999 899999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc-----EEEeeecc
Q 022617           90 SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-----VKIADFGL  163 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~-----~~l~dfg~  163 (294)
                      +..+++||++ +++|.+++.. ...+++..++.++.|++.||.|||+.||+|+||||+||+++.++.     ++|+|||+
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           78 KYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             CccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            9999999999 8899999986 467999999999999999999999999999999999999998877     99999999


Q ss_pred             cccccCCCc--------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhCC
Q 022617          164 SNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKIKGG  232 (294)
Q Consensus       164 ~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~  232 (294)
                      +........        .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||....   .......+...
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  235 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT  235 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence            986543322        235568999999999988776 789999999999999999999998743   33333333322


Q ss_pred             CccCC-----CCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          233 IYTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       233 ~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ....+     ..++ ++.+++..||+.||.+||++.+|++
T Consensus       236 ~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          236 KRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            22222     3355 9999999999999999999998876

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2e-47  Score=325.16  Aligned_cols=262  Identities=24%  Similarity=0.397  Sum_probs=195.0

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCceeEEEEEEEc
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~   88 (294)
                      ...+.-.++|++.+.||+|+||.||+|.+..+++.|++|++.....  ......+..|+. +++.++||||+++++++..
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            3345667899999999999999999999999999999999865432  223344555555 7778899999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeec
Q 022617           89 PSDIYVVMEYVKSGELFDYIVE-----KGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFG  162 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg  162 (294)
                      .+..++++||+.+ +|.+++..     ...+++..++.++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            9999999999976 88888864     46799999999999999999999998 99999999999999999999999999


Q ss_pred             ccccccCCCccccccCCCcccCCcccc----CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhCCC-ccC
Q 022617          163 LSNIMRDGHFLKTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGI-YTL  236 (294)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~-~~~  236 (294)
                      ++.............+++.|+|||.+.    +..+ +.++||||||+++|+|++|..||..... .+....+..+. ..+
T Consensus       172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3aln_A          172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL  250 (327)
T ss_dssp             SSCC------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred             CceecccccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            998765554444557899999999983    3334 7899999999999999999999976432 12222222222 112


Q ss_pred             ----CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          237 ----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       237 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                          ...++..+.+++.+||+.||.+|||+.++++||||....
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                235889999999999999999999999999999997653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.3e-47  Score=324.86  Aligned_cols=252  Identities=25%  Similarity=0.434  Sum_probs=215.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceE--EEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKV--AIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~--~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   90 (294)
                      .-.++|++.+.||.|+||.||+|.+..++..+  ++|.+...  ........+.+|+.+++++ +||||+++++++...+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            33489999999999999999999998888765  88887532  2233456788999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW  154 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~  154 (294)
                      ..+++|||+++++|.+++....                .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            9999999999999999997654                699999999999999999999999999999999999999999


Q ss_pred             cEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC
Q 022617          155 NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI  233 (294)
Q Consensus       155 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~  233 (294)
                      .++|+|||++.............+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+.
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  258 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  258 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence            999999999875433333334456788999999977766 789999999999999998 999999998888877776553


Q ss_pred             -ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       234 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                       ...+..++..+.+++.+||..||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             45667889999999999999999999999999873

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.8e-47  Score=319.74  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=208.0

Q ss_pred             ccccccCCcccccccccCceEEEEEE----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      .+...++|++.+.||+|+||+||+|.    +..+++.|++|++...   .....+.+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            45678899999999999999999998    5678899999998643   3345678899999999999999999999985


Q ss_pred             c--CCeEEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           88 T--PSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        88 ~--~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                      .  ....++++||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  356899999999999999997754 4999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------H
Q 022617          165 NIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----------------N  224 (294)
Q Consensus       165 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~----------------~  224 (294)
                      .......    ......++..|+|||.+.+..+ +.++||||||+++|+|++|..|+......                .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            8664332    1223345667999999987776 78999999999999999999998543221                1


Q ss_pred             HHHHHh-CCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          225 LFKKIK-GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       225 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ....+. ....+.+..++.++.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            222222 3345667789999999999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.2e-48  Score=333.60  Aligned_cols=259  Identities=26%  Similarity=0.466  Sum_probs=209.5

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-----------CCceeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-----------HPHIIRL   82 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~   82 (294)
                      ...++|++.+.||+|+||+||+|.+..+++.|++|++....    .....+.+|+.+++++.           |+||+++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            34679999999999999999999999999999999986432    33567788999888876           7899999


Q ss_pred             EEEEEcCC----eEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEec----
Q 022617           83 YEVIETPS----DIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLD----  151 (294)
Q Consensus        83 ~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~----  151 (294)
                      ++++...+    ..++++|++ +++|.+++...  ..+++..++.++.|++.||.|||+. ||+|+||||+||+++    
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987654    789999999 77999999763  4599999999999999999999998 999999999999995    


Q ss_pred             --CCCcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------H
Q 022617          152 --SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI------P  223 (294)
Q Consensus       152 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~------~  223 (294)
                        ..+.++|+|||++......  .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||.....      .
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence              3447999999999765432  234568999999999988776 7999999999999999999999976542      1


Q ss_pred             HHHHHHhC------------------------------------------CCccCCCCCChhHHHHHHHhcccCCCCCCC
Q 022617          224 NLFKKIKG------------------------------------------GIYTLPSHLSPGARDLIPRMLIVDPMKRIT  261 (294)
Q Consensus       224 ~~~~~~~~------------------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  261 (294)
                      .....+..                                          ....++..++.++.+||.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            11111110                                          011222345678899999999999999999


Q ss_pred             HhHHhcCCcccccCCcccc
Q 022617          262 IPEIRQHPWFQAHLPRYLA  280 (294)
Q Consensus       262 ~~~il~h~~~~~~~~~~~~  280 (294)
                      +.|+|+||||++.+.....
T Consensus       328 ~~ell~hp~f~~~~~~~~~  346 (373)
T 1q8y_A          328 AGGLVNHPWLKDTLGMEEI  346 (373)
T ss_dssp             HHHHHTCGGGTTCTTCTTC
T ss_pred             HHHHhhChhhhcccCcccc
Confidence            9999999999997655443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.3e-47  Score=324.85  Aligned_cols=263  Identities=22%  Similarity=0.335  Sum_probs=219.8

Q ss_pred             cccccCCcccccccccCceEEEEEE-----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      +...++|++.+.||.|+||.||+|.     +..++..|++|++....  .......+.+|+.++++++||||+++++++.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            5667899999999999999999999     55677899999986332  3344567889999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEE
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKG-------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVK  157 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~  157 (294)
                      .....++++||+.+++|.+++....       .+++..++.++.|++.||.+||+.|++|+||+|+||+++.   +..++
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999999998753       4899999999999999999999999999999999999984   44699


Q ss_pred             EeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC
Q 022617          158 IADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI  233 (294)
Q Consensus       158 l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~  233 (294)
                      |+|||.+.......   ......+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+....
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  262 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  262 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence            99999987553322   2233456889999999877666 789999999999999998 999999888888777776554


Q ss_pred             -ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617          234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY  278 (294)
Q Consensus       234 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~  278 (294)
                       ...+..++..+.+++.+||+.||.+|||+.+++++.++-...+..
T Consensus       263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~  308 (327)
T 2yfx_A          263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  308 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence             456678999999999999999999999999999998876544433

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.9e-47  Score=320.81  Aligned_cols=264  Identities=23%  Similarity=0.370  Sum_probs=225.3

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL   82 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   82 (294)
                      ..+......++|++.+.||+|+||.||+|.+.     .+++.|++|++....  .......+.+|+.++++++|+||+++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            34455677889999999999999999999876     357789999986432  22345678899999999999999999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC
Q 022617           83 YEVIETPSDIYVVMEYVKSGELFDYIVEK----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS  152 (294)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~  152 (294)
                      ++++...+..+++||++.+++|.+++...          .++++..++.++.|++.||.+||+.|++|+||+|+||+++.
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE  173 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcC
Confidence            99999999999999999999999999753          35789999999999999999999999999999999999999


Q ss_pred             CCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022617          153 KWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKK  228 (294)
Q Consensus       153 ~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~  228 (294)
                      ++.++|+|||++........   .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  252 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF  252 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence            99999999999876543322   223345788999999887666 789999999999999999 8999999888887777


Q ss_pred             HhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC------Cccccc
Q 022617          229 IKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH------PWFQAH  274 (294)
Q Consensus       229 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h------~~~~~~  274 (294)
                      +.... ...+..++..+.+++.+||+.||.+|||+.+++++      ++|+..
T Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~  305 (322)
T 1p4o_A          253 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  305 (322)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence            76544 45667899999999999999999999999999885      566543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-46  Score=314.91  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=216.0

Q ss_pred             ccccccCCcccc-cccccCceEEEEEEE--ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617           12 VDMFLPNYKLGK-TLGIGSFGKVKIAEH--ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        12 ~~~~~~~y~~~~-~lg~g~~~~vy~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      +..-.++|++.+ .||+|+||+||+|.+  ..+++.|++|++..... .....+.+.+|+.+++.++||||+++++++ .
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            344567899998 999999999999954  55678899999875532 234467899999999999999999999999 5


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      .+..++++|++.+++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            67789999999999999999988889999999999999999999999999999999999999999999999999987664


Q ss_pred             CCCcc----ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCCh
Q 022617          169 DGHFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSP  242 (294)
Q Consensus       169 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~  242 (294)
                      .....    ....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.... ...+..++.
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR  247 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            43221    12234678999999977666 689999999999999999 999999988888777776554 556678999


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+.+++.+||+.||.+|||+.++++
T Consensus       248 ~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          248 EMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999987

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-46  Score=321.40  Aligned_cols=257  Identities=25%  Similarity=0.453  Sum_probs=220.1

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEc-------cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCcee
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHA-------LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHII   80 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~   80 (294)
                      ........++|++.+.||+|+||.||+|.+.       .++..|++|++....  .......+.+|+.+++++ +||||+
T Consensus        27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv  104 (334)
T 2pvf_A           27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNII  104 (334)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence            3444666789999999999999999999975       356789999986543  334567889999999999 899999


Q ss_pred             EEEEEEEcCCeEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 022617           81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLK  144 (294)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~  144 (294)
                      ++++++...+..++++||+.+++|.+++....                .+++..++.++.|++.||.+||+.|++|+||+
T Consensus       105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  184 (334)
T 2pvf_A          105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA  184 (334)
T ss_dssp             CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence            99999999999999999999999999997654                38999999999999999999999999999999


Q ss_pred             CCCeEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 022617          145 PENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDE  220 (294)
Q Consensus       145 p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~  220 (294)
                      |+||+++.++.++|+|||++........   .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            9999999999999999999976644322   223345778999999877666 789999999999999999 99999998


Q ss_pred             CHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          221 NIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       221 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ...+....+.... ...+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8888777765543 55667899999999999999999999999999873

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.7e-46  Score=315.23  Aligned_cols=254  Identities=20%  Similarity=0.282  Sum_probs=213.6

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS   90 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   90 (294)
                      .+.+.++|++.+.||+|++|.||+|.+..+++.|++|++.....     ...+.+|+..++.+ +|++++++++++....
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            35678899999999999999999999999999999999854432     24578899999999 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc-----EEEeeeccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-----VKIADFGLS  164 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~-----~~l~dfg~~  164 (294)
                      ..++++|++ +++|.+++...+ ++++..++.++.|++.||.+||+.|++|+||+|+||+++.++.     ++|+|||++
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999999 889999998654 5999999999999999999999999999999999999987765     999999999


Q ss_pred             ccccCCCc--------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhCCC
Q 022617          165 NIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKIKGGI  233 (294)
Q Consensus       165 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~~  233 (294)
                      ........        .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....   .......+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            86654322        234568999999999988776 789999999999999999999998743   333333332222


Q ss_pred             -----ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 -----YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                           ......++.++.+++.+||+.||++|||+.++++  .|++.
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~--~l~~~  281 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKV  281 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH--HHHHH
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH--HHHHH
Confidence                 2233578999999999999999999999999987  44443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.7e-47  Score=326.87  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=207.1

Q ss_pred             ccccCCcccccccccCceEEEEEEEc---cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      .-.++|++.+.||+|+||.||+|.+.   .++..|++|++....  .......+.+|+.++++++||||+++++++...+
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            44568999999999999999999876   456789999986542  3345678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           91 DIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      ..++||||+++++|.+++.+.+ .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999999997653 699999999999999999999999999999999999999999999999999876543


Q ss_pred             CCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChh
Q 022617          170 GHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPG  243 (294)
Q Consensus       170 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  243 (294)
                      ...    .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.... .+.+..++..
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  278 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA  278 (373)
T ss_dssp             --------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred             CCccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence            321    112234668999999987766 789999999999999998 999999988888887776653 4556688999


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+++.+||+.||.+||++.++++
T Consensus       279 l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          279 LYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCcChhhCcCHHHHHH
Confidence            999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-46  Score=311.12  Aligned_cols=248  Identities=24%  Similarity=0.451  Sum_probs=217.0

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      -.++|++.+.||+|++|.||+|.+. ++..|++|++......    .+.+.+|++++++++||||+++++++...+..++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            3578999999999999999999986 6778999998755432    3678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--
Q 022617           95 VMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--  171 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--  171 (294)
                      ++|++++++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            99999999999999765 568999999999999999999999999999999999999999999999999987654322  


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHH
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP  249 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~  249 (294)
                      ......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..+. ...+..++..+.+++.
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  239 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  239 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             ccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence            1223345678999999987666 789999999999999999 999999988888887777654 4456678999999999


Q ss_pred             HhcccCCCCCCCHhHHhcC
Q 022617          250 RMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       250 ~~l~~~p~~Rps~~~il~h  268 (294)
                      +||+.||.+|||+.+++++
T Consensus       240 ~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          240 HCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999873

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.2e-47  Score=326.65  Aligned_cols=253  Identities=29%  Similarity=0.469  Sum_probs=212.7

Q ss_pred             cccccCCcccccccccCceEEEEEE-----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVI   86 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   86 (294)
                      ....++|++.+.||.|+||.||+|.     +..+++.|++|++....  .......+.+|+++++++ +||||+++++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            4567899999999999999999998     45566899999986542  233457789999999999 789999999999


Q ss_pred             EcCCe-EEEEEeccCCCChHHHHHHhCC----------------------------------------------------
Q 022617           87 ETPSD-IYVVMEYVKSGELFDYIVEKGR----------------------------------------------------  113 (294)
Q Consensus        87 ~~~~~-~~lv~e~~~~~sL~~~l~~~~~----------------------------------------------------  113 (294)
                      ...+. .++++||+.+++|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            77554 8999999999999999976432                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---ccccc
Q 022617          114 --------------LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTS  176 (294)
Q Consensus       114 --------------l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~  176 (294)
                                    +++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......   .....
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                          8999999999999999999999999999999999999999999999999997653322   22344


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHh-CCCccCCCCCChhHHHHHHHhcc
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENI-PNLFKKIK-GGIYTLPSHLSPGARDLIPRMLI  253 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~  253 (294)
                      .+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+... ......+. ......+..+++++.+++.+||+
T Consensus       256 ~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  334 (359)
T 3vhe_A          256 RLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  334 (359)
T ss_dssp             EECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            56788999999987766 789999999999999998 9999987653 33333333 33456677899999999999999


Q ss_pred             cCCCCCCCHhHHhcC
Q 022617          254 VDPMKRITIPEIRQH  268 (294)
Q Consensus       254 ~~p~~Rps~~~il~h  268 (294)
                      .||.+|||+.++++|
T Consensus       335 ~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          335 GEPSQRPTFSELVEH  349 (359)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999984

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.7e-46  Score=313.95  Aligned_cols=253  Identities=29%  Similarity=0.496  Sum_probs=206.8

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ...++|++.+.||+|++|.||+|.+..+++.|++|++.............+.+|+.++++++|+||+++++++...+..+
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            45678999999999999999999999999999999997655555566788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           94 VVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      +++|++.+++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999999964    35689999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhCCCcc-C-CCCCChhH
Q 022617          170 GH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE--NIPNLFKKIKGGIYT-L-PSHLSPGA  244 (294)
Q Consensus       170 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~~~~~~-~-~~~~~~~l  244 (294)
                      .. ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+.  ........+.....+ . ...++.++
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  267 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  267 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred             CCccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence            32 2234467889999999987766 78999999999999999999999754  334444555444322 2 25689999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+++.+||+.||.+|||+.++++
T Consensus       268 ~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          268 RQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.7e-47  Score=321.61  Aligned_cols=251  Identities=26%  Similarity=0.410  Sum_probs=209.1

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceE----EEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKV----AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~----~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      ...++|++.+.||+|+||+||+|.+..+++.+    ++|.+....  .......+.+|+.++++++||||+++++++...
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            34578999999999999999999988777654    677664322  223457889999999999999999999999875


Q ss_pred             CeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      . .+++++++.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            4 7789999999999999976 4579999999999999999999999999999999999999999999999999997664


Q ss_pred             CCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChh
Q 022617          169 DGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPG  243 (294)
Q Consensus       169 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  243 (294)
                      ....   .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.... .+.+..++.+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             CCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            3332   223345778999999987766 789999999999999999 999999888887777776554 5667789999


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      +.+++.+||+.||.+|||+.+++++
T Consensus       248 ~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-46  Score=318.47  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=211.9

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCC----ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTG----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      +....+|++.+.||+|+||+||+|.+..++    ..|++|++....  .......+.+|+.++++++||||+++++++..
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            455678999999999999999999986553    359999986442  23445678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      .+..+++||++.+++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999999764 57999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCC
Q 022617          168 RDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLS  241 (294)
Q Consensus       168 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~  241 (294)
                      .....    .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+ ..+.+..++
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  276 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP  276 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred             ccccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence            43221    122335678999999987766 789999999999999998 99999988888887777665 355667899


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ..+.+++.+||+.+|.+||++.++++
T Consensus       277 ~~l~~li~~~l~~~p~~Rps~~~l~~  302 (333)
T 1mqb_A          277 SAIYQLMMQCWQQERARRPKFADIVS  302 (333)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999887

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-46  Score=315.84  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=209.3

Q ss_pred             ccccccCCcccccccccCceEEEEEE----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      ......+|++.+.||+|+||.||+|.    +..+++.|++|++....  .......+.+|+.++++++|+||+++++++.
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICT   93 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            34456779999999999999999998    56788999999987543  2234577899999999999999999999998


Q ss_pred             cC--CeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           88 TP--SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        88 ~~--~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                      ..  +..++++||+.+++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence            76  6789999999999999999554 57999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHH
Q 022617          165 NIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---------------NIPNL  225 (294)
Q Consensus       165 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------------~~~~~  225 (294)
                      ........    .....++..|+|||.+.+..+ +.++||||||+++|+|++|..|+...               .....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            77654332    233456778999999987766 68999999999999999998876322               11222


Q ss_pred             HHHHhC-CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          226 FKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       226 ~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ...+.. ...+.+..++.++.+++.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            233332 335567789999999999999999999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.4e-46  Score=330.48  Aligned_cols=245  Identities=27%  Similarity=0.520  Sum_probs=213.2

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-e
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-D   91 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~   91 (294)
                      ..-.++|++.+.||+|+||.||+|.+.  ++.||||++....     ..+.+.+|+.++++++||||+++++++.... .
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            455678999999999999999999874  6799999986542     3467899999999999999999999987655 7


Q ss_pred             EEEEEeccCCCChHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           92 IYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      .+++|||+.+++|.+++.+.+.  +++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999999987654  79999999999999999999999999999999999999999999999999875433


Q ss_pred             CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHH
Q 022617          170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDL  247 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  247 (294)
                      ..  ....++..|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..+ ....+..++.++.++
T Consensus       342 ~~--~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          342 TQ--DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cc--cCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            22  23356789999999988776 789999999999999998 99999988777777777655 356778899999999


Q ss_pred             HHHhcccCCCCCCCHhHHhc
Q 022617          248 IPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~  267 (294)
                      |.+||+.||.+|||+.++++
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-46  Score=318.49  Aligned_cols=259  Identities=29%  Similarity=0.449  Sum_probs=217.4

Q ss_pred             CCCCCccccccCCcccccccccCceEEEEEEE-----ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCcee
Q 022617            7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHII   80 (294)
Q Consensus         7 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~   80 (294)
                      +.....+...++|++.+.||.|+||.||+|.+     ..+++.|++|++....  .....+.+.+|+.+++++ +||||+
T Consensus        13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~   90 (313)
T 1t46_A           13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIV   90 (313)
T ss_dssp             CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCee
Confidence            34445566778999999999999999999985     4567889999986543  223457889999999999 899999


Q ss_pred             EEEEEEEcCCeEEEEEeccCCCChHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 022617           81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEKG------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRD  142 (294)
Q Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~d  142 (294)
                      ++++++...+..++++||+++++|.+++....                  .+++..++.++.|++.||.+||+.|++|+|
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  170 (313)
T 1t46_A           91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD  170 (313)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             eEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            99999999999999999999999999997654                  489999999999999999999999999999


Q ss_pred             CCCCCeEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCC
Q 022617          143 LKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFD  218 (294)
Q Consensus       143 i~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~  218 (294)
                      |+|+||+++.++.++|+|||.+........   .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.
T Consensus       171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999876654332   223345678999999877666 789999999999999998 999998


Q ss_pred             CCCHHHHH-HHHhCC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          219 DENIPNLF-KKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       219 ~~~~~~~~-~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ........ ..+... ....+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            76543333 333322 334456789999999999999999999999999873

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.1e-46  Score=331.22  Aligned_cols=261  Identities=25%  Similarity=0.476  Sum_probs=221.2

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ......++|++.+.||+|+||.||+|.++ .+..||||++.....    ..+.+.+|+.++++++||||+++++++. .+
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            34566789999999999999999999986 567899999865432    3578899999999999999999999986 66


Q ss_pred             eEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      ..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            789999999999999999754  368999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhH
Q 022617          169 DGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGA  244 (294)
Q Consensus       169 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  244 (294)
                      ....  .....++..|+|||++....+ +.++||||||+++|+|++ |..||.+....+....+..+ ..+.+..++.++
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  414 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL  414 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred             CCceeccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            3221  122335678999999987766 789999999999999999 99999998888877776654 356677899999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhc--CCcccccCCcc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQ--HPWFQAHLPRY  278 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~--h~~~~~~~~~~  278 (294)
                      .++|.+||+.||++|||+.+|++  ..++.+..+.+
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~  450 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQY  450 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSS
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHHHHhcccccc
Confidence            99999999999999999999987  34444433333

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=322.91  Aligned_cols=253  Identities=27%  Similarity=0.438  Sum_probs=210.9

Q ss_pred             cccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVI   86 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   86 (294)
                      +.-.++|++.+.||.|+||.||+|.+.     .++..|++|++....  .......+.+|+.+++++ +||||+++++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            445679999999999999999999973     355689999986432  223457889999999999 899999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKG-----------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDL  143 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di  143 (294)
                      ...+..+++|||+++++|.+++....                       .+++..++.++.|++.||.+||+.|++|+||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999997643                       2789999999999999999999999999999


Q ss_pred             CCCCeEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 022617          144 KPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDD  219 (294)
Q Consensus       144 ~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~  219 (294)
                      +|+||+++.++.++|+|||++........   .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||..
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999999976543322   223346778999999877666 789999999999999998 9999987


Q ss_pred             CCHHHH-HHHHhCC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          220 ENIPNL-FKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       220 ~~~~~~-~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ...... ...+... ....+..++.++.+++.+||..||.+|||+.+++++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            654433 3333333 345567889999999999999999999999999984

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.3e-47  Score=314.97  Aligned_cols=249  Identities=29%  Similarity=0.474  Sum_probs=214.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----   88 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   88 (294)
                      ..+.++|++.+.||+|++|.||+|.+..+++.|++|++....       ..+.+|++++++++||||+++++++..    
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence            456789999999999999999999999899999999986542       356789999999999999999998854    


Q ss_pred             ------------CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC
Q 022617           89 ------------PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW  154 (294)
Q Consensus        89 ------------~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~  154 (294)
                                  ....++++||+++++|.+++.+.  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence                        45589999999999999999764  5799999999999999999999999999999999999999999


Q ss_pred             cEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc
Q 022617          155 NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY  234 (294)
Q Consensus       155 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~  234 (294)
                      .++|+|||.+.............+++.|+|||.+.+..+ +.++||||||+++|+|++|..|+...  ......+...  
T Consensus       160 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--  234 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--  234 (284)
T ss_dssp             EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--
T ss_pred             CEEECcchhheeccccccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--
Confidence            999999999987765555556678999999999987766 78999999999999999998887432  2233333333  


Q ss_pred             cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                      ..+..++..+.+++.+||..||.+|||+.+++++++.-.
T Consensus       235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            235678999999999999999999999999999887644

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.7e-46  Score=309.66  Aligned_cols=248  Identities=19%  Similarity=0.343  Sum_probs=214.1

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--C
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--S   90 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~   90 (294)
                      ..-.++|++.+.||+|++|.||+|.+.  ++.+++|++...... ....+.+.+|+.++++++||||+++++++...  +
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            456789999999999999999999984  788999999765433 34457799999999999999999999999877  7


Q ss_pred             eEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      ..++++||+++++|.+++.+..  .+++..++.++.|++.||.|||+.|  ++|+||+|+||+++.++.++++|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            8899999999999999998755  4899999999999999999999999  99999999999999999999999888754


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCC--CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCCCCCCh
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAG--PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSP  242 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~--~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~  242 (294)
                      ...    ....+++.|+|||.+.+.....  .++||||||+++|+|++|..||...........+...  ....+..++.
T Consensus       163 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          163 FQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             TSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             ecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence            322    3345788999999998765522  2799999999999999999999988777765555432  3566778999


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.3e-46  Score=310.37  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=213.6

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      ......++|++.+.||+|++|+||+|.+...   +..|++|++....  .....+.+.+|+.++++++||||+++++++.
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            3466778999999999999999999987543   3459999986542  2344678899999999999999999999986


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      . +..++++|++.+++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            5 4568999999999999999765 4599999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCCh
Q 022617          167 MRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSP  242 (294)
Q Consensus       167 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  242 (294)
                      ......  .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |+.||...........+... ..+.+..+++
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP  241 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCH
T ss_pred             cccccccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCH
Confidence            544322  223445778999999977666 789999999999999998 99999887777666665543 3556678999


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .+.+++.+||..||++|||+.+++++
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHH
Confidence            99999999999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-46  Score=312.70  Aligned_cols=248  Identities=27%  Similarity=0.517  Sum_probs=207.7

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      .......++|++.+.||+|++|+||++.+  +++.|++|++....     ..+.+.+|+.++++++||||+++++++...
T Consensus        14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           14 SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             ccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            33456678999999999999999999987  47899999986432     356788999999999999999999987544


Q ss_pred             -CeEEEEEeccCCCChHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           90 -SDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        90 -~~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                       +..++++||+++++|.+++.+...  +++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  166 (278)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccc
Confidence             578999999999999999976543  89999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhH
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGA  244 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  244 (294)
                      .....  ....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+..+ ....+..+++.+
T Consensus       167 ~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (278)
T 1byg_A          167 ASSTQ--DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV  243 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred             ccccc--cCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence            54332  23356788999999877666 789999999999999998 99999988887777777655 355667899999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+++.+||+.||.+|||+.++++
T Consensus       244 ~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          244 YEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.8e-46  Score=333.73  Aligned_cols=256  Identities=24%  Similarity=0.418  Sum_probs=222.7

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .+.-..+|++.+.||+|+||.||+|.++.++..|++|++.....    ..+.+.+|+.++++++||||+++++++.....
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP  290 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            34556789999999999999999999998899999999865432    25678999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           92 IYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      .++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999999999764  4589999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617          170 GHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR  245 (294)
Q Consensus       170 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  245 (294)
                      ...  .....++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.....+.+.... ...+..++..+.
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  449 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY  449 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            322  223345678999999987776 789999999999999999 999999888877777766553 556778999999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ++|.+||+.||.+|||+.+|++  .|+..
T Consensus       450 ~li~~cl~~dP~~RPs~~el~~--~L~~~  476 (495)
T 1opk_A          450 ELMRACWQWNPSDRPSFAEIHQ--AFETM  476 (495)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH--HHHTS
T ss_pred             HHHHHHcCcChhHCcCHHHHHH--HHHHH
Confidence            9999999999999999999987  44443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=318.28  Aligned_cols=257  Identities=28%  Similarity=0.375  Sum_probs=207.7

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE-
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE-   87 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-   87 (294)
                      ...+..-.++|++.+.||+|+||.||+|.+..+++.|++|++...   .....+.+.+|+.++++++||||+++++++. 
T Consensus        21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            333445567999999999999999999999999999999998543   3345678899999999999999999999986 


Q ss_pred             ---cCCeEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEee
Q 022617           88 ---TPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD  160 (294)
Q Consensus        88 ---~~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~d  160 (294)
                         .....++++||+.+++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEe
Confidence               34578999999999999999976    46799999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCc----------cccccCCCcccCCccccCCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHH
Q 022617          161 FGLSNIMRDGHF----------LKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLF  226 (294)
Q Consensus       161 fg~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~  226 (294)
                      ||.+........          .....+++.|+|||.+.+..  ..+.++||||||+++|+|++|..||....  .....
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  257 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA  257 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence            998765432111          12234688999999986543  12689999999999999999999995311  11111


Q ss_pred             HHHh-CCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          227 KKIK-GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       227 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ..+. ....+.+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          258 LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            2222 22234456789999999999999999999999999984

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-46  Score=311.00  Aligned_cols=253  Identities=27%  Similarity=0.425  Sum_probs=216.2

Q ss_pred             ccccccCCcccc-cccccCceEEEEEEEc--cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617           12 VDMFLPNYKLGK-TLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        12 ~~~~~~~y~~~~-~lg~g~~~~vy~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      +..-.++|.+.+ .||+|+||.||+|.+.  .++..|++|++....  .....+.+.+|++++++++||||+++++++. 
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   80 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-   80 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence            344567888877 9999999999999864  467789999986542  3345678999999999999999999999994 


Q ss_pred             CCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      .+..++++|++.+++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            56789999999999999998643 56999999999999999999999999999999999999999999999999999866


Q ss_pred             cCCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCC
Q 022617          168 RDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLS  241 (294)
Q Consensus       168 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~  241 (294)
                      .....    .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+. ...+..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  239 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence            43322    122335788999999977666 789999999999999998 999999888777777776554 56678899


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .++.+++.+||+.||.+|||+.+++++
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999885

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.4e-47  Score=321.87  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=211.4

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCce----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      -.++|++.+.||+|+||+||+|.+..+++.    +++|.+....  .......+.+|+.++++++||||+++++++. .+
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            356899999999999999999999888876    6667654322  1122356678999999999999999999986 56


Q ss_pred             eEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           91 DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      ..++++||+.+++|.+++... +.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            789999999999999999764 5789999999999999999999999999999999999999999999999999987643


Q ss_pred             CC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhH
Q 022617          170 GH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA  244 (294)
Q Consensus       170 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  244 (294)
                      ..   ......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.... ...+..++.++
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV  246 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred             ccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence            32   2234456779999999987766 789999999999999999 999999888777777776653 55667889999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcC
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .+++.+||..||.+|||+.+++++
T Consensus       247 ~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          247 YMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             THHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999885

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.8e-46  Score=311.19  Aligned_cols=251  Identities=25%  Similarity=0.482  Sum_probs=216.6

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      .......++|++.+.||+|++|.||+|.+. ++..|++|++.....    ..+.+.+|++++++++||||+++++++. .
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   79 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-Q   79 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence            344567789999999999999999999976 567899999865432    2467889999999999999999999986 4


Q ss_pred             CeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      +..++++|++.+++|.+++....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            56899999999999999996543  6999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChh
Q 022617          168 RDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPG  243 (294)
Q Consensus       168 ~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  243 (294)
                      ......  ....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.... ...+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE  238 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCcccccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHH
Confidence            543322  23345678999999987666 789999999999999999 999999888888777776553 4556789999


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+++.+||+.||++|||+.++++
T Consensus       239 l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          239 LYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.2e-46  Score=313.49  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=211.4

Q ss_pred             CccccccCCcccccccccCceEEEEEEEcc-CCc--eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHAL-TGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      ......++|++.+.||.|++|+||+|.+.. +++  .|++|++...........+.+.+|+.++++++||||+++++++.
T Consensus        12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (291)
T 1u46_A           12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   91 (291)
T ss_dssp             CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            345557799999999999999999998643 333  58999987665445566788999999999999999999999997


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      .+. .++++|++.+++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        92 ~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           92 TPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             SSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             cCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            654 88999999999999999764 5699999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC--ccCCCC
Q 022617          167 MRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI--YTLPSH  239 (294)
Q Consensus       167 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~--~~~~~~  239 (294)
                      ......    .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+....  .+.+..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED  249 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence            644322    123345778999999987766 789999999999999999 999999988888877776543  445568


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ++.++.+++.+||..||.+|||+.++++  ++++..+
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~~~  284 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQP  284 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHC-
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHhCc
Confidence            9999999999999999999999999998  5555443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.2e-46  Score=329.01  Aligned_cols=261  Identities=26%  Similarity=0.475  Sum_probs=217.8

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ......++|++.+.||+|+||.||+|.+.. +..||+|++.....    ..+.+.+|+.++++++||||+++++++.. +
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            345567889999999999999999999874 46799999875432    24678999999999999999999999865 7


Q ss_pred             eEEEEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      ..++||||+.+++|.+++..  ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            78999999999999999964  3569999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhH
Q 022617          169 DGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA  244 (294)
Q Consensus       169 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  244 (294)
                      ....  .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+....+....+..+. .+.+..++..+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  410 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL  410 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             CCceecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            3322  223345678999999887766 789999999999999999 999999988888877776553 56678899999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhc--CCcccccCCcc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQ--HPWFQAHLPRY  278 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~--h~~~~~~~~~~  278 (294)
                      .++|.+||+.||++|||+.++++  ..++....+.+
T Consensus       411 ~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~  446 (452)
T 1fmk_A          411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  446 (452)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence            99999999999999999999988  45555544443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.2e-46  Score=315.85  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=208.8

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEcc---CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI   86 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   86 (294)
                      ..+..-.++|++.+.||+|+||.||+|.+..   ++..|++|++...... ......+.+|+.++++++||||+++++++
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3445667899999999999999999998765   4457999998755433 34467789999999999999999999998


Q ss_pred             EcCC-----eEEEEEeccCCCChHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc
Q 022617           87 ETPS-----DIYVVMEYVKSGELFDYIVE------KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN  155 (294)
Q Consensus        87 ~~~~-----~~~lv~e~~~~~sL~~~l~~------~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~  155 (294)
                      ...+     ..++++||+.+++|.+++..      ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            7654     35999999999999999853      346999999999999999999999999999999999999999999


Q ss_pred             EEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhC
Q 022617          156 VKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG  231 (294)
Q Consensus       156 ~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~  231 (294)
                      ++|+|||++........   .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  264 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH  264 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence            99999999876543321   223346778999999987766 789999999999999999 9999998887777776655


Q ss_pred             C-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          232 G-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       232 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      . ....+..++..+.+++.+||..||.+|||+.++++
T Consensus       265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  301 (313)
T 3brb_A          265 GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL  301 (313)
T ss_dssp             TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            4 35667789999999999999999999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-46  Score=312.62  Aligned_cols=257  Identities=25%  Similarity=0.435  Sum_probs=200.5

Q ss_pred             CCCCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEE
Q 022617            5 SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE   84 (294)
Q Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   84 (294)
                      +....+..+...++|++.+.||+|+||+||+|.+.   ..+++|++..... .....+.+.+|+.++++++|+||+++++
T Consensus        12 ~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (289)
T 3og7_A           12 SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMG   87 (289)
T ss_dssp             ------CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CCCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence            33445566888999999999999999999999864   3599999865532 3345678999999999999999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           85 VIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      +. .....++++||+.+++|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        88 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           88 YS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             EE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             ec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence            65 55678999999999999999854 45699999999999999999999999999999999999999999999999999


Q ss_pred             cccccC---CCccccccCCCcccCCcccc---CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhCCCc--
Q 022617          164 SNIMRD---GHFLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGIY--  234 (294)
Q Consensus       164 ~~~~~~---~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~--  234 (294)
                      +.....   ........+++.|+|||.+.   +..+ +.++||||||+++|+|++|..||..... ......+.....  
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  245 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP  245 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence            875432   22233456899999999986   3333 6789999999999999999999987544 344444433322  


Q ss_pred             ---cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          235 ---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       235 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                         .....++..+.+++.+||+.+|.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence               233578899999999999999999999999987

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.5e-45  Score=309.78  Aligned_cols=240  Identities=35%  Similarity=0.592  Sum_probs=197.6

Q ss_pred             CCCCccccccCCccc-ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCceeEEEEE
Q 022617            8 SSSGVDMFLPNYKLG-KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIRLYEV   85 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~   85 (294)
                      ..-..+.+.++|.+. +.||.|+||.||+|.+..+++.||+|++...        ....+|+.++ +.++||||++++++
T Consensus         8 ~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~   79 (299)
T 3m2w_A            8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDV   79 (299)
T ss_dssp             CCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             ccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhh
Confidence            334456788889887 7899999999999999999999999998532        3566788877 66689999999999


Q ss_pred             EEc----CCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcE
Q 022617           86 IET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNV  156 (294)
Q Consensus        86 ~~~----~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~  156 (294)
                      +..    ....++++||+.+++|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.   ++.+
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             EEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCE
T ss_pred             hhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcE
Confidence            876    678999999999999999998754  6999999999999999999999999999999999999998   7889


Q ss_pred             EEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hCC
Q 022617          157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI----KGG  232 (294)
Q Consensus       157 ~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~----~~~  232 (294)
                      +|+|||++.....                     ..+ +.++||||||+++|+|++|..||............    ...
T Consensus       160 kl~Dfg~a~~~~~---------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  217 (299)
T 3m2w_A          160 KLTDFGFAKETTG---------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG  217 (299)
T ss_dssp             EECCCTTCEECTT---------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred             EEecccccccccc---------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence            9999999865321                     123 67899999999999999999999776544432222    122


Q ss_pred             CccCC----CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          233 IYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       233 ~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      ....+    ..++.++.+++.+||+.||.+|||+.++++||||++....
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~  266 (299)
T 3m2w_A          218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  266 (299)
T ss_dssp             CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred             cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence            22223    5689999999999999999999999999999999886543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.7e-46  Score=318.16  Aligned_cols=254  Identities=26%  Similarity=0.437  Sum_probs=214.0

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCc-----eEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEE
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYE   84 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~   84 (294)
                      ......++|++.+.||.|+||.||+|.+..++.     .|++|++....  .......+.+|+.+++++ +||||+++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            455667899999999999999999999876654     79999986543  234467889999999999 8999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHHHh--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe
Q 022617           85 VIETPSDIYVVMEYVKSGELFDYIVEK--------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL  150 (294)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~sL~~~l~~~--------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili  150 (294)
                      ++...+..++++||+++++|.+++...              ..+++..++.++.|++.||.+||+.|++|+||+|+||++
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL  197 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence            999999999999999999999999753              357999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022617          151 DSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF  226 (294)
Q Consensus       151 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~  226 (294)
                      +.++.++|+|||++........   .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.........
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            9999999999999976543321   223345678999999887666 789999999999999998 99999876544333


Q ss_pred             HH-HhC-CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          227 KK-IKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       227 ~~-~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .. +.. .....+..++..+.+++.+||+.||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            33 222 234456678999999999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.7e-47  Score=322.14  Aligned_cols=256  Identities=22%  Similarity=0.339  Sum_probs=209.9

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      ..++....++|++.+.||+|+||+||+|.+. +++.|++|++....   ....+.+.+|+.++++++||||+++++++..
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            3455677899999999999999999999975 68899999886543   2346788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKG----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                      .+..++++||+.+++|.+++....    .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999999986543    4899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhCCC-
Q 022617          165 NIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-------KKIKGGI-  233 (294)
Q Consensus       165 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-------~~~~~~~-  233 (294)
                      .......   ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.........       ....... 
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            7643221   2233457889999999877766 78999999999999999999999754322111       1111111 


Q ss_pred             -----c----cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCC
Q 022617          234 -----Y----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  269 (294)
Q Consensus       234 -----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~  269 (294)
                           .    ..+..++..+.+++.+||+.||++|||+.+++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                 0    11223456789999999999999999999999753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.9e-46  Score=316.69  Aligned_cols=248  Identities=28%  Similarity=0.422  Sum_probs=209.8

Q ss_pred             ccCCcccccccccCceEEEEEE----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE--cC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TP   89 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~   89 (294)
                      .++|++.+.||+|+||.||+|.    +..+++.|++|++...   .....+.+.+|++++++++|+||+++++++.  ..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            4699999999999999999998    5678899999998644   3344577899999999999999999999886  45


Q ss_pred             CeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      +..++++||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            6799999999999999999764 569999999999999999999999999999999999999999999999999998664


Q ss_pred             CCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHHH
Q 022617          169 DGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKI  229 (294)
Q Consensus       169 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---------------~~~~~~~  229 (294)
                      ....    .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||.....               ......+
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            3332    223456778999999987766 7899999999999999999999854332               2222233


Q ss_pred             hC-CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          230 KG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       230 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .. ...+.+..++.++.+++.+||+.||.+|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            32 234566789999999999999999999999999965

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.6e-46  Score=318.46  Aligned_cols=261  Identities=30%  Similarity=0.417  Sum_probs=214.0

Q ss_pred             cccccCC-cccccccccCceEEEEEE----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           13 DMFLPNY-KLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        13 ~~~~~~y-~~~~~lg~g~~~~vy~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      ..+.++| ++++.||+|+||+||++.    +..+++.|++|++....  .......+.+|++++++++||||+++++++.
T Consensus        26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (318)
T 3lxp_A           26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCE  103 (318)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence            5677888 999999999999998775    44578899999987542  3345678899999999999999999999998


Q ss_pred             c--CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617           88 T--PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus        88 ~--~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                      .  ...+++++||+.+++|.+++.+ ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          104 DAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             ETTTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             cCCCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence            7  4678999999999999999964 458999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHH
Q 022617          166 IMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------------NLF  226 (294)
Q Consensus       166 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------------~~~  226 (294)
                      .......    .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||......               ...
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence            7654332    233456778999999987766 68999999999999999999998653221               122


Q ss_pred             HHHhC-CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617          227 KKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       227 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~  279 (294)
                      ..+.. ...+.+..++.++.+++.+||+.||.+|||+.++++  ++++....+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l~~~~~  313 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTVHEKYQ  313 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHHH
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHHHHhhc
Confidence            22222 234566789999999999999999999999999996  6665544443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=321.11  Aligned_cols=252  Identities=20%  Similarity=0.236  Sum_probs=200.5

Q ss_pred             ccccCCcccccccccCceEEEEEEEcc---CCceEEEEEeecccccchH--------HHHHHHHHHHHHHhCCCCceeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNME--------MEEKVRREIKILRLFMHPHIIRL   82 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~~K~~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~   82 (294)
                      ...++|++.+.||+|+||.||+|.+..   ++..+++|++.........        ....+.+|+..++.++|+||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            455799999999999999999999987   7889999998754321111        11345678889999999999999


Q ss_pred             EEEEEc----CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC--cE
Q 022617           83 YEVIET----PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW--NV  156 (294)
Q Consensus        83 ~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~--~~  156 (294)
                      ++++..    ....+++||++ +++|.+++...+.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999987    78899999999 889999998777899999999999999999999999999999999999998877  99


Q ss_pred             EEeeecccccccCCC--------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHH
Q 022617          157 KIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLF  226 (294)
Q Consensus       157 ~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~--~~~~~~~  226 (294)
                      +|+|||++.......        ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||..  .......
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            999999997653221        1134468999999999987766 7899999999999999999999964  2322222


Q ss_pred             HHHhCCCccCC---------CCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          227 KKIKGGIYTLP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       227 ~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ..........+         ..++.++.+++.+||+.||++|||+.++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            22211111111         278999999999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=317.68  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=208.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceE----EEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKV----AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~----~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      ...++|++.+.||+|+||.||+|.+..+++.+    ++|.+....  .......+.+|+.++++++||||+++++++...
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            34589999999999999999999998888765    555553222  223467889999999999999999999999875


Q ss_pred             CeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      . .+++++++.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            4 78899999999999999764 569999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChh
Q 022617          169 DGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPG  243 (294)
Q Consensus       169 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  243 (294)
                      ....   .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.... .+.+..++.+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            3322   223345778999999987766 789999999999999999 999999988888777776554 5667789999


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhc
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+++.+||..||.+|||+.++++
T Consensus       248 l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=328.16  Aligned_cols=252  Identities=26%  Similarity=0.424  Sum_probs=208.5

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC--
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--   90 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   90 (294)
                      ..+.++|++.+.||+|+||+||+|.+..+++.||+|++......  .....+.+|++++++++||||+++++++...+  
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            35678999999999999999999999999999999998754322  23567789999999999999999999998755  


Q ss_pred             eEEEEEeccCCCChHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe----cCCCcEEEeeecc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGL  163 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili----~~~~~~~l~dfg~  163 (294)
                      ..+++|||+.+++|.+++.....   +++..++.++.|++.||.|||+.||+|+||||+||++    +.++.++|+|||.
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            78999999999999999975433   9999999999999999999999999999999999999    7777899999999


Q ss_pred             cccccCCCccccccCCCcccCCccccC--------CccCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhC
Q 022617          164 SNIMRDGHFLKTSCGSPNYAAPEVISG--------KLYAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKG  231 (294)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~  231 (294)
                      +.............+++.|+|||++.+        ..+ +.++||||||+++|+|++|+.||...    ...+....+..
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            987766555556678999999999764        233 67899999999999999999999642    22333333333


Q ss_pred             CCcc-------------------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          232 GIYT-------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       232 ~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +.+.                         +...++..+.+++.+||+.||++|||+.++++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            2211                         11224557889999999999999999999855

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.3e-45  Score=309.52  Aligned_cols=247  Identities=24%  Similarity=0.290  Sum_probs=205.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEE-EEEEcCCeE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLY-EVIETPSDI   92 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~-~~~~~~~~~   92 (294)
                      .+.++|++.+.||+|++|.||+|.+..+++.|++|++......     ..+.+|+.+++.++|++++..+ .++...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence            4678999999999999999999999999999999998654322     3578999999999987755544 445677888


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec---CCCcEEEeeeccccccc
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD---SKWNVKIADFGLSNIMR  168 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~---~~~~~~l~dfg~~~~~~  168 (294)
                      ++++||+ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|||.+....
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            9999999 7899999974 45799999999999999999999999999999999999994   78899999999997665


Q ss_pred             CCCc--------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhCCCc---
Q 022617          169 DGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI---PNLFKKIKGGIY---  234 (294)
Q Consensus       169 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~~~~~---  234 (294)
                      ....        .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.....   ......+.....   
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            4332        234568999999999988776 7899999999999999999999976332   222222222222   


Q ss_pred             --cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          235 --TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       235 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                        ..+..++.++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence              233678999999999999999999999999887

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7e-46  Score=315.02  Aligned_cols=254  Identities=21%  Similarity=0.303  Sum_probs=203.3

Q ss_pred             CCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617            7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI   86 (294)
Q Consensus         7 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   86 (294)
                      ....++..-.++|++.+.||+|+||+||+|.+.  ++.||+|++....    .......+|+.++++++||||+++++++
T Consensus        14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~   87 (322)
T 3soc_A           14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAE   87 (322)
T ss_dssp             CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhccee
Confidence            444555666789999999999999999999874  7899999986443    2234556688899999999999999999


Q ss_pred             EcCC----eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCCeEecC
Q 022617           87 ETPS----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN----------MVVHRDLKPENLLLDS  152 (294)
Q Consensus        87 ~~~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~----------~i~h~di~p~nili~~  152 (294)
                      ....    .+++++||+.+++|.+++.+ ..+++..++.++.|++.||.|||+.          |++|+||||+||+++.
T Consensus        88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~  166 (322)
T 3soc_A           88 KRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN  166 (322)
T ss_dssp             EEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred             ccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence            7744    47999999999999999965 5699999999999999999999999          9999999999999999


Q ss_pred             CCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCc----cCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 022617          153 KWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCGTLPFDDEN----  221 (294)
Q Consensus       153 ~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~ll~~l~~g~~p~~~~~----  221 (294)
                      ++.+||+|||++........   .....+++.|+|||++.+..    ..+.++||||||+++|+|++|+.||.+..    
T Consensus       167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~  246 (322)
T 3soc_A          167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM  246 (322)
T ss_dssp             TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred             CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence            99999999999976544322   23356899999999987631    22567899999999999999999996532    


Q ss_pred             ------------HHHHHHHHhCCCc-c-CCC-----CCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          222 ------------IPNLFKKIKGGIY-T-LPS-----HLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       222 ------------~~~~~~~~~~~~~-~-~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                                  .......+..... + .+.     ..+.++.+++.+||+.||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                        2223332222221 1 111     12345999999999999999999999987

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=315.36  Aligned_cols=254  Identities=26%  Similarity=0.420  Sum_probs=192.0

Q ss_pred             CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEE
Q 022617            9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE   87 (294)
Q Consensus         9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   87 (294)
                      .+.++.-..+|++.+.||.|+||.||+|.+..+++.|++|++...   .......+.+|+.+++++. ||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            334455567999999999999999999999999999999998543   3344677889999999996 999999999984


Q ss_pred             --------cCCeEEEEEeccCCCChHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCCC
Q 022617           88 --------TPSDIYVVMEYVKSGELFDYIVE---KGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKW  154 (294)
Q Consensus        88 --------~~~~~~lv~e~~~~~sL~~~l~~---~~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~~  154 (294)
                              .....++++|++. ++|.+++..   .+++++..++.++.|++.||.|||+.|  ++|+||+|+||+++.++
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred             ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence                    3345899999996 599998865   456999999999999999999999999  99999999999999999


Q ss_pred             cEEEeeecccccccCCCcc-------------ccccCCCcccCCcccc---CCccCCCchhHHHHHHHHHHHHhCCCCCC
Q 022617          155 NVKIADFGLSNIMRDGHFL-------------KTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFD  218 (294)
Q Consensus       155 ~~~l~dfg~~~~~~~~~~~-------------~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~  218 (294)
                      .++|+|||++.........             ....+++.|+|||++.   +..+ +.++||||||+++|+|++|..||.
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCc
Confidence            9999999999765433221             1345788999999983   3434 789999999999999999999997


Q ss_pred             CCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCC
Q 022617          219 DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  269 (294)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~  269 (294)
                      ...........  ...+.+...+..+.+++.+||+.||.+|||+.+++++.
T Consensus       255 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          255 DGAKLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             chhHHHhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            65544332221  12333456788999999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-45  Score=313.02  Aligned_cols=253  Identities=28%  Similarity=0.455  Sum_probs=212.3

Q ss_pred             cccccCCcccccccccCceEEEEEEE-----ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVI   86 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   86 (294)
                      ....++|++.+.||.|+||+||+|.+     ..+++.|++|++....  .......+.+|+.+++++ +||||+++++++
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            45678999999999999999999985     3466889999986543  233456789999999999 689999999998


Q ss_pred             EcCC-eEEEEEeccCCCChHHHHHHhCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeE
Q 022617           87 ETPS-DIYVVMEYVKSGELFDYIVEKGR----------------LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLL  149 (294)
Q Consensus        87 ~~~~-~~~lv~e~~~~~sL~~~l~~~~~----------------l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nil  149 (294)
                      ...+ ..++++||+.+++|.+++.....                +++..++.++.|++.||.+||+.|++|+||+|+||+
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7654 58999999999999999976543                889999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCH-HH
Q 022617          150 LDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENI-PN  224 (294)
Q Consensus       150 i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~-~~  224 (294)
                      ++.++.++|+|||++........   .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||..... ..
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            99999999999999876543221   223446788999999987766 789999999999999998 9999987553 33


Q ss_pred             HHHHHhC-CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          225 LFKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       225 ~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ....+.. .....+..++.++.+++.+||+.||.+|||+.++++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3333333 3355667889999999999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.3e-45  Score=308.03  Aligned_cols=251  Identities=24%  Similarity=0.301  Sum_probs=202.0

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEE-EEEcCCeE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE-VIETPSDI   92 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~~   92 (294)
                      .+.++|++.+.||+|+||.||+|.+..+++.|++|++......     ..+.+|+.+++.++|++++..+. ++...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            5678999999999999999999999999999999986544322     35788999999999877555544 45777889


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe---cCCCcEEEeeeccccccc
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili---~~~~~~~l~dfg~~~~~~  168 (294)
                      ++++|++ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||.+....
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999999 7899999975 4679999999999999999999999999999999999999   788999999999998664


Q ss_pred             CCCc--------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhCCC----
Q 022617          169 DGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKKIKGGI----  233 (294)
Q Consensus       169 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~~~~----  233 (294)
                      ....        .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||......   .....+....    
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            4322        234568999999999988776 78999999999999999999999764321   2222222222    


Q ss_pred             -ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       234 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                       ......++.++.+++.+||+.||++|||+.++++  .|++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~  277 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRN  277 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHH
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH--HHHH
Confidence             2223678999999999999999999999999987  4444

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-45  Score=306.69  Aligned_cols=248  Identities=27%  Similarity=0.407  Sum_probs=209.7

Q ss_pred             cCCcccccccccCceEEEEEEEccCCc---eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE-
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI-   92 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-   92 (294)
                      -.|++.+.||+|+||+||+|.+..++.   .+++|++...  ......+.+.+|+.++++++||||+++++++...+.. 
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            356667999999999999999765554   7999998542  3334567889999999999999999999999766655 


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++++|++.+++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999999976 4568999999999999999999999999999999999999999999999999997553322


Q ss_pred             -----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhH
Q 022617          172 -----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA  244 (294)
Q Consensus       172 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  244 (294)
                           ......+++.|+|||.+.+..+ +.++||||||+++|+|++ +.+||...+.......+.... ...+..++..+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence                 2233456789999999987776 789999999999999999 566666677777666665554 55667889999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+++.+||+.||.+|||+.++++
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.2e-46  Score=320.52  Aligned_cols=251  Identities=17%  Similarity=0.235  Sum_probs=198.5

Q ss_pred             cccCCcccccccccCceEEEEEEEccC-----CceEEEEEeecccccchHH--------HHHHHHHHHHHHhCCCCceeE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEM--------EEKVRREIKILRLFMHPHIIR   81 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~~K~~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~   81 (294)
                      ..++|++.+.||+|+||.||+|.+..+     ++.|++|++..........        ......|+..++.++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            345999999999999999999998764     5789999986543111110        122334556677888999999


Q ss_pred             EEEEEEcC----CeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec--CCC
Q 022617           82 LYEVIETP----SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD--SKW  154 (294)
Q Consensus        82 ~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~--~~~  154 (294)
                      +++++...    ...+++|||+ |++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            99998764    4589999999 88999999876 6799999999999999999999999999999999999998  889


Q ss_pred             cEEEeeecccccccCCCcc--------ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHH
Q 022617          155 NVKIADFGLSNIMRDGHFL--------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNL  225 (294)
Q Consensus       155 ~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~  225 (294)
                      .++|+|||++.........        ....+++.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.. ....
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            9999999999765432211        23348999999999988776 799999999999999999999998532 2221


Q ss_pred             HHHHh----CCCc------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          226 FKKIK----GGIY------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       226 ~~~~~----~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .....    ....      .....++.++.+++..||..+|.+||++.+|++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            11111    0100      112578999999999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.4e-46  Score=341.67  Aligned_cols=261  Identities=30%  Similarity=0.429  Sum_probs=209.2

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--   88 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   88 (294)
                      ......++|++.+.||.|+||+||+|.+..+++.||+|++....  .......+.+|+.++++++||||+++++++..  
T Consensus         8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A            8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            34455699999999999999999999999999999999986542  33456778999999999999999999998755  


Q ss_pred             ----CCeEEEEEeccCCCChHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc---EEE
Q 022617           89 ----PSDIYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKI  158 (294)
Q Consensus        89 ----~~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~---~~l  158 (294)
                          .+..++++||+.|++|.+++....   .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.   ++|
T Consensus        86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence                677899999999999999997644   5899999999999999999999999999999999999997765   999


Q ss_pred             eeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------HHH
Q 022617          159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF---------KKI  229 (294)
Q Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~---------~~~  229 (294)
                      +|||.+.............+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.........         ..+
T Consensus       166 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          166 IDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             CSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             cccccccccccccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            99999988766665566778999999999987776 78999999999999999999999765332211         000


Q ss_pred             -----hCCCc------c----CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          230 -----KGGIY------T----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       230 -----~~~~~------~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                           ..+..      +    ....++..+.+++.+||..||.+|||+.++++||||+..
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence                 00000      1    112356789999999999999999999999999999653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.8e-45  Score=330.01  Aligned_cols=260  Identities=26%  Similarity=0.467  Sum_probs=220.9

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      ......++|++.+.||+|+||.||+|.+.. +..|+||++.....    ..+.+.+|++++++++|+||+++++++.. +
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            345667889999999999999999999864 46799999875432    24678999999999999999999999865 7


Q ss_pred             eEEEEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      ..++||||+.+++|.+++..  ...+++..++.++.|++.||.|||+.||+|+||+|+|||++.++.+||+|||++....
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            78999999999999999964  3569999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhH
Q 022617          169 DGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA  244 (294)
Q Consensus       169 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  244 (294)
                      ....  .....++..|+|||++....+ +.++||||||+++|+|++ |..||.+....+....+..+. .+.+..++.++
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  493 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL  493 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CCceecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            3221  122345678999999887766 789999999999999999 999999988888887776553 55677899999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhc--CCcccccCCc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQ--HPWFQAHLPR  277 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~--h~~~~~~~~~  277 (294)
                      .++|.+||+.||++|||+.+|++  ..+|....+.
T Consensus       494 ~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~  528 (535)
T 2h8h_A          494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  528 (535)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence            99999999999999999999988  3455544443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.1e-45  Score=307.25  Aligned_cols=247  Identities=24%  Similarity=0.415  Sum_probs=197.8

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCceeEEEEEEEc-
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL--FMHPHIIRLYEVIET-   88 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~-   88 (294)
                      ...+.++|++.+.||+|+||+||+|.+  +++.||+|++....      .....+|.+++..  ++||||+++++++.. 
T Consensus         3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            356789999999999999999999987  68899999985432      3455667777766  789999999998644 


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCeEecCCCcEE
Q 022617           89 ---PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH--------RNMVVHRDLKPENLLLDSKWNVK  157 (294)
Q Consensus        89 ---~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh--------~~~i~h~di~p~nili~~~~~~~  157 (294)
                         ....++++||+.+++|.++++ ...+++..++.++.|++.||.|||        +.|++|+||||+||+++.++.++
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             cCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence               356899999999999999994 457999999999999999999999        99999999999999999999999


Q ss_pred             EeeecccccccCCCcc-----ccccCCCcccCCccccCCccC-----CCchhHHHHHHHHHHHHhC----------CCCC
Q 022617          158 IADFGLSNIMRDGHFL-----KTSCGSPNYAAPEVISGKLYA-----GPEVDVWSCGVILYALLCG----------TLPF  217 (294)
Q Consensus       158 l~dfg~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~ll~~l~~g----------~~p~  217 (294)
                      |+|||++.........     ....+++.|+|||.+.+....     +.++||||||+++|+|++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            9999998765443322     233689999999998765321     3689999999999999999          8888


Q ss_pred             CCC-----CHHHHHHHHhCCC--ccCC-----CCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          218 DDE-----NIPNLFKKIKGGI--YTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       218 ~~~-----~~~~~~~~~~~~~--~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ...     .............  ...+     ..++.++.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            542     2223333222211  1222     124567999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.8e-46  Score=315.25  Aligned_cols=260  Identities=25%  Similarity=0.374  Sum_probs=209.3

Q ss_pred             CCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617            7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI   86 (294)
Q Consensus         7 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   86 (294)
                      .+...+....++|++.+.||+|+||.||+|.+. +++.|++|++.......  ....+.+|++++++++||||+++++++
T Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             ecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEE
Confidence            344556778899999999999999999999865 68899999986543221  123688999999999999999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCeEecCCCcEEEe
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKG----RLQEDEARNFFQQIISGVEYCHRN---MVVHRDLKPENLLLDSKWNVKIA  159 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~~~~ql~~~l~~Lh~~---~i~h~di~p~nili~~~~~~~l~  159 (294)
                      ...+..++++||+.+++|.+++....    ++++..++.++.|++.||.+||+.   |++|+||+|+||+++.++.++|+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997543    499999999999999999999999   99999999999999999999999


Q ss_pred             eecccccccCCC--ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHHhC-
Q 022617          160 DFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-----ENIPNLFKKIKG-  231 (294)
Q Consensus       160 dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-----~~~~~~~~~~~~-  231 (294)
                      |||++.......  ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||..     .........+.. 
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            999998664332  2334458999999999977776 7899999999999999999999952     111111111111 


Q ss_pred             --CC-c----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCc
Q 022617          232 --GI-Y----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  270 (294)
Q Consensus       232 --~~-~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~  270 (294)
                        .. .          ..+...+..+.+++.+||+.||.+|||+.++++|..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence              00 0          111123367999999999999999999999998654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.6e-45  Score=321.25  Aligned_cols=253  Identities=32%  Similarity=0.486  Sum_probs=195.3

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS   90 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   90 (294)
                      ...+.+.|.+.+.||+|+||+||.+. ..+|+.||||++....      .+.+.+|+.+++++ +||||+++++++...+
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            34566677778999999999998754 4578999999985432      34677899999876 8999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCC-------CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC----------
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRL-------QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK----------  153 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l-------~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~----------  153 (294)
                      ..++++|+++| +|.+++......       ++..++.++.|++.||.|||+.||+|+||||+||+++.+          
T Consensus        83 ~~~lv~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            99999999965 999999765432       223457899999999999999999999999999999754          


Q ss_pred             ---CcEEEeeecccccccCCCc-----cccccCCCcccCCccccC------CccCCCchhHHHHHHHHHHHHh-CCCCCC
Q 022617          154 ---WNVKIADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISG------KLYAGPEVDVWSCGVILYALLC-GTLPFD  218 (294)
Q Consensus       154 ---~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~-g~~p~~  218 (294)
                         +.++|+|||++........     .....+++.|+|||++.+      ....+.++||||||+++|+|++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               4799999999987644321     234468999999999865      1334789999999999999999 999997


Q ss_pred             CCCHHHHHHHHhCCCccCC-------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          219 DENIPNLFKKIKGGIYTLP-------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .......  .+.......+       ..++.++.++|.+||+.||.+|||+.++++||||...
T Consensus       242 ~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          242 DKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             STTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             CchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            6544332  2222222111       1235789999999999999999999999999999653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.9e-45  Score=306.48  Aligned_cols=253  Identities=25%  Similarity=0.376  Sum_probs=209.6

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCC---ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE-E
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI-E   87 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~   87 (294)
                      +..-..+|++.+.||+|+||+||+|.+..++   ..+++|.+...  ........+.+|+.++++++||||+++++++ .
T Consensus        20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (298)
T 3f66_A           20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR   97 (298)
T ss_dssp             CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence            3455668999999999999999999975433   35888887542  3334567889999999999999999999985 4


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      .++..++++||+.+++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence            566889999999999999999753 4589999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCCc-----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCC
Q 022617          167 MRDGHF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSH  239 (294)
Q Consensus       167 ~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~  239 (294)
                      ......     .....+++.|+|||.+.+..+ +.++||||||+++|+|++ +.+||...........+.... ...+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY  256 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCcc
Confidence            543221     223346778999999987766 789999999999999999 777787776666666655544 445677


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ++..+.+++.+||+.||.+|||+.++++
T Consensus       257 ~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          257 CPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8999999999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.4e-45  Score=320.25  Aligned_cols=250  Identities=28%  Similarity=0.417  Sum_probs=195.2

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .+|.+.+.||.|+||+||. ....+++.||||++......      .+.+|+.+++.+ +||||+++++++...+..+++
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            4699999999999999764 33457899999998654322      346799999999 799999999999999999999


Q ss_pred             EeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-----CCcEEEeeecccccccC
Q 022617           96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-----KWNVKIADFGLSNIMRD  169 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-----~~~~~l~dfg~~~~~~~  169 (294)
                      +|++.+ +|.+++.... ..++..++.++.|++.||.|||+.||+|+||||+||+++.     ...++|+|||++.....
T Consensus        97 ~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A           97 IELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             EECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            999965 9999997653 3556677899999999999999999999999999999953     23588999999876543


Q ss_pred             CC----ccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCCccC---CCC
Q 022617          170 GH----FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL---PSH  239 (294)
Q Consensus       170 ~~----~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~---~~~  239 (294)
                      ..    ......+++.|+|||++.+  ....+.++||||||+++|+|++ |..||...................   +..
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  255 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH  255 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence            32    2334568999999999874  2223678999999999999999 999997655444433332222111   122


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .+..+.++|.+||+.||.+|||+.++++||||...
T Consensus       256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            34568899999999999999999999999999753

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6e-45  Score=309.82  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=209.3

Q ss_pred             CccccccCCcccccccccCceEEEEEE----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI   86 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   86 (294)
                      ......++|++.+.||+|++|.||+|.    +..+++.|++|++...   .....+.+.+|+.++++++|+||+++++++
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  111 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVC  111 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            345567889999999999999999998    4568899999998653   334567899999999999999999999998


Q ss_pred             EcC--CeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           87 ETP--SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        87 ~~~--~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      ...  ...++++|++++++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus       112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence            654  3789999999999999999775 4599999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------
Q 022617          164 SNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----------------  223 (294)
Q Consensus       164 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~----------------  223 (294)
                      +........    .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||......                
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence            987654332    123345677999999887766 78999999999999999999988543111                


Q ss_pred             HHHHHHhC-CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          224 NLFKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       224 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .....+.. ...+.+..++.++.++|.+||+.||.+|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11222222 234566789999999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1e-44  Score=332.56  Aligned_cols=242  Identities=25%  Similarity=0.414  Sum_probs=208.3

Q ss_pred             ccccccCceEEEEEEE--ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617           23 KTLGIGSFGKVKIAEH--ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK  100 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  100 (294)
                      +.||+|+||.||+|.+  +.+++.||||++.... ......+.+.+|++++++++||||+++++++.. +..++||||+.
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            4799999999999965  4556789999986543 233456789999999999999999999999975 56889999999


Q ss_pred             CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc----cccc
Q 022617          101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTS  176 (294)
Q Consensus       101 ~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~  176 (294)
                      +++|.+++..++.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++........    ....
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  532 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  532 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence            999999998888899999999999999999999999999999999999999999999999999976543321    1223


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhccc
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIV  254 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~  254 (294)
                      .++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+..+. ...+..++.++.++|.+||+.
T Consensus       533 ~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~  611 (635)
T 4fl3_A          533 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY  611 (635)
T ss_dssp             --CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            35678999999987776 789999999999999998 999999999888888777654 566788999999999999999


Q ss_pred             CCCCCCCHhHHhc
Q 022617          255 DPMKRITIPEIRQ  267 (294)
Q Consensus       255 ~p~~Rps~~~il~  267 (294)
                      ||++|||+.++++
T Consensus       612 dP~~RPs~~~l~~  624 (635)
T 4fl3_A          612 DVENRPGFAAVEL  624 (635)
T ss_dssp             STTTSCCHHHHHH
T ss_pred             CHhHCcCHHHHHH
Confidence            9999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=315.08  Aligned_cols=242  Identities=14%  Similarity=0.158  Sum_probs=200.9

Q ss_pred             ccCCcccccccccCceEEEEEEEcc--------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeE------
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHAL--------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR------   81 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~--------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~------   81 (294)
                      .++|++.+.||+|+||.||+|.+..        .++.||+|++...        ..+.+|++++++++|||+++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            5799999999999999999999987        4789999998643        36778999999999998887      


Q ss_pred             ---------EEEEEEc-CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeE
Q 022617           82 ---------LYEVIET-PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLL  149 (294)
Q Consensus        82 ---------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nil  149 (294)
                               +++++.. .+..+++|||+ +++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     6777765 78899999999 88999999875  78999999999999999999999999999999999999


Q ss_pred             ecCCC--cEEEeeecccccccCCC--------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022617          150 LDSKW--NVKIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD  219 (294)
Q Consensus       150 i~~~~--~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~  219 (294)
                      ++.++  .++|+|||++.......        ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||..
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence            99988  89999999997654321        1133468999999999988766 7899999999999999999999976


Q ss_pred             CC--HHHHHHHH---hCCCccCC------CCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          220 EN--IPNLFKKI---KGGIYTLP------SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       220 ~~--~~~~~~~~---~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ..  ........   ......+.      ..++.++.+++.+||..||.+|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            53  33332222   22222211      256899999999999999999999999987

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=305.18  Aligned_cols=240  Identities=30%  Similarity=0.485  Sum_probs=197.9

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||+|+||.||+|.+.  ++.|++|.+...     ...+.+.+|+.++++++||||+++++++.  +..+++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv   77 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV   77 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEE
Confidence            578999999999999999999874  678999998532     33567889999999999999999999875  457899


Q ss_pred             EeccCCCChHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCCeEecCCCc-EEEeeeccccccc
Q 022617           96 MEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHR---NMVVHRDLKPENLLLDSKWN-VKIADFGLSNIMR  168 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~---~l~~~~~~~~~~ql~~~l~~Lh~---~~i~h~di~p~nili~~~~~-~~l~dfg~~~~~~  168 (294)
                      +||+++++|.+++....   .++...++.++.|++.||.|||+   .|++|+||+|+||+++.++. ++|+|||.+....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            99999999999997654   37899999999999999999999   89999999999999998886 7999999987553


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH-hCCCccCCCCCChhHH
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKI-KGGIYTLPSHLSPGAR  245 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~-~~~~~~~~~~~~~~l~  245 (294)
                      ..  .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....  .......+ .......+..++..+.
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (307)
T 2eva_A          158 TH--MTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE  234 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred             cc--cccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence            32  233458999999999987766 789999999999999999999997543  22232233 3334556678999999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhc
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +++.+||+.||.+|||+.++++
T Consensus       235 ~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          235 SLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=311.66  Aligned_cols=268  Identities=22%  Similarity=0.354  Sum_probs=213.1

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP   89 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   89 (294)
                      ...+...++|++.+.||.|++|.||+|.+..   .+++|++....... ...+.+.+|+.++++++|+||+++++++...
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            4445677899999999999999999998753   59999987553222 2335677899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           90 SDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        90 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      +..++++||+.+++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||+|+||+++ ++.++|+|||++....
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            99999999999999999997654 699999999999999999999999999999999999998 6799999999876542


Q ss_pred             C------CCccccccCCCcccCCccccCC--------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc
Q 022617          169 D------GHFLKTSCGSPNYAAPEVISGK--------LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY  234 (294)
Q Consensus       169 ~------~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~  234 (294)
                      .      ........+++.|+|||.+...        ...+.++||||||+++|+|++|..||...........+.....
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  260 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK  260 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence            1      1222334578899999998642        2236789999999999999999999999888887777766543


Q ss_pred             cC--CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCC
Q 022617          235 TL--PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP  284 (294)
Q Consensus       235 ~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~  284 (294)
                      +.  +..++.++.+++.+||..||.+|||+.++++  .+++..........|
T Consensus       261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~~~~~~~  310 (319)
T 2y4i_B          261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRRLSHP  310 (319)
T ss_dssp             CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC----------
T ss_pred             CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhhccCCCC
Confidence            32  2368899999999999999999999999998  666655554444444

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-45  Score=315.82  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=200.2

Q ss_pred             cCCcccccccccCceEEEEEEEccCC---ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE-cCCeE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE-TPSDI   92 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~   92 (294)
                      ..|++.+.||+|+||+||+|.+..++   ..+++|.+...  ........+.+|+.++++++||||+++++++. ..+..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            45788899999999999999876433   35889987542  23345678999999999999999999999864 45678


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++++||+.+++|.+++.+. ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999999754 458899999999999999999999999999999999999999999999999997653322


Q ss_pred             c-----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhH
Q 022617          172 F-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA  244 (294)
Q Consensus       172 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  244 (294)
                      .     .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+..+. ...+..++..+
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l  325 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  325 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            1     123345678999999987766 789999999999999999 788888766666555555444 45567899999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+++.+||..||++|||+.++++
T Consensus       326 ~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3e-44  Score=302.92  Aligned_cols=245  Identities=26%  Similarity=0.413  Sum_probs=201.3

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeeccc-ccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK-IKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      |...+.||+|++|.||+|.+  +++.+++|++.... .......+.+.+|+.++++++||||+++++++...+..++++|
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44559999999999999986  67899999986542 2233456789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---
Q 022617           98 YVKSGELFDYIVE---KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---  171 (294)
Q Consensus        98 ~~~~~sL~~~l~~---~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---  171 (294)
                      |+.+++|.+++..   ..++++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            9999999999974   3469999999999999999999999999999999999999999999999999987654322   


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhCCC-----------ccC
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGI-----------YTL  236 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~~~-----------~~~  236 (294)
                      ......+++.|+|||.+.+. + +.++||||||+++|+|++|..||.......    ....+....           ...
T Consensus       191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA  268 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred             cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence            12334689999999988754 4 789999999999999999999997643221    222222111           112


Q ss_pred             CCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      +..++..+.+++.+||..||.+|||+.++++
T Consensus       269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             chHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2234567899999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6e-44  Score=317.19  Aligned_cols=247  Identities=24%  Similarity=0.313  Sum_probs=207.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCCeE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIETPSDI   92 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~   92 (294)
                      .+.++|++.+.||.|+||.||+|.+..+++.|+||++......     ..+.+|+++++.+.| +++..+..++...+..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            5678999999999999999999999999999999987654322     357889999999987 5677777777888899


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe---cCCCcEEEeeeccccccc
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili---~~~~~~~l~dfg~~~~~~  168 (294)
                      +++|||+ +++|.+++.. ...+++..++.++.||+.+|.|||+.||+|+||||+|||+   +.++.++|+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 7899999975 5679999999999999999999999999999999999999   578899999999998665


Q ss_pred             CCCc--------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhC-----C
Q 022617          169 DGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI---PNLFKKIKG-----G  232 (294)
Q Consensus       169 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~~-----~  232 (294)
                      ....        .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||.....   ......+..     .
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            4322        125568999999999988776 7899999999999999999999987443   222222221     1


Q ss_pred             CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          233 IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ...+...++.++.+++..||+.+|++||++.+|++
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            12333678999999999999999999999998765

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=327.84  Aligned_cols=247  Identities=27%  Similarity=0.445  Sum_probs=207.5

Q ss_pred             cCCcccc-cccccCceEEEEEEEcc--CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           17 PNYKLGK-TLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        17 ~~y~~~~-~lg~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      +++.+.+ .||+|+||.||+|.+..  ++..||||++....  .....+.+.+|++++++++||||+++++++.. +..+
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            3445555 79999999999998753  45679999986542  22346789999999999999999999999976 5689


Q ss_pred             EEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      +||||+.+++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus       412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            999999999999999643 5699999999999999999999999999999999999999999999999999976543221


Q ss_pred             ----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617          173 ----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD  246 (294)
Q Consensus       173 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  246 (294)
                          .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..+. ...+..++.++.+
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  570 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA  570 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             eeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence                112234578999999987766 789999999999999998 999999988888887776654 5667789999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~  267 (294)
                      +|.+||..+|++|||+.++++
T Consensus       571 li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          571 LMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999855

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-44  Score=306.40  Aligned_cols=247  Identities=23%  Similarity=0.402  Sum_probs=195.8

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCceeEEEEEEEcC-
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL--FMHPHIIRLYEVIETP-   89 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~-   89 (294)
                      ..+.++|++.+.||.|+||.||+|.+.  ++.|++|++....      .....+|.+++..  ++|+||+++++++... 
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            567789999999999999999999874  8899999985432      2334445555544  4899999999999877 


Q ss_pred             ---CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCeEecCCCcEEE
Q 022617           90 ---SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN--------MVVHRDLKPENLLLDSKWNVKI  158 (294)
Q Consensus        90 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~--------~i~h~di~p~nili~~~~~~~l  158 (294)
                         ...+++|||+.+++|.+++.+ ..+++..++.++.|++.||.|||+.        |++|+||||+||+++.++.++|
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence               789999999999999999964 5799999999999999999999998        9999999999999999999999


Q ss_pred             eeecccccccCCCcc-----ccccCCCcccCCccccCCccCCC-----chhHHHHHHHHHHHHhC----------CCCCC
Q 022617          159 ADFGLSNIMRDGHFL-----KTSCGSPNYAAPEVISGKLYAGP-----EVDVWSCGVILYALLCG----------TLPFD  218 (294)
Q Consensus       159 ~dfg~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~-----~~Di~slG~ll~~l~~g----------~~p~~  218 (294)
                      +|||++.........     ....+++.|+|||++.+......     ++||||||+++|+|++|          ..||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            999999765433221     24468999999999976655222     38999999999999999          77775


Q ss_pred             CC-----CHHHHHHHHhCCC--ccCCC-----CCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          219 DE-----NIPNLFKKIKGGI--YTLPS-----HLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       219 ~~-----~~~~~~~~~~~~~--~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ..     ........+....  ...+.     .++.++.+++.+||+.||.+|||+.+++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            42     2223333222221  22222     455679999999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.9e-44  Score=327.46  Aligned_cols=253  Identities=27%  Similarity=0.467  Sum_probs=214.4

Q ss_pred             CccccccCCcccccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      ......++|++.+.||+|+||.||+|.+..+   +..+++|.+...  ......+.+.+|+.++++++||||+++++++.
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4455678899999999999999999998644   356899987543  23345678899999999999999999999984


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                       .+..++||||+.+++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence             567899999999999999997654 689999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCCh
Q 022617          167 MRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSP  242 (294)
Q Consensus       167 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~  242 (294)
                      ......  .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+....+....+..+. .+.+..++.
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  619 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  619 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence            644332  123345678999999977766 789999999999999997 999999988888777776543 567788999


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+.+++.+||..||.+|||+.++++
T Consensus       620 ~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=310.14  Aligned_cols=246  Identities=17%  Similarity=0.255  Sum_probs=198.7

Q ss_pred             CccccccCCcccccccccCceEEEEE-----EEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCceeEE
Q 022617           11 GVDMFLPNYKLGKTLGIGSFGKVKIA-----EHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRL   82 (294)
Q Consensus        11 ~~~~~~~~y~~~~~lg~g~~~~vy~~-----~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~   82 (294)
                      .+..-.++|++.+.||+|+||+||+|     .+..+++.||+|++....      ...+.+|.++++.+.   |+|++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            34455678999999999999999999     466788999999986442      346777888888887   8999999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-----
Q 022617           83 YEVIETPSDIYVVMEYVKSGELFDYIVE-----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-----  152 (294)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-----  152 (294)
                      ++++...+..++||||+.+++|.+++..     ...+++..++.++.|++.||.|||+.||+|+||||+||+++.     
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence            9999999999999999999999999974     456999999999999999999999999999999999999988     


Q ss_pred             ------CCcEEEeeeccccccc---CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022617          153 ------KWNVKIADFGLSNIMR---DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP  223 (294)
Q Consensus       153 ------~~~~~l~dfg~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~  223 (294)
                            ++.++|+|||++....   .........+|+.|+|||++.+..+ +.++||||||+++|+|++|+.||......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                  8999999999996543   3334455678999999999988876 79999999999999999999998543221


Q ss_pred             HHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          224 NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      ...  +.. ... ....+..+.+++..||+.+|.+|++..+.+.
T Consensus       292 ~~~--~~~-~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          292 ECK--PEG-LFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             EEE--ECS-CCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             cee--ech-hcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            100  000 000 1134678999999999999999965444333

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-45  Score=320.03  Aligned_cols=252  Identities=17%  Similarity=0.182  Sum_probs=196.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC-Cc--------------
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PH--------------   78 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~--------------   78 (294)
                      .-..+|+..+.||+|+||+||+|.+..+++.||||++...........+.+.+|+.+++.+.| ++              
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            344568899999999999999999999999999999875544444446788999999999876 21              


Q ss_pred             -------eeEEEEEEEc-----CCeEEEEEeccCCCChHHHHHH-------hCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 022617           79 -------IIRLYEVIET-----PSDIYVVMEYVKSGELFDYIVE-------KGRLQEDEARNFFQQIISGVEYCHRNMVV  139 (294)
Q Consensus        79 -------i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~-------~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~  139 (294)
                             ...+..++..     ....+++++.+ +++|.++++.       ...+++..++.++.|++.||.|||+.||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii  233 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  233 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence                   1111111111     23467888877 4699998852       23477888999999999999999999999


Q ss_pred             ecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccCCccc----------cCCccCCCchhHHHHHHHHHH
Q 022617          140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----------SGKLYAGPEVDVWSCGVILYA  209 (294)
Q Consensus       140 h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~~Di~slG~ll~~  209 (294)
                      |+||||+||+++.++.+||+|||++......  .....+ +.|+|||++          .+..+ +.++||||||+++|+
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHH
Confidence            9999999999999999999999998765433  334456 999999998          33344 689999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          210 LLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       210 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      |++|+.||...........+..    ....++.++.++|.+||+.||++|||+.++++||||+..
T Consensus       310 lltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            9999999987655443333322    234678999999999999999999999999999999764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.1e-43  Score=302.12  Aligned_cols=246  Identities=23%  Similarity=0.388  Sum_probs=202.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCceeEEEEEEEcCC-
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL--FMHPHIIRLYEVIETPS-   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~-   90 (294)
                      .+.++|++.+.||+|+||.||+|.+  +++.|++|++....      ...+.+|.++++.  ++||||+++++++.... 
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            4568999999999999999999997  58899999985432      3567788888887  78999999999998776 


Q ss_pred             ---eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCeEecCCCcEEEe
Q 022617           91 ---DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH--------RNMVVHRDLKPENLLLDSKWNVKIA  159 (294)
Q Consensus        91 ---~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh--------~~~i~h~di~p~nili~~~~~~~l~  159 (294)
                         ..++++||+.+++|.+++.+ ..+++..++.++.|++.+|.+||        +.|++|+||+|+||+++.++.++|+
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  189 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  189 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred             ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence               79999999999999999965 57899999999999999999999        8999999999999999999999999


Q ss_pred             eecccccccCCCc-----cccccCCCcccCCccccCCccC-----CCchhHHHHHHHHHHHHhC----------CCCCCC
Q 022617          160 DFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLYA-----GPEVDVWSCGVILYALLCG----------TLPFDD  219 (294)
Q Consensus       160 dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~ll~~l~~g----------~~p~~~  219 (294)
                      |||++........     .....+++.|+|||.+.+....     +.++||||||+++|+|++|          ..||..
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~  269 (342)
T 1b6c_B          190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  269 (342)
T ss_dssp             CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence            9999976654432     2344689999999998765321     2579999999999999999          788865


Q ss_pred             C-----CHHHHHHHHhCCC--ccCCC-----CCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          220 E-----NIPNLFKKIKGGI--YTLPS-----HLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       220 ~-----~~~~~~~~~~~~~--~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .     ........+....  ...+.     .++..+.+++.+||+.||++|||+.+++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            4     2344444443322  12221     234578999999999999999999999884

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=299.29  Aligned_cols=246  Identities=23%  Similarity=0.338  Sum_probs=188.6

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHH--HHHHHhCCCCceeEEEEEEEc--
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRRE--IKILRLFMHPHIIRLYEVIET--   88 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e--~~~l~~l~~~~i~~~~~~~~~--   88 (294)
                      ..-.++|++.+.||+|+||.||+|.+  +++.||+|++....      ......|  +..+..++|+||+++++.+..  
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVT   80 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence            45568999999999999999999976  67899999986443      2233334  444456899999999986532  


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCeEecCCCcE
Q 022617           89 ---PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN---------MVVHRDLKPENLLLDSKWNV  156 (294)
Q Consensus        89 ---~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~---------~i~h~di~p~nili~~~~~~  156 (294)
                         ...++++|||+++++|.+++... ..++..++.++.|++.||.|||+.         ||+|+||||+||+++.++.+
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence               23578999999999999999654 458999999999999999999999         99999999999999999999


Q ss_pred             EEeeecccccccCCC---------ccccccCCCcccCCccccCC------ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022617          157 KIADFGLSNIMRDGH---------FLKTSCGSPNYAAPEVISGK------LYAGPEVDVWSCGVILYALLCGTLPFDDEN  221 (294)
Q Consensus       157 ~l~dfg~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~g~~p~~~~~  221 (294)
                      +|+|||++.......         ......+++.|+|||++.+.      ...+.++||||||+++|+|++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999997654321         12244689999999998762      122568999999999999999977763211


Q ss_pred             ------------------HHHHHHHHhC--CCccCCCC------CChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          222 ------------------IPNLFKKIKG--GIYTLPSH------LSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       222 ------------------~~~~~~~~~~--~~~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                                        .......+..  ....++..      ++.++.++|.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                              1111111111  11223332      3347999999999999999999999965

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.2e-43  Score=292.31  Aligned_cols=224  Identities=17%  Similarity=0.173  Sum_probs=190.9

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .+.++|++.+.||+|+||.||+|.+..+++.|++|++.............+.+|+..+++++|+||+++++++...+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            67789999999999999999999999899999999998766555566788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617           94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL  173 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  173 (294)
                      ++|||++|++|.+++++ + ....++..++.|++.+|.|||+.||+|+||||+||+++.++.++|++++           
T Consensus       108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            99999999999999953 3 4666788999999999999999999999999999999999999998443           


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhCCCc---cCCCCCChhHHH
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF----KKIKGGIY---TLPSHLSPGARD  246 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~----~~~~~~~~---~~~~~~~~~l~~  246 (294)
                              |++|        .+.++||||||+++|+|++|+.||.+.+.....    ..+.....   .....++.++.+
T Consensus       175 --------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          175 --------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             --------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred             --------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence                    2232        278999999999999999999999875543211    11111111   223578999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~  267 (294)
                      ++.+||+.||.+| |+.++++
T Consensus       239 li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHcccCCccC-CHHHHHH
Confidence            9999999999999 9999988

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.3e-44  Score=307.53  Aligned_cols=245  Identities=19%  Similarity=0.220  Sum_probs=194.5

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc-----chHHHHHHHHHHHHHHhCC---------CCce
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLFM---------HPHI   79 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------~~~i   79 (294)
                      ...++|++.+.||+|+||+||+|.+  +++.||+|++......     .....+.+.+|+.+++.++         |+|+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            3468999999999999999999998  6799999999765422     2223467888999988885         8888


Q ss_pred             eEEEEEEE------------------------------cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHH
Q 022617           80 IRLYEVIE------------------------------TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG  129 (294)
Q Consensus        80 ~~~~~~~~------------------------------~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~  129 (294)
                      +++.+.+.                              ..+..++||||+.++++.+.+. .+.+++..++.++.|++.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-TTCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-hcCCCHHHHHHHHHHHHHH
Confidence            88877653                              2678999999998887666553 3678999999999999999


Q ss_pred             HHHHH-hCCceecCCCCCCeEecCCC--------------------cEEEeeecccccccCCCccccccCCCcccCCccc
Q 022617          130 VEYCH-RNMVVHRDLKPENLLLDSKW--------------------NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI  188 (294)
Q Consensus       130 l~~Lh-~~~i~h~di~p~nili~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~  188 (294)
                      |.||| +.||+|+||||+|||++.++                    .+||+|||++......    ...+|+.|+|||++
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence            99999 99999999999999999887                    8999999999876543    34689999999999


Q ss_pred             cCCccCCCchhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHh-CCCc--c----CCCCCChhHHHHHHHhcccCCCCC
Q 022617          189 SGKLYAGPEVDVWSCGVI-LYALLCGTLPFDDENI-PNLFKKIK-GGIY--T----LPSHLSPGARDLIPRMLIVDPMKR  259 (294)
Q Consensus       189 ~~~~~~~~~~Di~slG~l-l~~l~~g~~p~~~~~~-~~~~~~~~-~~~~--~----~~~~~~~~l~~li~~~l~~~p~~R  259 (294)
                      .+..  +.++||||++.+ .+++++|..||..... ......+. ....  .    .+..+++++.+||.+||+.|    
T Consensus       250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             cCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            8665  689999998766 6778889988854221 11222222 1111  1    12246788999999999976    


Q ss_pred             CCHhHHh-cCCccc
Q 022617          260 ITIPEIR-QHPWFQ  272 (294)
Q Consensus       260 ps~~~il-~h~~~~  272 (294)
                       |+.|+| +||||+
T Consensus       324 -sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -SATDLLCQHSLFK  336 (336)
T ss_dssp             -SHHHHHHHCGGGC
T ss_pred             -CHHHHHhcCCCcC
Confidence             999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.9e-43  Score=323.97  Aligned_cols=244  Identities=24%  Similarity=0.343  Sum_probs=201.1

Q ss_pred             cccccCCcccccccccCceEEEEEEEcc-CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      +.+.++|++.+.||.|+||.||+|.+.. +++.|+||++....  .......+.+|+.++++++||||+++++++...+.
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            4667999999999999999999999976 68999999986432  33455678899999999999999999999987665


Q ss_pred             -----EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617           92 -----IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus        92 -----~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                           .|+||||++|++|.+++..  .+++..++.++.|++.+|.|||+.||+|+||||+||+++.+ .++|+|||++..
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence                 7999999999999998754  79999999999999999999999999999999999999886 899999999976


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHH
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARD  246 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
                      ....   ....+++.|+|||++.+..  +.++||||||+++|+|++|..||.+......    .  ........+..+.+
T Consensus       231 ~~~~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----~--~~~~~~~~~~~l~~  299 (681)
T 2pzi_A          231 INSF---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----P--EDDPVLKTYDSYGR  299 (681)
T ss_dssp             TTCC---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----C--TTCHHHHHCHHHHH
T ss_pred             cccC---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc----c--ccccccccCHHHHH
Confidence            6443   3456899999999987553  6899999999999999999988765211100    0  00000123578999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCccc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                      +|.+||..||.+||+..+.+.|+|+.
T Consensus       300 li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          300 LLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHhhhccCChhhCCCHHHHHHHHHHH
Confidence            99999999999999999999888874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=9.6e-34  Score=256.45  Aligned_cols=184  Identities=15%  Similarity=0.103  Sum_probs=134.1

Q ss_pred             ccccCceEEEEEEEccCCceEEEEEeeccccc-------chHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEE
Q 022617           25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-------NMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ...|+.+....++....|+.+++|++......       .....+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45566666666666678899999999754221       223456799999999999 5999999999999999999999


Q ss_pred             eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccccc
Q 022617           97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKT  175 (294)
Q Consensus        97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~  175 (294)
                      ||++|++|.++|.+.+++++.   +++.||+.||.|+|++||+||||||+|||++.+|++||+|||++...... .....
T Consensus       322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t  398 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTN  398 (569)
T ss_dssp             ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHH
T ss_pred             ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccC
Confidence            999999999999988888865   47889999999999999999999999999999999999999998765433 33445


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG  213 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g  213 (294)
                      .++|+.|+|||++.+..  ..++|+|++|++++.+.++
T Consensus       399 ~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          399 LVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             HHHHHHHHHHHHC-------------------CCCCTT
T ss_pred             ceechhhccHHHhCCCC--CCcccccccccchhhhccc
Confidence            67899999999997653  5689999999988776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=3e-28  Score=219.34  Aligned_cols=184  Identities=21%  Similarity=0.218  Sum_probs=142.4

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeecccccc-----hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ..+.||+|+||.||+|.  ..+..+++|.........     ....+.+.+|++++++++||||+++..++...+..+++
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            46689999999999994  367789999865443322     22345689999999999999999655555567778999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc---
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---  172 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~---  172 (294)
                      |||++|++|.+++.+        +..++.|++.+|.|||+.||+|+||||+||+++.  .++|+|||++........   
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            999999999999854        6789999999999999999999999999999998  999999999987654322   


Q ss_pred             -----cccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCC
Q 022617          173 -----LKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPF  217 (294)
Q Consensus       173 -----~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~  217 (294)
                           .....+|+.|+|||++..  ..+ +...|+|+..+-..+-..++.+|
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhcccc
Confidence                 124568999999999875  444 56679999988888877766555

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=2.4e-25  Score=184.76  Aligned_cols=145  Identities=19%  Similarity=0.196  Sum_probs=114.0

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeecccccch---------------HHHHHHHHHHHHHHhCCCCceeEEE
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---------------EMEEKVRREIKILRLFMHPHIIRLY   83 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~~~~i~~~~   83 (294)
                      |.+.+.||.|++|.||+|.+ .+++.||+|++........               .....+.+|+.++++++|   +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence            44459999999999999999 7899999999864322111               235678899999999984   4444


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           84 EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      +++.. +..+++|||++|++|.+ +.      ......++.|++.+|.+||+.|++|+||||+||+++ ++.++|+|||+
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            44433 45699999999999988 41      123557999999999999999999999999999999 99999999999


Q ss_pred             cccccCCCccccccCCCcccCCccc
Q 022617          164 SNIMRDGHFLKTSCGSPNYAAPEVI  188 (294)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~aPE~~  188 (294)
                      +...            ..+.|||.+
T Consensus       239 a~~~------------~~~~a~e~l  251 (282)
T 1zar_A          239 SVEV------------GEEGWREIL  251 (282)
T ss_dssp             CEET------------TSTTHHHHH
T ss_pred             CeEC------------CCCCHHHHH
Confidence            8643            245677765

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=9.4e-22  Score=161.17  Aligned_cols=140  Identities=19%  Similarity=0.269  Sum_probs=108.9

Q ss_pred             CcccccccccCceEEEEEEEccCCce--EEEEEeecccccc---------------------hHHHHHHHHHHHHHHhCC
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKN---------------------MEMEEKVRREIKILRLFM   75 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~--~~~K~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~   75 (294)
                      |.+.+.||.|++|.||+|.+..+|+.  ||||++.......                     ......+.+|+..++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999998778888  9999975432110                     112246788999999998


Q ss_pred             CCce--eEEEEEEEcCCeEEEEEeccCC-C----ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCC
Q 022617           76 HPHI--IRLYEVIETPSDIYVVMEYVKS-G----ELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPEN  147 (294)
Q Consensus        76 ~~~i--~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh-~~~i~h~di~p~n  147 (294)
                      |+++  +.+++.    +..++||||+++ +    +|.++...   .++..+..++.|++.++.+|| +.|++|+||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8754  444443    356899999942 3    66665422   235567899999999999999 9999999999999


Q ss_pred             eEecCCCcEEEeeecccccc
Q 022617          148 LLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus       148 ili~~~~~~~l~dfg~~~~~  167 (294)
                      ||++.  .++|+|||++...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=4.2e-19  Score=151.35  Aligned_cols=139  Identities=15%  Similarity=0.233  Sum_probs=102.8

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeeccccc---------------chH----HHHHHHHHHHHHHhCCCCce
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---------------NME----MEEKVRREIKILRLFMHPHI   79 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~---------------~~~----~~~~~~~e~~~l~~l~~~~i   79 (294)
                      |.+...||.|++|.||+|.+. +|+.||||++......               ...    ..-....|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 6899999997543211               000    01123457777777765554


Q ss_pred             --eEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC---
Q 022617           80 --IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---  154 (294)
Q Consensus        80 --~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~---  154 (294)
                        ..+++.  .  ..+++|||++|.+|.++.      ..+....++.|++.++.+||+.|++|+||||.|||+++++   
T Consensus       176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEE--E--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeec--c--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence              333332  1  237999999998886543      1223567889999999999999999999999999998876   


Q ss_pred             -------cEEEeeeccccccc
Q 022617          155 -------NVKIADFGLSNIMR  168 (294)
Q Consensus       155 -------~~~l~dfg~~~~~~  168 (294)
                             .+.|+||+.+....
T Consensus       246 d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccceEEEEeCCcccCC
Confidence                   38999999876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.51  E-value=1.3e-13  Score=112.94  Aligned_cols=142  Identities=14%  Similarity=0.109  Sum_probs=112.4

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI   92 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   92 (294)
                      ...+.|++...++.|+.+.||++..  .+..+++|+........   ...+.+|+.+++.+. +..++++++++...+..
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            3456799999999999999999975  36789999976432111   235888999999885 56788999999888899


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-------------------------------------  135 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-------------------------------------  135 (294)
                      |++||+++|.+|.+.+.     +......++.++..++..||+                                     
T Consensus        86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999999877531     222345778899999999998                                     


Q ss_pred             ----------------------CCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617          136 ----------------------NMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus       136 ----------------------~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                                            ..++|+|++|.||++++++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  458999999999999876556799999774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.37  E-value=3.3e-12  Score=104.22  Aligned_cols=142  Identities=13%  Similarity=0.058  Sum_probs=103.9

Q ss_pred             CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeEEEEEEE
Q 022617           10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYEVIE   87 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~   87 (294)
                      ..+......|.+....+.|..+.||++.. .+|..+++|+.....      ...+.+|+.+++.+.+.+  +++++++..
T Consensus        13 ~~l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~   85 (264)
T 1nd4_A           13 AAWVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVT   85 (264)
T ss_dssp             GGGTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEE
T ss_pred             HHHHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEecc
Confidence            34556667788776666777799999965 456789999975431      245678888888886544  567888888


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM------------------------------  137 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~------------------------------  137 (294)
                      ..+..+++||+++|.+|.  .   ...+   ...++.++...+..||+..                              
T Consensus        86 ~~~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (264)
T 1nd4_A           86 EAGRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD  157 (264)
T ss_dssp             CSSCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred             CCCCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence            888899999999998884  2   1112   2245666677777777543                              


Q ss_pred             ----------------------------ceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617          138 ----------------------------VVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus       138 ----------------------------i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                                                  ++|+|++|.||++++++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                        99999999999998776667999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.26  E-value=2.1e-11  Score=104.40  Aligned_cols=143  Identities=15%  Similarity=0.265  Sum_probs=106.4

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEee--cccccchHHHHHHHHHHHHHHhCCC--CceeEEEEEEEcC---Ce
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILN--RRKIKNMEMEEKVRREIKILRLFMH--PHIIRLYEVIETP---SD   91 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~--~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~   91 (294)
                      ....+.|+.|.++.||++...  +..+++|+..  .....  .....+.+|+.+++.+..  ..+++++.++...   +.
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            334677899999999999864  4678999875  32211  124578889999999874  4578888888765   45


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR------------------------------------  135 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~------------------------------------  135 (294)
                      .|++||+++|.++.+..  -..++......++.++...|+.||+                                    
T Consensus       116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            88999999998775421  2346788888999999999999997                                    


Q ss_pred             ----------------------CCceecCCCCCCeEecCCCc--EEEeeecccccc
Q 022617          136 ----------------------NMVVHRDLKPENLLLDSKWN--VKIADFGLSNIM  167 (294)
Q Consensus       136 ----------------------~~i~h~di~p~nili~~~~~--~~l~dfg~~~~~  167 (294)
                                            .+++|+|+++.||+++.++.  +.|+||+.+...
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                  35899999999999987653  689999988643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=1.3e-10  Score=97.02  Aligned_cols=184  Identities=15%  Similarity=0.164  Sum_probs=120.9

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCc--eeEEEEEEEcCC---eEEEE
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPH--IIRLYEVIETPS---DIYVV   95 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv   95 (294)
                      .+.++.|..+.||++.     ..+++|+....     .....+.+|..+++.+. +..  +++++.......   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4568899999999874     46899985322     34567889999998874 333  455655543333   34789


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR----------------------------------------  135 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~----------------------------------------  135 (294)
                      |++++|.+|.+...  ..++.++...++.++...++.||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988876432  346777788888888888888885                                        


Q ss_pred             ------------------CCceecCCCCCCeEecC--CCcEEEeeecccccccCCCccccccCCCcccCCccccC--Ccc
Q 022617          136 ------------------NMVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG--KLY  193 (294)
Q Consensus       136 ------------------~~i~h~di~p~nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~  193 (294)
                                        ..++|+|++|.||+++.  ++.+.++||+.+.................-.+|+....  ..+
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                              13799999999999998  45678999998765432211111000000012221100  000


Q ss_pred             C-----------CCchhHHHHHHHHHHHHhCCCCC
Q 022617          194 A-----------GPEVDVWSCGVILYALLCGTLPF  217 (294)
Q Consensus       194 ~-----------~~~~Di~slG~ll~~l~~g~~p~  217 (294)
                      .           ....+.|+++.++|.+.+|..+|
T Consensus       253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0           11258999999999999997665

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.96  E-value=8.5e-09  Score=84.47  Aligned_cols=146  Identities=18%  Similarity=0.248  Sum_probs=102.7

Q ss_pred             CCccccccCCcccccccccCc-eEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeEEEEEEE
Q 022617           10 SGVDMFLPNYKLGKTLGIGSF-GKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIE   87 (294)
Q Consensus        10 ~~~~~~~~~y~~~~~lg~g~~-~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~   87 (294)
                      +.++.-...|+... +..|.. +.||+......+..+++|+-...      ....+.+|...++.+.. -.++++++++.
T Consensus        18 ~~l~~~l~g~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~   90 (272)
T 4gkh_A           18 SNLDADLYGYRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIR   90 (272)
T ss_dssp             -CHHHHHTTCEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred             HHHhccccCCeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEE
Confidence            33444444455433 333444 47999888777788999985432      35678889999988753 34788899999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR--------------------------------  135 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~--------------------------------  135 (294)
                      ..+..+++||+++|.++.+.....    ......+..++...|..||.                                
T Consensus        91 ~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (272)
T 4gkh_A           91 TPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASD  166 (272)
T ss_dssp             ETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGG
T ss_pred             ECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhh
Confidence            999999999999998887765432    12233455566666666663                                


Q ss_pred             --------------------------CCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617          136 --------------------------NMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus       136 --------------------------~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                                                ..++|+|+++.||+++.++.+-|+||+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          167 FDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                      1278999999999999877777999998854

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.82  E-value=1.1e-07  Score=79.27  Aligned_cols=134  Identities=18%  Similarity=0.204  Sum_probs=93.6

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---ceeEEEEEEE-cCCeEEEEEe
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP---HIIRLYEVIE-TPSDIYVVME   97 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e   97 (294)
                      .+.++.|....||++     +..+++|+...     ......+.+|..+++.+.+.   .+++++.++. ..+..+++|+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456788888899988     46688998421     23456889999999998752   3677777774 4556789999


Q ss_pred             ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 022617           98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-----------------------------------------  136 (294)
Q Consensus        98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~-----------------------------------------  136 (294)
                      +++|.++.+..  -..++......++.++...|+.||+.                                         
T Consensus        94 ~i~G~~l~~~~--~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDG--MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHH--HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhh--hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            99998887632  12234444444445554444444431                                         


Q ss_pred             -------------------CceecCCCCCCeEecC---CCc-EEEeeecccccc
Q 022617          137 -------------------MVVHRDLKPENLLLDS---KWN-VKIADFGLSNIM  167 (294)
Q Consensus       137 -------------------~i~h~di~p~nili~~---~~~-~~l~dfg~~~~~  167 (294)
                                         .++|+|++|.||+++.   ++. +.|+||+.+...
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                               3599999999999987   455 489999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.49  E-value=4.5e-07  Score=78.43  Aligned_cols=80  Identities=16%  Similarity=0.040  Sum_probs=49.9

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeecccc-cc---hHHHHHHHHHHHHHHhCCC--C-ceeEEEEEEEcCCeEE
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI-KN---MEMEEKVRREIKILRLFMH--P-HIIRLYEVIETPSDIY   93 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~-~~---~~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~~   93 (294)
                      ..+.||.|..+.||++.+..++..+++|....... ..   ......+..|.++++.+..  + .+++++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            35678999999999997765678899998643211 00   0123456778888877642  3 45566654  344567


Q ss_pred             EEEeccCCC
Q 022617           94 VVMEYVKSG  102 (294)
Q Consensus        94 lv~e~~~~~  102 (294)
                      ++||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.38  E-value=6.4e-06  Score=63.86  Aligned_cols=135  Identities=18%  Similarity=0.119  Sum_probs=92.1

Q ss_pred             CChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCC
Q 022617          102 GELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS  179 (294)
Q Consensus       102 ~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh-~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  179 (294)
                      .||.++|+. +.+++++++|.++.|.+.+|..+- .+.-...=+.|..|++..+|.+.+.+ ..+.           ...
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~  100 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE  100 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence            489999975 578999999999999999987762 22222344567899999999998774 1110           112


Q ss_pred             CcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhccc-----
Q 022617          180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV-----  254 (294)
Q Consensus       180 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-----  254 (294)
                      ..+.|||....  ..+.+.=|||||+++|..+--..|                 ..-+..+++.|.+||..|...     
T Consensus       101 ~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~~~d~~  161 (229)
T 2yle_A          101 PPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANTVEADG  161 (229)
T ss_dssp             ------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTCCC---
T ss_pred             cCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhcccccc
Confidence            35668887642  225778899999999998852222                 122357899999999999866     


Q ss_pred             --------------------CCCCCCCHhHHhc
Q 022617          255 --------------------DPMKRITIPEIRQ  267 (294)
Q Consensus       255 --------------------~p~~Rps~~~il~  267 (294)
                                          .+..|++++++++
T Consensus       162 ~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          162 SNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             -----------------CCSCCCCCCSHHHHHH
T ss_pred             cccccccccccccccccccccccCcCCHHHHHH
Confidence                                2468889998886

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.32  E-value=2e-06  Score=73.22  Aligned_cols=85  Identities=12%  Similarity=0.119  Sum_probs=54.6

Q ss_pred             ccccc-cccCceEEEEEEEc--c----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC---CceeEEEEEEEcC-
Q 022617           21 LGKTL-GIGSFGKVKIAEHA--L----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIRLYEVIETP-   89 (294)
Q Consensus        21 ~~~~l-g~g~~~~vy~~~~~--~----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~-   89 (294)
                      ..+.| +.|..+.+|++...  .    ++..+++|...............+.+|+.+++.+..   -.+++++.++... 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            35667 88888999988753  1    156799998654320000001356677777777643   3577788877654 


Q ss_pred             --CeEEEEEeccCCCChH
Q 022617           90 --SDIYVVMEYVKSGELF  105 (294)
Q Consensus        90 --~~~~lv~e~~~~~sL~  105 (294)
                        +..+++||+++|.++.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              3568999999886653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.22  E-value=1.9e-05  Score=66.50  Aligned_cols=30  Identities=20%  Similarity=0.273  Sum_probs=27.1

Q ss_pred             CCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617          136 NMVVHRDLKPENLLLDSKWNVKIADFGLSN  165 (294)
Q Consensus       136 ~~i~h~di~p~nili~~~~~~~l~dfg~~~  165 (294)
                      .+++|+|+++.||+++.++.+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888889999999774

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.12  E-value=2.4e-05  Score=65.14  Aligned_cols=76  Identities=16%  Similarity=0.238  Sum_probs=60.0

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCeEEEEEe
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYVVME   97 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e   97 (294)
                      -.+.|+.|....+|++..  ++..+++|+....      ....+..|...++.|.   ...+++++.++...+..+++||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            356789999999999975  4678999986532      2466788888888774   3568889999888889999999


Q ss_pred             ccCCCCh
Q 022617           98 YVKSGEL  104 (294)
Q Consensus        98 ~~~~~sL  104 (294)
                      +++|.++
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998765

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.07  E-value=2.9e-05  Score=67.59  Aligned_cols=32  Identities=16%  Similarity=0.245  Sum_probs=27.8

Q ss_pred             hCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617          135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus       135 ~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      ...++|||++|.||+++.++ +.++||+.+...
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            45699999999999998876 999999987654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.00  E-value=7.7e-06  Score=67.89  Aligned_cols=72  Identities=14%  Similarity=0.048  Sum_probs=45.1

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEEEecc-
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYV-   99 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~-   99 (294)
                      .+.|+.|....+|++      ..+++|+.......    .....+|+.+++.+...++ ++++++  .+...++++|++ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence            788899999999998      45899987542110    1122456666666643333 456554  344456899999 


Q ss_pred             CCCChH
Q 022617          100 KSGELF  105 (294)
Q Consensus       100 ~~~sL~  105 (294)
                      +|.++.
T Consensus        91 ~g~~l~   96 (301)
T 3dxq_A           91 GAQTMS   96 (301)
T ss_dssp             TCEECC
T ss_pred             CCccCC
Confidence            776553

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.82  E-value=9.5e-06  Score=67.90  Aligned_cols=152  Identities=13%  Similarity=0.114  Sum_probs=80.8

Q ss_pred             CCCCccccccCCcc-----cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--ee
Q 022617            8 SSSGVDMFLPNYKL-----GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--II   80 (294)
Q Consensus         8 ~~~~~~~~~~~y~~-----~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~   80 (294)
                      +...+..+..+|.+     .+.|+.|....+|++... + ..+++|+.....     ....+..|..+++.+...+  ++
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~-g~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-K-DPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-S-CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-C-ccEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCC
Confidence            33334444445544     345667888899998753 3 368999876421     1234455666666554222  23


Q ss_pred             EEEEE------EEcCCeEEEEEeccCCCChHH----HH----------HHh-CC--------CCHHHHHH----------
Q 022617           81 RLYEV------IETPSDIYVVMEYVKSGELFD----YI----------VEK-GR--------LQEDEARN----------  121 (294)
Q Consensus        81 ~~~~~------~~~~~~~~lv~e~~~~~sL~~----~l----------~~~-~~--------l~~~~~~~----------  121 (294)
                      +++..      ....+..++++++++|.++..    ..          ... ..        .....-..          
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            33321      122456789999998865321    11          110 00        01100000          


Q ss_pred             -----HHHHHHHHHHHHHh-------CCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617          122 -----FFQQIISGVEYCHR-------NMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus       122 -----~~~ql~~~l~~Lh~-------~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                           +...+...+..+..       .+++|+|+++.||+++.++.+.++||+.+..
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                 00113334444442       3699999999999998875568999997753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.68  E-value=7.4e-05  Score=62.79  Aligned_cols=32  Identities=31%  Similarity=0.426  Sum_probs=27.5

Q ss_pred             CCceecCCCCCCeEecCC----CcEEEeeecccccc
Q 022617          136 NMVVHRDLKPENLLLDSK----WNVKIADFGLSNIM  167 (294)
Q Consensus       136 ~~i~h~di~p~nili~~~----~~~~l~dfg~~~~~  167 (294)
                      ..++|||+++.||+++.+    +.+.++||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999874    67999999988654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.61  E-value=0.00012  Score=63.82  Aligned_cols=74  Identities=19%  Similarity=0.248  Sum_probs=48.4

Q ss_pred             cccccccCceEEEEEEEcc-------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEE
Q 022617           22 GKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIY   93 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~   93 (294)
                      .+.|+.|....+|++....       .+..+++|+.....  .   ...+.+|..+++.+...++ +++++.+.  +  .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence            4567888889999998642       25789999874321  1   1344468888887754333 56666553  2  2


Q ss_pred             EEEeccCCCCh
Q 022617           94 VVMEYVKSGEL  104 (294)
Q Consensus        94 lv~e~~~~~sL  104 (294)
                      ++++|++|.+|
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            88999987443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.55  E-value=0.00013  Score=62.32  Aligned_cols=137  Identities=15%  Similarity=0.142  Sum_probs=81.0

Q ss_pred             cccccccCceEEEEEEEcc-------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCCeEE
Q 022617           22 GKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSDIY   93 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~   93 (294)
                      .+.+..|-...+|++....       ++..+++|+.-.. .   .....+.+|..+++.+...+ .+++++++.  +  .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFP--E--G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--c
Confidence            3556778888999998642       3478999986321 1   12455668888888775333 356666653  2  2


Q ss_pred             EEEeccCCCChHH-----------HH---HH--hC------CCC--HHHHHHHHHHHHH-------------------HH
Q 022617           94 VVMEYVKSGELFD-----------YI---VE--KG------RLQ--EDEARNFFQQIIS-------------------GV  130 (294)
Q Consensus        94 lv~e~~~~~sL~~-----------~l---~~--~~------~l~--~~~~~~~~~ql~~-------------------~l  130 (294)
                      +|+||++|.+|..           +.   .+  ..      +..  ..++.+++.++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            8999999865531           11   10  10      111  3445555544422                   12


Q ss_pred             HHHH----h----CCceecCCCCCCeEecCC----CcEEEeeeccccc
Q 022617          131 EYCH----R----NMVVHRDLKPENLLLDSK----WNVKIADFGLSNI  166 (294)
Q Consensus       131 ~~Lh----~----~~i~h~di~p~nili~~~----~~~~l~dfg~~~~  166 (294)
                      ..|.    .    ..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3332    2    249999999999999876    7899999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.52  E-value=0.00024  Score=59.39  Aligned_cols=136  Identities=12%  Similarity=0.149  Sum_probs=76.4

Q ss_pred             ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeEEEEE-----EEcCCeEEEE
Q 022617           23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYEV-----IETPSDIYVV   95 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~lv   95 (294)
                      ..++ |....||++... +|+.+++|+.......    ...+..|..+++.+...+  +++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3455 777899988653 4667999998533211    345566777776664222  3444332     1224566889


Q ss_pred             EeccCCCChH----HHH----------HH---hC------CCCHHHH----------------------HHHHHHHHHHH
Q 022617           96 MEYVKSGELF----DYI----------VE---KG------RLQEDEA----------------------RNFFQQIISGV  130 (294)
Q Consensus        96 ~e~~~~~sL~----~~l----------~~---~~------~l~~~~~----------------------~~~~~ql~~~l  130 (294)
                      +++++|.++.    +.+          ..   ..      ..+....                      ...+.+++..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999875432    111          00   00      1111110                      11112222222


Q ss_pred             HHH----HhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617          131 EYC----HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus       131 ~~L----h~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      ..+    ....++|||+++.||+++ + .+.++||+.+..
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            222    123589999999999998 4 899999987754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.40  E-value=0.0018  Score=53.11  Aligned_cols=80  Identities=16%  Similarity=0.061  Sum_probs=55.8

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---ceeEEEEEEEcCCeEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP---HIIRLYEVIETPSDIY   93 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~   93 (294)
                      .+..-++.+|.|..+.||++... +|+.|++|+.......   ....+..|...|+.|...   .++++++..    .-+
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~   86 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT   86 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence            34556788899999999999864 7889999986433211   134577899988888532   355666543    236


Q ss_pred             EEEeccCCCCh
Q 022617           94 VVMEYVKSGEL  104 (294)
Q Consensus        94 lv~e~~~~~sL  104 (294)
                      ++||++.+...
T Consensus        87 lv~e~l~~~~~   97 (288)
T 3f7w_A           87 LAMEWVDERPP   97 (288)
T ss_dssp             EEEECCCCCCC
T ss_pred             EEEEeecccCC
Confidence            88999877653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.34  E-value=0.0003  Score=59.97  Aligned_cols=75  Identities=11%  Similarity=0.039  Sum_probs=43.6

Q ss_pred             cccccccCceEEEEEEEcc--------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCCeE
Q 022617           22 GKTLGIGSFGKVKIAEHAL--------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSDI   92 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~--------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~   92 (294)
                      .+.|+.|....+|++....        .+..+++|+..... .   .......|..+++.+...+ .+++++..  .  -
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-D---ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-G---GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-c---ceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence            4567788888999998653        13678999875321 1   1112356777777665333 45666544  2  2


Q ss_pred             EEEEeccCCCCh
Q 022617           93 YVVMEYVKSGEL  104 (294)
Q Consensus        93 ~lv~e~~~~~sL  104 (294)
                      ++++++++|.++
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            689999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.21  E-value=0.003  Score=53.09  Aligned_cols=32  Identities=19%  Similarity=0.373  Sum_probs=27.8

Q ss_pred             CCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617          136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus       136 ~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      ..++|+|+.+.||+++.++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            45999999999999998888999999877543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.21  E-value=0.01  Score=52.02  Aligned_cols=76  Identities=14%  Similarity=0.162  Sum_probs=48.2

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEEEecc
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYV   99 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~   99 (294)
                      -.+.|+.|-...+|++.....+..+++|+..... ..   .-.-.+|..+++.|...++ +++++.+  .+.  +++||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~---~idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE---IINREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS---CSCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh---hcCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEee
Confidence            3566788888999999875435789999874321 11   1112578888888875554 5677666  232  599999


Q ss_pred             CCCCh
Q 022617          100 KSGEL  104 (294)
Q Consensus       100 ~~~sL  104 (294)
                      +|.+|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.75  E-value=0.03  Score=48.43  Aligned_cols=75  Identities=11%  Similarity=0.144  Sum_probs=46.7

Q ss_pred             cccccccCceEEEEEEEccC-------CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCCeEE
Q 022617           22 GKTLGIGSFGKVKIAEHALT-------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSDIY   93 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~   93 (294)
                      ++.+..|-...+|++.....       +..+++++..... .   ..-...+|..+++.+...+ .+++++.+  .+  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~---~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-G---KFYDSKVELDVFRYLSNINIAPNIIADF--PE--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-c---hhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence            55677788889999986521       5789999864321 1   1112356777777665323 45556533  22  6


Q ss_pred             EEEeccCCCCh
Q 022617           94 VVMEYVKSGEL  104 (294)
Q Consensus        94 lv~e~~~~~sL  104 (294)
                      .|++|++|.+|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            88999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.62  E-value=0.054  Score=46.53  Aligned_cols=29  Identities=31%  Similarity=0.485  Sum_probs=25.1

Q ss_pred             ceecCCCCCCeEe------cCCCcEEEeeeccccc
Q 022617          138 VVHRDLKPENLLL------DSKWNVKIADFGLSNI  166 (294)
Q Consensus       138 i~h~di~p~nili------~~~~~~~l~dfg~~~~  166 (294)
                      ++|+|+.+.||++      ++++.+.++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            7899999999999      4466799999998864

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.21  E-value=1.2  Score=34.52  Aligned_cols=113  Identities=17%  Similarity=0.170  Sum_probs=74.6

Q ss_pred             CCCceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHH-HHHhCCceecCCCCCCeEecCC
Q 022617           75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE-YCHRNMVVHRDLKPENLLLDSK  153 (294)
Q Consensus        75 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~-~Lh~~~i~h~di~p~nili~~~  153 (294)
                      .||++  ...+-..++.+.+.++.-++..-+..+   ..++....++++.+|+.... ++  ..-.|--++|+|++++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            47777  444556777777777765443333333   34688999999999987655 33  445677899999999999


Q ss_pred             CcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhH-HHHHHHHHHHHhCCCCC
Q 022617          154 WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV-WSCGVILYALLCGTLPF  217 (294)
Q Consensus       154 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di-~slG~ll~~l~~g~~p~  217 (294)
                      +.+++.-.|.-..                ++|...       ...|. -.+=+++..++.++..|
T Consensus       121 ~~p~i~hRGi~~~----------------lpP~e~-------~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          121 LEPFFLHVGVKES----------------LPPDEW-------DDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             CCEEESCCEETTT----------------BSSCSC-------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CcEEEEEcCCccc----------------CCCCCC-------CHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999998886532                233321       12233 34557777787776555

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.17  E-value=1.9  Score=33.29  Aligned_cols=114  Identities=14%  Similarity=0.131  Sum_probs=75.2

Q ss_pred             CCCceeEEEEEEEcCCeEEEEEeccCCC-ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC
Q 022617           75 MHPHIIRLYEVIETPSDIYVVMEYVKSG-ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK  153 (294)
Q Consensus        75 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~  153 (294)
                      .+|+++.. .+-+..+.+.+.++.-+.+ +... +   ..++....++++.+|+....++  ..-+|--++|+|++++.+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence            57888766 4556667666666554322 2222 2   3468889999999999877433  334677899999999999


Q ss_pred             CcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCC
Q 022617          154 WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF  217 (294)
Q Consensus       154 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~  217 (294)
                      +.+++.-.|.....                +|..     . +...=.-..=+++..+++++..|
T Consensus       116 ~~p~i~~RGik~~l----------------~P~~-----~-~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          116 GLPIAKTRGLQNVV----------------DPLP-----V-SEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             SCEEESCCEETTTB----------------SCCC-----C-CHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             CCEEEEEccCccCC----------------CCCC-----C-CHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999987765322                2221     1 22223335567888888887776

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.97  E-value=0.12  Score=45.25  Aligned_cols=63  Identities=6%  Similarity=0.013  Sum_probs=17.2

Q ss_pred             cccccccccCceEEEEEEEccCCceEEE------EEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617           20 KLGKTLGIGSFGKVKIAEHALTGHKVAI------KILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI   86 (294)
Q Consensus        20 ~~~~~lg~g~~~~vy~~~~~~~~~~~~~------K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   86 (294)
                      .+.+.||   ||.||++.......+||+      |....... ..+....+.++..+.+.++|+|+++.+++.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceE
Confidence            4456666   999999998765567887      55432221 223345677788888889999999988765

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	294
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-98
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-93
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-91
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-90
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-89
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-89
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-88
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-88
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-88
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-87
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-86
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-86
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-85
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-84
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-83
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-83
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-82
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-81
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-80
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-79
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-77
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-76
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-76
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-75
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-73
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-72
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-71
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-71
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-70
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-69
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-69
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-69
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-68
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-68
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-68
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-68
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-67
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-67
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-67
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-67
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-66
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-66
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-66
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-66
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-65
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-65
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-65
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-62
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-61
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-60
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-59
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-59
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-57
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-57
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-55
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-54
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-46
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-22

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  286 bits (734), Expect = 5e-98
 Identities = 88/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++G+ LG G FG V +A    +   +A+K+L + +++   +E ++RRE++I     
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP+I+RLY      + +Y+++EY   G ++  + +  +  E     +  ++ + + YCH 
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             V+HRD+KPENLLL S   +KIADFG S          T CG+ +Y  PE+I G+++  
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMH-D 182

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
            +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 242

Query: 256 PMKRITIPEIRQHPWFQAH 274
           P +R  + E+ +HPW  A+
Sbjct: 243 PSQRPMLREVLEHPWITAN 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  276 bits (706), Expect = 1e-93
 Identities = 91/269 (33%), Positives = 155/269 (57%), Gaps = 8/269 (2%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           F+ ++ L +TLG G++G+V++A + +T   VA+KI++ ++    +  E +++EI I ++ 
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 60

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
            H ++++ Y      +  Y+ +EY   GELFD I     + E +A+ FF Q+++GV Y H
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGK 191
              + HRD+KPENLLLD + N+KI+DFGL+ + R       L   CG+  Y APE++  +
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLP--SHLSPGARDLI 248
            +    VDVWSCG++L A+L G LP+D   +    +   K     L     +      L+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
            ++L+ +P  RITIP+I++  W+   L +
Sbjct: 241 HKILVENPSARITIPDIKKDRWYNKPLKK 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  271 bits (693), Expect = 2e-91
 Identities = 87/264 (32%), Positives = 137/264 (51%), Gaps = 10/264 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++K GK LG GSF  V +A    T  + AIKIL +R I        V RE  ++    HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
             ++LY   +    +Y  + Y K+GEL  YI + G   E   R +  +I+S +EY H   
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYA 194
           ++HRDLKPEN+LL+   +++I DFG + ++          +  G+  Y +PE+++ K   
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA- 187

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
               D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ ++L++
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247

Query: 255 DPMKRITI------PEIRQHPWFQ 272
           D  KR+          ++ HP+F+
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFE 271

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  268 bits (686), Expect = 2e-90
 Identities = 102/277 (36%), Positives = 149/277 (53%), Gaps = 16/277 (5%)

Query: 15  FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM------EMEEKVRREI 68
           F  NY+  + LG G    V+   H  T  + A+KI++     +       E+ E   +E+
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 69  KILR-LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
            ILR +  HP+II+L +  ET +  ++V + +K GELFDY+ EK  L E E R   + ++
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 120

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
             +   H+  +VHRDLKPEN+LLD   N+K+ DFG S  +  G  L+  CG+P+Y APE+
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 188 ISGKLYA-----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---- 238
           I   +       G EVD+WS GVI+Y LL G+ PF       + + I  G Y   S    
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275
             S   +DL+ R L+V P KR T  E   HP+FQ ++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  268 bits (686), Expect = 1e-89
 Identities = 88/288 (30%), Positives = 152/288 (52%), Gaps = 12/288 (4%)

Query: 13  DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
           D  L +Y + + LG G+FG V       TG+  A K +      +   +E VR+EI+ + 
Sbjct: 22  DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMS 78

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVE 131
           +  HP ++ L++  E  +++ ++ E++  GELF+ + ++  ++ EDEA  + +Q+  G+ 
Sbjct: 79  VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138

Query: 132 YCHRNMVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           + H N  VH DLKPEN++  +K +  +K+ DFGL+  +     +K + G+  +AAPEV  
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198

Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245
           GK   G   D+WS GV+ Y LL G  PF  EN     + +K   + +     S +S   +
Sbjct: 199 GKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257

Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQ-AHLPRYLAVPPPDTMQQAKK 292
           D I ++L+ DP  R+TI +  +HPW    + P   +  P     + + 
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD 305

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  268 bits (686), Expect = 2e-89
 Identities = 81/282 (28%), Positives = 143/282 (50%), Gaps = 11/282 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y + + LG G+FG V       TG     K +N     +   +  V+ EI I+    HP
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHP 86

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRN 136
            +I L++  E   ++ +++E++  GELFD I  +  ++ E E  N+ +Q   G+++ H +
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 137 MVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
            +VH D+KPEN++ ++K    VKI DFGL+  +     +K +  +  +AAPE++  +   
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV- 205

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPR 250
           G   D+W+ GV+ Y LL G  PF  E+     + +K   +       S +SP A+D I  
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265

Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
           +L  +P KR+T+ +  +HPW +       +  P     + ++
Sbjct: 266 LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 307

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  264 bits (676), Expect = 1e-88
 Identities = 107/261 (40%), Positives = 145/261 (55%), Gaps = 10/261 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y     LG G+F +V +AE   T   VAIK + ++ ++  E    +  EI +L    HP+
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPN 68

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
           I+ L ++ E+   +Y++M+ V  GELFD IVEKG   E +A     Q++  V+Y H   +
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 139 VHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
           VHRDLKPENLL    D    + I+DFGLS +   G  L T+CG+P Y APEV++ K Y  
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 187

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
             VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I  +
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247

Query: 252 LIVDPMKRITIPEIRQHPWFQ 272
           +  DP KR T  +  QHPW  
Sbjct: 248 MEKDPEKRFTCEQALQHPWIA 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  263 bits (673), Expect = 2e-88
 Identities = 82/277 (29%), Positives = 140/277 (50%), Gaps = 9/277 (3%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y   + +G G+ G V  A    TG +VAI+ +    ++    +E +  EI ++R   +P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNP 77

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+   +      +++VVMEY+  G L D +  +  + E +     ++ +  +E+ H N 
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
           V+HRD+K +N+LL    +VK+ DFG    I  +     T  G+P + APEV++ K Y GP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 195

Query: 197 EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 253
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 254 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQA 290
           +D  KR +  E+ QH + +   P     P     ++A
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEA 292

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  263 bits (673), Expect = 4e-88
 Identities = 71/278 (25%), Positives = 115/278 (41%), Gaps = 7/278 (2%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           +   + +G GSFG V  A        VAIK ++    ++ E  + + +E++ L+   HP+
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 79  IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
            I+           ++VMEY          V K  LQE E        + G+ Y H + +
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY--AGP 196
           +HRD+K  N+LL     VK+ DFG ++IM   +   +  G+P + APEVI          
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYDG 193

Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
           +VDVWS G+    L     P  + N  +    I           H S   R+ +   L  
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253

Query: 255 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
            P  R T   + +H +     P  + +      + A +
Sbjct: 254 IPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 291

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  261 bits (669), Expect = 1e-87
 Identities = 75/283 (26%), Positives = 133/283 (46%), Gaps = 16/283 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            +++   LG G+FGKV  A++  T    A K+++    K+ E  E    EI IL    HP
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT---KSEEELEDYMVEIDILASCDHP 69

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRN 136
           +I++L +     +++++++E+   G +   ++E  R L E + +   +Q +  + Y H N
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYA- 194
            ++HRDLK  N+L     ++K+ADFG+S    R      +  G+P + APEV+  +    
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 195 ---GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLI 248
                + DVWS G+ L  +     P  + N   +  KI          PS  S   +D +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 291
            + L  +   R T  ++ QHP+      +    P  + + +AK
Sbjct: 250 KKCLEKNVDARWTTSQLLQHPFVTVDSNK----PIRELIAEAK 288

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (662), Expect = 3e-86
 Identities = 69/279 (24%), Positives = 128/279 (45%), Gaps = 12/279 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y + + LG G FG V       +      K +  +       +  V++EI IL +  H 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHR 61

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRN 136
           +I+ L+E  E+  ++ ++ E++   ++F+ I      L E E  ++  Q+   +++ H +
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 137 MVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
            + H D++PEN++  ++ +  +KI +FG +  ++ G   +    +P Y APEV    +  
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV- 180

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
               D+WS G ++Y LL G  PF  E    + + I    YT        +S  A D + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
           +L+ +   R+T  E  QHPW +  + R           +
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHR 279

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  258 bits (661), Expect = 4e-86
 Identities = 94/273 (34%), Positives = 146/273 (53%), Gaps = 8/273 (2%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-H 76
           ++ L K LG GSFGKV +AE   T    AIK L +  +   +  E    E ++L L   H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           P +  ++   +T  +++ VMEY+  G+L  +I    +     A  +  +II G+++ H  
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAG 195
            +V+RDLK +N+LLD   ++KIADFG+      G     + CG+P+Y APE++ G+ Y  
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-N 181

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD WS GV+LY +L G  PF  ++   LF  I+      P  L   A+DL+ ++ + +
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVRE 241

Query: 256 PMKRITIP-EIRQHPWFQ----AHLPRYLAVPP 283
           P KR+ +  +IRQHP F+      L R    PP
Sbjct: 242 PEKRLGVRGDIRQHPLFREINWEELERKEIDPP 274

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (649), Expect = 6e-85
 Identities = 86/266 (32%), Positives = 137/266 (51%), Gaps = 15/266 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y++  T+G GS+G+ +       G  +  K L+   +   E +  +  E+ +LR   HP
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHP 63

Query: 78  HIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVE 131
           +I+R Y+ I   T + +Y+VMEY + G+L   I     E+  L E+       Q+   ++
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 132 YCHR-----NMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAP 185
            CHR     + V+HRDLKP N+ LD K NVK+ DFGL+ I+  D  F K   G+P Y +P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGA 244
           E ++   Y   + D+WS G +LY L     PF   +   L  KI+ G +  +P   S   
Sbjct: 184 EQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242

Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPW 270
            ++I RML +    R ++ EI ++P 
Sbjct: 243 NEIITRMLNLKDYHRPSVEEILENPL 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  251 bits (643), Expect = 4e-84
 Identities = 68/264 (25%), Positives = 127/264 (48%), Gaps = 14/264 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
            K    +G GSF  V       T  +VA   L  RK+   E +   + E ++L+   HP+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPN 69

Query: 79  IIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           I+R Y+  E+       I +V E + SG L  Y+     ++    R++ +QI+ G+++ H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 135 RN--MVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
                ++HRDLK +N+ +     +VKI D GL+ + R   F K   G+P + APE+   K
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEK 188

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIY--TLPSHLSPGARDLI 248
                 VDV++ G+ +  +     P+ +  N   +++++  G+   +      P  +++I
Sbjct: 189 Y--DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246

Query: 249 PRMLIVDPMKRITIPEIRQHPWFQ 272
              +  +  +R +I ++  H +FQ
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFFQ 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (640), Expect = 5e-83
 Identities = 61/300 (20%), Positives = 122/300 (40%), Gaps = 49/300 (16%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +++    LG G+ G V    H  +G  +A K++         +  ++ RE+++L     P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSP 64

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RN 136
           +I+  Y    +  +I + ME++  G L   + + GR+ E         +I G+ Y   ++
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
            ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y   
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY-SV 182

Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS------------------ 238
           + D+WS G+ L  +  G  P    +   L       +    +                  
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242

Query: 239 --------------------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                                       S   +D + + LI +P +R  + ++  H + +
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  250 bits (639), Expect = 6e-83
 Identities = 84/262 (32%), Positives = 144/262 (54%), Gaps = 8/262 (3%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L ++++ +TLG GSFG+V +      G   A+K+L +  +  ++  E    E  +L +  
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP IIR++   +    I+++M+Y++ GELF  + +  R     A+ +  ++   +EY H 
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPEN+LLD   ++KI DFG +  + D     T CG+P+Y APEV+S K Y  
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPY-N 179

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             +D WS G+++Y +L G  PF D N    ++KI       P   +   +DL+ R++  D
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239

Query: 256 PMKRI-----TIPEIRQHPWFQ 272
             +R+        +++ HPWF+
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFK 261

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (633), Expect = 2e-82
 Identities = 101/265 (38%), Positives = 148/265 (55%), Gaps = 12/265 (4%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
           Y  G+ LG G F  VK      TG + A K + +R+ K+       E + RE+ IL+   
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           HP++I L+EV E  +D+ +++E V  GELFD++ EK  L E+EA  F +QI++GV Y H 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 136 NMVVHRDLKPENLLLDS----KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
             + H DLKPEN++L      K  +KI DFGL++ +  G+  K   G+P + APE+++ +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
              G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D 
Sbjct: 192 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250

Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQ 272
           I R+L+ DP KR+TI +  QHPW +
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWIK 275

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  247 bits (632), Expect = 4e-81
 Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 12/266 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRRE---IKILRLF 74
           ++ + + +G G FG+V     A TG   A+K L++++IK  + E     E   + ++   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
             P I+ +     TP  +  +++ +  G+L  ++ + G   E + R +  +II G+E+ H
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
              VV+RDLKP N+LLD   +V+I+D GL+           S G+  Y APEV+   +  
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAY 183

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRM 251
               D +S G +L+ LL G  PF      +   + +        LP   SP  R L+  +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243

Query: 252 LIVDPMKRITIP-----EIRQHPWFQ 272
           L  D  +R+        E+++ P+F+
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFFR 269

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (621), Expect = 6e-80
 Identities = 94/261 (36%), Positives = 140/261 (53%), Gaps = 7/261 (2%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           ++   K LG G+FGKV +     TG   A+KIL +  I   +       E ++L+   HP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            +  L    +T   +  VMEY   GELF ++  +    E+ AR +  +I+S +EY H   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
           VV+RD+K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G 
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 184

Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244

Query: 257 MKRI-----TIPEIRQHPWFQ 272
            +R+        E+ +H +F 
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL 265

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (610), Expect = 4e-79
 Identities = 85/261 (32%), Positives = 136/261 (52%), Gaps = 14/261 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN---MEMEEKVRREIKILRLF- 74
           Y++G  LG G FG V           VAIK + + +I +   +    +V  E+ +L+   
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 75  -MHPHIIRLYEVIETPSDIYVVMEYVK-SGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
                +IRL +  E P    +++E  +   +LFD+I E+G LQE+ AR+FF Q++  V +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 133 CHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           CH   V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I   
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYH 184

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
            Y G    VWS G++LY ++CG +PF+ +       +I  G       +S   + LI   
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWC 238

Query: 252 LIVDPMKRITIPEIRQHPWFQ 272
           L + P  R T  EI+ HPW Q
Sbjct: 239 LALRPSDRPTFEEIQNHPWMQ 259

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (600), Expect = 8e-77
 Identities = 95/283 (33%), Positives = 138/283 (48%), Gaps = 28/283 (9%)

Query: 13  DMFLPNYK-LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
           +  + +YK   + LG+G  GKV    +  T  K A+K+L            K RRE+++ 
Sbjct: 7   NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 58

Query: 72  -RLFMHPHIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
            R    PHI+R+ +V E        + +VME +  GELF  I ++G     E EA    +
Sbjct: 59  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118

Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
            I   ++Y H   + HRD+KPENLL  SK     +K+ DFG +      + L T C +P 
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 178

Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
           Y APEV+  + Y     D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P
Sbjct: 179 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237

Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
               S +S   + LI  +L  +P +R+TI E   HPW      
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  234 bits (598), Expect = 2e-76
 Identities = 93/262 (35%), Positives = 148/262 (56%), Gaps = 8/262 (3%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  +   KTLG GSFG+V + +H  +G+  A+KIL+++K+  ++  E    E +IL+   
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
            P +++L    +  S++Y+VMEYV  GE+F ++   GR  E  AR +  QI+   EY H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
             +++RDLKPENLL+D +  +++ DFG +  ++   +  T CG+P   APE+I  K Y  
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILSKGY-N 216

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
             VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276

Query: 256 PMKRI-----TIPEIRQHPWFQ 272
             KR       + +I+ H WF 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 8e-76
 Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 18/273 (6%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
              +G+ +G GSFG V   +       VA+K+LN       +++   + E+ +LR   H 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHV 64

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRN 136
           +I+       T   + +V ++ +   L+ ++ + + + +  +  +  +Q   G++Y H  
Sbjct: 65  NILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY 193
            ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI  +  
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 194 A--GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP------SHLSPGAR 245
                + DV++ G++LY L+ G LP+ + N  +    + G  Y  P      S+     +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243

Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPR 277
            L+   L     +R   P+I          LP+
Sbjct: 244 RLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  230 bits (586), Expect = 2e-75
 Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 13/268 (4%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+LG+ LG G   +V +A        VA+K+L     ++     + RRE +      HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 79  IIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           I+ +Y+  E  +      Y+VMEYV    L D +  +G +    A          + + H
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISG 190
           +N ++HRD+KP N+++ +   VK+ DFG++  + D            G+  Y +PE   G
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188

Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARD 246
                   DV+S G +LY +L G  PF  ++  ++  +        PS     LS     
Sbjct: 189 DSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 247

Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274
           ++ + L  +P  R       +    + H
Sbjct: 248 VVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (572), Expect = 4e-73
 Identities = 74/294 (25%), Positives = 117/294 (39%), Gaps = 34/294 (11%)

Query: 23  KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKILRLFMHPHII 80
             LG G F  V  A    T   VAIK +        +  +     REIK+L+   HP+II
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 81  RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
            L +     S+I +V +++++            L     + +    + G+EY H++ ++H
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-SCGSPNYAAPEVISGKLYAGPEVD 199
           RDLKP NLLLD    +K+ADFGL+      +   T    +  Y APE++ G    G  VD
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183

Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------------ 235
           +W+ G IL  LL        ++  +   +I   + T                        
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243

Query: 236 ----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
               + S       DLI  + + +P  RIT  +  +  +F     R    P   
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS---NRPGPTPGCQ 294

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 1e-72
 Identities = 69/256 (26%), Positives = 119/256 (46%), Gaps = 15/256 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             KL +T+G G FG V + ++   G+KVA+K      IKN    +    E  ++    H 
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEASVMTQLRHS 60

Query: 78  HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCH 134
           ++++L  V +E    +Y+V EY+  G L DY+  +GR  L  D    F   +   +EY  
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
            N  VHRDL   N+L+      K++DFGL+          T      + APE +  K + 
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKF- 177

Query: 195 GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRML 252
             + DVWS G++L+ +   G +P+    + ++  ++ KG     P    P   +++    
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237

Query: 253 IVDPMKRITIPEIRQH 268
            +D   R +  ++R+ 
Sbjct: 238 HLDAAMRPSFLQLREQ 253

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 3e-71
 Identities = 80/308 (25%), Positives = 133/308 (43%), Gaps = 43/308 (13%)

Query: 17  PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
           P Y     +G G++G V  A   +   +VAIK +     ++    ++  REIKIL  F H
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRH 65

Query: 77  PHIIRLYEVIETPS----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
            +II + ++I  P+        ++ ++   +L+  + +   L  D    F  QI+ G++Y
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVI 188
            H   V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------- 235
                    +D+WS G IL  +L     F  ++  +    I G + +             
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 236 ------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 276
                             L  +    A DL+ +ML  +P KRI + +   HP+  Q + P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304

Query: 277 RYLAVPPP 284
               +   
Sbjct: 305 SDEPIAEA 312

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 3e-71
 Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 47/308 (15%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y+    +G G+FG+V  A H  TG KVA+K +     K         REIKIL+L  H 
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHE 69

Query: 78  HIIRLYEVIETPS--------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           +++ L E+  T +         IY+V ++ +            +    E +   Q +++G
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAA 184
           + Y HRN ++HRD+K  N+L+     +K+ADFGL+           +       +  Y  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----- 239
           PE++ G+   GP +D+W  G I+  +   +         +    I     ++        
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 240 ---------------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                                        P A DLI ++L++DP +RI   +   H +F 
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309

Query: 273 -AHLPRYL 279
              +P  L
Sbjct: 310 SDPMPSDL 317

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  216 bits (551), Expect = 4e-70
 Identities = 78/287 (27%), Positives = 133/287 (46%), Gaps = 32/287 (11%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           +  Y   + +G G++G V  A++   G   A+K +   K ++  +     REI IL+   
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELK 58

Query: 76  HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
           H +I++LY+VI T   + +V E++         V +G L+   A++F  Q+++G+ YCH 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYA 194
             V+HRDLKP+NLL++ +  +KIADFGL+               +  Y AP+V+ G    
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------- 235
              +D+WS G I   ++ GT  F   +  +   +I   + T                   
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 236 ----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                         L     DL+ +ML +DP +RIT  +  +H +F+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 1e-69
 Identities = 65/273 (23%), Positives = 121/273 (44%), Gaps = 17/273 (6%)

Query: 14  MFLPNYKLG---KTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREI 68
           ++L    L    K LG G+FG VK   + +      VA+KIL + +  +  +++++  E 
Sbjct: 1   VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEA 59

Query: 69  KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
            +++   +P+I+R+  + E  S   +VME  + G L  Y+ +   +++        Q+  
Sbjct: 60  NVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS----CGSPNYAA 184
           G++Y   +  VHRDL   N+LL ++   KI+DFGLS  +R       +         + A
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSP 242
           PE I+   +   + DVWS GV+++     G  P+       +   + KG     P+    
Sbjct: 179 PECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 237

Query: 243 GARDLIPRMLIVDPMKRITIPEIR---QHPWFQ 272
              DL+      D   R     +    ++ ++ 
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (547), Expect = 5e-69
 Identities = 92/300 (30%), Positives = 155/300 (51%), Gaps = 20/300 (6%)

Query: 5   SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKI-KNMEM 60
           +N +     + + N++L K LG G++GKV +        TG   A+K+L +  I +  + 
Sbjct: 12  ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 71

Query: 61  EEKVRREIKILRLFMH-PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
            E  R E ++L      P ++ L+   +T + ++++++Y+  GELF ++ ++ R  E E 
Sbjct: 72  TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV 131

Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSC 177
           + +  +I+  +E+ H+  +++RD+K EN+LLDS  +V + DFGLS      +       C
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 191

Query: 178 GSPNYAAPEVISGKLYA-GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT- 235
           G+  Y AP+++ G        VD WS GV++Y LL G  PF  +   N   +I   I   
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251

Query: 236 ---LPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAHLPRYLA---VPPP 284
               P  +S  A+DLI R+L+ DP KR+        EI++H +FQ      LA   VP P
Sbjct: 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 311

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 8e-69
 Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 32/286 (11%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           N++  + +G G++G V  A + LTG  VA+K + R   +   +     REI +L+   HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 61

Query: 78  HIIRLYEVIETPSDIYVVMEYV-KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           +I++L +VI T + +Y+V E++ +  + F        +     +++  Q++ G+ +CH +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAG 195
            V+HRDLKP+NLL++++  +K+ADFGL+               +  Y APE++ G  Y  
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-------------------- 235
             VD+WS G I   ++     F  ++  +   +I   + T                    
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 236 ---------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                    +   L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 2e-68
 Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 42/291 (14%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+  + +G G++G V  A    TG KVAIK L  R  ++    ++  RE+++L+   H +
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHEN 78

Query: 79  IIRLYEVIETPS------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
           +I L +V           D Y+VM ++  G     +++  +L ED  +    Q++ G+ Y
Sbjct: 79  VIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
            H   ++HRDLKP NL ++    +KI DFGL+        +     +  Y APEVI   +
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVILNWM 194

Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS-------------- 238
                VD+WS G I+  ++ G   F   +  +  K+I     T P+              
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254

Query: 239 -----------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                            + SP A +L+ +ML++D  +R+T  E   HP+F+
Sbjct: 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 3e-68
 Identities = 77/294 (26%), Positives = 117/294 (39%), Gaps = 46/294 (15%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +Y   K +G GSFG V  A+   +G  VAIK + + K           RE++I+R   H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHC 73

Query: 78  HIIRLYEVIETPSD------IYVVMEYVKSG---ELFDYIVEKGRLQEDEARNFFQQIIS 128
           +I+RL     +  +      + +V++YV          Y   K  L     + +  Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 129 GVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
            + Y H   + HRD+KP+NLLLD     +K+ DFG +  +  G    +   S  Y APE+
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193

Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------ 235
           I G       +DVWS G +L  LL G   F  ++  +   +I   + T            
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 236 -----------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                                  P A  L  R+L   P  R+T  E   H +F 
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 4e-68
 Identities = 58/256 (22%), Positives = 113/256 (44%), Gaps = 11/256 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +    K LG G FG VK  +     + VAIK++    +     E++   E K++    H 
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHE 59

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRN 136
            +++LY V      I+++ EY+ +G L +Y+   + R Q  +     + +   +EY    
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA 194
             +HRDL   N L++ +  VK++DFGLS  + D  +  +        ++ PEV+    + 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF- 178

Query: 195 GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRML 252
             + D+W+ GV+++ +   G +P++        + I  G+    P   S     ++    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238

Query: 253 IVDPMKRITIPEIRQH 268
                +R T   +  +
Sbjct: 239 HEKADERPTFKILLSN 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 7e-68
 Identities = 68/286 (23%), Positives = 116/286 (40%), Gaps = 38/286 (13%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
           N + GK LG G+FGKV  A            +VA+K+L  +   +    E +  E+K++ 
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95

Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-------------------- 111
           +L  H +I+ L         IY++ EY   G+L +Y+  K                    
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 112 ---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168
                L  ++   F  Q+  G+E+      VHRDL   N+L+     VKI DFGL+  + 
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 169 DG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPN 224
                     +     + APE +   +Y   + DVWS G++L+ +   G  P+    +  
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 225 LFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
            F K+    + +  P + +     ++      D  KR + P +   
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 1e-67
 Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 15/269 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           + +L   LG G FG+V +     T  +VAIK L           E   +E ++++   H 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK----PGTMSPEAFLQEAQVMKKLRHE 72

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHR 135
            +++LY V+ +   IY+V EY+  G L D++  +    L+  +  +   QI SG+ Y  R
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLY 193
              VHRDL+  N+L+      K+ADFGL+ ++ D  +           + APE      +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251
              + DVWS G++L  L   G +P+       +  +++ G     P        DL+ + 
Sbjct: 192 -TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250

Query: 252 LIVDPMKRITIPEIRQ--HPWFQAHLPRY 278
              +P +R T   ++     +F +  P+Y
Sbjct: 251 WRKEPEERPTFEYLQAFLEDYFTSTEPQY 279

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 1e-67
 Identities = 62/270 (22%), Positives = 111/270 (41%), Gaps = 20/270 (7%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMH 76
           + K    +G G+FG+V  A     G ++   I   ++  + +       E+++L +L  H
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEAR 120
           P+II L    E    +Y+ +EY   G L D++ +                   L   +  
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
           +F   +  G++Y  +   +HRDL   N+L+   +  KIADFGLS                
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 190

Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKI-KGGIYTLPS 238
            + A E ++         DVWS GV+L+ ++  G  P+       L++K+ +G     P 
Sbjct: 191 RWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 249

Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           +      DL+ +     P +R +  +I   
Sbjct: 250 NCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 2e-67
 Identities = 71/275 (25%), Positives = 117/275 (42%), Gaps = 19/275 (6%)

Query: 13  DMFLP--NYKLGKT-LGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRRE 67
            +FL   N  +    LG G+FG V+   + +   +  VAIK+L  ++       E++ RE
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMRE 59

Query: 68  IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQI 126
            +I+    +P+I+RL  V +  + + +VME    G L  ++V K   +          Q+
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118

Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS----CGSPNY 182
             G++Y      VHRDL   N+LL ++   KI+DFGLS  +       T+         +
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY-TLPSHL 240
            APE I+ + +     DVWS GV ++  L  G  P+     P +   I+ G     P   
Sbjct: 179 YAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 237

Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQ---HPWFQ 272
            P    L+    I     R     + Q     ++ 
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 4e-67
 Identities = 68/262 (25%), Positives = 105/262 (40%), Gaps = 13/262 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
           + +L + LG GSFG V+  E      K   VA+K L    +   E  +   RE+  +   
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYC 133
            H ++IRLY V+ TP  + +V E    G L D + +  G         +  Q+  G+ Y 
Sbjct: 69  DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVIS 189
                +HRDL   NLLL ++  VKI DFGL   +          +       + APE + 
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARD 246
            + +     D W  GV L+ +   G  P+   N   +  KI      L  P        +
Sbjct: 188 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246

Query: 247 LIPRMLIVDPMKRITIPEIRQH 268
           ++ +     P  R T   +R  
Sbjct: 247 VMVQCWAHKPEDRPTFVALRDF 268

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 2e-66
 Identities = 83/305 (27%), Positives = 137/305 (44%), Gaps = 43/305 (14%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y+    +G G++G V  A    TG +VA+K L  R  +++   ++  RE+++L+   H 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 78  HIIRLYEVIETPS------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
           ++I L +V           D+Y+V   +  G   + IV+  +L +D  +    QI+ G++
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
           Y H   ++HRDLKP NL ++    +KI DFGL+        +     +  Y APE++   
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNW 193

Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL----------- 240
           ++    VD+WS G I+  LL G   F   +  +  K I   + T  + L           
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253

Query: 241 --------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYL 279
                               +P A DL+ +ML++D  KRIT  +   H +F Q H P   
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313

Query: 280 AVPPP 284
            V  P
Sbjct: 314 PVADP 318

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 3e-66
 Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 39/292 (13%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK-VAIKILNRRKIKNMEMEEKVRREIKILRL--- 73
            Y+    +G G++GKV  A     G + VA+K +  +  +   M     RE+ +LR    
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLET 66

Query: 74  FMHPHIIRLYEVIETPSD-----IYVVMEYVKSGEL-FDYIVEKGRLQEDEARNFFQQII 127
           F HP+++RL++V           + +V E+V      +   V +  +  +  ++   Q++
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
            G+++ H + VVHRDLKP+N+L+ S   +K+ADFGL+ I      L +   +  Y APEV
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186

Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------ 235
           +    Y    VD+WS G I   +      F   +  +   KI   I              
Sbjct: 187 LLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 236 ---------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                            + +    +DL+ + L  +P KRI+      HP+FQ
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 3e-66
 Identities = 67/264 (25%), Positives = 121/264 (45%), Gaps = 15/264 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
             KL + LG G FG+V +  +     KVA+K L +  +      +    E  +++   H 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQ 68

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHR 135
            ++RLY V+ T   IY++ EY+++G L D++      +L  ++  +   QI  G+ +   
Sbjct: 69  RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLY 193
              +HRDL+  N+L+    + KIADFGL+ ++ D      + +     + APE I+    
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-T 186

Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 251
              + DVWS G++L  ++  G +P+     P + + ++ G     P +       L+   
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246

Query: 252 LIVDPMKRITIPEIRQ--HPWFQA 273
               P  R T   +R     +F A
Sbjct: 247 WKERPEDRPTFDYLRSVLEDFFTA 270

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 3e-66
 Identities = 61/256 (23%), Positives = 109/256 (42%), Gaps = 11/256 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
                + +G G FG V +    L   KVAIK +    +     EE    E +++    HP
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHP 60

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ-EDEARNFFQQIISGVEYCHRN 136
            +++LY V    + I +V E+++ G L DY+  +  L   +        +  G+ Y    
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLYA 194
            V+HRDL   N L+     +K++DFG++  + D        +     +A+PEV S   Y 
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY- 179

Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRML 252
             + DVWS GV+++ +   G +P+++ +   + + I  G     P   S     ++    
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239

Query: 253 IVDPMKRITIPEIRQH 268
              P  R     + + 
Sbjct: 240 KERPEDRPAFSRLLRQ 255

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  207 bits (528), Expect = 4e-66
 Identities = 71/297 (23%), Positives = 129/297 (43%), Gaps = 51/297 (17%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMH 76
           +Y+L + LG G + +V  A +     KV +KIL   K      ++K++REIKIL  L   
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGG 89

Query: 77  PHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
           P+II L ++++ P      +V E+V + +          L + + R +  +I+  ++YCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146

Query: 135 RNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
              ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++     
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDEN--------------IPNLFKKIKGGIYTLP-- 237
               +D+WS G +L +++    PF   +                +L+  I      L   
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 238 ----------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
                                   +SP A D + ++L  D   R+T  E  +HP+F 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 7e-66
 Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 32/290 (11%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
            Y+  + +G G++G V  A++  T   VA+K + R    +  +     REI +L+   H 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 61

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
           +I+RL++V+ +   + +V E+        +    G L  +  ++F  Q++ G+ +CH   
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
           V+HRDLKP+NLL++    +K+A+FGL+               +  Y  P+V+ G      
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 197 EVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYT-------------------- 235
            +D+WS G I   L     P F   ++ +  K+I   + T                    
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 236 ---------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
                    +   L+   RDL+  +L  +P++RI+  E  QHP+F    P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  205 bits (522), Expect = 1e-65
 Identities = 61/256 (23%), Positives = 112/256 (43%), Gaps = 11/256 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
           +  +   LG G +G+V           VA+K L    ++     E+  +E  +++   HP
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHP 73

Query: 78  HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHR 135
           ++++L  V       Y++ E++  G L DY+ E  R  +          QI S +EY  +
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLY 193
              +HRDL   N L+     VK+ADFGLS +M    +   +       + APE ++   +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251
              + DVW+ GV+L+ +   G  P+   ++  +++ ++       P        +L+   
Sbjct: 194 -SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252

Query: 252 LIVDPMKRITIPEIRQ 267
              +P  R +  EI Q
Sbjct: 253 WQWNPSDRPSFAEIHQ 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 1e-65
 Identities = 65/277 (23%), Positives = 116/277 (41%), Gaps = 9/277 (3%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFMH 76
           +K  K LG G+FG V        G KV I +  +  R+  + +  +++  E  ++    +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
           PH+ RL  +  T +   +         L      K  +      N+  QI  G+ Y    
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY 193
            +VHRDL   N+L+ +  +VKI DFGL+ ++      +  +       + A E I  ++Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190

Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 251
              + DVWS GV ++ L+  G+ P+D      +   ++ G     P   +     ++ + 
Sbjct: 191 -THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249

Query: 252 LIVDPMKRITIPEIRQHPWFQAHLP-RYLAVPPPDTM 287
            ++D   R    E+       A  P RYL +   + M
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (521), Expect = 2e-65
 Identities = 62/263 (23%), Positives = 111/263 (42%), Gaps = 15/263 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
             K+ + +G G FG+V      L G +   VAIK L     +  +       E  I+  F
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQF 84

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYC 133
            HP++I L  V+   + + ++ E++++G L  ++ +  G+    +     + I +G++Y 
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS------CGSPNYAAPEV 187
                VHRDL   N+L++S    K++DFGLS  + D     T            + APE 
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 188 ISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGAR 245
           I  + +     DVWS G++++ ++  G  P+ D    ++   I+       P        
Sbjct: 205 IQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263

Query: 246 DLIPRMLIVDPMKRITIPEIRQH 268
            L+      D   R    +I   
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNT 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 9e-65
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 12/259 (4%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
             +LG+ +G G FG V    +         VAIK    +   +  + EK  +E   +R F
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQF 65

Query: 75  MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYC 133
            HPHI++L  VI T + ++++ME    GEL  ++  +   L       +  Q+ + + Y 
Sbjct: 66  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC--GSPNYAAPEVISGK 191
                VHRD+   N+L+ S   VK+ DFGLS  M D  + K S       + APE I+ +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIP 249
            +     DVW  GV ++ +L  G  PF      ++  +I  G    +P +  P    L+ 
Sbjct: 185 RF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243

Query: 250 RMLIVDPMKRITIPEIRQH 268
           +    DP +R    E++  
Sbjct: 244 KCWAYDPSRRPRFTELKAQ 262

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (503), Expect = 1e-62
 Identities = 65/284 (22%), Positives = 112/284 (39%), Gaps = 37/284 (13%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
           N +  + +G G+FG+V  A             VA+K+L  ++  + +M+   +RE  ++ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMA 71

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR------------------- 113
            F +P+I++L  V      + ++ EY+  G+L +++                        
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 114 -----LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168
                L   E     +Q+ +G+ Y      VHRDL   N L+     VKIADFGLS  + 
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 169 DGHFLKTS---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL-PFDDENIPN 224
              + K          +  PE I    Y   E DVW+ GV+L+ +    L P+       
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 225 LFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           +   +  G I   P +      +L+       P  R +   I +
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-61
 Identities = 80/319 (25%), Positives = 133/319 (41%), Gaps = 54/319 (16%)

Query: 16  LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
           L  Y+  K +G G+ G V  A  A+    VAIK L  R  +N    ++  RE+ +++   
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVN 74

Query: 76  HPHIIRLYEVIETPS------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
           H +II L  V           D+Y+VME + +         +  L  +       Q++ G
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131

Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
           +++ H   ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH---------- 239
           G       VD+WS G I+  ++   + F   +  + + K+   + T              
Sbjct: 192 GM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 240 --------------------------------LSPGARDLIPRMLIVDPMKRITIPEIRQ 267
                                            +  ARDL+ +ML++DP KRI++ +  Q
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

Query: 268 HPWFQ-AHLPRYLAVPPPD 285
           HP+    + P  +  PPP 
Sbjct: 311 HPYINVWYDPAEVEAPPPQ 329

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (487), Expect = 2e-60
 Identities = 59/277 (21%), Positives = 97/277 (35%), Gaps = 29/277 (10%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
           Y+LG+ +G GSFG + +      G +VAIK+   +         ++  E KI ++     
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGV 63

Query: 79  IIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
            I          D   +VME +       +     +           Q+IS +EY H   
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 138 VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDG--------HFLKTSCGSPNYAAPE 186
            +HRD+KP+N L+        V I DFGL+   RD            K   G+  YA+  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--------IYTLPS 238
              G        D+ S G +L     G+LP+         +K +          I  L  
Sbjct: 184 THLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242

Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ---HPWFQ 272
                    +     +    +     +RQ   + + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 3e-59
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 14/261 (5%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRL 73
                K +G G FG+V       +  K    VAIK L     +   ++     E  I+  
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMGQ 65

Query: 74  FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEY 132
           F H +IIRL  VI     + ++ EY+++G L  ++ EK G     +     + I +G++Y
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVI 188
                 VHRDL   N+L++S    K++DFGLS ++ D     +          + APE I
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 189 SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARD 246
           S + +     DVWS G++++ ++  G  P+ + +   + K I  G     P         
Sbjct: 186 SYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244

Query: 247 LIPRMLIVDPMKRITIPEIRQ 267
           L+ +    +  +R    +I  
Sbjct: 245 LMMQCWQQERARRPKFADIVS 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 4e-59
 Identities = 73/280 (26%), Positives = 110/280 (39%), Gaps = 33/280 (11%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKIL- 71
               GKTLG G+FGKV  A             VA+K+L  +   ++   E +  E+K+L 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLS 81

Query: 72  RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG------------------R 113
            L  H +I+ L           V+ EY   G+L +++  K                    
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 114 LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173
           L  ++  +F  Q+  G+ +      +HRDL   N+LL      KI DFGL+  +++    
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 174 KTS---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKK 228
                      + APE I        E DVWS G+ L+ L             +   +K 
Sbjct: 202 VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 229 IKGGIYTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           IK G   L P H      D++      DP+KR T  +I Q
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 6e-59
 Identities = 65/262 (24%), Positives = 114/262 (43%), Gaps = 15/262 (5%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
               + +G G FG V          K    A+K LN  +I ++    +   E  I++ F 
Sbjct: 29  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFS 86

Query: 76  HPHIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYC 133
           HP+++ L  + + +     VV+ Y+K G+L ++I  E       +   F  Q+  G+++ 
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 146

Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVI 188
                VHRDL   N +LD K+ VK+ADFGL+  M D      H    +     + A E +
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 189 SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARD 246
             +     + DVWS GV+L+ L+  G  P+ D N  ++   + +G     P +      +
Sbjct: 207 QTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265

Query: 247 LIPRMLIVDPMKRITIPEIRQH 268
           ++ +        R +  E+   
Sbjct: 266 VMLKCWHPKAEMRPSFSELVSR 287

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 9e-59
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 32/280 (11%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALT-------GHKVAIKILNRRKIKNMEMEEKVRREIKI 70
              LGK LG G+FG+V +AE             KVA+K+L     +  +    +  E+++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEM 71

Query: 71  L-RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----------------VEKGR 113
           +  +  H +II L         +YV++EY   G L +Y+                  + +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 114 LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173
           L   +  +   Q+  G+EY      +HRDL   N+L+     +KIADFGL+  +    + 
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 174 KTS---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKI 229
           K +        + APE +  ++Y   + DVWS GV+L+ +   G  P+    +  LFK +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 230 KGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
           K G     PS+ +     ++       P +R T  ++ + 
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 3e-57
 Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 29/281 (10%)

Query: 18  NYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
              + + LG GSFG V               +VAIK +N  +  +M    +   E  +++
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMK 78

Query: 73  LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----------LQEDEARNF 122
            F   H++RL  V+       V+ME +  G+L  Y+                   +    
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---CGS 179
             +I  G+ Y + N  VHRDL   N ++   + VKI DFG++  + +  + +        
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT-LPFDDENIPNLFKKI-KGGIYTLP 237
             + +PE +   ++     DVWS GV+L+ +      P+   +   + + + +GG+   P
Sbjct: 199 VRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257

Query: 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQ------HPWFQ 272
            +      +L+      +P  R +  EI         P F+
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  183 bits (464), Expect = 5e-57
 Identities = 48/272 (17%), Positives = 96/272 (35%), Gaps = 28/272 (10%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH- 76
           +YK+G+ +G GSFG +    + L   +VAIK   RR         ++R E +  +L    
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGC 60

Query: 77  PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
             I  +Y   +      +V++ +         +   +          +Q+++ V+  H  
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 137 MVVHRDLKPENLLLDSKW-----NVKIADFGLSNIMRDG--------HFLKTSCGSPNYA 183
            +V+RD+KP+N L+          + + DFG+    RD            K   G+  Y 
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--------GGIYT 235
           +     G+       D+ + G +    L G+LP+         +K +          +  
Sbjct: 181 SINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           L +         +     +          ++ 
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 5e-55
 Identities = 71/280 (25%), Positives = 112/280 (40%), Gaps = 32/280 (11%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
             KLGK LG G+FG+V  A+        T   VA+K+L             +  E+KIL 
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILI 71

Query: 73  LFMHPHIIRLYE--VIETPSDIYVVMEYVKSGELFDYIVEKGR----------------L 114
              H   +        +    + V++E+ K G L  Y+  K                  L
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 115 QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR---DGH 171
             +    +  Q+  G+E+      +HRDL   N+LL  K  VKI DFGL+  +    D  
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT-LPFDDENIPNLFKKI- 229
               +     + APE I  ++Y   + DVWS GV+L+ +      P+    I   F +  
Sbjct: 192 RKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250

Query: 230 -KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
            +G     P + +P     +      +P +R T  E+ +H
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-54
 Identities = 53/294 (18%), Positives = 106/294 (36%), Gaps = 51/294 (17%)

Query: 18  NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
              L +++G G FG+V   +    G +VA+KI + R+ ++   E     EI    +  H 
Sbjct: 4   TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE----AEIYQTVMLRHE 57

Query: 78  HIIRLYEVIE----TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
           +I+           T + +++V +Y + G LFDY+  +  +  +          SG+ + 
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHL 116

Query: 134 H--------RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSP 180
           H        +  + HRDLK +N+L+       IAD GL+                  G+ 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 181 NYAAPEVISGKLY-----AGPEVDVWSCGVILYALLCGTLPFD---------------DE 220
            Y APEV+   +      +    D+++ G++ + +                       D 
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 221 NIPNLFKKIKGGIY-------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
           ++  + K +                        ++      +   R+T   I++
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (395), Expect = 6e-46
 Identities = 71/340 (20%), Positives = 122/340 (35%), Gaps = 74/340 (21%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP- 77
           Y L + LG G F  V +A+  +    VA+KI+   K+      E    EIK+L+      
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDAD 70

Query: 78  ----------HIIRLYEVIET--PSDIYVVMEYVKSG---ELFDYIVEKGRLQEDEARNF 122
                     HI++L +      P+ ++VVM +   G          E   +     +  
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130

Query: 123 FQQIISGVEYCH-RNMVVHRDLKPENLLLDS----KWNVKIADFGLSNIMRDGHFLKTSC 177
            +Q++ G++Y H R  ++H D+KPEN+L++     +  ++I    L N          S 
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE----------------- 220
            +  Y +PEV+ G  + G   D+WS   +++ L+ G   F+ +                 
Sbjct: 191 QTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 221 ---------------------------NIPNL----FKKIKGGIYTLPSHLSPGARDLIP 249
                                      NI  L     + +    Y      +    D + 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 250 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
            ML +DP KR     +  HPW +  L       P   +  
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYG 349

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.2 bits (223), Expect = 2e-22
 Identities = 33/203 (16%), Positives = 64/203 (31%), Gaps = 39/203 (19%)

Query: 19  YKLGKTLGIGSFGKVKIAEHALTGHKVAIKIL-----NRRKIKNMEMEEKVR-------- 65
             +GK +G G    V          +  +K       + +K+K       +         
Sbjct: 2   DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 66  --REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF 123
              E + L+      + ++Y          V+ME + + EL+         + +      
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVL 109

Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYA 183
             I+  V   +   +VH DL   N+L+  +  + I DF  S  + +              
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG-------WREIL 161

Query: 184 APEVISGKLYA----GPEVDVWS 202
             +V +   Y       E D+ S
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	294
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.89
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.47
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.37
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.49
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.41
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.34

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-65  Score=415.21  Aligned_cols=257  Identities=34%  Similarity=0.714  Sum_probs=239.3

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||+|+||+||+|.++.+++.||+|++.............+.+|++++++++||||+++++++.+++..++|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            46899999999999999999999999999999999876655555678899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      |||+++++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++....... ...
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~  163 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTT  163 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-CEE
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-ccc
Confidence            9999999999999998999999999999999999999999999999999999999999999999999997665433 345


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      ..||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+..+....+......+|..+++++.++|.+||+.|
T Consensus       164 ~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  242 (263)
T d2j4za1         164 LCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN  242 (263)
T ss_dssp             TTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             cCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCC
Confidence            678999999999998877 7899999999999999999999999999999999999888899999999999999999999


Q ss_pred             CCCCCCHhHHhcCCccccc
Q 022617          256 PMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       256 p~~Rps~~~il~h~~~~~~  274 (294)
                      |++|||++|+|+||||+++
T Consensus       243 p~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         243 PSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             GGGSCCHHHHHTCHHHHHH
T ss_pred             HhHCcCHHHHHcCcCcCCc
Confidence            9999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-63  Score=411.66  Aligned_cols=258  Identities=34%  Similarity=0.634  Sum_probs=235.2

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++++.||+|+||+||+|.++.+++.||||++...........+.+.+|++++++++||||+++++++.+++.+|+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            36799999999999999999999999999999999876555555567899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---c
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---F  172 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---~  172 (294)
                      |||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......   .
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~  166 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR  166 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999998764322   2


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhc
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML  252 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  252 (294)
                      .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......+|..+++++.+||.+||
T Consensus       167 ~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  245 (288)
T d1uu3a_         167 ANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL  245 (288)
T ss_dssp             ---CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTS
T ss_pred             cccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence            345579999999999988877 7899999999999999999999999999999999988888889999999999999999


Q ss_pred             ccCCCCCCCHhH------HhcCCccccc
Q 022617          253 IVDPMKRITIPE------IRQHPWFQAH  274 (294)
Q Consensus       253 ~~~p~~Rps~~~------il~h~~~~~~  274 (294)
                      +.||.+|||++|      +++||||++.
T Consensus       246 ~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         246 VLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             CSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             cCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            999999999988      5889999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-63  Score=410.53  Aligned_cols=261  Identities=34%  Similarity=0.682  Sum_probs=223.6

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      +.++|++.+.||+|+||+||+|.++.+++.||+|++......  ...+.+.+|++++++++||||+++++++.+++..|+
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i   80 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   80 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence            457899999999999999999999999999999998765322  234678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---  171 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---  171 (294)
                      ||||++|++|.+++.+++.+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......   
T Consensus        81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999998764332   


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhCCC--ccCCCCCChhHHHHH
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGI--YTLPSHLSPGARDLI  248 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~--~~~~~~~~~~l~~li  248 (294)
                      ......||+.|+|||++.+..+.+.++||||||+++|+|++|+.||...... .....+....  ...+..+++++.+++
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  240 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence            2345679999999999988877667899999999999999999999765433 2222333222  223357899999999


Q ss_pred             HHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          249 PRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      .+||+.||++|||++|+|+||||++.+++
T Consensus       241 ~~~L~~dP~~R~t~~eil~hpwf~~~l~k  269 (271)
T d1nvra_         241 HKILVENPSARITIPDIKKDRWYNKPLKK  269 (271)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             HHHcCCChhHCcCHHHHhcCHhhCcCCCC
Confidence            99999999999999999999999987654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-62  Score=406.88  Aligned_cols=257  Identities=31%  Similarity=0.501  Sum_probs=227.5

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   94 (294)
                      ..++|++.+.||+|+||+||+|.++.+|+.||+|++.......   .+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence            4568999999999999999999999999999999987654332   4678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccc
Q 022617           95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL  173 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~  173 (294)
                      ||||++|++|.+++.+ +.+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++...... ...
T Consensus        95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  173 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (293)
T ss_dssp             EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence            9999999999998754 57999999999999999999999999999999999999999999999999999876433 344


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC---CccCCCCCChhHHHHHHH
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPR  250 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~  250 (294)
                      ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+...   ....+..++.++.+||.+
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred             cccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence            56679999999999998877 78999999999999999999999887776655554332   234456789999999999


Q ss_pred             hcccCCCCCCCHhHHhcCCcccccCC
Q 022617          251 MLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ||+.||.+|||+.|+|+||||+...|
T Consensus       253 ~L~~dP~~R~s~~eil~Hp~~~~~~~  278 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELLQHQFLKIAKP  278 (293)
T ss_dssp             HTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HccCChhHCcCHHHHhcCHhhCCCCC
Confidence            99999999999999999999986433

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-61  Score=407.71  Aligned_cols=258  Identities=36%  Similarity=0.606  Sum_probs=239.9

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++++.||+|+||.||+|+++.+++.||+|++.............+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            56899999999999999999999999999999999876555555578889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~  174 (294)
                      |||+.|++|.+++.+.+.+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++..... .....
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~  163 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  163 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999986543 33445


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhccc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV  254 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  254 (294)
                      ...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+.+.+......+|..+++++.+||.+||+.
T Consensus       164 ~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~  242 (337)
T d1o6la_         164 TFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK  242 (337)
T ss_dssp             CCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             cceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccC
Confidence            6679999999999999888 789999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC-----HhHHhcCCccccc
Q 022617          255 DPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       255 ~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      ||.+|++     ++++++||||++.
T Consensus       243 dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         243 DPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             STTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             CchhhcccccccHHHHHcCcccccC
Confidence            9999995     8999999999763

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-62  Score=407.75  Aligned_cols=260  Identities=40%  Similarity=0.693  Sum_probs=216.6

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .+.+.++|++.+.||+|+||+||+|.++.+++.||||++.......  ....+.+|+.++++++||||+++++++.+++.
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGH   81 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3457788999999999999999999999999999999997654332  24567899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec---CCCcEEEeeeccccccc
Q 022617           92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD---SKWNVKIADFGLSNIMR  168 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~---~~~~~~l~dfg~~~~~~  168 (294)
                      +|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+||++.   +++.+||+|||++....
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999999999998888999999999999999999999999999999999999995   47899999999998776


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC----CCCCChhH
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----PSHLSPGA  244 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~l  244 (294)
                      .........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.........+.......    +..+++++
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             -----------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             CCCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence            6666667789999999999988877 799999999999999999999999998888888887766443    35789999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .+||.+||+.||++|||+.|+++||||++.
T Consensus       241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-61  Score=400.96  Aligned_cols=260  Identities=38%  Similarity=0.661  Sum_probs=236.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc---hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN---MEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||||++.......   ....+.+.+|+.++++++||||+++++++.+++
T Consensus         7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (293)
T d1jksa_           7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   86 (293)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            36789999999999999999999999999999999997654332   124678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC----cEEEeeeccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSNI  166 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~----~~~l~dfg~~~~  166 (294)
                      .+|+||||++|++|.+++.+++.+++..++.++.|++.||.|||+.||+|+||||+||+++.++    .+|++|||++..
T Consensus        87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence            9999999999999999999989999999999999999999999999999999999999998776    599999999988


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCCh
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSP  242 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~  242 (294)
                      ...........+++.|+|||++.+..+ +.++||||+|+++|+|++|+.||.+.+..+....+.......+    ..++.
T Consensus       167 ~~~~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (293)
T d1jksa_         167 IDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  245 (293)
T ss_dssp             CTTSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             cCCCccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence            776666667788999999999988777 7999999999999999999999999999888888877765544    57899


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      ++.+||.+||+.||++|||++|+|+||||+..
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.9e-61  Score=402.39  Aligned_cols=256  Identities=33%  Similarity=0.685  Sum_probs=237.5

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...........+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            36799999999999999999999999999999999766555445578899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      |||+.|++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......  ..
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--~~  160 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YT  160 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--CC
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc--cc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999998765433  35


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      ..||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+..+....+.......+..+++++.+++.+||..|
T Consensus       161 ~~Gt~~Y~APE~l~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  239 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD  239 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSC
T ss_pred             ccCcccccCHHHHcCCCC-CchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhC
Confidence            679999999999988877 7899999999999999999999999999999999988888888999999999999999999


Q ss_pred             CCCCC-----CHhHHhcCCccccc
Q 022617          256 PMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       256 p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      |.+|+     |+++|++||||++.
T Consensus       240 p~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         240 LSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             TTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHhccccchhhHHHHHcCcccccC
Confidence            99996     89999999999875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.7e-60  Score=391.64  Aligned_cols=260  Identities=39%  Similarity=0.648  Sum_probs=232.4

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc------hHHHHHHHHHHHHHHhCC-CCceeEEEEEEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN------MEMEEKVRREIKILRLFM-HPHIIRLYEVIE   87 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~------~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   87 (294)
                      +.++|++.+.||+|+||+||+|++..+++.||||++.......      ....+.+.+|+.++++++ ||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            4689999999999999999999999999999999997654332      223456889999999997 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                      +++..|+||||+++++|.+++..++++++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCccccccCCCcccCCccccC-----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----C
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----S  238 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~  238 (294)
                      ..........+|+.|+|||.+.+     ....+.++||||+|+++|+|++|+.||.+.+.......+..+....+    .
T Consensus       161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (277)
T d1phka_         161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  240 (277)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            76666666789999999999853     22236789999999999999999999999998888887776654333    3


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .+++++.+++.+||+.||++|||++|+|+||||++.
T Consensus       241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            789999999999999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.1e-60  Score=404.34  Aligned_cols=259  Identities=33%  Similarity=0.623  Sum_probs=233.9

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +.+.++|++.+.||+|+||.||+|.++.+|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+.+
T Consensus        22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            456789999999999999999999999999999999986543   23457789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC--CCcEEEeeecccccccC
Q 022617           93 YVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRD  169 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~-~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~--~~~~~l~dfg~~~~~~~  169 (294)
                      |+||||++|++|.+++. ..+.+++..++.++.||+.||.|||+.||+|+||||+|||++.  ++.+||+|||++.....
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            99999999999999985 4567999999999999999999999999999999999999964  57899999999988777


Q ss_pred             CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhHH
Q 022617          170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR  245 (294)
Q Consensus       170 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~  245 (294)
                      ........+|+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+..+....+.......+    ..+++++.
T Consensus       179 ~~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         179 KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TSCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             ccccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            666677789999999999988877 7899999999999999999999999888888888876665443    46899999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      +||.+||..||.+|||++|+|+||||+...
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999998753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.1e-60  Score=403.63  Aligned_cols=259  Identities=31%  Similarity=0.563  Sum_probs=233.6

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .+.++|++++.||+|+||.||+|.+..+|+.||+|++.....   .....+.+|+.++++++||||+++++++.+++.+|
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            466889999999999999999999999999999999865432   33567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec--CCCcEEEeeecccccccCC
Q 022617           94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD--SKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~--~~~~~~l~dfg~~~~~~~~  170 (294)
                      +||||++|++|.+.+.+. .++++.+++.++.||+.||.|||+.||+||||||+|||++  .++.+||+|||++......
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999999999887654 4699999999999999999999999999999999999997  5789999999999988776


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhHHH
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARD  246 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~  246 (294)
                      .......+++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+    ..+++++.+
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             CceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            66677789999999999988877 7999999999999999999999999998888888876655443    578999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      ||.+||+.||.+|||+.|+|+||||+....
T Consensus       262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence            999999999999999999999999987543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-61  Score=397.58  Aligned_cols=259  Identities=27%  Similarity=0.405  Sum_probs=225.3

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .+.|++++.||+|+||+||+|.++.+++.||+|++.....   ...+.+.+|++++++++||||+++++++.+++.+++|
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   87 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence            3579999999999999999999999999999999865432   3356788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccc
Q 022617           96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL  173 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~  173 (294)
                      |||+++++|.+++.+ .+++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus        88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~  167 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  167 (288)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence            999999999999765 467999999999999999999999999999999999999999999999999998754332 223


Q ss_pred             ccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHH
Q 022617          174 KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARD  246 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~  246 (294)
                      ....||+.|+|||++..    ....+.++||||||+++|+|++|+.||.+.+..+....+....   ...+..+++++.+
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~  247 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD  247 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence            45678999999999842    2223789999999999999999999999888777777766554   3345678999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                      ||.+||+.||++|||+.|+|+||||+...++
T Consensus       248 li~~~L~~dp~~R~t~~ell~hp~~~~~~~~  278 (288)
T d2jfla1         248 FLKKCLEKNVDARWTTSQLLQHPFVTVDSNK  278 (288)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSGGGCCCCCH
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            9999999999999999999999999865443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-61  Score=393.85  Aligned_cols=254  Identities=32%  Similarity=0.589  Sum_probs=216.1

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--CCeEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIY   93 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~   93 (294)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++....... ...+.+.+|++++++++||||+++++++.+  .+.+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            367999999999999999999999999999999997765443 446778999999999999999999999854  56789


Q ss_pred             EEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           94 VVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNM-----VVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~-----i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                      +||||+++++|.+++.+    +..+++..++.++.|++.||.|||+.|     |+||||||+|||++.++.+||+|||++
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999999999864    357999999999999999999999976     999999999999999999999999999


Q ss_pred             ccccCCC-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCCh
Q 022617          165 NIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSP  242 (294)
Q Consensus       165 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~  242 (294)
                      ....... ......+|+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+..+....+..+.. ..+..+++
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  240 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD  240 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence            8765433 3345678999999999988877 7899999999999999999999999988888888776654 56778999


Q ss_pred             hHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617          243 GARDLIPRMLIVDPMKRITIPEIRQHPWF  271 (294)
Q Consensus       243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~  271 (294)
                      ++.++|.+||+.||.+|||+.|+++|||+
T Consensus       241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         241 ELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999999999999999999999996

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-60  Score=387.77  Aligned_cols=253  Identities=27%  Similarity=0.514  Sum_probs=219.6

Q ss_pred             ccCC-cccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----CC
Q 022617           16 LPNY-KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PS   90 (294)
Q Consensus        16 ~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~   90 (294)
                      .++| ++.+.||+|+||+||+|.+..++..||+|++...... ....+.+.+|++++++++||||+++++++..    ..
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            3455 7888999999999999999999999999998765543 3446788999999999999999999999865    35


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEec-CCCcEEEeeecccccc
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLD-SKWNVKIADFGLSNIM  167 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~-~~~~~~l~dfg~~~~~  167 (294)
                      .++++|||+++++|.+++.+...+++..++.++.|++.||.|||+.+  |+||||||+|||++ .++.+||+|||++...
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            68999999999999999999899999999999999999999999998  99999999999997 4789999999999764


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhCCCc--cCCCCCChhH
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIY--TLPSHLSPGA  244 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~l  244 (294)
                      .. .......||+.|+|||++.+. + +.++||||||+++|+|++|+.||... +.....+.+..+..  ..+...++++
T Consensus       166 ~~-~~~~~~~GT~~Y~aPE~~~~~-~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (270)
T d1t4ha_         166 RA-SFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  242 (270)
T ss_dssp             CT-TSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             cC-CccCCcccCccccCHHHhCCC-C-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence            33 334466799999999998754 5 79999999999999999999999764 45555566655442  3456788999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                      .++|.+||+.||++|||++|+|+|||||
T Consensus       243 ~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-60  Score=399.81  Aligned_cols=258  Identities=27%  Similarity=0.346  Sum_probs=228.7

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ...|+.++.||+|+||+||+|.+..+++.||||++...........+.+.+|++++++++||||+++++++.+++..|++
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            34699999999999999999999999999999999877666666678899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      |||+.+++|..++..++++++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......   ..
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~  170 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS  170 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred             EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---Cc
Confidence            999999999888888889999999999999999999999999999999999999999999999999999765432   34


Q ss_pred             ccCCCcccCCccccCC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-c-CCCCCChhHHHHHHHh
Q 022617          176 SCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIPRM  251 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~~~~l~~li~~~  251 (294)
                      ..||+.|+|||++.+.  ...+.++||||||+++|+|++|..||.+.........+..... . .+..+++++.+||.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            5799999999998642  2237899999999999999999999998877776666654432 2 3456899999999999


Q ss_pred             cccCCCCCCCHhHHhcCCcccccCC
Q 022617          252 LIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                      |+.||.+|||++|+|+||||+...+
T Consensus       251 L~~dP~~Rpt~~ell~Hp~~~~~~~  275 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLKHRFVLRERP  275 (309)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             CcCChhHCcCHHHHHhCHHhcCCCC
Confidence            9999999999999999999987543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-60  Score=402.65  Aligned_cols=256  Identities=36%  Similarity=0.653  Sum_probs=237.5

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++++.||+|+||.||+|.++.+|+.||||++...........+.+.+|+.+++.++||||+++++++...+..+++
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            47999999999999999999999999999999999766555545567889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT  175 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  175 (294)
                      +|++.+++|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++......  ...
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~  197 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT  197 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999876543  235


Q ss_pred             ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617          176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD  255 (294)
Q Consensus       176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  255 (294)
                      ..||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......+..+++++.++|.+||..|
T Consensus       198 ~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  276 (350)
T d1rdqe_         198 LCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD  276 (350)
T ss_dssp             CEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSC
T ss_pred             ccCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhC
Confidence            678999999999998877 7899999999999999999999999999999999998888889999999999999999999


Q ss_pred             CCCCC-----CHhHHhcCCccccc
Q 022617          256 PMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       256 p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      |.+|+     |+++|++||||++.
T Consensus       277 P~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         277 LTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             TTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHhccccccccHHHHHcCccccCC
Confidence            99995     89999999999764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-60  Score=399.21  Aligned_cols=261  Identities=26%  Similarity=0.516  Sum_probs=235.8

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .+.++|++.+.||+|+||+||+|.++.+++.||+|++....    .....+.+|+++++.++||||+++++++.+.+.+|
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            57899999999999999999999999999999999996553    22356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC--CcEEEeeecccccccCC
Q 022617           94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK--WNVKIADFGLSNIMRDG  170 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~--~~~~l~dfg~~~~~~~~  170 (294)
                      +||||++|++|.+++.+++ ++++.+++.++.||+.||.|||+.||+||||||+||+++.+  +.++|+|||++......
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            9999999999999997665 79999999999999999999999999999999999999854  47999999999887766


Q ss_pred             CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhHHH
Q 022617          171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARD  246 (294)
Q Consensus       171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~  246 (294)
                      .......+++.|+|||...+..+ +.++||||||+++|+|++|..||...+..+....+......++    ..++.++.+
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence            66667788999999999988877 7899999999999999999999999999998888887766554    478999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  279 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~  279 (294)
                      ||.+||..||++|||+.|+++||||++..+...
T Consensus       237 li~~~L~~dp~~R~s~~eil~hp~~~~~~~~~~  269 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQHPWLKQKIERVS  269 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGSC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhccCccccC
Confidence            999999999999999999999999987655433

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-60  Score=402.10  Aligned_cols=258  Identities=25%  Similarity=0.451  Sum_probs=220.4

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +...++|++.+.||+|+||+||+|.+..+|+.||+|++....  .......+.+|+.++++++||||+++++++.+++.+
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   79 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   79 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            456789999999999999999999999999999999987543  224457889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++||||+.|++|.+++.+++.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+|...... 
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            99999999999999999999999999999999999999999974 9999999999999999999999999999865432 


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------------------
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK------------------------  227 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~------------------------  227 (294)
                      .....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+......                        
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             ccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence            2335679999999999998877 799999999999999999999997654322111                        


Q ss_pred             ------------------HHhCCC-ccCC-CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          228 ------------------KIKGGI-YTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       228 ------------------~~~~~~-~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                        .+.... ...+ ..++.++.+||.+||..||.+|||++|+|+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                              011111 1111 2357899999999999999999999999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-59  Score=395.58  Aligned_cols=257  Identities=35%  Similarity=0.596  Sum_probs=232.7

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCceeEEEEEEEcCCeEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      ++|.+++.||+|+||+||+|.++.+++.||||++...........+.+..|..++ +.++||||+++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            6899999999999999999999999999999999765443334445556666655 578999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Cccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~  174 (294)
                      |||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||||+|||++.+++++|+|||.+...... ....
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~  161 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN  161 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999865433 3344


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhccc
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV  254 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  254 (294)
                      ...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+....+..|..+++++.+||.+||..
T Consensus       162 ~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~  240 (320)
T d1xjda_         162 TFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR  240 (320)
T ss_dssp             CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             ccCCCCCcCCHHHHcCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhccc
Confidence            5678999999999998887 789999999999999999999999999999999998888888999999999999999999


Q ss_pred             CCCCCCCHh-HHhcCCccccc
Q 022617          255 DPMKRITIP-EIRQHPWFQAH  274 (294)
Q Consensus       255 ~p~~Rps~~-~il~h~~~~~~  274 (294)
                      ||.+|||+. ++++||||++.
T Consensus       241 dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         241 EPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             SGGGSBTTBSCGGGSGGGTTC
T ss_pred             CCCCCcCHHHHHHhCchhccC
Confidence            999999996 89999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.7e-59  Score=397.81  Aligned_cols=258  Identities=28%  Similarity=0.471  Sum_probs=224.3

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHH---HHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR---EIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.............+.+   ++++++.++||||+++++++...+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            468999999999999999999999999999999997655443333333444   46677778899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      |+||||+.|++|.+++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++...... .
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-~  161 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-K  161 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-C
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-c
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999876543 3


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhCCCccCCCCCChhHHHHHH
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKKIKGGIYTLPSHLSPGARDLIP  249 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~  249 (294)
                      .....||+.|+|||++......+.++|||||||++|+|++|+.||......   .....+.......+..+++++.+||.
T Consensus       162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (364)
T d1omwa3         162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE  241 (364)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred             ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence            345679999999999976554489999999999999999999999765433   34444555566777889999999999


Q ss_pred             HhcccCCCCCCC-----HhHHhcCCccccc
Q 022617          250 RMLIVDPMKRIT-----IPEIRQHPWFQAH  274 (294)
Q Consensus       250 ~~l~~~p~~Rps-----~~~il~h~~~~~~  274 (294)
                      +||+.||.+|||     ++++++||||++.
T Consensus       242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            999999999999     7999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-59  Score=383.07  Aligned_cols=254  Identities=34%  Similarity=0.626  Sum_probs=221.6

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchH---HHHHHHHHHHHHHhCC--CCceeEEEEEEEcC
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM--HPHIIRLYEVIETP   89 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~---~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~   89 (294)
                      +.++|++.+.||+|+||+||+|.+..+++.||||++.........   ....+.+|+.++++++  ||||+++++++.++
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            578999999999999999999999999999999999765433211   2234668999999987  89999999999999


Q ss_pred             CeEEEEEeccCC-CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeecccccc
Q 022617           90 SDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIM  167 (294)
Q Consensus        90 ~~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~  167 (294)
                      +..+++||++.+ +++.+++.++..+++..++.++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++...
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence            999999999975 578888888899999999999999999999999999999999999999985 478999999999765


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHH
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL  247 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (294)
                      ... ......||+.|+|||++.+..+.+.++||||||+++|+|++|+.||...      +.+......++..+++++.+|
T Consensus       162 ~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~l  234 (273)
T d1xwsa_         162 KDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHL  234 (273)
T ss_dssp             CSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHHH
T ss_pred             ccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHHH
Confidence            433 3345679999999999987776567899999999999999999999753      234455667778899999999


Q ss_pred             HHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          248 IPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       248 i~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                      |.+||+.||++|||++|+++||||++.+
T Consensus       235 i~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         235 IRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999999998854

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-58  Score=383.69  Aligned_cols=254  Identities=28%  Similarity=0.402  Sum_probs=213.6

Q ss_pred             ccccccccCceEEEEEEEccCCceEEEEEeecccccch--HHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617           21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM--EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY   98 (294)
Q Consensus        21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   98 (294)
                      .+++||+|+||+||+|.++.+|+.||||++........  .....+.+|+.++++++||||+++++++..++.+++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            35789999999999999999999999999865543221  1235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccccc
Q 022617           99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSC  177 (294)
Q Consensus        99 ~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~  177 (294)
                      +.++++..+...+..+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||.+....... ......
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            9987777776666789999999999999999999999999999999999999999999999999997664433 334557


Q ss_pred             CCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-----------------------
Q 022617          178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----------------------  234 (294)
Q Consensus       178 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------------  234 (294)
                      +|+.|+|||++......+.++|||||||++|+|++|..||.+.+..+....+.....                       
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            899999999987666558899999999999999999999998887776665532100                       


Q ss_pred             -----cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          235 -----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       235 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                           ......++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                 0013567899999999999999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-57  Score=382.76  Aligned_cols=255  Identities=36%  Similarity=0.615  Sum_probs=216.6

Q ss_pred             cccccCCcccc-cccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeEEEEEEEc--
Q 022617           13 DMFLPNYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIET--   88 (294)
Q Consensus        13 ~~~~~~y~~~~-~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~--   88 (294)
                      +.+.++|.+.. .||+|+||+||+|.+..+++.||||++...        ..+.+|++++.+ ++||||++++++|.+  
T Consensus         7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            45678999875 699999999999999999999999998532        456789988654 589999999999865  


Q ss_pred             --CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEEEeee
Q 022617           89 --PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADF  161 (294)
Q Consensus        89 --~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~l~df  161 (294)
                        ...+|+|||||+||+|.+++.+.  ..+++.+++.++.|++.||+|||+.||+||||||+||+++.   ++.+||+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              46789999999999999999764  36999999999999999999999999999999999999975   567999999


Q ss_pred             cccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhCCCccCC
Q 022617          162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF----KKIKGGIYTLP  237 (294)
Q Consensus       162 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~  237 (294)
                      |++.............|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.......    ..+......++
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            99988776666677789999999999988877 78999999999999999999999765543332    33333444443


Q ss_pred             ----CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       238 ----~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                          ..+++++.+||.+||+.||++|||+.|+++||||++...
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  280 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  280 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence                257899999999999999999999999999999987543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=374.62  Aligned_cols=257  Identities=29%  Similarity=0.523  Sum_probs=216.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|++++++++||||+++++++.+++.+|++
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            36899999999999999999999999999999999655322 23356788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Cc
Q 022617           96 MEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HF  172 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~  172 (294)
                      |||+.+ ++.+++..  ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||.+...... ..
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            999976 55555533  356999999999999999999999999999999999999999999999999999876543 33


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc------------------
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------------  234 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------  234 (294)
                      .....+++.|+|||.+....+.+.++||||+|+++|+|++|+.||.+.+..+....+.....                  
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence            44567899999999988777778999999999999999999999998876665544321100                  


Q ss_pred             c-----------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          235 T-----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       235 ~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      .           ....++.++.+|+.+||..||++|||+.|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            0           013567889999999999999999999999999999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-56  Score=371.66  Aligned_cols=256  Identities=30%  Similarity=0.488  Sum_probs=217.6

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++.+.||+|+||+||+|+++ +++.||||++...... ....+.+.+|+.++++++||||+++++++..++..+++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            369999999999999999999996 7899999999765432 23457889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-cc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~  174 (294)
                      ++++.++.+..+....+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+|++|||.+........ ..
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            99998876676666678899999999999999999999999999999999999999999999999999987654332 34


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------------
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------  233 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  233 (294)
                      ...+++.|+|||.+.+....+.++||||||+++|+|++|+.||.+.+..+...++....                     
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            44688999999999877776899999999999999999999999887666555432100                     


Q ss_pred             --------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          234 --------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                              ......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                    0122457889999999999999999999999999999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.6e-56  Score=367.02  Aligned_cols=258  Identities=25%  Similarity=0.420  Sum_probs=217.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS---   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   90 (294)
                      .+.++|++.+.||+|+||+||+|.+..+++.||||++......+......+.+|++++++++||||+++++++...+   
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            46789999999999999999999999999999999998776666666788999999999999999999999987643   


Q ss_pred             -eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           91 -DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        91 -~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                       ..|+||||++|++|.+++...+++++.+++.++.|++.||.|||+.||+|+||||+||+++.++..+++|||.+.....
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence             3899999999999999999999999999999999999999999999999999999999999999999999998765433


Q ss_pred             CC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc----cCCCCCC
Q 022617          170 GH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----TLPSHLS  241 (294)
Q Consensus       170 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~  241 (294)
                      ..    ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+..+....+.....    .....++
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  242 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  242 (277)
T ss_dssp             ---------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred             ccccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence            22    2344568999999999988776 7899999999999999999999998887777666554432    2346789


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  272 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~h~~~~  272 (294)
                      +++.++|.+||+.||.+||+..+.+.|+|.+
T Consensus       243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            9999999999999999999544444456553

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-55  Score=364.13  Aligned_cols=255  Identities=24%  Similarity=0.407  Sum_probs=221.2

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +.-.++|++.+.||+|+||+||+|.++.+++.||||++.....    ..+.+.+|++++++++||||+++++++.+++.+
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            4456799999999999999999999999999999999865432    246789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           93 YVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      +++|||+++|+|.+++.+.  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            9999999999999999764  56899999999999999999999999999999999999999999999999999876544


Q ss_pred             Cc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhCC-CccCCCCCChhHHH
Q 022617          171 HF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGG-IYTLPSHLSPGARD  246 (294)
Q Consensus       171 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  246 (294)
                      ..  .....+++.|+|||++.+..+ +.++||||||+++|+|++|..| |...+.....+.+..+ ..+.+..++.++.+
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  247 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  247 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence            32  223357889999999988777 7999999999999999996555 5566777766666554 35677889999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                      |+.+||+.||++|||+.++++  +|+..
T Consensus       248 li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         248 LMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             HHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence            999999999999999999976  55544

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=363.85  Aligned_cols=246  Identities=25%  Similarity=0.420  Sum_probs=210.9

Q ss_pred             ccccccCceEEEEEEEcc--CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617           23 KTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK  100 (294)
Q Consensus        23 ~~lg~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  100 (294)
                      +.||+|+||+||+|.+..  +++.||||++..... +....+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            469999999999998653  456899999865433 33456789999999999999999999999975 45789999999


Q ss_pred             CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc----cccc
Q 022617          101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTS  176 (294)
Q Consensus       101 ~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~  176 (294)
                      +++|.+++.+..++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........    ....
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            999999999888999999999999999999999999999999999999999999999999999986543322    2234


Q ss_pred             cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhccc
Q 022617          177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIV  254 (294)
Q Consensus       177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~  254 (294)
                      .+|+.|+|||.+.+..+ +.++||||||+++|+|++ |+.||.+.+..+....+..+. .+.|..++.++.+++.+||+.
T Consensus       171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~  249 (277)
T d1xbba_         171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY  249 (277)
T ss_dssp             CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence            57889999999987777 789999999999999998 899999988888888777654 677889999999999999999


Q ss_pred             CCCCCCCHhHH---hcCCcc
Q 022617          255 DPMKRITIPEI---RQHPWF  271 (294)
Q Consensus       255 ~p~~Rps~~~i---l~h~~~  271 (294)
                      ||++|||+++|   |+|+|+
T Consensus       250 dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         250 DVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             STTTSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHhhCHHh
Confidence            99999999998   456555

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-55  Score=357.59  Aligned_cols=246  Identities=24%  Similarity=0.448  Sum_probs=219.9

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||+|+||+||+|+++ ++..||||++......    .+.+.+|++++++++||||+++++++.+++.+++||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            68999999999999999999985 7788999998765433    367899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--c
Q 022617           97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L  173 (294)
Q Consensus        97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--~  173 (294)
                      ||+.+++|.+++.. ...+++..+++++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++........  .
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence            99999999998754 46789999999999999999999999999999999999999999999999999976544332  2


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~  251 (294)
                      ....+++.|+|||.+.+..+ +.++||||||+++|+|+| |+.||...+..+....+..+. ...|..++.++.++|.+|
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  237 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC  237 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred             cccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHH
Confidence            23567889999999988777 789999999999999998 899999999888888887654 566778999999999999


Q ss_pred             cccCCCCCCCHhHHhcC
Q 022617          252 LIVDPMKRITIPEIRQH  268 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h  268 (294)
                      |+.||++|||+++|++|
T Consensus       238 l~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         238 WHEKADERPTFKILLSN  254 (258)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCCHhHCcCHHHHHHH
Confidence            99999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=370.83  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=211.8

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-------
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-------   88 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------   88 (294)
                      .++|++++.||+|+||+||+|.++.+|+.||||++..+... ......+.+|++++++++|+|++++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            48999999999999999999999999999999998765433 2345678899999999999999999998754       


Q ss_pred             -CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           89 -PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        89 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                       ++.+++++|++.++.+.........+++..++.++.|++.||.|||+.||+||||||+||+++.++.++++|||++...
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence             4568999999987666655555677999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCC-----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCC----
Q 022617          168 RDGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----  238 (294)
Q Consensus       168 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  238 (294)
                      ....     ......+|+.|+|||++.+....+.++||||+|+++|+|++|+.||.+.+.......+.......+.    
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            4222     2234468999999999987655589999999999999999999999988776666554332211110    


Q ss_pred             ----------------------------CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617          239 ----------------------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  273 (294)
Q Consensus       239 ----------------------------~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~  273 (294)
                                                  ..++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence                                        12567789999999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-55  Score=365.36  Aligned_cols=250  Identities=24%  Similarity=0.422  Sum_probs=208.3

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCc---eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      .++|++.+.||+|+||+||+|.++.+++   .|++|.+....  .....+.+.+|++++++++||||+++++++..++.+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            5789999999999999999999876664   47888775432  334567899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +++|||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999988764 569999999999999999999999999999999999999999999999999998664332


Q ss_pred             cc------ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChh
Q 022617          172 FL------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPG  243 (294)
Q Consensus       172 ~~------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  243 (294)
                      ..      ....+++.|+|||.+.+..+ +.++||||||+++|+|+| |..||.+....+....+..+. .+.+..++.+
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA  261 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHH
Confidence            21      12346889999999988777 789999999999999998 899999988888888876654 5677789999


Q ss_pred             HHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          244 ARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      +.+++.+||+.||++|||+.||+++
T Consensus       262 l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         262 LHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=368.77  Aligned_cols=258  Identities=28%  Similarity=0.437  Sum_probs=214.4

Q ss_pred             cccCCcccccccccCceEEEEEEEccC-CceEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeEEEEEEEc--
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALT-GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIET--   88 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~--   88 (294)
                      ..++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+++.+   +||||+++++++..  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            357999999999999999999999755 5678999987654332 1223455666666555   79999999999853  


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617           89 ---PSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS  164 (294)
Q Consensus        89 ---~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~  164 (294)
                         ...+++++|++.++++...... ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||.+
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence               3568999999988665544432 356899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC------------
Q 022617          165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG------------  232 (294)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------  232 (294)
                      .............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+...            
T Consensus       164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         164 RIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhhcccccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            87766666677789999999999988877 79999999999999999999999988877766554321            


Q ss_pred             ---------------CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          233 ---------------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       233 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                     ....+..+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                           011235678899999999999999999999999999999874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=359.84  Aligned_cols=246  Identities=24%  Similarity=0.478  Sum_probs=207.9

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM   96 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   96 (294)
                      ++|++.+.||+|+||+||+|.+. +++.||||++......    .+.+.+|++++++++||||+++++++..++..++||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            58999999999999999999986 5678999998654322    467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--c
Q 022617           97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L  173 (294)
Q Consensus        97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--~  173 (294)
                      ||+++++|.+++... ..+++..++.++.|++.||.|||+.+|+||||||+||++++++.+||+|||++........  .
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence            999999999998654 5688999999999999999999999999999999999999999999999999976644332  2


Q ss_pred             ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617          174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM  251 (294)
Q Consensus       174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~  251 (294)
                      ....+++.|+|||++.+..+ +.++||||||+++|+|+| |.+||...+.....+.+..+. ...|..+++++.+++.+|
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  238 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC  238 (263)
T ss_dssp             -----CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred             cceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence            34567899999999988877 789999999999999999 677777778777777776554 556678899999999999


Q ss_pred             cccCCCCCCCHhHHhcC
Q 022617          252 LIVDPMKRITIPEIRQH  268 (294)
Q Consensus       252 l~~~p~~Rps~~~il~h  268 (294)
                      |+.||++|||+++|++|
T Consensus       239 l~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         239 WKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCCHhHCcCHHHHHHH
Confidence            99999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=361.62  Aligned_cols=260  Identities=27%  Similarity=0.477  Sum_probs=223.6

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   95 (294)
                      .++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++|+||+++++++......+++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            3689999999999999999999999999999999976543 345678899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617           96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK  174 (294)
Q Consensus        96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  174 (294)
                      ++++.+++|..++...+.+++..++.++.|++.||+|||+.||+|+||||+||+++.++.++|+|||.+....... ...
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            9999999999988888899999999999999999999999999999999999999999999999999998765433 334


Q ss_pred             cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhCC---------------------
Q 022617          175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGG---------------------  232 (294)
Q Consensus       175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~~~---------------------  232 (294)
                      ...+++.|+|||.+......+.++||||||+++|+|++|+.||. +.+..+....+...                     
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            44567889999998877766899999999999999999998864 45555444443210                     


Q ss_pred             --------CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617          233 --------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  276 (294)
Q Consensus       233 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~  276 (294)
                              ........++.+.+|+.+||+.||.+|||++|+|+||||++..|
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                    01122456789999999999999999999999999999988554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-55  Score=360.25  Aligned_cols=254  Identities=26%  Similarity=0.489  Sum_probs=219.4

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +.-.++|++.+.||+|+||+||+|.++ ++..||||++.....    ..+.+.+|++++++++||||+++++++.+ +..
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~   82 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI   82 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence            445679999999999999999999986 677899999865432    24678999999999999999999998754 567


Q ss_pred             EEEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           93 YVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ++||||+++++|.+++..  ..++++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++......
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            999999999999997743  346999999999999999999999999999999999999999999999999999876544


Q ss_pred             Cc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617          171 HF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD  246 (294)
Q Consensus       171 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  246 (294)
                      ..  .....+++.|+|||++.+..+ +.++||||||+++|+|+| |.+|+......+....+..+. ...|..++.++.+
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  241 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ  241 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHH
Confidence            32  234567889999999987777 789999999999999999 566667777777777776654 5667789999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhc--CCcccc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQ--HPWFQA  273 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~--h~~~~~  273 (294)
                      ++.+||+.||++|||+.++++  |+||.+
T Consensus       242 li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         242 LMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            999999999999999999999  888865

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-55  Score=361.72  Aligned_cols=252  Identities=26%  Similarity=0.441  Sum_probs=216.4

Q ss_pred             cCCccccc-ccccCceEEEEEEEccC--CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           17 PNYKLGKT-LGIGSFGKVKIAEHALT--GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        17 ~~y~~~~~-lg~g~~~~vy~~~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      ++|.+.+. ||+|+||+||+|.++.+  +..||||++....  .....+.+.+|++++++++||||+++++++.. +.++
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            56778775 99999999999987543  4479999986442  33456789999999999999999999999875 5689


Q ss_pred             EEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      +||||+++++|.+++.. +..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus        85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            99999999999998754 46799999999999999999999999999999999999999999999999999987644322


Q ss_pred             ----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617          173 ----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD  246 (294)
Q Consensus       173 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  246 (294)
                          .....+++.|+|||++.+..+ +.++||||||+++|||+| |..||.+....+....+..+. .+.|..+++++.+
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  243 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA  243 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence                223457889999999987777 789999999999999998 999999888888887777654 5777899999999


Q ss_pred             HHHHhcccCCCCCCCHhHH---hcCCccc
Q 022617          247 LIPRMLIVDPMKRITIPEI---RQHPWFQ  272 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~i---l~h~~~~  272 (294)
                      +|.+||+.||++|||+.+|   |+|+|+.
T Consensus       244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999888   6688774

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-55  Score=359.42  Aligned_cols=258  Identities=24%  Similarity=0.394  Sum_probs=210.2

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   93 (294)
                      .-.++|++.+.||+|+||+||+|+.+   ..||||++...... ....+.+.+|++++++++||||+++++++. ...++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~   79 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA   79 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence            34678999999999999999999853   46999998765433 345678999999999999999999999875 45689


Q ss_pred             EEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617           94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-  171 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-  171 (294)
                      ++|||+++++|.+++... .++++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++....... 
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999999754 569999999999999999999999999999999999999999999999999997654322 


Q ss_pred             --ccccccCCCcccCCccccCCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhCCC-----ccCCCCCC
Q 022617          172 --FLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGI-----YTLPSHLS  241 (294)
Q Consensus       172 --~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~-----~~~~~~~~  241 (294)
                        ......+|+.|+|||++.+..  ..+.++||||||+++|+|+||+.||.+.+... ....+..+.     ...+..++
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  239 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP  239 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence              233456899999999986432  23789999999999999999999998765443 333333332     23456789


Q ss_pred             hhHHHHHHHhcccCCCCCCCHhHHhcC-CcccccCC
Q 022617          242 PGARDLIPRMLIVDPMKRITIPEIRQH-PWFQAHLP  276 (294)
Q Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~il~h-~~~~~~~~  276 (294)
                      +++.+++.+||+.||++|||+.+|+++ ..+++.+|
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            999999999999999999999999987 34444443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=370.42  Aligned_cols=257  Identities=29%  Similarity=0.375  Sum_probs=213.9

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc------CC
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------PS   90 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~   90 (294)
                      -+|+..++||+|+||+||+|++..+++.||||++.....       ...+|++++++++|+||+++++++..      ..
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            379999999999999999999999999999999865432       23479999999999999999999853      23


Q ss_pred             eEEEEEeccCCCChHHHH---HHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeeccccc
Q 022617           91 DIYVVMEYVKSGELFDYI---VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNI  166 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l---~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~  166 (294)
                      +++++|||++++.+..+.   .....+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++..
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            589999999764333332   2345799999999999999999999999999999999999999765 899999999988


Q ss_pred             ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--------------
Q 022617          167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--------------  232 (294)
Q Consensus       167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--------------  232 (294)
                      ...........+++.|+|||.+.+....+.++||||+||++|+|++|+.||...+..+....+...              
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             ccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            776666677789999999999876655589999999999999999999999887766655444210              


Q ss_pred             ---Cc------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcccc
Q 022617          233 ---IY------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLA  280 (294)
Q Consensus       233 ---~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~  280 (294)
                         ..            ......++++.+|+.+||..||++|||+.|+|+||||++..+....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~  315 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK  315 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCC
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCC
Confidence               00            0123578899999999999999999999999999999986554433

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-54  Score=367.22  Aligned_cols=256  Identities=30%  Similarity=0.492  Sum_probs=213.7

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS---   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   90 (294)
                      .+.++|++++.||+|+||+||+|.++.+|+.||||++..... .....+.+.+|+++++.++||||++++++|...+   
T Consensus        15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence            368899999999999999999999999999999999975433 3455678899999999999999999999997654   


Q ss_pred             ---eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617           91 ---DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM  167 (294)
Q Consensus        91 ---~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~  167 (294)
                         .+|++|||+ +.+|..++ ++..+++..++.++.|++.||.|||+.||+|+||||+|||++.++.++++|||.+...
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence               579999999 55777766 4568999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------
Q 022617          168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------  233 (294)
Q Consensus       168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  233 (294)
                      ...  .....+++.|+|||++.+....+.++||||+|+++|+|++|+.||.+.+.......+....              
T Consensus       172 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         172 DSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             CSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             CCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            443  3456789999999999876666899999999999999999999998877655443322110              


Q ss_pred             -----------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 -----------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                       .......++++.+||.+||..||++|||+.|+|+||||++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                             11234678899999999999999999999999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-54  Score=354.63  Aligned_cols=260  Identities=27%  Similarity=0.462  Sum_probs=217.0

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      +.-.++|++.+.||+|+||+||+|.++.+ ..||||++......    .+.+.+|+.++++++|+||+++++++. .+..
T Consensus        13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~   86 (285)
T d1fmka3          13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI   86 (285)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCe
Confidence            34468999999999999999999998744 57999998655432    367899999999999999999999985 4668


Q ss_pred             EEEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           93 YVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      ++||||+.+|+|..++..  .+.+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            999999999999988854  457999999999999999999999999999999999999999999999999999766433


Q ss_pred             C--ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHH
Q 022617          171 H--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARD  246 (294)
Q Consensus       171 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  246 (294)
                      .  ......+++.|+|||++....+ +.++||||||+++|+|++| .+|+......+....+..+ ..+.+..+++++.+
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  245 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  245 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             CceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence            3  2234567899999999987777 7899999999999999995 5556667777777776654 45778899999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhc--CCcccccCCccc
Q 022617          247 LIPRMLIVDPMKRITIPEIRQ--HPWFQAHLPRYL  279 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~--h~~~~~~~~~~~  279 (294)
                      ++.+||+.||++|||+.+|++  ++||+...|.+.
T Consensus       246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~  280 (285)
T d1fmka3         246 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ  280 (285)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred             HHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCC
Confidence            999999999999999999998  888887665443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-54  Score=364.96  Aligned_cols=260  Identities=31%  Similarity=0.521  Sum_probs=212.8

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS---   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   90 (294)
                      .+.++|++++.||+|+||+||+|.++.+|+.||||++....  .....+.+.+|+.++++++|||++++++++..+.   
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence            46689999999999999999999999999999999986543  3345678899999999999999999999986543   


Q ss_pred             --eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           91 --DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        91 --~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                        .++++ +++.+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        83 ~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          83 MKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             CCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence              34555 55568899999964 579999999999999999999999999999999999999999999999999987653


Q ss_pred             CCC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------
Q 022617          169 DGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----------  233 (294)
Q Consensus       169 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  233 (294)
                      ...    ......+++.|+|||++......+.++||||+|+++|+|++|+.||...+..+.........           
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            322    23455689999999998766555889999999999999999999998776544433321100           


Q ss_pred             --------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617          234 --------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  277 (294)
Q Consensus       234 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~  277 (294)
                                          .......++++.+|+.+||+.||.+|||+.|+|+||||+.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                                01124567899999999999999999999999999999976543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=365.81  Aligned_cols=249  Identities=27%  Similarity=0.447  Sum_probs=209.6

Q ss_pred             cCCcccccccccCceEEEEEEEccCCc-----eEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS   90 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   90 (294)
                      ++|++.+.||+|+||+||+|.+...++     .|++|.+....  .......+.+|+.+++++ +||||+++++++.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            689999999999999999999875543     58899875432  223456788999999988 8999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHh-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 022617           91 DIYVVMEYVKSGELFDYIVEK-----------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN  147 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~-----------------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~n  147 (294)
                      .+++||||+++|+|.+++.++                       ..+++..++.++.|++.||+|||+.||+||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            999999999999999999654                       248899999999999999999999999999999999


Q ss_pred             eEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022617          148 LLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP  223 (294)
Q Consensus       148 ili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~  223 (294)
                      |+++.++.+||+|||++........   .....+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999976544332   234457899999999987777 789999999999999998 89999876554


Q ss_pred             HHHH-HHhCC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          224 NLFK-KIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       224 ~~~~-~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .... .+..+ ..+.|..+++++.+||.+||+.||++|||++||++|
T Consensus       274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4433 33333 356677899999999999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-54  Score=361.28  Aligned_cols=259  Identities=32%  Similarity=0.567  Sum_probs=222.3

Q ss_pred             ccCCcccccccccCceEEEEEEE---ccCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMH-PHIIRLYEVIETPS   90 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~---~~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~   90 (294)
                      .++|++++.||+|+||+||+|.+   +.+|+.||||++...... +....+.+.+|++++++++| |||+++++++....
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            37899999999999999999987   346889999998765432 22335678899999999977 89999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-  169 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-  169 (294)
                      ..++++||+.+++|.+++...+.+++..++.++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||++..... 
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~  182 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  182 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999876533 


Q ss_pred             -CCccccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhCCCccCCCCCChh
Q 022617          170 -GHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPSHLSPG  243 (294)
Q Consensus       170 -~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~  243 (294)
                       ........+++.|++||.+.+.. ..+.++|||||||++|+|++|+.||.....    ..+.+.......+.+..++++
T Consensus       183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  262 (322)
T d1vzoa_         183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL  262 (322)
T ss_dssp             GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHH
Confidence             23345567899999999987544 346789999999999999999999976543    334444445566777889999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHhHHhcCCccccc
Q 022617          244 ARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  274 (294)
Q Consensus       244 l~~li~~~l~~~p~~Rp-----s~~~il~h~~~~~~  274 (294)
                      +.+|+.+||.+||.+||     |++|+++||||++.
T Consensus       263 ~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            99999999999999999     48999999999873

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.7e-53  Score=359.35  Aligned_cols=250  Identities=27%  Similarity=0.474  Sum_probs=210.8

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEc--CCeE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET--PSDI   92 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~   92 (294)
                      .++|++++.||+|+||+||+|+++.+++.||+|++....      .+.+.+|+++++++. ||||+++++++..  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            468999999999999999999999999999999986432      457889999999996 9999999999974  4569


Q ss_pred             EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~~~~~~  171 (294)
                      +++|||+.+++|..+.   +.+++..++.++.||+.||.|||+.||+|+||||+|||++.++ .++|+|||++.......
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999999987763   5699999999999999999999999999999999999998655 69999999998877666


Q ss_pred             ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhC-------------CC----
Q 022617          172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKG-------------GI----  233 (294)
Q Consensus       172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~-------------~~----  233 (294)
                      ......+|+.|+|||.+.+....+.++||||+|+++|+|++|..||..... .+....+..             ..    
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            666778899999999988776558999999999999999999999975432 211111100             00    


Q ss_pred             --------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          234 --------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       234 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                          ......+++++.+||++||..||.+|||++|+|+||||++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                                00112467889999999999999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=347.96  Aligned_cols=249  Identities=26%  Similarity=0.399  Sum_probs=207.6

Q ss_pred             ccCCcccccccccCceEEEEEEEccCC----ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTG----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD   91 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   91 (294)
                      .++|++.++||+|+||+||+|.++.++    ..||||++....  .......+.+|++++++++||||+++++++...+.
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            467999999999999999999987554    369999986443  22345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617           92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG  170 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~  170 (294)
                      .++++||+.++++.+.+... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999999988654 57999999999999999999999999999999999999999999999999999765433


Q ss_pred             C----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhCCC-ccCCCCCChhH
Q 022617          171 H----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA  244 (294)
Q Consensus       171 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  244 (294)
                      .    ......+|+.|+|||++.+..+ +.++||||||+++|+|+++ .+|+.........+.+..+. .+.+..++.++
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  242 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI  242 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred             CccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence            2    1223457889999999988777 7899999999999999995 55566677777777776554 56677899999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+++.+||+.||++|||+.+|++
T Consensus       243 ~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         243 YQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=364.53  Aligned_cols=256  Identities=31%  Similarity=0.520  Sum_probs=204.7

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc------
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------   88 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------   88 (294)
                      +.++|++++.||+|+||+||+|.++.+|+.||||++..... +......+.+|+.++++++||||+++++++..      
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            55789999999999999999999999999999999976543 34456788999999999999999999999853      


Q ss_pred             CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                      .+.+|++|||+.+ ++.+.+  ...+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++++|||.+....
T Consensus        94 ~~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          94 FQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             CCEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            4689999999976 555544  4678999999999999999999999999999999999999999999999999988777


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------  233 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------  233 (294)
                      .........+|+.|+|||++.+..+ +.++||||+||++++|++|+.||.+.+.......+....               
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence            6666667778999999999988766 789999999999999999999998776555544332100               


Q ss_pred             -------ccC--------------C------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617          234 -------YTL--------------P------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  275 (294)
Q Consensus       234 -------~~~--------------~------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~  275 (294)
                             ...              +      ...++++.+||++||..||++|||++|+|+||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                   000              0      11355788999999999999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=348.25  Aligned_cols=251  Identities=28%  Similarity=0.453  Sum_probs=207.5

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCC---ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS   90 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   90 (294)
                      .-.++|++.+.||+|+||+||+|.+..++   ..|++|.+...  ......+.+.+|+.++++++||||+++++++. .+
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            34579999999999999999999986543   45778877433  23445678999999999999999999999985 56


Q ss_pred             eEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617           91 DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD  169 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~  169 (294)
                      .+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            78999999999999998765 45699999999999999999999999999999999999999999999999999986543


Q ss_pred             CC--ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617          170 GH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR  245 (294)
Q Consensus       170 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  245 (294)
                      ..  ......+|+.|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+..+. .+.+..+++++.
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  239 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  239 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CcceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            32  2234457889999999987777 789999999999999998 899999988888888777655 577889999999


Q ss_pred             HHHHHhcccCCCCCCCHhHHhcC
Q 022617          246 DLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       246 ~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      ++|.+||+.||++|||+.+|+++
T Consensus       240 ~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         240 SLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=362.37  Aligned_cols=257  Identities=28%  Similarity=0.436  Sum_probs=213.7

Q ss_pred             ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----   89 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   89 (294)
                      .+.++|++++.||+|+||+||+|.+..+|+.||||++..... +....+.+.+|++++++++|+|++++++++...    
T Consensus        15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            346899999999999999999999999999999999975543 334457788999999999999999999998543    


Q ss_pred             -CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617           90 -SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR  168 (294)
Q Consensus        90 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~  168 (294)
                       ...+++++++.|++|.+++. .+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++++|||.+....
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             cCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence             23455667777889999884 4579999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-------------
Q 022617          169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-------------  235 (294)
Q Consensus       169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------  235 (294)
                      .  ......+++.|+|||...+....+.++||||||+++|+|++|+.||.+.+.......+......             
T Consensus       173 ~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         173 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             G--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             c--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence            3  2345567889999999887776689999999999999999999999887766655544321110             


Q ss_pred             ------------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617          236 ------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  274 (294)
Q Consensus       236 ------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~  274 (294)
                                        ....+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                              113578899999999999999999999999999999874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=354.34  Aligned_cols=249  Identities=25%  Similarity=0.427  Sum_probs=214.4

Q ss_pred             cCCcccccccccCceEEEEEEEccCCce--EEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY   93 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~--~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   93 (294)
                      ++|++.+.||+|+||+||+|.++.++..  |+||.+..  .......+.+.+|+++++++ +||||+++++++...+.++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC--C------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECc--ccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            6899999999999999999999888875  55666532  22334466799999999998 6999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617           94 VVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK  157 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~  157 (294)
                      +||||+++|+|.+++.++                ..+++..++.++.|++.|+.|||+.|++||||||+|||++.++.+|
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence            999999999999999643                4689999999999999999999999999999999999999999999


Q ss_pred             EeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhCC-Ccc
Q 022617          158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGG-IYT  235 (294)
Q Consensus       158 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~-~~~  235 (294)
                      |+|||++.............++..|+|||.+.+..+ +.++||||||+++|+|++| ..||...+..++...+..+ ..+
T Consensus       168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~  246 (309)
T d1fvra_         168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE  246 (309)
T ss_dssp             ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred             EccccccccccccccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            999999976655444455568999999999988877 7899999999999999995 5678888988888887654 466


Q ss_pred             CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .+..+++++.+||.+||+.||++|||+.+|+++
T Consensus       247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            778899999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-53  Score=346.41  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=205.7

Q ss_pred             ccCCcccccccccCceEEEEEEEccC-C--ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALT-G--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~-~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      .++|++.+.||+|+||+||+|.+... +  ..||||++...........+.+.+|++++++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            46799999999999999999986533 2  3689999877666666667889999999999999999999999965 567


Q ss_pred             EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      ++|+||++++++.+.+.. .+++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            899999999999987765 4579999999999999999999999999999999999999999999999999998764433


Q ss_pred             c----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC--ccCCCCCChhH
Q 022617          172 F----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGA  244 (294)
Q Consensus       172 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  244 (294)
                      .    .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+..+....+....  .+.+..+++++
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l  244 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI  244 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred             CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence            2    223346779999999988776 789999999999999998 899999999988888876554  45567899999


Q ss_pred             HHHHHHhcccCCCCCCCHhHHhc
Q 022617          245 RDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       245 ~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+++.+||..||++|||+.+|++
T Consensus       245 ~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         245 YNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=352.60  Aligned_cols=249  Identities=25%  Similarity=0.402  Sum_probs=209.9

Q ss_pred             cCCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI   92 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   92 (294)
                      .+|++.+.||+|+||+||+|.+..+|+    .||+|.+....  .....+.+.+|+.++++++||||+++++++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            469999999999999999999987776    47777765332  223467899999999999999999999999865 56


Q ss_pred             EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617           93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH  171 (294)
Q Consensus        93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~  171 (294)
                      +++++++.+++|.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            7788888889999888664 579999999999999999999999999999999999999999999999999998764432


Q ss_pred             c---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617          172 F---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD  246 (294)
Q Consensus       172 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  246 (294)
                      .   .....+|+.|+|||++.+..+ +.++||||||+++|+|+| |..||.+.+..++...+..+. .+.+..++.++.+
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~  244 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM  244 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred             ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            2   223457899999999988777 799999999999999998 899999988888877776554 5677889999999


Q ss_pred             HHHHhcccCCCCCCCHhHHhcCC
Q 022617          247 LIPRMLIVDPMKRITIPEIRQHP  269 (294)
Q Consensus       247 li~~~l~~~p~~Rps~~~il~h~  269 (294)
                      ++.+||..||.+|||+.+|++|.
T Consensus       245 li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         245 IMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhCCCChhhCcCHHHHHHHH
Confidence            99999999999999999999873

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=342.33  Aligned_cols=243  Identities=26%  Similarity=0.500  Sum_probs=206.4

Q ss_pred             ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-CCeEEE
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-PSDIYV   94 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l   94 (294)
                      .++|++.+.||+|+||.||+|.+  .++.||||++..+.     ..+.+.+|++++++++||||+++++++.+ .+.+++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence            46799999999999999999998  46789999985432     34678999999999999999999999854 466899


Q ss_pred             EEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617           95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF  172 (294)
Q Consensus        95 v~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  172 (294)
                      ||||+++++|.+++.++  ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++++|||++......  
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence            99999999999999654  35899999999999999999999999999999999999999999999999999865433  


Q ss_pred             cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHH
Q 022617          173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPR  250 (294)
Q Consensus       173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~  250 (294)
                      .....++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||...+..+....+..+ ..+.+..+++++.++|.+
T Consensus       157 ~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  235 (262)
T d1byga_         157 QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN  235 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred             CccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence            234457889999999987776 899999999999999998 79999998888888888764 467778899999999999


Q ss_pred             hcccCCCCCCCHhHHhcC
Q 022617          251 MLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       251 ~l~~~p~~Rps~~~il~h  268 (294)
                      ||..||.+|||+.+++++
T Consensus       236 cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         236 CWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HcccCHhHCcCHHHHHHH
Confidence            999999999999999873

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-52  Score=346.51  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=217.8

Q ss_pred             cccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE   87 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   87 (294)
                      +.-.++|++.+.||+|+||+||+|+++     .+++.||||++....  .....+.+.+|++++++++|||++++++++.
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            344578999999999999999999875     345789999986543  2345678999999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKG------------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDL  143 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~------------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di  143 (294)
                      ..+..++++|++.+++|.+++....                        .+++..++.++.|++.||+|||+.+++||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl  166 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  166 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence            9999999999999999999996432                        3889999999999999999999999999999


Q ss_pred             CCCCeEecCCCcEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC-CCCCCC
Q 022617          144 KPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDD  219 (294)
Q Consensus       144 ~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~  219 (294)
                      ||+||+++.++.+||+|||++.......   ......+++.|+|||.+.+..+ +.++||||||+++|+|++| ..||..
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCCCCCCC
Confidence            9999999999999999999987653332   2234567889999999988777 7899999999999999997 568988


Q ss_pred             CCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          220 ENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       220 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .+..+....+..+. .+.+..+++++.+++.+||+.+|++|||+.||++
T Consensus       246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88888888887766 4567789999999999999999999999999976

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=341.16  Aligned_cols=253  Identities=27%  Similarity=0.470  Sum_probs=214.4

Q ss_pred             ccccccCCcccccccccCceEEEEEEEccCC-------ceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEE
Q 022617           12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTG-------HKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLY   83 (294)
Q Consensus        12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~   83 (294)
                      .+.-.++|.+.+.||+|+||.||+|++..++       ..||||++....  .......+.+|...+.++ +||||++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            3445689999999999999999999876543       369999986543  223457788888888888 799999999


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 022617           84 EVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN  147 (294)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~n  147 (294)
                      +++.+++..++||||+.+|+|.+++...                ..+++..++.++.|++.||.|||+.+|+||||||+|
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            9999999999999999999999999644                248999999999999999999999999999999999


Q ss_pred             eEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022617          148 LLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP  223 (294)
Q Consensus       148 ili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~  223 (294)
                      ||++.++.+||+|||.+........   .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||......
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            9999999999999999986654332   234567889999999988777 799999999999999998 79999998888


Q ss_pred             HHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          224 NLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       224 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      .....+..+. .+.+..+++++.++|.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            8888776554 5677889999999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-51  Score=340.46  Aligned_cols=257  Identities=23%  Similarity=0.376  Sum_probs=222.3

Q ss_pred             ccccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET   88 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   88 (294)
                      .-.++|.+.+.||+|+||+||+|.++.     +++.||||++....  .......+.+|++++++++||||+++++++..
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            345899999999999999999998753     35789999986443  33445678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEE
Q 022617           89 PSDIYVVMEYVKSGELFDYIVEK----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI  158 (294)
Q Consensus        89 ~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l  158 (294)
                      ++..++|+||+.+|+|.+++...          ..++...+..++.|++.||.|||+.+|+||||||+|||++.++++||
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence            99999999999999999998643          24788999999999999999999999999999999999999999999


Q ss_pred             eeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhCCC-
Q 022617          159 ADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGI-  233 (294)
Q Consensus       159 ~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~-  233 (294)
                      +|||++........   .....+++.|+|||.+.+..+ +.++||||||+++|+|++| ..||.+.+.......+.++. 
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            99999976543322   233457899999999988777 6899999999999999997 68898888888888776655 


Q ss_pred             ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc------CCcccc
Q 022617          234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ------HPWFQA  273 (294)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~------h~~~~~  273 (294)
                      .+.+..++..+.++|.+||+.+|++|||+.+|++      +|+|++
T Consensus       254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            5567789999999999999999999999999988      777765

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-51  Score=340.32  Aligned_cols=250  Identities=28%  Similarity=0.430  Sum_probs=199.1

Q ss_pred             ccCCcccccccccCceEEEEEEEccC-----CceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC
Q 022617           16 LPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP   89 (294)
Q Consensus        16 ~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   89 (294)
                      .++|++.+.||+|+||.||+|.+...     ++.||+|++.....  ......+.+|...+.++ +|+||+.+++++...
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            47899999999999999999997543     46799999864432  23346677777777766 588999999987654


Q ss_pred             -CeEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC
Q 022617           90 -SDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS  152 (294)
Q Consensus        90 -~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~  152 (294)
                       ..++++|||+++++|.+++...                ..+++..++.++.|++.||.|||+.||+||||||+|||++.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence             5689999999999999999753                24889999999999999999999999999999999999999


Q ss_pred             CCcEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC-CCCCCCCCH-HHHHH
Q 022617          153 KWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENI-PNLFK  227 (294)
Q Consensus       153 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~-~~~~~  227 (294)
                      ++.+||+|||++.......   ......+|+.|+|||++.+..+ +.++||||+|+++|+|++| ..||..... .....
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~  248 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  248 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999997654332   2234568999999999988776 7999999999999999986 567876543 33444


Q ss_pred             HHhC-CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617          228 KIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       228 ~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h  268 (294)
                      .+.. .....+..+++++.+++.+||+.||++|||+.|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4443 3466778899999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-50  Score=334.47  Aligned_cols=251  Identities=29%  Similarity=0.450  Sum_probs=211.8

Q ss_pred             ccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEE
Q 022617           14 MFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIE   87 (294)
Q Consensus        14 ~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   87 (294)
                      .-.++|++.+.||+|+||.||+|.+.     .+++.||||++....  .......+.+|+.+++++ +||||+++++++.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            34579999999999999999999863     456789999987543  234456788999999999 6999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeE
Q 022617           88 TPSDIYVVMEYVKSGELFDYIVEKG------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLL  149 (294)
Q Consensus        88 ~~~~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nil  149 (294)
                      .++..+++|||+++++|.+++.+..                  .+++..+..++.|++.|++|||++|++|+||||+||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence            9999999999999999999997543                  5899999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022617          150 LDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNL  225 (294)
Q Consensus       150 i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~  225 (294)
                      ++.++.++++|||.+........   .....+++.|+|||.+.+..+ +.++||||||+++|+|+| |.+||........
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999986654322   233467899999999987766 789999999999999998 6666766554443


Q ss_pred             H-HHHhC-CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          226 F-KKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       226 ~-~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                      . +.+.. .....+...+.++.+||.+||+.||++|||+++|++
T Consensus       257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            3 33333 334556778999999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=332.11  Aligned_cols=244  Identities=25%  Similarity=0.360  Sum_probs=201.7

Q ss_pred             cccccccCceEEEEEEEccCC---ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-CCeEEEEEe
Q 022617           22 GKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-PSDIYVVME   97 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   97 (294)
                      .++||+|+||+||+|.+..++   ..||||.+...  .+....+.+.+|++++++++||||+++++++.. ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            578999999999999986543   35889988532  344557889999999999999999999999765 568999999


Q ss_pred             ccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc----
Q 022617           98 YVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----  172 (294)
Q Consensus        98 ~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~----  172 (294)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||++........    
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence            99999999998754 4577888999999999999999999999999999999999999999999999976543322    


Q ss_pred             -cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhCC-CccCCCCCChhHHHHHH
Q 022617          173 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGG-IYTLPSHLSPGARDLIP  249 (294)
Q Consensus       173 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  249 (294)
                       .....+++.|+|||.+....+ +.++||||||+++|+|++|..||.. .+..+....+..+ ....|..++.++.++|.
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence             223457889999999987776 7999999999999999997777654 3444444555444 45567789999999999


Q ss_pred             HhcccCCCCCCCHhHHhcC
Q 022617          250 RMLIVDPMKRITIPEIRQH  268 (294)
Q Consensus       250 ~~l~~~p~~Rps~~~il~h  268 (294)
                      +||..||++|||+.|+++|
T Consensus       269 ~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999997

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-49  Score=328.73  Aligned_cols=254  Identities=23%  Similarity=0.272  Sum_probs=204.0

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCCeEE
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSDIY   93 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~   93 (294)
                      ++++|++.+.||+|+||.||+|.+..+++.||||++......     ..+..|+++++.++|++ ++.+..++...+..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            457899999999999999999999999999999997654322     35788999999998765 566667778888999


Q ss_pred             EEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEEEeeecccccccC
Q 022617           94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRD  169 (294)
Q Consensus        94 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~l~dfg~~~~~~~  169 (294)
                      ++||++++ +|.+.+.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.   +..++|+|||++.....
T Consensus        80 ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            99999955 66666544 567999999999999999999999999999999999999864   45799999999987654


Q ss_pred             CCc--------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hCCC
Q 022617          170 GHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------KGGI  233 (294)
Q Consensus       170 ~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~--------~~~~  233 (294)
                      ...        .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+        ....
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            321        234468999999999988777 79999999999999999999999765543322221        1112


Q ss_pred             ccCCCCCChhHHHHHHHhcccCCCCCCCHhH---HhcCCcccccC
Q 022617          234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPE---IRQHPWFQAHL  275 (294)
Q Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~---il~h~~~~~~~  275 (294)
                      ......+|+++.+++..||+.+|++||++.+   +|+|+|.+..+
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~  282 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  282 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence            2334678999999999999999999999874   57787765543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.9e-48  Score=322.73  Aligned_cols=248  Identities=20%  Similarity=0.283  Sum_probs=207.3

Q ss_pred             cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCCe
Q 022617           13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIETPSD   91 (294)
Q Consensus        13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~   91 (294)
                      +++.++|++.+.||+|+||+||+|++..+++.||||++.....     ...+.+|++.++.+.| +|++.+++++.....
T Consensus         1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   75 (293)
T d1csna_           1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   75 (293)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence            4678999999999999999999999999999999998754321     2456788899999986 899999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-----CCcEEEeeecccc
Q 022617           92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-----KWNVKIADFGLSN  165 (294)
Q Consensus        92 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-----~~~~~l~dfg~~~  165 (294)
                      .+++||++ +++|.+++... ..++...+..++.|++.+|.+||+.||+||||||+||+++.     ++.++|+|||++.
T Consensus        76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99999999 56999998765 46999999999999999999999999999999999999964     5689999999998


Q ss_pred             cccCCC--------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhCC--
Q 022617          166 IMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI---PNLFKKIKGG--  232 (294)
Q Consensus       166 ~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~~~--  232 (294)
                      ......        ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+...   ......+...  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~  233 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  233 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence            654321        2234468999999999988776 7999999999999999999999975432   2222222211  


Q ss_pred             ---CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          233 ---IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       233 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                         ...+...+|+++.+++..|++.+|++||+++.+.+
T Consensus       234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence               12234678999999999999999999999887765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=320.58  Aligned_cols=246  Identities=21%  Similarity=0.324  Sum_probs=191.4

Q ss_pred             cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----
Q 022617           15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS----   90 (294)
Q Consensus        15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   90 (294)
                      +..+|.+.+.||+|+||+||+|++  +|+.||||++..+..    .......|+..+.+++||||+++++++...+    
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            356899999999999999999986  678999999854421    1122334555556789999999999997654    


Q ss_pred             eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCCeEecCCCcEEEeeec
Q 022617           91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR--------NMVVHRDLKPENLLLDSKWNVKIADFG  162 (294)
Q Consensus        91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~--------~~i~h~di~p~nili~~~~~~~l~dfg  162 (294)
                      .+|+||||+++++|.+++++ ..+++..++.++.|++.+|+|||.        .||+|+||||+|||++.++.+||+|||
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            58999999999999999965 468999999999999999999996        589999999999999999999999999


Q ss_pred             ccccccCCC-----ccccccCCCcccCCccccCCcc-----CCCchhHHHHHHHHHHHHhCCCCCCCC------------
Q 022617          163 LSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLY-----AGPEVDVWSCGVILYALLCGTLPFDDE------------  220 (294)
Q Consensus       163 ~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~g~~p~~~~------------  220 (294)
                      ++.......     ......+|+.|+|||.+.+...     .+.++||||||+++|+|+||..||...            
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            998765433     2234568999999999865431     156799999999999999998776321            


Q ss_pred             ---CHHHHHHHHhCCCc--cCCCC-----CChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617          221 ---NIPNLFKKIKGGIY--TLPSH-----LSPGARDLIPRMLIVDPMKRITIPEIRQ  267 (294)
Q Consensus       221 ---~~~~~~~~~~~~~~--~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~il~  267 (294)
                         ..............  .++..     ....+.+++.+||+.||.+|||+.||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence               12233333332221  22221     2245889999999999999999999977

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.1e-46  Score=319.38  Aligned_cols=254  Identities=29%  Similarity=0.503  Sum_probs=194.2

Q ss_pred             cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-----------CCceeEEEEE
Q 022617           17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-----------HPHIIRLYEV   85 (294)
Q Consensus        17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~   85 (294)
                      ++|++++.||+|+||+||+|++..+|+.||||++....    ...+.+.+|+++++.+.           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            57999999999999999999999999999999986543    23456778888887775           5789999888


Q ss_pred             EEc--CCeEEEEEeccCCCChHHH-HH--HhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCC-----
Q 022617           86 IET--PSDIYVVMEYVKSGELFDY-IV--EKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKW-----  154 (294)
Q Consensus        86 ~~~--~~~~~lv~e~~~~~sL~~~-l~--~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~-----  154 (294)
                      +..  ....+++++++........ ..  ....+++..++.++.|++.||.|||+ .||+|+||||+|||++.++     
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            753  4566666666544433332 22  23568999999999999999999997 8999999999999998654     


Q ss_pred             -cEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH
Q 022617          155 -NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN------LFK  227 (294)
Q Consensus       155 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~------~~~  227 (294)
                       .++++|||.+.....  ......+++.|+|||++....+ +.++||||+|+++++|++|+.||.......      ...
T Consensus       169 ~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             ceeeEeeccccccccc--ccccccccccccChhhccccCC-CccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence             399999999876543  3345678999999999988777 789999999999999999999997543211      110


Q ss_pred             HH---hC------------------------C---------------CccCCCCCChhHHHHHHHhcccCCCCCCCHhHH
Q 022617          228 KI---KG------------------------G---------------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEI  265 (294)
Q Consensus       228 ~~---~~------------------------~---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i  265 (294)
                      ..   ..                        .               ........++++.+|+.+||..||.+|||+.|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            00   00                        0               000112235678999999999999999999999


Q ss_pred             hcCCcccccCCc
Q 022617          266 RQHPWFQAHLPR  277 (294)
Q Consensus       266 l~h~~~~~~~~~  277 (294)
                      |+||||++..+.
T Consensus       326 L~Hp~f~~~~~~  337 (362)
T d1q8ya_         326 VNHPWLKDTLGM  337 (362)
T ss_dssp             HTCGGGTTCTTC
T ss_pred             hcCcccCCCCCc
Confidence            999999976444

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.3e-25  Score=173.99  Aligned_cols=168  Identities=18%  Similarity=0.216  Sum_probs=121.3

Q ss_pred             CcccccccccCceEEEEEEEccCCceEEEEEeeccccc---------------chHHHHHHHHHHHHHHhCCCCceeEEE
Q 022617           19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---------------NMEMEEKVRREIKILRLFMHPHIIRLY   83 (294)
Q Consensus        19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~~~   83 (294)
                      +.+.+.||+|+||+||+|.+. +|+.||||++......               ..........|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            467899999999999999985 7889999987532211               011234456788899999999999887


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617           84 EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL  163 (294)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~  163 (294)
                      ++.    ..+++||++++..+.+       ++......++.|++.++.+||+.||+|+||||+|||++++ .++|+|||.
T Consensus        81 ~~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             Eec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            653    2368999998755432       4556677899999999999999999999999999999976 589999999


Q ss_pred             cccccCCCccccccCCCcccCC--c---cccCCccCCCchhHHHHHHHH
Q 022617          164 SNIMRDGHFLKTSCGSPNYAAP--E---VISGKLYAGPEVDVWSCGVIL  207 (294)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~aP--E---~~~~~~~~~~~~Di~slG~ll  207 (294)
                      +.....+...       .|...  +   .+....+ +.++|+||+.--+
T Consensus       149 a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y-~~~~d~~s~~~~~  189 (191)
T d1zara2         149 SVEVGEEGWR-------EILERDVRNIITYFSRTY-RTEKDINSAIDRI  189 (191)
T ss_dssp             CEETTSTTHH-------HHHHHHHHHHHHHHHHHH-CCCCCHHHHHHHH
T ss_pred             cccCCCCCcH-------HHHHHHHHHHHHHHcCCC-CCcccHHHHHHHH
Confidence            8765433221       11110  0   0112334 6788999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.89  E-value=2.7e-09  Score=85.08  Aligned_cols=149  Identities=13%  Similarity=0.096  Sum_probs=100.4

Q ss_pred             CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEE
Q 022617            8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVI   86 (294)
Q Consensus         8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~   86 (294)
                      .+.++..+...|++++..+.++.+.||++.  .++..+++|.........   ...+.+|...++.+. +--+++++++.
T Consensus         5 ~~~~l~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~   79 (263)
T d1j7la_           5 ISPELKKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFE   79 (263)
T ss_dssp             SCHHHHHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred             cCHHHHHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEE
Confidence            344556677889988887766678999886  356678899875443222   335677888877665 33467888888


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------
Q 022617           87 ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-------------------------------  135 (294)
Q Consensus        87 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-------------------------------  135 (294)
                      ..++..+++|++++|.++.+.....     .....++.++...++.||+                               
T Consensus        80 ~~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          80 RHDGWSNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             EETTEEEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             ecCCceEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence            8889999999999987775543111     1112223333333333332                               


Q ss_pred             ----------------------------CCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617          136 ----------------------------NMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus       136 ----------------------------~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                                                  ..++|+|+.|.||++++++...|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                        1278999999999999876667999997753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.47  E-value=1.6e-07  Score=74.09  Aligned_cols=81  Identities=11%  Similarity=0.048  Sum_probs=54.6

Q ss_pred             CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--ceeEEEEEEEcCCeEEEE
Q 022617           18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEVIETPSDIYVV   95 (294)
Q Consensus        18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~lv   95 (294)
                      .++....-+..+.+.||++... .+..+++|......      ...+..|...++.+...  .+++++.+..+++..+++
T Consensus        12 g~~~~~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          12 GYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCceEEcCCcccCCeEEEEEeC-CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence            4455444333334688998864 56678899864432      23466777777766432  367788888888899999


Q ss_pred             EeccCCCChH
Q 022617           96 MEYVKSGELF  105 (294)
Q Consensus        96 ~e~~~~~sL~  105 (294)
                      |++++|.++.
T Consensus        85 ~~~i~G~~~~   94 (255)
T d1nd4a_          85 LGEVPGQDLL   94 (255)
T ss_dssp             EECCSSEETT
T ss_pred             EEeeeccccc
Confidence            9999886653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.37  E-value=7.1e-07  Score=74.99  Aligned_cols=81  Identities=16%  Similarity=0.033  Sum_probs=49.9

Q ss_pred             cccccccCceEEEEEEEccCCceEEEEEeeccccc-c---hHHHHHHHHHHHHHHhCC-C--CceeEEEEEEEcCCeEEE
Q 022617           22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-N---MEMEEKVRREIKILRLFM-H--PHIIRLYEVIETPSDIYV   94 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-~---~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~~~~~l   94 (294)
                      .+.||.|....||++.+..+++.+++|.-...-.. .   .........|.+.++.+. +  ..+++++.+.  +...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            45689999999999998777889999975431110 0   112344566777777653 2  3466666553  445578


Q ss_pred             EEeccCCCCh
Q 022617           95 VMEYVKSGEL  104 (294)
Q Consensus        95 v~e~~~~~sL  104 (294)
                      +||++.+.++
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.49  E-value=0.00019  Score=58.08  Aligned_cols=130  Identities=10%  Similarity=0.120  Sum_probs=75.0

Q ss_pred             ceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCcee--EEE-----EEEEcCCeEEEEEeccCCC
Q 022617           30 FGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII--RLY-----EVIETPSDIYVVMEYVKSG  102 (294)
Q Consensus        30 ~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~--~~~-----~~~~~~~~~~lv~e~~~~~  102 (294)
                      ...||++... +|..|++|+......    ....+..|...+..|...++.  ...     ..+......+.++++..|.
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            4589999874 788899999765432    245677788877766533221  111     1123456788889988764


Q ss_pred             ChH-----HHHH---------H---h------CC-------------------CCHH---HHHHHHHHHHHHHHHHH---
Q 022617          103 ELF-----DYIV---------E---K------GR-------------------LQED---EARNFFQQIISGVEYCH---  134 (294)
Q Consensus       103 sL~-----~~l~---------~---~------~~-------------------l~~~---~~~~~~~ql~~~l~~Lh---  134 (294)
                      .+.     .+..         .   .      ..                   ++..   .....+.++...+..+-   
T Consensus       110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~  189 (325)
T d1zyla1         110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED  189 (325)
T ss_dssp             ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred             CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence            321     1110         0   0      00                   1111   12223333333333321   


Q ss_pred             -hCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617          135 -RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus       135 -~~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                       ..+++|+|+++.||+++++  ..++||+.+..
T Consensus       190 ~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         190 FTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             SCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence             1358999999999999754  45899998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.41  E-value=6.3e-05  Score=60.71  Aligned_cols=31  Identities=23%  Similarity=0.231  Sum_probs=27.4

Q ss_pred             CCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617          136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNI  166 (294)
Q Consensus       136 ~~i~h~di~p~nili~~~~~~~l~dfg~~~~  166 (294)
                      .|++|+|+.+.||+++.+...-++||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            5799999999999999887778999998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.34  E-value=0.00038  Score=57.92  Aligned_cols=74  Identities=19%  Similarity=0.210  Sum_probs=49.1

Q ss_pred             cccccccCceEEEEEEEcc-------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCCeEE
Q 022617           22 GKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSDIY   93 (294)
Q Consensus        22 ~~~lg~g~~~~vy~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~   93 (294)
                      ++.|+.|-.-.+|++....       ..+.+++++.-..  .   ......+|..+++.+...+ .+++++++.  +  +
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E---TESHLVAESVIFTLLSERHLGPKLYGIFS--G--G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C---CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--c---hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--c
Confidence            4678888889999998653       2356888876421  1   1234567888888776434 457777763  2  5


Q ss_pred             EEEeccCCCCh
Q 022617           94 VVMEYVKSGEL  104 (294)
Q Consensus        94 lv~e~~~~~sL  104 (294)
                      +|++|+.|.++
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            78999987544